<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38864162</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>332</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Prolonged vs Intermittent Infusions of &#x3b2;-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>638</StartPage><EndPage>648</EndPage><MedlinePgn>638-648</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2024.9803</ELocationID><Abstract><AbstractText Label="IMPORTANCE">There is uncertainty about whether prolonged infusions of &#x3b2;-lactam antibiotics improve clinically important outcomes in critically ill adults with sepsis or septic shock.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether prolonged &#x3b2;-lactam antibiotic infusions are associated with a reduced risk of death in critically ill adults with sepsis or septic shock compared with intermittent infusions.</AbstractText><AbstractText Label="DATA SOURCES">The primary search was conducted with MEDLINE (via PubMed), CINAHL, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov from inception to May 2, 2024.</AbstractText><AbstractText Label="STUDY SELECTION">Randomized clinical trials comparing prolonged (continuous or extended) and intermittent infusions of &#x3b2;-lactam antibiotics in critically ill adults with sepsis or septic shock.</AbstractText><AbstractText Label="DATA EXTRACTION AND SYNTHESIS">Data extraction and risk of bias were assessed independently by 2 reviewers. Certainty of evidence was evaluated with the Grading of Recommendations Assessment, Development and Evaluation approach. A bayesian framework was used as the primary analysis approach and a frequentist framework as the secondary approach.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was all-cause 90-day mortality. Secondary outcomes included intensive care unit (ICU) mortality and clinical cure.</AbstractText><AbstractText Label="RESULTS">From 18 eligible randomized clinical trials that included 9108 critically ill adults with sepsis or septic shock (median age, 54 years; IQR, 48-57; 5961 men [65%]), 17 trials (9014 participants) contributed data to the primary outcome. The pooled estimated risk ratio for all-cause 90-day mortality for prolonged infusions of &#x3b2;-lactam antibiotics compared with intermittent infusions was 0.86 (95% credible interval, 0.72-0.98; I2&#x2009;=&#x2009;21.5%; high certainty), with a 99.1% posterior probability that prolonged infusions were associated with lower 90-day mortality. Prolonged infusion of &#x3b2;-lactam antibiotics was associated with a reduced risk of intensive care unit mortality (risk ratio, 0.84; 95% credible interval, 0.70-0.97; high certainty) and an increase in clinical cure (risk ratio, 1.16; 95% credible interval, 1.07-1.31; moderate certainty).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adults in the intensive care unit who had sepsis or septic shock, the use of prolonged &#x3b2;-lactam antibiotic infusions was associated with a reduced risk of 90-day mortality compared with intermittent infusions. The current evidence presents a high degree of certainty for clinicians to consider prolonged infusions as a standard of care in the management of sepsis and septic shock.</AbstractText><AbstractText Label="TRIAL REGISTRATION">PROSPERO Identifier: CRD42023399434.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdul-Aziz</LastName><ForeName>Mohd H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammond</LastName><ForeName>Naomi E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brett</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotta</LastName><ForeName>Menino O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Waele</LastName><ForeName>Jan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devaux</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Statistics Division, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Tanna</LastName><ForeName>Gian Luca</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Statistics Division, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Business Economics, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, Manno, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dulhunty</LastName><ForeName>Joel M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Redcliffe Hospital, Redcliffe, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkady</LastName><ForeName>Hatem</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Westmead Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eriksson</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UQ Library, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasan</LastName><ForeName>M Shahnaz</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Ayesha Bibi</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Division of Critical Care, University of Witwatersrand, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jamieson Trauma Institute, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Emergency and Pain Medicine, N&#xee;mes University Hospital, University of Montpellier, N&#xee;mes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoqiu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Statistics Division, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population Health, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myburgh</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, St George Hospital, Kogarah, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novy</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Service d'anesth&#xe9;sie-r&#xe9;animation et m&#xe9;dicine p&#xe9;ri-op&#xe9;ratoire Brabois adulte, CHRU de Nancy, Nancy, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; de Lorraine, SIMPA, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>Shahed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Critical Care, University of Witwatersrand, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajbhandari</LastName><ForeName>Dorrilyn</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roger</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>D&#xe9;partement d'anesth&#xe9;sie et r&#xe9;animation, douleur et m&#xe9;decine d'urgence, CHU Car&#xe9;meau, N&#xee;mes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UR UM 103IMAGINE, Facult&#xe9; de M&#xe9;decine, Montpellier Universit&#xe9;, N&#xee;mes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sj&#xf6;vall</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Intensive and Perioperative Care, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaghi</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Experimental Medicine, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Jason A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Emergency and Pain Medicine, N&#xee;mes University Hospital, University of Montpellier, N&#xee;mes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000097902">beta Lactam Antibiotics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2024 Aug 27;332(8):623-625. doi: 10.1001/jama.2024.10168.</RefSource><PMID Version="1">38864160</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097902" MajorTopicYN="Y">beta Lactam Antibiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Abdul-Aziz reported being a writing committee member of the BLISS trial, which is included in this meta-analysis. Dr Hammond reported being a writing committee member of the BLING III trial, which is included in this meta-analysis. Dr Brett reported a consultancy payment to his university from GSK for work on an analysis of sotrovimab in COVID-19 infection outside the submitted work; and reported being a writing committee member of the BLING III trial. Dr De Waele reported receiving honoraria from Pfizer, Menarini, and MSD paid to his institution; and consultancy fees from Viatris paid to his institution outside the submitted work. Dr Dulhunty reported being a writing committee member of the BLING I, BLING II, and BLING III trials, which are included in this meta-analysis. Dr Khan reported receiving grants from the Critical Care Society of Southern Africa outside the submitted work. Dr Liu reported being a writing committee member of the BLING III trial. Dr Monti reported receiving honoraria and consultancy fees from AOP Health, InfectoFos, and Pfizer outside the submitted work; and being a writing committee member of the MERCY trial, which is included in this meta-analysis. Dr Myburgh reported being a writing committee member of the BLING I, BLING II, and BLING III trials. Dr Omar reported receiving honoraria from Jafron Biomedical Co for lectures given on the removal of toxins using hemoadsorption therapy in poisoned patients outside the submitted work. Ms Rajbhandari reported being a writing committee member of the BLING III trial. Dr Roger reported receiving honoraria and consultancy fees from Shionogi, bioM&#xe9;rieux, Advanz Pharma, MSD, AOP Orphan, Viatris, Pfizer, and Fresenius outside the submitted work. Dr Zangrillo reported being a writing committee member of the MERCY trial. Dr Roberts reported receiving consulting fees from Qpex Biopharma, Gilead, Advanz Pharma, Pfizer, Sandoz, MSD, Cipla, and bioM&#xe9;rieux; receiving grants from Qpex Biopharma, the British Society for Antimicrobial Chemotherapy, Pfizer, and bioM&#xe9;rieux outside the submitted work; and being a writing committee member of the BLING I, BLING II, and BLING III trials. Dr Roberts reported being a writing committee member of the BLING I, BLING II, and BLING III trials and of the BLISS trial. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38864162</ArticleId><ArticleId IdType="pmc">PMC11170459</ArticleId><ArticleId IdType="doi">10.1001/jama.2024.9803</ArticleId><ArticleId IdType="pii">2819970</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roberts JA, Paul SK, Akova M, et al. ; DALI Study . DALI: defining antibiotic levels in intensive care unit patients: are current &#x3b2;-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis. 2014;58(8):1072-1083. doi: 10.1093/cid/ciu027</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu027</ArticleId><ArticleId IdType="pubmed">24429437</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Joynt GM, Lee A, et al. ; SMARRT Study Collaborators and the ANZICS Clinical Trials Group . The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the Multinational Sampling Antibiotics in Renal Replacement Therapy study. Clin Infect Dis. 2021;72(8):1369-1378. doi: 10.1093/cid/ciaa224</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa224</ArticleId><ArticleId IdType="pubmed">32150603</ArticleId></ArticleIdList></Reference><Reference><Citation>Shekar K, Abdul-Aziz MH, Cheng V, et al. Antimicrobial exposures in critically ill patients receiving extracorporeal membrane oxygenation. Am J Respir Crit Care Med. 2023;207(6):704-720. doi: 10.1164/rccm.202207-1393OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202207-1393OC</ArticleId><ArticleId IdType="pubmed">36215036</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1-10. doi: 10.1086/516284</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/516284</ArticleId><ArticleId IdType="pubmed">9455502</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouton JW, Vinks AA. Is continuous infusion of beta-lactam antibiotics worthwhile? efficacy and pharmacokinetic considerations. J Antimicrob Chemother. 1996;38(1):5-15. doi: 10.1093/jac/38.1.5</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/38.1.5</ArticleId><ArticleId IdType="pubmed">8858451</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Aziz MH, Portunato F, Roberts JA. Prolonged infusion of beta-lactam antibiotics for gram-negative infections: rationale and evidence base. Curr Opin Infect Dis. 2020;33(6):501-510. doi: 10.1097/QCO.0000000000000681</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000681</ArticleId><ArticleId IdType="pubmed">33009140</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaese S, Heffernan A, Liu D, et al. Prolonged versus intermittent infusion of &#x3b2;-lactam antibiotics: a systematic review and meta-regression of bacterial killing in preclinical infection models. Clin Pharmacokinet. 2020;59(10):1237-1250. doi: 10.1007/s40262-020-00919-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40262-020-00919-6</ArticleId><ArticleId IdType="pubmed">32710435</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Webb S, Paterson D, Ho KM, Lipman J. A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med. 2009;37(6):2071-2078. doi: 10.1097/CCM.0b013e3181a0054d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181a0054d</ArticleId><ArticleId IdType="pubmed">19384201</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Abdul-Aziz MH, Davis JS, et al. Continuous versus intermittent &#x3b2;-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med. 2016;194(6):681-691. doi: 10.1164/rccm.201601-0024OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201601-0024OC</ArticleId><ArticleId IdType="pubmed">26974879</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardakas KZ, Voulgaris GL, Maliaros A, Samonis G, Falagas ME. Prolonged versus short-term intravenous infusion of antipseudomonal &#x3b2;-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis. 2018;18(1):108-120. doi: 10.1016/S1473-3099(17)30615-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(17)30615-1</ArticleId><ArticleId IdType="pubmed">29102324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo Y, Ota K, Imura H, Hara N, Shime N. Prolonged versus intermittent &#x3b2;-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials. J Intensive Care. 2020;8:77. doi: 10.1186/s40560-020-00490-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-020-00490-z</ArticleId><ArticleId IdType="pmc">PMC7541232</ArticleId><ArticleId IdType="pubmed">33042550</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Long Y, Wu G, et al. Prolonged vs intermittent intravenous infusion of &#x3b2;-lactam antibiotics for patients with sepsis: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. Ann Intensive Care. 2023;13(1):121. doi: 10.1186/s13613-023-01222-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-023-01222-w</ArticleId><ArticleId IdType="pmc">PMC10697919</ArticleId><ArticleId IdType="pubmed">38051467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokhandwala A, Patel P, Isaak AK, et al. Comparison of the effectiveness of prolonged infusion and intermittent infusion of meropenem in patients with sepsis: a meta-analysis. Cureus. 2023;15(10):e46990. doi: 10.7759/cureus.46990</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.46990</ArticleId><ArticleId IdType="pmc">PMC10640903</ArticleId><ArticleId IdType="pubmed">38022273</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti G, Bradic N, Marzaroli M, et al. ; MERCY Investigators . Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial. JAMA. 2023;330(2):141-151. doi: 10.1001/jama.2023.10598</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.10598</ArticleId><ArticleId IdType="pmc">PMC10276329</ArticleId><ArticleId IdType="pubmed">37326473</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulhunty JM, Brett SJ, De Waele J, et al. Continuous vs intermittent &#x3b2;-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. JAMA. Published online June 12, 2024. doi: 10.1001/jama.2024.9779</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2024.9779</ArticleId><ArticleId IdType="pmc">PMC11170452</ArticleId><ArticleId IdType="pubmed">38864155</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Aziz MH, Hammond NE, Brett SJ, et al. Prolonged infusion versus intermittent infusion dosing of beta-lactam antibiotics in critically ill patients with sepsis: a protocol for a systematic review and meta-analysis of randomised controlled trials. Preprint posted online May 16, 2023. medRxiv 2023.05.15.23289889. doi: 10.1101/2023.05.15.23289889</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.05.15.23289889</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71):n71. doi: 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi: 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17-60. doi: 10.1007/s00134-007-0934-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0934-2</ArticleId><ArticleId IdType="pmc">PMC2249616</ArticleId><ArticleId IdType="pubmed">18058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, et al. ; International Sepsis Definitions Conference . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530-538. doi: 10.1007/s00134-003-1662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1662-x</ArticleId><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, et al. ; The ACCP/SCCM Consensus Conference Committee; American College of Chest Physicians/Society of Critical Care Medicine . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644-1655. doi: 10.1378/chest.101.6.1644</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.101.6.1644</ArticleId><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AB, Omar S. Continuous vs intermittent beta-lactam dosing in critically ill patients with sepsis: a randomized controlled trial. World Health Organization. Accessed May 2, 2024. https://trialsearch.who.int/Trial2.aspx?TrialID=PACTR202009811610400</Citation></Reference><Reference><Citation>Schandelmaier S, Briel M, Varadhan R, et al. Development of the Instrument to Assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses. CMAJ. 2020;192(32):E901-E906. doi: 10.1503/cmaj.200077</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.200077</ArticleId><ArticleId IdType="pmc">PMC7829020</ArticleId><ArticleId IdType="pubmed">32778601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner RM, Jackson D, Wei Y, Thompson SG, Higgins JP. Predictive distributions for between-study heterogeneity and simple methods for their application in bayesian meta-analysis. Stat Med. 2015;34(6):984-998. doi: 10.1002/sim.6381</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6381</ArticleId><ArticleId IdType="pmc">PMC4383649</ArticleId><ArticleId IdType="pubmed">25475839</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J, Ioannidis JPA, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14:25. doi: 10.1186/1471-2288-14-25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-25</ArticleId><ArticleId IdType="pmc">PMC4015721</ArticleId><ArticleId IdType="pubmed">24548571</ArticleId></ArticleIdList></Reference><Reference><Citation>Doleman B, Freeman SC, Lund JN, Williams JP, Sutton AJ. Funnel plots may show asymmetry in the absence of publication bias with continuous outcomes dependent on baseline risk: presentation of a new publication bias test. Res Synth Methods. 2020;11(4):522-534. doi: 10.1002/jrsm.1414</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1414</ArticleId><ArticleId IdType="pubmed">32362052</ArticleId></ArticleIdList></Reference><Reference><Citation>Doleman B, Mathiesen O, Jakobsen JC, et al. Methodologies for systematic reviews with meta-analysis of randomised clinical trials in pain, anaesthesia, and perioperative medicine. Br J Anaesth. 2021;126(4):903-911. doi: 10.1016/j.bja.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.01.004</ArticleId><ArticleId IdType="pubmed">33558052</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ver C. Bayesian random-effects meta-analysis using the bayesmeta R package. J Stat Softw. 2020;93(6):1-51. doi: 10.18637/jss.v093.i06</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v093.i06</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1-48. doi: 10.18637/jss.v036.i03</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v036.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. ; GRADE Working Group . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. doi: 10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines, 1: introduction&#x2014;GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394. doi: 10.1016/j.jclinepi.2010.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.026</ArticleId><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Georges B, Conil JM, Cougot P, et al. Cefepime in critically ill patients: continuous infusion vs an intermittent dosing regimen. Int J Clin Pharmacol Ther. 2005;43(8):360-369. doi: 10.5414/CPP43360</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CPP43360</ArticleId><ArticleId IdType="pubmed">16119511</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafati MR, Rouini MR, Mojtahedzadeh M, et al. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients. Int J Antimicrob Agents. 2006;28(2):122-127. doi: 10.1016/j.ijantimicag.2006.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2006.02.020</ArticleId><ArticleId IdType="pubmed">16815689</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Boots R, Rickard CM, et al. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? a randomized controlled pilot study. J Antimicrob Chemother. 2007;59(2):285-291. doi: 10.1093/jac/dkl478</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkl478</ArticleId><ArticleId IdType="pubmed">17135183</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Kirkpatrick CM, Roberts MS, Robertson TA, Dalley AJ, Lipman J. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother. 2009;64(1):142-150. doi: 10.1093/jac/dkp139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkp139</ArticleId><ArticleId IdType="pubmed">19398460</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. Int J Antimicrob Agents. 2010;35(2):156-163. doi: 10.1016/j.ijantimicag.2009.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2009.10.008</ArticleId><ArticleId IdType="pubmed">20018492</ArticleId></ArticleIdList></Reference><Reference><Citation>Chytra I, Stepan M, Benes J, et al. Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial. Crit Care. 2012;16(3):R113. doi: 10.1186/cc11405</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11405</ArticleId><ArticleId IdType="pmc">PMC3580671</ArticleId><ArticleId IdType="pubmed">22742765</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulhunty JM, Roberts JA, Davis JS, et al. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis. 2013;56(2):236-244. doi: 10.1093/cid/cis856</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis856</ArticleId><ArticleId IdType="pubmed">23074313</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulhunty JM, Roberts JA, Davis JS, et al. ; BLING II Investigators for the ANZICS Clinical Trials Group . A multicenter randomized trial of continuous versus intermittent &#x3b2;-lactam infusion in severe sepsis. Am J Respir Crit Care Med. 2015;192(11):1298-1305. doi: 10.1164/rccm.201505-0857OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201505-0857OC</ArticleId><ArticleId IdType="pubmed">26200166</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal JA, Mat-Nor MB, Mohamad-Nor FS, et al. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration. Int J Antimicrob Agents. 2015;45(1):41-45. doi: 10.1016/j.ijantimicag.2014.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2014.09.009</ArticleId><ArticleId IdType="pubmed">25455853</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal JA, Roberts DM, Udy AA, et al. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration. Int J Antimicrob Agents. 2015;46(1):39-44. doi: 10.1016/j.ijantimicag.2015.02.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2015.02.014</ArticleId><ArticleId IdType="pubmed">25881872</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Aziz MH, Sulaiman H, Mat-Nor MB, et al. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Intensive Care Med. 2016;42(10):1535-1545. doi: 10.1007/s00134-015-4188-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4188-0</ArticleId><ArticleId IdType="pubmed">26754759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao HY, Gu J, Lyu J, et al. Pharmacokinetic and pharmacodynamic efficacies of continuous versus intermittent administration of meropenem in patients with severe sepsis and septic shock: a prospective randomized pilot study. Chin Med J (Engl). 2017;130(10):1139-1145. doi: 10.4103/0366-6999.205859</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.205859</ArticleId><ArticleId IdType="pmc">PMC5443018</ArticleId><ArticleId IdType="pubmed">28485312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirjalili M, Zand F, Karimzadeh I, et al. The clinical and paraclinical effectiveness of four-hour infusion vs half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: an assessor-blinded randomized clinical trial. J Crit Care. 2023;73:154170. doi: 10.1016/j.jcrc.2022.154170</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2022.154170</ArticleId><ArticleId IdType="pubmed">36272277</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad SI, Aglan BM, Shaboob EA, Abdelghany HH. Continuous versus intermittent use of meropenem in septic critically ill patients: a randomized controlled trail. Benha Med J. 2024;41(2):38-48. doi: 10.21608/bmfj.2023.247556.1949</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/bmfj.2023.247556.1949</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez-Moreno CA, Nocua-B&#xe1;ez LC, Ortiz G, et al. Efficacy of continuous vs intermittent administration of cefepime in adult ICU patients with gram-negative bacilli bacteremia: a randomized double-blind clinical study. Antibiotics (Basel). 2024;13(3):229. doi: 10.3390/antibiotics13030229</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics13030229</ArticleId><ArticleId IdType="pmc">PMC10967321</ArticleId><ArticleId IdType="pubmed">38534664</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Aziz MH, Dulhunty JM, Bellomo R, Lipman J, Roberts JA. Continuous beta-lactam infusion in critically ill patients: the clinical evidence. Ann Intensive Care. 2012;2(1):37. doi: 10.1186/2110-5820-2-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-2-37</ArticleId><ArticleId IdType="pmc">PMC3475088</ArticleId><ArticleId IdType="pubmed">22898246</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31965266</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy.</ArticleTitle><Pagination><StartPage>383</StartPage><EndPage>400</EndPage><MedlinePgn>383-400</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-019-05872-y</ELocationID><Abstract><AbstractText Label="PURPOSE">Early clinical recognition of sepsis can be challenging. With the advancement of machine learning, promising real-time models to predict sepsis have emerged. We assessed their performance by carrying out a systematic review and meta-analysis.</AbstractText><AbstractText Label="METHODS">A systematic search was performed in PubMed, Embase.com and Scopus. Studies targeting sepsis, severe sepsis or septic shock in any hospital setting were eligible for inclusion. The index test was any supervised machine learning model for real-time prediction of these conditions. Quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, with a tailored Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) checklist to evaluate risk of bias. Models with a reported area under the curve of the receiver operating characteristic (AUROC) metric were meta-analyzed to identify strongest contributors to model performance.</AbstractText><AbstractText Label="RESULTS">After screening, a total of 28 papers were eligible for synthesis, from which 130 models were extracted. The majority of papers were developed in the intensive care unit (ICU, n&#x2009;=&#x2009;15; 54%), followed by hospital wards (n&#x2009;=&#x2009;7; 25%), the emergency department (ED, n&#x2009;=&#x2009;4; 14%) and all of these settings (n&#x2009;=&#x2009;2; 7%). For the prediction of sepsis, diagnostic test accuracy assessed by the AUROC ranged from 0.68-0.99 in the ICU, to 0.96-0.98 in-hospital and 0.87 to 0.97 in the ED. Varying sepsis definitions limit pooling of the performance across studies. Only three papers clinically implemented models with mixed results. In the multivariate analysis, temperature, lab values, and model type contributed most to model performance.</AbstractText><AbstractText Label="CONCLUSION">This systematic review and meta-analysis show that on retrospective data, individual machine learning models can accurately predict sepsis onset ahead of time. Although they present alternatives to traditional scoring systems, between-study heterogeneity limits the assessment of pooled results. Systematic reporting and clinical implementation studies are needed to bridge the gap between bytes and bedside.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fleuren</LastName><ForeName>Lucas M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-4056-1692</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&amp;II), Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands. l.fleuren@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Intelligence Group, Department of Computer Science, VU Amsterdam, Amsterdam, The Netherlands. l.fleuren@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klausch</LastName><ForeName>Thomas L T</ForeName><Initials>TLT</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zwager</LastName><ForeName>Charlotte L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&amp;II), Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoonmade</LastName><ForeName>Linda J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Medical Library, Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Tingjie</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&amp;II), Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roggeveen</LastName><ForeName>Luca F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&amp;II), Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Intelligence Group, Department of Computer Science, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swart</LastName><ForeName>Eleonora L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girbes</LastName><ForeName>Armand R J</ForeName><Initials>ARJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&amp;II), Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thoral</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&amp;II), Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ercole</LastName><ForeName>Ari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Anaesthesia, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Science Section, European Society of Intensive Care Medicine, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoogendoorn</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Computational Intelligence Group, Department of Computer Science, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elbers</LastName><ForeName>Paul W G</ForeName><Initials>PWG</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&amp;II), Amsterdam UMC, location VUmc, VU Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Science Section, European Society of Intensive Care Medicine, Brussels, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003955" MajorTopicYN="N">Diagnostic Tests, Routine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Prediction</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>The author(s) declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31965266</ArticleId><ArticleId IdType="pmc">PMC7067741</ArticleId><ArticleId IdType="doi">10.1007/s00134-019-05872-y</ArticleId><ArticleId IdType="pii">10.1007/s00134-019-05872-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259&#x2013;272. doi: 10.1164/rccm.201504-0781OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201504-0781OC</ArticleId><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009&#x2013;2014. JAMA. 2017;318:1241. doi: 10.1001/jama.2017.13836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13836</ArticleId><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvaro-Meca A, Jim&#xe9;nez-Sousa MA, Micheloud D, et al. Epidemiological trends of sepsis in the twenty-first century (2000&#x2013;2013): an analysis of incidence, mortality, and associated costs in Spain. Popul Health Metr. 2018;16:4. doi: 10.1186/s12963-018-0160-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12963-018-0160-x</ArticleId><ArticleId IdType="pmc">PMC5809921</ArticleId><ArticleId IdType="pubmed">29433513</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376:2235&#x2013;2244. doi: 10.1056/NEJMoa1703058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1703058</ArticleId><ArticleId IdType="pmc">PMC5538258</ArticleId><ArticleId IdType="pubmed">28528569</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu VX, Fielding-Singh V, Greene JD, et al. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med. 2017;196:856&#x2013;863. doi: 10.1164/rccm.201609-1848OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201609-1848OC</ArticleId><ArticleId IdType="pmc">PMC5649973</ArticleId><ArticleId IdType="pubmed">28345952</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304&#x2013;377. doi: 10.1007/s00134-017-4683-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4683-6</ArticleId><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour. Crit Care Med. 2014;42:1749&#x2013;1755. doi: 10.1097/CCM.0000000000000330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000330</ArticleId><ArticleId IdType="pubmed">24717459</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589&#x2013;1596. doi: 10.1097/01.CCM.0000217961.75225.E9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000217961.75225.E9</ArticleId><ArticleId IdType="pubmed">16625125</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J-L. The clinical challenge of sepsis identification and monitoring. PLoS Med. 2016;13:e1002022. doi: 10.1371/journal.pmed.1002022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002022</ArticleId><ArticleId IdType="pmc">PMC4871479</ArticleId><ArticleId IdType="pubmed">27187803</ArticleId></ArticleIdList></Reference><Reference><Citation>Talisa VB, Yende S, Seymour CW, Angus DC. Arguing for adaptive clinical trials in sepsis. Front Immunol. 2018;9:1502. doi: 10.3389/fimmu.2018.01502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01502</ArticleId><ArticleId IdType="pmc">PMC6031704</ArticleId><ArticleId IdType="pubmed">30002660</ArticleId></ArticleIdList></Reference><Reference><Citation>de Grooth H-J, Postema J, Loer SA, et al. Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates. Intensive Care Med. 2018;44:311&#x2013;322. doi: 10.1007/s00134-018-5134-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5134-8</ArticleId><ArticleId IdType="pmc">PMC5861172</ArticleId><ArticleId IdType="pubmed">29546535</ArticleId></ArticleIdList></Reference><Reference><Citation>Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;319:1317. doi: 10.1001/jama.2017.18391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.18391</ArticleId><ArticleId IdType="pubmed">29532063</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu K-H, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018;2:719&#x2013;731. doi: 10.1038/s41551-018-0305-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-018-0305-z</ArticleId><ArticleId IdType="pubmed">31015651</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoshnevisan F, Ivy J, Capan M, et al (2018) Recent temporal pattern mining for septic shock early prediction. In: 2018 IEEE international conference on healthcare informatics (ICHI). IEEE, pp 229&#x2013;240</Citation></Reference><Reference><Citation>Nachimuthu SK, Haug PJ. Early detection of sepsis in the emergency department using dynamic Bayesian networks. AMIA Annu Symp Proc AMIA Symp. 2012;2012:653&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540576</ArticleId><ArticleId IdType="pubmed">23304338</ArticleId></ArticleIdList></Reference><Reference><Citation>Thottakkara P, Ozrazgat-Baslanti T, Hupf BB, et al. Application of machine learning techniques to high-dimensional clinical data to forecast postoperative complications. PLoS One. 2016;11:e0155705. doi: 10.1371/journal.pone.0155705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155705</ArticleId><ArticleId IdType="pmc">PMC4883761</ArticleId><ArticleId IdType="pubmed">27232332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Ozrazgat-Baslanti T, Ebadi A, et al. My surgery risk. Ann Surg. 2019;269:652&#x2013;662. doi: 10.1097/SLA.0000000000002706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002706</ArticleId><ArticleId IdType="pmc">PMC6110979</ArticleId><ArticleId IdType="pubmed">29489489</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes MDF, Moher D, Thombs BD, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies the PRISMA-DTA statement. JAMA J Am Med Assoc. 2018;319:388&#x2013;396. doi: 10.1001/jama.2017.19163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.19163</ArticleId><ArticleId IdType="pubmed">29362800</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315:801. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Supervised learning&#x2014;scikit-learn 0.21.2 documentation (2019) https://scikit-learn.org/stable/supervised_learning.html. Accessed 8 Jul 2019</Citation></Reference><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G OA (2013) GRADE handbook for grading quality of evidence and strength of recommendations</Citation></Reference><Reference><Citation>Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529. doi: 10.7326/0003-4819-155-8-201110180-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00009</ArticleId><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Critical Appraisal Tools|Joanna Briggs Institute (2019) https://joannabriggs.org/critical_appraisal_tools. Accessed 8 Jul 2019</Citation></Reference><Reference><Citation>Kwong MT, Colopy GW, Weber AM, et al. The efficacy and effectiveness of machine learning for weaning in mechanically ventilated patients at the intensive care unit: a systematic review. Bio-Design Manuf. 2019;2:31&#x2013;40. doi: 10.1007/s42242-018-0030-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42242-018-0030-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Jay M, Hoffman JL, et al. Multicentre validation of a sepsis prediction algorithm using only vital sign data in the emergency department, general ward and ICU. BMJ Open. 2018;8:1&#x2013;11. doi: 10.1136/bmjopen-2017-017833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017833</ArticleId><ArticleId IdType="pmc">PMC5829820</ArticleId><ArticleId IdType="pubmed">29374661</ArticleId></ArticleIdList></Reference><Reference><Citation>Core Team R. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2019.</Citation></Reference><Reference><Citation>Barton C, Chettipally U, Zhou Y, et al. Evaluation of a machine learning algorithm for up to 48-hour advance prediction of sepsis using six vital signs. Comput Biol Med. 2019;109:79&#x2013;84. doi: 10.1016/j.compbiomed.2019.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2019.04.027</ArticleId><ArticleId IdType="pmc">PMC6556419</ArticleId><ArticleId IdType="pubmed">31035074</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SM, Jones J, Kuttler KG, et al. Prospective evaluation of an automated method to identify patients with severe sepsis or septic shock in the emergency department. BMC Emerg Med. 2016;16:1&#x2013;7. doi: 10.1186/s12873-016-0095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12873-016-0095-0</ArticleId><ArticleId IdType="pmc">PMC4994262</ArticleId><ArticleId IdType="pubmed">27549755</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel SW, Rosini JM, Shannon W, et al. Early prediction of septic shock in hospitalized patients. J Hosp Med. 2010;5:19&#x2013;25. doi: 10.1002/jhm.530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jhm.530</ArticleId><ArticleId IdType="pubmed">20063402</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini HM, Ginestra JC, Chivers C, et al. A machine learning algorithm to predict severe sepsis and septic shock. Crit Care Med. 2019 doi: 10.1097/ccm.0000000000003891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0000000000003891</ArticleId><ArticleId IdType="pmc">PMC8635476</ArticleId><ArticleId IdType="pubmed">31389839</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy A, Das R. Reducing patient mortality, length of stay and readmissions through machine learning-based sepsis prediction in the emergency department, intensive care unit and hospital floor units. BMJ open Qual. 2017;6:e000158. doi: 10.1136/bmjoq-2017-000158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjoq-2017-000158</ArticleId><ArticleId IdType="pmc">PMC5699136</ArticleId><ArticleId IdType="pubmed">29450295</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimabukuro DW, Barton CW, Feldman MD, et al. Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial. BMJ Open Respir Res. 2017;4:e000234. doi: 10.1136/bmjresp-2017-000234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2017-000234</ArticleId><ArticleId IdType="pmc">PMC5687546</ArticleId><ArticleId IdType="pubmed">29435343</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvert J, Desautels T, Chettipally U, et al. High-performance detection and early prediction of septic shock for alcohol-use disorder patients. Ann Med Surg. 2016;8:50&#x2013;55. doi: 10.1016/j.amsu.2016.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2016.04.023</ArticleId><ArticleId IdType="pmc">PMC4960347</ArticleId><ArticleId IdType="pubmed">27489621</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis. JAMA. 2016;315:762. doi: 10.1001/jama.2016.0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0288</ArticleId><ArticleId IdType="pmc">PMC5433435</ArticleId><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Horng S, Sontag DA, Halpern Y, et al. Creating an automated trigger for sepsis clinical decision support at emergency department triage using machine learning. PLoS One. 2017;12:e0174708. doi: 10.1371/journal.pone.0174708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174708</ArticleId><ArticleId IdType="pmc">PMC5383046</ArticleId><ArticleId IdType="pubmed">28384212</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss TJ, Lake DE, Calland JF, et al. Signatures of subacute potentially catastrophic illness in the ICU: model development and validation. Crit Care Med. 2016;44:1639&#x2013;1648. doi: 10.1097/CCM.0000000000001738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001738</ArticleId><ArticleId IdType="pmc">PMC4987175</ArticleId><ArticleId IdType="pubmed">27452809</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller MH, Alhazzani W, Shankar-Hari M. Focus on sepsis. Intensive Care Med. 2019;45:1459&#x2013;1461. doi: 10.1007/s00134-019-05680-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05680-4</ArticleId><ArticleId IdType="pubmed">31267195</ArticleId></ArticleIdList></Reference><Reference><Citation>Makam AN, Nguyen OK, Auerbach AD. Diagnostic accuracy and effectiveness of automated electronic sepsis alert systems: a systematic review. J Hosp Med. 2015;10:396&#x2013;402. doi: 10.1002/jhm.2347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jhm.2347</ArticleId><ArticleId IdType="pmc">PMC4477829</ArticleId><ArticleId IdType="pubmed">25758641</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsolamy S, Al Salamah M, Al Thagafi M, et al. Diagnostic accuracy of a screening electronic alert tool for severe sepsis and septic shock in the emergency department. BMC Med Inform Decis Mak. 2014;14:105. doi: 10.1186/s12911-014-0105-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-014-0105-7</ArticleId><ArticleId IdType="pmc">PMC4261595</ArticleId><ArticleId IdType="pubmed">25476738</ArticleId></ArticleIdList></Reference><Reference><Citation>Serafim R, Gomes JA, Salluh J, P&#xf3;voa P. A comparison of the quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest. 2018;153:646&#x2013;655. doi: 10.1016/J.CHEST.2017.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CHEST.2017.12.015</ArticleId><ArticleId IdType="pubmed">29289687</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiensch R, Poeran J, Saunders-Hao P, et al. Impact of an electronic sepsis initiative on antibiotic use and health care facility&#x2013;onset clostridium difficile infection rates. Am J Infect Control. 2017;45:1091&#x2013;1100. doi: 10.1016/j.ajic.2017.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2017.04.005</ArticleId><ArticleId IdType="pubmed">28602274</ArticleId></ArticleIdList></Reference><Reference><Citation>Parlato M, Philippart F, Rouquette A, et al. Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study. Intensive Care Med. 2018;44:1061&#x2013;1070. doi: 10.1007/s00134-018-5228-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5228-3</ArticleId><ArticleId IdType="pubmed">29959455</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari Manu, Datta Deepankar, Wilson Julie, Assi Valentina, Stephen Jacqueline, Weir Christopher J., Rennie Jillian, Antonelli Jean, Bateman Anthony, Felton Jennifer M., Warner Noel, Judge Kevin, Keenan Jim, Wang Alice, Burpee Tony, Brown Alun K., Lewis Sion M., Mare Tracey, Roy Alistair I., Wright John, Hulme Gillian, Dimmick Ian, Gray Alasdair, Rossi Adriano G., Simpson A. John, Conway Morris Andrew, Walsh Timothy S. Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study. Intensive Care Medicine. 2018;44(11):1836&#x2013;1848. doi: 10.1007/s00134-018-5389-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5389-0</ArticleId><ArticleId IdType="pubmed">30291379</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Thomas-R&#xfc;ddel DO, Schettler A, et al. Comparing the validity of different ICD coding abstraction strategies for sepsis case identification in German claims data. PLoS One. 2018;13:e0198847. doi: 10.1371/journal.pone.0198847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198847</ArticleId><ArticleId IdType="pmc">PMC6066203</ArticleId><ArticleId IdType="pubmed">30059504</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouza C, Lopez-Cuadrado T, Amate-Blanco JM. Use of explicit ICD9-CM codes to identify adult severe sepsis: impacts on epidemiological estimates. Crit Care. 2016;20:313. doi: 10.1186/s13054-016-1497-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1497-9</ArticleId><ArticleId IdType="pmc">PMC5047045</ArticleId><ArticleId IdType="pubmed">27716355</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M. NEWSDIG: the national early warning score development and implementation group. Clin Med. 2012;12:501&#x2013;503. doi: 10.7861/clinmedicine.12-6-501.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.12-6-501</ArticleId><ArticleId IdType="pmc">PMC5922584</ArticleId><ArticleId IdType="pubmed">23342400</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SM, Jones J, Kuttler KG, et al. Prospective evaluation of an automated method to identify patients with severe sepsis or septic shock in the emergency department. BMC Emerg Med. 2016;16:31. doi: 10.1186/s12873-016-0095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12873-016-0095-0</ArticleId><ArticleId IdType="pmc">PMC4994262</ArticleId><ArticleId IdType="pubmed">27549755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen SQ, Mwakalindile E, Booth JS, et al. Automated electronic medical record sepsis detection in the emergency department. PeerJ. 2014;2:e343. doi: 10.7717/peerj.343.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.343</ArticleId><ArticleId IdType="pmc">PMC3994640</ArticleId><ArticleId IdType="pubmed">24765577</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JL, Smith BL, Jared JD, Younger JG. Prospective trial of real-time electronic surveillance to expedite early care of severe sepsis. Ann Emerg Med. 2011;57:500&#x2013;504. doi: 10.1016/j.annemergmed.2010.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2010.12.008</ArticleId><ArticleId IdType="pubmed">21227543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper MH, Weavind L, Wheeler AP, et al. Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit. Crit Care Med. 2012;40:2096&#x2013;2101. doi: 10.1097/CCM.0b013e318250a887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318250a887</ArticleId><ArticleId IdType="pmc">PMC4451061</ArticleId><ArticleId IdType="pubmed">22584763</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini HM, Ginestra JC, Chivers C, et al. A machine learning algorithm to predict severe sepsis and septic shock: development, implementation, and impact on clinical practice. Crit Care Med. 2019 doi: 10.1097/CCM.0000000000003891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003891</ArticleId><ArticleId IdType="pmc">PMC8635476</ArticleId><ArticleId IdType="pubmed">31389839</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvert JS, Price DA, Chettipally UK, et al. A computational approach to early sepsis detection. Comput Biol Med. 2016;74:69&#x2013;73. doi: 10.1016/j.compbiomed.2016.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2016.05.003</ArticleId><ArticleId IdType="pubmed">27208704</ArticleId></ArticleIdList></Reference><Reference><Citation>Kam HJ, Kim HY. Learning representations for the early detection of sepsis with deep neural networks. Comput Biol Med. 2017;89:248&#x2013;255. doi: 10.1016/j.compbiomed.2017.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2017.08.015</ArticleId><ArticleId IdType="pubmed">28843829</ArticleId></ArticleIdList></Reference><Reference><Citation>Desautels T, Calvert J, Hoffman J, et al. Prediction of sepsis in the intensive care unit with minimal electronic health record data: a machine learning approach. JMIR Med Inf. 2016;4:e28. doi: 10.2196/medinform.5909.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/medinform.5909</ArticleId><ArticleId IdType="pmc">PMC5065680</ArticleId><ArticleId IdType="pubmed">27694098</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemati S, Holder A, Razmi F, et al. An interpretable machine learning model for accurate prediction of sepsis in the ICU. Crit Care Med. 2018;46:547&#x2013;553. doi: 10.1097/CCM.0000000000002936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002936</ArticleId><ArticleId IdType="pmc">PMC5851825</ArticleId><ArticleId IdType="pubmed">29286945</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry Katharine E., Hager David N., Pronovost Peter J., Saria Suchi. A targeted real-time early warning score (TREWScore) for septic shock. Science Translational Medicine. 2015;7(299):299ra122&#x2013;299ra122. doi: 10.1126/scitranslmed.aab3719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aab3719</ArticleId><ArticleId IdType="pubmed">26246167</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RZ, Sun CH, Schroeder PH et al (2018) Predictive models of sepsis in adult ICU patients. In: 2018 IEEE international conference on healthcare informatics (ICHI), IEEE, pp 390&#x2013;391. 10.1109/ICHI.2018.00068</Citation></Reference><Reference><Citation>Guill&#xe9;n J, Liu J, Furr M et al (2015) Predictive models for severe sepsis in adult ICU patients. In: 2015 systems and information engineering design symposium, IEEE, pp 182&#x2013;187. 10.1109/SIEDS.2015.7116970</Citation></Reference><Reference><Citation>Scherpf M, Gr&#xe4;&#xdf;er F, Malberg H, Zaunseder S. Predicting sepsis with a recurrent neural network using the MIMIC III database. Comput Biol Med. 2019;113:103395. doi: 10.1016/j.compbiomed.2019.103395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2019.103395</ArticleId><ArticleId IdType="pubmed">31480008</ArticleId></ArticleIdList></Reference><Reference><Citation>He Haibo, Garcia EA. Learning from imbalanced data. IEEE Trans Knowl Data Eng. 2009;21:1263&#x2013;1284. doi: 10.1109/TKDE.2008.239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TKDE.2008.239</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Faes L, Kale AU, et al. A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. Lancet Digit Heal. 2019;1:e271&#x2013;e297. doi: 10.1016/s2589-7500(19)30123-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2589-7500(19)30123-2</ArticleId><ArticleId IdType="pubmed">33323251</ArticleId></ArticleIdList></Reference><Reference><Citation>Haug P, Ferraro J, et al. Using a semi-automated modeling environment to construct a Bayesian, sepsis diagnostic system. BCB '16. 2016 doi: 10.1145/2975167.2985841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2975167.2985841</ArticleId></ArticleIdList></Reference><Reference><Citation>Delahanty RJ, Alvarez J, Flynn LM, et al. Development and evaluation of a machine learning model for the early identification of patients at risk for sepsis. Ann Emerg Med. 2018 doi: 10.1016/j.annemergmed.2018.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2018.11.036</ArticleId><ArticleId IdType="pubmed">30661855</ArticleId></ArticleIdList></Reference><Reference><Citation>Khojandi A, Tansakul V, Li X, et al. Prediction of sepsis and in-hospital mortality using electronic health records. Methods Inf Med. 2018;57:185&#x2013;193. doi: 10.3414/ME18-01-0014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-01-0014</ArticleId><ArticleId IdType="pubmed">30248708</ArticleId></ArticleIdList></Reference><Reference><Citation>Futoma J, Hariharan S, Heller K (2017) Learning to detect sepsis with a multitask Gaussian process RNN classifier. In: Proceedings of the 34th international conference on machine learning</Citation></Reference><Reference><Citation>Lin C, Zhang Y, Ivy J et al (2018) Early diagnosis and prediction of sepsis shock by combining static and dynamic information using convolutional-LSTM. In: 2018 IEEE international conference on healthcare informatics (ICHI), IEEE, pp 219&#x2013;228. 10.1109/ICHI.2018.00032</Citation></Reference><Reference><Citation>Shashikumar SP, Stanley MD, Sadiq I, et al. Early sepsis detection in critical care patients using multiscale blood pressure and heart rate dynamics. J Electrocardiol. 2017;50:739&#x2013;743. doi: 10.1016/j.jelectrocard.2017.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2017.08.013</ArticleId><ArticleId IdType="pmc">PMC5696025</ArticleId><ArticleId IdType="pubmed">28916175</ArticleId></ArticleIdList></Reference><Reference><Citation>Shashikumar SP, Li Q, Clifford GD, Nemati S. Multiscale network representation of physiological time series for early prediction of sepsis. Physiol Meas. 2017;38:2235&#x2013;2248. doi: 10.1088/1361-6579/aa9772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1361-6579/aa9772</ArticleId><ArticleId IdType="pmc">PMC5736369</ArticleId><ArticleId IdType="pubmed">29091053</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wyk F, Khojandi A, Mohammed A, et al. A minimal set of physiomarkers in continuous high frequency data streams predict adult sepsis onset earlier. Int J Med Inform. 2019;122:55&#x2013;62. doi: 10.1016/j.ijmedinf.2018.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2018.12.002</ArticleId><ArticleId IdType="pubmed">30623784</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wyk F, Khojandi A, Kamaleswaran R. Improving prediction performance using hierarchical analysis of real-time data : a sepsis case study. IEEE J Biomed Health Inf. 2018;2018:1&#x2013;9. doi: 10.1109/JBHI.2019.2894570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2019.2894570</ArticleId><ArticleId IdType="pubmed">30676988</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Jay M, Hoffman JL, et al. Multicentre validation of a sepsis prediction algorithm using only vital sign data in the emergency department, general ward and ICU. BMJ Open. 2018;8:e017833. doi: 10.1136/bmjopen-2017-017833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017833</ArticleId><ArticleId IdType="pmc">PMC5829820</ArticleId><ArticleId IdType="pubmed">29374661</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34612847</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Criteria for Pediatric Sepsis-A Systematic Review and Meta-Analysis by the Pediatric Sepsis Definition Taskforce.</ArticleTitle><Pagination><StartPage>21</StartPage><EndPage>36</EndPage><MedlinePgn>21-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000005294</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine the associations of demographic, clinical, laboratory, organ dysfunction, and illness severity variable values with: 1) sepsis, severe sepsis, or septic shock in children with infection and 2) multiple organ dysfunction or death in children with sepsis, severe sepsis, or septic shock.</AbstractText><AbstractText Label="DATA SOURCES">MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched from January 1, 2004, and November 16, 2020.</AbstractText><AbstractText Label="STUDY SELECTION">Case-control studies, cohort studies, and randomized controlled trials in children greater than or equal to 37-week-old postconception to 18 years with suspected or confirmed infection, which included the terms "sepsis," "septicemia," or "septic shock" in the title or abstract.</AbstractText><AbstractText Label="DATA EXTRACTION">Study characteristics, patient demographics, clinical signs or interventions, laboratory values, organ dysfunction measures, and illness severity scores were extracted from eligible articles. Random-effects meta-analysis was performed.</AbstractText><AbstractText Label="DATA SYNTHESIS">One hundred and six studies met eligibility criteria of which 81 were included in the meta-analysis. Sixteen studies (9,629 patients) provided data for the sepsis, severe sepsis, or septic shock outcome and 71 studies (154,674 patients) for the mortality outcome. In children with infection, decreased level of consciousness and higher Pediatric Risk of Mortality scores were associated with sepsis/severe sepsis. In children with sepsis/severe sepsis/septic shock, chronic conditions, oncologic diagnosis, use of vasoactive/inotropic agents, mechanical ventilation, serum lactate, platelet count, fibrinogen, procalcitonin, multi-organ dysfunction syndrome, Pediatric Logistic Organ Dysfunction score, Pediatric Index of Mortality-3, and Pediatric Risk of Mortality score each demonstrated significant and consistent associations with mortality. Pooled mortality rates varied among high-, upper middle-, and lower middle-income countries for patients with sepsis, severe sepsis, and septic shock (p &lt; 0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">Strong associations of several markers of organ dysfunction with the outcomes of interest among infected and septic children support their inclusion in the data validation phase of the Pediatric Sepsis Definition Taskforce.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Menon</LastName><ForeName>Kusum</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlapbach</LastName><ForeName>Luregn J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Pediatric and Neonatal ICU, University Children`s Hospital Zurich, Zurich, Switzerland, and Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akech</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>KEMRI Wellcome Trust Research Program, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argent</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biban</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Verona University Hospital, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrol</LastName><ForeName>Enitan D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Department of Clinical Infection Microbiology and Immunology, University of Liverpool Institute of Infection, Veterinary and Ecological Sciences, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiotos</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jobayer Chisti</LastName><ForeName>Mohammod</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Idris V R</ForeName><Initials>IVR</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Pittsburgh School of Medicine, and The Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inwald</LastName><ForeName>David P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Paediatric Intensive Care Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishimine</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departments of Emergency Medicine and Pediatrics, University of California San Diego School of Medicine, La Jolla, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kissoon</LastName><ForeName>Niranjan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of British Columbia and British Columbia Children's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lodha</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>All India Institute of Medical Sciences, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadel</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St. Mary's Hospital, Imperial College Healthcare NHS Trust, and Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Cl&#xe1;udio Flauzino</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Associa&#xe7;&#xe3;o de Medicina Intensiva Brasileira, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University College London Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadeghirad</LastName><ForeName>Benham</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Departments of Anesthesia and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Halden F</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics and Emergency Medicine, University of Colorado School of Medicine, Aurora, CO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza</LastName><ForeName>Daniela C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics, Hospital S&#xed;rio-Liban&#xea;s and Hospital Universit&#xe1;rio da Universidade de S&#xe3;o Paulo, S&#xe3;o Paolo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tissieres</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care, AP-HP Paris Saclay University, Bic&#xea;tre Hospital, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>R Scott</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiens</LastName><ForeName>Matthew O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mbarara University of Science and Technology, Mbarara, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wynn</LastName><ForeName>James L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Florida, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Jerry J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorce</LastName><ForeName>Lauren R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Ann &amp; Robert H. Lurie Children's Hospital and Department of Pediatrics, Northwestern University Feinberg School of Medicine, Lurie Children's Pediatric Research &amp; Evidence Synthesis Center (PRECIISE): A JBI Affiliated Group, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Pediatric Sepsis Definition Taskforce of the Society of Critical Care Medicine</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM108618</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R43 EB029863</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 HS025696</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>R01 HD097081</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM128452</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HD089939</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2022 Jan 1;50(1):148-150. doi: 10.1097/CCM.0000000000005350.</RefSource><PMID Version="1">34914644</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003243" MajorTopicYN="N">Consciousness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091569" MajorTopicYN="N">Sociodemographic Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Dr. Menon has a Canadian Institutes of Health Research grant for the study of corticosteroids in pediatric septic shock. Dr. Menon&#x2019;s institution received funding from Crowdsourcing; he disclosed that he is a principal investigator on an international trial on Steroids in Pediatric Sepsis Shock. Drs. Menon and Watson received funding from Society of Critical Care Medicine. Dr. Argent received funding from the World Federation of Pediatric Intensive and Critical Care Societies as a part of the process of working with the Pediatric Sepsis Definitions working group. Dr. Biban received funding from Chiesi and Getinge. Dr. Nadel received funding from Abbvie. Dr. Sadeghirad received funding from the Pre-Interventional Preventative Risk Assessment AG, Mitacs Canada, and Accelerate internship in partnership with Nestl&#xe9; Canada. Dr. Scott&#x2019;s institution received funding from the Agency for Healthcare Research and Quality (AHRQ K08HS025696); he received support for article research from the AHRQ. Dr. Tissieres received funding from Sedana, Inotrem, and Baxter. Dr. Wynn received funding from the National Institutes of Health (NIH) (R01GM128452; R01HD089939, R01HD097081, R43EB029863). Dr. Zimmerman&#x2019;s institution received funding from the NIH, the National Institute of Child Health and Human Development, and Immunexpress; he received funding from Elsevier Publishing. The remaining authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>6</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34612847</ArticleId><ArticleId IdType="pmc">PMC8670345</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000005294</ArticleId><ArticleId IdType="pii">00003246-202201000-00002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396:1204&#x2013;1222</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7567026</ArticleId><ArticleId IdType="pubmed">33069326</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, et al. . Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study. Lancet. 2020; 395:200&#x2013;211</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6:2&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">15636651</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SL, Peters MJ, Alhazzani W, et al. . Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020; 21:e52&#x2013;e106</Citation><ArticleIdList><ArticleId IdType="pubmed">32032273</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Phillips GS, Levy ML, et al. ; Sepsis Definitions Task Force. Developing a new definition and assessing new clinical criteria for septic shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315:775&#x2013;787</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman PKA, Schlapbach LJ, Giannoni E, et al. ; Swiss Pediatric Sepsis Study. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: A population-based cohort study. Lancet Child Adolesc Health. 2017; 1:124&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">30169202</ArticleId></ArticleIdList></Reference><Reference><Citation>Volakli EA, Sdougka M, Drossou-Agakidou V, et al. . Short-term and long-term mortality following pediatric intensive care. Pediatr Int. 2012; 54:248&#x2013;255</Citation><ArticleIdList><ArticleId IdType="pubmed">22168527</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack MM, Holubkov R, Funai T, et al. ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Simultaneous prediction of new morbidity, mortality, and survival without new morbidity from pediatric intensive care: A new paradigm for outcomes assessment. Crit Care Med. 2015; 43:1699&#x2013;1709</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657566</ArticleId><ArticleId IdType="pubmed">25985385</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberico AM, Ward JD, Choi SC, et al. . Outcome after severe head injury. Relationship to mass lesions, diffuse injury, and ICP course in pediatric and adult patients. J Neurosurg. 1987; 67:648&#x2013;656</Citation><ArticleIdList><ArticleId IdType="pubmed">3668633</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SL, Fitzgerald JC, Pappachan J, et al. ; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015; 191:1147&#x2013;1157</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4451622</ArticleId><ArticleId IdType="pubmed">25734408</ArticleId></ArticleIdList></Reference><Reference><Citation>Choong K, Bohn D, Fraser DD, et al. ; Canadian Critical Care Trials Group. Vasopressin in pediatric vasodilatory shock: A multicenter randomized controlled trial. Am J Respir Crit Care Med. 2009; 180:632&#x2013;639</Citation><ArticleIdList><ArticleId IdType="pubmed">19608718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauzier F, L&#xe9;vy B, Lamarre P, et al. . Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial. Intensive Care Med. 2006; 32:1782&#x2013;1789</Citation><ArticleIdList><ArticleId IdType="pubmed">17019548</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon K, Schlapbach LJ, Akech S, et al. . Pediatric sepsis definition-a systematic review protocol by the pediatric sepsis definition taskforce. Crit Care Explor. 2020; 2:e0123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314341</ArticleId><ArticleId IdType="pubmed">32695992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nama N, Sampson M, Barrowman N, et al. . Crowdsourcing the citation screening process for systematic reviews: Validation study. J Med Internet Res. 2019; 21:e12953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658317</ArticleId><ArticleId IdType="pubmed">31033444</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42:377&#x2013;381</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden JA, van der Windt DA, Cartwright JL, et al. . Assessing bias in studies of prognostic factors. Ann Intern Med. 2013; 158:280&#x2013;286</Citation><ArticleIdList><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference><Reference><Citation>Voils CI, Crandell JL, Chang Y, et al. . Combining adjusted and unadjusted findings in mixed research synthesis. J Eval Clin Pract. 2011; 17:429&#x2013;434</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063329</ArticleId><ArticleId IdType="pubmed">21040243</ArticleId></ArticleIdList></Reference><Reference><Citation>The World Bank. World Bank Country and Lending Groups.
Available at: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed April 12, 2021</Citation></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, et al. (Eds). Cochrane Handbook for Systematic Reviews of Interventions. Second Edition. Chichester, United Kingdom, John Wiley &amp; Sons, 2019</Citation></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005; 5:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177&#x2013;188</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, et al. ; International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 2003; 29:530&#x2013;538</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakkar RK, Weiss SL, Fitzgerald JC, et al. ; SPROUT Investigators; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Risk factors for mortality in pediatric postsurgical versus medical severe sepsis. J Surg Res. 2019; 242:100&#x2013;110</Citation><ArticleIdList><ArticleId IdType="pubmed">31075654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisti MJ, Salam MA, Bardhan PK, et al. . Severe sepsis in severely malnourished young Bangladeshi children with pneumonia: A retrospective case control study. PLoS One. 2015; 10:e0139966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4595075</ArticleId><ArticleId IdType="pubmed">26440279</ArticleId></ArticleIdList></Reference><Reference><Citation>Santolaya ME, Alvarez AM, Aviles CL, et al. . Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: A prospective, multicenter trial. Pediatr Infect Dis J. 2008; 27:538&#x2013;543</Citation><ArticleIdList><ArticleId IdType="pubmed">18458649</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S, Kaul A, Jadhav Y, et al. . Clinical outcome of severe sepsis and septic shock in critically ill children. Trop Doct. 2020; 50:186&#x2013;190</Citation><ArticleIdList><ArticleId IdType="pubmed">32216538</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Lin X, Yue H, et al. ; Collaborative Study Group for Pediatric Sepsis in Huai&#x2019;an. Evaluation of systemic inflammatory response syndrome-negative sepsis from a Chinese regional pediatric network. BMC Pediatr. 2019; 19:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6325779</ArticleId><ArticleId IdType="pubmed">30621637</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza DC, Shieh HH, Barreira ER, et al. ; LAPSES Group. Epidemiology of sepsis in children admitted to PICUs in South America. Pediatr Crit Care Med. 2016; 17:727&#x2013;734</Citation><ArticleIdList><ArticleId IdType="pubmed">27362850</ArticleId></ArticleIdList></Reference><Reference><Citation>Matics TJ, Sanchez-Pinto LN. Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the Sepsis-3 definitions in critically ill children. JAMA Pediatr. 2017; 171:e172352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583375</ArticleId><ArticleId IdType="pubmed">28783810</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco RG, Garcia PC, Piva JP, et al. . Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med. 2005; 6:470&#x2013;472</Citation><ArticleIdList><ArticleId IdType="pubmed">15982437</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabornisky R, S&#xe1;enz SS, Capocasa P, et al. ; Miembros del Grupo de Investigaci&#xf3;n Cl&#xed;nica y Epidemiol&#xf3;gica en Terapia Intensiva Pedi&#xe1;trica de la Sociedad Argentina de Pediatr&#xed;a (SAP). Epidemiological study of pediatric severe sepsis in Argentina. Arch Argent Pediatr. 2019; 117:S135&#x2013;S156</Citation><ArticleIdList><ArticleId IdType="pubmed">31833341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur G, Vinayak N, Mittal K, et al. . Clinical outcome and predictors of mortality in children with sepsis, severe sepsis, and septic shock from Rohtak, Haryana: A prospective observational study. Indian J Crit Care Med. 2014; 18:437&#x2013;441</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4118509</ArticleId><ArticleId IdType="pubmed">25097356</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MR, Maheshwari PK, Masood K, et al. . Epidemiology and outcome of sepsis in a tertiary care PICU of Pakistan. Indian J Pediatr. 2012; 79:1454&#x2013;1458</Citation><ArticleIdList><ArticleId IdType="pubmed">22392263</ArticleId></ArticleIdList></Reference><Reference><Citation>Villegas D, Echandia CA. Factors associated with mortality through sepsis syndrome in children 31 days to 14 years of age. Colombia Medica. 2010; 41:349&#x2013;357</Citation></Reference><Reference><Citation>Sakyi SA, Enimil A, Adu DK, et al. . Individual and combined bioscore model of presepsin, procalcitonin, and high sensitive C-reactive protein as biomarkers for early diagnosis of paediatric sepsis. Heliyon. 2020; 6:e04841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7494471</ArticleId><ArticleId IdType="pubmed">32984583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiens MO, Larson CP, Kumbakumba E, et al. . Application of sepsis definitions to pediatric patients admitted with suspected infections in Uganda. Pediatr Crit Care Med. 2016; 17:400&#x2013;405</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5237844</ArticleId><ArticleId IdType="pubmed">27043996</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Ma Y, Mao M, et al. . Application of regression model combined with computer technology in the construction of early warning model of sepsis infection in children. J Infect Public Health. 2020; 13:253&#x2013;259</Citation><ArticleIdList><ArticleId IdType="pubmed">31818709</ArticleId></ArticleIdList></Reference><Reference><Citation>Alejandre C, Guitart C, Balaguer M, et al. . Use of procalcitonin and C-reactive protein in the diagnosis of bacterial infection in infants with severe bronchiolitis. Eur J Pediatr. 2021; 180:833&#x2013;842</Citation><ArticleIdList><ArticleId IdType="pubmed">32929531</ArticleId></ArticleIdList></Reference><Reference><Citation>Smok B, Domagalski K, Paw&#x142;owska M. Diagnostic and prognostic value of IL-6 and sTREM-1 in SIRS and sepsis in children. Mediators Inflamm. 2020; 2020:8201585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327583</ArticleId><ArticleId IdType="pubmed">32655314</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranwal AK, Deepthi G, Rohit MK, et al. . Longitudinal study of CPK-MB and echocardiographic measures of myocardial dysfunction in pediatric sepsis: Are patients with shock different from those without? Indian J Crit Care Med. 2020; 24:109&#x2013;115</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7075059</ArticleId><ArticleId IdType="pubmed">32205942</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S, Deshmukh CT, Tullu MS. The predictors of outcome and progression of pediatric sepsis and septic shock: A prospective observational study from western India. J Postgrad Med. 2020; 66:67&#x2013;72</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239413</ArticleId><ArticleId IdType="pubmed">31997781</ArticleId></ArticleIdList></Reference><Reference><Citation>Ames SG, Davis BS, Angus DC, et al. . Hospital variation in risk-adjusted pediatric sepsis mortality. Pediatr Crit Care Med. 2018; 19:390&#x2013;396</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935525</ArticleId><ArticleId IdType="pubmed">29461429</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x130;&#x15f;g&#xfc;der R, Ceylan G, A&#x11f;in H, et al. . Increased mean platelet volume in children with sepsis as a predictor of mortality. Turk J Pediatr. 2016; 58:503&#x2013;511</Citation><ArticleIdList><ArticleId IdType="pubmed">28621091</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanziotti VS, P&#xf3;voa P, Prata-Barbosa A, et al. . Patterns of C-reactive protein ratio response to antibiotics in pediatric sepsis: A prospective cohort study. J Crit Care. 2018; 44:217&#x2013;222</Citation><ArticleIdList><ArticleId IdType="pubmed">29161668</ArticleId></ArticleIdList></Reference><Reference><Citation>Prout AJ, Talisa VB, Carcillo JA, et al. . Children with chronic disease bear the highest burden of pediatric sepsis. J Pediatr. 2018; 199:194&#x2013;199.e1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063765</ArticleId><ArticleId IdType="pubmed">29753542</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, MacLaren G, Festa M, et al. ; Australian &amp; New Zealand Intensive Care Society (ANZICS) Centre for Outcomes &amp; Resource Evaluation (CORE) and Australian &amp; New Zealand Intensive Care Society (ANZICS) Paediatric Study Group. Prediction of pediatric sepsis mortality within 1 h of intensive care admission. Intensive Care Med. 2017; 43:1085&#x2013;1096</Citation><ArticleIdList><ArticleId IdType="pubmed">28220227</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott HF, Brou L, Deakyne SJ, et al. . Association between early lactate levels and 30-day mortality in clinically suspected sepsis in children. JAMA Pediatr. 2017; 171:249&#x2013;255</Citation><ArticleIdList><ArticleId IdType="pubmed">28068437</ArticleId></ArticleIdList></Reference><Reference><Citation>Shime N, Kawasaki T, Saito O, et al. . Incidence and risk factors for mortality in paediatric severe sepsis: Results from the national paediatric intensive care registry in Japan. Intensive Care Med. 2012; 38:1191&#x2013;1197</Citation><ArticleIdList><ArticleId IdType="pubmed">22527068</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonial CT, Costa CAD, Andrades GRH, et al. . Performance of prognostic markers in pediatric sepsis. J Pediatr (Rio J). 2021; 97:287&#x2013;294</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9432292</ArticleId><ArticleId IdType="pubmed">32991837</ArticleId></ArticleIdList></Reference><Reference><Citation>Vila P&#xe9;rez D, Jordan I, Esteban E, et al. . Prognostic factors in pediatric sepsis study, from the Spanish Society of Pediatric Intensive Care. Pediatr Infect Dis J. 2014; 33:152&#x2013;157</Citation><ArticleIdList><ArticleId IdType="pubmed">24413407</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SJ, Ha EJ, Jhang WK, et al. . Elevated central venous pressure is associated with increased mortality in pediatric septic shock patients. BMC Pediatr. 2018; 18:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5811958</ArticleId><ArticleId IdType="pubmed">29439683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagher GA, Safa R, Hajjar K, et al. . Characteristics and outcomes of pediatric septic patients with cancer: A retrospective cohort study. J Emerg Med. 2019; 57:216&#x2013;226</Citation><ArticleIdList><ArticleId IdType="pubmed">31229302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazir M, Wani W, Dar SA, et al. . Lactate clearance prognosticates outcome in pediatric septic shock during first 24&#x2009;h of intensive care unit admission. J Intensive Care Soc. 2019; 20:290&#x2013;298</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6820231</ArticleId><ArticleId IdType="pubmed">31695733</ArticleId></ArticleIdList></Reference><Reference><Citation>Pound CM, Johnston DL, Armstrong R, et al. . The morbidity and mortality of pediatric oncology patients presenting to the intensive care unit with septic shock. Pediatr Blood Cancer. 2008; 51:584&#x2013;588</Citation><ArticleIdList><ArticleId IdType="pubmed">18623196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahiem SK, Galal YS, Youssef MR, et al. . Prognostic markers among Egyptian children with sepsis in the intensive care units, Cairo University Hospitals. Allergol Immunopathol (Madr). 2016; 44:46&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">26657169</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson LS, G&#xe1;llego Su&#xe1;rez C, Segaloff HE, et al. . Outcomes and resource use among overweight and obese children with sepsis in the pediatric intensive care unit. J Intensive Care Med. 2020; 35:472&#x2013;477</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027613</ArticleId><ArticleId IdType="pubmed">29471722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross PA, Klein MJ, Nguyen T, et al. . Body habitus and risk of mortality in pediatric sepsis and septic shock: A retrospective cohort study. J Pediatr. 2019; 210:178&#x2013;183.e2</Citation><ArticleIdList><ArticleId IdType="pubmed">31036411</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal P, Dewan P, Gomber S, et al. . Early lactate measurements for predicting in-hospital mortality in paediatric sepsis. J Paediatr Child Health. 2020; 56:1570&#x2013;1576</Citation><ArticleIdList><ArticleId IdType="pubmed">32861227</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters C, Murthy S, Brant R, et al. . Mortality risk using a pediatric quick sequential (sepsis-related) organ failure assessment varies with vital sign thresholds. Pediatr Crit Care Med. 2018; 19:e394&#x2013;e402</Citation><ArticleIdList><ArticleId IdType="pubmed">29939978</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam A, Gupta S. Lactate measurements and their association with mortality in pediatric severe sepsis in India: Evidence that 6-hour level performs best. J Intensive Care Med. 2020; 36:443&#x2013;450</Citation><ArticleIdList><ArticleId IdType="pubmed">32041465</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeddha NP, Schlapbach LJ, Driessen GJ, et al. ; EUCLIDS consortium. Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: A prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS). Crit Care. 2018; 22:143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5984383</ArticleId><ArticleId IdType="pubmed">29855385</ArticleId></ArticleIdList></Reference><Reference><Citation>Couto-Alves A, Wright VJ, Perumal K, et al. . A new scoring system derived from base excess and platelet count at presentation predicts mortality in paediatric meningococcal sepsis. Crit Care. 2013; 17:R68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672696</ArticleId><ArticleId IdType="pubmed">23577792</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho MV, Maluf MA, Catani R, et al. . Cytokines and pediatric open heart surgery with cardiopulmonary bypass. Cardiol Young. 2001; 11:36&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">11233396</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiser RT, West NK, Bush AJ, et al. . Outcome of severe sepsis in pediatric oncology patients. Pediatr Crit Care Med. 2005; 6:531&#x2013;536</Citation><ArticleIdList><ArticleId IdType="pubmed">16148811</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgis N, Asselin JM, Fontana C, et al. . Evaluation of the association of early elevated lactate with outcomes in children with severe sepsis or septic shock. Pediatr Emerg Care. 2019; 35:661&#x2013;665</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5502202</ArticleId><ArticleId IdType="pubmed">28072671</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Ning B, Wang Y, et al. . The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis. Medicine (Baltimore). 2019; 98:e15070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456134</ArticleId><ArticleId IdType="pubmed">30921240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarmin M, Afroze F, Sharifuzzaman , et al. . Predictor of death in diarrheal children under 5 years of age having severe sepsis in an urban critical care ward in Bangladesh. Glob Pediatr Health. 2019; 6:2333794X19862716</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6647208</ArticleId><ArticleId IdType="pubmed">31384628</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhoeven JJ, den Brinker M, Hokken-Koelega AC, et al. . Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: A prospective, observational cohort study. Crit Care. 2011; 15:R44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3221973</ArticleId><ArticleId IdType="pubmed">21276273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Cui Y, Miao H, et al. . Circulating vitronectin predicts liver injury and mortality in children with sepsis: A prospective observational study. Clin Appl Thromb Hemost. 2020; 26:1076029620935201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359640</ArticleId><ArticleId IdType="pubmed">32659109</ArticleId></ArticleIdList></Reference><Reference><Citation>Angurana SK, Bansal A, Muralidharan J, et al. . Cytokine levels in critically ill children with severe sepsis and their relation with the severity of illness and mortality. J Intensive Care Med. 2020; 36:576&#x2013;583</Citation><ArticleIdList><ArticleId IdType="pubmed">32207354</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Zayat RS, Shalaby AG. Mitral annular plane systolic excursion as a predictor of mortality in children with septic shock. Pediatr Crit Care Med. 2018; 19:e486&#x2013;e494</Citation><ArticleIdList><ArticleId IdType="pubmed">30024571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdev A, Raheja K, Gupta N, et al. . Association of urinary albumin:creatinine ratio with outcome of children with sepsis. Indian J Crit Care Med. 2020; 24:465&#x2013;472</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435108</ArticleId><ArticleId IdType="pubmed">32863641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Reyes CS, Baca-Velazquez LN, Villasis-Keever MA, et al. . Shock index utility to predict mortality in pediatric patients with septic shock or severe sepsis. Boletin Medico del Hospital Infantil de Mexico. 2018; 75:192&#x2013;198</Citation><ArticleIdList><ArticleId IdType="pubmed">30084442</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseaux J, Grandbastien B, Dorkenoo A, et al. . Prognostic value of shock index in children with septic shock. Pediatr Emerg Care. 2013; 29:1055&#x2013;1059</Citation><ArticleIdList><ArticleId IdType="pubmed">24076606</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary R, Sitaraman S, Choudhary A. Lactate clearance as the predictor of outcome in pediatric septic shock. J Emerg Trauma Shock. 2017; 10:55&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5357872</ArticleId><ArticleId IdType="pubmed">28367008</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Lu X, Hu L, et al. . Development and validation of a mortality risk model for pediatric sepsis. Medicine (Baltimore). 2017; 96:e6923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5440147</ArticleId><ArticleId IdType="pubmed">28514310</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SJ, Ha E, Jhang WK, et al. . Platelet indices as predictive markers of prognosis in pediatric septic shock patients. Iran J Pediatr. 2017; 27:e2712</Citation></Reference><Reference><Citation>da Silva ED, Koch Nogueira PC, Russo Zamataro TM, et al. . Risk factors for death in children and adolescents with cancer and sepsis/septic shock. J Pediatr Hematol Oncol. 2008; 30:513&#x2013;518</Citation><ArticleIdList><ArticleId IdType="pubmed">18797197</ArticleId></ArticleIdList></Reference><Reference><Citation>Goonasekera CDA, Carcillo JA, Deep A. Oxygen delivery and oxygen consumption in pediatric fluid refractory septic shock during the first 42&#x2009;h of therapy and their relationship to 28-day outcome. Front Pediatr. 2018; 6:314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6206202</ArticleId><ArticleId IdType="pubmed">30406065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski JA, MacLaren G, Alexander J, et al. . The burden of invasive infections in critically ill indigenous children in Australia. Med J Aust. 2017; 206:78&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">28152345</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Shao L, Dou J, et al. . Fibrinogen as a prognostic predictor in pediatric patients with sepsis: A database study. Mediators Inflamm. 2020; 2020:9153620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204196</ArticleId><ArticleId IdType="pubmed">32410872</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonial CT, Costa CAD, Andrades GRH, et al. . Prediction of poor outcomes for septic children according to ferritin levels in a middle-income setting. Pediatr Crit Care Med. 2020; 21:e259&#x2013;e266</Citation><ArticleIdList><ArticleId IdType="pubmed">32343115</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Li M, Xiong TT, et al. . Nested case-control study of multiple serological indexes and Brighton pediatric early warming score in predicting death of children with sepsis. World J Clin Cases. 2019; 7:431&#x2013;440</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6397812</ArticleId><ArticleId IdType="pubmed">30842954</ArticleId></ArticleIdList></Reference><Reference><Citation>Maat M, Buysse CM, Emonts M, et al. . Improved survival of children with sepsis and purpura: Effects of age, gender, and era. Crit Care. 2007; 11:R112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2556765</ArticleId><ArticleId IdType="pubmed">17945008</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederwanger C, Varga T, Hell T, et al. . Comparison of pediatric scoring systems for mortality in septic patients and the impact of missing information on their predictive power: A retrospective analysis. PeerJ. 2020; 8:e9993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543722</ArticleId><ArticleId IdType="pubmed">33083117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong M, Huang Y, Li T, et al. . Day-1 PELOD-2 and day-1 &#x201c;quick&#x201d; PELOD-2 scores in children with sepsis in the PICU. J Pediatr (Rio J). 2020; 96:660&#x2013;665</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9432166</ArticleId><ArticleId IdType="pubmed">31580846</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederwanger C, Bachler M, Hell T, et al. . Inflammatory and coagulatory parameters linked to survival in critically ill children with sepsis. Ann Intensive Care. 2018; 8:111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240023</ArticleId><ArticleId IdType="pubmed">30446841</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed SZ, Mahmoud MM, Moness HM, et al. . Admission platelet count and indices as predictors of outcome in children with severe sepsis: A prospective hospital-based study. BMC Pediatr. 2020; 20:387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437045</ArticleId><ArticleId IdType="pubmed">32814554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawang SA, Jayaganda DD. White blood cell, procalcitonin, C-reactive protein and TNF-alpha as prognostic factors in pediatric sepsis. Indian J Public Health Res Dev. 2019; 10:708&#x2013; 713</Citation></Reference><Reference><Citation>Liu GB, Cui XQ, Wang ZB, et al. . Detection of serum procalcitonin and hypersensitive C-reactive protein in patients with pneumonia and sepsis. J Biol Regul Homeost Agents. 2018; 32:1165&#x2013;1169</Citation><ArticleIdList><ArticleId IdType="pubmed">30334408</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Nie J, Wu FX, et al. . Prognostic value of high-sensitivity C-reactive protein, procalcitonin and pancreatic stone protein in pediatric sepsis. Med Sci Monit. 2017; 23:1533&#x2013;1539</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5384617</ArticleId><ArticleId IdType="pubmed">28358790</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederwanger C, Hell T, Hofer S, et al. . Antithrombin deficiency is associated with mortality and impaired organ function in septic pediatric patients: A retrospective study. PeerJ. 2018; 6:e5538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6129139</ArticleId><ArticleId IdType="pubmed">30202654</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaramillo-Bustamante JC, Mar&#xed;n-Agudelo A, Fern&#xe1;ndez-Laverde M, et al. . Epidemiology of sepsis in pediatric intensive care units: First Colombian multicenter study. Pediatr Crit Care Med. 2012; 13:501&#x2013;508</Citation><ArticleIdList><ArticleId IdType="pubmed">22460772</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C, Wang S, Fang F, et al. . Epidemiology of pediatric severe sepsis in main PICU centers in Southwest China. Pediatr Crit Care Med. 2019; 20:1118&#x2013;1125</Citation><ArticleIdList><ArticleId IdType="pubmed">31261227</ArticleId></ArticleIdList></Reference><Reference><Citation>Mianling Z, Yuge H, Tufeng L, et al. . Performance of the pediatric sequential organ failure assessment score in assessing the prognosis of children with sepsis in a PICU of a developing country: A single-center retrospective observational study. Iran J Pediatr. 2019; 29:e89024</Citation></Reference><Reference><Citation>Carrol ED, Newland P, Thomson AP, et al. . Prognostic value of procalcitonin in children with meningococcal sepsis. Crit Care Med. 2005; 33:224&#x2013;225</Citation><ArticleIdList><ArticleId IdType="pubmed">15644674</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey C, Los Arcos M, Concha A, et al. . Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med. 2007; 33:477&#x2013;484</Citation><ArticleIdList><ArticleId IdType="pubmed">17260130</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed L, Carroll J, Cummings A, et al. . Serum lactate as a screening tool and predictor of outcome in pediatric patients presenting to the emergency department with suspected infection. Pediatr Emerg Care. 2013; 29:787&#x2013;791</Citation><ArticleIdList><ArticleId IdType="pubmed">23823254</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindell RB, Gertz SJ, Rowan CM, et al. ; Sepsis PRevalence, OUtcomes, and Therapies Study Investigators and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. High levels of morbidity and mortality among pediatric hematopoietic cell transplant recipients with severe sepsis: Insights from the sepsis PRevalence, OUtcomes, and Therapies International Point Prevalence Study. Pediatr Crit Care Med. 2017; 18:1114&#x2013;1125</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7339740</ArticleId><ArticleId IdType="pubmed">28926489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortz TB, Sawe HR, Murray B, et al. . Clinical presentation and outcomes among children with sepsis presenting to a public tertiary hospital in Tanzania. Front Pediatr. 2017; 5:278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5743673</ArticleId><ArticleId IdType="pubmed">29312910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdemir R, Isguder R, Kucuk M, et al. . A valuable tool in predicting poor outcome due to sepsis in pediatric intensive care unit: Tp-e/QT ratio. J Trop Pediatr. 2016; 62:377&#x2013;384</Citation><ArticleIdList><ArticleId IdType="pubmed">27085180</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque A, Siddiqui NR, Munir O, et al. . Association between vasoactive-inotropic score and mortality in pediatric septic shock. Indian Pediatr. 2015; 52:311&#x2013;313</Citation><ArticleIdList><ArticleId IdType="pubmed">25929629</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Alam A. Shock index-a useful noninvasive marker associated with age-specific early mortality in children with severe sepsis and septic shock: Age-specific shock index cut-offs. J Intensive Care Med. 2020; 35:984&#x2013;991</Citation><ArticleIdList><ArticleId IdType="pubmed">30278814</ArticleId></ArticleIdList></Reference><Reference><Citation>Lautz AJ, Wong HR, Ryan TD, et al. . Myocardial dysfunction is independently associated with mortality in pediatric septic shock. Crit Care Explor. 2020; 2:e0231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7553396</ArticleId><ArticleId IdType="pubmed">33134933</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankar J, Das RR, Jain A, et al. . Prevalence and outcome of diastolic dysfunction in children with fluid refractory septic shock&#x2013;a prospective observational study. Pediatr Crit Care Med. 2014; 15:e370&#x2013;e378</Citation><ArticleIdList><ArticleId IdType="pubmed">25230313</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanbabaee G, Hashemi SM, Salarian S, et al. . Red cell distribution width elevation and sepsis in pediatric critically ill patients. Arch Pediatr Infect Dis. 2010; 6:e12210</Citation></Reference><Reference><Citation>Onwuneme C, Carroll A, Doherty D, et al. . Inadequate vitamin D levels are associated with culture positive sepsis and poor outcomes in paediatric intensive care. Acta Paediatr. 2015; 104:e433&#x2013;e438</Citation><ArticleIdList><ArticleId IdType="pubmed">26096884</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizarro CF, Troster EJ, Damiani D, et al. . Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med. 2005; 33:855&#x2013;859</Citation><ArticleIdList><ArticleId IdType="pubmed">15818116</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh NY, Abo El Fotoh WMM. Low serum zinc level: The relationship with severe pneumonia and survival in critically ill children. Int J Clin Pract. 2018; 72:e13211.</Citation><ArticleIdList><ArticleId IdType="pubmed">29855123</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermont CL, den Brinker M, K&#xe2;keci N, et al. . Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med. 2005; 33:1610&#x2013;1615</Citation><ArticleIdList><ArticleId IdType="pubmed">16003070</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildizdas D, Yapicioglu H, Celik U, et al. . Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med. 2008; 34:511&#x2013;517</Citation><ArticleIdList><ArticleId IdType="pubmed">18092150</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira NS, Silva VR, Castelo JS, et al. . Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock. Pediatr Crit Care Med. 2008; 9:414&#x2013;417</Citation><ArticleIdList><ArticleId IdType="pubmed">18843251</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustafa AA, Antonios MA, Abdellatif EM, et al. . Association of lactate/albumin ratio level to organ failure and mortality in severe sepsis in a pediatric intensive care unit in Egypt. Turk J Pediatr. 2018; 60:691&#x2013;701</Citation><ArticleIdList><ArticleId IdType="pubmed">31365206</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott HF, Brou L, Deakyne SJ, et al. . Lactate clearance and normalization and prolonged organ dysfunction in pediatric sepsis. J Pediatr. 2016; 170:149&#x2013;155.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">26711848</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaud-Althaus C, Althaus F, Genton B, et al. . Clinical features for diagnosis of pneumonia in children younger than 5 years: A systematic review and meta-analysis. Lancet Infect Dis. 2015; 15:439&#x2013;450</Citation><ArticleIdList><ArticleId IdType="pubmed">25769269</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K, Kiguli S, Opoka RO, et al. ; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011; 364:2483&#x2013;2495</Citation><ArticleIdList><ArticleId IdType="pubmed">21615299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiens MO, Kumbakumba E, Kissoon N, et al. . Pediatric sepsis in the developing world: Challenges in defining sepsis and issues in post-discharge mortality. Clin Epidemiol. 2012; 4:319&#x2013;325</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514048</ArticleId><ArticleId IdType="pubmed">23226074</ArticleId></ArticleIdList></Reference><Reference><Citation>Balamuth F, Schlapbach LJ. Paediatric patient stratification in the emergency department. Lancet Child Adolesc Health. 2020; 4:557&#x2013;558</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7375780</ArticleId><ArticleId IdType="pubmed">32710836</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29726345</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>391</Volume><Issue>10131</Issue><PubDate><Year>2018</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1693</StartPage><EndPage>1705</EndPage><MedlinePgn>1693-1705</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(18)30479-3</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(18)30479-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Supplemental oxygen is often administered liberally to acutely ill adults, but the credibility of the evidence for this practice is unclear. We systematically reviewed the efficacy and safety of liberal versus conservative oxygen therapy in acutely ill adults.</AbstractText><AbstractText Label="METHODS">In the Improving Oxygen Therapy in Acute-illness (IOTA) systematic review and meta-analysis, we searched the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, HealthSTAR, LILACS, PapersFirst, and the WHO International Clinical Trials Registry from inception to Oct 25, 2017, for randomised controlled trials comparing liberal and conservative oxygen therapy in acutely ill adults (aged &#x2265;18 years). Studies limited to patients with chronic respiratory diseases or psychiatric disease, patients on extracorporeal life support, or patients treated with hyperbaric oxygen therapy or elective surgery were excluded. We screened studies and extracted summary estimates independently and in duplicate. We also extracted individual patient-level data from survival curves. The main outcomes were mortality (in-hospital, at 30 days, and at longest follow-up) and morbidity (disability at longest follow-up, risk of hospital-acquired pneumonia, any hospital-acquired infection, and length of hospital stay) assessed by random-effects meta-analyses. We assessed quality of evidence using the grading of recommendations assessment, development, and evaluation approach. This study is registered with PROSPERO, number CRD42017065697.</AbstractText><AbstractText Label="FINDINGS">25 randomised controlled trials enrolled 16&#x2008;037 patients with sepsis, critical illness, stroke, trauma, myocardial infarction, or cardiac arrest, and patients who had emergency surgery. Compared with a conservative oxygen strategy, a liberal oxygen strategy (median baseline saturation of peripheral oxygen [SpO<sub>2</sub>] across trials, 96% [range 94-99%, IQR 96-98]) increased mortality in-hospital (relative risk [RR] 1&#xb7;21, 95% CI 1&#xb7;03-1&#xb7;43, I<sup>2</sup>=0%, high quality), at 30 days (RR 1&#xb7;14, 95% CI 1&#xb7;01-1&#xb7;29, I<sup>2</sup>=0%, high quality), and at longest follow-up (RR 1&#xb7;10, 95% CI 1&#xb7;00-1&#xb7;20, I<sup>2</sup>=0%, high quality). Morbidity outcomes were similar between groups. Findings were robust to trial sequential, subgroup, and sensitivity analyses.</AbstractText><AbstractText Label="INTERPRETATION">In acutely ill adults, high-quality evidence shows that liberal oxygen therapy increases mortality without improving other patient-important outcomes. Supplemental oxygen might become unfavourable above an SpO<sub>2</sub> range of 94-96%. These results support the conservative administration of oxygen therapy.</AbstractText><AbstractText Label="FUNDING">None.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Derek K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Lisa H-Y</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand; Intensive Care Unit, Wellington Regional Hospital, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamiri</LastName><ForeName>Nima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almenawer</LastName><ForeName>Saleh A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaeschke</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xfc;nemann</LastName><ForeName>Holger J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neary</LastName><ForeName>John D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhazzani</LastName><ForeName>Waleed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. Electronic address: alhazzaw@mcmaster.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2018 Apr 28;391(10131):1640-1642. doi: 10.1016/S0140-6736(18)30546-4.</RefSource><PMID Version="1">29726326</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Arch Dis Child. 2019 Feb;104(2):106-107. doi: 10.1136/archdischild-2018-315437.</RefSource><PMID Version="1">30213801</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Intern Med. 2018 Sep 18;169(6):JC29. doi: 10.7326/ACPJC-2018-169-6-029.</RefSource><PMID Version="1">30242402</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ Evid Based Med. 2019 Jun;24(3):113-114. doi: 10.1136/bmjebm-2018-111054.</RefSource><PMID Version="1">30266723</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Dtsch Arztebl Int. 2018 Oct 12;115(41):685-686. doi: 10.3238/arztebl.2018.0685b.</RefSource><PMID Version="1">30406753</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2018 Dec 8;392(10163):2436. doi: 10.1016/S0140-6736(18)32219-0.</RefSource><PMID Version="1">30527412</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2018 Dec 8;392(10163):2436-2437. doi: 10.1016/S0140-6736(18)32201-3.</RefSource><PMID Version="1">30527413</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2018 Dec 8;392(10163):2437. doi: 10.1016/S0140-6736(18)32194-9.</RefSource><PMID Version="1">30527415</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am Fam Physician. 2019 Jan 1;99(1):Online.</RefSource><PMID Version="1">30600981</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>CJEM. 2019 Mar;21(2):296-298. doi: 10.1017/cem.2018.482.</RefSource><PMID Version="1">30651153</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2019 Apr 18;23(1):132. doi: 10.1186/s13054-018-2165-z.</RefSource><PMID Version="1">30999939</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 Feb 15;201(4):478-480. doi: 10.1164/rccm.201905-1029RR.</RefSource><PMID Version="1">31816250</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072700" MajorTopicYN="N">Conservative Treatment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007049" MajorTopicYN="N">Iatrogenic Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29726345</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(18)30479-3</ArticleId><ArticleId IdType="pii">S0140-6736(18)30479-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36446854</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Machine-learning-derived sepsis bundle of care.</ArticleTitle><Pagination><StartPage>26</StartPage><EndPage>36</EndPage><MedlinePgn>26-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-022-06928-2</ELocationID><Abstract><AbstractText Label="PURPOSE">Compliance to the Surviving Sepsis Campaign (SSC) guidelines is limited. This is known to be associated with increased mortality. The aim of this retrospective cohort study was to identify among the SCC guidelines the optimal bundle of recommendations that minimize 28-day mortality.</AbstractText><AbstractText Label="METHODS">We used a training cohort to identify, using a least absolute shrinkage and selection operator penalized machine learning model, this bundle. Patients with sepsis/septic shock admitted to the intensive care unit (ICU) were extracted from two US databases, the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database (training and internal validation cohorts) and the eICU Collaborative Research Database (eICU-CRD) (external validation cohort). In the validation cohorts, we defined a bundle group that includes patients who were treated with at least all the recommendations selected in our bundle and a no-bundle group that includes patients in whom at least one recommendation from our bundle was omitted.</AbstractText><AbstractText Label="RESULTS">All-cause 28-day mortality was the primary outcome measure. A total of 42,735 patients were included. Six recommendations (antimicrobials, balanced crystalloid, insulin therapy, corticosteroids, vasopressin, and bicarbonate therapy) were identified from the training cohort to be included in our bundle. In the propensity score-(PS)-matched internal validation cohort, the bundle group was associated with a lower mortality (OR 0.41 [0.33-0.53]; p&#x2009;&lt;&#x2009;0.001) compared to the no-bundle group. This was confirmed in the PS-matched external validation cohort (OR 0.75 [0.60-0.94]; p 0.02).</AbstractText><AbstractText Label="CONCLUSION">Our bundle of six recommendations is associated with a dramatic reduction in mortality in sepsis and septic shock. This bundle needs to be evaluated prospectively.</AbstractText><CopyrightInformation>&#xa9; 2022. Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalimouttou</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Inserm UMR 1153, Center of Research in Epidemiology and StatisticS (CRESS), ECSTRRA Team, Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, 75004, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Assistance Publique H&#xf4;pitaux de Paris-Centre (AP-HP), Georges Pompidou European Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lerner</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Assistance Publique H&#xf4;pitaux de Paris-Centre (AP-HP), Georges Pompidou European Hospital, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inserm, Centre de Recherche des Cordeliers, Sorbonne Universit&#xe9;, Universit&#xe9; Paris Cit&#xe9;, 75006, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HeKA, Inria Paris, 75015, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheurfa</LastName><ForeName>Ch&#xe9;rifa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Assistance Publique H&#xf4;pitaux de Paris-Centre (AP-HP), Cochin Hospital, Universit&#xe9; Paris Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jannot</LastName><ForeName>Anne-Sophie</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Assistance Publique H&#xf4;pitaux de Paris-Centre (AP-HP), Georges Pompidou European Hospital, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inserm, Centre de Recherche des Cordeliers, Sorbonne Universit&#xe9;, Universit&#xe9; Paris Cit&#xe9;, 75006, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HeKA, Inria Paris, 75015, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirracchio</LastName><ForeName>Romain</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7007-4908</Identifier><AffiliationInfo><Affiliation>Inserm UMR 1153, Center of Research in Epidemiology and StatisticS (CRESS), ECSTRRA Team, Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, 75004, Paris, France. Romain.Pirracchio@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, 1001 Potrero Avenue, San Francisco, CA, 94910, USA. Romain.Pirracchio@ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Intensive Care Med. 2023 Feb;49(2):262-263. doi: 10.1007/s00134-022-06961-1.</RefSource><PMID Version="1">36592206</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Compliance</Keyword><Keyword MajorTopicYN="N">Guidelines</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36446854</ArticleId><ArticleId IdType="doi">10.1007/s00134-022-06928-2</ArticleId><ArticleId IdType="pii">10.1007/s00134-022-06928-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801&#x2013;810</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Mellhammar L, Rose N, Cassini A, Rudd KE, Schlattmann P et al (2020) Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med 46(8):1552&#x2013;1562</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06151-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369(9):840&#x2013;851</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1208623</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaieski DF, Edwards JM, Kallan MJ, Carr BG (2013) Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41(5):1167&#x2013;1174</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827c09f8</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C et al (2021) Executive summary: surviving sepsis campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021. Crit Care Med 49(11):1974&#x2013;1982</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005357</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M, Ragonnet B, Alonso S, Allaouchiche B, Constantin JM, Jaber S et al (2012) Variable compliance with clinical practice guidelines identified in a 1-day audit at 66 French adult intensive care units. Crit Care Med 40(12):3189&#x2013;3195</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31826571f2</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitton E, Zimmerman S, Azevedo LCP, Benhamou D, Cecconi M, De Waele JJ et al (2022) An international survey of adherence to Surviving Sepsis Campaign Guidelines 2016 regarding fluid resuscitation and vasopressors in the initial management of septic shock. J Crit Care 68:144&#x2013;154</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.11.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn JM, Davis BS, Yabes JG, Chang CCH, Chong DH, Hershey TB et al (2019) Association between state-mandated protocolized sepsis care and in-hospital mortality among adults with sepsis. JAMA 322(3):240&#x2013;250</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.9021</ArticleId></ArticleIdList></Reference><Reference><Citation>You JS, Park YS, Chung SP, Lee HS, Jeon S, Kim WY et al (2022) Relationship between time of emergency department admission and adherence to the Surviving Sepsis Campaign bundle in patients with septic shock. Crit Care 26(1):43</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-03899-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiani E, Donati A, Serafini G, Rinaldi L, Adrario E, Pelaia P et al (2015) Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS ONE 10(5):e0125827</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125827</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED et al (2017) Balanced crystalloids versus saline in the intensive care unit. The SALT randomized trial. Am J Respir Crit Care Med 195(10):1362&#x2013;1372</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201607-1345OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X, Hua Y, Liu J, Gong C, Zhao W (2017) Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials. CMAJ 189(7):E260&#x2013;E267</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.160570</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA et al (2019) Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med 380(21):1997&#x2013;2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1901686</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaber S, Paugam C, Futier E, Lefrant JY, Lasocki S, Lescot T et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392(10141):31&#x2013;40</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31080-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Marker S, Krag M, Perner A, Wetterslev J, Lange T, Wise MP et al (2019) Pantoprazole in ICU patients at risk for gastrointestinal bleeding-1-year mortality in the SUP-ICU trial. Acta Anaesthesiol Scand 63(9):1184&#x2013;1190</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13436</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 12(12):1495&#x2013;1499</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.07.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MY, Langan S, Benchimol EI (2016) Routinely collected electronic health data and STI research: RECORD extension to the STROBE guidelines. Sex Transm Infect 92(1):2&#x2013;3</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/sextrans-2015-052360</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson A, Bulgarelli L, Pollard T, Horng S, Celi LA. MIMIC-IV (version 0.4). PhysioNet 2020</Citation></Reference><Reference><Citation>Pollard TJ, Johnson AEW, Raffa JD, Celi LA, Mark RG, Badawi O (2018) The eICU Collaborative Research Database, a freely available multi-center database for critical care research [Internet]. Sci Data. https://doi.org/10.1038/sdata.2018.178</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2018.178</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707&#x2013;710</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270(24):2957&#x2013;2963</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1993.03510240069035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R (1996) Regression shrinkage and selection via the Lasso. J R Stat Soc Series B Stat Methodol 58(1):267&#x2013;288</Citation></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33(1):1&#x2013;22</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v033.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Kennedy JN, Wang S, Chang CCH, Elliott CF, Xu Z et al (2019) Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA 321(20):2003&#x2013;2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.5791</ArticleId></ArticleIdList></Reference><Reference><Citation>Haute Autorit&#xe9; de Sant&#xe9;. Niveau de preuve et gradation des recommandations de bonne pratique. 2013. https://www.has-sante.fr/jcms/c_1600564/fr/niveau-de-preuve-et-gradation-des-recommandations-de-bonne-pratique-etat-des-lieux</Citation></Reference><Reference><Citation>Rhee C, Yu T, Wang R, Kadri SS, Fram D, Chen HC et al (2021) Association Between implementation of the severe sepsis and septic shock early management bundle performance measure and outcomes in patients with suspected sepsis in US hospitals. JAMA Netw Open 4(12):e2138596</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.38596</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R et al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378(9):797&#x2013;808</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1705835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryg&#xe5;rd SL, Butler E, Granholm A, M&#xf8;ller MH, Cohen J, Finfer S et al (2018) Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 44(7):1003&#x2013;1016</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5197-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S et al (2018) Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 378(9):809&#x2013;818</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1705716</ArticleId></ArticleIdList></Reference><Reference><Citation>Preiser JC, Devos P, Ruiz-Santana S, M&#xe9;lot C, Annane D, Groeneveld J et al (2009) A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 35(10):1738&#x2013;1748</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1585-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Griesdale DEG, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A et al (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180(8):821&#x2013;827</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.090206</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SYS, Blair D, Foster D et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360(13):1283&#x2013;1297</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509&#x2013;518</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.10485</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, H&#xe9;bert PC, Cooper DJ et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358(9):877&#x2013;887</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa067373</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235&#x2013;2244</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1703058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalil AC, Johnson DW, Lisco SJ, Sun J (2017) Early goal-directed therapy for sepsis: a novel solution for discordant survival outcomes in clinical trials. Crit Care Med 45(4):607&#x2013;614</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A et al (2009) Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 180(9):861&#x2013;866</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200812-1912OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F (1991) Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 19(11):1352&#x2013;1356</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199111000-00008</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RM, Wang L, Coston TD, Krishnan NI, Casey JD, Wanderer JP et al (2019) Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med 200(12):1487&#x2013;1495</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201903-0557OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW et al (2018) Balanced crystalloids versus saline in critically ill adults. N Engl J Med 378(9):829&#x2013;839</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1711584</ArticleId></ArticleIdList></Reference><Reference><Citation>Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A (2015) Vasopressors for the treatment of septic shock: systematic review and meta-analysis. PLoS ONE 10(8):e0129305</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0129305</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A et al (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161(5):347&#x2013;355</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-0178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis SR, Pritchard MW, Evans DJ, Butler AR, Alderson P, Smith AF et al (2018) Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev 8:CD000567</Citation></Reference><Reference><Citation>Wang H, Xu Q, Zhou L (2015) Large unbalanced credit scoring using Lasso-logistic regression ensemble. PLoS ONE 10(2):e0117844</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0117844</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu GH, Yi LZ, Pan J (2019) LASSO-based false-positive selection for class-imbalanced data in metabolomics. J Chemom [Internet]. https://doi.org/10.1002/cem.3177</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cem.3177</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32870298</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>324</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Effect of Intraoperative Low Tidal Volume vs Conventional Tidal Volume on Postoperative Pulmonary Complications in Patients Undergoing Major Surgery: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>848</StartPage><EndPage>858</EndPage><MedlinePgn>848-858</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2020.12866</ELocationID><Abstract><AbstractText Label="IMPORTANCE">In patients who undergo mechanical ventilation during surgery, the ideal tidal volume is unclear.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether low-tidal-volume ventilation compared with conventional ventilation during major surgery decreases postoperative pulmonary complications.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Single-center, assessor-blinded, randomized clinical trial of 1236 patients older than 40 years undergoing major noncardiothoracic, nonintracranial surgery under general anesthesia lasting more than 2 hours in a tertiary hospital in Melbourne, Australia, from February 2015 to February 2019. The last date of follow-up was February 17, 2019.</AbstractText><AbstractText Label="INTERVENTIONS">Patients were randomized to receive a tidal volume of 6 mL/kg predicted body weight (n&#x2009;=&#x2009;614; low tidal volume group) or a tidal volume of 10 mL/kg predicted body weight (n&#x2009;=&#x2009;592; conventional tidal volume group). All patients received positive end-expiratory pressure (PEEP) at 5 cm H2O.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was a composite of postoperative pulmonary complications within the first 7 postoperative days, including pneumonia, bronchospasm, atelectasis, pulmonary congestion, respiratory failure, pleural effusion, pneumothorax, or unplanned requirement for postoperative invasive or noninvasive ventilation. Secondary outcomes were postoperative pulmonary complications including development of pulmonary embolism, acute respiratory distress syndrome, systemic inflammatory response syndrome, sepsis, acute kidney injury, wound infection (superficial and deep), rate of intraoperative need for vasopressor, incidence of unplanned intensive care unit admission, rate of need for rapid response team call, intensive care unit length of stay, hospital length of stay, and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">Among 1236 patients who were randomized, 1206 (98.9%) completed the trial (mean age, 63.5 years; 494 [40.9%] women; 681 [56.4%] undergoing abdominal surgery). The primary outcome occurred in 231 of 608 patients (38%) in the low tidal volume group compared with 232 of 590 patients (39%) in the conventional tidal volume group (difference, -1.3% [95% CI, -6.8% to 4.2%]; risk ratio, 0.97 [95% CI, 0.84-1.11]; P&#x2009;=&#x2009;.64). There were no significant differences in any of the secondary outcomes.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adult patients undergoing major surgery, intraoperative ventilation with low tidal volume compared with conventional tidal volume, with PEEP applied equally between groups, did not significantly reduce pulmonary complications within the first 7 postoperative days.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ANZCTR Identifier: ACTRN12614000790640.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karalapillai</LastName><ForeName>Dharshi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellard</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Raymond</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearce</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chong O</ForeName><Initials>CO</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oughton</LastName><ForeName>Chad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galtieri</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>Ary</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Amsterdam University Medical Centres, Location AMC, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eastwood</LastName><ForeName>Glenn</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Daryl A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Jan 19;325(3):306. doi: 10.1001/jama.2020.22627.</RefSource><PMID Version="1">33464328</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Jan 19;325(3):307. doi: 10.1001/jama.2020.22630.</RefSource><PMID Version="1">33464329</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Jan 19;325(3):306-307. doi: 10.1001/jama.2020.22633.</RefSource><PMID Version="1">33464330</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="Y">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Peyton reported receipt of personal fees from Maquet Critical Care. Dr Wilson reported receipt of personal fees from Fisher Paykel. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32870298</ArticleId><ArticleId IdType="pmc">PMC7489812</ArticleId><ArticleId IdType="doi">10.1001/jama.2020.12866</ArticleId><ArticleId IdType="pii">2770010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meara JG, Leather AJM, Hagander L, et al. . Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386(9993):569-624. doi:10.1016/S0140-6736(15)60160-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60160-X</ArticleId><ArticleId IdType="pubmed">25924834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Bustamante A, Frendl G, Sprung J, et al. . Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the Perioperative Research Network Investigators. JAMA Surg. 2017;152(2):157-166. doi:10.1001/jamasurg.2016.4065</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.4065</ArticleId><ArticleId IdType="pmc">PMC5334462</ArticleId><ArticleId IdType="pubmed">27829093</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017;118(3):317-334. doi:10.1093/bja/aex002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex002</ArticleId><ArticleId IdType="pubmed">28186222</ArticleId></ArticleIdList></Reference><Reference><Citation>Young CC, Harris EM, Vacchiano C, et al. . Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations. Br J Anaesth. 2019;123(6):898-913. doi:10.1016/j.bja.2019.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.08.017</ArticleId><ArticleId IdType="pubmed">31587835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendixen HH, Hedley-Whyte J, Laver MB. Impaired oxygenation in surgical patients during general anesthesia with controlled ventilation: a concept of atelectasis. N Engl J Med. 1963;269:991-996. doi:10.1056/NEJM196311072691901</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196311072691901</ArticleId><ArticleId IdType="pubmed">14059732</ArticleId></ArticleIdList></Reference><Reference><Citation>Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A; Acute Respiratory Distress Syndrome Network . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308. doi:10.1056/NEJM200005043421801</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200005043421801</ArticleId><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Cardoso SO, Manetta JA, et al. . Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012;308(16):1651-1659. doi:10.1001/jama.2012.13730</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.13730</ArticleId><ArticleId IdType="pubmed">23093163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zupancich E, Paparella D, Turani F, et al. . Mechanical ventilation affects inflammatory mediators in patients undergoing cardiopulmonary bypass for cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg. 2005;130(2):378-383. doi:10.1016/j.jtcvs.2004.11.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2004.11.061</ArticleId><ArticleId IdType="pubmed">16077402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrigge H, Uhlig U, Baumgarten G, et al. . Mechanical ventilation strategies and inflammatory responses to cardiac surgery: a prospective randomized clinical trial. Intensive Care Med. 2005;31(10):1379-1387. doi:10.1007/s00134-005-2767-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2767-1</ArticleId><ArticleId IdType="pubmed">16132888</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Miranda D, Gommers D, Struijs A, et al. . Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery. Eur J Cardiothorac Surg. 2005;28(6):889-895. doi:10.1016/j.ejcts.2005.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.10.007</ArticleId><ArticleId IdType="pubmed">16271479</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, et al. ; IMPROVE Study Group . A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428-437. doi:10.1056/NEJMoa1301082</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanderer JP, Blum JM, Ehrenfeld JM. Intraoperative low-tidal-volume ventilation. N Engl J Med. 2013;369(19):1861. doi:10.1056/NEJMc1311316</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1311316</ArticleId><ArticleId IdType="pubmed">24195560</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin MA, McCormick PJ, Lin HM, Hosseinian L, Fischer GW. Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality. Br J Anaesth. 2014;113(1):97-108. doi:10.1093/bja/aeu054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu054</ArticleId><ArticleId IdType="pmc">PMC9585620</ArticleId><ArticleId IdType="pubmed">24623057</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Galtieri J, et al. . Current ventilation practice during general anaesthesia: a prospective audit in Melbourne, Australia. BMC Anesthesiol. 2014;14:85. doi:10.1186/1471-2253-14-85</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-14-85</ArticleId><ArticleId IdType="pmc">PMC4190393</ArticleId><ArticleId IdType="pubmed">25302048</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, et al. . Low tidal volume ventilation during anaesthesia for major surgery: protocol and statistical analysis plan. Crit Care Resusc. 2019;21(4):243-250.</Citation><ArticleIdList><ArticleId IdType="pubmed">31778630</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg L, Li M, Churilov L, et al. . Associations of fluid amount, type, and balance and acute kidney injury in patients undergoing major surgery. Anaesth Intensive Care. 2018;46(1):79-87. doi:10.1177/0310057X1804600112</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1804600112</ArticleId><ArticleId IdType="pubmed">29361260</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ; PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology . High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014;384(9942):495-503. doi:10.1016/S0140-6736(14)60416-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60416-5</ArticleId><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluth T, Serpa Neto A, Schultz MJ, et al. ; Writing Committee for the PROBESE Collaborative Group of the Protective Ventilation Network (PROVEnet) for the Clinical Trial Network of the European Society of Anaesthesiology; PROBESE Collaborative Group . Effect of intraoperative high positive end-expiratory pressure (PEEP) with recruitment maneuvers vs low PEEP on postoperative pulmonary complications in obese patients: a randomized clinical trial. JAMA. 2019;321(23):2292-2305. doi:10.1001/jama.2019.7505</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.7505</ArticleId><ArticleId IdType="pmc">PMC6582260</ArticleId><ArticleId IdType="pubmed">31157366</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti AB, Suzumura &#xc9;A, Laranjeira LN, et al. ; Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial Investigators . Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2017;318(14):1335-1345. doi:10.1001/jama.2017.14171</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.14171</ArticleId><ArticleId IdType="pmc">PMC5710484</ArticleId><ArticleId IdType="pubmed">28973363</ArticleId></ArticleIdList></Reference><Reference><Citation>LAS VEGAS Investigators Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS&#x2014;an observational study in 29 countries. Eur J Anaesthesiol. 2017;34(8):492-507. doi:10.1097/EJA.0000000000000646</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000646</ArticleId><ArticleId IdType="pmc">PMC5502122</ArticleId><ArticleId IdType="pubmed">28633157</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39736782</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>30</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>439</StartPage><MedlinePgn>439</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">439</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-024-05212-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Excessive exposure to adrenergic vasopressors may be harmful. Non-adrenergic vasopressors may spare adrenergic agents and potentially improve outcomes. We aimed to conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy of non-adrenergic vasopressors in adult patients receiving vasopressor therapy for vasodilatory shock or perioperative vasoplegia.</AbstractText><AbstractText Label="METHODS">We searched PubMed, Embase, and Cochrane Library for RCTs comparing non-adrenergic vasopressors with adrenergic vasopressors alone or placebo in critically ill or perioperative patients. Each eligible study was categorized into septic shock, cardiac surgery, or non-cardiac surgery. Non-adrenergic vasopressors included vasopressin, terlipressin, selepressin, angiotensin II, methylene blue, and hydroxocobalamin. The primary outcome was mortality at longest follow-up. We conducted a random-effects meta-analysis. We registered the protocol in PROSPERO International Prospective Register of Systematic Reviews (CRD42024505039).</AbstractText><AbstractText Label="RESULTS">Among 51 eligible RCTs totaling 5715 patients, the predominant population was septic shock in 30 studies, cardiac surgery in 11 studies, and non-cardiac surgery in 10 studies. Cochrane risk-of-bias tool for randomized trials version 2 identified 17 studies as low risk of bias. In septic shock, mortality was significantly lower in the non-adrenergic group (960/2232 [43%] vs. 898/1890 [48%]; risk ratio [RR], 0.92; 95% confidence interval [95% CI], 0.86-0.97; P&#x2009;=&#x2009;0.03; I<sup>2</sup>&#x2009;=&#x2009;0%), with none of the individual non-adrenergic vasopressors showing significant survival benefits. No significant mortality difference was observed in patients undergoing cardiac surgery (34/410 [8.3%] vs. 47/412 [11%]; RR, 0.82; 95% CI, 0.55-1.22; P&#x2009;=&#x2009;0.32; I<sup>2</sup>&#x2009;=&#x2009;12%) or those undergoing non-cardiac surgery (9/388 [2.3%] vs. 18/383 [4.7%]; RR, 0.66; 95% CI, 0.31-1.41; P&#x2009;=&#x2009;0.28; I<sup>2</sup>&#x2009;=&#x2009;0%).</AbstractText><AbstractText Label="CONCLUSIONS">Administration of non-adrenergic vasopressors was significantly associated with reduced mortality in patients with septic shock. However, no single agent achieved statistical significance in separate analyses. Although the pooled effects of non-adrenergic vasopressors on survival did not reach statistical significance in patients undergoing cardiac or non-cardiac surgery, the confidence intervals included the possibility of both no effect and a clinically important benefit from non-adrenergic agents. These findings justify the conduct of further RCTs comparing non-adrenergic vasopressors to usual care based on noradrenaline alone.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kotani</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9532-2859</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kameda Medical Center, 929 Higashi-Cho, Kamogawa, 296-8602, Japan. kotani.yuki@kameda.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3131-0565</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonaccorso</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wieruszewski</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Jikei University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>Ashish K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Section On Critical Care Medicine, Wake Forest School of Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outcomes Research Consortium, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Heidelberg, Melbourne, VIC, 3084, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation, Austin Hospital, Heidelberg, Melbourne, VIC, 3084, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056987" MajorTopicYN="Y">Vasoplegia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="Y">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012769" MajorTopicYN="N">Shock</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiotensin II</Keyword><Keyword MajorTopicYN="N">Arginine vasopressin</Keyword><Keyword MajorTopicYN="N">Catecholamines</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Methylene blue</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: YK has received consultancy fees from Viatris. PMW previously received consultant fees from Viatris. AKK received consulting fees from Medtronic, Edwards Life Sciences, Philips Research North America, Hillrom, GE Healthcare, Potrero Medical, Viatris Pharma, Trevena Pharma, Fifth Eye Inc., Pharmazz Inc., Retia Medical and Caretaker Medical. He is also funded with a Wake Forest Clinical and Translational Science Institute (CTSI) grant on renin dysfunction in septic shock. GL has received speaker fees from Medis, Paion, and Viatris and consultancy fees from Paion and Viatris. RB has received grants and consultancy fees from La Jolla Pharmaceuticals, Paion AG, and Viatris. The other authors have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>31</Day><Hour>11</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>31</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>31</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39736782</ArticleId><ArticleId IdType="pmc">PMC11686893</ArticleId><ArticleId IdType="doi">10.1186/s13054-024-05212-7</ArticleId><ArticleId IdType="pii">10.1186/s13054-024-05212-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">24171518</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse LW, Barker N, Petersen C. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. Crit Care. 2020;24:36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7001322</ArticleId><ArticleId IdType="pubmed">32019600</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M, Einav S, Antonucci E, Depret F, Lakbar I, Martin-Loeches I, et al. Multimodal strategy to counteract vasodilation in septic shock. Anaesth Crit Care Pain Med. 2023;42:101193.</Citation><ArticleIdList><ArticleId IdType="pubmed">36621622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarra-Estrada M, Kattan E, Aguilera-Gonz&#xe1;lez P, Sandoval-Plascencia L, Rico-Jauregui U, G&#xf3;mez-Partida CA, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023;27:110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10010212</ArticleId><ArticleId IdType="pubmed">36915146</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JJ, Willoughby R, Peterson J, Carver T, Zelten J, Markiewicz A, et al. High-dose intravenous hydroxocobalamin (Vitamin B12) in septic shock: a double-blind, allocation-concealed, placebo-controlled single-center pilot randomized controlled trial (the IV-HOCSS trial). Chest. 2022. 10.1016/j.chest.2022.09.021.</Citation><ArticleIdList><ArticleId IdType="pubmed">36174744</ArticleId></ArticleIdList></Reference><Reference><Citation>Auchet T, Regnier M-A, Girerd N, Levy B. Outcome of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care. 2017;7:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5397393</ArticleId><ArticleId IdType="pubmed">28425079</ArticleId></ArticleIdList></Reference><Reference><Citation>Belletti A, Musu M, Silvetti S, Saleh O, Pasin L, Monaco F, et al. Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS ONE. 2015;10:e0142605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4641698</ArticleId><ArticleId IdType="pubmed">26558621</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, et al. Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA. 2018;319:1889&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583502</ArticleId><ArticleId IdType="pubmed">29801010</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, et al. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med. 2019;45:844&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">31062052</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruna A, Bonaccorso A, Belletti A, Turi S, Di Prima AL, D&#x2019;amico F, et al. Methylene blue reduces mortality in critically ill and perioperative patients: a meta-analysis of randomized trials. J Cardiothorac Vasc Anesth. 2023. 10.1053/j.jvca.2023.09.037.</Citation><ArticleIdList><ArticleId IdType="pubmed">37880041</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">28528561</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadjadi M, von Groote T, Weiss R, Strau&#xdf; C, Wempe C, Albert F, et al. A pilot study of renin-guided angiotensin-ii infusion to reduce kidney stress after cardiac surgery. Anesth Analg. 2024. 10.1213/ANE.0000000000006839.</Citation><ArticleIdList><ArticleId IdType="pubmed">38289858</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulson TG, Miles LF, Serpa Neto A, Pilcher D, Weinberg L, Landoni G, et al. A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery*. Anaesthesia. 2022;77:999&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9543254</ArticleId><ArticleId IdType="pubmed">35915923</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>McMaster University (developed by Evidence Prime). GRADEpro GDT 2015.</Citation></Reference><Reference><Citation>Gaudry S, Messika J, Ricard J-D, Guillo S, Pasquet B, Dubief E, et al. Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review. Ann Intensive Care. 2017;7:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5340787</ArticleId><ArticleId IdType="pubmed">28271450</ArticleId></ArticleIdList></Reference><Reference><Citation>Harhay MO, Wagner J, Ratcliffe SJ, Bronheim RS, Gopal A, Green S, et al. Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med. 2014;189:1469&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4226016</ArticleId><ArticleId IdType="pubmed">24786714</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker HGM, Brown AJ, Vaz IP, Reed R, Schofield MA, Shao J, et al. Composite outcome measures in high-impact critical care randomised controlled trials: a systematic review. Crit Care. 2024;28:184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11134769</ArticleId><ArticleId IdType="pubmed">38807143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani Y, Di Gioia A, Landoni G, Belletti A, Khanna AK. An updated &#x201c;norepinephrine equivalent&#x201d; score in intensive care as a marker of shock severity. Crit Care. 2023;27:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9854213</ArticleId><ArticleId IdType="pubmed">36670410</ArticleId></ArticleIdList></Reference><Reference><Citation>Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61:763&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference><Reference><Citation>Alban&#xe8;se J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med. 2005;33:1897&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">16148457</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora V, Maiwall R, Rajan V, Jindal A, Muralikrishna Shasthry S, Kumar G, et al. Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure. Hepatology. 2020;71:600&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">30076614</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzegar E, Ahmadi A, Mousavi S, Nouri M, Mojtahedzadeh M. The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: microcirculation, is it the black box? Acta Med Iran. 2016;54:15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26853286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, et al. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care. 2014;18:534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4212099</ArticleId><ArticleId IdType="pubmed">25286986</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Kedarisetty CK, Vashishtha C, Saini D, Kumar S, Maiwall R, et al. A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock. Liver Int. 2017;37:552&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">27633962</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;nser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12732600</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca-Ruiz NJ, Cano ASL, Carmona DPO, Aguirre MC, G&#xf3;mez Hern&#xe1;ndez MP, Garc&#xed;a CO, et al. Uso de vasopresina en pacientes con choque s&#xe9;ptico refractario a catecolaminas. Acta Colomb Cuid Intensivo. 2013;13:114&#x2013;23.</Citation></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, et al. Vasopressin versus norepinephrine for the management of septic shock in cancer patients: the VANCS II randomized clinical trial. Crit Care Med. 2019;47:1743&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">31609774</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua F, Wang X, Zhu L. Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock. J Emerg Med. 2013;44:434&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9904411</ArticleId><ArticleId IdType="pubmed">22921855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussien RM, El-Gendy HA, Elsaidy MI, Abdelhamid MS, Shabana TS. Comparison between norepinephrine alone versus norepinephrine/vasopressin combination for resuscitation in septic shock: a randomized clinical trial. Egypt J Crit Care Med. 2021;8:58.</Citation></Reference><Reference><Citation>Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbj&#xf8;rnsson B, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001;29:1860&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11588440</ArticleId></ArticleIdList></Reference><Reference><Citation>Laterre P-F, Berry SM, Blemings A, Carlsen JE, Fran&#xe7;ois B, Graves T, et al. Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT Randomized clinical trial. JAMA. 2019;322:1476&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802260</ArticleId><ArticleId IdType="pubmed">31577035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauzier F, L&#xe9;vy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med. 2006;32:1782&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17019548</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZM, Chen J, Kou Q, Lin Q, Huang X, Tang Z, et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018;44:1816&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">29971593</ArticleId></ArticleIdList></Reference><Reference><Citation>Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47:699&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">10528604</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Yu H, Liu Q, Yao M, Zhu J. The therapeutic effect of continuous intravenous infusion of methylene blue on patients with septic shock. Natl Med J China. 2019;99:868&#x2013;71.</Citation></Reference><Reference><Citation>Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care. 2002;30:755&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">12500513</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Lange M, D&#xfc;nser M, Rehberg S, Van Aken H, et al. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth. 2008;100:494&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">18308741</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13:R130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2750187</ArticleId><ArticleId IdType="pubmed">19664253</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Vincent J-L, Kj&#xf8;lbye AL, Olsson H, Blemings A, Spapen H, et al. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Crit Care. 2017;21:213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5557574</ArticleId><ArticleId IdType="pubmed">28807037</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, H&#xe9;bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo P, Kothari N, Goyal S, Sharma A, Bhatia PK. Comparison of norepinephrine and terlipressin vs norepinephrine alone for management of septic shock: a randomized control study. Indian J Crit Care Med. 2022;26:669&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9237141</ArticleId><ArticleId IdType="pubmed">35836627</ArticleId></ArticleIdList></Reference><Reference><Citation>Senthilnathan M, Cherian A, Balachander H, Maroju NK. Role of methylene blue in the maintenance of postinduction hemodynamic status in patients with perforation peritonitis: a pilot study. Anesth Essays Res. 2017;11:665&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5594787</ArticleId><ArticleId IdType="pubmed">28928568</ArticleId></ArticleIdList></Reference><Reference><Citation>Svoboda P, Scheer P, Kantorov&#xe1; I, Doubek J, Dudra J, Radvan M, et al. Terlipressin in the treatment of late phase catecholamine-resistant septic shock. Hepatogastroenterology. 2012;59:1043&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22580654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Shi M, Huang L, Li Q, Meng S, Xu J, et al. Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study. Ren Fail. 2022;44:1207&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307113</ArticleId><ArticleId IdType="pubmed">35856162</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X, Zhang J, Wang Y, Zhou J, Zhu Y, Jiang D, et al. Effects of terlipressin on patients with sepsis via improving tissue blood flow. J Surg Res. 2016;200:274&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">26253455</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett SR, McKeown J, Drew P, Griffin S. Angiotensin in cardiac surgery: efficacy in patients on angiotensin converting enzyme inhibitors. Eur J Heart Fail. 2001;3:587&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">11595607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, Rhodes A, Landoni G, Osawa EA, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology. 2017;126:85&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">27841822</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004;77:496&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14759425</ArticleId></ArticleIdList></Reference><Reference><Citation>Luckner G, D&#xfc;nser MW, Stadlbauer K-H, Mayr VD, Jochberger S, Wenzel V, et al. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care. 2006;10:R40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1550871</ArticleId><ArticleId IdType="pubmed">16542484</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslow AD, Stearns G, Butala P, Schwartz CS, Gough J, Singh AK. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg. 2006;103:2&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16790616</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DLS, Garrido MJ, Madigan JD, Helman DN, Faber J, Williams MR, et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003;75:926&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">12645718</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto Y, Nohmi T, Higa Y, Seki K, Yamashita A. Vasopressin does not raise cardiac enzymes following cardiac surgery: a randomized double-blind clinical trial. J Cardiothorac Vasc Anesth. 2015;29:46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">25440643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozal E, Kuralay E, Yildirim V, Kilic S, Bolcal C, K&#xfc;c&#xfc;karslan N, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005;79:1615&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15854942</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos G, Sintou E, Siminelakis S, Koletsis E, Baikoussis NG, Apostolakis E. Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting&#x2013;a double-blind randomized study. J Cardiothorac Surg. 2010;5:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2855562</ArticleId><ArticleId IdType="pubmed">20346182</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Wang R, Li S, Zhu X, Wang T, Wu J, et al. Methylene blue reduces incidence of early postoperative cognitive disorders in elderly patients undergoing major non-cardiac surgery: an open-label randomized controlled clinical trial. J Clin Anesth. 2021;68:110108.</Citation><ArticleIdList><ArticleId IdType="pubmed">33091706</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgebaly AS, Abd El Ghafar MS, Fathy SM, Shaddad MN. Vasopressin continuous infusion improves intracranial pressure and patient outcomes after surgical clipping or endovascular coiling of cerebral aneurysm. Anesth Essays Res. 2019;13:528&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6775829</ArticleId><ArticleId IdType="pubmed">31602073</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SH, Lee JM, Choi JH, Chung HS, Park JH, Park CS. Perioperative assessment of terlipressin infusion during living donor liver transplantation. J Int Med Res. 2012;40:225&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">22429362</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Gao X, Wang M, Yang Z, Xiang L, Li Y, et al. Prophylactic administration with methylene blue improves hemodynamic stabilization during obstructive jaundice-related diseases&#x2019; operation: a blinded randomized controlled trial. J Gastrointest Surg. 2023;27:1837&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10511601</ArticleId><ArticleId IdType="pubmed">37101089</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelzow H, Gedney JA, Baumann J, Snook NJ, Bellamy MC. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg. 2002;94:824&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11916779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler A, Perrodin S, De Gottardi A, Candinas D, Beldi G. Effectiveness of terlipressin for prevention of complications after major liver resection&#x2013;a randomized placebo-controlled trial. HPB. 2020;22:884&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">31680011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdy MM, Abbas MS, Kamel EZ, Mostafa MF, Herdan R, Hassan SA, et al. Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial. BMC Anesthesiol. 2019;19:106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6570915</ArticleId><ArticleId IdType="pubmed">31200638</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy MS, Kaliamoorthy I, Rajakumar A, Malleeshwaran S, Appuswamy E, Lakshmi S, et al. Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation. Liver Transpl. 2017;23:1007&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">28294557</ArticleId></ArticleIdList></Reference><Reference><Citation>Song T, Kim MK, Kim M-L, Jung YW, Yun BS, Seong SJ. Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015;195:177&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">26550945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Tian M, Sun L-Y, Zhu Z-J. Prophylactic terlipressin infusion for severe postreperfusion syndrome in patients undergoing deceased donor liver transplantation: the TIPS-DDLT randomized controlled trial. Int J Surg. 2023;109:1923&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10389645</ArticleId><ArticleId IdType="pubmed">37161582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasija S, Makhija N, Choudhury M, Hote M, Chauhan S, Kiran U. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2010;24:230&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19875309</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Sheng Y, Feng X, Wu J. The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis. Crit Care. 2019;23:91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6419432</ArticleId><ArticleId IdType="pubmed">30871607</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;nser MW, Bouvet O, Knotzer H, Arulkumaran N, Hajjar LA, Ulmer H, et al. Vasopressin in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2018;32:2225&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">29748077</ArticleId></ArticleIdList></Reference><Reference><Citation>Heybati K, Xie G, Ellythy L, Poudel K, Deng J, Zhou F, et al. Outcomes of vasopressin-receptor agonists versus norepinephrine in adults with perioperative hypotension: a systematic review. J Cardiothorac Vasc Anesth. 2024;38:1577&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">38580478</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, Ji X-W, Wang H-L, Zhao G-M, Zhou Q, Xie B. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials. J Intensive Care. 2020;8:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7603734</ArticleId><ArticleId IdType="pubmed">33292658</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando SM, Tran A, Soliman K, Flynn B, Oommen T, Wenzhe L, et al. Methylene blue in septic shock: a systematic review and meta-analysis. Crit Care Explor. 2024;6:e1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11196076</ArticleId><ArticleId IdType="pubmed">38904978</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the working group on prevention, AKI section, European society of intensive care medicine. Intensive Care Med. 2017;43:730&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5487598</ArticleId><ArticleId IdType="pubmed">28577069</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, et al. Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II. Crit Care Med. 2018;46:949&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5959265</ArticleId><ArticleId IdType="pubmed">29509568</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the global burden of disease study. Lancet. 2020;395:200&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Alipanah-Lechner N, Bos LD, Dianti J, Diaz JV, Finfer S, et al. From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU. Am J Respir Crit Care Med. 2024;210:155&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11273306</ArticleId><ArticleId IdType="pubmed">38687499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Forni LG, Busse LW, McCurdy MT, Ham KR, Boldt DW, et al. Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial. Am J Respir Crit Care Med. 2020;202:1253&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605187</ArticleId><ArticleId IdType="pubmed">32609011</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth D, Heidinger B, Havel C, Herkner H. Different mortality time points in critical care trials: current practice and influence on effect estimates in meta-analyses. Crit Care Med. 2016;44:e737&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">26963325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieruszewski PM, Leone M, Kaas-Hansen BS, Dugar S, Legrand M, McKenzie CA, et al. Position paper on the reporting of norepinephrine formulations in critical care from the society of critical care medicine and European society of intensive care medicine joint task force. Crit Care Med. 2024;52:521&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">38240498</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37470680</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Blood Purification for Adult Patients With Severe Infection or Sepsis/Septic Shock: A Network Meta-Analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>1777</StartPage><EndPage>1789</EndPage><MedlinePgn>1777-1789</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000005991</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study aimed to conduct a comprehensive and updated systematic review with network meta-analysis (NMA) to assess the outcome benefits of various blood purification modalities for adult patients with severe infection or sepsis.</AbstractText><AbstractText Label="DATA SOURCES">We conducted a search of PubMed, MEDLINE, clinical trial registries, Cochrane Library, and Embase databases with no language restrictions.</AbstractText><AbstractText Label="STUDY SELECTION">Only randomized controlled trials (RCTs) were selected.</AbstractText><AbstractText Label="DATA EXTRACTION">The primary outcome was overall mortality. The secondary outcomes were the length of mechanical ventilation (MV) days and ICU stay, incidence of acute kidney injury (AKI), and kidney replacement therapy requirement.</AbstractText><AbstractText Label="DATA SYNTHESIS">We included a total of 60 RCTs with 4,595 participants, comparing 16 blood purification modalities with 17 interventions. Polymyxin-B hemoperfusion (relative risk [RR]: 0.70; 95% CI, 0.57-0.86) and plasma exchange (RR: 0.61; 95% CI, 0.42-0.91) were associated with low mortality (very low and low certainty of evidence, respectively). Because of the presence of high clinical heterogeneity and intransitivity, the potential benefit of polymyxin-B hemoperfusion remained inconclusive. The analysis of secondary outcomes was limited by the scarcity of available studies. HA330 with high-volume continuous venovenous hemofiltration (CVVH), HA330, and standard-volume CVVH were associated with shorter ICU stay. HA330 with high-volume CVVH, HA330, and standard-volume CVVH were beneficial in reducing MV days. None of the interventions showed a significant reduction in the incidence of AKI or the need for kidney replacement therapy.</AbstractText><AbstractText Label="CONCLUSIONS">Our NMA suggests that plasma exchange and polymyxin-B hemoperfusion may provide potential benefits for adult patients with severe infection or sepsis/septic shock when compared with standard care alone, but most comparisons were based on low or very low certainty evidence. The therapeutic effect of polymyxin-B hemoperfusion remains uncertain. Further RCTs are required to identify the specific patient population that may benefit from extracorporeal blood purification.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jia-Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Pei-Chun</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Education Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Tao-Han</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Chansn Hospital, Taoyuan City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yen-Ta</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>J2VZ07J96K</RegistryNumber><NameOfSubstance UI="D011112">Polymyxin B</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006440" MajorTopicYN="N">Hemofiltration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006464" MajorTopicYN="Y">Hemoperfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010951" MajorTopicYN="N">Plasma Exchange</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011112" MajorTopicYN="N">Polymyxin B</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>12</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37470680</ArticleId><ArticleId IdType="pmc">PMC10645104</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000005991</ArticleId><ArticleId IdType="pii">00003246-202312000-00014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. : The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016; 315:801&#x2013;810</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, et al. : Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021; 49:e1063&#x2013;e1143</Citation><ArticleIdList><ArticleId IdType="pubmed">34605781</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Ogura H, Yatabe T, et al. : The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). J Intensive Care. 2021; 9:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384927</ArticleId><ArticleId IdType="pubmed">34433491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, Monneret G, Payen D: Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013; 13:862&#x2013;874</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4077177</ArticleId><ArticleId IdType="pubmed">24232462</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Poll T, van de Veerdonk FL, Scicluna BP, et al. : The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017; 17:407&#x2013;420</Citation><ArticleIdList><ArticleId IdType="pubmed">28436424</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriyama K, Nishida O: Targeting cytokines, pathogen-associated molecular patterns, and damage-associated molecular patterns in sepsis via blood purification. Int J Mol Sci. 2021; 22:8882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8396222</ArticleId><ArticleId IdType="pubmed">34445610</ArticleId></ArticleIdList></Reference><Reference><Citation>Monard C, Abraham P, Schneider A, et al. : New targets for extracorporeal blood purification therapies in sepsis. Blood Purif. 2023; 52:1&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">35717943</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Leopold SJ, Cranendonk DR, et al. : Host innate immune responses to sepsis. Virulence. 2014; 5:36&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3916381</ArticleId><ArticleId IdType="pubmed">23774844</ArticleId></ArticleIdList></Reference><Reference><Citation>Deans KJ, Haley M, Natanson C, et al. : Novel therapies for sepsis: A review. J Trauma. 2005; 58:867&#x2013;874</Citation><ArticleIdList><ArticleId IdType="pubmed">15824673</ArticleId></ArticleIdList></Reference><Reference><Citation>Putzu A, Schorer R, Lopez-Delgado JC, et al. : Blood purification and mortality in sepsis and septic shock: A systematic review and meta-analysis of randomized trials. Anesthesiology. 2019; 131:580&#x2013;593</Citation><ArticleIdList><ArticleId IdType="pubmed">31246600</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu C, Mao Z, et al. : Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis. J Crit Care. 2021; 63:187&#x2013;195</Citation><ArticleIdList><ArticleId IdType="pubmed">33012579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SH, Chan WS, Liu CM, et al. : Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: A randomized controlled trial. Ann Intensive Care. 2020; 10:80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290141</ArticleId><ArticleId IdType="pubmed">32533380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipcsey M, Tenhunen J, Pischke SE, et al. : Endotoxin removal in septic shock with the Alteco LPS adsorber was safe but showed no benefit compared to placebo in the double-blind randomized controlled trial&#x2014;the asset study. Shock. 2020; 54:224&#x2013;231</Citation><ArticleIdList><ArticleId IdType="pubmed">31880758</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin Tang PF, Li H, Ping C, et al. : Endotoxin adsorption therapy in patients with sepsis or infectious shock due to gram-negative bacterial infections in abdominal cavity: A multicenter randomized controlled trial. Med J West China. 2022; 34:729&#x2013;734</Citation></Reference><Reference><Citation>Radhakrishnan M, Batra A, Periyavan S, et al. : Hydroxyethyl starch and kidney function: A retrospective study in patients undergoing therapeutic plasma exchange. J Clin Apher. 2018; 33:278&#x2013;282</Citation><ArticleIdList><ArticleId IdType="pubmed">29083113</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Jackson D, Barrett JK, et al. : Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies. Res Synth Methods. 2012; 3:98&#x2013;110</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433772</ArticleId><ArticleId IdType="pubmed">26062084</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolakopoulou A, Higgins JPT, Papakonstantinou T, et al. : CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020; 17:e1003082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7122720</ArticleId><ArticleId IdType="pubmed">32243458</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovic J, Page MJ, et al. : RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignardello-Petersen R, Bonner A, Alexander PE, et al. ; GRADE Working Group: Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. J Clin Epidemiol. 2018; 93:36&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pubmed">29051107</ArticleId></ArticleIdList></Reference><Reference><Citation>Asch S, Kaufmann TP, Walter M, et al. : The effect of perioperative hemadsorption in patients operated for acute infective endocarditis&#x2014;a randomized controlled study. Artif Organs. 2021; 45:1328&#x2013;1337</Citation><ArticleIdList><ArticleId IdType="pubmed">34152632</ArticleId></ArticleIdList></Reference><Reference><Citation>Boussekey N, Chiche A, Faure K, et al. : A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med. 2008; 34:1646&#x2013;1653</Citation><ArticleIdList><ArticleId IdType="pubmed">18542921</ArticleId></ArticleIdList></Reference><Reference><Citation>Busund R, Koukline V, Utrobin U, et al. : Plasmapheresis in severe sepsis and septic shock: A prospective, randomised, controlled trial. Intensive Care Med. 2002; 28:1434&#x2013;1439</Citation><ArticleIdList><ArticleId IdType="pubmed">12373468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantaluppi V, Assenzio B, Pasero D, et al. : Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med. 2008; 34:1638&#x2013;1645</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2517091</ArticleId><ArticleId IdType="pubmed">18463848</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Li G, Yu Y, et al. : Clinical effects of hemoperfusion combined with pulse high-volume hemofiltration on septic shock. Medicine (Baltim). 2020; 99:e19058</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7478611</ArticleId><ArticleId IdType="pubmed">32118713</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung KK, Coates EC, Smith DJ, Jr, et al. ; Randomized controlled Evaluation of high-volume hemofiltration in adult burn patients with Septic shoCk and acUte kidnEy injury (RESCUE) Investigators: High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: A multicenter randomized controlled trial. Crit Care. 2017; 21:289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5702112</ArticleId><ArticleId IdType="pubmed">29178943</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole L, Bellomo R, Hart G, et al. : A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med. 2002; 30:100&#x2013;106</Citation><ArticleIdList><ArticleId IdType="pubmed">11902250</ArticleId></ArticleIdList></Reference><Reference><Citation>Coudroy R, Payen D, Launey Y, et al. ; ABDOMIX group: Modulation by polymyxin-B hemoperfusion of inflammatory response related to severe peritonitis. Shock. 2017; 47:93&#x2013;99</Citation><ArticleIdList><ArticleId IdType="pubmed">27984535</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz DN, Antonelli M, Fumagalli R, et al. : Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial. JAMA. 2009; 301:2445&#x2013;2452</Citation><ArticleIdList><ArticleId IdType="pubmed">19531784</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Bagshaw SM, Antonelli M, et al. ; EUPHRATES Trial Investigators: Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: The EUPHRATES randomized clinical trial. JAMA. 2018; 320:1455&#x2013;1463</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6233793</ArticleId><ArticleId IdType="pubmed">30304428</ArticleId></ArticleIdList></Reference><Reference><Citation>Diab M, Lehmann T, Bothe W, et al. ; REMOVE Trial Investigators*: Cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis REMOVE: Results from a multicenter randomized controlled trial. Circulation. 2022; 145:959&#x2013;968</Citation><ArticleIdList><ArticleId IdType="pubmed">35213213</ArticleId></ArticleIdList></Reference><Reference><Citation>Faqihi F, Alharthy A, Abdulaziz S, et al. : Therapeutic plasma exchange in patients with life-threatening COVID-19: A randomised controlled clinical trial. Int J Antimicrob Agents. 2021; 57:106334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8024223</ArticleId><ArticleId IdType="pubmed">33838224</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J, Zhang S, Ai T, et al. : Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: A pilot randomized controlled trial. Int J Artif Organs. 2022; 45:801&#x2013;808</Citation><ArticleIdList><ArticleId IdType="pubmed">35864718</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbero E, Livigni S, Ferrari F, et al. ; GiViTI: High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: A multicentre, adaptive, randomised clinical trial. Intensive Care Med. 2021; 47:1303&#x2013;1311</Citation><ArticleIdList><ArticleId IdType="pubmed">34601619</ArticleId></ArticleIdList></Reference><Reference><Citation>Gim&#xe9;nez-Esparza C, Portillo-Requena C, Colomina-Climent F, et al. : The premature closure of ROMPA clinical trial: Mortality reduction in septic shock by plasma adsorption. BMJ Open. 2019; 9:e030139</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924739</ArticleId><ArticleId IdType="pubmed">31796477</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SS, Sun T, Li Z, et al. : Effect of continuous blood purification on endothelial cell function in patients with severe sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011; 23:81&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">21315003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan J, Cader RA, Kong NC, et al. : Coupled Plasma Filtration Adsorption (CPFA) plus Continuous Veno-Venous Haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis. EXCLI J. 2013; 12:681&#x2013;692</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653725</ArticleId><ArticleId IdType="pubmed">26600735</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Wang SR, Su W, et al. : Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 2010; 14:596&#x2013;602</Citation><ArticleIdList><ArticleId IdType="pubmed">21118369</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Wang SR, Yang ZL, et al. : Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 2013; 17:454&#x2013;461</Citation><ArticleIdList><ArticleId IdType="pubmed">23931889</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawchar F, Laszlo I, Oveges N, et al. : Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. J Crit Care. 2019; 49:172&#x2013;178</Citation><ArticleIdList><ArticleId IdType="pubmed">30448517</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannes-Boyau O, Honor&#xe9; PM, Perez P, et al. : High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): A multicentre randomized controlled trial. Intensive Care Med. 2013; 39:1535&#x2013;1546</Citation><ArticleIdList><ArticleId IdType="pubmed">23740278</ArticleId></ArticleIdList></Reference><Reference><Citation>John S, Griesbach D, Baumg&#xe4;rtel M, et al. : Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: A prospective, randomized clinical trial. Nephrol Dial Transplant. 2001; 16:320&#x2013;327</Citation><ArticleIdList><ArticleId IdType="pubmed">11158407</ArticleId></ArticleIdList></Reference><Reference><Citation>Livigni S, Bertolini G, Rossi C, et al. ; GiViTI: Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva (Italian Group for the Evaluation of Interventions in Intensive Care Medicine) is an independent collaboration network of Italian Intensive Care units: Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial. BMJ Open. 2014; 4:e003536</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3902195</ArticleId><ArticleId IdType="pubmed">24401721</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng JB, Lai ZZ, Xu XJ, et al. : Effects of early continuous venovenous hemofiltration on E-Selectin, hemodynamic stability, and ventilatory function in patients with septic-shock-induced acute respiratory distress syndrome. Biomed Res Int. 2016; 2016:7463130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5156784</ArticleId><ArticleId IdType="pubmed">28044135</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Ebihara I, Shoji H, et al. : Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin. Inflamm Res. 1999; 48:171&#x2013;175</Citation><ArticleIdList><ArticleId IdType="pubmed">10344466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Ushiyama C, Suzuki S, et al. : Effect of polymyxin B-immobilized fiber hemoperfusion on sepsis-induced rhabdomyolysis with acute renal failure. Nephron. 2000; 86:210.</Citation><ArticleIdList><ArticleId IdType="pubmed">11015003</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Ushiyama C, Suzuki Y, et al. : Effect of polymyxin B-immobilized fibre on various mediators in patients with hypothermic sepsis. Clin Intensive Care. 2001; 12:223&#x2013;228</Citation></Reference><Reference><Citation>Nakamura T, Ushiyama C, Suzuki Y, et al. : Hemoperfusion with polymyxin B immobilized fibers for urinary albumin excretion in septic patients with trauma. ASAIO J. 2002; 48:244&#x2013;248</Citation><ArticleIdList><ArticleId IdType="pubmed">12058997</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Ushiyama C, Shoji H, et al. : Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis. ASAIO J. 2002; 48:41&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pubmed">11814097</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Ushiyama C, Suzuki Y, et al. : Hemoperfusion with polymyxin B-immobilized fiber in septic patients with methicillin-resistant Staphylococcus aureus-associated glomerulonephritis. Nephron Clin Pract. 2003; 94:c33&#x2013;c39</Citation><ArticleIdList><ArticleId IdType="pubmed">12845235</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Ushiyama C, Suzuki Y, et al. : Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2003; 53:58&#x2013;63</Citation><ArticleIdList><ArticleId IdType="pubmed">12495686</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Kawagoe Y, Matsuda T, et al. : Effects of polymyxin B immobilized fiber on urinary N-acetyl-beta-glucosaminidase in patients with severe sepsis. ASAIO J. 2004; 50:563&#x2013;567</Citation><ArticleIdList><ArticleId IdType="pubmed">15672789</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Kawagoe Y, Matsuda T, et al. : Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis. Intensive Care Med. 2004; 30:1838&#x2013;1841</Citation><ArticleIdList><ArticleId IdType="pubmed">15197430</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemoto H, Nakamoto H, Okada H, et al. : Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif. 2001; 19:361&#x2013;368; discussion 368-369</Citation><ArticleIdList><ArticleId IdType="pubmed">11574732</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JT, Lee H, Kee YK, et al. : High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: A randomized controlled trial. Am J Kidney Dis. 2016; 68:599&#x2013;608</Citation><ArticleIdList><ArticleId IdType="pubmed">27084247</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen D, Mateo J, Cavaillon JM, et al. ; Hemofiltration and Sepsis Group of the Coll&#xe8;ge National de R&#xe9;animation et de M&#xe9;decine d&#x2019;Urgence des H&#xf4;pitaux extra-Universitaires: Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit Care Med. 2009; 37:803&#x2013;810</Citation><ArticleIdList><ArticleId IdType="pubmed">19237881</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen DM, Guilhot J, Launey Y, et al. ; ABDOMIX Group: Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: A multicenter randomized control trial. Intensive Care Med. 2015; 41:975&#x2013;984</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4477725</ArticleId><ArticleId IdType="pubmed">25862039</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Yuan Z, Li H: Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis. Burns. 2005; 31:623&#x2013;628</Citation><ArticleIdList><ArticleId IdType="pubmed">15975721</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Z, Pai P, Han-Min W, et al. : Evaluation of the effects of pulse high-volume hemofiltration in patients with severe sepsis: A preliminary study. Int J Artif Organs. 2010; 33:505&#x2013;511</Citation><ArticleIdList><ArticleId IdType="pubmed">20872345</ArticleId></ArticleIdList></Reference><Reference><Citation>Quenot JP, Binquet C, Vinsonneau C, et al. : Very high volume hemofiltration with the Cascade system in septic shock patients. Intensive Care Med. 2015; 41:2111&#x2013;2120</Citation><ArticleIdList><ArticleId IdType="pubmed">26431720</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves JH, Butt WW, Shann F, et al. : Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med. 1999; 27:2096&#x2013;2104</Citation><ArticleIdList><ArticleId IdType="pubmed">10548188</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Meier-Hellmann A, Beale R, et al. ; EASy-Study Group: Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis. Crit Care Med. 2004; 32:1662&#x2013;1668</Citation><ArticleIdList><ArticleId IdType="pubmed">15286541</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;dler D, Pausch C, Heise D, et al. : The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS One. 2017; 12:e0187015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5662220</ArticleId><ArticleId IdType="pubmed">29084247</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Wand P, Seeliger B, et al. : Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: Results from a randomized controlled trial. Crit Care. 2022; 26:134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9097091</ArticleId><ArticleId IdType="pubmed">35551628</ArticleId></ArticleIdList></Reference><Reference><Citation>Shum HP, Leung YW, Lam SM, et al. : Alteco endotoxin hemoadsorption in Gram-negative septic shock patients. Indian J. 2014; 18:783&#x2013;788</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4271277</ArticleId><ArticleId IdType="pubmed">25538412</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisawat N, Tungsanga S, Lumlertgul N, et al. : The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients. Crit Care. 2018; 22:279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6204024</ArticleId><ArticleId IdType="pubmed">30367647</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockmann H, Thelen P, Stroben F, et al. : CytoSorb rescue for COVID-19 patients with vasoplegic shock and multiple organ failure: A prospective, open-label, randomized controlled pilot study. Crit Care Med. 2022; 50:964&#x2013;976</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9112514</ArticleId><ArticleId IdType="pubmed">35135967</ArticleId></ArticleIdList></Reference><Reference><Citation>Supady A, Weber E, Rieder M, et al. : Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): A single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021; 9:755&#x2013;762</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8121541</ArticleId><ArticleId IdType="pubmed">34000236</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Nemoto H, Nakamoto H, et al. : Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther Apher. 2002; 6:234&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pubmed">12109950</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumlin JA, Galphin CM, Tolwani AJ, et al. : A multi-center, randomized, controlled, pivotal study to assess the safety and efficacy of a selective cytopheretic device in patients with acute kidney injury. PLoS One. 2015; 10:e0132482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4526678</ArticleId><ArticleId IdType="pubmed">26244978</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Laterre PF, Cohen J, et al. : A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock. 2005; 23:400&#x2013;405</Citation><ArticleIdList><ArticleId IdType="pubmed">15834304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CT, Ren HS, Jiang JJ, et al. : Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and pro-inflammatory cytokines in patients with refractory septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009; 21:421&#x2013;424</Citation><ArticleIdList><ArticleId IdType="pubmed">19615135</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J, Chen M, Fang D, et al. : Therapeutic plasma exchange protects patients with sepsis-associated disseminated intravascular coagulation by improving endothelial function. Clin Appl Thromb Hemost. 2021; 27:10760296211053313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8597066</ArticleId><ArticleId IdType="pubmed">34775801</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Pu X, Chen X: Impacts of different hemofiltration methods on the prognosis of patients with sepsis. Biomed Res. 2017; 28:5473&#x2013;5478</Citation></Reference><Reference><Citation>Lijun Y, Tie L, Jing Y: Effect of hemofiltration combined with hemoabsorption on improvement of immune function in septic patients with low expression of human leukocyte antigen DR. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015; 27:750&#x2013;753</Citation><ArticleIdList><ArticleId IdType="pubmed">26955702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Yang Y, Lv R, et al. : Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: A single-center randomized clinical trial. Nephrol Dial Transplant. 2012; 27:967&#x2013;973</Citation><ArticleIdList><ArticleId IdType="pubmed">21891773</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruixiang Z, Fangzhong W, Wei D, et al. : The organ protective effects and timing of continuous blood purification in the treatment of severe sepsis: A double-blind randomized controlled trial. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016; 28:241&#x2013;245</Citation><ArticleIdList><ArticleId IdType="pubmed">29917338</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, et al. ; Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39:165&#x2013;228</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, et al. : Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017; 43:304&#x2013;377</Citation><ArticleIdList><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshanov PS, Dennis BB, Pasic N, et al. : When is a meta-analysis conclusive? A guide to trial sequential analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery. Nephrol Dial Transplant. 2017; 32(suppl_2):ii23&#x2013;ii30</Citation><ArticleIdList><ArticleId IdType="pubmed">28380638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H: Trial sequential analysis: Novel approach for meta-analysis. Anesth Pain Med (Seoul). 2021; 16:138&#x2013;150</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107247</ArticleId><ArticleId IdType="pubmed">33940767</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberger KJ, Duan R, Chen Y, et al. : Predictive P-score for treatment ranking in Bayesian network meta-analysis. BMC Med Res Methodol. 2021; 21:213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8520624</ArticleId><ArticleId IdType="pubmed">34657593</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30365341</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>199</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial.</ArticleTitle><Pagination><StartPage>980</StartPage><EndPage>986</EndPage><MedlinePgn>980-986</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201807-1419OC</ELocationID><Abstract><AbstractText Label="RATIONALE">There remains uncertainty about the role of corticosteroids in sepsis with clear beneficial effects on shock duration, but conflicting survival effects. Two transcriptomic sepsis response signatures (SRSs) have been identified. SRS1 is relatively immunosuppressed, whereas SRS2 is relatively immunocompetent.</AbstractText><AbstractText Label="OBJECTIVES">We aimed to categorize patients based on SRS endotypes to determine if these profiles influenced response to either norepinephrine or vasopressin, or to corticosteroids in septic shock.</AbstractText><AbstractText Label="METHODS">A post hoc analysis was performed of a double-blind, randomized clinical trial in septic shock (VANISH [Vasopressin vs. Norepinephrine as Initial Therapy in Septic Shock]). Patients were included within 6 hours of onset of shock and were randomized to receive norepinephrine or vasopressin followed by hydrocortisone or placebo. Genome-wide gene expression profiling was performed and SRS endotype was determined by a previously established model using seven discriminant genes.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Samples were available from 176 patients: 83 SRS1 and 93 SRS2. There was no significant interaction between SRS group and vasopressor assignment (P&#x2009;=&#x2009;0.50). However, there was an interaction between assignment to hydrocortisone or placebo, and SRS endotype (P&#x2009;=&#x2009;0.02). Hydrocortisone use was associated with increased mortality in those with an SRS2 phenotype (odds ratio&#x2009;=&#x2009;7.9; 95% confidence interval&#x2009;=&#x2009;1.6-39.9).</AbstractText><AbstractText Label="CONCLUSIONS">Transcriptomic profile at onset of septic shock was associated with response to corticosteroids. Those with the immunocompetent SRS2 endotype had significantly higher mortality when given corticosteroids compared with placebo. Clinical trial registered with www.clinicaltrials.gov (ISRCTN 20769191).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Antcliffe</LastName><ForeName>David B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0002-1846-9160</Identifier><AffiliationInfo><Affiliation>1 Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Centre for Perioperative and Critical Care Research, Imperial College Healthcare National Health Service Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burnham</LastName><ForeName>Katie L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0001-8680-2933</Identifier><AffiliationInfo><Affiliation>3 Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Beidh</LastName><ForeName>Farah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>1 Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santhakumaran</LastName><ForeName>Shalini</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0988-9339</Identifier><AffiliationInfo><Affiliation>4 Imperial Clinical Trials Unit, Faculty of Medicine, Imperial College London, London, United Kingdom; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brett</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-4545-8413</Identifier><AffiliationInfo><Affiliation>2 Centre for Perioperative and Critical Care Research, Imperial College Healthcare National Health Service Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinds</LastName><ForeName>Charles J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>5 Intensive Care Unit, Barts and the London, Queen Mary School of Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashby</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3146-7466</Identifier><AffiliationInfo><Affiliation>4 Imperial Clinical Trials Unit, Faculty of Medicine, Imperial College London, London, United Kingdom; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Julian C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-0377-5536</Identifier><AffiliationInfo><Affiliation>3 Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Anthony C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-0419-547X</Identifier><AffiliationInfo><Affiliation>1 Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Centre for Perioperative and Critical Care Research, Imperial College Healthcare National Health Service Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NIHR/CS/009/007</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>204969/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>090532/Z/09/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>11000-17-2</RegistryNumber><NameOfSubstance UI="D014667">Vasopressins</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2019 Apr 15;199(8):936-938. doi: 10.1164/rccm.201811-2148ED.</RefSource><PMID Version="1">30540491</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Am J Respir Crit Care Med. 2022 Dec 15;206(12):1572-1573. doi: 10.1164/rccm.v206erratum10.</RefSource><PMID Version="1">36519797</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="Y">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007121" MajorTopicYN="N">Immunocompetence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014667" MajorTopicYN="N">Vasopressins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">corticosteroids</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">transcriptomics</Keyword><Keyword MajorTopicYN="N">vasopressin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30365341</ArticleId><ArticleId IdType="pmc">PMC6467319</ArticleId><ArticleId IdType="doi">10.1164/rccm.201807-1419OC</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. ADRENAL Trial Investigators and the Australian&#x2013;New Zealand Intensive Care Society Clinical Trials Group. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378:797&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">29347874</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot J-P, Siami S, et al. CRICS-TRIGGERSEP Network. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">29490185</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4:259&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4820667</ArticleId><ArticleId IdType="pubmed">26917434</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnham KL, Davenport EE, Radhakrishnan J, Humburg P, Gordon AC, Hutton P, et al. Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia. Am J Respir Crit Care Med. 2017;196:328&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5549866</ArticleId><ArticleId IdType="pubmed">28036233</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. VANISH Investigators. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Ashby D, Brett SJ. Protocol for a randomised controlled trial of vasopressin versus noradrenaline as initial therapy in septic shock (VANISH) BMJ Open. 2014;4:e005866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4091463</ArticleId><ArticleId IdType="pubmed">24993769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">18184957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DR, Snell EJ. Analysis of binary data. 2nd ed. London: Chapman &amp; Hall; 1989.</Citation></Reference><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014;42:1325&#x2013;1333.</Citation><ArticleIdList><ArticleId IdType="pubmed">24557425</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Tulzo Y, Pangault C, Amiot L, Guilloux V, Tribut O, Arvieux C, et al. Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med. 2004;169:1144&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">15028560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim TK, Chen GH, McDonald RA, Toews GB. Granulocyte-macrophage colony&#x2013;stimulating factor overrides the immunosuppressive function of corticosteroids on rat pulmonary dendritic cells. Stem Cells. 1996;14:292&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">8724695</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Garde MDB, Martinez FO, Melgert BN, Hylkema MN, Jonkers RE, Hamann J. Chronic exposure to glucocorticoids shapes gene expression and modulates innate and adaptive activation pathways in macrophages with distinct changes in leukocyte attraction. J Immunol. 2014;192:1196&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">24395918</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung DYM, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2003;111:3&#x2013;22, quiz 23.</Citation><ArticleIdList><ArticleId IdType="pubmed">12532089</ArticleId></ArticleIdList></Reference><Reference><Citation>Olnes MJ, Kotliarov Y, Biancotto A, Cheung F, Chen J, Shi R, et al. CHI Consortium. Corrigendum: effects of systemically administered hydrocortisone on the human immunome. Sci Rep. 2016;6:25215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4855172</ArticleId><ArticleId IdType="pubmed">27141995</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway Morris A, Datta D, Shankar-Hari M, Stephen J, Weir CJ, Rennie J, et al. Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Med. 2018;44:627&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6006236</ArticleId><ArticleId IdType="pubmed">29915941</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med. 2015;191:309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4351580</ArticleId><ArticleId IdType="pubmed">25489881</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TE, Azad TD, Donato M, Haynes WA, Perumal TM, Henao R, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018;46:915&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953807</ArticleId><ArticleId IdType="pubmed">29537985</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35961815</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Outcomes of dexmedetomidine versus propofol sedation in critically ill adults requiring mechanical ventilation: a systematic review and meta-analysis of randomised controlled trials.</ArticleTitle><Pagination><StartPage>515</StartPage><EndPage>526</EndPage><MedlinePgn>515-526</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2022.06.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(22)00321-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Guidelines have recommended the use of dexmedetomidine or propofol for sedation after cardiac surgery, and propofol monotherapy for other patients. Further outcome data are required for these drugs.</AbstractText><AbstractText Label="METHODS">This systematic review and meta-analysis was prospectively registered on PROSPERO. The primary outcome was ICU length of stay. Secondary outcomes included duration of mechanical ventilation, ICU delirium, all-cause mortality, and haemodynamic effects. Intensive care patients were analysed separately as cardiac surgical, medical/noncardiac surgical, those with sepsis, and patients in neurocritical care. Subgroup analyses based on age and dosage were conducted.</AbstractText><AbstractText Label="RESULTS">Forty-one trials (N=3948) were included. Dexmedetomidine did not significantly affect ICU length of stay across any ICU patient subtype when compared with propofol, but it reduced the duration of mechanical ventilation (mean difference&#xa0;-0.67 h; 95% confidence interval:&#xa0;-1.31 to&#xa0;-0.03 h; P=0.041; low certainty) and the risk of ICU delirium (risk ratio 0.49; 95% confidence interval: 0.29-0.87; P=0.019; high certainty) across cardiac surgical patients. Dexmedetomidine was also associated with a greater risk of bradycardia across a variety of ICU patients. Subgroup analyses revealed that age might affect the incidence of haemodynamic side-effects and mortality among cardiac surgical and medical/other surgical patients.</AbstractText><AbstractText Label="CONCLUSION">Dexmedetomidine did not significantly impact ICU length of stay compared with propofol, but it significantly reduced the duration of mechanical ventilation and the risk of delirium in cardiac surgical patients. It also significantly increased the risk of bradycardia across ICU patient subsets.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heybati</LastName><ForeName>Kiyan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic - Rochester, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fangwen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Saif</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jiawen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohananey</LastName><ForeName>Divyanshu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Medical College of Wisconsin, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villablanca</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Henry Ford Hospital, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramakrishna</LastName><ForeName>Harish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic - Rochester, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001919" MajorTopicYN="N">Bradycardia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">intensive care unit</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">propofol</Keyword><Keyword MajorTopicYN="N">sedation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>22</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35961815</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2022.06.020</ArticleId><ArticleId IdType="pii">S0007-0912(22)00321-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37513620</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>14</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>19</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>The Effectiveness of Early Enteral Nutrition on Clinical Outcomes in Critically Ill Sepsis Patients: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3201</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu15143201</ELocationID><Abstract><AbstractText>The optimal timing of enteral nutrition (EN) in sepsis patients is controversial among societal guidelines. We aimed to evaluate the evidence of early EN's impact on critically ill sepsis patients' clinical outcomes. We searched the MEDLINE, Embase, CINAHL, Cochrane Library, ClinicalTrials.gov, and ICTRP databases on 10 March 2023. We included studies published after 2004 that compared early EN versus delayed EN in sepsis patients. We included randomized controlled trials (RCTs), non-RCTs, cohort studies, and case-control studies. Forest plots were used to summarize risk ratios (RRs), including mortality and mean difference (MD) of continuous variables such as intensive care unit (ICU) length of stay and ventilator-free days. We identified 11 eligible studies with sample sizes ranging from 31 to 2410. The RR of short-term mortality from three RCTs was insignificant, and the MD of ICU length of stay from two RCTs was -2.91 and -1.00 days (95% confidence interval [CI], -5.53 to -0.29 and -1.68 to -0.32). Although the RR of intestinal-related complications from one RCT was 3.82 (95% CI, 1.43 to 10.19), indicating a significantly higher risk for the early EN group than the control group, intestinal-related complications of EN reported in five studies were inconclusive. This systematic review did not find significant benefits of early EN on mortality in sepsis patients. Evidence, however, is weak due to inconsistent definitions, heterogeneity, risk of bias, and poor methodology in the existing studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Sun Jae</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-3786-6935</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Ryoung-Eun</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Chi-Min</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Gee Young</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Jinseub</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3805-1546</Identifier><AffiliationInfo><Affiliation>Department of Data Science, Daegu University, Gyeongsan 38453, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Chi Ryang</ForeName><Initials>CR</Initials><Identifier Source="ORCID">0000-0003-1830-307X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004750" MajorTopicYN="Y">Enteral Nutrition</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enteral nutrition</Keyword><Keyword MajorTopicYN="N">intensive care unit</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37513620</ArticleId><ArticleId IdType="pmc">PMC10383540</ArticleId><ArticleId IdType="doi">10.3390/nu15143201</ArticleId><ArticleId IdType="pii">nu15143201</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Niekerk G., Engelbrecht A.M. Inflammation-induced metabolic derangements or adaptation: An immunometabolic perspective. Cytokine Growth Factor Rev. 2018;43:47&#x2013;53. doi: 10.1016/j.cytogfr.2018.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2018.06.003</ArticleId><ArticleId IdType="pubmed">29970338</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid C.L., Campbell I.T., Little R.A. Muscle wasting and energy balance in critical illness. Clin. Nutr. 2004;23:273&#x2013;280. doi: 10.1016/S0261-5614(03)00129-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0261-5614(03)00129-8</ArticleId><ArticleId IdType="pubmed">15030968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochala J., Gustafson A.M., Diez M.L., Renaud G., Li M., Aare S., Qaisar R., Banduseela V.C., Hedstrom Y., Tang X., et al. Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: Underlying mechanisms. J. Physiol. 2011;589:2007&#x2013;2026. doi: 10.1113/jphysiol.2010.202044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2010.202044</ArticleId><ArticleId IdType="pmc">PMC3090600</ArticleId><ArticleId IdType="pubmed">21320889</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharshar T., Bastuji-Garin S., Stevens R.D., Durand M.C., Malissin I., Rodriguez P., Cerf C., Outin H., De Jonghe B., Groupe de R&#xe9;flexion et d&#x2019;Etude des Neuromyopathies En R&#xe9;animation Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit. Care Med. 2009;37:3047&#x2013;3053. doi: 10.1097/CCM.0b013e3181b027e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181b027e9</ArticleId><ArticleId IdType="pubmed">19770751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohbe H., Jo T., Matsui H., Fushimi K., Yasunaga H. Differences in effect of early enteral nutrition on mortality among ventilated adults with shock requiring low-, medium-, and high-dose noradrenaline: A propensity-matched analysis. Clin. Nutr. 2020;39:460&#x2013;467. doi: 10.1016/j.clnu.2019.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2019.02.020</ArticleId><ArticleId IdType="pubmed">30808573</ArticleId></ArticleIdList></Reference><Reference><Citation>Piton G., Le Gouge A., Boisrame-Helms J., Anguel N., Argaud L., Asfar P., Botoc V., Bretagnol A., Brisard L., Bui H.N., et al. Factors associated with acute mesenteric ischemia among critically ill ventilated patients with shock: A post hoc analysis of the NUTRIREA2 trial. Intensive Care Med. 2022;48:458&#x2013;466. doi: 10.1007/s00134-022-06637-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06637-w</ArticleId><ArticleId IdType="pubmed">35190840</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., Sevransky J.E., Sprung C.L., Douglas I.S., Jaeschke R., et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 2013;41:580&#x2013;637. doi: 10.1097/CCM.0b013e31827e83af.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827e83af</ArticleId><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor B.E., McClave S.A., Martindale R.G., Warren M.M., Johnson D.R., Braunschweig C., McCarthy M.S., Davanos E., Rice T.W., Cresci G.A., et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Crit. Care Med. 2016;44:390&#x2013;438. doi: 10.1097/CCM.0000000000001525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001525</ArticleId><ArticleId IdType="pubmed">26771786</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer P., Blaser A.R., Berger M.M., Alhazzani W., Calder P.C., Casaer M.P., Hiesmayr M., Mayer K., Montejo J.C., Pichard C., et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin. Nutr. 2019;38:48&#x2013;79. doi: 10.1016/j.clnu.2018.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2018.08.037</ArticleId><ArticleId IdType="pubmed">30348463</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M., Ogura H., Yatabe T., Atagi K., Inoue S., Iba T., Kakihana Y., Kawasaki T., Kushimoto S., Kuroda Y., et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020) J. Intensive Care. 2021;9:53. doi: 10.1186/s40560-021-00555-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-021-00555-7</ArticleId><ArticleId IdType="pmc">PMC8384927</ArticleId><ArticleId IdType="pubmed">34433491</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C.M., French C., Machado F.R., McIntyre L., Ostermann M., Prescott H.C., et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit. Care Med. 2021;49:e1063&#x2013;e1143. doi: 10.1097/CCM.0000000000005337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005337</ArticleId><ArticleId IdType="pubmed">34605781</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra T., Cohen J., Gea-Banacloche J., Keh D., Marshall J.C., Parker M.M., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med. 2004;32:858&#x2013;873. doi: 10.1097/01.CCM.0000117317.18092.E4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000117317.18092.E4</ArticleId><ArticleId IdType="pubmed">15090974</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger R.P., Levy M.M., Carlet J.M. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 2008;36:296&#x2013;327. doi: 10.1097/01.CCM.0000298158.12101.41. Erratum in Crit. Care Med. 2008, 36, 1394&#x2013;1396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000298158.12101.41</ArticleId><ArticleId IdType="pubmed">18158437</ArticleId></ArticleIdList></Reference><Reference><Citation>Boullata J.I., Carrera A.L., Harvey L., Escuro A.A., Hudson L., Mays A., McGinnis C., Wessel J.J., Bajpai S., Beebe M.L., et al. ASPEN Safe Practices for Enteral Nutrition Therapy. J. Parenter. Enter. Nutr. 2017;41:15&#x2013;103. doi: 10.1177/0148607116673053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607116673053</ArticleId><ArticleId IdType="pubmed">27815525</ArticleId></ArticleIdList></Reference><Reference><Citation>Reintam Blaser A., Starkopf J., Alhazzani W., Berger M.M., Casaer M.P., Deane A.M., Fruhwald S., Hiesmayr M., Ichai C., Jakob S.M., et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med. 2017;43:380&#x2013;398. doi: 10.1007/s00134-016-4665-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4665-0</ArticleId><ArticleId IdType="pmc">PMC5323492</ArticleId><ArticleId IdType="pubmed">28168570</ArticleId></ArticleIdList></Reference><Reference><Citation>Taverny G., Lescot T., Pardo E., Thonon F., Maarouf M., Alberti C. Outcomes used in randomised controlled trials of nutrition in the critically ill: A systematic review. Crit. Care. 2019;23:12. doi: 10.1186/s13054-018-2303-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2303-7</ArticleId><ArticleId IdType="pmc">PMC6332589</ArticleId><ArticleId IdType="pubmed">30642377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapple L.-a.S., Summers M.J., Weinel L.M., Deane A.M. Outcome Measures in Critical Care Nutrition Interventional Trials: A Systematic Review. Nutr. Clin. Pract. 2020;35:506&#x2013;513. doi: 10.1002/ncp.10478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ncp.10478</ArticleId><ArticleId IdType="pubmed">32141140</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Li T., Deeks J.J. Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A., editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane; London, UK: 2022. version 6.3 (updated February 2022)</Citation></Reference><Reference><Citation>Sterne J.A.C., Savovic J., Page M.J., Elbers R.G., Blencowe N.S., Boutron I., Cates C.J., Cheng H.Y., Corbett M.S., Eldridge S.M., et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010;25:603&#x2013;605. doi: 10.1007/s10654-010-9491-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Haac B., Henry S., Diaz J., Scalea T., Stein D. Early enteral nutrition is associated with reduced morbidity in critically Ill soft tissue patients. Am. Surg. 2018;84:1003&#x2013;1009. doi: 10.1177/000313481808400656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481808400656</ArticleId><ArticleId IdType="pubmed">29981639</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Hu B., Zhang S., Cai M., Chu X., Zheng D., Lou M., Cui K., Zhang M., Sun R., et al. Effects of early enteral nutrition on the prognosis of patients with sepsis: Secondary analysis of acute gastrointestinal injury study. Ann. Palliat. Med. 2020;9:3793&#x2013;3801. doi: 10.21037/apm-20-1650.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-20-1650</ArticleId><ArticleId IdType="pubmed">33302649</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga Y., Fujita M., Yagi T., Todani M., Nakahara T., Kawamura Y., Kaneda K., Oda Y., Tsuruta R. Early enteral nutrition is associated with reduced in-hospital mortality from sepsis in patients with sarcopenia. J. Crit. Care. 2018;47:153&#x2013;158. doi: 10.1016/j.jcrc.2018.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2018.06.026</ArticleId><ArticleId IdType="pubmed">29990793</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhao W., Chen W., Shen X., Fu R., Zhao Y., Liu H. Effects of Early Enteral Nutrition on Immune Function and Prognosis of Patients with Sepsis on Mechanical Ventilation. J. Intensive Care Med. 2020;35:1053&#x2013;1061. doi: 10.1177/0885066618809893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066618809893</ArticleId><ArticleId IdType="pubmed">30384813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Reyes L., Patel J.J., Jiang X., Coz Yataco A., Day A.G., Shah F., Zelten J., Tamae-Kakazu M., Rice T., Heyland D.K. Early versus delayed enteral nutrition in mechanically ventilated patients with circulatory shock: A nested cohort analysis of an international multicenter, pragmatic clinical trial. Crit. Care. 2022;26:173. doi: 10.1186/s13054-022-04047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04047-4</ArticleId><ArticleId IdType="pmc">PMC9185884</ArticleId><ArticleId IdType="pubmed">35681220</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel J.J., Kozeniecki M., Biesboer A., Peppard W., Ray A.S., Thomas S., Jacobs E.R., Nanchal R., Kumar G. Early Trophic Enteral Nutrition Is Associated with Improved Outcomes in Mechanically Ventilated Patients with Septic Shock: A Retrospective Review. J. Intensive Care Med. 2016;31:471&#x2013;477. doi: 10.1177/0885066614554887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066614554887</ArticleId><ArticleId IdType="pubmed">25315218</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel J.J., Kozeniecki M., Peppard W.J., Peppard S.R., Zellner-Jones S., Graf J., Szabo A., Heyland D.K. Phase 3 Pilot Randomized Controlled Trial Comparing Early Trophic Enteral Nutrition With &#x201c;No Enteral Nutrition&#x201d; in Mechanically Ventilated Patients with Septic Shock. J. Parenter. Enter. Nutr. 2020;44:866&#x2013;873. doi: 10.1002/jpen.1706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jpen.1706</ArticleId><ArticleId IdType="pubmed">31535394</ArticleId></ArticleIdList></Reference><Reference><Citation>Reignier J., Boisram&#xe9;-Helms J., Brisard L., Lascarrou J.B., Ait Hssain A., Anguel N., Argaud L., Asehnoune K., Asfar P., Bellec F., et al. Enteral versus parenteral early nutrition in ventilated adults with shock: A randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2) Lancet. 2018;391:133&#x2013;143. doi: 10.1016/S0140-6736(17)32146-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32146-3</ArticleId><ArticleId IdType="pubmed">29128300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J.K., Yuan S.T., Mu X.W., Zhang W.H., Liu Y., Zou L., Wang X., Zheng S.Y. Effects of early enteral nutrition on T helper lymphocytes of surgical septic patients. Medicine. 2017;96:e7702. doi: 10.1097/MD.0000000000007702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000007702</ArticleId><ArticleId IdType="pmc">PMC5556220</ArticleId><ArticleId IdType="pubmed">28796054</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J.K., Zhang W.H., Chen W.X., Wang X., Mu X.W. Effects of early enteral nutrition on Th17/Treg cells and IL-23/IL-17 in septic patients. World J. Gastroenterol. 2019;25:2799&#x2013;2808. doi: 10.3748/wjg.v25.i22.2799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v25.i22.2799</ArticleId><ArticleId IdType="pmc">PMC6580355</ArticleId><ArticleId IdType="pubmed">31236002</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y., Ren J., Gu G., Chen J., Li J. Early enteral nutrition improves outcomes of open abdomen in gastrointestinal fistula patients complicated with severe sepsis. Nutr. Clin. Pract. 2011;26:688&#x2013;694. doi: 10.1177/0884533611426148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0884533611426148</ArticleId><ArticleId IdType="pubmed">22205557</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuntrasakul C., Siltharm S., Chinswangwatanakul V., Pongprasobchai T., Chockvivatanavanit S., Bunnak A. Early nutritional support in severe traumatic patients. J. Med. Assoc. Thai. 1996;79:21&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">8867397</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Haren F.M., Sleigh J.W., Pickkers P., Van der Hoeven J.G. Gastrointestinal perfusion in septic shock. Anaesth. Intensive Care. 2007;35:679&#x2013;694. doi: 10.1177/0310057X0703500505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X0703500505</ArticleId><ArticleId IdType="pubmed">17933153</ArticleId></ArticleIdList></Reference><Reference><Citation>Panchal A.K., Manzi J., Connolly S., Christensen M., Wakeham M., Goday P.S., Mikhailov T.A. Safety of Enteral Feedings in Critically Ill Children Receiving Vasoactive Agents. J. Parenter. Enter. Nutr. 2016;40:236&#x2013;241. doi: 10.1177/0148607114546533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607114546533</ArticleId><ArticleId IdType="pubmed">25168592</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong C.S., Brown P.M., Yesantharao P., Zhou X., Young A., Canner J.K., Quinlan M., Brown E.F., Sussman M.S., Whitman G.J.R. Vasoactive and Inotropic Support, Tube Feeding, and Ischemic Gut Complications After Cardiac Surgery. J. Parenter. Enter. Nutr. 2020;44:1461&#x2013;1467. doi: 10.1002/jpen.1769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jpen.1769</ArticleId><ArticleId IdType="pubmed">32010992</ArticleId></ArticleIdList></Reference><Reference><Citation>Preiser J.C., Arabi Y.M., Berger M.M., Casaer M., McClave S., Montejo-Gonzalez J.C., Peake S., Reintam Blaser A., Van den Berghe G., van Zanten A., et al. A guide to enteral nutrition in intensive care units: 10 expert tips for the daily practice. Crit. Care. 2021;25:424. doi: 10.1186/s13054-021-03847-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03847-4</ArticleId><ArticleId IdType="pmc">PMC8669237</ArticleId><ArticleId IdType="pubmed">34906215</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38892494</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Early Enteral Nutrition (within 48 h) for Patients with Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1560</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu16111560</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Medical nutrition therapy provides the opportunity to compensate for muscle wasting and immune response activation during stress and trauma. The objective of this systematic review is to assess the safety and effectiveness of early enteral nutrition (EEN) in adults with sepsis or septic shock.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The MEDLINE, Embase, CENTRAL, CINAHL, ClinicalTrials.gov, and ICTRP tools were searched from inception until July 2023. Conference proceedings, the reference lists of included studies, and expert content were queried to identify additional publications. Two review authors completed the study selection, data extraction, and risk of bias assessment; disagreements were resolved through discussion. Inclusion criteria were randomized controlled trials (RCTs) and non-randomized studies (NRSs) comparing the administration of EEN with no or delayed enteral nutrition (DEE) in adult populations with sepsis or septic shock.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five RCTs (<i>n</i> = 442 participants) and ten NRSs (<i>n</i> = 3724 participants) were included. Low-certainty evidence from RCTs and NRSs suggests that patients receiving EEN could require fewer days of mechanical ventilation (MD -2.65; 95% CI, -4.44-0.86; and MD -2.94; 95% CI, -3.64--2.23, respectively) and may show lower SOFA scores during follow-up (MD -1.64 points; 95% CI, -2.60--0.68; and MD -1.08 points; 95% CI, -1.90--0.26, respectively), albeit with an increased frequency of diarrhea episodes (OR 2.23, 95% CI 1.115-4.34). Even though the patients with EEN show a lower in-hospital mortality rate both in RCTs (OR 0.69; 95% CI, 0.39-1.23) and NRSs (OR 0.89; 95% CI, 0.69-1.13), this difference does not achieve statistical significance. There were no apparent differences for other outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Low-quality evidence suggests that EEN may be a safe and effective intervention for the management of critically ill patients with sepsis or septic shock.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grillo-Ardila</LastName><ForeName>Carlos F</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0001-5355-729X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Pontificia Universidad Javeriana, Bogot&#xe1; 110231, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, School of Medicine, Universidad Nacional de Colombia, Bogot&#xe1; 111321, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Universitario San Ignacio, Bogot&#xe1; 110231, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tibavizco-Palacios</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Pontificia Universidad Javeriana, Bogot&#xe1; 110231, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Universitario San Ignacio, Bogot&#xe1; 110231, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triana</LastName><ForeName>Luis C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Pontificia Universidad Javeriana, Bogot&#xe1; 110231, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Universitario San Ignacio, Bogot&#xe1; 110231, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rugeles</LastName><ForeName>Sa&#xfa;l J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, School of Medicine, Pontificia Universidad Javeriana, Bogot&#xe1; 110231, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallejo-Ortega</LastName><ForeName>Mar&#xed;a T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Clinical Research Institute, Universidad Nacional de Colombia, Bogot&#xe1; 11001, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calder&#xf3;n-Franco</LastName><ForeName>Carlos H</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-9823-8409</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Universidad del Bosque, Bogot&#xe1; 11001, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Mosquera</LastName><ForeName>Juan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>School of Medicine, Pontificia Universidad Javeriana, Bogot&#xe1; 110231, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004750" MajorTopicYN="Y">Enteral Nutrition</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">enteral nutrition</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38892494</ArticleId><ArticleId IdType="pmc">PMC11174497</ArticleId><ArticleId IdType="doi">10.3390/nu16111560</ArticleId><ArticleId IdType="pii">nu16111560</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.-D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C.M., French C., Machado F.R., Mcintyre L., Ostermann M., Prescott H.C., et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181&#x2013;1247. doi: 10.1007/s00134-021-06506-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  . Global Report on the Epidemiology and Burden of Sepsis: Current Evidence, Identifying Gaps and Future Directions. World Health Organization; Geneva, Switzerland: 2020.  [(accessed on 6 May 2024)].  Available online:  https://iris.who.int/bitstream/handle/10665/334216/9789240010789-eng.pdf?sequence=1.</Citation></Reference><Reference><Citation>Estrada-Orozco K., Cantor-Cruz F., Larrotta-Castillo D., D&#xed;az-R&#xed;os S., Ruiz-Cardozo M.A. Central venous catheter insertion and maintenance: Evidence-based clinical recommendations. Rev. Colomb. Obstet. Ginecol. 2020;71:115&#x2013;162. doi: 10.18597/RCOG.3413.</Citation><ArticleIdList><ArticleId IdType="doi">10.18597/RCOG.3413</ArticleId><ArticleId IdType="pubmed">32770871</ArticleId></ArticleIdList></Reference><Reference><Citation>Compher C., Bingham A.L., McCall M., Patel J., Rice T.W., Braunschweig C., McKeever L. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition. J. Parenter. Enter. Nutr. 2022;46:12&#x2013;41. doi: 10.1002/jpen.2267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jpen.2267</ArticleId><ArticleId IdType="pubmed">34784064</ArticleId></ArticleIdList></Reference><Reference><Citation>Rugeles S.-J., Rueda J.-D., D&#xed;az C.-E., Rosselli D. Hyperproteic hypocaloric enteral nutrition in the critically ill patient: A randomized controlled clinical trial. Indian J. Crit. Care Med. 2013;17:343&#x2013;349. doi: 10.4103/0972-5229.123438.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-5229.123438</ArticleId><ArticleId IdType="pmc">PMC3902568</ArticleId><ArticleId IdType="pubmed">24501485</ArticleId></ArticleIdList></Reference><Reference><Citation>Wischmeyer P.E. Tailoring nutrition therapy to illness and recovery. Crit. Care. 2017;21:316. doi: 10.1186/s13054-017-1906-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1906-8</ArticleId><ArticleId IdType="pmc">PMC5751603</ArticleId><ArticleId IdType="pubmed">29297385</ArticleId></ArticleIdList></Reference><Reference><Citation>Barazzoni R., Deutz N.E.P., Biolo G., Bischoff S., Boirie Y., Cederholm T., Cuerda C., Delzenne N., Leon Sanz M., Ljungqvist O., et al. Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. Clin. Nutr. 2017;36:355&#x2013;363. doi: 10.1016/j.clnu.2016.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2016.09.010</ArticleId><ArticleId IdType="pubmed">27686693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Dong Y., Han X., Qi X.-Q., Huang C.-G., Hou L.-J. Nutritional Support for Patients Sustaining Traumatic Brain Injury: A Systematic Review and Meta-Analysis of Prospective Studies. PLoS ONE. 2013;8:e58838. doi: 10.1371/journal.pone.0058838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058838</ArticleId><ArticleId IdType="pmc">PMC3602547</ArticleId><ArticleId IdType="pubmed">23527035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojo O., Ojo O.O., Feng Q., Boateng J., Wang X., Brooke J., Adegboye A.R.A. The Effects of Enteral Nutrition in Critically Ill Patients with COVID-19: A Systematic Review and Meta-Analysis. Nutrients. 2022;14:1120. doi: 10.3390/nu14051120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14051120</ArticleId><ArticleId IdType="pmc">PMC8912272</ArticleId><ArticleId IdType="pubmed">35268095</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu H., Doig G.S., Heighes P.T., Allingstrup M.J. Early Enteral Nutrition Reduces Mortality and Improves Other Key Outcomes in Patients With Major Burn Injury: A Meta-Analysis of Randomized Controlled Trials. Crit. Care Med. 2018;46:2036&#x2013;2042. doi: 10.1097/CCM.0000000000003445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003445</ArticleId><ArticleId IdType="pubmed">30222632</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Zhong Y., Lu X., Kang X., Wang Y., Guo W., Liu J., Yang Y., Pei L. Enteral nutrition provided within 48 hours after admission in severe acute pancreatitis: A systematic review and meta-analysis. Medicine. 2018;97:e11871. doi: 10.1097/MD.0000000000011871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011871</ArticleId><ArticleId IdType="pmc">PMC6112989</ArticleId><ArticleId IdType="pubmed">30142782</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer P., Blaser A.R., Berger M.M., Calder P.C., Casaer M., Hiesmayr M., Mayer K., Montejo-Gonzalez J.C., Pichard C., Preiser J.-C., et al. ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit. Clin. Nutr. 2023;42:1671&#x2013;1689. doi: 10.1016/j.clnu.2023.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2023.07.011</ArticleId><ArticleId IdType="pubmed">37517372</ArticleId></ArticleIdList></Reference><Reference><Citation>Elke G., Wang M., Weiler N., Day A.G., Heyland D.K. Close to recommended caloric and protein intake by enteral nutrition is associated with better clinical outcome of critically ill septic patients: Secondary analysis of a large international nutrition database. Crit. Care. 2014;18:R29. doi: 10.1186/cc13720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13720</ArticleId><ArticleId IdType="pmc">PMC4056527</ArticleId><ArticleId IdType="pubmed">24506888</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuntrasakul C., Siltharm S., Chinswangwatanakul V., Pongprasobchai T., Chockvivatanavanit S., Bunnak A. Early nutritional support in severe traumatic patients. J. Med. Assoc. Thai. 1996;79:21&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">8867397</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid I., Doshi P., DiGiovine B. Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. Am. J. Crit. Care. 2010;19:261&#x2013;268. doi: 10.4037/ajcc2010197.</Citation><ArticleIdList><ArticleId IdType="doi">10.4037/ajcc2010197</ArticleId><ArticleId IdType="pubmed">20436064</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Green S. Cochrane Handbook for Systematic Reviews of Interventions. Wiley; Hoboken, NJ, USA: 2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470712184</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann H.J., Tugwell P., Reeves B.C., Akl E.A., Santesso N., Spencer F.A., Shea B., Wells G., Helfand M. Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions. Res. Synth Methods. 2013;4:49&#x2013;62. doi: 10.1002/jrsm.1078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1078</ArticleId><ArticleId IdType="pubmed">26053539</ArticleId></ArticleIdList></Reference><Reference><Citation>Grillo-Ardila C.F., Paez-Castellanos E., Bola&#xf1;os-Palacios J.C., Bautista-Charry A.A. Spatulas for operative vaginal birth: A systematic review and meta-analysis. Int. J. Gynecol. Obstet. 2022;156:197&#x2013;205. doi: 10.1002/ijgo.13681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.13681</ArticleId><ArticleId IdType="pubmed">33754367</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A., Hern&#xe1;n M.A., Reeves B.C., Savovi&#x107; J., Berkman N.D., Viswanathan M., Henry D., Altman D.G., Ansari M.T., Boutron I., et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X., Wang W., Liu J., Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med. Res. Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>GRADEpro GDT: GRADEpro Guideline Development Tool. McMaster University and Evidence Prime; Hamilton, ON, Canada: 2023.  [(accessed on 6 May 2024)].  Available online:  http://gradepro.org.</Citation></Reference><Reference><Citation>Hultcrantz M., Rind D., Akl E.A., Treweek S., Mustafa R.A., Iorio A., Alper B.S., Meerpohl J.J., Murad M.H., Ansari M.T., et al. The GRADE Working Group clarifies the construct of certainty of evidence. J. Clin. Epidemiol. 2017;87:4&#x2013;13. doi: 10.1016/j.jclinepi.2017.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2017.05.006</ArticleId><ArticleId IdType="pmc">PMC6542664</ArticleId><ArticleId IdType="pubmed">28529184</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann H.J. Interpreting GRADE&#x2019;s levels of certainty or quality of the evidence: GRADE for statisticians, considering review information size or less emphasis on imprecision? J. Clin. Epidemiol. 2016;75:6&#x2013;15. doi: 10.1016/j.jclinepi.2016.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2016.03.018</ArticleId><ArticleId IdType="pubmed">27063205</ArticleId></ArticleIdList></Reference><Reference><Citation>Beale R.J., Sherry T., Lei K., Campbell-Stephen L., McCook J., Smith J., Venetz W., Alteheld B., Stehle P., Schneider H. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: Outcome of a randomized, controlled, double-blind trial. Crit. Care Med. 2008;36:131&#x2013;144. doi: 10.1097/01.CCM.0000297954.45251.A9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000297954.45251.A9</ArticleId><ArticleId IdType="pubmed">18007263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur N., Gupta M.K., Minocha V.R. Early Enteral Feeding by Nasoenteric Tubes in Patients with Perforation Peritonitis. World J. Surg. 2005;29:1023&#x2013;1027. doi: 10.1007/s00268-005-7491-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-005-7491-z</ArticleId><ArticleId IdType="pubmed">15981045</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra A., Mathur A.K., Gupta S. Early enteral nutrition after surgical treatment of gut perforations: A prospective randomised study. J. Postgrad. Med. 2004;50:102&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">15235203</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel J.J., Kozeniecki M., Peppard W.J., Peppard S.R., Zellner-Jones S., Graf J., Szabo A., Heyland D.K. Phase 3 Pilot Randomized Controlled Trial Comparing Early Trophic Enteral Nutrition With &#x201c;No Enteral Nutrition&#x201d; in Mechanically Ventilated Patients With Septic Shock. J. Parenter. Enter. Nutr. 2020;44:866&#x2013;873. doi: 10.1002/jpen.1706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jpen.1706</ArticleId><ArticleId IdType="pubmed">31535394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J.-K., Zhang W.-H., Chen W.-X., Wang X., Mu X.-W. Effects of early enteral nutrition on Th17/Treg cells and IL-23/IL-17 in septic patients. World J. Gastroenterol. 2019;25:2799&#x2013;2808. doi: 10.3748/wjg.v25.i22.2799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v25.i22.2799</ArticleId><ArticleId IdType="pmc">PMC6580355</ArticleId><ArticleId IdType="pubmed">31236002</ArticleId></ArticleIdList></Reference><Reference><Citation>Haac B., Henry S., Diaz J., Scalea T., Stein D. Early Enteral Nutrition is Associated with Reduced Morbidity in Critically Ill Soft Tissue Patients. Am. Surg. 2018;84:1003&#x2013;1009. doi: 10.1177/000313481808400656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481808400656</ArticleId><ArticleId IdType="pubmed">29981639</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Hu B., Zhang S., Cai M., Chu X., Zheng D., Lou M., Cui K., Zhang M., Sun R., et al. Effects of early enteral nutrition on the prognosis of patients with sepsis: Secondary analysis of acute gastrointestinal injury study. Ann. Palliat. Med. 2020;9:3793&#x2013;3801. doi: 10.21037/apm-20-1650.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-20-1650</ArticleId><ArticleId IdType="pubmed">33302649</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga Y., Fujita M., Yagi T., Todani M., Nakahara T., Kawamura Y., Kaneda K., Oda Y., Tsuruta R. Early enteral nutrition is associated with reduced in-hospital mortality from sepsis in patients with sarcopenia. J. Crit. Care. 2018;47:153&#x2013;158. doi: 10.1016/j.jcrc.2018.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2018.06.026</ArticleId><ArticleId IdType="pubmed">29990793</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhao W., Chen W., Shen X., Fu R., Zhao Y., Liu H. Effects of Early Enteral Nutrition on Immune Function and Prognosis of Patients With Sepsis on Mechanical Ventilation. J. Intensive Care Med. 2020;35:1053&#x2013;1061. doi: 10.1177/0885066618809893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066618809893</ArticleId><ArticleId IdType="pubmed">30384813</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;ngeles M&#xe1;rquez M., Aisa &#xc1;lvarez A., Aguirre S&#xe1;nchez J.S., Mart&#xed;nez D&#xed;az B.A., Monta&#xf1;o Jim&#xe9;nez A. Cohort study to evaluate the association between the time of initiation of nutrition with days of invasive mechanical ventilation in patients with septic shock. Med. Cr&#xed;tica. 2023;37:82&#x2013;87. doi: 10.35366/110441.</Citation><ArticleIdList><ArticleId IdType="doi">10.35366/110441</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Reyes L., Patel J.J., Jiang X., Yataco A.C., Day A.G., Shah F., Zelten J., Tamae-Kakazu M., Rice T., Heyland D.K. Early versus delayed enteral nutrition in mechanically ventilated patients with circulatory shock: A nested cohort analysis of an international multicenter, pragmatic clinical trial. Crit. Care. 2022;26:173. doi: 10.1186/s13054-022-04047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04047-4</ArticleId><ArticleId IdType="pmc">PMC9185884</ArticleId><ArticleId IdType="pubmed">35681220</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel J.J., Kozeniecki M., Biesboer A., Peppard W., Ray A.S., Thomas S., Jacobs E.R., Nanchal R., Kumar G. Early Trophic Enteral Nutrition Is Associated with Improved Outcomes in Mechanically Ventilated Patients with Septic Shock: A Retrospective Review. J. Intensive Care Med. 2016;31:471&#x2013;477. doi: 10.1177/0885066614554887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066614554887</ArticleId><ArticleId IdType="pubmed">25315218</ArticleId></ArticleIdList></Reference><Reference><Citation>Slone S.D. Effect of Enteral Feeding Timing in Septic Shock Patients. DNP Projects 98. 2016.  [(accessed on 6 May 2024)].  Available online:  https://uknowledge.uky.edu/dnp_etds/98.</Citation></Reference><Reference><Citation>Sun J.-K., Yuan S.-T., Mu X.-W., Zhang W.-H., Liu Y., Zou L., Wang X., Zheng S.-Y. Effects of early enteral nutrition on T helper lymphocytes of surgical septic patients. Medicine. 2017;96:e7702. doi: 10.1097/MD.0000000000007702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000007702</ArticleId><ArticleId IdType="pmc">PMC5556220</ArticleId><ArticleId IdType="pubmed">28796054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Jiang L., Ding S., He S.-Y., Liu S.-B., Lu Z.-J., Liu Y.-Z., Hou L.-W., Wang B.-S., Zhang J.-B. Early Enteral Nutrition and Sepsis-Associated Acute Kidney Injury: A Propensity Score Matched Cohort Study Based on the MIMIC-III Database. Yonsei Med. J. 2023;64:259&#x2013;268. doi: 10.3349/ymj.2022.0276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2022.0276</ArticleId><ArticleId IdType="pmc">PMC10067798</ArticleId><ArticleId IdType="pubmed">36996897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos R.C.A., Mendoza A.J.C., Ballesteros D&#xed;az H. Nutritional evaluation in gynecological surgery. Rev. Colomb. Obstet. Ginecol. 1989;40:205&#x2013;214. doi: 10.18597/rcog.2482.</Citation><ArticleIdList><ArticleId IdType="doi">10.18597/rcog.2482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-V&#xe9;lez R., de Plata A.A., Mosquera-Escudero M., Ortega J.G., Salazar B., Echeverri I., Saldarriaga-Gil W. The effect of aerobic exercise on oxygen consumption in healthy females: A randomized clinical trial. Rev. Colomb. Obstet. Ginecol. 2011;62:15&#x2013;23. doi: 10.18597/rcog.227.</Citation><ArticleIdList><ArticleId IdType="doi">10.18597/rcog.227</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro A., Barriga A.P., Perdomo O. Medici&#xf3;n del consumo de ox&#xed;geno del miocardio en el puerperio normal: Ejemplo de eficiencia fisiol&#xf3;gica. Rev. Colomb. Obstet. Ginecol. 2005;56:288&#x2013;293. doi: 10.18597/rcog.517.</Citation><ArticleIdList><ArticleId IdType="doi">10.18597/rcog.517</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Su&#xe1;rez J.A., Gonz&#xe1;lez M.V., Monsalve G., Escobar-Vidarte M.F., Vasco-Ram&#xed;rez M. Colombian consensus for the definition of admission criteria to intensive care units in critically ill pregnant patients. Rev. Colomb. Obstet. Gynecol. 2014;65:47&#x2013;74. doi: 10.18597/rcog.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.18597/rcog.79</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon S.J., Ko R.-E., Park C.-M., Suh G.Y., Hwang J., Chung C.R. The Effectiveness of Early Enteral Nutrition on Clinical Outcomes in Critically Ill Sepsis Patients: A Systematic Review. Nutrients. 2023;15:3201. doi: 10.3390/nu15143201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15143201</ArticleId><ArticleId IdType="pmc">PMC10383540</ArticleId><ArticleId IdType="pubmed">37513620</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38562922</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Predictive value of the neutrophil-to-lymphocyte ratio in the prognosis and risk of death for adult sepsis patients: a meta-analysis.</ArticleTitle><Pagination><StartPage>1336456</StartPage><MedlinePgn>1336456</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1336456</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1336456</ELocationID><Abstract><AbstractText Label="BACKGROUND">The neutrophil-to-lymphocyte ratio (NLR) is a commonly used biomarker for acute inflammation that often rises during sepsis, making it a valuable diagnostic indicator for clinical practice. However, no consensus has been reached on the prognostic value of NLR for predicting the prognosis and mortality risk in adult sepsis patients. In light of this controversy, we conducted a meta-analysis to clarify the prognostic significance of NLR in adult sepsis patients. The meta-analysis was registered in the PROSPERO database (registration number CRD42023433143).</AbstractText><AbstractText Label="METHODS">We performed a comprehensive literature search in PubMed, Cochrane Library, Ovid, and Springer databases, using retrieval terms "<i>sepsis</i>" or "<i>septic shock</i>" and "<i>prognosis</i>" or "<i>mortality</i>" for studies published between January 1, 2000, and May 31, 2023. Children and neonates with sepsis were excluded from our research. Two independent researchers conducted the literature search and data extraction. Consensus was reached when discrepancies occurred, and in case of persistent discrepancies, the final decision was made by the research supervisor. The hazard ratio (HR) and its corresponding 95% confidence interval (95% CI) were extracted from each study included in the analysis. A random-effects model was used to synthesize all HRs and their 95% CIs. Sensitivity analysis was performed to investigate heterogeneity. Sensitivity analysis was conducted to identify studies that had a significant impact on the overall results of the meta-analysis. Subgroup analysis and meta-regression were performed to explore sources of heterogeneity. Egger's test was also used to investigate publication bias in this meta-analysis.</AbstractText><AbstractText Label="RESULTS">After a comprehensive literature search and screening, we included 12 studies comprising 10,811 patients for the meta-analysis. The pooled results indicated that patients with a higher NLR level were associated with a poor prognosis (Random-effects model, HR: 1.6273, 95% CI: 1.3951-1.8981). Heterogeneity testing showed significant heterogeneity (I<sup>2 =</sup> 87.2%, 95% CI: 79.5-92, p&lt;0.0001). Sensitivity analysis was performed to investigate the sources of heterogeneity, which revealed that the omission of one highly sensitive study significantly reduced the I<sup>2</sup> value. After removing this study, a strong association was found between a higher NLR level and poor prognosis and risk of death in adult sepsis patients (Random-effects model, HR: 1.6884, 95% CI: 1.4338-1.9882). Both subgroup analysis and meta-regression indicated that the study design and testing time of NLR were sources of heterogeneity. Egger's test showed no obvious publication bias in this meta-analysis.</AbstractText><AbstractText Label="CONCLUSION">NLR is a reliable and valuable biomarker for predicting prognosis and the risk of death in adult sepsis patients.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION">[https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023433143] PROSPERO, identifier [CRD42023433143].</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wu, Cao, Ji, Luo, Huang and Ma.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hongsheng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary Pancreatic Surgery, Huadu District People's Hospital of Guangzhou, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Tiansheng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary Pancreatic Surgery, Huadu District People's Hospital of Guangzhou, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Tengfei</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary Pancreatic Surgery, Huadu District People's Hospital of Guangzhou, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yumei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary Pancreatic Surgery, Huadu District People's Hospital of Guangzhou, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jianbin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary Pancreatic Surgery, Huadu District People's Hospital of Guangzhou, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Keqiang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary Pancreatic Surgery, Huadu District People's Hospital of Guangzhou, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="Y">Neutrophils</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="Y">Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018655" MajorTopicYN="N">Lymphocyte Count</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NLR</Keyword><Keyword MajorTopicYN="N">adult sepsis</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>2</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38562922</ArticleId><ArticleId IdType="pmc">PMC10982325</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1336456</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet (London England). (2018) 392:75&#x2013;87. doi: 10.1016/S0140-6736(18)30696-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30696-2</ArticleId><ArticleId IdType="pubmed">29937192</ArticleId></ArticleIdList></Reference><Reference><Citation>Oczkowski S, Alshamsi F, Belley-Cote E, Centofanti JE, Moller MH, Nunnaly ME, et al. . Surviving Sepsis Campaign Guidelines 2021: highlights for the practicing clinician. Polish Arch Internal Med. (2022) 132:7&#x2013;8. doi: 10.20452/pamw.16290</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16290</ArticleId><ArticleId IdType="pubmed">35791800</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman C.S, Seymour C.W, Shankar-Hari M, Annane D, Bauer M, et al. . The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. (2016) 315:801&#x2013;10. doi: 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheen N. Sepsis-3 definitions. Ann Emergency Med. (2016) 68:784&#x2013;5. doi: 10.1016/j.annemergmed.2016.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2016.07.008</ArticleId><ArticleId IdType="pubmed">27894635</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Meng Z, Li Y, Zhao J, Wu S, Gou S, et al. . Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with Sepsis. Scand J Trauma Resuscitation Emergency Med. (2019) 27:51. doi: 10.1186/s13049-019-0609-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13049-019-0609-3</ArticleId><ArticleId IdType="pmc">PMC6492372</ArticleId><ArticleId IdType="pubmed">31039813</ArticleId></ArticleIdList></Reference><Reference><Citation>Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, et al. . Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. (2017) 317:290&#x2013;300. doi: 10.1001/jama.2016.20328</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.20328</ArticleId><ArticleId IdType="pubmed">28114553</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: time for a reappraisal. Crit Care (London England). (2020) 24:287. doi: 10.1186/s13054-020-02993-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02993-5</ArticleId><ArticleId IdType="pmc">PMC7273821</ArticleId><ArticleId IdType="pubmed">32503670</ArticleId></ArticleIdList></Reference><Reference><Citation>Catenacci V, Sheikh F, Patel K, Fox-Robichaud AE. The prognostic utility of protein C as a biomarker for adult sepsis: a systematic review and meta-analysis. Crit Care (London England). (2022) 26:21. doi: 10.1186/s13054-022-03889-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-03889-2</ArticleId><ArticleId IdType="pmc">PMC8760778</ArticleId><ArticleId IdType="pubmed">35031071</ArticleId></ArticleIdList></Reference><Reference><Citation>Beliaev AM, Angelo N, Booth M, Bergin C. Evaluation of neutrophil-to-lymphocyte ratio as a potential biomarker for acute cholecystitis. J Surg Res. (2017) 209:93&#x2013;101. doi: 10.1016/j.jss.2016.09.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2016.09.034</ArticleId><ArticleId IdType="pubmed">28032577</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Li W, Zou B, Wang B, Meng S, Sun X, et al. . Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC. Int Immunopharmacol. (2019) 72:395&#x2013;401. doi: 10.1016/j.intimp.2019.04.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.04.032</ArticleId><ArticleId IdType="pubmed">31030095</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehman FU, Khan A, Aziz A, Iqbal M, Mahmood Saad BZ, Ali N, et al. . Neutrophils to lymphocyte ratio: earliest and efficacious markers of sepsis. Cureus. (2020) 12:e10851. doi: 10.7759/cureus.10851</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10851</ArticleId><ArticleId IdType="pmc">PMC7651770</ArticleId><ArticleId IdType="pubmed">33178505</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang P, Yu F. Predictive value of procalcitonin and neutrophil-to-lymphocyte ratio variations for bloodstream infection with septic shock. Med Sci Monitor: Int Med J Exp Clin Res. (2022) 28:e935966. doi: 10.12659/MSM.935966</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.935966</ArticleId><ArticleId IdType="pmc">PMC9083214</ArticleId><ArticleId IdType="pubmed">35509186</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H-B, Chen J, Lan QF, Ma XJ, Zhang SY. Diagnostic values of red cell distribution width, platelet distribution width and neutrophil-lymphocyte count ratio for sepsis. Exp Ther Med. (2016) 12:2215&#x2013;9. doi: 10.3892/etm.2016.3583</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3583</ArticleId><ArticleId IdType="pmc">PMC5038364</ArticleId><ArticleId IdType="pubmed">27698714</ArticleId></ArticleIdList></Reference><Reference><Citation>Schupp T, Weidner K, Rusnak J, Jawhar S, Forner J, Dulatahu F, et al. . The neutrophil-to-lymphocyte-ratio as diagnostic and prognostic tool in sepsis and septic shock. Clin Lab. (2023) 69:912&#x2013;24. doi: 10.7754/Clin.Lab.2022.220812</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2022.220812</ArticleId><ArticleId IdType="pubmed">37145065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo CK-L, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Method. (2014) 14:45. doi: 10.1186/1471-2288-14-45</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-45</ArticleId><ArticleId IdType="pmc">PMC4021422</ArticleId><ArticleId IdType="pubmed">24690082</ArticleId></ArticleIdList></Reference><Reference><Citation>Terradas R, Santiago G, Jordi B, Marta R, Pere S, Xavier C, et al. . Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PloS One. (2012) 7:e42860. doi: 10.1371/journal.pone.0042860</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0042860</ArticleId><ArticleId IdType="pmc">PMC3415420</ArticleId><ArticleId IdType="pubmed">22912753</ArticleId></ArticleIdList></Reference><Reference><Citation>Akilli NB, Yortanli M, Mutlu H, G&#xfc;naydin YK, Koylu R, Akca HS, et al. . Prognostic importance of neutrophil-lymphocyte ratio in critically ill patients: short- and long-term outcomes. Am J Emerg Med. (2014) 32:1476&#x2013;80. doi: 10.1016/j.ajem.2014.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2014.09.001</ArticleId><ArticleId IdType="pubmed">25264245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SY, Shin TG, Jo IJ, Jeon K, Suh GY, Lee TR, et al. . Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am J Emerg Med. (2017) 35:234&#x2013;9. doi: 10.1016/j.ajem.2016.10.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2016.10.055</ArticleId><ArticleId IdType="pubmed">27806894</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente L, Mart&#xed;n MM, Ortiz-L&#xf3;pez R, Alvarez-Castillo A, Ruiz C, Uribe L, et al. . Association between neutrophil-to-lymphocyte ratio in the first seven days of sepsis and mortality. Enferm Infecc Microbiol Clin (Engl Ed). (2020), 235&#x2013;240. doi:&#xa0;10.1016/j.eimc.2020.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2020.11.004</ArticleId><ArticleId IdType="pubmed">35577441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye W, Chen X, Huang Y, Li Y, Li Y. The association between neutrophil-to-lymphocyte count ratio and mortality in septic patients: a retrospective analysis of the MIMIC-III database. J Thorac Dis. (2020) 12:1843&#x2013;55. doi: 10.21037/jtd-20-1169</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-20-1169</ArticleId><ArticleId IdType="pmc">PMC7330395</ArticleId><ArticleId IdType="pubmed">32642088</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JY, Yao RQ, Liu SQ, Zhang YF, Yao YM, Tian YP. Efficiency of monocyte/high-density lipoprotein cholesterol ratio combined with neutrophil/lymphocyte ratio in predicting 28-day mortality in patients with sepsis. Front Med (Lausanne). (2021) 8:741015. doi: 10.3389/fmed.2021.741015</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.741015</ArticleId><ArticleId IdType="pmc">PMC8548423</ArticleId><ArticleId IdType="pubmed">34722578</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Xie J, Huang Y, Liu S, Guo F, Liu L, et al. . Leukocyte kinetics during the early stage acts as a prognostic marker in patients with septic shock in intensive care unit. Med (Baltimore). (2021) 100:e26288. doi: 10.1097/MD.0000000000026288</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000026288</ArticleId><ArticleId IdType="pmc">PMC8202536</ArticleId><ArticleId IdType="pubmed">34115032</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SQ, Li YX, She F, Zhao XD, Yao YM. Predictive value of immune cell counts and neutrophil-to-lymphocyte ratio for 28-day mortality in patients with sepsis caused by intra-abdominal infection. Burns Trauma. (2021) 9:tkaa040. doi: 10.1093/burnst/tkaa040</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/burnst/tkaa040</ArticleId><ArticleId IdType="pmc">PMC7982795</ArticleId><ArticleId IdType="pubmed">33768121</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Wang X, She F, Zhao X. Effects of neutrophil-to-lymphocyte ratio combined with interleukin-6 in predicting 28-day mortality in patients with sepsis. Front Immunol. (2021) 12:639735. doi: 10.3389/fimmu.2021.639735</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.639735</ArticleId><ArticleId IdType="pmc">PMC8007868</ArticleId><ArticleId IdType="pubmed">33796105</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang RZ, Cheng J, Wu JF, Zhang SH. Ratio of serum procalcitonin to monocytic HLA-DR as a reliable parameter in prognosis prediction of sepsis. Clin Chim Acta; Int J Clin Chem. (2021) 519:94&#x2013;100. doi: 10.1016/j.cca.2021.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2021.04.011</ArticleId><ArticleId IdType="pubmed">33887265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chebl RB, Assaf M, Kattouf N, Haidar S, Khamis M, Abdeldaem K, et al. . The association between the neutrophil to lymphocyte ratio and in-hospital mortality among sepsis patients: A prospective study. Med (Baltimore). (2022) 101:e29343. doi: 10.1097/MD.0000000000029343</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000029343</ArticleId><ArticleId IdType="pmc">PMC9333497</ArticleId><ArticleId IdType="pubmed">35905272</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Huang XR, Yang LT, Li J, Liu CH, Pu YJ, et al. . Neutrophil-to-Lymphocyte ratio as a prognostic marker of mortality and disease severity in septic Acute kidney injury Patients: A retrospective study. Int Immunopharmacol. (2023) 116:109778. doi: 10.1016/j.intimp.2023.109778</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2023.109778</ArticleId><ArticleId IdType="pubmed">36738677</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres LK, Pickkers P, van der Poll T. Sepsis-induced immunosuppression. Annu Rev Physiol. (2022) 84:157&#x2013;81. doi: 10.1146/annurev-physiol-061121-040214</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-061121-040214</ArticleId><ArticleId IdType="pubmed">34705481</ArticleId></ArticleIdList></Reference><Reference><Citation>Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. (2018) 14:121&#x2013;37. doi: 10.1038/nrneph.2017.165</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.165</ArticleId><ArticleId IdType="pubmed">29225343</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. . Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Military Med Res. (2022) 9:56. doi: 10.1186/s40779-022-00422-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-022-00422-y</ArticleId><ArticleId IdType="pmc">PMC9547753</ArticleId><ArticleId IdType="pubmed">36209190</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneja R, Parodo J, Jia SH, Kapus A, Rotstein OD, Marshall JC. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med. (2004) 32:1460&#x2013;9. doi: 10.1097/01.CCM.0000129975.26905.77</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000129975.26905.77</ArticleId><ArticleId IdType="pubmed">15241089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratislavske Lekarske Listy. (2021) 122:474&#x2013;88. doi: 10.4149/BLL_2021_078</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/BLL_2021_078</ArticleId><ArticleId IdType="pubmed">34161115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriplani A, Kriplani A, Pandit S, Choudhary A. Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) in predicting systemic inflammatory response syndrome (SIRS) and sepsis after percutaneous nephrolithotomy (PNL). Urolithiasis. (2022) 50:341&#x2013;8. doi: 10.1007/s00240-022-01319-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-022-01319-0</ArticleId><ArticleId IdType="pmc">PMC9110452</ArticleId><ArticleId IdType="pubmed">35246692</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang P, Yu F. Value of CRP, PCT, and NLR in prediction of severity and prognosis of patients with bloodstream infections and sepsis. Front In Surg. (2022) 9:857218. doi: 10.3389/fsurg.2022.857218</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2022.857218</ArticleId><ArticleId IdType="pmc">PMC8957078</ArticleId><ArticleId IdType="pubmed">35345421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik R, Gupta M, Sharma M, Jash D, Jain N, Sinha N, et al. . Diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in early and late phase of sepsis. Indian J Crit Care Med. (2018) 22:660&#x2013;3. doi: 10.4103/ijccm.IJCCM_59_18</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijccm.IJCCM_59_18</ArticleId><ArticleId IdType="pmc">PMC6161585</ArticleId><ArticleId IdType="pubmed">30294133</ArticleId></ArticleIdList></Reference><Reference><Citation>Spoto S, Lupoi DM, Valeriani E, Fogolari M, Locorriere L, Anguissola GB, et al. . Diagnostic accuracy and prognostic value of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in septic patients outside the intensive care unit. Medicina (Kaunas Lithuania). (2021) 57:1&#x2013;11. doi: 10.3390/medicina57080811</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57080811</ArticleId><ArticleId IdType="pmc">PMC8399559</ArticleId><ArticleId IdType="pubmed">34441017</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Fu ZY, Huang WJ, Huang KG. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. Am J Emerg Med. (2020) 38:641&#x2013;7. doi: 10.1016/j.ajem.2019.10.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2019.10.023</ArticleId><ArticleId IdType="pubmed">31785981</ArticleId></ArticleIdList></Reference><Reference><Citation>Salciccioli JD, Marshall DC, Pimentel MA, Santos MD, Shalhoub J. The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study. Crit Care (London England). (2015) 19:13. doi: 10.1186/s13054-014-0731-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0731-6</ArticleId><ArticleId IdType="pmc">PMC4344736</ArticleId><ArticleId IdType="pubmed">25598149</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KS, Lee SH, Yun SJ, Ryu S, Kim K. Neutrophil-to-lymphocyte ratio as a feasible prognostic marker for pyogenic liver abscess in the emergency department. Eur J Trauma Emergency Surg. (2019) 45:343&#x2013;51. doi: 10.1007/s00068-018-0925-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00068-018-0925-8</ArticleId><ArticleId IdType="pubmed">29480320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Jin P, Feng M, Yang J, Huang J, Chen L, et al. . Causal inference with marginal structural modeling for longitudinal data in laparoscopic surgery: A technical note. Laparoscopic Endoscopic Robotic Surg. (2022) 5:146&#x2013;52. doi: 10.1016/j.lers.2022.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lers.2022.10.002</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38178170</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>04</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>12</StartPage><MedlinePgn>12</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-023-04795-x</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The impact of therapeutic plasma exchange (TPE) on short-term mortality in adult patients with sepsis-induced organ dysfunction remains uncertain. The objective of the study is to assess the effect of adjunct TPE in this setting through a comprehensive literature review.</AbstractText><AbstractText Label="METHODS">The National Library of Medicine's Medline, Ovid (Embase), the Cochrane Library database and clinicaltrial.gov from January 01, 1966, until October 01, 2022, were searched for terms: therapeutic plasma exchange, plasmapheresis, sepsis, and septic shock. We reviewed, selected and extracted data from relevant randomized clinical trials (RCTs) and matched cohort studies (MCSs) comparing short-term mortality in critically ill adult septic patients treated with standard therapy versus those receiving adjunct TPE. Risk of bias was assessed in the RCTs using Cochrane Collaboration tool and in MCSs using ROBINS-I tool. Summary statistics, risk ratios (RRs), and confidence intervals (CIs) were calculated using random effects model.</AbstractText><AbstractText Label="RESULTS">This systematic review included 937 adult critically ill septic patients from five RCTs (n&#x2009;=&#x2009;367) and fifteen MCSs (n&#x2009;=&#x2009;570). Of these total, 543 received treatment with TPE in addition to standard care. The meta-analysis includes all five RCTs and only six MCSs (n&#x2009;=&#x2009;627). The adjunct TPE treatment (n&#x2009;=&#x2009;300) showed a significant reduction in short-term mortality (RR 0.59, 95% CI 0.47-0.74, I2 3%) compared to standard therapy alone (n&#x2009;=&#x2009;327). The systematic review of all 20 trials revealed that adding TPE to the standard therapy of critically ill septic patients resulted in faster clinical and/or laboratory recovery.</AbstractText><AbstractText Label="CONCLUSIONS">Our comprehensive and up-to-date review demonstrates that adjunct TPE may provide potential survival benefits when compared to standard care for critically ill adult patients with sepsis-induced organ dysfunction. While results of this meta-analysis are encouraging, large well-designed randomized trials are required to identify the optimal patient population and TPE procedure characteristics prior to widespread adoption into practice.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuklin</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Ahus University Hospital, Sykehusveien, 25, 1478, Lorenskog, Norway. vkuklin@me.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sovershaev</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>F&#xfc;rst Medical Laboratory, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjerner</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>F&#xfc;rst Medical Laboratory, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keith</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Critical Care Medicine, Lexington Medical Center, West Columbia, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>L Keith</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Louisiana State University Health Sciences Center, Shreveport, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Owen Matthew Truscott</ForeName><Initials>OMT</Initials><AffiliationInfo><Affiliation>Department of Health Services Research, Ahus University Hospital, Lorenskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szpirt</LastName><ForeName>Wladimir</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rock</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stegmayr</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010951" MajorTopicYN="N">Plasma Exchange</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>23</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38178170</ArticleId><ArticleId IdType="pmc">PMC10768220</ArticleId><ArticleId IdType="doi">10.1186/s13054-023-04795-x</ArticleId><ArticleId IdType="pii">10.1186/s13054-023-04795-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Arina P, Singer M. Pathophysiology of sepsis. Curr Opin Anaesthesiol. 2021;34(2):77&#x2013;84. doi: 10.1097/ACO.0000000000000963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000963</ArticleId><ArticleId IdType="pubmed">33652454</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;-Carvajal AJ, Sol&#xe0; I, Lathyris D, Cardona AF. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev. 2011 doi: 10.1002/14651858.CD004388.pub.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004388.pub</ArticleId><ArticleId IdType="pubmed">21491390</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, Lemeshow S, Osborn T, Terry KM, Levy MM. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235&#x2013;2244. doi: 10.1056/NEJMoa1703058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1703058</ArticleId><ArticleId IdType="pmc">PMC5538258</ArticleId><ArticleId IdType="pubmed">28528569</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharfman WB, Tillotson JR, Taft EG, Wright E. Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N Engl J Med. 1979;300(22):1277&#x2013;1278. doi: 10.1056/NEJM197905313002220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197905313002220</ArticleId><ArticleId IdType="pubmed">431695</ArticleId></ArticleIdList></Reference><Reference><Citation>Vain NE, Mazlumian JR, Swarner OW, Cha CC. Role of exchange transfusion in the treatment of severe septicemia. Pediatrics. 1980;66(5):693&#x2013;697. doi: 10.1542/peds.66.5.693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.66.5.693</ArticleId><ArticleId IdType="pubmed">7432874</ArticleId></ArticleIdList></Reference><Reference><Citation>Norska-Borowka I, Grzywna W, Monsiol A, Karczewska K, Godula-Stuglik U. Usefulness of exchange transfusions in the treatment of septicemia complicated by intravascular coagulation in newborn infants. Pediatr Pol. 1980;55:943&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">7001329</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorvatn B, Bjertnaes L, Fadnes HO, Flaegstad T, Gutteberg TJ, Kristiansen BE, Pape J, Rekvig OP, Osterud B, Aanderud L. Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J. 1984;288(6415):439&#x2013;441. doi: 10.1136/bmj.288.6415.439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.288.6415.439</ArticleId><ArticleId IdType="pmc">PMC1444687</ArticleId><ArticleId IdType="pubmed">6419956</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost. 1983;49(1):5&#x2013;7. doi: 10.1055/s-0038-1657303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1657303</ArticleId><ArticleId IdType="pubmed">6845273</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandtzaeg P, Sirnes K, Folsland B, et al. Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients. Scand J Clin Lab Invest. 1985;178:53&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">3867122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ender LA, Lobakov AI, Lipats AA, Vatazin AV, Filizhanko VN. Plasmapheresis in the complex treatment of suppurative-septic complications of acute surgical diseases of the abdominal organs. Klin Med. 1985;63:98&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">4046544</ArticleId></ArticleIdList></Reference><Reference><Citation>Drapkin MS, Wisch JS, Gelfand JA, Cannon JG, Dinarello CA. Plasmapheresis for fulminant meningococcemia. Pediatr Infect Dis J. 1989;8(6):399&#x2013;400. doi: 10.1097/00006454-198906000-00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-198906000-00015</ArticleId><ArticleId IdType="pubmed">2501752</ArticleId></ArticleIdList></Reference><Reference><Citation>McClelland P, Williams PS, Yaqoob M, et al. Multiple organ failure&#x2014;a role for plasma exchange? Intensive Care Med. 1990;16:100&#x2013;103. doi: 10.1007/BF02575302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02575302</ArticleId><ArticleId IdType="pubmed">2332535</ArticleId></ArticleIdList></Reference><Reference><Citation>Janbon B, Vuillez JP, Carpentier F, Barnoud D, Andr&#xe9;-Poyaud P, Barbe G, Guignier M. Removal of circulating tumor necrosis factor. Its role in septic shock treatment. Ann Med Interne. 1992;143(Suppl 1):13&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">1300881</ArticleId></ArticleIdList></Reference><Reference><Citation>Westendorp RG, Brand A, Haanen J, van Hinsbergh VW, Thompson J, van Furth R, Meinders EA. Leukaplasmapheresis in meningococcal septic shock. Am J Med. 1992;92(5):577&#x2013;578. doi: 10.1016/0002-9343(92)90761-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(92)90761-y</ArticleId><ArticleId IdType="pubmed">1580309</ArticleId></ArticleIdList></Reference><Reference><Citation>van Deuren M, Santman FW, van Dalen R, Sauerwein RW, Span LF, van der Meer JW. Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis. 1992;15(3):424&#x2013;430. doi: 10.1093/clind/15.3.424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clind/15.3.424</ArticleId><ArticleId IdType="pubmed">1520788</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe5;rdlund B, Sj&#xf6;lin J, Nilsson A, Roll M, Wickerts CJ, Wikstr&#xf6;m B, Wretlind B. Plasmapheresis in the treatment of primary septic shock in humans. Scand J Infect Dis. 1993;25(6):757&#x2013;761. doi: 10.3109/00365549309008575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365549309008575</ArticleId><ArticleId IdType="pubmed">8052817</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchwell KB, McManus ML, Kent P, Gorlin J, Galacki D, Humphreys D, Kevy SV. Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia. J Clin Apher. 1995;10(4):171&#x2013;177. doi: 10.1002/jca.2920100403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jca.2920100403</ArticleId><ArticleId IdType="pubmed">8770708</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe5;rdlund B, Sj&#xf6;lin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis. 1995;172(1):296&#x2013;301. doi: 10.1093/infdis/172.1.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/172.1.296</ArticleId><ArticleId IdType="pubmed">7797935</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;tt U, Bj&#xf6;rsell-Ostling E. Sonoclot coagulation analysis and plasma exchange in a case of meningococcal septicaemia. Can J Anaesth. 1995;42(1):64&#x2013;68. doi: 10.1007/BF03010573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03010573</ArticleId><ArticleId IdType="pubmed">7889586</ArticleId></ArticleIdList></Reference><Reference><Citation>Haupt W, Fritzsche H, Hohenberger W, Zirngibl H. Selective cytokine release induced by serum and separated plasma from septic patients. Eur J Surg. 1996;162(10):769&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">8934105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok Q, Butt W. The outcome of children admitted to intensive care with meningococcal septicaemia. Intensive Care Med. 1996;22(3):259&#x2013;263. doi: 10.1007/BF01712247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01712247</ArticleId><ArticleId IdType="pubmed">8727442</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell WN, Joshi M, Sileo D. Osteonecrosis following meningococcemia and disseminated intravascular coagulation in an adult: case report and review. Clin Infect Dis. 1997;24(3):452&#x2013;455. doi: 10.1093/clinids/24.3.452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/24.3.452</ArticleId><ArticleId IdType="pubmed">9114199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Kanagasundaram NS, Collyns TA, Davison AM. Plasma exchange and haemodiafiltration in fulminant meningococcal sepsis. Nephrol Dial Transplant. 1998;13(2):484&#x2013;487. doi: 10.1093/oxfordjournals.ndt.a027853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.ndt.a027853</ArticleId><ArticleId IdType="pubmed">9509469</ArticleId></ArticleIdList></Reference><Reference><Citation>Darmon M, Azoulay E, Thiery G, Ciroldi M, Galicier L, Parquet N, Veyradier A, Le Gall JR, Oksenhendler E, Schlemmer B. Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange. Crit Care Med. 2006;34(8):2127&#x2013;2133. doi: 10.1097/01.CCM.0000227659.14644.3E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000227659.14644.3E</ArticleId><ArticleId IdType="pubmed">16763519</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, Orr RA, Janosky J, Carcillo JA. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med. 2008;36(10):2878&#x2013;2887. doi: 10.1097/CCM.0b013e318186aa49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318186aa49</ArticleId><ArticleId IdType="pmc">PMC2772176</ArticleId><ArticleId IdType="pubmed">18828196</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevketoglu E, Yildizdas D, Horoz OO, Kihtir HS, Kendirli T, Bayraktar S, Carcillo JA. Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network. Pediatr Crit Care Med. 2014;15(8):e354&#x2013;359. doi: 10.1097/PCC.0000000000000227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000227</ArticleId><ArticleId IdType="pmc">PMC5287151</ArticleId><ArticleId IdType="pubmed">25068251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadem J, Hafer C, Schneider AS, Wiesner O, Beutel G, Fuehner T, Welte T, Hoeper MM, Kielstein JT. Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients. BMC Anesthesiol. 2014;14:24. doi: 10.1186/1471-2253-14-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-14-24</ArticleId><ArticleId IdType="pmc">PMC3986467</ArticleId><ArticleId IdType="pubmed">24708653</ArticleId></ArticleIdList></Reference><Reference><Citation>De Simone N, Racsa L, Bevan S, Matevosyan K, Valley T, Girod C, Sarode R. Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: a report of three cases. J Clin Apher. 2014;29(2):127&#x2013;131. doi: 10.1002/jca.21296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jca.21296</ArticleId><ArticleId IdType="pubmed">24000124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai Y, Cornell TT, Cooley EG, Beckman CN, Baldridge PK, Mottes TA, Luckritz KE, Plomaritas KS, Meade JM, Odetola FO, Han YY, Blatt NB, Annich GM. Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support. Pediatr Crit Care Med. 2015;16(4):366&#x2013;374. doi: 10.1097/PCC.0000000000000351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000351</ArticleId><ArticleId IdType="pmc">PMC4424057</ArticleId><ArticleId IdType="pubmed">25599148</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG. Plasmapheresis in severe sepsis or septic shock. Blood Purif. 1996;14(1):94&#x2013;101. doi: 10.1159/000170250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000170250</ArticleId><ArticleId IdType="pubmed">8718572</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG. Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome. Ther Apher. 2001;5(2):123&#x2013;127. doi: 10.1046/j.1526-0968.2001.005002123.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1526-0968.2001.005002123.x</ArticleId><ArticleId IdType="pubmed">11354296</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr B. Apheresis in patients with severe sepsis and multi organ dysfunction syndrome. Transfus Apher Sci. 2008;38(3):203&#x2013;208. doi: 10.1016/j.transci.2008.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2008.03.009</ArticleId><ArticleId IdType="pubmed">18492616</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbero E, Livigni S, Ferrari F, Finazzi S, Langer M, Malacarne P, Meca MCC, Mosca S, Olivieri C, Pozzato M, Rossi C, Tavola M, Terzitta M, Viaggi B, Bertolini G. GiViTI High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial. Intensive Care Med. 2021;47(11):1303&#x2013;1311. doi: 10.1007/s00134-021-06501-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06501-3</ArticleId><ArticleId IdType="pubmed">34601619</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med. 1999;27(10):2096&#x2013;2104. doi: 10.1097/00003246-199910000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199910000-00003</ArticleId><ArticleId IdType="pubmed">10548188</ArticleId></ArticleIdList></Reference><Reference><Citation>Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med. 2002;28(10):1434&#x2013;1439. doi: 10.1007/s00134-002-1410-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-002-1410-7</ArticleId><ArticleId IdType="pubmed">12373468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med. 2013;41(9):2209&#x2013;2220. doi: 10.1097/CCM.0b013e31828cf412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828cf412</ArticleId><ArticleId IdType="pmc">PMC3758418</ArticleId><ArticleId IdType="pubmed">23860248</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimmer E, Houston BL, Kumar A, Abou-Setta AM, Friesen C, Marshall JC, Rock G, Turgeon AF, Cook DJ, Houston DS, Zarychanski R. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis. Crit Care. 2014;18(6):699. doi: 10.1186/s13054-014-0699-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0699-2</ArticleId><ArticleId IdType="pmc">PMC4318234</ArticleId><ArticleId IdType="pubmed">25527094</ArticleId></ArticleIdList></Reference><Reference><Citation>Putzu A, Schorer R, Lopez-Delgado JC, Cassina T, Landoni G. Blood purification and mortality in sepsis and septic shock: a systematic review and meta-analysis of randomized trials. Anesthesiology. 2019;131(3):580&#x2013;593. doi: 10.1097/ALN.0000000000002820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002820</ArticleId><ArticleId IdType="pubmed">31246600</ArticleId></ArticleIdList></Reference><Reference><Citation>Snow TAC, Littlewood S, Corredor C, Singer M, Arulkumaran N. Effect of extracorporeal blood purification on mortality in sepsis: a meta-analysis and trial sequential analysis. Blood Purif. 2021;50(4&#x2013;5):462&#x2013;472. doi: 10.1159/000510982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000510982</ArticleId><ArticleId IdType="pubmed">33113533</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash S, Sahu A, Routray SS, Maiti R, Mitra JK, Mukherjee S. Efficacy of therapeutic plasma exchange in severe COVID-19 disease: a meta-analysis. Vox Sang. 2023;118(1):49&#x2013;58. doi: 10.1111/vox.13367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vox.13367</ArticleId><ArticleId IdType="pmc">PMC9874931</ArticleId><ArticleId IdType="pubmed">36254849</ArticleId></ArticleIdList></Reference><Reference><Citation>Connelly-Smith L, Alquist CR, Aqui N, Hofmann J, Klingel R, Onwuemene O, Patriquin C, Pham H, Sanchez A, Schneiderman J, Witt V, Zantek N, Dunbar N. Guidelines on the use of therapeutic apheresis in clinical practice&#x2013;evidence-based approach from the writing committee of the American society for apheresis: the ninth special issue. J Clin Apher. 2023;38(2):77&#x2013;278. doi: 10.1002/jca.22043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jca.22043</ArticleId><ArticleId IdType="pubmed">37017433</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr&#xf3;bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group. Cochrane Statistical Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hr&#xf3;bjartsson A, Kirkham J, J&#xfc;ni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch&#xfc;nemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team (2023). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, https://www.R-project.org/.</Citation></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153&#x2013;160. doi: 10.1136/ebmental-2019-300117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness, LA robvis: An R package and web application for visualising risk-of-bias assessments. 2019, https://github.com/mcguinlu/robvis</Citation><ArticleIdList><ArticleId IdType="pubmed">32336025</ArticleId></ArticleIdList></Reference><Reference><Citation>Faqihi F, Alharthy A, Abdulaziz S, Balhamar A, Alomari A, AlAseri Z, Tamim H, Alqahtani SA, Kutsogiannis DJ, Brindley PG, Karakitsos D, Memish ZA. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial. Int J Antimicrob Agents. 2021;57(5):106334. doi: 10.1016/j.ijantimicag.2021.106334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2021.106334</ArticleId><ArticleId IdType="pmc">PMC8024223</ArticleId><ArticleId IdType="pubmed">33838224</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J, Chen M, Fang D, Liu D, Guo R, Yang S. Therapeutic plasma exchange protects patients with sepsis-associated disseminated intravascular coagulation by improving endothelial function. Clin Appl Thromb Hemost. 2021 doi: 10.1177/10760296211053313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296211053313</ArticleId><ArticleId IdType="pmc">PMC8597066</ArticleId><ArticleId IdType="pubmed">34775801</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Wand P, Seeliger B, Wendel-Garcia PD, Schmidt JJ, Schmidt BMW, Sauer A, Lehmann F, Budde U, Busch M, Wiesner O, Welte T, Haller H, Wedemeyer H, Putensen C, Hoeper MM, Bode C, David S. Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial. Crit Care. 2022;26(1):134. doi: 10.1186/s13054-022-04003-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04003-2</ArticleId><ArticleId IdType="pmc">PMC9097091</ArticleId><ArticleId IdType="pubmed">35551628</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG, Jakobson S, Rydvall A, Bj&#xf6;rsell-Ostling E. Plasma exchange in patients with acute renal failure in the course of multiorgan failure. Int J Artif Organs. 1995;18(1):45&#x2013;52. doi: 10.1177/039139889501800110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039139889501800110</ArticleId><ArticleId IdType="pubmed">7607758</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG. Plasma exchange in patients with septic shock including acute renal failure. Blood Purif. 1996;14(1):102&#x2013;108. doi: 10.1159/000170251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000170251</ArticleId><ArticleId IdType="pubmed">8718573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjorth V, Stenlund G. Plasmapheresis as part of the treatment for septic shock. Scand J Infect Dis. 2000;32(5):511&#x2013;514. doi: 10.1080/003655400458794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/003655400458794</ArticleId><ArticleId IdType="pubmed">11055656</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt J, Mann S, Mohr VD, Lampert R, Firla U, Zirngibl H. Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis. Intensive Care Med. 2000;26(5):532&#x2013;537. doi: 10.1007/s001340051200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340051200</ArticleId><ArticleId IdType="pubmed">10923726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ataman K, Jehmlich M, Kock S, Neumann S, Leischik M, Filipovic Z, Hopf HB. Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock. Intensive Care Med. 2002;28(8):1164&#x2013;1167. doi: 10.1007/s00134-002-1375-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-002-1375-6</ArticleId><ArticleId IdType="pubmed">12185443</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG, Banga R, Berggren L, Norda R, Rydvall A, Vikerfors T. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med. 2003;31(6):1730&#x2013;1736. doi: 10.1097/01.CCM.0000064742.00981.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000064742.00981.14</ArticleId><ArticleId IdType="pubmed">12794412</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, Welte T, Haller H, Kielstein JT, Hoeper MM, David S. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018;22(1):285. doi: 10.1186/s13054-018-2220-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2220-9</ArticleId><ArticleId IdType="pmc">PMC6206942</ArticleId><ArticleId IdType="pubmed">30373638</ArticleId></ArticleIdList></Reference><Reference><Citation>Keith PD, Wells AH, Hodges J, Fast SH, Adams A, Scott LK. The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience. Crit Care. 2020;24(1):518. doi: 10.1186/s13054-020-03241-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03241-6</ArticleId><ArticleId IdType="pmc">PMC7443810</ArticleId><ArticleId IdType="pubmed">32831133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Soliman AR, Yousry A, Marzouk K, Faris F. Efficacy of 4-hour rescue therapeutic plasma exchange in severe septic shock patients. Rom J Intern Med. 2020;58(2):75&#x2013;80. doi: 10.2478/rjim-2019-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rjim-2019-0026</ArticleId><ArticleId IdType="pubmed">31955149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gucyetmez B, Atalan HK, Sertdemir I, Cakir U, Telci L, COVID-19 Study Group Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study. Crit Care. 2020;24(1):492. doi: 10.1186/s13054-020-03215-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03215-8</ArticleId><ArticleId IdType="pmc">PMC7414262</ArticleId><ArticleId IdType="pubmed">32771054</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, Al Khalili H, Memish Z. Therapeutic plasma exchange in adults with severe COVID-19 infection. Int J Infect Dis. 2020;99:214&#x2013;218. doi: 10.1016/j.ijid.2020.06.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.064</ArticleId><ArticleId IdType="pmc">PMC7308750</ArticleId><ArticleId IdType="pubmed">32585284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamran SM, Mirza ZE, Naseem A, Liaqat J, Fazal I, Alamgir W, Saeed F, Saleem S, Nisar S, Yousaf MA, Khan AZ, Hussain M, Azam R, Hussain M, Khan KA, Jamal Y, Iftikhar R. Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study. PLoS ONE. 2021;16(1):e0244853. doi: 10.1371/journal.pone.0244853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244853</ArticleId><ArticleId IdType="pmc">PMC7790281</ArticleId><ArticleId IdType="pubmed">33411791</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal V, Nasa P, Raouf M, Gupta M, Dewedar H, Mohammad H, Al Rais Z, Ali Baqer M, Alsabbah A, Ibrahim Y, Salem M, Shammass D, Marashi M. Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19-An exploratory study. Int J Infect Dis. 2021;102:332&#x2013;334. doi: 10.1016/j.ijid.2020.10.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.085</ArticleId><ArticleId IdType="pmc">PMC7607263</ArticleId><ArticleId IdType="pubmed">33157287</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676&#x2013;680. doi: 10.1001/jama.295.6.676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.6.676</ArticleId><ArticleId IdType="pubmed">16467236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee OPE, Kanesan N, Leow EH, Sultana R, Chor YK, Gan CS, Lee JH. Survival benefits of therapeutic plasma exchange in severe sepsis and septic shock: a systematic review and meta-analysis. J Intensive Care Med. 2023;38(7):598&#x2013;611. doi: 10.1177/08850666231170775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666231170775</ArticleId><ArticleId IdType="pubmed">37097910</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18:1324&#x2013;1329. doi: 10.1111/jth.14859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14859</ArticleId><ArticleId IdType="pmc">PMC7264730</ArticleId><ArticleId IdType="pubmed">32306492</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ, Lai PC, Lee TH, Huang YT. Blood purification for adult patients with severe infection or sepsis/septic shock: a network meta-analysis of randomized controlled trials. Crit Care Med. 2023 doi: 10.1097/CCM.0000000000005991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005991</ArticleId><ArticleId IdType="pmc">PMC10645104</ArticleId><ArticleId IdType="pubmed">37470680</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan D, Yao R, Xie X, Fu X, Pei S, Wang Y, Xu D, Li N. The therapeutic efficacy of plasmapheresis for sepsis with multiple organ failure: a propensity score-matched analysis based on the MIMIC-IV database. Shock. 2023 doi: 10.1097/SHK.0000000000002254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000002254</ArticleId><ArticleId IdType="pubmed">37988068</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock G, Weber V, Stegmayr B. Therapeutic plasma exchange (TPE) as a plausible rescue therapy in severe vaccine-induced immune thrombotic thrombocytopenia. Transfus Apher Sci. 2021;60(4):103174. doi: 10.1016/j.transci.2021.103174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2021.103174</ArticleId><ArticleId IdType="pubmed">34088601</ArticleId></ArticleIdList></Reference><Reference><Citation>Momen-Heravi F. Isolation of extracellular vesicles by ultracentrifugation. Methods Mol Biol. 2017;1660:25&#x2013;32. doi: 10.1007/978-1-4939-7253-1_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7253-1_3</ArticleId><ArticleId IdType="pubmed">28828645</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr B, Abdel-Rahman EM, Balogun RA. Septic shock with multiorgan failure: from conventional apheresis to adsorption therapies. Semin Dial. 2012;25:171&#x2013;175. doi: 10.1111/j.1525-139X.2011.01029.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-139X.2011.01029.x</ArticleId><ArticleId IdType="pubmed">22329732</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura Y, Holland LZ. COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm. Int J Hematol. 2022;115(4):457&#x2013;469. doi: 10.1007/s12185-022-03324-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-022-03324-w</ArticleId><ArticleId IdType="pmc">PMC8938647</ArticleId><ArticleId IdType="pubmed">35316498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedeva C, Menassa J, Puthalakath H. Sepsis: inflammation is a necessary evil. Front Cell Dev Biol. 2019;7:108. doi: 10.3389/fcell.2019.00108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00108</ArticleId><ArticleId IdType="pmc">PMC6596337</ArticleId><ArticleId IdType="pubmed">31281814</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Angl&#xe9;s-Cano E, Sattler L, Mertes PM, Meziani F, CRICS TRIGGERSEP Group High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">35460725</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0641</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of hepatology</Title><ISOAbbreviation>J Hepatol</ISOAbbreviation></Journal><ArticleTitle>A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial].</ArticleTitle><Pagination><StartPage>670</StartPage><EndPage>682</EndPage><MedlinePgn>670-682</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhep.2022.03.043</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-8278(22)00239-2</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS">The choice of resuscitation fluid in patients with cirrhosis and sepsis-induced hypotension is unclear. 5% albumin was superior to normal saline in the FRISC study. We compared the efficacy and safety of 20% albumin, which has greater oncotic properties, to plasmalyte in reversing sepsis-induced hypotension.</AbstractText><AbstractText Label="METHODS">Critically ill patients with cirrhosis underwent open-label randomization to receive either 20% albumin (0.5-1.0&#xa0;g/kg over 3 hours; n&#xa0;= 50) or plasmalyte (30&#xa0;ml/kg over 3 hours, n&#xa0;= 50). The primary endpoint of the study was the attainment of mean arterial pressure (MAP) above 65&#xa0;mmHg at 3 hours.</AbstractText><AbstractText Label="RESULTS">Baseline characteristics were comparable in albumin and plasmalyte groups; arterial lactate (6.16&#xb1;3.18&#xa0;mmol/L vs. 6.38&#xb1;4.77&#xa0;mmol/L; p&#xa0;= 0.78), MAP (51.4&#xb1;6.52&#xa0;mmHg vs. 49.9&#xb1;4.45&#xa0;mmHg; p&#xa0;= 0.17) and SOFA score (10.8&#xb1;2.96 vs. 11.1&#xb1;4.2; p&#xa0;= 0.68), respectively. Most patients were alcoholics (39%) and had pneumonia (40%). In the intention-to-treat analysis, albumin was superior to plasmalyte in achieving the primary endpoint (62% vs. 22%; p &lt;0.001). A faster decline in arterial lactate (p&#xa0;= 0.03), a reduced need for dialysis (48% vs. 62%; p&#xa0;= 0.16), and a longer time to initiation of dialysis (in hours) (68.13&#xb1;47.79 vs. 99.7&#xb1; 63.4; p&#xa0;= 0.06) were seen with albumin. However, the 28-day mortality rate was not different (58% vs. 62%, p&#xa0;= 0.57) and treatment had to be discontinued in 11 (22%) patients in the albumin group due to adverse effects compared to no discontinuations in the plasmalyte group.</AbstractText><AbstractText Label="CONCLUSION">In patients with cirrhosis and sepsis-induced hypotension, 20% albumin leads to a faster improvement in hemodynamics and lactate clearance than plasmalyte, while 28-day survival was similar. However, patients on 20% albumin need to be closely monitored as it was more often associated with pulmonary complications.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">NCT02721238.</AbstractText><AbstractText Label="LAY SUMMARY">The current randomized-controlled trial performed in critically ill patients with cirrhosis and sepsis-induced hypotension highlights that 20% albumin restores arterial pressure more quickly but causes more pulmonary complications than plasmalyte. The impact on renal functions was also modest. These effects did not result in improvement in survival at 28 days. Plasmalyte is safer and well-tolerated and can be considered for volume resuscitation in patients with cirrhosis and sepsis-induced hypotension.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maiwall</LastName><ForeName>Rakhi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Mizoram University (A Central University), Pachhunga University College Campus, Aizawl, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Abhinav</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Mizoram University (A Central University), Pachhunga University College Campus, Aizawl, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasupuleti</LastName><ForeName>Samba Siva Rao</ForeName><Initials>SSR</Initials><AffiliationInfo><Affiliation>Department of Statistics, Mizoram University (A Central University), Pachhunga University College Campus, Aizawl, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hidam</LastName><ForeName>Ashini Kumar</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tevethia</LastName><ForeName>Harshvardhan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Mizoram University (A Central University), Pachhunga University College Campus, Aizawl, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Guresh</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Mizoram University (A Central University), Pachhunga University College Campus, Aizawl, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahney</LastName><ForeName>Amrish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Mizoram University (A Central University), Pachhunga University College Campus, Aizawl, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitra</LastName><ForeName>Lalita Gouri</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Critical Care and Anaesthesia, Institute of Liver and Biliary Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarin</LastName><ForeName>Shiv Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Mizoram University (A Central University), Pachhunga University College Campus, Aizawl, India. Electronic address: sksarin@ilbs.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02721238</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Hepatol</MedlineTA><NlmUniqueID>8503886</NlmUniqueID><ISSNLinking>0168-8278</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000418">Albumins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004573">Electrolytes</NameOfSubstance></Chemical><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>97397-05-2</RegistryNumber><NameOfSubstance UI="C048013">Plasmalyte A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Hepatol. 2022 Dec;77(6):1731-1732. doi: 10.1016/j.jhep.2022.07.001.</RefSource><PMID Version="1">35810928</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Hepatol. 2022 Dec;77(6):1732-1733. doi: 10.1016/j.jhep.2022.08.038.</RefSource><PMID Version="1">36113719</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000418" MajorTopicYN="N">Albumins</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004573" MajorTopicYN="N">Electrolytes</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007023" MajorTopicYN="Y">Hypotension, Controlled</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACLF</Keyword><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">critically ill</Keyword><Keyword MajorTopicYN="N">dialysis</Keyword><Keyword MajorTopicYN="N">lactate</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35460725</ArticleId><ArticleId IdType="doi">10.1016/j.jhep.2022.03.043</ArticleId><ArticleId IdType="pii">S0168-8278(22)00239-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27695824</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>316</Volume><Issue>17</Issue><PubDate><Year>2016</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>1775</StartPage><EndPage>1785</EndPage><MedlinePgn>1775-1785</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2016.14799</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Adjunctive hydrocortisone therapy is suggested by the Surviving Sepsis Campaign in refractory septic shock only. The efficacy of hydrocortisone in patients with severe sepsis without shock remains controversial.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether hydrocortisone therapy in patients with severe sepsis prevents the development of septic shock.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Double-blind, randomized clinical trial conducted from January 13, 2009, to August 27, 2013, with a follow-up of 180 days until February 23, 2014. The trial was performed in 34 intermediate or intensive care units of university and community hospitals in Germany, and it included 380 adult patients with severe sepsis who were not in septic shock.</AbstractText><AbstractText Label="INTERVENTIONS">Patients were randomly allocated 1:1 either to receive a continuous infusion of 200 mg of hydrocortisone for 5 days followed by dose tapering until day 11 (n&#x2009;=&#x2009;190) or to receive placebo (n&#x2009;=&#x2009;190).</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was development of septic shock within 14 days. Secondary outcomes were time until septic shock, mortality in the intensive care unit or hospital, survival up to 180 days, and assessment of secondary infections, weaning failure, muscle weakness, and hyperglycemia (blood glucose level &gt;150 mg/dL [to convert to millimoles per liter, multiply by 0.0555]).</AbstractText><AbstractText Label="RESULTS">The intention-to-treat population consisted of 353 patients (64.9% male; mean [SD] age, 65.0 [14.4] years). Septic shock occurred in 36 of 170 patients (21.2%) in the hydrocortisone group and 39 of 170 patients (22.9%) in the placebo group (difference, -1.8%; 95% CI, -10.7% to 7.2%; P&#x2009;=&#x2009;.70). No significant differences were observed between the hydrocortisone and placebo groups for time until septic shock; mortality in the intensive care unit or in the hospital; or mortality at 28 days (15 of 171 patients [8.8%] vs 14 of 170 patients [8.2%], respectively; difference, 0.5%; 95% CI, -5.6% to 6.7%; P&#x2009;=&#x2009;.86), 90 days (34 of 171 patients [19.9%] vs 28 of 168 patients [16.7%]; difference, 3.2%; 95% CI, -5.1% to 11.4%; P&#x2009;=&#x2009;.44), and 180 days (45 of 168 patients [26.8%] vs 37 of 167 patients [22.2%], respectively; difference, 4.6%; 95% CI, -4.6% to 13.7%; P&#x2009;=&#x2009;.32). In the hydrocortisone vs placebo groups, 21.5% vs 16.9% had secondary infections, 8.6% vs 8.5% had weaning failure, 30.7% vs 23.8% had muscle weakness, and 90.9% vs 81.5% had hyperglycemia.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adults with severe sepsis not in septic shock, use of hydrocortisone compared with placebo did not reduce the risk of septic shock within 14 days. These findings do not support the use of hydrocortisone in these patients.</AbstractText><AbstractText Label="TRIAL REGISTRATION">clinicaltrials.gov Identifier: NCT00670254.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keh</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trips</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Trial Centre Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marx</LastName><ForeName>Gernot</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirtz</LastName><ForeName>Stefan P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, HELIOS Hospital Bad Saarow, Bad Saarow, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abduljawwad</LastName><ForeName>Emad</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, HELIOS Hospital Bad Saarow, Bad Saarow, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bercker</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogatsch</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Trial Centre Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briegel</LastName><ForeName>Josef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Klinikum der Ludwig-Maximilians-Universit&#xe4;t, M&#xfc;nchen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engel</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerlach</LastName><ForeName>Herwig</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Management, Vivantes-Klinikum Neuk&#xf6;lln, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldmann</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuhn</LastName><ForeName>Sven-Olaf</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Ernst Moritz Arndt University, Greifswald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;ter</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Zentralklinik Bad Berka, Bad Berka, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meier-Hellmann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Management, HELIOS Hospital Erfurt, Erfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nierhaus</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluge</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmke</LastName><ForeName>Josefa</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Intensive Care Medicine, Vivantes Humboldt Klinikum, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loeffler</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oppert</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency and Intensive Care Medicine, Klinikum Ernst von Bergmann, Potsdam, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resener</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, HELIOS Hospital Berlin-Buch, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xe4;dler</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuerholz</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiler</LastName><ForeName>Norbert</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weyland</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Management, Klinikum Oldenburg Medical Campus Carl von Ossietzky Universit&#xe4;t, Oldenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinhart</LastName><ForeName>Konrad</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunkhorst</LastName><ForeName>Frank M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Center for Clinical Studies, Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SepNet&#x2013;Critical Care Trials Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00670254</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2016 Nov 1;316(17):1769-1771. doi: 10.1001/jama.2016.13904.</RefSource><PMID Version="1">27695850</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Intern Med. 2017 Jan 17;166(2):JC10. doi: 10.7326/ACPJC-2017-166-2-010.</RefSource><PMID Version="1">28114466</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2017 Dec 1;196(11):1473-1475. doi: 10.1164/rccm.201701-0245RR.</RefSource><PMID Version="1">29043839</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057194" MajorTopicYN="N">Intention to Treat Analysis</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27695824</ArticleId><ArticleId IdType="doi">10.1001/jama.2016.14799</ArticleId><ArticleId IdType="pii">2565176</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25987293</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Early mobilization in the critical care unit: A review of adult and pediatric literature.</ArticleTitle><Pagination><StartPage>664</StartPage><EndPage>672</EndPage><MedlinePgn>664-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2015.03.032</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(15)00141-0</ELocationID><Abstract><AbstractText>Early mobilization of critically ill patients is beneficial, suggesting that it should be incorporated into daily clinical practice. Early passive, active, and combined progressive mobilizations can be safely initiated in intensive care units (ICUs). Adult patients receiving early mobilization have fewer ventilator-dependent days, shorter ICU and hospital stays, and better functional outcomes. Pediatric ICU data are limited, but recent studies also suggest that early mobilization is achievable without increasing patient risk. In this review, we provide a current and comprehensive appraisal of ICU mobilization techniques in both adult and pediatric critically ill patients. Contraindications and perceived barriers to early mobilization, including cost and health care provider views, are identified. Methods of overcoming barriers to early mobilization and enhancing sustainability of mobilization programs are discussed. Optimization of patient outcomes will require further studies on mobilization timing and intensity, particularly within specific ICU populations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cameron</LastName><ForeName>Saoirse</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Functional Recovery in Critically Ill Children: The "Wee-Cover" Longitudinal Cohort Study; Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study; Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cepinskas</LastName><ForeName>Gediminas</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study; Medical Biophysics, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choong</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Functional Recovery in Critically Ill Children: The "Wee-Cover" Longitudinal Cohort Study; Pediatrics, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doherty</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Functional Recovery in Critically Ill Children: The "Wee-Cover" Longitudinal Cohort Study; Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study; Physical Medicine and Rehabilitation, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study; Medicine, Western University, London, ON, Canada; Medical Biophysics, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Claudio M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study; Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mele</LastName><ForeName>Tina S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study; Surgery, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharpe</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study; Anesthesia and Perioperative Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoemaker</LastName><ForeName>J Kevin</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Functional Recovery in Critically Ill Children: The "Wee-Cover" Longitudinal Cohort Study; Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study; Kinesiology, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>Douglas D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Functional Recovery in Critically Ill Children: The "Wee-Cover" Longitudinal Cohort Study; Targeted Exercise to Reduce Morbidity and Mortality in Severe Sepsis (TERMS) Study; Pediatrics, Western University, London, ON, Canada. Electronic address: douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004434" MajorTopicYN="N">Early Ambulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061345" MajorTopicYN="N">Early Medical Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026741" MajorTopicYN="Y">Physical Therapy Modalities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012449" MajorTopicYN="N">Safety</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adult</Keyword><Keyword MajorTopicYN="N">Exercise</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Intervention</Keyword><Keyword MajorTopicYN="N">Mobility</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25987293</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2015.03.032</ArticleId><ArticleId IdType="pii">S0883-9441(15)00141-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39197514</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>167</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Mortality in Patients With Sepsis Treated With Esmolol or Landiolol: A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>121</StartPage><EndPage>138</EndPage><MedlinePgn>121-138</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2024.08.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(24)05061-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The latest meta-analysis indicated potential survival benefits from ultra-short-acting &#x3b2;-blockers in patients with sepsis with persistent tachycardia. However, subsequent multicenter randomized controlled trials (RCTs) have reported conflicting findings, prompting the need for an updated meta-analysis to incorporate these newly published RCTs.</AbstractText><AbstractText Label="RESEARCH QUESTION" NlmCategory="OBJECTIVE">Does the use of ultra-short-acting &#x3b2;-blockers (esmolol or landiolol) in patients with sepsis with persistent tachycardia improve mortality?</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">We conducted an updated systematic search through April 2, 2024, exploring the MEDLINE, Cochrane Central Register of Controlled Trials, and Embase databases for RCTs reporting mortality in adult patients with sepsis treated with esmolol or landiolol as compared with those treated with neither of these or receiving placebo and published in English. Meta-analyses were conducted with the random effects model. The primary outcome was mortality at the longest follow-up, with subgroup analysis separating single-center RCTS from large multicenter RCTs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight RCTs (885 patients) were included in the primary analysis. Ultra-short-acting &#x3b2;-blockers did not improve mortality significantly at the longest follow-up (risk ratio, 0.84; 95%&#xa0;CI, 0.68-1.02; P&#xa0;= .08; I<sup>2</sup>&#xa0;= 51%; very low certainty of the evidence) and 28-day mortality (risk ratio, 0.77; 95%&#xa0;CI, 0.59-1.00; P&#xa0;= .05; I<sup>2</sup>&#xa0;= 62%). Subgroup analyses of mortality outcomes pointed toward different results between single-center and multicenter RCTs. Trial sequence analyses showed that both mortality outcomes were not robust. The sensitivity analyses suggested a significant reduction in mortality by adding RCTs published in non-English languages.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">In this updated meta-analysis, the use of esmolol or landiolol did not reduce mortality in patients with sepsis with persistent tachycardia. However, results were not robust and outcomes differed between single-center and multicenter RCTs. Moreover, sensitivity analyses showed the fragility of the primary outcome. Further studies regarding ultra-short-acting &#x3b2;-blockers with advanced cardiac monitoring or serial echocardiography are warranted.</AbstractText><AbstractText Label="TRIAL REGISTRY" NlmCategory="BACKGROUND">International Prospective Register of Systematic Reviews; No.: CRD42024503570; URL: https://www.crd.york.ac.uk/prospero/.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Ryota</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Medicine, The Queen's Medical Center, Honolulu, HI. Electronic address: st051035@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, A.O.U. Policlinico-San Marco, Site "Policlinico G. Rodolico", Catania, Italy; School of Anesthesia and Intensive Care, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santonocito</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, A.O.U. Policlinico-San Marco, Site "Policlinico G. Rodolico", Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scimonello</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Anesthesia and Intensive Care, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Anesthesia and Intensive Care, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department Clinical Internal, Anesthesiological and Cardiovascular Sciences, University of Rome, "La Sapienza," Policlinico Umberto Primo, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dugar</LastName><ForeName>Siddharth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH; Cleveland Clinic Lerner College of Medicine, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, A.O.U. Policlinico-San Marco, Site "Policlinico G. Rodolico", Catania, Italy; Department of Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>62NWQ924LH</RegistryNumber><NameOfSubstance UI="C077049">landiolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>MDY902UXSR</RegistryNumber><NameOfSubstance UI="C036604">esmolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>8W8T17847W</RegistryNumber><NameOfSubstance UI="D014508">Urea</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009025">Morpholines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011412">Propanolamines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014508" MajorTopicYN="Y">Urea</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009025" MajorTopicYN="Y">Morpholines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="Y">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011412" MajorTopicYN="Y">Propanolamines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013610" MajorTopicYN="Y">Tachycardia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">esmolol</Keyword><Keyword MajorTopicYN="N">landiolol</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">tachycardia</Keyword><Keyword MajorTopicYN="N">&#x3b2;-blockers</Keyword></KeywordList><CoiStatement>Financial/Nonfinancial Disclosures None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>11</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39197514</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2024.08.020</ArticleId><ArticleId IdType="pii">S0012-3692(24)05061-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29070011</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>The obesity conundrum in sepsis.</ArticleTitle><Pagination><StartPage>147</StartPage><MedlinePgn>147</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">147</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-017-0434-z</ELocationID><Abstract><AbstractText>While the long-term negative effects of obesity on health is a well-studied phenomenon, its effects on acute illnesses seem to be the contrary. Several studies have indicated the possibility of an 'obesity paradox' in sepsis - where overweight and obese patients have better outcomes than normal weight patients. These meta-analyses including large numbers of patients across different countries raised an interesting but debatable topic. Results from meta-analyses of observational studies should be interpreted with caution, and a prove of association not be mistaken as prove of causality. Limitations common to such studies include inadequate adjustment for confounding and selection bias. More rigorous investigations to clarify any causal relationship between obesity and mortality in sepsis are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Pauline Yeung</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Adult Intensive Care Unit, Queen Mary Hospital and The University of Hong Kong, Pok Fu Lam, Hong Kong. drpaulineyng@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eikermann</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1268-0106</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Obesity paradox</Keyword><Keyword MajorTopicYN="N">Overweight</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: Matthias Eikermann is a Section Editor of BMC Anesthesiology. The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29070011</ArticleId><ArticleId IdType="pmc">PMC5657099</ArticleId><ArticleId IdType="doi">10.1186/s12871-017-0434-z</ArticleId><ArticleId IdType="pii">10.1186/s12871-017-0434-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Niedziela J, Hudzik B, Niedziela N, Gasior M, Gierlotka M, Wasilewski J, Myrda K, Lekston A, Polonski L, Rozentryt P. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801&#x2013;812. doi: 10.1007/s10654-014-9961-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-014-9961-9</ArticleId><ArticleId IdType="pmc">PMC4220102</ArticleId><ArticleId IdType="pubmed">25354991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni YN, Luo J, Yu H, Wang YW, YH H, Liu D, Liang BM, Liang ZA. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis. Crit Care. 2017;21(1):36. doi: 10.1186/s13054-017-1615-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1615-3</ArticleId><ArticleId IdType="pmc">PMC5320793</ArticleId><ArticleId IdType="pubmed">28222804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Liu X, Chen Q, Liu C, Huang C, Fang X. The role of increased body mass index in outcomes of sepsis: a systematic review and meta-analysis. BMC Anesthesiol. 2017;17(1):118. doi: 10.1186/s12871-017-0405-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-017-0405-4</ArticleId><ArticleId IdType="pmc">PMC5579888</ArticleId><ArticleId IdType="pubmed">28859605</ArticleId></ArticleIdList></Reference><Reference><Citation>Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894:i-xii, 1&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">11234459</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Colditz GA. Prevalence of overweight and obesity in the United States, 2007-2012. JAMA Intern Med. 2015;175(8):1412&#x2013;1413. doi: 10.1001/jamainternmed.2015.2405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2015.2405</ArticleId><ArticleId IdType="pmc">PMC4625533</ArticleId><ArticleId IdType="pubmed">26098405</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int. 1999;55(4):1560&#x2013;1567. doi: 10.1046/j.1523-1755.1999.00389.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1999.00389.x</ArticleId><ArticleId IdType="pubmed">10201023</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39(4):578&#x2013;584. doi: 10.1016/S0735-1097(01)01802-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01802-2</ArticleId><ArticleId IdType="pubmed">11849854</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin CH, Grabitz SD, Timm FP, Mueller N, Chhangani K, Ladha K, Devine S, Kurth T, Eikermann M. Development and validation of a score for preoperative prediction of obstructive sleep apnea (SPOSA) and its perioperative outcomes. BMC Anesthesiol. 2017;17(1):71. doi: 10.1186/s12871-017-0361-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-017-0361-z</ArticleId><ArticleId IdType="pmc">PMC5450400</ArticleId><ArticleId IdType="pubmed">28558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepper DJ, Sun J, Welsh J, Cui X, Suffredini AF, Eichacker PQ. Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2016;20(1):181. doi: 10.1186/s13054-016-1360-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1360-z</ArticleId><ArticleId IdType="pmc">PMC4908772</ArticleId><ArticleId IdType="pubmed">27306751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 2006;14(Suppl 5):242S&#x2013;249S. doi: 10.1038/oby.2006.317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2006.317</ArticleId><ArticleId IdType="pubmed">17021375</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler G, Kiss S, Keszthelyi L, Sapi Z, Ory I, Salamon F, Kovacs M, Vargha P, Szekeres O, Speer G, et al. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol. 2003;149(2):129&#x2013;135. doi: 10.1530/eje.0.1490129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje.0.1490129</ArticleId><ArticleId IdType="pubmed">12887290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548&#x2013;2556. doi: 10.1210/jc.2004-0395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2004-0395</ArticleId><ArticleId IdType="pubmed">15181022</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Dara SI, Tamim HM, Rishu AH, Bouchama A, Khedr MK, Feinstein D, Parrillo JE, Wood KE, Keenan SP, et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013;17(2):R72. doi: 10.1186/cc12680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12680</ArticleId><ArticleId IdType="pmc">PMC3672731</ArticleId><ArticleId IdType="pubmed">23594407</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott HC, Chang VW, O'Brien JM, Jr., Langa KM, Iwashyna TJ: Obesity and 1-year outcomes in older Americans with severe sepsis. Crit Care Med 2014, 42(8):1766&#x2013;1774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4205159</ArticleId><ArticleId IdType="pubmed">24717466</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38598125</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Effects of restrictive fluid therapy on the time to resolution of hyperlactatemia in ICU patients with septic shock. A secondary post hoc analysis of the CLASSIC randomized trial.</ArticleTitle><Pagination><StartPage>678</StartPage><EndPage>686</EndPage><MedlinePgn>678-686</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-024-07385-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this study was to examine the effects of intravenous (IV) fluid restriction on time to resolution of hyperlactatemia in septic shock. Hyperlactatemia in sepsis is associated with worse outcome. Sepsis guidelines suggest targeting lactate clearance to guide fluid therapy despite the complexity of hyperlactatemia and the potential harm of fluid overload.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a post hoc analysis of serial plasma lactate concentrations in a sub-cohort of 777 patients from the international multicenter clinical CLASSIC trial (restriction of intravenous fluids in intensive care unit (ICU) patients with septic shock). Adult ICU patients with septic shock had been randomized to restrictive (n&#x2009;=&#x2009;385) or standard (n&#x2009;=&#x2009;392) intravenous fluid therapy. The primary outcome, time to resolution of hyperlactatemia, was analyzed with a competing-risks regression model. Death and discharge were competing outcomes, and administrative censoring was imposed 72 h after randomization if hyperlactatemia persisted. The regression analysis was adjusted for the same stratification variables and covariates as in the original CLASSIC trial analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The hazard ratios (HRs) for the cumulative probability of resolution of hyperlactatemia, in the restrictive vs the standard group, in the unadjusted analysis, with time split, were 0.94 (confidence interval (CI) 0.78-1.14) at day 1 and 1.21 (0.89-1.65) at day 2-3. The adjusted analyses were consistent with the unadjusted results.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this post hoc retrospective analysis of a multicenter randomized controlled trial (RCT), a restrictive intravenous fluid strategy did not seem to affect the time to resolution of hyperlactatemia in adult ICU patients with septic shock.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahlstedt</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0005-8206-0801</Identifier><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden. christian.ahlstedt@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden. christian.ahlstedt@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark. christian.ahlstedt@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivapalan</LastName><ForeName>Praleene</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kriz</LastName><ForeName>Miroslav</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, First Department of Internal Medicine, Faculty of Medicine, Teaching Hospital and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobson</LastName><ForeName>Gustaf</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sylvest Meyhoff</LastName><ForeName>Tine</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skov Kaas-Hansen</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Manne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollenberg</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Science and Education, Karolinska Institutet, S&#xf6;dersjukhuset, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Intensive Care Unit, S&#xf6;dersjukhuset, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalos</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Intensive Care Unit, First Department of Internal Medicine, Faculty of Medicine, Teaching Hospital and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Perioperative and Intensive Care Medicine, Masaryk Hospital, Jan Evangelista Purkyn&#x4d7; University, &#xda;sti Nad Labem, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rooijackers</LastName><ForeName>Olav</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hylander M&#xf8;ller</LastName><ForeName>Morten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science and Education, Karolinska Institutet, S&#xf6;dersjukhuset, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grip</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065906" MajorTopicYN="Y">Hyperlactatemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fluid therapy</Keyword><Keyword MajorTopicYN="N">Hyperlactatemia</Keyword><Keyword MajorTopicYN="N">Lactate</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38598125</ArticleId><ArticleId IdType="pmc">PMC11078841</ArticleId><ArticleId IdType="doi">10.1007/s00134-024-07385-9</ArticleId><ArticleId IdType="pii">10.1007/s00134-024-07385-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):775&#x2013;787. doi: 10.1001/jama.2016.0289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0289</ArticleId><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez G, Bellomo R, Bakker J. The ten pitfalls of lactate clearance in sepsis. Intensive Care Med. 2019;45(1):82&#x2013;85. doi: 10.1007/s00134-018-5213-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5213-x</ArticleId><ArticleId IdType="pmc">PMC6334727</ArticleId><ArticleId IdType="pubmed">29754310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker J, de Backer D, Hernandez G. Lactate-guided resuscitation saves lives: we are not sure. Intensive Care Med. 2016;42(3):472&#x2013;474. doi: 10.1007/s00134-016-4220-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4220-z</ArticleId><ArticleId IdType="pubmed">26831675</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063&#x2013;e1143. doi: 10.1097/CCM.0000000000005337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005337</ArticleId><ArticleId IdType="pubmed">34605781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushimoto S, Akaishi S, Sato T, Nomura R, Fujita M, Kudo D, et al. Lactate, a useful marker for disease mortality and severity but an unreliable marker of tissue hypoxia/hypoperfusion in critically ill patients. Acute Med Surg. 2016;3(4):293&#x2013;297. doi: 10.1002/ams2.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ams2.207</ArticleId><ArticleId IdType="pmc">PMC5667335</ArticleId><ArticleId IdType="pubmed">29123802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloos F, Zhang Z, Boulain T. Lactate-guided resuscitation saves lives: yes. Intensive Care Med. 2016;42(3):466&#x2013;469. doi: 10.1007/s00134-015-4196-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4196-0</ArticleId><ArticleId IdType="pubmed">26831674</ArticleId></ArticleIdList></Reference><Reference><Citation>Monnet X, Delaney A, Barnato A. Lactate-guided resuscitation saves lives: no. Intensive Care Med. 2016;42(3):470&#x2013;471. doi: 10.1007/s00134-016-4235-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4235-5</ArticleId><ArticleId IdType="pubmed">26831673</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259&#x2013;265. doi: 10.1097/CCM.0b013e3181feeb15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181feeb15</ArticleId><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Haijin L, An Y, Wei X, Yi X, Yi H. Early lactate levels for prediction of mortality in patients with sepsis or septic shock: a meta-analysis. Int J Clin Exp Med. 2017;10:37&#x2013;47.</Citation></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, M&#xf8;ller MH, Wetterslev J, Lange T, Kjaer MN, et al. Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2019;63(9):1262&#x2013;1271. doi: 10.1111/aas.13434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13434</ArticleId><ArticleId IdType="pubmed">31276193</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M, et al. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386(26):2459&#x2013;2470. doi: 10.1056/NEJMoa2202707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2202707</ArticleId><ArticleId IdType="pubmed">35709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xe6;r MN, Meyhoff TS, Sivapalan P, Granholm A, Hjortrup PB, Madsen MB, et al. Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Intensive Care Med. 2023;49(7):820&#x2013;830. doi: 10.1007/s00134-023-07114-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07114-8</ArticleId><ArticleId IdType="pmc">PMC10354110</ArticleId><ArticleId IdType="pubmed">37330928</ArticleId></ArticleIdList></Reference><Reference><Citation>Granholm A, Perner A, Krag M, Hjortrup PB, Haase N, Holst LB, et al. Simplified Mortality Score for the Intensive Care Unit (SMS-ICU): protocol for the development and validation of a bedside clinical prediction rule. BMJ Open. 2017;7(3):e015339. doi: 10.1136/bmjopen-2016-015339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-015339</ArticleId><ArticleId IdType="pmc">PMC5353313</ArticleId><ArticleId IdType="pubmed">28279999</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller B, Schmidt G, Ulm K. Applying competing risks regression models: an overview. Lifetime Data Anal. 2013;19(1):33&#x2013;58. doi: 10.1007/s10985-012-9230-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10985-012-9230-8</ArticleId><ArticleId IdType="pubmed">23010807</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis Part III: multivariate data analysis&#x2014;choosing a model and assessing its adequacy and fit. Br J Cancer. 2003;89(4):605&#x2013;611. doi: 10.1038/sj.bjc.6601120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6601120</ArticleId><ArticleId IdType="pmc">PMC2376927</ArticleId><ArticleId IdType="pubmed">12915864</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Wetterslev J, Lange T, Bundgaard H, Rasmussen BS, et al. Effects of fluid restriction on measures of circulatory efficacy in adults with septic shock. Acta Anaesthesiol Scand. 2017;61(4):390&#x2013;398. doi: 10.1111/aas.12862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12862</ArticleId><ArticleId IdType="pubmed">28150304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettil&#xe4; V, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42(11):1695&#x2013;1705. doi: 10.1007/s00134-016-4500-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4500-7</ArticleId><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32(8):1637&#x2013;1642. doi: 10.1097/01.CCM.0000132904.35713.A7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000132904.35713.A7</ArticleId><ArticleId IdType="pubmed">15286537</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold RC, Shapiro NI, Jones AE, Schorr C, Pope J, Casner E, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32(1):35&#x2013;39. doi: 10.1097/SHK.0b013e3181971d47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3181971d47</ArticleId><ArticleId IdType="pubmed">19533847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertoff J, Chisum M, Garcia B, Lascano J. Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further research. J Intensive Care. 2015;3:39. doi: 10.1186/s40560-015-0105-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-015-0105-4</ArticleId><ArticleId IdType="pmc">PMC4594907</ArticleId><ArticleId IdType="pubmed">26445673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattan E, Hern&#xe1;ndez G, Ospina-Tasc&#xf3;n G, Valenzuela ED, Bakker J, Castro R. A lactate-targeted resuscitation strategy may be associated with higher mortality in patients with septic shock and normal capillary refill time: a post hoc analysis of the ANDROMEDA-SHOCK study. Ann Intensive Care. 2020;10(1):114. doi: 10.1186/s13613-020-00732-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00732-1</ArticleId><ArticleId IdType="pmc">PMC7450018</ArticleId><ArticleId IdType="pubmed">32845407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez G, Ospina-Tasc&#xf3;n GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321(7):654&#x2013;664. doi: 10.1001/jama.2019.0071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.0071</ArticleId><ArticleId IdType="pmc">PMC6439620</ArticleId><ArticleId IdType="pubmed">30772908</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739&#x2013;746. doi: 10.1001/jama.2010.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.158</ArticleId><ArticleId IdType="pmc">PMC2918907</ArticleId><ArticleId IdType="pubmed">20179283</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182(6):752&#x2013;761. doi: 10.1164/rccm.200912-1918OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200912-1918OC</ArticleId><ArticleId IdType="pubmed">20463176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattan E, Bakker J, Estenssoro E, Ospina-Tasc&#xf3;n GA, Cavalcanti AB, Backer D, et al. Hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial study protocol. Rev Bras Ter Intensiva. 2022;34(1):96&#x2013;106. doi: 10.5935/0103-507X.20220004-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/0103-507X.20220004-en</ArticleId><ArticleId IdType="pmc">PMC9345585</ArticleId><ArticleId IdType="pubmed">35766659</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34036519</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1936-0541</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Hepatology international</Title><ISOAbbreviation>Hepatol Int</ISOAbbreviation></Journal><ArticleTitle>Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial.</ArticleTitle><Pagination><StartPage>983</StartPage><EndPage>994</EndPage><MedlinePgn>983-994</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12072-021-10164-z</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Sepsis and septic shock are common causes of hospitalization and mortality in patients with cirrhosis. There is no data on the choice of fluid and resuscitation protocols in sepsis-induced hypotension in cirrhosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this open-label trial conducted at a single center, we enrolled 308 cirrhotics with sepsis-induced hypotension and randomized them to receive either 5% albumin or normal saline. The primary endpoint was a reversal of hypotension [mean arterial pressure, MAP,&#x2009;&#x2265;&#x2009;65&#xa0;mmHg] at 3&#xa0;h. Secondary endpoints included serial effects on heart rate, arterial lactate and urine output.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">154 patients each received 5% albumin (males, 79.8%, mean MAP 52.9&#x2009;&#xb1;&#x2009;7.0&#xa0;mm Hg) or 0.9% saline (85.1%, 53.4&#x2009;&#xb1;&#x2009;6.3&#xa0;mm Hg) with comparable baseline parameters and liver disease severity. Reversal of hypotension was higher in patients receiving 5% albumin than saline at the end of one hour [25.3% and 11.7%, p&#x2009;=&#x2009;0.03, Odds ratio (95% CI)-1.9 (1.08-3.42)] and at the end of three hours [11.7% and 3.2%, p&#x2009;=&#x2009;0.008, 3.9 (1.42-10.9)]. Sustained reduction in heart rate and hyperlactatemia (p&#x2009;&lt;&#x2009;0.001) was better in the albumin group. At one week, the proportion of patients surviving was higher in the albumin group than those receiving saline (43.5% vs 38.3%, p&#x2009;=&#x2009;0.03). Female gender and SOFA&#x2009;&#x2265;&#x2009;11 were predictors of non-response to fluid.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">5% human albumin is safe and beneficial in reversing sepsis-induced hypotension compared to normal saline in patients with cirrhosis improving clinically assessable parameters of systemic hemodynamics, tissue perfusion and in-hospital short-term survival of cirrhosis patients with sepsis.</AbstractText><CopyrightInformation>&#xa9; 2021. Asian Pacific Association for the Study of the Liver.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Philips</LastName><ForeName>Cyriac Abby</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 1100071, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maiwall</LastName><ForeName>Rakhi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 1100071, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Manoj Kumar</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 1100071, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jindal</LastName><ForeName>Ankur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 1100071, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhury</LastName><ForeName>Ashok Kumar</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 1100071, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Guresh</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Research and Biostatistics, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhardwaj</LastName><ForeName>Ankit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Research and Biostatistics, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitra</LastName><ForeName>Lalita Gouri</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Prashant Mohan</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarin</LastName><ForeName>Shiv Kumar</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0002-0544-5610</Identifier><AffiliationInfo><Affiliation>Department of Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 1100071, India. shivsarin@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research and Biostatistics, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110070, India. shivsarin@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hepatol Int</MedlineTA><NlmUniqueID>101304009</NlmUniqueID><ISSNLinking>1936-0533</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077330">Saline Solution</NameOfSubstance></Chemical><Chemical><RegistryNumber>ZIF514RVZR</RegistryNumber><NameOfSubstance UI="D000075462">Serum Albumin, Human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007023" MajorTopicYN="Y">Hypotension, Controlled</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077330" MajorTopicYN="N">Saline Solution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075462" MajorTopicYN="N">Serum Albumin, Human</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">CTP</Keyword><Keyword MajorTopicYN="N">Colloid</Keyword><Keyword MajorTopicYN="N">Crystalloid</Keyword><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">MELD</Keyword><Keyword MajorTopicYN="N">Portal hypertension</Keyword><Keyword MajorTopicYN="N">SOFA</Keyword><Keyword MajorTopicYN="N">Shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>26</Day><Hour>7</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34036519</ArticleId><ArticleId IdType="doi">10.1007/s12072-021-10164-z</ArticleId><ArticleId IdType="pii">10.1007/s12072-021-10164-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jawad I, Luk&#x161;ic I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health 2012;2:010404</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.01.010404</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368&#x2013;1377</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010307</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Liu B, Taylor C, et al. Resuscitation fluid use in critically ill adults. An international cross-sectional study in 391 intensive care units. Crit Care 2010;14:R185</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9293</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. The SAFE study investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247&#x2013;2256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa040232</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 2011;39:386&#x2013;91</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181ffe217</ArticleId></ArticleIdList></Reference><Reference><Citation>Caraceni P, Tufoni M, Bonavita ME. Clinical use of albumin. Blood Transfus 2013;11(4):s18-25</Citation><ArticleIdList><ArticleId IdType="pubmed">24333308</ArticleId><ArticleId IdType="pmc">3853979</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JC, Wendon JA, Kramer DJ, et al. Intensive care of the patient with cirrhosis. Hepatology 2011;54:1864&#x2013;1872</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.24622</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau R, Hadengue A, Soupison T, et al. Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med 1992;20(6):746&#x2013;750</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199206000-00008</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassford NJ, Eastwood GM, Bellomo R. Physiological changes after fluid bolus therapy in sepsis: a systematic review of contemporary data. Crit Care 2014;18(6):696</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0696-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu JY, Chen QH, Xie JF, et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials. Crit Care 2014;18:702</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0702-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollefson BJ, Jones AE. Does resuscitation with albumin-containing solutions improve mortality in sepsis? Ann Emerg Med 2012;59:432&#x2013;433</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2011.11.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S. Clinical controversies in the management of critically ill patients with severe sepsis: resuscitation fluids and glucose control. Virulence 2013;5:200&#x2013;205</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.25855</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med 2018;44(6):925&#x2013;8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5085-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Daviaud F, Grimaldi D, Dechartres A, Charpentier J, Geri G, Marin N, et al. Timing and causes of death in septic shock. Ann Intensive Care 2015;5:16</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-015-0058-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Varon J, Baron RM. A current appraisal of evidence for the approach to sepsis and septic shock. Ther Adv Infect Dis 2019;6:2049936119856517</Citation><ArticleIdList><ArticleId IdType="pubmed">31308945</ArticleId><ArticleId IdType="pmc">6613063</ArticleId></ArticleIdList></Reference><Reference><Citation>Roger C, Zieleskiewicz L, Demattei C, Lakhal K, Piton G, Louart B, et al. Time course of fluid responsiveness in sepsis: the fluid challenge revisiting (FCREV) study. Crit Care 2019;23:179</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2448-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu KH, Jenq CC, Tsai MH, Hsu HH, Chang MY, Tian YC, et al. Outcome scoring systems for short-term prognosis in critically ill cirrhotic patients. Shock 2011;36(5):445&#x2013;450</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e31822fb7e2</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehler M, Kokoska J, Reulbach U, Hahn EG, Strauss R. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 2001;34(2):255&#x2013;261</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jhep.2001.26522</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibovici LA, GafterGvili M, Paul N, et al. Relative tachycardia in patients with sepsis: an independent risk factor for mortality. QJM 2007;100:629&#x2013;634</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcm074</ArticleId></ArticleIdList></Reference><Reference><Citation>The SAFE Study Investigators. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011;37:86&#x2013;96</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-010-2039-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Marty P, Roquilly A, Vall&#xe9;e F, et al. Lactate clearance for death prediction in severe sepsis or septic shock patients during the first 24 hours in intensive care unit: an observational study. Ann Intensive Care 2013;3:3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-3-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen TC, van Bommel J, Mulder PG, Lima AP, van der Hoven B, Rommes JH, Snellen FT, Bakker J. Prognostic value of blood lactate levels: does the clinical diagnosis at admission matter? J Trauma 2009;66:377&#x2013;385</Citation><ArticleIdList><ArticleId IdType="pubmed">19204510</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichol A, Bailey M, Egi M, et al. Dynamic lactate indices as predictors of outcome in critically ill patients. Crit Care 2011;15(5):R242</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10497</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Cove ME, Peng ZY, et al. Normal saline resuscitation worsens hyperlactatemia in experimental sepsis. Crit Care 2012;16(Suppl 1):P253</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10860</ArticleId></ArticleIdList></Reference><Reference><Citation>Amathieu R, Al-Khafaji A, Sileanu FE, Foldes E, DeSensi R, Hilmi I, Kellum JA. Significance of oliguria in critically ill patients with chronic liver disease. Hepatology 2017;66(5):1592&#x2013;1600</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.29303</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J-Y, Chen Q-H, Xie J-F, et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials. Crit Care 2014;18(6):702</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0702-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccolini F, Sartelli M, Catena F, Ceresoli M, Montori G, Ansaloni L. Early goal-directed treatment versus standard care in management of early septic shock: meta-analysis of randomized trials. J Trauma Acute Care Surg 2016;81:971&#x2013;978</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001246</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med 2019;7:2050312119835043</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050312119835043</ArticleId></ArticleIdList></Reference><Reference><Citation>Malbrain MLNG, Van Regenmortel N, Saugel B, et al. Principles of fluid management and stewardship in septic shock: it is time to consider the four D&#x2019;s and the four phases of fluid therapy. Ann Intensive Care 2018;8:66</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0402-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Jozwiak M, Monnet X, Teboul JL. Prediction of fluid responsiveness in ventilated patients. Ann Transl Med 2018;6:352</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2018.05.03</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009;37:1649&#x2013;1654</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31819def97</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Elia C, Mascia L, Barberis B, Cardellino S, Livigni S, Fiore G, Filippini C, Ranieri VM. The influence of gender on the epidemiology of and outcome from severe sepsis. Crit Care 2013;17(2):R50</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12570</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietropaoli AP, Glance LG, Oakes D, Fisher SG. Gender differences in mortality in patients with severe sepsis or septic shock. Gend Med 2010;7:422&#x2013;437</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Failla KR, Connelly CD, Ecoff L, Macauley K, Bush R. Does gender matter in septic patient outcomes? J Nurs Scholarsh 2019;51(4):438&#x2013;448</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnu.12478</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanelli F, Landoni G, Cabrini L, Zangrillo A. Gender differences in septic intensive care unit patients. Minerva Anestesiol 2018;84(4):504&#x2013;508</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.17.12187-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterling SA, Miller WR, Pryor J, Puskarich MA, Jones AE. The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis. Crit Care Med 2015;43(9):1907&#x2013;1915</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001142</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, Escobar GJ. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 2017;196(7):856&#x2013;863</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201609-1848OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim RY, Ng AM, Persaud AK, Furmanek SP, Kothari YN, Price JD, Wiemken TL, Saad MA, Guardiola JJ, Cavallazzi RS. Antibiotic timing and outcomes in sepsis. Am J Med Sci 2018;355(6):524&#x2013;549</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2018.02.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez ML, Plata-Menchaca EP, Ruiz-Rodr&#xed;guez JC, Ferrer R. An approach to antibiotic treatment in patients with sepsis. J Thorac Dis 2020;12(3):1007&#x2013;1021</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2020.01.47</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39622601</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2586-6060</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Acute and critical care</Title><ISOAbbreviation>Acute Crit Care</ISOAbbreviation></Journal><ArticleTitle>Early management of adult sepsis and septic shock: Korean clinical practice guidelines.</ArticleTitle><Pagination><StartPage>445</StartPage><EndPage>472</EndPage><MedlinePgn>445-472</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4266/acc.2024.00920</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite recent advances and global improvements in sepsis recognition and supportive care, mortality rates remain high, and adherence to sepsis bundle components in Korea is low. To address this, the Korean Sepsis Alliance, affiliated with the Korean Society of Critical Care Medicine, developed the first sepsis treatment guidelines for Korea based on a comprehensive systematic review and meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A de novo method was used to develop the guidelines. Methodologies included determining key questions, conducting a literature search and selection, assessing the risk of bias, synthesizing evidence, and developing recommendations. The certainty of evidence and the strength of recommendations were determined using the Grading of Recommendations, Assessment, Development, and Evaluations approach. Draft recommendations underwent internal and external review processes and public hearings. The development of these guidelines was supported by a research grant from the Korean Disease Control and Prevention Agency.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In these guidelines, we focused on early treatments for adult patients with sepsis and septic shock. Through the guideline development process, 12 key questions and their respective recommendations were formulated. These include lactate measurement, fluid therapies, target blood pressure, antibiotic administration, use of vasopressors and dobutamine, extracorporeal membrane oxygenation, and echocardiography.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These guidelines aim to support medical professionals in making appropriate decisions about treating adult sepsis and septic shock. We hope these guidelines will increase awareness of sepsis and reduce its mortality rate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Chul</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ulsan University Hospital, Ulsan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ku</LastName><ForeName>Nam Su</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Division of Infective Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Dae Won</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Joo Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Department of Internal Medicine, Seoul Metropolitan Seonam Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Tae Sun</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Do Wan</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital and Medical School, Gwangju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>So Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Youjin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inje University Sanggye Paik Hospital, College of Medicine, Inje University Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Kwang Wook</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Moon Seong</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Yijun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Tae Gun</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Gina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jongmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yong Jun</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Ji Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Yun Tae</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Surgery, Gangneung Asan Hospital, Gangneung, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Inseok</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital and Medical School, Gwangju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Hwa Jin</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Chonnam National University Children's Hospital, Chonnam National University Medical School, Gwangju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Ala</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sua</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Dae-Hwan</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Bucheon Sejong Hospital, Bucheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Sung Wook</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sun Hyo</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Gee Young</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sunghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CDA 10-016</GrantID><Acronym>HX</Acronym><Agency>HSRD VA</Agency><Country>United States</Country></Grant><Grant><Agency>Korean Society of Critical Care Medicine</Agency><Country/></Grant><Grant><GrantID>2022-10-016</GrantID><Agency>Korea Disease Control and Prevention Agency</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016431">Guideline</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Acute Crit Care</MedlineTA><NlmUniqueID>101726905</NlmUniqueID><ISSNLinking>2586-6052</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">guidelines</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList><CoiStatement>
<b>CONFLICT OF INTEREST</b>
. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>20</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39622601</ArticleId><ArticleId IdType="pmc">PMC11617831</ArticleId><ArticleId IdType="doi">10.4266/acc.2024.00920</ArticleId><ArticleId IdType="pii">acc.2024.00920</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Sepsis Alliance  . Global Sepsis Alliance; 2024. Sepsis: a global health crisis [Internet] [cited 2024 Sep 15]. Available from:  https://globalsepsisalliance.org/sepsis#:~:text=Sepsis%20is%20a%20global%20health,the%20rest%20of%20their%20lives.</Citation></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Phua J, Koh Y, Du B, Tang YQ, Divatia JV, Tan CC, et al. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ. 2011;342:d3245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3113333</ArticleId><ArticleId IdType="pubmed">21669950</ArticleId></ArticleIdList></Reference><Reference><Citation>Namgung M, Ahn C, Park Y, Kwak IY, Lee J, Won M. Mortality among adult patients with sepsis and septic shock in Korea: a systematic review and meta-analysis. Clin Exp Emerg Med. 2023;10:157&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10350360</ArticleId><ArticleId IdType="pubmed">36882054</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon K, Na SJ, Oh DK, Park S, Choi EY, Kim SC, et al. Characteristics, management and clinical outcomes of patients with sepsis: a multicenter cohort study in Korea. Acute Crit Care. 2019;34:179&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6849014</ArticleId><ArticleId IdType="pubmed">31723927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15090974</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavar&#xe9; A, O&#x2019;Flynn N. Recognition, diagnosis, and early management of sepsis: NICE guideline. Br J Gen Pract. 2017;67:185&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5565828</ArticleId><ArticleId IdType="pubmed">28360070</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016) J Intensive Care. 2018;6:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5797365</ArticleId><ArticleId IdType="pubmed">29435330</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020) J Intensive Care. 2021;9:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384927</ArticleId><ArticleId IdType="pubmed">34433491</ArticleId></ArticleIdList></Reference><Reference><Citation>The Cochrane Collaboration  . The Cochrane Collaboration; 2020. Review Manager (RevMan) [Internet] [cited 2024 Sep 15]. Available from:  https://training.cochrane.org/online-learning/core-software/revman.</Citation></Reference><Reference><Citation>GRADE Working Group  . McMaster University; 2023. GRADEpro GDT: GRADEpro Guideline Development Tool [Internet] [cited 2024 Sep 15]. Available from:  https://www.gradepro.org/</Citation></Reference><Reference><Citation>Ahn C, Yu G, Shin TG, Cho Y, Park S, Suh GY. Comparison of early and late norepinephrine administration in patients with septic shock: a systematic review and meta-analysis. Chest. 2024. Jul 5, [Epub].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2024.05.042</ArticleId><ArticleId IdType="pubmed">38972348</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">18158437</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlbom DJ, Rubenfeld GD. Barriers to implementing protocol-based sepsis resuscitation in the emergency department: results of a national survey. Crit Care Med. 2007;35:2525&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">18075366</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2918907</ArticleId><ArticleId IdType="pubmed">20179283</ArticleId></ArticleIdList></Reference><Reference><Citation>ARISE Investigators. ANZICS Clinical Trials Group. Peake SL, Delaney A, Bailey M, Bellomo R, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">25272316</ArticleId></ArticleIdList></Reference><Reference><Citation>ProCESS Investigators. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">25776532</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick HA, Brunt LK, Mitchem KL, Chaloner C. Does lactate measurement performed on admission predict clinical outcome on the intensive care unit?: a concise systematic review. Ann Clin Biochem. 2012;49(Pt 4):391&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">22715295</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Heffner AC, Kline JA, et al. Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med. 2012;19:252&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3313083</ArticleId><ArticleId IdType="pubmed">22435856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Liu D, Su L, Yao B, Long Y, Wang X, et al. Use of stepwise lactate kinetics-oriented hemodynamic therapy could improve the clinical outcomes of patients with sepsis-associated hyperlactatemia. Crit Care. 2017;21:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5312433</ArticleId><ArticleId IdType="pubmed">28202033</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Xu J, Wang X, Wang Y, Tong F. Early lactate-guided resuscitation of elderly septic patients. J Intensive Care Med. 2022;37:686&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">34184576</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H, Lee J, Oh DK, Park MH, Lim CM, Lee SM, et al. Korean Sepsis Alliance (KSA) Investigators Serial evaluation of the serum lactate level with the SOFA score to predict mortality in patients with sepsis. Sci Rep. 2023;13:6351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113181</ArticleId><ArticleId IdType="pubmed">37072424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez G, Ospina-Tasc&#xf3;n GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA. 2019;321:654&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439620</ArticleId><ArticleId IdType="pubmed">30772908</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro R, Kattan E, Ferri G, Pairumani R, Valenzuela ED, Alegr&#xed;a L, et al. Effects of capillary refill time-vs. lactate-targeted fluid resuscitation on regional, microcirculatory and hypoxia-related perfusion parameters in septic shock: a randomized controlled trial. Ann Intensive Care. 2020;10:150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606372</ArticleId><ArticleId IdType="pubmed">33140173</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39:259&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Rubatto Birri PN, Kotfis K, Nanchal R, Shah B, Kluge S, et al. Higher fluid balance increases the risk of death from sepsis: results from a large international audit. Crit Care Med. 2017;45:386&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">27922878</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Linde-Zwirble WT, Bittner EA, Sahatjian J, Hansell D. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med. 2017;43:625&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">28130687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuttab HI, Lykins JD, Hughes MD, Wroblewski K, Keast EP, Kukoyi O, et al. Evaluation and predictors of fluid resuscitation in patients with severe sepsis and septic shock. Crit Care Med. 2019;47:1582&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096207</ArticleId><ArticleId IdType="pubmed">31393324</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376:2235&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538258</ArticleId><ArticleId IdType="pubmed">28528569</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews B, Semler MW, Muchemwa L, Kelly P, Lakhi S, Heimburger DC, et al. Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA. 2017;318:1233&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710318</ArticleId><ArticleId IdType="pubmed">28973227</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborn TM. Severe sepsis and septic shock trials (ProCESS, ARISE, ProMISe): what is optimal resuscitation? Crit Care Clin. 2017;33:323&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">28284298</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M, et al. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386:2459&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">35709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xe6;r MN, Meyhoff TS, Sivapalan P, Granholm A, Hjortrup PB, Madsen MB, et al. Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Intensive Care Med. 2023;49:820&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10354110</ArticleId><ArticleId IdType="pubmed">37330928</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunos NM, Kim IB, Bellomo R, Bailey M, Ho L, Story D, et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med. 2011;39:2419&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">21705897</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">23073953</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378:829&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846085</ArticleId><ArticleId IdType="pubmed">29485925</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghunathan K, Shaw A, Nathanson B, St&#xfc;rmer T, Brookhart A, Stefan MS, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014;42:1585&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24674927</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond NE, Taylor C, Finfer S, Machado FR, An Y, Billot L, et al. Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: an international cross-sectional study. PLoS One. 2017;12:e0176292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428917</ArticleId><ArticleId IdType="pubmed">28498856</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RM, Wang L, Coston TD, Krishnan NI, Casey JD, Wanderer JP, et al. Balanced crystalloids versus saline in sepsis: a secondary analysis of the SMART Clinical Trial. Am J Respir Crit Care Med. 2019;200:1487&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909845</ArticleId><ArticleId IdType="pubmed">31454263</ArticleId></ArticleIdList></Reference><Reference><Citation>Myburgh J. Patient-centered outcomes and resuscitation fluids. N Engl J Med. 2018;378:862&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">29485927</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Lu G, Wang D, Lei Y, Mao Z, Hu P, et al. Balanced crystalloids versus normal saline for fluid resuscitation in critically ill patients: a systematic review and meta-analysis with trial sequential analysis. Am J Emerg Med. 2019;37:2072&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30852043</ArticleId></ArticleIdList></Reference><Reference><Citation>Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT Randomized Clinical Trial. JAMA. 2015;314:1701&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26444692</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, et al. Balanced crystalloids versus saline in the intensive care unit: the SALT Randomized Trial. Am J Respir Crit Care Med. 2017;195:1362&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5443900</ArticleId><ArticleId IdType="pubmed">27749094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Golla R, Bhalla A, Sharma N, Varma S. 0.9% saline v/s Ringer&#x2019;s lactate for fluid resuscitation in adult sepsis patients in emergency medical services: an open label randomized controlled trial. J Assoc Physicians India. 2020;68:87.</Citation></Reference><Reference><Citation>Zampieri FG, Machado FR, Biondi RS, Freitas FG, Veiga VC, Figueiredo RC, et al. Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS Randomized Clinical Trial. JAMA. 2021;326:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356144</ArticleId><ArticleId IdType="pubmed">34375394</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Micallef S, Hammond N, Navarra L, Bellomo R, Billot L, et al. Balanced multielectrolyte solution versus saline in critically ill adults. N Engl J Med. 2022;386:815&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">35041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampieri FG, Machado FR, Biondi RS, Freitas FG, Veiga VC, Figueiredo RC, et al. Association between type of fluid received prior to enrollment, type of admission, and effect of balanced crystalloid in critically ill adults: a secondary exploratory analysis of the BaSICS Clinical Trial. Am J Respir Crit Care Med. 2022;205:1419&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">35349397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampieri FG, Machado FR, Veiga VC, Azevedo LC, Bagshaw SM, Damiani LP, et al. Determinants of fluid use and the association between volume of fluid used and effect of balanced solutions on mortality in critically ill patients: a secondary analysis of the BaSICS trial. Intensive Care Med. 2024;50:79&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">38010383</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">24635770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Meade MO, H&#xe9;bert PC, Asfar P, Lauzier F, Seely AJ, et al. Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med. 2016;42:542&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">26891677</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouncey PR, Richards-Belle A, Thomas K, Harrison DA, Sadique MZ, Grieve RD, et al. Reduced exposure to vasopressors through permissive hypotension to reduce mortality in critically ill people aged 65 and over: the 65 RCT. Health Technol Assess. 2021;25:1&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7957458</ArticleId><ArticleId IdType="pubmed">33648623</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinsky MR, Brochard L, Mancebo J, Hedenstierna G. Applied physiology in intensive care medicine. Springer; 2006.</Citation></Reference><Reference><Citation>Kumar A, Anel R, Bunnell E, Habet K, Zanotti S, Marshall S, et al. Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med. 2004;32:691&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15090949</ArticleId></ArticleIdList></Reference><Reference><Citation>Michard F. Using pulse oximetry waveform analysis to guide fluid therapy: are we there yet? Anesth Analg. 2007;104:1606&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17513674</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009;37:2642&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19602972</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouira S, Elatrous S, Dimassi S, Besbes L, Boukef R, Mohamed B, et al. Effects of norepinephrine on static and dynamic preload indicators in experimental hemorrhagic shock. Crit Care Med. 2005;33:2339&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">16215390</ArticleId></ArticleIdList></Reference><Reference><Citation>Renner J, Gruenewald M, Quaden R, Hanss R, Meybohm P, Steinfath M, et al. Influence of increased intra-abdominal pressure on fluid responsiveness predicted by pulse pressure variation and stroke volume variation in a porcine model. Crit Care Med. 2009;37:650&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19114894</ArticleId></ArticleIdList></Reference><Reference><Citation>Vistisen ST, Koefoed-Nielsen J, Larsson A. Should dynamic parameters for prediction of fluid responsiveness be indexed to the tidal volume? Acta Anaesthesiol Scand. 2010;54:191&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19764908</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadian M, Severyn DA, Pinsky MR. The effects of vasoactive drugs on pulse pressure and stroke volume variation in postoperative ventilated patients. J Crit Care. 2011;26:328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3103641</ArticleId><ArticleId IdType="pubmed">21036528</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Kollef MH. Targeted fluid minimization following initial resuscitation in septic shock: a pilot study. Chest. 2015;148:1462&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26291900</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard JC, Bayle F, Bourdin G, Leray V, Debord S, Delannoy B, et al. Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial. Crit Care. 2015;19:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310180</ArticleId><ArticleId IdType="pubmed">25572383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan WS, Ibrahim I, Leong BS, Jain S, Lu Q, Cheung YB, et al. Emergency department management of sepsis patients: a randomized, goal-oriented, noninvasive sepsis trial. Ann Emerg Med. 2016;67:367&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">26475246</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas IS, Alapat PM, Corl KA, Exline MC, Forni LG, Holder AL, et al. Fluid response evaluation in sepsis hypotension and shock: a randomized clinical trial. Chest. 2020;158:1431&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9490557</ArticleId><ArticleId IdType="pubmed">32353418</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med. 2009;180:861&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19696442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalil AC, Johnson DW, Lisco SJ, Sun J. Early goal-directed therapy for sepsis: a novel solution for discordant survival outcomes in clinical trials. Crit Care Med. 2017;45:607&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">28067711</ArticleId></ArticleIdList></Reference><Reference><Citation>Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Horton JM, Studnek JR, et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med. 2011;39:2066&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3158284</ArticleId><ArticleId IdType="pubmed">21572327</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor SP, Anderson WE, Beam K, Taylor B, Ellerman J, Kowalkowski MA. The association between antibiotic delay intervals and hospital mortality among patients treated in the emergency department for suspected sepsis. Crit Care Med. 2021;49:741&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33591002</ArticleId></ArticleIdList></Reference><Reference><Citation>IDSA Sepsis Task Force Infectious Diseases Society of America (IDSA) position statement: why IDSA did not endorse the surviving sepsis campaign guidelines. Clin Infect Dis. 2018;66:1631&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6927848</ArticleId><ArticleId IdType="pubmed">29182749</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018;44:925&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29675566</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Rhodes A, Evans LE, Steering and Executive Committee of the Surviving Sepsis Campaign Counterpoint: should the surviving sepsis campaign guidelines be retired?: no. Chest. 2019;155:14&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30616720</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Chiotos K, Cosgrove SE, Heil EL, Kadri SS, Kalil AC, et al. Infectious Diseases Society of America Position Paper: recommended revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure. Clin Infect Dis. 2021;72:541&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189682</ArticleId><ArticleId IdType="pubmed">32374861</ArticleId></ArticleIdList></Reference><Reference><Citation>Yealy DM, Mohr NM, Shapiro NI, Venkatesh A, Jones AE, Self WH. Early care of adults with suspected sepsis in the emergency department and out-of-hospital environment: a consensus-based task force report. Ann Emerg Med. 2021;78:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">33840511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, You SM, Oh SH, Koh BS, Son CH, An S, et al. Impact of antibiotic administration within 1 hour from septic shock on patients' outcomes. J Korean Emerg Med. 2015;26:89&#x2013;94.</Citation></Reference><Reference><Citation>Savran Y, Duran Y, Comert B. Impact of time to antibiotics on mortality in severe sepsis and septic shock. Acta Med Mediterr. 2016;32:17&#x2013;22.</Citation></Reference><Reference><Citation>Tan IR, Mendoza MT. Early antibiotic therapy (EAT) decreases in-hospital mortality of patients with sepsis at the emergency department. Philipp J Intern Med. 2019;57:87&#x2013;92.</Citation></Reference><Reference><Citation>Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">16625125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lueangarun S, Leelarasamee A. Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: a retrospective study. Interdiscip Perspect Infect Dis. 2012;2012:765205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3419419</ArticleId><ArticleId IdType="pubmed">22919379</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloos F, Thomas-R&#xfc;ddel D, R&#xfc;ddel H, Engel C, Schwarzkopf D, Marshall JC, et al. Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care. 2014;18:R42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057316</ArticleId><ArticleId IdType="pubmed">24589043</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota PK, Marra AR, Martino MD, Victor ES, Dur&#xe3;o MS, Edmond MB, et al. Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock: a quality improvement study. PLoS One. 2014;9:e104475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4222820</ArticleId><ArticleId IdType="pubmed">25375775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryoo SM, Kim WY, Sohn CH, Seo DW, Koh JW, Oh BJ, et al. Prognostic value of timing of antibiotic administration in patients with septic shock treated with early quantitative resuscitation. Am J Med Sci. 2015;349:328&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">25651372</ArticleId></ArticleIdList></Reference><Reference><Citation>Suberviola Ca&#xf1;as B, J&#xe1;uregui R, Ballesteros M&#xc1;, Leizaola O, Gonz&#xe1;lez-Castro A, Castellanos-Ortega &#xc1;. Effects of antibiotic administration delay and inadequacy upon the survival of septic shock patients. Med Intensiva. 2015;39:459&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">25843698</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, Kushimoto S, Tokuda Y, Phillips GS, Rhodes A, Sugiyama T, et al. Implementation of earlier antibiotic administration in patients with severe sepsis and septic shock in Japan: a descriptive analysis of a prospective observational study. Crit Care. 2019;23:360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6862854</ArticleId><ArticleId IdType="pubmed">31744549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Xiang H, Dong Y, Portner E, Peng Z, Kashani K. Timeline of sepsis bundle component completion and its association with septic shock outcomes. J Crit Care. 2020;60:143&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">32805593</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang CY, Yang YY, Hung CC, Wang TH, Hsu YC. Prognostic values of the timing of antibiotic administration and the sepsis bundle component in elderly patients with septic shock: a retrospective study. Shock. 2022;57:181&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34559742</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam N, Oskam E, Stassen PM, Exter PV, van de Ven PM, Haak HR, et al. Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 2018;6:40&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29196046</ArticleId></ArticleIdList></Reference><Reference><Citation>Althunayyan SM, Aljanoubi MA, Alghadeer SM, Alharthi MZ, Alotaibi RN, Mubarak AM, et al. The impact of emergency antibiotic administration time on patients with sepsis. Saudi Med J. 2021;42:1002&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9280501</ArticleId><ArticleId IdType="pubmed">34470839</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascuntar J, Mendoza D, Jaimes F. Author&#x2019;s response to letter &#x201c;Antimicrobials administration time in patients with suspected sepsis: faster is better for severe patients&#x201d;. J Intensive Care. 2020;8:55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376705</ArticleId><ArticleId IdType="pubmed">32714557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulle EB, Peake SL, Finnis M, Bellomo R, Delaney A, on&#x2009;behalf&#x2009;of&#x2009;the&#x2009;ARISE Investigators et al. Time to antimicrobial therapy in septic shock patients treated with an early goal-directed resuscitation protocol: a post-hoc analysis of the ARISE trial. Emerg Med Australas. 2021;33:409&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">38019012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso T, Carneiro AH, Ribeiro O, Teixeira-Pinto A, Costa-Pereira A. Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study) Crit Care. 2010;14:R83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2911711</ArticleId><ArticleId IdType="pubmed">20459716</ArticleId></ArticleIdList></Reference><Reference><Citation>Drumheller BC, Agarwal A, Mikkelsen ME, Sante SC, Weber AL, Goyal M, et al. Risk factors for mortality despite early protocolized resuscitation for severe sepsis and septic shock in the emergency department. J Crit Care. 2016;31:13&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">26611382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010;38:1045&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">20048677</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SY, Shin J, Jo IJ, Park JE, Yoon H, Cha WC, et al. Delayed antibiotic therapy and organ dysfunction in critically ill septic patients in the emergency department. J Clin Med. 2019;8:222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6406307</ArticleId><ArticleId IdType="pubmed">30744073</ArticleId></ArticleIdList></Reference><Reference><Citation>Im Y, Kang D, Ko RE, Lee YJ, Lim SY, Park S, et al. Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. Crit Care. 2022;26:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8756674</ArticleId><ArticleId IdType="pubmed">35027073</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo YM, Chae MK, Hwang SY, Jin SC, Lee TR, Cha WC, et al. Impact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department. Clin Exp Emerg Med. 2014;1:35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5052817</ArticleId><ArticleId IdType="pubmed">27752550</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim RY, Ng AM, Persaud AK, Furmanek SP, Kothari YN, Price JD, et al. Antibiotic timing and outcomes in sepsis. Am J Med Sci. 2018;355:524&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29891035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko BS, Choi SH, Kang GH, Shin TG, Kim K, Jo YH, et al. Time to antibiotics and the outcome of patients with septic shock: a propensity score analysis. Am J Med. 2020;133:485&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">31622578</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, et al. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med. 2017;196:856&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5649973</ArticleId><ArticleId IdType="pubmed">28345952</ArticleId></ArticleIdList></Reference><Reference><Citation>Londo&#xf1;o J, Ni&#xf1;o C, Archila A, Valencia M, C&#xe1;rdenas D, Perdomo M, et al. Antibiotics has more impact on mortality than other early goal-directed therapy components in patients with sepsis: an instrumental variable analysis. J Crit Care. 2018;48:191&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30218959</ArticleId></ArticleIdList></Reference><Reference><Citation>Morneau K, Chisholm GB, Tverdek F, Bruno J, Toale KM. Timing to antibiotic therapy in septic oncologic patients presenting without hypotension. Support Care Cancer. 2017;25:3357&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">28550443</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltan ID, Brown SM, Bledsoe JR, Sorensen J, Samore MH, Allen TL, et al. ED door-to-antibiotic time and long-term mortality in sepsis. Chest. 2019;155:938&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6533450</ArticleId><ArticleId IdType="pubmed">30779916</ArticleId></ArticleIdList></Reference><Reference><Citation>Seok H, Song J, Jeon JH, Choi HK, Choi WS, Moon S, et al. Timing of antibiotics in septic patients: a prospective cohort study. Clin Microbiol Infect. 2020;26:1495&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">32062049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tantarattanapong S, Hemwej T. Door-to-antibiotic time and in-hospital mortality of elder patients presenting to emergency department with sepsis: a cross-sectional study. Arch Acad Emerg Med. 2021;9:e44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221551</ArticleId><ArticleId IdType="pubmed">34223189</ArticleId></ArticleIdList></Reference><Reference><Citation>Waechter J, Kumar A, Lapinsky SE, Marshall J, Dodek P, Arabi Y, et al. Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med. 2014;42:2158&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">25072761</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li H, Zhang D. Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis. Crit Care. 2020;24:488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409707</ArticleId><ArticleId IdType="pubmed">32762765</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo HJ, Lee YS, Kim TH, Jang JH, Lee HB, Oh DK, et al. Vasopressor initiation within 1 hour of fluid loading is associated with increased mortality in septic shock patients: analysis of national registry data. Crit Care Med. 2022;50:e351&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">34612848</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald SP, Keijzers G, Taylor DM, Kinnear F, Arendts G, Fatovich DM, et al. Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial. Intensive Care Med. 2018;44:2070&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30382308</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbouhy MA, Soliman M, Gaber A, Taema KM, Abdel-Aziz A. Early use of norepinephrine improves survival in septic shock: earlier than early. Arch Med Res. 2019;50:325&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">31677537</ArticleId></ArticleIdList></Reference><Reference><Citation>Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER): a randomized trial. Am J Respir Crit Care Med. 2019;199:1097&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">30704260</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network. Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, et al. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388:499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10685906</ArticleId><ArticleId IdType="pubmed">36688507</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai X, Yu W, Ji W, Lin Z, Tan S, Duan K, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care. 2014;18:532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194405</ArticleId><ArticleId IdType="pubmed">25277635</ArticleId></ArticleIdList></Reference><Reference><Citation>Colon Hidalgo D, Patel J, Masic D, Park D, Rech MA. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care. 2020;55:145&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31731173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ospina-Tasc&#xf3;n GA, Hernandez G, Alvarez I, Calder&#xf3;n-Tapia LE, Manzano-Nunez R, S&#xe1;nchez-Ortiz AI, et al. Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis. Crit Care. 2020;24:52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7023737</ArticleId><ArticleId IdType="pubmed">32059682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusakabe A, Sweeny A, Keijzers G, Steering Committee of the ARISE FLUIDS Observational Study Group Early vs. late vassopressor therapy in the management of patients with sepsis and hypotension: a multicenter observational study. Arch Med Res. 2021;52:836&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">34275667</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouffroy R, Hajjar A, Gilbert B, Tourtier JP, Bloch-Laine E, Ecollan P, et al. Prehospital norepinephrine administration reduces 30-day mortality among septic shock patients. BMC Infect Dis. 2022;22:345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8988327</ArticleId><ArticleId IdType="pubmed">35387608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DS, Park JE, Hwang SY, Jeong D, Lee GT, Kim T, et al. Prediction of vasopressor requirement among hypotensive patients with suspected infection: usefulness of diastolic shock index and lactate. Clin Exp Emerg Med. 2022;9:176&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9561204</ArticleId><ArticleId IdType="pubmed">36164800</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Zhong R, Shi S, Zeng Y, Tang Z. Early initiation of norepinephrine in patients with septic shock: A propensity score-based analysis. Am J Emerg Med. 2022;54:287&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">35227959</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Nielsen ND, Shapiro NI, Gerbasi ME, Grossman A, Doroff R, et al. Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database. Ann Intensive Care. 2018;8:107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6223403</ArticleId><ArticleId IdType="pubmed">30411243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur SK, Dhunna R, Chakraborty A. Comparison of norepinephrine and dopamine in the management of septic shock using impedance cardiography. Indian J Crit Care Med. 2011;11:186&#x2013;91.</Citation></Reference><Reference><Citation>Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest. 1993;103:1826&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">8404107</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA. 1994;272:1354&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7933396</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">20200382</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock. 2010;33:375&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">19851126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sazgar M, Golikhatir I, Pashaee SM, Tirandaz F, Firouzian A, Miniahidashti H. Norepinephrine with dopamine infusion on the end-tidal carbon dioxide (ETcO2) pressure in patients with septic shock. Caspian J Intern Med. 2021;12:580&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590414</ArticleId><ArticleId IdType="pubmed">34820066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Zhu B, Jiang J, Zhou G, Zhou S. Norepinephrine, dopamine, and vasopressin in patients with sepsis and preexisting or acute heart failure: a retrospective cohort study. Med Sci Monit. 2021;27:e927716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836321</ArticleId><ArticleId IdType="pubmed">33476310</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH Randomized Clinical Trial. JAMA. 2016;316:509&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauzier F, L&#xe9;vy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med. 2006;32:1782&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17019548</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13:R130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2750187</ArticleId><ArticleId IdType="pubmed">19664253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, et al. Vasopressin versus norepinephrine for the management of septic shock in cancer patients: the VANCS II Randomized Clinical Trial. Crit Care Med. 2019;47:1743&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">31609774</ArticleId></ArticleIdList></Reference><Reference><Citation>Daley MJ, Lat I, Mieure KD, Jennings HR, Hall JB, Kress JP. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock. Ann Pharmacother. 2013;47:301&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">23447481</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Wellman H, Walley KR. Vasopressin versus norepinephrine in septic shock: a propensity score matched efficiency retrospective cohort study in the VASST coordinating center hospital. J Intensive Care. 2018;6:73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240281</ArticleId><ArticleId IdType="pubmed">30473792</ArticleId></ArticleIdList></Reference><Reference><Citation>Haan BJ, Cadiz ML, Natavio AM. Efficacy and safety of vasopressin as first-line treatment of distributive and hemorrhagic shock states. Ann Pharmacother. 2020;54:213&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31625395</ArticleId></ArticleIdList></Reference><Reference><Citation>Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med. 2008;34:2226&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">18654759</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Laderchi A, et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care. 2008;12:R143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2646303</ArticleId><ArticleId IdType="pubmed">19017409</ArticleId></ArticleIdList></Reference><Reference><Citation>Law AC, Bosch NA, Peterson D, Walkey AJ. Comparison of heart rate after phenylephrine vs norepinephrine initiation in patients with septic shock and atrial fibrillation. Chest. 2022;162:796&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9808602</ArticleId><ArticleId IdType="pubmed">35526604</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Kedarisetty CK, Vashishtha C, Saini D, Kumar S, Maiwall R, et al. A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock. Liver Int. 2017;37:552&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">27633962</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZM, Chen J, Kou Q, Lin Q, Huang X, Tang Z, et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018;44:1816&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">29971593</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, et al. Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA. 2018;319:1889&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583502</ArticleId><ArticleId IdType="pubmed">29801010</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, H&#xe9;bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med. 2003;31:1659&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">12794401</ArticleId></ArticleIdList></Reference><Reference><Citation>Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A. Vasopressors for the treatment of septic shock: systematic review and meta-analysis. PLoS One. 2015;10:e0129305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4523170</ArticleId><ArticleId IdType="pubmed">26237037</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001;120:989&#x2013;1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">11555538</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley MS, Barletta JF, Smithburger PL, Radosevich JJ, Kane-Gill SL. Catecholamine vasopressor support sparing strategies in vasodilatory shock. Pharmacotherapy. 2019;39:382&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">30506565</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96:576&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11873030</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzegar E, Ahmadi A, Mousavi S, Nouri M, Mojtahedzadeh M. The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: microcirculation, is it the black box? Acta Med Iran. 2016;54:15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26853286</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzegar E, Nouri M, Mousavi S, Ahmadi A, Mojtahedzadeh M. Vasopressin in septic shock; assessment of sepsis biomarkers: a randomized, controlled trial. Indian J Crit Care Med. 2017;21:578&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5613609</ArticleId><ArticleId IdType="pubmed">28970657</ArticleId></ArticleIdList></Reference><Reference><Citation>Walley KR. Sepsis-induced myocardial dysfunction. Curr Opin Crit Care. 2018;24:292&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29846206</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato R, Ariyoshi N, Hasegawa D, Crossey E, Hamahata N, Ishihara T, et al. Effects of inotropes on the mortality in patients with septic shock. J Intensive Care Med. 2021;36:211&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31793373</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Yin H, Zhang R, Ye X, Wei J. The effect of dobutamine in sepsis: a propensity score matched analysis. BMC Infect Dis. 2021;21:1151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8582172</ArticleId><ArticleId IdType="pubmed">34758739</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YF, Pan Y, Tang Q, Lou N, Wang DF. Early administration of dobutamine in the treatment of septic shock patients with tumor-a retrospective comparative cohort study. Ann Transl Med. 2022;10:828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9403911</ArticleId><ArticleId IdType="pubmed">36035000</ArticleId></ArticleIdList></Reference><Reference><Citation>Adjunctive dobutamine in septic cardiomyopathy with tissue hypoperfusion (ADAPT)   U.S. National Library of Medicine; 2023. In: ClinicalTrials.gov [Internet] [cited 2024 Sep 15]. Available from:  https://classic.clinicaltrials.gov/ct2/show/NCT04166331.</Citation></Reference><Reference><Citation>Levy B, Bollaert PE, Lucchelli JP, Sadoune LO, Nace L, Larcan A. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med. 1997;25:1649&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">9377878</ArticleId></ArticleIdList></Reference><Reference><Citation>Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med. 1999;27:893&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">10362410</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou SX, Qiu HB, Huang YZ, Yang Y, Zheng RQ. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin. 2002;23:654&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12100762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez G, Bruhn A, Luengo C, Regueira T, Kattan E, Fuentealba A, et al. Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study. Intensive Care Med. 2013;39:1435&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">23740284</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C, Saux P, Eon B, Aknin P, Gouin F. Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand. 1990;34:413&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2389659</ArticleId></ArticleIdList></Reference><Reference><Citation>Berr&#xe9; J, De Backer D, Moraine JJ, M&#xe9;lot RJ, Vincent JL. Dobutamine increases cerebral blood flow velocity and jugular bulb hemoglobin saturation in septic patients. Crit Care Med. 1997;25:392&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9118652</ArticleId></ArticleIdList></Reference><Reference><Citation>Joly LM, Monchi M, Cariou A, Chiche JD, Bellenfant F, Brunet F, et al. Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock. Am J Respir Crit Care Med. 1999;160:1983&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10588617</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C, Viviand X, Arnaud S, Vialet R, Rougnon T. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients. Crit Care Med. 1999;27:1708&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">10507587</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Creteur J, Dubois MJ, Sakr Y, Koch M, Verdant C, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med. 2006;34:403&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16424721</ArticleId></ArticleIdList></Reference><Reference><Citation>Enrico C, Kanoore Edul VS, Vazquez AR, Pein MC, P&#xe9;rez de la Hoz RA, Ince C, et al. Systemic and microcirculatory effects of dobutamine in patients with septic shock. J Crit Care. 2012;27:630&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23084135</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Zhang N, Wu Y, Zheng Y, You X, Cao Z, et al. Effects of dopamine, norepinephrine and dobutamine on gastric mucosal pH of septic shock patients. Exp Ther Med. 2016;12:975&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4950373</ArticleId><ArticleId IdType="pubmed">27446306</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Dai J, Du M, Wang W, Guo C, Wang Y, et al. Effect of dobutamine on extravascular lung water index, ventilator function, and perfusion parameters in acute respiratory distress syndrome associated with septic shock. Artif Cells Nanomed Biotechnol. 2016;44:1326&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">26178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Razazi K, Labb&#xe9; V, Laine L, Bedet A, Carteaux G, de Prost N, et al. Hemodynamic effects and tolerance of dobutamine for myocardial dysfunction during septic shock: an observational multicenter prospective echocardiographic study. Front Cardiovasc Med. 2022;9:951016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9500364</ArticleId><ArticleId IdType="pubmed">36158835</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkman E, Kaukonen KM, Pettil&#xe4; V, Kuitunen A, Varpula M. Association between inotrope treatment and 90-day mortality in patients with septic shock. Acta Anaesthesiol Scand. 2013;57:431&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">23298252</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Yan J, Han S, Chen Q, Chen M, Jiang H, et al. Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials. Crit Care. 2019;23:168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6518735</ArticleId><ArticleId IdType="pubmed">31088524</ArticleId></ArticleIdList></Reference><Reference><Citation>Extracorporeal Life Support Organization  . Extracorporeal Life Support Organization; 2024. Life Support Organization. ECLS international summary of statistics [Internet] [cited Sep 15]. Available from:  https://www.elso.org/registry/internationalsummaryandreports/internationalsummary.aspx.</Citation></Reference><Reference><Citation>Takauji S, Hayakawa M, Ono K, Makise H. Respiratory extracorporeal membrane oxygenation for severe sepsis and septic shock in adults: a propensity score analysis in a multicenter retrospective observational study. Acute Med Surg. 2017;4:408&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5649301</ArticleId><ArticleId IdType="pubmed">29123901</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe9;chot N, Hajage D, Kimmoun A, Demiselle J, Agerstrand C, Montero S, et al. Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study. Lancet. 2020;396:545&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">32828186</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha Y, Yuan J, Bao J, Fang M, Liu N, Huang R, et al. Veno-venous extracorporeal membrane oxygenation for septic shock patients with pulmonary infection: a propensity score matching-based retrospective study. Artif Organs. 2022;46:2304&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">35491962</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A, Hajage D, Capellier G, Demoule A, Lavou&#xe9; S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">29791822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling RR, Ramanathan K, Poon WH, Tan CS, Brechot N, Brodie D, et al. Venoarterial extracorporeal membrane oxygenation as mechanical circulatory support in adult septic shock: a systematic review and meta-analysis with individual participant data meta-regression analysis. Crit Care. 2021;25:246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278703</ArticleId><ArticleId IdType="pubmed">34261492</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugar S, Sato R, Chawla S, You JY, Wang X, Grimm R, et al. Is left ventricular systolic dysfunction associated with increased mortality among patients with sepsis and septic shock? Chest. 2023;163:1437&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">36646415</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng M, McSparron JI, Kien DT, Stone DJ, Roberts DH, Schwartzstein RM, et al. Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database. Intensive Care Med. 2018;44:884&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">29806057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan P, Wang TT, Li HY, Yan RS, Liao WC, Yu BW, et al. Utilization of echocardiography during septic shock was associated with a decreased 28-day mortality: a propensity score-matched analysis of the MIMIC-III database. Ann Transl Med. 2019;7:662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6944601</ArticleId><ArticleId IdType="pubmed">31930063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanumanthu BK, Nair AS, Katamreddy A, Gilbert JS, You JY, Offor OL, et al. Sepsis-induced cardiomyopathy is associated with higher mortality rates in patients with sepsis. Acute Crit Care. 2021;36:215&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8435447</ArticleId><ArticleId IdType="pubmed">34311515</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Yang Q, Kong T, Chen X, Wang R, Huo J, et al. Association between wait time for transthoracic echocardiography and 28-day mortality in patients with septic shock: a cohort study. J Clin Med. 2022;11:4131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9321017</ArticleId><ArticleId IdType="pubmed">35887895</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28351429</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Corticosteroids in septic shock: a systematic review and network meta-analysis.</ArticleTitle><Pagination><StartPage>78</StartPage><MedlinePgn>78</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">78</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-017-1659-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Multiple corticosteroids and treatment regimens have been used as adjuncts in the treatment of septic shock. Qualitative and quantitative differences exist at cellular and tissular levels between the different drugs and their patterns of delivery. The objective of this study was to elucidate any differences between the drugs and their treatment regimens regarding outcomes for corticosteroid use in adult patients with septic shock.</AbstractText><AbstractText Label="METHODS">Network meta-analysis of the data used for the recently conducted Cochrane review was performed. Studies that included children and were designed to assess respiratory function in pneumonia and acute respiratory distress syndrome, as well as cross-over studies, were excluded. Network plots were created for each outcome, and all analyses were conducted using a frequentist approach assuming a random-effects model.</AbstractText><AbstractText Label="RESULTS">Complete data from 22 studies and partial data from 1 study were included. Network meta-analysis provided no clear evidence that any intervention or treatment regimen is better than any other across the spectrum of outcomes. There was strong evidence of differential efficacy in only one area: shock reversal. Hydrocortisone boluses and infusions were more likely than methylprednisolone boluses and placebo to result in shock reversal.</AbstractText><AbstractText Label="CONCLUSIONS">There was no clear evidence that any one corticosteroid drug or treatment regimen is more likely to be effective in reducing mortality or reducing the incidence of gastrointestinal bleeding or superinfection in septic shock. Hydrocortisone delivered as a bolus or as an infusion was more likely than placebo and methylprednisolone to result in shock reversal.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gibbison</LastName><ForeName>Ben</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3635-6212</Identifier><AffiliationInfo><Affiliation>Cardiac Anaesthesia and Intensive Care, Bristol Heart Institute - University Hospitals Bristol NHS Foundation Trust, University of Bristol, Bristol, UK. mdbjjg@bristol.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-L&#xf3;pez</LastName><ForeName>Jos&#xe9; A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higgins</LastName><ForeName>Julian P T</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Centre for Research Synthesis and Decision Analysis, School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiac Anaesthesia and Intensive Care, Bristol Heart Institute - University Hospitals Bristol NHS Foundation Trust, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelini</LastName><ForeName>Gianni D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Bristol Heart Institute - University Hospitals Bristol NHS Foundation Trust, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lightman</LastName><ForeName>Stafford L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Henry Wellcome Laboratories for Integrative Neuroscience and Metabolism, School of Clinical Sciences, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annane</LastName><ForeName>Djillali</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medicine: Critical Care Medicine, H&#xf4;pital Raymond Poincar&#xe9;, Assistance Publique H&#xf4;pitaux de Paris (APHP), Garches, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, Versailles, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CH/1992027/7163</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Emerg Med. 2018 Jan;71(1):34-36. doi: 10.1016/j.annemergmed.2017.05.025.</RefSource><PMID Version="1">28688770</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adrenal</Keyword><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Glucocorticoids</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Steroids</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28351429</ArticleId><ArticleId IdType="pmc">PMC5371269</ArticleId><ArticleId IdType="doi">10.1186/s13054-017-1659-4</ArticleId><ArticleId IdType="pii">10.1186/s13054-017-1659-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937&#x2013;49. doi: 10.1097/CCM.0b013e31817603ba.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31817603ba</ArticleId><ArticleId IdType="pubmed">18496365</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating sepsis. Cochrane Database Syst Rev. 2015;12:CD002243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494587</ArticleId><ArticleId IdType="pubmed">26633262</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran JL, Graham PL, Rockliff S, Bersten AD. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care. 2010;14:R134. doi: 10.1186/cc9182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9182</ArticleId><ArticleId IdType="pmc">PMC2945102</ArticleId><ArticleId IdType="pubmed">20626892</ArticleId></ArticleIdList></Reference><Reference><Citation>Volbeda M, Wetterslev J, Gluud C, Zijlstra JG, van der Horst ICC, Keus F. Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2015;41:1220&#x2013;34. doi: 10.1007/s00134-015-3899-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3899-6</ArticleId><ArticleId IdType="pmc">PMC4483251</ArticleId><ArticleId IdType="pubmed">26100123</ArticleId></ArticleIdList></Reference><Reference><Citation>Demoly P, Chung KF. Pharmacology of corticosteroids. Respir Med. 1998;92:385&#x2013;94. doi: 10.1016/S0954-6111(98)90280-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0954-6111(98)90280-3</ArticleId><ArticleId IdType="pubmed">9692094</ArticleId></ArticleIdList></Reference><Reference><Citation>Henley DE, Leendertz JA, Russell GM, Wood SA, Taheri S, Woltersdorf WW, et al. Development of an automated blood sampling system for use in humans. J Med Eng Technol. 2009;33:199&#x2013;208. doi: 10.1080/03091900802185970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03091900802185970</ArticleId><ArticleId IdType="pubmed">19340690</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbison B, Spiga F, Walker JJ, Russell GM, Stevenson K, Kershaw Y, et al. Dynamic pituitary-adrenal interactions in response to cardiac surgery. Crit Care Med. 2015;43:791&#x2013;800. doi: 10.1097/CCM.0000000000000773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000773</ArticleId><ArticleId IdType="pmc">PMC4359905</ArticleId><ArticleId IdType="pubmed">25517478</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonen E, Meersseman P, Vervenne H, Meyfroidt G, Gu&#xef;za F, Wouters PJ, et al. Reduced nocturnal ACTH-driven cortisol secretion during critical illness. Am J Physiol Endocrinol Metab. 2014;306:E883&#x2013;92. doi: 10.1152/ajpendo.00009.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00009.2014</ArticleId><ArticleId IdType="pmc">PMC3989736</ArticleId><ArticleId IdType="pubmed">24569590</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org.</Citation></Reference><Reference><Citation>Caldwell DM. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331:897&#x2013;900. doi: 10.1136/bmj.331.7521.897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.331.7521.897</ArticleId><ArticleId IdType="pmc">PMC1255806</ArticleId><ArticleId IdType="pubmed">16223826</ArticleId></ArticleIdList></Reference><Reference><Citation>White IR. Network meta-analysis. Stata J. 2015;15:951&#x2013;85.</Citation></Reference><Reference><Citation>Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171:242&#x2013;8. doi: 10.1164/rccm.200406-808OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200406-808OC</ArticleId><ArticleId IdType="pubmed">15557131</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijvis SCA, Hardeman H, Remmelts HHF, Heijligenberg R, Rijkers GT, van Velzen-Blad H, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:2023&#x2013;30. doi: 10.1016/S0140-6736(11)60607-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60607-7</ArticleId><ArticleId IdType="pubmed">21636122</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezk NA, Ibrahim AM. Effects of methyl prednisolone in early ARDS. Egypt J Chest Dis Tuberc. 2013;62:167&#x2013;72. doi: 10.1016/j.ejcdt.2013.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcdt.2013.02.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Snijders D, Daniels JMA, de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181:975&#x2013;82. doi: 10.1164/rccm.200905-0808OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200905-0808OC</ArticleId><ArticleId IdType="pubmed">20133929</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313:677&#x2013;86. doi: 10.1001/jama.2015.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.88</ArticleId><ArticleId IdType="pubmed">25688779</ArticleId></ArticleIdList></Reference><Reference><Citation>Slusher T, Gbadero D, Howard C, Lewison L, Giroir B, Toro L, et al. Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis. Pediatr Infect Dis J. 1996;15:579&#x2013;83. doi: 10.1097/00006454-199607000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199607000-00004</ArticleId><ArticleId IdType="pubmed">8823850</ArticleId></ArticleIdList></Reference><Reference><Citation>Valoor HT, Singhi S, Jayashree M. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a Third World setting. Pediatr Crit Care Med. 2009;10:121&#x2013;5. doi: 10.1097/PCC.0b013e3181936ab3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3181936ab3</ArticleId><ArticleId IdType="pubmed">19057445</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooperative Study Group The effectiveness of hydrocortisone in the management of severe infections. JAMA. 1963;183:462&#x2013;5. doi: 10.1001/jama.1963.63700060029012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1963.63700060029012</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh JW, Lim CM, Koh Y, Hong SB. Effect of low doses of hydrocortisone in patient with septic shock and relative adrenal insufficiency: 3&#xa0;days versus 7&#xa0;days treatment [abstract 369] Crit Care Med. 2006;34(12 Suppl):A101. doi: 10.1097/00003246-200612002-00350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200612002-00350</ArticleId></ArticleIdList></Reference><Reference><Citation>Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, et al. Immunologic and hemodynamic effects of &#x201c;low-dose&#x201d; hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med. 2003;167:512&#x2013;20. doi: 10.1164/rccm.200205-446OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200205-446OC</ArticleId><ArticleId IdType="pubmed">12426230</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandan SM, Guleria R, Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised controlled trial from India [abstract]. In: Proceedings of the American Thoracic Society Meeting, New York, NY, USA; 2005. p A24.</Citation></Reference><Reference><Citation>Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988;138:62&#x2013;8. doi: 10.1164/ajrccm/138.1.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm/138.1.62</ArticleId><ArticleId IdType="pubmed">3202402</ArticleId></ArticleIdList></Reference><Reference><Citation>The Veterans Administration Systemic Sepsis Cooperative Study Group Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med. 1987;317:659&#x2013;65. doi: 10.1056/NEJM198709103171102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198709103171102</ArticleId><ArticleId IdType="pubmed">2888017</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317:653&#x2013;8. doi: 10.1056/NEJM198709103171101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198709103171101</ArticleId><ArticleId IdType="pubmed">3306374</ArticleId></ArticleIdList></Reference><Reference><Citation>Klastersky J, Cappel R, Debusscher L. Effectiveness of betamethasone in management of severe infections: a double-blind study. N Engl J Med. 1971;284:1248&#x2013;50. doi: 10.1056/NEJM197106032842206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197106032842206</ArticleId><ArticleId IdType="pubmed">4929896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas CE, Ledgerwood AM. The cardiopulmonary response to massive doses of steroids in patients with septic shock. Arch Surg. 1984;119:537&#x2013;41. doi: 10.1001/archsurg.1984.01390170037008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.1984.01390170037008</ArticleId><ArticleId IdType="pubmed">6712466</ArticleId></ArticleIdList></Reference><Reference><Citation>Molenaar N, Johan Groeneveld AB, Dijstelbloem HM, de Jong MF, Girbes AR, Heijboer AC, et al. Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness. Intensive Care Med. 2011;37:1986&#x2013;93. doi: 10.1007/s00134-011-2342-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2342-x</ArticleId><ArticleId IdType="pubmed">21850531</ArticleId></ArticleIdList></Reference><Reference><Citation>Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med. 2001;27:1584&#x2013;91. doi: 10.1007/s001340101073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340101073</ArticleId><ArticleId IdType="pubmed">11685298</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh B, Mortimer RH, Couchman B, Hall J. Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study. Anaesth Intensive Care. 2005;33:201&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15960402</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000;283:1038&#x2013;45. doi: 10.1001/jama.283.8.1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.8.1038</ArticleId><ArticleId IdType="pubmed">10697064</ArticleId></ArticleIdList></Reference><Reference><Citation>COIITSS Study Investigators Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303:341&#x2013;8. doi: 10.1001/jama.2010.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.2</ArticleId><ArticleId IdType="pubmed">20103758</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014;42:1325&#x2013;33. doi: 10.1097/CCM.0000000000000212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000212</ArticleId><ArticleId IdType="pubmed">24557425</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabry NA, Omar EED. Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacol Pharm. 2011;2:73&#x2013;81. doi: 10.4236/pp.2011.22009.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/pp.2011.22009</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med. 2013;41:580&#x2013;637. doi: 10.1097/CCM.0b013e31827e83af.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827e83af</ArticleId><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny FM, Preeyasombat C, Migeon CJ. Cortisol production rate. II. Normal infants, children, and adults. Pediatrics. 1966;37:34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">5323003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergthorsdottir R, Leonsson-Zachrisson M, Od&#xe9;n A, Johannsson G. Premature mortality in patients with Addison&#x2019;s disease: a population-based study. J Clin Endocrinol Metab. 2006;91:4849&#x2013;53. doi: 10.1210/jc.2006-0076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2006-0076</ArticleId><ArticleId IdType="pubmed">16968806</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell GM, Durant C, Ataya A, Papastathi C, Bhake R, Woltersdorf W, et al. Subcutaneous pulsatile glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 2014;81:289&#x2013;93. doi: 10.1111/cen.12470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.12470</ArticleId><ArticleId IdType="pmc">PMC4231230</ArticleId><ArticleId IdType="pubmed">24735400</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway-Campbell BL, Sarabdjitsingh RA, McKenna MA, Pooley JR, Kershaw YM, Meijer OC, et al. Glucocorticoid ultradian rhythmicity directs cyclical gene pulsing of the clock gene period 1 in rat hippocampus. J Neuroendocrinol. 2010;22:1093&#x2013;100. doi: 10.1111/j.1365-2826.2010.02051.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2826.2010.02051.x</ArticleId><ArticleId IdType="pmc">PMC4968637</ArticleId><ArticleId IdType="pubmed">20649850</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiga F, Lightman SL. Dynamics of adrenal glucocorticoid steroidogenesis in health and disease. Mol Cell Endocrinol. 2015;408:227&#x2013;34. doi: 10.1016/j.mce.2015.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2015.02.005</ArticleId><ArticleId IdType="pubmed">25662280</ArticleId></ArticleIdList></Reference><Reference><Citation>Henley D, Lightman S, Carrell R. Cortisol and CBG&#x2014;getting cortisol to the right place at the right time. Pharmacol Ther. 2016;166:128&#x2013;35. doi: 10.1016/j.pharmthera.2016.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2016.06.020</ArticleId><ArticleId IdType="pubmed">27411675</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway-Campbell B, Birnie M, Flynn B, Kershaw Y, Lightman S. Glucocorticoid pattern-dependent gene regulation in the rat hippocampus [abstract OC3.5]. In: Endocrine Abstracts. Vol. 38. Bristol, UK: BioScientifica; 2015. doi:10.1530/endoabs.38.OC3.5.</Citation></Reference><Reference><Citation>Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3:80&#x2013;97. doi: 10.1002/jrsm.1037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1037</ArticleId><ArticleId IdType="pubmed">26062083</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2000;376:1339&#x2013;46. doi: 10.1016/S0140-6736(10)60446-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60446-1</ArticleId><ArticleId IdType="pmc">PMC7136988</ArticleId><ArticleId IdType="pubmed">20934212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111&#x2013;24. doi: 10.1056/NEJMoa071366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa071366</ArticleId><ArticleId IdType="pubmed">18184957</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med. 1984;311:1137&#x2013;43. doi: 10.1056/NEJM198411013111801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198411013111801</ArticleId><ArticleId IdType="pubmed">6384785</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862&#x2013;71. doi: 10.1001/jama.288.7.862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.288.7.862</ArticleId><ArticleId IdType="pubmed">12186604</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ. 2010;182:1971&#x2013;7. doi: 10.1503/cmaj.090707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.090707</ArticleId><ArticleId IdType="pmc">PMC3001503</ArticleId><ArticleId IdType="pubmed">21059778</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998;26:645&#x2013;50. doi: 10.1097/00003246-199804000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199804000-00010</ArticleId><ArticleId IdType="pubmed">9559600</ArticleId></ArticleIdList></Reference><Reference><Citation>Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999;27:723&#x2013;32. doi: 10.1097/00003246-199904000-00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199904000-00025</ArticleId><ArticleId IdType="pubmed">10321661</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla K, Kupfer Y, Goldman I, Tessler S. Hydrocortisone reverses refractory septic shock [abstract] Crit Care Med. 1999;27(Suppl 1):33A. doi: 10.1097/00003246-199901001-00022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199901001-00022</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicarelli DD, Vieira JE, Bensenor FE. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J. 2007;125:237&#x2013;41. doi: 10.1590/S1516-31802007000400009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1516-31802007000400009</ArticleId><ArticleId IdType="pmc">PMC11020550</ArticleId><ArticleId IdType="pubmed">17992396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Li JG, Liang H, Zhou Q, Yu Z, Li L, et al. The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock [in Chinese] Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21:529&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">19751560</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, et al. The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency [in Chinese] Zhonghua Nei Ke Za Zhi. 2012;51:599&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">23158856</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131:954&#x2013;63. doi: 10.1378/chest.06-2100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.06-2100</ArticleId><ArticleId IdType="pubmed">17426195</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppert M, Schindler R, Husung C, Offermann K, Gr&#xe4;f KJ, Boenisch O, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33:2457&#x2013;64. doi: 10.1097/01.CCM.0000186370.78639.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000186370.78639.23</ArticleId><ArticleId IdType="pubmed">16276166</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi S, Adembri C, Grechi S, De Gaudio AR. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med. 2006;34:2334&#x2013;9. doi: 10.1097/01.CCM.0000233872.04706.BB.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000233872.04706.BB</ArticleId><ArticleId IdType="pubmed">16850006</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg. 1976;184:333&#x2013;41. doi: 10.1097/00000658-197609000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-197609000-00011</ArticleId><ArticleId IdType="pmc">PMC1344393</ArticleId><ArticleId IdType="pubmed">786190</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz O, Do&#x11f;anay M, Aygen B, G&#xfc;ven M, Kele&#x15f;timur F, Tutu&#x15f; A. Physiological-dose steroid therapy in sepsis [ISRCTN36253388] Crit Care. 2002;6:251&#x2013;9. doi: 10.1186/cc1498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc1498</ArticleId><ArticleId IdType="pmc">PMC125315</ArticleId><ArticleId IdType="pubmed">12133187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz O, Tanriverdi F, Simsek S, Aygen B, Kele&#x15f;timur F. The effects of moderate-dose steroid therapy in sepsis: a placebo-controlled, randomized study. J Res Med Sci. 2011;16:1410&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430057</ArticleId><ArticleId IdType="pubmed">22973341</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39605034</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>27</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Mortality in septic patients treated with short-acting betablockers: a comprehensive meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>392</StartPage><MedlinePgn>392</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">392</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-024-05174-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">Treatment with short-acting betablockers in septic patients remains controversial. Two recent large multicenter trials have provided additional evidence on this therapeutic approach. We thus performed a meta-analysis, including the most recent data, to evaluate the potential impacts of treatment with short-acting betablockers on mortality in adult septic patients.</AbstractText><AbstractText Label="METHODS">The data search included PubMed, Web of Science, ClinicalTrials.gov and the Cochrane Library. A meta-analysis of all eligible peer-reviewed studies was performed in accordance with the PRISMA statement. Only randomized, controlled studies with valid classifications of sepsis and intravenous treatment with short-acting betablockers (landiolol or esmolol) were included. Short-term mortality served as the primary endpoint. Secondary endpoints included effects on short-term mortality regarding patient age and cardiac rhythm.</AbstractText><AbstractText Label="RESULTS">A total of seven studies summarizing 854 patients fulfilled the predefined criteria and were included. Short-term mortality as well as pooled mortality (longest period of data on mortality) was not significantly impacted by treatment with short-acting betablockers when compared to the reference treatment (Risk difference, -&#x2009;0.10 [95% CI, -&#x2009;0.22 to 0.02]; p&#x2009;=&#x2009;0.11; p for Cochran's Q test&#x2009;=&#x2009;0.001; I<sup>2</sup>&#x2009;=&#x2009;73%). No difference was seen when comparing patients aged&#x2009;&lt;&#x2009;65 versus&#x2009;&#x2265;&#x2009;65&#xa0;years (p&#x2009;=&#x2009;0.11) or sinus tachycardia with atrial fibrillation (p&#x2009;=&#x2009;0.27). Despite statistical heterogeneity, no significant publication bias was observed.</AbstractText><AbstractText Label="CONCLUSION">Administration of short-acting betablockers did not reduce short-term mortality in septic patients with persistent tachycardia. Future studies should also provide extensive hemodynamic data to enable characterization of cardiac function before and during treatment.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alexandru</LastName><ForeName>Mihai-Gabriel</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Hospital of Bielefeld, Campus Bielefeld-Bethel, University of Bielefeld, Burgsteig 13, Haus Gilead I, 33617, Bielefeld, Germany. alexandrumihaig@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niewald</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Hospital of Bielefeld, Campus Bielefeld-Bethel, University of Bielefeld, Burgsteig 13, Haus Gilead I, 33617, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kr&#xfc;ger</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Hospital of Bielefeld, Campus Bielefeld-Bethel, University of Bielefeld, Burgsteig 13, Haus Gilead I, 33617, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borgstedt</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Hospital of Bielefeld, Campus Bielefeld-Bethel, University of Bielefeld, Burgsteig 13, Haus Gilead I, 33617, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitehouse</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Queen Elizabeth Hospital Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Mervyn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehberg</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Hospital of Bielefeld, Campus Bielefeld-Bethel, University of Bielefeld, Burgsteig 13, Haus Gilead I, 33617, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scholz</LastName><ForeName>Sean S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Hospital of Bielefeld, Campus Bielefeld-Bethel, University of Bielefeld, Burgsteig 13, Haus Gilead I, 33617, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>MDY902UXSR</RegistryNumber><NameOfSubstance UI="C036604">esmolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>62NWQ924LH</RegistryNumber><NameOfSubstance UI="C077049">landiolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011412">Propanolamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>8W8T17847W</RegistryNumber><NameOfSubstance UI="D014508">Urea</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="Y">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011412" MajorTopicYN="N">Propanolamines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014508" MajorTopicYN="N">Urea</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Betablocker</Keyword><Keyword MajorTopicYN="N">Esmolol</Keyword><Keyword MajorTopicYN="N">Landiolol</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>Declarations. Human ethics and consent to participate: Not applicable. Consent for publication: All authors have read and approved the submission of this manuscript. Competing interests: M.A., P.N., S.K., R.B., and S.S.S. report no competing interests. S. R. served as a speaker for AOP Health. T.W. was the Chief Investigator for STRESS&#x2010;L which was funded by the National Institute for Health Research (NIHR) Efficacy and Mechanism Evaluation (Project Number: EME&#x2010;14/150/85) and during the conduct of the study, he received personal fees and non&#x2010;financial support from AOP Orphan, manufacturer of landiolol. M.S. (or Institution) receives funding for studies, advisory board or speaker fees from the NIHR, Medical Research Council, AOP Pharma, Aptarion, Biomerieux, Biotest, deePull, Deltex Medical, Gentian, Matisse, Roche Diagnostics, Safeguard Biosystems, Volition. Singer is Sepsis Topic Advisor for NICE and sits on the council of the International Sepsis Forum.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>3</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39605034</ArticleId><ArticleId IdType="pmc">PMC11603935</ArticleId><ArticleId IdType="doi">10.1186/s13054-024-05174-w</ArticleId><ArticleId IdType="pii">10.1186/s13054-024-05174-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the Global Burden of Disease Study. The Lancet. 2020;395:200&#x2013;11. 10.1016/S0140-6736(19)32989-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and costs of sepsis in the united states&#x2014;an analysis based on timing of diagnosis and severity level*. Crit Care Med. 2018;46:1889&#x2013;97. 10.1097/CCM.0000000000003342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6250243</ArticleId><ArticleId IdType="pubmed">30048332</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J-L, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019;23:196. 10.1186/s13054-019-2478-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6545004</ArticleId><ArticleId IdType="pubmed">31151462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostel Z, Perl A, Marck M, Mehdi SF, Lowell B, Bathija S, et al. Post-sepsis syndrome&#x2014;an evolving entity that afflicts survivors of sepsis. Mol Med. 2020;26:6. 10.1186/s10020-019-0132-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6938630</ArticleId><ArticleId IdType="pubmed">31892321</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann C, Hartmann M, Hartog C, Welte T, Heublein S, Thomas-Rueddel D, et al. Epidemiology of sepsis in Germany: incidence, mortality and associated costs of care 2007&#x2013;2013. Intensive Care Med Exp. 2015;3:A50. 10.1186/2197-425X-3-S1-A50.</Citation></Reference><Reference><Citation>Lescroart M, Pequignot B, Kimmoun A, Klein T, Levy B. Beta-blockers in septic shock: What is new? J Intensive Med. 2022;2:150&#x2013;5. 10.1016/j.jointm.2022.01.004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923987</ArticleId><ArticleId IdType="pubmed">36789018</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz SS, Borgstedt R, Ebeling N, Menzel LC, Jansen G, Rehberg S. Mortality in septic patients treated with vitamin C: a systematic meta-analysis. Crit Care. 2021;25:17. 10.1186/s13054-020-03438-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787590</ArticleId><ArticleId IdType="pubmed">33407793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruning R, Dykes H, Jones TW, Wayne NB, Sikora Newsome A. Beta-adrenergic blockade in critical illness. Front Pharmacol. 2021. 10.3389/fphar.2021.735841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8554196</ArticleId><ArticleId IdType="pubmed">34721025</ArticleId></ArticleIdList></Reference><Reference><Citation>Belletti A, Landoni G, Lomivorotov VV, Oriani A, Ajello S. Adrenergic downregulation in critical care: molecular mechanisms and therapeutic evidence. J Cardiothorac Vasc Anesth. 2020;34:1023&#x2013;41. 10.1053/j.jvca.2019.10.017.</Citation><ArticleIdList><ArticleId IdType="pubmed">31839459</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehberg S, Joannidis M, Whitehouse T, Morelli A. Landiolol for managing atrial fibrillation in intensive care. Eur Heart J Suppl. 2018;20:A15&#x2013;8. 10.1093/eurheartj/sux039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5909768</ArticleId><ArticleId IdType="pubmed">30188960</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock. JAMA. 2013;310:1683. 10.1001/jama.2013.278477.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Wu Q, Nie X, Guo J, Yang C. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective. Randomized Trial Clin Drug Investig. 2015;35:707&#x2013;16. 10.1007/s40261-015-0325-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">26387030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, et al. Efficacy and safety of landiolol, an ultra-short-acting &#x3b2;1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med. 2020;8:863&#x2013;72. 10.1016/S2213-2600(20)30037-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243865</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehouse T, Hossain A, Perkins GD, Gordon AC, Bion J, Young D, et al. Landiolol and organ failure in patients with septic shock. JAMA. 2023;330:1641. 10.1001/jama.2023.20134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10600724</ArticleId><ArticleId IdType="pubmed">37877587</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehberg S, Frank S, &#x10c;ern&#xfd; V, Cihl&#xe1;&#x159; R, Borgstedt R, Biancofiore G, et al. Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med. 2024;50(10):1622&#x2013;34. 10.1007/s00134-024-07587-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11447033</ArticleId><ArticleId IdType="pubmed">39297945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gao X, He Z, Wang J, Xu G, Li T. Evaluating the effects of Esmolol on cardiac function in patients with Septic cardiomyopathy by Speck-tracking echocardiography&#x2014;a randomized controlled trial. BMC Anesthesiol. 2023;23:51. 10.1186/s12871-023-01983-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9912519</ArticleId><ArticleId IdType="pubmed">36765286</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocchi MN, Dargin J, Chase M, Patel PV, Grossestreuer A, Balaji L, et al. Esmolol to treat the hemodynamic effects of septic shock: a randomized controlled trial. Shock. 2022;57:508&#x2013;17. 10.1097/SHK.0000000000001905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10448435</ArticleId><ArticleId IdType="pubmed">35066509</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Liu Z, Yang W, Zhang G, Hou B, Liu J, et al. Effects of the &#x3b2;-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26:714&#x2013;7. 10.3760/cma.j.issn.2095-4352.2014.10.007.</Citation><ArticleIdList><ArticleId IdType="pubmed">25315942</ArticleId></ArticleIdList></Reference><Reference><Citation>Xinqiang L, Weiping H, Miaoyun W, Wenxin Z, Wenqiang J, Shenglong C, et al. Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27:759&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">26955704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Li M, Duan J, Yi L, Huang X, Chen D, et al. Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017;29:390&#x2013;5. 10.3760/cma.j.issn.2095-4352.2017.05.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">28524025</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Ding XF, Zhang SG, Wang HX, Luo YG, Duan XG, Liu SH, Zhang RF, Zhang XJ, Qin CH, Han B, Wang Y, Sun TW. Effect of esmolol in septic shock patients with tachycardia: a randomized clinical trial. Zhonghua Yi Xue Za Zhi. 2019;99(17):1317&#x2013;22. 10.3760/cma.j.issn.0376-2491.2019.17.009. (Chinese).</Citation><ArticleIdList><ArticleId IdType="pubmed">31091579</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W, Wang X-T, Long Y, Liu D-W. Efficacy and safety of esmolol in treatment of patients with septic shock. Chin Med J (Engl). 2016;129:1658&#x2013;65. 10.4103/0366-6999.185856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4960954</ArticleId><ArticleId IdType="pubmed">27411452</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko C, Gopal S. Systematic review of use of &#x3b2;-blockers in sepsis. J Anaesthesiol Clin Pharmacol. 2015;31:460. 10.4103/0970-9185.169063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4676233</ArticleId><ArticleId IdType="pubmed">26702201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F, Santonocito C, Morelli A, Foex P. Beta-blocker use in severe sepsis and septic shock: a systematic review. Curr Med Res Opin. 2015;31:1817&#x2013;25. 10.1185/03007995.2015.1062357.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121122</ArticleId></ArticleIdList></Reference><Reference><Citation>Heliste M, Pettil&#xe4; V, Berger D, Jakob SM, Wilkman E. Beta-blocker treatment in the critically ill: a systematic review and meta-analysis. Ann Med. 2022;54:1994&#x2013;2010. 10.1080/07853890.2022.2098376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9291706</ArticleId><ArticleId IdType="pubmed">35838226</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa D, Sato R, Prasitlumkum N, Nishida K, Takahashi K, Yatabe T, et al. Effect of ultrashort-acting &#x3b2;-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation. Chest. 2021;159:2289&#x2013;300. 10.1016/j.chest.2021.01.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">33434497</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger M, Morelli A, Singer M, Radermacher P, Rehberg S, Trimmel H, et al. Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial. Trials. 2018;19:637. 10.1186/s13063-018-3024-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6245811</ArticleId><ArticleId IdType="pubmed">30454042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall R, Mistry D, Skilton E, Boota N, Regan S, Bion J, et al. Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial. BMJ Open. 2021;11: e043194. 10.1136/bmjopen-2020-043194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7888319</ArticleId><ArticleId IdType="pubmed">33593781</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda N, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, et al. Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study. EClinicalMedicine. 2020;28: 100571. 10.1016/j.eclinm.2020.100571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7700908</ArticleId><ArticleId IdType="pubmed">33294804</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Donati A, Ertmer C, Rehberg S, Kampmeier T, Orecchioni A, et al. Microvascular effects of heart rate control with esmolol in patients with septic shock. Crit Care Med. 2013;41:2162&#x2013;8. 10.1097/CCM.0b013e31828a678d.</Citation><ArticleIdList><ArticleId IdType="pubmed">23873274</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantzarlis K, Vazgiourakis V, Makris D. Use of landiolol for patients with septic shock and organ failure. JAMA. 2024;331:705. 10.1001/jama.2023.27647.</Citation><ArticleIdList><ArticleId IdType="pubmed">38411653</ArticleId></ArticleIdList></Reference><Reference><Citation>Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2023;2024:149. 10.1161/CIR.0000000000001263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11095842</ArticleId><ArticleId IdType="pubmed">38033089</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrollahi-Shirazi S, Sucic S, Yang Q, Freissmuth M, Nanoff C. Comparison of the -adrenergic receptor antagonists landiolol and esmolol: receptor selectivity, partial agonism, and pharmacochaperoning actions. J Pharmacol Exp Ther. 2016;359:73&#x2013;81. 10.1124/jpet.116.232884.</Citation><ArticleIdList><ArticleId IdType="pubmed">27451411</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumpl G, Ulc I, Trebs M, Kadlecov&#xe1; P, Hodisch J. Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group. Eur J Clin Pharmacol. 2017;73:417&#x2013;28. 10.1007/s00228-016-2176-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">28091703</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#x2019;Heureux M, Sternberg M, Brath L, Turlington J, Kashiouris MG. Sepsis-induced cardiomyopathy: a comprehensive review. Curr Cardiol Rep. 2020;22:35. 10.1007/s11886-020-01277-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7222131</ArticleId><ArticleId IdType="pubmed">32377972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40439536</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>A Multinational Randomized Trial of Mega-Dose Esomeprazole as Anti-Inflammatory Agent in Sepsis.</ArticleTitle><Pagination><StartPage>e1554</StartPage><EndPage>e1566</EndPage><MedlinePgn>e1554-e1566</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000006720</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Proton pump inhibitors have dose-dependent immunomodulatory effects. We tested the hypothesis that mega-dose esomeprazole therapy would reduce organ dysfunction in patients with sepsis or septic shock.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A multinational, randomized, double-blind, placebo-controlled clinical trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Seventeen ICUs or emergency departments in three countries.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Adult patients with sepsis or septic shock.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Mega-dose (1024&#x2009;mg) esomeprazole or placebo over a 72-hour period.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The primary outcome was mean daily Sequential Organ Failure Assessment (SOFA) score to day 10. Secondary outcomes included antibiotics-free days, ICU-free days at day 28, and all-cause mortality. We also conducted a mechanistic study of the in vitro effects of esomeprazole in sepsis. We randomized 307 patients and assigned 148 to esomeprazole and 159 to placebo. Mean age was 71 years; 166 patients (54%) had septic shock and median SOFA score at randomization was 7. The median mean daily SOFA score in the first 10 days post-randomization was 5 (interquartile range [IQR], 3-9) in the esomeprazole group and 5 (IQR, 3-8) in the placebo group (risk difference, 0.1; 95% CI, -0.8 to 1.0; p &gt; 0.99). No differences were observed in secondary outcomes. Monocytes isolated from patients' peripheral blood and activated with a toll-like receptor agonist exhibited a pro-inflammatory phenotype, which was not affected by esomeprazole therapy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients with sepsis or septic shock, mega-dose esomeprazole did not reduce organ dysfunction or other patient-related or biological secondary outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carta</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UO Medicina Nucleare, IRCCS Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotani</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konkayeva</LastName><ForeName>Maiya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Astana Medical University, National Scientific Center of Traumatology and Orthopedics named after N. Batpenov, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anaesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yakovlev</LastName><ForeName>Aleksey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Resuscitation and Rehabilitation, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cucciolini</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shemetova</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>V. Negovsky Reanimatology Research Institute FRCC RR, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Moscow State Budgetary Healthcare Institution, "Moscow City Oncological Hospital No.1, Moscow Healthcare Department," Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scapol</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Momesso</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione, AULSS 4 Veneto Orientale, San Don&#xe0; di Piave (VE), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brizzi</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anaesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldassarri</LastName><ForeName>Rubia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anaesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajello</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isirdi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meroi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiardo Redaelli</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boffa</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione, AULSS 4 Veneto Orientale, San Don&#xe0; di Piave (VE), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Votta</LastName><ForeName>Carmine Domenico</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Department, Anesthesia and Intensive Care Unit, Maggiore Hospital, ASST Lodi, Lodi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borghi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montrucchio</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Intensive Care and Emergency, "Citt&#xe0; della Salute e della Scienza" Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauch</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Hospital of Merano (SABES-ASDAA), Merano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pace</LastName><ForeName>Maria Caterina</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Women, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Napoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, School of Medicine, University of Basilicata; Anaesthesia and ICU, San Calo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitale</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UO Medicina Nucleare, IRCCS Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giardina</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labanca</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marmiere</LastName><ForeName>Marilena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzaroli</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakhnoukh</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plumari</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scandroglio</LastName><ForeName>Anna Mara</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scquizzato</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sordoni</LastName><ForeName>Stella</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valsecchi</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Emergency Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agr&#xf2;</LastName><ForeName>Felice Eugenio</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finco</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine (DMED), University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corradi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>V. Negovsky Reanimatology Research Institute FRCC RR, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konkayev</LastName><ForeName>Aidos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Astana Medical University, National Scientific Center of Traumatology and Orthopedics named after N. Batpenov, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8594-5980</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PPI-SEPSIS Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03452865</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>N3PA6559FT</RegistryNumber><NameOfSubstance UI="D064098">Esomeprazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054328">Proton Pump Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064098" MajorTopicYN="Y">Esomeprazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054328" MajorTopicYN="Y">Proton Pump Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="Y">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">esomeprazole</Keyword><Keyword MajorTopicYN="N">proton pump inhibitors</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList><CoiStatement>Dr. Guarracino received funding from Abbott, Chiesi, Edwards, Masimo, Orion, Orphan, Viatris, and Vygon. Drs. Isirdi, Meroi, Corradi, and Bellomo disclosed off-label use of Esomeprazole. Drs. Borghi&#x2019;s, Marmiere&#x2019;s, and Landoni&#x2019;s institutions received funding from the Italian Ministry of Health. Dr. Montrucchio received funding from 3M and Thermofisher. Dr. Vitale received support for article research from the National Institutes of Health. Drs. Marmiere and Landoni received support for article research from the Italian Ministry of Health. Dr. Sordoni received support for article research from the Italian Ministry of Health (Progetto di Ricerca Finalizzata Ordinaria, GR-2016- 02363630). The remaining authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nuzzi</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oriani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Panozzo</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pasculli</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pieri</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pontillo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ortalda</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sacchi</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pazzanese</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Peveri</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Furlan</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pruna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sgobba</LastName><ForeName>Stefano Pietro</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Maltese</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Neri</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Anesthesia and ICU, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Corea</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and ICU, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bosco</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anesthesia and ICU, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bertini</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Doroni</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Villano</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Taddei</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Taddei</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bologna</LastName><ForeName>Maria Lidia</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brizzi</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Orso</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale [ASUFC], Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sartori</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale [ASUFC], Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brussa</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale [ASUFC], Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Guarino</LastName><ForeName>Maria Carmen</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione, AULSS 4 Veneto Orientale, San Don&#xe0; di Piave [VE], Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Salvini</LastName><ForeName>Adelasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione, AULSS 4 Veneto Orientale, San Don&#xe0; di Piave [VE], Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kadantseva</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>V. Negovsky Reanimatology Research Institute FRCC RR, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Redkin</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Center of Resuscitation and Rehabilitation, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Banova</LastName><ForeName>Zhanna</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Moscow State Budgetary Healthcare Institution, "Moscow City Oncological Hospital No.1, Moscow Healthcare Department," Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Formicola</LastName><ForeName>Giuseppe Luca</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Department, Anaesthesia and Intensive Care Unit, Maggiore Hospital, ASST Lodi, Lodi, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Cesaris</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Emergency, "Citt&#xe0; della Salute e della Scienza" Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mattei</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Seraglio</LastName><ForeName>Paolo Mario Enrico</ForeName><Initials>PME</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Hospital of Merano [SABES-ASDAA], Merano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Leggieri</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Hospital of Merano [SABES-ASDAA], Merano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kadralinova</LastName><ForeName>Asiya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Astana Medical University, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zhanarystan</LastName><ForeName>Nazerke</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Astana Medical University, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abdirakhym</LastName><ForeName>Gaziza</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Astana Medical University, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sardo</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pota</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universit&#xe0; della Campania "Luigi Vanvitelli," Napoli, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vignale</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Anesthesia and ICU, San Calo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Greco</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ajello</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and Intensive Care, Hospital Tor Vergata Roma, Rome, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Benedetto</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>University of G. d'Annunzio Chieti and Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>D'Ascenzo</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Turin, Turin, Italy; Citt&#xe0; Della Salute e Della Scienza Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yavorovsky</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IM Sechenov First Moscow State Medical University, Ministry of Public Health of Russia, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>13</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40439536</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000006720</ArticleId><ArticleId IdType="pii">00003246-990000000-00532</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al.: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801&#x2013;810</Citation></Reference><Reference><Citation>Fleischmann-Struzek C, Mellhammar L, Rose N, et al.: Incidence and mortality of hospital- and ICU-treated sepsis: Results from an updated and expanded systematic review and meta-analysis. Intensive Care Med 2020; 46:1552&#x2013;1562</Citation></Reference><Reference><Citation>Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369:840&#x2013;851</Citation></Reference><Reference><Citation>Chousterman BG, Swirski FK, Weber GF: Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol 2017; 39:517&#x2013;528</Citation></Reference><Reference><Citation>Neumann I, Letelier LM, Rada G, et al.: Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2013; 2013:CD007999</Citation></Reference><Reference><Citation>Strand DS, Kim D, Peura DA: 25 years of proton pump inhibitors: A comprehensive review. Gut Liver 2017; 11:27&#x2013;37</Citation></Reference><Reference><Citation>Sachs G, Shin JM, Howden CW: Review article: The clinical pharmacology of proton pump inhibitors. Aliment Pharmacol Ther 2006; 23:2&#x2013;8</Citation></Reference><Reference><Citation>Chopra YM, Choundary J, Justice R : Pharmacology/Toxicology Review and Evaluation: NDA 21-689. U.S. Food and Drug Administration. 2004. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021689s000_PharmR.pdf . Accessed November 1, 2024</Citation></Reference><Reference><Citation>Parikh N, Howden CW: The safety of drugs used in acid-related disorders and functional gastrointestinal disorders. Gastroenterol Clin North Am 2010; 39:529&#x2013;542</Citation></Reference><Reference><Citation>Garc&#xed;a Rodr&#xed;guez LA, Ruig&#xf3;mez A, Pan&#xe9;s J: Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol 2007; 5:1418&#x2013;1423</Citation></Reference><Reference><Citation>Norgard NB, Mathews KD, Wall GC: Drug&#x2013;drug interaction between clopidogrel and the proton pump inhibitors. Ann Pharmacother 2009; 43:1266&#x2013;1274</Citation></Reference><Reference><Citation>Laine L, Hennekens C: Proton pump inhibitor and clopidogrel interaction: Fact or fiction? Am J Gastroenterol 2010; 105:34&#x2013;41</Citation></Reference><Reference><Citation>Wolfe MM, Sachs G: Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 2000; 118:S9&#x2013;31</Citation></Reference><Reference><Citation>Barkun AN, Almadi M, Kuipers EJ, et al.: Management of nonvariceal upper gastrointestinal bleeding: Guideline recommendations from the International Consensus Group. Ann Intern Med 2019; 171:805&#x2013;822</Citation></Reference><Reference><Citation>Balza E, Piccioli P, Carta S, et al.: Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance. Cell Death Dis 2016; 7:e2304&#x2013;e2304</Citation></Reference><Reference><Citation>Monti G, Konkayev A, Carta S, et al.; Collaborators: High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial. Contemp Clin Trials 2023; 133:107319</Citation></Reference><Reference><Citation>Bi&#xe7;ak&#xe7;i U, Tander B, Arit&#xfc;rk E, et al.: Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/reoxygenation induced intestinal injury in newborn rats. Pediatr Surg Int 2005; 21:800&#x2013;805</Citation></Reference><Reference><Citation>Kotsuka M, Hashimoto Y, Nakatake R, et al.: Omeprazole increases survival through the inhibition of inflammatory mediaters in two rat sepsis models. Shock 2022; 57:444&#x2013;456</Citation></Reference><Reference><Citation>Evans CE, Peng Y, Zhu MM, et al.: Rabeprazole promotes vascular repair and resolution of sepsis-induced inflammatory lung injury through HIF-1&#x3b1;. Cells 2022; 11:1425</Citation></Reference><Reference><Citation>Le Gall J-R, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957&#x2013;2963</Citation></Reference><Reference><Citation>Levy MM, Evans LE, Rhodes A: The Surviving Sepsis Campaign bundle: 2018 update. Intensive Care Med 2018; 44:925&#x2013;928</Citation></Reference><Reference><Citation>International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH harmonized tripartite guideline: Guideline for good clinical practice. J Postgrad Med 2001; 47:45&#x2013;50</Citation></Reference><Reference><Citation>Gordon AC, Perkins GD, Singer M, et al.: Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 2016; 375:1638&#x2013;1648</Citation></Reference><Reference><Citation>Ferreira FL, Bota DP, Bross A, et al.: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754&#x2013;1758</Citation></Reference><Reference><Citation>De Milito A, Canese R, Marino ML, et al.: pH&#x2010;dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 2010; 127:207&#x2013;219</Citation></Reference><Reference><Citation>de Grooth H-J, Geenen IL, Girbes AR, et al.: SOFA and mortality endpoints in randomized controlled trials: A systematic review and meta-regression analysis. Crit Care 2017; 21:38</Citation></Reference><Reference><Citation>Thabane L, Mbuagbaw L, Zhang S, et al.: A tutorial on sensitivity analyses in clinical trials: The what, why, when and how. BMC Med Res Methodol 2013; 13:92</Citation></Reference><Reference><Citation>Reilly JP: Safety profile of the proton-pump inhibitors. Am J Health Syst Pharm 1999; 56:S11&#x2013;S17</Citation></Reference><Reference><Citation>Cavaillon J, Singer M, Skirecki T: Sepsis therapies: Learning from 30 years of failure of translational research to propose new leads. EMBO Mol Med 2020; 12:e10128</Citation></Reference><Reference><Citation>Steger-Hartmann T, Raschke M: Translating in vitro to in vivo and animal to human. Curr Opin Toxicol 2020; 23&#x2013;24:6&#x2013;10</Citation></Reference><Reference><Citation>Mak IW, Evaniew N, Ghert M: Lost in translation: Animal models and clinical trials in cancer treatment. Am J Transl Res 2014; 6:114&#x2013;118</Citation></Reference><Reference><Citation>Leenaars CHC, Kouwenaar C, Stafleu FR, et al.: Animal to human translation: A systematic scoping review of reported concordance rates. J Transl Med 2019; 17:223</Citation></Reference><Reference><Citation>Zschaler J, Schlorke D, Arnhold J: Differences in innate immune response between man and mouse. Crit Rev Immunol 2014; 34:433&#x2013;454</Citation></Reference><Reference><Citation>Baillie TA, Rettie AE: Role of biotransformation in drug-induced toxicity: Influence of intra- and inter-species differences in drug metabolism. Drug Metab Pharmacokinet 2011; 26:15&#x2013;29</Citation></Reference><Reference><Citation>Wang N, Lu Y, Zheng J, et al.: Of mice and men: Laboratory murine models for recapitulating the immunosuppression of human sepsis. Front Immunol 2022; 13:956448</Citation></Reference><Reference><Citation>Arrazuria R, Kerscher B, Huber KE, et al.: Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents. Front Microbiol 2022; 13:988728</Citation></Reference><Reference><Citation>Roberts JA, Abdul-Aziz M-H, Davis JS, et al.: Continuous versus intermittent &#x3b2;-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med 2016; 194:681&#x2013;691</Citation></Reference><Reference><Citation>Kayambankadzanja RK, Schell CO, Gerdin W&#xe4;rnberg M, et al.: Towards definitions of critical illness and critical care using concept analysis. BMJ Open 2022; 12:e060972</Citation></Reference><Reference><Citation>Rice TW, Wheeler AP, Bernard GR, et al.: A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 2010; 38:1685&#x2013;1694</Citation></Reference><Reference><Citation>Zygun DA, Laupland KB, Fick GH, et al.: Neuroanesthesia and intensive care limited ability of SOFA and MOD scores to discriminate outcome: A prospective evaluation in 1,436 patients. Can J Anaesth 2005; 52:302&#x2013;308</Citation></Reference><Reference><Citation>Marmiere M, D&#x2019;Amico F, Monti G, et al.: Mastering the Sequential Organ Failure Assessment score: Critical choices of score statistic, timing, imputations, and competing risk handling in major trials&#x2014;a systematic review. Crit Care Med 2024; 53:e1116&#x2013;e1124</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40307943</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2052-0492</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of intensive care</Title><ISOAbbreviation>J Intensive Care</ISOAbbreviation></Journal><ArticleTitle>One-year outcomes in sepsis: a prospective multicenter cohort study in Japan.</ArticleTitle><Pagination><StartPage>23</StartPage><MedlinePgn>23</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40560-025-00792-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sepsis is a leading cause of death in intensive care units (ICU). Sepsis survivors are often left with significant morbidity, termed post-intensive care syndrome (PICS), impacting post-sepsis life. The aim was to present detailed data on the prognostic and functional long-term outcomes of ICU patients with sepsis in Japan, which is currently lacking and therefore prevents development of targeted solutions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multicenter prospective study, involving 21 ICUs in 20 tertiary hospitals in Japan, included all consecutive adult ICU patients between November 2020 and April 2022, and diagnosed with sepsis at ICU admission (Sepsis 3). Follow-ups were performed at 3, 6, and 12&#xa0;months after hospital discharge by telephone and mail. Primary outcome was death or incidence of PICS, defined by any of physical dysfunction (Barthel Index&#x2009;&#x2264;&#x2009;90), cognitive dysfunction (Short Memory Questionnaire&#x2009;&lt;&#x2009;40), or mental disorder (any subscales for anxiety or depression of Hospital Anxiety and Depression Scale&#x2009;&#x2265;&#x2009;8, or Impact of Event Scale-Revised&#x2009;&#x2265;&#x2009;25). Secondary outcomes included Quality of Life (QOL), employment, and use of hospital, emergency, rehabilitation, and psychiatric services. A multivariable analysis investigated independent factors associated with each dysfunction at each follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 339 patients were included (median age 74 [67-82] years, 60% male, 77% septic shock, and a median SOFA of 9 [6-12]). Mortality was 23% at hospital discharge, increasing to 37% at 12&#xa0;months. The rate of death for those who met PICS Criteria at hospital discharge was 89%, with a death or PICS incidence of 73%, 64%, and 65% at 3, 6, and 12&#xa0;months, respectively. Limited improvements in QOL and return to work (44%), high rates of hospital readmissions (40%), frequent emergency service usage (31%), and low utilization of rehabilitation and psychiatric services (15% and 7%) were identified over the first year. The incidence of any PICS-related dysfunction was consistently an independent factor for the incidence of the same dysfunction at the following follow-ups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This multicenter study identified the distinct realities of post-sepsis life in Japanese ICU patients, highlighting the unique challenges in improving their functions and returning to daily life. Trial Registration University Hospital Medical Information Network UMIN000041433.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Keibun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Non-Profit Organization ICU Collaboration Network (ICON), Tokyo, Japan. keiliu0406@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>, 2-15-13 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan. keiliu0406@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Watanabe</LastName><ForeName>Shinichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Gifu University of Health Science, Gifu, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Kensuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Yokohama City University Hospital, 3-9, Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, 236-0004, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Hitachi General Hospital, Hitachi, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Hidehiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Hitachi General Hospital, Hitachi, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motoki</LastName><ForeName>Maiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Hitachi General Hospital, Hitachi, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamijo</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Shinshu University School of Medicine, Nagano, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayaka</LastName><ForeName>Matsuoka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine Faculty, Saga University Hospital, Saga, Saga, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishii</LastName><ForeName>Kenzo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Unit, Fukuyama City Hospital, Fukuyama, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Yasunari</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Intensive Care Medicine, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hongo</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-Cho, Okayama Kita-Ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency, Okayama Saiseikai General Hospital, 2-25 Kokutaityo, Okayama Kita-Ku, Okayama, 700-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimojo</LastName><ForeName>Nobutake</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Yukiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency, Tsukuba Medical Center Hospital, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanazawa</LastName><ForeName>Manabu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Japan Red Cross Narita Hospital, Narita, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamagami</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tajima Emergency &amp; Critical Care Medical Center, Toyooka Public Hospital, Toyooka, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oike</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasugai</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakuda</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Okinawa Kyodo Hospital, Naha, Okinawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irie</LastName><ForeName>Yuhei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Fukuoka University Hospital, Fukuoka, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitta</LastName><ForeName>Masakazu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Niigata University Medical and Dental Hospital, Niigata, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akieda</LastName><ForeName>Kazuki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, SUBARU Health Insurance Society Ota Memorial Hospital, Ota, Gunma, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimakura</LastName><ForeName>Daigo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Graduate School of Data Science, Shiga University, Shiga, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsukawa</LastName><ForeName>Hajime</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Japanese Society for Early Mobilization, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotani</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Showa Medical University, Shinagawa, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McWilliams</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Care Excellence, Coventry University, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Care, University Hospitals Coventry &amp; Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nydahl</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nursing Research, University Hospital Schleswig-Holstein, Kiel, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Nursing Science and Development, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaller</LastName><ForeName>Stefan J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Clinical Division of General Anesthesia and Intensive Care Medicine, Medical University of Vienna, Wien, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charit&#xe9; - Universit&#xe4;tsmedizin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogura</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine and Critical Care Medicine, Tochigi Prefectural Emergency and Critical Care Center, Saiseikai Utsunomiya Hospital, Utsunomiya, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ILOSS Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019-03</GrantID><Agency>the Japanese Association for Acute Medicine</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Intensive Care</MedlineTA><NlmUniqueID>101627304</NlmUniqueID><ISSNLinking>2052-0492</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Intensive Care. 2025 May 22;13(1):28. doi: 10.1186/s40560-025-00799-7.</RefSource><PMID Version="1">40405308</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Morbidity</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Post-intensive care syndrome</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study received ethics approvals from Saiseikai Utsunomiya Hospital (2020&#x2013;42) and all other participating institutions. It was registered in the University Hospital Medical Information Network Clinical Trials Registry (Trial registration number: UMIN 000041433), and informed consent was obtained from all patients. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>23</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40307943</ArticleId><ArticleId IdType="pmc">PMC12044722</ArticleId><ArticleId IdType="doi">10.1186/s40560-025-00792-0</ArticleId><ArticleId IdType="pii">10.1186/s40560-025-00792-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">23984731</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer NJ, Prescott HC. Sepsis and septic shock. N Engl J Med. 2024;391:2133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">39774315</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the global burden of disease study. Lancet. 2020;395:200&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen K-M, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x2013;2012. JAMA. 2014;311:1308&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Rubenfeld GD. Understanding long-term outcomes following sepsis: implications and challenges. Curr Infect Dis Rep. 2016;18:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5052282</ArticleId><ArticleId IdType="pubmed">27709504</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue S, Nakanishi N, Amaya F, Fujinami Y, Hatakeyama J, Hifumi T, et al. Post-intensive care syndrome: recent advances and future directions. Acute Med Surg. 2024;11: e929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10879727</ArticleId><ArticleId IdType="pubmed">38385144</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey MA, Davidson JE. Postintensive care syndrome: right care, right now&#x2026;and later. Crit Care Med. 2016;44:381&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">26771784</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai SV, Law TJ, Needham DM. Long-term complications of critical care. Crit Care Med. 2011;39:371&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20959786</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuthbertson BH, Elders A, Hall S, Taylor J, MacLennan G, Mackirdy F, et al. Mortality and quality of life in the five years after severe sepsis. Crit Care. 2013;17:R70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057306</ArticleId><ArticleId IdType="pubmed">23587132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurematsu K, Ikematsu Y. Quality of life of sepsis survivors. Crit Care Med. 2023;51:1339&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">37314395</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Klompas M. Sepsis trends: increasing incidence and decreasing mortality, or changing denominator? J Thorac Dis. 2020;12:S89-100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7024753</ArticleId><ArticleId IdType="pubmed">32148931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Born S, Kesselmeier M, Ely EW, T&#xf6;pfer K, Romeike H, et al. Functional dependence following intensive care unit-treated sepsis: three-year follow-up results from the prospective Mid-German Sepsis Cohort (MSC). Lancet Reg Health Eur. 2024;46: 101066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11415812</ArticleId><ArticleId IdType="pubmed">39308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson CL, Higgins AM, Bailey M, Barrett J, Bellomo R, Cooper DJ, et al. Comparison of 6-month outcomes of sepsis versus non-sepsis critically ill patients receiving mechanical ventilation. Crit Care. 2022;26:174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189265</ArticleId><ArticleId IdType="pubmed">35698201</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaeda T, Nakada T-A, Takahashi N, Yamao Y, Nakagawa S, Ogura H, et al. Trends in the incidence and outcome of sepsis using data from a Japanese nationwide medical claims database-the Japan Sepsis Alliance (JaSA) study group. Crit Care. 2021;25:338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444487</ArticleId><ArticleId IdType="pubmed">34530884</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno RR, Wernly B, Mamandipoor B, Rezar R, Binneb&#xf6;ssel S, Baldia PH, et al. ICU-mortality in old and very old patients suffering from sepsis and septic shock. Front Med (Lausanne). 2021;8: 697884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8299710</ArticleId><ArticleId IdType="pubmed">34307423</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe T, Araujo KLB, Van Ness PH, Pisani MA, Juthani-Mehta M. Outcomes of older adults with sepsis at admission to an intensive care unit. Open Forum Infect Dis. 2016;3:ofw010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4766385</ArticleId><ArticleId IdType="pubmed">26925430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotfis K, Wittebole X, Jaschinski U, Sol&#xe9;-Viol&#xe1;n J, Kashyap R, Leone M, et al. A worldwide perspective of sepsis epidemiology and survival according to age: observational data from the ICON audit. J Crit Care. 2019;51:122&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30802758</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J Intensiv Care Med. 2021;9:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384927</ArticleId><ArticleId IdType="pubmed">34433491</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Kotani T, Nakamura K, Chihiro T, Morita Y, Ishii K, et al. Effects of evidence-based ICU care on long-term outcomes of patients with sepsis or septic shock (ILOSS): protocol for a multicentre prospective observational cohort study in Japan. BMJ Open. 2022;12: e054478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8961143</ArticleId><ArticleId IdType="pubmed">35351710</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin JW, Skrobik Y, G&#xe9;linas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">30113379</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">34991091</ArticleId></ArticleIdList></Reference><Reference><Citation>Church S, Rogers E, Rockwood K, Theou O. A scoping review of the Clinical Frailty Scale. BMC Geriatr. 2020;20:393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540438</ArticleId><ArticleId IdType="pubmed">33028215</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure on behalf of the working group on sepsis-related problems of the european society of intensive care medicine. Intensiv Care Med. 1996;22:707&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson CL, Higgins AM, Bailey MJ, Anderson S, Bernard S, Fulcher BJ, et al. Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study. Lancet Respir Med. 2022;10:1038&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">36174613</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi N, Liu K, Kawauchi A, Okamura M, Tanaka K, Katayama S, et al. Instruments to assess post-intensive care syndrome assessment: a scoping review and modified Delphi method study. Crit Care. 2023;27:430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10629074</ArticleId><ArticleId IdType="pubmed">37936249</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami D, Fujitani S, Morimoto T, Dote H, Takita M, Takaba A, et al. Prevalence of post-intensive care syndrome among Japanese intensive care unit patients: a prospective, multicenter, observational J-PICS study. Crit Care. 2021;25:69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7888178</ArticleId><ArticleId IdType="pubmed">33593406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatakeyama J, Inoue S, Liu K, Yamakawa K, Nishida T, Ohshimo S, et al. Prevalence and risk factor analysis of post-intensive care syndrome in patients with COVID-19 requiring mechanical ventilation: a multicenter prospective observational study. J Clin Med Res. 2022;11:5758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9571505</ArticleId><ArticleId IdType="pubmed">36233627</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Asukai N, Kato H, Kawamura N, Kim Y, Yamamoto K, Kishimoto J, et al. Reliability and validity of the Japanese-language version of the impact of event scale-revised (IES-R-J): four studies of different traumatic events. J Nerv Ment Dis. 2002;190:175&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11923652</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, et al. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25:707&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4759213</ArticleId><ArticleId IdType="pubmed">26303761</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Ando K, Kobayashi K, Seki T, Hamada T, Machino M, et al. Association between locomotive syndrome and the Japanese version of the EQ-5D-5L in middle-aged and elderly people in Japan. Nagoya J Med Sci. 2020;82:5&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7103873</ArticleId><ArticleId IdType="pubmed">32273627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatakeyama J, Nakamura K, Inoue S, Liu K, Yamakawa K, Nishida T, et al. Two-year trajectory of functional recovery and quality of life in post-intensive care syndrome: a multicenter prospective observational study on mechanically ventilated patients with coronavirus disease-19. J Intensiv Care. 2025;13:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11800417</ArticleId><ArticleId IdType="pubmed">39915821</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Ogura T, Takahashi K, Nakamura M, Ohtake H, Fujiduka K, et al. A Progressive early mobilization program is significantly associated with clinical and economic improvement: a single-center quality comparison study. Crit Care Med. 2019;47:e744&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">31162197</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Tronstad O, Flaws D, Churchill L, Jones AYM, Nakamura K, et al. From bedside to recovery: exercise therapy for prevention of post-intensive care syndrome. J Intensiv Care Med. 2024;12:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10902959</ArticleId><ArticleId IdType="pubmed">38424645</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesina RS Jr, Rust&#xf8;en T, Hagen M, Laake JH, Hofs&#xf8; K. Long-term functional disabilities in intensive care unit survivors: a prospective cohort study. Aust Crit Care. 2024;37:843&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">38171986</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, Liu K, Nakamura K, Kozu R, Horibe T, Ishii K, et al. Association between early mobilization in the ICU and psychiatric symptoms after surviving a critical illness: a multi-center prospective cohort study. J Clin Med Res. 2022;11:2587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9099642</ArticleId><ArticleId IdType="pubmed">35566716</ArticleId></ArticleIdList></Reference><Reference><Citation>Maley JH, Sandsmark DK, Trainor A, Bass GD, Dabrowski CL, Magdamo BA, et al. Six-month impairment in cognition, mental health, and physical function following COVID-19-associated respiratory failure. Crit Care Explor. 2022;4: e0673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963828</ArticleId><ArticleId IdType="pubmed">35372848</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Nakashima T, Goto T, Nakamura K, Nakano H, Motoki M, et al. Phenotypes of functional decline or recovery in sepsis ICU survivors: Insights from a 1-year follow-up multicenter cohort analysis. Crit Care Med. 2025. 10.1097/CCM.0000000000006621.</Citation><ArticleIdList><ArticleId IdType="pubmed">39992173</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe D, Yoshida T, Watanabe Y, Yamada Y, Kimura M. Is a higher body mass index associated with longer duration of survival with disability in frail than in non-frail older adults? Int J Obes (Lond). 2025;49:348&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11805705</ArticleId><ArticleId IdType="pubmed">39548219</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter JE, MacInnis RJ, Wattanapenpaiboon N, Nowson CA. BMI and all-cause mortality in older adults: a meta-analysis. Am J Clin Nutr. 2014;99:875&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">24452240</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley C, Thompson C, Hakendorf P, Horwood C. The effect of age upon the interrelationship of BMI and inpatient health outcomes. J Nutr Health Aging. 2019;23:558&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">31233078</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">16374151</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Loeches I, Guia MC, Vallecoccia MS, Suarez D, Ibarz M, Irazabal M, et al. Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study. Ann Intensive Care. 2019;9:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6362175</ArticleId><ArticleId IdType="pubmed">30715638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak H, Beckmann TS, Dos Santos RA, Pugin J, Heidegger C-P, Cereghetti S. Long-stay ICU patients with frailty: mortality and recovery outcomes at 6 months. Ann Intensiv Care. 2024;14:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10894177</ArticleId><ArticleId IdType="pubmed">38401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Kudo D, Kushimoto S, Hasegawa M, Ito F, Yamanouchi S, et al. Associations between low body mass index and mortality in patients with sepsis: A retrospective analysis of a cohort study in Japan. PLoS ONE. 2021;16: e0252955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186780</ArticleId><ArticleId IdType="pubmed">34101752</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RC, Wang Z. Precision medicine: disease subtyping and tailored treatment. Cancers. 2023;15:3837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10417651</ArticleId><ArticleId IdType="pubmed">37568653</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa DK, White MR, Ginier E, Manojlovich M, Govindan S, Iwashyna TJ, et al. Identifying barriers to delivering the awakening and breathing coordination, delirium, and early exercise/mobility bundle to minimize adverse outcomes for mechanically ventilated patients: a systematic review. Chest. 2017;152:304&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554074</ArticleId><ArticleId IdType="pubmed">28438605</ArticleId></ArticleIdList></Reference><Reference><Citation>Alowais SA, Alghamdi SS, Alsuhebany N, Alqahtani T, Alshaya AI, Almohareb SN, et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med Educ. 2023;23:689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10517477</ArticleId><ArticleId IdType="pubmed">37740191</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannan Panday RS, Minderhoud TC, Chantalou DS, Alam N, Nanayakkara PWB. Health related quality of life in sepsis survivors from the prehospital antibiotics against sepsis (PHANTASi) trial. PLoS ONE. 2019;14: e0222450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772145</ArticleId><ArticleId IdType="pubmed">31574094</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam N, Nannan Panday RS, Heijnen JR, van Galen LS, Kramer MHH, Nanayakkara PWB. Long-term health related quality of life in patients with sepsis after intensive care stay: a systematic review. Acute Med. 2017;16:164&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29300794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xe6;r M-BN, Bruun CRL, Granholm A, M&#xf8;ller MH, Rasmussen BS, Mortensen CB, et al. A core outcome set for adult general ICU patients. Crit Care Med. 2025;53:e575-89.</Citation><ArticleIdList><ArticleId IdType="pubmed">40036020</ArticleId></ArticleIdList></Reference><Reference><Citation>Unoki T, Kitayama M, Sakuramoto H, Ouchi A, Kuribara T, Yamaguchi T, et al. Employment status and its associated factors for patients 12 months after intensive care: Secondary analysis of the SMAP-HoPe study. PLoS ONE. 2022;17: e0263441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8932587</ArticleId><ArticleId IdType="pubmed">35302991</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheu C-C, Gong MN, Zhai R, Chen F, Bajwa EK, Clardy PF, et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest. 2010;138:559&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2940067</ArticleId><ArticleId IdType="pubmed">20507948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatakeyama J, Nakamura K, Sumita H, Kawakami D, Nakanishi N, Kashiwagi S, et al. Intensive care unit follow-up clinic activities: a scoping review. J Anesth. 2024;38:542&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">38652320</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi N, Liu K, Hatakeyama J, Kawauchi A, Yoshida M, Sumita H, et al. Post-intensive care syndrome follow-up system after hospital discharge: a narrative review. J Intensiv Care Med. 2024;12:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10785368</ArticleId><ArticleId IdType="pubmed">38217059</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirasaki K, Hifumi T, Nakanishi N, Nosaka N, Miyamoto K, Komachi MH, et al. Postintensive care syndrome family: a comprehensive review. Acute Med Surg. 2024;11: e939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10928249</ArticleId><ArticleId IdType="pubmed">38476451</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue S, Hatakeyama J, Kondo Y, Hifumi T, Sakuramoto H, Kawasaki T, et al. Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg. 2019;6:233&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6603316</ArticleId><ArticleId IdType="pubmed">31304024</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielis M, Movio F, Milanese G, Mattiussi E. Patients&#x2019; reports on their delusional memories from the intensive care unit: a systematic review of qualitative studies. Intensiv Crit Care Nurs. 2024;81: 103617.</Citation><ArticleIdList><ArticleId IdType="pubmed">38176133</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda T, Watanabe N, Sakaki K, Monna Y, Terachi S, Miyazaki S, et al. Identifying cues of distorted memories in intensive care by focus group interview of nurses. Nurs Open. 2022;9:666&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8685829</ArticleId><ArticleId IdType="pubmed">34719130</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaeda T, Oami T, Takahashi N, Saito D, Higashi A, Nakada T-A. Epidemiology of sepsis in a Japanese administrative database. Acute Med Surg. 2023;10: e890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10570497</ArticleId><ArticleId IdType="pubmed">37841963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogura H, Gando S, Saitoh D, Takeyama N, Kushimoto S, Fujishima S, et al. Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother. 2014;20:157&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">24530102</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32695992</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2639-8028</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Critical care explorations</Title><ISOAbbreviation>Crit Care Explor</ISOAbbreviation></Journal><ArticleTitle>Pediatric Sepsis Definition-A Systematic Review Protocol by the Pediatric Sepsis Definition Taskforce.</ArticleTitle><Pagination><StartPage>e0123</StartPage><MedlinePgn>e0123</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0123</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCE.0000000000000123</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Sepsis is responsible for a substantial proportion of global childhood morbidity and mortality. However, evidence demonstrates major inaccuracies in the use of the term "sepsis" in clinical practice, coding, and research. Current and previous definitions of sepsis have been developed using expert consensus but the specific criteria used to identify children with sepsis have not been rigorously evaluated. Therefore, as part of the Society of Critical Care Medicine's Pediatric Sepsis Definition Taskforce, we will conduct a systematic review to synthesize evidence on individual factors, clinical criteria, or illness severity scores that may be used to identify children with infection who have or are at high risk of developing sepsis-associated organ dysfunction and separately those factors, criteria, and scores that may be used to identify children with sepsis who are at high risk of progressing to multiple organ dysfunction or death.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">We will identify eligible studies by searching the following databases: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">We will include all randomized trials and cohort studies published between January 1, 2004, and March 16, 2020.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Data extraction will include information related to study characteristics, population characteristics, clinical criteria, and outcomes.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">We will calculate sensitivity and specificity of each criterion for predicting sepsis and conduct a meta-analysis if the data allow. We will also provide pooled estimates of overall hospital mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The potential risk factors, clinical criteria, and illness severity scores from this review which identify patients with infection who are at high risk of developing sepsis-associated organ dysfunction and/or progressing to multiple organ dysfunction or death will be used to inform the next steps of the Pediatric Sepsis Definition Taskforce.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Menon</LastName><ForeName>Kusum</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlapbach</LastName><ForeName>Luregn J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Paediatric Critical Care Research Group, Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric ICU, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akech</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>KEMRI Wellcome Trust Research Program, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argent</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiotos</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chisti</LastName><ForeName>Mohammod Jobayer</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamid</LastName><ForeName>Jemila</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishimine</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of California San Diego, San Diego, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kissoon</LastName><ForeName>Niranjan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, British Columbia Children's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lodha</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Cl&#xe1;udio Flauzino</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Associa&#xe7;&#xe3;o de Medicina Intensiva Brasileira, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University College London Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tissieres</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital de Bicetre, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>R Scott</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Center for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle Children's Hospital, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiens</LastName><ForeName>Matthew O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mbarara University of Science and Technology, Mbarara, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wynn</LastName><ForeName>James L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Florida, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorce</LastName><ForeName>Lauren R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Ann &amp; Robert H. Lurie Children's Hospital, Chicago, IL.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM128452</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Explor</MedlineTA><NlmUniqueID>101746347</NlmUniqueID><ISSNLinking>2639-8028</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">childhood</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">organ dysfunction</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList><CoiStatement>The authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>6</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32695992</ArticleId><ArticleId IdType="pmc">PMC7314341</ArticleId><ArticleId IdType="doi">10.1097/CCE.0000000000000123</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Salvi S, Apte K, Madas S, et al. . Symptoms and medical conditions in 204 912 patients visiting primary health-care practitioners in India: A 1-day point prevalence study (the POSEIDON study). Lancet Glob Health. 2015; 3:e776&#x2013;e784</Citation><ArticleIdList><ArticleId IdType="pubmed">26566749</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill C, Owens P. Reasons for Being Admitted to the Hospital Through the Emergency Department for Children and Adolescents. 2004Rockville, MD: Healthcare cost and utilization project, Agency for Healthcare Research and Quality</Citation><ArticleIdList><ArticleId IdType="pubmed">21850774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, et al. . Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study. Lancet. 2020; 395:200&#x2013;211</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Johnson HL, Cousens S, et al. ; Child Health Epidemiology Reference Group of WHO and UNICEF Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379:2151&#x2013;2161</Citation><ArticleIdList><ArticleId IdType="pubmed">22579125</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, et al. . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101:1644&#x2013;1655</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Daniels R, Kissoon N, et al. . Recognizing sepsis as a global health priority - a WHO resolution. N Engl J Med. 2017; 377:414&#x2013;417</Citation><ArticleIdList><ArticleId IdType="pubmed">28658587</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. . The global burden of paediatric and neonatal sepsis: A systematic review. Lancet Respir Med. 2018; 6:223&#x2013;230</Citation><ArticleIdList><ArticleId IdType="pubmed">29508706</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SL, Fitzgerald JC, Maffei FA, et al. ; SPROUT Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators Network SPROUT Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators Network. Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study. Crit Care. 2015; 19:325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4572676</ArticleId><ArticleId IdType="pubmed">26373923</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6:2&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">15636651</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, et al. ; International Sepsis Definitions Conference International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 2003; 29:530&#x2013;538</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. . The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315:801&#x2013;810</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Straney L, Bellomo R, et al. . Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit. Intensive Care Med. 2018; 44:179&#x2013;188</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5816088</ArticleId><ArticleId IdType="pubmed">29256116</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SL, Fitzgerald JC, Pappachan J, et al. ; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015; 191:1147&#x2013;1157</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4451622</ArticleId><ArticleId IdType="pubmed">25734408</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Straney L, Alexander J, et al. ; ANZICS Paediatric Study Group ANZICS Paediatric Study Group. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: A multicentre retrospective cohort study. Lancet Infect Dis. 2015; 15:46&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pubmed">25471555</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K, Kiguli S, Opoka RO, et al. ; FEAST Trial Group FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011; 364:2483&#x2013;2495</Citation><ArticleIdList><ArticleId IdType="pubmed">21615299</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman PKA, Schlapbach LJ, Giannoni E, et al. ; Swiss Pediatric Sepsis Study Swiss Pediatric Sepsis Study. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: A population-based cohort study. Lancet Child Adolesc Health. 2017; 1:124&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">30169202</ArticleId></ArticleIdList></Reference><Reference><Citation>Volakli EA, Sdougka M, Drossou-Agakidou V, et al. . Short-term and long-term mortality following pediatric intensive care. Pediatr Int. 2012; 54:248&#x2013;255</Citation><ArticleIdList><ArticleId IdType="pubmed">22168527</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack MM, Holubkov R, Funai T, et al. ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Simultaneous prediction of new morbidity, mortality, and survival without new morbidity from pediatric intensive care: A new paradigm for outcomes assessment. Crit Care Med. 2015; 43:1699&#x2013;1709</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657566</ArticleId><ArticleId IdType="pubmed">25985385</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberico AM, Ward JD, Choi SC, et al. . Outcome after severe head injury. Relationship to mass lesions, diffuse injury, and ICP course in pediatric and adult patients. J Neurosurg. 1987; 67:648&#x2013;656</Citation><ArticleIdList><ArticleId IdType="pubmed">3668633</ArticleId></ArticleIdList></Reference><Reference><Citation>Choong K, Bohn D, Fraser DD, et al. ; Canadian Critical Care Trials Group Canadian Critical Care Trials Group. Vasopressin in pediatric vasodilatory shock: A multicenter randomized controlled trial. Am J Respir Crit Care Med. 2009; 180:632&#x2013;639</Citation><ArticleIdList><ArticleId IdType="pubmed">19608718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauzier F, L&#xe9;vy B, Lamarre P, et al. . Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial. Intensive Care Med. 2006; 32:1782&#x2013;1789</Citation><ArticleIdList><ArticleId IdType="pubmed">17019548</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L. Bias caused by sampling error in meta-analysis with small sample sizes. PLoS One. 2018; 13:e0204056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6136825</ArticleId><ArticleId IdType="pubmed">30212588</ArticleId></ArticleIdList></Reference><Reference><Citation>McGovern M, Giannoni E, Kuester H, et al. . Challenges in developing a consensus definition of neonatal sepsis. Pediatr Res. 2020. Mar 3. [online ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">32126571</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider H, Danko J, Huch R, et al. . Homeostasis of fetal lactate metabolism in late pregnancy and the changes during labor and delivery. Eur J Obstet Gynecol Reprod Biol. 1984; 17:183&#x2013;192</Citation><ArticleIdList><ArticleId IdType="pubmed">6376200</ArticleId></ArticleIdList></Reference><Reference><Citation>Slater A, Shann F, Pearson G; Paediatric Index of Mortality (PIM) Study Group Paediatric Index of Mortality (PIM) Study Group. PIM2: A revised version of the Paediatric Index of Mortality. Intensive Care Med. 2003; 29:278&#x2013;285</Citation><ArticleIdList><ArticleId IdType="pubmed">12541154</ArticleId></ArticleIdList></Reference><Reference><Citation>Leteurtre S, Martinot A, Duhamel A, et al. . Validation of the paediatric logistic organ dysfunction (PELOD) score: Prospective, observational, multicentre study. Lancet. 2003; 362:192&#x2013;197</Citation><ArticleIdList><ArticleId IdType="pubmed">12885479</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack MM, Patel KM, Ruttimann UE. PRISM III: An updated Pediatric Risk of Mortality score. Crit Care Med. 1996; 24:743&#x2013;752</Citation><ArticleIdList><ArticleId IdType="pubmed">8706448</ArticleId></ArticleIdList></Reference><Reference><Citation>Matics TJ, Sanchez-Pinto L. Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically ill children. JAMA Pediatr. 2017; 171:e172352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583375</ArticleId><ArticleId IdType="pubmed">28783810</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Liu VX, Iwashyna TJ, et al. . Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315:762&#x2013;774</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5433435</ArticleId><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson RS, Crow SS, Hartman ME, et al. . Epidemiology and outcomes of pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med. 2017; 18:S4&#x2013;S16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5334773</ArticleId><ArticleId IdType="pubmed">28248829</ArticleId></ArticleIdList></Reference><Reference><Citation>Nama N, Sampson M, Barrowman N, et al. . Crowdsourcing the citation screening process for systematic reviews: Validation study. J Med Internet Res. 2019; 21:e12953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658317</ArticleId><ArticleId IdType="pubmed">31033444</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42:377&#x2013;381</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-Central Line Associated Bloodstream Infection) Atlanta, GA, Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/hai/bsi/bsi.html. Accessed June 2, 2020</Citation></Reference><Reference><Citation>Hayden JA, van der Windt DA, Cartwright JL, et al. . Assessing bias in studies of prognostic factors. Ann Intern Med. 2013; 158:280&#x2013;286</Citation><ArticleIdList><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36243265</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of general versus regional anesthesia for lower extremity amputation.</ArticleTitle><Pagination><StartPage>1542</StartPage><EndPage>1552.e9</EndPage><MedlinePgn>1542-1552.e9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2022.10.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(22)02338-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Postoperative morbidity in patients undergoing lower extremity amputation (LEA) has remained high. Studies investigating the influence of the anesthetic modality on the postoperative outcomes have yielded conflicting results. The aim of our study was to assess the effects of regional anesthesia vs general anesthesia on postoperative complications for patients undergoing LEA.</AbstractText><AbstractText Label="METHODS">We systematically searched PubMed, Embase, MEDLINE, Web of Science, and Google Scholar from 1990 to 2022 for studies investigating the effect of the anesthetic modality on the postoperative outcomes after LEA. Regional anesthesia (RA) included neuraxial anesthesia and peripheral nerve blocks. The outcomes included 30-day mortality, respiratory failure (unplanned postoperative intubation, failure to wean, mechanical ventilation &gt;24&#xa0;hours), surgical site infection, cardiac complications, urinary tract infection, renal failure, sepsis, venous thrombosis, pneumonia, and myocardial infarction.</AbstractText><AbstractText Label="RESULTS">Of the 25 studies identified, we included 10 retrospective observational studies with 81,736 patients, of whom 69,754 (85.3%) had received general anesthesia (GA) and 11,980 (14.7%) had received RA. In the GA group, 50,468 patients were men (63.8%), and in the RA group, 7813 patients were men (62.3%). The results of the meta-analyses revealed that GA was associated with a higher rate of respiratory failure (odds ratio, 1.38; 95% confidence interval, 1.06-1.80; P&#xa0;= .02) and sepsis (odds ratio, 1.21; 95% confidence interval, 1.11-1.33; P&#xa0;&lt; .0001) compared with RA. No differences were found in postoperative 30-day mortality, surgical site infection, cardiac complications, urinary tract infection, renal failure, venous thrombosis, pneumonia, and myocardial infarction between the GA and RA groups.</AbstractText><AbstractText Label="CONCLUSIONS">The results of our meta-analysis have shown that GA could be associated with a higher rate of respiratory failure and sepsis compared with RA for LEA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mufarrih</LastName><ForeName>Syed H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Nada Q</ForeName><Initials>NQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yunus</LastName><ForeName>Rayaan A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsiampoura</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quraishi</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharkey</LastName><ForeName>Aidan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmood</LastName><ForeName>Feroze</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matyal</LastName><ForeName>Robina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: rmatyal1@bidmc.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="Y">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="N">Amputation, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Lower extremity amputation</Keyword><Keyword MajorTopicYN="N">RA vs GA</Keyword><Keyword MajorTopicYN="N">Regional anesthesia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>19</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36243265</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2022.10.005</ArticleId><ArticleId IdType="pii">S0741-5214(22)02338-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38523060</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>Immunomodulatory drugs in sepsis: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>869</StartPage><EndPage>879</EndPage><MedlinePgn>869-879</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.16263</ELocationID><Abstract><AbstractText>Dysregulation of the host immune response has a central role in the pathophysiology of sepsis. There has been much interest in immunomodulatory drugs as potential therapeutic adjuncts in sepsis. We conducted a systematic review and meta-analysis of randomised controlled trials evaluating the safety and clinical effectiveness of immunomodulatory drugs as adjuncts to standard care in the treatment of adults with sepsis. Our primary outcomes were serious adverse events and all-cause mortality. Fifty-six unique, eligible randomised controlled trials were identified, assessing a range of interventions including cytokine inhibitors; anti-inflammatories; immune cell stimulators; platelet pathway inhibitors; and complement inhibitors. At 1-month follow-up, the use of cytokine inhibitors was associated with a decreased risk of serious adverse events,&#xa0;based on 11 studies involving 7138 patients (RR (95%CI) 0.95 (0.90-1.00), I<sup>2</sup>&#x2009;=&#x2009;0%). The only immunomodulatory drugs associated with an increased risk of serious adverse events were toll-like receptor 4 antagonists (RR (95%CI) 1.18 (1.04-1.34), I<sup>2</sup>&#x2009;=&#x2009;0% (two trials, 567 patients)). Based on 18 randomised controlled trials, involving 11,075 patients, cytokine inhibitors reduced 1-month mortality (RR (95%CI) 0.88 (0.78-0.98), I<sup>2</sup>&#x2009;=&#x2009;57%). Mortality reduction was also shown in the subgroup of 13 randomised controlled trials that evaluated anti-tumour necrosis factor &#x3b1; interventions (RR (95%CI) 0.93 (0.87-0.99), I<sup>2</sup>&#x2009;=&#x2009;0%). Anti-inflammatory drugs had the largest apparent effect on mortality at 2&#x2009;months at any dose (two trials, 228 patients, RR (95%CI) 0.64 (0.51-0.80), I<sup>2</sup>&#x2009;=&#x2009;0%) and at 3&#x2009;months at any dose (three trials involving 277 patients, RR (95%CI) 0.67 (0.55-0.81), I<sup>2</sup>&#x2009;=&#x2009;0%). These data indicate that, except for toll-like receptor 4 antagonists, there is no evidence of safety concerns for the use of immunomodulatory drugs in sepsis, and they may show some short-term mortality benefit for selected drugs.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Anaesthesia published by John Wiley &amp; Sons Ltd on behalf of Association of Anaesthetists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Robey</LastName><ForeName>R C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0001-8862-4923</Identifier><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logue</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caird</LastName><ForeName>C A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansel</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellyer</LastName><ForeName>T P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dark</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Care Unit, Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Salford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathioudakis</LastName><ForeName>A G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felton</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Manchester Biomedical Research Centre</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000091369">Immunomodulating Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091369" MajorTopicYN="Y">Immunomodulating Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">immunomodulatory drugs</Keyword><Keyword MajorTopicYN="N">meta&#x2010;analysis</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>15</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>24</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38523060</ArticleId><ArticleId IdType="doi">10.1111/anae.16263</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et&#xa0;al. The third international consensus definitions for sepsis and septic shock (sepsis&#x2010;3). Journal of the American Medical Association 2016; 315: 801&#x2013;810.</Citation></Reference><Reference><Citation>Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority &#x2010; a WHO resolution. New England Journal of Medicine 2017; 377: 414&#x2013;417.</Citation></Reference><Reference><Citation>Peters van Ton AM, Kox M, Abdo WF, Pickkers P. Precision immunotherapy for sepsis. Frontiers in Immunology 2018; 9: 1926.</Citation></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, et&#xa0;al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644&#x2013;1655.</Citation></Reference><Reference><Citation>Abraham E, Wunderink R, Silverman H, et&#xa0;al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double&#x2010;blind, multicenter clinical trial. TNF&#x2010;alpha MAb Sepsis Study Group. Journal of the American Medical Association 1995; 273: 934&#x2013;941.</Citation></Reference><Reference><Citation>Fisher CJ Jr, Dhainaut JF, Opal SM, et&#xa0;al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double&#x2010;blind, placebo&#x2010;controlled trial. Phase III rhIL&#x2010;1ra Sepsis Syndrome Study Group. Journal of the American Medical Association 1994; 271: 1836&#x2013;1843.</Citation></Reference><Reference><Citation>Van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nature Reviews Immunology 2017; 17: 407&#x2013;420.</Citation></Reference><Reference><Citation>Davies R, O'Dea K, Gordon A. Immune therapy in sepsis: are we ready to try again? Journal of the Intensive Care Society 2018; 19: 326&#x2013;344.</Citation></Reference><Reference><Citation>Jarczak D, Kluge S, Nierhaus A. Sepsis&#x2010;pathophysiology and therapeutic concepts. Frontiers in Medicine (Lausanne) 2021; 14: 628302.</Citation></Reference><Reference><Citation>Hotchkiss RS, Colston E, Yende S, et&#xa0;al. Immune checkpoint inhibition in sepsis: a phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab. Intensive Care Medicine 2019; 45: 1360&#x2013;1371.</Citation></Reference><Reference><Citation>Marshall JC. Why have clinical trials in sepsis failed? Trends in Molecular Medicine 2014; 20: 195&#x2013;203.</Citation></Reference><Reference><Citation>Delano MJ, Ward PA. Sepsis&#x2010;induced immune dysfunction: can immune therapies reduce mortality? Journal of Clinical Investigation 2016; 126: 23&#x2013;31.</Citation></Reference><Reference><Citation>RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID&#x2010;19 (RECOVERY): a randomised, controlled, open&#x2010;label, platform trial. Lancet 2021; 397: 1637&#x2013;1645.</Citation></Reference><Reference><Citation>REMAP&#x2010;CAP Investigators. Interleukin&#x2010;6 receptor antagonists in critically ill patients with Covid&#x2010;19. New England Journal of Medicine 2021; 384: 1491&#x2013;1502.</Citation></Reference><Reference><Citation>Wallis RS, O'Garra A, Sher A, Wack A. Host&#x2010;directed immunotherapy of viral and bacterial infections: past, present and future. Nature Reviews Immunology 2023; 23: 121&#x2013;133.</Citation></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, et&#xa0;al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3. (updated February 2022).</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et&#xa0;al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic Reviews 2021; 10: 89.</Citation></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et&#xa0;al. RoB 2: a revised tool for assessing risk of bias in randomised trials. British Medical Journal 2019; 366: l4898.</Citation></Reference><Reference><Citation>Kalil AC, LaRosa SP. Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta&#x2010;analysis and metaregression. The Lancet Infectious Diseases 2012; 12: 678&#x2013;686.</Citation></Reference><Reference><Citation>Wishart DS, Feunang YD, Guo AC, et&#xa0;al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Research 2018; 46: D1074&#x2013;D1082.</Citation></Reference><Reference><Citation>Aikawa N, Takahashi T, Fujimi S, et&#xa0;al. A phase II study of polyclonal anti&#x2010;TNF&#x2010;&#x3b1; (AZD9773) in Japanese patients with severe sepsis and/or septic shock. Journal of Infection and Chemotherapy 2013; 19: 931&#x2013;940.</Citation></Reference><Reference><Citation>Bernard GR, Francois B, Mira JP, et&#xa0;al. Evaluating the efficacy and safety of two doses of the polyclonal anti&#x2010;tumor necrosis factor&#x2010;&#x3b1; fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double&#x2010;blind, placebo&#x2010;controlled phase IIb study*. Critical Care Medicine 2014; 42: 504&#x2013;511.</Citation></Reference><Reference><Citation>Stephens DP, Thomas JH, Higgins A, Bailey M, Anstey NM, Currie BJ, Cheng AC. Randomized, double&#x2010;blind, placebo&#x2010;controlled trial of granulocyte colony&#x2010;stimulating factor in patients with septic shock. Critical Care Medicine 2008; 36: 448&#x2013;454.</Citation></Reference><Reference><Citation>Chen H, He MY, Li YM. Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study. Chinese Medical Journal (Engl) 2009; 122: 883&#x2013;888.</Citation></Reference><Reference><Citation>Zhang Y, Chen H, Li YM, et&#xa0;al. Thymosin alpha1&#x2010; and ulinastatin&#x2010;based immunomodulatory strategy for sepsis arising from intra&#x2010;abdominal infection due to carbapenem&#x2010;resistant bacteria. Journal of Infectious Diseases 2008; 198: 723&#x2013;730.</Citation></Reference><Reference><Citation>Singh S, Loke YK. Drug safety assessment in clinical trials: methodological challenges and opportunities. Trials 2012; 13: 138.</Citation></Reference><Reference><Citation>Marshall JC, Vincent JL, Guyatt G, et&#xa0;al. Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Critical Care Medicine 2005; 33: 1708&#x2013;1716.</Citation></Reference><Reference><Citation>Clarke M, Williamson PR. Core outcome sets and systematic reviews. Systematic Reviews 2016; 5: 11.</Citation></Reference><Reference><Citation>Mathioudakis AG, Khaleva E, Fally M, et&#xa0;al. Core outcome sets, developed collaboratively with patients, can improve the relevance and comparability of clinical trials. European Respiratory Journal 2023; 61: 2202107.</Citation></Reference><Reference><Citation>Schinkel M, Nanayakkara PWB, Wiersinga WJ. Sepsis performance improvement programs: from evidence toward clinical implementation. Critical Care 2022; 26: 77.</Citation></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID&#x2010;19 infection. A minimal common outcome measure set for COVID&#x2010;19 clinical research. Lancet Infectious Diseases 2020; 20: e192&#x2013;e197. Epub 2020 Jun 12. Erratum in: Lancet Infectious Disease. 2020 Oct;20(10):e250.</Citation></Reference><Reference><Citation>Shakoory B, Carcillo JA, Chatham WW, et&#xa0;al. Interleukin&#x2010;1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Critical Care Medicine 2016; 44: 275&#x2013;281.</Citation></Reference><Reference><Citation>Meyer NJ, Reilly JP, Anderson BJ, et&#xa0;al. Mortality benefit of recombinant human interleukin&#x2010;1 receptor antagonist for sepsis varies by initial interleukin&#x2010;1 receptor antagonist plasma concentration. Critical Care Medicine 2018; 46: 21&#x2013;28.</Citation></Reference><Reference><Citation>Sweeney TE, Azad TD, Donato M, et&#xa0;al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Critical Care Medicine 2018; 46: 915&#x2013;925.</Citation></Reference><Reference><Citation>Maslove DM, Tang B, Shankar&#x2010;Hari M, et&#xa0;al. Redefining critical illness. Nature Medicine 2022; 28: 1141&#x2013;1148.</Citation></Reference><Reference><Citation>Vincent JL, van der Poll T, Marshall JC. The end of "one size fits all" sepsis therapies: toward an individualized approach. Biomedicines 2022; 10: 2260.</Citation></Reference><Reference><Citation>Berry SM, Connor JT, Lewis RJ. The platform trial: an efficient strategy for evaluating multiple treatments. Journal of the American Medical Association 2015; 313: 1619&#x2013;1620.</Citation></Reference><Reference><Citation>Leventogiannis K, Kyriazopoulou E, Antonakos N, et&#xa0;al. Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial. Cell Reports Medicine 2022; 3: 100817.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34090150</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Vasopressor and inotrope treatment for septic shock: An umbrella review of reviews.</ArticleTitle><Pagination><StartPage>65</StartPage><EndPage>71</EndPage><MedlinePgn>65-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2021.05.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(21)00104-0</ELocationID><Abstract><AbstractText Label="PURPOSE">To review the characteristics, findings and quality of systematic reviews (SRs) on the effect of any vasopressor/inotrope on outcomes in adult patients with sepsis compared with either no treatment, another vasopressor or inotrope or fluids.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We systematically searched Cochrane Central Register of Controlled Trials, PubMed and Embase (January 1993-March 2021). Descriptive statistics were used.</AbstractText><AbstractText Label="RESULTS">Among the 28 SRs identified, mortality was the primary outcome in most (26/28) and mortality was usually (23/28) studied using randomised controlled trials (RCTs). Fifteen SRs focused exclusively on patients with sepsis or septic shock. Sepsis and septic shock were always grouped for the analysis. Publication bias was consistently low when studied. The most consistent findings were a survival advantage with norepinephrine versus dopamine, which disappeared in analyses restricted to 28-day mortality, and more arrhythmias with dopamine. However, these analyses were dominated by a single study. Only 2 SRs were judged to be of moderate-high quality. Lack of blinding and attrition bias may have affected the outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">The quality of SRs on the effect of vasopressors/inotropes on the outcomes of adult patients with sepsis can be improved, but high-quality, multicenter, RCTs should be preferred to additional SRs on this topic.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Einav</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of the Shaare Zedek Medical Medical Centre and Hebrew University Faculty of Medicine, Jerusalem, Israel. Electronic address: einav_s@szmc.org.il.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helviz</LastName><ForeName>Yigal</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of the Shaare Zedek Medical Medical Centre and Hebrew University Faculty of Medicine, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ippolito</LastName><ForeName>Mariachiara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy; Department of Anaesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiotonic agents</Keyword><Keyword MajorTopicYN="N">Catecholamines</Keyword><Keyword MajorTopicYN="N">Review</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Vasoconstrictor agents</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest SE is associate editor of Intensive Care Medicine and a Cochrane Editor. AC is an advisory board member of Critical Care and an associate Editorial Board member of BJA. The other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>5</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34090150</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2021.05.017</ArticleId><ArticleId IdType="pii">S0883-9441(21)00104-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36071820</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-1683</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>European urology open science</Title><ISOAbbreviation>Eur Urol Open Sci</ISOAbbreviation></Journal><ArticleTitle>Risk of Sepsis in Retrograde Intrarenal Surgery: A Systematic Review of the Literature.</ArticleTitle><Pagination><StartPage>84</StartPage><EndPage>91</EndPage><MedlinePgn>84-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.euros.2022.08.008</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="UNASSIGNED">Nowadays, urolithiasis has become a highly prevalent disease. Recent studies indicate that retrograde intrarenal surgery (RIRS) is becoming more popular among surgical treatments due to the preference of patients and providers. This minimally invasive procedure results in high stone-free rates and relatively low morbidity; however, complications resulting from infection can still occur, including acute urinary tract infection, systemic inflammatory response syndrome, and sepsis.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To identify the independent risk factors for sepsis following RIRS, as well as general risk factors that may contribute to this life-threatening complication in the pre- and intraoperative periods.</AbstractText><AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="UNASSIGNED">A literature review was conducted in April 2020 using the Medline, Scopus, and Cochrane databases. We searched the references of included papers.</AbstractText><AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="UNASSIGNED">We screened 2306 manuscripts and selected 13 for inclusion. The sepsis rate ranged from 0.5% to 11.1%, and the septic shock rate ranged from 0.3% to 4.6%. All selected studies mentioned risks for sepsis and/or infective complications (including sepsis), but only four of them addressed independent risks for urosepsis. These independent risk factors were stone size, high irrigation pressure, prolonged stent dwelling time (&gt;30 d), sepsis as an indication for stent insertion, female gender, positive intraoperative bladder urine culture, longer surgical time, and diabetes mellitus.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">RIRS is associated with a low sepsis rate, according to the latest evidence. However, given that this is a serious life-threatening complication, knowing its potential risk factors is extremely important.</AbstractText><AbstractText Label="PATIENT SUMMARY" NlmCategory="UNASSIGNED">In this report, we looked at the outcome of sepsis after planned retrograde intrarenal surgery for stone disease in patients with and without comorbidities. This information may be useful for colleagues in their daily practice.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corrales</LastName><ForeName>Mariela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Tenon, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sierra</LastName><ForeName>Alba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, Hospital Clinic, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doizi</LastName><ForeName>Steeve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Tenon, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traxer</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Tenon, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur Urol Open Sci</MedlineTA><NlmUniqueID>101771568</NlmUniqueID><ISSNLinking>2666-1683</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Intrarenal ureteroscopy</Keyword><Keyword MajorTopicYN="N">Retrograde intrarenal surgery</Keyword><Keyword MajorTopicYN="N">Risk factor</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Ureteroscopies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>2</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36071820</ArticleId><ArticleId IdType="pmc">PMC9442387</ArticleId><ArticleId IdType="doi">10.1016/j.euros.2022.08.008</ArticleId><ArticleId IdType="pii">S2666-1683(22)00879-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rukin N.J., Siddiqui Z.A., Chedgy E.C.P., Somani B.K. Trends in upper tract stone disease in England: evidence from the Hospital Episodes Statistics database. Urol Int. 2017;98:391&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">27694759</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorokin I., Mamoulakis C., Miyazawa K., Rodgers A., Talati J., Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017;35:1301&#x2013;1320.</Citation><ArticleIdList><ArticleId IdType="pubmed">28213860</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xfc;rk C, Neisius A, Petrik A, et al. EAU guidelines on urolithiasis. 2020.</Citation></Reference><Reference><Citation>Raheem O.A., Khandwala Y.S., Sur R.L., Ghani K.R., Denstedt J.D. Burden of urolithiasis: trends in prevalence, treatments, and costs. Eur Urol Focus. 2017;3:18&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">28720363</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietropaolo A., Proietti S., Geraghty R., et al. Trends of &#x201c;urolithiasis: interventions, simulation, and laser technology&#x201d; over the last 16 years (2000&#x2013;2015) as published in the literature (PubMed): a systematic review from European Section of Uro-technology (ESUT) World J Urol. 2017;35:1651&#x2013;1658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5649597</ArticleId><ArticleId IdType="pubmed">28593477</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xfc;rk C., Pet&#x159;&#xed;k A., Sarica K., et al. EAU guidelines on interventional treatment for urolithiasis. Eur Urol. 2016;69:475&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">26344917</ArticleId></ArticleIdList></Reference><Reference><Citation>Baboudjian M., Gondran-Tellier B., Abdallah R., et al. Predictive risk factors of urinary tract infection following flexible ureteroscopy despite preoperative precautions to avoid infectious complications. World J Urol. 2020;38:1253&#x2013;1259.</Citation><ArticleIdList><ArticleId IdType="pubmed">31359106</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietropaolo A., Geraghty R.M., Veeratterapillay R., et al. A machine learning predictive model for post-ureteroscopy urosepsis needing intensive care unit admission: a case-control YAU endourology study from nine European centres. J Clin Med. 2021;10:3888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8432042</ArticleId><ArticleId IdType="pubmed">34501335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644&#x2013;1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak J.M., Hladun T., Krenz B., Bromber K., Salagierski M., Marczak M. Can we identify patients in danger of complications in retrograde intrarenal surgery?&#x2014;A retrospective risk factors analysis. Int J Environ Res Public Health. 2022;19:1114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8834554</ArticleId><ArticleId IdType="pubmed">35162137</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenlehner F.M., Lichtenstern C., Rolfes C., et al. Diagnosis and management for urosepsis. Int J Urol. 2013;20:963&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">23714209</ArticleId></ArticleIdList></Reference><Reference><Citation>Dybowski B., Bres-Niewada E., Rzeszutko M., et al. Risk factors for infectious complications after retrograde intrarenal surgery&#x2014;a systematic review and narrative synthesis. Cent Eur J Urol. 2021;74:437&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8552946</ArticleId><ArticleId IdType="pubmed">34729234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y.C., Jian Z.Y., Yuan C., Li H., Wang K.J. Risk factors of infectious complications after ureteroscopy: a systematic review and meta-analysis based on adjusted effect estimate. Surg Infect (Larchmt) 2020;21:811&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">32286933</ArticleId></ArticleIdList></Reference><Reference><Citation>Le S.J., Xu J.N., Ouyang J. Risk factors of infectious complications following ureteroscopy: a systematic review and meta-analysis. Urol Int. 2020;104:113&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">31846966</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida Y., Takazawa R., Kitayama S., Tsujii T. Predictive risk factors for systemic inflammatory response syndrome following ureteroscopic laser lithotripsy. Urolithiasis. 2018;46:375&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">28695238</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">20171303</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugihara T., Yasunaga H., Horiguchi H., et al. A nomogram predicting severe adverse events after ureteroscopic lithotripsy: 12 372 patients in a Japanese national series. BJU Int. 2013;111:459&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">23253797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Zhou P.H., Wang W., Zhang L., Zhang X.-B. Prognostic value of adrenomedullin and natriuretic peptides in uroseptic patients induced by ureteroscopy. Mediators Inflamm. 2016;2016:9743198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4736384</ArticleId><ArticleId IdType="pubmed">26880865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood B., Habashy D., Mayne D.J., Dhar A., Purvis C., Skyring T. The utility of preoperative and intraoperative cultures for guiding urosepsis empirical treatment. J Clin Urol. 2019;13:132&#x2013;139.</Citation></Reference><Reference><Citation>Zisman A., Badaan S., Kastin A., Kravtsov A., Amiel G.E., Mullerad M. Tailoring antibiotic prophylaxis for ureteroscopic procedures based on local resistance profiles may lead to reduced rates of infections and urosepsis. Urol Int. 2020;104:106&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">31743924</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Liu M., Ming S., Yu W., Li L., Lu C., et al. Safety of a novel thulium fiber laser for lithotripsy: an in vitro study on the thermal effect and its impact factor. J Endourol. 2020;34:88&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">31608659</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmur J.P., Maitra N.U., Marri R.R., Housami F., Malki M., Mcilhenny C. Analysis of factors&#x2019; association with risk of postoperative urosepsis in patients undergoing ureteroscopy for treatment of stone disease. J Endourol. 2016;30:963&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pubmed">27317017</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevo A., Mano R., Baniel J., Lifshitz D.A. Ureteric stent dwelling time: a risk factor for post-ureteroscopy sepsis. BJU Int. 2017;120:117&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">28145037</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom J., Fox C., Fullerton S., Matthews G., Phillips J. Sepsis after elective ureteroscopy. Can J Urol. 2017;24:9017&#x2013;9023.</Citation><ArticleIdList><ArticleId IdType="pubmed">28971790</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Min Z., Wan S.P., Nie H., Duan G. Complications of retrograde intrarenal surgery classified by the modified Clavien grading system. Urolithiasis. 2018;46:197&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">28236022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogreden E., O&#x1e7;uz U., Demirelli E., Benli E., &#xd6;zen &#xd6;. The impact of ureteral double-J stent insertion following ureterorenoscopy in patients with ureteral stones accompanied by perirenal fat stranding. Arch Ital Di Urol Androl. 2018;90:15&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">29633793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozgor F., Sahan M., Cubuk A., Ortac M., Ayranci A., Sarilar O. Factors affecting infectious complications following flexible ureterorenoscopy. Urolithiasis. 2019;47:481&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">30448869</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai T., Yu X., Qin C., et al. Identification of factors associated with postoperative urosepsis after ureteroscopy with holmium:yttrium-aluminum-garnet laser lithotripsy. Urol Int. 2019;103:311&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">31461729</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az P&#xe9;rez D., Laso Garc&#xed;a I., S&#xe1;nchez Guerrero C., et al. Urinary sepsis after endourological ureterorenoscopy for the treatment of lithiasis. Actas Urol Esp. 2019;43:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">31056221</ArticleId></ArticleIdList></Reference><Reference><Citation>Moses R.A., Ghali F.M., Pais V.M., Hyams E.S. Unplanned hospital return for infection following ureteroscopy&#x2014;can we identify modifiable risk factors? J Urol. 2016;195:931&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pubmed">26410731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bapir R., Bhatti K.H., Eliwa A., et al. Infectious complications of endourological treatment of kidney stones: a meta-analysis of randomized clinical trials. Arch Ital Urol Androl. 2022;94:97&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">35352534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsuzuka K., Nakano O., Takahashi N., Satoh M. Identification of factors associated with postoperative febrile urinary tract infection after ureteroscopy for urinary stones. Urolithiasis. 2016;44:257&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">26321205</ArticleId></ArticleIdList></Reference><Reference><Citation>Southern J.B., Higgins A.M., Young A.J., et al. Risk factors for postoperative fever and systemic inflammatory response syndrome after ureteroscopy for stone disease. J Endourol. 2019;33:516&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pubmed">30569755</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhojani N., Miller L.E., Bhattacharyya S., Cutone B., Chew B.H. Risk factors for urosepsis after ureteroscopy for stone disease: a systematic review with meta-analysis. J Endourol. 2021;35:991&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">33544019</ArticleId></ArticleIdList></Reference><Reference><Citation>Cindolo L., Castellan P., Scoffone C.M., et al. Mortality and flexible ureteroscopy: analysis of six cases. World J Urol. 2016;34:305&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">26210344</ArticleId></ArticleIdList></Reference><Reference><Citation>Chugh S., Pietropaolo A., Montanari E., Sarica K., Somani B.K. Predictors of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review from EAU Section of Urolithiasis (EULIS) Curr Urol Rep. 2020;21:16.</Citation><ArticleIdList><ArticleId IdType="pubmed">32211969</ArticleId></ArticleIdList></Reference><Reference><Citation>Khusid J.A., Hordines J.C., Sadiq A.S., Atallah W.M., Gupta M. Prevention and management of infectious complications of retrograde intrarenal surgery. Front Surg. 2021;8:718583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381273</ArticleId><ArticleId IdType="pubmed">34434958</ArticleId></ArticleIdList></Reference><Reference><Citation>Martov A., Gravas S., Etemadian M., et al. Postoperative infection rates in patients with a negative baseline urine culture undergoing ureteroscopic stone removal: a matched case-control analysis on antibiotic prophylaxis from the CROES URS global study. J Endourol. 2015;29:171&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">25072350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sammon J.D., Ghani K.R., Karakiewicz P.I., et al. Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Eur Urol. 2013;64:85&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">23031677</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariappan P., Tolley D.A. Endoscopic stone surgery: minimizing the risk of post-operative sepsis. Curr Opin Urol. 2005;15:101&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">15725933</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C.G., Guo Y.L. Diagnostic and prognostic values of BMPER in patients with urosepsis following ureteroscopic lithotripsy. Biomed Res Int. 2019;2019:8078139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6360565</ArticleId><ArticleId IdType="pubmed">30800678</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a Rojo E., Teoh J.Y.C., Castellani D., et al. Real-world global outcomes of retrograde intrarenal surgery in anomalous kidneys: a high volume international multicenter study. Urology. 2022;159:41&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">34715241</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S., Gong B., Hao Z., et al. Risk factors of infectious complications following flexible ureteroscope with a holmium laser: a retrospective study. Int J Clin Exp Med. 2015;8:11252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565315</ArticleId><ArticleId IdType="pubmed">26379932</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokas T., Herrmann T.R.W., Skolarikos A., Nagele U. Pressure matters: intrarenal pressures during normal and pathological conditions, and impact of increased values to renal physiology. World J Urol. 2019;37:125&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">29915945</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H.U., Frimodt-M&#xf8;ller P.C., Osther P.J., Mortensen J. Pharmacological effect on pyeloureteric dynamics with a clinical perspective: a review of the literature. Urol Res. 2006;34:341&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">17019613</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotland K.B., Lange D. Prevention and management of urosepsis triggered by ureteroscopy. Res Rep Urol. 2018;10:43&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6038880</ArticleId><ArticleId IdType="pubmed">30013956</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong W., Leto G., Wang L., Zeng G. Systemic inflammatory response syndrome after flexible ureteroscopic lithotripsy: a study of risk factors. J Endourol. 2015;29:25&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">24999535</ArticleId></ArticleIdList></Reference><Reference><Citation>De Coninck V., Keller E.X., Rodr&#xed;guez-Monsalve M., Audouin M., Doizi S., Traxer O. Systematic review of ureteral access sheaths: facts and myths. BJU Int. 2018;122:959&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pubmed">29752769</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazan O., Cakici M., Keser F., et al. The role of preoperative urinalysis in predicting postoperative infection after retrograde intrarenal surgery in patients with sterile urine culture. Turkish J Urol. 2022;48:136&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9612787</ArticleId><ArticleId IdType="pubmed">35420056</ArticleId></ArticleIdList></Reference><Reference><Citation>Zowawi H.M., Harris P.N.A., Roberts M.J., et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015;12:570&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pubmed">26334085</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietropaolo A., Hendry J., Kyriakides R., et al. Outcomes of elective ureteroscopy for ureteric stones in patients with prior urosepsis and emergency drainage: prospective study over 5 yr from a tertiary endourology centre. Eur Urol Focus. 2020;6:151&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">30219711</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37213241</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-1683</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>European urology open science</Title><ISOAbbreviation>Eur Urol Open Sci</ISOAbbreviation></Journal><ArticleTitle>Incidence of Rectal Injury After Radical Prostatectomy: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>85</StartPage><EndPage>99</EndPage><MedlinePgn>85-99</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.euros.2023.03.017</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="UNASSIGNED">Rectal injury (RI) is a dreaded complication after radical prostatectomy (RP), increasing the risk of early postoperative complications, such as bleeding and severe infection/sepsis, and late sequelae, such as a rectourethral fistula (RUF). Considering its traditionally low incidence, uncertainty remains as to predisposing risk factors and management.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To examine the incidence of RI after RP in contemporary series and to propose a pragmatic algorithm for its management.</AbstractText><AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="UNASSIGNED">A systematic literature search was performed using the Medline and Scopus databases. Studies reporting data on RI incidence were selected. Subgroup analyses were conducted to assess the differential incidence by age, surgical approach, salvage RP after radiation therapy, and previous benign prostatic hyperplasia (BPH)-related surgery.</AbstractText><AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="UNASSIGNED">Eighty-eight, mostly retrospective noncomparative, studies were selected. The meta-analysis obtained a pooled RI incidence of 0.58% (95% confidence interval [CI] 0.46-0.73) in contemporary series with significant across-study heterogeneity (I<sup>2</sup>&#xa0;=&#xa0;100%, <i>p</i>&#xa0;&lt;&#xa0;0.00001). The highest RI incidence was found in patients undergoing open RP (1.25%; 95% CI 0.66-2.38) and laparoscopic RP (1.25%; 95% CI 0.75-2.08) followed by perineal RP (0.19%; 95% CI 0-276.95) and robotic RP (0.08%; 95% CI 0.02-0.31). Age &#x2265;60 yr (0.56%; 95% CI 0.37-06) and salvage RP after radiation therapy (6.01%; 95% CI 3.99-9.05), but not previous BPH-related surgery (4.08%, 95% CI 0.92-18.20), were also associated with an increased RI incidence. Intraoperative versus postoperative RI detection was associated with a significantly decreased risk of severe postoperative complications (such as sepsis and bleeding) and subsequent formation of a RUF.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">RI is a rare, but potentially devastating, complication following RP. RI incidence was higher in patients &#x2265;60 yr of age, and in those who underwent open/laparoscopic approach or salvage RP after radiation therapy. Intraoperative RI detection and repair apparently constitute the single most critical step to significantly decrease the risk of major postoperative complications and subsequent RUF formation. Conversely, intraoperatively undetected RI can lead more often to severe infective complications and RUF, the management of which remains poorly standardised and requires complex procedures.</AbstractText><AbstractText Label="PATIENT SUMMARY" NlmCategory="UNASSIGNED">Accidental rectum tear is a rare, but potentially devastating, complication in men undergoing prostate removal for cancer. It occurs more often in patients aged 60 yr or older as well as in those who underwent prostate removal via an open/laparoscopic approach and/or prostate removal after radiation therapy for recurrent disease. Prompt identification and repair of this condition during the initial operation are the key to reduce further complications such as the formation of an abnormal opening between the rectum and the urinary tract.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romito</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Gaetano Barresi Department of Human and Paediatric Pathology, Urology Section, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannarini</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Urology Unit, Santa Maria della Misericordia University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossanese</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gaetano Barresi Department of Human and Paediatric Pathology, Urology Section, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mucciardi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gaetano Barresi Department of Human and Paediatric Pathology, Urology Section, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonato</LastName><ForeName>Alchiede</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Sciences, Urology Section, University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ficarra</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Gaetano Barresi Department of Human and Paediatric Pathology, Urology Section, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur Urol Open Sci</MedlineTA><NlmUniqueID>101771568</NlmUniqueID><ISSNLinking>2666-1683</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Prostate cancer</Keyword><Keyword MajorTopicYN="N">Radical prostatectomy</Keyword><Keyword MajorTopicYN="N">Rectal injury</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>13</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>11</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37213241</ArticleId><ArticleId IdType="pmc">PMC10192923</ArticleId><ArticleId IdType="doi">10.1016/j.euros.2023.03.017</ArticleId><ArticleId IdType="pii">S2666-1683(23)00184-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walsh P.C., DeWeese T.L., Eisenberger M.A. Clinical practice. Localized prostate cancer. N Engl J Med. 2007;357:2696&#x2013;2705.</Citation><ArticleIdList><ArticleId IdType="pubmed">18160689</ArticleId></ArticleIdList></Reference><Reference><Citation>Hechenbleikner E.M., Buckley J.C., Wick E.C. Acquired rectourethral fistulas in adults: a systematic review of surgical repair techniques and outcomes. Dis Colon Rectum. 2013;56:374&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">23392154</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura H., Tsukamoto T. Rectourinary fistula after radical prostatectomy: review of the literature for incidence, etiology, and management. Prostate Cancer. 2011;2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3216010</ArticleId><ArticleId IdType="pubmed">22110993</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789819</ArticleId></ArticleIdList></Reference><Reference><Citation>Howick J, Chalmers I, Glasziou P, et al. Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence (background document). Oxford Centre for Evidence-Based Medicine. https://www.cebm.net.</Citation></Reference><Reference><Citation>Arai Y., Egawa S., Terachi T., et al. Morbidity of laparoscopic radical prostatectomy: summary of early multi-institutional experience in Japan. Int J Urol. 2003;10:430&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">12887364</ArticleId></ArticleIdList></Reference><Reference><Citation>Artibani W., Grosso G., Novara G., et al. Is laparoscopic radical prostatectomy better than traditional retropubic radical prostatectomy? An analysis of peri-operative morbidity in two contemporary series in Italy. Eur Urol. 2003;44:401&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">14499672</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin H., Hammerer P., Graefen M., et al. Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002. Eur Urol. 2003;43:113&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">12565767</ArticleId></ArticleIdList></Reference><Reference><Citation>Badani K.K., Kaul S., Menon M. Evolution of robotic radical prostatectomy: assessment after 2766 procedures. Cancer. 2007;110:1951&#x2013;1958.</Citation><ArticleIdList><ArticleId IdType="pubmed">17893904</ArticleId></ArticleIdList></Reference><Reference><Citation>Barashi N.S., Pearce S.M., Cohen A.J., Pariser J.J., Packiam V.T., Eggener S.E. incidence, risk factors, and outcomes for rectal injury during radical prostatectomy: a population-based study. Eur Urol Oncol. 2018;1:501&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">31158094</ArticleId></ArticleIdList></Reference><Reference><Citation>Beech B., Follett G., Ghosh S., et al. Are urologic surgeons performing robot-assisted radical prostatectomy at the University of Alberta meeting surgical quality performance benchmarks? The PROCURE-02 quality assurance study. Can Urol Assoc J. 2020;14:E369&#x2013;E372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402697</ArticleId><ArticleId IdType="pubmed">32209214</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumberg J.M., Lesser T., Tran V.Q., Aboseif S.R., Bellman G.C., Abbas M.A. Management of rectal injuries sustained during laparoscopic radical prostatectomy. Urology. 2009;73:163&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">18952259</ArticleId></ArticleIdList></Reference><Reference><Citation>Boczko J., Erturk E., Golijanin D., Madeb R., Patel H., Joseph J.V. Impact of prostate size in robot-assisted radical prostatectomy. J Endourol. 2007;21:184&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">17338619</ArticleId></ArticleIdList></Reference><Reference><Citation>Borland R.N., Walsh P.C. The management of rectal injury during radical retropubic prostatectomy. J Urol. 1992;147:905&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pubmed">1538494</ArticleId></ArticleIdList></Reference><Reference><Citation>Carini M., Masieri L., Minervini A., Lapini A., Serni S. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer. Eur Urol. 2008;53:554&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">17683854</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlsson S., Nilsson A.E., Schumacher M.C., et al. Surgery-related complications in 1253 robot-assisted and 485 open retropubic radical prostatectomies at the Karolinska University Hospital. Sweden. Urology. 2010;75:1092&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">20022085</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J.S., Kim W.T., Ham W.S., et al. Comparison of oncological results, functional outcomes, and complications for transperitoneal versus extraperitoneal robot-assisted radical prostatectomy: a single surgeon's experience. J Endourol. 2011;25:787&#x2013;792.</Citation><ArticleIdList><ArticleId IdType="pubmed">21114412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen M.S., Triaca V., Silverman M.L., Tuerk I.A. Progression of laparoscopic radical prostatectomy: improved outcomes with the extraperitoneal approach and a running anastomosis. J Endourol. 2006;20:574&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">16903818</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinides C.A., Tyritzis S.I., Skolarikos A., Liatsikos E., Zervas A., Deliveliotis C. Short- and long-term complications of open radical prostatectomy according to the Clavien classification system. BJU Int. 2009;103:336&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">18782300</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pierro G.B., Baumeister P., Stucki P., Beatrice J., Danuser H., Mattei A. A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre with a limited caseload. Eur Urol. 2011;59:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21035248</ArticleId></ArticleIdList></Reference><Reference><Citation>Do M., Ragavan N., Dietel A., et al. Feasibility of minimally invasive radical prostatectomy in prostate cancer patients with high prostate-specific antigen: feasibility and 1-year outcomes. Int J Urol. 2012;19:923&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pubmed">22762411</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogra P.N., Javali T.D., Singh P., et al. Perioperative outcome of initial 190 cases of robot-assisted laparoscopic radical prostatectomy&#x2014;a single-center experience. Indian J Urol. 2012;28:159&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3424891</ArticleId><ArticleId IdType="pubmed">22919130</ArticleId></ArticleIdList></Reference><Reference><Citation>Eden C.G., Chang C.M., Gianduzzo T., Moon D.A. The impact of obesity on laparoscopic radical prostatectomy. BJU Int. 2006;98:1279&#x2013;1282.</Citation><ArticleIdList><ArticleId IdType="pubmed">16879436</ArticleId></ArticleIdList></Reference><Reference><Citation>Galli S., Simonato A., Bozzola A., et al. Oncologic outcome and continence recovery after laparoscopic radical prostatectomy: 3 years' follow-up in a &#x201c;second generation center&#x201d;. Eur Urol. 2006;49:859&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pubmed">16519991</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Zhou J.H., Li L.Y., Qiu J.G., Pu X.Y. Laparoscopic radical prostatectomy: oncological and functional results of 126 patients with a minimum 3-year follow-up at a single Chinese institute. Asian J Androl. 2009;11:548&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3735014</ArticleId><ArticleId IdType="pubmed">19648935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheiler E.L., Tefilli M.V., Tiguert R., et al. Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology. 1998;51:789&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pubmed">9610593</ArticleId></ArticleIdList></Reference><Reference><Citation>Goeman L., Salomon L., La De T.A., et al. Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients. World J Urol. 2006;24:281&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">16508788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gontero P., Marra G., Alessio P., et al. Salvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approaches. J Urol. 2019;202:725&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pubmed">31075058</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalgo M.L., Pavlovich C.P., Trock B.J., Link R.E., Sullivan W., Su L.M. Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy. J Urol. 2005;174:135&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">15947598</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotto G.T., Yunis L.H., Vora K., Eastham J.A., Scardino P.T., Rabbani F. Impact of prior prostate radiation on complications after radical prostatectomy. J Urol. 2010;184:136&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">20478594</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco F., Wagner S., Hoda M.R., et al. Laparoscopic vs open retropubic intrafascial nerve-sparing radical prostatectomy: surgical and functional outcomes in 300 patients. BJU Int. 2010;106:543&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">20067455</ArticleId></ArticleIdList></Reference><Reference><Citation>Guazzoni G., Cestari A., Naspro R., et al. Intra- and peri-operative outcomes comparing radical retropubic and laparoscopic radical prostatectomy: results from a prospective, randomised, single-surgeon study. Eur Urol. 2006;50:98&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">16563608</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillonneau B., Gupta R., El Fettouh H., Cathelineau X., Baumert H., Vallancien G. Laparoscopic [correction of laproscopic] management of rectal injury during laparoscopic [correction of laproscopic] radical prostatectomy. J Urol. 2003;169:1694&#x2013;1696.</Citation><ArticleIdList><ArticleId IdType="pubmed">12686810</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeuser L., Reese S.W., Paciotti M., et al. Surgical complications requiring intervention in open versus minimally invasive radical prostatectomy. Urol Int. 2022;106:51&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">33902060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajili T., Ohlmann C.H., Linxweiler J., et al. Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up. BJU Int. 2019;123:58&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">29772100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ham W.S., Park S.Y., Kim W.T., Koo K.C., Lee Y.S., Choi Y.D. Open versus robotic radical prostatectomy: a prospective analysis based on a single surgeon's experience. J Robot Surg. 2008;2:235&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">27637793</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich A., Richter S., Th&#xfc;er D., Pfister D. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Eur Urol. 2010;57:437&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">19303197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeh B., Preisser F., Wenzel M., et al. Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltration. Urol Oncol. 2022;40:59.e7&#x2013;59.e12.</Citation><ArticleIdList><ArticleId IdType="pubmed">34456124</ArticleId></ArticleIdList></Reference><Reference><Citation>Hruza M., Weiss H.O., Pini G., et al. Complications in 2200 consecutive laparoscopic radical prostatectomies: standardised evaluation and analysis of learning curves. Eur Urol. 2010;58:733&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">20800341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J.C., Nelson R.A., Wilson T.G., et al. Perioperative complications of laparoscopic and robotic assisted laparoscopic radical prostatectomy. J Urol. 2006;175:541&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">16406991</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C.F., Yang C.K., Ou Y.C. Robotic assisted laparoscopic radical prostatectomy following transurethral resection of the prostate: perioperative, oncologic and functional outcomes. Prostate Int. 2014;2:82&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4099399</ArticleId><ArticleId IdType="pubmed">25032194</ArticleId></ArticleIdList></Reference><Reference><Citation>Jak&#xf3;bczyk B., Wrona M., Wrona-Lis M., et al. Endoscopic extraperitoneal radical prostatectomy: An initial report following the first 30 cases. Cent European J Urol. 2017;70:48&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407326</ArticleId><ArticleId IdType="pubmed">28461988</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong J., Choi E.Y., Kim I.Y. Clavien classification of complications after the initial series of robot-assisted radical prostatectomy: the Cancer Institute of New Jersey/Robert Wood Johnson Medical School experience. J Endourol. 2010;24:1457&#x2013;1461.</Citation><ArticleIdList><ArticleId IdType="pubmed">20673148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal E., Bhandari A., Siddiqui S., Pokala N., Peabody J., Menon M. Management of rectal injury during robotic radical prostatectomy. Urology. 2011;77:976&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296400</ArticleId></ArticleIdList></Reference><Reference><Citation>Klevecka V., Burmester L., Musch M., Roggenbuck U., Kroepfl D. Intraoperative and early postoperative complications of radical retropubic prostatectomy. Urol Int. 2007;79:217&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">17940353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lein M., Stibane I., Mansour R., et al. Complications, urinary continence, and oncologic outcome of 1000 laparoscopic transperitoneal radical prostatectomies&#x2014;experience at the Charit&#xe9; Hospital Berlin. Campus Mitte. Eur Urol. 2006;50:1278&#x2013;1282.</Citation><ArticleIdList><ArticleId IdType="pubmed">16846677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepor H., Nieder A.M., Ferrandino M.N. Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases. J Urol. 2001;166:1729&#x2013;1733.</Citation><ArticleIdList><ArticleId IdType="pubmed">11586211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner S.E., Blute M.L., Lieber M.M., Zincke H. Morbidity of contemporary radical retropubic prostatectomy for localized prostate cancer. Oncology (Williston Park) 1995;9:379&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">7547200</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Suzuki K., Tsuru N., Ushiyama T., Ozono S. Retrospective comparative study of 59 cases of laparoscopic radical prostatectomy: transperitoneal anterior versus transperitoneal posterior approach. Int J Urol. 2007;14:1005&#x2013;1008.</Citation><ArticleIdList><ArticleId IdType="pubmed">17956527</ArticleId></ArticleIdList></Reference><Reference><Citation>Liss M.A., Skarecky D., Morales B., Osann K., Eichel L., Ahlering T.E. Preventing perioperative complications of robotic-assisted radical prostatectomy. Urology. 2013;81:319&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3952012</ArticleId><ArticleId IdType="pubmed">23374792</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;ppenberg B., Noldus J., Holz A., Palisaar R.J. Reporting complications after open radical retropubic prostatectomy using the Martin criteria. J Urol. 2010;184:944&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pubmed">20643456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowrance W.T., Elkin E.B., et al. Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. J Urol. 2010;183:1366&#x2013;1372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2866516</ArticleId><ArticleId IdType="pubmed">20188381</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffezzini M., Seveso M., Taverna G., Giusti G., Benetti A., Graziotti P. Evaluation of complications and results in a contemporary series of 300 consecutive radical retropubic prostatectomies with the anatomic approach at a single institution. Urology. 2003;61:982&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">12736020</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel P., Linnemannst&#xf6;ns A., Chun F., et al. Incidence, risk factors, management, and complications of rectal injuries during radical prostatectomy. Eur Urol Focus. 2018;4:554&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">28753847</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariano M.B., Tefilli M.V., Fonseca G.N., Goldraich I.H. Laparoscopic radical prostatectomy: 10 years&#x2019; experience. Int Braz J Urol. 2009;35:565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">19860935</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T., Kinoshita H., Nishida S., Kawa G., Kawakita M., Matsuda T. Rectal injury during laparoscopic radical prostatectomy: detection and management. Int J Urol. 2010;17:492&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pubmed">20415710</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren R.H., Barrett D.M., Zincke H. Rectal injury occurring at radical retropubic prostatectomy for prostate cancer: etiology and treatment. Urology. 1993;42:401&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">8212438</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeill A.S., Nabi G., McLornan L., Cook J., Bollina P., Stolzenberg J.U. Endoscopic extraperitoneal radical prostatectomy: critical analysis of outcomes and learning curve. BJU Int. 2010;106:1537&#x2013;1543.</Citation><ArticleIdList><ArticleId IdType="pubmed">20346047</ArticleId></ArticleIdList></Reference><Reference><Citation>Moul J.W., Paulson D.F. The role of radical surgery in the management of radiation recurrent and large volume prostate cancer. Cancer. 1991;68:1265&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pubmed">1873780</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy D.G., Kerger M., Crowe H., Peters J.S., Costello A.J. Operative details and oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy: 400 cases with a minimum of 12 months follow-up. Eur Urol. 2009;55:1358&#x2013;1366.</Citation><ArticleIdList><ArticleId IdType="pubmed">19147274</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers S.N., Ghani K.R., Dunn R.L., et al. Notable outcomes and trackable events after surgery: evaluating an uncomplicated recovery after radical prostatectomy. J Urol. 2016;196:399&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">26916722</ArticleId></ArticleIdList></Reference><Reference><Citation>Neerhut G.J., Wheeler T., Cantini M., Scardino P.T. Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate. J Urol. 1988;140:544&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">3411670</ArticleId></ArticleIdList></Reference><Reference><Citation>Novara G., Ficarra V., D'Elia C., Secco S., Cavalleri S., Artibani W. Prospective evaluation with standardised criteria for postoperative complications after robotic-assisted laparoscopic radical prostatectomy. Eur Urol. 2010;57:363&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">19944519</ArticleId></ArticleIdList></Reference><Reference><Citation>Onaca M., Nita G., Manu M., Adou L., Tie G., Copaescu C. Retroperitoneal laparoscopic radical prostatectomy. Chirurgia (Bucur) 2018;113:542&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">30183585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou Y.C., Yang C.R., Wang J., Cheng C.L., Patel V.R. Comparison of robotic-assisted versus retropubic radical prostatectomy performed by a single surgeon. Anticancer Res. 2009;29:1637&#x2013;1642.</Citation><ArticleIdList><ArticleId IdType="pubmed">19443379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou Y.C., Yang C.R., Wang J., et al. The learning curve for reducing complications of robotic-assisted laparoscopic radical prostatectomy by a single surgeon. BJU Int. 2011;108:420&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">21050363</ArticleId></ArticleIdList></Reference><Reference><Citation>Paiva C.S., Andreoni C., Cunha G.P., Khalil W., Ortiz V. Differences among patients undergoing perineal or retropubic radical prostatectomy in pain and perioperative variables: a prospective study. BJU Int. 2009;104:1219&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pubmed">19389007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontes J.E., Montie J., Klein E., Huben R. Salvage surgery for radiation failure in prostate cancer. Cancer. 1993;71:976&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">8428347</ArticleId></ArticleIdList></Reference><Reference><Citation>Porpiglia F., Terrone C., Tarabuzzi R., et al. Transperitoneal versus extraperitoneal laparoscopic radical prostatectomy: experience of a single center. Urology. 2006;68:37680.</Citation><ArticleIdList><ArticleId IdType="pubmed">16904456</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassweiler J., Seemann O., Schulze M., Teber D., Hatzinger M., Frede T. Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. J Urol. 2003;169:1689&#x2013;1693.</Citation><ArticleIdList><ArticleId IdType="pubmed">12686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Remzi M., Klingler H.C., Tinzl M.V., et al. Morbidity of laparoscopic extraperitoneal versus transperitoneal radical prostatectomy versus open retropubic radical prostatectomy. Eur Urol. 2005;48:83&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">15967256</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts W.B., Tseng K., Walsh P.C., Han M. Critical appraisal of management of rectal injury during radical prostatectomy. Urology. 2010;76:1088&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pubmed">20646745</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers E., Ohori M., Kassabian V.S., Wheeler T.M., Scardino P.T. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol. 1995;153:104&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">7526002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz L., Salomon L., Hoznek A., et al. Comparison of early oncologic results of laparoscopic radical prostatectomy by extraperitoneal versus transperitoneal approach. Eur Urol. 2004;46:50&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">15183547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson K.M., Penson D.F., Cai J., et al. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol. 2006;176:2025&#x2013;2031.</Citation><ArticleIdList><ArticleId IdType="pubmed">17070244</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitges J., Trinh Q.D., Sun M., et al. Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy. Urology. 2012;79:796&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">22469573</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Fagin R., Shah G., Shekarriz B. Impact of prostate size and body mass index on perioperative morbidity after laparoscopic radical prostatectomy. J Urol. 2005;173:552&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">15643251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sood R., Khattar N., Nayyar R., Kathuria S., Narang V., Kaushal D. Case for resurgence of radical perineal prostatectomy in Indian subcontinent. Indian J Urol. 2012;28:418&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3579122</ArticleId><ArticleId IdType="pubmed">23449760</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinualnad S., Udompunturak S. Extraperitoneal laparoscopic radical prostatectomy: early experience in Thailand. Asian J Surg. 2007;30:272&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">17962131</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein A., Smith R.B., deKernion J.B. Salvage radical prostatectomy after failure of curative radiotherapy for adenocarcinoma of prostate. Urology. 1992;40</Citation><ArticleIdList><ArticleId IdType="pubmed">1523739</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson A.J., Scardino P.T., Bianco F.J., Jr, DiBlasio C.J., Fearn P.A., Eastham J.A. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol. 2004;172:2239&#x2013;2243.</Citation><ArticleIdList><ArticleId IdType="pubmed">15538239</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolzenburg J.U., Kallidonis P., Minh D., et al. Endoscopic extraperitoneal radical prostatectomy: evolution of the technique and experience with 2400 cases. J Endourol. 2009;23:1467&#x2013;1472.</Citation><ArticleIdList><ArticleId IdType="pubmed">19698051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugihara T., Yasunaga H., Horiguchi H., et al. Does mechanical bowel preparation ameliorate damage from rectal injury in radical prostatectomy? Analysis of 151 rectal injury cases. Int J Urol. 2014;21:566&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">24330099</ArticleId></ArticleIdList></Reference><Reference><Citation>Teber D., Cresswell J., Ates M., et al. Laparoscopic radical prostatectomy in clinical T1a and T1b prostate cancer: oncologic and functional outcomes&#x2014;a matched-pair analysis. Urology. 2009;73:577&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">19100598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tewari A., Srivasatava A., Menon M., Members of the VIP Team A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution. BJU Int. 2003;92:205&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">12887468</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel D.D., Chavez M., Brisson T.E. Transition from resident robotic training program to clinical practice: robotic-assisted radical prostatectomy benchmark for perioperative safety. J Laparoendosc Adv Surg Tech A. 2013;23:516&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">23517615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tozawa K., Hashimoto Y., Yasui T., et al. Evaluation of operative complications related to laparoscopic radical prostatectomy. Int J Urol. 2008;15:222&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">18304216</ArticleId></ArticleIdList></Reference><Reference><Citation>Verze P., Greco F., Scuzzarella S., et al. The impact of previous prostate surgery on the outcomes of laparoscopic radical prostatectomy. Minerva Urol Nefrol. 2017;69:76&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">28009148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward J.F., Sebo T.J., Blute M.L., Zincke H. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol. 2005;173:1156&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pubmed">15758726</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster T.M., Newell C., Amrhein J.F., Newell K.J. Cancer Care Ontario guidelines for radical prostatectomy: striving for continuous quality improvement in community practice. Can Urol Assoc J. 2012;6:442&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3526627</ArticleId><ArticleId IdType="pubmed">21914426</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedmid A., Mendoza P., Sharma S., et al. Rectal injury during robot-assisted radical prostatectomy: incidence and management. J Urol. 2011;186:1928&#x2013;1933.</Citation><ArticleIdList><ArticleId IdType="pubmed">21944109</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;ld&#x131;r&#x131;m M., G&#xf6;kta&#x15f; C., Horuz R., et al. Rectal injury during radical prostatectomy. Ulus Travma Acil Cerrahi Derg. 2012;18:250&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">22864718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zincke H., Bergstralh E.J., Blute M.L., et al. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol. 1994;12:2254&#x2013;2263.</Citation><ArticleIdList><ArticleId IdType="pubmed">7964940</ArticleId></ArticleIdList></Reference><Reference><Citation>Galfano A., Secco S., Dell'Oglio P., et al. Retzius-sparing robot-assisted radical prostatectomy: early learning curve experience in three continents. BJU Int. 2021;127:412&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">32745367</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheem A.A., Chang K.D., Alenzi M.J., et al. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: analysis of 359 cases with a median follow-up period of 26 months. Int J Urol. 2018;25:1006&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pubmed">30276864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura M., Mouraviev V., Tsivian M., Mayes J.M., Satoh T., Polascik T.J. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int. 2010;105:191&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">19583717</ArticleId></ArticleIdList></Reference><Reference><Citation>Luciani L.G., Mattevi D., Puglisi M., et al. Robotic-assisted radical prostatectomy following colo-rectal surgery: a user's guide. J Robot Surg. 2022;16:189&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">33743146</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;enaga K.F., Matos D., Wille-J&#xf8;rgensen P. Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev. 2011; 2011::CD001544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7066937</ArticleId><ArticleId IdType="pubmed">21901677</ArticleId></ArticleIdList></Reference><Reference><Citation>Canda A.E., Tilki D., Mottrie A. Rectal injury during radical prostatectomy: focus on robotic surgery. Eur Urol Oncol. 2018;1:507&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">31158095</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz R., Borkowski T., Hoznek A., Salomon L., de la Taille A., Abbou C.C. Operative management of rectal injuries during laparoscopic radical prostatectomy. Urology. 2003;62:310&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">12893341</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo O.A., Bodden E., Vitagliano G. Management of rectal injury during laparoscopic radical prostatectomy. Int Braz J Urol. 2006;32:428&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">16953909</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee D.S., Ornstein D.K. Repair of rectal injury during robotic-assisted laparoscopic prostatectomy. Urology. 2008;72:428&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">18455762</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolay K., Aras B., Tu&#x11f;cu V., Ozbay B., Ayg&#xfc;n E., Ta&#x15f;&#xe7;i A.I. Combined treatment of iatrogenic rectourethral fistula with endoscopic fibrin glue application and clipping. J Endourol. 2007;21:433&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">17451338</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini A., Gandaglia G., Nicita G., Montorsi F. A novel classification proposal for rectourethral fistulas after primary treatment of prostate cancer. Eur Urol Oncol. 2018;1:510&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">31158096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinman L. The management of the complex recto-urethral fistula. BJU Int. 2004;94:1212&#x2013;1213.</Citation><ArticleIdList><ArticleId IdType="pubmed">15610089</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas C., Jones J., J&#xe4;ger W., Hampel C., Th&#xfc;roff J.W., Gillitzer R. Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy. J Urol. 2010;183:608&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">20018317</ArticleId></ArticleIdList></Reference><Reference><Citation>Fengler S.A., Abcarian H. The York Mason approach to repair of iatrogenic rectourinary fistulae. Am J Surg. 1997;173:213&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">9124629</ArticleId></ArticleIdList></Reference><Reference><Citation>Renschler T.D., Middleton R.G. 30 years of experience with York-Mason repair of recto-urinary fistulas. J Urol. 2003;170:1222&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pubmed">14501729</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37598662</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9921</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>4</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes</Title><ISOAbbreviation>Eur Surg Res</ISOAbbreviation></Journal><ArticleTitle>Systematic Review and Meta-Analysis: Association between Preoperative Ustekinumab and Surgical Complications in Crohn's Disease Patients.</ArticleTitle><Pagination><StartPage>412</StartPage><EndPage>421</EndPage><MedlinePgn>412-421</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000533594</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The impact of ustekinumab (UST) therapy on surgical complications in patients with Crohn's disease (CD) remains controversial. The aim of this meta-analysis is to explore the link between these two.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Databases (PubMed, Web of Science, Cochrane, and Springer Link) were searched until April 2022. Studies of CD patients who received UST and no UST prior to surgery (including no biological therapy, anti-tumor necrosis factor-&#x3b1; [anti-TNF-&#x3b1;] agent, and vedolizumab [VDZ]) were included. Primary outcomes included overall complications, infectious complications, and noninfectious complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine studies totaling 3,225 CD patients were enrolled; 332 patients received UST treatment. There was no evidence of difference in the overall complications (odds ratio [OR] = 0.84, p = 0.37, 95% confidence interval [CI] = [0.57-1.23], I2 = 40%) between CD patients who had UST treatment preoperatively and those who had no UST treatment. There was no evidence of a difference in infectious complications (OR = 1.15, p = 0.35, 95% CI = [0.86-1.53], I2 = 2%). Additionally, there was no significant evidence of difference between these groups in terms of noninfectious complications and death. Specifically, there was no evidence of difference in overall complications, infection complications (including wound complications, sepsis, abscess, and anastomotic leakage), and noninfection complications (ileus, readmission, and return to operation), compared with no biological therapy and anti-TNF-&#x3b1; agents. At the same time, no significant evidence of difference was discovered in the comparison of preoperative UST and VDZ therapy in terms of overall complications, infectious complications (sepsis and abscess), and noninfectious complications (intestinal obstruction, readmission, and recovery surgery).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In general, compared with other biological agents, preoperative use of UST in the treatment of CD patients is usually safe and does not increase surgical complications.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s). Published by S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lingna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pharmacy Department, The Affiliated Hospital of Ningbo University, LiHuiLi Hospital, Ningbo, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Dandi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mengting</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yetan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Jingyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Nursing Department, Ningbo No. 2 Hospital, Ningbo, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Eur Surg Res</MedlineTA><NlmUniqueID>0174752</NlmUniqueID><ISSNLinking>0014-312X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>FU77B4U5Z0</RegistryNumber><NameOfSubstance UI="D000069549">Ustekinumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000079424">Tumor Necrosis Factor Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003424" MajorTopicYN="Y">Crohn Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069549" MajorTopicYN="N">Ustekinumab</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079424" MajorTopicYN="N">Tumor Necrosis Factor Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000038" MajorTopicYN="N">Abscess</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Crohn&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Surgical</Keyword><Keyword MajorTopicYN="N">Ustekinumab</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>20</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37598662</ArticleId><ArticleId IdType="pmc">PMC10733938</ArticleId><ArticleId IdType="doi">10.1159/000533594</ArticleId><ArticleId IdType="pii">000533594</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baumgart DC, Sandborn WJ. Crohn&#x2019;s disease. Lancet. 2012 Nov 3;380(9853):1590&#x2013;605. 10.1016/s0140-6736(12)60026-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(12)60026-9</ArticleId><ArticleId IdType="pubmed">22914295</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn&#x2019;s disease. Dis Mon. 2018 Feb;64(2):20&#x2013;57. 10.1016/j.disamonth.2017.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.disamonth.2017.07.001</ArticleId><ArticleId IdType="pubmed">28826742</ArticleId></ArticleIdList></Reference><Reference><Citation>Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, et al. Ustekinumab as induction and maintenance therapy for Crohn&#x2019;s disease. N Engl J Med. 2016 Nov 17;375(20):1946&#x2013;60. 10.1056/nejmoa1602773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1602773</ArticleId><ArticleId IdType="pubmed">27959607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Maintenance infliximab for Crohns disease: the ACCENT I randomised trial. Lancet. 2002 May 4;359(9317):1541&#x2013;9. 10.1016/S0140-6736(02)08512-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)08512-4</ArticleId><ArticleId IdType="pubmed">12047962</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn&#x2019;s disease: the CHARM trial. Gastroenterology. 2007 Jan;132(1):52&#x2013;65. 10.1053/j.gastro.2006.11.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2006.11.041</ArticleId><ArticleId IdType="pubmed">17241859</ArticleId></ArticleIdList></Reference><Reference><Citation>de Buck van Overstraeten A, Wolthuis A, D&#x2019;Hoore A. Surgery for Crohn&#x2019;s disease in the era of biologicals: a reduced need or delayed verdict? World J Gastroenterol. 2012 Aug 7;18(29):3828&#x2013;32. 10.3748/wjg.v18.i29.3828.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v18.i29.3828</ArticleId><ArticleId IdType="pmc">PMC3413054</ArticleId><ArticleId IdType="pubmed">22876034</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ, Loftus EV Jr. Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol. 2012 Nov;107(11):1693&#x2013;701. 10.1038/ajg.2012.298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2012.298</ArticleId><ArticleId IdType="pmc">PMC3572861</ArticleId><ArticleId IdType="pubmed">22945286</ArticleId></ArticleIdList></Reference><Reference><Citation>Holubar SD, Dozois EJ, Privitera A, Pemberton JH, Cima RR, Larson DW. Minimally invasive colectomy for Crohn&#x2019;s colitis: a single institution experience. Inflamm Bowel Dis. 2010 Nov;16(11):1940&#x2013;6. 10.1002/ibd.21265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.21265</ArticleId><ArticleId IdType="pubmed">20848480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lightner AL, McKenna NP, Tse CS, Hyman N, Smith R, Ovsepyan G, et al. Postoperative outcomes in ustekinumab-treated patients undergoing abdominal operations for Crohn&#x2019;s disease. J Crohns Colitis. 2018 Mar 28;12(4):402&#x2013;7. 10.1093/ecco-jcc/jjx163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjx163</ArticleId><ArticleId IdType="pubmed">29220430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lightner AL, Grass F, Alsughayer A, Petersen MM, Raffals LE, Loftus EV Jr. Postoperative outcomes in ustekinumab-treated patients undergoing abdominal operations for Crohn&#x2019;s disease: single-center series. Crohn&#x2019;s and Colitis 360. 2019;1(2). 10.1093/crocol/otz018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/crocol/otz018</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah RS, Bachour S, Jia X, Holubar SD, Hull TL, Achkar JP, et al. Hypoalbuminaemia, not biologic exposure, is associated with postoperative complications in Crohn&#x2019;s disease patients undergoing ileocolic resection. J Crohns Colitis. 2021 Jul 5;15(7):1142&#x2013;51. 10.1093/ecco-jcc/jjaa268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjaa268</ArticleId><ArticleId IdType="pmc">PMC8427722</ArticleId><ArticleId IdType="pubmed">33388775</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd El Aziz MA, Abdalla S, Calini G, Saeed H, Stocchi L, Merchea A, et al. Postoperative safety profile of minimally invasive ileocolonic resections for Crohn&#x2019;s disease in the era of biologic therapy. J Crohns Colitis. 2022 Jan 19;16(7):1079&#x2013;88. jjac012. 10.1093/ecco-jcc/jjac012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjac012</ArticleId><ArticleId IdType="pubmed">35045164</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia MJ, Rivero M, Miranda-Bautista J, Baston-Rey I, Mesonero F, Leo-Carnerero E, et al. Impact of biological agents on postsurgical complications in inflammatory bowel disease: a multicentre study of geteccu. J Clin Med. 2021 Sep 26;10(19):4402. 10.3390/jcm10194402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194402</ArticleId><ArticleId IdType="pmc">PMC8509475</ArticleId><ArticleId IdType="pubmed">34640421</ArticleId></ArticleIdList></Reference><Reference><Citation>Novello M, Stocchi L, Holubar S, Shawki S, Lipman J, Gorgun E, et al. Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis. Int J Colorectal Dis. 2019 Mar;34(3):451&#x2013;7. 10.1007/s00384-018-3212-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-018-3212-6</ArticleId><ArticleId IdType="pubmed">30535559</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim HH, Ma C, Kotze PG, Seow CH, Al-Farhan H, Al-Darmaki AK, et al. Preoperative ustekinumab treatment is not associated with increased postoperative complications in Crohn&#x2019;s disease: a Canadian multi-centre observational cohort study. J Can Assoc Gastroenterol. 2018 Sep;1(3):115&#x2013;23. 10.1093/jcag/gwy013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jcag/gwy013</ArticleId><ArticleId IdType="pmc">PMC6507292</ArticleId><ArticleId IdType="pubmed">31294352</ArticleId></ArticleIdList></Reference><Reference><Citation>Buisson A, Nancey S, Manlay L, Rubin DT, Hebuterne X, Pariente B, et al. Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn&#x2019;s disease. United Eur Gastroenterol J. 2021 Jun;9(5):552&#x2013;60. 10.1002/ueg2.12068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ueg2.12068</ArticleId><ArticleId IdType="pmc">PMC8259431</ArticleId><ArticleId IdType="pubmed">33951350</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino M, Ikeuchi H, Horio Y, Kuwahara R, Minagawa T, Kusunoki K, et al. Association between preoperative biologic use and surgical morbidity in patients with Crohn&#x2019;s disease. Int J Colorectal Dis. 2022 May;37(5):999&#x2013;1010. 10.1007/s00384-022-04140-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-022-04140-8</ArticleId><ArticleId IdType="pubmed">35384495</ArticleId></ArticleIdList></Reference><Reference><Citation>Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets. 2009 Mar;8(1):40&#x2013;52. 10.2174/187152809787582507.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152809787582507</ArticleId><ArticleId IdType="pubmed">19275692</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson JM, Peritt D, Scallon BJ, Heavner GA, Shealy DJ, Giles-Komar JM, et al. Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders. MAbs. 2011 Nov-Dec;3(6):535&#x2013;45. 10.4161/mabs.3.6.17815.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/mabs.3.6.17815</ArticleId><ArticleId IdType="pmc">PMC3242840</ArticleId><ArticleId IdType="pubmed">22123062</ArticleId></ArticleIdList></Reference><Reference><Citation>Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, et al. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA. 1996 Nov 26;93(24):14002&#x2013;7. 10.1073/pnas.93.24.14002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.24.14002</ArticleId><ArticleId IdType="pmc">PMC19484</ArticleId><ArticleId IdType="pubmed">8943050</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003 Jan 17;278(3):1910&#x2013;4. 10.1074/jbc.M207577200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207577200</ArticleId><ArticleId IdType="pubmed">12417590</ArticleId></ArticleIdList></Reference><Reference><Citation>Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007 Jul 26;448(7152):427&#x2013;34. 10.1038/nature06005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06005</ArticleId><ArticleId IdType="pubmed">17653185</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaluso FS, Orlando A, Cottone M. Anti-interleukin-12 and anti-interleukin-23 agents in Crohn&#x2019;s disease. Expert Opin Biol Ther. 2019 Feb;19(2):89&#x2013;98. 10.1080/14712598.2019.1561850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2019.1561850</ArticleId><ArticleId IdType="pubmed">30571147</ArticleId></ArticleIdList></Reference><Reference><Citation>Alazawi W, Pirmadjid N, Lahiri R, Bhattacharya S. Inflammatory and immune responses to surgery and their clinical impact. Ann Surg. 2016 Jul;264(1):73&#x2013;80. 10.1097/SLA.0000000000001691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001691</ArticleId><ArticleId IdType="pubmed">27275778</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo D, Jiang K, Hong J, Zhang M, Shi Y, Zhou B. Association between vedolizumab and postoperative complications in IBD: a systematic review and meta-analysis. Int J Colorectal Dis. 2021 Oct;36(10):2081&#x2013;92. 10.1007/s00384-021-04017-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-021-04017-2</ArticleId><ArticleId IdType="pubmed">34467414</ArticleId></ArticleIdList></Reference><Reference><Citation>Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013 Aug 22;369(8):699&#x2013;710. 10.1056/nejmoa1215734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1215734</ArticleId><ArticleId IdType="pubmed">23964932</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar HJ, Markandey B, Ma C, Ramsewak D, Walsh JC, Jairath V. Vedolizumab induced clinical, endoscopic, and histological improvement in common variable immunodeficiency disease-associated intestinal enteropathy. Inflamm Bowel Dis. 2020 Mar 4;26(4):e22&#x2013;3. 10.1093/ibd/izaa012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izaa012</ArticleId><ArticleId IdType="pubmed">32002555</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller-Heck RM, Bosken B, Michiels I, Dudda M, Jager M, Flohe SB. Major surgical trauma impairs the function of natural killer cells but does not affect monocyte cytokine synthesis. Life. 2021 Dec 22;12(1):13. 10.3390/life12010013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12010013</ArticleId><ArticleId IdType="pmc">PMC8777869</ArticleId><ArticleId IdType="pubmed">35054405</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensler T, Heidecke CD, Hecker H, Heeg K, Bartels H, Zantl N, et al. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol. 1998 Sep 1;161(5):2655&#x2013;9. 10.4049/jimmunol.161.5.2655.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.161.5.2655</ArticleId><ArticleId IdType="pubmed">9725269</ArticleId></ArticleIdList></Reference><Reference><Citation>Weighardt H, Heidecke CD, Westerholt A, Emmanuilidis K, Maier S, Veit M, et al. Impaired monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis. Ann Surg. 2002 Apr;235(4):560&#x2013;7. 10.1097/00000658-200204000-00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-200204000-00015</ArticleId><ArticleId IdType="pmc">PMC1422472</ArticleId><ArticleId IdType="pubmed">11923613</ArticleId></ArticleIdList></Reference><Reference><Citation>Noviello D, Mager R, Roda G, Borroni RG, Fiorino G, Vetrano S. The IL23-IL17 immune Axis in the treatment of ulcerative colitis: successes, defeats, and ongoing challenges. Front Immunol. 2021 May 17;12:611256. 10.3389/fimmu.2021.611256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.611256</ArticleId><ArticleId IdType="pmc">PMC8165319</ArticleId><ArticleId IdType="pubmed">34079536</ArticleId></ArticleIdList></Reference><Reference><Citation>The FO, Bennink RJ, Ankum WM, Buist MR, Busch OR, Gouma DJ, et al. Intestinal handling-induced mast cell activation and inflammation in human postoperative ileus. Gut. 2008 Jan;57(1):33&#x2013;40. 10.1136/gut.2007.120238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2007.120238</ArticleId><ArticleId IdType="pubmed">17591620</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeckxstaens GE, de Jonge WJ. Neuroimmune mechanisms in postoperative ileus. Gut. 2009 Sep;58(9):1300&#x2013;11. 10.1136/gut.2008.169250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2008.169250</ArticleId><ArticleId IdType="pubmed">19671558</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29148123</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2018</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Donohue syndrome: A review of literature, case series, and anesthetic considerations.</ArticleTitle><Pagination><StartPage>23</StartPage><EndPage>27</EndPage><MedlinePgn>23-27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pan.13273</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Donohue syndrome is a rare autosomal recessive disorder of insulin resistance, causing a functional defect in insulin receptor function, and affecting the ability of the insulin to bind the receptor. Features include severe hyperinsulinism and fasting hypoglycemia, along with severe failure to thrive despite feeding. An accelerated fasting state results in muscle wasting, decreased subcutaneous fat, and an excess of thick skin. A reduced thoracic diameter is accentuated by increased abdominal distension, which impacts on respiratory reserve. Cardiac disease develops early in life, with progressive hypertrophic cardiomyopathy as a result of hyperinsulinism. Prognosis is poor with the majority of patients dying in infancy of sepsis. The aim of this review is to report our experience of providing anesthesia for patients with Donohue syndrome, and inform guidance for safe management of these children, based on a comprehensive literature review.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search was carried out using PubMed, Medline, and the Cochrane Library, and using the MESH search terms detailed below. Patients were identified by formal request to the department of pediatric endocrinology at Great Ormond Street Hospital. Each patient's notes were searched manually and electronically for both clinical presentation and outcome, and anesthesia records.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">There is currently no published literature relating to anesthetic management of Donohue syndrome. We report a case series of 5 patients with Donohue syndrome who have presented to our institution. This small series of children with this complex disorder demonstrates a clearly increased risk of general anesthesia. Many of the risks relate to restrictive lung disease and abdominal distension which worsens with bag valve mask ventilation and limited respiratory reserve which leads to precipitous desaturation. During induction, a spontaneously breathing technique is recommended. If required, bag valve mask ventilation should be accompanied by constant gastric aspiration. Intubation is challenging, and a difficult airway plan, including a second experienced anesthetist and ENT support, should be in place. These children are predisposed to developing cardiomyopathy and therefore at risk of cardiovascular collapse under anesthesia.</AbstractText><CopyrightInformation>&#xa9; 2017 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kirkwood</LastName><ForeName>Alana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1867-7186</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia, Great Ormond Street Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>Grant</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Great Ormond Street Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harding</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Great Ormond Street Hospital, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="N">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056731" MajorTopicYN="N">Donohue Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Donohue syndrome</Keyword><Keyword MajorTopicYN="N">Mendenhall syndrome</Keyword><Keyword MajorTopicYN="N">insulin</Keyword><Keyword MajorTopicYN="N">insulin resistance</Keyword><Keyword MajorTopicYN="N">leprechaunism</Keyword><Keyword MajorTopicYN="N">receptor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29148123</ArticleId><ArticleId IdType="doi">10.1111/pan.13273</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31991422</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1661-7819</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>3</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Neonatology</Title><ISOAbbreviation>Neonatology</ISOAbbreviation></Journal><ArticleTitle>Epidural-Related Fever and Maternal and Neonatal Morbidity: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>259</StartPage><EndPage>270</EndPage><MedlinePgn>259-270</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000504805</ELocationID><Abstract><AbstractText Label="BACKGROUND">While epidural analgesia (EA) is associated with maternal fever during labor, the impact on the risk for maternal and/or neonatal sepsis is unknown.</AbstractText><AbstractText Label="OBJECTIVES">The aim of this systematic review was to investigate the effect of epidural-related intrapartum fever on maternal and neonatal outcomes.</AbstractText><AbstractText Label="METHODS">OVID MEDLINE, OVID Embase, the Cochrane Library, Cochrane Controlled Register of Trials, and clinical trial registries were searched for randomized controlled trials (RCT) and observational cohort studies from inception to November 2018. A total of 761 studies were identified with 100 eligible for full-text review. Only articles investigating the relationship between EA and maternal fever during labor were eligible for inclusion. Study quality was assessed using the Cochrane's Risk of Bias tool and National Institute of Health Quality Assessment Tool. Two meta-analyses - one each for the RCT and observational cohort groups - were performed using the random-effects model of Mantel-Haenszel to produce summary risk ratios (RR) with 95% CI.</AbstractText><AbstractText Label="RESULTS">Twelve RCTs and 16 observational cohort studies involving 579,157 parturients were included. RRs for maternal fever for the RCT and cohort analyses were 3.54 (95% CI 2.61-4.81) and 5.60 (95% CI 4.50-6.97), respectively. Meta-analyses of RR for maternal infection in both groups were infeasible given few occurrences. Meta-analysis of data from observational studies showed an increased risk for maternal antibiotic treatment in the epidural group (RR 2.60; 95% CI 1.31-5.17). For both analyses, neonates born to women with an epidural were not evaluated more often for suspected sepsis. Neither analysis reported an increased rate of neonatal bacteremia or neonatal antibiotic treatment after EA, although data precluded conclusiveness.</AbstractText><AbstractText Label="CONCLUSION">EA increases the risk of intrapartum fever and maternal antibiotic treatment. However, a definite conclusion on whether EA increases the risk for a proven maternal and/or neonatal bacteremia cannot be drawn due to the low quality of data. Further research on whether epidural-related intrapartum fever is of infectious origin or not is therefore needed.</AbstractText><CopyrightInformation>&#xa9; 2020 The Author(s) Published by S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Leiden University Medical Center (LUMC), Leiden, The Netherlands, s.j.jansen@lumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopriore</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naaktgeboren</LastName><ForeName>Christiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Medical Center Utrecht (UMCU), Department of Data Management and Research Support, Julius Center for Health Science and Primary Care, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sueters</LastName><ForeName>Marieke</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limpens</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Library, Research Support, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Leeuwen</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Amsterdam University Medical Center (UMC), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekker</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity Amsterdam (CINIMA), Emma Children's Hospital, Amsterdam University Medical Center (UMC), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Neonatology</MedlineTA><NlmUniqueID>101286577</NlmUniqueID><ISSNLinking>1661-7800</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015360" MajorTopicYN="Y">Analgesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036801" MajorTopicYN="N">Parturition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidural analgesia</Keyword><Keyword MajorTopicYN="N">Maternal fever</Keyword><Keyword MajorTopicYN="N">Neonatal sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31991422</ArticleId><ArticleId IdType="doi">10.1159/000504805</ArticleId><ArticleId IdType="pii">000504805</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33264235</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1529-7535</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies</Title><ISOAbbreviation>Pediatr Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Echocardiographic Parameters and Mortality in Pediatric Sepsis: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>261</EndPage><MedlinePgn>251-261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PCC.0000000000002622</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We conducted a systematic review and meta-analysis to investigate the prognostic value of echocardiographic parameters in pediatric septic patients.</AbstractText><AbstractText Label="DATA SOURCES">MEDLINE, PubMed, and EMBASE (last update April 5, 2020).</AbstractText><AbstractText Label="STUDY SELECTION">Observational studies of pediatric sepsis providing echocardiographic parameters in relation to mortality.</AbstractText><AbstractText Label="DATA EXTRACTION">Echocardiography data were categorized as those describing left ventricular systolic or diastolic function, right ventricular function, and strain echocardiography parameters. Data from neonates and children were considered separately. Analysis is reported as standardized mean difference and 95% CI.</AbstractText><AbstractText Label="DATA SYNTHESIS">We included data from 14 articles (n = 5 neonates, n = 9 children). The fractional shortening was the most commonly reported variable (11 studies, n = 555 patients) and we did not identify an association with mortality (standardized mean difference 0.22, 95% CI [-0.02 to 0.47]; p = 0.07, I2 = 28%). In addition, we did not find any association with mortality also for left ventricular ejection fraction (nine studies, n = 417; standardized mean difference 0.06, 95% CI [-0.27 to 0.40]; p = 0.72, I2 = 51%), peak velocity of systolic mitral annular motion determined by tissue Doppler imaging wave (four studies, n = 178; standardized mean difference -0.01, 95% CI [-0.34 to 0.33]; p = 0.97, I2 = 0%), and myocardial performance index (five studies, n = 219; standardized mean difference -0.51, 95% CI [-1.10 to 0.08]; p = 0.09, I2 = 63%). However, in regard to left ventricular diastolic function, there was an association with mortality for higher early wave of transmitral flow/peak velocity of early diastolic mitral annular motion determined by tissue Doppler imaging ratio (four studies, n = 189, standardized mean difference -0.45, 95% CI [-0.80 to -0.10]; p = 0.01, I2 = 0%) or lower peak velocity of early diastolic mitral annular motion determined by tissue Doppler imaging wave (three studies, n = 159; standardized mean difference 0.49, 95% CI [0.13-0.85]; p = 0.008, I2 = 0%). We did not find any association with mortality for early wave of transmitral flow/late (atrial) wave of trans-mitral flow ratio (six studies, n = 273; standardized mean difference 0.28, 95% CI [-0.42 to 0.99]; p = 0.43, I2 = 81%) and peak velocity of systolic mitral annular motion determined by tissue Doppler imaging wave measured at the tricuspid annulus (three studies, n = 148; standardized mean difference -0.18, 95% CI [-0.53 to 0.17]; p = 0.32, I2 = 0%). Only a few studies were conducted with strain echocardiography.</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis of echocardiography parameters in pediatric sepsis failed to find any association between the measures of left ventricular systolic or right ventricular function and mortality. However, mortality was associated with higher early wave of transmitral flow/peak velocity of early diastolic mitral annular motion determined by tissue Doppler imaging or lower peak velocity of early diastolic mitral annular motion determined by tissue Doppler imaging, indicating possible importance of left ventricular diastolic dysfunction. These are preliminary findings because of high clinical heterogeneity in the studies to date.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Rosa</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Anaesthesia and Intensive Care, University Hospital "G. Rodolico," University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grasso</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Anaesthesia and Intensive Care, University Hospital "G. Rodolico," University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santonocito</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minardi</LastName><ForeName>Carmelo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacobelli</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Cardiology Unit, Bambino Gesu' Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astuto</LastName><ForeName>Marinella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Anaesthesia and Intensive Care, University Hospital "G. Rodolico," University of Catania, Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Surgery and Medical-Surgical Specialties, Section of Anesthesia and Intensive Care, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Crit Care Med</MedlineTA><NlmUniqueID>100954653</NlmUniqueID><ISSNLinking>1529-7535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Pediatr Crit Care Med. 2021 Mar 1;22(3):329-332. doi: 10.1097/PCC.0000000000002671.</RefSource><PMID Version="1">33657615</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001783" MajorTopicYN="N">Blood Flow Velocity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018619" MajorTopicYN="N">Echocardiography, Doppler, Pulsed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="Y">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33264235</ArticleId><ArticleId IdType="doi">10.1097/PCC.0000000000002622</ArticleId><ArticleId IdType="pii">00130478-202103000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al.: The global burden of paediatric and neonatal sepsis: A systematic review. Lancet Respir Med. 2018; 6:223&#x2013;230</Citation></Reference><Reference><Citation>Liu L, Oza S, Hogan D, et al.: Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis. Lancet. 2015; 385:430&#x2013;440</Citation></Reference><Reference><Citation>Weiss SL, Fitzgerald JC, Pappachan J, et al.; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015; 191:1147&#x2013;1157</Citation></Reference><Reference><Citation>Kaur G, Vinayak N, Mittal K, et al.: Clinical outcome and predictors of mortality in children with sepsis, severe sepsis, and septic shock from Rohtak, Haryana: A prospective observational study. Indian J Crit Care Med. 2014; 18:437&#x2013;441</Citation></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6:2&#x2013;8</Citation></Reference><Reference><Citation>Raj S, Killinger JS, Gonzalez JA, et al.: Myocardial dysfunction in pediatric septic shock. J Pediatr. 2014; 164:72&#x2013;77.e2</Citation></Reference><Reference><Citation>Sanfilippo F, Orde S, Oliveri F, et al.: The challenging diagnosis of septic cardiomyopathy. Chest. 2019; 156:635&#x2013;636</Citation></Reference><Reference><Citation>Weiss SL, Balamuth F, Hensley J, et al.: The epidemiology of hospital death following pediatric severe sepsis: When, why, and how children with sepsis die. Pediatr Crit Care Med. 2017; 18:823&#x2013;830</Citation></Reference><Reference><Citation>Weiss SL, Peters MJ, Alhazzani W, et al.: Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020; 21:e52&#x2013;e106</Citation></Reference><Reference><Citation>Davis AL, Carcillo JA, Aneja RK, et al.: American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med. 2017; 45:1061&#x2013;1093</Citation></Reference><Reference><Citation>Expert Round Table on Echocardiography in ICU. International consensus statement on training standards for advanced critical care echocardiography. Intensive Care Med. 2014; 40:654&#x2013;666</Citation></Reference><Reference><Citation>Vieillard-Baron A, Millington SJ, Sanfilippo F, et al.: A decade of progress in critical care echocardiography: A narrative review. Intensive Care Med. 2019; 45:770&#x2013;788</Citation></Reference><Reference><Citation>Sanfilippo F, Corredor C, Arcadipane A, et al.: Tissue Doppler assessment of diastolic function and relationship with mortality in critically ill septic patients: A systematic review and meta-analysis. Br J Anaesth. 2017; 119:583&#x2013;594</Citation></Reference><Reference><Citation>Sanfilippo F, Corredor C, Fletcher N, et al.: Diastolic dysfunction and mortality in septic patients: A systematic review and meta-analysis. Intensive Care Med. 2015; 41:1004&#x2013;1013</Citation></Reference><Reference><Citation>Sanfilippo F, Corredor C, Fletcher N, et al.: Erratum to: Diastolic dysfunction and mortality in septic patients: A systematic review and meta-analysis. Intensive Care Med. 2015; 41:1178&#x2013;1179</Citation></Reference><Reference><Citation>Sanfilippo F, Corredor C, Fletcher N, et al.: Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: A systematic review and meta-analysis. Crit Care. 2018; 22:183</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al.: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol. 2009; 62:e1&#x2013;34</Citation></Reference><Reference><Citation>Luo D, Wan X, Liu J, et al.: Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018; 27:1785&#x2013;1805</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, et al.: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14:135</Citation></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D, et al.: The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm . Accessed July 10, 2020</Citation></Reference><Reference><Citation>Jain A, Sankar J, Anubhuti A, et al.: Prevalence and outcome of sepsis-induced myocardial dysfunction in children with &#x2018;sepsis&#x2019; &#x2018;with&#x2019; and &#x2018;without shock&#x2019;-a prospective observational study. J Trop Pediatr. 2018; 64:501&#x2013;509</Citation></Reference><Reference><Citation>Sankar J, Das RR, Jain A, et al.: Prevalence and outcome of diastolic dysfunction in children with fluid refractory septic shock&#x2013;a prospective observational study. Pediatr Crit Care Med. 2014; 15:e370&#x2013;e378</Citation></Reference><Reference><Citation>Abdel-Hady HE, Matter MK, El-Arman MM: Myocardial dysfunction in neonatal sepsis: A tissue Doppler imaging study. Pediatr Crit Care Med. 2012; 13:318&#x2013;323</Citation></Reference><Reference><Citation>Baranwal AK, Deepthi G, Rohit MK, et al.: Longitudinal study of CPK-MB and echocardiographic measures of myocardial dysfunction in pediatric sepsis: Are patients with shock different from those without? Indian J Crit Care Med. 2020; 24:109&#x2013;115</Citation></Reference><Reference><Citation>Domico M, Liao P, Anas N, et al.: Elevation of brain natriuretic peptide levels in children with septic shock. Pediatr Crit Care Med. 2008; 9:478&#x2013;483</Citation></Reference><Reference><Citation>El-Zayat RS, Shalaby AG: Mitral annular plane systolic excursion as a predictor of mortality in children with septic shock. Pediatr Crit Care Med. 2018; 19:e486&#x2013;e494</Citation></Reference><Reference><Citation>Fahmey SS, Hodeib M, Refaat K, et al.: Evaluation of myocardial function in neonatal sepsis using tissue Doppler imaging. Journal Matern Fetal Neonatal Med. 2019; 33:3752&#x2013;3756</Citation></Reference><Reference><Citation>Li J, Ning B, Wang Y, et al.: The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis. Medicine (Baltimore). 2019; 98:e15070</Citation></Reference><Reference><Citation>Tomerak RH, El-Badawy AA, Hussein G, et al.: Echocardiogram done early in neonatal sepsis: What does it add? J Invest Med. 2012; 60:680&#x2013;684</Citation></Reference><Reference><Citation>Williams FZ, Sachdeva R, Travers CD, et al.: Characterization of myocardial dysfunction in fluid- and catecholamine-refractory pediatric septic shock and its clinical significance. J Intensive Care Med. 2019; 34:17&#x2013;25</Citation></Reference><Reference><Citation>Wu JR, Chen IC, Dai ZK, et al.: Early elevated b-type natriuretic peptide levels are associated with cardiac dysfunction and poor clinical outcome in pediatric septic patients. Acta Cardiol Sin. 2015; 31:485&#x2013;493</Citation></Reference><Reference><Citation>Carmona F, Manso PH, Silveira VS, et al.: Inflammation, myocardial dysfunction, and mortality in children with septic shock: An observational study. Pediatr Cardiol. 2014; 35:463&#x2013;470</Citation></Reference><Reference><Citation>Patel MD, Mariano K, Dunbar T, et al.: Cardiac dysfunction identified by strain echocardiography is associated with illness severity in pediatric sepsis. Pediatr Crit Care Med. 2020; 21:e192&#x2013;e199</Citation></Reference><Reference><Citation>Saini SS, Kumar P, Kumar RM: Hemodynamic changes in preterm neonates with septic shock: A prospective observational study*. Pediatr Crit Care Med. 2014; 15:443&#x2013;450</Citation></Reference><Reference><Citation>Haileselassie B, Su E, Pozios I, et al.: Strain echocardiography parameters correlate with disease severity in children and infants with sepsis. Pediatr Crit Care Med. 2016; 17:383&#x2013;390</Citation></Reference><Reference><Citation>Basu S, Frank LH, Fenton KE, et al.: Two-dimensional speckle tracking imaging detects impaired myocardial performance in children with septic shock, not recognized by conventional echocardiography. Pediatr Crit Care Med. 2012; 13:259&#x2013;264</Citation></Reference><Reference><Citation>Huang S, Sanfilippo F, Herpain A, et al.: Systematic review and literature appraisal on methodology of conducting and reporting critical-care echocardiography studies: A report from the European Society of Intensive Care Medicine PRICES expert panel. Ann Intensive Care. 2020; 10:49</Citation></Reference><Reference><Citation>Sanfilippo F, Scolletta S, Morelli A, et al.: Practical approach to diastolic dysfunction in light of the new guidelines and clinical applications in the operating room and in the intensive care. Ann Intensive Care. 2018; 8:100</Citation></Reference><Reference><Citation>Dallaire F, Slorach C, Hui W, et al.: Reference values for pulse wave Doppler and tissue Doppler imaging in pediatric echocardiography. Circ Cardiovasc Imaging. 2015; 8:e002167</Citation></Reference><Reference><Citation>Nagueh SF, Smiseth OA, Appleton CP, et al.; Houston, Texas; Oslo, Norway; Phoenix, Arizona; Nashville, Tennessee; Hamilton, Ontario, Canada; Uppsala, Sweden; Ghent and Li&#xe8;ge, Belgium; Cleveland, Ohio; Novara, Italy; Rochester, Minnesota; Bucharest, Romania; and St. Louis, Missouri. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016; 17:1321&#x2013;1360</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36325342</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Diagnostic value of RDW for the prediction of mortality in adult sepsis patients: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>997853</StartPage><MedlinePgn>997853</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">997853</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.997853</ELocationID><Abstract><AbstractText Label="BACKGROUND">Red blood cell distribution width (RDW) is a common biomarker of bacterial infections, and it can be easily obtained from a routine blood test. We investigate the diagnostic value of RDW for the prediction of mortality in adult sepsis patients through a review and meta-analysis. We registered this review in PROSPERO (Registration Number: CRD42022357712), and the details of the registration are included in Appendix 1.</AbstractText><AbstractText Label="METHODS">We searched PubMed, Cochrane Library, Springer, and Embase between Jan. 1, 2000, and May 30, 2022, for primary studies about this research. We collected articles that investigated RDW for varying degrees of sepsis patients-those who suffered from sepsis, severe sepsis, or sepsis shock. Studies of healthy people and sepsis of children and neonates were excluded from our research. The definition of study characteristics and data extraction were finished by two independent researchers and discrepancies resolved by consensus. The combined sensitivities and specificities were calculated by meta-analysis using STATA14.0. The sensitivity of the included studies was analyzed by excluding studies that had potential heterogeneity. A summary operating characteristic curve was made to evaluate the diagnostic value for the prediction of mortality in adult sepsis patients. The Fagan test was used to explore likelihood ratios and posttest probabilities. Finally, we investigated the source of heterogeneity using meta-regression.</AbstractText><AbstractText Label="RESULTS">Twenty-four studies, including 40,763 cases altogether, were included in this analysis. Bivariate analysis indicated a combined sensitivity of 0.81 (95% CI 0.73-0.86) and specificity of 0.65 (95% CI 0.54-0.75). The area under the summary receiver operating characteristic curve was 0.81 (95% CI 0.77-0.84). Substantial heterogeneity resided in the studies (<i>I<sup>2 =</sup></i> 96.68, 95% CI 95.95-97.4). Meta-regression showed that the reference description, prospective design, and blinded interpretation of the included studies could be responsible for the heterogeneity.</AbstractText><AbstractText Label="CONCLUSIONS">RWD is an available and valuable biomarker for prediction of mortality in adult sepsis patients.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION">https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022357712.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wu, Liao, Cao, Ji, Huang and Ma.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hongsheng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hepatobiliary Pancreatic Surgery Department, Affiliated Huadu Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Biling</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hepatobiliary Pancreatic Surgery Department, Affiliated Huadu Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Tiansheng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hepatobiliary Pancreatic Surgery Department, Affiliated Huadu Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Tengfei</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hepatobiliary Pancreatic Surgery Department, Affiliated Huadu Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jianbin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hepatobiliary Pancreatic Surgery Department, Affiliated Huadu Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Keqiang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Hepatobiliary Pancreatic Surgery Department, Affiliated Huadu Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diagnostic value</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">red blood cell distribution width</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>2</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36325342</ArticleId><ArticleId IdType="pmc">PMC9618606</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.997853</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Esposito S, De Simone G, Boccia G, De Caro F, Pagliano P. Sepsis and septic shock: New definitions, new diagnostic and therapeutic approaches. J Global antimicrob. resist. (2017) 10:204&#x2013;12. doi:&#xa0;10.1016/j.jgar.2017.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgar.2017.06.013</ArticleId><ArticleId IdType="pubmed">28743646</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracht H, Hafner S, Wei&#xdf; M. Sepsis update: Definition and epidemiology. Anasthesiol. Intensivmedizin Notfallmedizin Schmerztherapie AINS. (2019) 54(1):10&#x2013;20. doi: 10.1055/a-0625-5492</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0625-5492</ArticleId><ArticleId IdType="pubmed">30620952</ArticleId></ArticleIdList></Reference><Reference><Citation>Salom&#xe3;o R, Ferreira BL, Salom&#xe3;o MC, Santos SS, Azevedo LCP, Brunialti MKC. Sepsis: evolving concepts and challenges. Braz J Med Biol Res = Rev Bras pesquisas medicas e biologicas. (2019) 52(4):e8595. doi:&#xa0;10.1590/1414-431X20198595</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431X20198595</ArticleId><ArticleId IdType="pmc">PMC6472937</ArticleId><ArticleId IdType="pubmed">30994733</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson K, Venkatesh B, Finfer S. Sepsis and septic shock: Current approaches to management. Internal Med J (2019) 49(2):160&#x2013;70. doi: 10.1111/imj.14199</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.14199</ArticleId><ArticleId IdType="pubmed">30754087</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcarea A, Sovaila S. Sepsis, a 2020 review for the internist. Romanian J Internal Med = Rev roumaine med interne. (2020) 58(3):129&#x2013;37. doi: 10.2478/rjim-2020-0012</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rjim-2020-0012</ArticleId><ArticleId IdType="pubmed">32396142</ArticleId></ArticleIdList></Reference><Reference><Citation>Opal SM, Wittebole X. Biomarkers of infection and sepsis. Crit Care clinics. (2020) 36(1):11&#x2013;22. doi: 10.1016/j.ccc.2019.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2019.08.002</ArticleId><ArticleId IdType="pubmed">31733673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yu CH, Guo KP, Huang CZ, Mo LY. Prognostic role of red blood cell distribution width in patients with sepsis: a systematic review and meta-analysis. BMC Immunol (2020) 21(1):40. doi: 10.1186/s12865-020-00369-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12865-020-00369-6</ArticleId><ArticleId IdType="pmc">PMC7339553</ArticleId><ArticleId IdType="pubmed">32631218</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Zhou H, Tang Q. Red blood cell distribution width: A novel predictive indicator for cardiovascular and cerebrovascular diseases. Dis markers. (2017) 2017:7089493. doi: 10.1155/2017/7089493</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7089493</ArticleId><ArticleId IdType="pmc">PMC5606102</ArticleId><ArticleId IdType="pubmed">29038615</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x10d;as JW. Toward a blood-borne biomarker of chronic hypoxemia: Red cell distribution width and respiratory disease. Adv Clin Chem (2017) 82:105&#x2013;97. doi: 10.1016/bs.acc.2017.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.acc.2017.06.002</ArticleId><ArticleId IdType="pubmed">28939210</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X, Deng H, Wang X, Fu S, Liu Z, Sang J, et al. . Association of red blood cell distribution width with severity of hepatitis b virus-related liver diseases. Clinica Chimica Acta; Int J Clin Chem (2018) 482:155&#x2013;60. doi: 10.1016/j.cca.2018.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2018.04.002</ArticleId><ArticleId IdType="pubmed">29627486</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand S, Krishnan N, Juki&#x107; M, Kri&#x17e;anac Z, Llorente Mu&#xf1;oz CM, Pogoreli&#x107; Z. Utility of red cell distribution width (RDW) as a noninvasive biomarker for the diagnosis of acute appendicitis: A systematic review and meta-analysis of 5222 cases. Diagn (Basel Switzerland) (2022) 12(4):1&#x2013;11. doi: 10.3390/diagnostics12041011</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12041011</ArticleId><ArticleId IdType="pmc">PMC9032964</ArticleId><ArticleId IdType="pubmed">35454059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HB, Chen J, Lan QF, Ma XJ, Zhang SY. Diagnostic values of red cell distribution width, platelet distribution width and neutrophil-lymphocyte count ratio for sepsis. Exp Ther Med (2016) 12(4):2215&#x2013;9. doi: 10.3892/etm.2016.3583</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3583</ArticleId><ArticleId IdType="pmc">PMC5038364</ArticleId><ArticleId IdType="pubmed">27698714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CH, Park JT, Kim EJ, Han JH, Han JS, Choi JY, et al. . An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Crit Care (London England). (2013) 17(6):R282. doi: 10.1186/cc13145</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13145</ArticleId><ArticleId IdType="pmc">PMC4056357</ArticleId><ArticleId IdType="pubmed">24321201</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogan P, Guney Varal I. Red cell distribution width as a predictor of late-onset gram-negative sepsis. Pediatr Int Off J Japan Pediatr Society. (2020) 62(3):341&#x2013;6. doi: 10.1111/ped.14123</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.14123</ArticleId><ArticleId IdType="pubmed">31880020</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. . The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama (2016) 315(8):801&#x2013;10. doi: 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. . 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med (2003) 29(4):530&#x2013;8. doi: 10.1007/s00134-003-1662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1662-x</ArticleId><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res methodol. (2003) 3:25. doi: 10.1186/1471-2288-3-25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-3-25</ArticleId><ArticleId IdType="pmc">PMC305345</ArticleId><ArticleId IdType="pubmed">14606960</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. . The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ (2021) 372:n71. doi:&#xa0;10.1186/s13643-021-01626-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01626-4</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CK, Lin SC, Wu CC, Chen LM, Tzeng IS, Chen KF. STARD-compliant article: The utility of red cell distribution width to predict mortality for septic patients visiting the emergency department. Medicine (2016) 95(24):e3692. doi: 10.1097/MD.0000000000003692</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003692</ArticleId><ArticleId IdType="pmc">PMC4998434</ArticleId><ArticleId IdType="pubmed">27310948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TH, Hsu YC. Red cell distribution width as a prognostic factor and its comparison with lactate in patients with sepsis. Diagn (Basel Switzerland) (2021) 11(8):1&#x2013;9. doi: 10.3390/diagnostics11081474</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11081474</ArticleId><ArticleId IdType="pmc">PMC8394551</ArticleId><ArticleId IdType="pubmed">34441408</ArticleId></ArticleIdList></Reference><Reference><Citation>Dankl D, Rezar R, Mamandipoor B, Zhou Z, Wernly S, Wernly B, et al. . Red cell distribution width is independently associated with mortality in sepsis. Med Princ Pract (2022) 31(2):187&#x2013;94. doi: 10.1159/000522261</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522261</ArticleId><ArticleId IdType="pmc">PMC9209973</ArticleId><ArticleId IdType="pubmed">35093953</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo YH, Kim K, Lee JH, Kang C, Kim T, Park HM, et al. . Red cell distribution width is a prognostic factor in severe sepsis and septic shock. Am J Emergency Med (2013) 31(3):545&#x2013;8. doi: 10.1016/j.ajem.2012.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2012.10.017</ArticleId><ArticleId IdType="pubmed">23380094</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna V, Pillai G, Velickakathu Sukumaran S. Red cell distribution width as a predictor of mortality in patients with sepsis. Cureus (2021) 13(1):e12912. doi: 10.7759/cureus.12912</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12912</ArticleId><ArticleId IdType="pmc">PMC7906276</ArticleId><ArticleId IdType="pubmed">33654597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Huang J, Liao W, Xu J, He Z, Liu Y, et al. . Prognostic value of the red cell distribution width in patients with sepsis-induced acute respiratory distress syndrome: A retrospective cohort study. Dis Markers. (2021) 2021:5543822. doi: 10.1155/2021/5543822</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5543822</ArticleId><ArticleId IdType="pmc">PMC8189810</ArticleId><ArticleId IdType="pubmed">34122669</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zdo&#x11f;an HK, Karateke F, &#xd6;zyaz&#x131;c&#x131; S, &#xd6;zdo&#x11f;an M, &#xd6;zaltun P, Kuvvetli A, et al. . The predictive value of red cell distribution width levels on mortality in intensive care patients with community-acquired intra-abdominal sepsis. Ulusal travma ve acil cerrahi dergisi = Turkish J Trauma Emerg Surg TJTES. (2015) 21(5):352&#x2013;7. doi:&#xa0;10.5505/tjtes.2015.26737</Citation><ArticleIdList><ArticleId IdType="doi">10.5505/tjtes.2015.26737</ArticleId><ArticleId IdType="pubmed">26388271</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Jiang FQ, Kong F, An MM, Jin BB, Cao D, et al. . Inflammatory anemia-associated parameters are related to 28-day mortality in patients with sepsis admitted to the ICU: a preliminary observational study. Ann Intensive Care (2019) 9(1):67. doi: 10.1186/s13613-019-0542-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-019-0542-7</ArticleId><ArticleId IdType="pmc">PMC6557959</ArticleId><ArticleId IdType="pubmed">31183575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen K, Du H, Tang B, Xiong B, Zhang A, Wang P. Complete blood count and myocardial markers combination with sequential organ failure assessment score can effectively predict the mortality in sepsis: A derivation and validation study. Int J Gen Med (2022) 15:3265&#x2013;80. doi: 10.2147/IJGM.S349751</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S349751</ArticleId><ArticleId IdType="pmc">PMC8958200</ArticleId><ArticleId IdType="pubmed">35355798</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, She Y, Fu L, Zhou R, Xiang W, Luo L. Association between red cell distribution width and hospital mortality in patients with sepsis. J Int Med Res (2021) 49(4):3000605211004221. doi: 10.1177/03000605211004221</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605211004221</ArticleId><ArticleId IdType="pmc">PMC8033474</ArticleId><ArticleId IdType="pubmed">33823636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente L, Mart&#xed;n MM, Abreu-Gonz&#xe1;lez P, Sol&#xe9;-Viol&#xe1;n J, Ferreres J, Labarta L, et al. . Red blood cell distribution width during the first week is associated with severity and mortality in septic patients. PloS One (2014) 9(8):e105436. doi: 10.1371/journal.pone.0105436</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105436</ArticleId><ArticleId IdType="pmc">PMC4143268</ArticleId><ArticleId IdType="pubmed">25153089</ArticleId></ArticleIdList></Reference><Reference><Citation>Havens JM, Seshadri AJ, Salim A, Christopher KB. Red cell distribution width predicts out of hospital outcomes in critically ill emergency general surgery patients. Trauma Surg acute Care Open (2018) 3(1):e000147. doi: 10.1136/tsaco-2017-000147</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/tsaco-2017-000147</ArticleId><ArticleId IdType="pmc">PMC5931307</ArticleId><ArticleId IdType="pubmed">29766132</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey A, Kumar S, Acharya S, Wanjari AK, Bawankule S, Agrawal S, et al. . Impact of red cell and platelet distribution width in patients of medical intensive care unit. J Lab Physicians (2021) 13(4):309&#x2013;16. doi: 10.1055/s-0041-1730883</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1730883</ArticleId><ArticleId IdType="pmc">PMC8714314</ArticleId><ArticleId IdType="pubmed">34975248</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Jiang S, Li W, Fan Y, Leng Y, Gao C. Establishment and effectiveness evaluation of a scoring system-RAAS (RDW, AGE, APACHE II, SOFA) for sepsis by a retrospective analysis. J Inflamm Res (2022) 15:465&#x2013;74. doi: 10.2147/JIR.S348490</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S348490</ArticleId><ArticleId IdType="pmc">PMC8786358</ArticleId><ArticleId IdType="pubmed">35082513</ArticleId></ArticleIdList></Reference><Reference><Citation>Song K, Guo C, Zeng Z, Li C, Ding N. Factors associated with in-hospital mortality in adult sepsis with escherichia coli infection. BMC Infect Dis. (2022) 22(1):197. doi: 10.1186/s12879-022-07201-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07201-z</ArticleId><ArticleId IdType="pmc">PMC8886752</ArticleId><ArticleId IdType="pubmed">35227247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghimire R, Shakya YM, Shrestha TM, Neupane RP. The utility of red cell distribution width to predict mortality of septic patients in a tertiary hospital of Nepal. BMC Emergency Med (2020) 20(1):43. doi: 10.1186/s12873-020-00337-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12873-020-00337-8</ArticleId><ArticleId IdType="pmc">PMC7249690</ArticleId><ArticleId IdType="pubmed">32456665</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadaka F, O'Brien J, Prakash S. Red cell distribution width and outcome in patients with septic shock. J Intensive Care Med (2013) 28(5):307&#x2013;13. doi: 10.1177/0885066612452838</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066612452838</ArticleId><ArticleId IdType="pubmed">22809690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Lee K, Kim I, Jung S, Kim MJ. Red cell distribution width and early mortality in elderly patients with severe sepsis and septic shock. Clin Exp Emergency Med (2015) 2(3):155&#x2013;61. doi: 10.15441/ceem.15.037</Citation><ArticleIdList><ArticleId IdType="doi">10.15441/ceem.15.037</ArticleId><ArticleId IdType="pmc">PMC5052839</ArticleId><ArticleId IdType="pubmed">27752590</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana V, Spadaro S, Bond O, Cavicchi FZ, Annoni F, Donadello K, et al. . No relationship between red blood cell distribution width and microcirculatory alterations in septic patients. Clin Hemorheol Microcirculation (2017) 66(2):131&#x2013;41. doi: 10.3233/CH-160154</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-160154</ArticleId><ArticleId IdType="pubmed">28128746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju X, Wang F, Wang Li. Dynamic change of red cell distribution width levels in prediction of hospital mortality in Chinese elderly patients with septic shock. Chin Med J (2017) 130(10):1189&#x2013;95. doi: 10.4103/0366-6999.205858</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.205858</ArticleId><ArticleId IdType="pmc">PMC5443025</ArticleId><ArticleId IdType="pubmed">28485319</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta MK, Yadav G, Singh Y, Bhalekar A. Correlation of the changing trends of red cell distribution width and serum lactate as a prognostic factor in sepsis and septic shock. J Anaesthesiol Clin Pharmacol (2020) 36(4):531&#x2013;4. doi:&#xa0;10.4103/joacp.JOACP_105_19</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/joacp.JOACP_105_19</ArticleId><ArticleId IdType="pmc">PMC8022044</ArticleId><ArticleId IdType="pubmed">33840936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J, Liao T, Wu Y, Wang Z, Jin H, Lu F, et al. . Predictive value of red blood cell distribution width in septic shock patients with thrombocytopenia: A retrospective study using machine learning. J Clin Lab Analysis (2021) 35(12):e24053. doi: 10.1002/jcla.24053</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24053</ArticleId><ArticleId IdType="pmc">PMC8649348</ArticleId><ArticleId IdType="pubmed">34674393</ArticleId></ArticleIdList></Reference><Reference><Citation>Jandial A, Kumar S, Bhalla A, Sharma N, Varma N, Varma S. Elevated red cell distribution width as a prognostic marker in severe sepsis: A prospective observational study. Indian J Crit Care Med peer-reviewed Off Publ Indian Soc Crit Care Med (2017) 21(9):552&#x2013;62. doi:&#xa0;10.4103/ijccm.IJCCM_208_17</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijccm.IJCCM_208_17</ArticleId><ArticleId IdType="pmc">PMC5613605</ArticleId><ArticleId IdType="pubmed">28970653</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. . Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama (2016) 315(8):775&#x2013;87. doi: 10.1001/jama.2016.0289</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0289</ArticleId><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. . Assessment of global incidence and mortality of hospital-treated sepsis. Curr Estimates Limitations. Am J Respir Crit Care Med (2016) 193(3):259&#x2013;72. doi: 10.1164/rccm.201504-0781OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201504-0781OC</ArticleId><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C, Legrand M. Epidemiology of sepsis and septic shock. Curr Opin Anaesthesiol (2021) 34(2):71&#x2013;6. doi: 10.1097/ACO.0000000000000958</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000958</ArticleId><ArticleId IdType="pubmed">33492864</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. . Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet (London England) (2020) 395(10219):200&#x2013;11. doi: 10.1016/S0140-6736(19)32989-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32989-7</ArticleId><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Huang T, Xu F, Li S, Zheng S, Lyu J, et al. . Prediction of prognosis in elderly patients with sepsis based on machine learning (random survival forest). BMC Emergency Med (2022) 22(1):26. doi: 10.1186/s12873-022-00582-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12873-022-00582-z</ArticleId><ArticleId IdType="pmc">PMC8832779</ArticleId><ArticleId IdType="pubmed">35148680</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain K, Sharma D, Patidar M, Nandedkar S, Pathak A, Purohit M. Red cell distribution width as a predictor of mortality in patients with clinical sepsis: Experience from a single rural center in central India. Clin Pathol (Thousand Oaks Ventura County Calif) (2022) 15:2632010x221075592. doi: 10.1177/2632010X221075592</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2632010X221075592</ArticleId><ArticleId IdType="pmc">PMC8819754</ArticleId><ArticleId IdType="pubmed">35141523</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang AY, Ma HP, Kao WF, Tsai SH, Chang CK. Red blood cell distribution width is associated with mortality in elderly patients with sepsis. Am J Emergency Med (2018) 36(6):949&#x2013;53. doi: 10.1016/j.ajem.2017.10.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2017.10.056</ArticleId><ArticleId IdType="pubmed">29133071</ArticleId></ArticleIdList></Reference><Reference><Citation>Uffen JW, Oomen P, de Regt M, Oosterheert JJ, Kaasjager K. The prognostic value of red blood cell distribution width in patients with suspected infection in the emergency department. BMC Emergency Med (2019) 19(1):76. doi: 10.1186/s12873-019-0293-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12873-019-0293-7</ArticleId><ArticleId IdType="pmc">PMC6889630</ArticleId><ArticleId IdType="pubmed">31795936</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37386595</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2731-3786</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of anesthesia, analgesia and critical care</Title><ISOAbbreviation>J Anesth Analg Crit Care</ISOAbbreviation></Journal><ArticleTitle>Hyperoxia in critically ill patients with sepsis and septic shock: a systematic review.</ArticleTitle><Pagination><StartPage>12</StartPage><MedlinePgn>12</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s44158-023-00096-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In septic patients, hyperoxia may help with its bactericidal effects, but it may cause systemic impairments. The role of hyperoxia and the appropriate oxygen target in these patients is unknown. The aim of this systematic review was to summarize the available literature.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic search screening PubMed and Cochrane Library. Studies on adult patients with sepsis or septic shock and admitted to ICU addressing the topic of hyperoxia were included and described.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 12 studies, for a total of 15.782 included patients. Five studies were randomized controlled trials (RCTs) or analyses from RCTs, three were prospective observational studies, and four were retrospective observational studies. The definition of hyperoxia was heterogeneous across the included studies. Mortality was the most frequent outcome: six studies showed an increased rate or risk of mortality with hyperoxia, three found no differences, and one a protective effect of hyperoxia. At the critical appraisal assessment stage, no major methodological flaws were detected, except for a single-center, pilot study, with a lack of adjustment for confounders and imbalance between the groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The optimum range of oxygen level able to minimize risks and provide benefits in patients with sepsis or septic shock seems still unknown. Clinical equipoise between hyperoxia and normoxia is uncertain as conflicting evidence exists. Further studies should aim at identifying the best range of oxygenation and its optimal duration, investigating how effects of different levels of oxygen may vary according to identified pathogens, source of infection, and prescribed antibiotics in critically ill patients with sepsis and septic shock.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Catalanotto</LastName><ForeName>Francesca Romana</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S), University of Palermo, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ippolito</LastName><ForeName>Mariachiara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S), University of Palermo, 90127, Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Via del Vespro 129, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirasola</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S), University of Palermo, 90127, Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catalisano</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S), University of Palermo, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milazzo</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S), University of Palermo, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giarratano</LastName><ForeName>Antonino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S), University of Palermo, 90127, Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Via del Vespro 129, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1416-9993</Identifier><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S), University of Palermo, 90127, Palermo, Italy. andrea.cortegiani@unipa.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Via del Vespro 129, 90127, Palermo, Italy. andrea.cortegiani@unipa.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Anesth Analg Crit Care</MedlineTA><NlmUniqueID>9918591885906676</NlmUniqueID><ISSNLinking>2731-3786</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hyperoxia</Keyword><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">Oxygen</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37386595</ArticleId><ArticleId IdType="pmc">PMC10245526</ArticleId><ArticleId IdType="doi">10.1186/s44158-023-00096-5</ArticleId><ArticleId IdType="pii">10.1186/s44158-023-00096-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vincent J-L, De Backer D. Circulatory shock. N Engl J Med. 2013;369(18):1726&#x2013;1734. doi: 10.1056/NEJMra1208943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1208943</ArticleId><ArticleId IdType="pubmed">24171518</ArticleId></ArticleIdList></Reference><Reference><Citation>Girardis M, Alhazzani W, Rasmussen BS. What&#x2019;s new in oxygen therapy? Intensive Care Med. 2019;45(7):1009&#x2013;1011. doi: 10.1007/s00134-019-05619-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05619-9</ArticleId><ArticleId IdType="pubmed">31089763</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, M&#xf8;ller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Med. 2021;47(11):1181&#x2013;1247. doi: 10.1007/s00134-021-06506-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Magder S. Reactive oxygen species: toxic molecules or spark of life? Crit Care. 2006;10(1):208. doi: 10.1186/cc3992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3992</ArticleId><ArticleId IdType="pmc">PMC1550838</ArticleId><ArticleId IdType="pubmed">16469133</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C-W, Herrera Abreu MT, Suzuki T, Downey GP. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol. 2003;29(4):427&#x2013;431. doi: 10.1165/rcmb.F278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.F278</ArticleId><ArticleId IdType="pubmed">14500253</ArticleId></ArticleIdList></Reference><Reference><Citation>Beno&#xee;t Z, Wicky S, Fischer J-F, Frascarolo P, Chapuis C, Spahn DR, Magnusson L. The effect of increased Fio2 before tracheal extubation on postoperative atelectasis. Anesth Analg. 2002;95(6):1777&#x2013;1781. doi: 10.1097/00000539-200212000-00058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200212000-00058</ArticleId><ArticleId IdType="pubmed">12456458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak S, Azevedo ER, Liu PP, Newton GE. Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure. Chest. 2001;120(2):467&#x2013;473. doi: 10.1378/chest.120.2.467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.120.2.467</ArticleId><ArticleId IdType="pubmed">11502645</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Laskar N, Kadouri DE. Evaluating the effect of oxygen concentrations on antibiotic sensitivity, growth, and biofilm formation of human pathogens. Microbiol Insights. 2016;9:37&#x2013;46. doi: 10.4137/MBI.S40767.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/MBI.S40767</ArticleId><ArticleId IdType="pmc">PMC5113855</ArticleId><ArticleId IdType="pubmed">27891050</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiani E, Adrario E, Girardis M, Romano R, Pelaia P, Singer M, Donati A. Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care. 2014;18(6):711. doi: 10.1186/s13054-014-0711-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0711-x</ArticleId><ArticleId IdType="pmc">PMC4298955</ArticleId><ArticleId IdType="pubmed">25532567</ArticleId></ArticleIdList></Reference><Reference><Citation>Girardis M, Busani S, Damiani E, Donati A, Rinaldi L, Marudi A, Morelli A, Antonelli M, Singer M. Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA. 2016;316(15):1583. doi: 10.1001/jama.2016.11993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.11993</ArticleId><ArticleId IdType="pubmed">27706466</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmerhorst HJF, Roos-Blom M-J, van Westerloo DJ, de Jonge E. Association between arterial hyperoxia and outcome in subsets of critical illness: a systematic review, meta-analysis, and meta-regression of cohort studies*. Critical Care Medicine. 2015;43(7):1508&#x2013;1519. doi: 10.1097/CCM.0000000000000998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000998</ArticleId><ArticleId IdType="pubmed">25855899</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr&#xf3;bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 Statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>(2020) Chapter 3: Systematic reviews of effectiveness. In JBI Manual for Evidence Synthesis; JBI. 10.46658/JBIMES-20-04.</Citation></Reference><Reference><Citation>(2020) Chapter 7: Systematic reviews of etiology and risk. In JBI Manual for Evidence Synthesis; JBI. 10.46658/JBIMES-20-08.</Citation></Reference><Reference><Citation>Munn, Z.; Barker, T. H.; Moola, S.; Tufanaru, C.; Stern, C.; McArthur, A.; Stephenson, M.; Aromataris, E. (2019) Methodological quality of case series studies: an introduction to the JBI Critical Appraisal Tool. JBI Database of Systematic Reviews and Implementation Reports, Publish Ahead of Print. 10.11124/JBISRIR-D-19-00099.</Citation><ArticleIdList><ArticleId IdType="pubmed">33038125</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolmeijer R, ter Maaten JC, Zijlstra JG, Ligtenberg JJM. Oxygen therapy for sepsis patients in the emergency department: a little less? Eur J Emerg Med. 2014;21(3):233&#x2013;235. doi: 10.1097/MEJ.0b013e328361c6c7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEJ.0b013e328361c6c7</ArticleId><ArticleId IdType="pubmed">23611817</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P, Schortgen F, Boisram&#xe9;-Helms J, Charpentier J, Gu&#xe9;rot E, Megarbane B, Grimaldi D, Grelon F, Anguel N, Lasocki S, Henry-Lagarrigue M, Gonzalez F, Legay F, Guitton C, Schenck M, Doise JM, Devaquet J, Van Der Linden T, Chatellier D, Rigaud JP, Dellamonica J, Tamion F, Meziani F, Mercat A, Dreyfuss D, Seegers V, Radermacher P. Hyperoxia and Hypertonic Saline in Patients with Septic Shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial. Lancet Respir Med. 2017;5(3):180&#x2013;190. doi: 10.1016/S2213-2600(17)30046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(17)30046-2</ArticleId><ArticleId IdType="pubmed">28219612</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AC, Spencer E, Mackle D, Hunt A, Judd H, Mehrtens J, Parker K, Stockwell Z, Gale C, Beaumont M, Kaur S, Bihari S, Young PJ. The effect of conservative oxygen therapy on systemic biomarkers of oxidative stress in critically ill patients. Free Radic Biol Med. 2020;160:13&#x2013;18. doi: 10.1016/j.freeradbiomed.2020.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.06.018</ArticleId><ArticleId IdType="pubmed">32768569</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalisano G, Ippolito M, Blanda A, Meessen J, Giarratano A, Todesco N, Bonato V, Restuccia F, Montomoli J, Fiore G, Grasselli G, Caironi P, Latini R, Cortegiani A. Effects of hyperoxemia in patients with sepsis &#x2013; a post-hoc analysis of a multicentre randomized clinical trial. Pulmonology. 2023;S2531-0437(23):00042&#x2013;9. doi: 10.1016/j.pulmoe.2023.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2023.02.005</ArticleId><ArticleId IdType="pubmed">36907813</ArticleId></ArticleIdList></Reference><Reference><Citation>the HYPER2S investigators. Demiselle J, Wepler M, Hartmann C, Radermacher P, Schortgen F, Meziani F, Singer M, Seegers V, Asfar P. Hyperoxia toxicity in septic shock patients according to the Sepsis-3 criteria: a post hoc analysis of the HYPER2S trial. Ann Intensive Care. 2018;8(1):90. doi: 10.1186/s13613-018-0435-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0435-1</ArticleId><ArticleId IdType="pmc">PMC6141409</ArticleId><ArticleId IdType="pubmed">30225670</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouffroy R, Saade A, Saint Martin LC, Philippe P, Carli P, Vivien B. Prognosis value of partial arterial oxygen pressure in patients with septic shock subjected to pre-hospital invasive ventilation. Am J Emerg Med. 2019;37(1):56&#x2013;60. doi: 10.1016/j.ajem.2018.04.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2018.04.050</ArticleId><ArticleId IdType="pubmed">29709397</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto K, Umegaki T, Ohira S, Soeda T, Anada N, Uba T, Shoji T, Kusunoki M, Nakajima Y, Kamibayashi T. Impact of permissive hypoxia and hyperoxia avoidance on clinical outcomes in septic patients receiving mechanical ventilation: a retrospective single-center study. BioMed Res Int. 2021;2021:1&#x2013;10. doi: 10.1155/2021/7332027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7332027</ArticleId><ArticleId IdType="pmc">PMC8531788</ArticleId><ArticleId IdType="pubmed">34692840</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Fern&#xe1;ndez M, Heredia-Rodr&#xed;guez M, Gonz&#xe1;lez-Jim&#xe9;nez I, Lorenzo-L&#xf3;pez M, G&#xf3;mez-Pesquera E, Poves-&#xc1;lvarez R, &#xc1;lvarez FJ, Jorge-Monjas P, Beltr&#xe1;n-DeHeredia J, Guti&#xe9;rrez-Abej&#xf3;n E, Herrera-G&#xf3;mez F, Guzzo G, G&#xf3;mez-S&#xe1;nchez E, Tamayo-Velasco &#xc1;, Aller R, Pelosi P, Villar J, Tamayo E. Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality. Crit Care. 2022;26(1):4. doi: 10.1186/s13054-021-03875-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03875-0</ArticleId><ArticleId IdType="pmc">PMC8744280</ArticleId><ArticleId IdType="pubmed">35000603</ArticleId></ArticleIdList></Reference><Reference><Citation>Young P, Mackle D, Bellomo R, Bailey M, Beasley R, Deane A, Eastwood G, Finfer S, Freebairn R, King V, Linke N, Litton E, McArthur C, McGuinness S, Panwar R. Conservative oxygen therapy for mechanically ventilated adults with sepsis: a post hoc analysis of data from the intensive care unit randomized trial comparing two approaches to oxygen therapy (ICU-ROX) Intensive Care Med. 2020;46(1):17&#x2013;26. doi: 10.1007/s00134-019-05857-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05857-x</ArticleId><ArticleId IdType="pmc">PMC7223684</ArticleId><ArticleId IdType="pubmed">31748836</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhao L, Yu Y, Zhang K, Jiang Y, Wang Z, Xie K, Yu Y. Conservative oxygen therapy in critically ill and perioperative period of patients with sepsis-associated encephalopathy. Front Immunol. 2022;13:1035298. doi: 10.3389/fimmu.2022.1035298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1035298</ArticleId><ArticleId IdType="pmc">PMC9626799</ArticleId><ArticleId IdType="pubmed">36341421</ArticleId></ArticleIdList></Reference><Reference><Citation>Popoff B, Besnier E, Dureuil B, Veber B, Clavier T. Effect of early hyperoxemia on mortality in mechanically ventilated septic shock patients according to Sepsis-3 criteria: analysis of the MIMIC-III database. Eur J Emerg Med. 2021;28(6):469&#x2013;475. doi: 10.1097/MEJ.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEJ.0000000000000854</ArticleId><ArticleId IdType="pubmed">34285171</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi P, Tauzin L, Weiss M, Rostain J-C, Sainty J-M, Boussuges A. Could hyperoxic ventilation impair oxygen delivery in septic patients? Clin Physiol Funct Imaging. 2007;27(3):180&#x2013;184. doi: 10.1111/j.1475-097X.2007.00732.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-097X.2007.00732.x</ArticleId><ArticleId IdType="pubmed">17445069</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018;44(6):925&#x2013;928. doi: 10.1007/s00134-018-5085-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5085-0</ArticleId><ArticleId IdType="pubmed">29675566</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36(2):222&#x2013;231. doi: 10.1007/s00134-009-1738-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1738-3</ArticleId><ArticleId IdType="pmc">PMC2826633</ArticleId><ArticleId IdType="pubmed">20069275</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiani E, Donati A, Serafini G, Rinaldi L, Adrario E, Pelaia P, Busani S, Girardis M. Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS One. 2015;10(5):e0125827. doi: 10.1371/journal.pone.0125827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125827</ArticleId><ArticleId IdType="pmc">PMC4422717</ArticleId><ArticleId IdType="pubmed">25946168</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche J-D, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent J-L, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock. Crit Care Med. 2017;45(3):486&#x2013;552. doi: 10.1097/CCM.0000000000002255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002255</ArticleId><ArticleId IdType="pubmed">28098591</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;berg F, Singer M. The medical use of oxygen: a time for critical reappraisal. J Intern Med. 2013;274(6):505&#x2013;528. doi: 10.1111/joim.12139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12139</ArticleId><ArticleId IdType="pubmed">24206183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafner S, Beloncle F, Koch A, Radermacher P, Asfar P. Hyperoxia in intensive care, emergency, and peri-operative medicine: Dr. Jekyll or Mr. Hyde? A 2015 Update. Ann Intensive Care. 2015;5(1):42. doi: 10.1186/s13613-015-0084-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-015-0084-6</ArticleId><ArticleId IdType="pmc">PMC4653126</ArticleId><ArticleId IdType="pubmed">26585328</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87(1):315&#x2013;424. doi: 10.1152/physrev.00029.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00029.2006</ArticleId><ArticleId IdType="pmc">PMC2248324</ArticleId><ArticleId IdType="pubmed">17237348</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552(2):335&#x2013;344. doi: 10.1113/jphysiol.2003.049478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2003.049478</ArticleId><ArticleId IdType="pmc">PMC2343396</ArticleId><ArticleId IdType="pubmed">14561818</ArticleId></ArticleIdList></Reference><Reference><Citation>McNulty PH, Robertson BJ, Tulli MA, Hess J, Harach LA, Scott S, Sinoway LI. Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease. J Appl Physiol. 2007;102(5):2040&#x2013;2045. doi: 10.1152/japplphysiol.00595.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00595.2006</ArticleId><ArticleId IdType="pubmed">17303710</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276(5321):2034&#x2013;2037. doi: 10.1126/science.276.5321.2034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.276.5321.2034</ArticleId><ArticleId IdType="pubmed">9197264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014;370(17):1626&#x2013;1635. doi: 10.1056/NEJMra1209390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1209390</ArticleId><ArticleId IdType="pubmed">24758618</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboab J, Jonson B, Kouatchet A, Taille S, Niklason L, Brochard L. Effect of inspired oxygen fraction on alveolar derecruitment in acute respiratory distress syndrome. Intensive Care Med. 2006;32(12):1979&#x2013;1986. doi: 10.1007/s00134-006-0382-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-006-0382-4</ArticleId><ArticleId IdType="pubmed">17019545</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallet RH, Matthay MA. Hyperoxic acute lung injury. Respiratory Care. 2013;58(1):123&#x2013;141. doi: 10.4187/respcare.01963.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.01963</ArticleId><ArticleId IdType="pmc">PMC3915523</ArticleId><ArticleId IdType="pubmed">23271823</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaporidi K, Akoumianaki E, Telias I, Goligher EC, Brochard L, Georgopoulos D. Respiratory drive in critically ill patients. Pathophysiology and Clinical Implications. Am J Respir Crit Care Med. 2020;201(1):20&#x2013;32. doi: 10.1164/rccm.201903-0596SO.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201903-0596SO</ArticleId><ArticleId IdType="pubmed">31437406</ArticleId></ArticleIdList></Reference><Reference><Citation>Linton RAF, Poole-Wilson PA, Davies RJ, Cameron IR. A comparison of the ventilatory response to carbon dioxide by steady-state and rebreathing methods during metabolic acidosis and alkalosis. Clin Sci. 1973;45(2):239&#x2013;249. doi: 10.1042/cs0450239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs0450239</ArticleId><ArticleId IdType="pubmed">4522362</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang G-J, Kou YR, Lin YS. Peripheral neural modulation of endotoxin-induced hyperventilation. Critical Care Med. 1998;26(9):1558&#x2013;1563. doi: 10.1097/00003246-199809000-00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199809000-00024</ArticleId><ArticleId IdType="pubmed">9751593</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri T, Spinelli E, Pavlovsky B, Grieco DL, Ottaviani I, Basile MC, Dalla Corte F, Pintaudi G, Garofalo E, Rundo A, Volta CA, Pesenti A, Spadaro S. Respiratory drive in patients with sepsis and septic shock: modulation by high-flow nasal cannula. Anesthesiology. 2021;135(6):1066&#x2013;1075. doi: 10.1097/ALN.0000000000004010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004010</ArticleId><ArticleId IdType="pmc">PMC10348628</ArticleId><ArticleId IdType="pubmed">34644374</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggiore SM, Grieco DL, Lemiale V. The use of high-flow nasal oxygen. Intensive Care Med. 2023 doi: 10.1007/s00134-023-07067-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07067-y</ArticleId><ArticleId IdType="pmc">PMC10117236</ArticleId><ArticleId IdType="pubmed">37079086</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri T, Turrini C, Eronia N, Grasselli G, Volta CA, Bellani G, Pesenti A. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207&#x2013;1215. doi: 10.1164/rccm.201605-0916OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201605-0916OC</ArticleId><ArticleId IdType="pubmed">27997805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri T, Alban L, Turrini C, Cambiaghi B, Carlesso E, Taccone P, Bottino N, Lissoni A, Spadaro S, Volta CA, Gattinoni L, Pesenti A, Grasselli G. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med. 2017;43(10):1453&#x2013;1463. doi: 10.1007/s00134-017-4890-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4890-1</ArticleId><ArticleId IdType="pubmed">28762180</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent J-L, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315(8):801. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34301988</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Nationwide case-control study of risk factors and outcomes for community-acquired sepsis.</ArticleTitle><Pagination><StartPage>15118</StartPage><MedlinePgn>15118</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-94558-x</ELocationID><Abstract><AbstractText>Sepsis is the main cause of death in the intensive care units (ICU) and increasing incidences of ICU admissions for sepsis are reported. Identification of patients at risk for sepsis and poor outcome is therefore of outmost importance. We performed a nation-wide case-control study aiming at identifying and quantifying the association between co-morbidity and socio-economic factors with intensive care admission for community-acquired sepsis. We also explored 30-day mortality. All adult patients (n&#x2009;=&#x2009;10,072) with sepsis admitted from an emergency department to an intensive care unit in Sweden between 2008 and 2017 and a control population (n&#x2009;=&#x2009;50,322), matched on age, sex and county were included. In the sepsis group, 69% had a co-morbid condition at ICU admission, compared to 31% in the control group. Multivariable conditional logistic regression analysis was performed and there was a large variation in the influence of different risk factors associated with ICU-admission, renal disease, liver disease, metastatic malignancy, substance abuse, and congestive heart failure showed the strongest associations. Low&#xa0;income and&#xa0;low&#xa0;education&#xa0;level&#xa0;were more common in&#xa0;sepsis&#xa0;patients&#xa0;compared to&#xa0;controls.&#xa0;The adjusted OR for 30-day mortality for sepsis patients was 132 (95% CI 110-159) compared to controls.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lindstr&#xf6;m</LastName><ForeName>Ann-Charlotte</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden. ann-charlotte.l.lindstrom@sll.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. ann-charlotte.l.lindstrom@sll.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eriksson</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Operation and Intensive Care, Uppsala University Hospital, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe5;rtensson</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oldner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34301988</ArticleId><ArticleId IdType="pmc">PMC8302728</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-94558-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-94558-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kumar G, et al. Nationwide trends of severe sepsis in the 21st century (2000&#x2013;2007) Chest. 2011;140:1223&#x2013;1231. doi: 10.1378/chest.11-0352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-0352</ArticleId><ArticleId IdType="pubmed">21852297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: Comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br. J. Anaesth. 2017;119:626&#x2013;636. doi: 10.1093/bja/aex234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex234</ArticleId><ArticleId IdType="pubmed">29121281</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 2003;348:1546&#x2013;1554. doi: 10.1056/NEJMoa022139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022139</ArticleId><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Valles J, et al. Trends in the incidence and mortality of patients with community-acquired septic shock 2003&#x2013;2016. J. Crit. Care. 2019;53:46&#x2013;52. doi: 10.1016/j.jcrc.2019.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2019.05.025</ArticleId><ArticleId IdType="pubmed">31195155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubens M, et al. Increasing sepsis rates in the United States: Results from national inpatient sample, 2005 to 2014. J. Intensive Care Med. 2020;35:858&#x2013;868. doi: 10.1177/0885066618794136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066618794136</ArticleId><ArticleId IdType="pubmed">30175649</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Klompas M. Sepsis trends: Increasing incidence and decreasing mortality, or changing denominator? J. Thorac. Dis. 2020;12:S89&#x2013;s100. doi: 10.21037/jtd.2019.12.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2019.12.51</ArticleId><ArticleId IdType="pmc">PMC7024753</ArticleId><ArticleId IdType="pubmed">32148931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann C, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am. J. Respir. Crit. Care Med. 2016;193:259&#x2013;272. doi: 10.1164/rccm.201504-0781OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201504-0781OC</ArticleId><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x2013;2012. JAMA. 2014;311:1308&#x2013;1316. doi: 10.1001/jama.2014.2637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.2637</ArticleId><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference><Reference><Citation>Strandberg G, Walther S, Agvald &#xd6;hman C, Lipcsey M. Mortality after severe sepsis and septic shock in Swedish intensive care units 2008&#x2013;2016-A nationwide observational study. Acta Anaesthesiol. Scand. 2020;64:967&#x2013;975. doi: 10.1111/aas.13587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13587</ArticleId><ArticleId IdType="pubmed">32232853</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadri SS, et al. Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data. Chest. 2017;151:278&#x2013;285. doi: 10.1016/j.chest.2016.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.07.010</ArticleId><ArticleId IdType="pmc">PMC5310115</ArticleId><ArticleId IdType="pubmed">27452768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009&#x2013;2014. JAMA. 2017;318:1241&#x2013;1249. doi: 10.1001/jama.2017.13836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13836</ArticleId><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001;29:1303&#x2013;1310. doi: 10.1097/00003246-200107000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelms SB, Walther SM, Huss F, Sj&#xf6;berg F. Severe sepsis in the ICU is often missing in hospital discharge codes. Acta Anaesthesiol. Scand. 2017;61:186&#x2013;193. doi: 10.1111/aas.12814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12814</ArticleId><ArticleId IdType="pubmed">27699759</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch CA, Harrison DA, Hutchings A, Rowan K. The association between deprivation and hospital mortality for admissions to critical care units in England. J. Crit. Care. 2010;25:382&#x2013;390. doi: 10.1016/j.jcrc.2009.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2009.11.003</ArticleId><ArticleId IdType="pubmed">20074907</ArticleId></ArticleIdList></Reference><Reference><Citation>Rush B, et al. Association of household income level and in-hospital mortality in patients with sepsis: A nationwide retrospective cohort analysis. J. Intensive Care Med. 2018;33:551&#x2013;556. doi: 10.1177/0885066617703338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066617703338</ArticleId><ArticleId IdType="pmc">PMC5680141</ArticleId><ArticleId IdType="pubmed">28385107</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int. J. Surg. 2014;12:1495&#x2013;1499. doi: 10.1016/j.ijsu.2014.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.07.013</ArticleId><ArticleId IdType="pubmed">25046131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: Possibilities and pitfalls in healthcare and medical research. Eur. J. Epidemiol. 2009;24:659&#x2013;667. doi: 10.1007/s10654-009-9350-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-009-9350-y</ArticleId><ArticleId IdType="pmc">PMC2773709</ArticleId><ArticleId IdType="pubmed">19504049</ArticleId></ArticleIdList></Reference><Reference><Citation>Svenska Intensivv&#xe5;rdsregistret (SIR), https://www.icuregswe.org/.</Citation></Reference><Reference><Citation>Nationella kvalitetsregister, Swedish National Quality Registries., https://kvalitetsregister.se/index.html.</Citation></Reference><Reference><Citation>SCB. Statistics Sweden, https://www.scb.se/en/.</Citation></Reference><Reference><Citation>Socialstyrelsen. Patientregistret, https://www.socialstyrelsen.se/statistik-och-data/register/alla-register/patientregistret/ (2018).</Citation></Reference><Reference><Citation>Quan H, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care. 2005;43:1130&#x2013;1139. doi: 10.1097/01.mlr.0000182534.19832.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000182534.19832.83</ArticleId><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweden, S. Longitudinal integrated database for health insurance and labour market studies (LISA), https://www.scb.se/en/services/guidance-for-researchers-and-universities/vilka-mikrodata-finns/longitudinella-register/longitudinal-integrated-database-for-health-insurance-and-labour-market-studies-lisa/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6451717</ArticleId><ArticleId IdType="pubmed">30929112</ArticleId></ArticleIdList></Reference><Reference><Citation>Socialstyrelsen, T. S. b. o. h. a. w. D&#xf6;dsorsaksregistret, Cause of death register, https://www.socialstyrelsen.se/statistik-och-data/register/alla-register/dodsorsaksregistret/ (2018).</Citation></Reference><Reference><Citation>Henriksen DP, et al. Risk factors for hospitalization due to community-acquired sepsis&#x2014;A population-based case-control study. PLoS ONE. 2015;10:e0124838. doi: 10.1371/journal.pone.0124838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0124838</ArticleId><ArticleId IdType="pmc">PMC4405362</ArticleId><ArticleId IdType="pubmed">25898024</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HE, et al. Chronic medical conditions and risk of sepsis. PLoS ONE. 2012;7:e48307. doi: 10.1371/journal.pone.0048307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048307</ArticleId><ArticleId IdType="pmc">PMC3485139</ArticleId><ArticleId IdType="pubmed">23118977</ArticleId></ArticleIdList></Reference><Reference><Citation>Frydrych LM, Fattahi F, He K, Ward PA, Delano MJ. Diabetes and sepsis: Risk, recurrence, and ruination. Front. Endocrinol. (Lausanne) 2017;8:271. doi: 10.3389/fendo.2017.00271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2017.00271</ArticleId><ArticleId IdType="pmc">PMC5670360</ArticleId><ArticleId IdType="pubmed">29163354</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AMN, et al. Prevalence and predictors of sepsis death in patients with chronic heart failure and reduced left ventricular ejection fraction. J. Am. Heart Assoc. 2018;7:e009684. doi: 10.1161/jaha.118.009684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.118.009684</ArticleId><ArticleId IdType="pmc">PMC6474963</ArticleId><ArticleId IdType="pubmed">30371261</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J, Li S, Li S. The role of the liver in sepsis. Int. Rev. Immunol. 2014;33:498&#x2013;510. doi: 10.3109/08830185.2014.889129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2014.889129</ArticleId><ArticleId IdType="pmc">PMC4160418</ArticleId><ArticleId IdType="pubmed">24611785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance. World J. Hepatol. 2016;8:307&#x2013;321. doi: 10.4254/wjh.v8.i6.307.</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v8.i6.307</ArticleId><ArticleId IdType="pmc">PMC4766259</ArticleId><ArticleId IdType="pubmed">26962397</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58:1758&#x2013;1764. doi: 10.1111/j.1523-1755.2000.00337.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2000.00337.x</ArticleId><ArticleId IdType="pubmed">11012910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin JF, Mart&#xed;n-Fernandez M, L&#xf3;pez-Mestanza C, Duque P, Almansa R. Shared features of endothelial dysfunction between sepsis and its preceding risk factors (aging and chronic disease) J. Clin. Med. 2018 doi: 10.3390/jcm7110400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7110400</ArticleId><ArticleId IdType="pmc">PMC6262336</ArticleId><ArticleId IdType="pubmed">30380785</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin. Infect. Dis. 2005;41(Suppl 7):S490&#x2013;497. doi: 10.1086/432003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/432003</ArticleId><ArticleId IdType="pubmed">16237652</ArticleId></ArticleIdList></Reference><Reference><Citation>Trevejo-Nunez G, Kolls JK, de Wit M. Alcohol use as a risk factor in infections and healing: A clinician&#x2019;s perspective. Alcohol Res. 2015;37:177&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4590615</ArticleId><ArticleId IdType="pubmed">26695743</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenstein TK. The role of opioid receptors in immune system function. Front. Immunol. 2019;10:2904. doi: 10.3389/fimmu.2019.02904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02904</ArticleId><ArticleId IdType="pmc">PMC6934131</ArticleId><ArticleId IdType="pubmed">31921165</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrawashdeh M, Klompas M, Kimmel S, et al. 56: Epidemiology, outcomes, and trends of sepsis in patients with opioid use disorders in U.S. hospitals. Crit. Care Med. 2020;48(1):28. doi: 10.1097/01.ccm.0000618724.61285.b0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000618724.61285.b0</ArticleId><ArticleId IdType="pmc">PMC8602712</ArticleId><ArticleId IdType="pubmed">34314131</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch K, S&#xf8;gaard M, N&#xf8;rgaard M, Thomsen RW, Sch&#xf8;nheyder HC. Socioeconomic inequalities in risk of hospitalization for community-acquired bacteremia: A Danish population-based case-control study. Am. J. Epidemiol. 2014;179:1096&#x2013;1106. doi: 10.1093/aje/kwu032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwu032</ArticleId><ArticleId IdType="pubmed">24682527</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnegelsberg A, et al. Impact of socioeconomic status on mortality and unplanned readmission in septic intensive care unit patients. Acta Anaesthesiol. Scand. 2016;60:465&#x2013;475. doi: 10.1111/aas.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12644</ArticleId><ArticleId IdType="pubmed">26490972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37188157</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1756-2872</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2023</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Therapeutic advances in urology</Title><ISOAbbreviation>Ther Adv Urol</ISOAbbreviation></Journal><ArticleTitle>Concurrent radical cystectomy and nephroureterectomy indications and outcomes: a systematic review and comparative analysis.</ArticleTitle><Pagination><StartPage>17562872231171757</StartPage><MedlinePgn>17562872231171757</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17562872231171757</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/17562872231171757</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Urothelial carcinoma can arise from the urinary bladder or from the upper urinary tract. In some instances, urinary bladder cancer (UBC) and upper tract urothelial carcinoma (UTUC) can be concurrently diagnosed, necessitating a combined radical cystectomy (RC) with radical nephroureterectomy (RNU). A systematic review was done on the combined procedure exploring outcomes and indications, in addition to a comparative analysis between the combined procedure and cystectomy alone.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">For the systematic review, three databases (Embase, PubMed, and Cochrane) were queried, selecting only studies that included intraoperative and perioperative data. For the comparative analysis, using the NSQIP database, CPT codes for RC and RNU were used to identify two cohorts, one with RC and RNU and one with RC alone. A descriptive analysis was performed on all preoperative variables, and propensity score matching (PSM) was performed. Postoperative events were then compared between the two matched cohorts.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">For the systematic review, 28 relevant articles were included amounting to 947 patients who underwent the combined procedure. The most common indication was synchronous multifocal disease, the most common approach was open surgery, and the most common diversion technique was using an ileal conduit. Almost 28% of patients required blood transfusion and remained in the hospital for an average of 13&#x2009;days. The most common postoperative complication was prolonged paralytic ileus. For the comparative analysis, 11,759 patients were included of which 97.5% underwent RC only and 2.5% underwent the combined procedure. After PSM, the cohort that had undergone the combined procedure showed an increased risk of renal injury, increased readmission rates, and increased reoperation rates. Whereas the cohort that had undergone RC only showed an increased risk of deep venous thrombosis (DVT), sepsis, or septic shock.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">A combined RC and RNU is a treatment option for concurrent UCB and UTUC that should be cautiously utilized as it is associated with high morbidity and mortality. Patient selection, discussion of the risks and benefits of the procedure, and explanation of the available treatment options remain the most important pillars in managing patients with this complex disease.</AbstractText><CopyrightInformation>&#xa9; The Author(s), 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zein</LastName><ForeName>Marwan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3188-9899</Identifier><AffiliationInfo><Affiliation>American University of Beirut Medical Center, PO Box: 11-0236 Riad El Solh, Beirut 1107 2020, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasrallah</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0001-7086-1410</Identifier><AffiliationInfo><Affiliation>American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abou Heidar</LastName><ForeName>Nassib F</ForeName><Initials>NF</Initials><AffiliationInfo><Affiliation>American University of Beirut, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najdi</LastName><ForeName>Jad</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hneiny</LastName><ForeName>Layal</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>American University of Beirut, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Hajj</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>American University of Beirut, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Urol</MedlineTA><NlmUniqueID>101487328</NlmUniqueID><ISSNLinking>1756-2872</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bladder cancer</Keyword><Keyword MajorTopicYN="N">radical cystectomy</Keyword><Keyword MajorTopicYN="N">radical nephroureterectomy</Keyword><Keyword MajorTopicYN="N">urothelial carcinoma</Keyword></KeywordList><CoiStatement>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37188157</ArticleId><ArticleId IdType="pmc">PMC10176578</ArticleId><ArticleId IdType="doi">10.1177/17562872231171757</ArticleId><ArticleId IdType="pii">10.1177_17562872231171757</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, Miller KD, Fuchs HE, et al.. Cancer statistics, 2021. CA Cancer J Clin 2021; 71: 7&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33433946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H, Ferlay J, Siegel RL, et al.. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol 2020; 38: 1895&#x2013;1904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363726</ArticleId><ArticleId IdType="pubmed">31676912</ArticleId></ArticleIdList></Reference><Reference><Citation>Witjes JA, Bruins HM, Cathomas R, et al.. European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol 2021; 79: 82&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">32360052</ArticleId></ArticleIdList></Reference><Reference><Citation>Babjuk M, Burger M, Comp&#xe9;rat EM, et al.. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ) - 2019 update. Eur Urol 2019; 76: 639&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">31443960</ArticleId></ArticleIdList></Reference><Reference><Citation>Roupr&#xea;t M, Babjuk M, Burger M, et al.. European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 2021; 79: 62&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">32593530</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki J, Nishiyama H. Epidemiology of urothelial carcinoma. Int J Urol 2017; 24: 730&#x2013;734.</Citation><ArticleIdList><ArticleId IdType="pubmed">28543959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino M, Palou J, Gaya JM, et al.. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol 2013; 31: 141&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">22552732</ArticleId></ArticleIdList></Reference><Reference><Citation>Mill&#xe1;n-Rodr&#xed;guez F, Ch&#xe9;chile-Toniolo G, Salvador-Bayarri J, et al.. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups. J Urol 2000; 164: 1183&#x2013;1187.</Citation><ArticleIdList><ArticleId IdType="pubmed">10992362</ArticleId></ArticleIdList></Reference><Reference><Citation>van Doeveren T, van de Werken HJG, van Riet J, et al.. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review. Urol Oncol 2020; 38: 590&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">32057596</ArticleId></ArticleIdList></Reference><Reference><Citation>Holton MR, Van Zijl PS, Oberle WT, et al.. Complete urinary tract extirpation: the University of Maryland experience. Urology 2006; 68: 65&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">16806413</ArticleId></ArticleIdList></Reference><Reference><Citation>Akand M, K&#x131;l&#x131;&#xe7; &#xd6;, Harmankaya, et al.. Aggressive treatment for urothelial cancer-complete urinary tract extirpation: Operative feasibility in two cases. Turk J Urol 2019; 45: 393&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6739080</ArticleId><ArticleId IdType="pubmed">31509514</ArticleId></ArticleIdList></Reference><Reference><Citation>Barros R, Frota R, Stein RJ, et al.. Simultaneous laparoscopic nephroureterectomy and cystectomy: a preliminary report. Int Braz J Urol 2008; 34: 413&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">18778492</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng S-F, Chuang Y-C, Yang W-C. Long-term outcome of radical cystectomy in ESRD patients with bladder urothelial carcinoma. Int Urol Nephrol 2011; 43: 1067&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pubmed">21516473</ArticleId></ArticleIdList></Reference><Reference><Citation>Jipp J, Chartier A, Smith Z, et al.. A nationwide analysis of complete urinary tract extirpation. J Urol 2020; 203: e943.</Citation></Reference><Reference><Citation>Ou CH, Yang WH. Complete urinary tract exenteration for a dialysis patient with urothelial cancer: lower midline and extraperitoneal approach in a supine position. Urology 2011; 77: 1244&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pubmed">21333333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou CH, Yang WH. Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer. Int Urol Nephrol 2017; 49: 623&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">28161840</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou YC, Yang CR, Yang CK, et al.. Simultaneous robot-assisted nephroureterectomy and cystectomy in patients with uremia and multifocal urothelial carcinoma. J Endourol 2011; 25: 979&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pubmed">21476927</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin VC, Hung KC, Chen MJ, et al.. Single-session laparoscopic total urinary tract exenteration without repositioning for multifocal urothelial carcinoma in dialysis-dependent patients. Urology 2011; 77: 98&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">20627285</ArticleId></ArticleIdList></Reference><Reference><Citation>Buse S, Hach C, Alexandrov A. Robot-assisted en-bloc radical cystectomy with nephroureterectomy and intracorporeal urinary diversion in ten patients with muscle-invasive bladder cancer and simultaneous upper urinary tract urothelial cell carcinoma or functionless kidney. Eur Urol Suppl 2015; 14: eV45.</Citation></Reference><Reference><Citation>Buse S, Hach CE, Alexandrov A, et al.. Simultaneous en-bloc robot-assisted radical cystectomy and nephro-ureterectomy: technique description, outcomes, and literature summary. J Robot Surg 2016; 10: 315&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">27153839</ArticleId></ArticleIdList></Reference><Reference><Citation>Krude J, Alexandrov A, Lund P, et al.. Robot-assisted en-bloc radical cystectomy with nephroureterectomy and intracorporeal urinary diversion by seven patients with muscle-invasive bladder cancer and upper urinary tract urothelial cell carcinoma. Eur Urol Suppl 2014; 13: 6.</Citation></Reference><Reference><Citation>Pisipati S, Bach C, Daneshwar D, et al.. Concurrent upper and lower urinary tract robotic surgery: A case series. Urology 2013; 82: S178&#x2013;S179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4250252</ArticleId><ArticleId IdType="pubmed">25485015</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#x142;ojewski M, Ch&#x142;osta P, My&#x15b;lak M, et al.. Single-session laparoscopic cystectomy and nephroureterectomy. Wideochir Inne Tech Maloinwazyjne 2013; 8: 158&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3699764</ArticleId><ArticleId IdType="pubmed">23837100</ArticleId></ArticleIdList></Reference><Reference><Citation>Berglund RK, Matin SF, Desai M, et al.. Laparoscopic radical cystoprostatectomy with bilateral nephroureterectomy: initial report. BJU Int 2006; 97: 37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">16336325</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, Okamura T, Chaya R, et al.. Outcomes and complications of simultaneous laparoscopic cystectomy and laparoscopic nephroureterectomy with umbilical reduced port surgery. Asian Pac J Cancer Prev 2018; 19: 3495&#x2013;3500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6428533</ArticleId><ArticleId IdType="pubmed">30583675</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360123</ArticleId><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Utrilla P&#xe9;rez M, Aguilera Baz&#xe1;n A, Alonso Dorrego JM, et al.. Simultaneous cystectomy and nephroureterectomy due to synchronous upper urinary tract tumors and invasive bladder cancer: open and laparoscopic approaches. Curr Urol 2012; 6: 76&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3783321</ArticleId><ArticleId IdType="pubmed">24917718</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen IH, Lin JT, Tsai JY, et al.. A modified single mini-incision complete urinary tract exenteration for urothelial carcinoma in dialysis patients. Biomed Res Int 2014; 2014: 649642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4142548</ArticleId><ArticleId IdType="pubmed">25180189</ArticleId></ArticleIdList></Reference><Reference><Citation>Navas Pastor J, Garc&#xed;a Ligero J, Garc&#xed;a Garc&#xed;a F, et al.. [Synchronous tumor of the upper urinary tract with bladder cancer. Opportunity for nephroureterectomy and block-cystectomy]. Arch Esp Urol 2001; 54: 1095&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pubmed">11852517</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastroianni R, Ferriero M, Tuderti G, et al.. Open radical cystectomy versus robot-assisted radical cystectomy with intracorporeal urinary diversion: early outcomes of a single-center randomized controlled trial. J Urol 2022; 207: 982&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pubmed">34986007</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanet S, Basile G, Baboudjian M, et al.. Robot-assisted vs. open radical cystectomy: systematic review and meta-analysis of randomized controlled trials. Actas Urol Esp (Engl Ed). Epub ahead of print 2 February 2023. DOI: 10.1016/j.acuroe.2023.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acuroe.2023.01.003.</ArticleId><ArticleId IdType="pubmed">36737037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38180329</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1899-5276</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Advances in clinical and experimental medicine : official organ Wroclaw Medical University</Title><ISOAbbreviation>Adv Clin Exp Med</ISOAbbreviation></Journal><ArticleTitle>Prebiotics and sepsis in infants: An updated systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>999</StartPage><EndPage>1005</EndPage><MedlinePgn>999-1005</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.17219/acem/174307</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sepsis is a critical situation, and its treatment and reduction are important clinical issues. Antibiotics are a routine treatment option, but their adverse effects are a concern in pediatric patients, especially infants. Prebiotics might be an alternative option.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to provide an updated systemic review and meta-analysis of randomized controlled trials (RCTs) on the use of prebiotics for sepsis in infants, which could assist clinicians in deciding whether to use this treatment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study included RCTs related to prebiotics and sepsis in infants. A random effects model and the odds ratio (OR) were applied to estimate the effect of prebiotic use and the incidence of sepsis in infants. The analysis included 16 studies with a total of 6,438 infants. The primary outcome was the OR of sepsis for infants who received prebiotics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The results of the meta-analysis demonstrated that the pooled OR of sepsis was significantly lower for infants who used prebiotics. However, the results indicated a medium level of heterogeneity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results showed that the use of prebiotics might be associated with a reduction of sepsis in infants. The standardized application of this treatment might be an intriguing topic for future clinical research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Yuejia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Anesthesiology Department, Tumor Hospital Affiliated to Guangxi Medical University, Nanning, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Liuzhou People's Hospital Affiliated to Guangxi Medical University, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Clinical Research Center for Anesthesiology (GK AD22035214), Nanning, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Health Commission Key Laboratory of Basic Science and Prevention of Perioperative Organ Disfunction, Nanning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Linhui</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesiology Department, Tumor Hospital Affiliated to Guangxi Medical University, Nanning, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Clinical Research Center for Anesthesiology (GK AD22035214), Nanning, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Health Commission Key Laboratory of Basic Science and Prevention of Perioperative Organ Disfunction, Nanning, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Adv Clin Exp Med</MedlineTA><NlmUniqueID>101138582</NlmUniqueID><ISSNLinking>1899-5276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056692">Prebiotics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056692" MajorTopicYN="Y">Prebiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">infant</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">odds ratio</Keyword><Keyword MajorTopicYN="N">prebiotic</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>9</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38180329</ArticleId><ArticleId IdType="doi">10.17219/acem/174307</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34226045</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-7361</ISSN><JournalIssue CitedMedium="Internet"><Volume>170</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Surgery</Title><ISOAbbreviation>Surgery</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of the outcome of ileal pouch anal anastomosis in patients with obesity.</ArticleTitle><Pagination><StartPage>1629</StartPage><EndPage>1636</EndPage><MedlinePgn>1629-1636</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surg.2021.06.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0039-6060(21)00556-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Ileal-pouch anal anastomosis is used for treatment of different conditions, including mucosal ulcerative colitis and familial adenomatous polyposis. The present systematic review aimed to assess the literature for studies that compared the outcome of ileal-pouch anal anastomosis in patients with obesity versus patients with ideal weight.</AbstractText><AbstractText Label="METHODS">A systematic literature search of electronic databases including PubMed, Scopus, Web of Science, and Cochrane library was performed and reported in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The main outcome measures were pouch failure, pouch complications, overall complications, operation time, blood loss, and hospital stay.</AbstractText><AbstractText Label="RESULTS">This systematic review included 6 retrospective studies (3,460 patients). Out of the total number of patients, 19.8% had obesity or overweight. Patients with obesity were significantly less likely to have laparoscopic ileal-pouch anal anastomosis compared with patients with ideal body mass index (odds ratio&#xa0;= 0.436; P&#xa0;= .017). The weighted mean operation time and blood loss were significantly longer in the obesity group than the ideal weight group (weighted mean difference&#xa0;= 22.84; P&#xa0;= .006) and (weighted mean difference&#xa0;= 85.8; P &lt; .001). The obesity group was associated with significantly higher odds of total complications (odds ratio&#xa0;= 2.27; P &lt; .001), leak (odds ratio&#xa0;= 1.81; P&#xa0;= .036), and incisional hernia (odds ratio&#xa0;= 4.56; P &lt; .001). The 2 groups had comparable rates of pouch failure, pouchitis, stricture, pelvic sepsis, wound infection, bowel obstruction, ileus, and venous thromboembolism. Male sex, longer operation time, and including inflammatory bowel disease patients only were significantly associated with higher complications in the obesity group.</AbstractText><AbstractText Label="CONCLUSION">Patients with obesity who undergo ileal-pouch anal anastomosis are more likely to have laparotomy rather than a laparoscopic procedure, have longer operation time, greater blood loss, higher overall complications, leak and incisional hernia, and longer hospital stay.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emile</LastName><ForeName>Sameh Hany</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>General Surgery Department, Mansoura University Hospitals, Mansoura University, Egypt. Electronic address: Sameh200@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Sualeh Muslim</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan. Electronic address: https://twitter.com/SualehMKhan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wexner</LastName><ForeName>Steven D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. Electronic address: https://twitter.com/SWexner.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surgery</MedlineTA><NlmUniqueID>0417347</NlmUniqueID><ISSNLinking>0039-6060</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D011125" MajorTopicYN="N">Adenomatous Polyposis Coli</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="N">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039021" MajorTopicYN="N">Colonic Pouches</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007082" MajorTopicYN="N">Ileum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016737" MajorTopicYN="N">Proctocolectomy, Restorative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>6</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34226045</ArticleId><ArticleId IdType="doi">10.1016/j.surg.2021.06.009</ArticleId><ArticleId IdType="pii">S0039-6060(21)00556-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40319710</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Sepsis on dementia risk: A population-based cohort study with dose-dependent analysis.</ArticleTitle><Pagination><StartPage>155100</StartPage><MedlinePgn>155100</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2025.155100</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(25)00087-5</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Emerging evidence links sepsis-related inflammation to dementia risk, but the dose-dependent effects of recurrent sepsis episodes remain unclear. This study assessed whether sepsis increases dementia risk and explored a potential dose-response relationship between sepsis frequency and dementia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study using Taiwan's National Health Insurance Research Database (2005-2022), enrolling patients aged &#x2265;18&#xa0;years hospitalized with sepsis. An index period (2008-2013) was used to identify patients without prior dementia. A fixed 12-month landmark period (calendar year 2014) was applied to assess the number of sepsis episodes. Patients who died during the landmark period were excluded. Propensity score matching was performed to generate well-balanced sepsis and non-sepsis groups. Follow-up for dementia and mortality began after the landmark period and continued for up to 64&#xa0;months. Cox and Fine-Gray models were used to account for competing risks of death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sepsis was associated with a significantly increased risk of all-cause dementia (HR 1.59; 95&#xa0;% CI, 1.47-1.72; P&#xa0;&lt;&#xa0;0.0001). A dose-response relationship was observed: patients with multiple sepsis episodes had the highest dementia risk (sHR 1.63; 95&#xa0;% CI, 1.39-1.91). Vascular dementia showed the strongest association, with a higher incidence in the sepsis group (1.2&#xa0;% vs. 0.6&#xa0;%, P&#xa0;=&#xa0;0.0003).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings provide robust evidence of a dose-dependent association between sepsis and increased dementia risk, particularly vascular dementia, even after adjusting for competing mortality risks.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">This study addresses the limitations of previous research by not only employing propensity score matching (PSM) to balance confounding factors between the sepsis and non-sepsis groups but also using an index period and landmark period design to better explore potential causal relationships. These periods ensure that dementia onset occurred after sepsis and allow for the examination of dose-response relationship between sepsis episode frequency and dementia. Furthermore, this is the largest study to date involving sepsis patients, providing more robust evidence than prior studies, which were often smaller and lacked adjustments for competing risks of death.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Mingyang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fangfang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yangyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Mengrong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Zhongyuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China; Academy of Medical Sciences of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wan-Ming</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan; Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Szu-Yuan</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan; Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan; Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan; Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan; Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan; Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan; Cancer Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan; Centers for Regional Anesthesia and Pain Medicine, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. Electronic address: szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiaqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China. Electronic address: zhangjiq@zzu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Neuroinflammation. Dose-response relationship</Keyword><Keyword MajorTopicYN="N">Population-based cohort study</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors have no potential conflicts of interest to declare. The datasets supporting the study conclusions are included within the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>8</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>5</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>4</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40319710</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2025.155100</ArticleId><ArticleId IdType="pii">S0883-9441(25)00087-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27073082</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4626</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract</Title><ISOAbbreviation>J Gastrointest Surg</ISOAbbreviation></Journal><ArticleTitle>Probiotics and Synbiotics Decrease Postoperative Sepsis in Elective Gastrointestinal Surgical Patients: a Meta-Analysis.</ArticleTitle><Pagination><StartPage>1123</StartPage><EndPage>1131</EndPage><MedlinePgn>1123-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11605-016-3142-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">The health benefits of probiotics and synbiotics are well established in healthy adults, but their role in preventing postoperative sepsis remains controversial. This meta-analysis assesses the impact of probiotics and synbiotics on the incidence of postoperative sepsis in gastrointestinal (GI) surgical patients.</AbstractText><AbstractText Label="METHODS">A comprehensive literature search of all published randomized control trials (RCTs) was conducted using PubMed, Cochrane Central Registry of Controlled Trials, and Google Scholar (1966-2015). Inclusion criteria included RCTs comparing the use of any strain or dose of a specified probiotic/synbiotic with placebo or a "no treatment" control group. The incidence of postoperative sepsis (within 1&#xa0;month of surgery) and postoperative mortality were analyzed.</AbstractText><AbstractText Label="RESULTS">Fifteen RCTs involving 1201 patients (192 receiving probiotics, 413 receiving synbiotics, and 596 receiving placebo) were analyzed. Overall, probiotic and synbiotic uses significantly reduced the risk of developing postoperative sepsis by 38&#xa0;% (relative risk (RR)&#x2009;=&#x2009;0.62, 95&#xa0;% confidence interval (CI) 0.52-0.74, p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">The use of probiotic/synbiotic supplementation is associated with a significant reduction in the risk of developing postoperative sepsis in patients undergoing elective GI surgery. Probiotic/synbiotic supplementation is a valuable adjunct in the care of patients undergoing GI surgery. Additional studies are required to determine the optimal dose and strain of probiotic/synbiotic.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arumugam</LastName><ForeName>Sudha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Saint Barnabas Medical Center, 94 Old Short Hills Road, Livingston, NJ, 07039, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Christine S M</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Saint Barnabas Medical Center, 94 Old Short Hills Road, Livingston, NJ, 07039, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saint George's University School of Medicine, True Blue, Grenada, West Indies.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chamberlain</LastName><ForeName>Ronald S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Saint Barnabas Medical Center, 94 Old Short Hills Road, Livingston, NJ, 07039, USA. rchamberlain@barnabashealth.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Rutgers University, New Jersey Medical School, Newark, NJ, USA. rchamberlain@barnabashealth.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saint George's University School of Medicine, True Blue, Grenada, West Indies. rchamberlain@barnabashealth.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Gastrointest Surg</MedlineTA><NlmUniqueID>9706084</NlmUniqueID><ISSNLinking>1091-255X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="N">Digestive System Surgical Procedures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="N">Probiotics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058616" MajorTopicYN="N">Synbiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gastrointestinal surgery</Keyword><Keyword MajorTopicYN="N">Perioperative mortality</Keyword><Keyword MajorTopicYN="N">Postoperative sepsis</Keyword><Keyword MajorTopicYN="N">Probiotic</Keyword><Keyword MajorTopicYN="N">Synbiotic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27073082</ArticleId><ArticleId IdType="doi">10.1007/s11605-016-3142-y</ArticleId><ArticleId IdType="pii">S1091-255X(23)06635-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ned Tijdschr Geneeskd. 2008 Mar 22;152(12):685-96</Citation><ArticleIdList><ArticleId IdType="pubmed">18438065</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2009 Dec;198(6):868-74</Citation><ArticleIdList><ArticleId IdType="pubmed">19969144</ArticleId></ArticleIdList></Reference><Reference><Citation>JPEN J Parenter Enteral Nutr. 2011 May;35(3):317-28</Citation><ArticleIdList><ArticleId IdType="pubmed">21527594</ArticleId></ArticleIdList></Reference><Reference><Citation>Langenbecks Arch Surg. 2005 Apr;390(2):104-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15711820</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2005 Jan;5(1):125-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15636620</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2014 Feb;101(3):189-99</Citation><ArticleIdList><ArticleId IdType="pubmed">24402842</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Clin Nutr Metab Care. 2001 Nov;4(6):571-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11706296</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrition. 2013 Oct;29(10):1224-30</Citation><ArticleIdList><ArticleId IdType="pubmed">23867209</ArticleId></ArticleIdList></Reference><Reference><Citation>Benef Microbes. 2015 Mar;6(1):3-17</Citation><ArticleIdList><ArticleId IdType="pubmed">25304690</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Nutr. 2008 Nov;88(5):1438-46</Citation><ArticleIdList><ArticleId IdType="pubmed">18996881</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2010 Feb;36(2):222-31</Citation><ArticleIdList><ArticleId IdType="pubmed">20069275</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 1990 Mar;125(3):403-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2407230</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2010 Dec;139(6):1808-12</Citation><ArticleIdList><ArticleId IdType="pubmed">20965190</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Nutr. 2013 Jan;97(1):117-26</Citation><ArticleIdList><ArticleId IdType="pubmed">23235200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 1999 Aug;45(2):223-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10403734</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Biochem Eng Biotechnol. 2008;111:1-66</Citation><ArticleIdList><ArticleId IdType="pubmed">18461293</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1993 Jan;80(1):66-71</Citation><ArticleIdList><ArticleId IdType="pubmed">8428299</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2009 Jan;37(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19050636</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Nutr. 2010 Feb;64(2):146-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19756029</ArticleId></ArticleIdList></Reference><Reference><Citation>JPEN J Parenter Enteral Nutr. 2013 Mar;37(2):243-53</Citation><ArticleIdList><ArticleId IdType="pubmed">22750803</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Nutr. 2001 Feb;73(2 Suppl):361S-364S</Citation><ArticleIdList><ArticleId IdType="pubmed">11157342</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2007 Jul;246(1):36-41</Citation><ArticleIdList><ArticleId IdType="pubmed">17592288</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2001 Jul;29(7):1303-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Gastroenterol. 2015 Mar 20;15:34</Citation><ArticleIdList><ArticleId IdType="pubmed">25881090</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrition. 2002 Jul-Aug;18(7-8):609-15</Citation><ArticleIdList><ArticleId IdType="pubmed">12093440</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliment Pharmacol Ther. 2011 Jan;33(1):50-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21083585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1990 Aug 1;113(3):227-42</Citation><ArticleIdList><ArticleId IdType="pubmed">2197912</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med Bull. 2004 Dec 13;71:1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">15596865</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 1992 Jun;101(6):1644-55</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2007 May;94(5):546-54</Citation><ArticleIdList><ArticleId IdType="pubmed">17443852</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2015 Nov;39(11):2776-83</Citation><ArticleIdList><ArticleId IdType="pubmed">25894405</ArticleId></ArticleIdList></Reference><Reference><Citation>Natl Vital Stat Rep. 2001 Sep 21;49(8):1-113</Citation><ArticleIdList><ArticleId IdType="pubmed">11591077</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Apr 17;348(16):1546-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2011 Apr;201(4):498-502</Citation><ArticleIdList><ArticleId IdType="pubmed">20619394</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Nutr. 2008 Mar;87(3):785-91</Citation><ArticleIdList><ArticleId IdType="pubmed">18326619</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Gen Med. 2016 Feb 22;9:27-37</Citation><ArticleIdList><ArticleId IdType="pubmed">26955289</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1995 Jul 26;274(4):338-45</Citation><ArticleIdList><ArticleId IdType="pubmed">7609265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2004 Feb;53(2):241-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14724157</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2002 Nov 15;35(10):1155-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12410474</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 2002 Jul 15;74(1):123-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12134110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2010 Dec;252(6):1065-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutr Cancer. 2015;67(3):457-62</Citation><ArticleIdList><ArticleId IdType="pubmed">25803626</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34750650</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis.</ArticleTitle><Pagination><StartPage>16</StartPage><EndPage>24</EndPage><MedlinePgn>16-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-021-06558-0</ELocationID><Abstract><AbstractText>We aimed to compare the effects of vitamin C, glucocorticoids, vitamin B1, combinations of these drugs, and placebo or usual care on longer-term mortality in adults with sepsis or septic shock. MEDLINE, Embase, CENTRAL, ClinicalTrials.gov and WHO-ICTRP were searched. The final search was carried out on September 3rd, 2021. Multiple reviewers independently selected randomized controlled trials (RCTs) comparing very-high-dose vitamin C (&#x2265;&#x2009;12&#xa0;g/day), high-dose vitamin C (&lt;&#x2009;12,&#x2009;&#x2265;&#x2009;6&#xa0;g/day), vitamin C (&lt;&#x2009;6&#xa0;g/day), glucocorticoid (&lt;&#x2009;400&#xa0;mg/day of hydrocortisone), vitamin B1, combinations of these drugs, and placebo/usual care. We performed random-effects network meta-analysis and, where applicable, a random-effects component network meta-analysis. We used the Confidence in Network Meta-Analysis framework to assess the degree of treatment effect certainty. The primary outcome was longer-term mortality (90-days to 1-year). Secondary outcomes were severity of organ dysfunction over 72&#xa0;h, time to cessation of vasopressor therapy, and length of stay in intensive care unit (ICU). Forty-three RCTs (10,257 patients) were eligible. There were no significant differences in longer-term mortality between treatments and placebo/usual care or between treatments (10 RCTs, 7,096 patients, moderate to very-low-certainty). We did not find any evidence that vitamin C or B1 affect organ dysfunction or ICU length of stay. Adding glucocorticoid to other treatments shortened duration of vasopressor therapy (incremental mean difference, -&#x2009;29.8&#xa0;h [95% CI -&#x2009;44.1 to -&#x2009;15.5]) and ICU stay (incremental mean difference, -&#x2009;1.3&#xa0;days [95% CI -&#x2009;2.2 to -&#x2009;0.3]). Metabolic resuscitation with vitamin C, glucocorticoids, vitamin B1, or combinations of these drugs was not significantly associated with a decrease in longer-term mortality.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3854-4081</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Jikei University Hospital, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan. tofujii-tky@umin.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. tofujii-tky@umin.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behaviour, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan. tofujii-tky@umin.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salanti</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Austin Hospital, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>Anitra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furukawa</LastName><ForeName>Toshi A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behaviour, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luethi</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Inselspital University Hospital Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behaviour, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartini</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsujimoto</LastName><ForeName>Yasushi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behaviour, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scientific Research Works Peer Support Group (SRWS-PSG), Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udy</LastName><ForeName>Andrew A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, The Alfred, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanase</LastName><ForeName>Fumitaka</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Austin Hospital, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Wellington Regional Hospital, Wellington, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>X66NSO3N35</RegistryNumber><NameOfSubstance UI="D013831">Thiamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Intensive Care Med. 2022 Nov;48(11):1621-1624. doi: 10.1007/s00134-022-06822-x.</RefSource><PMID Version="1">35960273</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013831" MajorTopicYN="N">Thiamine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hydrocortisone</Keyword><Keyword MajorTopicYN="N">Network meta-analysis</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Thiamine</Keyword><Keyword MajorTopicYN="N">Vitamin C</Keyword></KeywordList><CoiStatement>None to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34750650</ArticleId><ArticleId IdType="pmc">PMC8724116</ArticleId><ArticleId IdType="doi">10.1007/s00134-021-06558-0</ArticleId><ArticleId IdType="pii">10.1007/s00134-021-06558-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sevransky JE, Rothman RE, Hager DN, Bernard GR, Brown SM, Buchman TG, Busse LW, Coopersmith CM, DeWilde C, Ely EW, et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA. 2021;325(8):742&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903252</ArticleId><ArticleId IdType="pubmed">33620405</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AA, 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, Thacker LR, 2nd, Natarajan R, Brophy DF, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322(13):1261&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6777268</ArticleId><ArticleId IdType="pubmed">31573637</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskowitz A, Huang DT, Hou PC, Gong J, Doshi PB, Grossestreuer AV, Andersen LW, Ngo L, Sherwin RL, Berg KM, et al. Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA. 2020;324(7):642&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435341</ArticleId><ArticleId IdType="pubmed">32809003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Luethi N, Young PJ, Frei DR, Eastwood GM, French CJ, Deane AM, Shehabi Y, Hajjar LA, Oliveira G, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA. 2020;323(5):423&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7029761</ArticleId><ArticleId IdType="pubmed">31950979</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Deane AM, Nair P. Metabolic support in sepsis: corticosteroids and vitamins: the why, the when, the how. Curr Opin Crit Care. 2020;26(4):363&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">32487845</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. 2017;21(1):300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5725835</ArticleId><ArticleId IdType="pubmed">29228951</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AA, 3rd, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, Farthing CA, Larus TL, Martin E, Brophy DF, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3937164</ArticleId><ArticleId IdType="pubmed">24484547</ArticleId></ArticleIdList></Reference><Reference><Citation>Rygard SL, Butler E, Granholm A, Moller MH, Cohen J, Finfer S, Perner A, Myburgh J, Venkatesh B, Delaney A. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2018;44(7):1003&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">29761216</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Martin C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">29490185</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, Billot L, Correa M, Glass P, Harward M, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">29347874</ArticleId></ArticleIdList></Reference><Reference><Citation>van Snippenburg W, Reijnders MGJ, Hofhuis JGM, de Vos R, Kamphuis S, Spronk PE. Thiamine levels during intensive insulin therapy in critically ill patients. J Intensive Care Med. 2017;32(9):559&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">27440134</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP, Ngo L. Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010;25(4):576&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">20646908</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnino MW, Andersen LW, Chase M, Berg KM, Tidswell M, Giberson T, Wolfe R, Moskowitz A, Smithline H, Ngo L, et al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Crit Care Med. 2016;44(2):360&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4754670</ArticleId><ArticleId IdType="pubmed">26771781</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AC. Vitamin C administration in the critically ill: a summary of recent meta-analyses. Crit Care. 2019;23(1):265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664573</ArticleId><ArticleId IdType="pubmed">31362775</ArticleId></ArticleIdList></Reference><Reference><Citation>Welton NJ, Caldwell DM, Adamopoulos E, Vedhara K. Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol. 2009;169(9):1158&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">19258485</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Belletti A, Carr A, Furukawa TA, Luethi N, Putzu A, Sartini C, Salanti G, Tsujimoto Y, Udy AA, et al. Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis. BMJ Open. 2019;9(11):e033458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858173</ArticleId><ArticleId IdType="pubmed">31722954</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner AK, Ghita GL, Wang Z, Ozrazgat-Baslanti T, Raymond SL, Mankowski RT, Brumback BA, Efron PA, Bihorac A, Moore FA, et al. The development of chronic critical illness determines physical function, quality of life, and long-term survival among early survivors of sepsis in surgical ICUs. Crit Care Med. 2019;47(4):566&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6422682</ArticleId><ArticleId IdType="pubmed">30664526</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP (2011) GS: Cochrane handbook for systematic reviews of interventions, Version 5.1.0</Citation></Reference><Reference><Citation>Bakbergenuly I, Hoaglin DC, Kulinskaya E. Pitfalls of using the risk ratio in meta-analysis. Res Synth Methods. 2019;10(3):398&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6767076</ArticleId><ArticleId IdType="pubmed">30854785</ArticleId></ArticleIdList></Reference><Reference><Citation>Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP. Evaluating the quality of evidence from a network meta-analysis. PLoS ONE. 2014;9(7):e99682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4084629</ArticleId><ArticleId IdType="pubmed">24992266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaimani A, Caldwell D, Li T, Higgins J, Salanti G (2021) Chapter 11: undertaking network meta-analyses. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V (eds) Cochrane handbook for systematic reviews of interventions. Version 6.2 (updated February 2021) edn</Citation></Reference><Reference><Citation>Friedrich JO, Adhikari NK, Beyene J. The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med Res Methodol. 2008;8:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2430201</ArticleId><ArticleId IdType="pubmed">18492289</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich JO, Adhikari NK, Beyene J. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. J Clin Epidemiol. 2011;64(5):556&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">21447428</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;cker G et al. (2018) netmeta: network meta-analysis using frequentist methods. In: R package version 0.9-8</Citation></Reference><Reference><Citation>Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, Salanti G. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLOS Mede. 2020;17(4):e1003082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7122720</ArticleId><ArticleId IdType="pubmed">32243458</ArticleId></ArticleIdList></Reference><Reference><Citation>Papakonstantinou T, Nikolakopoulou A, Higgins JPT, Egger M, Salanti G (2020) CINeMA: software for semiautomated assessment of the confidence in the results of network meta&#x2010;analysis. Campbell Syst Rev 16(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356302</ArticleId><ArticleId IdType="pubmed">37131978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirea L, Ungureanu R, Pavelescu D, Grintescu IC, Mirea D, Tiganiuc L, Dumitrache C, Grintescu I. PP007-MON: discontinuous corticosteroids administration increase the risk of hyperglycaemia in septic shock. Clin Nutr. 2014;33:S132.</Citation></Reference><Reference><Citation>Jiang XYD, Zhao H, Yang F, Yuan Z, Lu P, Tian H. Early low-dose glucocorticoid therapy effectively suppresses serum pro-inflammatory factors such as IL-6 and inhibits apoptosis of CD4+ cells in septic shock patients. Int J Clin Exp Med. 2019;12(1):718&#x2013;723.</Citation></Reference><Reference><Citation>Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pubmed">12186604</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">18184957</ArticleId></ArticleIdList></Reference><Reference><Citation>Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, Bogatsch H, Briegel J, Engel C, Gerlach H, et al. Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA. 2016;316(17):1775&#x2013;1785.</Citation><ArticleIdList><ArticleId IdType="pubmed">27695824</ArticleId></ArticleIdList></Reference><Reference><Citation>Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, Meduri GU. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care. 2016;20(1):329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065699</ArticleId><ArticleId IdType="pubmed">27741949</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv QQ, Gu XH, Chen QH, Yu JQ, Zheng RQ. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial. Am J Emerg Med. 2017;35(12):1810&#x2013;1814.</Citation><ArticleIdList><ArticleId IdType="pubmed">28615145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SY, Ryoo SM, Park JE, Jo YH, Jang DH, Suh GJ, Kim T, Kim YJ, Kim S, Cho H, et al. Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study. Intensive Care Med. 2020;46(11):2015&#x2013;2025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417779</ArticleId><ArticleId IdType="pubmed">32780166</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh B, Finfer S, Myburgh J, Cohen J, Billot L. Long-term outcomes of the ADRENAL trial. N Engl J Med. 2018;378(18):1744&#x2013;1745.</Citation><ArticleIdList><ArticleId IdType="pubmed">29694789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wani SJ, Mufti SA, Jan RA, Shah SU, Qadri SM, Khan UH, Bagdadi F, Mehfooz N, Koul PA. Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: results from an open label randomised controlled clinical trial and a review of the literature. Infect Dis (Lond) 2020;52(4):271&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">31990246</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, Knawy BA, Hajeer AH, Tamimi W, Cherfan A. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ. 2010;182(18):1971&#x2013;1977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3001503</ArticleId><ArticleId IdType="pubmed">21059778</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998;26(4):645&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">9559600</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, Brett SJ. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014;42(6):1325&#x2013;1333.</Citation><ArticleIdList><ArticleId IdType="pubmed">24557425</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Gu C, Zhang S, Lian R, Zhang G. Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock. Chin Crit Care Med. 2016;28(9):780&#x2013;784.</Citation></Reference><Reference><Citation>Oppert M, Schindler R, Husung C, Offermann K, Graf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33(11):2457&#x2013;2464.</Citation><ArticleIdList><ArticleId IdType="pubmed">16276166</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz O, Doganay M, Aygen B, Guven M, Kelestimur F, Tutuu A. Physiological-dose steroid therapy in sepsis [ISRCTN36253388] Crit Care. 2002;6(3):251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125315</ArticleId><ArticleId IdType="pubmed">12133187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz O, Tanriverdi F, Simsek S, Aygen B, Kelestimur F. The effects of moderate-dose steroid therapy in sepsis: a placebo-controlled, randomized study. J Res Med Sci. 2011;16(11):1410&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430057</ArticleId><ArticleId IdType="pubmed">22973341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabet MH, Mohammadi M, Ramezani M, Khalili H. Effect of high-dose ascorbic acid on vasopressor's requirement in septic shock. J Res Pharm Pract. 2016;5(2):94&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843590</ArticleId><ArticleId IdType="pubmed">27162802</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P, Liao Y, Guan J, Guo Y, Zhao M, Hu J, Zhou J, Wang H, Cen Z, Tang Y, et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock: a randomized controlled trial. Chest. 2020;158(1):174&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv SJ, Zhang GH, Xia JM, Yu H, Zhao F. Early use of high-dose vitamin C is beneficial in treatment of sepsis. Ir J Med Sci. 2020;190:1183&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33094466</ArticleId></ArticleIdList></Reference><Reference><Citation>Petsakul S, Morakul S, Tangsujaritvijit V, Kunawut P, Singhatas P, Sanguanwit P. Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial. BMC Anesthesiol. 2020;20(1):280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7650202</ArticleId><ArticleId IdType="pubmed">33167911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein AA, Sabry NA, Abdalla MS, Farid SF. A prospective, randomised clinical study comparing triple therapy regimen to hydrocortisone monotherapy in reducing mortality in septic shock patients. Int J Clin Pract. 2021;75(9):e14376.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferron-Celma I, Mansilla A, Hassan L, Garcia-Navarro A, Comino AM, Bueno P, Ferron JA. Effect of vitamin C administration on neutrophil apoptosis in septic patients after abdominal surgery. J Surg Res. 2009;153(2):224&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">18952228</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri GU, Golden E, Umberger R. Prospective double-blind randomized clinical trial on the effects of low-dose hydrocortisone infusion in patients with severe sepsis. Chest. 2009;136(4):45S.</Citation></Reference><Reference><Citation>Iglesias J, Vassallo AV, Patel VV, Sullivan JB, Cavanaugh J, Elbaga Y. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: the ORANGES trial. Chest. 2020;158(1):164&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">32194058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed ZU, Prasannan P, Moni M, Edathadathil F, Prasanna P, Menon A, Nair S, Greeshma CR, Sathyapalan DT, Menon V, et al. Vitamin C therapy for routine care in septic shock (ViCTOR) trial: effect of intravenous vitamin C, thiamine, and hydrocortisone administration on inpatient mortality among patients with septic shock. Indian J Crit Care Med. 2020;24(8):653&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519616</ArticleId><ArticleId IdType="pubmed">33024370</ArticleId></ArticleIdList></Reference><Reference><Citation>Harun NF, Cheah SK, Yusof AM, Lau CL, Masdar A, Mahdi SNM, Yahya N, Mohamad N, Rahman RA. Intravenous thiamine as an adjuvant therapy for hyperlactatemia in septic shock patients. Crit Care Shock. 2019;22(6):288&#x2013;298.</Citation></Reference><Reference><Citation>Rahardjo TM, Redjeki I, Maskoen T. Effect of vitamin C 1000 mg IV therapy to lactate level, base deficit and Svo2 in septic patient. Crit Care Med. 2013;41:A283.</Citation></Reference><Reference><Citation>Rinaldi S, Adembri C, Grechi S, De Gaudio AR. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med. 2006;34(9):2334&#x2013;2339.</Citation><ArticleIdList><ArticleId IdType="pubmed">16850006</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Fowler R, Vincent JL. Vitamin C and thiamine for sepsis: time to go back to fundamental principles. Intensive Care Med. 2020;46(11):2061&#x2013;2063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32945934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Li JG, Liang H, Zhou Q, Yu Z, Li L, Luo Y, Liu C, Gan Q. The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21(9):529&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">19751560</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanase F, Fujii T, Naorungroj T, Belletti A, Luethi N, Carr AC, Young PJ, Bellomo R. Harm of IV high-dose vitamin C therapy in adult patients: a scoping review. Crit Care Med. 2020;48(7):e620&#x2013;e628.</Citation><ArticleIdList><ArticleId IdType="pubmed">32404636</ArticleId></ArticleIdList></Reference><Reference><Citation>Young PJ. Hydrocortisone in septic shock: is it worth it? Crit Care Resusc. 2020;22(3):189&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10692505</ArticleId><ArticleId IdType="pubmed">32900324</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AA, 3rd, Fisher BJ, Kashiouris MG. Vitamin C for sepsis and acute respiratory failure-reply. JAMA. 2020;323(8):792&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32096845</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28092497</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8674</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Surgical infections</Title><ISOAbbreviation>Surg Infect (Larchmt)</ISOAbbreviation></Journal><ArticleTitle>Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>233</EndPage><MedlinePgn>225-233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/sur.2016.168</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To evaluate the efficacy and safety of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) therapy in patients with sepsis.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A systematic review and meta-analysis of four major databases: Cochrane Central Register of Controlled Trials, MEDLINE, Scopus, and Science Citation Index Expanded.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Randomized controlled trials comparing PMX-DHP with conventional therapy on the outcome of mortality in patients with severe sepsis/septic shock.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Two reviewers independently applied eligibility criteria, assessed quality, and extracted data. Primary outcomes were mortality and adverse events. We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to rate quality of evidence and grade the strength of recommendation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In seven trials enrolling 841 patients, assessment for risk of bias indicated variations in study quality from high (n&#x2009;=&#x2009;4) to unclear (n&#x2009;=&#x2009;3) resulting from a lack of adequate randomization, blinding, and incomplete outcomes. Polymyxin B-immobilized fiber therapy was associated with lower mortality (risk ratio, 0.65; 95% confidence interval [CI], 0.47-0.89; p&#x2009;=&#x2009;0.007; I<sup>2</sup>&#x2009;=&#x2009;72%). Significant heterogeneity among trials was explained partly by study venue and baseline mortality rate. Meta-regression analysis revealed a significant negative slope between effect size of PMX-DHP therapy and baseline mortality rate in individual studies (p&#x2009;=&#x2009;0.003), suggesting the probability of a beneficial effect with PMX-DHP increased with increasing baseline risk. Polymyxin B-immobilized fiber therapy did not increase the risk of hemoperfusion-related adverse events. The quality of the body of evidence was considered low for both mortality and adverse events.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Polymyxin B-immobilized fiber therapy was associated with reduced mortality in sepsis/septic shock. Based on the low quality of evidence, therapeutic use of PMX-DHP for survival benefit may be recommended conditionally for patients with high risk of death. Additional large randomized controlled trials are needed to confirm or refute this evidence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Terayama</LastName><ForeName>Takero</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>1 Department of Emergency and Critical Care, Osaka General Medical Center , Osaka, Japan .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Kazuma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>2 Division of Trauma and Surgical Critical Care, Osaka General Medical Center , Osaka, Japan .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umemura</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>3 Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine , Osaka, Japan .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aihara</LastName><ForeName>Morio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>4 Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine , Hirosaki, Japan .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujimi</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1 Department of Emergency and Critical Care, Osaka General Medical Center , Osaka, Japan .</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surg Infect (Larchmt)</MedlineTA><NlmUniqueID>9815642</NlmUniqueID><ISSNLinking>1096-2964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>J2VZ07J96K</RegistryNumber><NameOfSubstance UI="D011112">Polymyxin B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006464" MajorTopicYN="Y">Hemoperfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011112" MajorTopicYN="N">Polymyxin B</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hemoperfusion</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">polymixin B</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28092497</ArticleId><ArticleId IdType="doi">10.1089/sur.2016.168</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39696003</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Ramelteon exposure and survival of critically Ill sepsis patients: a retrospective study from MIMIC-IV.</ArticleTitle><Pagination><StartPage>454</StartPage><MedlinePgn>454</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">454</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-024-02851-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effect of ramelteon, a melatonin receptor agonist, on survival in septic patients remains unknown. The purpose of this retrospective cohort study was to explore the relationship between ramelteon exposure and survival outcomes in septic patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from septic patients admitted to the intensive care unit (ICU) were extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, with patients categorized into ramelteon exposure and non-exposure groups based on the use of ramelteon. The primary outcome was 30-day mortality, and secondary outcomes included 90-day mortality, in-hospital mortality, length of ICU stay, and hospital stay. Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were employed to address confounding variables. Kaplan-Meier (K-M) analysis and Cox proportional hazards regression models for stepwise regression were utilized to assess the impact of ramelteon exposure on survival.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study included 22,152 unexposed patients and 2,708 exposed patients, resulting in 2,607 matched pairs after PSM. Following PSM, ramelteon exposure was associated with significantly lower in-hospital mortality (11.6% vs.19.7%, p&#x2009;&lt;&#x2009;0.001), 30-day mortality (13.4% vs. 23.2%, p&#x2009;&lt;&#x2009;0.001), and 90-day mortality (22.1% vs. 30%, p&#x2009;&lt;&#x2009;0.001).K-M curves demonstrated a significant difference in 30-day and 90-day mortality between the two groups (P&#x2009;&lt;&#x2009;0.001), irrespective of PSM application. Both PSM (hazard ratio [HR]&#x2009;=&#x2009;0.53, 95% confidence intervals [CIs] 0.47-0.61, p&#x2009;&lt;&#x2009;0.001) and IPTW models (HR&#x2009;=&#x2009;0.59, 95% CI 0.50-0.70, p&#x2009;&lt;&#x2009;0.001) indicated a significant positive effect of ramelteon usage on 30-day mortality among septic patients compared to the non-exposure group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This exploratory, retrospective study suggests an association between ramelteon exposure and reduced 30-day and 90-day mortality in septic patients compared with the non-exposure group. Considering the limitations of the retrospective design and the potential for unmeasured confounding, well-designed prospective studies and randomized controlled trials will be needed to confirm these findings.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Han</LastName><ForeName>Yun-Yang</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tian</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital of Southern Medical University, Guangzhou, 510280, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. liukexuan705@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>901AS54I69</RegistryNumber><NameOfSubstance UI="C495910">ramelteon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007192">Indenes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007192" MajorTopicYN="Y">Indenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">MIMIC-IV</Keyword><Keyword MajorTopicYN="N">Melatonin</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Ramelteon</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Authorization for this investigation was granted by the Massachusetts Institute of Technology (MIT) and Beth Israel Deaconess Medical Center (BIDMC) institutional review boards, with informed consent waived. Database access was granted to a researcher (HYY) who completed the Collaborative Institutional Training Initiative test (name ID: 10112186, record ID: 42408105). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39696003</ArticleId><ArticleId IdType="pmc">PMC11653545</ArticleId><ArticleId IdType="doi">10.1186/s12871-024-02851-9</ArticleId><ArticleId IdType="pii">10.1186/s12871-024-02851-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA-J AM MED ASSOC. 2016;315(8):801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. CRIT CARE. 2020;24(1):239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236499</ArticleId><ArticleId IdType="pubmed">32430052</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YC, Yao Y, Yu MM, Gao YL, Qi AL, Jiang TY, Chen ZS, Shou ST, Chai YF. Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis. BMC INFECT DIS. 2022;22(1):564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210671</ArticleId><ArticleId IdType="pubmed">35729526</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AD, MacCallum NS, Harris S, Brealey DA, Palmer E, Hetherington J, Shi S, Perez-Suarez D, Ercole A, Watkinson PJ et al: Descriptors of Sepsis Using the Sepsis-3 Criteria: A Cohort Study in Critical Care Units Within the U.K. National Institute for Health Research Critical Care Health Informatics Collaborative. CRIT CARE MED 2021, 49(11):1883&#x2013;1894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508729</ArticleId><ArticleId IdType="pubmed">34259454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J CLIN SLEEP MED. 2017;13(2):307&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5263087</ArticleId><ArticleId IdType="pubmed">27998379</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox ME, Burry L, Englesakis M, Coman B, Daou M, van Haren FM, Ely EW, Bosma KJ, Knauert MP. Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review. Thorax. 2024;79(10):988&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">38350730</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, Nakamura H. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA PSYCHIAT. 2014;71(4):397&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">24554232</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto M. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS NEUROSCI THER. 2009;15(1):32&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2871175</ArticleId><ArticleId IdType="pubmed">19228178</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpsoe NG, Andersen LP, Gogenur I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic review. EUR J CLIN PHARMACOL. 2015;71(8):901&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26008214</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim A, Tolbert D, Cao C. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia. J CLIN PHARMACOL. 2006;46(2):140&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16432265</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Wu X, Zhang Q, Li Y, Ye Y, Li P, Chen S, Peng Y, Hardeland R, Xia Y. Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic Insights. FRONT IMMUNOL. 2021;12: 683879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8201398</ArticleId><ArticleId IdType="pubmed">34135911</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Luo X, Li J, Lei Y, Zeng F, Huang X, Lan Y, Yang F. Melatonin: A window into the organ-protective effects of sepsis. BIOMED PHARMACOTHER. 2022;154: 113556.</Citation><ArticleIdList><ArticleId IdType="pubmed">35994818</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang L, Du N, Yin X, Shao H, Yang L. Ramelteon Ameliorates LPS-Induced Hyperpermeability of the Blood-Brain Barrier (BBB) by Activating Nrf2. Inflammation. 2021;44(5):1750&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">33876343</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Wang J, Wang D, Guo L, Yu D. Melatonin Receptor Agonist Ramelteon Suppresses LPS-Induced Neuroinflammation in Astrocytes. ACS CHEM NEUROSCI. 2021;12(9):1498&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Zhang Y, Lu D, Huang T, Yan K, Wang W, Gao J. Ramelteon protects against human pulmonary microvascular endothelial cell injury induced by lipopolysaccharide (LPS) via activating nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. Bioengineered. 2022;13(1):1518&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8805948</ArticleId><ArticleId IdType="pubmed">34986734</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton SS, Magagnoli J, Cummings TH, Hardin JW. Melatonin use and the risk of 30-day mortality among US veterans with sepsis: A retrospective study. J PINEAL RES. 2022;73(2): e12811.</Citation><ArticleIdList><ArticleId IdType="pubmed">35652450</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink T, Glas M, Wolf A, Kleber A, Reus E, Wolff M, Kiefer D, Wolf B, Rensing H, Volk T, et al. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis. CRIT CARE MED. 2014;42(1):e22&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">24145838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikimi M, Numaguchi A, Takahashi K, Miyagawa Y, Matsui K, Higashi M, Makishi G, Matsui S, Matsuda N. Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial. CRIT CARE MED. 2018;46(7):1099&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6012040</ArticleId><ArticleId IdType="pubmed">29595562</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen AB, Mikkelsen EM, Cronin-Fenton D, Kristensen NR, Pham TM, Pedersen L, Petersen I. Missing data and multiple imputation in clinical epidemiological research. CLIN EPIDEMIOL. 2017;9:157&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5358992</ArticleId><ArticleId IdType="pubmed">28352203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Kim HJ, Lonjon G, Zhu Y. Balance diagnostics after propensity score matching. ANN TRANSL MED. 2019;7(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351359</ArticleId><ArticleId IdType="pubmed">30788363</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Vico A, Lardone PJ, Naji L, Fernandez-Santos JM, Martin-Lacave I, Guerrero JM, Calvo JR. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J PINEAL RES. 2005;39(4):400&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16207296</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wang L, Xie W, Hu S, Zhou H, Zhu P, Zhu H. Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: A new mechanism involving BAP31 upregulation and MAPK-ERK pathway. J CELL PHYSIOL. 2020;235(3):2847&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">31535369</ArticleId></ArticleIdList></Reference><Reference><Citation>Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making. MED CLIN N AM. 2020;104(4):573&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">32505253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi SM, Nabavi SF, Sureda A, Xiao J, Dehpour AR, Shirooie S, Silva AS, Baldi A, Khan H, Daglia M. Anti-inflammatory effects of Melatonin: A mechanistic review. CRIT REV FOOD SCI. 2019;59(sup1):S4&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">29902071</ArticleId></ArticleIdList></Reference><Reference><Citation>Galano A, Reiter RJ. Melatonin and its metabolites vs oxidative stress: From individual actions to collective protection. J PINEAL RES. 2018;65(1): e12514.</Citation><ArticleIdList><ArticleId IdType="pubmed">29888508</ArticleId></ArticleIdList></Reference><Reference><Citation>Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J CLIN INVEST. 2006;116(4):984&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1421348</ArticleId><ArticleId IdType="pubmed">16585964</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecon E, Izabelle C, Poder SL, Real F, Zhu A, Tu L, Ghigna MR, Klonjkowski B, Bomsel M, Jockers R, et al. Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2. J PINEAL RES. 2022;72(1): e12772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646885</ArticleId><ArticleId IdType="pubmed">34586649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameri A, Frouz AM, Ziaei A, Vatankhah M, Safa O, Kamali M, Fathalipour M, Mahmoodi M, Hassanipour S. Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial. Inflammopharmacology. 2023;31(1):265&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9676876</ArticleId><ArticleId IdType="pubmed">36401728</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PY, Wu JY, Liu TH, Tsai YW, Chen PT, Liao CT, Toh HS. The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. FRONT MED-LAUSANNE. 2023;10:1171294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10166833</ArticleId><ArticleId IdType="pubmed">37181363</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai S, Kadomura S, Miyai T, Kashiwagi H, Sato Y, Sugawara M, Takekuma Y. Using Japanese big data to investigate novel factors and their high-risk combinations that affect vancomycin-induced nephrotoxicity. BRIT J CLIN PHARMACO. 2022;88(7):3241&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">35106797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingren MS, Starr ME, Saito H. Divergent Sepsis Pathophysiology in Older Adults. ANTIOXID REDOX SIGN. 2021;35(16):1358&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905233</ArticleId><ArticleId IdType="pubmed">34210173</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu C, Wang F, Zhang YT, Wei SZ, Liu JY, Sun HY, Wang GH, Liu CF. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell. 2021;20(6): e13375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8208780</ArticleId><ArticleId IdType="pubmed">33964119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu GC, Peng CK, Liao WI, Pao HP, Huang KL, Chu SJ. Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production. RESP RES. 2020;21(1):65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7059294</ArticleId><ArticleId IdType="pubmed">32143642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathes AM, Kubulus D, Waibel L, Weiler J, Heymann P, Wolf B, Rensing H. Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat. CRIT CARE MED. 2008;36(10):2863&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">18766086</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroethoff M, Christoph I, Behmenburg F, Raupach A, Bunte S, Senpolat S, Heinen A, Hollmann MW, Mathes A, Huhn R. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels. J CARDIOVASC PHARM. 2018;72(2):106&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">29787401</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33092804</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Systematic review and consensus definitions for the Standardized Endpoints in Perioperative Medicine (StEP) initiative: cardiovascular outcomes.</ArticleTitle><Pagination><StartPage>56</StartPage><EndPage>66</EndPage><MedlinePgn>56-66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2020.09.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(20)30780-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Adverse cardiovascular events are a leading cause of perioperative morbidity and mortality. The definitions of perioperative cardiovascular adverse events are heterogeneous. As part of the international Standardized Endpoints in Perioperative Medicine initiative, this study aimed to find consensus amongst clinical trialists on a set of standardised and valid cardiovascular outcomes for use in future perioperative clinical trials.</AbstractText><AbstractText Label="METHODS">We identified currently used perioperative cardiovascular outcomes by a systematic review of the anaesthesia and perioperative medicine literature (PubMed/Ovid, Embase, and Cochrane Library). We performed a three-stage Delphi consensus-gaining process that involved 55 clinician researchers worldwide. Cardiovascular outcomes were first shortlisted and the most suitable definitions determined. These cardiovascular outcomes were then assessed for validity, reliability, feasibility, and clarity.</AbstractText><AbstractText Label="RESULTS">We identified 18 cardiovascular outcomes. Participation in the three Delphi rounds was 100% (n=19), 71% (n=55), and 89% (n=17), respectively. A final list of nine cardiovascular outcomes was elicited from the consensus: myocardial infarction, myocardial injury, cardiovascular death, non-fatal cardiac arrest, coronary revascularisation, major adverse cardiac events, pulmonary embolism, deep vein thrombosis, and atrial fibrillation. These nine cardiovascular outcomes were rated by the majority of experts as valid, reliable, feasible, and clearly defined.</AbstractText><AbstractText Label="CONCLUSIONS">These nine consensus cardiovascular outcomes can be confidently used as endpoints in clinical trials designed to evaluate perioperative interventions with the goal of improving perioperative outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beattie</LastName><ForeName>W Scott</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Cardiovascular Anesthesia, University Health Network, University of Toronto, Toronto, ON, Canada. Electronic address: scott.beattie@uhn.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocock</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Li Ka Shing Knowledge Institute, St Michaels Hospital, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagele</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, University of Pennsylvania Health System, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howell</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Leeds School of Medicine, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovani</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Intensive Care and Anesthesiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Alfred Health and Monash University Department of Anaesthesia and Perioperative Medicine, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>StEP COMPAC Group</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Patient Comfort</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Clinical Indicators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Delirium Postoperative Cognitive Dysfunction Stroke</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Cardiovascular</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Data Extractors</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Respiratory</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Inflammation Sepsis</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Acute Kidney Injury</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Bleeding Complications Patient Blood Management</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Healthcare Resource Utilisation</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Patient-Centred Outcomes</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Organ Failure and Survival</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Cancer Surgery</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>10/104/06</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003697" MajorTopicYN="N">Delphi Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079645" MajorTopicYN="N">Perioperative Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MACE</Keyword><Keyword MajorTopicYN="N">cardiovascular events</Keyword><Keyword MajorTopicYN="N">clinical trials</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">outcome measures</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">standardised endpoint</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>D Jamie</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gan</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peyton</LastName><ForeName>Phil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tram&#xe8;r</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cyna</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Oliveira</LastName><ForeName>Gildasio S</ForeName><Initials>GS</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kehlet</LastName><ForeName>Henrik</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Botti</LastName><ForeName>Mari</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boney</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haller</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gruen</LastName><ForeName>Russell</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bampoe</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evered</LastName><ForeName>Lis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silbert</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Diederik</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haller</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eckenhoff</LastName><ForeName>Rod</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eriksson</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Howell</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagele</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartlett</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>McMonnies</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerstl</LastName><ForeName>Jakob V.E.</ForeName><Initials>JV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jay</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kishlyansky</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Machina</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bobcock</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feng</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>Rupert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mythen</LastName><ForeName>Monty</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canet</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moller</LastName><ForeName>Ann</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gin</LastName><ForeName>Tony</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Futier</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Creagh-Brown</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abbott</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mythen</LastName><ForeName>Monty</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klein</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>D Jamie</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieleman</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diouf</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prowle</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karkouti</LastName><ForeName>Keyvan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Billings</LastName><ForeName>Josh</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klein</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazer</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jayarajah</LastName><ForeName>Mohindas</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karkouti</LastName><ForeName>Keyvan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartoszko</LastName><ForeName>Justyna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sneyd</LastName><ForeName>Rob</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>Ron</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonesinghe</LastName><ForeName>Ramani</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shulman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lane-Fall</LastName><ForeName>Meghan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Ulrica</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stevenson</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>Rupert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonesinghe</LastName><ForeName>Ramani</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>Jamie Dj</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Klei</LastName><ForeName>Wilton</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cabrini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Sandy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buggy</LastName><ForeName>Donal</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riedel</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gottumukkala</LastName><ForeName>Vijay</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alkhaffaf</LastName><ForeName>Bilal</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>23</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33092804</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2020.09.023</ArticleId><ArticleId IdType="pii">S0007-0912(20)30780-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40162865</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2639-8028</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care explorations</Title><ISOAbbreviation>Crit Care Explor</ISOAbbreviation></Journal><ArticleTitle>Sex Differences in Pediatric Sepsis Mortality: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e1226</StartPage><MedlinePgn>e1226</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1226</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCE.0000000000001226</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Pediatric sepsis remains a leading cause of childhood mortality worldwide. Sex differences have been shown to modify risk factors, treatment, and outcome of various diseases, and adult studies revealed sex differences in pathophysiological responses to septic shock. We aimed to perform a systematic review and meta-analysis on the association of sex with outcomes in hospitalized children with sepsis.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Medline and Embase databases were searched for studies of children &lt; 18 years with sepsis published between January 01, 2005, and March 31, 2022.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">We included cohort studies, and randomized controlled trials in children greater than or equal to 37-week-old postconception to 18 years which included sepsis, severe sepsis or septic shock, and mortality as an outcome.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Study characteristics, patient demographics, and illness severity scores were extracted from eligible articles. Random-effects meta-analysis was performed.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">We screened 14,791 studies, with 912 full-text reviews and inclusion of 124 studies. The total population involved 426,163 patients, of which 47% (201,438) were girls. Meta-regression showed moderate evidence for a higher mortality in boys compared with girls. The estimated risk difference of mortality between boys and girls with all types of sepsis was -0.005 (95% CI, -0.0099 to -0.00001; p = 0.049), indicating slightly higher mortality for boys. When including the World Bank income level as a moderator, the effect was -0.008 (95% CI, -0.013 to -0.002; p = 0.005).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This large systematic review and meta-analysis on sex differences in pediatric sepsis mortality showed moderate evidence for a higher sepsis mortality in boys compared with girls. The effect persisted when adjusting for country's income level.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Uchenna K</ForeName><Initials>UK</Initials><Identifier Source="ORCID">0000-0001-8662-5033</Identifier><AffiliationInfo><Affiliation>Children's Research Center, Division of Pediatric Urology, Department of Pediatric Surgery, University Children's Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moulin</LastName><ForeName>Juliette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;hrer</LastName><ForeName>Lea</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim Fang Nian</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Queenstown, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halter</LastName><ForeName>Leyla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;hni</LastName><ForeName>Luzius</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;zelg&#xfc;n</LastName><ForeName>Melisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menon</LastName><ForeName>Kusum</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jan Hau</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Children's Intensive Care Unit, Department of Intensive Care, KK Women's and Children's Hospital, Duke National University Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlapbach</LastName><ForeName>Luregn J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care and Neonatology, and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Held</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Explor</MedlineTA><NlmUniqueID>101746347</NlmUniqueID><ISSNLinking>2639-8028</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>21</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>21</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>9</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40162865</ArticleId><ArticleId IdType="pmc">PMC11960803</ArticleId><ArticleId IdType="doi">10.1097/CCE.0000000000001226</ArticleId><ArticleId IdType="pii">02107256-202504000-00020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schlapbach LJ, Straney L, Alexander J, et al. ; ANZICS Paediatric Study Group: Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: A multicentre retrospective cohort study. Lancet Infect Dis 2015; 15:46&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pubmed">25471555</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, et al. ; International Surviving Sepsis Campaign Guidelines Committee: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296&#x2013;327</Citation><ArticleIdList><ArticleId IdType="pubmed">18158437</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Johnson HL, Cousens S, et al. ; Child Health Epidemiology Reference Group of WHO and UNICEF: Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151&#x2013;2161</Citation><ArticleIdList><ArticleId IdType="pubmed">22579125</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, et al. : Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study. Lancet 2020; 395:200&#x2013;211</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. : The global burden of paediatric and neonatal sepsis: A systematic review. Lancet Respir Med 2018; 6:223&#x2013;230</Citation><ArticleIdList><ArticleId IdType="pubmed">29508706</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman PKA, Schlapbach LJ, Giannoni E, et al. ; Swiss Pediatric Sepsis Study: Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: A population-based cohort study. Lancet Child Adolesc Health 2017; 1:124&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">30169202</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, MacLaren G, Festa M, et al. ; Australian &amp; New Zealand Intensive Care Society (ANZICS) Centre for Outcomes &amp; Resource Evaluation (CORE) and Australian &amp; New Zealand Intensive Care Society (ANZICS) Paediatric Study Group: Prediction of pediatric sepsis mortality within 1&#x2009;h of intensive care admission. Intensive Care Med 2017; 43:1085&#x2013;1096</Citation><ArticleIdList><ArticleId IdType="pubmed">28220227</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza DC, Goncalves Martin J, Soares Lanziotti V, et al. ; SPREAD PED Investigators and the Instituto Latino Americano de Sepsis Network: The epidemiology of sepsis in paediatric intensive care units in Brazil (the Sepsis PREvalence Assessment Database in Pediatric population, SPREAD PED): An observational study. Lancet Child Adolescent Health 2021; 5:873&#x2013;881</Citation><ArticleIdList><ArticleId IdType="pubmed">34756191</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza DC, Machado FR: Epidemiology of pediatric septic shock. J Pediat Intens Care 2019; 8:3&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6506671</ArticleId><ArticleId IdType="pubmed">31073502</ArticleId></ArticleIdList></Reference><Reference><Citation>Regitz-Zagrosek V, Seeland U: Sex and gender differences in clinical medicine. Handb Exp Pharmacol 2012; 214:3&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pubmed">23027443</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, et al. : Sex and gender: Modifiers of health, disease, and medicine. Lancet 2020; 396:565&#x2013;582</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440877</ArticleId><ArticleId IdType="pubmed">32828189</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi D, Bianucci R, Donell S: Gender medicine: its historical roots. Postgrad Med J 2020; 96:480&#x2013;486</Citation><ArticleIdList><ArticleId IdType="pubmed">32471879</ArticleId></ArticleIdList></Reference><Reference><Citation>West C, Zimmerman D: Doing gender. In: Gender&amp;Society. Vol. 1. Richards P, Rudrappa S. (Eds). Sage Journals, 1987, pp 125&#x2013;151</Citation></Reference><Reference><Citation>Heidari S, Babor TF, De Castro P, et al. : Sex and gender equity in research: Rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev 2016; 1:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5793986</ArticleId><ArticleId IdType="pubmed">29451543</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson K, Venkatesh B, Hammond N, et al. ; on behalf of the ADRENAL Investigators, Sex-Disaggregated Analysis Steering Committee: Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock. Intensive Care Med 2021; 47:246&#x2013;248</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7790338</ArticleId><ArticleId IdType="pubmed">33415351</ArticleId></ArticleIdList></Reference><Reference><Citation>Failla KR, Connelly CD: Systematic review of gender differences in sepsis management and outcomes. J Nurs Scholarsh 2017; 49:312&#x2013;324</Citation><ArticleIdList><ArticleId IdType="pubmed">28419753</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanrooij VHM, Cobussen M, Stoffers J, et al. : Sex differences in clinical presentation and mortality in emergency department patients with sepsis. Ann Med 2023; 55:2244873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10424597</ArticleId><ArticleId IdType="pubmed">37566727</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KJ, Finfer SR, Woodward M, et al. : Sex differences in sepsis hospitalisations and outcomes in older women and men: A prospective cohort study. J Infect 2022; 84:770&#x2013;776</Citation><ArticleIdList><ArticleId IdType="pubmed">35472366</ArticleId></ArticleIdList></Reference><Reference><Citation>Adrie C, Azoulay E, Francais A, et al. ; OutcomeRea Study Group: Influence of gender on the outcome of severe sepsis: A reappraisal. Chest 2007; 132:1786&#x2013;1793</Citation><ArticleIdList><ArticleId IdType="pubmed">17890473</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen TE, Simmons J, Choo EK, et al. : The DISPARITY Study: Do gender differences exist in Surviving Sepsis Campaign resuscitation bundle completion, completion of individual bundle elements, or sepsis mortality? J Crit Care 2014; 29:473.e7&#x2013;473.e11</Citation><ArticleIdList><ArticleId IdType="pubmed">24559576</ArticleId></ArticleIdList></Reference><Reference><Citation>Modra LJ, Higgins AM, Pilcher DV, et al. : Sex differences in vital organ support provided to ICU patients. Crit Care Med 2024; 52:1&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715697</ArticleId><ArticleId IdType="pubmed">37846932</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL: Sex differences in immune responses. Nat Rev Immunol 2016; 16:626&#x2013;638</Citation><ArticleIdList><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghuman AK, Newth CJ, Khemani RG: Impact of gender on sepsis mortality and severity of illness for prepubertal and postpubertal children. J Pediatr 2013; 163:835&#x2013;840</Citation><ArticleIdList><ArticleId IdType="pubmed">23706357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciesielski TH, Zhang X, Tacconelli A, et al. ; NeoMero Consortium: Late-onset neonatal sepsis: Genetic differences by sex and involvement of the NOTCH pathway. Pediatr Res 2023; 93:1085&#x2013;1095</Citation><ArticleIdList><ArticleId IdType="pubmed">35835848</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson AT, Wenner MM, Bunsawat K, et al. : When it&#x2019;s time for the sex talk, words matter. Am J Physiol Heart Circ Physiol 2022; 322:H66&#x2013;H70</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8698506</ArticleId><ArticleId IdType="pubmed">34797173</ArticleId></ArticleIdList></Reference><Reference><Citation>De Klerk S: Why should you stop referring to women as &#x201c;females&#x201c;?
Available at: https://www.linkedin.com/pulse/why-should-you-stop-referring-women-females-sacha-de-klerk/. Zurich, Switzerland. Accessed December 5, 2024</Citation></Reference><Reference><Citation>Kennedy U, Moulin J, Schlapbach LJ, et al. : Sex differences in pediatric sepsis&#x2014;a systematic review protocol. Syst Rev 2024; 13:214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11308706</ArticleId><ArticleId IdType="pubmed">39118182</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis: International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">15636651</ArticleId></ArticleIdList></Reference><Reference><Citation>Covidence Systematic Review Software. Melbourne, Australia: Veritas Health Innovation;
Available at: www.covidence.org. Accessed March 16, 2022</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. : Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42:377&#x2013;381</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden JA, van der Windt DA, Cartwright JL, et al. : Assessing bias in studies of prognostic factors. Ann Intern Med 2013; 158:280&#x2013;286</Citation><ArticleIdList><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference><Reference><Citation>The World Bank. World Bank Country and Lending Groups. Available at: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Zurich, Switzerland. Accessed May 2023</Citation></Reference><Reference><Citation>R Core Team. Vienna ARFfSCAf.
Available at: https://www.r-project.org/. Zurich, Switzerland. Accessed May 2023</Citation></Reference><Reference><Citation>Xie Y.: knitr: A General-Purpose Package for Dynamic Report Generation in R. R package version 1.44.
Available at: https://yihui.org/knitr/. 2023. Zurich, Switzerland. Accessed May 2023</Citation></Reference><Reference><Citation>DerSimonian R, Laird N: Meta-analysis in clinical trials revisited. Contemp Clin Trials 2015; 45:139&#x2013;145</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639420</ArticleId><ArticleId IdType="pubmed">26343745</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J, Ioannidis JP, Rovers MM, et al. : Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open 2016; 6:e010247</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4947751</ArticleId><ArticleId IdType="pubmed">27406637</ArticleId></ArticleIdList></Reference><Reference><Citation>Abulebda K, Cvijanovich NZ, Thomas NJ, et al. : Post-ICU admission fluid balance and pediatric septic shock outcomes: A risk-stratified analysis. Crit Care Med 2014; 42:397&#x2013;403</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3947064</ArticleId><ArticleId IdType="pubmed">24145842</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman PKA, Schlapbach LJ, Giannoni E, et al. ; Swiss Pediatric Sepsis Study: Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: A population-based cohort study. Lancet Child Adolescent Health 2017; 1:124&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">30169202</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Eyadhy A, Hasan G, Temsah MH, et al. : Initial fluid balance associated outcomes in children with severe sepsis and septic shock. Pediatr Emerg Care 2022; 38:e1112&#x2013;e1117</Citation><ArticleIdList><ArticleId IdType="pubmed">34469401</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam A, Gupta S: Lactate measurements and their association with mortality in pediatric severe sepsis in India: Evidence that 6-hour level performs best. J Intensive Care Med 2021; 36:443&#x2013;450</Citation><ArticleIdList><ArticleId IdType="pubmed">32041465</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali MK, Islam R, Naim E: Performance of day 1 paediatric logistic organ dysfunction-2 score in children with severe sepsis: A prospective cohort study. J Clin Diagn Res 2021; 15:SC06&#x2013;SC09</Citation></Reference><Reference><Citation>Ames SG, Davis BS, Angus DC, et al. : Hospital variation in risk-adjusted pediatric sepsis mortality. Pediat Crit Care Med 2018; 19:390&#x2013;396</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935525</ArticleId><ArticleId IdType="pubmed">29461429</ArticleId></ArticleIdList></Reference><Reference><Citation>Angurana SK, Bansal A, Muralidharan J, et al. : Cytokine levels in critically ill children with severe sepsis and their relation with the severity of illness and mortality. J Intensive Care Med 2021; 36:576&#x2013;583</Citation><ArticleIdList><ArticleId IdType="pubmed">32207354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayar G, Sahin S, Men Atmaca Y, et al. : Thiol-disulphide homeostasis is an oxidative stress indicator in critically ill children with sepsis. Archivos Argentinos de Pediatria 2019; 117:143&#x2013;148</Citation><ArticleIdList><ArticleId IdType="pubmed">31063297</ArticleId></ArticleIdList></Reference><Reference><Citation>Aygun F, Varol F, Durak C, et al. : Evaluation of continuous renal replacement therapy and therapeutic plasma exchange, in severe sepsis or septic shock in critically ill children. Medicina 2019; 55:350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6680968</ArticleId><ArticleId IdType="pubmed">31284692</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo ZM, Moore DB, Lima FC, et al. : Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: Importance in ARDS in septic pediatric critically ill patients. Hum Immunol 2012; 73:661&#x2013;667</Citation><ArticleIdList><ArticleId IdType="pubmed">22507624</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker AH, Monuteaux MC, Eisenberg MA, et al. : Pediatric sepsis survival in pediatric and general emergency departments. Am J Emerg Med 2022; 51:53&#x2013;57</Citation><ArticleIdList><ArticleId IdType="pubmed">34673476</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu RK, Hackbarth R, Gillespie S, et al. : Clinical phenotypes of acute kidney injury are associated with unique outcomes in critically ill septic children. Pediatr Res 2021; 90:1031&#x2013;1038</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852056</ArticleId><ArticleId IdType="pubmed">33531676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobelyte O, Gailiute I, Zubka V, et al. : Sepsis epidemiology and outcome in the paediatric intensive care unit of Vilnius University Children&#x2019;s Hospital. Acta Medica Lituanica 2017; 24:113&#x2013;120</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5566950</ArticleId><ArticleId IdType="pubmed">28845129</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeddha NP, Schlapbach LJ, Driessen GJ, et al. ; EUCLIDS consortium: Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: A prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS). Crit Care 2018; 22:143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5984383</ArticleId><ArticleId IdType="pubmed">29855385</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongers TN, Emonts M, De Maat MPM, et al. : Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome. Thromb Haemost 2010; 103:1181&#x2013;1187</Citation><ArticleIdList><ArticleId IdType="pubmed">20390223</ArticleId></ArticleIdList></Reference><Reference><Citation>Born S, Dame C, Matthaus-Kramer C, et al. : Epidemiology of sepsis among children and neonates in Germany: Results from an observational study based on nationwide diagnosis-related groups data between 2010 and 2016. Crit Care Med 2021; 49:1049&#x2013;1057</Citation><ArticleIdList><ArticleId IdType="pubmed">33729720</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartaya Yrastorza JM, Rovira LE, Segredo Y, et al. : Implementing ACCM critical care guidelines for septic shock management in a Cuban pediatric intensive care unit. MEDICC Rev 2014; 16:47&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pubmed">25208120</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang TH, Wu ET, Lu CY, et al. : Pathogens and outcomes in pediatric septic shock patients supported by extracorporeal membrane oxygenation. J Microbiol Immunol Infect 2018; 51:385&#x2013;391</Citation><ArticleIdList><ArticleId IdType="pubmed">28821378</ArticleId></ArticleIdList></Reference><Reference><Citation>Chegondi M, Devarashetty S, Balakumar N, et al. : The need for hemodialysis is associated with increased mortality in mechanically ventilated children: A propensity score-matched outcome study. Pediat Nephrol 2021; 36:409&#x2013;416</Citation><ArticleIdList><ArticleId IdType="pubmed">32686034</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Zhang G, Li Q, et al. : Time to positivity of Klebsiella pneumoniae in blood culture as prognostic indicator for pediatric bloodstream infections. Eur J Pediatr 2020; 179:1689&#x2013;1698</Citation><ArticleIdList><ArticleId IdType="pubmed">32394266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Li X, Bai Z, et al. : Association of fluid accumulation with clinical outcomes in critically ill children with severe sepsis. PLoS One 2016; 11:e0160093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4965086</ArticleId><ArticleId IdType="pubmed">27467522</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SJ, Ha EJ, Jhang WK, et al. : Elevated central venous pressure is associated with increased mortality in pediatric septic shock patients. BMC Pediatr 2018; 18:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5811958</ArticleId><ArticleId IdType="pubmed">29439683</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary R, Sitaraman S, Choudhary A: Lactate clearance as the predictor of outcome in pediatric septic shock. J Emerg Trauma Shock 2017; 10:55&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5357872</ArticleId><ArticleId IdType="pubmed">28367008</ArticleId></ArticleIdList></Reference><Reference><Citation>Chukwumeze F, Lenglet A, Olubiyo R, et al. : Multi-drug resistance and high mortality associated with community-acquired bloodstream infections in children in conflict-affected northwest Nigeria. Sci Rep 2021; 11:20814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8531324</ArticleId><ArticleId IdType="pubmed">34675262</ArticleId></ArticleIdList></Reference><Reference><Citation>Couto-Alves A, Wright VJ, Perumal K, et al. : A new scoring system derived from base excess and platelet count at presentation predicts mortality in paediatric meningococcal sepsis. Crit Care 2013; 17:R68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672696</ArticleId><ArticleId IdType="pubmed">23577792</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Shan Y, Chen R, et al. : Elevated serum total bilirubin level is associated with poor outcomes in pediatric patients with sepsis-associated liver injury. Canad J Infect Dis Med Microbiol 2018; 2018:4591729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6205097</ArticleId><ArticleId IdType="pubmed">30410637</ArticleId></ArticleIdList></Reference><Reference><Citation>Cvetkovic M, Lutman D, Ramnarayan P, et al. : Timing of death in children referred for intensive care with severe sepsis: Implications for interventional studies. Pediat Crit Care Med 2015; 16:410&#x2013;417</Citation><ArticleIdList><ArticleId IdType="pubmed">25739013</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaja AS, Zimmerman JJ, Nathens AB: Readmission and late mortality after pediatric severe sepsis. Pediatrics 2009; 123:849&#x2013;857</Citation><ArticleIdList><ArticleId IdType="pubmed">19255013</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva ED, Koch Nogueira PC, Russo Zamataro TM, et al. : Risk factors for death in children and adolescents with cancer and sepsis/septic shock. J Pediatr Hematol Oncol 2008; 30:513&#x2013;518</Citation><ArticleIdList><ArticleId IdType="pubmed">18797197</ArticleId></ArticleIdList></Reference><Reference><Citation>Deep A, Goonasekera CD, Wang Y, et al. : Evolution of haemodynamics and outcome of fluid-refractory septic shock in children. Intensive Care Med 2013; 39:1602&#x2013;1609</Citation><ArticleIdList><ArticleId IdType="pubmed">23812341</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza DC, Shieh HH, Barreira ER, et al. ; LAPSES Group: Epidemiology of sepsis in children admitted to PICUs in South America. Pediat Crit Care Med 2016; 17:727&#x2013;734</Citation><ArticleIdList><ArticleId IdType="pubmed">27362850</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte MC, Amorim MR, Cuevas LE, et al. : Risk factors for death from meningococcal infection in Recife, Brazil. J Trop Pediatr 2005; 51:227&#x2013;231</Citation><ArticleIdList><ArticleId IdType="pubmed">16000346</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Nawawy A, El-Kinany H, Hamdy El-Sayed M, et al. : Intravenous polyclonal immunoglobulin administration to sepsis syndrome patients: A prospective study in a pediatric intensive care unit. J Trop Pediatr 2005; 51:271&#x2013;278</Citation><ArticleIdList><ArticleId IdType="pubmed">15917261</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Zayat RS, Shalaby AG: Mitral annular plane systolic excursion as a predictor of mortality in children with septic shock. Pediat Crit Care Med 2018; 19:e486&#x2013;e494</Citation><ArticleIdList><ArticleId IdType="pubmed">30024571</ArticleId></ArticleIdList></Reference><Reference><Citation>Emonts M, de Bruijne EL, Guimaraes AH, et al. : Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children. J Thromb Haemost 2008; 6:268&#x2013;276</Citation><ArticleIdList><ArticleId IdType="pubmed">18021301</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiser RT, West NK, Bush AJ, et al. : Outcome of severe sepsis in pediatric oncology patients. Pediat Crit Care Med 2005; 6:531&#x2013;536</Citation><ArticleIdList><ArticleId IdType="pubmed">16148811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganda IJ, Ali I, Lawang SA, et al. : The prognostic value of soluble vascular cell adhesion molecules-1 (sVCAM-1) in children with septic shock. Curr Pediat Res 2018; 22:131&#x2013;136</Citation></Reference><Reference><Citation>Garcia PC, Longhi F, Branco RG, et al. : Ferritin levels in children with severe sepsis and septic shock. Acta Paediatrica 2007; 96:1829&#x2013;1831</Citation><ArticleIdList><ArticleId IdType="pubmed">18001337</ArticleId></ArticleIdList></Reference><Reference><Citation>Goonasekera CDA, Carcillo JA, Deep A: Oxygen delivery and oxygen consumption in pediatric fluid refractory septic shock during the first 42&#x2009;h of therapy and their relationship to 28-day outcome. Front Pediatr 2018; 6:314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6206202</ArticleId><ArticleId IdType="pubmed">30406065</ArticleId></ArticleIdList></Reference><Reference><Citation>He D, Li N, Lu X, et al. : Association of mitochondrial respiratory chain enzymes with the risk and mortality of sepsis among Chinese children. BMC Infect Dis 2022; 22:34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8740061</ArticleId><ArticleId IdType="pubmed">34991517</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppenbrouwers T, Boeddha NP, Ekinci E, et al. : Neutrophil extracellular traps in children with meningococcal sepsis. Pediat Crit Care Med 2018; 19:e286&#x2013;e291</Citation><ArticleIdList><ArticleId IdType="pubmed">29432403</ArticleId></ArticleIdList></Reference><Reference><Citation>Humoodi MO, Aldabbagh MA, Salem MM, et al. : Epidemiology of pediatric sepsis in the pediatric intensive care unit of king Abdulaziz Medical City, Jeddah, Saudi Arabia. BMC Pediatr 2021; 21:222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8103596</ArticleId><ArticleId IdType="pubmed">33962589</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahiem SK, Galal YS, Youssef MR, et al. : Prognostic markers among Egyptian children with sepsis in the Intensive Care Units, Cairo University Hospitals. Allergol Immunopathol (Madr) 2016; 44:46&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">26657169</ArticleId></ArticleIdList></Reference><Reference><Citation>Isguder R, Ceylan G, Agin H, et al. : Increased mean platelet volume in children with sepsis as a predictor of mortality. Turk J Pediatr 2016; 58:503&#x2013;511</Citation><ArticleIdList><ArticleId IdType="pubmed">28621091</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal P, Dewan P, Gomber S, et al. : Early lactate measurements for predicting in-hospital mortality in paediatric sepsis. J Paediatr Child Health 2020; 56:1570&#x2013;1576</Citation><ArticleIdList><ArticleId IdType="pubmed">32861227</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaramillo-Bustamante JC, Marin-Agudelo A, Fernandez-Laverde M, et al. : Epidemiology of sepsis in pediatric intensive care units: First Colombian multicenter study. Pediat Crit Care Med 2012; 13:501&#x2013;508</Citation><ArticleIdList><ArticleId IdType="pubmed">22460772</ArticleId></ArticleIdList></Reference><Reference><Citation>Jat KR, Jhamb U, Gupta VK: Serum lactate levels as the predictor of outcome in pediatric septic shock. Indian J Crit Care Med 2011; 15:102&#x2013;107</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3145293</ArticleId><ArticleId IdType="pubmed">21814374</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang WM, Lee J, Eun SJ, et al. : Travel time to emergency care not by geographic time, but by optimal time: A nationwide cross-sectional study for establishing optimal hospital access time to emergency medical care in South Korea. PLoS One 2021; 16:e0251116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8092794</ArticleId><ArticleId IdType="pubmed">33939767</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KT, Gorges M, Murthy S: Characteristics and timing of mortality in children dying with infections in North American PICUs. Pediat Crit Care Med 2021; 22:365&#x2013;379</Citation><ArticleIdList><ArticleId IdType="pubmed">33591070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallekkattu D, Rameshkumar R, Chidambaram M, et al. : Threshold of inotropic score and vasoactive-inotropic score for predicting mortality in pediatric septic shock. Indian J Pediatr 2021; 89:432&#x2013;437</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315255</ArticleId><ArticleId IdType="pubmed">34318405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur G, Vinayak N, Mittal K, et al. : Clinical outcome and predictors of mortality in children with sepsis, severe sepsis, and septic shock from Rohtak, Haryana: A prospective observational study. Indian J Crit Care Med 2014; 18:437&#x2013;441</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4118509</ArticleId><ArticleId IdType="pubmed">25097356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YA, Ha EJ, Jhang WK, et al. : Early blood lactate area as a prognostic marker in pediatric septic shock. Intensive Care Med 2013; 39:1818&#x2013;1823</Citation><ArticleIdList><ArticleId IdType="pubmed">23818093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk AHP, Ong C, Wong JJM, et al. : Nutritional intake in children with septic shock: A retrospective single-center study. J Pediat Intens Care 2021; 13:18&#x2013;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10987225</ArticleId><ArticleId IdType="pubmed">38571981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowara Y, Utariani A, Semedi BP, et al. : Venous-arterial CO2 difference to arterial-venous O2 content difference ratio as marker of resuscitation in pediatric septic shock. Crit Care Shock 2020; 23:95&#x2013;104</Citation></Reference><Reference><Citation>Lalitha AV, Satish JK, Reddy M, et al. : Sequential organ failure assessment score as a predictor of outcome in sepsis in pediatric intensive care unit. J Pediat Intens Care 2021; 10:110&#x2013;117</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8052111</ArticleId><ArticleId IdType="pubmed">33884211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanziotti VS, Povoa P, Prata-Barbosa A, et al. : Patterns of C-reactive protein ratio response to antibiotics in pediatric sepsis: A prospective cohort study. J Crit Care 2018; 44:217&#x2013;222</Citation><ArticleIdList><ArticleId IdType="pubmed">29161668</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawang SA, Jayaganda I, Daud D: White blood cell, procalcitonin, C-reactive protein and TNF-&#x3b1; as prognostic factors in pediatric sepsis. Indian J Public Health Research Develop 2019; 10:692&#x2013;697</Citation></Reference><Reference><Citation>Lee EP, Hsia SH, Lin JJ, et al. : Hemodynamic analysis of pediatric septic shock and cardiogenic shock using transpulmonary thermodilution. Biomed Res Int 2017; 2017:3613475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5376469</ArticleId><ArticleId IdType="pubmed">28401152</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefevre N, Noyon B, Biarent D, et al. : Sex differences in inflammatory response and acid base balance in prepubertal children with severe sepsis. Shock 2017; 47:422&#x2013;428</Citation><ArticleIdList><ArticleId IdType="pubmed">27755508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lestari IN, Yoel C, Lubis M: The association between the level of antithrombin III and mortality in children with sepsis. Open Access Macedonian J Med Sci 2019; 7:959&#x2013;961</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454173</ArticleId><ArticleId IdType="pubmed">30976340</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Ning B, Wang Y, et al. : The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis. Medicine (Baltimore) 2019; 98:e15070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456134</ArticleId><ArticleId IdType="pubmed">30921240</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Cheng J, Wu Y, et al. : Effects of delayed antibiotic therapy on outcomes in children with Streptococcus pneumoniae sepsis. Antimicrob Agents Chemother 2019; 63:9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6709508</ArticleId><ArticleId IdType="pubmed">31262764</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindell RB, Nishisaki A, Weiss SL, et al. : Risk of mortality in immunocompromised children with severe sepsis and septic shock. Crit Care Med 2020; 48:1026&#x2013;1033</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7311286</ArticleId><ArticleId IdType="pubmed">32301846</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JJ, Hsiao HJ, Chan OW, et al. : Increased serum thrombomodulin level is associated with disease severity and mortality in pediatric sepsis. PLoS One 2017; 12:e0182324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5542536</ArticleId><ArticleId IdType="pubmed">28771554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodha R, Vivekanandhan S, Sarthi M, et al. : Serial circulating vasopressin levels in children with septic shock. Pediat Crit Care Med 2006; 7:220&#x2013;224</Citation><ArticleIdList><ArticleId IdType="pubmed">16575349</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Reyes CS, Baca-Vel&#xe1;zquez LN, Villas&#xed;s-Keever MA, et al. : Shock index utility to predict mortality in pediatric patients with septic shock or severe sepsis. Boletin Medico del Hospital Infantil de Mexico 2018; 75:192&#x2013;198</Citation><ArticleIdList><ArticleId IdType="pubmed">30084442</ArticleId></ArticleIdList></Reference><Reference><Citation>Maat M, Buysse CM, Emonts M, et al. : Improved survival of children with sepsis and purpura: Effects of age, gender, and era. Crit Care 2007; 11:R112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2556765</ArticleId><ArticleId IdType="pubmed">17945008</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamdouh F, Bazaraa H, Baz A, et al. : Prognostic value of baseline carotid blood flow in critically ill children with septic shock. PLoS One 2021; 16:e0251154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302249</ArticleId><ArticleId IdType="pubmed">34298550</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoli TF, Delgado AF, Troster EJ, et al. : Lymphocyte count as a sign of immunoparalysis and its correlation with nutritional status in pediatric intensive care patients with sepsis: A pilot study. Clinics 2016; 71:644&#x2013;649</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108166</ArticleId><ArticleId IdType="pubmed">27982165</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquardt DJ, Knatz NL, Wetterau LA, et al. : Failure to recover somatotropic axis function is associated with mortality from pediatric sepsis-induced multiple organ dysfunction syndrome. Pediat Crit Care Med 2010; 11:18&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pubmed">19561558</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquez-Gonzalez H, Casanova-Bracamontes L, Munoz-Ramirez CM, et al. : Relation between fluid overload and mortality in children with septic shock. Archivos Argentinos de Pediatria 2019; 117:105&#x2013;113</Citation><ArticleIdList><ArticleId IdType="pubmed">30869483</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros DNM, Mafra A, Carcillo JA, et al. : A pediatric sepsis protocol reduced mortality and dysfunctions in a Brazilian Public Hospital. Front Pediatr 2021; 9:757721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8633899</ArticleId><ArticleId IdType="pubmed">34869114</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon K, McNally D, O&#x2019;Hearn K, et al. ; Canadian Critical Care Trials Group: A randomized controlled trial of corticosteroids in pediatric septic shock: A pilot feasibility study. Pediat Crit Care Med 2017; 18:505&#x2013;512</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5457353</ArticleId><ArticleId IdType="pubmed">28406862</ArticleId></ArticleIdList></Reference><Reference><Citation>Mianling Z, Yuge H, Tufeng L, et al. : Performance of the pediatric sequential organ failure assessment score in assessing the prognosis of children with sepsis in a PICU of a developing country: A single-center retrospective observational study. Iranian J Pediat 2019; 29:89024</Citation></Reference><Reference><Citation>Michalek J, Svetlikova P, Fedora M, et al. : Bactericidal permeability increasing protein gene variants in children with sepsis. Intensive Care Med 2007; 33:2158&#x2013;2164</Citation><ArticleIdList><ArticleId IdType="pubmed">17898994</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed NA, Youness ER: Clinical role of serum lactate dehydrogenase assessment in critically ill pediatric patients with sepsis. Biomed Pharmacol J 2021; 14:1941&#x2013;1953</Citation></Reference><Reference><Citation>Mohammed A, Cui Y, Mas VR, et al. : Differential gene expression analysis reveals novel genes and pathways in pediatric septic shock patients. Sci Rep 2019; 9:11270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6677896</ArticleId><ArticleId IdType="pubmed">31375728</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazir M, Wani W, Dar SA, et al. : Lactate clearance prognosticates outcome in pediatric septic shock during first 24&#x2009;h of intensive care unit admission. J Intens Care Soc 2019; 20:290&#x2013;298</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6820231</ArticleId><ArticleId IdType="pubmed">31695733</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederwanger C, Varga T, Hell T, et al. : Comparison of pediatric scoring systems for mortality in septic patients and the impact of missing information on their predictive power: A retrospective analysis. PeerJ 2020; 8:e9993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543722</ArticleId><ArticleId IdType="pubmed">33083117</ArticleId></ArticleIdList></Reference><Reference><Citation>Odetola FO, Gebremariam A: Resource use and outcomes for children hospitalized with severe sepsis or septic shock. J Intensive Care Med 2021; 36:89&#x2013;100</Citation><ArticleIdList><ArticleId IdType="pubmed">31707898</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira CF, Nogueira de Sa FR, Oliveira DS, et al. : Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: Barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world. Pediat Emerg Care 2008; 24:810&#x2013;815</Citation><ArticleIdList><ArticleId IdType="pubmed">19050666</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedro TC, Morcillo AM, Baracat EC: Etiology and prognostic factors of sepsis among children and adolescents admitted to the intensive care unit. Revista Brasileira de Terapia Intensiva 2015; 27:240&#x2013;246</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4592118</ArticleId><ArticleId IdType="pubmed">26465245</ArticleId></ArticleIdList></Reference><Reference><Citation>Prout AJ, Talisa VB, Carcillo JA, et al. : Bacterial and fungal etiology of sepsis in children in the United States: Reconsidering empiric therapy. Crit Care Med 2020; 48:e192&#x2013;e199</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875440</ArticleId><ArticleId IdType="pubmed">31789702</ArticleId></ArticleIdList></Reference><Reference><Citation>Pudjiadi AH, Pramesti DL, Pardede SO, et al. : Validation of the vasoactive-inotropic score in predicting pediatric septic shock mortality: A retrospective cohort study. Inter J Crit Ill Inj Sci 2021; 11:117&#x2013;122</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8547676</ArticleId><ArticleId IdType="pubmed">34760657</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathinavelu M, Uppara V, Lingutla A, et al. : Pediatric sepsis: Clinical outcome and predictors of mortality from a secondary referral healthcare setting of South India. Pharma Times 2021; 53:7&#x2013;9</Citation></Reference><Reference><Citation>Reddy AR, Badolato GM, Chamberlain JM, et al. : Disparities associated with sepsis mortality in critically ill children. J Pediat Intens Care 2020; 11:147&#x2013;152</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9208841</ArticleId><ArticleId IdType="pubmed">35734203</ArticleId></ArticleIdList></Reference><Reference><Citation>Riyuzo MC, Silveira LV, Macedo CS, et al. : Predictive factors of mortality in pediatric patients with acute renal injury associated with sepsis. Jornal de Pediatria 2017; 93:28&#x2013;34</Citation><ArticleIdList><ArticleId IdType="pubmed">27379973</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseaux J, Grandbastien B, Dorkenoo A, et al. : Prognostic value of shock index in children with septic shock. Pediatr Emerg Care 2013; 29:1055&#x2013;1059</Citation><ArticleIdList><ArticleId IdType="pubmed">24076606</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmawatiningtyas D, Rahmawati A, Makrufardi F, Mardhiah N, Murni IK, Uiterwaal CSPM, Savitri AI, Kumara IF: Factors associated with mortality of pediatric sepsis patients at the pediatric intensive care unit in a low-resource setting. BMC Pediatr 2021; 21:471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8543407</ArticleId><ArticleId IdType="pubmed">34696763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruth A, McCracken CE, Fortenberry JD, et al. : Pediatric severe sepsis: current trends and outcomes from the Pediatric Health Information Systems database. Pediat Crit Care Med 2014; 15:828&#x2013;838</Citation><ArticleIdList><ArticleId IdType="pubmed">25226500</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdev A, Raheja K, Gupta N, et al. : Association of urinary albumin:creatinine ratio with outcome of children with sepsis. Indian J Crit Care Med 2020; 24:465&#x2013;472</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435108</ArticleId><ArticleId IdType="pubmed">32863641</ArticleId></ArticleIdList></Reference><Reference><Citation>Samransamruajkit R, Hiranrat T, Prapphal N, et al. : Levels of protein C activity and clinical factors in early phase of pediatric septic shock may be associated with the risk of death. Shock 2007; 28:518&#x2013;523</Citation><ArticleIdList><ArticleId IdType="pubmed">17589380</ArticleId></ArticleIdList></Reference><Reference><Citation>Samransamruajkit R, Wong JJ, Smathakane C, et al. ; Pediatric Sepsis Asian Collaboration (PEDSAC) Investigators and on behalf of the Pediatric Acute and Critical Care Medicine Asian Network (PACCMAN): Pediatric severe sepsis and shock in three Asian Countries: A retrospective study of outcomes in nine PICUs. Pediat Crit Care Med 2021; 22:713&#x2013;721</Citation><ArticleIdList><ArticleId IdType="pubmed">33729727</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano H, Kobayashi R, Iguchi A, et al. : Risk factors for sepsis-related death in children and adolescents with hematologic and malignant diseases. J Microbiol Immunol Infect 2017; 50:232&#x2013;238</Citation><ArticleIdList><ArticleId IdType="pubmed">26055687</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarmin M, Afroze F, Sharifuzzaman, et al.: Predictor of death in diarrheal children under 5 years of age having severe sepsis in an urban critical care ward in Bangladesh. Lobal Pediatric Health 2019; 6:2333794X19862716</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6647208</ArticleId><ArticleId IdType="pubmed">31384628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed SZ, Mahmoud MM, Moness HM, et al. : Admission platelet count and indices as predictors of outcome in children with severe Sepsis: A prospective hospital-based study. BMC Pediatr 2020; 20:387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437045</ArticleId><ArticleId IdType="pubmed">32814554</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott HF, Brou L, Deakyne SJ, et al. : Association between early lactate levels and 30-day mortality in clinically suspected sepsis in children. JAMA Pediat 2017; 171:249&#x2013;255</Citation><ArticleIdList><ArticleId IdType="pubmed">28068437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevketoglu E, Yildizdas D, Horoz OO, et al. : Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network. Pediat Crit Care Med 2014; 15:e354&#x2013;e359</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5287151</ArticleId><ArticleId IdType="pubmed">25068251</ArticleId></ArticleIdList></Reference><Reference><Citation>Shime N, Kawasaki T, Saito O, et al. : Incidence and risk factors for mortality in paediatric severe sepsis: Results from the national paediatric intensive care registry in Japan. Intensive Care Med 2012; 38:1191&#x2013;1197</Citation><ArticleIdList><ArticleId IdType="pubmed">22527068</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AM, Sawe HR, Matthay MA, et al. : Delayed presentation and mortality in children with sepsis in a public tertiary care hospital in Tanzania. Front Pediatr 2021; 9:764163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8669816</ArticleId><ArticleId IdType="pubmed">34917561</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza DC, Barreira ER, Shieh HH, et al. : Prevalence and outcomes of sepsis in children admitted to public and private hospitals in Latin America: A multicenter observational study. Revista Brasileira de Terapia Intensiva 2021; 33:231&#x2013;242</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8275081</ArticleId><ArticleId IdType="pubmed">34231803</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Shao L, Dou J, et al. : Fibrinogen as a prognostic predictor in pediatric patients with sepsis: A database study. Mediators Inflamm 2020; 2020:9153620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204196</ArticleId><ArticleId IdType="pubmed">32410872</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekin D, Dalgic N, Kayaalti Z, et al. : Importance of NOD2/CARD15 gene variants for susceptibility to and outcome of sepsis in Turkish children. Pediat Crit Care Med 2012; 13:e73&#x2013;e77</Citation><ArticleIdList><ArticleId IdType="pubmed">21460759</ArticleId></ArticleIdList></Reference><Reference><Citation>Thavamani A, Umapathi KK, Dhanpalreddy H, et al. : Epidemiology, clinical and microbiologic profile and risk factors for inpatient mortality in pediatric severe sepsis in the United States From 2003 to 2014: A large population analysis. Pediatr Infect Dis J 2020; 39:781&#x2013;788</Citation><ArticleIdList><ArticleId IdType="pubmed">32221163</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonial CT, Costa CAD, Andrades GRH, et al. : Prediction of poor outcomes for septic children according to ferritin levels in a middle-income setting. Pediat Crit Care Med 2020; 21:e259&#x2013;e266</Citation><ArticleIdList><ArticleId IdType="pubmed">32343115</ArticleId></ArticleIdList></Reference><Reference><Citation>Top AP, Ince C, de Meij N, et al. : Persistent low microcirculatory vessel density in nonsurvivors of sepsis in pediatric intensive care. Crit Care Med 2011; 39:8&#x2013;13</Citation><ArticleIdList><ArticleId IdType="pubmed">21076287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vekaria-Hirani V, Kumar R, Musoke RN, et al. : Prevalence and management of septic shock among children admitted at the Kenyatta National Hospital, Longitudinal Survey. Inter J Pediat 2019; 2019:1502963</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6942836</ArticleId><ArticleId IdType="pubmed">31929805</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhoeven JJ, den Brinker M, Hokken-Koelega AC, et al. : Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: A prospective, observational cohort study. Crit Care 2011; 15:R44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3221973</ArticleId><ArticleId IdType="pubmed">21276273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Cui Y, Miao H, et al. : Apolipoprotein A-V is a novel diagnostic and prognostic predictor in pediatric patients with sepsis: A prospective pilot study in PICU. Mediators Inflamm 2020; 2020:8052954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7157801</ArticleId><ArticleId IdType="pubmed">32322166</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SL, Fitzgerald JC, Pappachan J, et al. ; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study. Am J Resp Crit Care Med 2015; 191:1147&#x2013;1157</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4451622</ArticleId><ArticleId IdType="pubmed">25734408</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams V, Menon N, Bhatia P, et al. : Serum ferritin predicts neither organ dysfunction nor mortality in pediatric sepsis due to tropical infections. Front Pediatr 2020; 8:607673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7747694</ArticleId><ArticleId IdType="pubmed">33344390</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong JJ, Ho SX, Lee AOC, et al. : Positive fluid balance is associated with poor clinical outcomes in paediatric severe sepsis and septic shock. Ann Acad Med Singapore 2019; 48:290&#x2013;297</Citation><ArticleIdList><ArticleId IdType="pubmed">31737894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong HR, Weiss SL, Giuliano JS, Jr, et al. : Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One 2014; 9:e86242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906040</ArticleId><ArticleId IdType="pubmed">24489704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JR, Chen IC, Dai ZK, et al. : Early elevated B-type natriuretic peptide levels are associated with cardiac dysfunction and poor clinical outcome in pediatric septic patients. Acta Cardiologica Sinica 2015; 31:485&#x2013;493</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4804972</ArticleId><ArticleId IdType="pubmed">27122912</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C, Wang S, Fang F, et al. : Epidemiology of pediatric severe sepsis in main PICU Centers in Southwest China. Pediat Crit Care Med 2019; 20:1118&#x2013;1125</Citation><ArticleIdList><ArticleId IdType="pubmed">31261227</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Cheng J, Yu Q, et al. : Prognostic role of time to positivity of blood culture in children with Pseudomonas aeruginosa bacteremia. BMC Infect Dis 2020; 20:665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488235</ArticleId><ArticleId IdType="pubmed">32907533</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimatsu S, Sugaya T, Hossain MI, et al. : Urinary L-FABP as a mortality predictor in &lt;5-year-old children with sepsis in Bangladesh. Pediatr Int 2016; 58:185&#x2013;191</Citation><ArticleIdList><ArticleId IdType="pubmed">26214495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki M, Galeb S, Eid AR, et al. : Molecular characterization of Staphylococcus aureus isolated from hospital acquired sepsis in pediatrics, relation to antibiotics, resistance and virulence genes. Germs 2020; 10:295&#x2013;302</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7811860</ArticleId><ArticleId IdType="pubmed">33489944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata-Tarr&#xe9;s M, Kl&#xfc;nder-Kl&#xfc;nder M, Cicero-Oneto C, et al. : Analysis of complications during treatment of children with acute lymphoblastic leukemia. Boletin Medico del Hospital Infantil de Mexico 2012; 69:218&#x2013;225</Citation></Reference><Reference><Citation>Zhang Y, Cao B, Cao W, et al. : Clinical characteristics and death risk factors of severe sepsis in children. Comp Math Met Med 2022; 2022:4200605</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8803443</ArticleId><ArticleId IdType="pubmed">35111234</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong M, Huang Y, Li T, et al. : Day-1 PELOD-2 and day-1 &#x201c;quick&#x201d; PELOD-2 scores in children with sepsis in the PICU. Jornal de Pediatria 2020; 96:660&#x2013;665</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9432166</ArticleId><ArticleId IdType="pubmed">31580846</ArticleId></ArticleIdList></Reference><Reference><Citation>Muenchhoff M, Goulder PJ: Sex differences in pediatric infectious diseases. J Infect Dis 2014; 209:S120&#x2013;S126</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4072001</ArticleId><ArticleId IdType="pubmed">24966192</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyson JE, Parikh NA, Langer J, et al. ; National Institute of Child Health and Human Development Neonatal Research Network: Intensive care for extreme prematurity&#x2014;moving beyond gestational age. N Engl J Med 2008; 358:1672&#x2013;1681</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2597069</ArticleId><ArticleId IdType="pubmed">18420500</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D, Zou L, Lei X, et al. : Gender differences in infant mortality and neonatal morbidity in mixed-gender twins. Sci Rep 2017; 7:8736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5562818</ArticleId><ArticleId IdType="pubmed">28821800</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker M: Addressing Sex and Gender in Epidemic-Prone Infectious Diseases. Geneva, Switzerland, World Health Organization, 2007</Citation></Reference><Reference><Citation>Prout AJ, Banks RK, Reeder RW, et al. : Association of sex and age with mortality and health-related quality of life in children with septic shock: A secondary analysis of the life after pediatric sepsis evaluation. J Intensive Care Med 2023:8850666231190270. [online first]</Citation><ArticleIdList><ArticleId IdType="pubmed">37529851</ArticleId></ArticleIdList></Reference><Reference><Citation>Almossawi O, Friend A, Palla L, et al. : Is there a sex difference in mortality rates in paediatric intensive care units?: A systematic review. Front Pediatr 2023; 11:1225684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10591324</ArticleId><ArticleId IdType="pubmed">37876523</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderer S: Meta-analysis: Females at higher risk of death from Staph infection. JAMA 2024; 331:1172</Citation><ArticleIdList><ArticleId IdType="pubmed">38488812</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslove DM, Tang B, Shankar-Hari M, et al. : Redefining critical illness. Nat Med 2022; 28:1141&#x2013;1148</Citation><ArticleIdList><ArticleId IdType="pubmed">35715504</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon K, Sorce LR, Argent A, et al. ; Pediatric Sepsis Definition Taskforce: Reporting of social determinants of health in pediatric sepsis studies. Pediatr Crit Care Med 2023; 24:301&#x2013;310</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10332854</ArticleId><ArticleId IdType="pubmed">36696549</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Watson RS, Sorce LR, et al. ; Society of Critical Care Medicine Pediatric Sepsis Definition Task Force: International Consensus Criteria for pediatric sepsis and septic shock. JAMA 2024; 331:665&#x2013;674</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10900966</ArticleId><ArticleId IdType="pubmed">38245889</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32597018</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-2197</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>ANZ journal of surgery</Title><ISOAbbreviation>ANZ J Surg</ISOAbbreviation></Journal><ArticleTitle>The feasibility and safety of early ileostomy reversal: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1580</StartPage><EndPage>1587</EndPage><MedlinePgn>1580-1587</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.16079</ELocationID><Abstract><AbstractText Label="BACKGROUND">Recent evidence supports the safety of early reversal of a temporary stoma, within 14&#x2009;days of construction. The aim of this systematic review and meta-analysis was to evaluate the post-operative morbidity and overall feasibility of early stoma reversal.</AbstractText><AbstractText Label="METHODS">Medline and Cochrane databases were searched for studies up to June 2019 that investigated the outcomes of early stoma reversal (EC, defined as closure &#x2264;14&#x2009;days from the index operation) versus late stoma reversal (LC, &#x2265;8&#x2009;weeks from the index operation). Meta-analysis was performed on the respective rates of post-operative morbidity, anastomotic leak, wound infection, bleeding, sepsis, small bowel obstruction and ileus.</AbstractText><AbstractText Label="RESULTS">Nine studies were included (667 patients analysed). Meta-analysis showed no significant difference in the post-operative morbidity rate, anastomotic leak rate, rates of small bowel obstruction, bleeding and ileus between EC and LC. However, the wound infection rate was significantly higher after EC than LC; relative difference 0.10 (95% confidence interval 0.00-0.19, P = 0.047). The stoma-related complication rate was significantly higher after LC than EC; relative difference -0.28 (95% confidence interval -0.45 to -0.11, P = 0.001).</AbstractText><AbstractText Label="CONCLUSION">The concept of early stoma reversal is appealing, and this meta-analysis confirms the safety of early stoma closure with an associated reduction in stoma-related complications despite higher wound infection rates. However, the results need to be interpreted with caution due to the heterogeneity of the studies included, especially in respect of the definition of complications that were used. Further well-designed prospective studies are required prior to confident adoption of early stoma closure into clinical practice.</AbstractText><CopyrightInformation>&#xa9; 2020 Royal Australasian College of Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Zi Qin</ForeName><Initials>ZQ</Initials><Identifier Source="ORCID">0000-0002-6272-4640</Identifier><AffiliationInfo><Affiliation>Colorectal Unit, Department of General Surgery, St John of God Subiaco Hospital, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levitt</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Colorectal Unit, Department of General Surgery, St John of God Subiaco Hospital, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Platell</LastName><ForeName>Cameron</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Colorectal Unit, Department of General Surgery, St John of God Subiaco Hospital, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Surgery, University of Western Australia, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>ANZ J Surg</MedlineTA><NlmUniqueID>101086634</NlmUniqueID><ISSNLinking>1445-1433</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="N">Anastomotic Leak</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007081" MajorTopicYN="Y">Ileostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054047" MajorTopicYN="Y">Surgical Stomas</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">closure</Keyword><Keyword MajorTopicYN="N">complication</Keyword><Keyword MajorTopicYN="N">early</Keyword><Keyword MajorTopicYN="N">reversal</Keyword><Keyword MajorTopicYN="N">safety</Keyword><Keyword MajorTopicYN="N">stoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32597018</ArticleId><ArticleId IdType="doi">10.1111/ans.16079</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Huser N, Michalski CW, Erkan M et al. Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann. Surg. 2008; 248: 52-60.</Citation></Reference><Reference><Citation>Gustafsson CP, Gunnarsson U, Dahlstrand U, Lindforss U. Loop-ileostomy reversal-patient-related characteristics influencing time to closure. Int. J. Colorectal Dis. 2018; 33: 593-600.</Citation></Reference><Reference><Citation>Platell C, Barwood N, Makin G. Clinical utility of a de-functioning loop ileostomy. ANZ J. Surg. 2005; 75: 147-51.</Citation></Reference><Reference><Citation>Gadan S, Lindgren R, Floodeen H, Matthiessen P. Reversal of defunctioning stoma following rectal cancer surgery: are we getting better? A population-based single centre experience. ANZ J. Surg. 2019; 89: 403-7.</Citation></Reference><Reference><Citation>Menahem B, Lubrano J, Vallois A, Alves A. Early closure of defunctioning loop ileostomy: is it beneficial for the patient? A meta-analysis. World J. Surg. 2018; 42: 3171-8.</Citation></Reference><Reference><Citation>Lee KH, Kim HO, Kim JS, Kim JY. Prospective study on the safety and feasibility of early ileostomy closure 2&#x2009;weeks after lower anterior resection for rectal cancer. Ann. Surg. Treat. Res. 2019; 96: 41-6.</Citation></Reference><Reference><Citation>Klek S, Pisarska M, Milian-Ciesielska K et al. Early closure of the protective ileostomy after rectal resection should become part of the enhanced recovery after surgery (ERAS) protocol: a randomized, prospective, two-center clinical trial. Wideochir. Inne Tech. Maloinwazyjne 2018; 13: 435-41.</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.</Citation></Reference><Reference><Citation>Wells G, Shea B, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. 2013. [Cited 5 Jan 2020.] Available from URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. (Accessed 5 January 2020).</Citation></Reference><Reference><Citation>Danielsen AK, Park J, Jansen JE et al. Early closure of a temporary ileostomy in patients with rectal cancer: a multicenter randomized controlled trial. Ann. Surg. 2017; 265: 284-90.</Citation></Reference><Reference><Citation>Alves A, Panis Y, Lelong B, Dousset B, Benoist S, Vicaut E. Randomized clinical trial of early versus delayed temporary stoma closure after proctectomy. Br. J. Surg. 2008; 95: 693-8.</Citation></Reference><Reference><Citation>Lasithiotakis K, Aghahoseini A, Alexander D. Is early reversal of defunctioning ileostomy a shorter, easier and less expensive operation? World J. Surg. 2016; 40: 1737-40.</Citation></Reference><Reference><Citation>Bakx R, Busch OR, van Geldere D, Bemelman WA, Slors JF, van Lanschot JJ. Feasibility of early closure of loop ileostomies: a pilot study. Dis. Colon Rectum 2003; 46: 1680-4.</Citation></Reference><Reference><Citation>Robertson J, Linkhorn H, Vather R, Jaung R, Bissett IP. Cost analysis of early versus delayed loop ileostomy closure: a case-matched study. Dig. Surg. 2015; 32: 166-72.</Citation></Reference><Reference><Citation>Omundsen M, Hayes J, Collinson R, Merrie A, Parry B, Bissett I. Early ileostomy closure: is there a downside? ANZ J. Surg. 2012; 82: 352-4.</Citation></Reference><Reference><Citation>Krand O, Yalti T, Berber I, Tellioglu G. Early vs. delayed closure of temporary covering ileostomy: a prospective study. Hepatogastroenterology 2008; 55: 142-5.</Citation></Reference><Reference><Citation>Menegaux F, Jordi-Galais P, Turrin N, Chigot JP. Closure of small bowel stomas on postoperative day 10. Eur. J. Surg. 2002; 168: 713-5.</Citation></Reference><Reference><Citation>Jordi-Galais P, Turrin N, Tresallet C, Nguyen-Thanh Q, Chigot JP, Menegaux F. Early closure of temporary stoma of the small bowel. Gastroenterol. Clin. Biol. 2003; 27: 697-9.</Citation></Reference><Reference><Citation>Tang CL, Seow-Choen F, Fook-Chong S, Eu KW. Bioresorbable adhesion barrier facilitates early closure of the defunctioning ileostomy after rectal excision: a prospective, randomized trial. Dis. Colon Rectum 2003; 46: 1200-7.</Citation></Reference><Reference><Citation>Worni M, Witschi A, Gloor B, Candinas D, Laffer UT, Kuehni CE. Early closure of ileostomy is associated with less postoperative nausea and vomiting. Dig. Surg. 2011; 28: 417-23.</Citation></Reference><Reference><Citation>Memon S, Heriot AG, Atkin CE, Lynch AC. Facilitated early ileostomy closure after rectal cancer surgery: a case-matched study. Tech. Coloproctol. 2012; 16: 285-90.</Citation></Reference><Reference><Citation>Figueiredo MN, Mege D, Maggiori L, Ferron M, Panis Y. When is the best time for temporary stoma closure in laparoscopic sphincter-saving surgery for rectal cancer? A study of 259 consecutive patients. Tech. Coloproctol. 2015; 19: 469-74.</Citation></Reference><Reference><Citation>Zhen L, Wang Y, Zhang Z et al. Effectiveness between early and late temporary ileostomy closure in patients with rectal cancer: a prospective study. Curr. Probl. Cancer 2017; 41: 231-40.</Citation></Reference><Reference><Citation>Zhou MW, Wang ZH, Chen ZY, Xiang JB, Gu XD. Advantages of early preventive ileostomy closure after total mesorectal excision surgery for rectal cancer: an institutional retrospective study of 123 consecutive patients. Dig. Surg. 2017; 34: 305-11.</Citation></Reference><Reference><Citation>Pedrazzani C, Secci F, Fernandes E et al. Early ileostomy reversal after minimally invasive surgery and ERAS program for mid and low rectal cancer. Updates Surg. 2019; 71: 485-92.</Citation></Reference><Reference><Citation>Nelson T, Pranavi AR, Sureshkumar S, Sreenath GS, Kate V. Early versus conventional stoma closure following bowel surgery: a randomized controlled trial. Saudi J. Gastroenterol. 2018; 24: 52-8.</Citation></Reference><Reference><Citation>Wong KS, Remzi FH, Gorgun E et al. Loop ileostomy closure after restorative proctocolectomy: outcome in 1,504 patients. Dis. Colon Rectum 2005; 48: 243-50.</Citation></Reference><Reference><Citation>Chand M, Nash GF, Talbot RW. Timely closure of loop ileostomy following anterior resection for rectal cancer. Eur. J. Cancer Care 2008; 17: 611-5.</Citation></Reference><Reference><Citation>Tulchinsky H, Shacham-Shmueli E, Klausner JM, Inbar M, Geva R. Should a loop ileostomy closure in rectal cancer patients be done during or after adjuvant chemotherapy? J. Surg. Oncol. 2014; 109: 266-9.</Citation></Reference><Reference><Citation>Li W, Ozuner G. Does the timing of loop ileostomy closure affect outcome: a case-matched study. Int. J. Surg. 2017; 43: 52-5.</Citation></Reference><Reference><Citation>Khan N, Bangash A, Hadi A, Ahmad M. Is early closure of stoma warranted in the management of temporary loop ileostomy? JPMI 2010; 24: 295-300.</Citation></Reference><Reference><Citation>Alam M, Gondal K, Siddique H. Outcome of early closure of temporary stoma. Ann. Dent. 2015; 21: 214-8.</Citation></Reference><Reference><Citation>Sarawgi M, Singh S, Tiwary A. Early vs delayed loop ileostomy closure: a comparative study. J. Dent. Med. Sci. 2017; 16: 08-13.</Citation></Reference><Reference><Citation>Shah NA, Hussain M, Kalim M, Mehreen T et al. Experience with early vs routine enteric stoma closures: a comparative study. J. Postgrad. Med. Inst. 2016; 30: 360-3.</Citation></Reference><Reference><Citation>Gentilli S, Pizzorno C, Pessione S, Montinoa F, Bellora P, Garavoglia M. Early stoma closure in colorectal resections after endoscopic monitoring of the anastomosis. Clinical results. Chir. Ital. 2007; 59: 507-12.</Citation></Reference><Reference><Citation>Farag S, Rehman S, Sains P, Baig MK, Sajid MS. Early vs delayed closure of loop defunctioning ileostomy in patients undergoing distal colorectal resections: an integrated systematic review and meta-analysis of published randomized controlled trials. Colorectal Dis. 2017; 19: 1050-7.</Citation></Reference><Reference><Citation>Chow A, Tilney HS, Paraskeva P, Jeyarajah S, Zacharakis E, Purkayastha S. The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6,107 cases. Int. J. Colorectal Dis. 2009; 24: 711-23.</Citation></Reference><Reference><Citation>Yin TC, Tsai HL, Yang PF et al. Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer. World J. Surg. Oncol. 2017; 15: 80.</Citation></Reference><Reference><Citation>Fielding A, Woods R, Moosvi SR et al. Renal impairment after ileostomy formation: a frequent event with long-term consequences. Colorectal Dis. 2019; 22: 269-78.</Citation></Reference><Reference><Citation>Fazekas B, Fazekas B, Hendricks J, Smart N, Arulampalam T. The incidence of incisional hernias following ileostomy reversal in colorectal cancer patients treated with anterior resection. Ann. R. Coll. Surg. Engl. 2017; 99: 319-24.</Citation></Reference><Reference><Citation>Baek SJ, Kim SH, Lee CK et al. Relationship between the severity of diversion colitis and the composition of colonic bacteria: a prospective study. Gut Liver. 2014; 8: 170-6.</Citation></Reference><Reference><Citation>Keane C, Park J, Oberg S et al. Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer. Br. J. Surg. 2019; 106: 645-52.</Citation></Reference><Reference><Citation>Park J, Angenete E, Bock D et al. Cost analysis in a randomized trial of early closure of a temporary ileostomy after rectal resection for cancer (EASY trial). Surg. Endosc. 2019; 34: 69-76.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27890015</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Nov</Month><Day>28</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>The involvement of regulatory non-coding RNAs in sepsis: a systematic review.</ArticleTitle><Pagination><StartPage>383</StartPage><MedlinePgn>383</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">383</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sepsis coincides with altered gene expression in different tissues. Accumulating evidence has suggested that microRNAs, long non-coding RNAs, and circular RNAs are important molecules involved in the crosstalk with various pathways pertinent to innate immunity, mitochondrial functions, and apoptosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched articles indexed in PubMed (MEDLINE), EMBASE and Europe PubMed Central databases using the Medical Subject Heading (MeSH) or Title/Abstract words ("microRNA", "long non-coding RNA", "circular RNA", "sepsis" and/or "septic shock") from inception to Sep 2016. Studies investigating the role of host-derived microRNA, long non-coding RNA, and circular RNA in the pathogenesis of and as biomarkers or therapeutics in sepsis were included. Data were extracted in terms of the role of non-coding RNAs in pathogenesis, and their applicability for use as biomarkers or therapeutics in sepsis. Two independent researchers assessed the quality of studies using a modified guideline from the Systematic Review Center for Laboratory animal Experimentation (SYRCLE), a tool based on the Cochrane Collaboration Risk of Bias tool.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Observational studies revealed dysregulation of non-coding RNAs in septic patients. Experimental studies confirmed their crosstalk with JNK/NF-&#x3ba;B and other cellular pathways pertinent to innate immunity, mitochondrial function, and apoptosis. Of the included studies, the SYRCLE scores ranged from 3 to 7 (average score of 4.55). This suggests a moderate risk of bias. Of the 10 articles investigating non-coding RNAs as biomarkers, none of them included a validation cohort. Selective reporting of sensitivity, specificity, and receiver operating curve was common.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although non-coding RNAs appear to be good candidates as biomarkers and therapeutics for sepsis, their differential expression across tissues complicated the process. Further investigation on organ-specific delivery of these regulatory molecules may be useful.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Jeffery</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Hung</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Sunny H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Digestive Disease, LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong, Special Administrative Region of China. wonghei@cuhk.edu.hk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China. wonghei@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Maggie H T</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Digestive Disease, LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Zhangang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Czarina C H</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wai T</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Orthopedics Surgery Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gin</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China. mtvchan@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>William K K</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong, Special Administrative Region of China. wukakei@cuhk.edu.hk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Digestive Disease, LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong, Special Administrative Region of China. wukakei@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000079962">RNA, Circular</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022661">RNA, Untranslated</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079962" MajorTopicYN="N">RNA, Circular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022661" MajorTopicYN="N">RNA, Untranslated</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Shock</Keyword><Keyword MajorTopicYN="N">circRNA</Keyword><Keyword MajorTopicYN="N">lncRNA</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27890015</ArticleId><ArticleId IdType="pmc">PMC5125038</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1555-3</ArticleId><ArticleId IdType="pii">10.1186/s13054-016-1555-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Angus DC, Van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840&#x2013;51. doi: 10.1056/NEJMra1208623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1208623</ArticleId><ArticleId IdType="pubmed">23984731</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;10. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:762&#x2013;74. doi: 10.1001/jama.2016.0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0288</ArticleId><ArticleId IdType="pmc">PMC5433435</ArticleId><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208:2581&#x2013;90. doi: 10.1084/jem.20111354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111354</ArticleId><ArticleId IdType="pmc">PMC3244029</ArticleId><ArticleId IdType="pubmed">22110166</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris KV, Mattick JS. The rise of regualatory RNA. Nat Rev Genet. 2014;15:423&#x2013;37. doi: 10.1038/nrg3722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3722</ArticleId><ArticleId IdType="pmc">PMC4314111</ArticleId><ArticleId IdType="pubmed">24776770</ArticleId></ArticleIdList></Reference><Reference><Citation>Brudecki L, Ferguson DA, McCall CE, El Gazzar M. MicroRNA-146a and RBM4 form a negative feed-forward loop that disrupts cytokine mRNA translation following TLR4 responses in human THP-1 monocytes. Immunol Cell Biol. 2013;91:532&#x2013;40. doi: 10.1038/icb.2013.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2013.37</ArticleId><ArticleId IdType="pmc">PMC3770753</ArticleId><ArticleId IdType="pubmed">23897118</ArticleId></ArticleIdList></Reference><Reference><Citation>Brudecki L, Ferguson DA, McCall CE, El Gazzar M. Mitogen-activated protein kinase phosphatase 1 disrupts proinflammatory protein synthesis in endotoxin-adapted monocytes. Clin Vaccine Immunol. 2013;20:1396&#x2013;404. doi: 10.1128/CVI.00264-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00264-13</ArticleId><ArticleId IdType="pmc">PMC3889586</ArticleId><ArticleId IdType="pubmed">23825193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D, Yu Y, Li M, et al. Inhibition of microRNA 195 prevents apoptosis and multiple-organ injury in mouse models of sepsis. J Infect Dis. 2016;213:1661&#x2013;70. doi: 10.1093/infdis/jiv760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv760</ArticleId><ArticleId IdType="pmc">PMC4837905</ArticleId><ArticleId IdType="pubmed">26704614</ArticleId></ArticleIdList></Reference><Reference><Citation>Precone V, Stornaiuolo G, Amato A, et al. Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis. Liver Int. 2013;33:834&#x2013;42. doi: 10.1111/liv.12169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.12169</ArticleId><ArticleId IdType="pubmed">23590253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M, Kim N. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2016;15:509&#x2013;24. doi: 10.1038/nrm3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3838</ArticleId><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Kowdley KV. MicroRNAs in common human diseases. Genomics, Proteomics Bioinformatics. 2012;5:246&#x2013;53. doi: 10.1016/j.gpb.2012.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2012.07.005</ArticleId><ArticleId IdType="pmc">PMC3611977</ArticleId><ArticleId IdType="pubmed">23200134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007;179:5082&#x2013;9. doi: 10.4049/jimmunol.179.8.5082.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.8.5082</ArticleId><ArticleId IdType="pubmed">17911593</ArticleId></ArticleIdList></Reference><Reference><Citation>How CK, Hou SK, Shih HC, et al. Expression profile of MicroRNAs in gram-negative bacterial sepsis. Shock. 2015;43:121&#x2013;7. doi: 10.1097/SHK.0000000000000282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000282</ArticleId><ArticleId IdType="pubmed">25394245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho PC, Chang KC, Chuang YS, Wei LN. Cholesterol regulation of receptor interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J. 2011;25:1758&#x2013;66. doi: 10.1096/fj.10-179267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.10-179267</ArticleId><ArticleId IdType="pmc">PMC3079307</ArticleId><ArticleId IdType="pubmed">21285396</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin AJ, Guo C, Cook JA, et al. Plasma levels of microRNA are altered with the development of shock in human sepsis: an observational study. Crit Care. 2015;19:440. doi: 10.1186/s13054-015-1162-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1162-8</ArticleId><ArticleId IdType="pmc">PMC4699334</ArticleId><ArticleId IdType="pubmed">26683209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Vilanova D, Atalar K, et al. Genome-wide sequencing of cellular microRNAs identifies a combinatorial expression signature diagnostic of sepsis. PLoS One. 2013;8 doi: 10.1371/journal.pone.0075918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075918</ArticleId><ArticleId IdType="pmc">PMC3797812</ArticleId><ArticleId IdType="pubmed">24146790</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L, Liu Z, Zhu J, et al. Clinical evaluation of circulating microRNA-25 level change in sepsis and its potential relationship with oxidative stress. Int J Clin Exp Pathol. 2015;8:7675&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4555662</ArticleId><ArticleId IdType="pubmed">26339334</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhang P, Chen W, et al. Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects. Clin Chem Lab Med. 2012;50:1423&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22868808</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HJ, Zhang PJ, Chen WJ, et al. Four serum microRNAs identified as diagnostic biomarkers of sepsis. J Trauma Acute Care Surg. 2012;73:850&#x2013;4. doi: 10.1097/TA.0b013e31825a7560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31825a7560</ArticleId><ArticleId IdType="pubmed">23026916</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Sun Z, Yan W, et al. Identification of microRNA as sepsis biomarker based on miRNAs regulatory network analysis. Biomed Res Int. 2014;2014:594350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3997997</ArticleId><ArticleId IdType="pubmed">24809055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JF, Yu ML, Yu G, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun. 2010;394:184&#x2013;8. doi: 10.1016/j.bbrc.2010.02.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.02.145</ArticleId><ArticleId IdType="pubmed">20188071</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey BK, Mueller AC, Dutta A. Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014;5 doi: 10.4161/21541272.2014.944014.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/21541272.2014.944014</ArticleId><ArticleId IdType="pmc">PMC4581346</ArticleId><ArticleId IdType="pubmed">25483404</ArticleId></ArticleIdList></Reference><Reference><Citation>Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354&#x2013;61. doi: 10.1016/j.tcb.2011.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2011.04.001</ArticleId><ArticleId IdType="pubmed">21550244</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Ferguson JF, Xue C, et al. Tissue-specific RNA-Seq in human evoked inflammation identifies blood and adipose LincRNA signatures of cardiometabolic diseases. Arterioscler Thromb Vasc Biol. 2014;34:902&#x2013;12. doi: 10.1161/ATVBAHA.113.303123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.113.303123</ArticleId><ArticleId IdType="pmc">PMC3966947</ArticleId><ArticleId IdType="pubmed">24504737</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Liu J, Li W, Liu G, Li Z. LncRNA-HOTAIR promotes TNF-alpha production in cardiomyocytes of LPS-induced sepsis mice by activating NF-kappaB pathway. Biochem Biophys Res Commun. 2016;471:240&#x2013;6. doi: 10.1016/j.bbrc.2016.01.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.01.117</ArticleId><ArticleId IdType="pubmed">26806307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J, Zhang X, Xue C, et al. The long noncoding RNA landscape in hypoxic and inflammatory renal epithelial injury. Am J Physiol Renal Physiol. 2015;309:F901&#x2013;13. doi: 10.1152/ajprenal.00462.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00462.2014</ArticleId><ArticleId IdType="pmc">PMC4669357</ArticleId><ArticleId IdType="pubmed">26400545</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, Matkar PN, Muhammad S, et al. Investigation of novel LPS-induced differentially expressed long non-coding RNAs in endothelial cells. Mol Cell Biochem. 2016;421:157&#x2013;68. doi: 10.1007/s11010-016-2797-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-016-2797-8</ArticleId><ArticleId IdType="pubmed">27565812</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui H, Xie N, Tan Z, et al. The human long noncoding RNA lnc-IL7R regulates the inflammatory response. Eur J Immunol. 2014;44:2085&#x2013;95. doi: 10.1002/eji.201344126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201344126</ArticleId><ArticleId IdType="pmc">PMC4107034</ArticleId><ArticleId IdType="pubmed">24723426</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17:205&#x2013;11. doi: 10.1038/nrm.2015.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2015.32</ArticleId><ArticleId IdType="pubmed">26908011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng WL, Marinov GK, Liau ES, et al. Inducible RasGEF1B circular RNA is a positive regulator of ICAM-1 in the TLR4/LPS pathway. RNA Biol. 2016;13:861&#x2013;71. doi: 10.1080/15476286.2016.1207036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2016.1207036</ArticleId><ArticleId IdType="pmc">PMC5014010</ArticleId><ArticleId IdType="pubmed">27362560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooijmans CR, Rovers MM, de Vries RB, et al. SYRCLE&#x2019;s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43. doi: 10.1186/1471-2288-14-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-43</ArticleId><ArticleId IdType="pmc">PMC4230647</ArticleId><ArticleId IdType="pubmed">24667063</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med. 2007;35:2408&#x2013;16. doi: 10.1097/01.CCM.0000282072.56245.91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000282072.56245.91</ArticleId><ArticleId IdType="pubmed">17948334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaan Z, Gardner S, Carruba C, Mattingly J, Druen D, Cheadle WG. Macrophage genetic reprogramming during chronic peritonitis is augmented by LPS pretreatment. J Surg Res. 2012;1175:289&#x2013;97. doi: 10.1016/j.jss.2011.04.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2011.04.051</ArticleId><ArticleId IdType="pubmed">21696761</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederhuber H, Baer K, Altiok I, Sadeghi K, Herkner KR, Kasper DC. MicroRNA-146: tiny player in neonatal innate immunity? Neonatology. 2011;99:51&#x2013;6. doi: 10.1159/000301938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000301938</ArticleId><ArticleId IdType="pubmed">20616571</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Cao D, Mo G, Zhang L. Effects of microRNA-294 on inflammatory factor of sepsis by targeting triggering receptor expressed on myeloid cells-1. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26:661&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25230869</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier M, Wutzler S, Bauer M, Trendafilov P, Henrich D, Marzi I. Altered gene expression patterns in dendritic cells after severe trauma: implications for systemic inflammation and organ injury. Shock. 2008;30:344&#x2013;51. doi: 10.1097/SHK.0b013e3181673eb4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3181673eb4</ArticleId><ArticleId IdType="pubmed">18323745</ArticleId></ArticleIdList></Reference><Reference><Citation>Billeter AT, Hellmann J, Roberts H, et al. MicroRNA-155 potentiates the inflammatory response in hypothermia by suppressing IL-10 production. FASEB J. 2014;28:5322&#x2013;36. doi: 10.1096/fj.14-258335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.14-258335</ArticleId><ArticleId IdType="pmc">PMC4232280</ArticleId><ArticleId IdType="pubmed">25231976</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt WM, Spiel AO, Jilma B, Wolzt M, Muller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun. 2009;380:437&#x2013;41. doi: 10.1016/j.bbrc.2008.12.190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2008.12.190</ArticleId><ArticleId IdType="pubmed">19284987</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SC, Yang JC, Rau CS, et al. Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture. PLoS One. 2013;8 doi: 10.1371/journal.pone.0077936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077936</ArticleId><ArticleId IdType="pmc">PMC3813489</ArticleId><ArticleId IdType="pubmed">24205035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh CH, Rau CS, Jeng JC, et al. Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides. J Biomed Sci. 2012;19:69. doi: 10.1186/1423-0127-19-69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-19-69</ArticleId><ArticleId IdType="pmc">PMC3419134</ArticleId><ArticleId IdType="pubmed">22849760</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Jiang S, Cao Y, Yang Y. Altered miRNAs expression profiles and modulation of immune response genes and proteins during neonatal sepsis. J Clin Immunol. 2014;34:340&#x2013;8. doi: 10.1007/s10875-014-0004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-014-0004-9</ArticleId><ArticleId IdType="pubmed">24668300</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett RE, Conklin DJ, Ryan L, et al. Anti-inflammatory effects of miR-21 in the macrophage response to peritonitis. J Leukoc Biol. 2016;99:361&#x2013;71. doi: 10.1189/jlb.4A1014-489R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.4A1014-489R</ArticleId><ArticleId IdType="pmc">PMC6608009</ArticleId><ArticleId IdType="pubmed">26382295</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossato M, Curtale G, Tamassia N, et al. IL-10-induced microRNA-187 negatively regulates TNF-&#x3b1;, IL-6, and IL-12p40 production in TLR4-stimulated monocytes. Proc Natl Acad Sci U S A. 2012;109:E3101&#x2013;10. doi: 10.1073/pnas.1209100109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1209100109</ArticleId><ArticleId IdType="pmc">PMC3494907</ArticleId><ArticleId IdType="pubmed">23071313</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TE, Suliman HB, Hollingsworth JW, Piantadosi CA. Differential regulation of the PGC family of genes in a mouse model of Staphylococcus aureus sepsis. PLoS One. 2010;5 doi: 10.1371/journal.pone.0011606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011606</ArticleId><ArticleId IdType="pmc">PMC2905396</ArticleId><ArticleId IdType="pubmed">20657826</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Icli B, Wara AK, et al. MicroRNA-181b regulates NF-kappaB-mediated vascular inflammation. J Clin Invest. 2012;122:1973&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3366408</ArticleId><ArticleId IdType="pubmed">22622040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Wang X, Ha T, et al: MicroRNA-125b prevents cardiac dysfunction in polymicrobial sepsis by targeting TRAK6 mediated NFkB activation and p53 mediated apoptotic signaling. J Infect Dis. 2016. doi:10.1093/infdis/jiw449</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5144735</ArticleId><ArticleId IdType="pubmed">27683819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Hao L, Bu HF, et al. Spherical nucleic acid targeting microRNA-99b enhances intestinal MFG-E8 gene expression and restores enterocyte migration in lipopolysaccharide-induced septic mice. Sci Rep. 2016;6:31687. doi: 10.1038/srep31687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31687</ArticleId><ArticleId IdType="pmc">PMC4990839</ArticleId><ArticleId IdType="pubmed">27538453</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Dai QC, Shen HL, et al. Diagnostic value of elevated serum miRNA-143 levels in sepsis. J Int Med Res. 2016;44:875&#x2013;81. doi: 10.1177/0300060516645003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060516645003</ArticleId><ArticleId IdType="pmc">PMC5536632</ArticleId><ArticleId IdType="pubmed">27225861</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore CC, McKillop IH, Huynh T. MicroRNA expression following activated protein C treatment during septic shock. J Surg Res. 2013;182:116&#x2013;26. doi: 10.1016/j.jss.2012.07.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2012.07.063</ArticleId><ArticleId IdType="pubmed">22940033</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HJ, Zhang PJ, Chen WJ, et al. Characterization and identification of novel serum microRNAs in sepsis patients with different outcomes. Shock. 2013;39:480&#x2013;7. doi: 10.1097/SHK.0b013e3182940cb8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3182940cb8</ArticleId><ArticleId IdType="pubmed">23612084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang HC, Chen C, et al. Differential expression of plasma miR-146a in sepsis patients compared with non-sepsis-SIRS patients. Exp Ther Med. 2013;5:1101&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3627686</ArticleId><ArticleId IdType="pubmed">23596477</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y, Li J, Cai Y, et al. The functional polymorphisms of miR-146a are associated with susceptibility to severe sepsis in the Chinese population. Mediators Inflamm. 2014;2014:916202. doi: 10.1155/2014/916202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/916202</ArticleId><ArticleId IdType="pmc">PMC3950573</ArticleId><ArticleId IdType="pubmed">24701036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Wang X, Liu X, et al. miR-15a/16 are upregulated in the serum of neonatal sepsis patients and inhibit the LPS-induced inflammatory pathway. Int J Clin Exp Med. 2015;8:5683&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4483976</ArticleId><ArticleId IdType="pubmed">26131152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Li C, He Y, et al. Relationship between expression of microRNA and inflammatory cytokines plasma level in pediatric patients with sepsis. Zhonghua Er Ke Za Zhi. 2014;52:28&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">24680405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LA, Oakes JL, Burton R, et al. The role of the E2F1 transcription factor in the innate immune response to systemic LPS. Am J Physiol Lung Cell Mol Physiol. 2012;303:L391&#x2013;400. doi: 10.1152/ajplung.00348.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00348.2011</ArticleId><ArticleId IdType="pmc">PMC4587596</ArticleId><ArticleId IdType="pubmed">22707615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudor S, Giza DE, Lin HY, et al. Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis. 2014;5 doi: 10.1038/cddis.2014.515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.515</ArticleId><ArticleId IdType="pmc">PMC4649832</ArticleId><ArticleId IdType="pubmed">25476907</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Chaudhry H, Zhong Y, et al. Dysregulation in microRNA expression in peripheral blood mononuclear cells of sepsis patients is associated with immunopathology. Cytokine. 2015;71:89&#x2013;100. doi: 10.1016/j.cyto.2014.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.09.003</ArticleId><ArticleId IdType="pmc">PMC4252591</ArticleId><ArticleId IdType="pubmed">25265569</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao AP, Shen J, Zuo Z. Expression and regulation of long noncoding RNAs in TLR4 signaling in mouse macrophages. BMC Genomics. 2015;16:45. doi: 10.1186/s12864-015-1270-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-015-1270-5</ArticleId><ArticleId IdType="pmc">PMC4320810</ArticleId><ArticleId IdType="pubmed">25652569</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon HG, Yang J, Zheng Y, Jin Y. miR-15a/16 regulates macrophage phagocytosis after bacterial infection. J Immunol. 2014;193:4558&#x2013;67. doi: 10.4049/jimmunol.1401372.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1401372</ArticleId><ArticleId IdType="pmc">PMC4216178</ArticleId><ArticleId IdType="pubmed">25261473</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan C, Jinjun B, Zi-Chun H, et al. Modulation of TNF-&#x3b1; mRNA stability by human antigen R and miR181s in sepsis-induced immunoparalysis. EMBO Mol Med. 2015;7:140&#x2013;57. doi: 10.15252/emmm.201404797.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404797</ArticleId><ArticleId IdType="pmc">PMC4328645</ArticleId><ArticleId IdType="pubmed">25535255</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyn J, Ledderose C, Hinske LC, et al. Adenosine A2A receptor upregulation in human PMNs is controlled by miRNA-214, miRNA-15, and miRNA-16. Shock. 2012;37:156&#x2013;63. doi: 10.1097/SHK.0b013e31823f16bc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e31823f16bc</ArticleId><ArticleId IdType="pubmed">22249219</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Wang J, Li Z, et al. MicroRNA-25-5b inhibits HMGB1 expression in LPS-induced sepsis. Int J Mol Med. 2016;38:312&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27246725</ArticleId></ArticleIdList></Reference><Reference><Citation>El Gazzar M, Church A, Liu T, McCall CE. MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming. J Leukoc Biol. 2011;90:509&#x2013;19. doi: 10.1189/jlb.0211074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0211074</ArticleId><ArticleId IdType="pmc">PMC3157899</ArticleId><ArticleId IdType="pubmed">21562054</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L, Feng Y, Xu G, Jian W, Chao W. Splenic RNA and microRNA mimics promote complement factor B production and alternative pathway activation via innate immune signaling. J Immunol. 2016;196:2788&#x2013;98. doi: 10.4049/jimmunol.1502106.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1502106</ArticleId><ArticleId IdType="pmc">PMC6464635</ArticleId><ArticleId IdType="pubmed">26889043</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn EM, Wang JH, O'Callaghan G, Redmond HP. MicroRNA-146a is upregulated by and negatively regulates TLR2 signaling. PLoS One. 2013;8 doi: 10.1371/journal.pone.0062232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0062232</ArticleId><ArticleId IdType="pmc">PMC3639252</ArticleId><ArticleId IdType="pubmed">23638011</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Y, Yao H, Wang J, Sun K, Cao L, Wang Y. NF-kappaB-DICER-miRs axis regulates TNF-alpha expression in responses to endotoxin stress. Int J Biol Sci. 2015;11:1257&#x2013;68. doi: 10.7150/ijbs.12611.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.12611</ArticleId><ArticleId IdType="pmc">PMC4582149</ArticleId><ArticleId IdType="pubmed">26435691</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HC, Yu HR, Huang LT, et al. MiRNA-125b regulates TNF-alpha production in CD14+ neonatal monocytes via post-transcriptional regulation. J Leukoc Biol. 2012;92:171&#x2013;82. doi: 10.1189/jlb.1211593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1211593</ArticleId><ArticleId IdType="pubmed">22581933</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L, Rong H, Cheng Y, et al. Identification of microRNAs dysregulated in CD14 gene silencing RAW264.7 macrophage cells. Inflammation. 2014;37:287&#x2013;94. doi: 10.1007/s10753-013-9739-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-013-9739-3</ArticleId><ArticleId IdType="pubmed">24062059</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppresion: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72:1491&#x2013;501. doi: 10.1097/TA.0b013e318256e000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e318256e000</ArticleId><ArticleId IdType="pmc">PMC3705923</ArticleId><ArticleId IdType="pubmed">22695412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J, Yu J, Wong SH, et al. Autophagy in sepsis: degradation into exhaustion? Autophagy. 2016;12:1073&#x2013;82. doi: 10.1080/15548627.2016.1179410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1179410</ArticleId><ArticleId IdType="pmc">PMC4990998</ArticleId><ArticleId IdType="pubmed">27172163</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Shi K, Chen M, et al. Elevated miR-155 expression induces immunosuppression via CD39(+) regulatory T-cells in sepsis patient. Int J Infect Dis. 2015;40:135&#x2013;41. doi: 10.1016/j.ijid.2015.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2015.09.016</ArticleId><ArticleId IdType="pubmed">26433115</ArticleId></ArticleIdList></Reference><Reference><Citation>McClure C, Brudecki L, Ferguson DA, et al. MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect Immun. 2014;82:3816&#x2013;25. doi: 10.1128/IAI.01495-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.01495-14</ArticleId><ArticleId IdType="pmc">PMC4187818</ArticleId><ArticleId IdType="pubmed">24980967</ArticleId></ArticleIdList></Reference><Reference><Citation>McClure C, Ali E, Youssef D, Yao ZQ, McCall CE, El Gazzar M. NFI-A disrupts myeloid cell differentiation and maturation in septic mice. J Leukoc Biol. 2016;99:201&#x2013;11. doi: 10.1189/jlb.4A0415-171RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.4A0415-171RR</ArticleId><ArticleId IdType="pmc">PMC4673479</ArticleId><ArticleId IdType="pubmed">26259914</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heide V, Mohnle P, Rink J, Briegel J, Kreth S. Down-regulation of microRNA-31 in CD4+ T cells contributes to immunosuppression in human sepsis by promoting TH2 skewing. Anesthesiology. 2016;124:908&#x2013;22. doi: 10.1097/ALN.0000000000001031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001031</ArticleId><ArticleId IdType="pubmed">26978146</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Dalli J, Chiang N, Baron RM, Quintana C, Serhan CN. Plasticity of leukocytic exudates in resolving acute inflammation is regulated by microRNA and proresolving mediators. Immunity. 2013;39:885&#x2013;98. doi: 10.1016/j.immuni.2013.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.10.011</ArticleId><ArticleId IdType="pmc">PMC3888517</ArticleId><ArticleId IdType="pubmed">24238341</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Li T, Wu B, et al. STAT1 regulates MD-2 expression in monocytes of sepsis via miR-30a. Inflammation. 2014;37:1903&#x2013;11. doi: 10.1007/s10753-014-9922-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-014-9922-1</ArticleId><ArticleId IdType="pubmed">24858600</ArticleId></ArticleIdList></Reference><Reference><Citation>McClure C, McPeak MB, Youssef D, et al. Stat3 and C/EBP&#x3b2; synergize to induce miR-21 and miR-181b expression during sepsis. Immunol Cell Biol. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5209283</ArticleId><ArticleId IdType="pubmed">27430527</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis AM, Fagundes CT, Yang G, et al. Circadian control of innate immunity in macrophages by miR-155 targeting Bmal1. Proc Natl Acad Sci U S A. 2015;112:7231&#x2013;6. doi: 10.1073/pnas.1501327112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1501327112</ArticleId><ArticleId IdType="pmc">PMC4466714</ArticleId><ArticleId IdType="pubmed">25995365</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinini AM, Midwood KS. Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155. Cell Rep. 2012;2:914&#x2013;26. doi: 10.1016/j.celrep.2012.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.09.005</ArticleId><ArticleId IdType="pmc">PMC3607221</ArticleId><ArticleId IdType="pubmed">23084751</ArticleId></ArticleIdList></Reference><Reference><Citation>Monk CE, Hutvagner G, Arthur JS. Regulation of miRNA transcription in macrophages in response to Candida albicans. PLoS One. 2010;5 doi: 10.1371/journal.pone.0013669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013669</ArticleId><ArticleId IdType="pmc">PMC2965114</ArticleId><ArticleId IdType="pubmed">21060679</ArticleId></ArticleIdList></Reference><Reference><Citation>Papurica M, Rogobete AF, Sandesc D et al. The expression of nuclear transcription facor kappa B in the case of critically ill polytrauma patients with sepsis and its interactions with microRNAs. Biochem Genet. 2016;54:337-47.</Citation><ArticleIdList><ArticleId IdType="pubmed">27003424</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Zhou H, Ma D, Chen ZK, Cai X. MicroRNA-19a and CD22 comprise a feedback loop for B cell response in sepsis. Med Sci Monit. 2015;21:1548&#x2013;55. doi: 10.12659/MSM.894321.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.894321</ArticleId><ArticleId IdType="pmc">PMC4459571</ArticleId><ArticleId IdType="pubmed">26017478</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi J, Qiao Y, Wang P, Li S, Zhao W, Gao C. MicroRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-&#x3ba;B1 in murine macrophages. FEBS Lett. 2012;586:1201&#x2013;7. doi: 10.1016/j.febslet.2012.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2012.03.011</ArticleId><ArticleId IdType="pubmed">22575656</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X, Wang CT, Geng XH. MicroRNA-29a promotes apoptosis of monocytes by targeting STAT3 during sepsis. Genet Mol Res. 2015;14:13746&#x2013;53. doi: 10.4238/2015.October.28.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/2015.October.28.37</ArticleId><ArticleId IdType="pubmed">26535690</ArticleId></ArticleIdList></Reference><Reference><Citation>Larkin CM, Santos-Martines MJ, Ryan T, Radomski MW. Sepsis-associated thrombocytopenia. Thromb Res. 2016;141:11&#x2013;6. doi: 10.1016/j.thromres.2016.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.02.022</ArticleId><ArticleId IdType="pubmed">26953822</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui YL, Wang B, Gao HM, et al. Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia. Patient Prefer Adherence. 2016;10:313&#x2013;9. doi: 10.2147/PPA.S95588.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PPA.S95588</ArticleId><ArticleId IdType="pmc">PMC4795447</ArticleId><ArticleId IdType="pubmed">27042022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HJ, Deng J, Wang JY, et al. Serum miR-122 levels are related to coagulation disorders in sepsis patients. Clin Chem Lab Med. 2014;52:927&#x2013;33. doi: 10.1515/cclm-2013-0899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2013-0899</ArticleId><ArticleId IdType="pubmed">24421215</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Anand AR, Ganju RK. Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia. J Immunol. 2014;192:385&#x2013;93. doi: 10.4049/jimmunol.1302021.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302021</ArticleId><ArticleId IdType="pmc">PMC3908786</ArticleId><ArticleId IdType="pubmed">24272999</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee V, Beard RS, Jr, Reynolds JJ, et al. MicroRNA-147b regulates vascular endothelial barrier function by targeting ADAM15 expression. PLoS One. 2014;9 doi: 10.1371/journal.pone.0110286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0110286</ArticleId><ArticleId IdType="pmc">PMC4198252</ArticleId><ArticleId IdType="pubmed">25333931</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HS, Sivachandran N, Lau A, et al. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med. 2013;5:949&#x2013;66. doi: 10.1002/emmm.201202318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202318</ArticleId><ArticleId IdType="pmc">PMC3721471</ArticleId><ArticleId IdType="pubmed">23733368</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput C, Tauseef M, Farazuddin M, et al. MicroRNA-150 suppression of angiopoetin-2 generation and signaling is crucial for resolving vascular injury. Arterioscler Thromb Vasc Biol. 2016;36:380&#x2013;8. doi: 10.1161/ATVBAHA.115.306997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.115.306997</ArticleId><ArticleId IdType="pmc">PMC4732888</ArticleId><ArticleId IdType="pubmed">26743170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M, Gu JT, Yi B, Tang ZZ, Tao GC. MicroRNA-23b regulates the expression of inflammatory factors in vascular endothelial cells during sepsis. Exp Ther Med. 2015;9:1125&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4353782</ArticleId><ArticleId IdType="pubmed">25780398</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H, Goodwin AJ, Chang E, et al. Endothelial progenitor cells and a stromal cell-derived factor-1&#x3b1; analogue synergistically improve survival in sepsis. Am J Respir Crit Care Med. 2014;189:1509&#x2013;19. doi: 10.1164/rccm.201312-2163OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201312-2163OC</ArticleId><ArticleId IdType="pmc">PMC4226015</ArticleId><ArticleId IdType="pubmed">24707934</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajic O, Dabbagh O, Park PK, et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med. 2011;183:462&#x2013;70. doi: 10.1164/rccm.201004-0549OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201004-0549OC</ArticleId><ArticleId IdType="pmc">PMC3056224</ArticleId><ArticleId IdType="pubmed">20802164</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggimann P, Harbarth S, Ricou B et al. Acute respiratory distress syndrome after bacteremic sepsis does not increase mortality. Am J Respir Crit Care Med. 2003;167:1210&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12615616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WY, Hong SB. Sepsis and acute respiratory distress syndrome: recent update. Tuberc Respir Dis. 2016;79:53&#x2013;7. doi: 10.4046/trd.2016.79.2.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.4046/trd.2016.79.2.53</ArticleId><ArticleId IdType="pmc">PMC4823184</ArticleId><ArticleId IdType="pubmed">27066082</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin G, Brunkhorst FM, Janes JM, et al. The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes. Crit Care. 2009;13:R103. doi: 10.1186/cc7936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7936</ArticleId><ArticleId IdType="pmc">PMC2717475</ArticleId><ArticleId IdType="pubmed">19566927</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Ruan Z, Mao Y, et al. MiR-27a is up regulated and promotes inflammatory response in sepsis. Cell Immunol. 2014;290:190&#x2013;5. doi: 10.1016/j.cellimm.2014.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2014.06.006</ArticleId><ArticleId IdType="pubmed">25043848</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Li Y, Jiang R, et al. MiR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway. Exp Lung Res. 2015;41:261&#x2013;9. doi: 10.3109/01902148.2015.1004206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01902148.2015.1004206</ArticleId><ArticleId IdType="pubmed">26052826</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying H, Kang Y, Zhang H, et al. MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway. J Immunol. 2015;194:1239&#x2013;51. doi: 10.4049/jimmunol.1402088.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1402088</ArticleId><ArticleId IdType="pubmed">25520401</ArticleId></ArticleIdList></Reference><Reference><Citation>Adyshev DM, Moldobaeva N, Mapes B, Elangovan V, Garcia JG. MicroRNA regulation of nonmuscle myosin light chain kinase expression in human lung endothelium. Am J Respir Cell Mol Biol. 2013;49:58&#x2013;66. doi: 10.1165/rcmb.2012-0397OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2012-0397OC</ArticleId><ArticleId IdType="pmc">PMC3727884</ArticleId><ArticleId IdType="pubmed">23492194</ArticleId></ArticleIdList></Reference><Reference><Citation>Drosatos K, Drosatos-Tampakaki Z, Khan R, et al. Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction. J Biol Chem. 2011;286:36331&#x2013;9. doi: 10.1074/jbc.M111.272146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.272146</ArticleId><ArticleId IdType="pmc">PMC3196095</ArticleId><ArticleId IdType="pubmed">21873422</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Hu X, Liu G, et al. Phosphatase Wip1 negatively regulates neutrophil migration and inflammation. J Immunol. 2014;192:1184&#x2013;95. doi: 10.4049/jimmunol.1300656.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300656</ArticleId><ArticleId IdType="pubmed">24395919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding T, Li Y, Tang R, et al. Differential expression of miRNAs in myocardial tissues of rats with lipopolysaccharide-induced endotoxemia. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35:213&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25736115</ArticleId></ArticleIdList></Reference><Reference><Citation>Essandoh K, Li Y, Huo J, Fan GC. MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock. 2016;46:122-31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4949115</ArticleId><ArticleId IdType="pubmed">26954942</ArticleId></ArticleIdList></Reference><Reference><Citation>Flierl MA, Rittirsch D, Huber-Lang MS. Molecular events in the cardiomyopathy of sepsis. Mol Med. 2008;14:327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2227904</ArticleId><ArticleId IdType="pubmed">18256728</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilescu C, Rossi S, Shimizu M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009;4 doi: 10.1371/journal.pone.0007405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0007405</ArticleId><ArticleId IdType="pmc">PMC2756627</ArticleId><ArticleId IdType="pubmed">19823581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Huang W, Yang Y, et al. Loss of duplex miR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis. Biochem Biophysica Acta. 2014;1842:701&#x2013;11. doi: 10.1016/j.bbadis.2014.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.01.012</ArticleId><ArticleId IdType="pmc">PMC3959587</ArticleId><ArticleId IdType="pubmed">24486439</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue WL, Bai X, Zhang L. rhTNFR:Fc increases Nrf2 expression via miR-27a mediation to protect myocardium against sepsis injury. Biochem Biophys Res Commun. 2015;464:855&#x2013;61. doi: 10.1016/j.bbrc.2015.07.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.07.051</ArticleId><ArticleId IdType="pubmed">26171875</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Bei Y, Shen S, et al. Mir-21-3p controls sepsis associated cardiac dysfunction via regulating SORBS2. J Mol Cell Cardiol. 2016;94:43&#x2013;53. doi: 10.1016/j.yjmcc.2016.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2016.03.014</ArticleId><ArticleId IdType="pubmed">27033308</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Z, Wang J, Shi Q, et al. SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition. Apoptosis. 2016;21:174&#x2013;83. doi: 10.1007/s10495-015-1201-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-015-1201-6</ArticleId><ArticleId IdType="pmc">PMC4712245</ArticleId><ArticleId IdType="pubmed">26659076</ArticleId></ArticleIdList></Reference><Reference><Citation>Risoe PK, Ryg U, Wang YY, et al. Cecal ligation and puncture sepsis is associated with attenuated expression of adenylyl cyclase 9 and increased miR142-3p. Shock. 2011;36:390&#x2013;5. doi: 10.1097/SHK.0b013e318228ec6f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318228ec6f</ArticleId><ArticleId IdType="pubmed">21701418</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZH, Liang YB, Tang H, et al. Expression and effects of microRNA-155 in the livers of septic mice. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012;24:154&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22685717</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia P, Teng J, Zou J, et al. Xenon protects against septic acute kidney injury via miR-21 target signaling pathway. Crit Care Med. 2015;43:e250&#x2013;9. doi: 10.1097/CCM.0000000000001001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001001</ArticleId><ArticleId IdType="pmc">PMC4467582</ArticleId><ArticleId IdType="pubmed">25844699</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XY, Zhang K, Jiang ZY, Cai LH. MiR-204/miR-211 downregulation contributes to candidemia-induced kidney injuries via derepression of Hmx1 expression. Life Sci. 2014;102:139&#x2013;44. doi: 10.1016/j.lfs.2014.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2014.03.010</ArticleId><ArticleId IdType="pubmed">24641951</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhao Q, Matta R, et al. Inducible nitric oxide synthase expression is regulated by mitogen-activated protein kinase phosphatase-1. J Biol Chem. 2009;284:27123&#x2013;34. doi: 10.1074/jbc.M109.051235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.051235</ArticleId><ArticleId IdType="pmc">PMC2785641</ArticleId><ArticleId IdType="pubmed">19651781</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Fu SL, Liu Y, Liu YL, Wang WJ. Analysis of microRNA expression profiles in weaned pig skeletal muscle after lipopolysaccharide challenge. Int J Mol Sci. 2015;16:22438&#x2013;55. doi: 10.3390/ijms160922438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160922438</ArticleId><ArticleId IdType="pmc">PMC4613317</ArticleId><ArticleId IdType="pubmed">26389897</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredrisksson K, Tjader I, Keller P, et al. Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure. PLoS One. 2008;3 doi: 10.1371/journal.pone.0003686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003686</ArticleId><ArticleId IdType="pmc">PMC2579334</ArticleId><ArticleId IdType="pubmed">18997871</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang AQ, Gu W, Zeng L, et al. Genetic variants of microRNA sequences and susceptibility to sepsis in patients with major blunt trauma. Ann Surg. 2015;261:189&#x2013;96. doi: 10.1097/SLA.0000000000000687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000687</ArticleId><ArticleId IdType="pubmed">24743625</ArticleId></ArticleIdList></Reference><Reference><Citation>Roderburg C, Benz F, Vargas Cardenas D, et al. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int. 2015;35:1172&#x2013;84. doi: 10.1111/liv.12627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.12627</ArticleId><ArticleId IdType="pubmed">25039534</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett RE, Keskey RC, Rao JM, et al. Poor outcome in bacterial peritonitis is associated with dysregulated microRNAs and an increased inflammatory response. Surgery. 2013;154:521&#x2013;7. doi: 10.1016/j.surg.2013.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2013.06.048</ArticleId><ArticleId IdType="pubmed">23972658</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients&#x2019; mortality: a prospective observational study. PLoS One. 2012;7 doi: 10.1371/journal.pone.0038885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0038885</ArticleId><ArticleId IdType="pmc">PMC3376145</ArticleId><ArticleId IdType="pubmed">22719975</ArticleId></ArticleIdList></Reference><Reference><Citation>Roderburg C, Luedde M, Vargas Cardenas D, et al. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One. 2013;8 doi: 10.1371/journal.pone.0054612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054612</ArticleId><ArticleId IdType="pmc">PMC3555785</ArticleId><ArticleId IdType="pubmed">23372743</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacke F, Roderburg C, Benz F, et al. Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients. Crit Care Med. 2014;42:1096&#x2013;104. doi: 10.1097/CCM.0000000000000131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000131</ArticleId><ArticleId IdType="pubmed">24413579</ArticleId></ArticleIdList></Reference><Reference><Citation>Benz F, Tacke F, Luedde M, et al. Circulating microRNA-223 serum levels do not predict sepsis or survival in patients with critical illness. Dis Markers. 2015;2015:384208. doi: 10.1155/2015/384208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/384208</ArticleId><ArticleId IdType="pmc">PMC4355123</ArticleId><ArticleId IdType="pubmed">25810564</ArticleId></ArticleIdList></Reference><Reference><Citation>Leelahavanichkul A, Somparn P, Panich T, et al. Serum miRNA-122 in acute liver injury induced by kidney injury and sepsis in CD-1 mouse models. Hepatol Res. 2015;45:1341&#x2013;52. doi: 10.1111/hepr.12501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hepr.12501</ArticleId><ArticleId IdType="pubmed">25655304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Meng K, Chen W, Feng D, Jia Y, Xie L. Serum miR-574-5p: a prognostic predictor of sepsis patients. Shock. 2012;37:263&#x2013;7. doi: 10.1097/SHK.0b013e318241baf8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318241baf8</ArticleId><ArticleId IdType="pubmed">22344312</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlosser K, McIntyre LA, White RJ, Stewart DJ. Customized internal reference controls for improved assessement of circulating microRNAs in disease. PLoS One. 2015;10 doi: 10.1371/journal.pone.0127443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0127443</ArticleId><ArticleId IdType="pmc">PMC4444297</ArticleId><ArticleId IdType="pubmed">26010841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HJ, Wang BZ, Zhang PJ, et al. Identification of four novel serum protein biomarkers in sepsis encoded by target genes of sepsis-related miRNAs. Clin Sci (Lond) 2014;126:857&#x2013;67. doi: 10.1042/CS20130301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20130301</ArticleId><ArticleId IdType="pmc">PMC4202716</ArticleId><ArticleId IdType="pubmed">24303815</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yu B, Deng J, Jin Y, Xie L. Serum miR-122 correlates with short term mortality in sepsis patients. Crit Care. 2014;18:704. doi: 10.1186/s13054-014-0704-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0704-9</ArticleId><ArticleId IdType="pmc">PMC4262971</ArticleId><ArticleId IdType="pubmed">25672224</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WH, Wu HY, Zhang HZ, Liu HX, Wei YJ, Shi B. Prognostic value of Picco monitoring combined with plasma microRNA-150 detection in septic shock patients. Zhejiang Da Xue Bao Yi Xue Ban. 2015;44:659&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10397082</ArticleId><ArticleId IdType="pubmed">26822049</ArticleId></ArticleIdList></Reference><Reference><Citation>Caserta S, Kern F, Cohen J, et al. Circulating plasma microRNAs can differentiate human sepsis and systemic inflammatory response syndrome (SIRS) Sci Rep. 2016;6:28006. doi: 10.1038/srep28006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28006</ArticleId><ArticleId IdType="pmc">PMC4913253</ArticleId><ArticleId IdType="pubmed">27320175</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhao C, Cai Q, Zhu H. Expression of microRNA-155 and regulative T cell in sepsis patients and their relationship. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26:179&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">24598292</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Liu C, Wang Z, Huang J, Zeng Q. MicroRNA-23a-5p acts as a potential biomarker for sepsis-induced acute respiratory distress syndrome in early stage. Cell Mol Biol. 2016;62:31&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26950448</ArticleId></ArticleIdList></Reference><Reference><Citation>Puimege L, Van Hauwermeiren F, Steeland S, et al. Glucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1. EMBO Mol Med. 2015;7:1004&#x2013;17. doi: 10.15252/emmm.201405010.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201405010</ArticleId><ArticleId IdType="pmc">PMC4551340</ArticleId><ArticleId IdType="pubmed">25995337</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Herrera M, Lorenzo-Diaz F, Pino-Yanes M, et al. Lung transcriptomics during protective ventilatory support in sepsis-induced acute lung injury. PLoS One. 2015;10 doi: 10.1371/journal.pone.0132296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132296</ArticleId><ArticleId IdType="pmc">PMC4492998</ArticleId><ArticleId IdType="pubmed">26147972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledderose C, Mohnle P, Limbeck E, et al. Corticosteroid resistance in sepsis is influenced by microRNA-124-induced downregulation of glucocorticoid receptor-alpha. Crit Care Med. 2012;40:2745&#x2013;53. doi: 10.1097/CCM.0b013e31825b8ebc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31825b8ebc</ArticleId><ArticleId IdType="pubmed">22846781</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZH, Liang YB, Tang H, et al. Dexamethasone down-regulates the expression of microRNA-155 in the livers of septic mice. PLoS One. 2013;8 doi: 10.1371/journal.pone.0080547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080547</ArticleId><ArticleId IdType="pmc">PMC3823654</ArticleId><ArticleId IdType="pubmed">24244697</ArticleId></ArticleIdList></Reference><Reference><Citation>El Gazzar M, McGall CE. MicroRNAs distinguish translational from transcriptinal silencing during endotoxin tolerance. J Biol Chem. 2010;285:20940&#x2013;51. doi: 10.1074/jbc.M110.115063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.115063</ArticleId><ArticleId IdType="pmc">PMC2898346</ArticleId><ArticleId IdType="pubmed">20435889</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S, Meng J, Das S, et al. Morphine induced exacerbation of sepsis is mediated by tempering endotoxin tolerance through modulation of miR-146a. Sci Rep. 2013;3:1977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3679508</ArticleId><ArticleId IdType="pubmed">23756365</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahid MA, Pauley KM, Satoh M, et al. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem. 2009;284:34590&#x2013;9. doi: 10.1074/jbc.M109.056317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.056317</ArticleId><ArticleId IdType="pmc">PMC2787321</ArticleId><ArticleId IdType="pubmed">19840932</ArticleId></ArticleIdList></Reference><Reference><Citation>Doxaki C, Kampranis SC, Eliopoulos AG, et al. Coordinated regulation of miR-155 and miR-146a genes during induction of endotoxin tolerance in Macrophages. J Immunol. 2015;195:5750&#x2013;61. doi: 10.4049/jimmunol.1500615.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500615</ArticleId><ArticleId IdType="pubmed">26538391</ArticleId></ArticleIdList></Reference><Reference><Citation>Androulidaki A, Iliopoulos D, Arranz A, et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity. 2009;31:220&#x2013;31. doi: 10.1016/j.immuni.2009.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.06.024</ArticleId><ArticleId IdType="pmc">PMC2865583</ArticleId><ArticleId IdType="pubmed">19699171</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahid MA, Satoh M, Chan EK. Interleukin 1beta-responsive microRNA-146a is critical for the cytokine-induced tolerance and cross-tolerance to toll-like receptor ligands. J Innate Immun. 2015;7:428&#x2013;40. doi: 10.1159/000371517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371517</ArticleId><ArticleId IdType="pmc">PMC4485520</ArticleId><ArticleId IdType="pubmed">25896300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y, Jia P, Fang Y, et al. miR-146a is essential for lipopolysaccharide (LPS)-induced cross-tolerance against kidney ischemia/reperfusion injury in mice. Sci Rep. 2016;6:27091. doi: 10.1038/srep27091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27091</ArticleId><ArticleId IdType="pmc">PMC4890025</ArticleId><ArticleId IdType="pubmed">27250735</ArticleId></ArticleIdList></Reference><Reference><Citation>Arango D, Diosa-Toro M, Rojas-Hernandez LS, et al. Dietary apigenin reduces LPS-induced expression of miR-155 restoring immune balance during inflammation. Mol Nutr Food Res. 2015;59:763&#x2013;72. doi: 10.1002/mnfr.201400705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201400705</ArticleId><ArticleId IdType="pmc">PMC7955240</ArticleId><ArticleId IdType="pubmed">25641956</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Liu D, Gong W, et al. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting miR-143. Stem cells. 2014;32:521&#x2013;33. doi: 10.1002/stem.1543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1543</ArticleId><ArticleId IdType="pubmed">24105952</ArticleId></ArticleIdList></Reference><Reference><Citation>Sari AN, Korkmaz B, Serin MS, et al. Effects of 5,14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKK&#x3b2;/I&#x3ba;B-&#x3b1;/NF-&#x3ba;B pathway and circulating miR-150, miR-223, and miR-297 levels in a rat model of septic shock. Inflamm Res. 2014;63:741&#x2013;56. doi: 10.1007/s00011-014-0747-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-014-0747-z</ArticleId><ArticleId IdType="pmc">PMC4158117</ArticleId><ArticleId IdType="pubmed">24915805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Tan L, Jin J, et al. Non-cultured dermal-derived mesenchymal cells attenuate sepsis induced by cecal ligation and puncture in mice. Sci Rep. 2015;5:16973. doi: 10.1038/srep16973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16973</ArticleId><ArticleId IdType="pmc">PMC4653757</ArticleId><ArticleId IdType="pubmed">26586517</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho MS, Mei SH, Stewart DJ. The immunomodulatory and therapeutic effects of mesenchymal stromal cells for acute lung injury and sepsis. J Cell Physiol. 2015;230:2606&#x2013;17. doi: 10.1002/jcp.25028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25028</ArticleId><ArticleId IdType="pubmed">25913273</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla K, Sharma AK, Ward A, et al. Micro RNA-30c-2-3p negatively regulates NF&#x3ba;B signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer. Mol Oncol. 2015;9:1106&#x2013;19. doi: 10.1016/j.molonc.2015.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molonc.2015.01.008</ArticleId><ArticleId IdType="pmc">PMC5528752</ArticleId><ArticleId IdType="pubmed">25732226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M, Wang X, Zhang X, et al. Attenuation of cardiac dysfunction in polymicrobial sepsis by microRNA-146a is mediated via targeting of IRAK1 and TRAF6 expression. J Immunol. 2015;195:672&#x2013;82. doi: 10.4049/jimmunol.1403155.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1403155</ArticleId><ArticleId IdType="pmc">PMC4490963</ArticleId><ArticleId IdType="pubmed">26048146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Ding C, Shao Q, et al. The protective effects of transfected microRNA-146a on mice with sepsis induced acute lung injury in vivo. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27:591&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">26138422</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohnle P, Schutz SV, van der Heide V, et al. MicroRNA-146a controls Th1-cell differentiation of human CD4+ T lymphocytes by targeting PRKC&#x3b5;. Eur J Immunol. 2015;45:260&#x2013;72. doi: 10.1002/eji.201444667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201444667</ArticleId><ArticleId IdType="pubmed">25308712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Li Q, Gui H, et al. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Res. 2013;23:1270&#x2013;83. doi: 10.1038/cr.2013.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2013.116</ArticleId><ArticleId IdType="pmc">PMC3817544</ArticleId><ArticleId IdType="pubmed">23979021</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao G, Su Z, Song D, et al. The long non-coding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-kB. FEBS Lett. 2016;590:2884&#x2013;95. doi: 10.1002/1873-3468.12315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12315</ArticleId><ArticleId IdType="pubmed">27434861</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Goodwin AJ, Buie JN, et al. A stromal cell-derived factor 1 alpha analogue improves endothelial cell function in lipopolysaccharide-induced acute respiratory distress syndrome. Mol Med. 2016. doi:10.2119/molmed.2015.00240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5004713</ArticleId><ArticleId IdType="pubmed">27031787</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37388580</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Prone Vs. Supine Position Ventilation in Intubated COVID-19 Patients: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e39636</StartPage><MedlinePgn>e39636</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39636</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.39636</ELocationID><Abstract><AbstractText>Whether prone positioning of patients undergoing mechanical ventilation for COVID-19 pneumonia has benefits over supine positioning is not clear. We conducted a systematic review with meta-analysis to determine whether prone versus supine positioning during ventilation resulted in different outcomes for patients with COVID-19 pneumonia. We searched Ovid Medline, Embase, and Web of Science for prospective and retrospective studies up through April 2023.&#xa0;We included studies that compared outcomes of patients with COVID-19 after ventilation in prone and supine positions.&#xa0;The primary outcomes were three mortality measures: hospital, overall, and intensive care unit (ICU). Secondary outcomes were mechanical ventilation days, intensive care unit (ICU) length of stay, and hospital length of stay. We conducted risk of bias analysis and used meta-analysis software to analyze results. Mean difference (MD) was used for continuous data, and odds ratio (OR) was used for dichotomous data, both with 95% CIs. Significant heterogeneity (I<sup>2</sup>) was considered if I<sup>2</sup>&#xa0;was &gt;50%. A statistically significant result was considered if the&#xa0;p-value&#xa0;was &lt;0.05. Of 1787 articles identified, 93 were retrieved, and seven retrospective cohort studies encompassing 5216 patients with COVID-19 were analyzed. ICU mortality was significantly higher in the prone group (OR 2.22, 95% CI 1.43-3.43; p=0.0004). No statistically significant difference was observed between prone and supine groups for hospital mortality (OR, 0.95; 95% CI, 0.66-1.37;&#xa0;p=0.78)&#xa0;or overall mortality (OR, 1.08; 95% CI, 0.72-1.64;&#xa0;p=0.71). Studies that analyzed primary outcomes had significant heterogeneity. Hospital length of stay&#xa0;was significantly higher in the prone than in the supine group (MD, 6.06; 95 % CI, 3.15-8.97; p&lt;0.0001). ICU length of stay and days of mechanical ventilation did not differ between the two groups. In conclusion,&#xa0;mechanical ventilation with prone positioning for all patients with COVID-19 pneumonia may not provide a mortality benefit over supine positioning.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Fayed et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fayed</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anesthesiology, Pain Management and Perioperative Medicine, Henry Ford Health System, Detroit, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maroun</LastName><ForeName>Wissam</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Anesthesiology, Pain Management and Perioperative Medicine, Henry Ford Health System, Detroit, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elnahla</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesiology, Pain Management and Perioperative Medicine, Henry Ford Health System, Detroit, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeldo</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Anesthesiology, Pain Management and Perioperative Medicine, Henry Ford Health System, Detroit, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Was</LastName><ForeName>Jessica R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Anesthesiology, Pain Management and Perioperative Medicine, Henry Ford Health System, Detroit, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penning</LastName><ForeName>Donald H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Anesthesiology, Pain Management and Perioperative Medicine, Henry Ford Health System, Detroit, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute respiratory distress syndrome [ards]</Keyword><Keyword MajorTopicYN="N">covid 19</Keyword><Keyword MajorTopicYN="N">covid-19 mortality</Keyword><Keyword MajorTopicYN="N">icu mortality rate</Keyword><Keyword MajorTopicYN="N">invasive mechanical ventilation</Keyword><Keyword MajorTopicYN="N">prone positioning</Keyword><Keyword MajorTopicYN="N">severe respiratory failure</Keyword><Keyword MajorTopicYN="N">severe sepsis</Keyword><Keyword MajorTopicYN="N">supine position</Keyword><Keyword MajorTopicYN="N">systematic review and meta analysis</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37388580</ArticleId><ArticleId IdType="pmc">PMC10305786</ArticleId><ArticleId IdType="doi">10.7759/cureus.39636</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adult respiratory distress syndrome profiles by computed tomography. Gattinoni L, Presenti A, Torresin A, et al. J Thorac Imaging. 1986;1:25&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">3298678</ArticleId></ArticleIdList></Reference><Reference><Citation>Computed tomography in adult respiratory distress syndrome: what has it taught us? Pelosi P, Crotti S, Brazzi L, Gattinoni L. Eur Respir J. 1996;9:1055&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pubmed">8793469</ArticleId></ArticleIdList></Reference><Reference><Citation>An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Fan E, Del Sorbo L, Goligher EC, et al. Am J Respir Crit Care Med. 2017;195:1253&#x2013;1263.</Citation><ArticleIdList><ArticleId IdType="pubmed">28459336</ArticleId></ArticleIdList></Reference><Reference><Citation>Prone positioning in severe acute respiratory distress syndrome. Gu&#xe9;rin C, Reignier J, Richard JC, et al. N Engl J Med. 2013;368:2159&#x2013;2168.</Citation><ArticleIdList><ArticleId IdType="pubmed">23688302</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleural pressure distribution and its relationship to lung volume and interstitial pressure. Lai-Fook SJ, Rodarte JR. J Appl Physiol (1985) 1991;70:967&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pubmed">2033012</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome. Cornejo RA, D&#xed;az JC, Tobar EA, et al. Am J Respir Crit Care Med. 2013;188:440&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pubmed">23348974</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary perfusion is more uniform in the prone than in the supine position: scintigraphy in healthy humans. Nyr&#xe9;n S, Mure M, Jacobsson H, Larsson SA, Lindahl SG. J Appl Physiol (1985) 1999;86:1135&#x2013;1141.</Citation><ArticleIdList><ArticleId IdType="pubmed">10194194</ArticleId></ArticleIdList></Reference><Reference><Citation>Prone position in acute respiratory distress syndrome. Pelosi P, Brazzi L, Gattinoni L. Eur Respir J. 2002;20:1017&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">12412699</ArticleId></ArticleIdList></Reference><Reference><Citation>Prone position augments recruitment and prevents alveolar overinflation in acute lung injury. Galiatsou E, Kostanti E, Svarna E, Kitsakos A, Koulouras V, Efremidis SC, Nakos G. Am J Respir Crit Care Med. 2006;174:187&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">16645177</ArticleId></ArticleIdList></Reference><Reference><Citation>Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Wichmann D, Sperhake JP, L&#xfc;tgehetmann M, et al. Ann Intern Med. 2020;173:268&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Menter T, Haslbauer JD, Nienhold R, et al. Histopathology. 2020;77:198&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7496150</ArticleId><ArticleId IdType="pubmed">32364264</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. Ackermann M, Verleden SE, Kuehnel M, et al. N Engl J Med. 2020;383:120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Postmortem examination of patients with COVID-19. Schaller T, Hirschb&#xfc;hl K, Burkhardt K, Braun G, Trepel M, M&#xe4;rkl B, Claus R. JAMA. 2020;323:2518&#x2013;2520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243161</ArticleId><ArticleId IdType="pubmed">32437497</ArticleId></ArticleIdList></Reference><Reference><Citation>Computed tomography scan in COVID-19: a systematic review and meta-analysis. Sharif PM, Nematizadeh M, Saghazadeh M, Saghazadeh A, Rezaei N. Pol J Radiol. 2022;87:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8814899</ArticleId><ArticleId IdType="pubmed">35140824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung mechanics in type L COVID-19 pneumonia: a pseudo-normal ARDS (Preprint) Viola L, Bufalini OM, Russo E, et al. Research Square. 2020;[Online ahead of press]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750393</ArticleId><ArticleId IdType="pubmed">33363256</ArticleId></ArticleIdList></Reference><Reference><Citation>954: Prone ventilation in intubated COVID-19 patients: systematic review and meta-analysis. Fayed M, Elnahla A, Maroun W, et al. Crit Care Med. 2023;51:470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10305786</ArticleId><ArticleId IdType="pubmed">37388580</ArticleId></ArticleIdList></Reference><Reference><Citation>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Shamseer L, Moher D, Clarke M, et al. BMJ. 2015;349:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Shamseer L, Moher D, Clarke M, et al. BMJ. 2015;350:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute.  [
May;
2023 
]. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</Citation></Reference><Reference><Citation>Prone positioning in intubated and mechanically ventilated patients with SARS-CoV-2. Chen Y, Zhang J, Feng H, Wan F, Zhang Y, Tan L. J Clin Anesth. 2021;71:110258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006210</ArticleId><ArticleId IdType="pubmed">33812212</ArticleId></ArticleIdList></Reference><Reference><Citation>Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients. Langer T, Brioni M, Guzzardella A, et al. Crit Care. 2021;25:128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8022297</ArticleId><ArticleId IdType="pubmed">33823862</ArticleId></ArticleIdList></Reference><Reference><Citation>Prone positioning and survival in mechanically ventilated patients with coronavirus disease 2019-related respiratory failure. Mathews KS, Soh H, Shaefi S, et al. Crit Care Med. 2021;49:1026&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8277560</ArticleId><ArticleId IdType="pubmed">33595960</ArticleId></ArticleIdList></Reference><Reference><Citation>Prone positioning in moderate to severe acute respiratory distress syndrome due to COVID-19: a cohort study and analysis of physiology. Shelhamer MC, Wesson PD, Solari IL, et al. J Intensive Care Med. 2021;36:241&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7780273</ArticleId><ArticleId IdType="pubmed">33380236</ArticleId></ArticleIdList></Reference><Reference><Citation>Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom. Patel BV, Haar S, Handslip R, et al. Intensive Care Med. 2021;47:549&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8111053</ArticleId><ArticleId IdType="pubmed">33974106</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and practice of early prone positioning in invasively ventilated COVID-19 patients-insights from the PRoVENT-COVID observational study. Stilma W, van Meenen DM, Valk CM, de Bruin H, Paulus F, Serpa Neto A, Schultz MJ. J Clin Med. 2021;10:4783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8541588</ArticleId><ArticleId IdType="pubmed">34682907</ArticleId></ArticleIdList></Reference><Reference><Citation>Early prone versus supine positioning in moderate to severe coronavirus disease 2019 patients with acute respiratory distress syndrome. Al Hashim AH, Al-Zakwani I, Al Jadidi A, et al. Oman Med J. 2023;38:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9990371</ArticleId><ArticleId IdType="pubmed">36895639</ArticleId></ArticleIdList></Reference><Reference><Citation>Should we reconsider published studies during the early phase of the COVID pandemic? (Preprint) Fayed M, Maroun W. Authorea. 2023</Citation></Reference><Reference><Citation>Prone versus supine ventilation and mortality outcome in intubated COVID-19 patients, a revision letter. Fayed M, Maroun W. J Intensive Care Med. 2023;38:321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9780559</ArticleId><ArticleId IdType="pubmed">36536990</ArticleId></ArticleIdList></Reference><Reference><Citation>Outcomes in temporary ICUs versus conventional ICUs: an observational cohort of mechanically ventilated patients with COVID-19-induced acute respiratory distress syndrome. Jimenez JV, Olivas-Martinez A, Rios-Olais FA, et al. Crit Care Explor. 2022;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963854</ArticleId><ArticleId IdType="pubmed">35372841</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and impact of early prone position on 30-day mortality in mechanically ventilated patients with COVID-19: a nationwide cohort study. Engerstr&#xf6;m L, Thermaenius J, M&#xe5;rtensson J, Oldner A, Petersson J, K&#xe5;hlin J, Larsson E. Crit Care. 2022;26:264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9441133</ArticleId><ArticleId IdType="pubmed">36058932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33877463</PMID><DateRevised><Year>2021</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2110-5820</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>Annals of intensive care</Title><ISOAbbreviation>Ann Intensive Care</ISOAbbreviation></Journal><ArticleTitle>ABO blood types and sepsis mortality.</ArticleTitle><Pagination><StartPage>61</StartPage><MedlinePgn>61</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">61</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13613-021-00844-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We aimed to determine if the ABO blood types carry different risks of 30-day mortality, acute kidney injury (AKI), and endothelial damage in critically ill patients with sepsis. This was a retrospective cohort study of three independent cohorts of critically ill patients from the United States and Scandinavia consisting of adults with septic shock. We compared the 30-day mortality across the blood types within each cohort and pooled the results in a meta-analysis. We also estimated the incidence of AKI and degree of endothelial damage, as measured by blood concentrations of soluble thrombomodulin and syndecan-1.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 12,342 patients with severe sepsis. In a pooled analysis blood type B carried a slightly lower risk of 30-day all-cause mortality compared to non-blood type B (adjusted HR 0.88; 95%-CI 0.79-0.98; p&#x2009;=&#x2009;0.02). There was no difference in the risk of AKI. Soluble thrombomodulin and syndecan-1 concentrations were lower in patients with blood type B and O compared to blood type A, suggesting less endothelial damage.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Septic patients with blood type B had less endothelial damage, and a small reduction in mortality. The exposure is, however, unmodifiable.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Itenov</LastName><ForeName>Theis S</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-1204-3636</Identifier><AffiliationInfo><Affiliation>CHIP / PERSIMUNE, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, The Capital Region of Denmark, Denmark. Theis.skovsgaard.itenov@regionh.dk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark. Theis.skovsgaard.itenov@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>Ashish K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outcomes Research Consortium, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrowski</LastName><ForeName>Sisse R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>CHIP / PERSIMUNE, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, The Capital Region of Denmark, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>P&#xe4;r I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erikstrup</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Ole B</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, N&#xe6;stved Sygehus, N&#xe6;stved, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryg&#xe5;rd</LastName><ForeName>Sofie L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holst</LastName><ForeName>Lars B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bestle</LastName><ForeName>Morten H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hein</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindhardt</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tousi</LastName><ForeName>Hami</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Herlev Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Mads H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Gentofte Hospital, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lundgren</LastName><ForeName>Jens D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>CHIP / PERSIMUNE, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, The Capital Region of Denmark, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Jens-Ulrik</ForeName><Initials>JU</Initials><AffiliationInfo><Affiliation>CHIP / PERSIMUNE, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, The Capital Region of Denmark, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Section, Department of Internal Medicine, Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outcomes Research Consortium, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Grant 126</GrantID><Agency>Danmarks Grundforskningsfond</Agency><Country/></Grant><Grant><GrantID>A6052</GrantID><Agency>Region Hovedstaden</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Ann Intensive Care</MedlineTA><NlmUniqueID>101562873</NlmUniqueID><ISSNLinking>2110-5820</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaesthesia</Keyword><Keyword MajorTopicYN="N">Blood type</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33877463</ArticleId><ArticleId IdType="pmc">PMC8056100</ArticleId><ArticleId IdType="doi">10.1186/s13613-021-00844-2</ArticleId><ArticleId IdType="pii">10.1186/s13613-021-00844-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dean L. ABO Blood Group. Medical Genetics Summaries. 2015;1&#x2013;3.</Citation></Reference><Reference><Citation>Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. APMIS. 2000;108:1&#x2013;28. doi: 10.1034/j.1600-0463.2000.d01-1.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0463.2000.d01-1.x</ArticleId><ArticleId IdType="pubmed">10698081</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson P, Stensballe J, Ostrowski S. Shock induced endotheliopathy (SHINE) in acute critical illness&#x2014;a unifying pathophysiologic mechanism. Crit Care. 2017;21:25. doi: 10.1186/s13054-017-1605-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1605-5</ArticleId><ArticleId IdType="pmc">PMC5299749</ArticleId><ArticleId IdType="pubmed">28179016</ArticleId></ArticleIdList></Reference><Reference><Citation>Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101:3765&#x2013;3777. doi: 10.1182/blood-2002-06-1887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-06-1887</ArticleId><ArticleId IdType="pubmed">12543869</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen ME, Johansson PI, Ostrowski SR, Bestle MH, Hein L, Jensen ALG, et al. Profound endothelial damage predicts impending organ failure and death in sepsis. Semin Thromb Hemost. 2015;41:16&#x2013;25. doi: 10.1055/s-0034-1398377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1398377</ArticleId><ArticleId IdType="pubmed">25590523</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;1423. doi: 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3934-7</ArticleId><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar J, Blanco J, Anon JM, Santos-Bouza A, Blanch L, Ambros A, et al. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011;37:1932&#x2013;1941. doi: 10.1007/s00134-011-2380-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2380-4</ArticleId><ArticleId IdType="pubmed">21997128</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly JP, Meyer NJ, Shashaty MGS, Feng R, Lanken PN, Gallop R, et al. ABO blood type a is associated with increased risk of ARDS in whites following both major trauma and severe sepsis. Chest. 2014;145:753&#x2013;761. doi: 10.1378/chest.13-1962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.13-1962</ArticleId><ArticleId IdType="pmc">PMC3971970</ArticleId><ArticleId IdType="pubmed">24385226</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly JP, Anderson BJ, Mangalmurti NS, Nguyen TD, Holena DN, Wu Q, et al. The ABO histo-blood group and AKI in critically ill patients with trauma or sepsis. Clin J Am Soc Nephrol. 2015;10:1911&#x2013;1920. doi: 10.2215/CJN.12201214.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.12201214</ArticleId><ArticleId IdType="pmc">PMC4633800</ArticleId><ArticleId IdType="pubmed">26342043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezoagli E, Gatti S, Villa S, Villa G, Muttini S, Rossi F, et al. ABO blood types and major outcomes in patients with acute hypoxaemic respiratory failure: a multicenter retrospective cohort study. PLoS ONE. 2018;13:e0206403. doi: 10.1371/journal.pone.0206403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206403</ArticleId><ArticleId IdType="pmc">PMC6201964</ArticleId><ArticleId IdType="pubmed">30359446</ArticleId></ArticleIdList></Reference><Reference><Citation>Slade R, Alikhan R, Wise MP, Germain L, Stanworth S, Morgan M. Impact of blood group on survival following critical illness: a single-centre retrospective observational study. BMJ Open Respir Res. 2019;6:e000426. doi: 10.1136/bmjresp-2019-000426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2019-000426</ArticleId><ArticleId IdType="pmc">PMC6606056</ArticleId><ArticleId IdType="pubmed">31321058</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530&#x2013;538. doi: 10.1007/s00134-003-1662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1662-x</ArticleId><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med. 2011;39:2048&#x2013;2058. doi: 10.1097/CCM.0b013e31821e8791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31821e8791</ArticleId><ArticleId IdType="pubmed">21572328</ArticleId></ArticleIdList></Reference><Reference><Citation>Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371:1381&#x2013;1391. doi: 10.1056/NEJMoa1406617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1406617</ArticleId><ArticleId IdType="pubmed">25270275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney international supplements. 2012;2:1&#x2013;138.</Citation></Reference><Reference><Citation>Itenov TS, Berthelsen RE, Jensen J-U, Gerds TA, Pedersen LM, Strange D, et al. Predicting recovery from acute kidney injury in critically ill patients: development and validation of a prediction model. Crit Care Resusc. 2018;20:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">29458322</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">10075613</ArticleId></ArticleIdList></Reference><Reference><Citation>Jr FEH, Lee KL, Mark DB. Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. 1996;15:361&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">8668867</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong VMT, Moons KGM, Riley RD, Tudur Smith C, Marson AG, Eijkemans MJC, et al. Individual participant data meta-analysis of intervention studies with time-to-event outcomes: a review of the methodology and an applied example. Res Synth Methods. 2020;11:148&#x2013;168. doi: 10.1002/jrsm.1384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1384</ArticleId><ArticleId IdType="pmc">PMC7079159</ArticleId><ArticleId IdType="pubmed">31759339</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2017. https://www.r-project.org/</Citation></Reference><Reference><Citation>Garratty G, Glynn SA, McEntire R. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States. Transfusion. 2004;44:703&#x2013;706. doi: 10.1111/j.1537-2995.2004.03338.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1537-2995.2004.03338.x</ArticleId><ArticleId IdType="pubmed">15104651</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, H&#xe4;ussinger L, Steinacker JM, Dinse-Lambracht A. Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution. Epidemiol Infect. 2021:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844181</ArticleId><ArticleId IdType="pubmed">33407977</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol. 2020;190:24&#x2013;27. doi: 10.1111/bjh.16797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16797</ArticleId><ArticleId IdType="pmc">PMC7267665</ArticleId><ArticleId IdType="pubmed">32379894</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly JP, Meyer NJ, Shashaty MG, Anderson BJ, Ittner C, Dunn TG, et al. The ABO Histo-Blood Group, endothelial activation, and acute respiratory distress syndrome risk in critical illness. J Clin Invest. 2020 doi: 10.1172/JCI139700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139700</ArticleId><ArticleId IdType="pmc">PMC7773362</ArticleId><ArticleId IdType="pubmed">32931480</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35727062</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-2197</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>ANZ journal of surgery</Title><ISOAbbreviation>ANZ J Surg</ISOAbbreviation></Journal><ArticleTitle>The complication profile of low Hartmann's in rectal cancer: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2829</StartPage><EndPage>2839</EndPage><MedlinePgn>2829-2839</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.17827</ELocationID><Abstract><AbstractText Label="BACKGROUND">Non-restorative options for low rectal cancer not invading the sphincter includes low Hartmann's procedure (LH) and inter-sphincteric abdominoperineal resection (ISAPR). There is currently little comparative data to differentiate these options.</AbstractText><AbstractText Label="OBJECTIVES">The aim of this review was to assess the peri-operative morbidity of LH, and then to compare it to that of ISAPR.</AbstractText><AbstractText Label="DATA SOURCES">An up-to-date systematic review was performed on the available literature between 2000-2020 on PubMed, EMBASE, Medline, and Cochrane Library databases.</AbstractText><AbstractText Label="STUDY SELECTION">All studies reporting on non-restorative surgeries for rectal cancer were analysed. Outcomes were firstly analysed between LH and non-LH groups, with further sub-analysis comparing the LH and ISAPR groups.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURE">The main outcome measures were the rates of pelvic sepsis, rates of overall post-operative complication rates, oncological outcomes, and survival.</AbstractText><AbstractText Label="RESULTS">A total of 12 observational studies were included. There were 3526 patients (61.1%) in the LH group, and 2238 patients (38.9%) in the non-LH group, which included 461 patients who underwent ISAPR. The LH group had a higher rate of pelvic sepsis as compared to the non-LH group (OR: 1.79, 95% CI: 1.39-2.29, P&#x2009;&lt;&#x2009;0.001). The difference is more marked in the sub-analysis comparing LH and ISAPR alone (OR: 3.94, 95% CI: 1.88-7.84, P&#x2009;&lt;&#x2009;0.01) corresponding to a higher rate of unplanned re-intervention. LH was associated with a higher rate of short-term post-operative mortality as compared to the non-LH group.</AbstractText><AbstractText Label="CONCLUSION">ISAPR is the preferred option for non-restorative rectal surgery, with a more favourable peri-operative morbidity and short-term mortality profile as compared to LH.</AbstractText><CopyrightInformation>&#xa9; 2022 Royal Australasian College of Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choy</LastName><ForeName>Kay Tai</ForeName><Initials>KT</Initials><Identifier Source="ORCID">0000-0001-5763-5742</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dewei Jordan</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-9207-727X</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prabhakaran</LastName><ForeName>Swetha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3010-5247</Identifier><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warrier</LastName><ForeName>Satish</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heriot</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9846-8776</Identifier><AffiliationInfo><Affiliation>Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Joseph C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-1392-2480</Identifier><AffiliationInfo><Affiliation>Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>ANZ J Surg</MedlineTA><NlmUniqueID>101086634</NlmUniqueID><ISSNLinking>1445-1433</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012007" MajorTopicYN="N">Rectum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078542" MajorTopicYN="Y">Proctectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003125" MajorTopicYN="N">Colostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">inter-sphincteric abdominopelvic resection</Keyword><Keyword MajorTopicYN="N">low Hartmann's</Keyword><Keyword MajorTopicYN="N">non-restorative rectal surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>21</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35727062</ArticleId><ArticleId IdType="doi">10.1111/ans.17827</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Adams W, Mann L, Bokey E, Chapuis P, Koorey S, Hughes W. Hartmann's procedure for carcinoma of the rectum and sigmoid colon. Aust. N. Z. J. Surg. 1992; 62: 200-3.</Citation></Reference><Reference><Citation>Sverrisson I, Nikberg M, Chabok A, Smedh K. Hartmann's procedure in rectal cancer: a population-based study of postoperative complications. Int. J. Colorectal Dis. 2015; 30: 181-6.</Citation></Reference><Reference><Citation>Rodr&#xed;guez JLM, Flor-Lorente B, Frasson M et al. Low rectal cancer: abdominoperineal resection or low Hartmann resection? A postoperative outcome analysis. Dis. Colon Rectum 2011; 54: 958-62.</Citation></Reference><Reference><Citation>T&#xf8;ttrup A, Frost L. Pelvic sepsis after extended Hartmann's procedure. Dis. Colon Rectum 2005; 48: 251-5.</Citation></Reference><Reference><Citation>Smedh K, Sverrisson I, Chabok A, Nikberg M. Hartmann's procedure vs abdominoperineal resection with intersphincteric dissection in patients with rectal cancer: a randomized multicentre trial (HAPIrect). BMC Surg. 2016; 16: 1-6.</Citation></Reference><Reference><Citation>Westerduin E, Musters GD, van Geloven AA et al. Low Hartmann's procedure or intersphincteric proctectomy for distal rectal cancer: a retrospective comparative cohort study. Int. J. Colorectal Dis. 2017; 32: 1583-9.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6: e1000097.</Citation></Reference><Reference><Citation>Fowler H, Clifford R, Sutton P et al. Hartmann's procedure versus intersphincteric abdominoperineal excision (HiP study): a multicentre prospective cohort study. Colorectal Dis. 2020; 22: 2114-22.</Citation></Reference><Reference><Citation>Heah S, Eu K, Ho Y, Leong A, Seow-Choen F. Hartmann's procedure vs. abdominoperineal resection for palliation of advanced low rectal cancer. Dis. Colon Rectum 1997; 40: 1313-7.</Citation></Reference><Reference><Citation>Roodbeen SX, Blok RD, Borstlap WA et al. Does oncological outcome differ between restorative and non-restorative low anterior resection in patients with primary rectal cancer? Colorectal Dis. 2020; 23: 843-52.</Citation></Reference><Reference><Citation>Jonker F, Tanis P, Coene P et al. Comparison of a low Hartmann's procedure with low colorectal anastomosis with and without defunctioning ileostomy after radiotherapy for rectal cancer: results from a national registry. Colorectal Dis. 2016; 18: 785-92.</Citation></Reference><Reference><Citation>Popiolek M, Dehlaghi K, Gadan S, Baban B, Matthiessen P. Total mesorectal excision for mid-rectal cancer without anastomosis: low Hartmann's operation or intersphincteric abdomino-perineal excision? Scand. J. Surg. 2019; 108: 233-40.</Citation></Reference><Reference><Citation>Frye JN, Carne PW, Robertson GM, Frizelle FA. Abdominoperineal resection or low Hartmann's procedure. ANZ J. Surg. 2004; 74: 537-40.</Citation></Reference><Reference><Citation>Timofeiov S, Breab&#x103;n M, Drug V, Gervescu A, Hu&#x163;anu I. Extended low Hartmann operation with Total Mesorectal excision-optimal surgical treatment in stage IV mid and upper rectal cancer. J. Surg. 2014; 10: 223-7.</Citation></Reference><Reference><Citation>Wetterhall C, Mariusdottir E, Hall C, J&#xf6;rgren F, Buchwald P. Low incidence of pelvic sepsis after Hartmann's procedure: radiation therapy may be a risk factor. Gastrointest. Tumors 2018; 5: 77-81.</Citation></Reference><Reference><Citation>Sverrisson I, Nikberg M, Chabok A, Smedh K. Low risk of intra-abdominal infections in rectal cancer patients treated with Hartmann's procedure: a report from a national registry. Int. J. Colorectal Dis. 2018; 33: 327-32.</Citation></Reference><Reference><Citation>Schein M, Kopelman D, Nitecki S, Hashmonai M. Management of the leaking rectal stump after Hartmann's procedure. Am. J. Surg. 1993; 165: 285-7.</Citation></Reference><Reference><Citation>Bauer JJ, Gelernt IM, Salk BA, Kreel I. Proctectomy for inflammatory bowel disease. Am. J. Surg. 1986; 151: 157-62.</Citation></Reference><Reference><Citation>Musters GD, Buskens CJ, Bemelman WA, Tanis PJ. Perineal wound healing after abdominoperineal resection for rectal cancer: a systematic review and meta-analysis. Dis. Colon Rectum 2014; 57: 1129-39.</Citation></Reference><Reference><Citation>Blok RD, Musters GD, Borstlap WA, Buskens CJ, Bemelman WA, Tanis PJ. Snapshot study on the value of omentoplasty in abdominoperineal resection with primary perineal closure for rectal cancer. Ann. Surg. Oncol. 2018; 25: 729-36.</Citation></Reference><Reference><Citation>Blok RD, Hagemans JA, Klaver CE et al. A systematic review and meta-analysis on omentoplasty for the management of abdominoperineal defects in patients treated for cancer. Ann. Surg. 2020; 271: 654-62.</Citation></Reference><Reference><Citation>Westerduin E, Westerterp M, Bemelman WA, Tanis PJ, van Geloven AA. Low Hartmann's procedure or intersphincteric abdominoperineal resection in the primary treatment of low rectal cancer; a survey among surgeons evaluating current practice. Acta Chir. Belg. 2019; 119: 132-6.</Citation></Reference><Reference><Citation>Johnston S, De Lacavalerie P. Management of rectal stump leak following emergency Hartmann's procedure. J. Coloproctol. (Rio de Janeiro) 2020; 40: 386-9.</Citation></Reference><Reference><Citation>Westerduin E, Aukema T, van Geloven A, Bemelman W, Tanis P, Group DSR. What to do with the rectal stump during sphincter preserving rectal cancer resection with end colostomy: a collaborative snapshot study. Colorectal Dis. 2018; 20: 696-703.</Citation></Reference><Reference><Citation>Vignali A, Gianotti L, Braga M, Radaelli G, Malvezzi L, Di Carlo V. Altered microperfusion at the rectal stump is predictive for rectal anastomotic leak. Dis. Colon Rectum 2000; 43: 76-82.</Citation></Reference><Reference><Citation>Gu J, Stocchi L, Remzi F, Kiran RP. Intraperitoneal or subcutaneous: does location of the (Colo) rectal stump influence outcomes after laparoscopic total abdominal colectomy for ulcerative colitis? Dis. Colon Rectum 2013; 56: 615-21.</Citation></Reference><Reference><Citation>Trickett J, Tilney H, Gudgeon A, Mellor S, Edwards D. Management of the rectal stump after emergency sub-total colectomy: which surgical option is associated with the lowest morbidity? Colorectal Dis. 2005; 7: 519-22.</Citation></Reference><Reference><Citation>Jonker FH, Tanis PJ, Coene PP et al. Comparison of a low Hartmann's procedure with low colorectal anastomosis with and without defunctioning ileostomy after radiotherapy for rectal cancer: results from a national registry. Colorectal Disease. 2016; 18(8): 785-92.</Citation></Reference><Reference><Citation>Timofeiov S, Breab&#x103;n ME, Drug V, Gervescu A, Hu&#x163;anu I. Extended low hartmann operation with total mesorectal excision-optimal surgical treatment in stage IV mid and upper rectal cancer. Journal of Surgery [Jurnalul de chirurgie]. 2014; 10(3): 223-7.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40645596</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>09</Day></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Does cognition status affect spinal surgery outcomes: a systematic review and meta-analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(25)00326-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2025.07.020</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">Mild cognitive impairment (MCI) and Dementia have been shown to be independent risk factors for complications after spine surgery. To date, no systematic review has been conducted on the effect of cognitive impairment (CI) on spine surgery outcomes.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study aims to perform a systematic review and meta-analysis of previous studies on perioperative outcomes and facility-based measures in cognitively impaired patients undergoing spine surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis.</AbstractText><AbstractText Label="PATIENT SAMPLE" NlmCategory="METHODS">Eleven articles encompassing approximately 16,070 patients with cognitive impairment were included in this study.</AbstractText><AbstractText Label="OUTCOMES MEASURED" NlmCategory="METHODS">Data on postoperative outcomes including delirium, urinary tract infection (UTI), myocardial infarction, pulmonary embolism (PE), deep vein thrombosis (DVT), pneumonia, surgical site infection (SSI), wound dehiscence, sepsis, acute kidney injury, reoperation, readmission, intensive care unit (ICU) admission, length of stay, and cost were collected and assessed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search of PubMed, Embase, Cochrane Library, and Web of Science was conducted on July 8th, 2024. This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies directly comparing spine surgery outcomes in cognitively impaired populations versus normal cognition were included for meta-analysis. A Random-effect model was used to estimate the pooled odds ratios of relevant outcomes. Lumbar and cervical subgroup analyses were also conducted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1,074 articles were screened as titles and abstracts. 54 studies were included for full-text review, yielding 11 articles to be included in this study. These 11 studies (6 retrospective cohort studies, 5 prospective observational studies) directly analyzed the effect of CI on spine surgery outcomes. Random-effect model demonstrated patients with CI were found to have significantly higher odds of developing UTI (OR 4.32[2.24-8.33]), delirium (OR 2.33[1.68-3.22]), DVT (OR 2.49[1.23-5.03]) pneumonia (OR 3.24[1.94-5.43]), wound dehiscence (OR 1.50[1.08-2.08]), and sepsis (OR 2.18[1.04-4.56]). The presence of cognitive impairment was associated with a 2-fold higher odds of ICU admission after surgery (OR 2.05[1.22-3.44]), and 20% increase likelihood of 30-day readmission (OR 1.20[1.03-1.40]) after spine surgery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study suggests that preoperative CI is associated with worse postoperative health outcomes and inferior facility-based measures in patients undergoing spine surgery. These findings highlight the importance of early recognition and management of cognitive impairment prior to spine surgery, as doing so may mitigate postoperative risks and improve both clinical and facility-based outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karnati</LastName><ForeName>Janesh</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Mir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaghazchi</LastName><ForeName>Aydin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shankar</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranganathan</LastName><ForeName>Sruthi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Mikayla</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adogwa</LastName><ForeName>Owoicho</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Cincinnati College of Medicine, Cincinnati OH, USA; Spine Translational and Aging Laboratory, University of Cincinnati College of Medicine, Cincinnati OH, USA. Electronic address: owoicho.adogwa@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cervical</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Lumbar</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Mild cognitive impairment</Keyword><Keyword MajorTopicYN="N">Spine surgery</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>12</Day><Hour>16</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>12</Day><Hour>16</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>11</Day><Hour>19</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40645596</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2025.07.020</ArticleId><ArticleId IdType="pii">S1529-9430(25)00326-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29577558</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1463-1318</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland</Title><ISOAbbreviation>Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis comparing adverse events and functional outcomes of different pouch designs after restorative proctocolectomy.</ArticleTitle><Pagination><StartPage>664</StartPage><EndPage>675</EndPage><MedlinePgn>664-675</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/codi.14104</ELocationID><Abstract><AbstractText Label="AIM">There is no consensus as to which ileoanal pouch design provides better outcomes after restorative proctocolectomy. This study compares different pouch designs.</AbstractText><AbstractText Label="METHOD">A systematic review of the literature was performed. A random effects meta-analytical model was used to compare adverse events and functional outcome.</AbstractText><AbstractText Label="RESULTS">Thirty comparative studies comparing J, W, S and K pouch designs were included. No significant differences were identified between the different pouch designs with regard to anastomotic dehiscence, anastomotic stricture, pelvic sepsis, wound infection, pouch fistula, pouch ischaemia, perioperative haemorrhage, small bowel obstruction, pouchitis and sexual dysfunction. The W and K designs resulted in fewer cases of pouch failure compared with the J and S designs. J pouch construction resulted in a smaller maximum pouch volume compared with W and K pouches. Stool frequency per 24&#xa0;h and during daytime was higher following a J pouch than W, S or K constructions. The J design resulted in increased faecal urgency and seepage during daytime compared with the K design. The use of protective pads during daytime and night-time was greater with a J pouch compared to S or K. The use of antidiarrhoeal medication was greater after a J reservoir than a W reservoir. Difficulty in pouch evacuation requiring intubation was higher with an S pouch than with W or J pouches.</AbstractText><AbstractText Label="CONCLUSION">Despite its ease of construction and comparable complication rates, the J pouch is associated with higher pouch failure rates and worse function. Patient characteristics, technical factors and surgical expertise should be considered when choosing pouch design.</AbstractText><CopyrightInformation>Colorectal Disease &#xa9; 2018 The Association of Coloproctology of Great Britain and Ireland.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simillis</LastName><ForeName>C</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8864-4350</Identifier><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afxentiou</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellino</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontovounisios</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasheed</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faiz</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>St Mark's Academic Institute, Surgical Epidemiological Trials and Outcomes Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tekkis</LastName><ForeName>P P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Colorectal Dis</MedlineTA><NlmUniqueID>100883611</NlmUniqueID><ISSNLinking>1462-8910</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000930">Antidiarrheals</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000930" MajorTopicYN="N">Antidiarrheals</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039021" MajorTopicYN="N">Colonic Pouches</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003672" MajorTopicYN="N">Defecation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005242" MajorTopicYN="N">Fecal Incontinence</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016496" MajorTopicYN="N">Incontinence Pads</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016737" MajorTopicYN="N">Proctocolectomy, Restorative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Restorative proctocolectomy</Keyword><Keyword MajorTopicYN="N">ileal pouch-anal anastomosis</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">pouch design</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29577558</ArticleId><ArticleId IdType="doi">10.1111/codi.14104</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30597500</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2567-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Thrombosis and haemostasis</Title><ISOAbbreviation>Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Recombinant Human Soluble Thrombomodulin in Sepsis-Induced Coagulopathy: An Updated Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>56</StartPage><EndPage>65</EndPage><MedlinePgn>56-65</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0038-1676345</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">&#x2003;Clinical effectiveness of recombinant human soluble thrombomodulin (rhTM) in sepsis or sepsis-induced coagulopathy remains a matter of dispute. Recently, the <u>S</u>epsis <u>C</u>oagulopathy <u>A</u>sahi <u>R</u>ecombinant <u>LE</u> <u>T</u>hrombomodulin (SCARLET) trial, the latest multinational multi-centre phase III randomized controlled trial, was completed.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">&#x2003;This article assesses the benefits and harms of rhTM therapy in sepsis-induced coagulopathy by updating our previous systematic review.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">&#x2003;We performed a systematic review and meta-analysis of rhTM therapy for sepsis-induced coagulopathy in randomized controlled trials. All-cause 28-day mortality as efficacy and serious bleeding complications as the adverse effect were measured as primary outcomes. We assessed the certainty of a body of evidence at the outcome level using the Grading of Recommendations Assessment, Development and Evaluation approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">&#x2003;We analysed five trials enrolling 1,762 patients. Approximately 13% reduction in the risk of mortality was observed in the rhTM group, but the difference was not significant (relative risk, 0.87; 95% confidence interval, 0.74-1.03; <i>p</i>&#x2009;=&#x2009;0.10; <i>I</i> <sup>2</sup>&#x2009;=&#x2009;0%). Risk of serious bleeding complications did not increase with rhTM administration. We judged the certainty of evidence as moderate for mortality and low for serious bleeding. Trial sequential analysis indicated that only 42.0% of the required information size is actually available at this stage to reject or accept low risk-of-bias trials examining the anticipated effect for all-cause mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">&#x2003;Even in this updated review including the latest SCARLET trial, we currently cannot make any declarative judgments about the beneficial effects of rhTM in sepsis-induced coagulopathy, although some favourable effects were suggested.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart &#xb7; New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Kazuma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murao</LastName><ForeName>Shuhei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aihara</LastName><ForeName>Morio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Hirosaki University, Hirosaki, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thromb Haemost</MedlineTA><NlmUniqueID>7608063</NlmUniqueID><ISSNLinking>0340-6245</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C546931">THBD protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018180">Thrombomodulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001778" MajorTopicYN="N">Blood Coagulation Disorders</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017326" MajorTopicYN="N">Clinical Trials, Phase III as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004211" MajorTopicYN="N">Disseminated Intravascular Coagulation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018180" MajorTopicYN="N">Thrombomodulin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30597500</ArticleId><ArticleId IdType="doi">10.1055/s-0038-1676345</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37975538</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Albumin use in patients with septic shock-Post-hoc analyses of an international randomised fluid trial.</ArticleTitle><Pagination><StartPage>372</StartPage><EndPage>384</EndPage><MedlinePgn>372-384</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.14359</ELocationID><Abstract><AbstractText Label="BACKGROUND">Albumin administration is suggested in patients with sepsis and septic shock who have received large volumes of crystalloids. Given lack of firm evidence, clinical practice variation may exist. To address this, we investigated if patient characteristics or trial site were associated with albumin use in septic shock.</AbstractText><AbstractText Label="METHODS">We conducted a post-hoc study of the CLASSIC international, randomised clinical trial of fluid volumes in septic shock. Associations between selected baseline variables and trial site with albumin use during ICU stay were assessed in Cox models considering death, ICU discharge, and loss-to-follow-up as competing events. Baseline variables were first assessed individually, adjusted for treatment allocation (restrictive vs. standard IV fluid), and then adjusted for allocation and the other baseline variables. Site was assessed in a model adjusted for allocation and baseline variables.</AbstractText><AbstractText Label="RESULTS">We analysed 1541 of 1554 patients randomised in CLASSIC (99.2%). During ICU stay, 36.3% of patients in the restrictive-fluid group and 52.6% in the standard-fluid group received albumin. Gastrointestinal focus of infection and higher doses of norepinephrine were most strongly associated with albumin use (subgroup with highest quartile of norepinephrine doses, hazard ratio (HR) 2.58, 95% CI 1.89 to 3.53). HRs for associations between site and albumin use ranged from 0.11 (95% CI 0.05 to 0.26) to 1.70 (95% CI 1.06 to 2.74); test for overall effect of site: p&#x2009;&lt;&#x2009;.001.</AbstractText><AbstractText Label="CONCLUSIONS">In adults with septic shock, gastrointestinal focus of infection and higher doses of norepinephrine at baseline were associated with albumin use, which also varied substantially between sites.</AbstractText><CopyrightInformation>&#xa9; 2023 Acta Anaesthesiologica Scandinavica Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Tine Sylvest</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-1840-1596</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granholm</LastName><ForeName>Anders</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5799-7655</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjortrup</LastName><ForeName>Peter Buhl</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic Anaesthesia and Intensive Care, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivapalan</LastName><ForeName>Praleene</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0442-0032</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Theis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laake</LastName><ForeName>Jon Henrik</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Rikshospitalet, Oslo University Hospital, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Emergencies and Critical Care, Rikshospitalet, Oslo University Hospital, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakob</LastName><ForeName>Stephan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Rozzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalos</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit 1, Interni klinika, Fakultni Nemocnice, Plzen, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostermann</LastName><ForeName>Marlies</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Guy's and St Thomas' Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malbrain</LastName><ForeName>Manu L N G</ForeName><Initials>MLNG</Initials><Identifier Source="ORCID">0000-0002-1816-5255</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospital Brussels (UZB), Jette, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>First Department of Anaesthesiology and Intensive Therapy, Medical University of Lublin, Lublin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Morten Hylander</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000418">Albumins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000418" MajorTopicYN="N">Albumins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>15</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>7</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37975538</ArticleId><ArticleId IdType="doi">10.1111/aas.14359</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181-1247.</Citation></Reference><Reference><Citation>Vesteinsdottir E, Sigurdsson MI, Gottfredsson M, Blondal A, Karason S. Temporal trends in the epidemiology, management, and outcome of sepsis-a nationwide observational study. Acta Anaesthesiol Scand. 2022;66:497-506.</Citation></Reference><Reference><Citation>Lind&#xe9;n-S&#xf8;nders&#xf8; A, Jungner M, Sp&#xe5;ngfors M, et al. Survey of non-resuscitation fluids administered during septic shock: a multicenter prospective observational study. Ann Intensive Care. 2019;9:132.</Citation></Reference><Reference><Citation>Xu J, Cai H, Zheng X. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases. BMC Infect Dis. 2023;23:199.</Citation></Reference><Reference><Citation>Finfer S, Myburgh J, Bellomo R. Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol. 2018;14:541-557.</Citation></Reference><Reference><Citation>Ellekjaer KL, Perner A, Jensen MM, M&#xf8;ller MH. Lactate versus acetate buffered intravenous crystalloid solutions: a scoping review. Br J Anaesth. 2020;125:693-703.</Citation></Reference><Reference><Citation>Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1-10.</Citation></Reference><Reference><Citation>M&#xe5;rtensson J, Bihari S, Bannard-Smith J, et al. Small volume resuscitation with 20% albumin in intensive care: physiological effects: the SWIPE randomised clinical trial. Intensive Care Medicine. 2018;44:1797-1806.</Citation></Reference><Reference><Citation>Finfer S, McEvoy S, Bellomo R, et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011;37:86-96.</Citation></Reference><Reference><Citation>Taylor C, Yang L, Finfer S, et al. An international comparison of the cost of fluid resuscitation therapies. Aust Crit Care. 2021;34:23-32.</Citation></Reference><Reference><Citation>Hoppe JD, Scriba PC, Kl&#xfc;ter H. 5 Human Albumin. Transfus Med Hemotherapy. 2009;36:399-407.</Citation></Reference><Reference><Citation>Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247-2256.</Citation></Reference><Reference><Citation>Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412-1421.</Citation></Reference><Reference><Citation>Bellomo R, McEvoy S, Kai Lo S, et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ. 2006;333:1044-1046.</Citation></Reference><Reference><Citation>Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:4561.</Citation></Reference><Reference><Citation>Lewis SR, Pritchard MW, Evans DJW, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev. 2018;8:CD000567.</Citation></Reference><Reference><Citation>Hammond NE, Taylor C, Finfer S, et al. Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: An international cross-sectional study. PLoS One. 2017;12:e0176292.</Citation></Reference><Reference><Citation>Zampieri FG, Bagshaw SM, Semler MW. Fluid therapy for critically ill adults with sepsis: a review. JAMA. 2023;329:1967-1980.</Citation></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386:2459-2470.</Citation></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, M&#xf8;ller MH, et al. Conservative versus Liberal fluid therapy in septic shock (CLASSIC) trial - protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2019;63:1262-1271.</Citation></Reference><Reference><Citation>Meyhoff TS, Granholm A, Hjortrup PB, et al. Albumin administration in septic shock-protocol for post-hoc analyses of data from a multicentre RCT. Acta Anaesthesiol Scand. 2023;67:1128-1136.</Citation></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344-349.</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801-810.</Citation></Reference><Reference><Citation>Kjaer M-BN, Meyhoff TS, Sivapalan P, et al. Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Intensive Care Med. 2023;49:820-830.</Citation></Reference><Reference><Citation>Granholm A, Perner A, Krag M, et al. Development and internal validation of the simplified mortality score for the intensive care unit (SMS-ICU). Acta Anaesthesiol Scand. 2018;62:336-346.</Citation></Reference><Reference><Citation>Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part IV: further concepts and methods in survival analysis. Br J Cancer. 2003;89:781-786.</Citation></Reference><Reference><Citation>Beyersmann J, Allignol A, Schumacher M. Competing Risks and Multistate Models with R. Springer; 2012.</Citation></Reference><Reference><Citation>Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis part III: multivariate data analysis-choosing a model and assessing its adequacy and fit. Br J Cancer. 2003;89:605-611.</Citation></Reference><Reference><Citation>Angeli P, Bernardi M, Villanueva C, et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460.</Citation></Reference><Reference><Citation>Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases practice guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology (Baltimore, Md). 2013;57:1651-1653.</Citation></Reference><Reference><Citation>Hjortrup PB, Haase N, Wetterslev J, Perner A. Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One. 2016;11:e0155767.</Citation></Reference><Reference><Citation>Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124-134.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33736605</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2369</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC nephrology</Title><ISOAbbreviation>BMC Nephrol</ISOAbbreviation></Journal><ArticleTitle>Morbidity after elective surgery in patients on chronic dialysis: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>97</StartPage><MedlinePgn>97</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">97</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-021-02279-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients on chronic dialysis are at increased risk of postoperative mortality following elective surgery compared to patients with normal kidney function, but morbidity outcomes are less often reported. This study ascertains the excess odds of postoperative cardiovascular and infection related morbidity outcomes for patients on chronic dialysis.</AbstractText><AbstractText Label="METHODS">Systematic searches were performed using MEDLINE, Embase and the Cochrane Library to identify relevant studies published from inception to January 2020. Eligible studies reported postoperative morbidity outcomes in chronic dialysis and non-dialysis patients undergoing major non-transplant surgery. Risk of bias was assessed using the Newcastle-Ottawa Scale and the certainty of evidence was summarised using GRADE. Random effects meta-analyses were performed to derive summary odds estimates. Meta-regression and sensitivity analyses were performed to explore heterogeneity.</AbstractText><AbstractText Label="RESULTS">Forty-nine studies involving 10,513,934 patients with normal kidney function and 43,092 patients receiving chronic dialysis were included. Patients on chronic dialysis had increased unadjusted odds of postoperative cardiovascular and infectious complications within each surgical discipline. However, the excess odds of cardiovascular complications was attenuated when odds ratios were adjusted for age and comorbidities; myocardial infarction (general surgery, OR 1.83 95% 1.29-2.36) and stroke (general surgery, OR 0.95, 95%CI 0.84-1.06). The excess odds of infectious complications remained substantially higher for patients on chronic dialysis, particularly sepsis (general surgery, OR 2.42, 95%CI 2.12-2.72).</AbstractText><AbstractText Label="CONCLUSION">Patients on chronic dialysis are at increased odds of both cardiovascular and infectious complications following elective surgery, with the excess odds of cardiovascular complications attributable to being on dialysis being highest among younger patients without comorbidities. However, further research is needed to better inform perioperative risk assessment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palamuthusingam</LastName><ForeName>Dharmenaan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Metro South Integrated Nephrology and Transplant Services, Logan Hospital, Armstrong Road &amp; Loganlea Road, Meadowbrook, Queensland, 4131, Australia. Dharmenaan.palamuthusingam@health.qld.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Queensland, Armstrong Road &amp; Loganlea Road, St Lucia, Queensland, 4072, Australia. Dharmenaan.palamuthusingam@health.qld.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Griffith University, 68 University Dr, Meadowbrook, QLD, 4131, Australia. Dharmenaan.palamuthusingam@health.qld.gov.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadarajah</LastName><ForeName>Arun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Sunshine Coast University Hospital, Doherty St, Birtinya, Queensland, 4575, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>David Wayne</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Queensland, Armstrong Road &amp; Loganlea Road, St Lucia, Queensland, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metro South and Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Queensland, 4074, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Institute, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pascoe</LastName><ForeName>Elaine Marie</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Centre for Health Services Research, University of Queensland, St Lucia, Queensland, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawley</LastName><ForeName>Carmel Marie</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Queensland, Armstrong Road &amp; Loganlea Road, St Lucia, Queensland, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metro South and Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Queensland, 4074, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Health Services Research, University of Queensland, St Lucia, Queensland, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fahim</LastName><ForeName>Magid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Metro South and Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Queensland, 4074, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Health Services Research, University of Queensland, St Lucia, Queensland, 4072, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Nephrol</MedlineTA><NlmUniqueID>100967793</NlmUniqueID><ISSNLinking>1471-2369</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007239" MajorTopicYN="N">Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic dialysis</Keyword><Keyword MajorTopicYN="N">End-stage kidney failure</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Perioperative morbidity</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList><CoiStatement>DP&#xa0;has received speaking honoraria from the Australian Medical Forum. DJ is a current recipient of an Australian National Health and Medical Research Council Practitioner Fellowship. DJ has previously received consultancy fees, research grants, speaker&#x2019;s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care. CH has received funding from Janssen and GlaxoSmithKline to her institution for trial steering committee roles and research grant support to her institution from Shire, Baxter, Fresenius, and Otsuka and travel sponsorship from Otsuka.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>19</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33736605</ArticleId><ArticleId IdType="pmc">PMC7977605</ArticleId><ArticleId IdType="doi">10.1186/s12882-021-02279-0</ArticleId><ArticleId IdType="pii">10.1186/s12882-021-02279-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after surgery in Europe: a 7 day cohort study. 2012;380(9847):1059&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493988</ArticleId><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajdos C, Hawn MT, Kile D, Robinson TN, Henderson WG. Risk of major nonemergent inpatient general surgical procedures in patients on long-term dialysis. JAMA Surgery. 2013;148(2):137&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">23560284</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JY, Birkmeyer NJO, Sanders JH, Morton JR, Henriques HF, Lahey SJ, et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circulation. 2000;102(24):2973&#x2013;2977.</Citation><ArticleIdList><ArticleId IdType="pubmed">11113048</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamuthusingam D, Nadarajah A, Pascoe EM, Craig J, Johnson DW, Hawley CM, et al. Postoperative mortality in patients on chronic dialysis following elective surgery: a systematic review and meta-analysis. PLoS One. 2020;15(6):e0234402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319352</ArticleId><ArticleId IdType="pubmed">32589638</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlisle J. Pre-operative co-morbidity and postoperative survival in the elderly: beyond one lunar orbit. Anaesthesia. 2014;69(s1):17&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">24303857</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A, Sainsbury P, Carter SM, Hall B, Harris DC, Walker RG, et al. Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrol Dial Transplant. 2008;23(10):3206&#x2013;3214.</Citation><ArticleIdList><ArticleId IdType="pubmed">18445638</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006&#x2013;1012.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. Jama. 2000;283(15):2008&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360123</ArticleId><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Balshem H, Helfand M, Sch&#xfc;nemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F. Exploring heterogeneity in meta-analysis: is the L'Abbe plot useful? J Clin Epidemiol. 1999;52(8):725&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">10465316</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraf N, Thalib L, Hughes A, Houlihan M, Tolan M, Young V, et al. The effect of preoperative renal dysfunction with or without dialysis on early postoperative outcome following cardiac surgery. Int J Surg. 2011;9(2):183&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">21087685</ArticleId></ArticleIdList></Reference><Reference><Citation>Charytan DM, Kuntz RE. Risks of coronary artery bypass surgery in dialysis-dependent patients--analysis of the 2001 National Inpatient Sample. Nephrol Dial Transplant. 2007;22(6):1665&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">17299001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chikwe J, Castillo JG, Rahmanian PB, Akujuo A, Adams DH, Filsoufi F. The impact of moderatetoend-stage renal failure on outcomes after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2010;24(4):574&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">20570181</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper WA, O'Brien SM, Thourani VH, Guyton RA, Bridges CR, Szczech LA, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113(8):1063&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">16490821</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukushima S, Kobayashi J, Tagusari O, Bando K, Niwaya K, Nakajima H, et al. Early results of off-pump coronary artery bypass grafting for patients on chronic renal dialysis. The Japanese Journal Of Thoracic And Cardiovascular Surgery. 2005;53(4):186&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">15875551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kan CD, Yang YJ. Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Tex Heart Inst J. 2004;31(3):224&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC521761</ArticleId><ArticleId IdType="pubmed">15562841</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai N, Kodera K, Sasaki A, Asano R, Kataoka G, Ikeda M, et al. Prognosis after off-pump coronary artery bypass in patients receiving hemodialysis. Annals Of Thoracic And Cardiovascular Surgery. 2007;13(6):396&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">18292722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmanian PB, Adams DH, Castillo JG, Vassalotti J, Filsoufi F. Early and late outcome of cardiac surgery in dialysis-dependent patients: single-center experience with 245 consecutive patients. J Thorac Cardiovasc Surg. 2008;135(4):915&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pubmed">18374780</ArticleId></ArticleIdList></Reference><Reference><Citation>Raza S, Hussain ST, Rajeswaran J, Ansari A, Trezzi M, Arafat A, et al. Value of surgery for infective endocarditis in dialysis patients. Journal of Thoracic and Cardiovascular Surgery. 2017;154(1):61&#x2013;70.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28633210</ArticleId></ArticleIdList></Reference><Reference><Citation>Thourani VH, Sarin EL, Kilgo PD, Lattouf OM, Puskas JD, Chen EP, et al. Short- and long-term outcomes in patients undergoing valve surgery with end-stage renal failure receiving chronic hemodialysis. J Thorac Cardiovasc Surg. 2012;144(1):117&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">21868043</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassileva CM, Brennan JM, Gammie JS, Sheng S, Boley T, Saha-Chaudhuri P, et al. Mitral procedure selection in patients on dialysis: Does mitral repair influence outcomes? Journal of Thoracic and Cardiovascular Surgery. 2014;148(1):144&#x2013;50.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">24100095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong D, Thompson G, Buth K, Sullivan J, Ali I. Angiographic coronary diffuseness and outcomes in dialysis patients undergoing coronary artery bypass grafting surgery. European journal of cardio-thoracic surgery. 2003;24(3):388&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">12965309</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi T, Miyata H, Sakaguchi T, Miyagawa S, Yoshikawa Y, Takeda K, et al. Coronary artery bypass grafting in hemodialysis-dependent patients: analysis of Japan adult cardiovascular surgery database. Circ J. 2012;76(5):1115&#x2013;1120.</Citation><ArticleIdList><ArticleId IdType="pubmed">22333214</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin BR, Kohtz PD, Bronsert M, Reece TB, Cleveland JC, Fullerton DA, et al. Postoperative complications are not elevated in well-compensated ESRD patients undergoing cardiac surgery: end-stage renal disease cardiac surgery outcomes. J Surg Res. 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192065</ArticleId><ArticleId IdType="pubmed">31785887</ArticleId></ArticleIdList></Reference><Reference><Citation>Andalib A, Aminian A, Khorgami Z, Navaneethan SD, Schauer PR, Brethauer SA. Safety analysis of primary bariatric surgery in patients on chronic dialysis. Surg Endosc. 2016;30(6):2583&#x2013;2591.</Citation><ArticleIdList><ArticleId IdType="pubmed">26416373</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbas AS, Speicher PJ, Clary BM. Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis. HPB. 2014;16(11):1016&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4487753</ArticleId><ArticleId IdType="pubmed">24931135</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherng YG, Liao CC, Chen TH, Xiao D, Wu CH, Chen TL. Are Non-cardiac Surgeries Safe for Dialysis Patients? - A Population-Based Retrospective Cohort Study. PLoS ONE. 2013;8:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3597566</ArticleId><ArticleId IdType="pubmed">23516581</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloyd JM, Ma Y, Morton JM, Kurella Tamura M, Poultsides GA, Visser BC. Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the National Surgical Quality Improvement Program. J Gastrointestinal Surg. 2014;18(3):605&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">24241964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekici Y, Karakayali F, Yagmurdur MC, Moray G, Karakayali H, Haberal M. Laparoscopic cholecystectomy in patients undergoing continuous ambulatory peritoneal dialysis: a case-control study. Surgical Laparoscopy, Endoscopy and Percutaneous Techniques. 2009;19(2):101&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">19390273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu WH, Cajas-Monson LC, Eisenstein S, Parry L, Ramamoorthy S. Association of dialysis with adverse postoperative outcomes in colorectal cancer&#x2014;an analysis of ACS-NSQIP. Int J Color Dis. 2015;30(11):1557&#x2013;1562.</Citation><ArticleIdList><ArticleId IdType="pubmed">26243472</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao A, Polanco A, Chin E, Divino CM, Qiu S, Nguyen SQ. Safety of elective laparoscopic cholecystectomy in patients on dialysis: an analysis of the ACS NSQIP database. Surg Endosc. 2014;28(7):2208&#x2013;2212.</Citation><ArticleIdList><ArticleId IdType="pubmed">24566745</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CR, Cobb W, Patel S, Cull D, Anna C, Roettger R. Elective surgery in patients with end stage renal disease: What's the risk? Am Surg. 2009;75(9):790&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">19774950</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam SF, Au JT, Chung PJ, Duncan A, Alfonso AE, Sugiyama G. Is it time to rethink our management of dialysis patients undergoing elective ventral hernia repair? Analysis of the ACS NSQIP database. Hernia. 2015;19(5):827&#x2013;833.</Citation><ArticleIdList><ArticleId IdType="pubmed">25504451</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery JR, Waits SA, Dimick JB, Telem DA. 30-day outcomes of bariatric surgery among patients with end-stage renal disease. J Am Coll Surg. 2019;229(4):S16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6764119</ArticleId><ArticleId IdType="pubmed">31553417</ArticleId></ArticleIdList></Reference><Reference><Citation>Manrique OJ, Ciudad P, Sharaf B, Martinez-Jorge J, Moran S, Mardini S, et al. Free tissue transfers for head and neck reconstruction in patients with end-stage renal disease on Dialysis: analysis of outcomes using the Taiwan National Health Insurance Research Database. J Reconstr Microsurg. 2017;33(8):587&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">28622701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chikuda H, Yasunaga H, Horiguchi H, Takeshita K, Kawaguchi H, Matsuda S, et al. Mortality and morbidity in dialysis-dependent patients undergoing spinal surgery: analysis of a National Administrative Database in Japan. J Bone and Joint Surgery - Series A. 2012;94(5):433&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">22398737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung AS, Campbell DH, Hustedt JW, Olmscheid N, Chutkan N. Inpatient Outcomes in Dialysis-Dependent Patients Undergoing Elective Lumbar Surgery for Degenerative Lumbar Disease. Spine. 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28198782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lizaur-Utrilla A, Martinez-Mendez D, Collados-Maestre I, Marco-G&#xf3;mez L, Lopez-Prats FA. Elective Total knee Arthroplasty in patients with end-stage renal disease: is it a safe procedure? J Arthroplasty. 2016;31(10):2152&#x2013;2155.</Citation><ArticleIdList><ArticleId IdType="pubmed">27129761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponnusamy KE, Jain A, Thakkar SC, Sterling RS, Skolasky RL, Khanuja HS. Inpatient mortality and morbidity for dialysis-dependent patients undergoing primary total hip or knee arthroplasty. J Bone Joint Surg (Am Vol) 2015;97(16):1326&#x2013;1332.</Citation><ArticleIdList><ArticleId IdType="pubmed">26290083</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu YH, Chen WJ, Chen LH, Niu CC, Fu TS, Lai PL. Posterior instrumented lumbar spinal surgery in uremic patients under maintenance hemodialysis. Spine. 2011;36(8):660&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pubmed">21178839</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottesen TD, McLynn RP, Zogg CK, Shultz BN, Ondeck NT, Bovonratwet P, et al. Dialysis is an independent risk factor for perioperative adverse events, readmission, reoperation, and mortality for patients undergoing elective spine surgery. Spine J. 2018;18(11):2033&#x2013;2042.</Citation><ArticleIdList><ArticleId IdType="pubmed">30077772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottesen TD, Zogg CK, Haynes MS, Malpani R, Bellamkonda KS, Grauer JN. Dialysis patients undergoing Total knee Arthroplasty have significantly increased odds of perioperative adverse events independent of demographic and comorbidity factors. J Arthroplast. 2018;33(9):2827&#x2013;2834.</Citation><ArticleIdList><ArticleId IdType="pubmed">29754981</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickson LJ, Farah WH, Johnson RL, Thorsteinsdottir B, Ubl DS, Yuan BJ, et al. Death and postoperative complications after hip fracture repair: Dialysis effect. Kidney International Reports. 2018;3(6):1294&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6224855</ArticleId><ArticleId IdType="pubmed">30450456</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue T, Mizutamari M, Fukuda K, Hatake K. Postoperative complications in Dialysis-dependent patients undergoing elective decompression surgery without fusion or instrumentation for degenerative cervical or lumbar lesions. Spine. 2018;43(17):1169&#x2013;1175.</Citation><ArticleIdList><ArticleId IdType="pubmed">30106388</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SJ, Chen TH, Kuo LT, Yu PA, Chen CL, Hsu WH. Effects of chronic kidney disease on Hemiarthroplasty outcomes for fragility hip fracture in diabetic patients: a Nationwide population-based observational study. J Arthroplasty. 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31594704</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancienne JM, Kew ME, Deasey MJ, Brockmeier SF, Werner BC. Dialysis dependence and modality impact complication rates after shoulder arthroplasty. J Shoulder Elb Surg. 2019;28(3):e71&#x2013;ee7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30392936</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino M, Oshima H, Narita Y, Abe T, Mutsuga M, Fujimoto KL, et al. Early and late outcomes of thoracic aortic surgery in hemodialysis patients. Ann Thorac Surg. 2016;102(4):1282&#x2013;1288.</Citation><ArticleIdList><ArticleId IdType="pubmed">27234577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lantis JC, Conte MS, Belkin M, Whittemore AD, Mannick JA, Donaldson MC. Infrainguinal bypass grafting in patients with end-stage renal disease: improving outcomes? J Vasc Surg. 2001;33(6):1171&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pubmed">11389414</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hare AM, Feinglass J, Reiber GE, Rodriguez RA, Daley J, Khuri S, et al. Postoperative mortality after nontraumatic lower extremity amputation in patients with renal insufficiency. J Am Soc Nephrol. 2004;15(2):427&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">14747390</ArticleId></ArticleIdList></Reference><Reference><Citation>Balceniuk MD, Zhao P, Ayers BC, Doyle AJ, Glocker RJ, Stoner MC. IP199. Association Between Distal Lower Extremity Bypass and Dialysis Status on Short-term Outcomes. J Vasc Surg. 2019;69(6):e164.</Citation></Reference><Reference><Citation>Ambur V, Park P, Gaughan JP, Golarz S, Schmieder F, Van Bemmelen P, et al. The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia. J Vasc Surg. 2019;69(2):491&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">30154013</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajdos C, Hawn MT, Kile D, Henderson WG, Robinson T, McCarter M, et al. The risk of major elective vascular surgical procedures in patients with end-stage renal disease. Ann Surg. 2013;257(4):766&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">22982978</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickson LJ, Rule AD, Thorsteinsdottir B, Shields RC, Porter IE, Fleming MD, et al. Predictors of early mortality and readmissions among dialysis patients undergoing lower extremity amputation. J Vasc Surg. 2018;68(5):1505&#x2013;1516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6211198</ArticleId><ArticleId IdType="pubmed">30369411</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornara P, Doehn C, Miglietti G, Fricke L, Steinhoff J, Sack K, et al. Laparoscopic nephrectomy: comparison of dialysis and non-dialysis patients. Nephrology Dialysis Transplantation. 1998;13(5):1221&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pubmed">9623558</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitges J, Trinh QD, Sun M, Hansen J, Bianchi M, Jeldres C, et al. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis. BJU Int. 2012;110(6B):E183&#x2013;EE90.</Citation><ArticleIdList><ArticleId IdType="pubmed">22321256</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita K, Ito F, Nakazawa H. Perioperative outcomes of laparoscopic radical nephrectomy for renal cell carcinoma in patients with Dialysis-dependent end-stage renal disease. Ther Apher Dial. 2012;16(3):254&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">22607569</ArticleId></ArticleIdList></Reference><Reference><Citation>May D, Khaled D, Matrana MR, Bardot SF, Lata-Arias K, Canter D. Effect of the need for preoperative Dialysis on perioperative outcomes on patients undergoing laparoscopic nephrectomy: an analysis of the National Surgical Quality Improvement Program Database. Urology. 2019;124:154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">30448368</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholas GG, Bozorgnia M, Nastasee SA, Reed IJF. Infrainguinal bypass in patients with end-stage renal disease: survival and ambulation. Vasc Surg. 2000;34(2):147&#x2013;156.</Citation></Reference><Reference><Citation>Rao A, Baldwin M, Cornwall J, Marin M, Faries P, Vouyouka A. Contemporary outcomes of surgical revascularization of the lower extremity in patients on dialysis. Journal of Vascular Surgery. 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28390771</ArticleId></ArticleIdList></Reference><Reference><Citation>Thourani VH, Sarin EL, Kilgo PD, Lattouf OM, Puskas JD, Chen EP, et al. Short-and long-term outcomes in patients undergoing valve surgery with end-stage renal failure receiving chronic hemodialysis. J Thorac Cardiovasc Surg. 2012;144(1):117&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">21868043</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic Kidney Disease and Coronary Artery Disease. &lt;span class="subtitle"&gt;&lt;em&gt;JACC&lt;/em&gt; State-of-the-Art Review&lt;/span&gt;. 2019;74(14):1823&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">31582143</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman SJ, Johnson EW, Nakatsu C, Alkan M, Chen R, LeDuc J. Burden of infection in patients with end-stage renal disease requiring long-term Dialysis. Clin Infect Dis. 2004;39(12):1747&#x2013;1753.</Citation><ArticleIdList><ArticleId IdType="pubmed">15578394</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle JF, Forni LG. Acute kidney injury: short-term and long-term effects. Crit Care. 2016;20(1):188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4931701</ArticleId><ArticleId IdType="pubmed">27373891</ArticleId></ArticleIdList></Reference><Reference><Citation>Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney International. 55(3):1081&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">10027947</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between Dialysis modality and mortality. J Am Soc Nephrol. 2009;20(1):155&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615722</ArticleId><ArticleId IdType="pubmed">19092128</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int. 2000;57(3):1176&#x2013;1181.</Citation><ArticleIdList><ArticleId IdType="pubmed">10720970</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew A, Devereaux P, O'hare A, Tonelli M, Thiessen-Philbrook H, Nevis I, et al. Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis. Kidney Int. 2008;73(9):1069&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">18288098</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamuthusingam D, Johnson DW, Hawley CM, Pascoe E, Sivalingam P, Fahim M. Perioperative outcomes and risk assessment in dialysis patients: current knowledge and future directions. 2019. pp. 702&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">30485661</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39478824</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Early detection of sepsis using machine learning algorithms: a systematic review and network meta-analysis.</ArticleTitle><Pagination><StartPage>1491358</StartPage><MedlinePgn>1491358</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1491358</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1491358</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">With machine learning (ML) carving a niche in diverse medical disciplines, its role in sepsis prediction, a condition where the 'golden hour' is critical, is of paramount interest. This study assesses the factors influencing the efficacy of ML models in sepsis prediction, aiming to optimize their use in clinical practice.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched Medline, PubMed, Google Scholar, and CENTRAL for studies published from inception to October 2023. We focused on studies predicting sepsis in real-time settings in adult patients in any hospital settings without language limits. The primary outcome was area under the curve (AUC) of the receiver operating characteristic. This meta-analysis was conducted according to PRISMA-NMA guidelines and Cochrane Handbook recommendations. A Network Meta-Analysis using the CINeMA approach compared ML models against traditional scoring systems, with meta-regression identifying factors affecting model quality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">From 3,953 studies, 73 articles encompassing 457,932 septic patients and 256 models were analyzed. The pooled AUC for ML models was 0.825 and it significantly outperformed traditional scoring systems. Neural Network and Decision Tree models demonstrated the highest AUC metrics. Significant factors influencing AUC included ML model type, dataset type, and prediction window.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This study establishes the superiority of ML models, especially Neural Network and Decision Tree types, in sepsis prediction. It highlights the importance of model type and dataset characteristics for prediction accuracy, emphasizing the necessity for standardized reporting and validation in ML healthcare applications. These findings call for broader clinical implementation to evaluate the effectiveness of these models in diverse patient groups.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">https://inplasy.com/inplasy-2023-12-0062/, identifier, INPLASY2023120062.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Yadgarov, Landoni, Berikashvili, Polyakov, Kadantseva, Smirnova, Kuznetsov, Shemetova, Yakovlev and Likhvantsev.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yadgarov</LastName><ForeName>Mikhail Ya</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berikashvili</LastName><ForeName>Levan B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polyakov</LastName><ForeName>Petr A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadantseva</LastName><ForeName>Kristina K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smirnova</LastName><ForeName>Anastasia V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuznetsov</LastName><ForeName>Ivan V</ForeName><Initials>IV</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shemetova</LastName><ForeName>Maria M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yakovlev</LastName><ForeName>Alexey A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery V</ForeName><Initials>VV</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">decision trees</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">network meta-analysis</Keyword><Keyword MajorTopicYN="N">neural networks</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>31</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>31</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>31</Day><Hour>4</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39478824</ArticleId><ArticleId IdType="pmc">PMC11523135</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1491358</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. . Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations. Am J Respir Crit Care Med. (2016) 193:259&#x2013;72. doi: 10.1164/rccm.201504-0781OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201504-0781OC</ArticleId><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. . Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. (2021) 47:1181&#x2013;247. doi: 10.1007/s00134-021-06506-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Rababa M, Hamad DB, Hayajneh AA. Sepsis assessment and management in critically ill adults: a systematic review. PLoS One. (2022) 17:e0270711. doi: 10.1371/journal.pone.0270711, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270711</ArticleId><ArticleId IdType="pmc">PMC9249173</ArticleId><ArticleId IdType="pubmed">35776738</ArticleId></ArticleIdList></Reference><Reference><Citation>Il KH, Park S. Sepsis: early recognition and optimized treatment. Tuberc Respir Dis (Seoul). (2019) 82:6&#x2013;14. doi: 10.4046/trd.2018.0041, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4046/trd.2018.0041</ArticleId><ArticleId IdType="pmc">PMC6304323</ArticleId><ArticleId IdType="pubmed">30302954</ArticleId></ArticleIdList></Reference><Reference><Citation>Im Y, Kang D, Ko RE, Lee YJ, Lim SY, Park S, et al. . Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. Crit Care. (2022) 26:19. doi: 10.1186/s13054-021-03883-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03883-0</ArticleId><ArticleId IdType="pmc">PMC8756674</ArticleId><ArticleId IdType="pubmed">35027073</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MM, Nasrin T, Walther BA, Wu CC, Yang HC, Li YC. Prediction of sepsis patients using machine learning approach: a meta-analysis. Comput Methods Prog Biomed. (2019) 170:1&#x2013;9. doi: 10.1016/j.cmpb.2018.12.027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2018.12.027</ArticleId><ArticleId IdType="pubmed">30712598</ArticleId></ArticleIdList></Reference><Reference><Citation>Schinkel M, van der Poll T, Wiersinga WJ. Artificial intelligence for early Sepsis detection a word of caution. Am J Respir Crit Care Med. (2023) 207:853&#x2013;4. doi: 10.1164/rccm.202212-2284VP, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202212-2284VP</ArticleId><ArticleId IdType="pmc">PMC10111986</ArticleId><ArticleId IdType="pubmed">36724366</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Vegt AH, Scott IA, Dermawan K, Schnetler RJ, Kalke VR, Lane PJ. Deployment of machine learning algorithms to predict sepsis: systematic review and application of the SALIENT clinical AI implementation framework. J Am Med Informatics Assoc. (2023) 30:1349&#x2013;61. doi: 10.1093/jamia/ocad075, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocad075</ArticleId><ArticleId IdType="pmc">PMC10280361</ArticleId><ArticleId IdType="pubmed">37172264</ArticleId></ArticleIdList></Reference><Reference><Citation>Komorowski M, Green A, Tatham KC, Seymour C, Antcliffe D. Sepsis biomarkers and diagnostic tools with a focus on machine learning. EBioMedicine. (2022) 86:104394. doi: 10.1016/j.ebiom.2022.104394, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104394</ArticleId><ArticleId IdType="pmc">PMC9783125</ArticleId><ArticleId IdType="pubmed">36470834</ArticleId></ArticleIdList></Reference><Reference><Citation>Moor M, Rieck B, Horn M, Jutzeler CR, Borgwardt K. Early prediction of Sepsis in the ICU using machine learning: a systematic review. Front Med. (2021) 8:607952. doi: 10.3389/fmed.2021.607952, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.607952</ArticleId><ArticleId IdType="pmc">PMC8193357</ArticleId><ArticleId IdType="pubmed">34124082</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HF, Sun MW, Wang Y, Zeng J, Yuan T, Li T, et al. . Evaluating machine learning models for sepsis prediction: a systematic review of methodologies. iScience. (2022) 25:103651. doi: 10.1016/j.isci.2021.103651</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103651</ArticleId><ArticleId IdType="pmc">PMC8741489</ArticleId><ArticleId IdType="pubmed">35028534</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan MY, Gustad LT, Nytr&#xf8; &#xd8;. Sepsis prediction, early detection, and identification using clinical text for machine learning: a systematic review. J Am Med Informatics Assoc. (2022) 29:559&#x2013;75. doi: 10.1093/jamia/ocab236, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab236</ArticleId><ArticleId IdType="pmc">PMC8800516</ArticleId><ArticleId IdType="pubmed">34897469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kausch SL, Moorman JR, Lake DE, Keim-Malpass J. Physiological machine learning models for prediction of sepsis in hospitalized adults: an integrative review. Intensive Crit Care Nurs. (2021) 65:103035. doi: 10.1016/j.iccn.2021.103035, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iccn.2021.103035</ArticleId><ArticleId IdType="pubmed">33875337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauritsen SM, Thiesson B, J&#xf8;rgensen MJ, Riis AH, Espelund US, Weile JB, et al. . The framing of machine learning risk prediction models illustrated by evaluation of sepsis in general wards. Npj Digit Med. (2021) 4:1&#x2013;12. doi: 10.1038/s41746-021-00529-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-021-00529-x</ArticleId><ArticleId IdType="pmc">PMC8593052</ArticleId><ArticleId IdType="pubmed">34782696</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleuren LM, Klausch TLT, Zwager CL, Schoonmade LJ, Guo T, Roggeveen LF, et al. . Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy. Intensive Care Med. (2020) 46:383&#x2013;400. doi: 10.1007/s00134-019-05872-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05872-y</ArticleId><ArticleId IdType="pmc">PMC7067741</ArticleId><ArticleId IdType="pubmed">31965266</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Cui X, Song Z. Predicting sepsis onset in ICU using machine learning models: a systematic review and meta-analysis. BMC Infect Dis. (2023) 23:635&#x2013;21. doi: 10.1186/s12879-023-08614-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08614-0</ArticleId><ArticleId IdType="pmc">PMC10523763</ArticleId><ArticleId IdType="pubmed">37759175</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. . The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. (2015) 162:777&#x2013;84. doi: 10.7326/M14-2385, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-2385</ArticleId><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. . Cochrane handbook for systematic reviews of interventions. Cochrane Handb Syst Rev Interv. (2019):1&#x2013;694. doi: 10.1002/9781119536604</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9781119536604</ArticleId><ArticleId IdType="pmc">PMC10284251</ArticleId><ArticleId IdType="pubmed">31643080</ArticleId></ArticleIdList></Reference><Reference><Citation>Litmaps  Literature Map Software for Lit Reviews and Research. (2023) Available at: https://www.litmaps.com/ (Accessed November 24, 2023).</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. . The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. (2016) 315:801&#x2013;10. doi: 10.1001/jama.2016.0287, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbord RM, Higgins JPT. Meta-regression in Stata. Stata J. (2008) 8:493&#x2013;519. doi: 10.1177/1536867x0800800403</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867x0800800403</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del GC, Egger M, et al. . Cinema: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med. (2020) 17:e1003082. doi: 10.1371/JOURNAL.PMED.1003082</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PMED.1003082</ArticleId><ArticleId IdType="pmc">PMC7122720</ArticleId><ArticleId IdType="pubmed">32243458</ArticleId></ArticleIdList></Reference><Reference><Citation>Papakonstantinou T, Nikolakopoulou A, Higgins JPT, Egger M, Salanti G. CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis. Campbell Syst Rev. (2020) 16:e1080. doi: 10.1002/cl2.1080, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cl2.1080</ArticleId><ArticleId IdType="pmc">PMC8356302</ArticleId><ArticleId IdType="pubmed">37131978</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiocchia V, Nikolakopoulou A, Higgins JPT, Page MJ, Papakonstantinou T, Cipriani A, et al. . ROB-MEN: a tool to assess risk of bias due to missing evidence in network meta-analysis. BMC Med. (2021) 19:304. doi: 10.1186/s12916-021-02166-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02166-3</ArticleId><ArticleId IdType="pmc">PMC8609747</ArticleId><ArticleId IdType="pubmed">34809639</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. . Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. (2011) 155:529&#x2013;36. doi: 10.7326/0003-4819-155-8-201110180-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00009</ArticleId><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Aromataris E, Munn Z, Moola S, Tufanaru C, Sears K, Sfetcu R, et al. . Checklist for analytical cross sectional studies. (2020). Available at: https://synthesismanual.jbi.global/ (Accessed November 24, 2023).</Citation></Reference><Reference><Citation>Abromavi&#x10d;ius V, Plonis D, Tarasevi&#x10d;ius D, Serackis A. Two-stage monitoring of patients in intensive care unit for sepsis prediction using non-overfitted machine learning models. Electron. (2020) 9:1&#x2013;14. doi: 10.3390/electronics9071133</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/electronics9071133</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho-Cogollo JE, Bonet I, Gil B, Iadanza E. Machine learning models for early prediction of Sepsis on large healthcare datasets. Electron. (2022) 11:1507. doi: 10.3390/electronics11091507</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/electronics11091507</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Hern&#xe1;ndez A. Towards an explainable model for Sepsis detection based on sensitivity analysis. Irbm. (2022) 43:75&#x2013;86. doi: 10.1016/j.irbm.2021.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.irbm.2021.05.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Li R, Lin CC, Lai C, Chen D, Qu H, et al. . Transferability and interpretability of the sepsis prediction models in the intensive care unit. BMC Med Inform Decis Mak. (2022) 22:343&#x2013;10. doi: 10.1186/s12911-022-02090-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-022-02090-3</ArticleId><ArticleId IdType="pmc">PMC9798724</ArticleId><ArticleId IdType="pubmed">36581881</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Chen B, Yang J, Li X, Peng X, Feng Y, et al. . Development and validation of a practical machine learning model to predict sepsis after liver transplantation. Ann Med. (2023) 55:624&#x2013;33. doi: 10.1080/07853890.2023.2179104, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2023.2179104</ArticleId><ArticleId IdType="pmc">PMC9937004</ArticleId><ArticleId IdType="pubmed">36790357</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JS, Trinh TX, Ha J, Yang MS, Lee Y, Kim YE, et al. . Implementation of complementary model using optimal combination of hematological parameters for Sepsis screening in patients with fever. Sci Rep. (2020) 10:273&#x2013;10. doi: 10.1038/s41598-019-57107-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-57107-1</ArticleId><ArticleId IdType="pmc">PMC6959355</ArticleId><ArticleId IdType="pubmed">31937825</ArticleId></ArticleIdList></Reference><Reference><Citation>Delahanty RJ, Alvarez JA, Flynn LM, Sherwin RL, Jones SS. Development and evaluation of a machine learning model for the early identification of patients at risk for Sepsis. Ann Emerg Med. (2019) 73:334&#x2013;44. doi: 10.1016/j.annemergmed.2018.11.036, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2018.11.036</ArticleId><ArticleId IdType="pubmed">30661855</ArticleId></ArticleIdList></Reference><Reference><Citation>Desautels T, Calvert J, Hoffman J, Jay M, Kerem Y, Shieh L, et al. . Prediction of sepsis in the intensive care unit with minimal electronic health record data: a machine learning approach. JMIR Med Informatics. (2016) 4:e28. doi: 10.2196/medinform.5909, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/medinform.5909</ArticleId><ArticleId IdType="pmc">PMC5065680</ArticleId><ArticleId IdType="pubmed">27694098</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, Huo J, Chen M, Hou F, Yan G, Li S, et al. . Early prediction of sepsis using double fusion of deep features and handcrafted features. Appl Intell. (2023) 53:17903&#x2013;19. doi: 10.1007/s10489-022-04425-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10489-022-04425-z</ArticleId><ArticleId IdType="pmc">PMC9843111</ArticleId><ArticleId IdType="pubmed">36685641</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Rashidy N, Abuhmed T, Alarabi L, El-Bakry HM, Abdelrazek S, Ali F, et al. . Sepsis prediction in intensive care unit based on genetic feature optimization and stacked deep ensemble learning. Neural Comput &amp; Applic. (2022) 34:3603&#x2013;32. doi: 10.1007/s00521-021-06631-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00521-021-06631-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagerstr&#xf6;m J, B&#xe5;ng M, Wilhelms D, Chew MS. LiSep LSTM: a machine learning algorithm for early detection of septic shock. Sci Rep. (2019) 9:15132&#x2013;8. doi: 10.1038/s41598-019-51219-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-51219-4</ArticleId><ArticleId IdType="pmc">PMC6805937</ArticleId><ArticleId IdType="pubmed">31641162</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrollahi F, Shashikumar SP, Razmi F, Nemati S. Contextual Embeddings from clinical notes improves prediction of Sepsis. AMIA Annu Symp Proc. (2020) 2020:197&#x2013;202. PMID:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075484</ArticleId><ArticleId IdType="pubmed">33936391</ArticleId></ArticleIdList></Reference><Reference><Citation>Faisal M, Scally A, Richardson D, Beatson K, Howes R, Speed K, et al. . Development and external validation of an automated computer-aided risk score for predicting sepsis in emergency medical admissions using the patient&#x2019;s first electronically recorded vital signs and blood test results. Crit Care Med. (2018) 46:612&#x2013;8. doi: 10.1097/CCM.0000000000002967, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002967</ArticleId><ArticleId IdType="pubmed">29369828</ArticleId></ArticleIdList></Reference><Reference><Citation>Gholamzadeh M, Abtahi H, Safdari R. Comparison of different machine learning algorithms to classify patients suspected of having sepsis infection in the intensive care unit. Inform Med Unlock. (2023) 38:101236. doi: 10.1016/j.imu.2023.101236</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2023.101236</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini HM, Ginestra JC, Chivers C, Draugelis M, Hanish A, Schweickert WD, et al. . A machine learning algorithm to predict severe Sepsis and septic shock: development, implementation, and impact on clinical practice. Crit Care Med. (2019) 47:1485&#x2013;92. doi: 10.1097/CCM.0000000000003891, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003891</ArticleId><ArticleId IdType="pmc">PMC8635476</ArticleId><ArticleId IdType="pubmed">31389839</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh KH, Wang L, Yeow AYK, Poh H, Li K, Yeow JJL, et al. . Artificial intelligence in sepsis early prediction and diagnosis using unstructured data in healthcare. Nat Commun. (2021) 12:711&#x2013;10. doi: 10.1038/s41467-021-20910-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-20910-4</ArticleId><ArticleId IdType="pmc">PMC7846756</ArticleId><ArticleId IdType="pubmed">33514699</ArticleId></ArticleIdList></Reference><Reference><Citation>Horng S, Sontag DA, Halpern Y, Jernite Y, Shapiro NI, Nathanson LA. Creating an automated trigger for sepsis clinical decision support at emergency department triage using machine learning. PLoS One. (2017) 12:e0174708. doi: 10.1371/journal.pone.0174708, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174708</ArticleId><ArticleId IdType="pmc">PMC5383046</ArticleId><ArticleId IdType="pubmed">28384212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim ZM, Wu H, Hamoud A, Stappen L, Dobson RJB, Agarossi A. On classifying sepsis heterogeneity in the ICU: insight using machine learning. J Am Med Informatics Assoc. (2020) 27:437&#x2013;43. doi: 10.1093/jamia/ocz211, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz211</ArticleId><ArticleId IdType="pmc">PMC7025363</ArticleId><ArticleId IdType="pubmed">31951005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaji DA, Zech JR, Kim JS, Cho SK, Dangayach NS, Costa AB, et al. . An attention based deep learning model of clinical events in the intensive care unit. PLoS One. (2019) 14:e0211057. doi: 10.1371/journal.pone.0211057, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0211057</ArticleId><ArticleId IdType="pmc">PMC6373907</ArticleId><ArticleId IdType="pubmed">30759094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kam HJ, Kim HY. Learning representations for the early detection of sepsis with deep neural networks. Comput Biol Med. (2017) 89:248&#x2013;55. doi: 10.1016/j.compbiomed.2017.08.015, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2017.08.015</ArticleId><ArticleId IdType="pubmed">28843829</ArticleId></ArticleIdList></Reference><Reference><Citation>Khojandi A, Tansakul V, Li X, Koszalinski RS, Paiva W. Prediction of Sepsis and in-hospital mortality using electronic health records. Methods Inf Med. (2018) 57:185&#x2013;93. doi: 10.3414/ME18-01-0014</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-01-0014</ArticleId><ArticleId IdType="pubmed">30248708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kijpaisalratana N, Sanglertsinlapachai D, Techaratsami S, Musikatavorn K, Saoraya J. Machine learning algorithms for early sepsis detection in the emergency department: a retrospective study. Int J Med Inform. (2022) 160:104689. doi: 10.1016/j.ijmedinf.2022.104689, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2022.104689</ArticleId><ArticleId IdType="pubmed">35078027</ArticleId></ArticleIdList></Reference><Reference><Citation>A&#x15f;uro&#x11f;lu T, O&#x11f;ul H. A deep learning approach for sepsis monitoring via severity score estimation. Comput Methods Prog Biomed. (2021) 198:105816. doi: 10.1016/j.cmpb.2020.105816, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2020.105816</ArticleId><ArticleId IdType="pubmed">33157471</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo YY, Huang ST, Chiu HW. Applying artificial neural network for early detection of sepsis with intentionally preserved highly missing real-world data for simulating clinical situation. BMC Med Inform Decis Mak. (2021) 21:290&#x2013;11. doi: 10.1186/s12911-021-01653-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01653-0</ArticleId><ArticleId IdType="pmc">PMC8539833</ArticleId><ArticleId IdType="pubmed">34686163</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon J, Myoung LYR, Jung MS, Lee YJ, Jo YY, Kang DY, et al. . Deep-learning model for screening sepsis using electrocardiography. Scand J Trauma Resusc Emerg Med. (2021) 29:1&#x2013;12. doi: 10.1186/s13049-021-00953-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13049-021-00953-8</ArticleId><ArticleId IdType="pmc">PMC8487616</ArticleId><ArticleId IdType="pubmed">34602084</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauritsen SM, Kal&#xf8;r ME, Kongsgaard EL, Lauritsen KM, J&#xf8;rgensen MJ, Lange J, et al. . Early detection of sepsis utilizing deep learning on electronic health record event sequences. Artif Intell Med. (2020) 104:101820. doi: 10.1016/j.artmed.2020.101820</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2020.101820</ArticleId><ArticleId IdType="pubmed">32498999</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Xu X, Xie F, Xu X, Sun Y, Liu X, et al. . A time-phased machine learning model for real-time prediction of Sepsis in critical care. Crit Care Med. (2020) 48:E884&#x2013;8. doi: 10.1097/CCM.0000000000004494, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004494</ArticleId><ArticleId IdType="pubmed">32931194</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PC, Chen KT, Chen HC, Islam MM, Lin MC. Machine learning model to identify sepsis patients in the emergency department: algorithm development and validation. J Pers Med. (2021) 11:1055. doi: 10.3390/jpm11111055, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11111055</ArticleId><ArticleId IdType="pmc">PMC8623760</ArticleId><ArticleId IdType="pubmed">34834406</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Khojandi A, Li X, Mohammed A, Davis RL, Kamaleswaran R. A machine learning&#x2013;enabled partially observable Markov decision process framework for early Sepsis prediction. INFORMS J Comput. (2022) 34:2039&#x2013;57. doi: 10.1287/ijoc.2022.1176</Citation><ArticleIdList><ArticleId IdType="doi">10.1287/ijoc.2022.1176</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Yao J, Liu C, Shou S. Construction and validation of machine learning models for sepsis prediction in patients with acute pancreatitis. BMC Surg. (2023) 23:267&#x2013;13. doi: 10.1186/s12893-023-02151-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12893-023-02151-y</ArticleId><ArticleId IdType="pmc">PMC10474758</ArticleId><ArticleId IdType="pubmed">37658375</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharjan J, Thapa R, Calvert J, Attwood MM, Shokouhi S, Casie Chetty S, et al. . A new standard for Sepsis prediction algorithms: using time-dependent analysis for earlier clinically relevant alerts. SSRN Electron J. (2022). doi: 10.2139/ssrn.4130480</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4130480</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Jay M, Hoffman JL, Calvert J, Barton C, Shimabukuro D, et al. . Multicentre validation of a sepsis prediction algorithm using only vital sign data in the emergency department, general ward and ICU. BMJ Open. (2018) 8:e017833. doi: 10.1136/bmjopen-2017-017833, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017833</ArticleId><ArticleId IdType="pmc">PMC5829820</ArticleId><ArticleId IdType="pubmed">29374661</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy A, Das R. Reducing patient mortality, length of stay and readmissions through machine learning-based sepsis prediction in the emergency department, intensive care unit and hospital floor units. BMJ Open Qual. (2017) 6:e000158. doi: 10.1136/bmjoq-2017-000158, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjoq-2017-000158</ArticleId><ArticleId IdType="pmc">PMC5699136</ArticleId><ArticleId IdType="pubmed">29450295</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao C, Deng F, Zhao S. Machine-learning models for prediction of sepsis patients mortality. Med Intens. (2023) 47:315&#x2013;25. doi: 10.1016/j.medine.2022.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medine.2022.06.024</ArticleId><ArticleId IdType="pubmed">36344339</ArticleId></ArticleIdList></Reference><Reference><Citation>Moor M, Bennett N, Ple&#x10d;ko D, Horn M, Rieck B, Meinshausen N, et al. . Predicting sepsis using deep learning across international sites: a retrospective development and validation study. eClinicalMedicine. (2023) 62:102124. doi: 10.1016/j.eclinm.2023.102124, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102124</ArticleId><ArticleId IdType="pmc">PMC10425671</ArticleId><ArticleId IdType="pubmed">37588623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemati S, Holder A, Razmi F, Stanley MD, Clifford GD, Buchman TG. An interpretable machine learning model for accurate prediction of Sepsis in the ICU. Crit Care Med. (2018) 46:547&#x2013;53. doi: 10.1097/CCM.0000000000002936, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002936</ArticleId><ArticleId IdType="pmc">PMC5851825</ArticleId><ArticleId IdType="pubmed">29286945</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesaragi N, Patidar S. An explainable machine learning model for early prediction of Sepsis using ICU data. Infect Sepsis Dev. (2021). doi: 10.5772/intechopen.98957</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/intechopen.98957</ArticleId></ArticleIdList></Reference><Reference><Citation>Oei SP, van Sloun RJ, van der Ven M, Korsten HH, Mischi M. Towards early sepsis detection from measurements at the general ward through deep learning. Intell Med. (2021) 5:100042. doi: 10.1016/j.ibmed.2021.100042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ibmed.2021.100042</ArticleId></ArticleIdList></Reference><Reference><Citation>Persson I, &#xd6;stling A, Arlbrandt M, S&#xf6;derberg J, Becedas D. A machine learning Sepsis prediction algorithm for intended intensive care unit use (NAVOY Sepsis): proof-of-concept study. JMIR Form Res. (2021) 5:e28000. doi: 10.2196/28000, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28000</ArticleId><ArticleId IdType="pmc">PMC8517825</ArticleId><ArticleId IdType="pubmed">34591016</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiei A, Rezaee A, Hajati F, Gheisari S, Golzan M. SSP: early prediction of sepsis using fully connected LSTM-CNN model. Comput Biol Med. (2021) 128:104110. doi: 10.1016/j.compbiomed.2020.104110, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2020.104110</ArticleId><ArticleId IdType="pubmed">33227577</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangan ES, Pathinarupothi RK, Anand KJS, Snyder MP. Performance effectiveness of vital parameter combinations for early warning of sepsis - an exhaustive study using machine learning. JAMIA Open. (2022) 5:1&#x2013;11. doi: 10.1093/jamiaopen/ooac080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooac080</ArticleId><ArticleId IdType="pmc">PMC9566305</ArticleId><ArticleId IdType="pubmed">36267121</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosnati M, Fortuin V. MGP-AttTCN: an interpretable machine learning model for the prediction of sepsis. PLoS One. (2021) 16:e0251248. doi: 10.1371/journal.pone.0251248, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251248</ArticleId><ArticleId IdType="pmc">PMC8104377</ArticleId><ArticleId IdType="pubmed">33961681</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadasivuni S, Saha M, Bhatia N, Banerjee I, Sanyal A. Fusion of fully integrated analog machine learning classifier with electronic medical records for real-time prediction of sepsis onset. Sci Rep. (2022) 12:1&#x2013;11. doi: 10.1038/s41598-022-09712-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09712-w</ArticleId><ArticleId IdType="pmc">PMC8983688</ArticleId><ArticleId IdType="pubmed">35383233</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma DK, Lakhotia P, Sain P, Brahmachari S. Early prediction and monitoring of sepsis using sequential long short term memory model. Expert Syst. (2022) 39:e12798. doi: 10.1111/exsy.12798</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exsy.12798</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton C, Chettipally U, Zhou Y, Jiang Z, Lynn-Palevsky A, Le S, et al. . Evaluation of a machine learning algorithm for up to 48-hour advance prediction of sepsis using six vital signs. Comput Biol Med. (2019) 109:79&#x2013;84. doi: 10.1016/j.compbiomed.2019.04.027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2019.04.027</ArticleId><ArticleId IdType="pmc">PMC6556419</ArticleId><ArticleId IdType="pubmed">31035074</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherpf M, Gr&#xe4;&#xdf;er F, Malberg H, Zaunseder S. Predicting sepsis with a recurrent neural network using the MIMIC III database. Comput Biol Med. (2019) 113:103395. doi: 10.1016/j.compbiomed.2019.103395</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2019.103395</ArticleId><ArticleId IdType="pubmed">31480008</ArticleId></ArticleIdList></Reference><Reference><Citation>Schamoni S, Lindner HA, Schneider-Lindner V, Thiel M, Riezler S. Leveraging implicit expert knowledge for non-circular machine learning in sepsis prediction. Artif Intell Med. (2019) 100:101725. doi: 10.1016/j.artmed.2019.101725</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2019.101725</ArticleId><ArticleId IdType="pubmed">31607345</ArticleId></ArticleIdList></Reference><Reference><Citation>Shashikumar SP, Stanley MD, Sadiq I, Li Q, Holder A, Clifford GD, et al. . Early sepsis detection in critical care patients using multiscale blood pressure and heart rate dynamics. J Electrocardiol. (2017) 50:739&#x2013;43. doi: 10.1016/j.jelectrocard.2017.08.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2017.08.013</ArticleId><ArticleId IdType="pmc">PMC5696025</ArticleId><ArticleId IdType="pubmed">28916175</ArticleId></ArticleIdList></Reference><Reference><Citation>Shashikumar SP, Li Q, Clifford GD, Nemati S. Multiscale network representation of physiological time series for early prediction of sepsis. Physiol Meas. (2017) 38:2235&#x2013;48. doi: 10.1088/1361-6579/aa9772, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1361-6579/aa9772</ArticleId><ArticleId IdType="pmc">PMC5736369</ArticleId><ArticleId IdType="pubmed">29091053</ArticleId></ArticleIdList></Reference><Reference><Citation>Shashikumar SP, Josef CS, Sharma A, Nemati S. DeepAISE &#x2013; an interpretable and recurrent neural survival model for early prediction of sepsis. Artif Intell Med. (2021) 113:102036. doi: 10.1016/j.artmed.2021.102036, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2021.102036</ArticleId><ArticleId IdType="pmc">PMC8029104</ArticleId><ArticleId IdType="pubmed">33685592</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh YV, Singh P, Khan S, Singh RS. A machine learning model for early prediction and detection of Sepsis in intensive care unit patients. J Healthc Eng. (2022) 2022:1&#x2013;11. doi: 10.1155/2022/9263391, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9263391</ArticleId><ArticleId IdType="pmc">PMC8976655</ArticleId><ArticleId IdType="pubmed">35378945</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimabukuro DW, Barton CW, Feldman MD, Mataraso SJ, Das R. Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial. BMJ Open Respir Res. (2017) 4:e000234. doi: 10.1136/bmjresp-2017-000234, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2017-000234</ArticleId><ArticleId IdType="pmc">PMC5687546</ArticleId><ArticleId IdType="pubmed">29435343</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneja I, Reddy B, Damhorst G, Dave Zhao S, Hassan U, Price Z, et al. . Combining biomarkers with EMR data to identify patients in different phases of Sepsis. Sci Rep. (2017) 7:10800&#x2013;12. doi: 10.1038/s41598-017-09766-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09766-1</ArticleId><ArticleId IdType="pmc">PMC5589821</ArticleId><ArticleId IdType="pubmed">28883645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang G, Luo Y, Lu F, Li W, Liu X, Nan Y, et al. . Prediction of Sepsis in COVID-19 using laboratory indicators. Front Cell Infect Microbiol. (2021) 10:586054. doi: 10.3389/fcimb.2020.586054, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.586054</ArticleId><ArticleId IdType="pmc">PMC7966961</ArticleId><ArticleId IdType="pubmed">33747973</ArticleId></ArticleIdList></Reference><Reference><Citation>Valik JK, Ward L, Tanushi H, Johansson AF, F&#xe4;rnert A, Mogensen ML, et al. . Predicting sepsis onset using a machine learned causal probabilistic network algorithm based on electronic health records data. Sci Rep. (2023) 13:11760&#x2013;12. doi: 10.1038/s41598-023-38858-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-38858-4</ArticleId><ArticleId IdType="pmc">PMC10359402</ArticleId><ArticleId IdType="pubmed">37474597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedoya AD, Futoma J, Clement ME, Corey K, Brajer N, Lin A, et al. . Machine learning for early detection of sepsis: an internal and temporal validation study. JAMIA Open. (2020) 3:252&#x2013;60. doi: 10.1093/jamiaopen/ooaa006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooaa006</ArticleId><ArticleId IdType="pmc">PMC7382639</ArticleId><ArticleId IdType="pubmed">32734166</ArticleId></ArticleIdList></Reference><Reference><Citation>van Wyk F, Khojandi A, Mohammed A, Begoli E, Davis RL, Kamaleswaran R. A minimal set of physiomarkers in continuous high frequency data streams predict adult sepsis onset earlier. Int J Med Inform. (2019) 122:55&#x2013;62. doi: 10.1016/j.ijmedinf.2018.12.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2018.12.002</ArticleId><ArticleId IdType="pubmed">30623784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Li J, Sun Y, Ding X, Zhang X, Liu S, et al. . A machine learning model for accurate prediction of Sepsis in ICU patients. Front Public Heal. (2021) 9:754348. doi: 10.3389/fpubh.2021.754348, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.754348</ArticleId><ArticleId IdType="pmc">PMC8553999</ArticleId><ArticleId IdType="pubmed">34722452</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Yao B. Multi-branching temporal convolutional network for Sepsis prediction. IEEE J Biomed Heal Inform. (2022) 26:876&#x2013;87. doi: 10.1109/JBHI.2021.3092835</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2021.3092835</ArticleId><ArticleId IdType="pubmed">34181558</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A, Otles E, Donnelly JP, Krumm A, McCullough J, DeTroyer-Cooley O, et al. . External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern Med. (2021) 181:1065&#x2013;70. doi: 10.1001/jamainternmed.2021.2626, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.2626</ArticleId><ArticleId IdType="pmc">PMC8218233</ArticleId><ArticleId IdType="pubmed">34152373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Liu C, Wang X, Li Y, Gao H, Liu X, et al. . An explainable artificial intelligence predictor for early detection of Sepsis. Crit Care Med. (2020) 48:E1091&#x2013;6. doi: 10.1097/CCM.0000000000004550, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004550</ArticleId><ArticleId IdType="pubmed">32885937</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, Kim J, Yoo J, Cha WC, Paik H. Identifying the risk of Sepsis in patients with Cancer using digital health care records: machine learning-based approach. JMIR Med Inform. (2022) 10:e37689. doi: 10.2196/37689, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37689</ArticleId><ArticleId IdType="pmc">PMC9244654</ArticleId><ArticleId IdType="pubmed">35704364</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu SC, Gupta A, Betthauser KD, Lyons PG, Lai AM, Kollef MH, et al. . Sepsis prediction for the general Ward setting. Front Digit Heal. (2022) 4:848599. doi: 10.3389/fdgth.2022.848599, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fdgth.2022.848599</ArticleId><ArticleId IdType="pmc">PMC8957791</ArticleId><ArticleId IdType="pubmed">35350226</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan KC, Tsai LW, Lee KH, Cheng YW, Hsu SC, Lo YS, et al. . The development an artificial intelligence algorithm for early sepsis diagnosis in the intensive care unit. Int J Med Inform. (2020) 141:104176. doi: 10.1016/j.ijmedinf.2020.104176</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2020.104176</ArticleId><ArticleId IdType="pubmed">32485555</ArticleId></ArticleIdList></Reference><Reference><Citation>Zargoush M, Sameh A, Javadi M, Shabani S, Ghazalbash S, Perri D. The impact of recency and adequacy of historical information on sepsis predictions using machine learning. Sci Rep. (2021) 11:20869. doi: 10.1038/s41598-021-00220-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00220-x</ArticleId><ArticleId IdType="pmc">PMC8531301</ArticleId><ArticleId IdType="pubmed">34675275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Yin C, Hunold KM, Jiang X, Caterino JM, Zhang P. An interpretable deep-learning model for early prediction of sepsis in the emergency department. Patterns. (2021) 2:100196. doi: 10.1016/j.patter.2020.100196, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.patter.2020.100196</ArticleId><ArticleId IdType="pmc">PMC7892361</ArticleId><ArticleId IdType="pubmed">33659912</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloch E, Rotem T, Cohen J, Singer P, Aperstein Y. Machine learning models for analysis of vital signs dynamics: a case for Sepsis onset prediction. J Healthc Eng. (2019) 2019:1&#x2013;11. doi: 10.1155/2019/5930379, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/5930379</ArticleId><ArticleId IdType="pmc">PMC6925691</ArticleId><ArticleId IdType="pubmed">31885832</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang TY, Zhong M, Cheng YZ, Zhang MW. An interpretable machine learning model for real-time sepsis prediction based on basic physiological indicators. Eur Rev Med Pharmacol Sci. (2023) 27:4348&#x2013;56. doi: 10.26355/eurrev_202305_32439, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202305_32439</ArticleId><ArticleId IdType="pubmed">37259715</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Duan Y, Hou F, Yan G, Li S, Wang H, et al. . Early prediction of sepsis using a high-order Markov dynamic Bayesian network (HMDBN) classifier. Appl Intell. (2023) 53:26384&#x2013;99. doi: 10.1007/s10489-023-04920-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10489-023-04920-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Shen W, Wang G. Early prediction of Sepsis based on machine learning algorithm. Comput Intell Neurosci. (2021) 2021:6522633. doi: 10.1155/2021/6522633, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6522633</ArticleId><ArticleId IdType="pmc">PMC8526252</ArticleId><ArticleId IdType="pubmed">34675971</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdick H, Pino E, Gabel-Comeau D, Gu C, Roberts J, Le S, et al. . Validation of a machine learning algorithm for early severe sepsis prediction: a retrospective study predicting severe sepsis up to 48 h in advance using a diverse dataset from 461 US hospitals. BMC Med Inform Decis Mak. (2020) 20:1&#x2013;10. doi: 10.1186/s12911-020-01284-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-020-01284-x</ArticleId><ArticleId IdType="pmc">PMC7590695</ArticleId><ArticleId IdType="pubmed">33109167</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvert JS, Price DA, Chettipally UK, Barton CW, Feldman MD, Hoffman JL, et al. . A computational approach to early sepsis detection. Comput Biol Med. (2016) 74:69&#x2013;73. doi: 10.1016/j.compbiomed.2016.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2016.05.003</ArticleId><ArticleId IdType="pubmed">27208704</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29574007</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1036-7314</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Australian critical care : official journal of the Confederation of Australian Critical Care Nurses</Title><ISOAbbreviation>Aust Crit Care</ISOAbbreviation></Journal><ArticleTitle>A systematic review on risk factors associated with sepsis in patients admitted to intensive care units.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>164</EndPage><MedlinePgn>155-164</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aucc.2018.02.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1036-7314(17)30384-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We sought to systematically review data on the risk factors influencing the incidence of sepsis in patients admitted to intensive care units (ICUs).</AbstractText><AbstractText Label="REVIEW METHODS">An electronic search was undertaken in PubMed, MEDLINE, Scopus, and the Cochrane Library for studies reporting the risk factors of sepsis from the earliest available date up to December 30, 2016.</AbstractText><AbstractText Label="RESULTS">Among the 2978 articles, 14 studies met the inclusion criteria with a total of 56 164 participants from nine countries. The extracted risk factors were from the following categories: demographic, critical care interventions, surgery-related factors, pre-existing comorbidities, severity of organ injury, and biomarkers&#xa0;and biochemical and molecular indicators. From demographic factors, older age and male gender were associated with an increased risk of sepsis among ICU-admitted patients.</AbstractText><AbstractText Label="CONCLUSION">Our analysis comprehensively summarised the risk factors of sepsis in patients admitted to medical, surgical, neurologic, trauma, and general ICUs. Age, sex, and comorbidities were non-modifiable risk factors; however, critical care interventions and surgery-related factors were modifiable factors&#xa0;and suggest that improving the care of surgical patients and effective management of critical care interventions may play a key role in decreasing the development of sepsis in patients admitted to the ICUs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fathi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Critical Care Quality Improvement Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markazi-Moghaddam</LastName><ForeName>Nader</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Public Health, School of Medicine, AJA University of Medical Sciences, Tehran, Iran; Critical Care Quality Improvement Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramezankhani</LastName><ForeName>Azra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: az.ramezankhani@sbmu.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Aust Crit Care</MedlineTA><NlmUniqueID>9207852</NlmUniqueID><ISSNLinking>1036-7314</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Case control</Keyword><Keyword MajorTopicYN="N">Cohort</Keyword><Keyword MajorTopicYN="N">Health</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Risk factor</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29574007</ArticleId><ArticleId IdType="doi">10.1016/j.aucc.2018.02.005</ArticleId><ArticleId IdType="pii">S1036-7314(17)30384-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38769373</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5578</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Molecular psychiatry</Title><ISOAbbreviation>Mol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Severe mental illness and mortality in sepsis and septic shock: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>3857</StartPage><EndPage>3864</EndPage><MedlinePgn>3857-3864</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41380-024-02603-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There have been conflicting reports regarding the case-fatality outcomes associated with sepsis and septic shock in patients with severe mental illness (SMI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched Medline&#xae;, Web of Science&#xae; and the Cochrane Library&#xae; databases (from inception to 4-July-2023) for papers reporting outcomes associated with sepsis and septic shock in adult with (cases) vs. without SMI (controls). The main study outcome was the unadjusted case-fatality rate at hospital discharge, or 30 days if unavailable. Secondary outcomes included the rates of adjusted case-fatality at hospital discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of six studies were included in the systematic review, of which four provided data for meta-analysis involving 2,124,072 patients. Compared to controls, patients with SMI were younger and more frequently women. Unadjusted analyses showed that SMI patients had a lower case-fatality rate associated with sepsis and septic shock than their non-SMI counterparts (OR 0.61, 95% CI [0.58-0.65], PI 95% CI [0.49-0.77], I<sup>2</sup>&#x2009;=&#x2009;91%). Meta-regression and subgroup analyses showed that the denominator of the study population (i.e. septic shock or sepsis) was associated with the outcome with an R<sup>2</sup> of 59.7%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In conclusion, our study reveals a survival advantage of SMI patients over their non-SMI counterparts. Further research is needed to fully elucidate the mechanisms involved and to develop targeted interventions that can improve the prognosis of both SMI and non-SMI patients facing sepsis.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lakbar</LastName><ForeName>Ines</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0049-6248</Identifier><AffiliationInfo><Affiliation>AP-HM, Aix-Marseille Univ, CEReSS, Health Service Research and Quality of Life Centre, School of Medicine - La Timone Medical, Marseille, France. ines.lakbar@chu-montpellier.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care; Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, PhyMedExp, University of Montpellier, INSERM U1046, 1, 80 Avenue Augustin Fliche, Montpellier Cedex 5, Montpellier, France. ines.lakbar@chu-montpellier.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maakaron</LastName><ForeName>Eloise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>APHM, service de psychiatrie universitaire, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leone</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>AP-HM, Aix-Marseille Univ, CEReSS, Health Service Research and Quality of Life Centre, School of Medicine - La Timone Medical, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aix-Marseille University, AP-HM, North Hospital, Department of Anesthesia and Intensive Care Medicine, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delamarre</LastName><ForeName>Louis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care; Anesthesia and Critical Care Department C, Gui de Chauliac Teaching Hospital, 80 Avenue Augustin Fliche, Montpellier Cedex 5, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yon</LastName><ForeName>Dong Keon</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0003-1628-9948</Identifier><AffiliationInfo><Affiliation>Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Bach</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyer</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1229-6622</Identifier><AffiliationInfo><Affiliation>AP-HM, Aix-Marseille Univ, CEReSS, Health Service Research and Quality of Life Centre, School of Medicine - La Timone Medical, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FondaMental Fondation, Cr&#xe9;teil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fond</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AP-HM, Aix-Marseille Univ, CEReSS, Health Service Research and Quality of Life Centre, School of Medicine - La Timone Medical, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, service de psychiatrie universitaire, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FondaMental Fondation, Cr&#xe9;teil, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Psychiatry</MedlineTA><NlmUniqueID>9607835</NlmUniqueID><ISSNLinking>1359-4184</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="Y">Mental Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>21</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38769373</ArticleId><ArticleId IdType="doi">10.1038/s41380-024-02603-8</ArticleId><ArticleId IdType="pii">10.1038/s41380-024-02603-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lakbar I, Leone M, Pauly V, Orleans V, Srougbo K, Diao S, et al. Association of severe mental illness and septic shock case fatality rate in patients admitted to the intensive care unit: A national population-based cohort study. PLOS Med. 2023;20:e1004202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004202</ArticleId><ArticleId IdType="pubmed">36913434</ArticleId><ArticleId IdType="pmc">10042353</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M, Lakbar I, Vincent J-L. Sepsis: Actual numbers and uncertainties. Revue d&#x2019;&#xc9;pid&#xe9;miologie. et de St&#xe9; Publique. 2023;71:102176.</Citation></Reference><Reference><Citation>Ishida T, Nakamura K, Miyazaki K, Yukawa T, Yamagishi T, Sugiyama K, et al. Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review. Psychiatry Res. 2019;279:372&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2018.12.061</ArticleId><ArticleId IdType="pubmed">30558820</ArticleId></ArticleIdList></Reference><Reference><Citation>Soubani AO, Sharma A, Soubani O, Mishra T. Septic Shock Short-Term Outcomes in Hospitalized Patients With Major Psychiatric Disorders: Analysis From the National Inpatient Sample Database. J Acad Consult Liaison Psychiatry. 2023. https://doi.org/10.1016/j.jaclp.2023.03.003 .</Citation></Reference><Reference><Citation>Nilsson NH, Bendix M, &#xd6;hlund L, Widerstr&#xf6;m M, Werneke U, Maripuu M. Increased Risks of Death and Hospitalization in Influenza/Pneumonia and Sepsis for Individuals Affected by Psychotic Disorders, Bipolar Disorders, and Single Manic Episodes: A Retrospective Cross-Sectional Study. J Clin Med. 2021;10:4411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194411</ArticleId><ArticleId IdType="pubmed">34640430</ArticleId><ArticleId IdType="pmc">8509221</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Pauly V, Bege T, Orleans V, Braunstein D, Leone M, et al. Trauma-related mortality of patients with severe psychiatric disorders: population-based study from the French national hospital database. Br J Psychiatry. 2020;217:568&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2019.139</ArticleId><ArticleId IdType="pubmed">31217045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Pauly V, Leone M, Llorca P-M, Orleans V, Loundou A, et al. Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study. Schizophr Bull. 2021;47:624&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbaa158</ArticleId><ArticleId IdType="pubmed">33089862</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Pauly V, Leone M, Orleans V, Garosi A, Lancon C, et al. Mortality among inpatients with bipolar disorders and COVID-19: a propensity score matching analysis in a national French cohort study. Psychol Med. 2023;53:1979&#x2013;88.</Citation></Reference><Reference><Citation>Davydow DS, Ribe AR, Pedersen HS, Vestergaard M, Fenger-Gr&#xf8;n M. The association of unipolar depression with thirty-day mortality after hospitalization for infection: A population-based cohort study in Denmark. J Psychosom Res. 2016;89:32&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2016.08.006</ArticleId><ArticleId IdType="pubmed">27663108</ArticleId></ArticleIdList></Reference><Reference><Citation>Correll CU, Solmi M, Croatto G, Schneider LK, Rohani&#x2010;Montez SC, Fairley L, et al. Mortality in people with schizophrenia: a systematic review and meta&#x2010;analysis of relative risk and aggravating or attenuating factors. World Psychiatry. 2022;21:248&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20994</ArticleId><ArticleId IdType="pubmed">35524619</ArticleId><ArticleId IdType="pmc">9077617</ArticleId></ArticleIdList></Reference><Reference><Citation>Solmi M, Fiedorowicz J, Poddighe L, Delogu M, Miola A, H&#xf8;ye A, et al. Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies. AJP. 2021;178:793&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2021.21010031</ArticleId></ArticleIdList></Reference><Reference><Citation>PRISMA-P Group, Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">4320440</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 13 November 2023.</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId><ArticleId IdType="pmc">2335261</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Deeks J. Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021), Cochrane. 2021. Available from www.training.cochrane.org/handbook .</Citation></Reference><Reference><Citation>Deeks J, Higgins J, Altman D. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021), Cochrane. 2021. Available from www.training.cochrane.org/handbook .</Citation></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. vol. 77. Chichester, UK: John Wiley&amp;Sons; 2011.</Citation></Reference><Reference><Citation>R&#xfc;cker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Stat Med. 2008;27:746&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2971</ArticleId><ArticleId IdType="pubmed">17592831</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters JL. Comparison of Two Methods to Detect Publication Bias in Meta-analysis. JAMA. 2006;295:676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.6.676</ArticleId><ArticleId IdType="pubmed">16467236</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25:3443&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2380</ArticleId><ArticleId IdType="pubmed">16345038</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId><ArticleId IdType="pmc">2127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002&#x2013;d4002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d4002</ArticleId><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId><ArticleId IdType="pmc">10231495</ArticleId></ArticleIdList></Reference><Reference><Citation>Oud L, Garza J. Impact of history of mental disorders on short-term mortality among hospitalized patients with sepsis: A population-based cohort study. PLoS One. 2022;17:e0265240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0265240</ArticleId><ArticleId IdType="pubmed">35271683</ArticleId><ArticleId IdType="pmc">8912146</ArticleId></ArticleIdList></Reference><Reference><Citation>Arsenovi&#x107; S, Trajkovi&#x107; G, Pekmezovi&#x107; T, Gazibara T. Association of health literacy with physical and mental health in people with chronic diseases. Rev Epidemiol Sante Publique. 2023;71:101419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.respe.2022.101419</ArticleId><ArticleId IdType="pubmed">36563616</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmi L-R, Saillour-Gl&#xe9;nisson F, Alla F, Boussat B. Evaluation and research on public health interventions. Rev Epidemiol Sante Publique. 2023;71:101836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.respe.2023.101836</ArticleId><ArticleId IdType="pubmed">36965306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonkat N, Fellendorf FT, Dalkner N, Reininghaus EZ. Severe mental disorders and vaccinations &#x2013; a systematic review. World J Biol Psychiatry. 2022;23:501&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15622975.2021.2013095</ArticleId><ArticleId IdType="pubmed">35014937</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner J, Jacobs R, Panteli B, Brauner M, Schiltz K, Bahn S, et al. Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. Eur Arch Psychiatry Clin Neurosci. 2010;260:509&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-010-0098-x</ArticleId><ArticleId IdType="pubmed">20107825</ArticleId></ArticleIdList></Reference><Reference><Citation>Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun. 2012;26:469&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.12.011</ArticleId><ArticleId IdType="pubmed">22251606</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21:1696&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.3</ArticleId><ArticleId IdType="pubmed">26903267</ArticleId><ArticleId IdType="pmc">6056174</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth PM, Douchant K, Uyanwune Y, Larocque M, Anantharajah A, Borgundvaag E, et al. Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital. PLOS One. 2019;14:e0207138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0207138</ArticleId><ArticleId IdType="pubmed">30742636</ArticleId><ArticleId IdType="pmc">6370182</ArticleId></ArticleIdList></Reference><Reference><Citation>Land&#xe9;n M, Larsson H, Lichtenstein P, Westin J, Song J. Respiratory infections during lithium and valproate medication: a within-individual prospective study of 50,000 patients with bipolar disorder. Int J Bipolar Disord. 2021;9:4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40345-020-00208-y</ArticleId><ArticleId IdType="pubmed">33521836</ArticleId><ArticleId IdType="pmc">7847747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N, S&#xe1;nchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021;26:5199&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01021-4</ArticleId><ArticleId IdType="pubmed">33536545</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26117275</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-1409</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Burns : journal of the International Society for Burn Injuries</Title><ISOAbbreviation>Burns</ISOAbbreviation></Journal><ArticleTitle>Vasoconstrictor clysis in burn surgery and its impact on outcomes: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1140</StartPage><EndPage>1146</EndPage><MedlinePgn>1140-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.burns.2015.03.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0305-4179(15)00086-8</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Clysis is the subcutaneous or subdermal injection of a vasopressor containing fluid, with or without local anaesthetic agent, and has been used to limit blood loss in patients undergoing surgical burn management. In this systematic review and meta-analysis we aimed to determine the impact of clysis of a vasoconstrictor on burn patient outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic review to identify trials investigating clysis in burn patients undergoing debridement and/or skin grafting. For each eligible trial we aimed to extract the outcomes of perioperative blood loss, blood transfusion, duration of surgery, graft success and healing time, inflammatory response, sepsis, mortality, duration of hospital stay, catecholamine levels and cardiovascular effects in both the short (&lt;72h) and long term (30 days) after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From 443 citations, we selected 39 for full-text evaluation, and identified 10 eligible trials. Due to a lack of reporting on outcomes of interest, meta-analysis could only be conducted for the outcome of red blood cell (RBC) units transfused per patient. Patients receiving clysis (n=222) were transfused 1.89 less units (95% CI -2.12 to -1.66) as compared to those not receiving clysis, although this was associated with a high degree of heterogeneity (I(2)=88%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Few studies have adequately evaluated the impact of clysis in burn surgery on patient important outcomes such mortality, duration of surgery and graft success. These results suggest clysis may reduce the need for blood transfusion but additional high quality research is required.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Ltd and ISBI. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allorto</LastName><ForeName>N L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Pietermaritzburg Metropolitan Complex, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa. Electronic address: nikkiallorto@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bishop</LastName><ForeName>D G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Pietermaritzburg Metropolitan Complex, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodseth</LastName><ForeName>R N</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Pietermaritzburg Metropolitan Complex, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Burns</MedlineTA><NlmUniqueID>8913178</NlmUniqueID><ISSNLinking>0305-4179</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="N">Burns</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003646" MajorTopicYN="N">Debridement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006488" MajorTopicYN="N">Hemostasis, Surgical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007279" MajorTopicYN="N">Injections, Subcutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016038" MajorTopicYN="N">Skin Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">Burn surgery</Keyword><Keyword MajorTopicYN="N">Clysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26117275</ArticleId><ArticleId IdType="doi">10.1016/j.burns.2015.03.010</ArticleId><ArticleId IdType="pii">S0305-4179(15)00086-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38632681</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2362</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European journal of clinical investigation</Title><ISOAbbreviation>Eur J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e14225</StartPage><MedlinePgn>e14225</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/eci.14225</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Midregional-proAdrenomedullin (MR-proADM) has been recently proposed as a tool in patients with sepsis and septic shock. Our aim was to evaluate the prognostic role of MR-proADM in hospitalized patients with sepsis and septic shock.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PRISMA guideline was followed. MEDLINE and EMBASE were searched up to June 2023. Primary outcome was mean difference in MR-proADM among survivors and nonsurvivors, secondary outcome mean difference in MR-proADM according to infection severity and type. Risk of bias was evaluated using Newcastle-Ottawa scale for observational studies and Cochrane tool for randomized trials. Pooled mean differences (MD) with corresponding 95% confidence intervals (CIs) were calculated in a random-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four studies included 6730 adult patients (1208 nonsurvivors and 5522 survivors) and three studies included 195 paediatric patients (30 nonsurvivors and 165 survivors). A total of 10, 4 and 13 studies included, respectively, patients with sepsis (3602 patients), septic shock (386 patients) and a mixed population (2937 patients). Twenty-one studies included patients with different source of infection, three with pneumonia and one with a catheter-related infection. Most studies (n&#x2009;=&#x2009;12) had a follow-up of 28&#x2009;days. In adult cohort, pooled mean difference between nonsurvivors and survivors of MR-proADM was 2.55&#x2009;mmol/L (95% CI: 1.95-3.15) with higher values in patients with septic shock (4.25&#x2009;mmol/L; 95% CI, 2.23-6.26&#x2009;mmol/L) than in patients with sepsis (1.77&#x2009;mmol/L; 95% CI: 1.11-2.44&#x2009;mmol/L). In paediatric cohort, pooled mean difference was 3.11&#x2009;mmol/L (95% CI: -0.02-6.24&#x2009;mmol/L).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Higher values of MR-proADM are detectable in nonsurvivors adult and paediatric-hospitalized patients with sepsis or septic shock.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. European Journal of Clinical Investigation published by John Wiley &amp; Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valeriani</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9729-3214</Identifier><AffiliationInfo><Affiliation>Department of General Surgery and Surgical Specialty, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious disease, Umberto I Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falletta</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastori</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-6357-5213</Identifier><AffiliationInfo><Affiliation>Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porfidia</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Universit&#xe0; Cattolica del Sacro Cuore, Largo Agostino Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastroianni</LastName><ForeName>Claudio Maria</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Bari</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motta</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pignatelli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0832-7975</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Clin Invest</MedlineTA><NlmUniqueID>0245331</NlmUniqueID><ISSNLinking>0014-2972</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>148498-78-6</RegistryNumber><NameOfSubstance UI="D053607">Adrenomedullin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C088633">proadrenomedullin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053607" MajorTopicYN="Y">Adrenomedullin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="Y">Protein Precursors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adrenomedullin</Keyword><Keyword MajorTopicYN="N">infections</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38632681</ArticleId><ArticleId IdType="doi">10.1111/eci.14225</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Evans L , Rhodes A , Alhazzani W , et&#xa0;al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181&#x2010;1247.</Citation></Reference><Reference><Citation>WHO. Sepsis [Internet]. 2018. Available from: https://www.who.int/newsroom/fact&#x2010;sheets/detail/sepsis. Accessed June 20, 2023.</Citation></Reference><Reference><Citation>Bauer M , Gerlach H , Vogelmann T , Preissing F , Stiefel J , Adam D . Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019&#x2010; results from a systematic review and meta&#x2010;analysis. Crit Care. 2020;24(1):239.</Citation></Reference><Reference><Citation>Nargis W , Ibrahim M , Ahamed BU . Procalcitonin versus C&#x2010;reactive protein: usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014;4(3):195&#x2010;199.</Citation></Reference><Reference><Citation>Paudel R , Dogra P , Montgomery&#x2010;Yates AA , Coz Yataco A . Procalcitonin: a promising tool or just another overhyped test? Int J Med Sci. 2020;17(3):332&#x2010;337.</Citation></Reference><Reference><Citation>Suberviola B , Castellanos&#x2010;Ortega A , Llorca J , Ortiz F , Iglesias D , Prieto B . Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community&#x2010;acquired pneumonia. Swiss Med Wkly. 2012;142:w13542.</Citation></Reference><Reference><Citation>Lundberg OHM , Rosenqvist M , Bronton K , Schulte J , Friberg H , Melander O . Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care. PLoS One. 2022;17(4):e0267497.</Citation></Reference><Reference><Citation>Christ&#x2010;Crain M , Morgenthaler NG , Struck J , Harbarth S , Bergmann A , Muller B . Mid&#x2010;regional pro&#x2010;adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care. 2005;9(6):R816&#x2010;R824.</Citation></Reference><Reference><Citation>Li P , Wang C , Pang S . The diagnostic accuracy of mid&#x2010;regional pro&#x2010;adrenomedullin for sepsis: a systematic review and meta&#x2010;analysis. Minerva Anestesiol. 2021;87(10):1117&#x2010;1127.</Citation></Reference><Reference><Citation>Page MJ , Moher D , Bossuyt PM , et&#xa0;al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.</Citation></Reference><Reference><Citation>Wells GA , Shea B , O'Connel D , Peterson J , Welch V , Losos M . The Newcastle&#x2010;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta&#x2010;Analyses. 2012. Available online: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed January 10, 2023).</Citation></Reference><Reference><Citation>Deeks JJ , Higgins JPT , AltmaN DG . Analysing data and undertaking meta&#x2010;analyses. In: Higgins JPT , Thomas J , Chandler J , Cumpston M , Li T , Page MJ , Welch VA , (Eds.). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (Updated August 2023). Cochrane, 2023. Available from https://www.training.cochrane.org/handbook. Accessed January 2023.</Citation></Reference><Reference><Citation>Luo D , Wan X , Liu J , Tong T . Optimally estimating the sample mean from the sample size, median, mid&#x2010;range, and/or mid&#x2010;quartile range. Stat Methods Med Res. 2018;27(6):1785&#x2010;1805.</Citation></Reference><Reference><Citation>Akpinar S , Rollas K , Alagoz A , Segmen F , Sipit T . Performance evaluation of MR&#x2010;proadrenomedullin and other scoring systems in severe sepsis with pneumonia. J Thorac Dis. 2014;6(7):921&#x2010;929.</Citation></Reference><Reference><Citation>Andaluz&#x2010;Ojeda D , Nguyen HB , Meunier&#x2010;Beillard N , et&#xa0;al. Superior accuracy of mid&#x2010;regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity. Ann Intensive Care. 2017;7(1):15.</Citation></Reference><Reference><Citation>Badia Tejero AM , Martinez Sagasti F , Domingo Mar&#x131;n S , et&#xa0;al. Superior accuracy of mid&#x2010;regional proadrenomedullin over C reactive protein, procalcitonin and lactate for ICU mortality prediction in septic patients. Infection. 2017;45(1):S58&#x2010;S59.</Citation></Reference><Reference><Citation>Baldira J , Ruiz&#x2010;Rodriguez JC , Wilson DC , et&#xa0;al. Biomarkers and clinical scores to aid the identification of disease severity and intensive care requirement following activation of an in&#x2010;hospital sepsis code. Ann Intensive Care. 2020;10(1):7.</Citation></Reference><Reference><Citation>Bernal&#x2010;Morell E , Garcia&#x2010;Villalba E , Vera MDC , et&#xa0;al. Usefulness of midregional pro&#x2010;adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis. J Infect. 2018;76(3):249&#x2010;257.</Citation></Reference><Reference><Citation>Charles PE , Peju E , Dantec A , et&#xa0;al. Mr&#x2010;Proadm elevation upon Icu admission predicts the outcome of septic patients and is correlated with upcoming fluid overload. Shock. 2017;48(4):418&#x2010;426.</Citation></Reference><Reference><Citation>Christ&#x2010;Crain M , Morgenthaler NG , Stolz D , et&#xa0;al. Pro&#x2010;adrenomedullin to predict severity and outcome in community&#x2010;acquired pneumonia [ISRCTN04176397]. Crit Care. 2006;10(3):R96.</Citation></Reference><Reference><Citation>De La Torre&#x2010;Prados MV , Garcia&#x2010;De La Torre A , Enguix A , Mayor&#x2010;Reyes M , Nieto&#x2010;Gonzalez M , Garcia&#x2010;Alcantara A . Mid&#x2010;regional pro&#x2010;adrenomedullin as prognostic biomarker in septic shock. Minerva Anestesiol. 2016;82(7):760&#x2010;766.</Citation></Reference><Reference><Citation>Elke G , Bloos F , Wilson DC , et&#xa0;al. The use of mid&#x2010;regional proadrenomedullin to identify disease severity and treatment response to sepsis &#x2010; a secondary analysis of a large randomised controlled trial. Crit Care. 2018;22(1):79.</Citation></Reference><Reference><Citation>Fahmy AA , Azab MM , Amr GE , Matar HM . Sediq AM . al. eMid&#x2010;regional proadrenomedullin is a good prognostic marker for patients in the intensive care unit with sepsis. Crit Care Shock. 2022;25:309&#x2010;316.</Citation></Reference><Reference><Citation>Haag E , Gregoriano C , Molitor A , et&#xa0;al. Does mid&#x2010;regional pro&#x2010;adrenomedullin (MR&#x2010;proADM) improve the sequential organ failure assessment&#x2010;score (SOFA score) for mortality&#x2010;prediction in patients with acute infections? Results of a prospective observational study. Clin Chem Lab Med. 2021;59(6):1165&#x2010;1176.</Citation></Reference><Reference><Citation>Hoeboer SH , Alberts E , van den Hul I , Tacx AN , Debets&#x2010;Ossenkopp YJ , Groeneveld AB . Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin. J Infect. 2012;64(5):484&#x2010;493.</Citation></Reference><Reference><Citation>Julian&#x2010;Jimenez A , Yanez MC , Gonzalez&#x2010;Del Castillo J , et&#xa0;al. Prognostic power of biomarkers for short&#x2010;term mortality in the elderly patients seen in emergency departments due to infections. Enferm Infecc Microbiol Clin (Engl ed). 2019;37(1):11&#x2010;18.</Citation></Reference><Reference><Citation>Lundberg OH , Bergenzaun L , Ryden J , Rosenqvist M , Melander O , Chew MS . Adrenomedullin and endothelin&#x2010;1 are associated with myocardial injury and death in septic shock patients. Crit Care. 2016;20(1):178.</Citation></Reference><Reference><Citation>Mearelli F , Barbati G , Casarsa C , et&#xa0;al. The integration of qSOFA with clinical variables and serum biomarkers improves the prognostic value of qSOFA alone in patients with suspected or confirmed sepsis at ED admission. J Clin Med. 2020;9(4):1205.</Citation></Reference><Reference><Citation>Ni J , Sun Y , Qu H , Wang A , Cao Y , Li X . Prognostic value of serum proadrenomedullin in catheter&#x2010;related bloodstream infection in the intensive care unit: a prospective observational study. Medicine (Baltimore). 2018;97(42):e12821.</Citation></Reference><Reference><Citation>Saeed K , Wilson DC , Bloos F , et&#xa0;al. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi&#x2010;centre derivation and validation study. Crit Care. 2019;23(1):40.</Citation></Reference><Reference><Citation>Schuetz P , Christ&#x2010;Crain M , Morgenthaler NG , Struck J , Bergmann A , Muller B . Circulating precursor levels of endothelin&#x2010;1 and adrenomedullin, two endothelium&#x2010;derived, counteracting substances, in sepsis. Endothelium. 2007;14(6):345&#x2010;351.</Citation></Reference><Reference><Citation>Serano AMN , Alonso JV , Pinero GR , Camacho AR , Benet JS , Vaquero M . Biomarkers in shock patients and their value as a prognostic tool; a prospective multi&#x2010;center cohort study. Bull Emerg Trauma. 2019;7(3):232&#x2010;239.</Citation></Reference><Reference><Citation>Suberviola B , Castellanos&#x2010;Ortega A , Ruiz Ruiz A , Lopez&#x2010;Hoyos M , Santibanez M . Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Med. 2013;39(11):1945&#x2010;1952.</Citation></Reference><Reference><Citation>Valenzuela&#x2010;Sanchez F , Valenzuela&#x2010;Mendez B , Bohollo de Austria R , et&#xa0;al. Plasma levels of mid&#x2010;regional pro&#x2010;adrenomedullin in sepsis are associated with risk of death. Minerva Anestesiol. 2019;85(4):366&#x2010;375.</Citation></Reference><Reference><Citation>Bima P , Montrucchio G , Caramello V , et&#xa0;al. Prognostic value of mid&#x2010;regional Proadrenomedullin sampled at presentation and after 72 hours in septic patients presenting to the emergency department: an observational two&#x2010;center study. Biomedicine. 2022;10(3):719.</Citation></Reference><Reference><Citation>Helan M , Malaska J , Tomandl J , et&#xa0;al. Kinetics of biomarkers of oxidative stress in septic shock: a pilot study. Antioxidants (Basel). 2022;11(4):640.</Citation></Reference><Reference><Citation>Fahmey SS , Mostafa H , Elhafeez NA , Hussain H . Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis. Korean J Pediatr. 2018;61(5):156&#x2010;159.</Citation></Reference><Reference><Citation>Hagag AA , Elmahdy HS , Ezzat AA . Prognostic value of plasma pro&#x2010;adrenomedullin and antithrombin levels in neonatal sepsis. Indian Pediatr. 2011;48(6):471&#x2010;473.</Citation></Reference><Reference><Citation>Jordan I , Corniero P , Balaguer M , et&#xa0;al. Adrenomedullin is a useful biomarker for the prognosis of critically ill septic children. Biomark Med. 2014;8(9):1065&#x2010;1072.</Citation></Reference><Reference><Citation>Struck J , Tao C , Morgenthaler NG , Bergmann A . Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides. 2004;25(8):1369&#x2010;1372.</Citation></Reference><Reference><Citation>Liang J , Cai Y , Shao Y . Comparison of presepsin and mid&#x2010;regional pro&#x2010;adrenomedullin in the diagnosis of sepsis or septic shock: a systematic review and meta&#x2010;analysis. BMC Infect Dis. 2023;23(1):288.</Citation></Reference><Reference><Citation>Liu D , Xie L , Zhao H , Liu X , Cao J . Prognostic value of mid&#x2010;regional pro&#x2010;adrenomedullin (MR&#x2010;proADM) in patients with community&#x2010;acquired pneumonia: a systematic review and meta&#x2010;analysis. BMC Infect Dis. 2016;16:232.</Citation></Reference><Reference><Citation>Garcia de Guadiana&#x2010;Romualdo L , Calvo Nieves MD , Rodriguez Mulero MD , et&#xa0;al. MR&#x2010;proADM as marker of endotheliitis predicts COVID&#x2010;19 severity. Eur J Clin Invest. 2021;51(5):e13511.</Citation></Reference><Reference><Citation>Spoto S , Fogolari M , De Florio L , et&#xa0;al. Procalcitonin and MR&#x2010;proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock. Microb Pathog. 2019;137:103763.</Citation></Reference><Reference><Citation>Corr MP , Fairley D , McKenna JP , Shields MD , Waterfield T . Diagnostic value of mid&#x2010;regional pro&#x2010;adrenomedullin as a biomarker of invasive bacterial infection in children: a systematic review. BMC Pediatr. 2022;22(1):176.</Citation></Reference><Reference><Citation>Hupf J , Mustroph J , Hanses F , Evert K , Maier LS , Jungbauer CG . RNA&#x2010;expression of adrenomedullin is increased in patients with severe COVID&#x2010;19. Crit Care. 2020;24(1):527.</Citation></Reference><Reference><Citation>Michels M , Djamiatun K , Faradz SM , Koenders MM , de Mast Q , van der Ven AJ . High plasma mid&#x2010;regional pro&#x2010;adrenomedullin levels in children with severe dengue virus infections. J Clin Virol. 2011;50(1):8&#x2010;12.</Citation></Reference><Reference><Citation>Fialek B , De Roquetaillade C , Pruc M , et&#xa0;al. Systematic review with meta&#x2010;analysis of mid&#x2010;regional pro&#x2010;adrenomedullin (MR&#x2010;proadm) as a prognostic marker in Covid&#x2010;19&#x2010;hospitalized patients. Ann Med. 2023;55(1):379&#x2010;387.</Citation></Reference><Reference><Citation>Montrucchio G , Sales G , Balzani E , et&#xa0;al. Effectiveness of mid&#x2010;regional pro&#x2010;adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID&#x2010;19 critically ill patients: new evidence from a 15&#x2010;month observational prospective study. Front Med (Lausanne). 2023;10:1122367.</Citation></Reference><Reference><Citation>Sozio E , Moore NA , Fabris M , et&#xa0;al. Identification of COVID&#x2010;19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid&#x2010;regional pro&#x2010;adrenomedullin. Respir Res. 2022;23(1):221.</Citation></Reference><Reference><Citation>Lampsas S , Tsaplaris P , Pantelidis P , et&#xa0;al. The role of endothelial related circulating biomarkers in COVID&#x2010;19. A systematic review and meta&#x2010;analysis. Curr Med Chem. 2022;29(21):3790&#x2010;3805.</Citation></Reference><Reference><Citation>Zaninotto M , Mion MM , Marchioro L , Padoan A , Plebani M . Endothelial dysfunction and mid&#x2010;regional proAdrenomedullin: what role in SARS&#x2010;CoV&#x2010;2 infected patients? Clin Chim Acta. 2021;523:185&#x2010;190.</Citation></Reference><Reference><Citation>Sozio E , Tascini C , Fabris M , et&#xa0;al. MR&#x2010;proADM as prognostic factor of outcome in COVID&#x2010;19 patients. Sci Rep. 2021;11(1):5121.</Citation></Reference><Reference><Citation>Andres C , Andaluz&#x2010;Ojeda D , Cicuendez R , et&#xa0;al. MR&#x2010; proADM to detect specific types of organ failure in infection. Eur J Clin Invest. 2020;50(6):e13246.</Citation></Reference><Reference><Citation>Falkentoft AC , Rorth R , Iversen K , et&#xa0;al. MR&#x2010;proADM as a prognostic marker in patients with ST&#x2010;segment&#x2010;elevation myocardial infarction&#x2010;DANAMI&#x2010;3 (a Danish study of optimal acute treatment of patients with STEMI) substudy. J Am Heart Assoc. 2018;7(11):e008123.</Citation></Reference><Reference><Citation>Potocki M , Ziller R , Mueller C . Mid&#x2010;regional pro&#x2010;adrenomedullin in acute heart failure: a better biomarker or just another biomarker? Curr Heart Fail Rep. 2012;9(3):244&#x2010;251.</Citation></Reference><Reference><Citation>Myhre PL , Liu Y , Kulac IJ , et&#xa0;al. Changes in mid&#x2010;regional pro&#x2010;adrenomedullin during treatment with sacubitril/valsartan. Eur J Heart Fail. 2023;25(8):1396&#x2010;1405.</Citation></Reference><Reference><Citation>Nunez J , de la Espriella R , Rossignol P , et&#xa0;al. Congestion in heart failure: a circulating biomarker&#x2010;based perspective. A review from the biomarkers working Group of the Heart Failure Association, European Society of Cardiology. Eur J Heart Fail. 2022;24(10):1751&#x2010;1766.</Citation></Reference><Reference><Citation>Spinarova M , Spinar J , Spinarova L , et&#xa0;al. Relation between mid&#x2010;regional pro&#x2010;adrenomedullin in patients with chronic heart failure and the dose of diuretics in 2&#x2010;year follow&#x2010;up&#x2014;Data from FAR NHL registry. Medicina (Kaunas). 2022;58(10):1477.</Citation></Reference><Reference><Citation>Sabatine MS , Morrow DA , de Lemos JA , et&#xa0;al. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease. Circulation. 2012;125(2):233&#x2010;240.</Citation></Reference><Reference><Citation>von Haehling S , Filippatos GS , Papassotiriou J , et&#xa0;al. Mid&#x2010;regional pro&#x2010;adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail. 2010;12(5):484&#x2010;491.</Citation></Reference><Reference><Citation>Dieplinger B , Mueller T , Kollerits B , et&#xa0;al. Pro&#x2010;A&#x2010;type natriuretic peptide and pro&#x2010;adrenomedullin predict progression of chronic kidney disease: the MMKD study. Kidney Int. 2009;75(4):408&#x2010;414.</Citation></Reference><Reference><Citation>Yan H , Jin S , Liang L , Du J , Aithal GP , Li L . Pro&#x2010;adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute&#x2010;on&#x2010;chronic liver failure and short&#x2010;term survival. Scand J Gastroenterol. 2020;55(5):606&#x2010;614.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30261898</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Septic shock-3 vs 2: an analysis of the ALBIOS study.</ArticleTitle><Pagination><StartPage>237</StartPage><MedlinePgn>237</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">237</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-018-2169-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">A reanalysis of the ALBIOS trial suggested that patients with septic shock - defined by vasopressor-dependent hypotension in the presence of severe sepsis (Shock-2) - had a survival benefit when treated with albumin. The new septic shock definition (Shock-3) added the criterion of a lactate threshold of 2&#xa0;mmol/L. We investigated how the populations defined according to Shock-2 and Shock-3 differed and whether the albumin benefit would be confirmed.</AbstractText><AbstractText Label="METHODS">This is a retrospective analysis of the ALBIOS study, a randomized controlled study conducted between 2008 and 2012 in 100 intensive care units in Italy comparing the administration of 20% albumin and crystalloids versus crystalloids alone in patients with severe sepsis or septic shock. We analyzed data from 1741 patients from ALBIOS with serum lactate measurement available at baseline. We compared group size, physiological variables and 90-day mortality between patients defined by Shock-2 and Shock-3 and between the albumin and crystalloid treatment groups.</AbstractText><AbstractText Label="RESULTS">We compared the Shock-2 and the Shock-3 definitions and the albumin and crystalloid treatment groups in terms of group size and physiological, laboratory and outcome variables. The Shock-3 definition reduced the population with shock by 34%. The Shock-3 group had higher lactate (p&#x2009;&lt;&#x2009;0.001), greater resuscitation-fluid requirement (p&#x2009;=&#x2009;0.014), higher Simplified Acute Physiology Score II (p&#x2009;&lt;&#x2009;0.001) and Sepsis-related Organ Failure Assessment scores (p&#x2009;=&#x2009;0.022), lower platelet count (p&#x2009;=&#x2009;0.002) and higher 90-day mortality (46.7% vs 51.9%; p&#x2009;=&#x2009;0.031). Albumin decreased mortality in Shock-2 patients compared to crystalloids (43.5% vs 49.9%; 12.6% relative risk reduction; p&#x2009;=&#x2009;0.04). In patients defined by Shock-3 a similar benefit was observed for albumin with a 11.3% relative risk reduction (48.7% vs 54.9%; 11.3% relative risk reduction; p&#x2009;=&#x2009;0.22).</AbstractText><AbstractText Label="CONCLUSIONS">The Sepsis-3 definition reduced the size of the population with shock and showed a similar effect size in the benefits of albumin. The Shock-3 criteria will markedly slow patients' recruitment rates, in view of testing albumin in septic shock.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov, number NCT00707122 . Registered on 30 June 2008.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vasques</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duscio</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romitti</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasticci</LastName><ForeName>Iacopo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caironi</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Azienda-Ospedaliero Universitaria S. Luigi Gonzaga, Orbassano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Oncologia, Universit&#xe0; degli Studi di Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meessen</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Research, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latini</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Research, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cressoni</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze della Salute, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camporota</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, and Division of Asthma, Allergy and Lung Biology, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesenti</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dipartimento di Anestesia, Rianimazione ed Emergenza Urgenza, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dipartimento di Anestesia, Rianimazione ed Emergenza Urgenza, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Milan-Bicocca, School of Medicine and Surgery, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintel</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gattinoni</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany. gattinoniluciano@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00707122</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>ZIF514RVZR</RegistryNumber><NameOfSubstance UI="D000075462">Serum Albumin, Human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075462" MajorTopicYN="N">Serum Albumin, Human</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALBIOS</Keyword><Keyword MajorTopicYN="N">Albumin</Keyword><Keyword MajorTopicYN="N">Crystalloids</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Shock-3</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The ALBIOS study was approved by the ethical commission. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30261898</ArticleId><ArticleId IdType="pmc">PMC6161337</ArticleId><ArticleId IdType="doi">10.1186/s13054-018-2169-8</ArticleId><ArticleId IdType="pii">10.1186/s13054-018-2169-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caironi P, Tognoni G, Masson S, Fumagalli R, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412&#x2013;21. doi: 10.1056/NEJMoa1305727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1305727</ArticleId><ArticleId IdType="pubmed">24635772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644&#x2013;55. doi: 10.1378/chest.101.6.1644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.101.6.1644</ArticleId><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Int Care Med. 1996;22:707&#x2013;10. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Ranieri VM, Pesenti A. Sepsis: needs for defining severity. Int Care Med. 2015;41:551&#x2013;2. doi: 10.1007/s00134-014-3598-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3598-8</ArticleId><ArticleId IdType="pubmed">25518952</ArticleId></ArticleIdList></Reference><Reference><Citation>Holst LB, Haase N, Wetterslev J, Wernerman J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371:1381&#x2013;1391. doi: 10.1056/NEJMoa1406617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1406617</ArticleId><ArticleId IdType="pubmed">25270275</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P, Meziani F, Hamel JF, Grelon F, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583&#x2013;93. doi: 10.1056/NEJMoa1312173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1312173</ArticleId><ArticleId IdType="pubmed">24635770</ArticleId></ArticleIdList></Reference><Reference><Citation>Yealy DM, Kellum JA, Huang DT, Barnato AE, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683&#x2013;93. doi: 10.1056/NEJMoa1401602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401602</ArticleId><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>Peake SL, Delaney A, Bailey M, Bellomo R, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496&#x2013;506. doi: 10.1056/NEJMoa1404380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1404380</ArticleId><ArticleId IdType="pubmed">25272316</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;10. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, Howell MD, Talmor D, Nathanson LA, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45:524&#x2013;8. doi: 10.1016/j.annemergmed.2004.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2004.12.006</ArticleId><ArticleId IdType="pubmed">15855951</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Lee T, Singer J, Boyd JH, et al. The septic shock 3.0 definition and trials: a vasopressin and septic shock trial experience. Crit Care Med. 2017;45:940&#x2013;8. doi: 10.1097/CCM.0000000000002323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002323</ArticleId><ArticleId IdType="pubmed">28333757</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877&#x2013;87. doi: 10.1056/NEJMoa067373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa067373</ArticleId><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:775&#x2013;87. doi: 10.1001/jama.2016.0289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0289</ArticleId><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;77. doi: 10.1056/NEJMoa010307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010307</ArticleId><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">24612945</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2014</Year><Month>Mar</Month><Day>10</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)--systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>41</StartPage><MedlinePgn>41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1741-7015-12-41</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading treatment option for severe aortic valve stenosis. Traditionally, in most centers, this procedure is done under GA, but more recently procedures with MAC have been reported.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a systematic review and meta-analysis comparing MAC versus GA in patients undergoing transfemoral TAVR. Trials were identified through a literature search covering publications from 1 January 2005 through 31 January 2013. The main outcomes of interest of this literature meta-analysis were 30-day overall mortality, cardiac-/procedure-related mortality, stroke, myocardial infarction, sepsis, acute kidney injury, procedure time and duration of hospital stay. A random effects model was used to calculate the pooled relative risks (RR) with 95% confidence intervals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven observational studies and a total of 1,542 patients were included in this analysis. None of the studies were randomized. Compared to GA, MAC was associated with a shorter hospital stay (-3.0 days (-5.0 to -1.0); P = 0.004) and a shorter procedure time (MD -36.3 minutes (-58.0 to -15.0 minutes); P &lt;0.001). Overall 30-day mortality was not significantly different between MAC and GA (RR 0.77 (0.38 to 1.56); P = 0.460), also cardiac- and procedure-related mortality was similar between both groups (RR 0.90 (0.34 to 2.39); P = 0.830).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These data did not show a significant difference in short-term outcomes for MAC or GA in TAVR. MAC may be associated with reduced procedural time and shorter hospital stay. Now randomized trials are needed for further evaluation of MAC in the setting of TAVR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fr&#xf6;hlich</LastName><ForeName>Georg M</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Lansky</LastName><ForeName>Alexandra J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Roffi</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Toggweiler</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Reinthaler</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Duolao</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Hutchinson</LastName><ForeName>Nevil</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Wendler</LastName><ForeName>Olaf</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Hildick-Smith</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Heart Hospital, University College London Hospitals, London, UK. pascalmeier74@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="N">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24612945</ArticleId><ArticleId IdType="pmc">PMC4022332</ArticleId><ArticleId IdType="doi">10.1186/1741-7015-12-41</ArticleId><ArticleId IdType="pii">1741-7015-12-41</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597&#x2013;1607. doi: 10.1056/NEJMoa1008232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1008232</ArticleId><ArticleId IdType="pubmed">20961243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, Donal E, Prendergast B, Magne J, La Canna G, Pi&#xe9;rard LA, Maurer G. ESC Working Group on Valvular Heart Disease Position Paper - heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34:1597&#x2013;1606. doi: 10.1093/eurheartj/ehs443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs443</ArticleId><ArticleId IdType="pubmed">23293304</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carri&#xe9; D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R. et al.Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705&#x2013;1715. doi: 10.1056/NEJMoa1114705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1114705</ArticleId><ArticleId IdType="pubmed">22551129</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiles S.  TAVR in-Hospital Death, Stroke Rates Stay Low Even as Use Climbs: GARY. Munich: European Society of Cardiology ESC 2012; 2012.   http://www.medscape.com/viewarticle/769866.</Citation></Reference><Reference><Citation>Linke A, Bosmans J, Gerckens U, Wenaweser P, Tamburino C, Brecker S, Bauernschmitt R. Local vs. General Anaesthesia: Impact on the outcomes of transcatheter aortic valve implantation: insights from the multicentre ADVANCE study. Munich: European Society of Cardiology ESC; 2012.</Citation></Reference><Reference><Citation>Motloch LJ, Rottlaender D, Reda S, Larbig R, Bruns M, M&#xfc;ller-Ehmsen J, Strauch J, Madershahian N, Erdmann E, Wahlers T, Hoppe UC. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol. 2012;101:45&#x2013;53. doi: 10.1007/s00392-011-0362-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-011-0362-8</ArticleId><ArticleId IdType="pubmed">21931964</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin JL, Lim P, Dubois-Rande JL, Teiger E. Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2013;111:94&#x2013;99. doi: 10.1016/j.amjcard.2012.08.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.08.053</ArticleId><ArticleId IdType="pubmed">23068861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruppert V, Leurs LJ, Rieger J, Steckmeier B, Buth J, Umscheid T. EUROSTAR Collaborators. Risk-adapted outcome after endovascular aortic aneurysm repair: analysis of anesthesia types based on EUROSTAR data. J Endovasc Ther. 2007;14:12&#x2013;22. doi: 10.1583/06-1957.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/06-1957.1</ArticleId><ArticleId IdType="pubmed">17291150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick B, Slinger P. Lung protective strategies in anaesthesia. Br J Anaesth. 2010;105:i108&#x2013;i116. doi: 10.1093/bja/aeq299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq299</ArticleId><ArticleId IdType="pmc">PMC9149602</ArticleId><ArticleId IdType="pubmed">21148650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim T, Kim HJ, Lee JM, Kim JH, Hong DM, Jeon Y, Roh YJ, Lim YJ, Bahk JH. The head-down tilt position decreases vasopressor requirement during hypotension following induction of anaesthesia in patients undergoing elective coronary artery bypass graft and valvular heart surgeries. Eur J Anaesthesiol. 2011;28:45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">21088595</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323&#x2013;2329. doi: 10.1001/jama.2009.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1754</ArticleId><ArticleId IdType="pubmed">19952319</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Straus SE, Moher D. How can we improve the interpretation of systematic reviews? BMC Med. 2011;9:31. doi: 10.1186/1741-7015-9-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-9-31</ArticleId><ArticleId IdType="pmc">PMC3072347</ArticleId><ArticleId IdType="pubmed">21450084</ArticleId></ArticleIdList></Reference><Reference><Citation>tctmd. The Source for Interventional Cardiovascular News and Education.   http://www.tctmd.com.</Citation></Reference><Reference><Citation>The Heart Org. Medscape Cardiology.   http://www.theheart.org.</Citation></Reference><Reference><Citation>EuroPCR:   http://www.europcronline.com.</Citation></Reference><Reference><Citation>American College of Cardiology. CardioSource.   http://www.cardiosource.com.</Citation></Reference><Reference><Citation>CRTonline.   http://www.crtonline.org.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137&#x2013;159. doi: 10.1111/j.1467-985X.2008.00552.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-985X.2008.00552.x</ArticleId><ArticleId IdType="pmc">PMC2667312</ArticleId><ArticleId IdType="pubmed">19381330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankey SS, Weissfeld LA, Fine MJ, Kapoor W. An assessment of the use of the continuity correction for sparse data in meta-analysis. Commun Stat. 1996;25:1031&#x2013;1056.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat. 1978;32:138.</Citation></Reference><Reference><Citation>Behan M, Haworth P, Hutchinson N, Trivedi U, Laborde JC, Hildick-Smith D. Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv. 2008;72:1012&#x2013;1015. doi: 10.1002/ccd.21777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.21777</ArticleId><ArticleId IdType="pubmed">19021273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Dor I, Looser PM, Maluenda G, Weddington TC, Kambouris NG, Barbash IM, Hauville C, Okubagzi P, Corso PJ, Satler LF, Pichard AD, Waksman R. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovasc Revasc Med. 2012;13:207&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">22818531</ArticleId></ArticleIdList></Reference><Reference><Citation>Covello RD, Ruggeri L, Landoni G, Guarracino F, Bignami E, Gonfalini M, Virzo I, Michev I, Colombo A, Zangrillo A. Transcatheter implantation of an aortic valve: anesthesiological management. Minerva Anestesiol. 2010;76:100&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">20150850</ArticleId></ArticleIdList></Reference><Reference><Citation>Deh&#xe9;din B, Guinot PG, Ibrahim H, Allou N, Provench&#xe8;re S, Dilly MP, Vahanian A, Himbert D, Brochet E, Radu C, Nataf P, Montravers P, Longrois D, Depoix JP. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth. 2011;25:1036&#x2013;1043. doi: 10.1053/j.jvca.2011.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.05.008</ArticleId><ArticleId IdType="pubmed">21803602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulur P, Nishimori M, Ballantyne JC. Regional anaesthesia versus general anaesthesia, morbidity and mortality. Best Pract Res Clin Anaesthesiol. 2006;20:249&#x2013;263. doi: 10.1016/j.bpa.2005.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2005.10.002</ArticleId><ArticleId IdType="pubmed">16850776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bainbridge D, Martin J, Arango M, Cheng D. for the Evidence-based Peri-operative Clinical Outcomes Research (EpiCOR) Group. Evidence-based peri-operative clinical outcomes research, perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Lancet. 2012;380:1075&#x2013;1081. doi: 10.1016/S0140-6736(12)60990-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)60990-8</ArticleId><ArticleId IdType="pubmed">22998717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioni M, Taramasso M, Giacomini A, Montorfano M, Latib A, Colombo A, Alfieri O, Maisano F. Transaxillary approach: short- and mid-term results in a single-center experience. Innovations (Phila) 2011;6:361&#x2013;365. doi: 10.1097/IMI.0b013e318248e9ed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IMI.0b013e318248e9ed</ArticleId><ArticleId IdType="pubmed">22436770</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips D. Aortic stenosis: a review. AANA J. 2006;74:309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">16918123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gripari P, Ewe SH, Fusini L, Muratori M, Ng AC, Cefal&#xf9; C, Delgado V, Schalij MJ, Bax JJ, Marsan NA, Tamborini G, Pepi M. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation. Heart. 2012;98:1229&#x2013;1236. doi: 10.1136/heartjnl-2012-301998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-301998</ArticleId><ArticleId IdType="pubmed">22826560</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold M, Achenbach S, Pfeiffer I, Ensminger S, Marwan M, Einhaus F, Pflederer T, Ropers D, Schuhbaeck A, Anders K, Lell M, Uder M, Ludwig J, Weyand M, Daniel WG, Feyrer R. A method to determine suitable fluoroscopic projections for transcatheter aortic valve implantation by computed tomography. J Cardiovasc Comput Tomogr. 2012;6:422&#x2013;428. doi: 10.1016/j.jcct.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcct.2012.10.008</ArticleId><ArticleId IdType="pubmed">23217463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Ling LH, Halloran K, Morton JB, Spence SJ, Joseph S, Kistler PM, Sparks PB, Kalman JM. Esophageal hematoma after atrial fibrillation ablation: incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol. 2012;5:701&#x2013;705. doi: 10.1161/CIRCEP.112.970624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.112.970624</ArticleId><ArticleId IdType="pubmed">22544279</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of Anaesthetists of Great Britain and Ireland. Day case and short stay surgery: 2. Anaesthesia. 2011;66:417&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">21418041</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. 2001;7:174&#x2013;177. doi: 10.3201/eid0702.010203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0702.010203</ArticleId><ArticleId IdType="pmc">PMC2631709</ArticleId><ArticleId IdType="pubmed">11294700</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggan M, Kavanagh BP. Perioperative modifications of respiratory function. Best Pract Res Clin Anaesthesiol. 2010;24:145&#x2013;155. doi: 10.1016/j.bpa.2009.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2009.12.001</ArticleId><ArticleId IdType="pubmed">20608553</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Guerrero ML, Verdejo C, Azofra J, de G&#xf3;rgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis. 1995;20:16&#x2013;23. doi: 10.1093/clinids/20.1.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.1.16</ArticleId><ArticleId IdType="pubmed">7727642</ArticleId></ArticleIdList></Reference><Reference><Citation>Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open. 2012;2:e001032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3358616</ArticleId><ArticleId IdType="pubmed">22561354</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33:1266&#x2013;1271. doi: 10.1097/01.CCM.0000164543.14619.00.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000164543.14619.00</ArticleId><ArticleId IdType="pubmed">15942342</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantini G, Gasparetto V, Napodano M, Fraccaro C, Gerosa G, Isabella G. Valvular leak after transcatheter aortic valve implantation: a clinician update on epidemiology, pathophysiology and clinical implications. Am J Cardiovasc Dis. 2011;1:312&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253519</ArticleId><ArticleId IdType="pubmed">22254207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33287861</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Role of extracorporeal membrane oxygenation in children with sepsis: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>684</StartPage><MedlinePgn>684</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">684</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-020-03418-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">The benefits of extracorporeal membrane oxygenation (ECMO) in children with sepsis remain controversial. Current guidelines on management of septic shock in children recommend consideration of ECMO as salvage therapy. We sought to review peer-reviewed publications on effectiveness of ECMO in children with sepsis.</AbstractText><AbstractText Label="METHODS">Studies reporting on mortality in children with sepsis supported with ECMO, published in PubMed, Scopus and Embase from 1972 till February 2020, were included in the review. This study was done in adherence to Preferred Reporting Items for Systematic Review and Meta-Analysis statement after registering the review protocol with PROSPERO. Study eligibility was independently assessed by two authors and disagreements resolved by a third author. Publications were reviewed for quality using Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Random-effects meta-analyses (DerSimonian and Laird) were conducted, and 95% confidence intervals were computed using the Clopper-Pearson method. Outliers were identified by the Baujat plot and leave-one-out analysis if there was considerable heterogeneity. The primary outcome measure was survival to discharge. Secondary outcome measures included hospital length of stay, subgroup analysis of neonatal and paediatric groups, types and duration of ECMO and complications .</AbstractText><AbstractText Label="RESULTS">Of the 2054 articles screened, we identified 23 original articles for systematic review and meta-analysis. Cumulative estimate of survival (13 studies, 2559 patients) in the cohort was 59% (95%CI: 51-67%). Patients had a median length of hospital stay of 28.8&#xa0;days, median intensive care unit stay of 13.5&#xa0;days, and median ECMO duration of 129&#xa0;h. Children needing venoarterial ECMO (9 studies, 208 patients) showed overall pooled survival of 65% (95%CI: 50-80%). Neonates (&lt;&#x2009;4&#xa0;weeks of age) with sepsis needing ECMO (7 studies, 85 neonates) had pooled survival of 73% (95%CI: 56- 87%). Gram positive organisms were the most common pathogens (47%) in septic children supported with ECMO.</AbstractText><AbstractText Label="CONCLUSION">Survival rates of children with sepsis needing ECMO was 59%. Neonates had higher survival rates (73%); gram positive organisms accounted for most common infections in children needing ECMO. Despite limitations, pooled survival data from this review indicates consideration of ECMO in refractory septic shock for all pediatric age groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramanathan</LastName><ForeName>Kollengode</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1822-9455</Identifier><AffiliationInfo><Affiliation>Cardiothoracic Intensive Care Unit, Department of Cardiothoracic Surgery, National University Hospital, Singapore, 119228, Singapore. ram_ramanathan@nuhs.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. ram_ramanathan@nuhs.edu.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Queen's University Belfast School of Medicine, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Peta</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raman</LastName><ForeName>Lakshmi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Texas Southwestern Medical Center, Dallas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbaro</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, University of Michigan, Ann Arbor, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chuen Seng</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlapbach</LastName><ForeName>Luregn J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine and Neonatology, and Children's Research Center, University Children's Hospital of Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Critical Care Research Group, Child Health Research Centre, The University of Queensland and Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLaren</LastName><ForeName>Graeme</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiothoracic Intensive Care Unit, Department of Cardiothoracic Surgery, National University Hospital, Singapore, 119228, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K12 HL138039</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Neonatal</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>The authors have no conflict of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>8</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33287861</ArticleId><ArticleId IdType="pmc">PMC7720382</ArticleId><ArticleId IdType="doi">10.1186/s13054-020-03418-z</ArticleId><ArticleId IdType="pii">10.1186/s13054-020-03418-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">29508706</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Kissoon N. Defining pediatric sepsis. JAMA Pediatr. 2018;172(4):312&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">29459982</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaud J, Guellec I, Leger PL, Renolleau S, Guilbert J. Venoarterial extracorporeal membrane oxygenation support for neonatal and pediatric refractory septic shock. Indian J Crit Care Med. 2015;19(10):600&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4637960</ArticleId><ArticleId IdType="pubmed">26628825</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority: a WHO resolution. N Engl J Med. 2017;377(5):414&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">28658587</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B, Wong JJ, Sultana R, Koh J, Jit M, Mok YH, Lee JH. Global case-fatality rates in pediatric severe sepsis and septic shock: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(4):352&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450287</ArticleId><ArticleId IdType="pubmed">30742207</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans IVR, Phillips GS, Alpern ER, Angus DC, Friedrich ME, Kissoon N, Lemeshow S, Levy MM, Parker MM, Terry KM, et al. Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis. JAMA. 2018;320(4):358&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6500448</ArticleId><ArticleId IdType="pubmed">30043064</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Straney L, Alexander J, MacLaren G, Festa M, Schibler A, Slater A, Group APS Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002&#x2013;13: a multicentre retrospective cohort study. Lancet Infect Dis. 2015;15(1):46&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">25471555</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclerc F, Leteurtre S, Duhamel A, Grandbastien B, Proulx F, Martinot A, Gauvin F, Hubert P, Lacroix J. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Respir Crit Care Med. 2005;171(4):348&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">15516535</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med. 2005;6(3 Suppl):S3&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15857554</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L, Ray S, Wilson C, Remy S, Benissa MR, Jansen NJG, Javouhey E, Peters MJ, Kneyber M, De Luca D, et al. Refractory septic shock in children: a European Society of Paediatric and Neonatal Intensive Care definition. Intensive Care Med. 2016;42(12):1948&#x2013;1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5106490</ArticleId><ArticleId IdType="pubmed">27709263</ArticleId></ArticleIdList></Reference><Reference><Citation>Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37(2):666&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4447433</ArticleId><ArticleId IdType="pubmed">19325359</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruth A, McCracken CE, Fortenberry JD, Hebbar KB. Extracorporeal therapies in pediatric severe sepsis: findings from the pediatric health-care information system. Crit Care. 2015;19:397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4640405</ArticleId><ArticleId IdType="pubmed">26552921</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLaren G, Butt W, Best D, Donath S, Taylor A. Extracorporeal membrane oxygenation for refractory septic shock in children: one institution's experience. Pediatr Crit Care Med. 2007;8(5):447&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">17693912</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett RH. Extracorporeal support for septic shock. Pediatr Crit Care Med. 2007;8(5):498&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pubmed">17873786</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLaren G, Butt W, Best D, Donath S. Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatr Crit Care Med. 2011;12(2):133&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">20453704</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC, Okhuysen-Cawley RS, Relvas MS, Rozenfeld RA, Skippen PW, et al. American college of critical care medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med. 2017;45(6):1061&#x2013;1093.</Citation><ArticleIdList><ArticleId IdType="pubmed">28509730</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Chatfield MD, Rycus P, MacLaren G. Extracorporeal membrane oxygenation for group B streptococcal sepsis in neonates: a retrospective study of the extracorporeal life support organization registry. Pediatr Crit Care Med. 2020;21:505.</Citation><ArticleIdList><ArticleId IdType="pubmed">32168303</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020;21(2):e52&#x2013;e106.</Citation><ArticleIdList><ArticleId IdType="pubmed">32032273</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLaren G, Butt, W.: ECMO for septic shock. Ann Arbor, MI: ELSO&#x2014;Extracorporeal Life Support Organization; 2018.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4154549</ArticleId><ArticleId IdType="pubmed">25197676</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">21185693</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;1:607&#x2013;611.</Citation></Reference><Reference><Citation>Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat. 1978;32(4):138.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">26061377</ArticleId></ArticleIdList></Reference><Reference><Citation>Baujat B, Mahe C, Pignon JP, Hill C. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Stat Med. 2002;21(18):2641&#x2013;2652.</Citation><ArticleIdList><ArticleId IdType="pubmed">12228882</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillehei CW, O'Rourke PP, Vacanti JP, Crone RK. Role of extracorporeal membrane oxygenation in selected pediatric respiratory problems. J Thorac Cardiovasc Surg. 1989;98(5 Pt 2):968&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">2811427</ArticleId></ArticleIdList></Reference><Reference><Citation>McCune S, Short BL, Miller MK, Lotze A, Anderson KD. Extracorporeal membrane oxygenation therapy in neonates with septic shock. J Pediatr Surg. 1990;25(5):479&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">2352078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hocker JR, Simpson PM, Rabalais GP, Stewart DL, Cook LN. Extracorporeal membrane oxygenation and early-onset group B streptococcal sepsis. Pediatrics. 1992;89(1):1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">1727991</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagaya MTM, Futamura M. The efficacy of extracorporeal membrane oxygenation (ECMO) in newborns with septic shock. Pediatr Surg Int. 1993;8:298&#x2013;302.</Citation></Reference><Reference><Citation>Beca J, Butt W. Extracorporeal membrane oxygenation for refractory septic shock in children. Pediatrics. 1994;93(5):726&#x2013;729.</Citation><ArticleIdList><ArticleId IdType="pubmed">8165069</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman AP, Kerr SJ, Butt W, Marsh MJ, Murdoch IA, Paul T, Firmin RK, Tasker RC, Macrae DJ. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet. 1997;349(9050):466&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">9040577</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyt DK, Pridgeon J, Brown J, Peek G, Firmin R, Pandya HC. Extracorporeal life support for children with meningococcal septicaemia. Acta Paediatr. 2004;93(12):1608&#x2013;1611.</Citation><ArticleIdList><ArticleId IdType="pubmed">15841769</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiruvoipati R, Moorthy T, Balasubramanian SK, Platt V, Peek GJ. Extracorporeal membrane oxygenation and extracorporeal albumin dialysis in pediatric patients with sepsis and multi-organ dysfunction syndrome. Int J Artif Organs. 2007;30(3):227&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">17417762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SJCM, Sun S, Li JY. Extracorporeal membrane oxygenation for acute respiratory distress syndrome: a single center experience. Acta Cardiol Sin. 2007;23(2):741.</Citation></Reference><Reference><Citation>Horton S, d'Udekem Y, Shann F, Butt W, Bennett M, Best D, Brizard C. Extracorporeal membrane oxygenation via sternotomy for circulatory shock. J Thorac Cardiovasc Surg. 2010;139(2):e12&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">19660260</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng CC, Wu SJ, Chen MR, Chiu NC, Chi H. Clinical experience of extracorporeal membrane oxygenation for acute respiratory distress syndrome associated with pneumonia in children. J Formos Med Assoc. 2012;111(3):147&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">22423668</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai Y, Cornell TT, Cooley EG, Beckman CN, Baldridge PK, Mottes TA, Luckritz KE, Plomaritas KS, Meade JM, Odetola FO, et al. Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support. Pediatr Crit Care Med. 2015;16(4):366&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4424057</ArticleId><ArticleId IdType="pubmed">25599148</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KY, Cheung M, Burgner DP, Curtis N. Toxic shock syndrome in Australian children. Arch Dis Child. 2016;101(8):736&#x2013;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">27117838</ArticleId></ArticleIdList></Reference><Reference><Citation>Sole A, Jordan I, Bobillo S, Moreno J, Balaguer M, Hernandez-Platero L, Segura S, Cambra FJ, Esteban E, Rodriguez-Fanjul J. Venoarterial extracorporeal membrane oxygenation support for neonatal and pediatric refractory septic shock: more than 15 years of learning. Eur J Pediatr. 2018;177(8):1191&#x2013;1200.</Citation><ArticleIdList><ArticleId IdType="pubmed">29799085</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberender F, Ganeshalingham A, Fortenberry JD, Hobson MJ, Houmes RJ, Morris KP, Numa A, Hoq MM, Donath S, Beca J, et al. Venoarterial extracorporeal membrane oxygenation versus conventional therapy in severe pediatric septic shock. Pediatr Crit Care Med. 2018;19(10):965&#x2013;972.</Citation><ArticleIdList><ArticleId IdType="pubmed">30048365</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang TH, Wu ET, Lu CY, Huang SC, Yang TI, Wang CC, Chen JM, Lee PI, Huang LM, Chang LY. Pathogens and outcomes in pediatric septic shock patients supported by extracorporeal membrane oxygenation. J Microbiol Immunol Infect. 2018;51(3):385&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">28821378</ArticleId></ArticleIdList></Reference><Reference><Citation>Robb K, Badheka A, Wang T, Rampa S, Allareddy V, Allareddy V. Use of extracorporeal membrane oxygenation and associated outcomes in children hospitalized for sepsis in the United States: A large population-based study. PLoS ONE. 2019;14(4):e0215730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485643</ArticleId><ArticleId IdType="pubmed">31026292</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Chiletti R, Straney L, Festa M, Alexander D, Butt W, MacLaren G, Resource E, et al. Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis-a binational multicenter cohort study. Crit Care. 2019;23(1):429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6937937</ArticleId><ArticleId IdType="pubmed">31888705</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbaro RP, Paden ML, Guner YS, Raman L, Ryerson LM, Alexander P, Nasr VG, Bembea MM, Rycus PT, Thiagarajan RR, et al. Pediatric extracorporeal life support organization registry international report 2016. ASAIO J. 2017;63(4):456&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5626007</ArticleId><ArticleId IdType="pubmed">28557863</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner SC, Iocono JA, Ballard HO, Turner MD, Ward AN, Davenport DL, Paden ML, Zwischenberger JB. Improved survival in venovenous vs venoarterial extracorporeal membrane oxygenation for pediatric noncardiac sepsis patients: a study of the Extracorporeal Life Support Organization registry. J Pediatr Surg. 2012;47(1):63&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">22244394</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips MR, Khoury AL, Stephenson BJ, Edwards LJ, Charles AG, McLean SE. Outcomes of pediatric patients with abdominal sepsis requiring surgery and extracorporeal membrane oxygenation using the Extracorporeal Life Support Organization database. Am Surg. 2015;81(3):245&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5892180</ArticleId><ArticleId IdType="pubmed">25760199</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, McGinn T, Hayden J, Williams K, Shea B, et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ. 2015;350:h870.</Citation><ArticleIdList><ArticleId IdType="pubmed">25775931</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke MA, Long BJ, Del Mar MA, Arbyn M, Bakkum-Gamez JN, Wentzensen N. Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis. JAMA Internal Medicine. 2018;178(9):1210&#x2013;1222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142981</ArticleId><ArticleId IdType="pubmed">30083701</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoushhal Z, Hussain MA, Greco E, Mamdani M, Verma S, Rotstein O, Tricco AC, Al-Omran M. Prevalence and causes of attrition among surgical residents: a systematic review and meta-analysis. JAMA Surgery. 2017;152(3):265&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">27973673</ArticleId></ArticleIdList></Reference><Reference><Citation>ten Broek RPG, Issa Y, van Santbrink EJP, Bouvy ND, Kruitwagen RFPM, Jeekel J, Bakkum EA, Rovers MM, van Goor H. Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis. BMJ. 2013;347:f5588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3789584</ArticleId><ArticleId IdType="pubmed">24092941</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15636651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hempel S, Miles JN, Booth MJ, Wang Z, Morton SC, Shekelle PG. Risk of bias: a simulation study of power to detect study-level moderator effects in meta-analysis. Syst Rev. 2013;2:107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4219184</ArticleId><ArticleId IdType="pubmed">24286208</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35352534</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2282-4197</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica</Title><ISOAbbreviation>Arch Ital Urol Androl</ISOAbbreviation></Journal><ArticleTitle>Infectious complications of endourological treatment of kidney stones: A meta-analysis of randomized clinical trials.</ArticleTitle><Pagination><StartPage>97</StartPage><EndPage>106</EndPage><MedlinePgn>97-106</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4081/aiua.2022.1.97</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Endourological treatment is associated with a risk of postoperative febrile urinary tract infections and sepsis. The aim of this study was to review the reported rate of infectious complications in relation to the type and modality of the endourologic procedure.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This systematic review was conducted in accordance with the PRISMA guidelines. Two electronic databases (PubMed and EMBASE) were searched. Out of 243 articles retrieved we included 49 studies after full-text evaluation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Random-effects meta-analysis demonstrated that retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PCNL) were associated with not significantly different odds of getting fever (OR = 1.54, 95% CI: 0.99 to 2.39; p = 0.06) or sepsis (OR = 1.52, 95% CI: 0.37 to 6.20, p = 0.56). The odds of getting fever were not significantly different for mini PCNL compared to standard PCNL (OR = 1.11, 95% CI: 0.85 to 1.44; p = 0.45) and for tubeless PCNL compared to standard PCNL (OR = 1.34 95% CI: 0.61 to 2.91, p = 0.47). However, the odds for fever after PCNL with suctioning sheath were lower than the corresponding odds for standard PCNL (OR = 0.37, 95% CI: 0.20 to 0.70, p = 0.002). The odds of getting fever after PCNL with perioperative prophylaxis were not different from the corresponding odds after PCNL with perioperative prophylaxis plus a short oral antibiotic course (before or after the procedure) (OR = 1.31, 95% CI: 0.71 to 2.39, p = 0.38).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The type of endourological procedure does not appear to be decisive in the onset of infectious complications, although the prevention of high intrarenal pressure during the procedure could be crucial in defining the risk of infectious complications. &#xa0; on behalf of U-merge Ltd. (Urology for emerging countries), London-Athens-Dubai.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bapir</LastName><ForeName>Rawa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Smart Health Tower, Sulaymaniyah, Kurdistan region. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatti</LastName><ForeName>Kamran Hassan</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Urology Department, HMC, Hamad Medical Corporation. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eliwa</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, Zagazig University, Zagazig, Sharkia. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Perdomo</LastName><ForeName>Herney Andr&#xe9;s</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Universidad del Valle, Cali. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gherabi</LastName><ForeName>Nazim</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Algiers 1, Algiers. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennessey</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Urology, Mercy University Hospital, Cork. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mourmouris</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>2nd Department of Urology, National and Kapodistrian University of Athens, Sismanoglio Hospital, Athens. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouattara</LastName><ForeName>Adama</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Urology, Souro Sanou University Teaching Hospital, Bobo-Dioulasso. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perletti</LastName><ForeName>Gianpaolo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Life Sciences, Section of Medical and Surgical Sciences, University of Insubria, Varese, Italy; Faculty of Medicine and Medical Sciences, Ghent University. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philipraj</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth, Puducherry. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trinchieri</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Urology School, University of Milan. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchholz</LastName><ForeName>Noor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Scientific Office, U-merge Ltd., Athens. alberto.trinchieri@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Arch Ital Urol Androl</MedlineTA><NlmUniqueID>9308247</NlmUniqueID><ISSNLinking>1124-3562</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007669" MajorTopicYN="Y">Kidney Calculi</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074642" MajorTopicYN="Y">Nephrolithotomy, Percutaneous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>30</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35352534</ArticleId><ArticleId IdType="doi">10.4081/aiua.2022.1.97</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33079281</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2110-5820</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>Annals of intensive care</Title><ISOAbbreviation>Ann Intensive Care</ISOAbbreviation></Journal><ArticleTitle>Sepsis and septic shock in France: incidences, outcomes and costs of care.</ArticleTitle><Pagination><StartPage>145</StartPage><MedlinePgn>145</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">145</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13613-020-00760-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sepsis is one of the leading causes of death worldwide. The associated incidence, mortality and trends do not differ greatly between documented reports. The purpose of this study was to provide an in-depth description of patients with sepsis and septic shock hospitalized in France from 2010 to 2015 and to explore the temporal trends of their clinical characteristics, costs and outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective cohort study of the French hospital administrative database in which organ failure therapies and severity scores are systematically registered. All patients admitted between 2010 and 2015 for sepsis and septic shock as defined by an ICD-10 code for infection, and for organ failure or the use of organ failure supplementation were included. Incidence, outcomes and trends were analyzed. Subgroup analyses based on several coding strategies and adjusted for severity scores were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 737,147 patients with sepsis and 492,902 patients with septic shock were included. From 2010 to 2015, the incidence of sepsis and septic shock increased, respectively, from 206 to 243 and from 135 to 171 cases per 100,000 population. Case fatality remained at 34% for sepsis, but decreased from 46 to 44% for septic shock. Median hospital stay costs amounted to &#x20ac;11,400 (IQR: 5036; 24,364) for patients with sepsis and &#x20ac;16,439 (IQR: 7339; 29,360) for patients with septic shock. After adjustment for case-mix and illness severity, the risk of death was stable for sepsis (0.08% [-&#x2009;0.04; 0.20] per year), but decreased for sepsis patients admitted to the intensive care unit and for cases of septic shock (-&#x2009;0.33%[ -&#x2009;0.40; -&#x2009;0.27] per year).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Sepsis is common, frequently fatal and expensive to treat. Its incidence has increased. Case fatality has decreased in most severely affected patients, owing partly to general improvements in care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dupuis</LastName><ForeName>Claire</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3533-3097</Identifier><AffiliationInfo><Affiliation>Medical Intensive Care Unit, Gabriel Montpied University Hospital, Clermont-Ferrand, France. cdupuis1@chu-clermontferrand.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR 1137-IAME Team 5-DeSCID: Decision Sciences in Infectious Diseases control and care INSERM/Univ Paris Diderot, Sorbonne Paris Cit&#xe9;, 75018, Paris, France. cdupuis1@chu-clermontferrand.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouadma</LastName><ForeName>Lila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UMR 1137-IAME Team 5-DeSCID: Decision Sciences in Infectious Diseases control and care INSERM/Univ Paris Diderot, Sorbonne Paris Cit&#xe9;, 75018, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical and Infectious Diseases Intensive Care Unit, Bichat Claude Bernard University Hospital, AP-HP, 46 rue Henri Huchard, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruckly</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UMR 1137-IAME Team 5-DeSCID: Decision Sciences in Infectious Diseases control and care INSERM/Univ Paris Diderot, Sorbonne Paris Cit&#xe9;, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perozziello</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UMR 1137-IAME Team 5-DeSCID: Decision Sciences in Infectious Diseases control and care INSERM/Univ Paris Diderot, Sorbonne Paris Cit&#xe9;, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van-Gysel</LastName><ForeName>Damien</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>D&#xe9;partement D'Informations M&#xe9;dicales, Bichat Claude Bernard University Hospital, AP-HP, 46 rue Henri Huchard, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mageau</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UMR 1137-IAME Team 5-DeSCID: Decision Sciences in Infectious Diseases control and care INSERM/Univ Paris Diderot, Sorbonne Paris Cit&#xe9;, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mourvillier</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, Robert Debr&#xe9; University Hospital, Rue du G&#xe9;n&#xe9;ral Koenig, 51100, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Montmollin</LastName><ForeName>Etienne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UMR 1137-IAME Team 5-DeSCID: Decision Sciences in Infectious Diseases control and care INSERM/Univ Paris Diderot, Sorbonne Paris Cit&#xe9;, 75018, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical and Infectious Diseases Intensive Care Unit, Bichat Claude Bernard University Hospital, AP-HP, 46 rue Henri Huchard, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailly</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>HP2 Laboratory, INSERM U1042, Univ. Grenoble Alpes, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EFCR Laboratory, Grenoble Alpes University Hospital, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papin</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Bichat Claude Bernard University Hospital, AP-HP, 46 rue Henri Huchard, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinnah</LastName><ForeName>Fabrice</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medical and Infectious Diseases Intensive Care Unit, Bichat Claude Bernard University Hospital, AP-HP, 46 rue Henri Huchard, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinclair</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Centre Hospitalier de La C&#xf4;te Basque, 64109, Bayonne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abid</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical and Infectious Diseases Intensive Care Unit, Bichat Claude Bernard University Hospital, AP-HP, 46 rue Henri Huchard, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonneville</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UMR 1137-IAME Team 5-DeSCID: Decision Sciences in Infectious Diseases control and care INSERM/Univ Paris Diderot, Sorbonne Paris Cit&#xe9;, 75018, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical and Infectious Diseases Intensive Care Unit, Bichat Claude Bernard University Hospital, AP-HP, 46 rue Henri Huchard, 75018, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timsit</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>UMR 1137-IAME Team 5-DeSCID: Decision Sciences in Infectious Diseases control and care INSERM/Univ Paris Diderot, Sorbonne Paris Cit&#xe9;, 75018, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical and Infectious Diseases Intensive Care Unit, Bichat Claude Bernard University Hospital, AP-HP, 46 rue Henri Huchard, 75018, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Ann Intensive Care</MedlineTA><NlmUniqueID>101562873</NlmUniqueID><ISSNLinking>2110-5820</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Secular trends</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>We declare that we have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>20</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33079281</ArticleId><ArticleId IdType="pmc">PMC7575668</ArticleId><ArticleId IdType="doi">10.1186/s13613-020-00760-x</ArticleId><ArticleId IdType="pii">10.1186/s13613-020-00760-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vincent J-L, Marshall JC, &#xd1;amendys-Silva SA, Fran&#xc7;ois B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2:380&#x2013;386. doi: 10.1016/S2213-2600(14)70061-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70061-X</ArticleId><ArticleId IdType="pubmed">24740011</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med. 2016;193:259&#x2013;272. doi: 10.1164/rccm.201504-0781OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201504-0781OC</ArticleId><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580&#x2013;637. doi: 10.1097/CCM.0b013e31827e83af.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827e83af</ArticleId><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Machado FR. The Global Epidemiology of Sepsis Does It Matter That We Know So Little? Am J Respir Crit Care Med. 2016;193:228&#x2013;230. doi: 10.1164/rccm.201510-1976ED.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201510-1976ED</ArticleId><ArticleId IdType="pubmed">26829417</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott HC, Iwashyna TJ, Blackwood B, Calandra T, Chlan LL, Choong K, et al. Understanding and enhancing sepsis survivorship priorities for research and practice. Am J Respir Crit Care Med. 2019;200:972&#x2013;981. doi: 10.1164/rccm.201812-2383CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201812-2383CP</ArticleId><ArticleId IdType="pmc">PMC6794113</ArticleId><ArticleId IdType="pubmed">31161771</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the Incidence and Mortality of Severe Sepsis in the United States. Crit Care Med. 2013;41:1167&#x2013;1174. doi: 10.1097/CCM.0b013e31827c09f8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827c09f8</ArticleId><ArticleId IdType="pubmed">23442987</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Mikolajetz A, Schwarzkopf D, Cohen J, Hartog CS, Pletz M, et al. Challenges in assessing the burden of sepsis and understanding the inequalities of sepsis outcomes between National Health Systems: secular trends in sepsis and infection incidence and mortality in Germany. Intensive Care Med. 2018;44:1826&#x2013;1835. doi: 10.1007/s00134-018-5377-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5377-4</ArticleId><ArticleId IdType="pmc">PMC6244521</ArticleId><ArticleId IdType="pubmed">30284637</ArticleId></ArticleIdList></Reference><Reference><Citation>Insee Institut national de la statistique et des &#xe9;tudes &#xe9;conomiques. Bilan d&#xe9;mographique 2016</Citation></Reference><Reference><Citation>Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med. 2007;35:1244&#x2013;1250. doi: 10.1097/01.CCM.0000261890.41311.E9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000261890.41311.E9</ArticleId><ArticleId IdType="pubmed">17414736</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130&#x2013;1139. doi: 10.1097/01.mlr.0000182534.19832.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000182534.19832.83</ArticleId><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Yu KF. What&#x2019;s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690&#x2013;1691. doi: 10.1001/jama.280.19.1690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.280.19.1690</ArticleId><ArticleId IdType="pubmed">9832001</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303&#x2013;1310. doi: 10.1097/00003246-200107000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546&#x2013;1554. doi: 10.1056/NEJMoa022139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022139</ArticleId><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, et al. Nationwide trends of severe sepsis in the 21st century (2000&#x2013;2007) Chest. 2011;140:1223&#x2013;1231. doi: 10.1378/chest.11-0352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-0352</ArticleId><ArticleId IdType="pubmed">21852297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagu T, Rothberg MB, Shieh M-S, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012;40:754&#x2013;761. doi: 10.1097/CCM.0b013e318232db65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318232db65</ArticleId><ArticleId IdType="pubmed">21963582</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouza C, L&#xf3;pez-Cuadrado T, Saz-Parkinson Z, Amate-Blanco JM. Epidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006&#x2013;2011) BMC Infect Dis. 2014;14:3863. doi: 10.1186/s12879-014-0717-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-014-0717-7</ArticleId><ArticleId IdType="pmc">PMC4327809</ArticleId><ArticleId IdType="pubmed">25528662</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoller J, Halpin L, Weis M, Aplin B, Qu W, Georgescu C, et al. Epidemiology of severe sepsis: 2008&#x2013;2012. J Crit Care. 2016;31:58&#x2013;62. doi: 10.1016/j.jcrc.2015.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.09.034</ArticleId><ArticleId IdType="pubmed">26601855</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohil SK, Cao C, Phelan M, Tjoa T, Rhee C, Platt R, et al. Impact of Policies on the Rise in Sepsis Incidence, 2000&#x2013;2010. Clin Infect Dis. 2016;62:695&#x2013;703. doi: 10.1093/cid/civ1019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/civ1019</ArticleId><ArticleId IdType="pmc">PMC4772840</ArticleId><ArticleId IdType="pubmed">26787173</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfeky S, Golabi P, Otgonsuren M, Djurkovic S, Schmidt ME, Younossi ZM. The epidemiologic characteristics, temporal trends, predictors of death, and discharge disposition in patients with a diagnosis of sepsis: A cross-sectional retrospective cohort study. J Crit Care. 2017;39:48&#x2013;55. doi: 10.1016/j.jcrc.2017.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.01.006</ArticleId><ArticleId IdType="pubmed">28199891</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xe9;benes JC, Ruiz-Rodriguez JC, Ferrer R, Cl&#xe8;ries M, Bosch A, Lorencio C, et al. Epidemiology of sepsis in Catalonia: analysis of incidence and outcomes in a European setting. Ann Intensive Care. 2017;7:19. doi: 10.1186/s13613-017-0241-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-017-0241-1</ArticleId><ArticleId IdType="pmc">PMC5318305</ArticleId><ArticleId IdType="pubmed">28220453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C-C, Yo C-H, Lee MG, Tsai K-C, Lee S-H, Chen Y-S, et al. Adult sepsis &#x2013; a nationwide study of trends and outcomes in a population of 23 million people. J Infect. 2017;75(5):409&#x2013;419. doi: 10.1016/j.jinf.2017.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2017.08.012</ArticleId><ArticleId IdType="pubmed">28851532</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009&#x2013;2014. JAMA. 2017;318:1241. doi: 10.1001/jama.2017.13836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13836</ArticleId><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17&#x2013;60. doi: 10.1007/s00134-007-0934-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0934-2</ArticleId><ArticleId IdType="pmc">PMC2249616</ArticleId><ArticleId IdType="pubmed">18058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadri SS, Rhee C, Strich JR, Morales MK, Hohmann S, Menchaca J, et al. Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical Data. Chest. 2017;151:278&#x2013;285. doi: 10.1016/j.chest.2016.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.07.010</ArticleId><ArticleId IdType="pmc">PMC5310115</ArticleId><ArticleId IdType="pubmed">27452768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Murphy MV, Li L, Platt R, Klompas M, for the Centers for Disease Control and Prevention Epicenters Program. Comparison of Trends in Sepsis Incidence and Coding Using Administrative Claims Versus Objective Clinical Data. Clin Infect Dis. 2015;60:88&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4318944</ArticleId><ArticleId IdType="pubmed">25258352</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Harrison DA, Rowan KM. Differences in impact of definitional elements on mortality precludes international comparisons of sepsis epidemiology&#x2014;a cohort study illustrating the need for standardized reporting. Crit Care Med. 2016;44:2223&#x2013;2230. doi: 10.1097/CCM.0000000000001876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001876</ArticleId><ArticleId IdType="pubmed">27352126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Artigas A, Levy MM, Blanco J, Gonz&#xe1;lez-D&#xed;az G, Garnacho-Montero J, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA. 2008;299:2294&#x2013;2303. doi: 10.1001/jama.299.19.2294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.299.19.2294</ArticleId><ArticleId IdType="pubmed">18492971</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Jentzsch MS, Kadri SS, Seymour CW, Angus DC, Murphy DJ, et al. Variation in identifying sepsis and organ dysfunction using administrative versus electronic clinical data and impact on hospital outcome comparisons. Crit Care Med. 2019;47:493&#x2013;500. doi: 10.1097/CCM.0000000000003554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003554</ArticleId><ArticleId IdType="pmc">PMC7970408</ArticleId><ArticleId IdType="pubmed">30431493</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolley RJ, Sawka KJ, Yergens DW, Quan H, Jett&#xe9; N, Doig CJ. Validity of administrative data in recording sepsis: a systematic review. Crit Care. 2015;19:139. doi: 10.1186/s13054-015-0847-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0847-3</ArticleId><ArticleId IdType="pmc">PMC4403835</ArticleId><ArticleId IdType="pubmed">25887596</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38386786</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1677-6119</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>International braz j urol : official journal of the Brazilian Society of Urology</Title><ISOAbbreviation>Int Braz J Urol</ISOAbbreviation></Journal><ArticleTitle>Postoperative antibiotic prophylaxis for percutaneous nephrolithotomy and risk of infection: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>152</StartPage><EndPage>163</EndPage><MedlinePgn>152-163</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/S1677-5538.IBJU.2023.0626</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this study is to perform a high-quality meta-analysis using only randomized controlled trials (RCT) to better define the role of postoperative antibiotics in patients undergoing percutaneous nephrolithotomy (PCNL).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A literature search for RCTs in EMBASE, PubMed, and Web of Science up to May 2023 was conducted following the PICO framework: Population-adult patients who underwent PCNL; Intervention-postoperative antibiotic prophylaxis until nephrostomy tube withdrawal; Control-single dose of antibiotic during the induction of anesthesia; and Outcome-systemic inflammatory response syndrome (SIRS) or sepsis and fever after PCNL. The protocol was registered on the PROSPERO database (CRD42022361579). We calculated odds ratios (OR) and 95% confidence intervals (CI). A random-effects model was employed, and the alpha risk was defined as &lt; 0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven articles, encompassing a total of 629 patients, were included in the analysis. The outcome of SIRS or sepsis was extracted from six of the included studies, while the outcome of postoperative fever was extracted from four studies. The analysis revealed no statistical association between the use of postoperative antibiotic prophylaxis until nephrostomy tube withdrawal and the occurrence of SIRS/sepsis (OR 1.236, 95% CI 0.731 - 2.089, p=0.429) or fever (OR 2.049, 95% CI 0.790 - 5.316, p=0.140).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings suggest that there is no benefit associated with the use of postoperative antibiotic prophylaxis until nephrostomy tube withdrawal in patients undergoing percutaneous nephrolithotomy (PCNL). We recommend that antibiotic prophylaxis should be administered only until the induction of anesthesia in PCNL.</AbstractText><CopyrightInformation>Copyright&#xae; by the International Brazilian Journal of Urology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Talizin</LastName><ForeName>Thalita Bento</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas, Universidade de S&#xe3;o Paulo - USP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danilovic</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas, Universidade de S&#xe3;o Paulo - USP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Alem&#xe3;o Oswaldo Cruz, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torricelli</LastName><ForeName>Fabio Cesar Miranda</ForeName><Initials>FCM</Initials><AffiliationInfo><Affiliation>Disciplina de Urologia, Faculdade de Medicina, Universidade de S&#xe3;o Paulo - USP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchini</LastName><ForeName>Giovanni S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Disciplina de Urologia, Faculdade de Medicina, Universidade de S&#xe3;o Paulo - USP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batagello</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas, Universidade de S&#xe3;o Paulo - USP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicentini</LastName><ForeName>Fabio C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Disciplina de Urologia, Faculdade de Medicina, Universidade de S&#xe3;o Paulo - USP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nahas</LastName><ForeName>William Carlos</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Divis&#xe3;o de Urologia, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo - ICESP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzucchi</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Disciplina de Urologia, Faculdade de Medicina, Universidade de S&#xe3;o Paulo - USP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Int Braz J Urol</MedlineTA><NlmUniqueID>101158091</NlmUniqueID><ISSNLinking>1677-5538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074642" MajorTopicYN="Y">Nephrolithotomy, Percutaneous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019072" MajorTopicYN="Y">Antibiotic Prophylaxis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="Y">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Prostatic Neoplasms</Keyword><Keyword MajorTopicYN="N">Robotic Surgical Procedures</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>22</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>22</Day><Hour>14</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38386786</ArticleId><ArticleId IdType="pmc">PMC10953597</ArticleId><ArticleId IdType="doi">10.1590/S1677-5538.IBJU.2023.0626</ArticleId><ArticleId IdType="pii">IBJU20230626</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geraghty RM, Davis NF, Tzelves L, Lombardo R, Yuan C, Thomas K, et al. Best Practice in Interventional Management of Urolithiasis: An Update from the European Association of Urology Guidelines Panel for Urolithiasis 2022. Eur Urol Focus. 2023;9:199&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">35927160</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez J, Smith A, Geavlete P, Shah H, Kural AR, de Sio M, et al. Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol. 2013;31:1135&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785702</ArticleId><ArticleId IdType="pubmed">22367718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G, Zhou Y, Chen R, Wang D, Zhou S, Zhong J, et al. The influencing factors of infectious complications after percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 2022;51:17&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9750925</ArticleId><ArticleId IdType="pubmed">36515726</ArticleId></ArticleIdList></Reference><Reference><Citation>Korets R, Graversen JA, Kates M, Mues AC, Gupta M. Post-percutaneous nephrolithotomy systemic inflammatory response: a prospective analysis of preoperative urine, renal pelvic urine and stone cultures. J Urol. 2011;186:1899&#x2013;1903.</Citation><ArticleIdList><ArticleId IdType="pubmed">21944106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A, Mittal J, Tripathi S, Paul S. Factors predicting infective complications following percutaneous nephrolithotomy and retrograde intrarenal surgery according to systemic inflammatory response syndrome and quick sequential organ failure assessment: A prospective study. Urol Ann. 2023;15:295&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10471817</ArticleId><ArticleId IdType="pubmed">37664105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">23327981</ArticleId></ArticleIdList></Reference><Reference><Citation>Berr&#xed;os-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152:784&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pubmed">28467526</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneidewind L, Kranz J, Tandogdu Z. Rising significance of antibiotic stewardship in urology and urinary tract infections - a rapid review. Curr Opin Urol. 2021;31:285&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">34009175</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#x3d5;tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1&#x2013;e34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med. 1992;20:724&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">1597021</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pubmed">12682500</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#x3d5;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. Cochrane Statistical Methods Group. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928&#x2013;d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirtas A, Yildirim YE, Sofikerim M, Kaya EG, Akinsal EC, Tombul ST, et al. Comparison of infection and urosepsis rates of ciprofloxacin and ceftriaxone prophylaxis before percutaneous nephrolithotomy: a prospective and randomised study. ScientificWorldJournal. 2012;2012:916381&#x2013;916381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539373</ArticleId><ArticleId IdType="pubmed">23319889</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyrek M, Binbay M, Yuruk E, Akman T, Aslan R, Yazici O, et al. Perioperative prophylaxis for percutaneous nephrolithotomy: randomized study concerning the drug and dosage. J Endourol. 2012;26:1431&#x2013;1436.</Citation><ArticleIdList><ArticleId IdType="pubmed">22612061</ArticleId></ArticleIdList></Reference><Reference><Citation>Do&#x11f;an HS, Sahin A, Cetinkaya Y, Akdo&#x11f;an B, Ozden E, Kendi S. Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol. 2002;16:649&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">12490017</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar M, Selim M, El Sherif E, Abozaid N, Farag E, El Garabawey M, et al. Ciprofloxacin infusion versus third generation cephalosporin as a surgical prophylaxis for percutaneous nephrolithotomy: a randomized study. Cent European J Urol. 2019;72:57&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6469015</ArticleId><ArticleId IdType="pubmed">31011442</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutajar CL. Norfloxacin prophylaxis for endoscopic urological surgery. Br J Urol. 1992;69:421&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">1581815</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuzel E, Aktepe OC, Akdogan B. Prospective comparative study of two protocols of antibiotic prophylaxis in percutaneous nephrolithotomy. J Endourol. 2013;27:172&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">22908891</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae HK, Kim M, Shin JH, Park HK. Comparison of the Efficacy between the Single-Dose and Three-Day Prophylactic Antibiotic Regimens for the Prevention of Bacterial Infections in Patients with Percutaneous Nephrolithotomy: A Randomized Controlled Study. Urogenit Tract Infect. 2018;13:66&#x2013;71.</Citation></Reference><Reference><Citation>Xie F, Deng S, Fei K, Xu H, Zhang H. Nomogram to predict the risk of adverse outcomes in patients with residual stones following percutaneous nephrolithotomy. Int Braz J Urol. 2023;49:599&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10482460</ArticleId><ArticleId IdType="pubmed">37390125</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahabi A, Aali S. An insight into the Nomogram of Percutaneous Nephrolithotomy. Int Braz J Urol. 2023;49:789&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10947617</ArticleId><ArticleId IdType="pubmed">37903013</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamon T, Kitirattrakarn P, Lojanapiwat B. Outcomes of percutaneous nephrolithotomy: comparison of elderly and younger patients. Int Braz J Urol. 2013;39:692&#x2013;700. discussion 701.</Citation><ArticleIdList><ArticleId IdType="pubmed">24267112</ArticleId></ArticleIdList></Reference><Reference><Citation>[No authors] Global Guidelines for the Prevention of Surgical Site Infection. Geneva: World Health Organization; 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27929621</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellit TH, Owens RC, McGowan JE, Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">17173212</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung HD, Cho KS, Moon YJ, Chung DY, Kang DH, Lee JY. Antibiotic prophylaxis for percutaneous nephrolithotomy: An updated systematic review and meta-analysis. PLoS One. 2022;17:e0267233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9012355</ArticleId><ArticleId IdType="pubmed">35427380</ArticleId></ArticleIdList></Reference><Reference><Citation>Danilovic A, Talizin TB, Torricelli FCM, Marchini GS, Batagello C, Vicentini FC, et al. One week pre-operative oral antibiotics for percutaneous nephrolithotomy reduce risk of infection: a systematic review and meta-analysis. Int Braz J Urol. 2023;49:184&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10247227</ArticleId><ArticleId IdType="pubmed">36515617</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin P, Zhang D, Huang T, Fang L, Cheng Y. Comparison of mini percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for renal stones &gt;2cm: a systematic review and meta-analysis. Int Braz J Urol. 2022;48:637&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9306366</ArticleId><ArticleId IdType="pubmed">34786926</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdemir H, Erbin A, Sahan M, Savun M, Cubuk A, Yazici O, et al. Comparison of supine and prone miniaturized percutaneous nephrolithotomy in the treatment of lower pole, middle pole and renal pelvic stones: A matched pair analysis. Int Braz J Urol. 2019;45:956&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6844341</ArticleId><ArticleId IdType="pubmed">31408287</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrella R, Vicentini FC, Paro ED, Torricelli FCM, Marchini GS, Danilovic A, et al. Supine versus Prone Percutaneous Nephrolithotomy for Complex Stones: A Multicenter Randomized Controlled Trial. J Urol. 2022;207:647&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">34694154</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef A, Esmat M, Wael M. When prone position is contraindicated or not preferable, can supine percutaneous nephrolithotomy solve the problem? Int Braz J Urol. 2012;38:57&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">22397781</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39263428</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2542-4548</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Mayo Clinic proceedings. Innovations, quality &amp; outcomes</Title><ISOAbbreviation>Mayo Clin Proc Innov Qual Outcomes</ISOAbbreviation></Journal><ArticleTitle>Perioperative Mortality: A Retrospective Cohort Study of 75,446 Noncardiac Surgery Patients.</ArticleTitle><Pagination><StartPage>435</StartPage><EndPage>442</EndPage><MedlinePgn>435-442</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mayocpiqo.2024.07.002</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate whether major adverse cardiac events (MACE) continue to be a major causative factor for mortality after noncardiac surgery.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">We performed retrospective study of 75,410 adult noncardiac surgery patients at Mayo Clinic Rochester, between January 1, 2016, and May 4, 2018. Electronic medical records were reviewed and data collected on all deaths within 30 days (n=692 patients) of surgery. The incidence of death due to MACE was calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Postoperative MACE occurred in 150 patients (21.4 events per 10,000 patients; 95% CI, 18.2-25.2 events per 10,000 patients) with most occurring within 3 days of surgery (n=113). Postoperative MACE events were associated with atrial fibrillation with rapid rate response in 25 patients (16.7%), sepsis in 15 patients (10%), and bleeding in 15 patients (10%). There were 12 intraoperative deaths of which 9 were due to exsanguination (75%) and the remaining 3 (25%) due to cardiac arrest. Of the 56 deaths on the first 24 hours after surgery, 7 were due to hemorrhage, 17 due to cardiovascular causes, 20 due to sepsis, and 7 due to neurologic disease. The leading cause of total death over 30 days postoperatively was sepsis (28%), followed by malignancy (27%), cardiovascular disease (12%) neurologic disease (12%), and hemorrhage (5%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">MACE was not the leading cause of death both intraoperatively and postoperatively.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nuttall</LastName><ForeName>Gregory A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merren</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naranjo</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portner</LastName><ForeName>Erica R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambrose</LastName><ForeName>Amanda R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rihal</LastName><ForeName>Charanjit S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mayo Clin Proc Innov Qual Outcomes</MedlineTA><NlmUniqueID>101728275</NlmUniqueID><ISSNLinking>2542-4548</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39263428</ArticleId><ArticleId IdType="pmc">PMC11387539</ArticleId><ArticleId IdType="doi">10.1016/j.mayocpiqo.2024.07.002</ArticleId><ArticleId IdType="pii">S2542-4548(24)00043-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiser T.G., Haynes A.B., Molina G., et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015;385(Suppl 2) doi: 10.1016/S0140-6736(15)60806-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60806-6</ArticleId><ArticleId IdType="pubmed">26313057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kable A.K., Gibberd R.W., Spigelman A.D. Adverse events in surgical patients in Australia. Int J Qual Health Care. 2002;14(4):269&#x2013;276. doi: 10.1093/intqhc/14.4.269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/14.4.269</ArticleId><ArticleId IdType="pubmed">12201185</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullen R., Scollay J.M., Hecht G., McPhillips G., Thompson A.M. Death within 48 h&#x2014;adverse events after general surgical procedures. Surgeon. 2012;10(1):1&#x2013;5. doi: 10.1016/j.surge.2011.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surge.2011.01.005</ArticleId><ArticleId IdType="pubmed">22233549</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse R.M., Moreno R.P., Bauer P., et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012;380(9847):1059&#x2013;1065. doi: 10.1016/S0140-6736(12)61148-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61148-9</ArticleId><ArticleId IdType="pmc">PMC3493988</ArticleId><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>International Surgical Outcomes Study Group Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth. 2016;117(5):601&#x2013;609. doi: 10.1093/bja/aew316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aew316</ArticleId><ArticleId IdType="pmc">PMC5091334</ArticleId><ArticleId IdType="pubmed">27799174</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin D.S., Lin A.Z., Ward R.P., Nagele P. Trends and in-hospital mortality for perioperative myocardial infarction after the introduction of a diagnostic code for type 2 myocardial infarction in the United States between 2016 and 2018. Anesth Analg. 2024;138(2):420&#x2013;429. doi: 10.1213/ANE.0000000000006404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006404</ArticleId><ArticleId IdType="pmc">PMC10427730</ArticleId><ArticleId IdType="pubmed">36795598</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonesinghe S.R., Mythen M.G., Grocott M.P. High-risk surgery: epidemiology and outcomes. Anesth Analg. 2011;112(4):891&#x2013;901. doi: 10.1213/ANE.0b013e3181e1655b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3181e1655b</ArticleId><ArticleId IdType="pubmed">20495138</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonesinghe S.R., Mythen M.G., Das P., Rowan K.M., Grocott M.P. Risk stratification tools for predicting morbidity and mortality in adult patients undergoing major surgery: qualitative systematic review. Anesthesiology. 2013;119(4):959&#x2013;981. doi: 10.1097/ALN.0b013e3182a4e94d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a4e94d</ArticleId><ArticleId IdType="pubmed">24195875</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah N., Hamilton M. Clinical review: can we predict which patients are at risk of complications following surgery? Crit Care. 2013;17(3):226. doi: 10.1186/cc11904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11904</ArticleId><ArticleId IdType="pmc">PMC3672530</ArticleId><ArticleId IdType="pubmed">23672931</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello C., Rossler J., Shehata P., Smilowitz N.R., Ruetzler K. Perioperative strategies to reduce risk of myocardial injury after non-cardiac surgery (MINS): a narrative review. J&#xa0;Clin Anesth. 2023;87 doi: 10.1016/j.jclinane.2023.111106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2023.111106</ArticleId><ArticleId IdType="pubmed">36931053</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz N.R., Gupta N., Ramakrishna H., Guo Y., Berger J.S., Bangalore S. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery. JAMA Cardiol. 2017;2(2):181&#x2013;187. doi: 10.1001/jamacardio.2016.4792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2016.4792</ArticleId><ArticleId IdType="pmc">PMC5563847</ArticleId><ArticleId IdType="pubmed">28030663</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz N.R., Berger J.S. Perioperative cardiovascular risk assessment and management for noncardiac surgery: a review. JAMA. 2020;324(3):279&#x2013;290. doi: 10.1001/jama.2020.7840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.7840</ArticleId><ArticleId IdType="pubmed">32692391</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui E., Banco D., Berger J.S., Smilowitz N.R. Frailty assessment and perioperative major adverse cardiovascular events after noncardiac surgery. Am J Med. 2023;136(4):372&#x2013;379.e5. doi: 10.1016/j.amjmed.2022.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2022.12.033</ArticleId><ArticleId IdType="pmc">PMC10038881</ArticleId><ArticleId IdType="pubmed">36657557</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriel R.A., Sztain J.F., A&#x2019;Court A.M., Hylton D.J., Waterman R.S., Schmidt U. Postoperative mortality and morbidity following non-cardiac surgery in a healthy patient population. J&#xa0;Anesth. 2018;32(1):112&#x2013;119. doi: 10.1007/s00540-017-2440-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-017-2440-1</ArticleId><ArticleId IdType="pubmed">29279996</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz L.G., Modolo N.S., do Nascimento P., Jr., et al. Perioperative cardiac arrest: a study of 53,718 anaesthetics over 9 yr from a Brazilian teaching hospital. Br J Anaesth. 2006;96(5):569&#x2013;575. doi: 10.1093/bja/ael065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/ael065</ArticleId><ArticleId IdType="pubmed">16565228</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecho K., Lunney A.T., Boysen P.G., Rock P., Norfleet E.A. Postoperative mortality after inpatient surgery: Incidence and risk factors. Ther Clin Risk Manag. 2008;4(4):681&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2621384</ArticleId><ArticleId IdType="pubmed">19209248</ArticleId></ArticleIdList></Reference><Reference><Citation>Glance L.G., Lustik S.J., Hannan E.L., et al. The Surgical Mortality Probability Model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg. 2012;255(4):696&#x2013;702. doi: 10.2147/tcrm.s2735.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/tcrm.s2735</ArticleId><ArticleId IdType="pubmed">22418007</ArticleId></ArticleIdList></Reference><Reference><Citation>Noordzij P.G., Poldermans D., Schouten O., Bax J.J., Schreiner F.A., Boersma E. Postoperative mortality in The Netherlands: a population-based analysis of surgery-specific risk in adults. Anesthesiology. 2010;112(5):1105&#x2013;1115. doi: 10.1097/ALN.0b013e3181d5f95c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181d5f95c</ArticleId><ArticleId IdType="pubmed">20418691</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.C., Braz J.R., Oliveira T.S., de Carvalho L.R., Castiglia Y.M., Braz L.G. Intraoperative and anesthesia-related cardiac arrest and its mortality in older patients: a 15-year survey in a tertiary teaching hospital. PLoS One. 2014;9(8) doi: 10.1371/journal.pone.0104041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104041</ArticleId><ArticleId IdType="pmc">PMC4130522</ArticleId><ArticleId IdType="pubmed">25117481</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunnally M.E., O'Connor M.F., Kordylewski H., Westlake B., Dutton R.P. The incidence and risk factors for perioperative cardiac arrest observed in the national anesthesia clinical outcomes registry. Anesth Analg. 2015;120(2):364&#x2013;370. doi: 10.1213/ANE.0000000000000527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000527</ArticleId><ArticleId IdType="pubmed">25390278</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zaane B., van Klei W.A., Buhre W.F., et al. Nonelective surgery at night and in-hospital mortality: prospective observational data from the European Surgical Outcomes Study. Eur J Anaesthesiol. 2015;32(7):477&#x2013;485. doi: 10.1097/EJA.0000000000000256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000256</ArticleId><ArticleId IdType="pubmed">26001104</ArticleId></ArticleIdList></Reference><Reference><Citation>Parashar A., Agarwal S., Krishnaswamy A., et al. Percutaneous intervention for myocardial infarction after noncardiac surgery: patient characteristics and outcomes. J&#xa0;Am Coll Cardiol. 2016;68(4):329&#x2013;338. doi: 10.1016/j.jacc.2016.03.602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.03.602</ArticleId><ArticleId IdType="pubmed">27443427</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman L., Caldera D.L., Nussbaum S.R., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N&#xa0;Engl J Med. 1977;297(16):845&#x2013;850. doi: 10.1056/NEJM197710202971601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197710202971601</ArticleId><ArticleId IdType="pubmed">904659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T.H., Marcantonio E.R., Mangione C.M., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043&#x2013;1049. doi: 10.1161/01.cir.100.10.1043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.100.10.1043</ArticleId><ArticleId IdType="pubmed">10477528</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta P.K., Gupta H., Sundaram A., et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011;124(4):381&#x2013;387. doi: 10.1161/CIRCULATIONAHA.110.015701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.015701</ArticleId><ArticleId IdType="pubmed">21730309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilimoria K.Y., Liu Y., Paruch J.L., et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J&#xa0;Am Coll Surg. 2013;217(5):833&#x2013;842. doi: 10.1016/j.jamcollsurg.2013.07.385. e1-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2013.07.385</ArticleId><ArticleId IdType="pmc">PMC3805776</ArticleId><ArticleId IdType="pubmed">24055383</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrezk R., Jackson N., Al Rezk M., et al. Derivation and validation of a geriatric-sensitive perioperative cardiac risk index. J&#xa0;Am Heart Assoc. 2017;6(11) doi: 10.1161/JAHA.117.006648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.006648</ArticleId><ArticleId IdType="pmc">PMC5721761</ArticleId><ArticleId IdType="pubmed">29146612</ArticleId></ArticleIdList></Reference><Reference><Citation>Dakik H.A., Chehab O., Eldirani M., et al. A&#xa0;new index for pre-operative cardiovascular evaluation. J&#xa0;Am Coll Cardiol. 2019;73(24):3067&#x2013;3078. doi: 10.1016/j.jacc.2019.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.04.023</ArticleId><ArticleId IdType="pubmed">31221255</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz N.R., Gupta N., Guo Y., Berger J.S., Bangalore S. Perioperative acute myocardial infarction associated with non-cardiac surgery. Eur Heart J. 2017;38(31):2409&#x2013;2417. doi: 10.1093/eurheartj/ehx313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx313</ArticleId><ArticleId IdType="pubmed">28821166</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuttall G.A., Merren M.P., Sandoval Y. 5-Lead electrocardiogram monitoring to detect perioperative myocardial infarction, noncardiac surgery patients. Mayo Clin Proc. 2023;98(10):1581&#x2013;1582. doi: 10.1016/j.mayocp.2023.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2023.08.004</ArticleId><ArticleId IdType="pubmed">37793733</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E., Altman D.G., Egger M., Pocock S.J., G&#xf8;tzsche P.C., Vandenbroucke J.P. Initiative STROBE. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495&#x2013;1499. doi: 10.1001/jama.2021.18236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.18236</ArticleId><ArticleId IdType="pubmed">25046131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ola O., Akula A., De Michieli L., et al. Clinical impact of high-sensitivity cardiac troponin T implementation in the community. J&#xa0;Am Coll Cardiol. 2021;77(25):3160&#x2013;3170. doi: 10.1016/j.jacc.2021.04.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.04.050</ArticleId><ArticleId IdType="pmc">PMC9090513</ArticleId><ArticleId IdType="pubmed">34167641</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacheron C.H., Hentzen J., Fauvernier M., et al. Association between short-, intermediate-, and long-term mortality and myocardial injury after noncardiac surgery after hip fracture surgery: a retrospective cohort. Anesth Analg. 2021;133(4):915&#x2013;923. doi: 10.1213/ANE.0000000000005528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005528</ArticleId><ArticleId IdType="pubmed">33830947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallqvist L., Granath F., Fored M., Bell M. Intraoperative hypotension and myocardial infarction development among high-risk patients undergoing noncardiac surgery: a nested case-control study. Anesth Analg. 2021;133(1):6&#x2013;15. doi: 10.1213/ANE.0000000000005391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005391</ArticleId><ArticleId IdType="pubmed">33555690</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux P.J., Chan M.T., Alonso-Coello P., et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307(21):2295&#x2013;2304. doi: 10.1001/jama.2012.5502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.5502</ArticleId><ArticleId IdType="pubmed">22706835</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux P.J., Szczeklik W. Myocardial injury after non-cardiac surgery: diagnosis and management. Eur Heart J. 2020;41(32):3083&#x2013;3091. doi: 10.1093/eurheartj/ehz301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz301</ArticleId><ArticleId IdType="pubmed">31095334</ArticleId></ArticleIdList></Reference><Reference><Citation>Botto F., Alonso-Coello P., Chan M.T., et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120(3):564&#x2013;578. doi: 10.1097/ALN.0000000000000113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000113</ArticleId><ArticleId IdType="pubmed">24534856</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the VISION Study Investigators. Devereaux P.J., Biccard B.M., Sigamani A., et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317(16):1642&#x2013;1651. doi: 10.1001/jama.2017.4360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.4360</ArticleId><ArticleId IdType="pubmed">28444280</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelacher C., Lurati Buse G., Seeberger D., et al. Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization. Circulation. 2018;137(12):1221&#x2013;1232. doi: 10.1161/CIRCULATIONAHA.117.030114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.030114</ArticleId><ArticleId IdType="pubmed">29203498</ArticleId></ArticleIdList></Reference><Reference><Citation>van Waes J.A., Grobben R.B., Nathoe H.M., et al. One-year mortality, causes of death, and cardiac interventions in patients with postoperative myocardial injury. Anesth Analg. 2016;123(1):29&#x2013;37. doi: 10.1213/ANE.0000000000001313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001313</ArticleId><ArticleId IdType="pubmed">27111647</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker R., Sullivan E., Camosso-Stefinovic J., et al. Making use of mortality data to improve quality and safety in general practice: a review of current approaches. Qual Saf Health Care. 2007;16(2):84&#x2013;89. doi: 10.1136/qshc.2006.019885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/qshc.2006.019885</ArticleId><ArticleId IdType="pmc">PMC2653161</ArticleId><ArticleId IdType="pubmed">17403750</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald N.C. Trends in automobile travel, motor vehicle fatalities, and physical activity: 2003-2015. Am J Prev Med. 2017;52(5):598&#x2013;605. doi: 10.1016/j.amepre.2016.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2016.12.012</ArticleId><ArticleId IdType="pubmed">28190689</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefani L.C., Gamermann P.W., Backof A., et al. Perioperative mortality related to anesthesia within 48h and up to 30 days following surgery: a retrospective cohort study of 11,562 anesthetic procedures. J&#xa0;Clin Anesth. 2018;49:79&#x2013;86. doi: 10.1016/j.jclinane.2018.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2018.06.025</ArticleId><ArticleId IdType="pubmed">29909205</ArticleId></ArticleIdList></Reference><Reference><Citation>Makary M.A., Segev D.L., Pronovost P.J., et al. Frailty as a predictor of surgical outcomes in older patients. J&#xa0;Am Coll Surg. 2010;210(6):901&#x2013;908. doi: 10.1016/j.jamcollsurg.2010.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2010.01.028</ArticleId><ArticleId IdType="pubmed">20510798</ArticleId></ArticleIdList></Reference><Reference><Citation>Shem Tov L., Matot I. Frailty and anesthesia. Curr Opin Anaesthesiol. 2017;30(3):409&#x2013;417. doi: 10.1097/ACO.0000000000000456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000456</ArticleId><ArticleId IdType="pubmed">28291129</ArticleId></ArticleIdList></Reference><Reference><Citation>Buigues C., Juarros-Folgado P., Fernandez-Garrido J., Navarro-Martinez R., Cauli O. Frailty syndrome and pre-operative risk evaluation: a systematic review. Arch Gerontol Geriatr. 2015;61(3):309&#x2013;321. doi: 10.1016/j.archger.2015.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2015.08.002</ArticleId><ArticleId IdType="pubmed">26272286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljungqvist O., de Boer H.D., Balfour A., et al. Opportunities and challenges for the next phase of enhanced recovery after surgery: a review. JAMA Surg. 2021;156(8):775&#x2013;784. doi: 10.1001/jamasurg.2021.0586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2021.0586</ArticleId><ArticleId IdType="pubmed">33881466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohn L., Corrigan J., Donaldson M. National Academy Press; 1999. To Err Is Human&#x2014;Building a Safer Health System.</Citation><ArticleIdList><ArticleId IdType="pubmed">25077248</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzau V.J., Shine K.I. Two decades since to err is human: progress, but still a &#x201c;chasm&#x201d;. JAMA. 2020;324(24):2489&#x2013;2490. doi: 10.1001/jama.2020.23151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.23151</ArticleId><ArticleId IdType="pubmed">33351025</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman M.A., Myles P.S., Chan M.T., McIlroy D.R., Wallace S., Ponsford J. Measurement of disability-free survival after surgery. Anesthesiology. 2015;122(3):524&#x2013;536. doi: 10.1097/ALN.0000000000000586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000586</ArticleId><ArticleId IdType="pubmed">25689757</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman M.A., Wallace S., Gilbert A., Reilly J.R., Kasza J., Myles P.S. Predicting death or disability after surgery in the older adult. Anesthesiology. 2023;139(4):420&#x2013;431. doi: 10.1097/ALN.0000000000004683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004683</ArticleId><ArticleId IdType="pubmed">37432667</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonesinghe S.R., Jackson A.I.R., Boney O., et al. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine initiative: patient-centred outcomes. Br J Anaesth. 2019;123(5):664&#x2013;670. doi: 10.1016/j.bja.2019.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.07.020</ArticleId><ArticleId IdType="pubmed">31493848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox T., Smilowitz N.R., Xia Y., Beckman J.A., Berger J.S. Cardiovascular risk factors and perioperative myocardial infarction after noncardiac surgery. Can J Cardiol. 2021;37(2):224&#x2013;231. doi: 10.1016/j.cjca.2020.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2020.04.034</ArticleId><ArticleId IdType="pmc">PMC9960189</ArticleId><ArticleId IdType="pubmed">32380229</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux P.J., Biccard B.M., Chan M.T.V. High-sensitivity troponin levels, ischemia, and mortality&#x2014;reply. JAMA. 2017;318(9):865. doi: 10.1001/jama.2017.9198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.9198</ArticleId><ArticleId IdType="pubmed">28873158</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26391132</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Causes of Death Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e002096</StartPage><MedlinePgn>e002096</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e002096</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.115.002096</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Transcatheter aortic valve replacement (TAVR) is an effective alternative to surgical aortic valve replacement in patients at high surgical risk. However, there is little published literature on the exact causes of death.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">The PubMed database was systematically searched for studies reporting causes of death within and after 30 days following TAVR. Twenty-eight studies out of 3934 results retrieved were identified. In the overall analysis, 46.4% and 51.6% of deaths were related to noncardiovascular causes within and after the first 30 days, respectively. Within 30 days of TAVR, infection/sepsis (18.5%), heart failure (14.7%), and multiorgan failure (13.2%) were the top 3 causes of death. Beyond 30 days, infection/sepsis (14.3%), heart failure (14.1%), and sudden death (10.8%) were the most common causes. All possible subgroup analyses were made. No significant differences were seen for proportions of cardiovascular deaths except the comparison between moderate (mean STS score 4 to 8) and high (mean STS score &gt;8) -risk patients after 30 days post-TAVR (56.0% versus 33.5%, P=0.005).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Cardiovascular and noncardiovascular causes of death are evenly balanced both in the perioperative period and at long-term follow-up after TAVR. Infection/sepsis and heart failure were the most frequent noncardiovascular and cardiovascular causes of death. This study highlights important areas of clinical focus that could further improve outcomes after TAVR.</AbstractText><CopyrightInformation>&#xa9; 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Tian-Yuan</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Yan-Biao</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhen-Gang</ForeName><Initials>ZG</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yuan-Ning</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Zhi-Liang</ForeName><Initials>ZL</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yi-Jian</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Jia-Yu</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jilaihawi</LastName><ForeName>Hasan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (H.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China (T.Y.X., Y.B.L., Z.G.Z., Y.N.X., X.W., Z.L.Z., Y.J.L., J.Y.C., H.T., Y.F., M.C.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="N">Cardiac Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003645" MajorTopicYN="Y">Death, Sudden</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006350" MajorTopicYN="N">Heart Valve Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="N">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aortic stenosis</Keyword><Keyword MajorTopicYN="N">death</Keyword><Keyword MajorTopicYN="N">transcatheter valve replacement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26391132</ArticleId><ArticleId IdType="pmc">PMC4599496</ArticleId><ArticleId IdType="doi">10.1161/JAHA.115.002096</ArticleId><ArticleId IdType="pii">JAHA.115.002096</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J&#xa0;Am Coll Cardiol. 2012;60:483&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">22749306</ArticleId></ArticleIdList></Reference><Reference><Citation>Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696&#x2013;1704.</Citation><ArticleIdList><ArticleId IdType="pubmed">22443478</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187&#x2013;2198.</Citation><ArticleIdList><ArticleId IdType="pubmed">21639811</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J, Jr, Kleiman NS. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790&#x2013;1798.</Citation><ArticleIdList><ArticleId IdType="pubmed">24678937</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Chen LM, Wang MN, Chen XJ, Li N, De Huang Y, Chen M. The G894t, T-786c and 4b/a polymorphisms in Enos gene and cancer risk: a meta-analysis. J Evid Based Med. 2014;7:263&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">25586457</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CC, Wang YQ, Li YP, Li XL. High-intensity focused ultrasound for treatment of pancreatic cancer: a systematic review. J Evid Based Med. 2014;7:270&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">25586458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappetein AP, Head SJ, G&#xe9;n&#xe9;reux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es G-A. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438&#x2013;1454.</Citation><ArticleIdList><ArticleId IdType="pubmed">23036636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y, Du L. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8:2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">25594108</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X, Li Y, Liu J, He S, Liu M. Aortic arch atheroma and the risk of stroke: a meta-analysis. J Evid Based Med. 2014;7:185&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">25154372</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez GJ, Seco M, Jaijee SK, Adams MR, Cartwright BL, Forrest P, Celermajer DS, Vallely MP, Wilson MK, Ng MK. Introduction of an interdisciplinary heart team-based transcatheter aortic valve implantation program: short and mid-term outcomes. Intern Med J. 2014;44:876&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pubmed">24965193</ArticleId></ArticleIdList></Reference><Reference><Citation>Stabile E, Pucciarelli A, Cota L, Sorropago G, Tesorio T, Salemme L, Popusoi G, Ambrosini V, Cioppa A, Agrusta M, Catapano D, Moscariello C, Trimarco B, Esposito G, Rubino P. SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. Int J Cardiol. 2014;174:624&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">24809922</ArticleId></ArticleIdList></Reference><Reference><Citation>Omer S, Kar B, Cornwell LD, Blaustein A, Levine GN, Ali N, Jneid H, Paniagua D, Atluri PV, Bechara CF, Kougias P, Ruma M, Preventza O, Bozkurt B, Carabello BA, Bakaeen FG. Early experience of a transcatheter aortic valve program at a Veterans Affairs facility. JAMA Surg. 2013;148:1087&#x2013;1093.</Citation><ArticleIdList><ArticleId IdType="pubmed">24048246</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble S, Frangos E, Samaras N, Ellenberger C, Frangos C, Cikirikcioglu M, Bendjelid K, Frei A, Myers P, Licker M, Roffi M. Transcatheter aortic valve implantation in nonagenarians: effective and safe. Eur J Intern Med. 2013;24:750&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pubmed">23932885</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther T, Thielmann M, Kempfert J, Schroefel H, Wimmer-Greinecker G, Treede H, Wahlers T, Wendler O. One-year multicentre outcomes of transapical aortic valve implantation using the SAPIEN XT valve: the PREVAIL transapical study. Eur J Cardiothorac Surg. 2013;43:986&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pubmed">23345186</ArticleId></ArticleIdList></Reference><Reference><Citation>Latib A, Maisano F, Bertoldi L, Giacomini A, Shannon J, Cioni M, Ielasi A, Figini F, Tagaki K, Franco A, Covello RD, Grimaldi A, Spagnolo P, Buchannan GL, Carlino M, Chieffo A, Montorfano M, Alfieri O, Colombo A. Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. Am Heart J. 2012;164:910&#x2013;917.</Citation><ArticleIdList><ArticleId IdType="pubmed">23194492</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin JL, Lim P, Dubois-Rande JL, Teiger E. Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged &gt;/=90&#xa0;years versus &lt;90&#xa0;years. Am J Cardiol. 2012;110:1156&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pubmed">23021601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendler O, Walther T, Schroefel H, Lange R, Treede H, Fusari M, Rubino P, Thomas M. Transapical aortic valve implantation: mid-term outcome from the SOURCE registry. Eur J Cardiothorac Surg. 2013;43:505&#x2013;511. discussion 511-502.</Citation><ArticleIdList><ArticleId IdType="pubmed">22648920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendler O, Thielmann M, Schroefel H, Rastan A, Treede H, Wahlers T, Eichinger W, Walther T. Worldwide experience with the 29-mm Edwards SAPIEN XT transcatheter heart valve in patients with large aortic annulus. Eur J Cardiothorac Surg. 2013;43:371&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">22522982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempfert J, Treede H, Rastan AJ, Schonburg M, Thielmann M, Sorg S, Mohr FW, Walther T. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA): 6-month outcomes. Eur J Cardiothorac Surg. 2013;43:52&#x2013;56. discussion 57.</Citation><ArticleIdList><ArticleId IdType="pubmed">22491663</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mieghem NM, van der Boon RM, Nuis RJ, Schultz C, van Geuns RJ, Serruys PW, Kappetein AP, van Domburg RT, de Jaegere PP. Cause of death after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2014;83:E277&#x2013;E282.</Citation><ArticleIdList><ArticleId IdType="pubmed">22887941</ArticleId></ArticleIdList></Reference><Reference><Citation>Doss M, Buhr EB, Martens S, Moritz A, Zierer A. Transcatheter-based aortic valve implantations at midterm: what happened to our initial patients? Ann Thorac Surg. 2012;94:1400&#x2013;1406.</Citation><ArticleIdList><ArticleId IdType="pubmed">22776084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducrocq G, Al-Attar N, Himbert D, Messika-Zeitoun D, Iung B, Descoutures F, Nataf P, Vahanian A. Early and mid-term outcomes in patients undergoing transcatheter aortic valve implantation after previous coronary artery bypass grafting. Eur J Cardiothorac Surg. 2012;41:499&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">22345175</ArticleId></ArticleIdList></Reference><Reference><Citation>Ussia GP, Barbanti M, Petronio AS, Tarantini G, Ettori F, Colombo A, Violini R, Ramondo A, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, De Carlo M, Napodano M, Fiorina C, De Marco F, Antoniucci D, de Cillis E, Capodanno D, Tamburino C. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J. 2012;33:969&#x2013;976.</Citation><ArticleIdList><ArticleId IdType="pubmed">22240494</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Onofrio A, Rubino P, Fusari M, Salvador L, Musumeci F, Rinaldi M, Vitali EO, Glauber M, Di Bartolomeo R, Alfieri OR, Polesel E, Aiello M, Casabona R, Livi U, Grossi C, Cassese M, Pappalardo A, Gherli T, Stefanelli G, Faggian GG, Gerosa G. Clinical and hemodynamic outcomes of &#x201c;all-comers&#x201d; undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA) J Thorac Cardiovasc Surg. 2011;142:768&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pubmed">21840020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosmans JM, Kefer J, De Bruyne B, Herijgers P, Dubois C, Legrand V, Verheye S, Rodrigus I. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011;12:762&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pubmed">21349890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Antolin RA, Garcia E, Sandoval S, Almeria C, Cuadrado A, Serrano J, de Obeso E, Del Valle R, Banuelos C, Alfonso F, Guerrero F, Heredia J, Martin Benitez JC, Garcia-Rubira JC, Rodriguez E, Macaya C. Findings of a mixed transfemoral aortic valve implantation program using Edwards and CoreValve devices. Rev Esp Cardiol (Engl Ed) 2011;64:35&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">21190774</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, Nozohoor S, Kimblad PO, Harnek J, Olivecrona GK, Sjogren J. Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety. Ann Thorac Surg. 2011;91:57&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">21172486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefevre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schachinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011;32:148&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3021390</ArticleId><ArticleId IdType="pubmed">21075775</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961243</ArticleId></ArticleIdList></Reference><Reference><Citation>Drews T, Pasic M, Buz S, Unbehaun A, Dreysse S, Kukucka M, Mladenow A, Hetzer R. Transapical aortic valve implantation after previous heart surgery. Eur J Cardiothorac Surg. 2011;39:625&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">20691604</ArticleId></ArticleIdList></Reference><Reference><Citation>Attias D, Himbert D, Ducrocq G, Detaint D, Al-Attar N, Iung B, Francis F, Maury JM, Brochet E, Enguerrand D, Nataf P, Vahanian A. Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis. Arch Cardiovasc Dis. 2010;103:236&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">20656634</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Cheung A, Lichtenstein SV, Nietlispach F, Albugami S, Masson JB, Thompson CR, Munt B, Moss R, Carere RG, Jamieson WR, Webb JG. Transapical transcatheter aortic valve implantation: follow-up to 3&#xa0;years. J&#xa0;Thorac Cardiovasc Surg. 2010;139:1107&#x2013;1113. 1113.e1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">20412948</ArticleId></ArticleIdList></Reference><Reference><Citation>Guinot PG, Depoix JP, Etchegoyen L, Benbara A, Provenchere S, Dilly MP, Philip I, Enguerand D, Ibrahim H, Vahanian A, Himbert D, Al-Attar N, Nataf P, Desmonts JM, Montravers P, Longrois D. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth. 2010;24:752&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">20188592</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzas P, Munoz-Garcia AJ, Segura J, Pan M, Alonso-Briales JH, Lozano I, Moris C, de Lezo JS, Hernandez-Garcia JM. Percutaneous implantation of the CoreValve((R)) self-expanding aortic valve prosthesis in patients with severe aortic stenosis: early experience in Spain. Rev Esp Cardiol (Engl Ed) 2010;63:141&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">20109412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapadia SR, Goel SS, Svensson L, Roselli E, Savage RM, Wallace L, Sola S, Schoenhagen P, Shishehbor MH, Christofferson R, Halley C, Rodriguez LL, Stewart W, Kalahasti V, Tuzcu EM. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg. 2009;137:1430&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pubmed">19464460</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther T, Falk V, Borger MA, Kempfert J, Ender J, Linke A, Schuler G, Mohr FW. Transapical aortic valve implantation in patients requiring redo surgery. Eur J Cardiothorac Surg. 2009;36:231&#x2013;234. discussion 234-235.</Citation><ArticleIdList><ArticleId IdType="pubmed">19324566</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">17646579</ArticleId></ArticleIdList></Reference><Reference><Citation>Zierer A, Wimmer-Greinecker G, Martens S, Moritz A, Doss M. Is transapical aortic valve implantation really less invasive than minimally invasive aortic valve replacement? J Thorac Cardiovasc Surg. 2009;138:1067&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pubmed">19740493</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaccarotella C, Mongiardo A, Indolfi C. Pathophysiology of aortic stenosis and approach to treatment with percutaneous valve implantation. Circ J. 2010;75:11&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">21178291</ArticleId></ArticleIdList></Reference><Reference><Citation>Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-B&#xe4;rwolf C, Boersma E, Ravaud P, Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714&#x2013;2720.</Citation><ArticleIdList><ArticleId IdType="pubmed">16141261</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Tuzcu EM, Krishnaswamy A, Schoenhagen P, Stewart WJ, Svensson LG, Kapadia SR. Transcatheter aortic valve replacement: current perspectives and future implications. Heart. 2015;101:169&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">25410500</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone M, Russo A, Mancone M, Carriero G, Mazzesi G, Miraldi F, Pennacchi M, Pugliese F, Tritapepe L, Vullo V. Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study. Clin Microbiol Infect. 2013;20:758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">24267878</ArticleId></ArticleIdList></Reference><Reference><Citation>Onsea K, Agostoni P, Voskuil M, Samim M, Stella P. Infective complications after transcatheter aortic valve implantation: results from a single centre. Neth Heart J. 2012;20:360&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430757</ArticleId><ArticleId IdType="pubmed">22890618</ArticleId></ArticleIdList></Reference><Reference><Citation>Monrad ES, Hess O, Murakami T, Nonogi H, Corin W, Krayenbuehl H. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation. 1988;77:1345&#x2013;1355.</Citation><ArticleIdList><ArticleId IdType="pubmed">2967128</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson LG, Blackstone EH, Rajeswaran J, Brozzi N, Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Tuzcu EM, Webb JG, Kapadia S, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Thourani VH, Pichard AD, Bavaria JE, Herrmann HC, Williams MR, Babaliaros V, Genereux P, Akin JJ. Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial. J Am Coll Cardiol. 2014;64:158&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">25011720</ArticleId></ArticleIdList></Reference><Reference><Citation>Asimakopoulos G, Edwards M-B, Taylor KM. Aortic valve replacement in patients 80&#xa0;years of age and older survival and cause of death based on 1100 cases: collective results from the UK heart valve registry. Circulation. 1997;96:3403&#x2013;3408.</Citation><ArticleIdList><ArticleId IdType="pubmed">9396434</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmann K, Sirotina M, De Rosa S, Ehrlich JR, Fox H, Weber J, Moritz A, Zeiher AM, Hofmann I, Sch&#xe4;chinger V. The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase. Interact Cardiovasc Thorac Surg. 2013;17:359&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715165</ArticleId><ArticleId IdType="pubmed">23644728</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31849646</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>1370</StartPage><MedlinePgn>1370</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1370</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2019.01370</ELocationID><Abstract><AbstractText><b>Background:</b> Ulinastatin has been prescribed to treat sepsis. However, there is doubt regarding the extent of any improvement in outcomes to guide future decision making. <b>Objectives:</b> To evaluate the effects of ulinastatin on mortality and related outcomes in sepsis patients. <b>Methods:</b> Thirteen randomized controlled trials and two prospective studies published before September 1, 2018, that included 1358 patients with sepsis, severe sepsis, or septic shock were evaluated. The electronic databases searched in this study were PubMed, Medline, Embase, and China National Knowledge Infrastructure (CNKI) for Chinese Technical Periodicals. <b>Results:</b> Ulinastatin significantly decreased the all-cause mortality {odds ratio (OR) = 0.48, 95% confidence interval (CI) [0.35-0.66], p &lt; 0.00001, I<sup>2</sup> = 13%}, Acute Physiology, Age, Chronic Health Evaluation II (APACHE II) score {mean difference (MD) = -2.40, 95% CI [-4.37, -0.44], p = 0.02, I<sup>2</sup> = 66%}, and reduced the incidence of multiple organ dysfunction syndrome (MODS) (OR = 0.3, 95% CI [0.18, 0.49], p &lt; 0.00001, I<sup>2</sup> = 0%). Ulinastatin also decreased the serum levels of IL-6 (MD = -88.5, 95% CI [-123.97, -53.04], p &lt; 0.00001), TNF-&#x3b1; (MD = -56.22, 95% CI [-72.11, -40.33], p &lt; 0.00001), and increased the serum levels of IL-10 (MD = 37.73, 95% CI [16.92, 58.54], p = 0.0004). Ulinastatin administration did not lead to any difference in the occurrence of adverse events. <b>Conclusions:</b> Ulinastatin improved all-cause mortality and other related outcomes in patients with sepsis or septic shock. The results of this meta-analysis suggest that ulinastatin may be an effective treatment for sepsis and septic shock.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Wang, Liu, Tang, Chang, Yao, Huang, Lodato and Liu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huifang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Emergency Department, Zhujiang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Lishuai</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgical, Zhujiang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lodato</LastName><ForeName>Robert F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Critical Care, and Sleep Medicine, Medical School, University of Texas Health Science Center at Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhanguo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Pharmacol. 2020 Feb 21;10:1697. doi: 10.3389/fphar.2019.01697.</RefSource><PMID Version="1">32153390</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">inflammatory cytokine</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">ulinastatin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31849646</ArticleId><ArticleId IdType="pmc">PMC6893897</ArticleId><ArticleId IdType="doi">10.3389/fphar.2019.01370</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Angus D. C., Linde-Zwirble W. T., Lidicker J., Clermont G., Carcillo J., Pinsky M. R. (2001). Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29 (7), 1303&#x2013;1310. 10.1097/00003246-200107000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong B. A., Betzold R. D., May A. K. (2017). Sepsis and septic shock strategies. Surg. Clin. North Am. 97 (6), 1339&#x2013;1379. 10.1016/j.suc.2017.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suc.2017.07.003</ArticleId><ArticleId IdType="pubmed">29132513</ArticleId></ArticleIdList></Reference><Reference><Citation>Atal S. S., Atal S. (2016). Ulinastatin - a newer potential therapeutic option for multiple organ dysfunction syndrome. J. Basic Clin. Physiol. Pharmacol. 27 (2), 91&#x2013;99. 10.1515/jbcpp-2015-0003</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jbcpp-2015-0003</ArticleId><ArticleId IdType="pubmed">26565549</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P., Liu J., Yu Y., Cui S. Y., Guo Z. H., Chen G. M. (2017. a). Alpha-lipoic acid suppresses extracellular histone-induced release of the infammatory mediator tumor necrosis factor-alpha by macrophages. Cell Physiol. Biochem. 42 (6), 2559&#x2013;2568. 10.1159/000480217</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000480217</ArticleId><ArticleId IdType="pubmed">28848097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P., Mo B., Cauvi D. M., Yu Y., Guo Z., Zhou J. (2017. b). Grape seed proanthocyanidin extract protects lymphocytes against histone-induced apoptosis. PeerJ 5, e3108. 10.7717/peerj.3108</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.3108</ArticleId><ArticleId IdType="pmc">PMC5363264</ArticleId><ArticleId IdType="pubmed">28344907</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Peng S., Chen Y. (2015). Comparative observation of curative effects by ulinastatin and conventional method in the treatment of severe sepsis. Chinese J. Modern Drug App. 9 (7), 1&#x2013;2, 3. 10.14164/j.cnki.cn11-5581/r.2015.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.14164/j.cnki.cn11-5581/r.2015.07.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhuri A. H., Tyagi R., Tyagi R., Agarwal D., Uppal R. (2015). Early use of ulinastatin reduces Multiorgan Dysfunction (MODS) in septic shock following anastomotic failure. Clin. Therapeutics 37 (8), e112.</Citation></Reference><Reference><Citation>Chousterman B. G., Swirski F. K., Weber G. F. (2017). Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 39 (5), 517&#x2013;528. 10.1007/s00281-017-0639-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0639-8</ArticleId><ArticleId IdType="pubmed">28555385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Q. X., Wang C. H. (2016). Effects of urinary trypsin inhibitor on serum levels of TNF-a, IL-8 and IL-10 in patients with severe sepsis. Chinese J. Biochem. Pharmaceutics 36 (3), 146&#x2013;148. 10.3969/j.issn.1005-1678.2016.03.48</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1005-1678.2016.03.48</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Q., Chen P. (2005). A Study on clinical efficacy of ulinastatin in severe sepsis patients and its mechanism of action. Chinese J. Of Infect. And Chemother. 5 (1), 13&#x2013;16. 10.3321/j.issn:1009-7708.2005.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.3321/j.issn:1009-7708.2005.01.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Q., Zhao X. (2017). Clinical effect of combined ulinastatin and continuous renal replacement therapy on management of severe sepsis with acute kidney injury. Tropical J. Pharmaceutical Res. 16 (4), 925&#x2013;930. 10.4314/tjpr.v16i4.26</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/tjpr.v16i4.26</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Zhong W.-H., Song W.-L., Deng Y.-Y., Yang D.-M., Xiong B. (2018). Ulinastatin ameliorates pulmonary capillary endothelial permeability induced by sepsis through protection of tight junctions via inhibition of TNF-alpha and related pathways. Front. Pharmacol. 9, 823. 10.3389/fphar.2018.00823</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00823</ArticleId><ArticleId IdType="pmc">PMC6099086</ArticleId><ArticleId IdType="pubmed">30150933</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z., Shi Q., Fan Y., Wang Q., Yin W. (2016). Ulinastatin and/or thymosin alpha1 for severe sepsis: a systematic review and meta-analysis. J. Trauma Acute Care Surg. 80 (2), 335&#x2013;340. 10.1097/ta.0000000000000909</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ta.0000000000000909</ArticleId><ArticleId IdType="pubmed">26517783</ArticleId></ArticleIdList></Reference><Reference><Citation>Girardot T., Rimmele T., Venet F., Monneret G. (2017). Apoptosis-induced lymphopenia in sepsis and other severe injuries. Apoptosis 22 (2), 295&#x2013;305. 10.1007/s10495-016-1325-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-016-1325-3</ArticleId><ArticleId IdType="pubmed">27812767</ArticleId></ArticleIdList></Reference><Reference><Citation>Han D., Shang W., Wang G., Sun L., Zhang Y., Wen H. (2015). Ulinastatin- and thymosin alpha1-based immunomodulatory strategy for sepsis: a meta-analysis. Int. Immunopharmacol. 29 (2), 377&#x2013;382. 10.1016/j.intimp.2015.10.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2015.10.026</ArticleId><ArticleId IdType="pubmed">26522590</ArticleId></ArticleIdList></Reference><Reference><Citation>Harjai M., Bogra J., Kohli M., Pant A. B. (2013). Is suppression of apoptosis a new therapeutic target in sepsis?. Anaesth. Intensive Care 41 (2), 175&#x2013;183. 10.1177/0310057X1304100207</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1304100207</ArticleId><ArticleId IdType="pubmed">23530784</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss R. S., Crouser E. (2015). Imaging apoptosis in sepsis&#x2013;A technology we would die for!. Crit. Care Med. 43 (11), 2506&#x2013;2508. 10.1097/ccm.0000000000001289</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0000000000001289</ArticleId><ArticleId IdType="pmc">PMC4837329</ArticleId><ArticleId IdType="pubmed">26468702</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss R. S., Nicholson D. W. (2006). Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6 (11), 813&#x2013;822. 10.1038/nri1943</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1943</ArticleId><ArticleId IdType="pubmed">17039247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss R. S., Monneret G., Payen D. (2013). Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13 (12), 862&#x2013;874. 10.1038/nri3552</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3552</ArticleId><ArticleId IdType="pmc">PMC4077177</ArticleId><ArticleId IdType="pubmed">24232462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui L., Shen F., Chang H., Li X., Gao G., Ma J. (2014). Effects of ulinastatin on cerebral oxygen metabolism and CRP levels in patients with severe traumatic brain injury. Exp. Therapeutic Med. 7 (6), 1683&#x2013;1686. 10.3892/etm.2014.1666</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2014.1666</ArticleId><ArticleId IdType="pmc">PMC4043583</ArticleId><ArticleId IdType="pubmed">24926366</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K.-I., Takano H. (2010). Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders. Expert Opin. Investig. Drugs 19 (4), 513&#x2013;520. 10.1517/13543781003649533</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543781003649533</ArticleId><ArticleId IdType="pubmed">20367192</ArticleId></ArticleIdList></Reference><Reference><Citation>Itaba S., Nakamura K., Aso A., Tokunaga S., Akiho H., Ihara E. (2013). Prospective, randomized, double-blind, placebo-controlled trial of ulinastatin for prevention of hyperenzymemia after double balloon endoscopy via the antegrade approach. Dig. Endosc. 25 (4), 421&#x2013;427. 10.1111/den.12014</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/den.12014</ArticleId><ArticleId IdType="pubmed">23368820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J., Gavaghan D. J. (1996). Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin. Trials 17 (1), 1&#x2013;12. 10.1016/0197-2456(95)00134-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(95)00134-4</ArticleId><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L. Y., Hong Y. L., Xing C. J. (2006). The effect of Ulinastatin on the delivery of cytokines in patients with septic shock. Chinese J. Of Emergency Med. 15 (1671-0282), 1136&#x2013;1138. 10.3760/j.issn:1671-0282.2006.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/j.issn:1671-0282.2006.12.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W., Yu X., Sun T., Chai Y., Chang P., Chen Z. (2018). ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial. Trials 19 (1), 133. 10.1186/s13063-018-2513-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-018-2513-y</ArticleId><ArticleId IdType="pmc">PMC5822617</ArticleId><ArticleId IdType="pubmed">29467017</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnad D. R., Bhadade R., Verma P. K., Moulick N. D., Daga M. K., Chafekar N. D. (2014). Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study. Intensive Care Med. 40 (6), 830&#x2013;838. 10.1007/s00134-014-3278-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3278-8</ArticleId><ArticleId IdType="pmc">PMC4028549</ArticleId><ArticleId IdType="pubmed">24737258</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Li T., Li Y., Cai S., Zhang Z., Zeng Z. (2014). Ulinastatin inhibits oxidant-induced endothelial hyperpermeability and apoptotic signaling. Int. J. Clin. Exp. Pathol. 7 (11), 7342&#x2013;7350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4270631</ArticleId><ArticleId IdType="pubmed">25550770</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Bo L., Liu Q., Jin F. (2015). Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis. Int. J. Infect. Dis. 33, 90&#x2013;96. 10.1016/j.ijid.2014.12.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2014.12.032</ArticleId><ArticleId IdType="pubmed">25532482</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Ma D., Chen M., Zhang L., Zhang L., Zhang J. (2016). Ulinastatin attenuates LPS-induced human endothelial cells oxidative damage through suppressing JNK/c-Jun signaling pathway. Biochem. Biophys. Res. Commun. 474 (3), 572&#x2013;578. 10.1016/j.bbrc.2016.04.104</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.04.104</ArticleId><ArticleId IdType="pubmed">27109479</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A., Altman D. G., Tetzlaff J., Mulrow C., Gotzsche P. C., Ioannidis J. P. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700. 10.1136/bmj.b2700</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Linder A., Russell J. A. (2014). An exciting candidate therapy for sepsis: ulinastatin, a urinary protease inhibitor. Intensive Care Med. 40 (8), 1164&#x2013;1167. 10.1007/s00134-014-3366-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3366-9</ArticleId><ArticleId IdType="pubmed">24990495</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.-G., Zhang J., He Y., Chang P., Gu D.-S., Luo Y.-W. (2011). Impact of transfusion of apoptotic and necrotic thymocytes on the survival of mice with sepsis. J. Of Southern Med. Univ. 31 (6), 960&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pubmed">21690045</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z. G., Ni S. Y., Chen G. M., Cai J., Guo Z. H., Chang P. (2013). Histones-mediated lymphocyte apoptosis during sepsis is dependent on p38 phosphorylation and mitochondrial permeability transition. PLoS One 8 (10), e77131. 10.1371/journal.pone.0077131</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077131</ArticleId><ArticleId IdType="pmc">PMC3805602</ArticleId><ArticleId IdType="pubmed">24167561</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Yu Z., Yin J., Chen Y., Zhang H., Fan X. (2017). Effect of ulinastatin combined with thymosin alpha1 on sepsis: a systematic review and meta-analysis of Chinese and Indian patients. J. Crit. Care 39, 285&#x2013;287. 10.1016/j.jcrc.2017.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.02.005</ArticleId><ArticleId IdType="pubmed">28283220</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin G. S., Mannino D. M., Eaton S., Moss M. (2003). The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348 (16), 1546&#x2013;1554. 10.1056/NEJMoa022139</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022139</ArticleId><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Minasyan H. (2017). Sepsis and septic shock: Pathogenesis and treatment perspectives. J. Crit. Care 40, 229&#x2013;242. 10.1016/j.jcrc.2017.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.04.015</ArticleId><ArticleId IdType="pubmed">28448952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni H. Y., Fang Q., Zhang Y. S. (2008). Effects of ulinastatin on Inflammatory response and curative effect in severe sepsis patients. Chinese J. Of Crit. Care Med. 28 (4), 342&#x2013;344. 10.3969/j.issn.1002-1949.2008.04.017</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1002-1949.2008.04.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Patera A. C., Drewry A. M., Chang K., Beiter E. R., Osborne D., Hotchkiss R. S. (2016). Frontline Science: defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. J. Leukoc. Biol. 100 (6), 1239&#x2013;1254. 10.1189/jlb.4HI0616-255R</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.4HI0616-255R</ArticleId><ArticleId IdType="pmc">PMC5110001</ArticleId><ArticleId IdType="pubmed">27671246</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavan Kumar Rao N., Sv S., Nayak K. S. (2017). Use of ulinastatin in renal failure patients developing sepsis. Indian J. Nephrol. 27, S68&#x2013;S69.</Citation></Reference><Reference><Citation>Rajaee A., Barnett R., Cheadle W. G. (2018). Pathogen- and danger-associated molecular patterns and the cytokine response in sepsis. Surg. Infect. (Larchmt) 19 (2), 107&#x2013;116. 10.1089/sur.2017.264</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2017.264</ArticleId><ArticleId IdType="pubmed">29364781</ArticleId></ArticleIdList></Reference><Reference><Citation>Servillo G., Vargas M., Pastore A., Procino A., Iannuzzi M., Capuano A. (2013). Immunomodulatory effect of continuous venovenous hemofiltration during sepsis: preliminary data. Biomed. Res. Int. 2013, 108951. 10.1155/2013/108951</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/108951</ArticleId><ArticleId IdType="pmc">PMC3736510</ArticleId><ArticleId IdType="pubmed">23971020</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y. M., Zhang L. Q., Deng L. H., Yao H. G. (2005). [Clinical study on effects of ulinastatin on patients with systemic inflammatory response syndrome]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 17 (4), 228&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">15836828</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu H., Liu K., He Q., Zhong F., Yang L., Li Q. (2014). Ulinastatin, a protease inhibitor, may inhibit allogeneic blood transfusion-associated pro-inflammatory cytokines and systemic inflammatory response syndrome and improve postoperative recovery. Blood Transfus. 12 Suppl 1, s109&#x2013;s118. 10.2450/2013.0224-12</Citation><ArticleIdList><ArticleId IdType="doi">10.2450/2013.0224-12</ArticleId><ArticleId IdType="pmc">PMC3934215</ArticleId><ArticleId IdType="pubmed">23736923</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C. S., Seymour C. W., Shankar-Hari M., Annane D., Bauer M. (2016). The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama 315 (8), 801&#x2013;810. 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J. E., Kang W. S., Kim D. K., Yoon T. G., Kim T. Y., Bang Y. S. (2011). The effect of ulinastatin on postoperative blood loss in patients undergoing open heart surgery with cardiopulmonary bypass. J. Int. Med. Res. 39 (4), 1201&#x2013;1210. 10.1177/147323001103900408</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/147323001103900408</ArticleId><ArticleId IdType="pubmed">21986122</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoller J., Halpin L., Weis M., Aplin B., Qu W., Georgescu C. (2016). Epidemiology of severe sepsis: 2008-2012. J. Crit. Care 31 (1), 58&#x2013;62. 10.1016/j.jcrc.2015.09.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.09.034</ArticleId><ArticleId IdType="pubmed">26601855</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun R., Zhang Y., Lv Q., Liu B., Jin M., Zhang W. (2011). Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J. Biol. Chem. 286 (18), 15918&#x2013;15928. 10.1074/jbc.M110.178798</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.178798</ArticleId><ArticleId IdType="pmc">PMC3091201</ArticleId><ArticleId IdType="pubmed">21367858</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung W. M., Sung W. L., Yun S. H., Dae W. P., Ik J. J., Young H. Y. (2009). The effects of urinary trypsin inhibitor on the outcomes of severe sepsis and septic shock patients. Korean Emergency Medical J. 20, 80&#x2013;85.</Citation></Reference><Reference><Citation>Tang J. (2013). The clinical effect analysis of treating septicopyemia patients with ulinastatin. Guide China Med. (15), 439&#x2013;440. 10.3969/j.issn.1671-8194.2013.15.333</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1671-8194.2013.15.333</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida M., Abe T., Ono K., Tamiya N. (2018). Ulinastatin did not reduce mortality in elderly multiple organ failure patients: a retrospective observational study in a single center ICU. Acute Med. Surg. 5 (1), 90&#x2013;97. 10.1002/ams2.304</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ams2.304</ArticleId><ArticleId IdType="pmc">PMC5797838</ArticleId><ArticleId IdType="pubmed">29445506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Li X., Kexi L. (2007). Influence of Ulinastatin on cytokines of patients with sepsis. Modern Med. J. Of China 9 (11), 23&#x2013;25. 10.3969/j.issn.1672-9463.2007.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1672-9463.2007.11.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F. Y., Fang B., Qiang X. H., Yu T. O., Zhong J. R., Cao J., et al. (2016). The efficacy and immunomodulatory effects of ulinastatin and thymosin alpha1 for sepsis: a systematic review and meta-analysis. Biomed. Res. Int. 2016, 9508493. 10.1155/2016/9508493</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9508493</ArticleId><ArticleId IdType="pmc">PMC4906180</ArticleId><ArticleId IdType="pubmed">27340674</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedow O., Meyer-Hoffert U. (2005). Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J. Intern. Med. 257 (4), 319&#x2013;328. 10.1111/j.1365-2796.2005.01476.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2005.01476.x</ArticleId><ArticleId IdType="pubmed">15788001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W. W. (1998). ICE family proteases in inflammation and apoptosis. Agents Actions Suppl 49, 5&#x2013;13. 10.1007/978-3-0348-8857-8_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-0348-8857-8_2</ArticleId><ArticleId IdType="pubmed">9426822</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Zhou L., Liu J., Ma G., Kou Q., He Z. (2013. a). The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit. Care 17 (1), R8. 10.1186/cc11932</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11932</ArticleId><ArticleId IdType="pmc">PMC4056079</ArticleId><ArticleId IdType="pubmed">23327199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T. J., Zhang L. N., Kang C. C. (2013. b). The effect of ulinastatin on disbalance of inflammation and immune status in patients with severe sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 25 (4), 219&#x2013;223. 10.3760/cma.j.issn.2095-4352.2013.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.2095-4352.2013.04.010</ArticleId><ArticleId IdType="pubmed">23660098</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Cui Z. B., Kang H. S., Zhao Y. Y., Liu S. H. (2016). Effect of ulinastatin on the serum levels of tumor necrosis factor &#x3b1;, interleukin 10,troponin I and C-reactive protein. J. Bengbu Med. College 41 (12), 1635&#x2013;1638. 10.13898/j.cnki.issn.1000-2200.2016.12.031</Citation><ArticleIdList><ArticleId IdType="doi">10.13898/j.cnki.issn.1000-2200.2016.12.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q., Yan Q., Chen S. (2018). Ulinastatin is effective in reducing mortality for critically ill patients with sepsis: a causal mediation analysis. Sci. Rep. 8 (1), 14360. 10.1038/s41598-018-32533-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32533-9</ArticleId><ArticleId IdType="pmc">PMC6156583</ArticleId><ArticleId IdType="pubmed">30254204</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Mao Y., Lu X., Sang X., Du S., Zhao H. (2011). The effects of urinary trypsin inhibitor on liver function and inflammatory factors in patients undergoing hepatectomy: a prospective, randomized, controlled clinical study. Am. J. Surg. 202 (2), 151&#x2013;157. 10.1016/j.amjsurg.2010.07.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2010.07.044</ArticleId><ArticleId IdType="pubmed">21718959</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhou Y., Lou J., Li J., Bo L., Zhu K. (2010). PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit. Care 14 (6), R220. 10.1186/cc9354</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9354</ArticleId><ArticleId IdType="pmc">PMC3220038</ArticleId><ArticleId IdType="pubmed">21118528</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Tan C., Wang X., Kang D., Chen Y., Xiong J. (2016). Preventive effects of ulinastatin on complications related to pancreaticoduodenectomy: a Consort-prospective, randomized, double-blind, placebo-controlled trial. Med. (Baltimore) 95 (24), e3731. 10.1097/md.0000000000003731</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000003731</ArticleId><ArticleId IdType="pmc">PMC4998438</ArticleId><ArticleId IdType="pubmed">27310952</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36142893</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>18</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Investigation of TLR2 and TLR4 Polymorphisms and Sepsis Susceptibility: Computational and Experimental Approaches.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10982</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms231810982</ELocationID><Abstract><AbstractText>Toll-like receptors (TLR) play an eminent role in the regulation of immune responses to invading pathogens during sepsis. TLR genetic variants might influence individual susceptibility to developing sepsis. The current study aimed to investigate the association of genetic polymorphisms of the <i>TLR2</i> and <i>TLR4</i> with the risk of developing sepsis with both a pilot study and in silico tools. Different in silico tools were used to predict the impact of our SNPs on protein structure, stability, and function. Furthermore, in our prospective study, all patients matching the inclusion criteria in the intensive care units (ICU) were included and followed up, and DNA samples were genotyped using real-time polymerase chain reaction (RT-PCR) technology. There was a significant association between <i>TLR2</i> Arg753Gln polymorphisms and sepsis under the over-dominant model (<i>p</i> = 0.043). In contrast, we did not find a significant difference with the <i>TLR4</i> Asp299Gly polymorphism with sepsis. However, there was a significant association between <i>TLR4</i> Asp299Gly polymorphisms and <i>Acinetobacter baumannii</i> infection which is quite a virulent organism in ICU (<i>p</i> = 0.001) and post-surgical cohorts (<i>p</i> = 0.033). Our results conclude that the <i>TLR2</i> genotype may be a risk factor for sepsis in adult patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Behairy</LastName><ForeName>Mohammed Y</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0001-8415-2914</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, University of Sadat City, Sadat City 32958, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelrahman</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toraih</LastName><ForeName>Eman A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0001-9267-3787</Identifier><AffiliationInfo><Affiliation>Department of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genetics Unit, Department of Histology &amp; Cell Biology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Emad El-Deen A</ForeName><Initials>EEA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azab</LastName><ForeName>Marwa M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayed</LastName><ForeName>Anwar A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-2243-0971</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology and Immunology, Taibah University, Madinah 42353, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London SW7 2BX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashem</LastName><ForeName>Hany R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Fayoum University, Fayoum 63514, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495342">TLR2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495345">TLR4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051195">Toll-Like Receptor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051193">Toll-Like Receptors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051195" MajorTopicYN="Y">Toll-Like Receptor 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051193" MajorTopicYN="N">Toll-Like Receptors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TLR</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">polymorphism</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36142893</ArticleId><ArticleId IdType="pmc">PMC9504743</ArticleId><ArticleId IdType="doi">10.3390/ijms231810982</ArticleId><ArticleId IdType="pii">ijms231810982</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Black R.E., Morris S.S., Bryce J. Where and why are 10 million children dying every year? Lancet. 2003;361:2226&#x2013;2234. doi: 10.1016/S0140-6736(03)13779-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13779-8</ArticleId><ArticleId IdType="pubmed">12842379</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.-L., Rello J., Marshall J., Silva E., Anzueto A., Martin C.D., Moreno R., Lipman J., Gomersall C., Sakr Y., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323&#x2013;2329. doi: 10.1001/jama.2009.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1754</ArticleId><ArticleId IdType="pubmed">19952319</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachtigall I., Tamarkin A., Tafelski S., Weimann A., Rothbart A., Heim S., Wernecke K.D., Spies C. Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients. J. Int. Med. Res. 2014;42:93&#x2013;110. doi: 10.1177/0300060513504358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060513504358</ArticleId><ArticleId IdType="pubmed">24366499</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.-D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001;29:1303&#x2013;1310. doi: 10.1097/00003246-200107000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Frodsham A.J., Hill A.V.S. Genetics of infectious diseases. Hum. Mol. Genet. 2004;13:R187&#x2013;R194. doi: 10.1093/hmg/ddh225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddh225</ArticleId><ArticleId IdType="pubmed">15358724</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng B., Mao Z., Pang K., Zhang S., Li L. Association of tumor necrosis factor &#x3b1; -308G/A and interleukin-6 -174G/C gene polymorphism with pneumonia-induced sepsis. J. Crit. Care. 2015;30:920&#x2013;923. doi: 10.1016/j.jcrc.2015.04.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.04.123</ArticleId><ArticleId IdType="pubmed">26025100</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomade O., Spies-Weisshart B., Glaser A., Schnetzke U., Hochhaus A., Scholl S. Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia. Ann. Hematol. 2013;92:1071&#x2013;1077. doi: 10.1007/s00277-013-1734-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-013-1734-0</ArticleId><ArticleId IdType="pubmed">23558906</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenten D., Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 2011;109:87&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">21569913</ArticleId></ArticleIdList></Reference><Reference><Citation>Noreen M., Arshad M. Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility. Immunol. Res. 2015;62:234&#x2013;252. doi: 10.1007/s12026-015-8640-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-015-8640-6</ArticleId><ArticleId IdType="pubmed">25784622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sameer A.S., Nissar S. Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility. Biomed. Res. Int. 2021;2021:1157023. doi: 10.1155/2021/1157023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/1157023</ArticleId><ArticleId IdType="pmc">PMC8452412</ArticleId><ArticleId IdType="pubmed">34552981</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S., Karmakar S., Babu S.P.S. TLR2 and TLR4 mediated host immune responses in major infectious diseases: A review. Braz. J. Infect. Dis. 2016;20:193&#x2013;204. doi: 10.1016/j.bjid.2015.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2015.10.011</ArticleId><ArticleId IdType="pmc">PMC9427569</ArticleId><ArticleId IdType="pubmed">26775799</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S., Huda S., Sinha Babu S.P. Toll-like receptor polymorphism in host immune response to infectious diseases: A review. Scand. J. Immunol. 2019;90:e12771. doi: 10.1111/sji.12771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12771</ArticleId><ArticleId IdType="pubmed">31054156</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G., Li C., Cao Z., Corbet E.F., Jin L. Toll-like receptors 2 and 4 gene polymorphisms in a Chinese population with periodontitis. Quintessence Int. 2008;39:217&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">18618036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohto U., Yamakawa N., Akashi-Takamura S., Miyake K., Shimizu T. Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I. J. Biol. Chem. 2012;287:40611&#x2013;40617. doi: 10.1074/jbc.M112.404608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.404608</ArticleId><ArticleId IdType="pmc">PMC3504774</ArticleId><ArticleId IdType="pubmed">23055527</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y., Song C., Snyder G.A., Sundberg E.J., Medvedev A.E. R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88. J. Biol. Chem. 2012;287:38327&#x2013;38337. doi: 10.1074/jbc.M112.375493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.375493</ArticleId><ArticleId IdType="pmc">PMC3488101</ArticleId><ArticleId IdType="pubmed">22992740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferwerda B., McCall M.B.B., Alonso S., Giamarellos-Bourboulis E.J., Mouktaroudi M., Izagirre N., Syafruddin D., Kibiki G., Cristea T., Hijmans A., et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. USA. 2007;104:16645&#x2013;16650. doi: 10.1073/pnas.0704828104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0704828104</ArticleId><ArticleId IdType="pmc">PMC2034238</ArticleId><ArticleId IdType="pubmed">17925445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioana M., Ferwerda B., Plantinga T.S., Stappers M., Oosting M., McCall M., Cimpoeru A., Burada F., Panduru N., Sauerwein R., et al. Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins. Infect. Immun. 2012;80:1917&#x2013;1922. doi: 10.1128/IAI.00121-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00121-12</ArticleId><ArticleId IdType="pmc">PMC3347449</ArticleId><ArticleId IdType="pubmed">22354034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 2002;162:1028&#x2013;1032. doi: 10.1001/archinte.162.9.1028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.162.9.1028</ArticleId><ArticleId IdType="pubmed">11996613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumpf O., Giamarellos-Bourboulis E.J., Koch A., Hamann L., Mouktaroudi M., Oh D.-Y., Latz E., Lorenz E., A Schwartz D., Ferwerda B., et al. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: An observational study in three cohorts. Crit. Care. 2010;14:R103. doi: 10.1186/cc9047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9047</ArticleId><ArticleId IdType="pmc">PMC2911747</ArticleId><ArticleId IdType="pubmed">20525286</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Zhang A., Wang X., Li Z., Yang J., Zeng L., Gu W., Jiang J.-X. Association between the TLR2 Arg753Gln polymorphism and the risk of sepsis: A meta-analysis. Crit. Care. 2015;19:416. doi: 10.1186/s13054-015-1130-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1130-3</ArticleId><ArticleId IdType="pmc">PMC4663740</ArticleId><ArticleId IdType="pubmed">26616674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain M.S., Roy A.S., Islam M.S. In silico analysis predicting effects of deleterious SNPs of human RASSF5 gene on its structure and functions. Sci. Rep. 2020;10:14542. doi: 10.1038/s41598-020-71457-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-71457-1</ArticleId><ArticleId IdType="pmc">PMC7471297</ArticleId><ArticleId IdType="pubmed">32884013</ArticleId></ArticleIdList></Reference><Reference><Citation>Behairy M.Y., Abdelrahman A.l.A., Abdallah H.Y., Ibrahim E.E.-D.A., Sayed A.A., Azab M.M. In silico analysis of missense variants of the C1qA gene related to infection and autoimmune diseases.  [(accessed on 4 August 2022)];J. Taibah. Univ. Med. Sci. 2022  Available online:  https://www.sciencedirect.com/science/article/pii/S1658361222000890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9519598</ArticleId><ArticleId IdType="pubmed">36212588</ArticleId></ArticleIdList></Reference><Reference><Citation>Behairy M.Y., Soltan M.A., Adam M.S., Refaat A.M., Ezz E.M., Albogami S., Fayad E., Althobaiti F., Gouda A.M., Sileem A.E., et al.  Computational Analysis of Deleterious SNPs in NRAS to Assess Their Potential Correlation with Carcinogenesis.  [(accessed on 19 August 2022)];Front. Genet. 2022 13:872845. Available online:  https://www.frontiersin.org/articles/10.3389/fgene.2022.872845.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.872845</ArticleId><ArticleId IdType="pmc">PMC9424727</ArticleId><ArticleId IdType="pubmed">36051694</ArticleId></ArticleIdList></Reference><Reference><Citation>Behairy M.Y., Abdelrahman A.A., Abdallah H.Y., Ibrahim E.E.-D.A., Hashem H.R., Sayed A.A., Azab M.M. Role of MBL2 Polymorphisms in Sepsis and Survival: A Pilot Study and In Silico Analysis. Diagnostics. 2022;12:460. doi: 10.3390/diagnostics12020460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12020460</ArticleId><ArticleId IdType="pmc">PMC8871458</ArticleId><ArticleId IdType="pubmed">35204551</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K., Akira S. TLR signaling pathways. Semin. Immunol. 2004;16:3&#x2013;9. doi: 10.1016/j.smim.2003.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2003.10.003</ArticleId><ArticleId IdType="pubmed">14751757</ArticleId></ArticleIdList></Reference><Reference><Citation>Deller M.C., Kong L., Rupp B. Protein stability: A crystallographer&#x2019;s perspective. Pt 2Acta Cryst. Sect. F Struct. Biol. Commun. 2016;72:72&#x2013;95. doi: 10.1107/S2053230X15024619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2053230X15024619</ArticleId><ArticleId IdType="pmc">PMC4741188</ArticleId><ArticleId IdType="pubmed">26841758</ArticleId></ArticleIdList></Reference><Reference><Citation>Berezin C., Glaser F., Rosenberg J., Paz I., Pupko T., Fariselli P., Casadio R., Ben-Tal N. ConSeq: The identification of functionally and structurally important residues in protein sequences. Bioinformatics. 2004;20:1322&#x2013;1324. doi: 10.1093/bioinformatics/bth070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bth070</ArticleId><ArticleId IdType="pubmed">14871869</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh M.A., Ramadan M.M., Arram E.O. Toll-like receptor-2 Arg753Gln and Arg677Trp polymorphisms and susceptibility to pulmonary and peritoneal tuberculosis. APMIS. 2017;125:558&#x2013;564. doi: 10.1111/apm.12680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.12680</ArticleId><ArticleId IdType="pubmed">28332241</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Lu W., Qian Q., Qi W., Hu J., Feng B. Frequency of TLR 2, 4, and 9 gene polymorphisms in Chinese population and their susceptibility to type 2 diabetes and coronary artery disease. J. Biomed. Biotechnol. 2012;2012:373945. doi: 10.1155/2012/373945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/373945</ArticleId><ArticleId IdType="pmc">PMC3469311</ArticleId><ArticleId IdType="pubmed">23091345</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X., Wu Y., Ye J., Ding Z., Qian C., Zhou A. Gene polymorphisms of Toll-like receptors in Chinese Han children with sepsis in Wenzhou. Zhonghua Er Ke Za Zhi = Chin. J. Pediatr. 2010;48:15&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">20441696</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawzy M.S., Hussein M.H., Abdelaziz E.Z., Yamany H.A., Ismail H.M., Toraih E.A. Association of MicroRNA-196a2 Variant with Response to Short-Acting &#x3b2;2-Agonist in COPD: An Egyptian Pilot Study. PLoS ONE. 2016;11:e0152834. doi: 10.1371/journal.pone.0152834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0152834</ArticleId><ArticleId IdType="pmc">PMC4820109</ArticleId><ArticleId IdType="pubmed">27043015</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumangger H., Jamil K.F. Contribution of genes polymorphism to susceptibility and outcome of sepsis. Egypt. J. Med. Hum. Genet. 2010;11:97&#x2013;103. doi: 10.1016/j.ejmhg.2010.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmhg.2010.10.001</ArticleId></ArticleIdList></Reference><Reference><Citation>David V.L., Ercisli M.F., Rogobete A.F., Boia E.S., Horhat R., Nitu R., Diaconu M.M., Pirtea L., Ciuca I., Horhat D.I., et al. Early Prediction of Sepsis Incidence in Critically Ill Patients Using Specific Genetic Polymorphisms. Biochem. Genet. 2017;55:193&#x2013;203. doi: 10.1007/s10528-016-9785-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10528-016-9785-2</ArticleId><ArticleId IdType="pubmed">27943002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzi M., Papanikolaou J., Makris D., Papathanasiou I., Tsezou A., Karvouniaris M., Zakynthinos E. Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece. J. Crit. Care. 2018;47:1&#x2013;8. doi: 10.1016/j.jcrc.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2018.05.012</ArticleId><ArticleId IdType="pubmed">29860039</ArticleId></ArticleIdList></Reference><Reference><Citation>March C., Regueiro V., Llobet E., Moranta D., Morey P., Garmendia J., Bengoechea J.A. Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response. PLoS ONE. 2010;5:e10033. doi: 10.1371/journal.pone.0010033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010033</ArticleId><ArticleId IdType="pmc">PMC2850920</ArticleId><ArticleId IdType="pubmed">20383325</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp S., Wieland C.W., Florquin S., Pantophlet R., Dijkshoorn L., Tshimbalanga N., Akira S., van der Poll T. Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am. J. Respir. Crit. Care Med. 2006;173:122&#x2013;129. doi: 10.1164/rccm.200505-730OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200505-730OC</ArticleId><ArticleId IdType="pubmed">16210672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.-H., Jeong Y.-J., Lee J., Jeon S.-J., Park S.-R., Kang M.-J., Park J.-H., Park J.-H. Essential role of toll-like receptor 4 in Acinetobacter baumannii-induced immune responses in immune cells. Microb. Pathog. 2013;54:20&#x2013;25. doi: 10.1016/j.micpath.2012.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2012.08.008</ArticleId><ArticleId IdType="pubmed">22982140</ArticleId></ArticleIdList></Reference><Reference><Citation>Erridge C., Moncayo-Nieto O.L., Morgan R., Young M., Poxton I.R. Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. J. Med. Microbiol. 2007;56 Pt 2:165&#x2013;171. doi: 10.1099/jmm.0.46823-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.46823-0</ArticleId><ArticleId IdType="pubmed">17244795</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch A., Hamann L., Schott M., Boehm O., Grotemeyer D., Kurt M., Schwenke C., Schumann R.R., Bornstein S.R., Zacharowski K. Genetic variation of TLR4 influences immunoendocrine stress response: An observational study in cardiac surgical patients. Crit. Care. 2011;15:R109. doi: 10.1186/cc10130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10130</ArticleId><ArticleId IdType="pmc">PMC3219387</ArticleId><ArticleId IdType="pubmed">21466684</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr F.B., Yende S., Angus D.C. Epidemiology of severe sepsis. Virulence. 2014;5:4&#x2013;11. doi: 10.4161/viru.27372.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.27372</ArticleId><ArticleId IdType="pmc">PMC3916382</ArticleId><ArticleId IdType="pubmed">24335434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong D.T., Gomez M., McGuire G.P., Kavanagh B. Utilization of intensive care unit days in a Canadian medical-surgical intensive care unit. Crit. Care Med. 1999;27:1319&#x2013;1324. doi: 10.1097/00003246-199907000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199907000-00020</ArticleId><ArticleId IdType="pubmed">10446826</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha F.J., Castro M.A., Landeiro N.M., Neves A.M., Santos C.C. Mortality and length of stay in a surgical intensive care unit. Rev. Bras. Anestesiol. 2006;56:34&#x2013;45. doi: 10.1590/S0034-70942006000100005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0034-70942006000100005</ArticleId><ArticleId IdType="pubmed">19468548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim N.L., Kumar P., Hu J., Henikoff S., Schneider G., Ng P.C. SIFT web server: Predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40:W452&#x2013;W457. doi: 10.1093/nar/gks539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks539</ArticleId><ArticleId IdType="pmc">PMC3394338</ArticleId><ArticleId IdType="pubmed">22689647</ArticleId></ArticleIdList></Reference><Reference><Citation>Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods. 2010;7:248&#x2013;249. doi: 10.1038/nmeth0410-248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth0410-248</ArticleId><ArticleId IdType="pmc">PMC2855889</ArticleId><ArticleId IdType="pubmed">20354512</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Thomas P.D. PANTHER-PSEP: Predicting disease-causing genetic variants using position-specific evolutionary preservation. Bioinformatics. 2016;32:2230&#x2013;2232. doi: 10.1093/bioinformatics/btw222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw222</ArticleId><ArticleId IdType="pubmed">27193693</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y., Chan A.P. PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745&#x2013;2747. doi: 10.1093/bioinformatics/btv195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv195</ArticleId><ArticleId IdType="pmc">PMC4528627</ArticleId><ArticleId IdType="pubmed">25851949</ArticleId></ArticleIdList></Reference><Reference><Citation>Capriotti E., Calabrese R., Fariselli P., Martelli P.L., Altman R.B., Casadio R. WS-SNPs&amp;GO: A web server for predicting the deleterious effect of human protein variants using functional annotation. BMC Genom. 2013;14((Suppl. S3)):S6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3665478</ArticleId><ArticleId IdType="pubmed">23819482</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum M., Chang H.Y., Chuguransky S., Grego T., Kandasaamy S., Mitchell A., Nuka G., Paysan-Lafosse T., Qureshi M., Raj S., et al. The InterPro protein families and domains database: 20 years on. Nucleic Acids Res. 2021;49:D344&#x2013;D354. doi: 10.1093/nar/gkaa977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa977</ArticleId><ArticleId IdType="pmc">PMC7778928</ArticleId><ArticleId IdType="pubmed">33156333</ArticleId></ArticleIdList></Reference><Reference><Citation>Capriotti E., Fariselli P., Casadio R. I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005;33:W306&#x2013;W310. doi: 10.1093/nar/gki375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki375</ArticleId><ArticleId IdType="pmc">PMC1160136</ArticleId><ArticleId IdType="pubmed">15980478</ArticleId></ArticleIdList></Reference><Reference><Citation>Bava K.A., Gromiha M.M., Uedaira H., Kitajima K., Sarai A. ProTherm, version 4.0: Thermodynamic database for proteins and mutants. Nucleic Acids Res. 2004;32:D120&#x2013;D121. doi: 10.1093/nar/gkh082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh082</ArticleId><ArticleId IdType="pmc">PMC308816</ArticleId><ArticleId IdType="pubmed">14681373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazy H., Abadi S., Martz E., Chay O., Mayrose I., Pupko T., Ben-Tal N. ConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 2016;44:W344&#x2013;W350. doi: 10.1093/nar/gkw408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw408</ArticleId><ArticleId IdType="pmc">PMC4987940</ArticleId><ArticleId IdType="pubmed">27166375</ArticleId></ArticleIdList></Reference><Reference><Citation>Venselaar H., Te Beek T.A., Kuipers R.K., Hekkelman M.L., Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinform. 2010;11:548. doi: 10.1186/1471-2105-11-548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-11-548</ArticleId><ArticleId IdType="pmc">PMC2992548</ArticleId><ArticleId IdType="pubmed">21059217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30632396</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-900X</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of endourology</Title><ISOAbbreviation>J Endourol</ISOAbbreviation></Journal><ArticleTitle>Infectious Complications of Conventional Laparoscopic vs Robotic Laparoscopic Prostatectomy: A Systematic Literature Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>179</StartPage><EndPage>188</EndPage><MedlinePgn>179-188</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/end.2018.0815</ELocationID><Abstract><AbstractText Label="BACKGROUND">Recent studies have shown that using minimally invasive surgical techniques (conventional laparoscopy or robotic) for prostatectomy is associated with lower perioperative complication rates compared with open radical retropubic prostatectomy. However, differences in infectious complications between these minimally invasive approaches are not well characterized. To study this further, we performed a systematic review of the literature and meta-analysis of the infectious complications of prostatectomy, comparing robotic prostatectomy (RP) with conventional laparoscopic prostatectomy (LP).</AbstractText><AbstractText Label="METHODS">We searched PubMed, CINAHL, CDSR, and EMBASE through September 2018 for studies evaluating minimally invasive prostatectomy and infectious complications. We employed random-effect models to obtain pooled odds ratio (pOR) estimates. Heterogeneity was evaluated with I<sup>2</sup> estimation and the Cochran Q statistic. pORs were calculated separately based on the indication for prostatectomy.</AbstractText><AbstractText Label="RESULTS">Fifteen studies were included in the final review for the meta-analysis with 14,121 patients undergoing minimally invasive prostatectomy. There was no statistically significant difference in the number of infectious complication events between RP and LP (pOR 0.94; 95% CI 0.50, 1.76). When we performed a stratified analysis, similar results were found with no statistically significant difference in infectious complications comparing RP with LP among patients with prostate cancer (pOR 0.73; 95% CI 0.43, 1.24). We observed that infectious complications were nearly threefold higher with the robotic approach in earlier studies (published between 2007 and 2012, pOR 2.81; 95% CI 1.07, 7.39), but no significant difference was found in later studies (between 2013 and 2018, pOR 0.80, 95% CI 0.40, 1.57).</AbstractText><AbstractText Label="CONCLUSIONS">The rate of infectious complications associated with RP was no different than that associated with conventional LP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marra</LastName><ForeName>Alexandre R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>1 Office of Clinical Quality, Safety and Performance Improvement, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Division of General Internal Medicine, Department of Internal Medicine, Carver College of Medicine, Iowa City, Iowa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3 Division of Medical Practice, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puig-Asensio</LastName><ForeName>Mireia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1 Office of Clinical Quality, Safety and Performance Improvement, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Division of General Internal Medicine, Department of Internal Medicine, Carver College of Medicine, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edmond</LastName><ForeName>Michael B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>1 Office of Clinical Quality, Safety and Performance Improvement, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Division of General Internal Medicine, Department of Internal Medicine, Carver College of Medicine, Iowa City, Iowa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>4 Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schweizer</LastName><ForeName>Marin L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>2 Division of General Internal Medicine, Department of Internal Medicine, Carver College of Medicine, Iowa City, Iowa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 The Center for Comprehensive Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nepple</LastName><ForeName>Kenneth G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>6 Department of Urology, University of Iowa Carver College of Medicine, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endourol</MedlineTA><NlmUniqueID>8807503</NlmUniqueID><ISSNLinking>0892-7790</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011468" MajorTopicYN="N">Prostatectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="N">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="N">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">infectious complication</Keyword><Keyword MajorTopicYN="N">laparoscopy</Keyword><Keyword MajorTopicYN="N">minimally invasive technique</Keyword><Keyword MajorTopicYN="N">prostatectomy</Keyword><Keyword MajorTopicYN="N">robotic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30632396</ArticleId><ArticleId IdType="doi">10.1089/end.2018.0815</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26474267</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1596</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Minerva anestesiologica</Title><ISOAbbreviation>Minerva Anestesiol</ISOAbbreviation></Journal><ArticleTitle>Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness.</ArticleTitle><Pagination><StartPage>559</StartPage><EndPage>572</EndPage><MedlinePgn>559-72</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION">Sepsis is characterized by a complex immune response. In this study we aimed to provide a review of the mechanisms of action of immunoglobulin (Ig) related to sepsis and an updated meta-analysis of the clinical effectiveness of the Ig use in septic patients.</AbstractText><AbstractText Label="EVIDENCE ACQUISITION">We performed two separate searches of Medline and other databases with the keywords Ig, sepsis, septic shock, septicemia, septicemia with no language restrictions in order to review the mechanisms of action of Igs in sepsis and to update the previous meta-analysis on the effects of the Ig therapy on the mortality of adult patients with septic shock.</AbstractText><AbstractText Label="EVIDENCE SYNTHESIS">Pathogens and toxin clearance, anti-inflammatory effects and anti-apoptotic effects on immune cells seems to be the main mechanisms of action of Ig therapy in sepsis. The meta-analysis of 18 RCTs indicated that the use of intravenous Ig reduces the mortality risk of septic patients (odds ratio=0.50 [95% CI 0.34-0.71], I2=44.68%). Low study quality, heterogeneous dosing regimens and type of Ig preparations, and different control interventions (placebo or albumin) may have influenced our results.</AbstractText><AbstractText Label="CONCLUSIONS">Our study showed that the use of intravenous Ig therapy in adult septic patients may have a rationale and seems to be associated with a reduced mortality. Anyway, the treatment effect generally tended to be smaller or less consistent if considering only those studies that were deemed adequate on each indicator. So, the available evidence is not clearly sufficient to support the widespread use of Ig in the treatment of sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Busani</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, University Hospital of Modena, Modena, Italy - girardis.massimo@unimo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damiani</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Cavazzuti</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Donati</LastName><ForeName>Abele</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Girardis</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Anestesiol</MedlineTA><NlmUniqueID>0375272</NlmUniqueID><ISSNLinking>0375-9393</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Minerva Anestesiol. 2016 May;82(5):505-7.</RefSource><PMID Version="1">26822818</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26474267</ArticleId><ArticleId IdType="pii">R02Y9999N00A150134</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32843007</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2369</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>BMC nephrology</Title><ISOAbbreviation>BMC Nephrol</ISOAbbreviation></Journal><ArticleTitle>Postoperative outcomes of kidney transplant recipients undergoing non-transplant-related elective surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>365</StartPage><MedlinePgn>365</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">365</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-020-01978-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Reliable estimates of the absolute and relative risks of postoperative complications in kidney transplant recipients undergoing elective surgery are needed to inform clinical practice. This systematic review and meta-analysis aimed to estimate the odds of both fatal and non-fatal postoperative outcomes in kidney transplant recipients following elective surgery compared to non-transplanted patients.</AbstractText><AbstractText Label="METHODS">Systematic searches were performed through Embase and MEDLINE databases to identify relevant studies from inception to January 2020. Risk of bias was assessed by the Newcastle Ottawa Scale and quality of evidence was summarised in accordance with GRADE methodology (grading of recommendations, assessment, development and evaluation). Random effects meta-analysis was performed to derive summary risk estimates of outcomes. Meta-regression and sensitivity analyses were performed to explore heterogeneity.</AbstractText><AbstractText Label="RESULTS">Fourteen studies involving 14,427 kidney transplant patients were eligible for inclusion. Kidney transplant recipients had increased odds of postoperative mortality; cardiac surgery (OR 2.2, 95%CI 1.9-2.5), general surgery (OR 2.2, 95% CI 1.3-4.0) compared to non-transplanted patients. The magnitude of the mortality odds was increased in the presence of diabetes mellitus. Acute kidney injury was the most frequently reported non-fatal complication whereby kidney transplant recipients had increased odds compared to their non-transplanted counterparts. The odds for acute kidney injury was highest following orthopaedic surgery (OR 15.3, 95% CI 3.9-59.4). However, there was no difference in the odds of stroke and pneumonia.</AbstractText><AbstractText Label="CONCLUSION">Kidney transplant recipients are at increased odds for postoperative mortality and acute kidney injury following elective surgery. This review also highlights the urgent need for further studies to better inform perioperative risk assessment to assist in planning perioperative care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palamuthusingam</LastName><ForeName>Dharmenaan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Metro South Integrated Nephrology and Transplant Services, Logan Hospital, Armstrong Road &amp; Loganlea Road, Meadowbrook, Queensland, 4131, Australia. Dharmenaan.palamuthusingam@health.qld.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Queensland, St Lucia, Queensland, 4072, Australia. Dharmenaan.palamuthusingam@health.qld.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Griffith University, Mount Gravatt, Queensland, Australia. Dharmenaan.palamuthusingam@health.qld.gov.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunarajah</LastName><ForeName>Kuhan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Sunshine Coast University Hospital, Doherty St, Birtinya, Queensland, 4575, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pascoe</LastName><ForeName>Elaine M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Centre for Health Services Research, University of Queensland, St Lucia, Queensland, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Queensland, St Lucia, Queensland, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metro South Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Queensland, 4074, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Institute, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawley</LastName><ForeName>Camel M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Queensland, St Lucia, Queensland, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metro South Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Queensland, 4074, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fahim</LastName><ForeName>Magid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Queensland, St Lucia, Queensland, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metro South Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Queensland, 4074, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Jacqout Research Entry Scholarship</GrantID><Agency>Royal Australasian College of Physicians</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Nephrol</MedlineTA><NlmUniqueID>100967793</NlmUniqueID><ISSNLinking>1471-2369</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="N">Gynecologic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="N">Orthopedic Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="N">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013520" MajorTopicYN="N">Urologic Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Kidney transplant</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Perioperative outcomes</Keyword><Keyword MajorTopicYN="N">Postoperative mortality</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Surgical risk</Keyword></KeywordList><CoiStatement>The Better Evidence And Translation &#x2013; Chronic Kidney Disease (BEAT-CKD) program is an independent collaborative research program funded by an Australian National Health and Medical Research Council (NHMRC) Program Grant (APP1092957) and supports research into kidney disease. DP is a recipient of the Royal Australasian College of Physicians Jacquot Research Entry Scholarship and has received speaking honoraria from the Australian Medical Forum. DJ is a current recipient of an Australian National Health and Medical Research Council Practitioner Fellowship. DJ has previously received consultancy fees, research grants, speaker&#x2019;s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care. CH has received funding from Janssen and GlaxoSmithKline to her institution for trial steering committee roles and research grant support to her institution from Shire, Baxter, Fresenius, and Otsuka and travel sponsorship from Otsuka.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32843007</ArticleId><ArticleId IdType="pmc">PMC7448361</ArticleId><ArticleId IdType="doi">10.1186/s12882-020-01978-4</ArticleId><ArticleId IdType="pii">10.1186/s12882-020-01978-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang KJJ. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA. 1993;270(11):1339&#x2013;1343. doi: 10.1001/jama.1993.03510110079036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1993.03510110079036</ArticleId><ArticleId IdType="pubmed">8360969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725&#x2013;1730. doi: 10.1056/NEJM199912023412303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199912023412303</ArticleId><ArticleId IdType="pubmed">10580071</ArticleId></ArticleIdList></Reference><Reference><Citation>Humar A and Matas AJ. Surgical complications after kidney transplantation. In: Seminars in dialysis. Wiley Online Library; 2005. p. 505&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">16398714</ArticleId></ArticleIdList></Reference><Reference><Citation>Halabi WJ, Jafari MD, Nguyen VQ, Carmichael JC, Mills S, Pigazzi A, et al. Colorectal surgery in kidney transplant recipients: a decade of trends and outcomes in the United States. Am Surg. 2013;79(10):1026&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">24160793</ArticleId></ArticleIdList></Reference><Reference><Citation>John R, Lietz K, Huddleston S, Matas A, Liao K, Shumway S, et al. Perioperative outcomes of cardiac surgery in kidney and kidney&#x2013;pancreas transplant recipients. J Thorac Cardiovasc Surg. 2007;133(5):1212&#x2013;1219. doi: 10.1016/j.jtcvs.2006.11.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2006.11.041</ArticleId><ArticleId IdType="pubmed">17467431</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008&#x2013;2012. doi: 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006&#x2013;1012. doi: 10.1016/j.jclinepi.2009.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.005</ArticleId><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205&#x2013;213. doi: 10.1097/01.sla.0000133083.54934.ae.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000133083.54934.ae</ArticleId><ArticleId IdType="pmc">PMC1360123</ArticleId><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavien PA, Barkun J, De Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187&#x2013;196. doi: 10.1097/SLA.0b013e3181b13ca2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181b13ca2</ArticleId><ArticleId IdType="pubmed">19638912</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605. doi: 10.1007/s10654-010-9491-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J, Ioannidis JPA, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14(1):25. doi: 10.1186/1471-2288-14-25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-25</ArticleId><ArticleId IdType="pmc">PMC4015721</ArticleId><ArticleId IdType="pubmed">24548571</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F. Exploring heterogeneity in meta-analysis: is the L'Abbe plot useful? J Clin Epidemiol. 1999;52(8):725&#x2013;730. doi: 10.1016/S0895-4356(99)00066-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(99)00066-9</ArticleId><ArticleId IdType="pubmed">10465316</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W, Cheung MWL. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112&#x2013;125. doi: 10.1002/jrsm.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.11</ArticleId><ArticleId IdType="pubmed">26061377</ArticleId></ArticleIdList></Reference><Reference><Citation>Balshem H, Helfand M, Sch&#xfc;nemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401&#x2013;406. doi: 10.1016/j.jclinepi.2010.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.07.015</ArticleId><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavanaugh PK, Chen AF, Rasouli MR, Post ZD, Orozco FR, Ong AC. Total joint arthroplasty in transplant recipients: in-hospital adverse outcomes. J Arthroplasty. 2015;30(5):840&#x2013;845. doi: 10.1016/j.arth.2014.11.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2014.11.037</ArticleId><ArticleId IdType="pubmed">25540994</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YJ, Lee EH, Hahm KD, Kwon K, Ro YJ. Transplantation is a risk factor for acute kidney injury in patients undergoing total hip replacement arthroplasty for avascular necrosis: an observational study. Transplant Proc. 2013;45(6):2220&#x2013;2225. doi: 10.1016/j.transproceed.2013.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2013.03.021</ArticleId><ArticleId IdType="pubmed">23953532</ArticleId></ArticleIdList></Reference><Reference><Citation>Farag M, Nikolic M, Arif R, Schmack B, Sabashnikov A, Zeriouh M, et al. Cardiac surgery in patients with previous hepatic or renal transplantation: a pair-matched study. Ann Thorac Surg. 2017;103(5):1467&#x2013;1474. doi: 10.1016/j.athoracsur.2016.08.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.08.092</ArticleId><ArticleId IdType="pubmed">27866651</ArticleId></ArticleIdList></Reference><Reference><Citation>Klement MR, Penrose CT, Bala A, Wellman SS, Bolognesi MP, Seyler TM. How do previous solid organ transplant recipients fare after primary total knee arthroplasty? J Arthroplasty. 2016;31(3):609&#x2013;15.e1. doi: 10.1016/j.arth.2015.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.10.007</ArticleId><ArticleId IdType="pubmed">26639984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohmoto T, Osaki S, Kaufman DB, Leverson G, DeOliveira N, Akhter SA, et al. Cardiac surgery outcomes in abdominal solid organ transplant recipients. Ann Thorac Surg. 2018;105(3):757&#x2013;762. doi: 10.1016/j.athoracsur.2017.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.09.002</ArticleId><ArticleId IdType="pubmed">29174777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederer A-K, Haffa D, Martini V, Huber R, Makowiec F, Fichtner-Feigl S, et al. Surgical outcomes of renal transplant recipients after abdominal surgery not connected with transplantation. A retrospective case-control study. Int J Surg. 2019;61:53&#x2013;59. doi: 10.1016/j.ijsu.2018.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2018.12.002</ArticleId><ArticleId IdType="pubmed">30540965</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Guo D, Shi G, Li R, Li X, Shen R, et al. Role of total hip replacement arthroplasty between transplantation and acute kidney injury. Ren Fail. 2014;36(6):899&#x2013;903. doi: 10.3109/0886022X.2014.900387.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2014.900387</ArticleId><ArticleId IdType="pubmed">24955625</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakhla J, de la Garza RR, Bhashyam N, Kobets A, Nasser R, Echt M, et al. The impact of kidney disease on acute tubular necrosis and surgical site infection after lumbar fusion. World Neurosurg. 2017;105:498&#x2013;502. doi: 10.1016/j.wneu.2017.05.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2017.05.088</ArticleId><ArticleId IdType="pubmed">28552699</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Hawley C, Griffin R, Mundy J, Peters P, Shah P. Cardiac surgical outcomes in abdominal solid organ (renal and hepatic) transplant recipients: a case-matched study. Interact Cardiovasc Thorac Surg. 2013;16(2):103&#x2013;111. doi: 10.1093/icvts/ivs442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivs442</ArticleId><ArticleId IdType="pmc">PMC3548526</ArticleId><ArticleId IdType="pubmed">23136146</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart DB, Hollenbeak C, Boltz M. Renal transplant status in patients undergoing colorectal surgery: is immunosuppression safer than kidney disease? Surgery. 2012;152(4):537&#x2013;549. doi: 10.1016/j.surg.2012.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2012.07.003</ArticleId><ArticleId IdType="pubmed">22929403</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun AY, Babbar P, Gill BC, Angermeier KW, Montague DK. Penile prosthesis in solid organ transplant recipients&#x2014;a matched cohort study. Urology. 2018;117:86&#x2013;88. doi: 10.1016/j.urology.2018.03.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2018.03.048</ArticleId><ArticleId IdType="pubmed">29656065</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargo PR, Schiltz NK, Johnston DR, Smedira NG, Moazami N, Blackstone EH, et al. Outcomes of cardiac surgery in patients with previous solid organ transplantation (kidney, liver, and pancreas) Am J Cardiol. 2015;116(12):1932&#x2013;1938. doi: 10.1016/j.amjcard.2015.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.09.036</ArticleId><ArticleId IdType="pubmed">26520471</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamuthusingam D, Johnson DW, Hawley CM, et al. Perioperative outcomes and risk assessment in dialysis patients: current knowledge and future directions. Intern Med J. 2019;49:702&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">30485661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew A, Devereaux P, O'hare A, Tonelli M, Thiessen-Philbrook H, Nevis I, et al. Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis. Kidney Int. 2008;73(9):1069&#x2013;1081. doi: 10.1038/ki.2008.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2008.29</ArticleId><ArticleId IdType="pubmed">18288098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043&#x2013;1049. doi: 10.1161/01.CIR.100.10.1043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.100.10.1043</ArticleId><ArticleId IdType="pubmed">10477528</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill CJ, Courtney AE, Cardwell CR, Maxwell AP, Lucarelli G, Veroux M, et al. Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30(8):1403&#x2013;1411. doi: 10.1093/ndt/gfv214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfv214</ArticleId><ArticleId IdType="pubmed">26044837</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardine AG, Gaston RS, Fellstrom BC, Holdaas H. Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet. 2011;378(9800):1419&#x2013;1427. doi: 10.1016/S0140-6736(11)61334-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61334-2</ArticleId><ArticleId IdType="pubmed">22000138</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(14):1823&#x2013;1838. doi: 10.1016/j.jacc.2019.08.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.08.1017</ArticleId><ArticleId IdType="pubmed">31582143</ArticleId></ArticleIdList></Reference><Reference><Citation>Velasco A, Reyes E, Hage FG. Guidelines in review: comparison of the 2014 ACC/AHA guidelines on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery and the 2014 ESC/ESA guidelines on noncardiac surgery: cardiovascular assessment and management. J Nucl Cardiol. 2017;24(1):165&#x2013;170. doi: 10.1007/s12350-016-0643-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12350-016-0643-8</ArticleId><ArticleId IdType="pubmed">27549425</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick E, Ferguson A. Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ. 2010;341:c3365. doi: 10.1136/bmj.c3365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c3365</ArticleId><ArticleId IdType="pubmed">20603317</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions: John Wiley &amp; sons. 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10284251</ArticleId><ArticleId IdType="pubmed">31643080</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38615549</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>298</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Sepsis and Septic Shock in Patients Undergoing Thyroidectomy: Incidence, Risk Factors, and Outcomes.</ArticleTitle><Pagination><StartPage>160</StartPage><EndPage>168</EndPage><MedlinePgn>160-168</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2024.03.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(24)00132-X</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Postoperative sepsis represents a rare complication following thyroidectomy. We aimed to explore the incidence, risk factors, sources, and outcomes of postoperative sepsis and septic shock among adult patients undergoing thyroidectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from the American College of Surgeons National Surgical Quality Improvement Program were used in this retrospective cohort study. Patients aged &#x2265;18&#xa0;y who underwent elective thyroidectomy between 2005 and 2019 were included. Multivariable binary logistic regression models were computed to explore risk factors and outcomes of 30-d sepsis and septic shock.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 180,373 included patients, 0.1% developed sepsis or septic shock. Male gender, low body mass index, American Society of Anesthesiologists classes 3-5, functional dependence, smoking, diabetes mellitus, pulmonary disease, inpatient surgery, malignant indication, clean-contaminated wound classification, and operation time &#x2265;150&#xa0;min were significant risk factors for development of sepsis or septic shock. Common infectious sources of sepsis included surgical site infections (29.6%), pneumonia (18.6%), urinary tract infections (16.2%), and multiple infections (6.9%). Patients with postoperative sepsis or septic shock were significantly more likely to develop complications, including wound disruption, stroke, cardiac and renal complications, thromboembolism, prolonged length of stay, unplanned reoperation, and mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Sepsis is rare following thyroidectomy. Our study provides insight into risk factors and procedural characteristics which may contribute to the development of postoperative sepsis or septic shock in this population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Waqar</LastName><ForeName>Usama</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Medical College, Aga Khan University, Karachi, Pakistan; Research Fellow, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio. Electronic address: usama.waqar@scholar.aku.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Namrah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical College, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhry</LastName><ForeName>Ahmad Areeb</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Medical College, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iftikhar</LastName><ForeName>Haissan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Epidemiology and Biostatistics, Fellow Rhinology and Skull Base, University Hospitals Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jivani</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Surgical Clinical Reviewer, Department of Infection Prevention and Hospital Epidemiology, Aga Khan University Hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Syed Akbar</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Assistant Professor, Section of Otolaryngology, Head and Neck Surgery, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013965" MajorTopicYN="Y">Thyroidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Thyroid</Keyword><Keyword MajorTopicYN="N">Thyroid surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>2</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>14</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38615549</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2024.03.021</ArticleId><ArticleId IdType="pii">S0022-4804(24)00132-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27102322</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-2451</ISSN><JournalIssue CitedMedium="Internet"><Volume>401</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Langenbeck's archives of surgery</Title><ISOAbbreviation>Langenbecks Arch Surg</ISOAbbreviation></Journal><ArticleTitle>Pancreaticojejunostomy is comparable to pancreaticogastrostomy after pancreaticoduodenectomy: an updated meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>427</StartPage><EndPage>437</EndPage><MedlinePgn>427-37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00423-016-1418-z</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To perform an up-to-date meta-analysis of randomized controlled trials (RCTs) comparing pancreaticojejunostomy (PJ) and pancreaticogastrostomy (PG) in order to determine the safer anastomotic technique. Compared to existing meta-analysis, new RCTs were evaluated and subgroup analyses of different anastomotic techniques were carried out.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a bibliographic research using the National Library of Medicine's PubMed database from January 1990 to July 2015 of RCTs. Only RCTs, in English, that compared PG versus all types of PJ were selected. Data were independently extracted by two authors. We performed a quantitative systematic review following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. A random-effect model was applied. Statistical heterogeneity was assessed using the I (2) and &#x3c7; (2) tests. Primary outcomes were rate of overall and clinically significant pancreatic fistula (POPF).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten RCTs were identified including 1629 patients, 826 undergoing PG and 803 undergoing PJ. RCTs showed significant heterogeneity regarding definitions of POPF, perioperative management, and characteristics of pancreatic gland. No significant differences were found in the rate of overall and clinically significant POPF, morbidity, mortality, reoperation, and intra-abdominal sepsis when PG was compared with all types PJ or when subgroup analysis (double-layer PG with or without anterior gastrotomy versus duct to mucosa PJ and single-layer PG versus single-layer end-to-end/end-to-side PJ) were analyzed.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PG is not superior to PJ in the prevention of POPF. Current RCTs have major methodological limitations with significant heterogeneity in regard to surgical techniques, definition of POPF/complications, and perioperative management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crippa</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Pancreatic Surgery, San Raffaele Scientific Institute, Vita e Salute University, Via Olgettina 60, 20132, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirocchi</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General and Oncologic Surgery, St. Maria Hospital, University of Perugia, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randolph</LastName><ForeName>Justus</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mercer University, Tift College of Education, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Partelli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Pancreatic Surgery, San Raffaele Scientific Institute, Vita e Salute University, Via Olgettina 60, 20132, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belfiori</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ospedali Riuniti, Universit&#xe0; Politecnica delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccioli</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ospedali Riuniti, Universit&#xe0; Politecnica delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parisi</LastName><ForeName>Amilcare</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Digestive and Liver Surgery Unit, St. Maria Hospital, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconi</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Pancreatic Surgery, San Raffaele Scientific Institute, Vita e Salute University, Via Olgettina 60, 20132, Milan, Italy. falconi.massimo@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Langenbecks Arch Surg</MedlineTA><NlmUniqueID>9808285</NlmUniqueID><ISSNLinking>1435-2443</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005774" MajorTopicYN="N">Gastrostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010185" MajorTopicYN="N">Pancreatic Fistula</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="N">Pancreaticoduodenectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010193" MajorTopicYN="N">Pancreaticojejunostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Pancreatic fistula</Keyword><Keyword MajorTopicYN="N">Pancreaticogastrostomy</Keyword><Keyword MajorTopicYN="N">Pancreaticojejunostomy</Keyword><Keyword MajorTopicYN="N">Randomized trial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27102322</ArticleId><ArticleId IdType="doi">10.1007/s00423-016-1418-z</ArticleId><ArticleId IdType="pii">10.1007/s00423-016-1418-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Surg. 2005 Dec;242(6):767-71, discussion 771-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16327486</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Res. 2014 Nov;192(1):68-75</Citation><ArticleIdList><ArticleId IdType="pubmed">24942400</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2002 Jun 15;21(11):1539-58</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2003 Jan;237(1):57-65</Citation><ArticleIdList><ArticleId IdType="pubmed">12496531</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Jul 22;343:d4002</Citation><ArticleIdList><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2007 Oct 30;26(24):4375-85</Citation><ArticleIdList><ArticleId IdType="pubmed">17768699</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 1991;44(2):127-39</Citation><ArticleIdList><ArticleId IdType="pubmed">1995774</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2005 Jun;189(6):720-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15910726</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008370</Citation><ArticleIdList><ArticleId IdType="pubmed">23633353</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>HPB (Oxford). 2015 Feb;17(2):113-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25040921</ArticleId></ArticleIdList></Reference><Reference><Citation>HPB (Oxford). 2014 Aug;16(8):713-22</Citation><ArticleIdList><ArticleId IdType="pubmed">24467711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1995 Oct;222(4):580-8; discussion 588-92</Citation><ArticleIdList><ArticleId IdType="pubmed">7574936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2015 May;261(5):882-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24979604</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgeon. 2011 Aug;9(4):211-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21672661</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2004 Mar;139(3):327-35</Citation><ArticleIdList><ArticleId IdType="pubmed">15006893</ArticleId></ArticleIdList></Reference><Reference><Citation>Dig Surg. 2013;30(4-6):415-24</Citation><ArticleIdList><ArticleId IdType="pubmed">24217416</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2010 Jul;145(7):634-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20644125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2013 Jan;216(1):1-14</Citation><ArticleIdList><ArticleId IdType="pubmed">23122535</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2009 Nov;144(11):1074-80</Citation><ArticleIdList><ArticleId IdType="pubmed">19917946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2008 Dec;248(6):930-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19092337</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Surg. 2015 Jun;58(3):154-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25799130</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2013 Nov;100(12):1597-605</Citation><ArticleIdList><ArticleId IdType="pubmed">24264781</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2014 Sep;101(10):1196-208</Citation><ArticleIdList><ArticleId IdType="pubmed">25042895</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Today. 2015 May;45(5):585-94</Citation><ArticleIdList><ArticleId IdType="pubmed">25256939</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2013 Jun;14(7):655-62</Citation><ArticleIdList><ArticleId IdType="pubmed">23643139</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Feb 10;342:d549</Citation><ArticleIdList><ArticleId IdType="pubmed">21310794</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2005 Nov-Dec;25(6):646-54</Citation><ArticleIdList><ArticleId IdType="pubmed">16282215</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2014 Sep;18(9):1693-704</Citation><ArticleIdList><ArticleId IdType="pubmed">24903847</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg Oncol. 2014 Oct;40(10):1177-85</Citation><ArticleIdList><ArticleId IdType="pubmed">25079195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2016 Mar;263(3):440-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26135690</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Stat Soc Ser A Stat Soc. 2009 Jan;172(1):137-159</Citation><ArticleIdList><ArticleId IdType="pubmed">19381330</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2012 Sep;16(9):1686-95</Citation><ArticleIdList><ArticleId IdType="pubmed">22744638</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2007 Mar;245(3):443-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17435552</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Oct 18;343:d5928</Citation><ArticleIdList><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2005 Jul;138(1):8-13</Citation><ArticleIdList><ArticleId IdType="pubmed">16003309</ArticleId></ArticleIdList></Reference><Reference><Citation>HPB (Oxford). 2015 Feb;17(2):123-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24888576</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39214800</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Analysis of Perioperative Factors Leading to Postoperative Pulmonary Complications, Graft Injury and Increased Postoperative Mortality in Lung Transplantation.</ArticleTitle><Pagination><StartPage>2712</StartPage><EndPage>2721</EndPage><MedlinePgn>2712-2721</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.08.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00521-4</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Postoperative complications such as postoperative pulmonary complications (PPCs) and other organ complications are associated with increased morbidity and mortality after successful lung transplantation and have a detrimental effect on patient recovery. The aim of this study was to investigate perioperative risk factors for in-hospital mortality and postoperative complications with a focus on PPC and graft injury in patients undergoing lung transplantation DESIGN: Single-center retrospective cohort study of 173 patients undergoing lung transplantation SETTING: University Hospital, Medical Center Freiburg.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">In the stepwise multivariate regression analysis, donor age &gt;60 years (odds ratio [OR], 1.85; 95% confidence interval [CI], 1.27-2.81), intraoperative extracorporeal membrane oxygenation (OR, 2.4; 95% CI, 1.7-3.3), transfusion of &gt;4 red blood cell concentrates (OR, 3.1; 95% CI, 1.82-5.1), mean pulmonary artery pressure of &gt;30 mmHg at the end of surgery (OR, 3.5; 95% CI, 2-6.3), the occurrence of postoperative graft injury (OR, 4.1; 95% CI, 2.8-5.9), PPCs (OR, 2.1; 95% CI, 1.7-2.6), sepsis (OR, 4.5; 95% CI, 2.8-7.3), and Kidney disease Improving Outcome grading system stage 3 acute renal failure (OR, 4.3; 95% CI, 2.4-7.7) were associated with increased in hospital mortality, whereas patients with chronic obstructive pulmonary disease had a lower in-hospital mortality (OR, 1.6; 95% CI, 1.4-1.9). The frequency and number of PPCs correlated with postoperative mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinical management and risk stratification focusing on the underlying identified factors that could help to improve patient outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Axel</LastName><ForeName>Semmelmann</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany. Electronic address: axel.semmelmann@uniklinik-freiburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moneke</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Autenrieth</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baar</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loop</LastName><ForeName>Torsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016040" MajorTopicYN="Y">Lung Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lung transplantation</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">anesthesia for lung transplantation</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">postoperative pulmonary complications</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>30</Day><Hour>22</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39214800</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.08.002</ArticleId><ArticleId IdType="pii">S1053-0770(24)00521-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29217448</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Perioperative Outcomes after Regional Versus General Anesthesia for Above the Knee Amputations.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>66</EndPage><MedlinePgn>53-66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2017.10.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(17)31122-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Nontraumatic lower extremity amputation (LEA) remains a common procedure among patients who frequently have significant comorbidities. Patients undergoing above knee amputation (AKA) have the highest rates of mortality in this cohort, yet there is little evidence to support selection between peripheral nerve block or neuraxial regional anesthesia (RA) versus general anesthesia (GA) techniques. The objective of this study was to determine whether RA (neuraxial or peripheral nerve block) techniques were associated with more favorable outcomes versus general anesthesia among patients undergoing AKA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective cohort study using propensity-matched groups. Patients undergoing AKA were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) data set and grouped according to anesthetic type as either RA or GA. Patients undergoing AKA with RA were propensity matched to similar patients who had GA. Primary outcome was 30-day mortality. Secondary outcomes were numerous and included cardiac, pulmonary, infectious, and bleeding complications, as well as length of stay. Among a subset of patients for whom readmission data were available, rate of readmission was compared as a secondary outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine thousand nine hundred ninety-nine patients were identified in the ACS-NSQIP database. One thousand three hundred twelve received a regional anesthetic, and the remainder had a general anesthetic. Factors significantly associated with GA included younger age (70 vs. 75&#xa0;years; P&#xa0;&lt;&#xa0;0.001), higher body mass index (26.5 vs. 25.4; P&#xa0;&lt;&#xa0;0.001), and ethnically white (62.4% vs. 57%; P&#xa0;&lt;&#xa0;0.001). Before matching, patients receiving RA were less likely to be smokers (22% vs. 29%; P&#xa0;&lt;&#xa0;0.001), have a bleeding disorder (15% vs 30%; P&#xa0;&lt;&#xa0;0.001), or have a diagnosis of sepsis (26% vs 34%; P&#xa0;&lt;&#xa0;0.001). Propensity score matching produced a cohort composed of 1,916 patients equally divided between RA and GA. We found no difference with respect to the primary end point of 30-day mortality (11.7% vs 11.7%; odds ratio [OR] 1.01; P&#xa0;=&#xa0;0.943) nor was there any difference with respect to secondary outcomes. Among patients for whom readmission data were available, there was no statistically significant difference between rates of readmission between the groups (15.6% for RA vs. 12.7% for GA; OR 1.26, confidence interval 0.87-1.828, P&#xa0;=&#xa0;0.221).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present investigation did not detect any difference between regional and general anesthetic with respect to morbidity or mortality among patients undergoing AKA. This data set did not allow us to address other relevant markers including pain control or phantom limb syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pisansky</LastName><ForeName>Andrew J B</ForeName><Initials>AJB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brovman</LastName><ForeName>Ethan Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Perioperative Research, Brigham and Women's Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaye</LastName><ForeName>Alan D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urman</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Center for Perioperative Research, Brigham and Women's Hospital, Boston, MA. Electronic address: rurman@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Vasc Surg. 2018 Aug;51:330. doi: 10.1016/j.avsg.2018.02.043.</RefSource><PMID Version="1">29772333</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="Y">Amputation, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009407" MajorTopicYN="Y">Nerve Block</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058729" MajorTopicYN="N">Peripheral Arterial Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29217448</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2017.10.014</ArticleId><ArticleId IdType="pii">S0890-5096(17)31122-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30857606</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: infection and sepsis.</ArticleTitle><Pagination><StartPage>500</StartPage><EndPage>508</EndPage><MedlinePgn>500-508</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2019.01.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(19)30044-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Perioperative infection and sepsis are of fundamental concern to perioperative clinicians. However, standardised endpoints are either poorly defined or not routinely implemented. The Standardised Endpoints in Perioperative Medicine (StEP) initiative was established to derive a set of standardised endpoints for use in perioperative clinical trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We undertook a systematic review to identify measures of infection and sepsis used in the perioperative literature. A multi-round Delphi consensus process that included more than 60 clinician researchers was then used to refine a recommended list of outcome measures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A literature search yielded 1857 titles of which 255 met inclusion criteria for endpoint extraction. A long list of endpoints, with definitions and timescales, was generated and those potentially relevant to infection and sepsis circulated to the theme subgroup and then the wider StEP-COMPAC working group, undergoing a three-stage Delphi process. The response rates for Delphi rounds 1, 3, and 3 were 89% (n=8), 67% (n=62), and 80% (n=8), respectively. A set of 13 endpoints including fever, surgical site, and organ-specific infections as defined by the US Centres for Disease Control and Sepsis-3 are proposed for future use.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We defined a consensus list of standardised endpoints related to infection and sepsis for perioperative trials using an established and rigorous approach. Each endpoint was evaluated with respect to validity, reliability, feasibility, and patient centredness. One or more of these should be considered for inclusion in future perioperative clinical trials assessing infection, sepsis, or both, thereby permitting synthesis and comparison of future results.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 British Journal of Anaesthesia. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Great Western Hospital, Swindon, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Perioperative Medicine, University College Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bloomsbury Institute of Intensive Care Medicine, University College London Hospital, London, UK. Electronic address: doc@steveharris.me.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shankar-Hari</LastName><ForeName>Manu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Immunology &amp; Microbial Sciences, Kings College London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diouf</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Le Dantec Hospital, Cheikh Anta DIOP University, Dakar, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jammer</LastName><ForeName>Ib</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Andrew A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Royal Papworth Hospital, Cambridgeshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieleman</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia &amp; Perioperative Medicine Westmead Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grocott</LastName><ForeName>Michael P W</ForeName><Initials>MPW</Initials><AffiliationInfo><Affiliation>Anaesthesia and Critical Care Research Group, NIHR Biomedical Research Centre, UK; Faculty of Medicine, University of Southampton, Southampton, UK; Department of Anaesthesiology, Duke University School of Medicine, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mythen</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Perioperative Medicine, University College Hospital, London, UK; National Institute of Health Research Biomedical Research Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>StEP-COMPAC group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>16/33/01</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CS-2016-16-011</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>DRF-2015-08-023</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>EME/16/33/01</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016446">Consensus Development Conference</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Anaesth. 2019 Apr;122(4):408-410. doi: 10.1016/j.bja.2019.02.007.</RefSource><PMID Version="1">30857595</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003697" MajorTopicYN="N">Delphi Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007239" MajorTopicYN="N">Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">core outcome measures</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">postoperative outcome</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">standardised endpoints</Keyword><Keyword MajorTopicYN="N">surgical site infection</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gan</LastName><ForeName>Tang Joon</ForeName><Initials>TJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peyton</LastName><ForeName>Phil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tram&#xe8;r</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cyna</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Oliveira</LastName><ForeName>Gildasio S</ForeName><Initials>GS</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kehlet</LastName><ForeName>Henrik</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Botti</LastName><ForeName>Mari</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boney</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haller</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gruen</LastName><ForeName>Russell</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bampoe</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evered</LastName><ForeName>Lis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silbert</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Diederik</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haller</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eckenhoff</LastName><ForeName>Rod</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eriksson</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Howell</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagele</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>Rupert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mythen</LastName><ForeName>Monty</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canet</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moller</LastName><ForeName>Ann</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gin</LastName><ForeName>Tony</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Futier</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Creagh-Brown</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fowler</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abbott</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mythen</LastName><ForeName>Monty</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klein</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>David James</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieleman</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diouf</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prowle</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karkouti</LastName><ForeName>Keyvan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Billings</LastName><ForeName>Josh</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klein</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazer</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jayarajah</LastName><ForeName>Mohindas</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karkouti</LastName><ForeName>Keyvan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartoszko</LastName><ForeName>Justyna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sneyd</LastName><ForeName>Rob</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>Ron</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonesinghe</LastName><ForeName>Ramani</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shulman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lane-Fall</LastName><ForeName>Meghan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Ulrica</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stevenson</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>Rupert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonesinghe</LastName><ForeName>Ramani</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>Jamie Dj</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Klei</LastName><ForeName>Wilton</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cabrini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Sandy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buggy</LastName><ForeName>Donal</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riedel</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gottumukkala</LastName><ForeName>Vijay</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alkhaffaf</LastName><ForeName>Bilal</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30857606</ArticleId><ArticleId IdType="pmc">PMC6435904</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2019.01.009</ArticleId><ArticleId IdType="pii">S0007-0912(19)30044-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Semmelweis I.P. &#xd6;sterreichische Nationalbibliothek; 1862. Offener brief an s&#xe4;mtliche professoren der Geburtshilfe.</Citation></Reference><Reference><Citation>Myles P.S., Grocott M.P.W., Boney O., Moonesinghe S.R., COMPAC-StEP Group Standardizing end points in perioperative trials: towards a core and extended outcome set. Br J Anaesth. 2016;116:586&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">27106961</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargon E., Williamson P.R., Altman D.G., Blazeby J.M., Tunis S., Clarke M. The COMET Initiative database: progress and activities update (2015) Trials. 2017;18:54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5291989</ArticleId><ArticleId IdType="pubmed">28159003</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson P., Altman D.G., Bagley H. The COMET handbook: version 1.0. Trials. 2017;18:280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5499094</ArticleId><ArticleId IdType="pubmed">28681707</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C.W. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Horan T.C., Gaynes R.P., Martone W.J., Jarvis W.R., Emori T.G. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">1334988</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M., Phillips G.S., Levy M.L. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:775&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>National Library of Medicine (U.S.) Bibliographic Services Division . 2003. Abridged Index Medicus (AIM or core clinical) Journal Titles.</Citation></Reference><Reference><Citation>Shankar-Hari M., Bertolini G., Brunkhorst F.M. Judging quality of current septic shock definitions and criteria. Crit Care. 2015;19:445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4699344</ArticleId><ArticleId IdType="pubmed">26702879</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles P., Grocott M., Boney O., Moonesinghe S. Standardising endpoints in perioperative trials: towards a core and extended outcome set. Br J Anaesth. 2016;116:586&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">27106961</ArticleId></ArticleIdList></Reference><Reference><Citation>House J., Alexandraki I.  BMJ Best Practice; 2018. Assessment of postoperative fever &#x2014; differential diagnosis of symptoms.https://bestpractice.bmj.com/topics/en-gb/898/pdf/898.pdf Available at:</Citation></Reference><Reference><Citation>Jain R., Saxena D. Pyrexia: an update on importance in clinical practice. Indian J Anaesth. 2015;59:207&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408647</ArticleId><ArticleId IdType="pubmed">25937645</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanning J., Neuhoff R.A., Brewer J.E., Castaneda T., Marcotte M.P., Jacobson R.L. Frequency and yield of postoperative fever evaluation. Infect Dis Obstet Gynecol. 1998;6:252&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1784817</ArticleId><ArticleId IdType="pubmed">9972487</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y.-T., Li L.H., Lei Q. Noninfectious fever following aortic surgery: incidence, risk factors, and outcomes. Chin Med Sci J. 2009;24:213&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">20120767</ArticleId></ArticleIdList></Reference><Reference><Citation>Galicier C., Richet H. A&#xa0;prospective study of postoperative fever in a general surgery department. Infect Control. 1985;6:487&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">3852797</ArticleId></ArticleIdList></Reference><Reference><Citation>Guinn S., Castro F.P., Jr., Garcia R., Barrack R.L. Fever following total knee arthroplasty. Am J Knee Surg. 1999;12:161&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">10496465</ArticleId></ArticleIdList></Reference><Reference><Citation>Pile J.C. Evaluating postoperative fever: a focused approach. Cleve Clin J Med. 2006;73:S62&#x2013;S66.</Citation><ArticleIdList><ArticleId IdType="pubmed">16570551</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolan R.D., McSorley S.T., McMillan D.C., Horgan P.G. Attitudes of surgeons to the use of postoperative markers of the systemic inflammatory response following elective surgery. Ann Med Surg (Lond) 2017;21:14&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5524306</ArticleId><ArticleId IdType="pubmed">28761641</ArticleId></ArticleIdList></Reference><Reference><Citation>Facy O., Pacquette B., Orry D. Inflammatory markers as early predictors of infection after colorectal surgery: the same cut-off values in laparoscopy and laparotomy? Int J Colorectal Dis. 2017;32:857&#x2013;863.</Citation><ArticleIdList><ArticleId IdType="pubmed">28386662</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B.M.P., Eslick G.D., Craig J.C., McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7:210&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">17317602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole D.S., Watts A., Scott-Coombes D., Avades T. Clinical utility of peri-operative C-reactive protein testing in general surgery. Ann R Coll Surg Engl. 2008;90:317&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2647195</ArticleId><ArticleId IdType="pubmed">18492397</ArticleId></ArticleIdList></Reference><Reference><Citation>Deirmengian G.K., Zmistowski B., Jacovides C., O'Neil J., Parvizi J. Leukocytosis is common after total hip and knee arthroplasty. Clin Orthop Relat Res. 2011;469:3031&#x2013;3036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3183208</ArticleId><ArticleId IdType="pubmed">21461866</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt I.H., Aydogdu O., Yonguc T. Predictive value of leukocytosis for infectious complications after percutaneous nephrolithotomy. Urology. 2015;86:25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">26142577</ArticleId></ArticleIdList></Reference><Reference><Citation>Surveillance Definitions. c2018. National healthcare safety network, Centers for Disease Control and prevention (accessed August, 2018). https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf.</Citation></Reference><Reference><Citation>Abbott T.E.F., Fowler A.J., Pelosi P. A&#xa0;systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications. Br J Anaesth. 2018;120:1066&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pubmed">29661384</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde M., Lawrence V. Postoperative pulmonary infections. BMJ Clin Evid. 2008</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2907981</ArticleId><ArticleId IdType="pubmed">19445796</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgical site infection (SSI) event. c2018. National healthcare safety network, Centers for Disease Control and prevention (accessed August 6, 2018) http://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf.</Citation></Reference><Reference><Citation>Surveillance of surgical site infections in NHS hospitals in England, 2016 to 2017. Public Health England; 2017. www.gov.uk/phe Available from:</Citation></Reference><Reference><Citation>NICE Quality Standard, Surgical Site Infection. c2013. National Institute for Health and care excellence (accessed August 6, 2018) https://www.nice.org.uk/guidance/qs49/resources/surgical-site-infection-2098675107781.</Citation></Reference><Reference><Citation>Vogel T.R., Dombrovskiy V.Y., Lowry S.F. Trends in postoperative sepsis: are we improving outcomes? Surg Infect. 2009;10:71&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2846560</ArticleId><ArticleId IdType="pubmed">19298170</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith V., Clarke M., Williamson P., Gargon E. Survey of new 2007 and 2011 Cochrane reviews found 37% of prespecified outcomes not reported. J&#xa0;Clin Epidemiol. 2015;68:237&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">25455837</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21314352</PMID><DateCompleted><Year>2011</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1545-1550</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists</Title><ISOAbbreviation>J Endovasc Ther</ISOAbbreviation></Journal><ArticleTitle>Endovascular management of arterioenteric fistulas: a systemic review and meta-analysis of the literature.</ArticleTitle><Pagination><StartPage>66</StartPage><EndPage>77</EndPage><MedlinePgn>66-77</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1583/10-3229.1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To present a systemic review and meta-analysis investigating the outcomes of endovascular management of arterioenteric fistula (AEF).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature review on AEF management with endovascular surgery using MEDLINE search, including two cases managed by the authors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-nine patients (50 men; mean age 68 years, range 23-90) were identified. AEF was successfully managed in 55 (93%) patients and 30-day mortality was 8.5% (5/59). During follow-up, 10 (19%) patients developed recurrent bleeding, which occurred more often in AEFs due to cancer. The freedom from recurrence rate at 12 and 24 months was 71.5%. Seventeen (32%) patients developed sepsis, which was managed conservatively in 8 (7 successful). Freedom from sepsis at 12 and 24 months was 64%, while the freedom from combined recurrence and sepsis at 12 and 24 months was 59%. Patients who did not have intestinal repair had a higher rate of combined recurrence and sepsis compared to patients who did; the freedom from combined recurrence and sepsis at 12 months was 52% for patients not having intestinal repair versus 100% in patients who did (p = 0.022). Total AEF-related mortality rates at 12 and 24 months were 15% and 19%, respectively, significantly worse when AEF recurred (p = 0.001). Overall survival rates at 12 and 24 months were 68% and 52%; prognosis was worse in patients with perioperative sepsis, large bowel fistulization, tube graft placement, no intestinal repair, and recurrent AEF.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Endovascular management of AEF can achieve satisfactory short and midterm results, better than those historically reported for open surgery, despite the high rate of recurrent bleeding and sepsis. Further investigation of the role played by intestinal repair is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kakkos</LastName><ForeName>Stavros K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital of Patras, Rio, Patras Greece. kakkos@upatras.gr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadoulas</LastName><ForeName>Spyros</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tsolakis</LastName><ForeName>Ioannis A</ForeName><Initials>IA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endovasc Ther</MedlineTA><NlmUniqueID>100896915</NlmUniqueID><ISSNLinking>1526-6028</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001018" MajorTopicYN="N">Aortic Diseases</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="Y">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007412" MajorTopicYN="N">Intestinal Fistula</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016157" MajorTopicYN="N">Vascular Fistula</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21314352</ArticleId><ArticleId IdType="doi">10.1583/10-3229.1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38037809</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1437-4331</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>25</Day></PubDate></JournalIssue><Title>Clinical chemistry and laboratory medicine</Title><ISOAbbreviation>Clin Chem Lab Med</ISOAbbreviation></Journal><ArticleTitle>Thrombopoietin levels in sepsis and septic shock&#xa0;-&#xa0;a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>999</StartPage><EndPage>1010</EndPage><MedlinePgn>999-1010</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1515/cclm-2023-0792</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Sepsis is a life-threatening condition implicating an inadequate activation of the immune system. Platelets act as modulators and contributors to immune processes. Indeed, altered platelet turnover, thrombotic events, and changes in thrombopoietin levels in systemic inflammation have been reported, but thrombopoietin-levels in sepsis and septic-shock have not yet been systematically evaluated. We therefore performed a meta-analysis of thrombopoietin (TPO)-levels in patients with sepsis.</AbstractText><AbstractText Label="METHODS">Two independent reviewers screened records and full-text articles for inclusion. Scientific databases were searched for studies examining thrombopoietin levels in adult sepsis and septic-shock patients until August 1st 2022.</AbstractText><AbstractText Label="RESULTS">Of 95 items screened, six studies met the inclusion criteria, including 598 subjects. Both sepsis and severe sepsis were associated with increased levels of thrombopoietin (sepsis vs. control: standardized mean difference 3.06, 95&#x202f;% CI 1.35-4.77; Z=3.50, p=0.0005) (sepsis vs. severe sepsis: standardized mean difference&#xa0;-1.67, 95&#x202f;% CI&#xa0;-2.46 to&#xa0;-0.88; Z=4.14, p&lt;0.0001). TPO-levels did not show significant differences between severe sepsis and septic shock patients but&#xa0;differed between sepsis and inflammation-associated non-septic controls. Overall, high heterogeneity and low sample size could be noted.</AbstractText><AbstractText Label="CONCLUSIONS">Concluding, increased levels of thrombopoietin appear to be present both in sepsis and severe sepsis with high heterogeneity but thrombopoietin does not allow to differentiate between severe sepsis and septic-shock. TPO may potentially serve to differentiate sepsis from non-septic trauma and/or tissue damage related (systemic) inflammation. Usage of different assays and high heterogeneity demand standardization of methods and further large multicenter trials.</AbstractText><CopyrightInformation>&#xa9; 2023 Walter de Gruyter GmbH, Berlin/Boston.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;rlich</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Biostatistics and Clinical Research, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowell</LastName><ForeName>Clifford A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Italiano</LastName><ForeName>Joseph E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Harvard Medical School and Vascular Biology Program, Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossaint</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bender</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Experimental Biomedicine&#xa0;- Chair I, University Hospital W&#xfc;rzburg, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarbock</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margraf</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6539-6478</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biochemical Pharmacology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Chem Lab Med</MedlineTA><NlmUniqueID>9806306</NlmUniqueID><ISSNLinking>1434-6621</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9014-42-0</RegistryNumber><NameOfSubstance UI="D013926">Thrombopoietin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013926" MajorTopicYN="N">Thrombopoietin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">thrombopoietin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38037809</ArticleId><ArticleId IdType="doi">10.1515/cclm-2023-0792</ArticleId><ArticleId IdType="pii">cclm-2023-0792</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Margraf, A, Ludwig, N, Zarbock, A, Rossaint, J. Systemic inflammatory response syndrome after surgery: mechanisms and protection. Anesth Analg 2020;131:1693&#x2013;707. https://doi.org/10.1213/ane.0000000000005175 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000005175</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, L, Rhodes, A, Alhazzani, W, Antonelli, M, Coopersmith, CM, French, C, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021;47:1181&#x2013;247. https://doi.org/10.1007/s00134-021-06506-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Margraf, A, Zarbock, A. Platelets in inflammation and resolution. J&#xa0;Immunol 2019;203:2357&#x2013;67. https://doi.org/10.4049/jimmunol.1900899 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900899</ArticleId></ArticleIdList></Reference><Reference><Citation>Margraf, A, Lowell, CA, Zarbock, A. Neutrophils in acute inflammation: current concepts and translational implications. Blood 2022;139:2130&#x2013;44. https://doi.org/10.1182/blood.2021012295 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012295</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaertner, F, Ahmad, Z, Rosenberger, G, Fan, S, Nicolai, L, Busch, B, et al.. Migrating platelets are mechano-scavengers that collect and bundle bacteria. Cell 2017;171:1368&#x2013;82 e23. https://doi.org/10.1016/j.cell.2017.11.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuchtriegel, G, Uhl, B, Puhr-Westerheide, D, Pornbacher, M, Lauber, K, Krombach, F, et al.. Platelets guide leukocytes to their sites of extravasation. PLoS Biol 2016;14:e1002459. https://doi.org/10.1371/journal.pbio.1002459 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002459</ArticleId></ArticleIdList></Reference><Reference><Citation>Margraf, A, Zarbock, A. Platelets in inflammation and resolution. J&#xa0;Immunol 2019;203:2357&#x2013;67. https://doi.org/10.4049/jimmunol.1900899 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900899</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiery-Antier, N, Binquet, C, Vinault, S, Meziani, F, Boisrame-Helms, J, Quenot, JP, et al.. Is thrombocytopenia an early prognostic marker in septic shock? Crit Care Med 2016;44:764&#x2013;72. https://doi.org/10.1097/ccm.0000000000001520 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0000000000001520</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaint, J, Kuhne, K, Skupski, J, Van Aken, H, Looney, MR, Hidalgo, A, et al.. Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. Nat Commun 2016;7:13464. https://doi.org/10.1038/ncomms13464 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13464</ArticleId></ArticleIdList></Reference><Reference><Citation>de Stoppelaar, SF, van&#x2019;t Veer, C, Claushuis, TA, Albersen, BJ, Roelofs, JJ, van der Poll, T. Thrombocytopenia impairs host defense in Gram-negative pneumonia-derived sepsis in mice. Blood 2014;124:3781&#x2013;90. https://doi.org/10.1182/blood-2014-05-573915 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-05-573915</ArticleId></ArticleIdList></Reference><Reference><Citation>Claushuis, TA, van Vught, LA, Scicluna, BP, Wiewel, MA, Klein Klouwenberg, PM, Hoogendijk, AJ, et al.. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood 2016;127:3062&#x2013;72. https://doi.org/10.1182/blood-2015-11-680744 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2015-11-680744</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama, K, Katayama, S, Muronoi, T, Tonai, K, Goto, Y, Koinuma, T, et al.. Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis. PLoS One 2018;13:e0192064. https://doi.org/10.1371/journal.pone.0192064 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192064</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakey, S, Karamanos, E, Louwers, L, Kolbe, N, Killu, K, Horst, H, et al.. Thrombocytosis vs. thrombocytopenia as risk factor for increased mortality in sepsis. Crit Care Med 2013;41:A263. https://doi.org/10.1097/01.ccm.0000440283.47246.33 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000440283.47246.33</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, JZ, Xia, YP, Kuter, DJ. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia. Br J Haematol 2000;111:943&#x2013;53. https://doi.org/10.1046/j.1365-2141.2000.02430.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2000.02430.x</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sauvage, FJ, Carver-Moore, K, Luoh, SM, Ryan, A, Dowd, M, Eaton, DL, et al.. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996;183:651&#x2013;6. https://doi.org/10.1084/jem.183.2.651 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.183.2.651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney, AL, Carver-Moore, K, de Sauvage, FJ, Moore, MW. Thrombocytopenia in c-mpl-deficient mice. Science 1994;265:1445&#x2013;7. https://doi.org/10.1126/science.8073287 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8073287</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel, SR, Hartwig, JH, Italiano, JEJr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 2005;115:3348&#x2013;54. https://doi.org/10.1172/jci26891 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci26891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballmaier, M, Holter, W, Germeshausen, M. Flow cytometric detection of MPL (CD110) as a diagnostic tool for differentiation of congenital thrombocytopenias. Haematologica 2015;100:e341&#x2013;4. https://doi.org/10.3324/haematol.2015.125963 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2015.125963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura, S, Nagasaki, M, Kunishima, S, Sawaguchi, A, Sakata, A, Sakaguchi, H, et al.. IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol 2015;209:453&#x2013;66. https://doi.org/10.1083/jcb.201410052 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201410052</ArticleId></ArticleIdList></Reference><Reference><Citation>Valet, C, Magnen, M, Qiu, L, Cleary, SJ, Wang, KM, Ranucci, S, et al.. Sepsis promotes splenic production of a protective platelet pool with high CD40 ligand expression. J Clin Invest 2022;132:e153920. https://doi.org/10.1172/jci153920 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci153920</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuccurullo, A, Greco, E, Lupia, E, De Giuli, P, Bosco, O, Martin-Conte, E, et al.. Blockade of thrombopoietin reduces organ damage in experimental endotoxemia and polymicrobial sepsis. PLoS One 2016;11:e0151088. https://doi.org/10.1371/journal.pone.0151088 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151088</ArticleId></ArticleIdList></Reference><Reference><Citation>Barichello, T, Generoso, JS, Singer, M, Dal-Pizzol, F. Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review. Crit Care 2022;26:14. https://doi.org/10.1186/s13054-021-03862-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03862-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozo, SP, Djulbegovic, B, Hozo, I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13. https://doi.org/10.1186/1471-2288-5-13 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins, JPT, Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions , 2nd ed. Hoboken, NJ: Wiley-Blackwell; 2020:pages cm.</Citation></Reference><Reference><Citation>Rossaint, J, Margraf, A, Zarbock, A. Role of platelets in leukocyte recruitment and resolution of inflammation. Front Immunol 2018;9:2712. https://doi.org/10.3389/fimmu.2018.02712 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreeramkumar, V, Adrover, JM, Ballesteros, I, Cuartero, MI, Rossaint, J, Bilbao, I, et al.. Neutrophils scan for activated platelets to initiate inflammation. Science 2014;346:1234&#x2013;8. https://doi.org/10.1126/science.1256478 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256478</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmons, RV, Reid, DM, Cohen, RL, Meng, G, Young, NS, Dunbar, CE, et al.. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996;87:4068&#x2013;71. https://doi.org/10.1182/blood.v87.10.4068.bloodjournal87104068 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.v87.10.4068.bloodjournal87104068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmeister, KM. TPO-logy accepted. Blood 2018;132:555&#x2013;7. https://doi.org/10.1182/blood-2018-06-854935 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-06-854935</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, M, Li, J, Neves, MAD, Zhu, G, Carrim, N, Yu, R, et al.. GPIbalpha is required for platelet-mediated hepatic thrombopoietin generation. Blood 2018;132:622&#x2013;34. https://doi.org/10.1182/blood-2017-12-820779 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-12-820779</ArticleId></ArticleIdList></Reference><Reference><Citation>Baaten, C, Swieringa, F, Misztal, T, Mastenbroek, TG, Feijge, MAH, Bock, PE, et al.. Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects. Blood Adv 2018;2:2320&#x2013;31. https://doi.org/10.1182/bloodadvances.2017011544 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2017011544</ArticleId></ArticleIdList></Reference><Reference><Citation>Folman, CC, Linthorst, GE, van Mourik, J, van Willigen, G, de Jonge, E, Levi, M, et al.. Platelets release thrombopoietin (TPO) upon activation: another regulatory loop in thrombocytopoiesis? Thromb Haemostasis 2000;83:923&#x2013;30. https://doi.org/10.1055/s-0037-1613944 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1613944</ArticleId></ArticleIdList></Reference><Reference><Citation>Makar, RS, Zhukov, OS, Sahud, MA, Kuter, DJ. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists. Am J Hematol 2013;88:1041&#x2013;4. https://doi.org/10.1002/ajh.23562 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.23562</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllister, SK, Bland, LA, Arduino, MJ, Aguero, SM, Wenger, PN, Jarvis, WR. Patient cytokine response in transfusion-associated sepsis. Infect Immun 1994;62:2126&#x2013;8. https://doi.org/10.1128/iai.62.5.2126-2128.1994 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.62.5.2126-2128.1994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, L, Zhao, H, Wang, D. Inflammatory cytokine expression in patients with sepsis at an intensive care unit. Exp Ther Med 2018;16:2126&#x2013;31. https://doi.org/10.3892/etm.2018.6376 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6376</ArticleId></ArticleIdList></Reference><Reference><Citation>Senderoff, RI, Kontor, KM, Heffernan, JK, Clarke, HJ, Garrison, LK, Kreilgaard, L, et al.. Aqueous stability of recombinant human thrombopoietin as a function of processing schemes. J Pharmaceut Sci 1996;85:749&#x2013;52. https://doi.org/10.1021/js950377g .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/js950377g</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato, T, Oda, A, Inagaki, Y, Ohashi, H, Matsumoto, A, Ozaki, K, et al.. Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin. Proc Natl Acad Sci USA 1997;94:4669&#x2013;74. https://doi.org/10.1073/pnas.94.9.4669 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.9.4669</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, J, Xia, Y, Kuter, DJ. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. Br J Haematol 1999;106:345&#x2013;56. https://doi.org/10.1046/j.1365-2141.1999.01571.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.1999.01571.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikawa, Y, Nishida, S, Kuroda, K, Kashiwagi, H, Tomiyama, Y, Kuwana, M. Development of an automated chemiluminescent enzyme immunoassay for measuring thrombopoietin in human plasma. Diagnostics 2022;12:313. https://doi.org/10.3390/diagnostics12020313 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12020313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupia, E, Bosco, O, Bergerone, S, Dondi, AE, Goffi, A, Oliaro, E, et al.. Thrombopoietin contributes to enhanced platelet activation in patients with unstable angina. J Am Coll Cardiol 2006;48:2195&#x2013;203. https://doi.org/10.1016/j.jacc.2006.04.106 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2006.04.106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota, Y, Arai, T, Tanaka, T, Yamaoka, G, Kiuchi, H, Kajikawa, T, et al.. Thrombopoietin modulates platelet activation in&#xa0;vitro through protein-tyrosine phosphorylation. Stem Cells 1996;14:439&#x2013;44. https://doi.org/10.1002/stem.140439 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.140439</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupia, E, Bosco, O, Mariano, F, Dondi, AE, Goffi, A, Spatola, T, et al.. Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation. J Thromb Haemostasis 2009;7:1000&#x2013;8. https://doi.org/10.1111/j.1538-7836.2009.03348.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2009.03348.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorup, CV, Christensen, S, Hvas, AM. Immature platelets as a predictor of disease severity and mortality in sepsis and septic shock: a systematic review. Semin Thromb Hemost 2020;46:320&#x2013;7. https://doi.org/10.1055/s-0039-3400256 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-3400256</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss, LJ, Manukjan, G, Pflug, A, Winter, N, Weigel, M, Nagler, N, et al.. Acquired platelet GPVI receptor dysfunction in critically ill patients with sepsis. Blood 2021;137:3105&#x2013;15. https://doi.org/10.1182/blood.2020009774 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020009774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceresa, IF, Noris, P, Ambaglio, C, Pecci, A, Balduini, CL. Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders. Platelets 2007;18:579&#x2013;82. https://doi.org/10.1080/09537100701593601 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537100701593601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupia, E, Pigozzi, L, Pivetta, E, Bosco, O, Vizio, B, Loiacono, M, et al.. Thrombopoietin as early biomarker of disease severity in patients with acute pancreatitis. Pancreas 2017;46:164&#x2013;9. https://doi.org/10.1097/mpa.0000000000000752 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mpa.0000000000000752</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Z, Feng, T, Xie, Y, Huang, P, Xie, H, Tian, R, et al.. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial). BMC Infect Dis 2019;19:780. https://doi.org/10.1186/s12879-019-4388-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4388-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakynthinos, SG, Papanikolaou, S, Theodoridis, T, Zakynthinos, EG, Christopoulou-Kokkinou, V, Katsaris, G, et al.. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med 2004;32:1004&#x2013;10. https://doi.org/10.1097/01.ccm.0000121433.61546.a0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000121433.61546.a0</ArticleId></ArticleIdList></Reference><Reference><Citation>Segre, E, Pigozzi, L, Lison, D, Pivetta, E, Bosco, O, Vizio, B, et al.. May thrombopoietin be a useful marker of sepsis severity assessment in patients with SIRS entering the emergency department? Clin Chem Lab Med 2014;52:1479&#x2013;83. https://doi.org/10.1515/cclm-2014-0219 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2014-0219</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu, M, Konishi, A, Nomura, S. Examination of biomarker expressions in sepsis-related DIC patients. Int J Gen Med 2018;11:353&#x2013;61. https://doi.org/10.2147/ijgm.s173684 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ijgm.s173684</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, WH, Mo, LC, Shi, MH, Rao, H, Zhan, XY, Yang, M. Correlation between thrombopoietin and inflammatory factors, platelet indices, and thrombosis in patients with sepsis: a retrospective study. World J Clin Cases 2022;10:4072&#x2013;83. https://doi.org/10.12998/wjcc.v10.i13.4072 .</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i13.4072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavranou, GA, Mentzelopoulos, S, Katsaounou, P, Siempos, I, Kalomenidis, I, Geranaki, A, et al.. Can coagulation system disorders and cytokine and inflammatory marker levels predict the temporary clinical deterioration or improvement of septic patients on ICU admission? J&#xa0;Clin Med 2021;10:1548. https://doi.org/10.3390/jcm10081548 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10081548</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34899560</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Cerebral Autoregulation in Non-Brain Injured Patients: A Systematic Review.</ArticleTitle><Pagination><StartPage>732176</StartPage><MedlinePgn>732176</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">732176</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2021.732176</ELocationID><Abstract><AbstractText><b>Introduction:</b> Cerebral autoregulation (CA) plays a fundamental role in the maintenance of adequate cerebral blood flow (CBF). CA monitoring, through direct and indirect techniques, may guide an appropriate therapeutic approach aimed at improving CBF and reducing neurological complications; so far, the role of CA has been investigated mainly in brain-injured patients. The aim of this study is to investigate the role of CA in non-brain injured patients. <b>Methods:</b> A systematic consultation of literature was carried out. Search terms included: "CA and sepsis," "CA and surgery," and "CA and non-brain injury." <b>Results:</b> Our research individualized 294 studies and after screening, 22 studies were analyzed in this study. Studies were divided in three groups: CA in sepsis and septic shock, CA during surgery, and CA in the pediatric population. Studies in sepsis and intraoperative setting highlighted a relationship between the incidence of sepsis-associated delirium and impaired CA. The most investigated setting in the pediatric population is cardiac surgery, but the role and measurement of CA need to be further elucidated. <b>Conclusion:</b> In non-brain injured patients, impaired CA may result in cognitive dysfunction, neurological damage, worst outcome, and increased mortality. Monitoring CA might be a useful tool for the bedside optimization and individualization of the clinical management in this group of patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Longhitano, Iannuzzi, Bonatti, Zanza, Messina, Godoy, Dabrowski, Xiuyun, Czosnyka, Pelosi, Badenes and Robba.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Longhitano</LastName><ForeName>Yaroslava</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, AO St. Antonio, Biagio and Cesare Arrigo, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iannuzzi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonatti</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Gaslini Hospital, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanza</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Foundation of "Nuovo Ospedale Alba-Bra" and Department of Emergency Medicine, Anesthesia and Critical Care Division, Michele and Pietro Ferrero Hospital, Verduno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Humanitas Clinical and Research Center - IRCCS, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godoy</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neurointensive Care Unit, Sanatorio Pasteur, 2 Intensive Care Unit, Hospital Carlos Malbran, Catamarca, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabrowski</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, University of Lublin, Lublin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiuyun</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology &amp; Critical Care Medicine, John Hopkins University, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czosnyka</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Brain Physics Laboratory, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badenes</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Surgical-Trauma Intensive Care, Hospital Clinic Universitari de Valencia, Department of Surgery, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robba</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cerebral autoregulation</Keyword><Keyword MajorTopicYN="N">neurologic outcome</Keyword><Keyword MajorTopicYN="N">non-brain injury</Keyword><Keyword MajorTopicYN="N">pediatric surgery</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>13</Day><Hour>17</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34899560</ArticleId><ArticleId IdType="pmc">PMC8660115</ArticleId><ArticleId IdType="doi">10.3389/fneur.2021.732176</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Armstead WM. Cerebral blood flow autoregulation and dysautoregulation. Anesthesiol Clin. (2016) 34:465&#x2013;77. 10.1016/j.anclin.2016.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2016.04.002</ArticleId><ArticleId IdType="pmc">PMC4988341</ArticleId><ArticleId IdType="pubmed">27521192</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Citerio G. How I manage intracranial hypertension. Crit Care. (2019) 23:243. 10.1186/s13054-019-2529-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2529-z</ArticleId><ArticleId IdType="pmc">PMC6611036</ArticleId><ArticleId IdType="pubmed">31272474</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Bonatti G, Battaglini D, Rocco PRM, Pelosi P. Mechanical ventilation in patients with acute ischaemic stroke: from pathophysiology to clinical practice. Crit Care. (2019) 23:388. 10.1186/s13054-019-2662-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2662-8</ArticleId><ArticleId IdType="pmc">PMC6889568</ArticleId><ArticleId IdType="pubmed">31791375</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Lara L, Zorrilla-Vaca A, Geocadin RG, Healy RJ, Ziai W, Mirski MA. Cerebral autoregulation-oriented therapy at the bedside: a comprehensive review. Anesthesiology. (2017) 126:1187&#x2013;99. 10.1097/ALN.0000000000001625</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001625</ArticleId><ArticleId IdType="pubmed">28383324</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SP, Depreitere B, Meyfroidt G. How I monitor cerebral autoregulation. Crit Care. (2019) 23:160. 10.1186/s13054-019-2454-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2454-1</ArticleId><ArticleId IdType="pmc">PMC6505261</ArticleId><ArticleId IdType="pubmed">31064383</ArticleId></ArticleIdList></Reference><Reference><Citation>Depreitere B, Citerio G, Smith M, Adelson PD, Aries MJ, Bleck TP, et al. . Cerebrovascular autoregulation monitoring in the management of adult severe traumatic brain injury: a delphi consensus of clinicians. Neurocrit Care. (2021) 34:731&#x2013;8. 10.1007/s12028-020-01185-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-020-01185-x</ArticleId><ArticleId IdType="pmc">PMC8179892</ArticleId><ArticleId IdType="pubmed">33495910</ArticleId></ArticleIdList></Reference><Reference><Citation>de Azevedo DS, Salinet ASM, de Lima Oliveira M, Teixeira MJ, Bor-Seng-Shu E, de Carvalho Nogueira R. Cerebral hemodynamics in sepsis assessed by transcranial Doppler: a systematic review and meta-analysis. J Clin MonitComput. (2017) 31:1123&#x2013;32. 10.1007/s10877-016-9945-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-016-9945-2</ArticleId><ArticleId IdType="pubmed">27757739</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg RM, Plovsing RR. Effects of short-term mechanical hyperventilation on cerebral blood flow and dynamic cerebral autoregulation in critically ill patients with sepsis. Scand J Clin Lab Invest. (2016) 76:226&#x2013;33. 10.3109/00365513.2015.1137350</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365513.2015.1137350</ArticleId><ArticleId IdType="pubmed">26935607</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura Y, Faegle R, Hori D, Al-Qamari A, Nemeth AJ, Gottesman R, et al. . Cerebral small vessel, but not large vessel disease, is associated with impaired cerebral autoregulation during cardiopulmonary bypass: a retrospective cohort study. Anesth Analg. (2018) 127:1314&#x2013;22. 10.1213/ANE.0000000000003384</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003384</ArticleId><ArticleId IdType="pmc">PMC6533899</ArticleId><ArticleId IdType="pubmed">29677060</ArticleId></ArticleIdList></Reference><Reference><Citation>Easley RB, Marino BS, Jennings J, Cassedy AE, Kibler KK, Brady KM, et al. . Impaired cerebral autoregulation and elevation in plasma glial fibrillary acidic protein level during cardiopulmonary bypass surgery for CHD. Cardiol Young. (2018) 28:55&#x2013;65. 10.1017/S1047951117001573</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951117001573</ArticleId><ArticleId IdType="pmc">PMC5955612</ArticleId><ArticleId IdType="pubmed">28835309</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson PJ, Kolias AG, Tajsic T, Adeleye A, Aklilu AT, Apriawan T, et al. . Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury: Consensus statement. Acta Neurochir (Wien). (2019) 161:1261&#x2013;74. 10.1007/s00701-019-03936-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-019-03936-y</ArticleId><ArticleId IdType="pmc">PMC6581926</ArticleId><ArticleId IdType="pubmed">31134383</ArticleId></ArticleIdList></Reference><Reference><Citation>Czosnyka M. In a Search of Pressure Which Optimizes Autoregulation of Cerebral Blood Flow. Crit Care Med. (2019) 47:1472&#x2013;3. 10.1097/CCM.0000000000003947</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003947</ArticleId><ArticleId IdType="pubmed">31524703</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly J, Aries MJ, Czosnyka M. Further understanding of cerebral autoregulation at the bedside: possible implications for future therapy. Expert Rev Neurother. (2015) 15:169&#x2013;85. 10.1586/14737175.2015.996552</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737175.2015.996552</ArticleId><ArticleId IdType="pubmed">25614952</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. (2015) 350:g7647. 10.1136/bmj.g7647</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Schramm P, Klein KU, Falkenberg L, Berres M, Closhen D, Werhahn KJ, et al. . Impaired cerebrovascular autoregulation in patients with severe sepsis and sepsis-associated delirium. Crit Care. (2012) 16:R181. 10.1186/cc11665</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11665</ArticleId><ArticleId IdType="pmc">PMC3682283</ArticleId><ArticleId IdType="pubmed">23036135</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindra J, Pham P, Chuan A, Jaeger M, Aneman A. Is impaired cerebrovascular autoregulation associated with outcome in patients admitted to the ICU with early septic shock? Crit Care Resusc. (2016) 18:95&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">27242107</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa IA, Subir&#xe0; C, Vincent JL, Fernandez RF, Hernandez SC, Cavicchi FZ, et al. . Impaired cerebral autoregulation is associated with brain dysfunction in patients with sepsis. Crit Care. (2018) 22:327. 10.1186/s13054-018-2258-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2258-8</ArticleId><ArticleId IdType="pmc">PMC6280405</ArticleId><ArticleId IdType="pubmed">30514349</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblatt K, Walker KA, Goodson C, Olson E, Maher D, Brown CH. Cerebral autoregulation-guided optimal blood pressure in sepsis-associated encephalopathy: a case series. J Intensive Care Med. (2020) 35:1453&#x2013;64. 10.1177/0885066619828293</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066619828293</ArticleId><ArticleId IdType="pmc">PMC6692246</ArticleId><ArticleId IdType="pubmed">30760173</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady KM, Mytar JO, Lee JK, Cameron DE, Vricella LA, Thompson WR, et al. . Monitoring cerebral blood flow pressure autoregulation in pediatric patients during cardiac surgery. Stroke. (2010) 41:1957&#x2013;62. 10.1161/STROKEAHA.109.575167</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.575167</ArticleId><ArticleId IdType="pmc">PMC5498798</ArticleId><ArticleId IdType="pubmed">20651273</ArticleId></ArticleIdList></Reference><Reference><Citation>Thewissen L, Caicedo A, Dereymaeker A, Van Huffel S, Naulaers G, Allegaert K, et al. . Cerebral autoregulation and activity after propofol for endotracheal intubation in preterm neonates. Pediatr Res. (2018) 84:719&#x2013;25. 10.1038/s41390-018-0160-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-018-0160-3</ArticleId><ArticleId IdType="pubmed">30201953</ArticleId></ArticleIdList></Reference><Reference><Citation>Joram N, Beqiri E, Pezzato S, Andrea M, Robba C, Liet JM, et al. . Continuous monitoring of cerebral autoregulation in children supported by extracorporeal membrane oxygenation: a pilot study. Neurocrit Care. (2021) 34:935&#x2013;45. 10.1007/s12028-020-01111-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-020-01111-1</ArticleId><ArticleId IdType="pubmed">33029743</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldas JR, Panerai RB, Bor-Seng-Shu E, Ferreira GSR, Camara L, Passos RH, et al. . Dynamic cerebral autoregulation: A marker of post-operative delirium? Clin Neurophysiol. (2019) 130:101&#x2013;8. 10.1016/j.clinph.2018.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2018.11.008</ArticleId><ArticleId IdType="pmc">PMC7106549</ArticleId><ArticleId IdType="pubmed">30503909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono M, Arnaoutakis GJ, Fine DM, Brady K, Easley RB, Zheng Y, et al. . Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med. (2013) 41:464&#x2013;71. 10.1097/CCM.0b013e31826ab3a1</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31826ab3a1</ArticleId><ArticleId IdType="pmc">PMC3769417</ArticleId><ArticleId IdType="pubmed">23263580</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori D, Max L, Laflam A, Brown C, Neufeld KJ, Adachi H, et al. . Blood pressure deviations from optimal mean arterial pressure during cardiac surgery measured with a novel monitor of cerebral blood flow and risk for perioperative delirium: a pilot study. J CardiothoracVascAnesth. (2016) 30:606&#x2013;12. 10.1053/j.jvca.2016.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2016.01.012</ArticleId><ArticleId IdType="pmc">PMC5508106</ArticleId><ArticleId IdType="pubmed">27321787</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori D, Brown C, Ono M, Rappold T, Sieber F, Gottschalk A, et al. . Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium. Br J Anaesth. (2014) 113:1009&#x2013;17. 10.1093/bja/aeu319</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu319</ArticleId><ArticleId IdType="pmc">PMC4235573</ArticleId><ArticleId IdType="pubmed">25256545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperna Weiland NH, Hermanides J, Hollmann MW, Preckel B, Stok WJ, van Lieshout JJ, et al. . Novel method for intraoperative assessment of cerebral autoregulation by paced breathing. Br J Anaesth. (2017) 119:1141&#x2013;9. 10.1093/bja/aex333</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex333</ArticleId><ArticleId IdType="pubmed">29028933</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuan A, Short TG, Peng AZY, Wen SYB, Sun AX, Ting TH, et al. . Is cerebrovascular autoregulation associated with outcomes after major noncardiac surgery? A prospective observational pilot study. Acta Anaesthesiol Scand. (2019) 63:8&#x2013;17. 10.1111/aas.13223</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13223</ArticleId><ArticleId IdType="pubmed">30079514</ArticleId></ArticleIdList></Reference><Reference><Citation>Goettel N, Burkhart CS, Rossi A, Cabella BC, Berres M, Monsch AU, et al. . Associations between impaired cerebral blood flow autoregulation, cerebral oxygenation, and biomarkers of brain injury and postoperative cognitive dysfunction in elderly patients after major noncardiac surgery. Anesth Analg. (2017) 124:934&#x2013;42. 10.1213/ANE.0000000000001803</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001803</ArticleId><ArticleId IdType="pubmed">28151820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Villamayor AJ, Merritt W, Pustavoitau A, Latif A, Bhambhani R, et al. . Continuous cerebral blood flow autoregulation monitoring in patients undergoing liver transplantation. Neurocrit Care. (2012) 17:77&#x2013;84. 10.1007/s12028-012-9721-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-012-9721-1</ArticleId><ArticleId IdType="pmc">PMC3748944</ArticleId><ArticleId IdType="pubmed">22644887</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogue CW, Brown CH, Hori D, Ono M, Nomura Y, Balmert LC, et al. . Personalized blood pressure management during cardiac surgery with cerebral autoregulation monitoring: a randomized trial. Semin Thorac Cardiovasc Surg. (2021) 33:429&#x2013;38. 10.1053/j.semtcvs.2020.09.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2020.09.032</ArticleId><ArticleId IdType="pubmed">33186735</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg RM, Plovsing RR, Bailey DM, Holstein-Rathlou NH, M&#xf8;ller K. Dynamic cerebral autoregulation to induced blood pressure changes in human experimental and clinical sepsis. Clin PhysiolFunct Imaging. (2016) 36:490&#x2013;6. 10.1111/cpf.12256</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpf.12256</ArticleId><ArticleId IdType="pubmed">26017052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori D, Hogue C, Adachi H, Max L, Price J, Sciortino C, et al. . Perioperative optimal blood pressure as determined by ultrasound tagged near infrared spectroscopy and its association with postoperative acute kidney injury in cardiac surgery patients. Interact Cardiovasc Thorac Surg. (2016) 22:445&#x2013;51. 10.1093/icvts/ivv371</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivv371</ArticleId><ArticleId IdType="pmc">PMC4801133</ArticleId><ArticleId IdType="pubmed">26763042</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldas JR, Haunton VJ, Panerai RB, Hajjar LA, Robinson TG. Cerebral autoregulation in cardiopulmonary bypass surgery: a systematic review. Interact Cardiovasc Thorac Surg. (2018) 26:494&#x2013;503. 10.1093/icvts/ivx357</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivx357</ArticleId><ArticleId IdType="pubmed">29155938</ArticleId></ArticleIdList></Reference><Reference><Citation>Goettel N, Patet C, Rossi A, Burkhart CS, Czosnyka M, Strebel SP, et al. . Monitoring of cerebral blood flow autoregulation in adults undergoing sevoflurane anesthesia: a prospective cohort study of two age groups. J Clin Monit Comput. (2016) 30:255&#x2013;64. 10.1007/s10877-015-9754-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-015-9754-z</ArticleId><ArticleId IdType="pubmed">26285741</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35355600</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Post-operative Planned Reintubation in Patients After General Anesthesia: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>839070</StartPage><MedlinePgn>839070</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">839070</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.839070</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The occurrence of postoperative reintubation (POR) in patients after general anesthesia (GA) is often synonymous with a poor prognosis in patients. This is the first review analyzing scientific literature to identify risk factors of POR after general anesthesia. The purpose of this study was to collect currently published studies to determine the most common and consistent risk factors associated with POR after GA.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We have retrieved all relevant research published before April 2021 from PubMed, Embase, Web of Science, and the Cochrane Library electronic databases. These studies were selected according to the inclusion and exclusion criteria. The Z test determined the combined odds ratio (OR) of risk factors. We used OR and its corresponding 95% confidence interval (CI) to identify significant differences in risk factors. The quality of the study was evaluated with the NOS scale, and meta-analysis was carried out with Cochrane Collaboration's Revman 5.0 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 10 studies were included, with a total of 7,789 recipients of POR. We identified 7 risk factors related to POR after GA: ASA &#x2265; 3 (OR = 3.58), COPD (OR = 2.09), thoracic surgery (OR = 17.09), airway surgery (OR = 9.93), head-and-neck surgery (OR = 3.49), sepsis (OR = 3.50), DVT (OR = 4.94).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our meta-analysis showed that ASA &#x2265; 3, COPD, thoracic surgery, airway surgery, head-and-neck surgery, sepsis and DVT were associated with POR after GA.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">https://www.crd.york.ac.uk/prospero/display_record.php?, Identifier: CRD42021252466.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Xie, Liu, Yang, Tang, Wang, Du and Yang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Zhiqin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nursing, First Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiawen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Nursing, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nursing, First Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Liping</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nursing, First Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shuilian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nursing, First Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Yunyu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Nursing, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Nursing, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">reintubation</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">systematic (literature) review</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>5</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35355600</ArticleId><ArticleId IdType="pmc">PMC8959864</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.839070</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen S, Zhang Y, Che L, Shen L, Huang Y. Risk factors for unplanned reintubation caused by acute airway compromise after general anesthesia: a case-control study. Bmc Anesthesiology. (2021) 21:17. 10.21203/rs.3.rs-50532/v3</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-50532/v3</ArticleId><ArticleId IdType="pmc">PMC7802267</ArticleId><ArticleId IdType="pubmed">33435881</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoftman N. Video on orotracheal intubation. N Engl J Med. (2007) 357:620. 10.1056/NEJMc071434</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc071434</ArticleId><ArticleId IdType="pubmed">17691134</ArticleId></ArticleIdList></Reference><Reference><Citation>Brovman EY, Steen TL, Urman RD. Associated risk factors and complications in vascular surgery patients requiring unplanned postoperative reintubation. J Cardiothorac Vasc Anesth. (2017) 31:554&#x2013;61. 10.1053/j.jvca.2016.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2016.11.013</ArticleId><ArticleId IdType="pubmed">28111104</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandyala S, Marquez-Lara A, Park D, Hassanzadeh H, Sankaranarayanan S, Noureldin M, et al. . Incidence, risk factors, and outcomes of postoperative airway management after cervical spine surgery. Spine. (2014) 39:E557&#x2013;63. 10.1097/BRS.0000000000000227</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000000227</ArticleId><ArticleId IdType="pubmed">24480959</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii E, Fujino K, Tanaka-Mizuno S, Eguchi Y. Variation of risk factors for cause-specific reintubation: a preliminary study. Can Respir J. (2018) 2018:3654251. 10.1155/2018/3654251</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/3654251</ArticleId><ArticleId IdType="pmc">PMC6230426</ArticleId><ArticleId IdType="pubmed">30510604</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaber S, Quintard H, Cinotti R, Asehnoune K, Arnal J, Guitton C, et al. . Risk factors and outcomes for airway failure versus non-airway failure in the intensive care unit: a multicenter observational study of 1514 extubation procedures. Crit Care. (2018) 22:236. 10.1186/s13054-018-2150-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2150-6</ArticleId><ArticleId IdType="pmc">PMC6151191</ArticleId><ArticleId IdType="pubmed">30243304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P, Chen C, Chiu H, Tai H, Lee D, Lai R. Outcomes of unplanned extubation in ordinary ward are similar to those in intensive care unit: A STROBE-compliant case-control study. Medicine. (2019) 98:e14841. 10.1097/MD.0000000000014841</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000014841</ArticleId><ArticleId IdType="pmc">PMC6426589</ArticleId><ArticleId IdType="pubmed">30882675</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes M, Moher D, Thombs B, McGrath T, Bossuyt P, Clifford T, et al. . Preferred Reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. (2018) 319:388&#x2013;96. 10.1001/jama.2017.19163</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.19163</ArticleId><ArticleId IdType="pubmed">29362800</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup D, Berlin J, Morton S, Olkin I, Williamson G, Rennie D, et al. . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. (2000) 283:2008&#x2013;12. 10.1001/jama.283.15.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. (2010) 25:603&#x2013;5. 10.1007/s10654-010-9491-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ. (2003) 327:557&#x2013;60. 10.1136/bmj.327.7414.557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbord R, Egger M, Sterne J. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. (2006) 25:3443&#x2013;57. 10.1002/sim.2380</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2380</ArticleId><ArticleId IdType="pubmed">16345038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos RDlG, Passias PG, Schwab F, Bydon A, Lafage V, Sciubba DM. Incidence, risk factors, and mortality of reintubation in adult spinal deformity surgery. Clin Spine Surg. (2017) 30:E896&#x2013;900. 10.1097/BSD.0000000000000404</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BSD.0000000000000404</ArticleId><ArticleId IdType="pubmed">27352366</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Garza Ramos R, Nakhla J, Nasser R, Jada A, Haranhalli N, Sciubba D, et al. . Factors associated with prolonged ventilation and reintubation in adult spinal deformity (ASD) surgery. Glob Spine J. (2017) 142S&#x2212;3S. 10.1016/j.jocn.2017.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2017.04.026</ArticleId><ArticleId IdType="pubmed">28551313</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco K, Conti B, Bucci C, Galvagno S. Rocuronium is associated with an increased risk of reintubation in patients with soft tissue infections. J Clin Anesth. (2016) 34:186&#x2013;91. 10.1016/j.jclinane.2016.03.073</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2016.03.073</ArticleId><ArticleId IdType="pubmed">27687370</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian L, Sheng S, Min Y, Zhongxiang Y. Risk factors for endotracheal re-intubation following coronary artery bypass grafting. BioMed Central. (2013) 8:208. 10.1186/1749-8090-8-208</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-8-208</ArticleId><ArticleId IdType="pmc">PMC3842842</ArticleId><ArticleId IdType="pubmed">24209453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H, Ting P, Chang W, Yang M, Chang C, Chou A. Predictive risk index and prognosis of postoperative reintubation after planned extubation during general anesthesia: a single-center retrospective case-controlled study in Taiwan from 2005 to 2009. Acta Anaesthesiol Taiwan. (2013) 51:3&#x2013;9. 10.1016/j.aat.2013.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aat.2013.03.004</ArticleId><ArticleId IdType="pubmed">23711598</ArticleId></ArticleIdList></Reference><Reference><Citation>Rujirojindakul P, Geater AF, McNeil EB, Vasinanukorn P, Prathep S, Asim W, et al. . Risk factors for reintubation in the post-anaesthetic care unit: a casecontrol study. Br J Anaesth. (2012) 109:636&#x2013;42. 10.1093/bja/aes226</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes226</ArticleId><ArticleId IdType="pubmed">22777658</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson LA, Zubizarreta N, Bekeris J, Poeran J, Liu J, Fiasconaro M, et al. . Risk factors for reintubation after anterior cervical discectomy and fusion surgery: evaluation of three observational data sets. Can J Anaesth. (2020) 67:42&#x2013;56. 10.1007/s12630-019-01492-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-019-01492-8</ArticleId><ArticleId IdType="pubmed">31571118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting PC, Chou AH, Yang MW, Ho AC, Chang CJ, Chang SC. Postoperative reintubation after planned extubation: a review of 137,866 general anesthetics from 2005 to 2007 in a medical center of Taiwan. Acta Anaesthesiol Taiwan. (2010) 48:167&#x2013;71. 10.1016/j.aat.2010.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aat.2010.12.003</ArticleId><ArticleId IdType="pubmed">21195986</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen G. American society of anesthesiologist classification-higher incentives for higher scores. JAMA Intern Med. (2016) 176:1578. 10.1001/jamainternmed.2016.5448</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2016.5448</ArticleId><ArticleId IdType="pubmed">27695838</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Esquinas A, Mina B. Coughing correlates: insights into an innovative study using cough peak expiratory flow to predict extubation failure. Critical care. (2016) 20:394. 10.1186/s13054-016-1574-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1574-0</ArticleId><ArticleId IdType="pmc">PMC5139113</ArticleId><ArticleId IdType="pubmed">27919282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukannek C, Shaefi S, Platzbecker K, Raub D, Santer P, Nabel S, et al. . The development and validation of the score for the prediction of postoperative respiratory complications (SPORC-2) to predict the requirement for early postoperative tracheal re-intubation: a hospital registry study. Anaesthesia. (2019) 74:1165&#x2013;74. 10.1111/anae.14742</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14742</ArticleId><ArticleId IdType="pmc">PMC7424553</ArticleId><ArticleId IdType="pubmed">31222727</ArticleId></ArticleIdList></Reference><Reference><Citation>Brueckmann B, Villa-Uribe J, Bateman B, Grosse-Sundrup M, Hess D, Schlett C, et al. . Development and validation of a score for prediction of postoperative respiratory complications. Anesthesiology. (2013) 118:1276&#x2013;85. 10.1097/ALN.0b013e318293065c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318293065c</ArticleId><ArticleId IdType="pubmed">23571640</ArticleId></ArticleIdList></Reference><Reference><Citation>An X, Zhong T, Qi H. Risk factors for postoperative reintubation in patients undergoing general anesthesia. Chin J Anesthesiol. (2013) 1427&#x2013;30.</Citation></Reference><Reference><Citation>Gali B, Whalen F, Schroeder D, Gay P, Plevak D. Identification of patients at risk for postoperative respiratory complications using a preoperative obstructive sleep apnea screening tool and postanesthesia care assessment. Anesthesiology. (2009) 110:869&#x2013;77. 10.1097/ALN.0b013e31819b5d70</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31819b5d70</ArticleId><ArticleId IdType="pubmed">19293694</ArticleId></ArticleIdList></Reference><Reference><Citation>Charters P, Ahmad I, Patel A, Russell S. Anaesthesia for head and neck surgery: United Kingdom national multidisciplinary guidelines. J Laryngol Otol. (2016) 130:S23&#x2013;S7. 10.1017/S0022215116000384</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215116000384</ArticleId><ArticleId IdType="pmc">PMC4873916</ArticleId><ArticleId IdType="pubmed">27841108</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MA, Fulkerson DH. Incidence of venous thromboembolism in hospitalized pediatric neurosurgical patients: a retrospective 25-year institutional experience. Childs Nerv Syst. (2020) 36:987&#x2013;92. 10.1007/s00381-019-04389-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00381-019-04389-5</ArticleId><ArticleId IdType="pubmed">31691011</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer PR, Kumbamu A, Wilson ME, Pannu JK, Egginton JS, Kashyap R, et al. . Timing of intubation in acute respiratory failure associated with sepsis: a mixed methods study. Mayo Clin Proc. (2017) 92:1502&#x2013;10. 10.1016/j.mayocp.2017.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2017.07.001</ArticleId><ArticleId IdType="pubmed">28867256</ArticleId></ArticleIdList></Reference><Reference><Citation>Thille AW, Harrois A, Schortgen F, Brun-Buisson C, Brochard L. Outcomes of extubation failure in medical intensive care unit patients. Crit Care Med. (2011) 39:2612&#x2013;8. 10.1097/CCM.0b013e3182282a5a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3182282a5a</ArticleId><ArticleId IdType="pubmed">21765357</ArticleId></ArticleIdList></Reference><Reference><Citation>Feltracco P, Tonetti T, Barbieri S, Frigo AC, Ori C. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial. J Clin Anesth. (2016) 35:198&#x2013;204. 10.1016/j.jclinane.2016.07.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2016.07.031</ArticleId><ArticleId IdType="pubmed">27871520</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy N, Parra MF, Brown ML, Sleeper LA, Nathan M, Sefton BA, et al. . Initial experience introducing an enhanced recovery program in congenital cardiac surgery. J Thorac Cardiovasc Surg. (2020) 160:1313&#x2013;21.e5. 10.1016/j.jtcvs.2019.10.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.10.049</ArticleId><ArticleId IdType="pubmed">31859070</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono M, Georgiev S, Burri M, Mayr B, Cleuziou J, Strbad M, et al. . Early extubation improves outcome following extracardiac total cavopulmonary connection. Interact Cardiovasc Thorac Surg. (2019) 29:85&#x2013;92. 10.1093/icvts/ivz010</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivz010</ArticleId><ArticleId IdType="pubmed">31220277</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26702201</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0970-9185</ISSN><JournalIssue CitedMedium="Print"><Volume>31</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Season>Oct-Dec</Season></PubDate></JournalIssue><Title>Journal of anaesthesiology, clinical pharmacology</Title><ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Systematic review of use of &#x3b2;-blockers in sepsis.</ArticleTitle><Pagination><StartPage>460</StartPage><EndPage>465</EndPage><MedlinePgn>460-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169063</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">We proposed a review of present literature and systematic analysis of present literature to summarize the evidence on the use of &#x3b2;-blockers on the outcome of a patient with severe sepsis and septic shock.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Medline, EMBASE, Cochrane Library were searched from 1946 to December 2013. The bibliography of all relevant articles was hand searched. Full-text search of the grey literature was done through the medical institution database. The database search identified a total of 1241 possible studies. The citation list was hand searched by both the authors. A total of 9 studies were identified.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most studies found a benefit from &#x3b2;-blocker administration in sepsis. This included improved heart rate (HR) control, decreased mortality and improvement in acid-base parameters. Chronic &#x3b2;-blocker usage in sepsis was also associated with improved mortality. The administration of &#x3b2;-blockers during sepsis was associated with better control of HR. The methodological quality of all the included studies, however, was poor.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There is insufficient evidence to justify the routine use of &#x3b2;-blockers in sepsis. A large adequately powered multi-centered randomized controlled clinical trial is required to address the question on the efficacy of &#x3b2;-blocker usage in sepsis. This trial should also consider a number of important questions including the choice of &#x3b2;-blocker used, optimal dosing, timing of intervention, duration of intervention and discontinuation of the drug. Until such time based on the available evidence, there is no place for the use of &#x3b2;-blockers in sepsis in current clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chacko</LastName><ForeName>Cyril Jacob</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopal</LastName><ForeName>Shameer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA><NlmUniqueID>9516972</NlmUniqueID><ISSNLinking>0970-9185</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac index</Keyword><Keyword MajorTopicYN="N">heart rate control</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">&#x3b2;-blockers</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26702201</ArticleId><ArticleId IdType="pmc">PMC4676233</ArticleId><ArticleId IdType="doi">10.4103/0970-9185.169063</ArticleId><ArticleId IdType="pii">JOACP-31-460</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carlson DL, Willis MS, White DJ, Horton JW, Giroir BP. Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction. Crit Care Med. 2005;33:1021&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15891331</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboab J, Sebille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, et al. Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med. 2011;37:1344&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">21567116</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T, Morisaki H, Serita R, Yamamoto M, Kotake Y, Ishizaka A, et al. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med. 2005;33:2294&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">16215384</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara S, Iwasaka H, Maeda H, Noguchi T. Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock. 2009;31:515&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">18791493</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Green S. Cochrane Hand Book for Systematic Review of Interventions Version 5.1.0. The Cochrane Collaboration. 2011.  [Last accessed on 2014 Feb 24; Last updated on 2011 Mar].  Available from:
http://www.cochrane-handbook.org .</Citation></Reference><Reference><Citation> [Last accessed on 2014 Jan 25].  Available from:
http://www.clinicaltrials.gov .</Citation></Reference><Reference><Citation>Morelli A, Ertmer C, Rehberg S, Orecchioni A, Cecchini V, Di Russo A, et al. Heart rate control with esmolol in septic shock: A randomized controlled trial. Intensive Care Med. 2011;37:0342.</Citation></Reference><Reference><Citation>Balik M, Rulisek J, Leden P, Zakharchenko M, Otahal M, Bartakova H. Is cardioprotective beta blockade feasible in severe sepsis? A pilot study. Intensive Care Med. 2011;37:0342.</Citation></Reference><Reference><Citation>Berk JL, Hagen JF, Dunn JM. The role of beta adrenergic blockade in the treatment of septic shock. Surg Gynecol Obstet. 1970;130:1025&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">4392669</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen S, Johansen MB, T&#xf8;nnesen E, Larsson A, Pedersen L, Lemeshow S, et al. Preadmission beta-blocker use and 30-day mortality among patients in intensive care: A cohort study. Crit Care. 2011;15:R87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219345</ArticleId><ArticleId IdType="pubmed">21385356</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial. JAMA. 2013;310:1683&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Macchia A, Romero M, Comignani PD, Mariani J, D&#x2019;Ettorre A, Prini N, et al. Previous prescription of &#xdf;-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med. 2012;40:2768&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">22824934</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez J, Hossam A, Lazarezcu R, Kay E, Rundek T. Effect of beta blockers on sepsis outcome. Med Sci Monit. 2009;15:CR499&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">19789508</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Donati A, Ertmer C, Rehberg S, Kampmeier T, Orecchioni A, et al. Microvascular effects of heart rate control with esmolol in patients with septic shock: A pilot study. Crit Care Med. 2013;41:2162&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23873274</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittinger CA, D&#xfc;nser MW, Haller M, Ulmer H, Luckner G, Torgersen C, et al. Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care. 2008;12:R99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2575588</ArticleId><ArticleId IdType="pubmed">18680591</ArticleId></ArticleIdList></Reference><Reference><Citation>Balik M, Rulisek J, Leden P, Zakharchenko M, Otahal M, Bartakova H, et al. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Wien Klin Wochenschr. 2012;124:552&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22815003</ArticleId></ArticleIdList></Reference><Reference><Citation>Berk JL, Hagen JF, Maly G, Koo R. The treatment of shock with beta adrenergic blockade. Arch Surg. 1973;104:46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">4399892</ArticleId></ArticleIdList></Reference><Reference><Citation>Misonoo Y, Yajima S, Morisaki H, Suzuki T, Takeda J. Efficacy and safety of beta1 adrenoreceptor blockade by landiolol in sepsis. Crit Care Med. 2009 37/12.</Citation></Reference><Reference><Citation>Gore DC, Wolfe RR. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery. 2006;139:686&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">16701103</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander O, Welters ID, Fo&#xeb;x P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med. 2005;33:81&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15644652</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol. 1986;57:43F&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2871745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuman KJ, McCarthy RJ. Individualizing beta-adrenergic blocker therapy: Patient-specific target-based heart rate control. Anesth Analg. 1999;88:475&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10071989</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;nser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">19703817</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittinger CA, Torgersen C, Luckner G, Schr&#xf6;der DC, Lorenz I, D&#xfc;nser MW. Adverse cardiac events during catecholamine vasopressor therapy: A prospective observational study. Intensive Care Med. 2012;38:950&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22527060</ArticleId></ArticleIdList></Reference><Reference><Citation>Novotny NM, Lahm T, Markel TA, Crisostomo PR, Wang M, Wang Y, et al. beta-Blockers in sepsis: Reexamining the evidence. Shock. 2009;31:113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18636043</ArticleId></ArticleIdList></Reference><Reference><Citation>Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001;345:1223&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11680441</ArticleId></ArticleIdList></Reference><Reference><Citation>de Montmollin E, Aboab J, Mansart A, Annane D. Bench-to-bedside review: Beta-adrenergic modulation in sepsis. Crit Care. 2009;13:230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784350</ArticleId><ArticleId IdType="pubmed">19863760</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthu K, Deng J, Romano F, He LK, Gamelli R, Shankar R, et al. Thermal injury and sepsis modulates beta-adrenergic receptors and cAMP responses in monocyte-committed bone marrow cells. J Neuroimmunol. 2005;165:129&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">15955567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjemdahl P, Larsson PT, Wall&#xe9;n NH. Effects of stress and beta-blockade on platelet function. Circulation. 1991;84(6 Suppl):VI44&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">1683610</ArticleId></ArticleIdList></Reference><Reference><Citation>Markel A, Brook JG, Levy Y, Aviram M, Youdim MB. Increased platelet adhesion and aggregation in hypertensive patients: Effect of atenolol. Br J Clin Pharmacol. 1983;16:663&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1428341</ArticleId><ArticleId IdType="pubmed">6661351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackland GL, Yao ST, Rudiger A, Dyson A, Stidwill R, Poputnikov D, et al. Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med. 2010;38:388&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">19829100</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29105078</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>A systematic review of the incidence of and risk factors for postoperative atrial fibrillation following general surgery.</ArticleTitle><Pagination><StartPage>490</StartPage><EndPage>498</EndPage><MedlinePgn>490-498</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.14118</ELocationID><Abstract><AbstractText>Atrial fibrillation is a common cardiac arrhythmia and can occur de novo following a surgical procedure. It is associated with increased inpatient and long-term mortality. There is limited evidence concerning new-onset atrial fibrillation following abdominal surgery. This study aimed to identify the prevalence of and risk factors for postoperative atrial fibrillation in the general surgical population. A systematic search of the Embase, MEDLINE and Cochrane (CENTRAL) databases was conducted. Studies were included in the review if they reported cases of new-onset atrial fibrillation within 30 days of the index operation. Results were evaluated qualitatively due to substantial clinical heterogeneity. Incidence rates were pooled using a weighted random-effects meta-analysis model. A total of 835 records were initially identified, from which 32 full texts were retrieved. Following review, 13 studies were included that involved 52,959 patients, of whom 10.94% (95%CI 7.22-15.33) developed atrial fibrillation. Five studies of patients undergoing oesophagectomy (n = 376/1923) had a weighted average rate of 17.66% (95%CI 12.16-21.47), compared with 7.63% (95%CI 4.39-11.98) from eight studies of non-oesophageal surgery (n = 2927/51,036). Identified risk factors included: increasing age; history of cardiac disease; postoperative complications, particularly, sepsis, pneumonia and pleural effusions. New-onset postoperative atrial fibrillation is common, and is more frequent after surgery involving the thorax. Future work should focus on stratifying risk to allow targeted prophylaxis of atrial fibrillation and other peri-operative complications.</AbstractText><CopyrightInformation>&#xa9; 2017 The Association of Anaesthetists of Great Britain and Ireland.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chebbout</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Wishaw General Hospital, Wishaw, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heywood</LastName><ForeName>E G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of General Surgery, University of Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drake</LastName><ForeName>T M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Clinical Surgery, University of Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>J R L</ForeName><Initials>JRL</Initials><AffiliationInfo><Affiliation>Leeds Teaching Hospitals NHS FT, FT, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Sheffield Teaching Hospitals NHS FT, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Health and Related Research (ScHARR) University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Sheffield Teaching Hospitals, Sheffield, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anaesthesia. 2018 Jul;73(7):910-911. doi: 10.1111/anae.14337.</RefSource><PMID Version="1">29889990</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arrhythmia</Keyword><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">peri-operative risk</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29105078</ArticleId><ArticleId IdType="doi">10.1111/anae.14118</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31562533</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8726</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>World journal of urology</Title><ISOAbbreviation>World J Urol</ISOAbbreviation></Journal><ArticleTitle>Antibiotic prophylaxis in perioperative period of percutaneous nephrolithotomy: a systematic review and meta-analysis of comparative studies.</ArticleTitle><Pagination><StartPage>1685</StartPage><EndPage>1700</EndPage><MedlinePgn>1685-1700</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00345-019-02967-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore the efficacy of antibiotic prophylaxis in perioperative period of percutaneous nephrolithotomy (PCNL) by conducting a systematic review and meta-analysis.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A systematic literature search using Pubmed, Embase, and the Chinese SinoMed, CNKI, WanFang and VIP databases was performed to find comparative studies on the efficacy of different antibiotic prophylaxis strategies in PCNL for preventing postoperative sepsis. The last search was conducted on 21 April 2019. All selected articles were reviewed independently by two, and in case of discordance, three reviewers. Summarized unadjusted odds ratios (ORs) or risk ratios (RRs) with 95% confidence intervals (CIs) were calculated to assess the efficacy of different antibiotic prophylaxis strategies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen independent studies comprising up to 1549 individuals were included. Compared with single dose before anesthesia, preoperative prophylactic antibiotics significantly reduced postoperative sepsis (OR 0.31, 95% CI 0.20-0.50; P&#x2009;&lt;&#x2009;0.00001) and fever (OR 0.26, 95% CI 0.14-0.48; P&#x2009;&lt;&#x2009;0.0001). But no remarkable difference in sepsis risk between patients with and without postoperative prophylactic antibiotics was detected (RR 1.19, 95% CI 0.72-1.97; P&#x2009;=&#x2009;0.49). And patients receiving postoperative prophylactic antibiotics were at a significantly high risk of fever (OR 1.88, 95% CI 1.01-3.05; P&#x2009;=&#x2009;0.05). Compared with single dose before anesthesia, preoperative prophylactic antibiotics significantly reduced positive pelvic urine (RR 0.22, 95% CI 0.09-0.54; P&#x2009;=&#x2009;0.0009) and stone cultures (RR 0.40, 95% CI 0.25-0.64; P&#x2009;=&#x2009;0.0001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The conclusion is drawn that preoperative prophylactic antibiotics indeed lowered the risk of postoperative sepsis and fever, whereas its postoperative use seems unnecessary. Besides, preoperative prophylactic antibiotics reduced positive pelvic urine and stone cultures significantly, which are a risk factor for sepsis. In our meta-analysis, the efficacy of different types of antibiotics and different courses of preoperative antibiotics could not be assessed. To verify the correctness of these conclusions, randomized controlled trials with a larger sample size and more rigorous study design are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Junjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Baoyu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Dalian Medical University, Dalian, Liaoning, People's Republic of China. 18705990111@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China. 18705990111@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jiangquan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of ICU, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Dalian Medical University, Dalian, Liaoning, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>China Medical University, Shenyang, Liaoning, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Dalian Medical University, Dalian, Liaoning, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shigao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Zhe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Dalian Medical University, Dalian, Liaoning, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Qun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xinxin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dalian Medical University, Dalian, Liaoning, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Zhexun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Dalian Medical University, Dalian, Liaoning, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Penglei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Dalian Medical University, Dalian, Liaoning, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of ICU, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Nantong West Road, Yangzhou, 225001, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>grant no. 81572702</GrantID><Agency>National Natural Science Foundation of China (CN)</Agency><Country/></Grant><Grant><GrantID>grant no. 81402101</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>World J Urol</MedlineTA><NlmUniqueID>8307716</NlmUniqueID><ISSNLinking>0724-4983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>World J Urol. 2020 Oct;38(10):2663. doi: 10.1007/s00345-019-02980-8.</RefSource><PMID Version="1">31659463</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D019072" MajorTopicYN="Y">Antibiotic Prophylaxis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074642" MajorTopicYN="Y">Nephrolithotomy, Percutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotics</Keyword><Keyword MajorTopicYN="N">Percutaneous nephrolithotomy</Keyword><Keyword MajorTopicYN="N">Prophylaxis</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31562533</ArticleId><ArticleId IdType="doi">10.1007/s00345-019-02967-5</ArticleId><ArticleId IdType="pii">10.1007/s00345-019-02967-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38211902</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Long-term survivability of surgical and nonsurgical management of spinal epidural abscess.</ArticleTitle><Pagination><StartPage>748</StartPage><EndPage>758</EndPage><MedlinePgn>748-758</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2023.12.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(24)00002-0</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">Spinal epidural abscess (SEA) is a rare and life-threatening infection within the epidural space with significant functional impairment and morbidity. Active debate remains over whether to operate for SEAs, with limited existing data comparing the long-term survivability after surgical versus nonsurgical management.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study aims to determine the long-term survival of patients who underwent surgical and nonsurgical management for SEA.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="PATIENT SAMPLE" NlmCategory="METHODS">A total of 250 consecutive SEA patients.</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Survival and mortality rates, complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All patients treated at a tertiary medical center for a primary SEA from January 2000 to June 2020 are identified. Data collection is by retrospective chart review. Cox proportional hazards regression models are used for all survival analyses while controlling for potential confounding variables and with multiple testing corrections.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 35 out of 250 patients died with an overall all-cause mortality of 14%. More than half of all deaths occurred within 90 days after treatment. The 90-day, 3-year, and 5-year survival rates are 92.8%, 89.2%, and 86.4%, respectively. Among surgery patients, the all-cause mortality was 13.07%, compared to 16.22% for medically-managed patients. Surgical treatment (decompression, fusion, debridement) significantly reduced the risk of death by 62.4% compared to medical therapy (p=.03), but surgery patients experienced a significantly longer mean length of stay (p=.01). Risk factors of short-term mortality included hypoalbuminemia (&lt;3.5 g/dL), American Society of Anesthesiologists (ASA) 4+, and cardiac arrest. Risk factors of long-term mortality were immunocompromised state, elevated WBC count &gt;12,000, sepsis, septic shock, ASA 4+, and cardiac arrest (p&lt;.05). In terms of complications, surgically-managed patients experienced a higher proportion of deep vein thrombosis (p&lt;.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The overall long-term survivability of SEA treatment is relatively high at (86% at 5-year) in this study. The following SEA mortality risk factors were identified: hypoalbuminemia (short-term), immunocompromised state (long-term), leukocytosis (long-term), sepsis and septic shock (long-term), ASA 4+ and cardiac arrest (overall). For primary SEA patients, surgical management may reduce mortality risk compared to nonsurgical management.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mingda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, 9501 Euclid Ave, Cleveland, OH 44106, USA. Electronic address: Mingda.Chen@case.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumann</LastName><ForeName>Anthony N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Northeast Ohio Medical University, 4209 State Route 44. Rootstown, OH 44272, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraiman</LastName><ForeName>Elad T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, 9501 Euclid Ave, Cleveland, OH 44106, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Christina W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, 9501 Euclid Ave, Cleveland, OH 44106, USA; Department of Orthopaedic Surgery, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH 44106, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furey</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, 9501 Euclid Ave, Cleveland, OH 44106, USA; Department of Orthopaedic Surgery, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH 44106, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020802" MajorTopicYN="Y">Epidural Abscess</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Decompression</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Long-term</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Non-surgical</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Spinal epidural abscess</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>19</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38211902</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2023.12.008</ArticleId><ArticleId IdType="pii">S1529-9430(24)00002-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40540789</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8171</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2025</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>The American journal of emergency medicine</Title><ISOAbbreviation>Am J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Fluid resuscitation management in patients with sepsis and septic shock: a network meta-analysis.</ArticleTitle><Pagination><StartPage>80</StartPage><EndPage>90</EndPage><MedlinePgn>80-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajem.2025.06.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-6757(25)00376-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fluid resuscitation is a cornerstone intervention for patients with sepsis. This network meta-analysis aimed to compare various fluid resuscitation strategies on complications, treatment responses, and outcomes in patients with sepsis or septic shock.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Cochrane Central Register of Controlled Trials, Embase, and Web of Science were comprehensively searched for records available up to September 2024. Studies were screened and data were extracted based on preset inclusion and exclusion criteria. The quality of studies was evaluated via the Risk of Bias 2 tool. Data analyses were done in Stata18 MP and R 4.4.1.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">28 randomized controlled trials were recruited, encompassing 8770 patients. Balanced crystalloids (BC) demonstrated superior efficacy over low molecular weight hydroxyethyl starch (L-HES) (RR -0.84; 95&#xa0;% CrI [0.75, 0.95]) and saline (RR -0.89; 95&#xa0;% CrI [0.81, 0.97]) in reducing 90-day mortality. In terms of complications, BC was linked with a reduced need for renal replacement therapy (RRT) (RR -0.59; 95&#xa0;% CrI [0.3, 0.99]) compared to high molecular weight hydroxyethyl starch (H-HES). BC ranked highest in reducing 28-day mortality (SUCRA&#xa0;=&#xa0;71.4&#xa0;%), demand for RRT (SUCRA&#xa0;=&#xa0;75.5&#xa0;%), blood transfusion (BT) (SUCRA&#xa0;=&#xa0;72.2&#xa0;%), and 90-day mortality (SUCRA&#xa0;=&#xa0;86.3&#xa0;%). Hyperoncotic albumin (Hyper-Alb) was most effective in reducing the incidence of acute kidney injury (AKI) (SUCRA&#xa0;=&#xa0;74.5&#xa0;%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">BC holds significant clinical potential for fluid resuscitation in patients with sepsis and septic shock. It outperforms both L-HES and saline in reducing mortality among these patients, while Hyper-Alb is most effective in mitigating renal injury.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518107, China. Electronic address: longj26@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhumei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518107, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Xiaochan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518107, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhen</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518107, China. Electronic address: zhenlei@sysush.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Xinjin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518107, China. Electronic address: chixinjin@yeah.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Emerg Med</MedlineTA><NlmUniqueID>8309942</NlmUniqueID><ISSNLinking>0735-6757</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Balanced crystalloids</Keyword><Keyword MajorTopicYN="N">Fluid resuscitation</Keyword><Keyword MajorTopicYN="N">Hyperoncotic albumin</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Shock septic</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>21</Day><Hour>0</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>21</Day><Hour>0</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>20</Day><Hour>18</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40540789</ArticleId><ArticleId IdType="doi">10.1016/j.ajem.2025.06.001</ArticleId><ArticleId IdType="pii">S0735-6757(25)00376-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22696379</PMID><DateCompleted><Year>2012</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>6</Issue><PubDate><Year>2012</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Somatostatin analogues for pancreatic surgery.</ArticleTitle><Pagination><StartPage>CD008370</StartPage><MedlinePgn>CD008370</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD008370.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pancreatic resections are associated with high morbidity (30% to 60%) and mortality (5%). Synthetic analogues of somatostatin are advocated by some surgeons to reduce complications following pancreatic surgery, however their use is controversial.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine whether prophylactic somatostatin analogues should be used routinely in pancreatic surgery.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">We searched the Cochrane Upper Gastrointestinal and Pancreatic Diseases Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 12), MEDLINE, EMBASE and Science Citation Index Expanded to December 2011.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">We included randomised controlled trials comparing prophylactic somatostatin or one of its analogues versus no drug or placebo during pancreatic surgery (irrespective of language or publication status).</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Two authors independently assessed trials for inclusion and independently extracted data. We analysed data with both the fixed-effect and random-effects models using Review Manager (RevMan). We calculated the risk ratio (RR), mean difference (MD) or standardised mean difference (SMD) with 95% confidence intervals (CI) based on an intention-to-treat or available case analysis. When it was not possible to perform either of the above, we performed per protocol analysis.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We identified 19 trials (17 trials of high risk of bias) involving 2245 patients. There was no significant difference in the perioperative mortality (RR 0.80; 95% CI 0.56 to 1.16; N = 2210) or the number of patients with drug-related adverse effects between the two groups (RR 2.09; 95% CI 0.83 to 5.24; N = 1199). Quality of life was not reported in any of the trials. The overall number of patients with postoperative complications was significantly lower in the somatostatin analogue group (RR 0.69; 95% CI 0.60 to 0.79; N = 1858) but there was no significant difference in the re-operation rate (RR 1.26; 95% CI 0.58 to 2.70; N = 687) or hospital stay (MD -1.04 days; 95% CI -2.54 to 0.46; N = 1269) between the groups. The incidence of pancreatic fistula was lower in the somatostatin analogue group (RR 0.63; 95% CI 0.52 to 0.77; N = 2161). The proportion of these fistulas that were clinically significant was not mentioned in most trials. On inclusion of trials that clearly distinguished clinically significant fistulas, there was no significant difference between the two groups (RR 0.69; 95% CI 0.34 to 1.41; N = 247).</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Somatostatin analogues may reduce perioperative complications but do not reduce perioperative mortality. Further adequately powered trials with low risk of bias are necessary. Based on the current available evidence, somatostatin and its analogues are recommended for routine use in patients undergoing pancreatic resection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gurusamy</LastName><ForeName>Kurinchi Selvan</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Royal Free Campus, UCL Medical School, London, UK. kurinchi2k@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koti</LastName><ForeName>Rahul</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Fusai</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>Brian R</ForeName><Initials>BR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005765">Gastrointestinal Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>51110-01-1</RegistryNumber><NameOfSubstance UI="D013004">Somatostatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>RWM8CCW8GP</RegistryNumber><NameOfSubstance UI="D015282">Octreotide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2010 Feb 17;(2):CD008370. doi: 10.1002/14651858.CD008370.</RefSource><PMID Version="1">20166101</PMID></CommentsCorrections><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008370. doi: 10.1002/14651858.CD008370.pub3.</RefSource><PMID Version="1">23633353</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005765" MajorTopicYN="N">Gastrointestinal Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015282" MajorTopicYN="N">Octreotide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010180" MajorTopicYN="N">Pancreatectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010182" MajorTopicYN="N">Pancreatic Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010185" MajorTopicYN="N">Pancreatic Fistula</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="N">Pancreaticoduodenectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013004" MajorTopicYN="N">Somatostatin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22696379</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD008370.pub2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34031967</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-2197</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>ANZ journal of surgery</Title><ISOAbbreviation>ANZ J Surg</ISOAbbreviation></Journal><ArticleTitle>Delayed coloanal anastomosis as a stoma-sparing alternative to immediate coloanal anastomosis: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>346</StartPage><EndPage>354</EndPage><MedlinePgn>346-354</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.16964</ELocationID><Abstract><AbstractText Label="BACKGROUND">Recent clinical trials have demonstrated favorable outcomes associated with trans-anal colonic pull-through for rectal resection followed by delayed coloanal anastomoses (DCA), resulting in a resurgence in popularity of the technique. This meta-analysis aims to review existing literature to evaluate the postoperative complications associated with DCA, and to make comparisons with immediate coloanal anastomoses (ICA) after colorectal resection to assess the suitability of DCA as an alternative form of surgical treatment.</AbstractText><AbstractText Label="METHODS">Medline and Embase databases were reviewed from inception until 31 July 2020 in accordance with PRISMA guidelines. Single-arm studies that involved patients undergoing DCA for benign or malignant causes were selected, and meta-analysis of proportions was conducted to determine the prevalence of postoperative complications following DCA. Comparative studies comparing postoperative outcomes between DCA and ICA were also included for comparative meta-analysis.</AbstractText><AbstractText Label="RESULTS">Patients undergoing DCA were significantly less likely to require diverting stoma construction as compared to ICA (odds ratio [OR]&#xa0;=&#xa0;0.04; confidence interval [CI]: 0.02-0.07; P&#x2009;&lt;&#x2009;0.001). Overall postoperative morbidity (OR&#xa0;=&#xa0;0.50; 95% CI: 0.23-1.12; P&#xa0;=&#xa0;0.09) and mortality (OR&#xa0;=&#xa0;0.49, 95% CI: 0.12-1.98; P&#xa0;=&#xa0;0.32) was comparable between DCA and ICA groups. No significant differences in perioperative complications, such as anastomotic leakage (OR&#xa0;=&#xa0;0.42; 95% CI: 0.11-1.64; P&#xa0;=&#xa0;0.21), postoperative ileus, pelvic abscesses, or sepsis, were noted between DCA and ICA.</AbstractText><AbstractText Label="CONCLUSION">Our study shows no differences in complications or functional outcomes between DCA and ICA. Pooled analysis expectedly revealed a lower rate of diverting stoma in patients undergoing DCA. DCA is thus a safe alternative to current surgical practices where avoidance of a stoma is desired.</AbstractText><CopyrightInformation>&#xa9; 2021 Royal Australasian College of Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Snow Y</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ow</LastName><ForeName>Zachariah G W</ForeName><Initials>ZGW</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Darren J H</ForeName><Initials>DJH</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tay</LastName><ForeName>Phoebe W L</ForeName><Initials>PWL</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Sze Y</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jieling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Neng W</ForeName><Initials>NW</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Surgical Cluster, National University Health System, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Kar Y</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Tan Tock Seng Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foo</LastName><ForeName>Fung J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Sengkang General Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Choon S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0003-0669-7307</Identifier><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University Surgical Cluster, National University Health System, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>ANZ J Surg</MedlineTA><NlmUniqueID>101086634</NlmUniqueID><ISSNLinking>1445-1433</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001003" MajorTopicYN="N">Anal Canal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012007" MajorTopicYN="N">Rectum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">colon and rectal surgery speciality</Keyword><Keyword MajorTopicYN="N">colorectal surgery</Keyword><Keyword MajorTopicYN="N">surgical anastomosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34031967</ArticleId><ArticleId IdType="doi">10.1111/ans.16964</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Cutait DE, Figliolini FJ. A new method of colorectal anastomosis in abdominoperineal resection. Dis Colon Rectum. 1961;4:335-42.</Citation></Reference><Reference><Citation>Turnbull RB Jr, Cuthbertson A. Abdominorectal pull-through resection for cancer and for Hirschsprung's disease. Delayed posterior colorectal anastomosis. Cleve Clin Q. 1961;28:109-15.</Citation></Reference><Reference><Citation>Baulieux J, Olagne E, Ducerf C, De La Roche E, Adham M, Berthoux N, et al., [Oncologic and functional results of resections with direct delayed coloanal anastomosis in previously irradiated cancers of the lower rectum]. Chirurgie. 1999;124:240-50.</Citation></Reference><Reference><Citation>Turnbull RB Jr. Pull-through resection of the rectum, with delayed anastomosis, for cancer or Hirschsprung's disease. Surgery. 1966;59:498-502.</Citation></Reference><Reference><Citation>Knight CD, Griffen FD. An improved technique for low anterior resection of the rectum using the EEA stapler. Surgery. 1980;88:710-4.</Citation></Reference><Reference><Citation>Jarry J, Faucheron JL. Laparoscopic rectosigmoid resection with transanal colonic pull-through and delayed coloanal anastomosis: a new approach to adult hirschsprung disease. Dis Colon Rectum. 2011;54:1313-9.</Citation></Reference><Reference><Citation>Hallet J, Bouchard A, Drolet S, et al. Anastomotic salvage after rectal cancer resection using the Turnbull-Cutait delayed anastomosis. Can J Surg. 2014;57:405-11.</Citation></Reference><Reference><Citation>Xynos E, Tekkis P, Gouvas N, et al. Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol. 2016;29:103-26.</Citation></Reference><Reference><Citation>Biondo S, Trenti L, Espin E, et al. Two-stage Turnbull-Cutait pull-through coloanal anastomosis for low rectal cancer: a randomized clinical trial. JAMA Surg. 2020;155:e201625.</Citation></Reference><Reference><Citation>Matthiessen P, Hallb&#xf6;&#xf6;k O, Ruteg&#xe5;rd J, Simert G, Sj&#xf6;dahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007;246:207-14.</Citation></Reference><Reference><Citation>Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010;251:807-18.</Citation></Reference><Reference><Citation>Murken DR, Bleier JIS. Ostomy-related complications. Clin Colon Rectal Surg. 2019;32:176-82.</Citation></Reference><Reference><Citation>Man VC, Choi HK, Law WL, Foo DC. Morbidities after closure of ileostomy: analysis of risk factors. Int J Colorectal Dis. 2016;31:51-7.</Citation></Reference><Reference><Citation>Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD. Quality of life in stoma patients. Dis Colon Rectum. 1999;42:1569-74.</Citation></Reference><Reference><Citation>Ayaz-Alkaya S. Overview of psychosocial problems in individuals with stoma: a review of literature. Int Wound J. 2019;16:243-9.</Citation></Reference><Reference><Citation>Boullenois H, Lefevre JH, Creavin B, et al. What is the functional result of a delayed coloanal anastomosis in redo rectal surgery? ANZ J Surg. 2019;89:E179-83. https://doi.org/10.1111/ans.15144.</Citation></Reference><Reference><Citation>Jarry J, Faucheron JL, Moreno W, Bellera CA, Evrard S. Delayed colo-anal anastomosis is an alternative to prophylactic diverting stoma after total mesorectal excision for middle and low rectal carcinomas. Eur J Surg Oncol. 2011;37:127-33.</Citation></Reference><Reference><Citation>Bianco F, Falato A, Belli A, De Franciscis S, De Leon Valdez JD, Romano GM. Modified pull-through technique with a delayed high coloanal anastomosis: no stoma and scarless surgery for low rectal cancer. Dis Colon Rectum. 2017;60:1113.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.</Citation></Reference><Reference><Citation>Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72:39.</Citation></Reference><Reference><Citation>Harris R, Bradburn M, Deeks J, Harbord R, Altman D, Sterne J. metan: fixed- and random-effects meta-analysis. Stata J. 2008;8:3-28.</Citation></Reference><Reference><Citation>Rousseau MJ, Evans JC. Key statistical assumptions and methods in one-arm meta-analyses with binary endpoints and low event rates, including a real-life example in the area of endoscopic colonic stenting. Cogent Med. 2017;4:1334318.</Citation></Reference><Reference><Citation>Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2.3 million patients with tuberculosis. Lancet Glob Health. 2019;7:e448-60.</Citation></Reference><Reference><Citation>Mogire RM, Mutua A, Kimita W, et al. Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis. Lancet Glob Health. 2020;8:e134-42.</Citation></Reference><Reference><Citation>Wells G, Shea B, O'Connell J. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Vol 7. Ottawa: Ottawa Health Research Institute; 2014.</Citation></Reference><Reference><Citation>Halpern S, Douglas M. Appendix: Jadad scale for reporting randomized controlled trials. Evidence-Based Obstetric Anesthesia. Hoboken, NJ: Blackwell Publishing; 2005. p. 237-8.</Citation></Reference><Reference><Citation>Blanche J, Harnoy Y, Maggiori L, Ferron M, Panis Y. Failed colorectal or coloanal anastomosis with chronic pelvic sepsis or rectovaginal fistula: transanal colonic pullthrough with delayed coloanal anastomosis is associated with a high success rate. Colorectal Dis. 2013;15:25.</Citation></Reference><Reference><Citation>Boullenois H, Lefevre JH, Creavin B, et al. Long-term functional results and quality of life after redo rectal surgery: delayed versus immediate colo-anal anastomosis. Colorectal Dis. 2020;22:885-93.</Citation></Reference><Reference><Citation>Bozio G, Mabrut JY, Mezoughi S, Ducerf C, Baulieux J. Delayed colo-anal anastomosis for lower third cancer. Ann Oncol. 2010;21:i42.</Citation></Reference><Reference><Citation>Faucheron JL, Sage PY, Trilling B, Barbois S, Waroquet PA. Laparoscopic total mesorectal excision and delayed coloanal anastomosis without stoma for low rectal cancer. Experience learnt from 100 consecutive patients. Colorectal Dis. 2015;17:18.</Citation></Reference><Reference><Citation>Hamel S, Frontali A, Bridoux V, Maggiori L, Panis Y, Tuech JJ. Functional results of delayed coloanal anastomosis in complex pelvic situations. Colorectal Dis. 2019;21:113.</Citation></Reference><Reference><Citation>Olagne E, Baulieux J, De la Roche E, et al. Functional results of delayed coloanal anastomosis after preoperative radiotherapy for lower third rectal cancer. J Am Coll Surg. 2000;191:643-9.</Citation></Reference><Reference><Citation>Popescu GO, Portale G, Assenat V, Francois MO, Denost Q, Rullier E. Outcome of delayed coloanal anastomosis in difficult low rectal cancer. Colorectal Dis. 2018;20:82.</Citation></Reference><Reference><Citation>Sage PY, Trilling B, Waroquet PA, Voirin D, Girard E, Faucheron JL. Laparoscopic delayed coloanal anastomosis without diverting ileostomy for low rectal cancer surgery: 85 consecutive patients from a single institution. Tech Coloproctol. 2018;22:511-8.</Citation></Reference><Reference><Citation>Fran&#xe7;ois MO, Buscail E, Vendrely V, et al. Delayed coloanal anastomosis: an alternative option for restorative rectal cancer surgery after high-dose pelvic radiotherapy for prostate cancer. Colorectal Dis. 2018;22:1545-52.</Citation></Reference><Reference><Citation>Milot H, Hallet J, Lebrun A, Drolet S, Bouchard A, Gr&#xe9;goire R. Turnbull-cutait delayed coloanal anastomosis for the treatment of complex anorectal conditions. Dis Colon Rectum. 2012;55:e146.</Citation></Reference><Reference><Citation>Maggiori L, Blanche J, Harnoy Y, Ferron M, Panis Y. Redo-surgery by transanal colonic pull-through for failed anastomosis associated with chronic pelvic sepsis or rectovaginal fistula. Int J Colorectal Dis. 2015;30:543-8.</Citation></Reference><Reference><Citation>Bandi B, Jarrar A, Stocchi L, Steele SR, Church J, Hull T. Turnbull cutait is a safe option prior to considering a permanent stoma. Dis Colon Rectum. 2019;62:e123.</Citation></Reference><Reference><Citation>Marcoux C, Courval V, Gr&#xe9;goire R, Bouchard A, Drolet S. Delayed coloanal anastomosis of turnbull-cutait does not reduce anastomotic leakage after low anterior resection for rectal cancer but may reduce its clinical impact. Dis Colon Rectum. 2019;62:e307.</Citation></Reference><Reference><Citation>Memon S, Gorgun E, Aydinli HH, et al. Restorative proctectomy for Crohn's proctitis: resurrecting the turnbull-Cutait coloanal anastomosis. Gastroenterology. 2016;150:S1222.</Citation></Reference><Reference><Citation>Remzi FH, El Gazzaz G, Kiran RP, Kirat HT, Fazio VW. Outcomes following Turnbull-Cutait abdominoperineal pull-through compared with coloanal anastomosis. Br J Surg. 2009;96:424-9.</Citation></Reference><Reference><Citation>Barugola G, Bertocchi E, Gentile I, Cracco N, Sartori CA, Ruffo G. Hostile pelvis: how to avoid permanent stoma. Updates Surg. 2018;70:459-65.</Citation></Reference><Reference><Citation>Bianco F, Belli A, De Franciscis S, Falato A, Romano GM. &#x201c;Scarless&#x201d; and no-stoma surgery for low rectal cancer: the laparoscopic pull-through delayed &#x201c;high&#x201d; colo-anal anastomosis. Updates Surg. 2016;68:99-104.</Citation></Reference><Reference><Citation>Bianco F, De Franciscis S, Belli A, Ragone V, Romano G. The pull-through procedure as first choice treatment in high-risk patients with low rectal cancer. Dis Colon Rectum. 2015;58:e373.</Citation></Reference><Reference><Citation>Scala D, Delrio P, Ruffolo F, et al. &#x201c;Pull-through&#x201d; technique with delayed colo-anal anastomoses in rectal cancer surgery: a single institution experience. Colorectal Dis. 2012;14:58.</Citation></Reference><Reference><Citation>Flores GF, Balaguer PF, Jordan Chaves CA, et al. Turnbull- Cutait technique, a way to avoid Hartman's procedure in upper and middle rectal anastomosis leakage. Eur J Surg Oncol. 2020;46:e79.</Citation></Reference><Reference><Citation>Cutait DE, Cutait R, Ioshimoto M. Abdominoperineal endoanal pull-through resection. A comparative study between immediate and delayed colorectal anastomosis. Dis Colon Rectum. 1985;28:294-9.</Citation></Reference><Reference><Citation>Gallardo C, Barrera A, Bannura G, Illanes F, Melo C. Short-term outcomes following turnbull-cutait procedure without prophylactic, covering stoma for the treatment of inferior rectal cancer compared to inmediate coloanal anastomosis: a case-matched study. Dis Colon Rectum. 2015;58:e358.</Citation></Reference><Reference><Citation>Xiong Y, Huang P, Ren QG. Transanal pull-through procedure with delayed versus immediate coloanal anastomosis for anus-preserving curative resection of lower rectal cancer: a case-control study. Am Surg. 2016;82:533-9.</Citation></Reference><Reference><Citation>Pujahari AK, Anand S. Trans-anal exteriorisation of colon and delayed colo-anal anastomosis for sphincter preservation in low carcinoma rectum. Int J Colorectal Dis. 2014;30:853-5.</Citation></Reference><Reference><Citation>Zanguie M, Abdollahi A, Salek R, et al. Three anastomotic techniques following laparoscopic rectal cancer resection: our experience in 155 patients. Surg Innov. 2018;25:57-61.</Citation></Reference><Reference><Citation>Tanaka K, Yamamoto M, Masubuchi S, et al. Laparoscopic intersphincteric resection combination with pull-through delayed coloanal anastomosis enables no-stoma surgery for ultralow rectal cancer. Surg Endosc. 2019;33:S671.</Citation></Reference><Reference><Citation>Bozbiyik O, Caliskan C, Kose OC, et al. Outcomes of intersphincteric resection for rectal cancer: comparison of two-stage (Turnbull-Cutait) anastomosis and coloanal anastomosis. Colorectal Dis. 2019;21:50.</Citation></Reference><Reference><Citation>Miron A, Calu V, Giulea C. Delayed coloanal anastomosis for lower third rectal cancer. Surg Endosc Other Interv Tech. 2015;29:S175.</Citation></Reference><Reference><Citation>Tan WS, Tang CL, Shi L, Eu KW. Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer. Br J Surg. 2009;96:462-72.</Citation></Reference><Reference><Citation>H&#xfc;ser N, Michalski CW, Erkan M, et al. Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg. 2008;248:52-60.</Citation></Reference><Reference><Citation>Belli A, Incollingo P, Falato A, De Franciscis S, Bianco F. Reappraisal of pull-through delayed colo-anal anastomosis for surgical treatment of low rectal cancer: do we have to look back to go forward? Ann Laparosc Endosc Surg. 2018;3:97-7.</Citation></Reference><Reference><Citation>Portale G, Popesc GO, Parotto M, Cavallin F. Delayed colo-anal anastomosis for rectal cancer: pelvic morbidity, functional results and oncological outcomes: a systematic review. World J Surg. 2019;43:1360-9.</Citation></Reference><Reference><Citation>Trenti L, Galvez A, Biondo S, et al. Quality of life and anterior resection syndrome after surgery for mid to low rectal cancer: a cross-sectional study. Eur J Surg Oncol. 2018;44:1031-9.</Citation></Reference><Reference><Citation>Cipe G, Erkek B, Kuzu A, Gecim E. Morbidity and mortality after the closure of a protective loop ileostomy: analysis of possible predictors. Hepatogastroenterology. 2012;59:2168-72.</Citation></Reference><Reference><Citation>Park J, Angenete E, Bock D, et al. Cost analysis in a randomized trial of early closure of a temporary ileostomy after rectal resection for cancer (EASY trial). Surg Endosc. 2020;34:69-76.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37369141</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2325-6621</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of the American Thoracic Society</Title><ISOAbbreviation>Ann Am Thorac Soc</ISOAbbreviation></Journal><ArticleTitle>Impact of Vasodilator Administration on Survival in Patients with Sepsis: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1345</StartPage><EndPage>1352</EndPage><MedlinePgn>1345-1352</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1513/AnnalsATS.202303-205OC</ELocationID><Abstract><AbstractText><b>Rationale:</b> Sepsis and septic shock are associated with microcirculatory dysfunction, which is believed to contribute to sepsis-induced organ failure. Vasodilators have been proposed to improve tissue perfusion in sepsis, but the overall survival impact of this strategy is unclear. <b>Objectives:</b> To evaluate the impact of systemic vasodilator administration in patients with sepsis and septic shock on mortality. <b>Methods:</b> We conducted a meta-analysis using a random effects model. Published and unpublished randomized trials in adult patients with sepsis and septic shock were included when comparing the use of systemic vasodilators against no vasodilators. The primary outcome was 28-30-day mortality, and secondary outcomes were organ function and resource use measures. <b>Results:</b> We included eight randomized trials (1,076 patients). In patients randomized to vasodilator arms compared with those randomized to treatment without vasodilators, the 28-30-day mortality risk ratio was 0.74 (95% confidence interval, 0.54-1.01). In a chronological cumulative meta-analysis, the association between vasodilators and survival improved over time. In a prespecified subgroup analysis in 104 patients in two randomized trials, prostacyclin analogues were associated with a decreased rate of 28-30-day mortality among patients with sepsis and septic shock (risk ratio, 0.46; 95% confidence interval, 0.25-0.85). <b>Conclusions:</b> In patients with sepsis and septic shock, administration of vasodilators is not associated with decreased 28-30-day mortality, but the confidence interval suggests potential benefit, and the meta-analysis might lack power. Prostacyclin appears the most promising. The results of this meta-analysis should encourage randomized trials evaluating the impact of vasodilators on mortality in sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mavrothalassitis</LastName><ForeName>Orestes Y</ForeName><Initials>OY</Initials><Identifier Source="ORCID">0000-0002-2301-9682</Identifier><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Anesthesia and Perioperative Care.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Isabel E</ForeName><Initials>IE</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzareschi</LastName><ForeName>Daniel V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Anesthesia and Perioperative Care.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahir</LastName><ForeName>Peggy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UCSF Library, University of California, San Francisco, San Francisco, California; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9788-5316</Identifier><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Anesthesia and Perioperative Care.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT) Network, Nancy, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Am Thorac Soc</MedlineTA><NlmUniqueID>101600811</NlmUniqueID><ISSNLinking>2325-6621</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dobutamine</Keyword><Keyword MajorTopicYN="N">microcirculation</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prostacyclin</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>17</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37369141</ArticleId><ArticleId IdType="doi">10.1513/AnnalsATS.202303-205OC</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36058820</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3562</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver</Title><ISOAbbreviation>Dig Liver Dis</ISOAbbreviation></Journal><ArticleTitle>Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis.</ArticleTitle><Pagination><StartPage>580</StartPage><EndPage>586</EndPage><MedlinePgn>580-586</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dld.2022.08.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1590-8658(22)00645-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Diabetes Mellitus (DM) may occur in IBD and influence the disease progression.</AbstractText><AbstractText Label="AIM">To compare disease course and treatment outcomes in IBD patients with and without DM.</AbstractText><AbstractText Label="METHODS">This is a systematic review with meta-analysis comparing patients with IBD plus DM with patients with IBD only.</AbstractText><AbstractText Label="PRIMARY ENDPOINTS">need for surgery, IBD-related complications, hospitalizations, sepsis, mortality. Quality of life and costs were assessed.</AbstractText><AbstractText Label="RESULTS">Five studies with 71,216 patients (49.1% with DM) were included. Risk for IBD-related complications (OR=1.12, I<sup>2</sup> 98% p&#xa0;=&#xa0;0.77), mortality (OR=1.52, I<sup>2</sup> 98% p&#xa0;=&#xa0;0.37) and IBD-related surgery (OR=1.20, I<sup>2</sup> 81% p&#xa0;=&#xa0;0.26) did not differ. Risk of IBD-related hospitalizations (OR=2.52, I<sup>2</sup> 0% p&#xa0;&lt;&#xa0;0.00001) and sepsis (OR=1.56, I<sup>2</sup> 88% p&#xa0;=&#xa0;0.0003) was higher in the IBD+DM group. Risk of pneumonia and urinary tract infections was higher in the IBD+DM group (OR=1.72 and OR=1.93), while risk of C. Difficile infection did not differ (OR=1.22 I<sup>2</sup> 88% p&#xa0;=&#xa0;0.37). Mean Short Inflammatory Bowel Disease Questionnaire score was lower in the IBD+DM group (38.9&#xa0;vs. 47, p&#xa0;=&#xa0;0.03). Mean health care costs per year were $10,598.2 vs $3747.3 (p&#xa0;&lt;&#xa0;0.001).</AbstractText><AbstractText Label="CONCLUSION">DM might negatively affect the course of IBD by increasing the risk of hospitalization and infections, but not IBD-related complications and mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fuschillo</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Celentano</LastName><ForeName>Valerio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom; Department of Surgery and Cancer. Imperial College, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rottoli</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero Universitaria di Bologna, Italy; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sciaudone</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gravina</LastName><ForeName>Antonietta Gerarda</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Precision Medicine, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrino</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Precision Medicine, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marfella</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Precision Medicine, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvaggi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellino</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", Naples, Italy; Colorectal Surgery, Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: gianluca.pellino@unicampania.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Dig Liver Dis</MedlineTA><NlmUniqueID>100958385</NlmUniqueID><ISSNLinking>1590-8658</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="Y">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003424" MajorTopicYN="Y">Crohn Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016360" MajorTopicYN="Y">Clostridioides difficile</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Crohn's disease</Keyword><Keyword MajorTopicYN="N">Diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Inflammatory bowel disease</Keyword><Keyword MajorTopicYN="N">Ulcerative colitis</Keyword></KeywordList><CoiStatement>Conflicts of interest and source of funding None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>4</Day><Hour>22</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36058820</ArticleId><ArticleId IdType="doi">10.1016/j.dld.2022.08.017</ArticleId><ArticleId IdType="pii">S1590-8658(22)00645-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37739691</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-4577</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical nutrition ESPEN</Title><ISOAbbreviation>Clin Nutr ESPEN</ISOAbbreviation></Journal><ArticleTitle>Association of preoperative hypoprotein malnutrition with spinal postoperative complications and other conditions: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>448</StartPage><EndPage>458</EndPage><MedlinePgn>448-458</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clnesp.2023.07.083</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-4577(23)01187-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Postoperative complications of spinal surgery are a common clinical problem, which impose significant economic and clinical burdens on patients and medical staff. Previous studies have suggested a close relationship between low-protein malnutrition and postoperative complications of surgery. However, the relationship between preoperative malnutrition and various orthopedic postoperative complications remains unclear.</AbstractText><AbstractText Label="PURPOSE">To investigate the association between protein malnutrition and postoperative complications and outcomes.</AbstractText><AbstractText Label="METHODS">We conducted a systematic search of the PubMed, Embase, Cochrane Library, and Web of Science databases for published research articles between the database inception and February 28th, 2023, that evaluated the association between malnutrition and the risk of postoperative complications and death in spinal surgery patients. Malnutrition was defined as low pre-albumin and albumin levels before surgery. Two evaluators independently extracted study data and assessed the risk of bias in each study. Fixed- or random-effect models were used to calculate the pooled effect estimates. Funnel plots and Egger's tests were used to detect publication bias, and the Trim-and -Fill method was conducted to evaluate the impact of publication bias on the results.</AbstractText><AbstractText Label="RESULTS">A total of 26 studies were included in this meta-analysis, comprising 17 retrospective cohort studies and 9 case-control studies. The study included more than 86,000 participants. Analysis of postoperative complications revealed that the overall incidence of malnutrition-related complications after surgery was 3.17 times higher (OR&#xa0;=&#xa0;3.17, 95% CI 2.69-3.75, z&#xa0;=&#xa0;13.57, P&#xa0;&lt;&#xa0;0.05). The incidence of surgical site infections was 2.08 times higher (OR&#xa0;=&#xa0;2.08, 95% CI 1.66-2.62, z&#xa0;=&#xa0;6.307, P&#xa0;&lt;&#xa0;0.05), and the incidence of postoperative urinary tract infections was 2.55 times higher (OR&#xa0;=&#xa0;2.55, 95% CI 1.80-3.60, z&#xa0;=&#xa0;5.30, P&#xa0;&lt;&#xa0;0.05). The incidence of postoperative sepsis was 3.31 times higher (OR&#xa0;=&#xa0;3.31, 95% CI 2.31-4.75, z&#xa0;=&#xa0;6.51, P&#xa0;&lt;&#xa0;0.05), and the incidence of postoperative pneumonia was 3.02 times higher (OR&#xa0;=&#xa0;3.02, 95% CI 1.331-6.857, z&#xa0;=&#xa0;2.64, P&#xa0;=&#xa0;0.008&#xa0;&lt;&#xa0;0.05). The incidence of postoperative cardiac complications was 4.24 times higher (OR&#xa0;=&#xa0;4.24, 95% CI 2.45-7.35, z&#xa0;=&#xa0;5.15, P&#xa0;&lt;&#xa0;0.05), and the incidence of postoperative renal complications was 4.04 times higher (OR&#xa0;=&#xa0;4.04, 95% CI 2.06-7.93, z&#xa0;=&#xa0;4.05, P&#xa0;&lt;&#xa0;0.05). The incidence of postoperative pulmonary complications was 2.38 times higher (OR&#xa0;=&#xa0;2.38, 95% CI 1.46-3.87, z&#xa0;=&#xa0;6.98, P&#xa0;&lt;&#xa0;0.05), while the incidence of postoperative thrombotic complications was 2.76 times higher (OR&#xa0;=&#xa0;2.76, 95% CI 1.756-4.345, z&#xa0;=&#xa0;4.40, P&#xa0;&lt;&#xa0;0.05). Furthermore, the incidence of transfusion during and after surgery was 1.33 times higher (OR&#xa0;=&#xa0;1.33, 95% CI 1.13-1.56, z&#xa0;=&#xa0;3.40, P&#xa0;=&#xa0;0.001&#xa0;&lt;&#xa0;0.05), the incidence of postoperative readmission was 1.67 times higher (OR&#xa0;=&#xa0;1.67, 95% CI 1.24-2.27, z&#xa0;=&#xa0;3.33, P&#xa0;=&#xa0;0.001&#xa0;&lt;&#xa0;0.05), and the risk of postoperative death was 6.01 times higher (OR&#xa0;=&#xa0;6.01, 95% CI 4.51-8.01, z&#xa0;=&#xa0;12.27, P&#xa0;&lt;&#xa0;0.05). After conducting a publication bias test and Trim-and -Fill method analysis, we found no evidence of publication bias, and the results remained stable.</AbstractText><AbstractText Label="CONCLUSION">Preoperative low protein malnutrition is closely related to the incidence of postoperative complications and postoperative status. More prospective multicenter studies should be conducted to validate this conclusion. Furthermore, more effective assessment and intervention of preoperative nutritional status should be carried out to prevent the occurrence of postoperative complications and mortality risk.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yongrong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Liping</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kunhai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610000, China. Electronic address: 50828536@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hongsheng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610000, China. Electronic address: hongsheng228@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Nutr ESPEN</MedlineTA><NlmUniqueID>101654592</NlmUniqueID><ISSNLinking>2405-4577</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000418">Albumins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044342" MajorTopicYN="Y">Malnutrition</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000418" MajorTopicYN="N">Albumins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis malnutrition spinal surgery complications</Keyword></KeywordList><CoiStatement>Declaration of competing interest No potential conflict of interest was reported by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>23</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37739691</ArticleId><ArticleId IdType="doi">10.1016/j.clnesp.2023.07.083</ArticleId><ArticleId IdType="pii">S2405-4577(23)01187-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27554107</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>8</Issue><PubDate><Year>2016</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Maternal morbidity and mortality from severe sepsis: a national cohort study.</ArticleTitle><Pagination><StartPage>e012323</StartPage><MedlinePgn>e012323</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e012323</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2016-012323</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To describe the incidence, characteristics and risk factors for critical care admission with severe maternal sepsis in the UK.</AbstractText><AbstractText Label="DESIGN">National cohort study.</AbstractText><AbstractText Label="SETTING">198 critical care units in the UK.</AbstractText><AbstractText Label="PARTICIPANTS">646 pregnant and recently pregnant women who had severe sepsis within the first 24&#x2005;hours of admission in 2008-2010.</AbstractText><AbstractText Label="PRIMARY AND SECONDARY OUTCOME MEASURES">Septic shock, mortality.</AbstractText><AbstractText Label="RESULTS">Of all maternal critical care admissions, 14.4% (n=646) had severe sepsis; 10.6% (n=474) had septic shock. The absolute risk of maternal critical care admission with severe sepsis was 4.1/10&#x2005;000 maternities. Pneumonia/respiratory infection (irrespective of the H1N1 pandemic influenza strain) and genital tract infection were the most common sources of sepsis (40% and 24%, respectively). We identified a significant gradient in the risk of severe maternal sepsis associated with increasing deprivation (RR=6.5; 95% CI 4.9 to 8.5 most deprived compared with most affluent women). The absolute risk of mortality was 1.8/100&#x2005;000 maternities. The most common source of infection among women who died was pneumonia/respiratory infection (41%). Known risk factors for morbidity supported by this study were: younger age, multiple gestation birth and caesarean section. Significant risk factors for mortality in unadjusted analysis were: age &#x2265;35&#x2005;years (unadjusted OR (uOR)=3.5; 95% CI 1.1 to 10.6), &#x2265;3 organ system dysfunctions (uOR=12.7; 95% CI 2.9 to 55.1), respiratory dysfunction (uOR=6.5; 95% CI1.9 to 21.6), renal dysfunction (uOR=5.6; 95% CI 2.3 to 13.4) and haematological dysfunction (uOR=6.5; 95% CI 2.9 to 14.6).</AbstractText><AbstractText Label="CONCLUSIONS">This study suggests a need to improve timely recognition of severe respiratory tract and genital tract infection in the obstetric population. The social gradient associated with the risk of severe sepsis morbidity and mortality raises important questions regarding maternal health service provision and usage.</AbstractText><CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Acosta</LastName><ForeName>Colleen D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>National Perinatal Epidemiology Unit (NPEU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Intensive Care National Audit &amp; Research Centre (ICNARC), London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowan</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Intensive Care National Audit &amp; Research Centre (ICNARC), London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>D Nuala</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Northwick Park Hospital, Harrow, Middlesex, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurinczuk</LastName><ForeName>Jennifer J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>National Perinatal Epidemiology Unit (NPEU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Perinatal Epidemiology Unit (NPEU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RP-PG-0608-10038</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008428" MajorTopicYN="N">Maternal Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010298" MajorTopicYN="N">Parity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011181" MajorTopicYN="N">Postnatal Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27554107</ArticleId><ArticleId IdType="pmc">PMC5013336</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2016-012323</ArticleId><ArticleId IdType="pii">bmjopen-2016-012323</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Senior K. In the dark about sepsis. Lancet Infect Dis 2012;12:751&#x2013;2. 10.1016/S1473-3099(12)70233-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(12)70233-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther 2012;10:701&#x2013;6. 10.1586/eri.12.50</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.12.50</ArticleId><ArticleId IdType="pmc">PMC3488423</ArticleId><ArticleId IdType="pubmed">22734959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantwell R, Clutton-Brock T, Cooper G et al. . Saving Mothers&#x2019; Lives: reviewing maternal deaths to make motherhood safer: 2006&#x2013;2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(Suppl 1):1&#x2013;203. 10.1111/j.1471-0528.2010.02847.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2010.02847.x</ArticleId><ArticleId IdType="pubmed">21356004</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight M, Kenyon S, Brocklehurst P et al. . eds Saving Lives, Improving Mothers&#x2019; Care&#x2014;Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009&#x2013;12. Oxford: National Perinatal Epidemiology Unit (NPEU), University of Oxford, 2014.</Citation></Reference><Reference><Citation>Sullivan EA, Hall B, King JF. 
Maternal deaths in Australia 2003&#x2013;2005. AIHW National Perinatal Statistics Unit: 1&#x2013;51
2008. 
http://www.preru.unsw.edu.au/PRERUWeb.nsf/resources/MD3/$file/md3a.pdf (accessed 16 Aug 2015).</Citation></Reference><Reference><Citation>Kramer HMC, Schutte JM, Zwart JJ et al. . Maternal mortality and severe morbidity from sepsis in the Netherlands. Acta Obstet Gynecol Scand 2009;88:647&#x2013;53. 10.1080/00016340902926734</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016340902926734</ArticleId><ArticleId IdType="pubmed">19412806</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucedo M, Deneux-Tharaux C. &#xc9;pid&#xe9;miologie des morts maternelles en France, 2001&#x2013;2006. Bull Epid&#xe9;miol Hebd 2010;no. 2&#x2013;3:10&#x2013;14.</Citation></Reference><Reference><Citation>Bauer ME, Bateman BT, Bauer ST et al. . Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg 2013;117:944&#x2013;50. 10.1213/ANE.0b013e3182a009c3</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182a009c3</ArticleId><ArticleId IdType="pubmed">24023020</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta CD, Kurinczuk JJ, Lucas DN et al. . Severe maternal sepsis in the UK, 2011&#x2013;2012: a national case-control study. PLoS Med 2014;11:e1001672 10.1371/journal.pmed.1001672</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001672</ArticleId><ArticleId IdType="pmc">PMC4086731</ArticleId><ArticleId IdType="pubmed">25003759</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison DA, Brady AR, Rowan K. Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit &amp; Research Centre Case Mix Programme Database. Crit Care 2004;8:R99&#x2013;111. 10.1186/cc2834</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2834</ArticleId><ArticleId IdType="pmc">PMC420043</ArticleId><ArticleId IdType="pubmed">15025784</ArticleId></ArticleIdList></Reference><Reference><Citation>ICNARC. Quarterly Quality Reports, 2015. 
https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports/Quarterly-Quality-Report (accessed 16 Aug 2015).</Citation></Reference><Reference><Citation>Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care 2006;10:R42 10.1186/cc4854</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc4854</ArticleId><ArticleId IdType="pmc">PMC1550902</ArticleId><ArticleId IdType="pubmed">16542492</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Maternities. Office for National Statistics, 2012. 
http://www.ons.gov.uk/ons/taxonomy/index.html?nscl=Maternities (accessed 1 Feb 2015).</Citation></Reference><Reference><Citation>Northern Ireland Statistics and Research Agency, editor. Births
2012. 
http://www.nisra.gov.uk/demography/default.asp8.htm (accessed 16 Aug 2015).</Citation></Reference><Reference><Citation>Northern Ireland Statistics and Research Agency. Census 2001 results. NISRA, 2012. 
http://www.nisra.gov.uk/Census/agreement.html (accessed 16 Aug 2015).</Citation></Reference><Reference><Citation>Hospital Episode Statistics. Hospital episode statistics: maternity data. HES, 2012. 
http://www.hesonline.nhs.uk/ (accessed 16 Aug 2015).</Citation></Reference><Reference><Citation>StatsWales. Method of delivery. StatsWales, 2012. 
http://www.statswales.wales.gov.uk/TableViewer/tableView.aspx?ReportId=2021 (accessed 22 Jul 2015).</Citation></Reference><Reference><Citation>Black LA.
Incidence of caesarean sections. Northern Ireland Assembly, 2011. 
http://www.niassembly.gov.uk/Documents/RaISe/Publications/2011/Health/14711.pdf (accessed 16 Aug 2015).</Citation></Reference><Reference><Citation>Scotland N.
Scottish Confidential Audit of Severe Maternal Morbidity. 6th Annual Report
Edinburgh: NHS QIS; 
2010. 
http://www.healthcareimprovementscotland.org/programmes/reproductive,_maternal__child/programme_resources/scasmm.aspx (accessed 16 Aug 2015).</Citation></Reference><Reference><Citation>Information Services Division. Maternity and births. ISD Scotland, 2012. 
http://www.isdscotland.org/Health-Topics/Maternity-and-Births/Publications/data-tables.asp (accessed Aug 2015).</Citation></Reference><Reference><Citation>Padkin A, Goldfrad C, Brady AR et al. . Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003;31:2332&#x2013;8. 10.1097/01.CCM.0000085141.75513.2B</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000085141.75513.2B</ArticleId><ArticleId IdType="pubmed">14501964</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MM, Shelhamer JH, Bacharach SL et al. . Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984;100:483&#x2013;90. 10.7326/0003-4819-100-4-483</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-100-4-483</ArticleId><ArticleId IdType="pubmed">6703540</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001;322:1089&#x2013;93. 10.1136/bmj.322.7294.1089</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.322.7294.1089</ArticleId><ArticleId IdType="pmc">PMC31259</ArticleId><ArticleId IdType="pubmed">11337436</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008;198:962&#x2013;70. 10.1086/591708</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591708</ArticleId><ArticleId IdType="pmc">PMC2599911</ArticleId><ArticleId IdType="pubmed">18710327</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulakou G, P&#xe9;rez M, Rello J. Severe acute respiratory infections in the postpandemic era of H1N1. Curr Opin Crit Care 2012;18:441&#x2013;50. 10.1097/MCC.0b013e32835605f2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0b013e32835605f2</ArticleId><ArticleId IdType="pubmed">22820154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakikhany K, Degail MA, Lamagni T et al. . Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011. Euro Surveill 2011;16:pii:19785.</Citation><ArticleIdList><ArticleId IdType="pubmed">21315057</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves B, Sheikh A. Investigating the relationship between affluence and elective caesarean sections. BJOG 2005;112:994&#x2013;6. 10.1111/j.1471-0528.2005.00657.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2005.00657.x</ArticleId><ArticleId IdType="pubmed">15958007</ArticleId></ArticleIdList></Reference><Reference><Citation>Marmot M, Bell R. Fair society, healthy lives. Public Health 2012;126(Suppl 1):S4&#x2013;10. 10.1016/j.puhe.2012.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2012.05.014</ArticleId><ArticleId IdType="pubmed">22784581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemingway H, Saunders D, Parsons L. Social class, spoken language and pattern of care as determinants of continuity of carer in maternity services in east London. J Public Health Med 1997;19:156&#x2013;61. 10.1093/oxfordjournals.pubmed.a024603</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.pubmed.a024603</ArticleId><ArticleId IdType="pubmed">9243430</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta CD, Bhattacharya S, Tuffnell D et al. . Maternal sepsis: a Scottish population-based case-control study. BJOG 2012;119:474&#x2013;83. 10.1111/j.1471-0528.2011.03239.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2011.03239.x</ArticleId><ArticleId IdType="pmc">PMC3328752</ArticleId><ArticleId IdType="pubmed">22251396</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller SE, Rosenberg D, Cox SM et al. . The continuum of maternal morbidity and mortality: factors associated with severity. Am J Obstet Gynecol 2004;191:939&#x2013;44. 10.1016/j.ajog.2004.05.099</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2004.05.099</ArticleId><ArticleId IdType="pubmed">15467568</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36515617</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1677-6119</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>International braz j urol : official journal of the Brazilian Society of Urology</Title><ISOAbbreviation>Int Braz J Urol</ISOAbbreviation></Journal><ArticleTitle>One week pre-operative oral antibiotics for percutaneous nephrolithotomy reduce risk of infection: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>184</StartPage><EndPage>193</EndPage><MedlinePgn>184-193</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/S1677-5538.IBJU.2022.0544</ELocationID><Abstract><AbstractText Label="PURPOSE">The aim of this meta-analysis is to assess the efficacy of extended dose of preoperative antibiotics to reduce infectious risk in patients undergoing percutaneous nephrolithotomy (PCNL).</AbstractText><AbstractText Label="MATERIALS AND METHODS">A literature search for prospective case-control studies or randomized controlled trials was done. PICO framework was used.</AbstractText><AbstractText Label="POPULATION">adult patients that underwent to PCNL; Intervention: extended dose preoperative antibiotic prophylaxis before PCNL; Control: short dose preoperative antibiotic prophylaxis before PCNL; and Outcome: systemic inflammatory response syndrome (SIRS) or sepsis, fever after PCNL and positive intraoperative urine and stone culture. This meta-analysis was registered in PROSPERO database under the number: CRD42022359589.</AbstractText><AbstractText Label="RESULTS">Three RCT and two prospective studies (475 patients) were included. SIRS/sepsis outcome was retrieved from all studies included. Seven days preoperative oral antibiotics for PCNL was a protective factor for developing SIRS/sepsis (OR 0.366, 95% CI 0.234 - 0.527, p &lt; 0.001). There was no statistical association between seven-day use of antibiotics and fever (OR 0.592, 95% CI 0.147 - 2.388, p = 0.462). Patients who received seven days preoperative antibiotics had lower positive intraoperative urine culture (OR 0.284, 95% CI 0.120 - 0.674, p = 0.004) and stone culture (OR 0.351, 95% CI 0.185 - 0.663, p = 0.001) than the control group.</AbstractText><AbstractText Label="CONCLUSION">one week of prophylactic oral antibiotics based on local bacterial sensitivity pattern plus a dose of intravenous antibiotics at the time of surgery in patients undergoing PCNL reduces the risk of infection.</AbstractText><CopyrightInformation>Copyright&#xae; by the International Brazilian Journal of Urology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Danilovic</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departamento de Urologia, Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas - HCUSP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Urologia, Hospital Alem&#xe3;o Oswaldo Cruz, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talizin</LastName><ForeName>Thalita Bento</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Departamento de Urologia, Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas - HCUSP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torricelli</LastName><ForeName>Fabio Cesar Miranda</ForeName><Initials>FCM</Initials><AffiliationInfo><Affiliation>Departamento de Urologia Faculdade de Medicina da Universidade de S&#xe3;o Paulo - FMUSP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchini</LastName><ForeName>Giovanni S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Departamento de Urologia, Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas - HCUSP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batagello</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departamento de Urologia Faculdade de Medicina da Universidade de S&#xe3;o Paulo - FMUSP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicentini</LastName><ForeName>Fabio C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Departamento de Urologia, Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas - HCUSP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nahas</LastName><ForeName>Willaim C</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Departamento de Urologia Faculdade de Medicina da Universidade de S&#xe3;o Paulo - FMUSP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzucchi</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Urologia, Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas - HCUSP, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Int Braz J Urol</MedlineTA><NlmUniqueID>101158091</NlmUniqueID><ISSNLinking>1677-5538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074642" MajorTopicYN="Y">Nephrolithotomy, Percutaneous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009403" MajorTopicYN="Y">Nephrostomy, Percutaneous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007669" MajorTopicYN="Y">Kidney Calculi</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-Bacterial Agents</Keyword><Keyword MajorTopicYN="N">Drug Therapy</Keyword><Keyword MajorTopicYN="N">Kidney Calculi</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36515617</ArticleId><ArticleId IdType="pmc">PMC10247227</ArticleId><ArticleId IdType="doi">10.1590/S1677-5538.IBJU.2022.0544</ArticleId><ArticleId IdType="pii">IBJU20220544</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geraghty RM, Davis NF, Tzelves L, Lombardo R, Yuan C, Thomas K, et al. Best Practice in Interventional Management of Urolithiasis: An Update from the European Association of Urology Guidelines Panel for Urolithiasis 2022. Eur Urol Focus. 2022 S2405-4569;(22):00144&#x2013;00144. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="pubmed">35927160</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam R, Matlaga BR, Alam A, Winoker JS. Contemporary considerations in the management and treatment of lower pole stones. Int Braz J Urol. 2021;47:957&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8321457</ArticleId><ArticleId IdType="pubmed">33861542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahan M, Yarimoglu S, Polat S, Nart B, Koras O, Bozkurt IH, et al. A novel nomogram and a simple scoring system for urinary leakage after percutaneous nephrolithotomy. Int Braz J Urol. 2022;48:817&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388186</ArticleId><ArticleId IdType="pubmed">35839435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes RI, Perrella R, Watanabe CH, Beltrame F, Danilovic A, Murta CB, et al. Patients with encrusted ureteral stents can be treated by a single session combined endourological approach. Int Braz J Urol. 2021;47:574&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993973</ArticleId><ArticleId IdType="pubmed">33621006</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz C, Desai M, H&#xe4;cker A, Hakenberg OW, Liatsikos E, Nagele U, et al. Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol. 2012;61:146&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">21978422</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez J, Smith A, Geavlete P, Shah H, Kural AR, Sio M, et al. Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol. 2013;31:1135&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785702</ArticleId><ArticleId IdType="pubmed">22367718</ArticleId></ArticleIdList></Reference><Reference><Citation>Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, et al. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. J Urol. 2016;196:1153&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pubmed">27238616</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung HD, Cho KS, Moon YJ, Chung DY, Kang DH, Lee JY. Antibiotic prophylaxis for percutaneous nephrolithotomy: An updated systematic review and meta-analysis. PLoS One. 2022;17:e0267233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9012355</ArticleId><ArticleId IdType="pubmed">35427380</ArticleId></ArticleIdList></Reference><Reference><Citation>Bapir R, Bhatti KH, Eliwa A, Garc&#xed;a-Perdomo HA, Gherabi N, Hennessey D, et al. Infectious complications of endourological treatment of kidney stones: A meta-analysis of randomized clinical trials. Arch Ital Urol Androl. 2022;94:97&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">35352534</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Guo B, Yu J, Chen T, Han X, Niu Q, et al. Antibiotic prophylaxis in perioperative period of percutaneous nephrolithotomy: a systematic review and meta-analysis of comparative studies. World J Urol. 2020;38:1685&#x2013;1700.</Citation><ArticleIdList><ArticleId IdType="pubmed">31562533</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo PAS, Vicentini FC, Perrella R, Murta CB, Claro JFA. Comparative study of percutaneous nephrolithotomy performed in the traditional prone position and in three different supine positions. Int Braz J Urol. 2019;45:108&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6442131</ArticleId><ArticleId IdType="pubmed">30521168</ArticleId></ArticleIdList></Reference><Reference><Citation>Isoglu CS, Suelozgen T, Boyacioglu H, Koc G. Effects of body mass index on the outcomes of percutaneous nephrolithotomy. Int Braz J Urol. 2017;43:698&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5557446</ArticleId><ArticleId IdType="pubmed">28537701</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin P, Zhang D, Huang T, Fang L, Cheng Y. Comparison of mini percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for renal stones &gt;2cm: a systematic review and meta-analysis. Int Braz J Urol. 2022;48:637&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9306366</ArticleId><ArticleId IdType="pubmed">34786926</ArticleId></ArticleIdList></Reference><Reference><Citation>Torricelli FC, Padovani GP, Marchini GS, Vicentini FC, Danilovic A, Reis ST, et al. Percutaneous nephrolithotomy in patients with solitary kidney: a critical outcome analysis. Int Braz J Urol. 2015;41:496&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4752142</ArticleId><ArticleId IdType="pubmed">26200542</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariappan P, Smith G, Moussa SA, Tolley DA. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int. 2006;98:1075&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pubmed">17034608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bag S, Kumar S, Taneja N, Sharma V, Mandal AK, Singh SK. One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. Urology. 2011;77:45&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">20570319</ArticleId></ArticleIdList></Reference><Reference><Citation>Sur RL, Krambeck AE, Large T, Bechis SK, Friedlander DF, Monga M, et al. A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics for Percutaneous Nephrolithotomy in Moderate to High Infectious Risk Population: A Report from the EDGE Consortium. J Urol. 2021;205:1379&#x2013;1386.</Citation><ArticleIdList><ArticleId IdType="pubmed">33369488</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med. 1992;20:724&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">1597021</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pubmed">12682500</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. d5928BMJ. 2011;343</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. i4919BMJ. 2016;355</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew BH, Miller NL, Abbott JE, Lange D, Humphreys MR, Pais VM, Jr, et al. A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics Prior to Percutaneous Nephrolithotomy in a Low Infectious Risk Population: A Report from the EDGE Consortium. J Urol. 2018;200:801&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">29684391</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P, Zhang S, Zhang Y, Zeng T, Chen D, Wu W, et al. Preoperative antibiotic therapy exceeding 7 days can minimize infectious complications after percutaneous nephrolithotomy in patients with positive urine culture. World J Urol. 2022;40:193&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">34550426</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol. 2005;173:1610&#x2013;1614.</Citation><ArticleIdList><ArticleId IdType="pubmed">15821509</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis A, Patterson DK, Winn WR, Hertzer J, Finegold SM. Nitrofurantoin: additional studies comparing in vitro drug susceptibility with clinical bacteriological response. Antimicrob Agents Chemother (Bethesda) 1966;6:182&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">4862163</ArticleId></ArticleIdList></Reference><Reference><Citation>Giske CG. Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin. Clin Microbiol Infect. 2015;21:899&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pubmed">26027916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kippax PW. The sensitivity of Proteus to nitrofurantoin in vitro. J Clin Pathol. 1957;10:197&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1024038</ArticleId><ArticleId IdType="pubmed">13428883</ArticleId></ArticleIdList></Reference><Reference><Citation>Geneletti S, Richardson S, Best N. Adjusting for selection bias in retrospective, case-control studies. Biostatistics. 2009;10:17&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">18482997</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17032319</PMID><DateCompleted><Year>2007</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1462-8910</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>2006</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland</Title><ISOAbbreviation>Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>Life-threatening sepsis following treatment for haemorrhoids: a systematic review.</ArticleTitle><Pagination><StartPage>748</StartPage><EndPage>755</EndPage><MedlinePgn>748-55</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Haemorrhoids are a common complaint with estimates suggesting a prevalence of 4% of the adult population. Treatments such as rubber band ligation (RBL), sclerotherapy and excisional surgery have been in use for many years, and recently stapled haemorrhoidopexy, or procedure for prolapsing haemorrhoids (PPH) has gained acceptance. However, there have been consistent reports of severe sepsis, including a number of deaths. The purpose of this review was to assess the scale of the problem, and identify any predisposing factors, common presenting features, and treatment options in those who suffer these complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-nine papers were identified, reporting 38 patients. Of these, 17 had undergone RBL, three had sclerotherapy, one had cryotherapy, 10 had excisional surgery and seven had PPH. Ten died as a result of their sepsis. The cases included 16 with perineal sepsis, seven with retroperitoneal gas and oedema, and six with liver abscesses. Common presenting features were urinary difficulties, fever, severe pain, septic shock and leucocytosis. Most were managed by means of surgery, although a minority survived having received conservative therapy. With the exception of two patients (one of whom was human immunodeficiency virus positive and the other had a drug-induced agranulocytosis) all were well prior to surgery.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although extremely uncommon, severe sepsis does occur post-treatment for haemorrhoids and all surgeons who treat such patients should be aware of the potential complications and alert to their presenting features. Early presentation without evidence of tissue necrosis may be managed conservatively, although most cases are managed by means of surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCloud</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Glenfield General Hospital, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>J S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>A N D</ForeName><Initials>AN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Colorectal Dis</MedlineTA><NlmUniqueID>100883611</NlmUniqueID><ISSNLinking>1462-8910</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="N">Digestive System Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005734" MajorTopicYN="N">Gangrene</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006484" MajorTopicYN="N">Hemorrhoids</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>21</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>1</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17032319</ArticleId><ArticleId IdType="doi">10.1111/j.1463-1318.2006.01028.x</ArticleId><ArticleId IdType="pii">CDI1028</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32927235</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Hemodynamic management and surgical site infection: Network meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>110021</StartPage><MedlinePgn>110021</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2020.110021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(20)31311-8</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">To investigate which hemodynamic management strategy is most effective in reducing surgical site infection (SSI).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Network meta-analysis of randomized controlled trials.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Perioperative setting.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Surgical patients.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Usual care vs. optimized hemodynamic management, including goal-directed hemodynamic therapy (GDHT) and liberal/restrictive fluid therapy.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">The primary outcome was SSI arising within postoperative 30&#xa0;days. The secondary outcomes included postoperative respiratory and urinary system infectious complications and sepsis/septic shock. The effect and ranking were assessed using network meta-analysis and the surface under the cumulative ranking curve (SUCRA) scores, respectively.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We systematically searched Ovid MEDLINE, Ovid Embase, and Web of Science for eligible randomized controlled trials from inception to October 11, 2019. Fifty-three eligible studies reported SSI and comprised of 56 GDHT groups (patients, n&#xa0;=&#xa0;4205) and 51 usual care groups (patients, n&#xa0;=&#xa0;3895). Comparing with usual care, GDHTs aimed at intravascular volume and stroke volume optimization (odds ratio (OR), 0.28 [95% credible interval (CrI), 0.13 to 0.56]; moderate quality), stroke volume and cardiac output optimization (OR, 0.34 [95% CrI, 0.16 to 0.70]; moderate quality), and intravascular volume and cardiac output optimization (OR, 0.51 [95% CrI, 0.24 to 0.99]; low quality) significantly reduced SSI. GDHT strategy aimed at intravascular volume and stroke volume optimization was likely most effective (SUCRA&#xa0;=&#xa0;80%). Certain GDHTs significantly reduced respiratory infectious complications; however, no GDHT significantly reduced urinary infectious complications and sepsis/septic shock. GDHT strategy aimed at intravascular volume, stroke volume, and cardiac output optimization was likely most effective for reducing respiratory infectious complications (SUCRA&#xa0;=&#xa0;88%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Different hemodynamic managements exert different effectiveness for SSI reduction. GDHTs aimed at intravascular volume, stroke volume, and cardiac output optimization are likely most effective based on the overall evidence.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yale University School of Medicine, New Haven, CT, United States of America; Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, Huanan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brackett</LastName><ForeName>Alexandria</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Yale University School of Public Health, New Haven, CT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Junmei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China. Electronic address: xujunmei@139.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Lingzhong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yale University School of Medicine, New Haven, CT, United States of America. Electronic address: lingzhong.meng@yale.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="Y">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Goal-directed hemodynamic therapy</Keyword><Keyword MajorTopicYN="N">Infectious complications, randomized controlled trial</Keyword><Keyword MajorTopicYN="N">Network meta-analysis</Keyword><Keyword MajorTopicYN="N">Surgical site infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>14</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32927235</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2020.110021</ArticleId><ArticleId IdType="pii">S0952-8180(20)31311-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26957690</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0259-1162</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Season>Jan-Apr</Season></PubDate></JournalIssue><Title>Anesthesia, essays and researches</Title><ISOAbbreviation>Anesth Essays Res</ISOAbbreviation></Journal><ArticleTitle>A retrospective cohort study of perioperative prognostic factors associated with intra-abdominal sepsis.</ArticleTitle><Pagination><StartPage>50</StartPage><EndPage>53</EndPage><MedlinePgn>50-3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/0259-1162.164678</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Intra-abdominal sepsis following laparotomy for acute abdomen remains still a challenging condition. The understanding of various perioperative risk factors by anesthesiologists are crucial in optimum management these patients.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The objective of this study is to assess the perioperative risk factors, which predicts the outcome of treatment.</AbstractText><AbstractText Label="SETTINGS AND DESIGN" NlmCategory="METHODS">This retrospective observational study of 603 patients who underwent Laparotomies between March 2012 and March 2015 at our University Medical College. Of 603 patients, 52 consecutive patients with intra-abdomen sepsis who underwent surgical procedures and admitted in Intensive Care Unit (ICU) were selected and analyzed for prognostic risk factors in relation to severity of the disease.</AbstractText><AbstractText Label="SUBJECTS AND METHODS" NlmCategory="METHODS">52 consecutive patients who developed intra-abdominal sepsis following laparotomy was allocated one of two groups; Group Sepsis, patients with peritonitis without systemic hypotension (mean arterial pressure [MAP] &gt;60 mm of Hg); and Group septic shock, patients with peritonitis with systemic hypotension (mean arterial pressure [MAP] &lt;60 mm of Hg) and patients were analyzed for prognostic risk factors.</AbstractText><AbstractText Label="STATISTICAL ANALYSIS USED" NlmCategory="METHODS">Categorical variables were analyzed by using Fisher's exact (two-tail) test and continuous variable were analyzed by using Mann-Whitney (two-tail) U-test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 603 patients who underwent laparotomy 52 patients developed an intra-abdominal septic complication. Of these 52 cases studied 28 patients developed septic shock and required a longer duration of admission in ICU and more inotropic support. Preoperative albumin and hematocrit level were significantly low in septic shock patients as compared to the patients with sepsis without systemic hypotension. PaCO2: FiO2 was also significantly low in these patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preoperative low hematocrit, low albumin level, and delay in laparotomy more than 72 h were also associated with adverse outcome in the patients with intra-abdominal sepsis. Clinicians should maintain equipoise on this topic pending prospective randomized clinical trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arun Kumar</LastName><ForeName>R V</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>Department of Surgery, Subbaiah Institute of Medical Sciences, Shimoga, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Channabasappa</LastName><ForeName>Shivakumar M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Subbaiah Institute of Medical Sciences, Shimoga, Karnataka, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Anesth Essays Res</MedlineTA><NlmUniqueID>101578762</NlmUniqueID><ISSNLinking>2229-7685</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Intra-abdominal sepsis</Keyword><Keyword MajorTopicYN="N">perioperative risk factors</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26957690</ArticleId><ArticleId IdType="pmc">PMC4767092</ArticleId><ArticleId IdType="doi">10.4103/0259-1162.164678</ArticleId><ArticleId IdType="pii">AER-10-50</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morar R, Richards GA, Galpin J, Herbert V. Outcome of patients with severe abdominal sepsis in intensive care &#x2013; Experience at Charlotte Maxeke Johannesburg Academic Hospital: Clinical case study. South Afr J Epidemiol Infect. 2010;25:23&#x2013;7.</Citation></Reference><Reference><Citation>Malangoni MA. Evaluation and management of tertiary peritonitis. Am Surg. 2000;66:157&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">10695746</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: Results from the National VA Surgical Risk Study. Arch Surg. 1999;134:36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">9927128</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Yiannibas V, Johnson C, Kline JA. Emergency department hypotension predicts sudden unexpected in-hospital mortality: A prospective cohort study. Chest. 2006;130:941&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17035422</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteban A, Frutos-Vivar F, Ferguson ND, Pe&#xf1;uelas O, Lorente JA, Gordo F, et al. Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward. Crit Care Med. 2007;35:1284&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17414725</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC. Principles of source control in the early management of sepsis. Curr Infect Dis Rep. 2010;12:345&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">21308516</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, al Naqbi A. Principles of source control in the management of sepsis. Crit Care Clin. 2009;25:753.</Citation><ArticleIdList><ArticleId IdType="pubmed">19892251</ArticleId></ArticleIdList></Reference><Reference><Citation>White LE, Hassoun HT, Bihorac A, Moore LJ, Sailors RM, McKinley BA, et al. Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis. J Trauma Acute Care Surg. 2013;75:432&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3823059</ArticleId><ArticleId IdType="pubmed">24089113</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger EP, Wertz MJ, Meakins JL, Solomkin JS, Allo MD, Howard RJ, et al. Surgical infection stratification system for intra-abdominal infection. Multicenter trial. Arch Surg. 1985;120:21&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">3966873</ArticleId></ArticleIdList></Reference><Reference><Citation>Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH. Surgical Infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome. Arch Surg. 1993;128:193&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8431120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson SE, Faulkner K. Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections. Am Surg. 1998;64:402&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9585772</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler JA, Huang J, Wilson SE. Repeated laparotomy for postoperative intra-abdominal sepsis. An analysis of outcome predictors. Arch Surg. 1987;122:702&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">3555412</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54:4851&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2976147</ArticleId><ArticleId IdType="pubmed">20733044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, et al. Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study. Am J Respir Crit Care Med. 2009;180:861&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19696442</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Ortega A, Suberviola B, Garc&#xed;a-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study. Crit Care Med. 2010;38:1036&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">20154597</ArticleId></ArticleIdList></Reference><Reference><Citation>Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Horton JM, Studnek JR, et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med. 2011;39:2066&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3158284</ArticleId><ArticleId IdType="pubmed">21572327</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26790973</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Acute mesenteric ischemia following cardiovascular surgery--A nested case-control study.</ArticleTitle><Pagination><StartPage>79</StartPage><EndPage>85</EndPage><MedlinePgn>79-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijsu.2015.12.066</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1743-9191(16)00030-3</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute mesenteric ischemia is a rare but often fatal complication following cardiovascular surgery. Early suspicion may reduce overall mortality. This retrospective study aims to identify predictors and risk factors that may determine the onset and evolution of acute mesenteric ischemia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a retrospective case-control study, we compared co-morbidities and peri-operative risk factors of patients with or without mesenteric ischemia following cardiac surgery using univariate and logistic regression analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 9385 patients, 108 (1.15%) were diagnosed with acute mesenteric ischemia within two weeks after cardiac surgery. In-hospital mortality was 68% for this group. Patients with ischemia and controls were matched in regard to patient's age and type of surgical intervention and showed similar pre-operative parameters. Only liver cirrhosis (OR 13.3, CI95% 3.6-49.3), and emergency operation (OR 2.6, CI95% 1.3-5.2) remained independent pre-operative predictors for acute mesenteric ischemia in multivariate analysis. In contrast, early postoperative parameters revealed a higher correlation with the occurrence of mesenteric ischemia including the use of norepinephrine (OR 3.5 CI95% 1.6-7.8), epinephrine (OR 2.0, CI95% 1.1-3.7), and serum lactate levels &gt;3 mmol/L (OR 2.9, CI95% 1.5-5.6). A set of key markers of regression analysis was evaluated in a ROC curve analysis. The area under curve was 0.835, which indicates moderate to good prognostic accuracy.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Early identification of pre- and post-operative predictors including liver cirrhosis, emergency operation, serum lactate &gt;3 mmol/L, and the use of norepinephrine and epinephrine may help facilitate early diagnosis of acute mesenteric ischemia following cardiac surgery, and thus may allow immediate adequate treatment, leading to a reduction in mortality rates.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mothes</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Vascular Surgery, University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany. Electronic address: henning.mothes@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koeppen</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Vascular Surgery, University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany. Electronic address: jonaskoeppen@posteo.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayer</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany. Electronic address: Ole.Bayer@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany. Electronic address: Markus.Richter@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabisch</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Central Service Provider for Information Technology (IT) Services, University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany. Electronic address: Bjoern.Kabisch@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwarzkopf</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Sepsis Control and Care, University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany. Electronic address: daniel.schwarzkopf@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hein</LastName><ForeName>H A T</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical School, 3300 Oak Lawn Ave, Ste 200, Dallas, TX 75219, Dallas, USA. Electronic address: tillhein@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanow</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Vascular Surgery, University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany. Electronic address: Juergen.Zanow@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doenst</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany. Electronic address: Doenst@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Settmacher</LastName><ForeName>U</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Vascular Surgery, University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany. Electronic address: utz.settmacher@med.uni-jena.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YKH834O4BH</RegistryNumber><NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065666" MajorTopicYN="N">Mesenteric Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute mesenteric ischaemia</Keyword><Keyword MajorTopicYN="N">Cardiovascular surgery</Keyword><Keyword MajorTopicYN="N">Case-control study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26790973</ArticleId><ArticleId IdType="doi">10.1016/j.ijsu.2015.12.066</ArticleId><ArticleId IdType="pii">S1743-9191(16)00030-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29967603</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-3224</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Plasminogen Activator Inhibitor 1 for Predicting Sepsis Severity and Mortality Outcomes: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1218</StartPage><MedlinePgn>1218</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1218</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2018.01218</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Plasminogen activator inhibitor-1 (PAI-1), a crucial regulator of fibrinolysis, is increased in sepsis, but its values in predicting disease severity or mortality outcomes have been controversial. Therefore, we conducted a systematic review and meta-analysis of its predictive values in sepsis.</AbstractText><AbstractText Label="METHODS">PubMed and Embase were searched until August 18, 2017 for studies that evaluated the relationships between PAI-1 levels and disease severity or mortality in sepsis.</AbstractText><AbstractText Label="RESULTS">A total of 112 and 251 entries were retrieved from the databases, of which 18 studies were included in the final meta-analysis. A total of 4,467 patients (36% male, mean age: 62&#x2009;years, mean follow-up duration: 36&#x2009;days) were analyzed. PAI-1 levels were significantly higher in non-survivors than survivors [odds ratios (OR): 3.93, 95% confidence interval (CI): 2.31-6.67, <i>P</i>&#x2009;&lt;&#x2009;0.0001] and in patients with severe sepsis than in those less severe sepsis (OR: 3.26, 95% CI: 1.37-7.75, <i>P</i>&#x2009;=&#x2009;0.008).</AbstractText><AbstractText Label="CONCLUSION">PAI-1 is a significant predictor of disease severity and all-cause mortality in sepsis. Although the predictive values of PAI-1 reached statistical significance, the clinical utility of PAI-1 in predicting outcomes will require carefully designed prospective trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tipoe</LastName><ForeName>Timothy L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>William K K</ForeName><Initials>WKK</Initials><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Lilianna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Federal University of Uberl&#xe2;ndia, Uberl&#xe2;ndia, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roever</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Federal University of Uberl&#xe2;ndia, Uberl&#xe2;ndia, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Jeffery</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Martin C S</ForeName><Initials>MCS</Initials><AffiliationInfo><Affiliation>JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MTV</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Justin C Y</ForeName><Initials>JCY</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Sunny H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017395">Plasminogen Activator Inhibitor 1</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017395" MajorTopicYN="N">Plasminogen Activator Inhibitor 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">plasminogen activator inhibitor-1</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29967603</ArticleId><ArticleId IdType="pmc">PMC6015919</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2018.01218</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA (2016) 315:801&#x2013;10.10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Raaphorst J, Johan Groeneveld AB, Bossink AW, Erik Hack C. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients. Thromb Haemost (2001) 86:543&#x2013;9.10.1055/s-0037-1616084</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1616084</ArticleId><ArticleId IdType="pubmed">11522001</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 285:L20&#x2013;8.10.1152/ajplung.00312.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00312.2002</ArticleId><ArticleId IdType="pubmed">12730079</ArticleId></ArticleIdList></Reference><Reference><Citation>Okabayashi K, Wada H, Ohta S, Shiku H, Nobori T, Maruyama K. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. Am J Hematol (2004) 76:225&#x2013;9.10.1002/ajh.20089</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.20089</ArticleId><ArticleId IdType="pubmed">15224356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeerleder S, Schroeder V, Hack CE, Kohler HP, Wuillemin WA. TAFI and PAI-1 levels in human sepsis. Thromb Res (2006) 118:205&#x2013;12.10.1016/j.thromres.2005.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2005.06.007</ArticleId><ArticleId IdType="pubmed">16009400</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Meijers JC, Levi M, Van &#x2019;T Veer C, Day NP, Peacock SJ, et al. Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis. J Thromb Haemost (2008) 6:32&#x2013;9.10.1111/j.1538-7836.2007.02796.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02796.x</ArticleId><ArticleId IdType="pubmed">17944999</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri T, Bellani G, Patroniti N, Coppadoro A, Peri G, Cuccovillo I, et al. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med (2010) 36:621&#x2013;9.10.1007/s00134-010-1752-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-010-1752-5</ArticleId><ArticleId IdType="pubmed">20119647</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, Schuetz P, Yano K, Sorasaki M, Parikh SM, Jones AE, et al. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care (2010) 14:R182.10.1186/cc9290</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9290</ArticleId><ArticleId IdType="pmc">PMC3219288</ArticleId><ArticleId IdType="pubmed">20942957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenaar JF, Goris MG, Partiningrum DL, Isbandrio B, Hartskeerl RA, Brandjes DP, et al. Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Health (2010) 15:152&#x2013;9.10.1111/j.1365-3156.2009.02434.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3156.2009.02434.x</ArticleId><ArticleId IdType="pubmed">20002620</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuetz P, Jones AE, Aird WC, Shapiro NI. Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension. Shock (2011) 36:104&#x2013;8.10.1097/SHK.0b013e31821e4e04</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e31821e4e04</ArticleId><ArticleId IdType="pmc">PMC3139767</ArticleId><ArticleId IdType="pubmed">21522043</ArticleId></ArticleIdList></Reference><Reference><Citation>Per&#xe9;s Wingeyer SD, Cunto ER, Nogueras CM, San Juan JA, Gomez N, De Larranaga GF. Biomarkers in sepsis at time zero: intensive care unit scores, plasma measurements and polymorphisms in Argentina. J Infect Dev Ctries (2012) 6:555&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">22842942</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalkanen V, Yang R, Linko R, Huhtala H, Okkonen M, Varpula T, et al. SuPAR and PAI-1 in critically ill, mechanically ventilated patients. Intensive Care Med (2013) 39:489&#x2013;96.10.1007/s00134-012-2730-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2730-x</ArticleId><ArticleId IdType="pubmed">23100007</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki Y, Wada H, Kawasugi K, Okamoto K, Uchiyama T, Kushimoto S, et al. A prospective analysis of disseminated intravascular coagulation in patients with infections. Intern Med (2013) 52:1893&#x2013;8.10.2169/internalmedicine.52.0571</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.52.0571</ArticleId><ArticleId IdType="pubmed">23994978</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama K, Madoiwa S, Nunomiya S, Koinuma T, Wada M, Sakata A, et al. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study. Crit Care (2014) 18:R13.10.1186/cc13190</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13190</ArticleId><ArticleId IdType="pmc">PMC4056264</ArticleId><ArticleId IdType="pubmed">24410881</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente L, Martin MM, Borreguero-Leon JM, Sole-Violan J, Ferreres J, Labarta L, et al. Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients. Thromb Res (2014) 134:182&#x2013;6.10.1016/j.thromres.2014.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.04.013</ArticleId><ArticleId IdType="pubmed">24814968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente L, Martin MM, Sole-Violan J, Blanquer J, Labarta L, Diaz C, et al. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio. PLoS One (2014) 9:e94318.10.1371/journal.pone.0094318</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0094318</ArticleId><ArticleId IdType="pmc">PMC3984125</ArticleId><ArticleId IdType="pubmed">24727739</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M, Zacchetti L, L&#x2019;Acqua C, Cressoni M, Anzoletti MB, Bader R, et al. Assessment of fibrinolysis in sepsis patients with urokinase modified thromboelastography. PLoS One (2015) 10:e0136463.10.1371/journal.pone.0136463</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0136463</ArticleId><ArticleId IdType="pmc">PMC4550424</ArticleId><ArticleId IdType="pubmed">26308340</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash S, Verghese S, Roxby D, Dixon D, Bihari S, Bersten A. Changes in fibrinolysis and severity of organ failure in sepsis: a prospective observational study using point-of-care test &#x2013; ROTEM. J Crit Care (2015) 30:264&#x2013;70.10.1016/j.jcrc.2014.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2014.10.014</ArticleId><ArticleId IdType="pubmed">25454072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino K, Kitamura T, Nakamura Y, Irie Y, Matsumoto N, Kawano Y, et al. Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis. J Intensive Care (2017) 5:42.10.1186/s40560-017-0238-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-017-0238-8</ArticleId><ArticleId IdType="pmc">PMC5504563</ArticleId><ArticleId IdType="pubmed">28702197</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsantes AE, Tsangaris I, Bonovas S, Kopterides P, Rapti E, Dimopoulou I, et al. The effect of four hemostatic gene polymorphisms on the outcome of septic critically ill patients. Blood Coagul Fibrinolysis (2010) 21:175&#x2013;81.10.1097/MBC.0b013e32833678a1</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e32833678a1</ArticleId><ArticleId IdType="pubmed">20051843</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedemann NC, Guo R-F, Ward PA. The enigma of sepsis. J Clin Invest (2003) 112:460&#x2013;7.10.1172/JCI200319523</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200319523</ArticleId><ArticleId IdType="pmc">PMC171398</ArticleId><ArticleId IdType="pubmed">12925683</ArticleId></ArticleIdList></Reference><Reference><Citation>Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood (2003) 101:3765.10.1182/blood-2002-06-1887</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-06-1887</ArticleId><ArticleId IdType="pubmed">12543869</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med (1999) 341:586&#x2013;92.10.1056/NEJM199908193410807</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199908193410807</ArticleId><ArticleId IdType="pubmed">10451465</ArticleId></ArticleIdList></Reference><Reference><Citation>Todoroki H, Nakamura S, Higure A, Okamoto K, Takeda S, Nagata N, et al. Neutrophils express tissue factor in a monkey model of sepsis. Surgery (2000) 127:209&#x2013;16.10.1067/msy.2000.103027</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/msy.2000.103027</ArticleId><ArticleId IdType="pubmed">10686987</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M. Disseminated intravascular coagulation. Crit Care Med (2007) 35:2191&#x2013;5.10.1097/01.CCM.0000281468.94108.4B</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000281468.94108.4B</ArticleId><ArticleId IdType="pubmed">17855836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesters RM, Florke N, Ostermann H, Kienast J. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis. Thromb Haemost (1996) 75:902&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8822584</ArticleId></ArticleIdList></Reference><Reference><Citation>Samransamruajkit R, Hiranrat T, Prapphal N, Sritippayawan S, Deerojanawong J, Poovorawan Y. Levels of protein C activity and clinical factors in early phase of pediatric septic shock may be associated with the risk of death. Shock (2007) 28:518&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">17589380</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkenpas MB, Lawrence DA, Ginsburg D. Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J (1995) 14:2969&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC394356</ArticleId><ArticleId IdType="pubmed">7621813</ArticleId></ArticleIdList></Reference><Reference><Citation>Massignon D, Lepape A, Bienvenu J, Barbier Y, Boileau C, Coeur P. Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state. Haemostasis (1994) 24:36&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">7959354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidokoro A, Iba T, Fukunaga M, Yagi Y. Alterations in coagulation and fibrinolysis during sepsis. Shock (1996) 5:223&#x2013;8.10.1097/00024382-199603000-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-199603000-00010</ArticleId><ArticleId IdType="pubmed">8696988</ArticleId></ArticleIdList></Reference><Reference><Citation>Leithauser B, Matthias FR, Nicolai U, Voss R. Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis. Possible indication of the degree of endothelial cell activation? Intensive Care Med (1996) 22:631&#x2013;6.10.1007/BF01709738</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709738</ArticleId><ArticleId IdType="pubmed">8844226</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargentini V, Collepardo D, D Alessandro M, Petralito G, Ceccarelli G, Alessandri F, et al. Role of biomarkers in adult sepsis and their application for a good laboratory practice: a pilot study. J Biol Regul Homeost Agents (2017) 31:1147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">29254328</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolin HH, Papadimos TJ, Stepkowski S, Chen X, Pan ZK. A novel combination of biomarkers to Herald the onset of sepsis prior to the manifestation of symptoms. Shock (2018) 49:364&#x2013;70.10.1097/SHK.0000000000001010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001010</ArticleId><ArticleId IdType="pmc">PMC5811232</ArticleId><ArticleId IdType="pubmed">29016484</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YT, Gong M, Chau A, Wong WT, Bazoukis G, Wong SH, et al. Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: a systematic review and meta-analysis. J Infect (2018) 76:1&#x2013;10.10.1016/j.jinf.2017.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2017.10.016</ArticleId><ArticleId IdType="pubmed">29174966</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebermann H, Tokuoka R, Deisenhofer J, Huber R. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol (1984) 177:531&#x2013;57.10.1016/0022-2836(84)90298-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(84)90298-5</ArticleId><ArticleId IdType="pubmed">6332197</ArticleId></ArticleIdList></Reference><Reference><Citation>Declerck PJ, De Mol M, Vaughan DE, Collen D. Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator. J Biol Chem (1992) 267:11693&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1601844</ArticleId></ArticleIdList></Reference><Reference><Citation>Urano T, Strandberg L, Johansson LB, Ny T. A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate. Eur J Biochem (1992) 209:985&#x2013;92.10.1111/j.1432-1033.1992.tb17372.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1992.tb17372.x</ArticleId><ArticleId IdType="pubmed">1425706</ArticleId></ArticleIdList></Reference><Reference><Citation>Prendergast GC, Diamond LE, Dahl D, Cole MD. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol Cell Biol (1990) 10:1265&#x2013;9.10.1128/MCB.10.3.1265</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.10.3.1265</ArticleId><ArticleId IdType="pmc">PMC361018</ArticleId><ArticleId IdType="pubmed">2406566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Im H. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies. Protein Expr Purif (2003) 31:99&#x2013;107.10.1016/S1046-5928(03)00160-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1046-5928(03)00160-8</ArticleId><ArticleId IdType="pubmed">12963346</ArticleId></ArticleIdList></Reference><Reference><Citation>Florova G, Karandashova S, Declerck PJ, Idell S, Komissarov AA. Remarkable stabilization of plasminogen activator inhibitor 1 in a &#x201c;molecular sandwich&#x201d; complex. Biochemistry (2013) 52:4697&#x2013;709.10.1021/bi400470s</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi400470s</ArticleId><ArticleId IdType="pmc">PMC3855604</ArticleId><ArticleId IdType="pubmed">23734661</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21150584</PMID><DateCompleted><Year>2011</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>380</StartPage><EndPage>385</EndPage><MedlinePgn>380-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0b013e3181ffd9f7</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">L-arginine is a conditionally essential amino acid that plays an important role in immune and vascular function in sepsis. Plasma concentrations of L-arginine are decreased after trauma or surgery but have been variably reported to be normal or decreased in patients with sepsis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched MEDLINE and Embase from database inception until January 2010 for the MESH terms "arginine," "amino acids," and "sepsis" and reviewed all studies that reported plasma arginine concentrations in humans with sepsis. Studies were grouped according to the presence or absence of trauma and surgery. We performed a pooled quantitative analysis on the subset of studies that reported appropriate data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 285 citations, of which 16 met inclusion criteria and 10 were included in the quantitative analysis. Plasma arginine concentration was lower in sepsis patients compared with concurrent or historical controls in three of four studies of surgical sepsis, one of four of sepsis after trauma, and all eight studies of predominantly medical sepsis. In the quantitative analysis, mean plasma L-arginine concentration was 33.9 &#x3bc;mol/L (95% confidence interval, 41.2-26.6) lower in sepsis patients than in concurrent nonseptic controls (p &lt; .001), which is a relative decrease of 41%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Plasma concentrations of plasma L-arginine are substantially decreased in patients with sepsis in the absence of trauma or surgery. There are not enough studies of sufficient quality to determine whether this is also the case for trauma-associated or surgery-associated sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Joshua S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia. Joshua.Davis@menzies.edu.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anstey</LastName><ForeName>Nicholas M</ForeName><Initials>NM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2011 Feb;39(2):417-8. doi: 10.1097/CCM.0b013e318205c386.</RefSource><PMID Version="1">21248531</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21150584</ArticleId><ArticleId IdType="doi">10.1097/CCM.0b013e3181ffd9f7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26862016</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Antithrombin&#xa0;III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis.</ArticleTitle><Pagination><StartPage>505</StartPage><EndPage>520</EndPage><MedlinePgn>505-520</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-016-4225-7</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties. We assessed the benefits and harms of AT III in critically ill patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched from inception to 27 August 2015 in CENTRAL, MEDLINE, EMBASE, CAB, BIOSIS and CINAHL. We included randomized controlled trials (RCTs) irrespective of publication status, date of publication, blinding status, outcomes published or language.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 30 RCTs with a total of 3933 participants. The majority of included trials were at high risk of bias. Combining all trials, regardless of bias, showed no statistically significant effect of AT III on mortality (RR 0.95, 95% CI 0.88-1.03, I (2) = 0%, fixed-effect model, 29 trials, 3882 participants). Among those with severe sepsis and disseminated intravascular coagulation (DIC), AT III showed no impact on mortality (RR 0.95, 95% Cl 0.88-1.03, I (2) = 0%, fixed-effect model, 12 trials, 2858 participants). We carried out multiple subgroup and sensitivity analyses to assess the benefits and harms of AT III and to examine the impact of risk of bias. AT III significantly increased bleeding events (RR 1.58, 95% CI 1.35-1.84, I (2) = 0%, fixed-effect model, 11 trials, 3019 participants). However, for all other outcome measures and analyses, the results did not reach statistical significance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is insufficient evidence to support AT III substitution in any category of critically ill participants including those with sepsis and DIC. AT III did not show an impact on mortality, but increased the risk of bleeding.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allingstrup</LastName><ForeName>Mikkel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, K&#xf8;ge Sygehus, Copenhagen University Hospital, Copenhagen, Denmark. mikkel.allingstrup@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatric and Obstetric Anaesthesia, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. mikkel.allingstrup@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetterslev</LastName><ForeName>J&#xf8;rn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravn</LastName><ForeName>Frederikke B</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>Department of Paediatric and Obstetric Anaesthesia, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Ann Merete</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>The Cochrane Anaesthesia, Critical and Emergency Care Group, University of Copenhagen Herlev Hospital, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afshari</LastName><ForeName>Arash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatric and Obstetric Anaesthesia, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Cochrane Anaesthesia, Critical and Emergency Care Group, University of Copenhagen Herlev Hospital, Herlev, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000991">Antithrombins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9000-94-6</RegistryNumber><NameOfSubstance UI="D000990">Antithrombin III</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000990" MajorTopicYN="N">Antithrombin III</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000991" MajorTopicYN="N">Antithrombins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004211" MajorTopicYN="N">Disseminated Intravascular Coagulation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antithrombin&#xa0;III</Keyword><Keyword MajorTopicYN="N">Bleeding</Keyword><Keyword MajorTopicYN="N">DIC</Keyword><Keyword MajorTopicYN="N">Multi organ failure</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>Mikkel Allingstrup, Frederikke B. Ravn, Ann Merete M&#xf8;ller and Arash Afshari declare that there are no conflicts of interest. J&#xf8;rn Wetterslev declares that he is a member of the task force on TSA at Copenhagen Trial Unit developing and programming TSA.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26862016</ArticleId><ArticleId IdType="pmc">PMC7095103</ArticleId><ArticleId IdType="doi">10.1007/s00134-016-4225-7</ArticleId><ArticleId IdType="pii">10.1007/s00134-016-4225-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wunsch H, Angus D, Harrison D, et al. Variation in critical care services across North America and Western Europe. Crit Care Med. 2008;36:2787&#x2013;2793. doi: 10.1097/CCM.0b013e318186aec8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318186aec8</ArticleId><ArticleId IdType="pubmed">18766102</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, De Jonge E, Van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med. 2004;36:41&#x2013;49. doi: 10.1080/07853890310017251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890310017251</ArticleId><ArticleId IdType="pubmed">15000346</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr F, Yende S, Angus D. Epidemiology of severe sepsis. Virulence. 2014;5:4&#x2013;11. doi: 10.4161/viru.27372.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.27372</ArticleId><ArticleId IdType="pmc">PMC3916382</ArticleId><ArticleId IdType="pubmed">24335434</ArticleId></ArticleIdList></Reference><Reference><Citation>Periti P. Current treatment of sepsis and endotoxaemia. Expert Opin Pharmacother. 2000;1:1203&#x2013;1217. doi: 10.1517/14656566.1.6.1203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14656566.1.6.1203</ArticleId><ArticleId IdType="pubmed">11249488</ArticleId></ArticleIdList></Reference><Reference><Citation>Polderman KH, Girbes ARJ. Drug intervention trials in sepsis: divergent results. Lancet. 2004;363:1721&#x2013;1723. doi: 10.1016/S0140-6736(04)16259-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)16259-4</ArticleId><ArticleId IdType="pubmed">15158636</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker BF, Heindl B, Kupatt C, Zahler S. Endothelial function and hemostasis. Z Kardiol. 2000;89:160&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">10798271</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz R, Moffett BS, Karabinas S, et al. Antithrombin concentrate use in children receiving unfractionated heparin for acute thrombosis. J Pediatr. 2015;167:645&#x2013;649. doi: 10.1016/j.jpeds.2015.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2015.06.006</ArticleId><ArticleId IdType="pubmed">26148660</ArticleId></ArticleIdList></Reference><Reference><Citation>Opal SM, Kessler CM, Roemisch J, Knaub S. Antithrombin, heparin, and heparan sulfate. Crit Care Med. 2002;30:325&#x2013;331. doi: 10.1097/00003246-200205001-00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200205001-00024</ArticleId><ArticleId IdType="pubmed">12004255</ArticleId></ArticleIdList></Reference><Reference><Citation>Rublee D, Opal SM, Schramm W, et al. Quality of life effects of antithrombin&#xa0;III in sepsis survivors: results from the KyberSept trial. Crit Care. 2002;6:349&#x2013;356. doi: 10.1186/cc1529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc1529</ArticleId><ArticleId IdType="pmc">PMC125322</ArticleId><ArticleId IdType="pubmed">12225612</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Kanji S, et al. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015;43:511&#x2013;518. doi: 10.1097/CCM.0000000000000763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000763</ArticleId><ArticleId IdType="pubmed">25493972</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch&#xfc;nemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration. http://www.cochrane-handbook.org. Accessed March 2011</Citation></Reference><Reference><Citation>Afshari A, Wetterslev J, Brok J, M&#xf8;ller A. Antithrombin&#xa0;III for critically ill patients. Cochrane Database Syst Rev. 2008;16(3):5370.</Citation><ArticleIdList><ArticleId IdType="pubmed">18646125</ArticleId></ArticleIdList></Reference><Reference><Citation>The Cochrane Collaboration (2014) Review Manager (RevMan), version 5.3.5. The Nordic Cochrane Centre, Copenhagen</Citation></Reference><Reference><Citation>Thorlund K, Engstr&#xf8;m J, Wetterslev J, Brok J, Imberger G, Gluud C (2011) User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark, pp 1&#x2013;115. http://www.ctu.dk/tsa/files/tsa_manual.pdf</Citation></Reference><Reference><Citation>Albert J, Blomqvist H, Gardlund B, et al. Effect of antithrombin concentrate on haemostatic variables in critically ill patients. Acta Anaesthesiol Scand. 1992;36:745&#x2013;752. doi: 10.1111/j.1399-6576.1992.tb03557.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.1992.tb03557.x</ArticleId><ArticleId IdType="pubmed">1466208</ArticleId></ArticleIdList></Reference><Reference><Citation>Balk RA, Bedrosian C, McCormick L, et al. Prospective double blind placebo-controlled trial of ATIII substitution in sepsis. Intensive Care Med. 1995;21:17.</Citation></Reference><Reference><Citation>Baudo F, DeGasperi A, De Cataldo F, et al. Antithrombin&#xa0;III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial. Thromb Res. 1992;68:409&#x2013;416. doi: 10.1016/0049-3848(92)90099-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0049-3848(92)90099-V</ArticleId><ArticleId IdType="pubmed">1290169</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudo F, Caimi TM, De Cataldo F, et al. Antithrombin&#xa0;III (ATIII) replacement therapy in patients with severe sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med. 1998;24:336&#x2013;342. doi: 10.1007/s001340050576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050576</ArticleId><ArticleId IdType="pubmed">9609411</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauhut B, Kramar H, Vinazzer H, Bergmann H. Substitution of antithrombin&#xa0;III in shock and DIC: a randomized study. Thromb Res. 1985;39:81&#x2013;89. doi: 10.1016/0049-3848(85)90123-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0049-3848(85)90123-9</ArticleId><ArticleId IdType="pubmed">4035650</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Cremades JM, Lorenzo R, S&#xe1;nchez M, et al. Use of antithrombin&#xa0;III in critical patients. Intensive Care Med. 1994;20:577&#x2013;580. doi: 10.1007/BF01705725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01705725</ArticleId><ArticleId IdType="pubmed">7706571</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisele B, Lamy M, Thijs LG, et al. Antithrombin&#xa0;III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin&#xa0;III in severe sepsis. Intensive Care Med. 1998;24:663&#x2013;672. doi: 10.1007/s001340050642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050642</ArticleId><ArticleId IdType="pubmed">9722035</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourrier F, Chopin C, Huart JJ, et al. Double-blind, placebo-controlled trial of antithrombin&#xa0;III concentrates in septic shock with disseminated intravascular coagulation. Chest. 1993;104:882&#x2013;888. doi: 10.1378/chest.104.3.882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.104.3.882</ArticleId><ArticleId IdType="pubmed">8365305</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulia F, Cordaro S, Meo P, et al. Can the administration of antithrombin&#xa0;III decrease the risk of cerebral hemorrhage in premature infants. Biol Neonate. 2003;83:1&#x2013;5. doi: 10.1159/000067005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000067005</ArticleId><ArticleId IdType="pubmed">12566675</ArticleId></ArticleIdList></Reference><Reference><Citation>Gando S, Saitoh D, Ishikura H, et al. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis. Crit Care. 2013;17:297. doi: 10.1186/cc13163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13163</ArticleId><ArticleId IdType="pmc">PMC4057033</ArticleId><ArticleId IdType="pubmed">24342495</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenander A, Bredbacka S, Rydvall A, et al. Antithrombin treatment in patients with traumatic brain injury: a pilot study. J Neurosurg Anesthesiol. 2001;13:49&#x2013;56. doi: 10.1097/00008506-200101000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008506-200101000-00010</ArticleId><ArticleId IdType="pubmed">11145479</ArticleId></ArticleIdList></Reference><Reference><Citation>Haire WD, Ruby EI, Stephens LC, et al. A prospective randomized double-blind trial of antithrombin&#xa0;III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 1998;4:142&#x2013;150. doi: 10.1016/S1083-8791(98)50003-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1083-8791(98)50003-1</ArticleId><ArticleId IdType="pubmed">9923412</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper PL, Williamson L, Park G, et al. A pilot study of antithrombin replacement in intensive care management: the effects on mortality, coagulation and renal function. Transfus Med. 1991;1:121&#x2013;128. doi: 10.1111/j.1365-3148.1991.tb00020.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3148.1991.tb00020.x</ArticleId><ArticleId IdType="pubmed">9259838</ArticleId></ArticleIdList></Reference><Reference><Citation>Inthorn D, Hoffmann JN, Hartl WH, et al. Antithrombin&#xa0;III supplementation in severe sepsis: beneficial effects on organ dysfunction. Shock. 1997;8:328&#x2013;334. doi: 10.1097/00024382-199711000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-199711000-00003</ArticleId><ArticleId IdType="pubmed">9361342</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Terao T, Ikenoue T, et al. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study. Semin Thromb Hemost. 2003;29:645&#x2013;652. doi: 10.1055/s-2004-815632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2004-815632</ArticleId><ArticleId IdType="pubmed">14719181</ArticleId></ArticleIdList></Reference><Reference><Citation>Langley PG, Hughes RD, Forbes A, et al. Controlled trial of antithrombin&#xa0;III supplementation in fulminant hepatic failure. J Hepatol. 1993;17:326&#x2013;331. doi: 10.1016/S0168-8278(05)80213-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-8278(05)80213-2</ArticleId><ArticleId IdType="pubmed">8315261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavrentieva A, Kontakiotis T, Bitzani M, et al. The efficacy of antithrombin administration in the acute phase of burn injury. Thromb Haemost. 2008;100:286&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">18690349</ArticleId></ArticleIdList></Reference><Reference><Citation>Maki M, Kobayashi T, Terao T, et al. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. Thromb Haemost. 2000;84:583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">11057854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell L, Andrew M, Hanna K, et al. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Thromb Haemost. 2003;90:235&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">12888870</ArticleId></ArticleIdList></Reference><Reference><Citation>Muntean W, Rossegger H. Antithrombin&#xa0;III concentrate in preterm infants with IRDS: an open, controlled, randomized clinical trial (abstract) Thromb Haemost. 1989;62:288.</Citation></Reference><Reference><Citation>Neporada E, Vorobyeva N, Nedashkovsky E. Antithrombin III deficiency correction in patients with disseminated intravascular coagulation. Obshaya Reanimatol. 2008;5:49&#x2013;54. doi: 10.15360/1813-9779-2008-5-49.</Citation><ArticleIdList><ArticleId IdType="doi">10.15360/1813-9779-2008-5-49</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama T, Kohno Y, Koishi K. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study. Am J Emerg Med. 2012;30:1219&#x2013;1223. doi: 10.1016/j.ajem.2011.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2011.06.003</ArticleId><ArticleId IdType="pubmed">22204993</ArticleId></ArticleIdList></Reference><Reference><Citation>Palareti G, Legnani C, Coccheri S, et al. Laboratory effects of antithrombin-III (ATIII) replacement in patients with sepsis and or postsurgical complications requiring hemodynamic and or respiratory support&#x2014;a controlled, double-blind, randomized multicenter study. Thromb Haemost. 1995;73:1251.</Citation></Reference><Reference><Citation>Schmidt B, Gillie P, Mitchell L, et al. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med. 1998;158:470&#x2013;476. doi: 10.1164/ajrccm.158.2.9712116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.158.2.9712116</ArticleId><ArticleId IdType="pubmed">9700123</ArticleId></ArticleIdList></Reference><Reference><Citation>Schorr M, Siebeck M, Zugel N, et al. Antithrombin&#xa0;III and local serum application: adjuvant therapy in peritonitis. Eur J Clin Invest. 2000;30:359&#x2013;366. doi: 10.1046/j.1365-2362.2000.00630.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2362.2000.00630.x</ArticleId><ArticleId IdType="pubmed">10759886</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster HP, Eisele B, Keinecke HO, et al. S-AT&#xa0;III study: antithrombin&#xa0;III in patients with sepsis. Intensive Care Med. 1997;23(Suppl 1):76.</Citation><ArticleIdList><ArticleId IdType="pubmed">9722035</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Erichsen N, Aasen AO, Kongsgaard UE, et al. The effect of antithrombin&#xa0;III substitution therapy on components of the plasma protease systems in surgical patients. Clin Intensive Care. 1996;7:291&#x2013;296. doi: 10.3109/tcic.7.6.291.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/tcic.7.6.291.296</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorobyeva N, Neporada E, Turundaevskaia O, Mel&#x2019;nikova G. Place of antithrombin&#xa0;III concentrate in the intensive care of disseminated intravascular coagulation. Anesteziol Reanimatol. 2007;2:42&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">17563999</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin&#xa0;III in severe sepsis, a randomized controlled trial. JAMA. 2001;286:1869&#x2013;1878. doi: 10.1001/jama.286.15.1869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.15.1869</ArticleId><ArticleId IdType="pubmed">11597289</ArticleId></ArticleIdList></Reference><Reference><Citation>Waydhas C, Nast-Kolb D, Gippner-Steppert C, et al. High-dose antithrombin&#xa0;III treatment of severely injured patients: results of a prospective study. J Trauma. 1998;45:931&#x2013;940. doi: 10.1097/00005373-199811000-00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199811000-00015</ArticleId><ArticleId IdType="pubmed">9820705</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo A, Valsecchi L (2015) High-dose antithrombin supplementation in early pre-eclampsia: a double-blind, placebo controlled study (on behalf of the AT&#xa0;III-EPAS study group). http://abstract.mci-group.com/cgi-bin/mc/printabs.pl?APP=ISTH2009ABS-abstract&amp;TEMPLATE=&amp;keyf=0771&amp;showHide=show&amp;client. Accessed 21 April 2015</Citation></Reference><Reference><Citation>Gotzsche PC. Why we need a broad perspective on meta-analysis. It may be crucially important for patients. BMJ. 2000;321:585&#x2013;586. doi: 10.1136/bmj.321.7261.585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.321.7261.585</ArticleId><ArticleId IdType="pmc">PMC1118486</ArticleId><ArticleId IdType="pubmed">10977820</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33049490</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Are thromboelastometric and thromboelastographic parameters associated with mortality in septic patients? A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>13</EndPage><MedlinePgn>5-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2020.09.034</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(20)30713-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Thromboelastometry/elastography (ROTEM/TEG) showed promising results for diagnosis of sepsis-induced coagulopathy, but their association with the outcome is unclear. Our aim was to assess any difference in ROTEM/TEG measurements between septic survivors and non-survivors.</AbstractText><AbstractText Label="METHODS">Pubmed, Web of Science, Embase and Cochrane Library databases were investigated. The research aimed to include any randomized or observational study: i) on septic adult patients admitted to Intensive Care Unit (ICU) or Emergency Department (ED); ii) including ROTEM/TEG; iii) assessing mortality.</AbstractText><AbstractText Label="RESULTS">Seven prospective and four retrospective observational studies (952 patients) were included. According to the INTEM/kaolin-assay, clotting time (CT)/R (standardized mean difference(SMD) -0.29, 95% CI -0.49 to -0.09, p&#x202f;=&#x202f;0.004) and clot formation time (CFT)/K (SMD -0.42, 95% CI -0.78 to -0.06, p&#x202f;=&#x202f;0.02) were shorter in survivors. According to the EXTEM-assay, CT was shorter (MD -11.66&#x202f;s, 95% CI -22.59 to -0.73, p&#x202f;=&#x202f;0.04), while MCF was higher (MD 3.49&#x202f;mm, 95% CI 0.43 to 6.55, p&#x202f;=&#x202f;0.03) in survivors. A hypocoagulable profile was more frequent in non-survivors (OR 0.31, 95%CI 0.18 to 0.55, p&#x202f;&lt;&#x202f;0.0001). Overall, the risk of bias of the included studies was moderate and the quality of evidence low.</AbstractText><AbstractText Label="CONCLUSIONS">Hypocoagulability and lower MCF in EXTEM may be associated with higher mortality in sepsis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boscolo</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy. Electronic address: annalisa.boscolo@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiezia</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombotic and Haemorrhagic Diseases Unit, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cassai</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesenti</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine-DIMED, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zatta</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine-DIMED, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampirollo</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine-DIMED, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreatta</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine-DIMED, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sella</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine-DIMED, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pettenuzzo</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rose</LastName><ForeName>Kirstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Royal Alexandria Hospital, Paisley, Scotland, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simioni</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombotic and Haemorrhagic Diseases Unit, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy; Department of Medicine-DIMED, University of Padua, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001778" MajorTopicYN="Y">Blood Coagulation Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013916" MajorTopicYN="N">Thrombelastography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hypocoagulability</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">ROTEM</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">TEG</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>13</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33049490</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2020.09.034</ArticleId><ArticleId IdType="pii">S0883-9441(20)30713-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37868575</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>The Effects of Restrictive Fluid Resuscitation on the Clinical Outcomes in Patients with Sepsis or Septic Shock: A Meta-Analysis of Randomized-Controlled Trials.</ArticleTitle><Pagination><StartPage>e45620</StartPage><MedlinePgn>e45620</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e45620</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.45620</ELocationID><Abstract><AbstractText>This study aims to assess the impact of a restrictive resuscitation strategy on the outcomes of patients with sepsis and septic shock.&#xa0;This meta-analysis was conducted in accordance with the recommendations from the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) guidelines.&#xa0;A systematic search was performed in databases, including PubMed, Web of Science, EMBASE, and the Cochrane Library, covering the period from the inception of the database to August 2023, with no limitations on the language of publication.&#xa0;Outcomes assessed in the meta-analysis included mortality, duration of intensive care unit (ICU) stay in days, duration of mechanical ventilation in days, acute kidney injury (AKI) or the need for renal replacement therapy (RRT), and length of hospital stay in days. Overall,&#xa0;12 studies met the inclusion criteria and were included in the present meta-analysis.&#xa0;The findings of this study indicate that&#xa0;although the risk of mortality was lower in fluid restriction compared to the control group,&#xa0;the difference was statistically insignificant (risk ratio (RR): 0.98; 95% confidence interval (CI): 0.9-1.05; P value: 0.61). Additionally, the duration of mechanical ventilation was significantly shorter in the restrictive fluid group compared to its counterparts (mean difference (MD): -1.02; 95% CI: -1.65 to -0.38; P value: 0.003).&#xa0;There were no significant differences found in relation to the duration of ICU stays, the incidence of AKI, the requirement for RRT, or the length of hospital stays measured in days.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Shahnoor et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shahnoor</LastName><ForeName>Husna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Internal Medicine, Deccan College of Medical Sciences, Hyderabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Divi</LastName><ForeName>Rachana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medicine and Surgery, GSL Medical College, Hyderabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addi Palle</LastName><ForeName>Lokeshwar Raaju</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Surgery, Kamala Children's Hospital, Chennai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Ashutosh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medicine, Kathmandu Medical College and Teaching Hospital, Kathmandu, NPL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contractor</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Internal Medicine, Smt. NHL Municipal Medical College, Ahmedabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krupanagaram</LastName><ForeName>Santoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medicine, MNR Medical College and Hospital, Sangareddy, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batool</LastName><ForeName>Saima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, Hameed Latif Hospital, Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Neelum</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Internal Medicine, University of Health Sciences, Lahore, PAK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fluid restriction</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">resuscitation</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37868575</ArticleId><ArticleId IdType="pmc">PMC10588294</ArticleId><ArticleId IdType="doi">10.7759/cureus.45620</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Rudd KE, Johnson SC, Agesa KM, et al. Lancet. 2020;395:200&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>The third international consensus definitions for sepsis and septic shock (sepsis-3) Singer M, Deutschman CS, Seymour CW, et al. JAMA. 2016;315:801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Rhodes A, Evans LE, Alhazzani W, et al. Crit Care Med. 2017;45:486&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">28098591</ArticleId></ArticleIdList></Reference><Reference><Citation>Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Dellinger RP, Levy MM, Rhodes A, et al. Intensive Care Med. 2013;39:165&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Crit Care Med. 2011;39:259&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Early goal-directed therapy in the treatment of severe sepsis and septic shock. Rivers E, Nguyen B, Havstad S, et al. N Engl J Med. 2001;345:1368&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Michard F, Teboul JL. Chest. 2002;121:2000&#x2013;2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">12065368</ArticleId></ArticleIdList></Reference><Reference><Citation>Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Marik PE, Cavallazzi R. Crit Care Med. 2013;41:1774&#x2013;1781.</Citation><ArticleIdList><ArticleId IdType="pubmed">23774337</ArticleId></ArticleIdList></Reference><Reference><Citation>Intravenous fluid therapy in the perioperative and critical care setting: executive summary of the International Fluid Academy (IFA) Malbrain ML, Langer T, Annane D, et al. Ann Intensive Care. 2020;10:64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245999</ArticleId><ArticleId IdType="pubmed">32449147</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of protocolized diuresis for de-resuscitation in the intensive care unit. Bissell BD, Laine ME, Thompson Bastin ML, et al. Crit Care. 2020;24:70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7048112</ArticleId><ArticleId IdType="pubmed">32111247</ArticleId></ArticleIdList></Reference><Reference><Citation>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Ann Intern Med. 2009;151:264&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. Andrews B, Semler MW, Muchemwa L, et al. JAMA. 2017;318:1233&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710318</ArticleId><ArticleId IdType="pubmed">28973227</ArticleId></ArticleIdList></Reference><Reference><Citation>Targeted fluid minimization following initial resuscitation in septic shock: a pilot study. Chen C, Kollef MH. Chest. 2015;148:1462&#x2013;1469.</Citation><ArticleIdList><ArticleId IdType="pubmed">26291900</ArticleId></ArticleIdList></Reference><Reference><Citation>The restrictive IV fluid trial in severe sepsis and septic shock (RIFTS): a randomized pilot study. Corl KA, Prodromou M, Merchant RC, et al. Crit Care Med. 2019;47:951&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6579683</ArticleId><ArticleId IdType="pubmed">30985449</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluid response evaluation in sepsis hypotension and shock: a randomized clinical trial. Douglas IS, Alapat PM, Corl KA, et al. Chest. 2020;158:1431&#x2013;1445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9490557</ArticleId><ArticleId IdType="pubmed">32353418</ArticleId></ArticleIdList></Reference><Reference><Citation>Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Hjortrup PB, Haase N, Bundgaard H, et al. Intensive Care Med. 2016;42:1695&#x2013;1705.</Citation><ArticleIdList><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Restrictive fluids versus standard care in adults with sepsis in the emergency department (REFACED): A multicenter, randomized feasibility trial. Jessen MK, Andersen LW, Thomsen MH, et al. Acad Emerg Med. 2022;29:1172&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9804491</ArticleId><ArticleId IdType="pubmed">35652491</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Kj&#xe6;r MN, Meyhoff TS, Sivapalan P, et al. Intensive Care Med. 2023;49:820&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10354110</ArticleId><ArticleId IdType="pubmed">37330928</ArticleId></ArticleIdList></Reference><Reference><Citation>Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial. Macdonald SP, Keijzers G, Taylor DM, et al. Intensive Care Med. 2018;44:2070&#x2013;2078.</Citation><ArticleIdList><ArticleId IdType="pubmed">30382308</ArticleId></ArticleIdList></Reference><Reference><Citation>Restriction of intravenous fluid in ICU patients with septic shock. Meyhoff TS, Hjortrup PB, Wetterslev J, et al. N Engl J Med. 2022;386:2459&#x2013;2470.</Citation><ArticleIdList><ArticleId IdType="pubmed">35709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparative study between restrictive versus liberal intravenous fluid administration in severe sepsis and septic shock; a randomized clinical trial. Noureldin BM, El shafei MM, Markos FA, Ahmed RM. QJM: An International Journal of Medicine. 2023;116</Citation></Reference><Reference><Citation>Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial. Richard JC, Bayle F, Bourdin G, et al. Crit Care. 2015;19:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310180</ArticleId><ArticleId IdType="pubmed">25572383</ArticleId></ArticleIdList></Reference><Reference><Citation>Early restrictive or liberal fluid management for sepsis-induced hypotension. Shapiro NI, Douglas IS, Brower RG, et al. N Engl J Med. 2023;388:499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10685906</ArticleId><ArticleId IdType="pubmed">36688507</ArticleId></ArticleIdList></Reference><Reference><Citation>Restrictive resuscitation in patients with sepsis and mortality: a systematic review and meta-analysis with trial sequential analysis. Reynolds PM, Stefanos S, MacLaren R. Pharmacotherapy. 2023;43:104&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10634281</ArticleId><ArticleId IdType="pubmed">36625778</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of two fluid-management strategies in acute lung injury. The National Heart, Lung Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. N Engl J Med. 2006;354:2564&#x2013;2575.</Citation><ArticleIdList><ArticleId IdType="pubmed">16714767</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggressive or moderate fluid resuscitation in acute pancreatitis. de-Madaria E, Buxbaum JL, Maisonneuve P, et al. N Engl J Med. 2022;387:989&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">36103415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lower vs higher fluid volumes during initial management of sepsis: a systematic review with meta-analysis and trial sequential analysis. Meyhoff TS, M&#xf8;ller MH, Hjortrup PB, Cronhjort M, Perner A, Wetterslev J. Chest. 2020;157:1478&#x2013;1496.</Citation><ArticleIdList><ArticleId IdType="pubmed">31982391</ArticleId></ArticleIdList></Reference><Reference><Citation>Restrictive versus liberal fluid therapy for major abdominal surgery. Myles PS, Bellomo R, Corcoran T, et al. N Engl J Med. 2018;378:2263&#x2013;2274.</Citation><ArticleIdList><ArticleId IdType="pubmed">29742967</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29174966</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J Infect</ISOAbbreviation></Journal><ArticleTitle>Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2017.10.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0163-4453(17)30351-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Pentraxin-3 (PTX-3) is a multi-functional pattern recognition molecule produced by various cell types of peripheral tissues in different infections. It is raised in sepsis, but its values in predicting disease severity or mortality outcomes have been controversial. Therefore, we conducted a systematic review and meta-analysis of these associations.</AbstractText><AbstractText Label="METHODS">PubMed and Embase were searched until July 18, 2017 for studies that evaluated the relationship between PTX-3 levels and disease severity or mortality in sepsis.</AbstractText><AbstractText Label="RESULTS">A total of 23 and 10 entries were retrieved from both databases, respectively, of which 16 studies were included in the final meta-analysis. A total of 3001 patients (56% male, mean age 63&#xa0;&#xb1;&#xa0;15 years; mean follow-up duration of 207 days) were analysed. PTX-3 was significantly higher in patients with more severe sepsis compared to those with less severe sepsis (standard mean difference&#xa0;=&#xa0;18.5&#xa0;ng/mL, standard error: 4.5&#xa0;ng/mL, P&#xa0;&lt;&#xa0;0.0001) and higher in non-survivors compared to survivors (standard mean difference&#xa0;=&#xa0;40.3&#xa0;ng/mL, standard error: 6.8&#xa0;ng/mL, P&#xa0;&lt;&#xa0;0.0001). Elevated PTX-3 levels significantly increased the risk of all-cause mortality (hazard ratio: 1.91, 95% CI: 1.53 to 2.46, P&#xa0;&lt;&#xa0;0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">PTX-3 significantly predicts disease severity and mortality in sepsis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yee Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chau</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wing Tak</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Chinese University of Hong Kong, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazoukis</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, Evangelismos General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Sunny Hei</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lampropoulos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, Evangelismos General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yunlong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guangping</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Martin C S</ForeName><Initials>MCS</Initials><AffiliationInfo><Affiliation>The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>William K K</ForeName><Initials>WKK</Initials><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; Department of Anaesthesia and Intensive Care, State Key Laboratory of Digestive Disease, LKS Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, SAR, China. Electronic address: wukakei@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China. Electronic address: tseg@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>International Heath Informatics Study (IHIS) Network</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000683">Serum Amyloid P-Component</NameOfSubstance></Chemical><Chemical><RegistryNumber>148591-49-5</RegistryNumber><NameOfSubstance UI="C077657">PTX3 protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2018 Apr;76(4):426-428. doi: 10.1016/j.jinf.2018.01.004.</RefSource><PMID Version="1">29360521</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2018 Jul;77(1):75-81. doi: 10.1016/j.jinf.2018.04.014.</RefSource><PMID Version="1">29778629</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000683" MajorTopicYN="N">Serum Amyloid P-Component</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Pentraxin-3</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Severity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29174966</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2017.10.016</ArticleId><ArticleId IdType="pii">S0163-4453(17)30351-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25264181</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>What is new in the diagnosis and prevention of spine surgical site infections.</ArticleTitle><Pagination><StartPage>336</StartPage><EndPage>347</EndPage><MedlinePgn>336-47</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2014.09.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(14)01495-8</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">Surgical site infection (SSI) after spinal surgery can result in several serious secondary complications, such as pseudoarthrosis, neurological injury, paralysis, sepsis, and death. There is an increasing body of literature on risk factors, diagnosis, and specific intraoperative interventions, including attention to sterility of instrumentation, application of minimally invasive fusion techniques, intraoperative irrigation, and application of topical antibiotics, that hold the most promise for reduction of SSI.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purpose of this review is to identify and summarize the recent literature on the incidence, risk factors, diagnosis, prevention, and treatment of SSIs after adult spine surgery.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">The study design included systematic review and literature synthesis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">For the systematic reviews, a search was performed in Medline and Scopus using keywords derived from a preliminary review of the literature and Medline MeSH terms. These studies were then manually filtered to meet the study criteria outlined in each section. Studies were excluded via predetermined criteria, and the majority of articles reviewed were excluded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There are a number of patient- and procedure-specific risk factors for SSI. Surgical site infection appears to have significant implications from the patients' perspective on outcome of care. Diagnosis of SSI appears to rely primarily on clinical factors, while laboratory values such as C-reactive protein are not universally sensitive. Similarly, novel methods of perioperative infection prophylaxis such as local antibiotic administration appear to be modestly effective.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Surgical site infections are a common multifactorial problem after spine surgery. There is compelling evidence that improved risk stratification, detection, and prevention will reduce SSIs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Radcliff</LastName><ForeName>Kris E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Institute, Thomas Jefferson University, 925 Chestnut St, 5th Floor, Philadelphia, PA 19107, USA. Electronic address: kris.radcliff@rothmaninstitute.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neusner</LastName><ForeName>Alexander D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Institute, Thomas Jefferson University, 925 Chestnut St, 5th Floor, Philadelphia, PA 19107, USA; Department of Surgery, Temple University Hospital, 3401 N. Broad St, Suite 400, Philadelphia, PA 19140, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millhouse</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Institute, Thomas Jefferson University, 925 Chestnut St, 5th Floor, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrop</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Thomas Jefferson University, 1015 Walnut St, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kepler</LastName><ForeName>Christopher K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Institute, Thomas Jefferson University, 925 Chestnut St, 5th Floor, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasouli</LastName><ForeName>Mohammad R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Institute, Thomas Jefferson University, 925 Chestnut St, 5th Floor, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Todd J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Institute, Thomas Jefferson University, 925 Chestnut St, 5th Floor, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaccaro</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Institute, Thomas Jefferson University, 925 Chestnut St, 5th Floor, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fusion</Keyword><Keyword MajorTopicYN="N">Inflammatory markers</Keyword><Keyword MajorTopicYN="N">Spinal infection</Keyword><Keyword MajorTopicYN="N">Spinal instrumentation</Keyword><Keyword MajorTopicYN="N">Surgical wound infection</Keyword><Keyword MajorTopicYN="N">Topical antibiotics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25264181</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2014.09.022</ArticleId><ArticleId IdType="pii">S1529-9430(14)01495-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31246600</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Blood Purification and Mortality in Sepsis and Septic Shock: A Systematic Review and Meta-analysis of Randomized Trials.</ArticleTitle><Pagination><StartPage>580</StartPage><EndPage>593</EndPage><MedlinePgn>580-593</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000002820</ELocationID><Abstract><AbstractText Label="BACKGROUND">Sepsis and septic shock are severe inflammatory conditions related to high morbidity and mortality. We performed a systematic review with meta-analysis of randomized trials to assess whether extracorporeal blood purification reduces mortality in this setting.</AbstractText><AbstractText Label="METHODS">Electronic databases were searched for pertinent studies up to January 2019. We included randomized controlled trials on the use of hemoperfusion, hemofiltration without a renal replacement purpose, and plasmapheresis as a blood purification technique in comparison to conventional therapy in adult patients with sepsis and septic shock. The primary outcome was mortality at the longest follow-up available. We calculated relative risks and 95% CIs. The grading of recommendations assessment, development and evaluation methodology for the certainty of evidence was used.</AbstractText><AbstractText Label="RESULTS">Thirty-seven trials with 2,499 patients were included in the meta-analysis. Hemoperfusion was associated with lower mortality compared to conventional therapy (relative risk = 0.88 [95% CI, 0.78 to 0.98], P = 0.02, very low certainty evidence). Low risk of bias trials on polymyxin B immobilized filter hemoperfusion showed no mortality difference versus control (relative risk = 1.14 [95% CI, 0.96 to 1.36], P = 0.12, moderate certainty evidence), while recent trials found an increased mortality (relative risk = 1.22 [95% CI, 1.03 to 1.45], P = 0.02, low certainty evidence); trials performed in the United States and Europe had no significant difference in mortality (relative risk = 1.13 [95% CI, 0.96 to 1.34], P = 0.15), while trials performed in Asia had a positive treatment effect (relative risk = 0.57 [95% CI, 0.47 to 0.69], P &lt; 0.001). Hemofiltration (relative risk = 0.79 [95% CI, 0.63 to 1.00], P = 0.05, very low certainty evidence) and plasmapheresis (relative risk = 0.63 [95% CI, 0.42 to 0.96], P = 0.03, very low certainty evidence) were associated with a lower mortality.</AbstractText><AbstractText Label="CONCLUSIONS">Very low-quality randomized evidence demonstrates that the use of hemoperfusion, hemofiltration, or plasmapheresis may reduce mortality in sepsis or septic shock. Existing evidence of moderate quality and certainty does not provide any support for a difference in mortality using polymyxin B hemoperfusion. Further high-quality randomized trials are needed before systematic implementation of these therapies in clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Division of Anesthesiology, Department of Anesthesiology, Pharmacology, Intensive Care, and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland (A.P., R.S.) the Hospital Universitari de Bellvitge, Intensive Care Department, and the Biomedical Investigation Institute of Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain (J.C.L.-D.) the Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland (T.C.) the Department of Anaesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy (G.L.) Vita-Salute San Raffaele University, Milan, Italy (G.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schorer</LastName><ForeName>Raoul</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Lopez-Delgado</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Cassina</LastName><ForeName>Tiziano</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006440" MajorTopicYN="N">Hemofiltration</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31246600</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000002820</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40357564</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>A systematic methodological evaluation of sepsis guidelines: Protocol for quality assessment and consistency of recommendations.</ArticleTitle><Pagination><StartPage>e70036</StartPage><MedlinePgn>e70036</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70036</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.70036</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sepsis is a leading cause of mortality worldwide, characterized by a dysregulated host response to infection. Despite the development of multiple clinical practice guidelines (CPGs) to standardize sepsis management, substantial variability exists in methodological quality and key clinical recommendations. This inconsistency complicates guideline implementation and potentially affects patient outcomes. The proposed systematic methodological review aims to evaluate the quality and consistency of sepsis guidelines to identify areas for improvement and provide actionable insights for guideline developers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This protocol outlines a systematic methodological review of sepsis CPGs published over the last two decades (2004-2025). A comprehensive search strategy will be conducted across PubMed, EMBASE, the Cochrane Library, and the official websites of professional societies to identify relevant guidelines. The inclusion criteria are CPGs targeting adult sepsis management published by recognized medical or governmental organizations with detailed methodological descriptions. We will use the Appraisal of Guidelines for Research and Evaluation II instrument to assess methodological quality across six domains: scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence. Data extraction will focus on key clinical recommendations, including fluid resuscitation, antimicrobial therapy, vasopressor and inotrope use, corticosteroids, source control, blood glucose management, hemodynamic management, and mechanical ventilation management. The consistency of the recommendations will be analyzed, and trends in guideline quality over time will be evaluated. Artificial intelligence (AI) tools will be evaluated for data extraction processes in systematic reviews to determine their capacity for efficiency and accuracy in extracting data compared to human-driven methods.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">By systematically appraising the quality and consistency of sepsis guidelines, this review aims to address the existing gaps and discrepancies in guideline development and application. These findings will provide valuable insights into the evolution of sepsis guideline quality, highlight areas for improvement, and support the development of more robust evidence-based recommendations. These results will inform clinicians and guideline developers, ultimately enhancing the standardization and effectiveness of sepsis management worldwide. Integrating AI into the review process represents a novel methodological advancement that streamlines data extraction and analysis.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Acta Anaesthesiologica Scandinavica published by John Wiley &amp; Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amer</LastName><ForeName>Marwa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9497-1451</Identifier><AffiliationInfo><Affiliation>Medical/Critical Pharmacy Division, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Morten Hylander</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granholm</LastName><ForeName>Anders</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5799-7655</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alotaibi</LastName><ForeName>Haifa F</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Health Research Center, Directorate General of Armed Forces Medical Services, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlMuhaidib</LastName><ForeName>Shadan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Independent Researcher, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Duhailib</LastName><ForeName>Zainab</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-0758-6695</Identifier><AffiliationInfo><Affiliation>College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Care Medicine Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arafat</LastName><ForeName>Amr</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Research Center, Directorate General of Armed Forces Medical Services, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0003-2888-4111</Identifier><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehn</LastName><ForeName>Marius</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9519-241X</Identifier><AffiliationInfo><Affiliation>Division of Prehospital Services, Air Ambulance Department, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Norwegian Air Ambulance Foundation, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigur&#xf0;sson</LastName><ForeName>Martin Ingi</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0001-7054-0844</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care Medicine, Landspitali-The National University Hospital of Iceland, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalliom&#xe4;ki</LastName><ForeName>Maija-Liisa</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Tampere University Hospital, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olkkola</LastName><ForeName>Klaus T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jalkanen</LastName><ForeName>Ville</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Tampere University Hospital Tampere, Pirkanmaa, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-1349-1123</Identifier><AffiliationInfo><Affiliation>Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krak&#xf3;w, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Department, 5th Military Hospital, Krak&#xf3;w, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshaqaq</LastName><ForeName>Hassan M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-4702-0917</Identifier><AffiliationInfo><Affiliation>Emergency Medicine Department, King Saud University Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Kimberley</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6610-3369</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research, Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute of St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carayannopoulos</LastName><ForeName>Kallirroi Laiya</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research, Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute of St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honarmand</LastName><ForeName>Kimia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Research, Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Critical Care, Department of Medicine, Mackenzie Health, Vaughan, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhuri</LastName><ForeName>Dipayan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research, Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alquraini</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Medicine/Critical Care/NeuroCritical Care Department, Almana Hospitals, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amer</LastName><ForeName>Yasser S</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Pediatrics Department, King Khalid University Hospital, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Practice Guidelines and Quality Research Unit, Quality Management Department, King Saud University Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Chair for Evidence-Based Health Care and Knowledge Translation, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alexandria Center for Evidence-Based Clinical Practice Guidelines, Alexandria University, Alexandria, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adaptation Working Group, Guidelines International Network, Perth, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshamsi</LastName><ForeName>Fayez</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Alain, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhazzani</LastName><ForeName>Waleed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Health Research Center, Directorate General of Armed Forces Medical Services, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Care and Internal Medicine Department, College of Medicine, Imam Abdulrahman Bin Faisal University, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AGREE II</Keyword><Keyword MajorTopicYN="N">clinical practice guidelines</Keyword><Keyword MajorTopicYN="N">consistency</Keyword><Keyword MajorTopicYN="N">guideline quality assessment</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>Waleed Alhazzani, Morten Hylander M&#xf8;ller, Fayez Alshamsi, Kimberley Lewis, and Dipayan Chaudhuri were members with conflicts of interest (involvement in the SCCM/ESICM Surviving Sepsis Campaign, Surviving Sepsis Campaign on the management of critically ill adults with Coronavirus Disease 2019, 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis) and will not be involved in the AGREE II assessment of the related guidelines. Kimia Honarmand is involved in ongoing updates of the Surviving Sepsis Campaign.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>13</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>5</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40357564</ArticleId><ArticleId IdType="pmc">PMC12070244</ArticleId><ArticleId IdType="doi">10.1111/aas.70036</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oczkowski S, Alshamsi F, Belley&#x2010;Cote E, et al. Surviving sepsis campaign guidelines 2021: highlights for the practicing clinician. Pol Arch Intern Med. 2022;132(7&#x2013;8):16290. doi:10.20452/pamw.16290</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16290</ArticleId><ArticleId IdType="pubmed">35791800</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J&#x2010;L, Singer M, Einav S, et al. Equilibrating SSC guidelines with individualized care. Crit Care. 2021;25(1):397. doi:10.1186/s13054-021-03813-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03813-0</ArticleId><ArticleId IdType="pmc">PMC8596086</ArticleId><ArticleId IdType="pubmed">34789298</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181&#x2010;1247. doi:10.1007/s00134-021-06506-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin&#x2010;Loeches I, Singer M, Leone M. Sepsis: key insights, future directions, and immediate goals. A review and expert opinion. Intensive Care Med. 2024;50(12):2043&#x2010;2049. doi:10.1007/s00134-024-07694-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-024-07694-z</ArticleId><ArticleId IdType="pubmed">39531053</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Ogura H, Yatabe T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J&#x2010;SSCG 2020). J Intensive Care. 2021;9(1):53. doi:10.1186/s40560-021-00555-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-021-00555-7</ArticleId><ArticleId IdType="pmc">PMC8384927</ArticleId><ArticleId IdType="pubmed">34433491</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta&#x2010;analysis protocols (PRISMA&#x2010;P) 2015 statement. Syst Rev. 2015;4(1):1. doi:10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S, Van Den Ben A. Cochrane handbook for systematic reviews of interventions. Int Coach Psychol Rev. 2020;15(2):123&#x2010;125. doi:10.53841/bpsicpr.2020.15.2.123</Citation><ArticleIdList><ArticleId IdType="doi">10.53841/bpsicpr.2020.15.2.123</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazzani W, M&#xf8;ller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID&#x2010;19). Intensive Care Med. 2020;46(5):854&#x2010;887. doi:10.1007/s00134-020-06022-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06022-5</ArticleId><ArticleId IdType="pmc">PMC7101866</ArticleId><ArticleId IdType="pubmed">32222812</ArticleId></ArticleIdList></Reference><Reference><Citation>
AGREE Next Steps Consortium
. The My AGREE PLUS Platform. AGREE Trust; 2017. 
https://www.agreetrust.org
</Citation></Reference><Reference><Citation>
Consortium TANS
. Appraisal of Guidelines for Research and Evaluation. Vol II. 2017. 
http://www.agreetrust.org
</Citation></Reference><Reference><Citation>Wang X, Zheng M&#x2010;Y, He H&#x2010;Y, et al. Quality evaluation of guidelines for the diagnosis and treatment of liver failure. Crit Care Med. 2024;52(10):1624&#x2010;1632. doi:10.1097/CCM.0000000000006346</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000006346</ArticleId><ArticleId IdType="pmc">PMC11392122</ArticleId><ArticleId IdType="pubmed">38832833</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839&#x2010;E842. doi:10.1503/cmaj.090449</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.090449</ArticleId><ArticleId IdType="pmc">PMC3001530</ArticleId><ArticleId IdType="pubmed">20603348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996;49(8):907&#x2010;916. doi:10.1016/0895-4356(96)00025-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(96)00025-x</ArticleId><ArticleId IdType="pubmed">8699212</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924&#x2010;926. doi:10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk SHB, Brusse&#x2010;Keizer MGJ, Bucs&#xe1;n CC, van der Palen J, Doggen CJM, Lenferink A. Artificial intelligence in systematic reviews: promising when appropriately used. BMJ Open. 2023;13(7):e072254. doi:10.1136/bmjopen-2023-072254</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-072254</ArticleId><ArticleId IdType="pmc">PMC10335470</ArticleId><ArticleId IdType="pubmed">37419641</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsen APH, Sunde PB, Olsen MH, et al. Opioids and personalized analgesia in the perioperative setting: a protocol for five systematic reviews. Acta Anaesthesiol Scand. 2024;68(10):1573&#x2010;1580. doi:10.1111/aas.14508</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.14508</ArticleId><ArticleId IdType="pubmed">39107975</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis&#x2010;3). Jama. 2016;315(8):801&#x2010;810. doi:10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Klompas M, Berra L, Branson R. Beware the siren's song of novel endotracheal tube designs. Intensive Care Med. 2017;43(11):1708&#x2010;1711. doi:10.1007/s00134-017-4778-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4778-0</ArticleId><ArticleId IdType="pubmed">28364302</ArticleId></ArticleIdList></Reference><Reference><Citation>Thwaites L, Nasa P, Abbenbroek B, et al. Management of adult sepsis in resource&#x2010;limited settings: global expert consensus statements using a Delphi method. Intensive Care Med. 2025;51(1):21&#x2010;38. doi:10.1007/s00134-024-07735-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-024-07735-7</ArticleId><ArticleId IdType="pmc">PMC11787051</ArticleId><ArticleId IdType="pubmed">39714613</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah FA, Talisa VB, Chang CH, et al. Heterogeneity in the effect of early goal&#x2010;directed therapy for septic shock: a secondary analysis of two multicenter international trials. Crit Care Med. 2025;53(1):e4&#x2010;e14. doi:10.1097/CCM.0000000000006463</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000006463</ArticleId><ArticleId IdType="pmc">PMC11710998</ArticleId><ArticleId IdType="pubmed">39440873</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastores SM, Annane D, Rochwerg B, Corticosteroid Guideline Task Force of SCCM and ESICM . Guidelines for the diagnosis and management of critical illness&#x2010;related corticosteroid insufficiency (CIRCI) in critically ill patients (part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2018;44(4):474&#x2010;477. doi:10.1007/s00134-017-4951-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4951-5</ArticleId><ArticleId IdType="pubmed">29090327</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness&#x2010;related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2017;45(12):2078&#x2010;2088. doi:10.1097/CCM.0000000000002737</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002737</ArticleId><ArticleId IdType="pubmed">28938253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge L, Agrawal R, Singer M, et al. Leveraging artificial intelligence to enhance systematic reviews in health research: advanced tools and challenges. Syst Rev. 2024;13(1):269. doi:10.1186/s13643-024-02682-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-024-02682-2</ArticleId><ArticleId IdType="pmc">PMC11504244</ArticleId><ArticleId IdType="pubmed">39456077</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Sun J, Tan X. Evaluating the effectiveness of large language models in abstract screening: a comparative analysis. Syst Rev. 2024;13(1):219. doi:10.1186/s13643-024-02609-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-024-02609-x</ArticleId><ArticleId IdType="pmc">PMC11337893</ArticleId><ArticleId IdType="pubmed">39169386</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27684877</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>39</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Prevalence and risk factors of sepsis-induced cardiomyopathy: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>e5031</StartPage><MedlinePgn>e5031</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5031</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000005031</ELocationID><Abstract><AbstractText>The aim of the study is to evaluate the epidemiology and clinical features of sepsis-induced cardiomyopathy (SICM).A retrospective cohort study was conducted.A total of 210 adult patients with sepsis or septic shock admitted to a Japanese tertiary care hospital from January 1, 2013, to December 31, 2015, who underwent transthoracic echocardiography (TTE) on admission.The definition of SICM was ejection fraction (EF)&#x200a;&lt;&#x200a;50% and a &#x2265;10% decrease compared to the baseline EF which recovered within 2 weeks, in sepsis or septic shock patients.Our primary outcome was the incidence rate of SICM. Our secondary outcomes were the in-hospital mortality rate and length of intensive care unit (ICU) stay according to the presence or absence of SICM. In total, 29 patients (13.8%) were diagnosed with SICM. The prevalence rate of SICM was significantly higher in male than in female (P = 0.02). Multivariate logistic regression analyses revealed that the incidence of SICM was associated with younger age (odds ratio [OR], 0.97; 95% confidence interval [CI], 0.95-0.99), higher lactate level on admission (OR, 1.18; 95% CI, 1.05-1.32) and history of heart failure (HF) (OR, 3.77; 95% CI, 1.37-10.40). There were no significant differences in the in-hospital and 30-day mortality between patients with and without SICM (24.1% vs 12.7%, P = 0.15; 20.7% vs 12.1%, P = 0.23). Lengths of hospital and ICU stay were significantly longer in patients with SICM than in those without SICM (median, 43 vs 26 days, P = 0.04; 9 vs 5 days, P&#x200a;&lt;&#x200a;0.01).SICM developed in 13.8% of patients with sepsis and septic shock. A younger age, higher lactate levels on admission and history of HF were risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Ryota</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>aDepartment of Emergency and Critical Care Medicine, Urasoe General Hospital bDepartment of General Medicine, Kurashiki Central Hospital cDepartment of Anesthesia, Urasoe General Hospital, Okinawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuriyama</LastName><ForeName>Akira</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Takada</LastName><ForeName>Tadaaki</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Nasu</LastName><ForeName>Michitaka</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Luthe</LastName><ForeName>Sarah Kyuragi</ForeName><Initials>SK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27684877</ArticleId><ArticleId IdType="pmc">PMC5265970</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000005031</ArticleId><ArticleId IdType="pii">00005792-201609270-00087</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">6703540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato R, Nasu M. A review of sepsis-induced cardiomyopathy. J Intensive care 2015; 3:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4642671</ArticleId><ArticleId IdType="pubmed">26566443</ArticleId></ArticleIdList></Reference><Reference><Citation>Flesch M, Kilter H, Cremers B, et al. Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite. J Am Coll Cardiol 1999; 33:1062&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">10091837</ArticleId></ArticleIdList></Reference><Reference><Citation>Natanson C, Eichenholz Pw Fau - Danner RL, Danner Rl Fau-Eichacker PQ, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169:823&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2189288</ArticleId><ArticleId IdType="pubmed">2647895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Thota V, Fau - Dee L, et al. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183:949&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192364</ArticleId><ArticleId IdType="pubmed">8642298</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardin F, Brun-Ney D, Auvert B, et al. Sepsis-related cardiogenic shock. Crit Care Med 1990; 18:1055&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pubmed">2209030</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard Baron A, Schmitt JM, Beauchet A, et al. Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology 2001; 94:400&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">11374597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhemad B, Nicolas-Robin A, Arbelot C, et al. Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 2009; 37:441&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pubmed">19114917</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard-Baron A, Caille V, Charron C, et al. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008; 36:1701&#x2013;1706.</Citation><ArticleIdList><ArticleId IdType="pubmed">18496368</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchecopar-Chevreuil C, Francois B, Clavel M, et al. Cardiac morphological and functional changes during early septic shock: a transesophageal echocardiographic study. Intensive Care Med 2008; 34:250&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">18004543</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Repesse X, Fau-Charron C, Charron C, et al. Evaluation of left ventricular systolic function revisited in septic shock. Crit Care (London, England) 2013; 17:164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3706940</ArticleId><ArticleId IdType="pubmed">23826739</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333:1025&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">7675044</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes MA, Timmins AC, Yau EH, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717&#x2013;1722.</Citation><ArticleIdList><ArticleId IdType="pubmed">7993413</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez G, Bruhn A, Luengo C, et al. Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study. Intensive Care Med 2013; 39:1435&#x2013;1443.</Citation><ArticleIdList><ArticleId IdType="pubmed">23740284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyte M, Freestone PP, Neal CP, et al. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet (London, England) 2003; 361:130&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkman E, Kaukonen KM, Pettila V, et al. Association between inotrope treatment and 90-day mortality in patients with septic shock. Acta Anaesthesiologica Scandinavica 2013; 57:431&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pubmed">23298252</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 2013; 310:1683&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SJ, Nalos M, McLean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care (London, England) 2013; 17:R96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056117</ArticleId><ArticleId IdType="pubmed">23706109</ArticleId></ArticleIdList></Reference><Reference><Citation>Robotham JL, Takata M, Fau-Berman M, et al. Ejection fraction revisited. Anesthesiology 1991; 74:172&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">1986643</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x2013;2012. JAMA 2014; 311:1308&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31808551</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>06</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Corticosteroids for treating sepsis in children and adults.</ArticleTitle><Pagination><StartPage>CD002243</StartPage><MedlinePgn>CD002243</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD002243</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD002243.pub4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Sepsis occurs when an infection is complicated by organ failure. Sepsis may be complicated by impaired corticosteroid metabolism. Thus, providing corticosteroids may benefit patients. The original review was published in 2004 and was updated in 2010 and 2015 prior to this update.</AbstractText><AbstractText Label="OBJECTIVES">To examine the effects of corticosteroids on death&#xa0;in children and adults with sepsis.</AbstractText><AbstractText Label="SEARCH METHODS">We searched CENTRAL, MEDLINE, Embase, LILACS, ClinicalTrials.gov, ISRCTN, and the WHO Clinical Trials Search Portal, on 25 July 2019. In addition, we conducted reference checking and citation searching, and contacted study authors, to identify additional studies as needed.</AbstractText><AbstractText Label="SELECTION CRITERIA">We included randomized controlled trials (RCTs) of corticosteroids versus placebo or usual care (antimicrobials, fluid replacement, and vasopressor therapy as needed) in children and adults with sepsis. We also included RCTs of continuous infusion versus intermittent bolus of corticosteroids.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">All review authors screened and selected studies for inclusion. One review author extracted data, which was checked by the others, and by the lead author of the primary study when possible. We obtained unpublished data from the authors of some trials. We assessed the methodological quality of trials and applied GRADE to assess the certainty of evidence. Review authors did not contribute to assessment of eligibility and risk of bias, nor to data extraction, for trials they had&#xa0;participated in.</AbstractText><AbstractText Label="MAIN RESULTS">We included 61 trials (12,192 participants), of which six included only children, two included children and adults, and the remaining trials included only adults. Nine studies are ongoing and will be considered in future versions of this review. We judged 19 trials as being at low risk of bias. Corticosteroids versus placebo or usual care Compared to placebo or usual care, corticosteroids probably&#xa0;slightly reduce 28-day mortality (risk ratio (RR) 0.91, 95% confidence interval (CI) 0.84 to 0.99; 11,233 participants; 50 studies; moderate-certainty evidence). Corticosteroids may result in little to no difference in long-term mortality (RR 0.97, 95% CI 0.91 to 1.03; 6236 participants; 7 studies; low-certainty evidence) and probably&#xa0;slightly reduce hospital mortality (RR 0.90, 95% CI 0.82 to 0.99; 8183 participants; 26 trials; moderate-certainty evidence). Corticosteroids reduced length of intensive care unit (ICU) stay for all participants&#xa0;(mean difference (MD) -1.07 days, 95% CI -1.95 to -0.19; 7612 participants; 21 studies; high-certainty evidence) and resulted in a large reduction in length of hospital stay for all participants&#xa0;(MD -1.63 days, 95% CI -2.93 to -0.33; 8795 participants; 22 studies; high-certainty evidence). Corticosteroids increase the risk of&#xa0;muscle weakness&#xa0;(RR 1.21, 95% CI 1.01 to 1.44; 6145 participants; 6 studies; high-certainty evidence). Corticosteroids probably do&#xa0;not increase the risk of superinfection (RR 1.06, 95% CI 0.95 to 1.19; 5356 participants; 25 studies; moderate-certainty evidence). Corticosteroids increase the risk of hypernatraemia (high-certainty evidence) and probably increase the risk of hyperglycaemia (moderate-certainty evidence).&#xa0;Moderate-certainty evidence shows that there is probably little or no difference in gastroduodenal bleeding, stroke, or cardiac events, and low-certainty evidence suggests that corticosteroids may result in little to no difference in neuropsychiatric events. Continuous infusion of corticosteroids versus intermittent bolus We are uncertain about the effects of continuous infusion of corticosteroids compared with intermittent bolus administration. Three studies reported data for this comparison, and the certainty of evidence for all outcomes was very low.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">Moderate-certainty evidence indicates that corticosteroids probably reduce 28-day and hospital mortality among patients with sepsis. Corticosteroids result in large reductions in ICU and hospital length of stay (high-certainty evidence). There may be little or no difference in the risk of major complications;&#xa0;however, corticosteroids increase the risk of muscle weakness and hypernatraemia, and probably increase the risk of hyperglycaemia. The effects of continuous versus intermittent bolus administration of corticosteroids are uncertain.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Annane</LastName><ForeName>Djillali</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Neuromuscular Diseases; Raymond Poincar&#xe9; Hospital (AP-HP), Department of Critical Care, Hyperbaric Medicine and Home Respiratory Unit, Faculty of Health Sciences Simone Veil, University of Versailles SQY- University of Paris Saclay, 104 Boulevard Raymond Poincar&#xe9;, Garches, France, 92380.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellissant</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Pontchaillou, Centre d'Investigation Clinique INSERM 0203, Rennes, France, 35033.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bollaert</LastName><ForeName>Pierre Edouard</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Central, Intensive Care Unit, Nancy, France, 54000.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briegel</LastName><ForeName>Josef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Klinikum der Universit&#xe4;t, Klinik fur An&#xe4;sthesiologie, M&#xfc;nchen, Germany, 81377.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keh</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Charit&#xe9;-Campus Virchow Clinic, Charit&#xe9; Universit&#xe4;tsmedizin Berlin, University Clinic of Anesthesiology and Intensive Care Medicine CCM/CVK, Augustenburger Platz 1, Berlin, Germany, 13353.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kupfer</LastName><ForeName>Yizhak</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Maimonides Medical Center, Division of Pulmonary and Critical Care Medicine, 4802 Tenth Avenue, Brooklyn, New York, USA, 11219.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirracchio</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Zuckerberg San Francisco General Hospital and Trauma Center, University of California, Department of Anesthesia and Perioperative Medicine, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rochwerg</LastName><ForeName>Bram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>McMaster University, Division of Critical Care, Department of Medicine, Box 211, Juravinski Hospital, 711 Concession St, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2015 Dec 03;(12):CD002243. doi: 10.1002/14651858.CD002243.pub3.</RefSource><PMID Version="1">26633262</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr. 2020 May;220:264-267. doi: 10.1016/j.jpeds.2020.02.067.</RefSource><PMID Version="1">32334669</PMID></CommentsCorrections><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2025 Jun 5;6:CD002243. doi: 10.1002/14651858.CD002243.pub5.</RefSource><PMID Version="1">40470636</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Djillali Annane is an author of the following studies included in this review: Aboab 2008; Annane 2002; Annane 2010; Annane 2018; Sprung 2008. He obtained funds from the French Minisitry of Health to conduct the following trials: Annane 2002; Annane 2010; and Annane 2018. He has been the chair of the international task force for elaborating 2017 guidelines for the diagnosis and treatment of critical illness&#x2010;related corticosteroid insufficiency. Eric Bellissant is an author of the following studies included in this review: Annane 2002; Annane 2018. Pierre Edouard Bollaert is an author of the following studies included in this review: Annane 2002; Bollaert 1998. He obtained public funds from the University of Nancy to conduct the trial (Bollaert 1998). Josef Briegel is an author of the following studies included in this review: Briegel 1999; Keh 2016; Sprung 2008. He obtained public funds to conduct the trial (Briegel 1999). He contributed to the international task force for elaborating 2017 guidelines for the diagnosis and treatment of critical illness&#x2010;related corticosteroid insufficiency. He participated in the European Society of Intensive Care Medicine, the Deutsche interdisziplin&#xe4;re Vereinigung Intensivmedizin, and the Deutsche Gesellschaft f&#xfc;r An&#xe4;sthesie und Intensivmedizin, and he has given lectures and talks on hydrocortisone treatment for septic shock. Didier Keh is an author of the following studies included in this review: Keh 2003; Keh 2016; Sprung 2008. He obtained public funds from Charit&#xe9;&#x2013;Universit&#xe4;tsmedizin Berlin and from the German Federal Ministry of Education and Research to conduct the following trials: Keh 2003; Keh 2016. Yizhak Kupfer is an author of the following studies included in this review: Chawla 1999. He is a member of the Pfizer/BMS speakers' bureau for epixaban. This product has no relationship to steroids in sepsis. He obtained funds from his institution to conduct the trial (Chawla 1999). Romain Pirracchio received funding for International Mobility from the Fulbright Foundation and from the Assistance Publique &#x2013; H&#xf4;pitaux de Paris (APHP). Bram Rochwerg is supported by McMaster University Department of Medicine early career research awards. He has contributed to the international task force for elaborating 2017 guidelines for the diagnosis and treatment of critical illness&#x2010;related corticosteroid insufficiency. He is a methodologist for American Thoracic Society, European Society of Intensive Care Medicine, and American Society of Haematology.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31808551</ArticleId><ArticleId IdType="pmc">PMC6953403</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD002243.pub4</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Aboab 2008 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Aboab J, Polito A, Orlikowski D, Sharshar T, Castel M, Annane D. Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach. Critical Care Medicine 2008;36(5):1481&#x2010;6. [PUBMED: 18434902]</Citation><ArticleIdList><ArticleId IdType="pubmed">18434902</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2002 {published and unpublished data}</Title><Reference><Citation>Annane D, Sebille V, Charpentier C, Bollaert PE, Fran&#xe7;ois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288(7):862&#x2010;71. [PUBMED: 12186604]</Citation><ArticleIdList><ArticleId IdType="pubmed">12186604</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2010 {published and unpublished data}</Title><Reference><Citation>COIITSS Study Investigators, Annane D, Cariou A, Maxime V, Azoulay E, D'honneur G, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 2010;303(4):341&#x2010;8. [PUBMED: 20103758]</Citation><ArticleIdList><ArticleId IdType="pubmed">20103758</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2018 {published and unpublished data}</Title><Reference><Citation>Annane D, Renault A, Brun&#x2010;Buisson C, Megarbane B, Quenot JP, Siami S, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. New England Journal of Medicine 2018;378(9):809&#x2010;18. [PUBMED: 29490185]</Citation><ArticleIdList><ArticleId IdType="pubmed">29490185</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Arabi 2011 {published and unpublished data}</Title><Reference><Citation>Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al&#x2010;Abdulkareem A, et al. Low&#x2010;dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. Canadian Medical Association Journal 2010;182(18):1971&#x2010;7. [PUBMED: 21059778]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3001503</ArticleId><ArticleId IdType="pubmed">21059778</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Blum 2015 {published data only}</Title><Reference><Citation>Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter&#x2010;Widmer I, et al. Adjunct prednisone therapy for patients with community&#x2010;acquired pneumonia: a multicentre, double&#x2010;blind, randomised, placebo&#x2010;controlled trial. Lancet 2015;385(9977):1511&#x2010;8. [PUBMED: 25608756]</Citation><ArticleIdList><ArticleId IdType="pubmed">25608756</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bollaert 1998 {published and unpublished data}</Title><Reference><Citation>Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Critical Care Medicine 1998;26(4):645&#x2010;50. [PUBMED: 9559600]</Citation><ArticleIdList><ArticleId IdType="pubmed">9559600</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bone 1987 {published data only}</Title><Reference><Citation>Bone RG, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high&#x2010;dose methylprednisolone in the treatment of severe sepsis and septic shock. New England Journal of Medicine 1987;317(11):653&#x2010;8. [PUBMED: 3306374]</Citation><ArticleIdList><ArticleId IdType="pubmed">3306374</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Briegel 1999 {published and unpublished data}</Title><Reference><Citation>Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double&#x2010;blind, single&#x2010;center study. Critical Care Medicine 1999;27(4):723&#x2010;32. [PUBMED: 10321661]</Citation><ArticleIdList><ArticleId IdType="pubmed">10321661</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chawla 1999 {published and unpublished data}</Title><Reference><Citation>Chawla K, Kupfer Y, Tessler S. Hydrocortisone reverses refractory septic shock. Critical Care Medicine 1999;27(1):A33.</Citation></Reference></ReferenceList><ReferenceList><Title>Cicarelli 2007 {published data only}</Title><Reference><Citation>Cicarelli DD, Vieira JE, Bense&#xf1;or FE. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Medical Journal 2007;125(4):237&#x2010;41. [PUBMED: 17992396 ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11020550</ArticleId><ArticleId IdType="pubmed">17992396</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Confalonieri 2005 {published and unpublished data}</Title><Reference><Citation>Confalonieri M, Urbino R, Potena A, Piatella M, Parigi P, Giacomo P, et al. Hydrocortisone infusion for severe community acquired pneumonia: a preliminary randomized study. American Journal of Respiratory and Critical Care Medicine 2005;171(3):242&#x2010;8. [PUBMED: 15557131]</Citation><ArticleIdList><ArticleId IdType="pubmed">15557131</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>CSG 1963 {published data only}</Title><Reference><Citation>Cooperative Study Group. The effectiveness of hydrocortisone in the management of severe infections. JAMA 1963;183(6):462&#x2010;5. [DOI: 10.1001/jama.1963.63700060029012]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1963.63700060029012</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Doluee 2018 {published data only}</Title><Reference><Citation>Talebi Doluee M, Salehi M, Mahmoudi Gharaee A, Jalalyazdi M, Reihani H. The effect of physiologic dose of intravenous hydrocortisone in patients with refractory septic shock: a randomized control trial. Journal of Emergency Practice and Trauma 2018;4:29&#x2010;33. [DOI: 10.15171/JEPT.2017.25]</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/JEPT.2017.25</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>El Ghamrawy 2006 {published data only}</Title><Reference><Citation>El&#x2010;Ghamraway AH, Shokeir MH, Esmat AA. Effects of low dose hydrocortisone in ICU patients with severe community acquired pneumonia. Egyptian Journal of Chest 2006;55:91&#x2010;9.</Citation></Reference></ReferenceList><ReferenceList><Title>El&#x2010;Nawawy 2017 {published data only}</Title><Reference><Citation>El&#x2010;Nawawy A, Khater D, Omar H, Wali Y. Evaluation of early corticosteroid therapy in management of paediatric septic shock in paediatric intensive care patients: a randomized clinical study. Pediatric Infectious Disease Journal 2017;36(2):155&#x2010;9. [PUBMED: 27798546]</Citation><ArticleIdList><ArticleId IdType="pubmed">27798546</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fern&#xe1;ndez&#x2010;Serrano 2011 {published data only}</Title><Reference><Citation>Fern&#xe1;ndez&#x2010;Serrano S, Dorca J, Garcia&#x2010;Vidal C, Fern&#xe1;ndez&#x2010;Sab&#xe9; N, Carratal&#xe0; J, Fern&#xe1;ndez&#x2010;Ag&#xfc;era A, et al. Effect of corticosteroids on the clinical course of community&#x2010;acquired pneumonia: a randomized controlled trial. Critical Care 2011;15(2):R96. [PUBMED: 21406101]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219361</ArticleId><ArticleId IdType="pubmed">21406101</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gordon 2014 {published and unpublished data}</Title><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Critical Care Medicine 2014;42(6):1325&#x2010;33. [PUBMED: 24557425]</Citation><ArticleIdList><ArticleId IdType="pubmed">24557425</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gordon 2016 {published and unpublished data}</Title><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 2016;316(5):509&#x2010;18. [PUBMED: 27483065]</Citation><ArticleIdList><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hu 2009 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Hu B, Li JG, Liang H, Zhou Q, Yu Z, Li L, et al. The effect of low&#x2010;dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2009;21(9):529&#x2010;31. [PUBMED: 19751560]</Citation><ArticleIdList><ArticleId IdType="pubmed">19751560</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huang 2014 {published data only}</Title><Reference><Citation>Huang R, Zhang Z, Xu M, Chang X, Qiao Q, Wang L, et al. Effect of Sini decoction on function of hypothalamic&#x2010;pituitary&#x2010;adrenal axis in patients with sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2014;26(3):184&#x2010;7. [PUBMED: 24598293]</Citation><ArticleIdList><ArticleId IdType="pubmed">24598293</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huh 2007 {published data only}</Title><Reference><Citation>Huh JW, Lim CM, Koh Y, Hong SB. Effect of low doses of hydrocortisone in patient with septic shock and relative adrenal insufficiency: 3 days versus 7 days treatment. Critical Care Medicine 2006;34(12 suppl):A101.</Citation></Reference></ReferenceList><ReferenceList><Title>Hyvernat 2016 {published and unpublished data}</Title><Reference><Citation>Hyvernat H, Barel R, Gentilhomme A, C&#xe9;sari&#x2010;Giordani JF, Freche A, Kaidomar M, et al. Effects of increasing hydrocortisone to 300&#x200a;mg per day in the treatment of septic shock: a pilot study. Shock 2016;46:498&#x2010;505. [PUBMED: 27405061]</Citation><ArticleIdList><ArticleId IdType="pubmed">27405061</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Keh 2003 {published and unpublished data}</Title><Reference><Citation>Keh D, Boehnke T, Weber&#x2010;Cartens S, Schulz C, Ahlers O, Bercker S, et al. Immunologic and hemodynamic effects of "low&#x2010;dose" hydrocortisone in septic shock: a double&#x2010;blind, randomized, placebo&#x2010;controlled, crossover study. American Journal of Respiratory and Critical Care Medicine 2003;167(4):512&#x2010;20. [PUBMED: 12426230 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12426230</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Keh 2016 {published and unpublished data}</Title><Reference><Citation>Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, et al. Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA 2016;316(17):1775&#x2010;85. [PUBMED: 27695824]</Citation><ArticleIdList><ArticleId IdType="pubmed">27695824</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kurungundla 2008 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Kurugundla N, Irugulapati L, Kilari D, Amchentsev A, Devakonda A, George L, et al. Effect of steroids in septic shock patients without relative adrenal insufficiency. American Thoracic Society 2008;116.</Citation></Reference></ReferenceList><ReferenceList><Title>Li 2016 {published data only}</Title><Reference><Citation>Li G, Gu C, Zhang S, Lian R, Zhang G. Value of glucocorticoid steroids in the treatment of patients with severe community acquired pneumonia complicated with septic shock. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2016;28(9):780&#x2010;4. [DOI: 10.3760/cma.j.issn.2095-4352.2016.09.003]</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.2095-4352.2016.09.003</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 2012 {published and unpublished data}</Title><Reference><Citation>Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, et al. The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness&#x2010;related corticosteroid insufficiency. Zhonghua Nei Ke Za Zhi 2012;51(8):599&#x2010;603. [PUBMED: 23158856]</Citation><ArticleIdList><ArticleId IdType="pubmed">23158856</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Loisa 2007 {published data only}</Title><Reference><Citation>Loisa P, Parviainen I, Tenhunen J, Hovilehto S, Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Critical Care 2007;11(1):R21. [PUBMED: 17306016]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2151907</ArticleId><ArticleId IdType="pubmed">17306016</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Luce 1988 {published and unpublished data}</Title><Reference><Citation>Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high&#x2010;dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. American Review of Respiratory Diseases 1988;138(1):62&#x2010;8. [PUBMED: 3202402 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3202402</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lv 2017 {published and unpublished data}</Title><Reference><Citation>Lv QQ, Gu XH, Chen QH, Yu JQ, Zheng RQ. Early initiation of low&#x2010;dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial. American Journal of Emergency Medicine 2017;35(12):1810&#x2010;4. [PUBMED: 28615145]</Citation><ArticleIdList><ArticleId IdType="pubmed">28615145</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McHardy 1972 {published data only}</Title><Reference><Citation>McHardy VU, Schonell ME. Ampicillin dosage and use of prednisolone in treatment of pneumonia: co&#x2010;operative controlled trial. BMJ 1972;4(5840):569&#x2010;73. [PUBMED: 4404939]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1786783</ArticleId><ArticleId IdType="pubmed">4404939</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Meduri 2007 {published and unpublished data}</Title><Reference><Citation>Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131(4):954&#x2010;63. [PUBMED: 17426195]</Citation><ArticleIdList><ArticleId IdType="pubmed">17426195</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Meduri 2009 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Meduri GU, Golden E, Freire AX, Umberger R. Randomized clinical trial (RCT) evaluating the effects of low&#x2010;dose prolonged hydrocortisone infusion on resolution of MODS in severe sepsis. Chest 2009;136:154.</Citation></Reference></ReferenceList><ReferenceList><Title>Meijvis 2011 {published data only}</Title><Reference><Citation>Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, Velzen&#x2010;Blad H, et al. Dexamethasone and length of hospital stay in patients with community&#x2010;acquired pneumonia: a randomised, double&#x2010;blind, placebo&#x2010;controlled trial. Lancet 2011;377(9782):2023&#x2010;30. [PUBMED: 21636122]</Citation><ArticleIdList><ArticleId IdType="pubmed">21636122</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Menon 2017 {published data only}</Title><Reference><Citation>Menon K, McNally D, O'Hearn K, Acharya A, Wong HR, Lawson M, et al. A randomized controlled trial of corticosteroids in paediatric septic shock: a pilot feasibility study. Pediatric Critical Care Medicine 2017;18(6):505&#x2010;12. [PUBMED: 28406862]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5457353</ArticleId><ArticleId IdType="pubmed">28406862</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mirea 2014 {published and unpublished data}</Title><Reference><Citation>Mirea L, Ungureanu R, Pavelescu D, Grintescu IC, Dumitrache C, Grintescu I, et al. Continuous administration of corticosteroids in septic shock can reduce risk of hypernatraemia. Critical Care 2014;18:S86.</Citation></Reference></ReferenceList><ReferenceList><Title>Nafae 2013 {published data only}</Title><Reference><Citation>Nafae RM, Ragab MI, Amany FM, Rashed SB. Adjuvant role of corticosteroids in the treatment of community acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis 2013;62:439&#x2010;45.</Citation></Reference></ReferenceList><ReferenceList><Title>Nagy 2013 {published data only}</Title><Reference><Citation>Nagy B, Gaspar I, Papp A, Bene Z, Nagy B Jr, Voko Z, et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology 2013;48:168&#x2010;75. [PUBMED: 22588852]</Citation><ArticleIdList><ArticleId IdType="pubmed">22588852</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ngaosuwan 2018 {published data only}</Title><Reference><Citation>Ngaosuwan K, Ounchokdee K, Chalermchai T. Clinical outcomes of minimized hydrocortisone dosage of 100mg/day on lower occurrence of hyperglycaemia in septic shock. Shock 2018;50(3):280&#x2010;5. [PUBMED: 29176402]</Citation><ArticleIdList><ArticleId IdType="pubmed">29176402</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Oppert 2005 {published and unpublished data}</Title><Reference><Citation>Oppert M, Schindler R, Husung C, Offerman K, Graef KJ, Boenisch O, et al. Low&#x2010;dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Critical Care Medicine 2005;33(11):2457&#x2010;64. [PUBMED: 16276166 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16276166</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rezk 2013 {published data only}</Title><Reference><Citation>Rezk NA, Ibrahim AM. Effects of methyl prednisolone in early ARDS. Egyptian Journal of Chest Diseases and Tuberculosis 2013;62(1):167&#x2013;72. [DOI: 10.1016/j.ejcdt.2013.02.013]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcdt.2013.02.013</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rinaldi 2006 {published data only}</Title><Reference><Citation>Rinaldi S, Adembri C, Grechi S, DeGaudio R. Low&#x2010;dose hydrocortisone during severe sepsis: effects on microalbuminemia. Critical Care Medicine 2006;34(9):2334&#x2010;9. [PUBMED: 16850006]</Citation><ArticleIdList><ArticleId IdType="pubmed">16850006</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sabry 2011 {published data only}</Title><Reference><Citation>Sabry NA, El&#x2010;Din Omar E. Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology and Pharmacy 2011;2:73&#x2010;81.</Citation></Reference></ReferenceList><ReferenceList><Title>Schumer 1976 {published data only}</Title><Reference><Citation>Schumer W. Steroids in the treatment of clinical septic shock. Annals of Surgery 1976;184(3):333&#x2010;41. [PUBMED: 786190 ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1344393</ArticleId><ArticleId IdType="pubmed">786190</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Slusher 1996 {published data only}</Title><Reference><Citation>Slusher T, Gbadero D, Howard C, Lewinson L, Giroir B, Toro L, et al. Randomized, placebo&#x2010;controlled, double blinded trial of dexamethasone in African children with sepsis. Pediatric Infectious Diseases Journal 1996;15(7):579&#x2010;83. [PUBMED: 8823850]</Citation><ArticleIdList><ArticleId IdType="pubmed">8823850</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Snijders 2010 {published data only}</Title><Reference><Citation>Snijders D, Daniels JMA, Graaff CS, Werf TS, Boersma WG. Efficacy of corticosteroids in community&#x2010;acquired pneumonia &#x2013; a randomized double blinded clinical trial. American Journal of Respiratory and Critical Care Medicine 2010;181(9):975&#x2010;82. [PUBMED: 20133929]</Citation><ArticleIdList><ArticleId IdType="pubmed">20133929</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sprung 1984 {published and unpublished data}</Title><Reference><Citation>Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, et al. The effects of high&#x2010;dose corticosteroids in patients with septic shock. A prospective, controlled study. New England Journal of Medicine 1984;311(18):1137&#x2010;43. [PUBMED: 6384785 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6384785</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sprung 2008 {published and unpublished data}</Title><Reference><Citation>Sprung C, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. Hydrocortisone therapy for patients with septic shock. New England Journal of Medicine 2008;358(2):111&#x2010;24. [PUBMED: 18184957]</Citation><ArticleIdList><ArticleId IdType="pubmed">18184957</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sui 2013 {published data only}</Title><Reference><Citation>Sui DJ, Zhang W, Li WS, Zhao HX, Wang ZY. Clinical efficacy in the treatment of severe community acquired pneumonia and its impact on CRP. Chinese Journal of Integrative Medicine 2013;18:1171&#x2010;3.</Citation></Reference></ReferenceList><ReferenceList><Title>Tagaro 2017 {published data only}</Title><Reference><Citation>Tagaro A, Otheo E, Baquero&#x2010;Artigao F, Navarro ML, Velasco R, Ruiz M, et al. Dexamethasone for parapneumonic pleural effusion: a randomized, double&#x2010;blind, clinical trial. Journal of Pediatrics 2017;185:117&#x2010;23. [PUBMED: 28363363]</Citation><ArticleIdList><ArticleId IdType="pubmed">28363363</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tandan 2005 {unpublished data only}</Title><Reference><Citation>Tandan SM, Guleria R, Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: a double&#x2010;blind randomised controlled trial from India. Proceedings of the American Thoracic Society Meeting. 2005:A24.</Citation></Reference></ReferenceList><ReferenceList><Title>Tilouche 2019 {published data only}</Title><Reference><Citation>Tilouche N, Jaoued O, Ben Sik Ali H, Gharbi R, Fekih Hassen M, Elatrous S. Comparison between continuous and intermittent administration of hydrocortisone during septic shock: a randomized controlled clinical trial. Shock 2019;52:481&#x2010;6. [DOI: 10.1097/SHK.0000000000001316.; PUBMED: 30628950]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001316.</ArticleId><ArticleId IdType="pubmed">30628950</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tongyoo 2016 {published and unpublished data}</Title><Reference><Citation>Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, et al. Hydrocortisone treatment in early sepsis associated acute respiratory distress syndrome: results of a randomized controlled trial. Critical Care 2016;20(1):329. [PUBMED: 27741949]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065699</ArticleId><ArticleId IdType="pubmed">27741949</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Torres 2015 {published data only}</Title><Reference><Citation>Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community&#x2010;acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015; Vol. 313, issue 7:677&#x2010;86. [PUBMED: 25688779]</Citation><ArticleIdList><ArticleId IdType="pubmed">25688779</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Valoor 2009 {published data only}</Title><Reference><Citation>Valoor HT, Singhi S, Jayashree M. Low&#x2010;dose hydrocortisone in paediatric septic shock: an exploratory study in a third world setting. Pediatric Critical Care Medicine 2009;10(1):121&#x2010;5. [PUBMED: 19057445]</Citation><ArticleIdList><ArticleId IdType="pubmed">19057445</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>VASSCSG 1987 {published data only}</Title><Reference><Citation>Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high&#x2010;dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. New England Journal of Medicine 1987;317(11):659&#x2010;65. [PUBMED: 2888017]</Citation><ArticleIdList><ArticleId IdType="pubmed">2888017</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Venkatesh 2018 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. New England Journal of Medicine 2018;378:797&#x2013;808. [DOI: 10.1056/NEJMoa1705835; PUBMED: 29347874]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1705835</ArticleId><ArticleId IdType="pubmed">29347874</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh B, Finfer S, Mybrugh J, Cohen J, Billot L. Long&#x2010;term outcomes of the ADRENAL trial [2018]. New England Journal of Medicine 2018;378(18):174&#x2010;5. [PUBMED: 29694789]</Citation><ArticleIdList><ArticleId IdType="pubmed">29694789</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yildiz 2002 {published data only}</Title><Reference><Citation>Yildiz O, Doganay M, Aygen B, Guven M, Keleutimur F, Tutuu A. Physiological&#x2010;dose steroid therapy in sepsis. Critical Care 2002;6(3):251&#x2010;9. [PUBMED: 12133187]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125315</ArticleId><ArticleId IdType="pubmed">12133187</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yildiz 2011 {published data only}</Title><Reference><Citation>Yildiz O, Tanriverdi F, Simsek S, Aygen B, Kelestimur F. The effects of moderate&#x2010;dose steroid therapy in sepsis: a placebo&#x2010;controlled, randomized study. Journal of Research in Medical Sciences 2011;16(11):1410&#x2010;21. [PUBMED: 22973341]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430057</ArticleId><ArticleId IdType="pubmed">22973341</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhou 2015 {published data only}</Title><Reference><Citation>Zhou M. Application value of glucocorticoid for comprehensive treatment of acute respiratory distress syndrome induced by serious community acquired pneumonia. Clinical Medicine and Engineering 2015;22:57&#x2010;8. [DOI: 10.3969/j.issn.1674-4659.2015.01.0057]</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1674-4659.2015.01.0057</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Asehnoune 2014 {published data only}</Title><Reference><Citation>Asehnoune K, Seguin P, Allary J, Feuillet F, Lasocki S, Cook F, et al. Hydrocortisone and fludrocortisone for prevention of hospital&#x2010;acquired pneumonia in patients with severe traumatic brain injury (Corti&#x2010;TC): a double&#x2010;blind, multicentre phase 3, randomised placebo&#x2010;controlled trial. The Lancet. Respiratory Medicine 2014;2:706&#x2010;16. [PUBMED: 25066331]</Citation><ArticleIdList><ArticleId IdType="pubmed">25066331</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bernard 1987 {published data only}</Title><Reference><Citation>Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al. High&#x2010;dose corticosteroids in patients with the adult respiratory distress syndrome. New England Journal of Medicine 1987;317:1565&#x2010;70. [PUBMED: 3317054]</Citation><ArticleIdList><ArticleId IdType="pubmed">3317054</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cicarelli 2006 {published data only}</Title><Reference><Citation>Cicarelli DD, Bensenor FEM, Vieira JE. Effects of single dose of dexamethasone on patients with systemic inflammatory response. Sao Paulo Medical Journal 2006;124(2):90&#x2010;5. [PUBMED: 16878192 ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11060357</ArticleId><ArticleId IdType="pubmed">16878192</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hahn 1951 {published data only}</Title><Reference><Citation>Hahn EO, Houser HB, Rammelkamp CH, Denny FW, Wannamaker LW. Effect of cortisone on acute streptococcal infections and post&#x2010;streptococcal complications. Journal of Clinical Investigation 1951;30:274&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC436257</ArticleId><ArticleId IdType="pubmed">14824277</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huang 2014a {published data only}</Title><Reference><Citation>Huang L, Gao X, Chen M. Early treatment with corticosteroids in patients with Mycoplasma pneumoniae pneumonia: a randomized clinical trial. Journal of Tropical Pediatrics 2014;64:338&#x2010;42. [PUBMED: 24710342]</Citation><ArticleIdList><ArticleId IdType="pubmed">24710342</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huang 2015 {published data only}</Title><Reference><Citation>Huang G, Liang B, Liu G, Liu K, Ding Z. Low dose of glucocorticoid decreases the incidence of complications in severely burned patients by attenuating systemic inflammation. J Crit Care 2015;436:436.e7&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">25307976</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hughes 1984 {published data only}</Title><Reference><Citation>Hughes GS Jr. Naloxone and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shock. Life Sciences 1984;35(23):2319&#x2010;26. [PUBMED: 6390057]</Citation><ArticleIdList><ArticleId IdType="pubmed">6390057</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kaufman 2008 {published and unpublished data}</Title><Reference><Citation>Kaufmann I, Briegel J, Schliephake F, Hoelzl A, Chouker A, Hummel T, et al. Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization&#x2010;dependent neutrophil functions. Intensive Care Medicine 2008;34(2):344&#x2010;9. [PUBMED: 17906853 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17906853</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Klastersky 1971 {published data only}</Title><Reference><Citation>Klastersky J, Cappel R, Debusscher L. Effectiveness of betamethasone in management of severe infections. A double&#x2010;blind study. New England Journal of Medicine 1971;284(22):1248&#x2010;50. [PUBMED: 4929896]</Citation><ArticleIdList><ArticleId IdType="pubmed">4929896</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lan 2015 {published data only}</Title><Reference><Citation>Lan Y, Yang D, Chen Z, Tang L, Xu Y, Cheng Y. Effectiveness of methylprednisolone in treatment of children with refractory Mycoplasma pneumoniae pneumonia and its relationship with bronchoalveolar lavage cytokine levels. Zhonghua Er Ke Za Zhi 2015;53:779&#x2010;83..</Citation><ArticleIdList><ArticleId IdType="pubmed">26758116</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lucas 1984 {published data only}</Title><Reference><Citation>Lucas C, Ledgerwood A. The cardiopulmonary response to massive doses of steroids in patients with septic shock. Archives of Surgery 1984;119(5):537&#x2010;41. [PUBMED: 6712466 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6712466</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Luo 2014 {published data only}</Title><Reference><Citation>Luo Z, Luo J, Liu E, Xu X, Liu Y, Zeng F, et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology 2014;49:377&#x2010;80. [PUBMED: 23401275]</Citation><ArticleIdList><ArticleId IdType="pubmed">23401275</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marik 1993 {published data only}</Title><Reference><Citation>Marik P, Kraus P, Sribante J, Havlik I, Lipman J, Johnson DW. Hydrocortisone and tumour necrosis factor in severe community&#x2010;acquired pneumonia. A randomized controlled study. Chest 1993;104:389&#x2010;92. [PUBMED: 8339624]</Citation><ArticleIdList><ArticleId IdType="pubmed">8339624</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McKee 1983 {published data only}</Title><Reference><Citation>McKee JI, Finlay WE. Cortisol replacement in severely stressed patients. Lancet 1983;1(8322):484. [PUBMED: 6131207 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6131207</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Meduri 1998b {published and unpublished data}</Title><Reference><Citation>Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280(2):159&#x2010;65. [PUBMED: 9669790]</Citation><ArticleIdList><ArticleId IdType="pubmed">9669790</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mikami 2007 {published data only}</Title><Reference><Citation>Mikami K, Suzuki M, Kitagawa H, Kawakami M, Hirota N, Yamaguchi H, et al. Efficacy of corticosteroids in the treatment of community&#x2010;acquired pneumonia requiring hospitalization. Lung 2007;185(5):249&#x2010;55. [PUBMED: 17710485]</Citation><ArticleIdList><ArticleId IdType="pubmed">17710485</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Newberry 2017 {published data only}</Title><Reference><Citation>Newberry L, O'Hare B, Kennedy N, Selman A, Omar S, Dawson P, Stevenson K, Nishihara Y, Lissauer S, Molyneux E. Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double&#x2010;blind, randomised clinical trial. Paediatr Int Child Health. 2017;37:121&#x2010;128..</Citation><ArticleIdList><ArticleId IdType="pubmed">28145162</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Peeters 2018 {published data only}</Title><Reference><Citation>Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Debaveye Y, Langouche L, Berghe G. ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double&#x2010;blind, placebo&#x2010;controlled, crossover cohort study. Intensive Care Medicine 2018;44:2048&#x2010;58..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280831</ArticleId><ArticleId IdType="pubmed">30374692</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rogers 1970 {published data only}</Title><Reference><Citation>Rogers J. Large doses of steroids in septicaemic shock. British Journal of Urology 1970;42(6):742. [PUBMED: 4923652]</Citation><ArticleIdList><ArticleId IdType="pubmed">4923652</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Roquilly 2011 {published data only}</Title><Reference><Citation>Roquilly A, Mahe PJ, Seguin P, Guitton C, Floch H, Tellier AC, et al. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA 2011;305:1201&#x2010;9. [PUBMED: 21427372]</Citation><ArticleIdList><ArticleId IdType="pubmed">21427372</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schwingshackl 2016 {published data only}</Title><Reference><Citation>Schwingshackl A, Kimura D, Rovnaghi CR, Saravia JS, Cormier SA, Teng B, et al. Regulation of inflammatory biomarkers by intravenous methylprednisolone in pediatric ARDS patients: results from a double&#x2010;blind, placebo&#x2010;controlled randomized pilot trial. Cytokine 2016;77:63&#x2010;71. [PUBMED: 26545141]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4666843</ArticleId><ArticleId IdType="pubmed">26545141</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Steinberg 2006 {published data only}</Title><Reference><Citation>Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. New England Journal of Medicine 2006;354:1671&#x2010;84. [PUBMED: 16625008]</Citation><ArticleIdList><ArticleId IdType="pubmed">16625008</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tam 2012 {published data only}</Title><Reference><Citation>Tam DT, Ngoc TV, Tien NT, Kieu NT, Thuy TT, Thanh LT, et al. Effects of short&#x2010;course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo&#x2010;controlled trial. Clinical Infectious Disease 2012;55(9):1216&#x2010;24. [PUBMED: 22865871]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3466094</ArticleId><ArticleId IdType="pubmed">22865871</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thompson 1976 {published data only}</Title><Reference><Citation>Thompson WL, Gurley HT, Lutz BA, Jackson DL, Kvols LK, Morris IA. Inefficacy of glucocorticoids in shock (double&#x2010;blind study). Clinical Research 1976;24:258A.</Citation></Reference></ReferenceList><ReferenceList><Title>van Woensel 2003 {published data only}</Title><Reference><Citation>Woensel JB, Aalderen WM, Weerd W, Jansen NJ, Gestel JP, Markhorst DG, et al. Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax 2003;58(5):383&#x2010;7. [PUBMED: 12728156]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1746666</ArticleId><ArticleId IdType="pubmed">12728156</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Venet 2015 {published data only}</Title><Reference><Citation>Venet F, Plassais J, Textoris J, Cazalis MA, Pachot A, Bertin&#x2010;Maghit M, et al. Low&#x2010;dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial. Critical Care 2015;19:21. [PUBMED: 25619170]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4347659</ArticleId><ArticleId IdType="pubmed">25619170</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wagner 1955 {published data only}</Title><Reference><Citation>Wagner HN, Bennett IL, Lasagna L, Cluff LE, Rosenthal MB, Mirick GS. The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bulletin of Johns Hopkins Hospital 1955;98(3):197&#x2010;215. [PUBMED: 13304518]</Citation><ArticleIdList><ArticleId IdType="pubmed">13304518</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Weigelt 1985 {published data only}</Title><Reference><Citation>Weigelt JA, Norcross JF, Borman KR, Snyder WH 3rd. Early steroid therapy for respiratory failure. Archives of Surgery 1985;120(5):536&#x2010;40. [PUBMED: 3885915 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3885915</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>NCT02517489 {published data only}</Title><Reference><Citation>NCT02517489. Community&#x2010;acquired pneumonia: evaluation of corticosteroids (CAPE COD) [Effects of low&#x2010;dose corticosteroids on survival of severe community&#x2010;acquired pneumonia]. https://clinicaltrials.gov/ct2/show/NCT02517489. First received 7 August 2015.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT02602210 {published data only}</Title><Reference><Citation>NCT02602210. Supplemental corticosteroids in cirrhotic hypotensive patients with suspicion of sepsis (SCOTCH) [Supplemental corticosteroids in cirrhotic hypotensive patients with suspicion of sepsis]. https://clinicaltrials.gov/ct2/show/NCT02602210. First received 11 November 2015.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03258684 {published data only}</Title><Reference><Citation>NCT03258684. Hydrocortisone, vitamin C, and thiamine for the treatment of sepsis and septic shock (HYVCTTSSS) [Hydrocortisone, vitamin C, and thiamine for the treatment of sepsis and septic shock: a prospective study]. https://clinicaltrials.gov/ct2/show/NCT03258684. First received 23 August 2017.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03333278 {published data only}</Title><Reference><Citation>NCT03333278. The vitamin C, hydrocortisone and thiamine in patients with septic shock trial (VITAMINS) [The vitamIn C, hydrocortisone and thiamine in patients with septic shock trial (VITAMINS trial) &#x2010; a prospective, feasibility, pilot, multi&#x2010;centre, randomised, open&#x2010;label controlled trial]. https://clinicaltrials.gov/ct2/show/NCT03333278. First received 6 November 2017.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03335124 {published data only}</Title><Reference><Citation>NCT03335124. The effect of vitamin C, thiamine and hydrocortisone on clinical course and outcome in patients with severe sepsis and septic shock [A randomized, double blind, placebo&#x2010;controlled study to investigate the effects of vitamin C, hydrocortisone and thiamine on the outcome of patients with severe sepsis and septic shock]. https://clinicaltrials.gov/ct2/show/NCT03335124. First received 7 November 2017.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03389555 {published data only}</Title><Reference><Citation>NCT03389555. Ascorbic acid, corticosteroids, and thiamine in sepsis (ACTS) trial [Ascorbic acid, hydrocortisone, and thiamine in sepsis and septic shock &#x2010; a randomized, double&#x2010;blind, placebo&#x2010;controlled trial]. https://clinicaltrials.gov/ct2/show/NCT03389555. First received 3 January 2018.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03422159 {published data only}</Title><Reference><Citation>NCT03422159. Metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in sepsis (ORANGES) [Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis]. https://clinicaltrials.gov/ct2/show/NCT03422159. First received 5 February 2018.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03509350 {published data only}</Title><Reference><Citation>NCT03509350. Vitamin C, thiamine, and steroids in sepsis (VICTAS) [A multi&#x2010;center, randomized, placebo&#x2010;controlled, double&#x2010;blind, adaptive clinical trial of vitamin C, thiamine and steroids as combination therapy in patients with sepsis]. https://clinicaltrials.gov/ct2/show/NCT03509350. First received 26 April 2018.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03592693 {published data only}</Title><Reference><Citation>NCT03592693. Vitamin C, hydrocortisone and thiamine for septic shock (CORVICTES) [A randomized, double blind, placebo&#x2010;controlled trial to investigate the effect of vitamin C, hydrocortisone and thiamine on the outcome of patients with septic shock]. https://clinicaltrials.gov/ct2/show/NCT03592693. First received 19 July 2018.</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>ACCP/SCCM 1992</Title><Reference><Citation>ACCP/SCCM Consensus Conference Panel. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992;20(6):864&#x2010;74. [PUBMED: 1597042 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1597042</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Allen 2018</Title><Reference><Citation>Allen JM, Feild C, Shoulders BR, Voils SA. Recent updates in the pharmacological management of sepsis and septic shock: a systematic review focused on fluid resuscitation, vasopressors, and corticosteroids. Annals of Pharmacotherapy 2018;53:385&#x2010;95. [DOI: 10.1177/1060028018812940; PUBMED: 30404539 ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1060028018812940</ArticleId><ArticleId IdType="pubmed">30404539</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Angus 2013</Title><Reference><Citation>Angus DC, Poll T. Severe sepsis and septic shock. New England Journal of Medicine 2013;369(21):840&#x2010;51. [PUBMED: 23984731]</Citation><ArticleIdList><ArticleId IdType="pubmed">23984731</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2000</Title><Reference><Citation>Annane D, S&#xe9;bille V, Troch&#xe9; G, Raphael JC, Gajdos P, Bellissant E. A 3&#x2010;level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283(8):1038&#x2010;45. [PUBMED: 10697064]</Citation><ArticleIdList><ArticleId IdType="pubmed">10697064</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2003</Title><Reference><Citation>Annane D, Aegerter P, Jars&#x2010;Guincestre MC, Guidet B, CUB&#x2010;Rea Network. Current epidemiology of septic shock: the CUB&#x2010;R&#xe9;a Network. American Journal of Respiratory and Critical Care Medicine 2003;168(2):165&#x2010;72. [PUBMED: 12851245]</Citation><ArticleIdList><ArticleId IdType="pubmed">12851245</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2005</Title><Reference><Citation>Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365(9453):63&#x2010;78. [PUBMED: 15639681]</Citation><ArticleIdList><ArticleId IdType="pubmed">15639681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2009b</Title><Reference><Citation>Annane D. Improving clinical trials in the critically ill: unique challenge: sepsis. Critical Care Medicine 2009;37(1 Suppl):117&#x2010;28. [PUBMED: 19104211]</Citation><ArticleIdList><ArticleId IdType="pubmed">19104211</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2017a</Title><Reference><Citation>Annane D, Pastores SM, Arlt W, Balk RA, Beishuizen A, Briegel J, et al. Critical illness&#x2010;related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM). Intensive Care Medicine 2017;43(12):1781&#x2010;92. [PUBMED: 28940017]</Citation><ArticleIdList><ArticleId IdType="pubmed">28940017</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2017b</Title><Reference><Citation>Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, et al. Guidelines for the diagnosis and management of critical illness&#x2010;related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Medicine 2017;43(12):1751&#x2010;63. [PUBMED: 28940011]</Citation><ArticleIdList><ArticleId IdType="pubmed">28940011</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Barczyk 2010</Title><Reference><Citation>Barczyk K, Ehrchen J, Tenbrock K, Ahlmann M, Kneidl J, Viemann D, et al. Glucocorticoids promote survival of anti&#x2010;inflammatory macrophages via stimulation of adenosine receptor A3. Blood 2010;116(3):446&#x2010;55. [PUBMED: 20460503]</Citation><ArticleIdList><ArticleId IdType="pubmed">20460503</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Barnes 1995</Title><Reference><Citation>Barnes PJ, Greening AP, Crompton GK. Glucocorticoid resistance in asthma. American Journal of Respiratory and Critical Care Medicine 1995;152(Suppl 6 Pt 2):125&#x2010;40. [PUBMED: 7489120]</Citation><ArticleIdList><ArticleId IdType="pubmed">7489120</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Boonen 2013</Title><Reference><Citation>Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, et al. Reduced cortisol metabolism during critical illness. New England Journal of Medicine 2013;388(16):1477&#x2010;88. [PUBMED: 23506003]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4413428</ArticleId><ArticleId IdType="pubmed">23506003</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Briegel 1994</Title><Reference><Citation>Briegel J, Kellermann W, Forst H, Haller M, Bittl M, Hoffmann GE, et al. Low&#x2010;dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group. Clinical Investigation 1994;72(10):782&#x2010;7. [PUBMED: 7865982]</Citation><ArticleIdList><ArticleId IdType="pubmed">7865982</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bruno 2012</Title><Reference><Citation>Bruno JJ, Dee BM, Anderegg BA, Hernandez M, Pravinkumar SE. US practitioner opinions and prescribing practices regarding corticosteroid therapy for severe sepsis and septic shock. Journal of Critical Care 2012;27(4):351&#x2010;61. [PUBMED: 22341726]</Citation><ArticleIdList><ArticleId IdType="pubmed">22341726</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cai 2008</Title><Reference><Citation>Cai L, Ji A, Beer FC, Tannock LR, Westhuyzen DR. SR&#x2010;BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. Journal of Clinical Investigation 2008;118(1):364&#x2013;75. [PUBMED: 18064300]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117761</ArticleId><ArticleId IdType="pubmed">18064300</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cain 2017</Title><Reference><Citation>Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nature Reviews. Immunology 2017;17(4):233&#x2010;47. [PUBMED: 28192415]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9761406</ArticleId><ArticleId IdType="pubmed">28192415</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chrousos 1995</Title><Reference><Citation>Chrousos GP. The hypothalamic&#x2010;pituitary&#x2010;adrenal axis and immune&#x2010;mediated inflammation. New England Journal of Medicine 1995;322(20):1351&#x2010;62. [PUBMED: 7715646]</Citation><ArticleIdList><ArticleId IdType="pubmed">7715646</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cooper 2003</Title><Reference><Citation>Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. New England Journal of Medicine 2003;348(8):727&#x2010;34. [PUBMED: 12594318 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12594318</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cronin 1995</Title><Reference><Citation>Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MAD, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta&#x2010;analysis of the literature. Critical Care Medicine 1995;23(8):1430&#x2010;9. [PUBMED: 7634816 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7634816</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>de Kruif 2007</Title><Reference><Citation>Kruif MD, Lemaire LC, Giebelen IA, Zoelen MA, Pater JM, Pangaart PS, et al. Prednisolone dose&#x2010;dependently influences inflammation and coagulation during human endotoxemia. Journal of Immunology 2007;178(3):1845&#x2010;51. [PUBMED: 17237435]</Citation><ArticleIdList><ArticleId IdType="pubmed">17237435</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Devereaux 2001</Title><Reference><Citation>Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Montori VM, et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 2001;285(15):2000&#x2010;3. [PUBMED: 11308438 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11308438</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>di Villa Bianca 2003</Title><Reference><Citation>Villa Bianca RE, Lippolis L, Autore G, Popolo A, Marzocco S, Sorrentino L, et al. Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP&#x2010;sensitive potassium channel activity. British Journal of Pharmacology 2003;140(1):91&#x2013;6. [PUBMED: 12967938]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1574004</ArticleId><ArticleId IdType="pubmed">12967938</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Duma 2004</Title><Reference><Citation>Duma D, Silva&#x2010;Santos JE, Assreuy J. Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats. Critical Care Medicine 2004;32(11):2304&#x2013;10. [PUBMED: 15640646]</Citation><ArticleIdList><ArticleId IdType="pubmed">15640646</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Egger 1997</Title><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta&#x2010;analysis detected by a simple, graphical test. BMJ 1997;315(7109):629&#x2010;34. [PUBMED: 9310563]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Erschen 2007</Title><Reference><Citation>Ehrchen J, Steinm&#xfc;ller L, Barczyk K, Tenbrock K, Nacken W, Eisenacher M, et al. Glucocorticoids induce differentiation of a specifically activated, anti&#x2010;inflammatory subtype of human monocytes. Blood 2007;109(3):1265&#x2010;74. [PUBMED: 17018861]</Citation><ArticleIdList><ArticleId IdType="pubmed">17018861</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fabian 1982</Title><Reference><Citation>Fabian TC, Patterson R. Steroid therapy in septic shock. Survival studies in a laboratory model. American Surgeon 1982;48(12):614&#x2010;7. [PUBMED: 6760756]</Citation><ArticleIdList><ArticleId IdType="pubmed">6760756</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fang 2018</Title><Reference><Citation>Fang F, Zhang Y, Tang J, Lunsford LD, Li T, Tang R, et al. Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta&#x2010;analysis. JAMA Internal Medicine 2019;179(2):213&#x2010;23. [DOI: 10.1001/jamainternmed.2018.5849; PUBMED: 30575845]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2018.5849</ArticleId><ArticleId IdType="pmc">PMC6439648</ArticleId><ArticleId IdType="pubmed">30575845</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Galigniana 1999</Title><Reference><Citation>Galigniana MD, Piwien&#x2010;Pilipuk G, Assreuy J. Inhibition of glucocorticoid receptor binding by nitric oxide. Molecular Pharmacology 1999;55(2):317&#x2013;23. [PUBMED: 9927624]</Citation><ArticleIdList><ArticleId IdType="pubmed">9927624</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Goodwin 2013</Title><Reference><Citation>Goodwin JE, Feng Y, Velazquez H, Sessa WC. Endothelial glucocorticoid receptor is required for protection against sepsis. Proceedings of the National Academy of Science 2013;110(1):306&#x2013;11. [PUBMED: 23248291]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538225</ArticleId><ArticleId IdType="pubmed">23248291</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>GRADEpro GDT 2015 [Computer program]</Title><Reference><Citation>McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 7 April 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.</Citation></Reference></ReferenceList><ReferenceList><Title>Guyatt 2008a</Title><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck&#x2010;Ytter Y, Alonso&#x2010;Coello P, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924&#x2010;6. [PUBMED: 18436948 ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2008b</Title><Reference><Citation>Guyatt GH, Wyer P, Ioannidis J. When to believe a subgroup analysis. In: Guyatt G, Rennie R, Meade M, Cook D editor(s). User&#x2019;s Guides to the Medical Literature: A Manual for Evidence&#x2010;Based Clinical Practice. New York: McGraw&#x2010;Hill, 2008.</Citation></Reference></ReferenceList><ReferenceList><Title>Guyatt 2013</Title><Reference><Citation>Guyatt GH, Busse J. Methods commentary: risk of bias in randomized trials 1. Evidence Partners 2013 (accessed 15 December 2018):http://distillercer.com/resources/methodological&#x2010;resources/risk&#x2010;of&#x2010;biascommentary/.</Citation></Reference></ReferenceList><ReferenceList><Title>Heller 2003</Title><Reference><Citation>Heller AR, Heller SC, Borkenstein A, Stehr SN, Koch T. Modulation of host defence by hydrocortisone in stress doses during endotoxaemia. Intensive Care Medicine 2003;29(9):1456&#x2010;63. [PUBMED: 12879235 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12879235</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Heming 2018</Title><Reference><Citation>Heming N, Sivanandamoorthy S, Meng P, Bounab R, Annane D. Immune effects of corticosteroids in sepsis. Frontiers in Immunology 2018;9:1736. [DOI: 10.3389/fimmu.2018.01736; PUBMED: 30105022]</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01736</ArticleId><ArticleId IdType="pmc">PMC6077259</ArticleId><ArticleId IdType="pubmed">30105022</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Hotta 1986</Title><Reference><Citation>Hotta M, Baird A. Differential effects of transforming growth factor type beta on the growth and function of adrenocortical cells in vitro. Proceedings of the National Academy of Sciences of the United States of America 1986;83(20):7795&#x2010;9. [PUBMED: 3020557]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC386808</ArticleId><ArticleId IdType="pubmed">3020557</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huang 1987</Title><Reference><Citation>Huang ZH, Gao H, Xu RB. Study on glucocorticoid receptors during intestinal ischemia shock and septic shock. Circulatory Shock 1987;23(1):27&#x2010;36. [PUBMED: 3690811]</Citation><ArticleIdList><ArticleId IdType="pubmed">3690811</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ioannidis 2004</Title><Reference><Citation>Ioannidis JPA. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Annals of Internal Medicine 2004;141(10):781&#x2010;8. [PUBMED: 15545678]</Citation><ArticleIdList><ArticleId IdType="pubmed">15545678</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jaattela 1991</Title><Reference><Citation>Jaattela M, Ilvesmaki V, Voutilainen R, Stenman UH, Saksela E. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin&#x2010;induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991;128(1):623&#x2010;9. [PUBMED: 1702707]</Citation><ArticleIdList><ArticleId IdType="pubmed">1702707</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kadri 2017</Title><Reference><Citation>Kadri SS, Rhee C, Strich JR, Morales MK, Hohmann S, Menchaca J, et al. Estimating ten&#x2010;year trends in septic shock incidence and mortality in United States academic medical centers using clinical data. Chest 2017;151(2):278&#x2010;28. [PUBMED: 27452768]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5310115</ArticleId><ArticleId IdType="pubmed">27452768</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kalil 2011</Title><Reference><Citation>Kalil AC, Sun J. Low&#x2010;dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies. Intensive Care Medicine 2011;37(3):420&#x2013;9. [PUBMED: 21243334]</Citation><ArticleIdList><ArticleId IdType="pubmed">21243334</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kanczkowski 2013</Title><Reference><Citation>Kanczkowski W, Alexaki VI, Tran N, Gro&#xdf;klaus S, Zacharowski K, Martinez A, et al. Hypothalamo&#x2010;pituitary and immune&#x2010;dependent adrenal regulation during systemic inflammation. Proceedings of the National Academy of Science 2013;110(36):14801&#x2013;6. [PUBMED: 23959899]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3767499</ArticleId><ArticleId IdType="pubmed">23959899</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Katsenos 2014</Title><Reference><Citation>Katsenos CS, Antonopoulou AN, Apostolidou EN, Ioakeimidou A, Kalpakou GT, Papanikolaou MN, et al. on behalf of the Hellenic Sepsis Study Group. Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response. Critical Care Medicine 2014;42(7):1651&#x2010;7. [PUBMED: 24674923]</Citation><ArticleIdList><ArticleId IdType="pubmed">24674923</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kellum 2007</Title><Reference><Citation>Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Archives of Internal Medicine 2007;167(15):1655&#x2010;63. [PUBMED: 17698689]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4495652</ArticleId><ArticleId IdType="pubmed">17698689</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lamontagne 2018</Title><Reference><Citation>Lamontagne F, Rochwerg B, Lytvyn L, Guyatt GH, M&#xf8;ller MH, Annane D, et al. Corticosteroid therapy for sepsis: a clinical practice guideline. BMJ 2018;362:k3284. [PUBMED: 30097460]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083439</ArticleId><ArticleId IdType="pubmed">30097460</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lefering 1995</Title><Reference><Citation>Lefering R, Neugebauer EAM. Steroid controversy in sepsis and septic shock: a meta&#x2010;analysis. Critical Care Medicine 1995;23(7):1294&#x2010;303. [PUBMED: 7600840 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7600840</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lipiner 2007</Title><Reference><Citation>Lipiner D, Sprung CL, Laterre PF, Weiss Y, Goodman SV, Vogeser M, et al. Adrenal function in sepsis: the retrospective CORTICUS cohort study. Critical Care Medicine 2007;35(4):1012&#x2010;8. [PUBMED: 17334243]</Citation><ArticleIdList><ArticleId IdType="pubmed">17334243</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lowenberg 2005</Title><Reference><Citation>Lowenberg M, Tuynman J, Bilderbeek J, Gaber T, Buttgereit F, Deventer S, et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 2005;106(5):1703&#x2010;10. [PUBMED: 15899916]</Citation><ArticleIdList><ArticleId IdType="pubmed">15899916</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marik 2008</Title><Reference><Citation>Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Critical Care Medicine 2008;36(6):1937&#x2013;49. [PUBMED: 18496365]</Citation><ArticleIdList><ArticleId IdType="pubmed">18496365</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Meduri 1998a</Title><Reference><Citation>Meduri GU, Chrousos GP. Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way?. Chest 1998;114(2):355&#x2010;60. [PUBMED: 9726712]</Citation><ArticleIdList><ArticleId IdType="pubmed">9726712</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Melby 1958</Title><Reference><Citation>Melby JC, Spink WW. Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection. Journal of Clinical Investigation 1958;37(12):1791&#x2010;8. [PUBMED: 13611047]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1062866</ArticleId><ArticleId IdType="pubmed">13611047</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Menon 2013</Title><Reference><Citation>Menon K, McNally D, Choong K, Sampson M. A systematic review and meta&#x2010;analysis on the effect of steroids in pediatric shock. Pediatric Critical Care Medicine 2013;14(5):474&#x2010;80. [PUBMED: 23867428]</Citation><ArticleIdList><ArticleId IdType="pubmed">23867428</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Molijn 1995</Title><Reference><Citation>Molijn GJ, Koper JW, Uffelen CJ, Jong FH, Brinkmann AO, Bruining HA, et al. Temperature&#x2010;induced down&#x2010;regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock. Clinical Endocrinology 1995;43(2):197&#x2010;203. [PUBMED: 7554315 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7554315</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moran 2010</Title><Reference><Citation>Moran JL, Graham PL, Rockliff S, Bersten AD. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta&#x2010;analytic perspective. Critical Care 2010;14(4):R134. [PUBMED: 20626892]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2945102</ArticleId><ArticleId IdType="pubmed">20626892</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ni 2018</Title><Reference><Citation>Ni YN, Liu YM, Wang YW, Liang BM, Liang ZA. Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta&#x2010;analysis. American Journal of Emergency Medicine 2018;S0735&#x2010;6757:30953&#x2010;7. [PUBMED: 30522935]</Citation><ArticleIdList><ArticleId IdType="pubmed">30522935</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nishida 2018</Title><Reference><Citation>Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J&#x2010;SSCG 2016). Acute Medicine and Surgery 2018;5:3&#x2010;89. [PUBMED: 29445505]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5797842</ArticleId><ArticleId IdType="pubmed">29445505</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Norman 2004</Title><Reference><Citation>Norman AW, Mizwicki MT, Norman DP. Steroid&#x2010;hormone rapid actions, membrane receptors, and a conformational ensemble model. Nature Reviews. Drug Discovery 2004;3(1):27&#x2010;41. [PUBMED: 14708019]</Citation><ArticleIdList><ArticleId IdType="pubmed">14708019</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Park 2012</Title><Reference><Citation>Park HY, Suh GY, Song JU, Yoo H, Jo IJ, Shin TG, et al. Early initiation of low&#x2010;dose corticosteroid therapy in the management of septic shock: a retrospective observational study. Critical Care 2012;16(1):R3. [PUBMED: 22226237]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3396228</ArticleId><ArticleId IdType="pubmed">22226237</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Parrillo 1993</Title><Reference><Citation>Parrillo JE. Pathogenic mechanisms of septic shock. New England Journal of Medicine 1993;328(20):1471&#x2010;7. [PUBMED: 8479467]</Citation><ArticleIdList><ArticleId IdType="pubmed">8479467</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Peters 2008</Title><Reference><Citation>Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour&#x2010;enhanced meta&#x2010;analysis funnel plots help distinguish publication bias from other causes of asymmetry. Journal of Clinical Epidemiology 2008;61(10):991&#x2010;6. [PUBMED: 18538991]</Citation><ArticleIdList><ArticleId IdType="pubmed">18538991</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Polito 2011</Title><Reference><Citation>Polito A, Sonneville R, Guidoux C, Barrett L, Viltart O, Mattot V, et al. Changes in CRH and ACTH synthesis during experimental and human septic shock. PLoS One 2011;6(11):e25905. [PUBMED: 22073145]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207830</ArticleId><ArticleId IdType="pubmed">22073145</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Review Manager 2014 [Computer program]</Title><Reference><Citation>Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.</Citation></Reference></ReferenceList><ReferenceList><Title>Rhee 2017</Title><Reference><Citation>Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. CDC Prevention Epicenter Program. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009&#x2010;2014. JAMA 2017;318(13):1241&#x2010;9. [PUBMED: 28903154]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rhen 2005</Title><Reference><Citation>Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids: new mechanisms for old drugs. New England Journal of Medicine 2005;353(16):1711&#x2010;23. [PUBMED: 16236742]</Citation><ArticleIdList><ArticleId IdType="pubmed">16236742</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rhodes 2017</Title><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine 2017;43(3):304&#x2010;77. [PUBMED: 28101605]</Citation><ArticleIdList><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rochwerg 2018</Title><Reference><Citation>Rochwerg B, Oczkowski SJ, Siemieniuk RAC, Agoritsas T, Belley&#x2010;Cote E, D'Aragon F, et al. Corticosteroids in sepsis: an updated systematic review and meta&#x2010;analysis. Critical Care Medicine 2018;46(9):1411&#x2010;20. [PUBMED: 29979221]</Citation><ArticleIdList><ArticleId IdType="pubmed">29979221</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rothwell 1991</Title><Reference><Citation>Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991;337(8741):582&#x2010;3. [PUBMED: 1671944]</Citation><ArticleIdList><ArticleId IdType="pubmed">1671944</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rygard 2018</Title><Reference><Citation>Ryg&#xe5;rd SL, Butler E, Granholm A, M&#xf8;ller MH, Cohen J, Finfer S, et al. Low&#x2010;dose corticosteroids for adult patients with septic shock: a systematic review with meta&#x2010;analysis and trial sequential analysis. Intensive Care Medicine 2018;44(7):1003&#x2010;16. [PUBMED: 29761216]</Citation><ArticleIdList><ArticleId IdType="pubmed">29761216</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sharshar 2003</Title><Reference><Citation>Sharshar T, Gray F, Lorin de la Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003;362(9398):1799&#x2010;805. [PUBMED: 14654318]</Citation><ArticleIdList><ArticleId IdType="pubmed">14654318</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sherwin 2012</Title><Reference><Citation>Sherwin RL, Garcia AJ, Bilkovski R. Do low&#x2010;dose corticosteroids improve mortality or shock reversal in patients with septic shock? A systematic review and position statement prepared for the American Academy of Emergency Medicine. Journal of Emergency Medicine 2012;43(1):7&#x2010;12. [PUBMED: 22221983]</Citation><ArticleIdList><ArticleId IdType="pubmed">22221983</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Singer 2016</Title><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar&#x2010;Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis&#x2010;3). JAMA 2016;315(8):801&#x2010;10. [PUBMED: 26903338]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stata 2015 [Computer program]</Title><Reference><Citation>StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP, 2015.</Citation></Reference></ReferenceList><ReferenceList><Title>Tavar&#xe9; 2017</Title><Reference><Citation>Tavar&#xe9; A, O&#x2019;Flynn N. Recognition, diagnosis, and early management of sepsis: NICE guideline. British Journal of General Practice 2017;67(657):185&#x2010;6. [PUBMED: 28360070]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5565828</ArticleId><ArticleId IdType="pubmed">28360070</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tsao 2004</Title><Reference><Citation>Tsao CM, Ho ST, Chen A, Wang JJ, Li CY, Tsai SK, et al. Low&#x2010;dose dexamethasone ameliorates circulatory failure and renal dysfunction in conscious rats with endotoxemia. Shock 2004;21(5):484&#x2010;91. [PUBMED: 15087827]</Citation><ArticleIdList><ArticleId IdType="pubmed">15087827</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vachharajani 2006</Title><Reference><Citation>Vachharajani V, Vital S, Russell J, Scott LK, Granger DN. Glucocorticoids inhibit the cerebral microvascular dysfunction associated with sepsis in obese mice. Microcirculation 2006;13(6):477&#x2010;87. [PUBMED: 16864414 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16864414</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>van der Poll 2017</Title><Reference><Citation>Poll T, Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nature Reviews. Immunology 2017;17(7):407&#x2010;20. [PUBMED: 28436424]</Citation><ArticleIdList><ArticleId IdType="pubmed">28436424</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Varga 2008</Title><Reference><Citation>Varga G, Ehrchen J, Tsianakas A, Tenbrock K, Rattenholl A, Seeliger S, et al. Glucocorticoids induce an activated, anti&#x2010;inflammatory monocyte subset in mice that resembles myeloid&#x2010;derived suppressor cells. Journal of Leukocyte Biology 2008;84(3):644&#x2010;50. [PUBMED: 18611985]</Citation><ArticleIdList><ArticleId IdType="pubmed">18611985</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vincent 1996</Title><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, Mendon&#xe7;a A, Bruining H, et al. The SOFA (Sepsis&#x2010;related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis&#x2010;Related Problems of the European Society of Intensive Care Medicine. Intensive Care Medicine 1996;22(7):707&#x2010;10. [PUBMED: 8844239]</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vincent 2013</Title><Reference><Citation>Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet 2013;381(9868):774&#x2010;5. [PUBMED: 23472921]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4535310</ArticleId><ArticleId IdType="pubmed">23472921</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>WHO 2018</Title><Reference><Citation>WHO. Improving prevention, diagnosis and clinical management of sepsis. https://www.who.int/servicedeliverysafety/areas/sepsis/en/#.XAAf362Zqkk.mendeley. 2018. Accessed 29 November 2018.</Citation></Reference></ReferenceList><ReferenceList><Title>Yang 2018</Title><Reference><Citation>Yang T, Li Z, Jiang L, Xi X. Corticosteroid use and intensive care unit&#x2010;acquired weakness: a systematic review and meta&#x2010;analysis. Critical Care 2018;22(1):187. [DOI: 10.1186/s13054-018-2111-0; PUBMED: 30075789]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2111-0</ArticleId><ArticleId IdType="pmc">PMC6091087</ArticleId><ArticleId IdType="pubmed">30075789</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Annane 2004</Title><Reference><Citation>Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating severe sepsis and septic shock. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD002243.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002243.pub2</ArticleId><ArticleId IdType="pubmed">14973984</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2009</Title><Reference><Citation>Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, Gaudio R, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009;301:2362&#x2010;75. [PUBMED: 19509383 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19509383</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Annane 2015</Title><Reference><Citation>Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating sepsis. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD002243.pub3]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002243.pub3</ArticleId><ArticleId IdType="pmc">PMC6494587</ArticleId><ArticleId IdType="pubmed">26633262</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gibbison 2017</Title><Reference><Citation>Gibbison B, L&#xf3;pez&#x2010;L&#xf3;pez JA, Higgins JP, Miller T, Angelini GD, Lightman SL, et al. Corticosteroids in septic shock: a systematic review and network meta&#x2010;analysis. Critical Care 2017;21:78. [PUBMED: 28351429]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5371269</ArticleId><ArticleId IdType="pubmed">28351429</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rochwerg 2018a</Title><Reference><Citation>Rochwerg B, Oczkowski SJ, Siemieniuk RAC, Agoritsas T, Belley&#x2010;Cote E, D'Aragon F, et al. Corticosteroids in sepsis: an updated systematic review and meta&#x2010;analysis. Critical Care Medicine 2018;46:1411&#x2010;20. [PUBMED: 29979221]</Citation><ArticleIdList><ArticleId IdType="pubmed">29979221</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27602898</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2163-0763</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The journal of trauma and acute care surgery</Title><ISOAbbreviation>J Trauma Acute Care Surg</ISOAbbreviation></Journal><ArticleTitle>Early goal-directed treatment versus standard care in management of early septic shock: Meta-analysis of randomized trials.</ArticleTitle><Pagination><StartPage>971</StartPage><EndPage>978</EndPage><MedlinePgn>971-978</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND">Since the incorporation of the early hemodynamic resuscitation in septic shock according to the early goal-directed therapy (EGDT) protocol among the 6-hour resuscitation bundle of the Surviving Sepsis Campaign guidelines, a great debate has been raised about the issue. The present meta-analysis aims to determine whether the resuscitative phase really takes advantages by being performed with EGDT.</AbstractText><AbstractText Label="METHODS">A systematic review with meta-analysis of randomized controlled trials (RCTs) of EGDT versus usual care in patients with early septic shock was performed.</AbstractText><AbstractText Label="RESULTS">Four high-quality RCTs have been included with 4,464 patients (1990 in EGDT and 2013 in usual care arm). ICU admission and cardiovascular support necessity increased in the EGDT group (OR = 2.00, 95% CI 1.55-2.57 and OR = 1.33, 95% CI 1.08-1.64, respectively). EGDT has no significant effect on mortality (90 days, 60 days, 28 days, and mortality by the time of hospital discharge). EGDT has no significant effect in reducing the length of hospital stay, the necessity of respiratory and renal function support, and the duration of respiratory and cardiocirculatory support.</AbstractText><AbstractText Label="CONCLUSIONS">EGDT seems to increase the resource demand in terms of ICU admissions and cardiocirculatory support necessity without reducing mortality, renal and respiratory organ support necessity, respiratory and cardiocirculatory support duration, and length of hospital stay.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">Systematic review, level I.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coccolini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the General Surgery Department (F.C., M.C., G.M., L.A.), Papa Giovanni XXIII Hospital, Bergamo, Italy; General Surgery Department (M.S.), Macerata Hospital, Macerata, Italy; and Emergency Surgery Department (F.C.), Maggiore University Hospital, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Catena</LastName><ForeName>Fausto</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ceresoli</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Montori</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Ansaloni</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma Acute Care Surg</MedlineTA><NlmUniqueID>101570622</NlmUniqueID><ISSNLinking>2163-0755</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010347" MajorTopicYN="Y">Patient Care Planning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059039" MajorTopicYN="Y">Standard of Care</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27602898</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000001246</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36051909</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-042X</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in physiology</Title><ISOAbbreviation>Front Physiol</ISOAbbreviation></Journal><ArticleTitle>Optimal target blood pressure in critically ill adult patients with vasodilatory shock: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>962670</StartPage><MedlinePgn>962670</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">962670</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphys.2022.962670</ELocationID><Abstract><AbstractText>While the Surviving Sepsis Campaign guidelines recommend an initial target value of 65&#xa0;mmHg as the mean arterial pressure (MAP) in patients with septic shock, the optimal MAP target for improving outcomes remains controversial. We performed a meta-analysis to evaluate the optimal MAP for patients with vasodilatory shock, which included three randomized controlled trials that recruited 3,357 patients. Between the lower (60-70&#xa0;mmHg) and higher (&gt;70&#xa0;mmHg) MAP target groups, there was no significant difference in all-cause mortality (risk ratio [RR], 1.06; 95% confidence intervals [CI], 0.98-1.16) which was similar in patients with chronic hypertension (RR, 1.10; 95% CI, 0.98-1.24) and patients aged &#x2265;65&#xa0;years (RR, 1.10; 95% CI, 0.99-1.21). No significant difference in adverse events was observed between the different MAP groups (RR, 1.04; 95% CI, 0.87-1.24); however, supraventricular arrhythmia was significantly higher in the higher MAP group (RR, 1.73; 95% CI, 1.15-2.60). Renal replacement therapy was reduced in the higher MAP group of patients with chronic hypertension (RR, 0.83; 95% CI, 0.71-0.98). Though the higher MAP control did not improve the mortality rate, it may be beneficial in reducing renal replacement therapy in patients with chronic hypertension. <b>Systematic review registration:</b> UMIN Clinical Trials Registry, identifier UMIN000042624.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Yoshimoto, Fukui, Higashio, Endo, Takasu and Yamakawa.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoshimoto</LastName><ForeName>Hidero</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukui</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higashio</LastName><ForeName>Koki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Endo</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Trauma and Acute Critical Care Center, Tokyo Medical and Dental University Hospital, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takasu</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Kazuma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Physiol</MedlineTA><NlmUniqueID>101549006</NlmUniqueID><ISSNLinking>1664-042X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">mean arterial pressure</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">vasoconstrictor agents</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>2</Day><Hour>2</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36051909</ArticleId><ArticleId IdType="pmc">PMC9424848</ArticleId><ArticleId IdType="doi">10.3389/fphys.2022.962670</ArticleId><ArticleId IdType="pii">962670</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abuelo J. G. (2007). Normotensive ischemic acute renal failure. N. Engl. J. Med. 357, 797&#x2013;805. 10.1056/NEJMra064398</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra064398</ArticleId><ArticleId IdType="pubmed">17715412</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P., Meziani F., Hamel J. F., Grelon F., Megarbane B., Anguel N., et al. (2014). High versus low blood-pressure target in patients with septic shock. N. Engl. J. Med. 370, 1583&#x2013;1593. 10.1056/NEJMoa1312173</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1312173</ArticleId><ArticleId IdType="pubmed">24635770</ArticleId></ArticleIdList></Reference><Reference><Citation>Badin J., Boulain T., Ehrmann S., Skarzynski M., Bretagnol A., Buret J., et al. (2011). Relation between mean arterial pressure and renal function in the early phase of shock: A prospective, explorative cohort study. Crit. Care 15, R135. 10.1186/cc10253</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10253</ArticleId><ArticleId IdType="pmc">PMC3219004</ArticleId><ArticleId IdType="pubmed">21645384</ArticleId></ArticleIdList></Reference><Reference><Citation>Corr&#xea;a T. D., Jakob S. M., Takala J. (2015). Arterial blood pressure targets in septic shock: Is it time to move to an individualized approach? Crit. Care 19, 264. 10.1186/s13054-015-0958-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0958-x</ArticleId><ArticleId IdType="pmc">PMC4472269</ArticleId><ArticleId IdType="pubmed">26084781</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Aragon F., Belley-Cote E. P., Meade M. O., Lauzier F., Adhikari N. K., Briel M., et al. (2015). Blood pressure targets for vasopressor therapy: A systematic review. Shock 43, 530&#x2013;539. 10.1097/SHK.0000000000000348</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000348</ArticleId><ArticleId IdType="pubmed">25895147</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C. M., French C., et al. (2021). Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47, 1181&#x2013;1247. 10.1007/s00134-021-06506-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorese Coimbra K. T., De Freitas F. G. R., Bafi A. T., Pinheiro T. T., Nunes N. F., de Azevedo L. C. P., et al. (2019). Effect of increasing blood pressure with noradrenaline on the microcirculation of patients with septic shock and previous arterial hypertension. Crit. Care Med. 47, 1033&#x2013;1040. 10.1097/CCM.0000000000003795</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003795</ArticleId><ArticleId IdType="pubmed">31094744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui S., Higashio K., Murao S., Endo A., Akira T., Yamakawa K. (2021). Optimal target blood pressure in critically ill adult patients with vasodilatory shock: a protocol for a systematic review and meta-analysis. BMJ Open 11, e048512. 10.1136/bmjopen-2020-048512</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048512</ArticleId><ArticleId IdType="pmc">PMC7986773</ArticleId><ArticleId IdType="pubmed">33741676</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E., Lefrant J. Y., Guinot P. G., Godet T., Lorne E., Cuvillon P., et al. (2017). Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: A randomized clinical trial. JAMA 318, 1346&#x2013;1357. 10.1001/jama.2017.14172</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.14172</ArticleId><ArticleId IdType="pmc">PMC5710560</ArticleId><ArticleId IdType="pubmed">28973220</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu J., Bro&#x17c;ek J. L., Terracciano L., Kreis J., Compalati E., Stein A. T., et al. (2011). Application of GRADE: making evidence-based recommendations about diagnostic tests in clinical practice guidelines. Implement. Sci. 6, 62. 10.1186/1748-5908-6-62</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-6-62</ArticleId><ArticleId IdType="pmc">PMC3126717</ArticleId><ArticleId IdType="pubmed">21663655</ArticleId></ArticleIdList></Reference><Reference><Citation>Hylands M., Moller M. H., Asfar P., Toma A., Frenette A. J., Beaudoin N., et al. (2017). A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension. Can. J. Anaesth. 64, 703&#x2013;715. 10.1007/s12630-017-0877-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-017-0877-1</ArticleId><ArticleId IdType="pubmed">28497426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F., Day A. G., Meade M. O., Cook D. J., Guyatt G. H., Hylands M., et al. (2018). Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med. 44, 12&#x2013;21. 10.1007/s00134-017-5016-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-5016-5</ArticleId><ArticleId IdType="pubmed">29260272</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F., Meade M. O., H&#xe9;bert P. C., Asfar P., Lauzier F., Seely A. J. E., et al. (2016). Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med. 42, 542&#x2013;550. 10.1007/s00134-016-4237-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4237-3</ArticleId><ArticleId IdType="pubmed">26891677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F., Richards-Belle A., Thomas K., Harrison D. A., Sadique M. Z., Grieve R. D., et al. (2020). Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: A randomized clinical trial. JAMA 323, 938&#x2013;949. 10.1001/jama.2020.0930</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.0930</ArticleId><ArticleId IdType="pmc">PMC7064880</ArticleId><ArticleId IdType="pubmed">32049269</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M., Asfar P., Radermacher P., Vincent J. L., Martin C. (2015). Optimizing mean arterial pressure in septic shock: A critical reappraisal of the literature. Crit. Care 19, 101. 10.1186/s13054-015-0794-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0794-z</ArticleId><ArticleId IdType="pmc">PMC4355573</ArticleId><ArticleId IdType="pubmed">25888071</ArticleId></ArticleIdList></Reference><Reference><Citation>Maheshwari K., Nathanson B. H., Munson S. H., Khangulov V., Stevens M., Badani H., et al. (2018). The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients. Intensive Care Med. 44, 857&#x2013;867. 10.1007/s00134-018-5218-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5218-5</ArticleId><ArticleId IdType="pmc">PMC6013508</ArticleId><ArticleId IdType="pubmed">29872882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M., Hammady H., Fedorowicz Z., Elmagarmid A. (2016). Rayyan-a web and mobile app for systematic reviews. Syst. Rev. 5, 210. 10.1186/s13643-016-0384-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M. J., McKenzie J. E., Bossuyt P. M., Boutron I., Hoffmann T. C., Mulrow C. D., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell J. A. (2020). Personalized blood pressure targets in shock: What if your normal blood pressure is &#x2018;Low. Am. J. Respir. Crit. Care Med. 202, 10&#x2013;12. 10.1164/rccm.202004-1124ED</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1124ED</ArticleId><ArticleId IdType="pmc">PMC7328338</ArticleId><ArticleId IdType="pubmed">32352319</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J. A. C., Savovi&#x107; J., Page M. J., Elbers R. G., Blencowe N. S., Boutron I., et al. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 366, l4898. 10.1136/bmj.l4898</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Varpula M., Tallgren M., Saukkonen K., Voipio-Pulkki L. M., Pettil&#xe4; V. (2005). Hemodynamic variables related to outcome in septic shock. Intensive Care Med. 31, 1066&#x2013;1071. 10.1007/s00134-005-2688-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2688-z</ArticleId><ArticleId IdType="pubmed">15973520</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J. Y., Ma S. Q., Pan C., He H. L., Cai S. X., Hu S. L., et al. (2015). A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: A prospective open label study. Crit. Care 19, 130. 10.1186/s13054-015-0866-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0866-0</ArticleId><ArticleId IdType="pmc">PMC4409762</ArticleId><ArticleId IdType="pubmed">25887027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36776034</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1876-4479</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Journal of Crohn's &amp; colitis</Title><ISOAbbreviation>J Crohns Colitis</ISOAbbreviation></Journal><ArticleTitle>Comparison of Restorative Proctocolectomy with and Without Defunctioning Loop Ileostomy in Patients with Ulcerative Colitis: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>876</StartPage><EndPage>895</EndPage><MedlinePgn>876-895</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ecco-jcc/jjad021</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Restorative proctocolectomy [RPC] without a defunctioning loop ileostomy [DLI] in patients with ulcerative colitis [UC] remains controversial.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To compare safety and efficacy of RPC with and without DLI in patients exclusively with UC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was performed according to PRISMA/MOOSE guidelines. Dichotomous variables were pooled as odds ratios [OR]. Continuous variables were pooled as weighted mean differences [WMD]. Quality assessment was performed using the Newcastle-Ottawa score [NOS].</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 20 studies [five paediatric and 15 adult] with 4550 UC patients [without DLI, n = 2370, 52.09%; with DLI, n = 2180, 47.91%] were eligible for inclusion. The median NOS was 8 [range 6-9]. There was no increased risk of anastomotic leak [AL] (OR 1.13, 95% confidence interval [CI]: 0.92, 1.39; p = 0.25), pouch excision [OR 1.01, 95% CI: 0.68, 1.50; p = 0.97], or overall major morbidity [OR 1.44, 95% CI, 0.91, 2.29; p = 0.12] for RPC without DLI, and this technique was associated with fewer anastomotic strictures [OR 0.45, 95% CI: 0.29, 0.68; p = 0.0002] and less bowel obstruction [OR 0.73, 95% CI: 0.57, 0.93; p = 0.01]. However, RPC without DLI increased the likelihood of pelvic sepsis [OR 1.68, 95% CI: 1.03, 2.75; p = 0.04] and emergency reoperation [OR 1.74, 95% CI: 1.22, 2.50; p = 0.002].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">RPC without DLI is not associated with increased clinically overt AL or pouch excision rates. However, it is associated with increased risk of pelvic sepsis and emergency reoperation. RPC without DLI is feasible, but should only be performed judiciously in select UC patient cohorts in high-volume, specialist, tertiary centres.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn&#x2019;s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Donnelly</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9824-3312</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Tallaght University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Odhr&#xe1;n K</ForeName><Initials>OK</Initials><Identifier Source="ORCID">0000-0003-2750-4607</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Tallaght University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>&#xc9;anna J</ForeName><Initials>&#xc9;J</Initials><Identifier Source="ORCID">0000-0003-2609-0836</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Tallaght University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bass</LastName><ForeName>Gary A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery and Surgical Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0002-0757-6411</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Tallaght University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNamara</LastName><ForeName>Deirdre</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, University of Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Tallaght University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whelan</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Tallaght University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neary</LastName><ForeName>Paul C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Surgery, Tallaght University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, University of Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Riordan</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Tallaght University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, University of Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavanagh</LastName><ForeName>Dara O</ForeName><Initials>DO</Initials><AffiliationInfo><Affiliation>Department of Surgery, Tallaght University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, University of Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Crohns Colitis</MedlineTA><NlmUniqueID>101318676</NlmUniqueID><ISSNLinking>1873-9946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016737" MajorTopicYN="Y">Proctocolectomy, Restorative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007081" MajorTopicYN="N">Ileostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="Y">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="N">Anastomotic Leak</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ulcerative colitis</Keyword><Keyword MajorTopicYN="N">inflammatory bowel disease</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>13</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36776034</ArticleId><ArticleId IdType="doi">10.1093/ecco-jcc/jjad021</ArticleId><ArticleId IdType="pii">7034901</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26093802</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.</ArticleTitle><Pagination><StartPage>908</StartPage><EndPage>913</EndPage><MedlinePgn>908-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2015.05.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(15)00319-6</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">There is controversy about the use of inotropes in the treatment of severe sepsis and septic shock. The objective of this study was to evaluate if levosimendan, as compared with standard inotropic therapy (eg, dobutamine), reduces mortality in septic patients.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">BioMedCentral, PubMed, EMBASE, and the Cochrane Central Register were searched for pertinent studies, up to 1st May 2015. Randomized trials on the use of levosimendan in patients with severe sepsis and septic shock were included if reporting mortality data. The primary outcome was mortality, whereas secondary outcomes were blood lactate, cardiac index, total fluid infused, norepinephrine dosage, and mean arterial pressure.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven studies for a total of 246 patients were included in the analysis. Levosimendan was associated with significantly reduced mortality compared with standard inotropic therapy (59/125 [47%] in the levosimendan group and 74/121 [61%] in the control group; risk difference = -0.14, risk ratio = 0.79 [0.63-0.98], P for effect = .03, I(2) = 0%, numbers needed to treat = 7). Blood lactate was significantly reduced in the levosimendan group, whereas cardiac index and total fluid infused were significantly higher in the levosimendan group. No difference in mean arterial pressure and norepinephrine usage was noted.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with severe sepsis and septic shock, levosimendan is associated with a significant reduction in mortality compared with standard inotropic therapy. A large ongoing multicenter randomized trial will have to confirm these findings.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University of Milan, Milan, Italy. Electronic address: zangrillo.alberto@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: alessandroputzu@ymail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: monaco.fabrizio@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oriani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: oriani.alessandro@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frau</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: frau.giovanna@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Luca</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: monica.deluca@libero.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Tomasso</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: noramed@hotmail.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bignami</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: bignami.elena@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, State Research Institute of Circulation Pathology, Novosibirsk, Russia. Electronic address: vvlom@mail.ru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anesthesiology &amp; Intensive Care Department, Moscow Regional Clinical &amp; Research Institute, Moscow, Russia. Electronic address: lik0704@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University of Milan, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006835">Hydrazones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011724">Pyridazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>349552KRHK</RegistryNumber><NameOfSubstance UI="D000077464">Simendan</NameOfSubstance></Chemical><Chemical><RegistryNumber>3S12J47372</RegistryNumber><NameOfSubstance UI="D004280">Dobutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002316" MajorTopicYN="N">Cardiotonic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004280" MajorTopicYN="N">Dobutamine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006835" MajorTopicYN="N">Hydrazones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011724" MajorTopicYN="N">Pyridazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077464" MajorTopicYN="N">Simendan</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Dobutamine</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Levosimendan</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Severe sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26093802</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2015.05.017</ArticleId><ArticleId IdType="pii">S0883-9441(15)00319-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31172283</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1436-2813</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Surgery today</Title><ISOAbbreviation>Surg Today</ISOAbbreviation></Journal><ArticleTitle>Clinical- and surgery-specific risk factors for post-operative sepsis: a systematic review and meta-analysis of over 30 million patients.</ArticleTitle><Pagination><StartPage>427</StartPage><EndPage>439</EndPage><MedlinePgn>427-439</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00595-019-01827-4</ELocationID><Abstract><AbstractText>Post-operative sepsis is a severe complication of surgery, which often worsens the clinical outcomes. While several risk factors have been identified, the importance of others remains uncertain. This systematic review and meta-analysis aimed to determine patient and surgery-related risk factors for post-operative sepsis. We reviewed Medline, the Web of Science, and the Cochrane library, systematically, for articles describing risk factors for sepsis. The role of eligible risk factors was investigated using a random-effects model, while analyzing univariate and multivariate data separately. Among 193 pro- and retrospective articles, comprising over 30 million patients, 38 eligible risk factors were selected for this meta-analysis. The patient-related risk factors associated with post-operative sepsis included male gender (odds ratio, OR 1.41), pre-existing heart failure (OR 2.53), diabetes (OR 1.41), and chronic kidney disease (OR 1.26). The surgery-related risk factors identified included emergency surgery (OR 3.38), peri-operative blood transfusion (OR 1.90), inpatient hospital stay (OR 2.31), and open surgery (OR 1.80). The adjusted overall incidence of surgical sepsis was 1.84%. In conclusion, multiple-patient and surgery-related risk factors are associated with the development of post-operative sepsis. Recognizing these risk factors could assist in the pre-operative identification of patients at risk of post-operative sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Plaeke</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2794-3570</Identifier><AffiliationInfo><Affiliation>Laboratory of Experimental Medicine and Pediatrics (LEMP), University of Antwerp, Universiteitsplein 1, 2610, Wilrijk (Antwerp), Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Abdominal Surgery, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Man</LastName><ForeName>Joris G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Medicine and Pediatrics (LEMP), University of Antwerp, Universiteitsplein 1, 2610, Wilrijk (Antwerp), Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coenen</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Social Medicine (ESOC), University of Antwerp, Universiteitsplein 1, 2610, Wilrijk (Antwerp), Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jorens</LastName><ForeName>Philippe G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Medicine and Pediatrics (LEMP), University of Antwerp, Universiteitsplein 1, 2610, Wilrijk (Antwerp), Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Winter</LastName><ForeName>Benedicte Y</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Medicine and Pediatrics (LEMP), University of Antwerp, Universiteitsplein 1, 2610, Wilrijk (Antwerp), Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hubens</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Abdominal Surgery, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Belgium. guy.hubens@uantwerpen.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Antwerp Surgical Training, Anatomy and Research Centre (ASTARC), University of Antwerp, Universiteitsplein 1, 2610, Wilrijk (Antwerp), Belgium. guy.hubens@uantwerpen.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Surg Today</MedlineTA><NlmUniqueID>9204360</NlmUniqueID><ISSNLinking>0941-1291</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004638" MajorTopicYN="N">Emergency Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Post-operative sepsis</Keyword><Keyword MajorTopicYN="N">Risk factors for sepsis</Keyword><Keyword MajorTopicYN="N">Surgical sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31172283</ArticleId><ArticleId IdType="doi">10.1007/s00595-019-01827-4</ArticleId><ArticleId IdType="pii">10.1007/s00595-019-01827-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA. 2016 Feb 23;315(8):801-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2013 Nov;217(5):833-42.e1-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24055383</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2011 Apr;39(4):818-26</Citation><ArticleIdList><ArticleId IdType="pubmed">21263315</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2005;9(6):R631-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16280064</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2003 Apr;29(4):530-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2018 Sep;44(9):1524-1527</Citation><ArticleIdList><ArticleId IdType="pubmed">29279970</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2010 Dec;252(6):1065-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 1992 Jun;101(6):1644-55</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2017 Mar;43(3):304-377</Citation><ArticleIdList><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>J Endourol. 2015 Oct;29(10):1126-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25919429</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2008 Jun;143(6):551-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18559747</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2017 Jun;161(6):1597-1608</Citation><ArticleIdList><ArticleId IdType="pubmed">28153378</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Surg. 2010;8(5):336-41</Citation><ArticleIdList><ArticleId IdType="pubmed">20171303</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35758282</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1651-226X</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Acta oncologica (Stockholm, Sweden)</Title><ISOAbbreviation>Acta Oncol</ISOAbbreviation></Journal><ArticleTitle>A nationwide study on characteristics and outcome of cancer patients with sepsis requiring intensive care.</ArticleTitle><Pagination><StartPage>946</StartPage><EndPage>954</EndPage><MedlinePgn>946-954</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0284186X.2022.2090276</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Sepsis is the leading cause of admission to the intensive care unit (ICU) for cancer patients and survival rates have historically been low. The aims of this nationwide cohort study were to describe the characteristics and outcomes of cancer patients admitted to the ICU with sepsis compared with other sepsis patients requiring ICU admission.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">This was a retrospective, observational study. All adult admissions to Icelandic ICUs during years 2006, 2008, 2010, 2012, 2014 and 2016 were screened for severe sepsis or septic shock by ACCP/SCCM criteria. Clinical characteristics and outcomes of sepsis patients with cancer were compared to those without cancer.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In the study period, 235 of 971 (24%) patients admitted to Icelandic ICUs because of sepsis had cancer, most often a solid tumour (100), followed by metastatic tumours (69) and haematological malignancies (66). Infections were more often hospital-acquired in cancer patients (52%) than other sepsis patients (18%, <i>p</i>&#x2009;&lt;&#x2009;0.001) and sites of infections differed, with abdominal infections being most common in patients with solid and metastatic tumours but lungs and bloodstream infections in haematological malignancies. The length of stay in the ICU was shorter for sepsis patients with metastatic disease than other sepsis patients (2 vs. 4&#x2009;days, <i>p</i>&#x2009;&lt;&#x2009;0.001) and they were more likely to have treatment limitations (52 vs. 19%, <i>p</i>&#x2009;&lt;&#x2009;0.05). Median survival of patients with metastatic disease was 19&#x2009;days from ICU admission. The 28-day mortality (25%) of solid tumour patients was comparable to that of sepsis patients without cancer (20%, <i>p</i>&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Cancer is a common comorbidity in patients admitted to the ICU with sepsis. The clinical presentation and outcome differs between cancer types. Individuals with metastatic cancer were unlikely to receive prolonged invasive ICU care treatment. Comparable short-term outcome was found for patients with solid tumours and no cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vesteinsdottir</LastName><ForeName>Edda</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7782-652X</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>Martin Ingi</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0001-7054-0844</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottfredsson</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2465-0422</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blondal</LastName><ForeName>Asbjorn</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Akureyri Hospital, Akureyri, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karason</LastName><ForeName>Sigurbergur</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0726-4378</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Acta Oncol</MedlineTA><NlmUniqueID>8709065</NlmUniqueID><ISSNLinking>0284-186X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019337" MajorTopicYN="Y">Hematologic Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">metastasis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>27</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35758282</ArticleId><ArticleId IdType="doi">10.1080/0284186X.2022.2090276</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38485953</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>14</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Identification of a hyperinflammatory sepsis phenotype using protein biomarker and clinical data in the ProCESS randomized trial.</ArticleTitle><Pagination><StartPage>6234</StartPage><MedlinePgn>6234</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6234</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-55667-5</ELocationID><Abstract><AbstractText>Sepsis is a heterogeneous syndrome and phenotypes have been proposed using clinical data. Less is known about the contribution of protein biomarkers to clinical sepsis phenotypes and their importance for treatment effects in randomized trials of resuscitation. The objective is to use both clinical and biomarker data in the Protocol-Based Care for Early Septic Shock (ProCESS) randomized trial to determine sepsis phenotypes and to test for heterogeneity of treatment effect by phenotype comparing usual care to protocolized early, goal-directed therapy(EGDT). In this secondary analysis of a subset of patients with biomarker sampling in the ProCESS trial (n&#x2009;=&#x2009;543), we identified sepsis phenotypes prior to randomization using latent class analysis of 20 clinical and biomarker variables. Logistic regression was used to test for interaction between phenotype and treatment arm for 60-day inpatient mortality. Among 543 patients with severe sepsis or septic shock in the ProCESS trial, a 2-class model best fit the data (p&#x2009;=&#x2009;0.01). Phenotype 1 (n&#x2009;=&#x2009;66, 12%) had increased IL-6, ICAM, and total bilirubin and decreased platelets compared to phenotype 2 (n&#x2009;=&#x2009;477, 88%, p&#x2009;&lt;&#x2009;0.01 for all). Phenotype 1 had greater 60-day inpatient mortality compared to Phenotype 2 (41% vs 16%; p&#x2009;&lt;&#x2009;0.01). Treatment with EGDT was associated with worse 60-day inpatient mortality compared to usual care (58% vs. 23%) in Phenotype 1 only (p-value for interaction&#x2009;=&#x2009;0.05). The 60-day inpatient mortality was similar comparing EGDT to usual care in Phenotype 2 (16% vs. 17%). We identified 2 sepsis phenotypes using latent class analysis of clinical and protein biomarker data at randomization in the ProCESS trial. Phenotype 1 had increased inflammation, organ dysfunction and worse clinical outcomes compared to phenotype 2. Response to EGDT versus usual care differed by phenotype.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>DeMerle</LastName><ForeName>Kimberley M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Jason N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chung-Chou H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delucchi</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>David T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Acute Care Research Organization (MACRO), Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kravitz</LastName><ForeName>Max S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Nathan I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yealy</LastName><ForeName>Donald M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angus</LastName><ForeName>Derek C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calfee</LastName><ForeName>Carolyn S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seymour</LastName><ForeName>Christopher W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Pittsburgh, PA, USA. seymourcw@upmc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA. seymourcw@upmc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, USA. seymourcw@upmc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, 3459 Fifth Avenue, NW628, Pittsburgh, PA, 15213, USA. seymourcw@upmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32HL007820</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL140026</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35GM119519</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM119519</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35HL140026</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002985" MajorTopicYN="N">Clinical Protocols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Phenotypes</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>15</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38485953</ArticleId><ArticleId IdType="pmc">PMC10940677</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-55667-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-55667-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu V, Escobar GJ, Greene JD, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312(1):90&#x2013;92. doi: 10.1001/jama.2014.5804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.5804</ArticleId><ArticleId IdType="pubmed">24838355</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009&#x2013;2014. JAMA. 2017;318(13):1241&#x2013;1249. doi: 10.1001/jama.2017.13836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13836</ArticleId><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantes RB, Epstein L. Combatting sepsis: A public health perspective. Clin. Infect. Dis. 2018;67(8):1300&#x2013;1302. doi: 10.1093/cid/ciy342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy342</ArticleId><ArticleId IdType="pmc">PMC6557150</ArticleId><ArticleId IdType="pubmed">29846544</ArticleId></ArticleIdList></Reference><Reference><Citation>Yealy DM, Kellum JA, et al. A randomized trial of protocolbased care for early septic shock. N. Engl. J. Med. 2014;370(18):1683&#x2013;1693. doi: 10.1056/NEJMoa1401602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401602</ArticleId><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003&#x2013;2017. doi: 10.1001/jama.2019.5791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.5791</ArticleId><ArticleId IdType="pmc">PMC6537818</ArticleId><ArticleId IdType="pubmed">31104070</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H, Huang J-H, Zhang X-W, et al. Identification of potential diagnostic biomarkers of acute pancreatitis by serum metabolomic profiles. Pancreatology. 2017;17(4):543&#x2013;549. doi: 10.1016/j.pan.2017.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pan.2017.04.015</ArticleId><ArticleId IdType="pubmed">28487129</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: Latent class analysis of data from two randomised controlled trials. Lancet Respir. Med. 2014;2(8):611&#x2013;620. doi: 10.1016/S2213-2600(14)70097-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70097-9</ArticleId><ArticleId IdType="pmc">PMC4154544</ArticleId><ArticleId IdType="pubmed">24853585</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr TF, Kraft M. Use of biomarkers to identify phenotypes and endotypes of severeasthma. Ann. Allergy Asthma Immunol. 2018;121(4):414&#x2013;420. doi: 10.1016/j.anai.2018.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2018.07.029</ArticleId><ArticleId IdType="pubmed">30059792</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowan KM, Angus DC, et al. Early, goal-directed therapy for septic shock&#x2014;a patient-level meta-analysis. N. Engl. J. Med. 2017;376(23):2223&#x2013;2234. doi: 10.1056/NEJMoa1701380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1701380</ArticleId><ArticleId IdType="pubmed">28320242</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermunt JK, van Ginkel JR, van der Ark LA, Sijtsma K. multiple imputation of incomplete categorical data using latent class analysis. Sociol. Methodol. 2008;38(1):369&#x2013;397. doi: 10.1111/j.1467-9531.2008.00202.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-9531.2008.00202.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber JB. Latent class analysis: An example for reporting results. Res. Soc. Adm. Pharm. 2017;13(6):1196&#x2013;1201. doi: 10.1016/j.sapharm.2016.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2016.11.011</ArticleId><ArticleId IdType="pubmed">27955976</ArticleId></ArticleIdList></Reference><Reference><Citation>Scicluna BP, van Vught LA, Zwinderman AH, et al. Classification of patients with sepsis according to blood genomic endotype: A prospective cohort study. Lancet Respir. Med. 2017;5(10):816&#x2013;826. doi: 10.1016/S2213-2600(17)30294-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(17)30294-1</ArticleId><ArticleId IdType="pubmed">28864056</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport EE, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: A prospective cohort study. Lancet Respir. Med. 2016;4(4):259&#x2013;271. doi: 10.1016/S2213-2600(16)00046-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00046-1</ArticleId><ArticleId IdType="pmc">PMC4820667</ArticleId><ArticleId IdType="pubmed">26917434</ArticleId></ArticleIdList></Reference><Reference><Citation>van Amstel RBE, Kennedy JN, Scicluna BP, et al. Uncovering heterogeneity in sepsis: A comparative analysis of subphenotypes. Intensive Care Med. 2023;1:1. doi: 10.1007/s00134-023-07239-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07239-w</ArticleId><ArticleId IdType="pmc">PMC10622359</ArticleId><ArticleId IdType="pubmed">37851064</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebregziabher M, DeSantis SM. Latent class based multiple imputation approach for missing categorical data. J. Stat. Plan. Inference. 2010;140(11):3252&#x2013;3262. doi: 10.1016/j.jspi.2010.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jspi.2010.04.020</ArticleId><ArticleId IdType="pmc">PMC6290917</ArticleId><ArticleId IdType="pubmed">30555206</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamovlasis D, Papageorgiou G, Tsitsipis G, Tsikalas T, Vaiopoulou J. Illustration of step-wise latent class modeling with covariates and taxometric analysis in research probing children&#x2019;s mental models in learning sciences. Front. Psychol. 2018;9:532. doi: 10.3389/fpsyg.2018.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2018.00532</ArticleId><ArticleId IdType="pmc">PMC5911829</ArticleId><ArticleId IdType="pubmed">29713300</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe5;rdlund B, Dmitrieva NO, Pieper CF, Finfer S, Marshall JC, Thompson TB. Six subphenotypes in septic shock: Latent class analysis of the PROWESS Shock study. J. Crit. Care. 2018;47:70&#x2013;79. doi: 10.1016/j.jcrc.2018.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2018.06.012</ArticleId><ArticleId IdType="pmc">PMC7416734</ArticleId><ArticleId IdType="pubmed">29933169</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24103711</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Reducing mortality in acute kidney injury patients: systematic review and international web-based survey.</ArticleTitle><Pagination><StartPage>1384</StartPage><EndPage>1398</EndPage><MedlinePgn>1384-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2013.06.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(13)00390-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify all interventions that increase or reduce mortality in patients with acute kidney injury (AKI) and to establish the agreement between stated beliefs and actual practice in this setting.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">Systematic literature review and international web-based survey.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">More than 300 physicians from 62 countries.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Several databases, including MEDLINE/PubMed, were searched with no time limits (updated February 14, 2012) to identify all the drugs/techniques/strategies that fulfilled all the following criteria: (a) published in a peer-reviewed journal, (b) dealing with critically ill adult patients with or at risk for acute kidney injury, and (c) reporting a statistically significant reduction or increase in mortality.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Of the 18 identified interventions, 15 reduced mortality and 3 increased mortality. Perioperative hemodynamic optimization, albumin in cirrhotic patients, terlipressin for hepatorenal syndrome type 1, human immunoglobulin, peri-angiography hemofiltration, fenoldopam, plasma exchange in multiple-myeloma-associated AKI, increased intensity of renal replacement therapy (RRT), CVVH in severely burned patients, vasopressin in septic shock, furosemide by continuous infusion, citrate in continuous RRT, N-acetylcysteine, continuous and early RRT might reduce mortality in critically ill patients with or at risk for AKI; positive fluid balance, hydroxyethyl starch and loop diuretics might increase mortality in critically ill patients with or at risk for AKI. Web-based opinion differed from consensus opinion for 30% of interventions and self-reported practice for 3 interventions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The authors identified all interventions with at least 1 study suggesting a significant effect on mortality in patients with or at risk of AKI and found that there is discordance between participant stated beliefs and actual practice regarding these topics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sz&#xe9;kely</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Comis</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rodseth</LastName><ForeName>Reitze N</ForeName><Initials>RN</Initials></Author><Author ValidYN="Y"><LastName>Pasero</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ponschab</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Mucchetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Azzolini</LastName><ForeName>Maria L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Caramelli</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Pala</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Cabrini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Daniele</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Borghi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Capasso</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Cariello</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Carpanese</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Feltracco</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Gottin</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lobreglio</LastName><ForeName>Rosetta</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Mattioli</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Morgese</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Musu</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Roasio</LastName><ForeName>Agostino</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Slaviero</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Villari</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Vittorio</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zucchetti</LastName><ForeName>Mariachiara</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>De Santis</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Del Sarto</LastName><ForeName>Paolo A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Corcione</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Finco</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney failure</Keyword><Keyword MajorTopicYN="N">acute renal injury</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">consensus</Keyword><Keyword MajorTopicYN="N">consensus conference</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">renal failure</Keyword><Keyword MajorTopicYN="N">survival</Keyword><Keyword MajorTopicYN="N">web vote</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24103711</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2013.06.028</ArticleId><ArticleId IdType="pii">S1053-0770(13)00390-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37273827</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-875X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in surgery</Title><ISOAbbreviation>Front Surg</ISOAbbreviation></Journal><ArticleTitle>Clinical phenotyping of spondylodiscitis and isolated spinal epidural empyema: a 20-year experience and cohort study.</ArticleTitle><Pagination><StartPage>1200432</StartPage><MedlinePgn>1200432</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1200432</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fsurg.2023.1200432</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The incidence of spondylodiscitis (SD) and isolated spinal epidural empyema (ISEE) has been increasing in the last decades, but the distinct differences between both entities are poorly understood. We aimed to evaluate the clinical phenotypes and long-term outcomes of SD and ISEE in depth.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We performed a chart review and analyzed data from our cohorts of consecutive SD and ISEE patients who were treated and assessed in detail for demographic, clinical, imaging, laboratory, and microbiologic characteristics at a university neurosurgical center in Germany from 2002 to 2021. Between-group comparisons were performed to identify meaningful differences in both entities.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We included 208 patients (72 females: age 75 [75 32-90] y vs. 136 males: 65 [23-87] y, median [interquartile range], <i>p</i>&#x2009;&lt;&#x2009;0.001), of which 142 (68.3%) had SD and 66 (31.7%) had ISEE. Patients with SD were older than ISEE (ISEE: 62&#x2005;y vs. SD: 70&#x2005;y, <i>p</i>&#x2009;=&#x2009;0.001). While SD was more common in males than females (males: <i>n</i>&#x2009;=&#x2009;101, 71.1% vs. females: <i>n</i>&#x2009;=&#x2009;41, 28.9%, <i>p</i>&#x2009;&lt;&#x2009;0.001), there was no sex-related difference in ISEE (males: <i>n</i>&#x2009;=&#x2009;35, 53.0% vs. females: <i>n</i>&#x2009;=&#x2009;31, 47.0%, <i>p</i>&#x2009;=&#x2009;0.71). Obesity was more frequent in ISEE than in SD (ISEE: <i>n</i>&#x2009;=&#x2009;29, 43.9% vs. SD: <i>n</i>&#x2009;=&#x2009;37, 26.1%, <i>p</i>&#x2009;=&#x2009;0.016). However, there were no between-group differences in rates of diabetes and immunodeficiency. In the entire study population, a causative pathogen was identified in 192 (92.3%) patients, with methicillin-susceptible staphylococcus aureus being most frequent (<i>n</i>&#x2009;=&#x2009;100, 52.1%) and being more frequent in ISEE than SD (ISEE: <i>n</i>&#x2009;=&#x2009;43, 65.2% vs. SD: <i>n</i>&#x2009;=&#x2009;57, 40.1%, <i>p</i>&#x2009;=&#x2009;0.003). SD and ISEE occurred most frequently in the lumbar spine, with no between-group differences (ISEE: <i>n</i>&#x2009;=&#x2009;25, 37.9% vs. SD: <i>n</i>&#x2009;=&#x2009;65, 45.8%, <i>p</i>&#x2009;=&#x2009;0.297). Primary infectious sources were identified in 145 patients (69.7%) and among this skin infection was most common in both entities (ISEE: <i>n</i>&#x2009;=&#x2009;14, 31.8% vs. SD: <i>n</i>&#x2009;=&#x2009;25, 24.8%, <i>p</i>&#x2009;=&#x2009;0.418). Furthermore, epidural administration was more frequent the primary cause of infection in ISEE than SD (ISEE: <i>n</i>&#x2009;=&#x2009;12, 27.3% vs. SD: <i>n</i>&#x2009;=&#x2009;5, 4.9%, <i>p</i>&#x2009;&lt;&#x2009;0.001). The most common surgical procedure in SD was instrumentation (<i>n</i>&#x2009;=&#x2009;87, 61%) and in ISEE abscess evacuation (<i>n</i>&#x2009;=&#x2009;63, 95%). Patients with ISEE displayed lower in-hospital complication rates compared to SD for sepsis (ISEE: <i>n</i>&#x2009;=&#x2009;12, 18.2% vs. SD: <i>n</i>&#x2009;=&#x2009;94, 66.2%, <i>p</i>&#x2009;&lt;&#x2009;0.001), septic embolism (ISEE: <i>n</i>&#x2009;=&#x2009;4/48 cases, 8.3% vs. SD: <i>n</i>&#x2009;=&#x2009;52/117 cases, 44.4%, <i>p</i>&#x2009;&lt;&#x2009;0.001), endocarditis (ISEE: <i>n</i>&#x2009;=&#x2009;1/52 cases, 1.9% vs. SD: <i>n</i>&#x2009;=&#x2009;23/125 cases, 18.4%, <i>p</i>&#x2009;=&#x2009;0.003), relapse rate (ISEE: <i>n</i>&#x2009;=&#x2009;4/46, 8.7% vs. SD: <i>n</i>&#x2009;=&#x2009;27/92, 29.3%, <i>p</i>&#x2009;=&#x2009;0.004), and disease-related mortality (ISEE: <i>n</i>&#x2009;=&#x2009;1, 1.5% vs. SD: <i>n</i>&#x2009;=&#x2009;11, 7.7%, <i>p</i>&#x2009;=&#x2009;0.108). Patients with SD showed prolonged length of hospital stay (ISEE: 22 [15, 30] d vs. SD: 38 [29, 53] d, <i>p</i>&#x2009;&lt;&#x2009;0.001) and extended intensive care unit stay (ISEE: 0 [0, 4] d vs. SD: 3 [0, 12] d, <i>p</i>&#x2009;&lt;&#x2009;0.002).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our 20-year experience and cohort analysis on the clinical management of SD and ISEE unveiled distinct clinical phenotypes and outcomes in both entities, with ISEE displaying a more favorable disease course with respect to complications and relapse rates as well as disease-related mortality.</AbstractText><CopyrightInformation>&#xa9; 2023 Hijazi, Siepmann, El-Battrawy, Glatte, Ey&#xfc;poglu, Schackert, Juratli and Podlesek.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hijazi</LastName><ForeName>Mido Max</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siepmann</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Battrawy</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Bergmannsheil University Hospitals Bergmannsheil, Ruhr University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glatte</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ey&#xfc;poglu</LastName><ForeName>Ilker</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schackert</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juratli</LastName><ForeName>Tareq A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podlesek</LastName><ForeName>Dino</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Surg</MedlineTA><NlmUniqueID>101645127</NlmUniqueID><ISSNLinking>2296-875X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">endocarditis</Keyword><Keyword MajorTopicYN="N">isolated spinal epidural empyema</Keyword><Keyword MajorTopicYN="N">primary spinal infection</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic embolism</Keyword><Keyword MajorTopicYN="N">spondylodiscitis</Keyword><Keyword MajorTopicYN="N">vertebral ostemyelitis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>13</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>11</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37273827</ArticleId><ArticleId IdType="pmc">PMC10232866</ArticleId><ArticleId IdType="doi">10.3389/fsurg.2023.1200432</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Calhoun JH, Manring MM. Adult osteomyelitis. Infect Dis Clin North Am. (2005) 19(4):765&#x2013;86. 10.1016/j.idc.2005.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2005.07.009</ArticleId><ArticleId IdType="pubmed">16297731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lener S, Hartmann S, Barbagallo GMV, Certo F, Thome C, Tschugg A. Management of spinal infection: a review of the literature. Acta Neurochir (Wien). (2018) 160(3):487&#x2013;96. 10.1007/s00701-018-3467-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-018-3467-2</ArticleId><ArticleId IdType="pmc">PMC5807463</ArticleId><ArticleId IdType="pubmed">29356895</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickerson EK, Sinha R. Vertebral osteomyelitis in adults: an update. Br Med Bull. (2016) 117(1):121&#x2013;38. 10.1093/bmb/ldw003</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldw003</ArticleId><ArticleId IdType="pubmed">26872859</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosc-Bereza K, Arkuszewski M, Ciach-Wysocka E, Boczarska-Jedynak M. Spinal epidural abscess: common symptoms of an emergency condition. A case report. Neuroradiol J. (2013) 26(4):464&#x2013;8. 10.1177/197140091302600411</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/197140091302600411</ArticleId><ArticleId IdType="pmc">PMC4202809</ArticleId><ArticleId IdType="pubmed">24007734</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjipavlou AG, Mader JT, Necessary JT, Muffoletto AJ. Hematogenous pyogenic spinal infections and their surgical management. Spine (Phila Pa 1976). (2000) 25(13):1668&#x2013;79. 10.1097/00007632-200007010-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200007010-00010</ArticleId><ArticleId IdType="pubmed">10870142</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrah TW, Enoch DA, Aliyu SH, Lever AM. Bacteraemia and subsequent vertebral osteomyelitis: a retrospective review of 125 patients. QJM. (2011) 104(3):201&#x2013;7. 10.1093/qjmed/hcq178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcq178</ArticleId><ArticleId IdType="pubmed">20934976</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuer C, Stoffel M, Hecker J, Ringel F, Meyer B. A staged treatment algorithm for spinal infections. J Neurol Surg A Cent Eur Neurosurg. (2013) 74(2):87&#x2013;95. 10.1055/s-0032-1320022</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1320022</ArticleId><ArticleId IdType="pubmed">23404554</ArticleId></ArticleIdList></Reference><Reference><Citation>Aagaard T, Roed C, Dahl B, Obel N. Long-term prognosis and causes of death after spondylodiscitis: a Danish nationwide cohort study. Infect Dis (Lond). (2016) 48(3):201&#x2013;8. 10.3109/23744235.2015.1103897</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/23744235.2015.1103897</ArticleId><ArticleId IdType="pubmed">26484577</ArticleId></ArticleIdList></Reference><Reference><Citation>Artenstein AW, Friderici J, Holers A, Lewis D, Fitzgerald J, Visintainer P. Spinal epidural abscess in adults: a 10-year clinical experience at a tertiary care academic medical center. Open Forum Infect Dis. (2016) 3(4):ofw191. 10.1093/ofid/ofw191</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofw191</ArticleId><ArticleId IdType="pmc">PMC5172511</ArticleId><ArticleId IdType="pubmed">28018923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehrer M, Pedersen C, Jensen TG, Lassen AT. Increasing incidence of pyogenic spondylodiscitis: a 14-year population-based study. J Infect. (2014) 68(4):313&#x2013;20. 10.1016/j.jinf.2013.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2013.11.011</ArticleId><ArticleId IdType="pubmed">24296494</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenfeld AJ, Wahlquist TC. Mortality, complication risk, and total charges after the treatment of epidural abscess. Spine J. (2015) 15(2):249&#x2013;55. 10.1016/j.spinee.2014.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2014.09.003</ArticleId><ArticleId IdType="pubmed">25241303</ArticleId></ArticleIdList></Reference><Reference><Citation>Herren C, Jung N, Pishnamaz M, Breuninger M, Siewe J, Sobottke R. Spondylodiscitis: diagnosis and treatment options. Dtsch Arztebl Int. (2017) 114(51&#x2013;52):875&#x2013;82. 10.3238/arztebl.2017.0875</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2017.0875</ArticleId><ArticleId IdType="pmc">PMC5769318</ArticleId><ArticleId IdType="pubmed">29321098</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lucas EM, Gonzalez Mandly A, Gutierrez A, Pellon R, Martin-Cuesta L, Izquierdo J, et al. CT-guided fine-needle aspiration in vertebral osteomyelitis: true usefulness of a common practice. Clin Rheumatol. (2009) 28(3):315&#x2013;20. 10.1007/s10067-008-1051-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-008-1051-5</ArticleId><ArticleId IdType="pubmed">19043772</ArticleId></ArticleIdList></Reference><Reference><Citation>Arko L. 4th, Quach E, Nguyen V, Chang D, Sukul V, Kim BS. Medical and surgical management of spinal epidural abscess: a systematic review. Neurosurg Focus. (2014) 37(2):E4. 10.3171/2014.6.FOCUS14127</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2014.6.FOCUS14127</ArticleId><ArticleId IdType="pubmed">25081964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju KL, Kim SD, Melikian R, Bono CM, Harris MB. Predicting patients with concurrent noncontiguous spinal epidural abscess lesions. Spine J. (2015) 15(1):95&#x2013;101. 10.1016/j.spinee.2014.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2014.06.008</ArticleId><ArticleId IdType="pubmed">24953159</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab JH, Shah AA. Spinal epidural abscess: diagnosis, management, and outcomes. J Am Acad Orthop Surg. (2020) 28(21):e929&#x2013;38. 10.5435/JAAOS-D-19-00685</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-19-00685</ArticleId><ArticleId IdType="pubmed">32694325</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AA, Ogink PT, Harris MB, Schwab JH. Development of predictive algorithms for pre-treatment motor deficit and 90-day mortality in spinal epidural abscess. J Bone Joint Surg Am. (2018) 100(12):1030&#x2013;8. 10.2106/JBJS.17.00630</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.17.00630</ArticleId><ArticleId IdType="pubmed">29916930</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschugg A, Lener S, Hartmann S, Rietzler A, Neururer S, Thome C. Primary acquired spondylodiscitis shows a more severe course than spondylodiscitis following spine surgery: a single-center retrospective study of 159 cases. Neurosurg Rev. (2018) 41(1):141&#x2013;7. 10.1007/s10143-017-0829-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10143-017-0829-9</ArticleId><ArticleId IdType="pmc">PMC5748409</ArticleId><ArticleId IdType="pubmed">28239759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Kang YJ, Chen WH. Continuous epidural irrigation and drainage combined with posterior debridement and posterior lumbar inter-body fusion for the management of single-segment lumbar pyogenic spondylodiscitis. Surg Infect (Larchmt). (2020) 21(3):262&#x2013;7. 10.1089/sur.2019.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2019.038</ArticleId><ArticleId IdType="pubmed">31647391</ArticleId></ArticleIdList></Reference><Reference><Citation>Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, et al. Executive summary: 2015 infectious diseases society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. (2015) 61(6):859&#x2013;63. 10.1093/cid/civ633</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/civ633</ArticleId><ArticleId IdType="pubmed">26316526</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. (2000) 30(4):633&#x2013;8. 10.1086/313753</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/313753</ArticleId><ArticleId IdType="pubmed">10770721</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammatico L, Baron S, Rusch E, Lepage B, Surer N, Desenclos JC, et al. Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002&#x2013;2003. Epidemiol Infect. (2008) 136(5):653&#x2013;60. 10.1017/S0950268807008850</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268807008850</ArticleId><ArticleId IdType="pmc">PMC2870846</ArticleId><ArticleId IdType="pubmed">17568478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mylona E, Samarkos M, Kakalou E, Fanourgiakis P, Skoutelis A. Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics. Semin Arthritis Rheum. (2009) 39(1):10&#x2013;7. 10.1016/j.semarthrit.2008.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2008.03.002</ArticleId><ArticleId IdType="pubmed">18550153</ArticleId></ArticleIdList></Reference><Reference><Citation>Reihsaus E, Waldbaur H, Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients. Neurosurg Rev. (2000) 23(4):175&#x2013;204; discussion 205. 10.1007/PL00011954</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00011954</ArticleId><ArticleId IdType="pubmed">11153548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarghooni K, Rollinghoff M, Sobottke R, Eysel P. Treatment of spondylodiscitis. Int Orthop. (2012) 36(2):405&#x2013;11. 10.1007/s00264-011-1425-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-011-1425-1</ArticleId><ArticleId IdType="pmc">PMC3282845</ArticleId><ArticleId IdType="pubmed">22143315</ArticleId></ArticleIdList></Reference><Reference><Citation>McHenry MC, Easley KA, Locker GA. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis. (2002) 34(10):1342&#x2013;50. 10.1086/340102</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/340102</ArticleId><ArticleId IdType="pubmed">11981730</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolla JM, Ariza J, Gomez-Vaquero C, Fiter J, Bermejo J, Valverde J, et al. Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Semin Arthritis Rheum. (2002) 31(4):271&#x2013;8. 10.1053/sarh.2002.29492</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/sarh.2002.29492</ArticleId><ArticleId IdType="pubmed">11836660</ArticleId></ArticleIdList></Reference><Reference><Citation>Stangenberg M, Mende KC, Mohme M, Kratzig T, Viezens L, Both A, et al. Influence of microbiological diagnosis on the clinical course of spondylodiscitis. Infection. (2021) 49(5):1017&#x2013;27. 10.1007/s15010-021-01642-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01642-5</ArticleId><ArticleId IdType="pmc">PMC8476479</ArticleId><ArticleId IdType="pubmed">34254283</ArticleId></ArticleIdList></Reference><Reference><Citation>Adogwa O, Karikari IO, Carr KR, Krucoff M, Ajay D, Fatemi P, et al. Spontaneous spinal epidural abscess in patients 50 years of age and older: a 15-year institutional perspective and review of the literature: clinical article. J Neurosurg Spine. (2014) 20(3):344&#x2013;9. 10.3171/2013.11.SPINE13527</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2013.11.SPINE13527</ArticleId><ArticleId IdType="pubmed">24359002</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker AS, Ojemann RG, Swartz MN, Richardson EP, Jr. Spinal epidural abscess. N Engl J Med. (1975) 293(10):463&#x2013;8. 10.1056/NEJM197509042931001</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197509042931001</ArticleId><ArticleId IdType="pubmed">1152860</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. (2015) 385(9971):875&#x2013;82. 10.1016/S0140-6736(14)61233-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61233-2</ArticleId><ArticleId IdType="pubmed">25468170</ArticleId></ArticleIdList></Reference><Reference><Citation>Colmenero JD, Jimenez-Mejias ME, Sanchez-Lora FJ, Reguera JM, Palomino-Nicas J, Martos F, et al. Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis. (1997) 56(12):709&#x2013;15. 10.1136/ard.56.12.709</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.56.12.709</ArticleId><ArticleId IdType="pmc">PMC1752312</ArticleId><ArticleId IdType="pubmed">9496149</ArticleId></ArticleIdList></Reference><Reference><Citation>Hlavin ML, Kaminski HJ, Ross JS, Ganz E. Spinal epidural abscess: a ten-year perspective. Neurosurgery. (1990) 27(2):177&#x2013;84. 10.1227/00006123-199008000-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/00006123-199008000-00001</ArticleId><ArticleId IdType="pubmed">2385333</ArticleId></ArticleIdList></Reference><Reference><Citation>Osenbach RK, Hitchon PW, Menezes AH. Diagnosis and management of pyogenic vertebral osteomyelitis in adults. Surg Neurol. (1990) 33(4):266&#x2013;75. 10.1016/0090-3019(90)90047-S</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-3019(90)90047-S</ArticleId><ArticleId IdType="pubmed">2326732</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigrau C, Almirante B, Flores X, Falco V, Rodriguez D, Gasser I, et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. Am J Med. (2005) 118(11):1287. 10.1016/j.amjmed.2005.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2005.02.027</ArticleId><ArticleId IdType="pubmed">16271915</ArticleId></ArticleIdList></Reference><Reference><Citation>Pojskic M, Carl B, Schmockel V, Vollger B, Nimsky C, Sabeta B. Neurosurgical management and outcome parameters in 237 patients with spondylodiscitis. Brain Sci. (2021) 11(8):1019. 10.3390/brainsci11081019</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11081019</ArticleId><ArticleId IdType="pmc">PMC8394582</ArticleId><ArticleId IdType="pubmed">34439638</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigamonti D, Liem L, Sampath P, Knoller N, Namaguchi Y, Schreibman DL, et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol. (1999) 52(2):189&#x2013;96.10.1016/S0090-3019(99)00055-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0090-3019(99)00055-5</ArticleId><ArticleId IdType="pubmed">10447289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryang YM, Akbar M. [Pyogenic spondylodiscitis: symptoms, diagnostics and therapeutic strategies]. Orthopade. (2020) 49(8):691&#x2013;701. 10.1007/s00132-020-03945-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00132-020-03945-1</ArticleId><ArticleId IdType="pubmed">32642943</ArticleId></ArticleIdList></Reference><Reference><Citation>Darouiche RO. Spinal epidural abscess. N Engl J Med. (2006) 355(19):2012&#x2013;20. 10.1056/NEJMra055111</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra055111</ArticleId><ArticleId IdType="pubmed">17093252</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. (2010) 65(Suppl 3):iii11&#x2013;24. 10.1093/jac/dkq303</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkq303</ArticleId><ArticleId IdType="pubmed">20876624</ArticleId></ArticleIdList></Reference><Reference><Citation>Loibl M, Stoyanov L, Doenitz C, Brawanski A, Wiggermann P, Krutsch W, et al. Outcome-related co-factors in 105 cases of vertebral osteomyelitis in a tertiary care hospital. Infection. (2014) 42(3):503&#x2013;10. 10.1007/s15010-013-0582-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-013-0582-0</ArticleId><ArticleId IdType="pubmed">24446233</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel AR, Alton TB, Bransford RJ, Lee MJ, Bellabarba CB, Chapman JR. Spinal epidural abscesses: risk factors, medical versus surgical management, a retrospective review of 128 cases. Spine J. (2014) 14(2):326&#x2013;30. 10.1016/j.spinee.2013.10.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2013.10.046</ArticleId><ArticleId IdType="pubmed">24231778</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinstein E. Staphylococcus aureus bacteraemia with known sources. Int J Antimicrob Agents. (2008) 32(Suppl 1):S18&#x2013;20. 10.1016/j.ijantimicag.2008.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2008.06.006</ArticleId><ArticleId IdType="pubmed">18715760</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamohan P, Berger JR. Spinal epidural abscess. Curr Infect Dis Rep. (2014) 16(11):436. 10.1007/s11908-014-0436-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-014-0436-7</ArticleId><ArticleId IdType="pubmed">25230605</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae HJ, Kim J, Kim C. Clinical characteristics of spinal epidural abscess accompanied by bacteremia. J Korean Neurosurg Soc. (2021) 64(1):88&#x2013;99. 10.3340/jkns.2020.0278</Citation><ArticleIdList><ArticleId IdType="doi">10.3340/jkns.2020.0278</ArticleId><ArticleId IdType="pmc">PMC7819787</ArticleId><ArticleId IdType="pubmed">33353288</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry WT, Jr, Hoh BL, Amin-Hanjani S, Eskandar EN. Spinal epidural abscess: clinical presentation, management, and outcome. Surg Neurol. (2005) 63(4):364&#x2013;71. 10.1016/j.surneu.2004.08.081</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surneu.2004.08.081</ArticleId><ArticleId IdType="pubmed">15808726</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen P. Spinal epidural abscesses: conservative treatment for selected subgroups of patients. Br J Neurosurg. (2003) 17(6):513&#x2013;8. 10.1080/02688690310001627731</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02688690310001627731</ArticleId><ArticleId IdType="pubmed">14756477</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschugg A, Hartmann S, Lener S, Rietzler A, Sabrina N, Thome C. Minimally invasive spine surgery in lumbar spondylodiscitis: a retrospective single-center analysis of 67 cases. Eur Spine J. (2017) 26(12):3141&#x2013;6. 10.1007/s00586-017-5180-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-017-5180-x</ArticleId><ArticleId IdType="pubmed">28608178</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya S, Kaya S, Kavak S, Comoglu S. A disease that is difficult to diagnose and treat: evaluation of 343 spondylodiscitis cases. J Int Med Res. (2021) 49(11):3000605211060197. 10.1177/03000605211060197</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605211060197</ArticleId><ArticleId IdType="pmc">PMC8647245</ArticleId><ArticleId IdType="pubmed">34851766</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarrouk V, Feydy A, Salles F, Dufour V, Guigui P, Redondo A, et al. Imaging does not predict the clinical outcome of bacterial vertebral osteomyelitis. Rheumatology (Oxford). (2007) 46(2):292&#x2013;5. 10.1093/rheumatology/kel228</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kel228</ArticleId><ArticleId IdType="pubmed">16877464</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann S, Schutze M, Sola S, Piek J. Nonspecific pyogenic spondylodiscitis: clinical manifestations, surgical treatment, and outcome in 24 patients. Neurosurg Focus. (2004) 17(6):E3. 10.3171/foc.2004.17.6.3</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/foc.2004.17.6.3</ArticleId><ArticleId IdType="pubmed">15636573</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler Crone C, Mose Tetens M, Bengaard Andersen A, Obel N, Lebech AM. Clinical characteristics of pyogenic vertebral osteomyelitis, and factors associated with inadequate treatment response. Int J Infect Dis. (2021) 108:487&#x2013;93. 10.1016/j.ijid.2021.05.078</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.05.078</ArticleId><ArticleId IdType="pubmed">34091001</ArticleId></ArticleIdList></Reference><Reference><Citation>Patzakis MJ, Rao S, Wilkins J, Moore TM, Harvey PJ. Analysis of 61 cases of vertebral osteomyelitis. Clin Orthop Relat Res. (1991) (264):178&#x2013;83. PMID:1997233</Citation><ArticleIdList><ArticleId IdType="pubmed">1997233</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelsom J, Solberg CO. Vertebral osteomyelitis at a Norwegian university hospital 1987&#x2013;97: clinical features, laboratory findings and outcome. Scand J Infect Dis. (1998) 30(2):147&#x2013;51. 10.1080/003655498750003537</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/003655498750003537</ArticleId><ArticleId IdType="pubmed">9730301</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledermann HP, Schweitzer ME, Morrison WB, Carrino JA. MR Imaging findings in spinal infections: rules or myths? Radiology. (2003) 228(2):506&#x2013;14. 10.1148/radiol.2282020752</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2282020752</ArticleId><ArticleId IdType="pubmed">12802004</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang WS, Ho MW, Lin PC, Ho CM, Chou CH, Lu MC, et al. Clinical characteristics, treatments, and outcomes of hematogenous pyogenic vertebral osteomyelitis, 12-year experience from a tertiary hospital in central Taiwan. J Microbiol Immunol Infect. (2018) 51(2):235&#x2013;42. 10.1016/j.jmii.2017.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2017.08.002</ArticleId><ArticleId IdType="pubmed">28847713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YM, Cho OH, Park SY, Moon C, Chong YP, Kim SH, et al. Factors associated with sequelae after treatment of hematogenous pyogenic vertebral osteomyelitis. Diagn Microbiol Infect Dis. (2019) 94(1):66&#x2013;72. 10.1016/j.diagmicrobio.2018.11.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2018.11.024</ArticleId><ArticleId IdType="pubmed">30594411</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KH, Cho OH, Lee JH, Park JS, Ryu KN, Park SY, et al. Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence. Clin Infect Dis. (2016) 62(10):1262&#x2013;9. 10.1093/cid/ciw098</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw098</ArticleId><ArticleId IdType="pubmed">26917813</ArticleId></ArticleIdList></Reference><Reference><Citation>Pola E, Taccari F, Autore G, Giovannenze F, Pambianco V, Cauda R, et al. Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients. Eur Spine J. (2018) 27(Suppl 2):229&#x2013;36. 10.1007/s00586-018-5598-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-018-5598-9</ArticleId><ArticleId IdType="pubmed">29667140</ArticleId></ArticleIdList></Reference><Reference><Citation>Torda AJ, Gottlieb T, Bradbury R. Pyogenic vertebral osteomyelitis: analysis of 20 cases and review. Clin Infect Dis. (1995) 20(2):320&#x2013;8. 10.1093/clinids/20.2.320</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.2.320</ArticleId><ArticleId IdType="pubmed">7742437</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegl UJA, Kilper A, Glasmacher S, Heyde CE, Josten C. [Which factors influence the inpatient course for patients with spondylodiscitis?]. Unfallchirurg. (2020) 123(9):724&#x2013;30. 10.1007/s00113-020-00781-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00113-020-00781-y</ArticleId><ArticleId IdType="pubmed">32060595</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung WY, Luk KD. Pyogenic spondylitis. Int Orthop. (2012) 36(2):397&#x2013;404. 10.1007/s00264-011-1384-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-011-1384-6</ArticleId><ArticleId IdType="pmc">PMC3282872</ArticleId><ArticleId IdType="pubmed">22033610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendi P, Bregenzer T, Zimmerli W. Spinal epidural abscess in clinical practice. QJM. (2008) 101(1):1&#x2013;12. 10.1093/qjmed/hcm100</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcm100</ArticleId><ArticleId IdType="pubmed">17982180</ArticleId></ArticleIdList></Reference><Reference><Citation>Heusner AP. Nontuberculous spinal epidural infections. N Engl J Med. (1948) 239(23):845&#x2013;54. 10.1056/NEJM194812022392301</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM194812022392301</ArticleId><ArticleId IdType="pubmed">18894306</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36044921</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1478-7083</ISSN><JournalIssue CitedMedium="Internet"><Volume>104</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of the Royal College of Surgeons of England</Title><ISOAbbreviation>Ann R Coll Surg Engl</ISOAbbreviation></Journal><ArticleTitle>Diagnostic accuracy of procalcitonin and interleukin-6 for postoperative infection in major gastrointestinal surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>561</StartPage><EndPage>570</EndPage><MedlinePgn>561-570</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1308/rcsann.2022.0053</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We aim to assess the diagnostic accuracy of procalcitonin (PCT) and interleukin-6 (IL-6) as diagnostic biomarkers for postoperative infection/sepsis following major abdominal surgery. Postoperative infection is an important cause for morbidity and mortality in major surgery. Early diagnosis and antimicrobial treatment improves outcomes, and high-performing biomarkers could guide clinical decision making.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic database search was conducted for studies reporting diagnostic performance of biomarkers (including PCT and IL-6) for infection/sepsis following major abdominal surgery. Studies were assessed for reporting of diagnostic accuracy, relevance and quality. Data were extracted for meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten studies with 1,611 participants reported the diagnostic accuracy of PCT, with pooled sensitivity, specificity and summary receiver operator curve of 72% (95% CI 66-78), 62% (95% CI 59-64) and 0.766, respectively. Four studies with 175 participants reported the diagnostic accuracy of IL-6, with pooled sensitivity, specificity and summary receiver operator curve of 84% (95% CI 72-92), 76% (95% CI 68-84) and 0.878, respectively There was variability in the timing of sampling and cut-off values and significant heterogeneity and inconsistency between studies (<i>I</i><sup>2</sup> diagnostic odds ratio (DOR)= 43.2% for PCT, <i>I</i><sup>2</sup> DOR=0% for IL-6).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PCT performs only moderately well as a diagnostic test for postoperative infection/sepsis in major abdominal surgery, demonstrating limited sensitivity and specificity. Heterogeneity between studies is a limitation of the meta-analysis. There is an ongoing need for a rapid, accurate biomarker for postoperative infection or sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jerome</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>King's College Hospital, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPhail</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>King's College Hospital, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menon</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>King's College Hospital, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann R Coll Surg Engl</MedlineTA><NlmUniqueID>7506860</NlmUniqueID><ISSNLinking>0035-8843</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="Y">Digestive System Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="N">Procalcitonin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker(s)</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Interleukin-6</Keyword><Keyword MajorTopicYN="N">Procalcitonin</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36044921</ArticleId><ArticleId IdType="pmc">PMC9433179</ArticleId><ArticleId IdType="doi">10.1308/rcsann.2022.0053</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Houwink AP, Rijkenberg S, Bosman RJet al. . The association between lactate, mean arterial pressure, central venous oxygen saturation and peripheral temperature and mortality in severe sepsis: a retrospective cohort analysis. Crit Care 2016; 20: 56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4788911</ArticleId><ArticleId IdType="pubmed">26968689</ArticleId></ArticleIdList></Reference><Reference><Citation>ICNARC. Case Mix Programme Summary Statistic 2018&#x2013;2019. London: Intensive Care National Audit and Research Centre; 2019.</Citation></Reference><Reference><Citation>Coello R, Charlett A, Wilson Jet al. . Adverse impact of surgical site infections in English hospitals. J Hosp Infect 2005; 60: 93&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">15866006</ArticleId></ArticleIdList></Reference><Reference><Citation>Plowman R, Graves N, Griffin MAet al. . The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001; 47: 198&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">11247680</ArticleId></ArticleIdList></Reference><Reference><Citation>General, T.C.a.A. The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England 2000. London: National Audit Office/The Stationery Office; 2020.</Citation></Reference><Reference><Citation>Surgical Site Infection Surveillance Service Protocol for the Surveillance of Surgical Site Infection. London: Public Health Enlgand; 2013.</Citation></Reference><Reference><Citation>Ferrer R, Martin-Loeches I, Phillips Get al. . Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014; 42: 1749&#x2013;1755.</Citation><ArticleIdList><ArticleId IdType="pubmed">24717459</ArticleId></ArticleIdList></Reference><Reference><Citation>Livermore DM. Fourteen years in resistance. Int J Antimicrob Agents 2012; 39: 283&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">22386741</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health England. Surveillance of surgical site infections in NHS hospitals in England April 2018 to March 2019; 2019.
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/854182/SSI_Annual_Report_2018_19.pdf
(cited October 29, 2020).</Citation></Reference><Reference><Citation>UK Health Security Agency. HCAI and Antimicrobial Point Prevalence Survey &#x2013; England; 2014.
www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/HCAI/HCAIPointPrevalenceSurvey/</Citation></Reference><Reference><Citation>Harbarth S, Holeckova K, Froidevaux Cet al. . Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">11500339</ArticleId></ArticleIdList></Reference><Reference><Citation>Luzzani A, Polati E, Dorizzi Ret al. . Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737&#x2013;1741.</Citation><ArticleIdList><ArticleId IdType="pubmed">12794413</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999; 3: 45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC29013</ArticleId><ArticleId IdType="pubmed">11056723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Zhang H, Yin YLet al. . Role of interleukin-6 to differentiate sepsis from non-infectious systemic inflammatory response syndrome. Cytokine 2016; 88: 126&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">27599258</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas AK. In: Lichtman AHH, Pillai S. (eds) Basic Immunology: Functions and Disorders of the Immune System. 6th ed.; Boston, MA: Elsevier 2019.</Citation></Reference><Reference><Citation>Tsalik EL, Jaggers LB, Glickman SWet al. . Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med 2012; 43: 97&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3740117</ArticleId><ArticleId IdType="pubmed">22056545</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff Jet al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SCet al. . Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis Of observational studies in epidemiology (MOOSE) group. JAMA 2000; 283: 2008&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting P, Rutjes AWS, Reitsma JBet al. . The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC305345</ArticleId><ArticleId IdType="pubmed">14606960</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PF, Rutjes AW, Westwood MEet al. . QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamora J, Muriel A, Abraira V. Meta-DiSc Statistical Methods. Madrid: Statistics in Medicine; 2006.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539&#x2013;1558.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12: 1293&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pubmed">8210827</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005; 58: 882&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">16085191</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersema GSA, Wu Z, Menon AGet al. . Systemic inflammatory cytokines predict the infectious complications but Not prolonged postoperative ileus after colorectal surgery. Mediators Inflamm 2018; 2018: 7141342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5859856</ArticleId><ArticleId IdType="pubmed">29692682</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xed;nguez-Comesa&#xf1;a E, Estevez-Fern&#xe1;ndez SM, L&#xf3;pez-G&#xf3;mez Vet al. . Procalcitonin and C-reactive protein as early markers of postoperative intra-abdominal infection in patients operated on colorectal cancer. Int J Colorectal Dis 2017; 32: 1771&#x2013;1774.</Citation><ArticleIdList><ArticleId IdType="pubmed">28918433</ArticleId></ArticleIdList></Reference><Reference><Citation>Durila M, Bronsk&#xfd; J, Haru&#x161;tiak Tet al. . Early diagnostic markers of sepsis after oesophagectomy (including thromboelastography). BMC Anesthesiol 2012; 12: 12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3458976</ArticleId><ArticleId IdType="pubmed">22742451</ArticleId></ArticleIdList></Reference><Reference><Citation>Facy O, Paquette B, Orry Det al. . Diagnostic accuracy of inflammatory markers As early predictors of infection after elective colorectal surgery: results from the IMACORS study. Ann Surg 2016; 263: 961&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pubmed">26135691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahiri R, Derwa Y, Bashir Zet al. . Systemic inflammatory response syndrome after major abdominal surgery predicted by early upregulation of TLR4 and TLR5. Ann Surg 2016; 263: 1028&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pubmed">26020106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokart D, Merlin M, Sannini Aet al. . Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005; 94: 767&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">15849208</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz JL, Ruiz-Tovar J, Miranda Eet al. . C-Reactive protein and procalcitonin as early markers of septic complications after laparoscopic sleeve gastrectomy in morbidly obese patients within an enhanced recovery after surgery program. J Am Coll Surg 2016; 222: 831&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">27010585</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberhofer D, Juras J, Pavi&#x10d;i&#x107; AMet al. . Comparison of C-reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery. Croat Med J 2012; 53: 612&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541587</ArticleId><ArticleId IdType="pubmed">23275327</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed K, Dale AP, Leung Eet al. . Procalcitonin levels predict infectious complications and response to treatment in patients undergoing cytoreductive surgery for peritoneal malignancy. Eur J Surg Oncol 2016; 42: 234&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">26560024</ArticleId></ArticleIdList></Reference><Reference><Citation>Takakura Y, Hinoi T, Egi Het al. . Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery. Langenbecks Arch Surg 2013; 398: 833&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pubmed">23784676</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi M, Yokose T, Kawakubo Het al. . The perioperative presepsin as an accurate diagnostic marker of postoperative infectious complications after esophagectomy: a prospective cohort study. Esophagus 2020; 17: 399&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pubmed">32303873</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H, Zhang P, Xiao Yet al. . Diagnostic accuracy of procalcitonin as an early predictor of infection after radical gastrectomy for gastric cancer: A prospective bicenter cohort study. Int J Surg 2020; 75: 3&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">31978647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, McKechnie T, Doumouras AGet al. . Diagnostic value of C-reactive protein levels in postoperative infectious complications after bariatric surgery: a systematic review and meta-analysis. Obes Surg 2019; 29: 2022&#x2013;2029.</Citation><ArticleIdList><ArticleId IdType="pubmed">30895509</ArticleId></ArticleIdList></Reference><Reference><Citation>Straatman J, Harmsen AM, Cuesta MAet al. . Predictive value of C-reactive protein for major complications after major abdominal surgery: A systematic review and pooled-analysis. PLoS ONE 2015; 10: e0132995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4503561</ArticleId><ArticleId IdType="pubmed">26177542</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsch T, M&#xfc;ller SA, Ulrich Aet al. . C-reactive protein as early predictor for infectious postoperative complications in rectal surgery. Int J Colorectal Dis 2007; 22: 1499&#x2013;1507.</Citation><ArticleIdList><ArticleId IdType="pubmed">17639424</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousin F, Ortega-Deballon P, Bourredjem Aet al. . Diagnostic accuracy of procalcitonin and C-reactive protein for the early diagnosis of intra-abdominal infection after elective colorectal surgery: A meta-analysis. Ann Surg 2016; 264: 252&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">27049766</ArticleId></ArticleIdList></Reference><Reference><Citation>Su'a BU, Mikaere HL, Rahiri JLet al. . Systematic review of the role of biomarkers in diagnosing anastomotic leakage following colorectal surgery. Br J Surg 2017; 104: 503&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pubmed">28295255</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan WJ, Ng WQ, Sultana Ret al. . Systematic review and meta-analysis of the use of serum procalcitonin levels to predict intra-abdominal infections after colorectal surgery. Int J Colorectal Dis 2018; 33: 171&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">29305753</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzzan B, Cohen R, Nicolas Pet al. . Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34: 1996&#x2013;2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">16715031</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FBet al. . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992; 101: 1644&#x2013;1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CWet al. . The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016; 315: 801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Horan TC, Andrus M, Dudeck MA. Cdc/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">18538699</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16437211</PMID><DateCompleted><Year>2007</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0179-1958</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>2007</Year><Month>Apr</Month></PubDate></JournalIssue><Title>International journal of colorectal disease</Title><ISOAbbreviation>Int J Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>Resection and primary anastomosis in acute complicated diverticulitis, a systematic review of the literature.</ArticleTitle><Pagination><StartPage>351</StartPage><EndPage>357</EndPage><MedlinePgn>351-7</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the safety and feasibility of primary resection and anastomosis with or without a diverting stoma, as compared to Hartmann's procedure, for patients with acute complicated sigmoid diverticulitis.</AbstractText><AbstractText Label="SEARCH STRATEGY" NlmCategory="METHODS">MEDLINE was searched for studies and trials conducted between 1966 and December 2003. This search revealed trials comparing primary resection and anastomosis to Hartmann's procedure. The term "diverticulitis, colonic" with the sub-heading "surgery" was used and the search was limited to human studies and clinical trials. Additional studies were found using the MeSH terms: "surgical procedures, operative", "surgical anastomosis", and "Hartmann procedure", combined with the term "diverticulitis, colonic". The author also searched EMBASE and the Cochrane database for clinical trials using similar terminology. No language restrictions were applied.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighteen studies met the inclusion criteria and reported 884 patients with acute complicated diverticulitis. None of these studies were randomised; it is likely that there was a significant degree of selection bias. No significant differences were found between primary resection with anastomosis and Hartmann's procedure with respect to mortality, morbidity, sepsis, wound complications and duration of procedure and anti-biotic treatment. Some studies found that primary anastomosis and a protecting stoma, with or without intra-operative colonic lavage, have more favourable results than Hartmann's procedure.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This review suggests that surgical resection and primary anastomosis in acute diverticulitis with peritonitis compares favourably with Hartmann's procedure in terms of peri-operative complications. The need for revision of Hartmann's procedure could be subsequently avoided. Some articles showed that patients with severe peritonitis, who had a diverting stoma, in the setting of resection and primary anastomosis, had the lowest complication rate. However, the quality of these studies was poor with the presence of selection bias.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Saleh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Auckland Hospital, Grafton, Auckland, New Zealand. salehabbas@yahoo.com</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int J Colorectal Dis</MedlineTA><NlmUniqueID>8607899</NlmUniqueID><ISSNLinking>0179-1958</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004239" MajorTopicYN="N">Diverticulitis, Colonic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016239" MajorTopicYN="N">MEDLINE</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>44</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>1</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>12</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>1</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16437211</ArticleId><ArticleId IdType="doi">10.1007/s00384-005-0059-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Surg Clin North Am. 1993 Oct;73(5):975-92</Citation><ArticleIdList><ArticleId IdType="pubmed">8378835</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med J. 1968 Aug 24;3(5616):465-6</Citation><ArticleIdList><ArticleId IdType="pubmed">5666803</ArticleId></ArticleIdList></Reference><Reference><Citation>Conn Med. 1991 May;55(5):258-61</Citation><ArticleIdList><ArticleId IdType="pubmed">1860312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Chir. 1991;45(10):896-900</Citation><ArticleIdList><ArticleId IdType="pubmed">1781611</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 1967 May;94(5):619-26</Citation><ArticleIdList><ArticleId IdType="pubmed">5297954</ArticleId></ArticleIdList></Reference><Reference><Citation>AMA Arch Surg. 1957 Apr;74(4):511-5</Citation><ArticleIdList><ArticleId IdType="pubmed">13410323</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1989 Nov;32(11):933-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2806021</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 1990 Dec;5(4):195-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2286801</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 1993 Jul;128(7):814-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8317964</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirurg. 2000 Feb;71(2):202-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10734590</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Chir Belg. 2002 Feb;102(1):24-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11925735</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1994 May;81(5):730-2</Citation><ArticleIdList><ArticleId IdType="pubmed">8044565</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2000 May;135(5):558-62; discussion 562-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg. 2001 Jan;167(1):35-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11213818</ArticleId></ArticleIdList></Reference><Reference><Citation>Chir Ital. 2002 Mar-Apr;54(2):203-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12038111</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Surg. 1999 Oct;65(10):931-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10515537</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2003 May;5(3):262-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12780890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1964 Feb 22;1(7330):413-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14092958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chir Ital. 2003 Mar-Apr;55(2):207-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12744095</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1993 Dec 1;270(21):2598-601</Citation><ArticleIdList><ArticleId IdType="pubmed">8230645</ArticleId></ArticleIdList></Reference><Reference><Citation>Dig Surg. 1999;16(5):420-4</Citation><ArticleIdList><ArticleId IdType="pubmed">10567805</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2001 May;44(5):699-703; discussion 703-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11357032</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatogastroenterology. 2002 May-Jun;49(45):664-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12063965</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 1996 Jun;131(6):612-5; discussion 616-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8645067</ArticleId></ArticleIdList></Reference><Reference><Citation>Langenbecks Arch Surg. 2000 Mar;385(2):143-51</Citation><ArticleIdList><ArticleId IdType="pubmed">10796053</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Surg. 2001 Dec;67(12 ):1185-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11768827</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Chir Belg. 1993 Jul-Aug;93(4):169-72</Citation><ArticleIdList><ArticleId IdType="pubmed">8237231</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1987 Mar;153(3):285-90</Citation><ArticleIdList><ArticleId IdType="pubmed">3826510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann R Coll Surg Engl. 1984 Mar;66(2):90-1</Citation><ArticleIdList><ArticleId IdType="pubmed">6703636</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1990 Mar;159(3):291-3; discussion 294</Citation><ArticleIdList><ArticleId IdType="pubmed">2305935</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Surg. 1974 Feb;44(1):16-20</Citation><ArticleIdList><ArticleId IdType="pubmed">4527781</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Surg. 1982 May;25(3):314-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7083080</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2002 Dec;45(12):1579-87</Citation><ArticleIdList><ArticleId IdType="pubmed">12473879</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 1997;12(5):285-90</Citation><ArticleIdList><ArticleId IdType="pubmed">9401843</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Surg. 1999 Oct;65(10):927-30</Citation><ArticleIdList><ArticleId IdType="pubmed">10515536</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Chir Belg. 1993 Nov-Dec;93(6):253-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8140834</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg. 2000 Nov;166(11):878-81</Citation><ArticleIdList><ArticleId IdType="pubmed">11097155</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2002 May;183(5):525-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12034385</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2003 Nov;18(6):503-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12910361</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 1994 Aug;9(3):158-62</Citation><ArticleIdList><ArticleId IdType="pubmed">7814991</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2001 Jan;3(1):42-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12791020</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1998 Nov;85(11):1539-42</Citation><ArticleIdList><ArticleId IdType="pubmed">9823920</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1997 Mar;84(3):380-3</Citation><ArticleIdList><ArticleId IdType="pubmed">9117315</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1971 Jun;121(6):702-5</Citation><ArticleIdList><ArticleId IdType="pubmed">5314526</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36945012</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2046-4053</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>21</Day></PubDate></JournalIssue><Title>Systematic reviews</Title><ISOAbbreviation>Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Sex-based analysis of treatment responses in animal models of sepsis: a preclinical systematic review protocol.</ArticleTitle><Pagination><StartPage>50</StartPage><MedlinePgn>50</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">50</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13643-023-02189-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">The importance of investigating sex- and gender-dependent differences has been recently emphasized by major funding agencies. Notably, the influence of biological sex on clinical outcomes in sepsis is unclear, and observational studies suffer from the effect of confounding factors. The controlled experimental environment afforded by preclinical studies allows for clarification and mechanistic evaluation of sex-dependent differences. We propose a systematic review to assess the impact of biological sex on baseline responses to disease induction as well as treatment responses in animal models of sepsis. Given the lack of guidance surrounding sex-based analyses in preclinical systematic reviews, careful consideration of various factors is needed to understand how best to conduct analyses and communicate findings.</AbstractText><AbstractText Label="METHODS">MEDLINE and Embase will be searched (2011-present) to identify preclinical studies of sepsis in which any intervention was administered and sex-stratified data reported. The primary outcome will be mortality. Secondary outcomes will include organ dysfunction, bacterial load, and IL-6 levels. Study selection will be conducted independently and in duplicate by two reviewers. Data extraction will be conducted by one reviewer and audited by a second independent reviewer.&#xa0;Data extracted from included studies will be pooled, and meta-analysis will be conducted using random effects modeling. Primary analyses will be stratified by animal age and will assess the impact of sex at the following time points: pre-intervention, in response to treatment, and post-intervention. Risk of bias will be assessed using the SYRCLE's risk-of-bias tool. Illustrative examples of potential methods to analyze sex-based differences are provided in this protocol.</AbstractText><AbstractText Label="DISCUSSION">Our systematic review will summarize the current state of knowledge on sex-dependent differences in sepsis. This will identify current knowledge gaps that future studies can address. Finally, this review will provide a framework for sex-based analysis in future preclinical systematic reviews.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION">PROSPERO CRD42022367726.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>MengQi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9822-1319</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, 451 Smyth Rd #2044, Ottawa, ON, K1H 8M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Blueprint Translational Group, Ottawa Hospital Research Institute, 501 Smyth Box 511, Ottawa, ON, K1H 8L6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fergusson</LastName><ForeName>Dean A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-3389-2485</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, 451 Smyth Rd #2044, Ottawa, ON, K1H 8M5, Canada. dafergusson@ohri.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Blueprint Translational Group, Ottawa Hospital Research Institute, 501 Smyth Box 511, Ottawa, ON, K1H 8L6, Canada. dafergusson@ohri.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7413-4253</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, 451 Smyth Rd #2044, Ottawa, ON, K1H 8M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoo</LastName><ForeName>Ciel</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9762-3241</Identifier><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Blueprint Translational Group, Ottawa Hospital Research Institute, 501 Smyth Box 511, Ottawa, ON, K1H 8L6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendelson</LastName><ForeName>Asher A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0003-2108-4752</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Critical Care Medicine, Rady Faculty of Health Sciences, University of Manitoba, 820 Sherbrook Street, Winnipeg, MB, R3A 1R9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDonald</LastName><ForeName>Braedon</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-8936-8992</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macala</LastName><ForeName>Kimberly F</ForeName><Initials>KF</Initials><Identifier Source="ORCID">0000-0002-9127-217X</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Royal Alexandra Hospital, University of Alberta, 2-214 Clinical Science Building, 8440-112Th Street, Edmonton, AB, T6G 2B7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Neha</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9481-7673</Identifier><AffiliationInfo><Affiliation>Department of Medical Sciences and Thrombosis and Atherosclerosis Research Institute, McMaster University, 237 Barton St East, Hamilton, ON, L8L 2X2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Sean E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0003-4791-1576</Identifier><AffiliationInfo><Affiliation>Centre for Critical Illness Research, Lawson Health Research Institutes, Victoria Research Labs, A6-134, 800 Commissioners Road Ease, London, ON, N6A 5W9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respirology, Department of Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiest</LastName><ForeName>Kirsten M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0002-7299-6594</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6419-9168</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, Pain Management and Perioperative Medicine, II Health Sciences Centre, 5850 College Street, Halifax, NS, B3H 1X5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorr</LastName><ForeName>Risa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Learning Services, The Ottawa Hospital, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahandideh</LastName><ForeName>Forough</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9731-0854</Identifier><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Blueprint Translational Group, Ottawa Hospital Research Institute, 501 Smyth Box 511, Ottawa, ON, K1H 8L6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology &amp; Pain Medicine, Katz Group Centre for Pharmacy and Health Research, University of Alberta, 3-020H, Edmonton, AB, T6G 2E1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourque</LastName><ForeName>Stephane L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0001-6375-7404</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology &amp; Pain Medicine, Katz Group Centre for Pharmacy and Health Research, University of Alberta, 3-020H, Edmonton, AB, T6G 2E1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Patricia C</ForeName><Initials>PC</Initials><Identifier Source="ORCID">0000-0002-7783-1393</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Thrombosis and Atherosclerosis Research Institute, McMaster University and Hamilton Health Sciences, 237 Barton St East, Hamilton, ON, L8L 2X2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox-Robichaud</LastName><ForeName>Alison</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9912-3606</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Thrombosis and Atherosclerosis Research Institute, McMaster University and Hamilton Health Sciences, 237 Barton St East, Hamilton, ON, L8L 2X2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-0322-382X</Identifier><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Blueprint Translational Group, Ottawa Hospital Research Institute, 501 Smyth Box 511, Ottawa, ON, K1H 8L6, Canada. mlalu@toh.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Room B307, 1053 Carling Avenue, Mail Stop 249, Ottawa, ON, K1Y 4E9, Canada. mlalu@toh.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, 501 Smyth Box 511, Ottawa, ON, K1H 8L6, Canada. mlalu@toh.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Canadian Critical Care Translational Biology Group, the Sepsis Canada National Preclinical Sepsis Platform</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>438017</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Syst Rev</MedlineTA><NlmUniqueID>101580575</NlmUniqueID><ISSNLinking>2046-4053</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Animal models</Keyword><Keyword MajorTopicYN="N">Intervention</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Sex</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Avey</LastName><ForeName>Marc T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Charbonney</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kristof</LastName><ForeName>Arnold</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vazquez-Grande</LastName><ForeName>Gloria</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veldhuizen</LastName><ForeName>Ruud</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winston</LastName><ForeName>Brent</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Salman</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhou</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36945012</ArticleId><ArticleId IdType="pmc">PMC10029211</ArticleId><ArticleId IdType="doi">10.1186/s13643-023-02189-2</ArticleId><ArticleId IdType="pii">10.1186/s13643-023-02189-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority - a WHO resolution. N Engl J Med. 2017;377(5):414&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">28658587</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrah K, McIntyre L, Doig CJ, Talarico R, Taljaard M, Krahn M, et al. Sepsis-associated mortality, resource use, and healthcare costs: a propensity-matched cohort study. Crit Care Med. 2021;49(2):215&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">33372748</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyson A, Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med. 2009;37(1 Suppl):S30&#x2013;S37.</Citation><ArticleIdList><ArticleId IdType="pubmed">19104223</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20(4):195&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">24581450</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Montroy J, Sharma R, Fergusson DA, Mendelson AA, Macala KF, et al. The effects of biological sex on sepsis treatments in animal models: a systematic review and a narrative elaboration on sex- and gender-dependent differences in sepsis. Crit Care Explor. 2021;3(6):e0433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8205191</ArticleId><ArticleId IdType="pubmed">34151276</ArticleId></ArticleIdList></Reference><Reference><Citation>Failla KR, Connelly CD. Systematic review of gender differences in sepsis management and outcomes. J Nurs Scholarsh. 2017;49(3):312&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">28419753</ArticleId></ArticleIdList></Reference><Reference><Citation>Papathanassoglou E, Middleton N, Benbenishty J, Williams G, Christofi MD, Hegadoren K. Systematic review of gender- dependent outcomes in sepsis. Nurs Crit Care. 2017;22(5):284&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">28295902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang MQ, Macala KF, Fox-Robichaud A, Mendelson AA, Lalu MM, Sepsis Canada National Preclinical Sepsis P Sex- and gender-dependent differences in clinical and preclinical sepsis. Shock. 2021;56(2):178&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">33399356</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Institutes of Health Research. How to integrate sex and gender into research 2019. Available from: https://cihr-irsc.gc.ca/e/50836.html. [cited March 2023]</Citation></Reference><Reference><Citation>Institute of Medicine (U.S.). Committee on understanding the biology of sex and gender differences. Wizemann TM, Pardue ML. Exploring the biological contributions to human health : does sex matter? Washington, D.C: National Academy Press; 2001. p. 267.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057540</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannenbaum C, Clow B, Haworth-Brockman M, Voss P. Sex and gender considerations in Canadian clinical practice guidelines: a systematic review. CMAJ Open. 2017;5(1):E66&#x2013;E73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5378537</ArticleId><ArticleId IdType="pubmed">28401121</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiebinger L, Stefanick ML. Gender matters in biological research and medical practice. J Am Coll Cardiol. 2016;67(2):136&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">26791058</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingarelli B, Coopersmith CM, Drechsler S, Efron P, Marshall JC, Moldawer L, et al. Part I: Minimum quality threshold in preclinical sepsis studies (MQTiPSS) for study design and humane modeling endpoints. Shock. 2019;51(1):10&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6296871</ArticleId><ArticleId IdType="pubmed">30106874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalu MM, Sullivan KJ, Mei SH, Moher D, Straus A, Fergusson DA, et al. Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial. Elife. 2016;5:e17850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5153252</ArticleId><ArticleId IdType="pubmed">27870924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalu MM, Moher D, Marshall J, Fergusson D, Mei SH, Macleod M, et al. Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol. Syst Rev. 2014;3:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046388</ArticleId><ArticleId IdType="pubmed">24887266</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3: Cochrane; 2022&#xa0;[Available from: www.training.cochrane.org/handbook].</Citation></Reference><Reference><Citation>Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230647</ArticleId><ArticleId IdType="pubmed">24667063</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalu MM, Montroy J, Dowlatshahi D, Hutton B, Juneau P, Wesch N, et al. From the lab to patients: a systematic review and meta-analysis of mesenchymal stem cell therapy for stroke. Transl Stroke Res. 2020;11(3):345&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">31654281</ArticleId></ArticleIdList></Reference><Reference><Citation>Suen CM, Stewart DJ, Montroy J, Welsh C, Levac B, Wesch N, et al. Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review. Stem Cell Res Ther. 2019;10(1):75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6404277</ArticleId><ArticleId IdType="pubmed">30841915</ArticleId></ArticleIdList></Reference><Reference><Citation>Vesterinen HM, Sena ES, Egan KJ, Hirst TC, Churolov L, Currie GL, et al. Meta-analysis of data from animal studies: a practical guide. J Neurosci Methods. 2014;221:92&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">24099992</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson AA, Lansdell C, Fox-Robichaud AE, Liaw P, Arora J, Cailhier JF, et al. National Preclinical Sepsis Platform: developing a framework for accelerating innovation in Canadian sepsis research. Intensive Care Med Exp. 2021;9(1):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7973346</ArticleId><ArticleId IdType="pubmed">33738642</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Critical Care Translational Biology Group. About us. Available from: https://ccctg.ca/CCCTBG/About-us. [cited March 2023]</Citation></Reference><Reference><Citation>Beery AK, Zucker I. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev. 2011;35(3):565&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3008499</ArticleId><ArticleId IdType="pubmed">20620164</ArticleId></ArticleIdList></Reference><Reference><Citation>Woitowich NC, Beery A, Woodruff T. A 10-year follow-up study of sex inclusion in the biological sciences. Elife. 2020;9:e56344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282816</ArticleId><ArticleId IdType="pubmed">32513386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada H, Miyauchi K, Daida H. Gender differences in the clinical features and outcomes of patients with coronary artery disease. Expert Rev Cardiovasc Ther. 2019;17(2):127&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">30569774</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenko E, van der Schaar M, Yoon J, Manfrini O, Vasiljevic Z, Vavlukis M, et al. Sex-related differences in heart failure after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2019;74(19):2379&#x2013;2389.</Citation><ArticleIdList><ArticleId IdType="pubmed">31699278</ArticleId></ArticleIdList></Reference><Reference><Citation>Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med. 2008;5 Suppl A:S3&#x2013;S10.</Citation><ArticleIdList><ArticleId IdType="pubmed">18395681</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3644551</ArticleId><ArticleId IdType="pubmed">19385708</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill MD, Kent DM, Hinchey J, Rowley H, Buchan AM, Wechsler LR, et al. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke. 2006;37(9):2322&#x2013;2325.</Citation><ArticleIdList><ArticleId IdType="pubmed">16888269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke. 2005;36(1):62&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">15569865</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med. 2002;347(18):1403&#x2013;1411.</Citation><ArticleIdList><ArticleId IdType="pubmed">12409542</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28460438</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>16</Issue><PubDate><Year>2017</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Early outcome of early-goal directed therapy for patients with sepsis or septic shock: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>27510</StartPage><EndPage>27519</EndPage><MedlinePgn>27510-27519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.15550</ELocationID><Abstract><AbstractText>Various trials and meta-analyses have reported conflicting results concerning the application of early goal-directed therapy (EGDT) for sepsis and septic shock. The aim of this study was to update the evidence by performing a systematic review and meta-analysis. Multiple databases were searched from initial through August, 2016 for randomized controlled trials (RCTs) which investigated the associations between the use of EGDT and mortality in patients with sepsis or septic shock. Meta-analysis was performed using random-effects model and heterogeneity was examined through subgroup analyses. The primary outcome of interest was patient all-cause mortality including hospital or ICU mortality. Seventeen RCTs including 6207 participants with 3234 in the EGDT group and 2973 in the control group were eligible for this study. Meta-analysis showed that EGDT did not significantly reduce hospital or intensive care unit (ICU) mortality (relative risk [RR] 0.89, 95% CI 0.78 to 1.02) compared with control group for patients with sepsis or septic shock. The findings of subgroup analyses stratified by study region, number of research center, year of enrollment, clinical setting, sample size, timing of EGDT almost remained constant with that of the primary analysis. Our findings provide evidence that EGDT offers neutral survival effects for patients with sepsis or septic shock. Further meta-analyses based on larger well-designed RCTs or individual patient data meta-analysis are required to explore the survival benefits of EDGT in patients with sepsis or septic shock.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaofan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, Sichuang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evidence-Based Medicine Research Centre, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Weifeng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Evidence-Based Medicine Research Centre, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, Sichuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Heyun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Evidence-Based Medicine Research Centre, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Liangming</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Second Department of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Dongmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Evidence-Based Medicine Research Centre, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Evidence-Based Medicine Research Centre, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, Sichuang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="Y">Time-to-Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">early-goal directed therapy</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList><CoiStatement><b>CONFLICTS OF INTEREST</b>. The authors declare no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28460438</ArticleId><ArticleId IdType="pmc">PMC5432353</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.15550</ArticleId><ArticleId IdType="pii">15550</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T, Wang HE, Hou PC, LoVecchio F, Filbin MR, Shapiro NI, Angus DC, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>Quenot JP, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, Castelain V, Barraud D, Cousson J, Louis G, Perez P, Kuteifan K, Noirot A, et al. The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care. 2013;17:R65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056892</ArticleId><ArticleId IdType="pubmed">23561510</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">18158437</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004;30:536&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">14997291</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">25776532</ArticleId></ArticleIdList></Reference><Reference><Citation>Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T, Wang HE, Hou PC, LoVecchio F, Filbin MR, Shapiro NI, Angus DC, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams PARISE Investigators, and ANZICS Clinical Trials Group Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">25272316</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira CF, de Oliveira DS, Gottschald AF, Moura JD, Costa GA, Ventura AC, Fernandes JC, Vaz FA, Carcillo JA, Rivers EP, Troster EJ. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med. 2008;34:1065&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">18369591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XZ, L&#xfc; CJ, Gao FQ, Li XH, Yan WF, Ning FY. Efficacy of goal-directed therapy in the treatment of septic shock. [Article in Chinese] Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006;18:661&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">17092415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock. 2006;26:551&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">17117128</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#xed;a I, Esteban A, Gordo F, Lorente JA, Diaz C, Rodriguez JA, Frutos F. A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest. 1999;115:453&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">10027447</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333:1025&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">7675044</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994;330:1717&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">7993413</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Goal-Directed Therapy Collaborative Group of Zhejiang Province The effect of early goal-directed therapy on treatment of critical patients with severe sepsis/septic shock: a multi-center, prospective, randomized, controlled study. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010;22:331&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">20594464</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Chi D, Wang S, Liu B. Effect of early goal-directed therapy on mortality in patients with severe sepsis or septic shock: a meta-analysis of randomised controlled trials. BMJ Open. 2016;6:e008330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4785309</ArticleId><ArticleId IdType="pubmed">26932135</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu JY, Chen QH, Liu SQ, Pan C, Xu XP, Han JB, Xie JF, Huang YZ, Guo FM, Yang Y, Qiu HB. The Effect of Early Goal-Directed Therapy on Outcome in Adult Severe Sepsis and Septic Shock Patients: A Meta-Analysis of Randomized Clinical Trials. Anesth Analg. 2016;123:371&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4956677</ArticleId><ArticleId IdType="pubmed">27049857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WK, Kim HY, Lee J, Koh SO, Kim JM, Na S. Protocol-Based Resuscitation for Septic Shock: A Meta-Analysis of Randomized Trials and Observational Studies. Yonsei Med J. 2016;57:1260&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4960395</ArticleId><ArticleId IdType="pubmed">27401660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu N, Zheng R, Lin H, Shao J, Yu J. Clinical studies of surviving sepsis bundles according to PiCCO on septic shock patients. [Article in Chinese] Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26:23&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">24506852</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews B, Muchemwa L, Kelly P, Lakhi S, Heimburger DC, Bernard GR. Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia. Crit Care Med. 2014;42:2315&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4199893</ArticleId><ArticleId IdType="pubmed">25072757</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu B, Tian HY, Hu ZJ, Zhao C, Liu LX, Zhang Y, Zhu GJ, Wang LT, Wu XH, Li J. Comparison of the effect of fluid resuscitation as guided either by lactate clearance rate or by central venous oxygen saturation in patients with sepsis. [Article in Chinese] Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013;25:578&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">24119693</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian HH, Han SS, Lv CJ, Wang T, Li Z, Hao D, Shang QM, Wang XZ. The effect of early goal lactate clearance rate on the outcome of septic shock patients with severe pneumonia. [Article in Chinese] Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012;24:42&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">22248751</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA, Emergency Medicine Shock Research Network (EMShockNet) Investigators Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2918907</ArticleId><ArticleId IdType="pubmed">20179283</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Levy MM, Smith P, Takiguchi SA, Miyasaki A, Myers SA, YU M. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med. 1993;21:830&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">8504649</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuchschmidt J, Fried J, Astiz M, Rackow E. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest. 1992;102:216&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">1623756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ros&#xe1;rio AL, Park M, Brunialti MK, Mendes M, Rapozo M, Fernandes D, Salom&#xe3;o R, Laurindo FR, Schettino GP, Azevedo LC. SvO(2)-guided resuscitation for experimental septic shock: effects of fluid infusion and dobutamine on hemodynamics, inflammatory response, and cardiovascular oxidative stress. Shock. 2011;36:604&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">21921835</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:2063.</Citation><ArticleIdList><ArticleId IdType="pubmed">24256390</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods G Cochrane Statistical Methods G, and Cochrane Bias Methods Group, and Cochrane Statistical Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">10877304</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37639341</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Print">2498-602X</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>Physiology international</Title><ISOAbbreviation>Physiol Int</ISOAbbreviation></Journal><ArticleTitle>Factors improving mortality in critically ill patients with liver failure - A systematic review.</ArticleTitle><Pagination><StartPage>211</StartPage><EndPage>226</EndPage><MedlinePgn>211-226</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1556/2060.2023.00211</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute and chronic hepatic failure can lead to increased mortality in critically ill and perioperative patients. Understanding the pathophysiological principles of these conditions in critically ill patients is of great importance to reduce mortality. The aim of our systematic literature review was to identify all randomized controlled trials on any intervention that had a statistically significant documented reduction in mortality in patients with hepatic failure.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched PubMed, Scopus and Embase databases for pertinent studies on January 1st 2021. The following studies were included: randomized controlled trials; studies investigating adult critically ill or perioperative patient populations with any form of hepatic failure; mortality as primary or secondary outcome; and statistically significant differences in mortality between the examined groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We finally found nine trials in our systematic review on the effect of antibiotic administration and infectious diseases among patients with cirrhosis (three studies); immune modulation after liver transplantation (one study); administration of colloids in cirrhotic patients (one study); the effect of high-volume plasma exchange in acute liver failure (one study); administration of N-acetylcysteine in acute liver failure (one study); and treatment with terlipressin (two studies).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In the present review we found only nine randomized studies with a documented survival benefit in patients with liver failure. Strategies that most improved mortality were associated with the outcome of sepsis and renal function.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kov&#xe1;cs</LastName><ForeName>Enik&#x151;</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2012-1136</Identifier><AffiliationInfo><Affiliation>1Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, H-1428, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maimeri</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>2Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orlando</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>2Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morselli</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>2Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pallanch</LastName><ForeName>Ottavia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>2Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fedrizzi</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>2Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xe1;l</LastName><ForeName>J&#xe1;nos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, H-1428, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sz&#xe9;kely</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, H-1428, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Hungary</Country><MedlineTA>Physiol Int</MedlineTA><NlmUniqueID>101696724</NlmUniqueID><ISSNLinking>2498-602X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017093" MajorTopicYN="Y">Liver Failure</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017114" MajorTopicYN="Y">Liver Failure, Acute</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="N">Acetylcysteine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute liver failure</Keyword><Keyword MajorTopicYN="N">cirrhosis</Keyword><Keyword MajorTopicYN="N">critically ill</Keyword><Keyword MajorTopicYN="N">hepatic dysfunction</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37639341</ArticleId><ArticleId IdType="doi">10.1556/2060.2023.00211</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35306586</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1262</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>International journal of colorectal disease</Title><ISOAbbreviation>Int J Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>Comparison of the colonic J-pouch versus straight (end-to-end) anastomosis following low anterior resection: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>919</StartPage><EndPage>938</EndPage><MedlinePgn>919-938</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00384-022-04130-w</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To evaluate comparative outcomes of straight (end-to-end) anastomosis versus colonic J-pouch anastomosis following anterior resection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search of multiple electronic data sources was conducted, and all studies comparing straight (end-to-end) anastomosis versus J-pouch anastomosis were included. Anastomotic complications, post-operative complications, re-operation, mortality, and functional outcomes were the evaluated outcome parameters. Revman 5.3 was used for data analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-seven studies reporting a total number of 3293 patients who underwent straight anastomosis (n&#x2009;=&#x2009;1581) or J-pouch (n&#x2009;=&#x2009;1712) were included. Anastomotic leak and re-operation rates were significantly higher in the straight group compared to the J-pouch group [RD 0.03, P&#x2009;=&#x2009;0.03] and [OR 1.87, P&#x2009;=&#x2009;0.003], respectively. Stool frequency per 24&#xa0;h at 6&#xa0;months and 12&#xa0;months was lower in the J-pouch group than the straight group [MD 2.13, P&#x2009;=&#x2009;0.003] and [MD 1.44, P&#x2009;=&#x2009;0.00001], respectively. In addition, the use of anti-diarrheal medication is lower at 12&#xa0;months in the J-pouch group [MD 3.85, P&#x2009;=&#x2009;0.03]. Moreover, the two groups showed comparable results regarding SSI, sepsis, paralytic ileus, anastomotic stricture formation, anastomotic bleeding, and mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">J-pouch anastomosis showed lower risk for anastomotic leak and re-operation. Furthermore, better functional outcomes such as stool frequency were achieved using the colonic J-pouch reconstruction over the conventional straight end-to-end anastomosis.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zaman</LastName><ForeName>Shafquat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Sandwell and West Birmingham Hospitals NHS Trust, West Midlands, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mohamedahmed</LastName><ForeName>Ali Yasen Y</ForeName><Initials>AYY</Initials><Identifier Source="ORCID">0000-0002-1219-7571</Identifier><AffiliationInfo><Affiliation>Department of General Surgery, Sandwell and West Birmingham Hospitals NHS Trust, West Midlands, Birmingham, UK. dr.aliyasen1@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ayeni</LastName><ForeName>Adewale Adeoba</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The Dudley Group NHS Trust, Russells Hall Hospital, West Midlands, Dudley, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peterknecht</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Sandwell and West Birmingham Hospitals NHS Trust, West Midlands, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mawji</LastName><ForeName>Sadiq</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Sandwell and West Birmingham Hospitals NHS Trust, West Midlands, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albendary</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Sandwell and West Birmingham Hospitals NHS Trust, West Midlands, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mankotia</LastName><ForeName>Rajnish</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Sandwell and West Birmingham Hospitals NHS Trust, West Midlands, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akingboye</LastName><ForeName>Akinfemi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The Dudley Group NHS Trust, Russells Hall Hospital, West Midlands, Dudley, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int J Colorectal Dis</MedlineTA><NlmUniqueID>8607899</NlmUniqueID><ISSNLinking>0179-1958</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001003" MajorTopicYN="N">Anal Canal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039021" MajorTopicYN="Y">Colonic Pouches</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016737" MajorTopicYN="Y">Proctocolectomy, Restorative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anterior resection</Keyword><Keyword MajorTopicYN="N">J-pouch</Keyword><Keyword MajorTopicYN="N">Straight anastomosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>20</Day><Hour>20</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35306586</ArticleId><ArticleId IdType="doi">10.1007/s00384-022-04130-w</ArticleId><ArticleId IdType="pii">10.1007/s00384-022-04130-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cardoso R, Guo F, Heisser T et al (2021) Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol 22(7):1002&#x2013;1013</Citation><ArticleIdList><ArticleId IdType="pubmed">34048685</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer &#xa0;(Accessed 11 Nov 2021)</Citation></Reference><Reference><Citation>Miles WE (1908) A method of performing abdominoperineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 2:1812&#x2013;1813</Citation></Reference><Reference><Citation>Heald RJ (1988) The &#x2018;Holy Plane&#x2019; of rectal surgery. J R Soc Med 81(9):503&#x2013;508</Citation><ArticleIdList><ArticleId IdType="pubmed">3184105</ArticleId><ArticleId IdType="pmc">1291757</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange MM, Rutten HJ, van de Velde CJ (2009) One hundred years of curative surgery for rectal cancer: 1908&#x2013;2008. Eur J Surg Oncol 35(5):456&#x2013;463</Citation><ArticleIdList><ArticleId IdType="pubmed">19013050</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordeianou L, Maguire LH, Alavi K, Sudan R, Wise PE, Kaiser AM (2014) Sphincter-sparing surgery in patients with low-lying rectal cancer: techniques, oncologic outcomes, and functional results. J GastroIntest Surg 18(7):1358&#x2013;1372</Citation><ArticleIdList><ArticleId IdType="pubmed">24820137</ArticleId><ArticleId IdType="pmc">4057635</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TY, Emmertsen KJ, Laurberg S (2014) Bowel dysfunction after rectal cancer treatment: a study comparing the specialist&#x2019;s versus patient&#x2019;s perspective. BMJ Open 4(1):e003374</Citation></Reference><Reference><Citation>Croese AD, Lonie JM, Trollope AF et al (2018) A meta-analysis of the prevalence of low anterior resection syndrome and systematic review of risk factors. Int J Surg 56:234&#x2013;241</Citation><ArticleIdList><ArticleId IdType="pubmed">29936195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazorthes F, Fages P, Chiotasso P, Lemozy J, Bloom E (1986) Resection of the rectum with construction of a colonic reservoir and colo-anal anastomosis for carcinoma of the rectum. Br J Surg 73(2):136&#x2013;138</Citation><ArticleIdList><ArticleId IdType="pubmed">3947904</ArticleId></ArticleIdList></Reference><Reference><Citation>Parc R, Tiret E, Frileux P, Moszkowski E, Loygue J (1986) Resection and coloanal anastomosis with colonic reservoir for rectal carcinoma. Br J Surg 73(2):139&#x2013;141</Citation><ArticleIdList><ArticleId IdType="pubmed">3947905</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto S, Kroesen AJ, Hotz HG, Buhr HJ, Kruschewski M (2008) Effect of anastomosis level on continence performance and quality of life after colonic J-pouch reconstruction. Dig Dis Sci 53(1):14&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">17520367</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CJ, Fenech DS, McLeod RS (2008) Reconstructive techniques after rectal resection for rectal cancer. Cochrane Database Syst Rev 2:CD006040</Citation></Reference><Reference><Citation>Hou S, Wang Q, Zhao S et al (2021) Safety and efficacy of side-to-end anastomosis versus colonic J-pouch anastomosis in sphincter-preserving resections: an updated meta-analysis of randomized controlled trials. World J Surg Onc 19(1):130</Citation></Reference><Reference><Citation>Wang Z (2021) Colonic J-pouch versus side-to-end anastomosis for rectal cancer: a systematic review and meta-analysis of randomized controlled trials. BMC Surg 21:331</Citation><ArticleIdList><ArticleId IdType="pubmed">34419022</ArticleId><ArticleId IdType="pmc">8379825</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S (eds) (2011) Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 [updated March 2011]. http://www.cochrane.org/handbook &#xa0;(Accessed 22 June 2015)</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336&#x2013;341</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD et al Cochrane Bias Methods Group, Cochrane Statistical Methods Group (2011) The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ 343: d5928.</Citation></Reference><Reference><Citation>Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P (2015) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.&#xa0;Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed Dec 2021)</Citation></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMCMed Res Methodol 5:13</Citation></Reference><Reference><Citation>Lau J, Ioannidis JPA, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820&#x2013;6</Citation></Reference><Reference><Citation>Seow-Choen F, Goh HS (1995) Prospective randomized trial comparing J colonic pouch-anal anastomosis and straight coloanal reconstruction. Br J Surg 82(5):608&#x2013;610</Citation><ArticleIdList><ArticleId IdType="pubmed">7613927</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallb&#xf6;&#xf6;k O, Johansson K, Sj&#xf6;dahl R (1996) Laser Doppler blood flow measurement in rectal resection for carcinoma&#x2013;comparison between the straight and colonic J pouch reconstruction. Br J Surg 83(3):389&#x2013;392</Citation><ArticleIdList><ArticleId IdType="pubmed">8665202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallb&#xf6;&#xf6;k O, P&#xe5;hlman L, Krog M, Wexner SD, Sj&#xf6;dahl R (1996) Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection. Ann Surg 224(1):58&#x2013;65</Citation><ArticleIdList><ArticleId IdType="pubmed">8678619</ArticleId><ArticleId IdType="pmc">1235247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho YH, Tan M, Seow-Choen F (1996) Prospective randomized controlled study of clinical function and anorectal physiology after low anterior resection: comparison of straight and colonic J pouch anastomoses. Br J Surg 83(7):978&#x2013;980</Citation><ArticleIdList><ArticleId IdType="pubmed">8813791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallb&#xf6;&#xf6;k O, Nystrom PO, Sj&#xf6;dahl R (1997) Physiologic characteristics of straight and colonic J-pouch anastomoses after rectal excision for cancer. Dis Colon Rectum 40(3):332&#x2013;338</Citation><ArticleIdList><ArticleId IdType="pubmed">9118750</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew SB, Tindal DS (1997) Colonic J-pouch as a neorectum: functional assessment. Aust N Z J Surg 67(9):607&#x2013;610</Citation><ArticleIdList><ArticleId IdType="pubmed">9322696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazorthes F, Chiotasso P, Gamagami RA, Istvan G, Chevreau P (1997) Late clinical outcome in a randomized prospective comparison of colonic J pouch and straight coloanal anastomosis. Br J Surg 84(10):1449&#x2013;1451</Citation><ArticleIdList><ArticleId IdType="pubmed">9361611</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehni N, Tiret E, Singland JD, Cunningham C, Schlegel RD, Guiguet M, Parc R (1998) Long-term functional outcome after low anterior resection: comparison of low colorectal anastomosis and colonic J-pouch-anal anastomosis. Dis Colon Rectum&#xa0;41(7):817&#x2013;22; discussion 822&#x2013;3</Citation></Reference><Reference><Citation>Hida J, Yasutomi M, Maruyama T, Fujimoto K, Nakajima A, Uchida T, Wakano T, Tokoro T, Kubo R, Shindo K (1998) Indications for colonic J-pouch reconstruction after anterior resection for rectal cancer: determining the optimum level of anastomosis. Dis Colon Rectum 41(5):558&#x2013;563</Citation><ArticleIdList><ArticleId IdType="pubmed">9593236</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo JS, Latulippe JF, Alabaz O et al (1998) Long-term functional evaluation of straight coloanal anastomosis and colonic J-pouch: is the functional superiority of colonic J-pouch sustained? Dis Colon Rectum 41:740&#x2013;746</Citation><ArticleIdList><ArticleId IdType="pubmed">9645742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho YH, Tan M, Leong AF, Seow-Choen F (2000) Ambulatory manometry in patients with colonic J-pouch and straight coloanal anastomoses: randomized, controlled trial. Dis Colon Rectum 43(6):793&#x2013;799</Citation><ArticleIdList><ArticleId IdType="pubmed">10859079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho YH, Seow-Choen F, Tan M (2001) Colonic J-pouch function at six months versus straight coloanal anastomosis at two years: randomized controlled trial. World J Surg 25:876&#x2013;881</Citation><ArticleIdList><ArticleId IdType="pubmed">11572027</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantyh CR, Hull TL, Fazio VW (2001) Coloplasty in low colorectal anastomosis: manometric and functional comparison with straight and colonic J-pouch anastomosis. Dis Colon Rectum 44(1):37&#x2013;42</Citation><ArticleIdList><ArticleId IdType="pubmed">11805561</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho YH, Yu S, Ang ES, Seow-Choen F, Sundram F (2002) Small colonic J-pouch improves colonic retention of liquids&#x2013;randomized, controlled trial with scintigraphy. Dis Colon Rectum 45(1):76&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">11786768</ArticleId></ArticleIdList></Reference><Reference><Citation>Oya M, Komatsu J, Takase Y, Nakamura T, Ishikawa H (2002) Comparison of defecatory function after colonic J-pouch anastomosis and straight anastomosis for stapled low anterior resection: results of a prospective randomized trial. Surg Today 32(2):104&#x2013;110</Citation><ArticleIdList><ArticleId IdType="pubmed">11998936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sailer M, Fuchs KH, Fein M, Thiede A (2002) Randomized clinical trial comparing quality of life after straight and pouch coloanal reconstruction. Br J Surg 89(9):1108&#x2013;1117</Citation><ArticleIdList><ArticleId IdType="pubmed">12190675</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugamata Y, Takase Y, Oya M (2003) Scintigraphic comparison of neorectal emptying between colonic J-pouch anastomosis and straight anastomosis after stapled low anterior resection. Int J Colorectal Dis 18(4):355&#x2013;360</Citation><ArticleIdList><ArticleId IdType="pubmed">12677455</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JG, Lee MR, Lim SB et al (2005) Colonic J-pouch anal anastomosis after ultralow anterior resection with upper sphincter excision for low-lying rectal cancer. World J Gastroenterol 11(17):2570&#x2013;2573</Citation><ArticleIdList><ArticleId IdType="pubmed">15849813</ArticleId><ArticleId IdType="pmc">4305745</ArticleId></ArticleIdList></Reference><Reference><Citation>Remzi FH, Fazio VW, Gorgun E, Zutshi M, Church JM, Lavery IC, Hull TL (2005) Quality of life, functional outcome, and complications of coloplasty pouch after low anterior resection. Dis Colon Rectum 48(4):735&#x2013;743</Citation><ArticleIdList><ArticleId IdType="pubmed">15785900</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazio VW, Zutshi M, Remzi FH, Parc Y, Ruppert R, F&#xfc;rst A, Celebrezze J Jr, Galanduik S, Orangio G, Hyman N, Bokey L, Tiret E, Kirchdorfer B, Medich D, Tietze M, Hull T, Hammel J (2007) A randomized multicenter trial to compare long-term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers. Ann Surg 246(3):481&#x2013;488</Citation><ArticleIdList><ArticleId IdType="pubmed">17717452</ArticleId><ArticleId IdType="pmc">1959344</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang JT, Lai HS, Lee PH, Huang KC (2007) Comparison of functional and surgical outcomes of laparoscopic-assisted colonic J-pouch versus straight reconstruction after total mesorectal excision for lower rectal cancer. Ann Surg Oncol 14(7):1972&#x2013;1979</Citation><ArticleIdList><ArticleId IdType="pubmed">17431725</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrvarz S, Towliat SM, Mohebbi HA, Derakhshani S, Abavisani M (2013) Comparison of colonic J-pouch and straight coloanal anastomosis after low anterior resection. Iran Red Crescent Med J 15(1):32&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">23486745</ArticleId><ArticleId IdType="pmc">3589776</ArticleId></ArticleIdList></Reference><Reference><Citation>Parray FQ, Magray JA, Dar MA, Chowdri NA, Wani RA, Thakur N (2014) Coloplasty neorectum versus straight anastomosis in low rectal cancers. ISRN Surg&#xa0;2014:382371</Citation></Reference><Reference><Citation>Steffen T, Tarantino I, Hetzer FH, Warschkow R, Lange J, Z&#xfc;nd M (2008) Safety and morbidity after ultra-low coloanal anastomoses: J-pouch vs end-to-end reconstruction. Int J Colorectal Dis 23(3):277&#x2013;281</Citation><ArticleIdList><ArticleId IdType="pubmed">18071719</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown S, Margolin DA, Altom LK, Green H, Beck DE, Kann BR, Whitlow CB, Vargas HD (2018) Morbidity following coloanal anastomosis: a comparison of colonic J-Pouch vs straight anastomosis. Dis Colon Rectum 61(2):156&#x2013;161</Citation><ArticleIdList><ArticleId IdType="pubmed">29337769</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucciarelli S, Del Bianco P, Pace U, Bianco F, Restivo A, Maretto I, Selvaggi F, Zorcolo L, De Franciscis S, Asteria C, Urso EDL, Cuicchi D, Pellino G, Morpurgo E, La Torre G, Jovine E, Belluco C, La Torre F, Amato A, Chiappa A, Infantino A, Barina A, Spolverato G, Rega D, Kilmartin D, De Salvo GL, Delrio P (2019) Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer. Br J Surg 106(9):1147&#x2013;1155</Citation><ArticleIdList><ArticleId IdType="pubmed">31233220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribi K, Marti WR, Bernhard J, Grieder F, Graf M, Gloor B, Curti G, Zuber M, Demartines N, Andrieu C, Bigler M, Hayoz S, Wehrli H, Kettelhack C, Lerf B, Fasolini F, Hamel C (2019) Swiss group for clinical cancer research, section surgery. Quality of life after total mesorectal excision and rectal replacement: comparing side-to-end, colon J-pouch and straight colorectal reconstruction in a randomized, phase III trial (SAKK 40/04). Ann Surg Oncol 26(11):3568&#x2013;3576</Citation></Reference><Reference><Citation>Chen ZZ, Li YD, Huang W, Chai NH, Wei ZQ (2021) Colonic pouch confers better bowel function and similar postoperative outcomes compared to straight anastomosis for low rectal cancer. World J Gastrointest Surg 13(3):303&#x2013;314</Citation><ArticleIdList><ArticleId IdType="pubmed">33796217</ArticleId><ArticleId IdType="pmc">7992999</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas MS, Margolin DA (2016) Management of colorectal anastomotic leak. Clin Colon Rectal Surg 29(2):138&#x2013;144</Citation><ArticleIdList><ArticleId IdType="pubmed">27247539</ArticleId><ArticleId IdType="pmc">4882170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho YH, Brown S, Heah SM et al (2002) Comparison of J-pouch and coloplasty pouch for low rectal cancers: a randomized, controlled trial investigating functional results and comparative anastomotic leak rates. Ann Surg 236(1):49&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">12131085</ArticleId><ArticleId IdType="pmc">1422548</ArticleId></ArticleIdList></Reference><Reference><Citation>Karanjia ND, Corder AP, Bearn P, Heald RJ (1994) Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg 81:1224&#x2013;1226</Citation><ArticleIdList><ArticleId IdType="pubmed">7953369</ArticleId></ArticleIdList></Reference><Reference><Citation>Law WI, Chu KW, Ho JW, Chan CW (2000) Risk factors for anastomotic leakage after low anterior resection with total mesorectal excision. Am J Surg 179:92&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">10773140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JK et al (2002) Comparison between straight and J-pouch coloanal anastomoses in surgery for rectal cancer. Surg Today 32:487&#x2013;492</Citation><ArticleIdList><ArticleId IdType="pubmed">12107771</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis S, Kasperk R, Braun J, Schumpelick V (2001) Comparison of colonic J-pouch reconstruction and straight coloanal anastomosis after intersphincteric rectal resection. Langenbecks Arch Surg 386:193&#x2013;199</Citation><ArticleIdList><ArticleId IdType="pubmed">11382321</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls RJ, Lubowski DZ, Donaldson DR (1988) Comparison of colonic reservoir and straight colo-anal reconstruction after rectal excision. Br J Surg 75:318&#x2013;320</Citation><ArticleIdList><ArticleId IdType="pubmed">3359144</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthiessen P, Hallbook O, Andersson M, Rutegard J, Sjodahl R (2004) Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis 6:462&#x2013;469</Citation><ArticleIdList><ArticleId IdType="pubmed">15521937</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado M, Nygren J, Goldman S, Ljungqvist O (2003) Similar outcome after colonic pouch and side-to-end anastomosis in low anterior resection for rectal cancer: a prospective randomized trial. Ann Surg 238:214&#x2013;220</Citation><ArticleIdList><ArticleId IdType="pubmed">12894014</ArticleId><ArticleId IdType="pmc">1422690</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger A, Tiret E, Parc R et al (1992) Excision of the rectum with colonic J pouch-anal anastomosis for adenocarcinoma of the low and mid rectum. World J Surg 16:470&#x2013;477</Citation><ArticleIdList><ArticleId IdType="pubmed">1589983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelissier EP, Blum D, Bachour A et al (1992) Functional results of coloanal anastomosis with reservoir. Dis Colon Rectum 35:843&#x2013;846</Citation><ArticleIdList><ArticleId IdType="pubmed">1511643</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallb&#xf6;&#xf6;k O, Sj&#xf6;dahl R (1997) Comparison between the colonic J pouch-anal anastomosis and healthy rectum: clinical and physiological function. Br J Surg 84:1437&#x2013;1441</Citation><ArticleIdList><ArticleId IdType="pubmed">9361608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazorthes F, Gamagami R, Chiotasso P et al (1997) Prospective, randomized study comparing clinical results between small and large colonic J-pouch following coloanal anstomosis. Dis Colon Rectum 40:1409&#x2013;1413</Citation><ArticleIdList><ArticleId IdType="pubmed">9407976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hida J, Yasutomi M, Fujimoto K et al (1996) Functional outcome after low anterior resection with low anastomosis for rectal cancer using the colonic J-pouch. Prospective randomized study for determination of optimum pouch size. Dis Colon Rectum 39:986&#x2013;991</Citation></Reference><Reference><Citation>Ortiz H, De Miguel M, Armendariz P et al (1995) Coloanal anastomosis: are functional results better with a pouch? Dis Colon Rectum 38:375&#x2013;377</Citation><ArticleIdList><ArticleId IdType="pubmed">7720443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hida J, Yasutomi M, Maruyama T et al (1999) Detection of a rectocele-like prolapse in the colonic J-pouch using pouchography: cause or effect of evacuation difficulties? Surg Today 29:1237&#x2013;1242</Citation><ArticleIdList><ArticleId IdType="pubmed">10639703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hida J, Yasutomi M, Maruyama T et al (1999) Horizontal inclination of the longitudinal axis of the colonic J-pouch: defining causes of evacuation difficulty. Dis Colon Rectum 42:1560&#x2013;1568</Citation><ArticleIdList><ArticleId IdType="pubmed">10613474</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehni N, Schlegel RD, Cunningham C et al (1998) Influence of a defunctioning stoma on leakage rates after low colorectal anastomosis and colonic J pouch-anal anastomosis. Br J Surg 85:1114&#x2013;1117</Citation><ArticleIdList><ArticleId IdType="pubmed">9718009</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur P, Hallan RI (2002) The colonic J-pouch in colo-anal anastomosis. Colorectal Dis 4(5):304&#x2013;312</Citation><ArticleIdList><ArticleId IdType="pubmed">12780572</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrier A,&#xa0;Martel P,&#xa0;Dugue L,&#xa0;Gallot D,&#xa0;Malafosse M (2001) Direct and reservoir colonic-anal anastomoses. Short and long term results.&#xa0;Ann Chir&#xa0;126:18&#x2013;25</Citation></Reference><Reference><Citation>Hallb&#xf6;&#xf6;k O, Hass U, W&#xe4;nstr&#xf6;m A, Sj&#xf6;dahl R (1997) Quality of life measurement after rectal excision for cancer. Comparison between straight and colonic J-pouch anastomosis. Scand J Gastroenterol 32(5):490&#x2013;3</Citation></Reference><Reference><Citation>Heriot AG, Tekkis PP, Constantinides V, Paraskevas P, Nicholls RJ, Darzi A, Fazio VW (2006) Meta-analysis of colonic reservoirs versus straight coloanal anastomosis after anterior resection. Br J Surg 93(1):19&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">16273532</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;ttner FJ, Tenckhoff S, Jensen K, Uhlmann L, Kulu Y, B&#xfc;chler MW, Diener MK, Ulrich A (2015) Meta-analysis of reconstruction techniques after low anterior resection for rectal cancer. Br J Surg 102(7):735&#x2013;745</Citation><ArticleIdList><ArticleId IdType="pubmed">25833333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31959476</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-1983</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical nutrition (Edinburgh, Scotland)</Title><ISOAbbreviation>Clin Nutr</ISOAbbreviation></Journal><ArticleTitle>Are omega-3 fatty acids safe and effective in acute pancreatitis or sepsis? A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2686</StartPage><EndPage>2694</EndPage><MedlinePgn>2686-2694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clnu.2019.12.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0261-5614(19)33175-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute pancreatitis (AP) is marked by a strong pro-inflammatory response, which may cause a systemic inflammatory response syndrome (SIRS), organ failure, and death. Early administration of omega-3 fatty acids (FA) may reduce the pro-inflammatory response and improve outcome in AP. A systematic review focusing on the safety and efficacy of omega-3 FA in AP is lacking.</AbstractText><AbstractText Label="AIM">Evaluate the safety and efficacy of an intervention with omega-3 FA in acute pancreatitis and additionally in sepsis.</AbstractText><AbstractText Label="METHODS">A systematic review and meta-analysis was performed using the PubMed, Embase, and Cochrane databases including only randomized controlled trials in AP and, for safety endpoints, in sepsis investigating intervention including omega-3 FA without other active components (e.g. addition of glutamine to the intervention). The primary outcome was mortality.</AbstractText><AbstractText Label="RESULTS">After screening 1186 studies, five randomized trials (n&#xa0;=&#xa0;229) with omega-3 FA in AP were included. In AP patients treated with omega-3 FA within 48&#xa0;h after hospitalization, a non-significant reduction of mortality was seen (OR 0&#x2219;50, 95%CI 0&#x2219;13-1&#x2219;99, p&#xa0;=&#xa0;0&#x2219;33), compared to controls. In two studies (n&#xa0;=&#xa0;85), omega-3 FA reduced the risk of new onset of organ failure (OR 0&#x2219;33, 95%CI 0&#x2219;12-0&#x2219;93, p&#xa0;=&#xa0;0&#x2219;04). Nine randomized trials with 312 patients suffering from sepsis (not pancreatitis related) demonstrated a reduced mortality (OR 0&#x2219;52, 95%CI 0&#x2219;28-0&#x2219;97, p&#xa0;=&#xa0;0&#xb7;04). None of these 14 randomized trials reported safety concerns.</AbstractText><AbstractText Label="CONCLUSIONS">Administration of omega-3 FA could reduce the risk of new-organ failure in patients with AP. There were no safety issues reported of the early administration of omega-3 FA in any of the included studies. To show the real clinical benefit of omega-3 FA in AP, a large and pragmatic randomized controlled trial is needed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wolbrink</LastName><ForeName>Daniel R J</ForeName><Initials>DRJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboud university medical center, Nijmegen, the Netherlands. Electronic address: Daan.Wolbrink@radboudumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grundsell</LastName><ForeName>Jessica R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witteman</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Gelderse Vallei Hospital, Ede, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poll</LastName><ForeName>Marcel van de</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine and Surgery, MUMC+, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santvoort</LastName><ForeName>Hjalmar C van</ForeName><Initials>HCV</Initials><AffiliationInfo><Affiliation>Department of Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands; Department of Surgery, UMC Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Issa</LastName><ForeName>Eyad</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, Leicester University Hospital, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dennison</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Leicester University Hospital, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goor</LastName><ForeName>Harry van</ForeName><Initials>HV</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboud university medical center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besselink</LastName><ForeName>Marc G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouwense</LastName><ForeName>Stefan A W</ForeName><Initials>SAW</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboud university medical center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dutch Pancreatitis Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Nutr</MedlineTA><NlmUniqueID>8309603</NlmUniqueID><ISSNLinking>0261-5614</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015525" MajorTopicYN="N">Fatty Acids, Omega-3</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010195" MajorTopicYN="N">Pancreatitis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute pancreatitis</Keyword><Keyword MajorTopicYN="N">Anti-inflammatory</Keyword><Keyword MajorTopicYN="N">Omega-3 fatty acids</Keyword><Keyword MajorTopicYN="N">Organ failure</Keyword><Keyword MajorTopicYN="N">Safety</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Conflict of interests No potential competing interests were reported by any authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31959476</ArticleId><ArticleId IdType="doi">10.1016/j.clnu.2019.12.006</ArticleId><ArticleId IdType="pii">S0261-5614(19)33175-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37142091</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>164</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Lower vs&#xa0;Higher Fluid Volumes in Adult Patients With Sepsis: An Updated Systematic Review With Meta-Analysis and Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>892</StartPage><EndPage>912</EndPage><MedlinePgn>892-912</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2023.04.036</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(23)00637-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">IV fluids are recommended for adults with sepsis. However, the optimal strategy for IV fluid management in sepsis is unknown, and clinical equipoise exists.</AbstractText><AbstractText Label="RESEARCH QUESTION">Do lower vs&#xa0;higher fluid volumes improve patient-important outcomes in adult patients with sepsis?</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS">We updated a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials assessing lower vs&#xa0;higher IV fluid volumes in adult patients with sepsis. The coprimary outcomes were all-cause mortality, serious adverse events, and health-related quality of life. We followed the recommendations from the Cochrane Handbook and used the Grading of Recommendations Assessment, Development and Evaluation approach. Primary conclusions were based on trials with low risk of bias if available.</AbstractText><AbstractText Label="RESULTS">We included 13 trials (N&#xa0;= 4,006) with four trials (n&#xa0;= 3,385) added to this update. The meta-analysis of all-cause mortality in eight trials with low risk of bias showed a relative risk of 0.99 (97%&#xa0;CI, 0.89-1.10; moderate certainty evidence). Six trials with predefined definitions of serious adverse events showed a relative risk of 0.95 (97%&#xa0;CI, 0.83-1.07; low certainty evidence). Health-related quality of life was not reported.</AbstractText><AbstractText Label="INTERPRETATION">Among adult patients with sepsis, lower IV fluid volumes probably result in little to no difference in all-cause mortality compared with higher IV fluid volumes, but the interpretation is limited by imprecision in the estimate, which does not exclude potential benefit or harm. Similarly, the evidence suggests lower IV fluid volumes result in little to no difference in serious adverse events. No trials reported on health-related quality of life.</AbstractText><AbstractText Label="TRIAL REGISTRATION">PROSPERO; No.: CRD42022312572; URL: https://www.crd.york.ac.uk/prospero/.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sivapalan</LastName><ForeName>Praleene</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark. Electronic address: praleene.sivapalan.01@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellekjaer</LastName><ForeName>Karen L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jessen</LastName><ForeName>Marie K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Research Center for Emergency Medicine, Aarhus University and University Hospital, Aarhus N, Denmark; Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Tine S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Department of Clinical Science and Education, S&#xf6;dersjukhuset, Section of Anaesthesia and Intensive Care, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjortrup</LastName><ForeName>Peter B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark; Department of Cardiothoracic Anaesthesia and Intensive Care, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetterslev</LastName><ForeName>J&#xf8;rn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Private Office, Tuborg Sundpark, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granholm</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Morten H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2023 Oct;164(4):812-813. doi: 10.1016/j.chest.2023.05.027.</RefSource><PMID Version="1">37805236</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fluid therapy</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37142091</ArticleId><ArticleId IdType="pmc">PMC10567931</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2023.04.036</ArticleId><ArticleId IdType="pii">S0012-3692(23)00637-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Evans L., Rhodes A., Alhazzani W., et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd J.H., Forbes J., Nakada T.A., Walley K.R., Russell J.A. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy C.V., Schramm G.E., Doherty J.A., et al. The importance of fluid management in acute lung injury secondary to septic shock. Chest. 2009;136(1):102&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">19318675</ArticleId></ArticleIdList></Reference><Reference><Citation>Acheampong A., Vincent J.L. A&#xa0;positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care. 2015;19(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4479078</ArticleId><ArticleId IdType="pubmed">26073560</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.H., Perner A. Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort. Crit Care. 2012;16(3):R76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580618</ArticleId><ArticleId IdType="pubmed">22568926</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K., Kiguli S., Opoka R.O., et al. Mortality after fluid bolus in African children with severe infection. N&#xa0;Engl J Med. 2011;364(26):2483&#x2013;2495.</Citation><ArticleIdList><ArticleId IdType="pubmed">21615299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann H.P., Wheeler A.P., Bernard G.R., et al. Comparison of two fluid-management strategies in acute lung injury. N&#xa0;Engl J Med. 2006;354(24):2564&#x2013;2575.</Citation><ArticleIdList><ArticleId IdType="pubmed">16714767</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronhjort M., Hjortrup P.B., Holst L.B., et al. Association between fluid balance and mortality in patients with septic shock: a post hoc analysis of the TRISS trial. Acta Anaesthesiol Scand. 2016;60(7):925&#x2013;933.</Citation><ArticleIdList><ArticleId IdType="pubmed">27030514</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff T.S., M&#xf8;ller M.H., Hjortrup P.B., Cronhjort M., Perner A., Wetterslev J. Lower vs&#xa0;higher fluid volumes during initial management of sepsis: a systematic review with meta-analysis and trial sequential analysis. Chest. 2020;157(6):1478&#x2013;1496.</Citation><ArticleIdList><ArticleId IdType="pubmed">31982391</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro N.I., Douglas I.S., et al. National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388(6):499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10685906</ArticleId><ArticleId IdType="pubmed">36688507</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas I.S., Alapat P.M., Corl K.A., et al. Fluid response evaluation in sepsis hypotension and shock: a randomized clinical trial. Chest. 2020;158(4):1431&#x2013;1445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9490557</ArticleId><ArticleId IdType="pubmed">32353418</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff T.S., Hjortrup P.B., Wetterslev J., et al. Restriction of intravenous fluid in ICU patients with septic shock. N&#xa0;Engl J Med. 2022;386(26):2459&#x2013;2470.</Citation><ArticleIdList><ArticleId IdType="pubmed">35709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen M.K., Andersen L.W., Thomsen M.H., et al. Restrictive Fluids Versus Standard Care in Adults with Sepsis in the Emergency Department (REFACED): a multicenter, randomized feasibility trial. Acad Emerg Med. 2022;29(10):1172&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9804491</ArticleId><ArticleId IdType="pubmed">35652491</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff T.S., M&#xf8;ller M.H., Hjortrup P.B., Cronhjort M., Perner A., Wetterslev J. Lower vs. higher fluid volumes in sepsis&#x2014;protocol for a systematic review with meta-analysis. Acta Anaesthesiol Scand. 2017;61(8):942&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pubmed">28782112</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022) Cochrane; 2022. www.training.cochrane.org/handbook Available from.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>H Sch&#xfc;nemann, J Bro&#x17c;ek, G Guyatt and A Oxman, Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Accessed May 25, 2023. GRADEPro GDT website. https://www.guidelinedevelopment.org/handbook</Citation></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Guideine: Integrated Addendum To ICH E6 (R1): Guideline for Good Clinical Practice. https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf</Citation></Reference><Reference><Citation>Chen C., Kollef M.H. Targeted fluid minimization following initial resuscitation in septic shock a pilot study. Chest. 2015;148(6):1462&#x2013;1469.</Citation><ArticleIdList><ArticleId IdType="pubmed">26291900</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup P.B., Haase N., Bundgaard H., et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42(11):1695&#x2013;1705.</Citation><ArticleIdList><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Corl K.A., Prodromou M., Merchant R.C., et al. The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): a randomized pilot study. Crit Care Med. 2019;47(7):951&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6579683</ArticleId><ArticleId IdType="pubmed">30985449</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronhjort M., Bergman M., Joelsson-Alm E., et al. Fluid responsiveness assessment using passive leg raising test to reduce fluid administration and weight gain in patients with septic shock. J Anesth Perioper Med. 2017;4 doi: 10.24015/JAPM.2016.0049.</Citation><ArticleIdList><ArticleId IdType="doi">10.24015/JAPM.2016.0049</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald S.P.J., Keijzers G., Taylor D.M.D., et al. Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial. Intensive Care Med. 2018;44(12):2070&#x2013;2078.</Citation><ArticleIdList><ArticleId IdType="pubmed">30382308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanspa M.J., Burk R.E., Wilson E.L., Hirshberg E.L., Grissom C.K., Brown S.M. Echocardiogram-guided resuscitation versus early goal-directed therapy in the treatment of septic shock: a randomized, controlled, feasibility trial. J Intensive Care. 2018;6(1):50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6090604</ArticleId><ArticleId IdType="pubmed">30123511</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler M., Janz D.R., Casey J.D., Self W.H., Rice T.W. Conservative fluid management after sepsis resuscitation: a pilot randomized trial. J&#xa0;Intensive Care Med. 2020;35(12):1374&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6620161</ArticleId><ArticleId IdType="pubmed">30630380</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard J.C., Bayle F., Bourdin G., et al. Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial. Crit Care. 2015;19(1):1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310180</ArticleId><ArticleId IdType="pubmed">25572383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A.C., Savovi&#x107; J., Page M.J., et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter B., Gelman A., Hoffman M.D., et al. Stan: a probabilistic programming language. J Stat Softw. 2017;76(1):1. doi: 10.18637/jss.v076.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v076.i01</ArticleId><ArticleId IdType="pmc">PMC9788645</ArticleId><ArticleId IdType="pubmed">36568334</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;rkner P.C. brms: an R package for Bayesian multilevel models using Stan. J Stat Softw. 2017;80(1) doi: 10.18637/jss.v080.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v080.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen J.C., Wetterslev J., Winkel P., Lange T., Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol. 2014;14(1):1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4251848</ArticleId><ArticleId IdType="pubmed">25416419</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J., Thorlund K., Brok J., Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2809074</ArticleId><ArticleId IdType="pubmed">20042080</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbord R.M., Egger M., Sterne J.A.C. A&#xa0;modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443&#x2013;3457.</Citation><ArticleIdList><ArticleId IdType="pubmed">16345038</ArticleId></ArticleIdList></Reference><Reference><Citation>Silversides J.A., Major E., Ferguson A.J., et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2017;43(2):155&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">27734109</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins D., Best D., Briss P.A., et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC428525</ArticleId><ArticleId IdType="pubmed">15205295</ArticleId></ArticleIdList></Reference><Reference><Citation>van Genderen M.E., Engels N., van der Valk R.J.P., et al. Early peripheral perfusion&#x2013;guided fluid therapy in patients with septic shock. Am J Respir Crit Care Med. 2015;191(4):477&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">25679107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed M.F.H., Malewicz N.M., Zehry H.I., et al. Fluid administration in emergency room limited by lung ultrasound in patients with sepsis: protocol for a prospective phase II multicenter randomized controlled trial. JMIR Res Protoc. 2020;9(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7481877</ArticleId><ArticleId IdType="pubmed">32657759</ArticleId></ArticleIdList></Reference><Reference><Citation>Controlled fluid resuscitation in sepsis  . 2023. ClinicalTrials.gov identifier: NCT03214913. Updated July 12, 2017. Accessed August 17,https://classic.clinicaltrials.gov/ct2/show/NCT03214913</Citation></Reference><Reference><Citation>Protocolized reduction of non-resuscitation fluids vs usual care in septic shock  . 2023. ClinicalTrials.gove identifier: NCT05249088. Updated September 29, 2022. Accessed August 17,https://clinicaltrials.gov/study/NCT05249088</Citation></Reference><Reference><Citation>Australian and New Zealand Intensive Care Research Centre. Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis (ARISE FLUIDS). NCT04569942. ClinicalTrials.gov. National Institutes of Health; 2020. Updated July 8, 2022. https://clinicaltrials.gov/show/NCT04569942</Citation></Reference><Reference><Citation>Pontificia Universidad Catolica de Chile. Hemodynamic phenotype and capillary refill time-targeted resuscitation strategy. NCT05057611. ClinicalTrials.gov. National Institutes of Health; 2021. Updated September 14, 2022. https://clinicaltrials.gov/show/NCT05057611</Citation></Reference><Reference><Citation>Lei C. Effects of different fluid resuscitation strategies on intestinal barrier function in patients with septic shock: a pilot, prospective, randomized, controlled trial, Chinese Clinical Trial Register, 2100043734.</Citation></Reference><Reference><Citation>Centre Hospitalier Universitaire de N&#x12b;mes  . National Institutes of Health; 2021. OPTImized Restrictive Strategy Targeting Non-Resuscitative FLUIDs in Septic Shock: pilot study. (OPTIFLUID). NCT04947904. ClinicalTrials.gov.https://clinicaltrials.gov/ct2/show/NCT04947904 Updated April 14, 2023.</Citation></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C., et al. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315(8):801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pubmed">1597042</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS Greater Glasgow and Clyde. Early Vasopressors in Sepsis (EVIS). NCT05179499. ClinicalTrials.gov. National Institutes of Health; 2022. Updated February 13, 2023. https://www.clinicaltrials.gov/ct2/show/NCT05179499</Citation></Reference><Reference><Citation>Driessen R.G.H., van de Poll M.C.G., Mol M.F., van Mook W.N.K.A., Schnabel R.M. The influence of a change in septic shock definitions on intensive care epidemiology and outcome: comparison of sepsis-2 and sepsis-3 definitions. Infect Dis (Auckl) 2018;50(3):207&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">28950786</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A., Haase N., Guttormsen A.B., et al. Hydroxyethyl starch 130/0.42 versus Ringer&#x2019;s acetate in severe sepsis. N&#xa0;Engl J Med. 2012;367(2):124&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">22738085</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39487358</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1433-8726</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>World journal of urology</Title><ISOAbbreviation>World J Urol</ISOAbbreviation></Journal><ArticleTitle>Clinical significance of stone culture during endourological procedures in predicting post-operative urinary sepsis: should it be a standard of care-evidence from a systematic review and meta-analysis from EAU section of Urolithiasis (EULIS).</ArticleTitle><Pagination><StartPage>614</StartPage><MedlinePgn>614</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00345-024-05319-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Urinary sepsis is the leading cause of mortality in the setting of endourological procedures for stone treatment such as URS and PCNL; renal stones themselves may be a source of infection. Aim of this study is to determine the diagnostic accuracy of stone cultures (SC) collected during URS and PCNL in predicting post-operative septic complications, compared to preoperative bladder urine culture (BUC).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic review (SR) of literature according to the PRISMA guidelines; Literature quality was evaluated according to The Risk Of Bias In Non-randomized Studies-of Interventions (ROBINS-I) assessment tool. A univariate meta-analysis (MA) was used to estimate pooled log odds ratio of BUC and SC, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 14 studies including 3646 patients met the inclusion criteria. Eight studies reported data from PCNL only; three from URS only; three from both URS and PCNL. Stone cultures showed a higher sensitivity (0.52 vs 0.32) and higher positive predictive value (0.28 vs 0.21) in predicting post-operative sepsis, compared to bladder urine cultures. The pool-weighted logarithmic odd risk (LOR) for BUC was 2.30 (95% CI 1.51-3.49, p&#x2009;&lt;&#x2009;0.001); the LOR for stone cultures (SC) in predicting post-operative sepsis was 5.79 (95% CI 3.58-9.38, p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The evidence from this SR and MA suggests that intraoperative SC from stone fragments retrieved during endourological procedures are better predictors of the likelihood of occurrence of post-operative sepsis compared to pre-operative BUC. Therefore, SC should be a standard of care in patients undergoing endourological interventions.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ripa</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7803-3879</Identifier><AffiliationInfo><Affiliation>Department of Urology, University College London Hospitals, London, UK. f.ripa@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerrato</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tando&#x11f;du</LastName><ForeName>Zafer</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Urology, University College London Hospitals, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery and Interventional Science, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seitz</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Urology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montanari</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Urology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choong</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, University College London Hospitals, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zumla</LastName><ForeName>Alimuddin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infection, Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Biomedical Research Centre, University College London Hospitals, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrmann</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Kantonspital Frauenfeld, Frauenfeld, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somani</LastName><ForeName>Bhaskar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>EAU section of Urolithiasis</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>World J Urol</MedlineTA><NlmUniqueID>8307716</NlmUniqueID><ISSNLinking>0724-4983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018666" MajorTopicYN="N">Ureteroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074642" MajorTopicYN="N">Nephrolithotomy, Percutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059039" MajorTopicYN="N">Standard of Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="N">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007669" MajorTopicYN="N">Kidney Calculi</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052878" MajorTopicYN="N">Urolithiasis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009403" MajorTopicYN="N">Nephrostomy, Percutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000092522" MajorTopicYN="N">Clinical Relevance</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PCNL</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Stone culture</Keyword><Keyword MajorTopicYN="N">Ureteroscopy</Keyword><Keyword MajorTopicYN="N">Urine culture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>2</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>2</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>2</Day><Hour>0</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39487358</ArticleId><ArticleId IdType="doi">10.1007/s00345-024-05319-0</ArticleId><ArticleId IdType="pii">10.1007/s00345-024-05319-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pietropaolo A, Proietti S, Geraghty R, Skolarikos A, Papatsoris A, Liatsikos E, Somani BK (2017) Trends of &#x201c;urolithiasis: interventions, simulation, and laser technology&#x201d; over the last 16 years (2000&#x2013;2015) as published in the literature (PubMed): a systematic review from European section of Uro-technology (ESUT). World J Urol 35:1651&#x2013;1658. https://doi.org/10.1007/s00345-017-2055-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-017-2055-z</ArticleId><ArticleId IdType="pubmed">28593477</ArticleId><ArticleId IdType="pmc">5649597</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehurst L, Jones P, Somani BK (2019) Mortality from kidney stone disease (KSD) as reported in the literature over the last two decades: a systematic review. World J Urol 37:759&#x2013;776. https://doi.org/10.1007/s00345-018-2424-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-018-2424-2</ArticleId><ArticleId IdType="pubmed">30151599</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhojani N, Miller LE, Bhattacharyya S, Cutone B, Chew BH (2021) Risk factors for urosepsis after ureteroscopy for stone disease: a systematic review with meta-analysis. J Endourol 35:991&#x2013;1000. https://doi.org/10.1089/end.2020.1133</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/end.2020.1133</ArticleId><ArticleId IdType="pubmed">33544019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhojani N, Eisner B, Monga M, Paranjpe R, Cutone B, Chew BH (2023) Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults. BJU Int 132:210&#x2013;216. https://doi.org/10.1111/bju.16029</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bju.16029</ArticleId><ArticleId IdType="pubmed">37057736</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreydin EI, Eisner BH (2013) Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol 10:598&#x2013;605. https://doi.org/10.1038/nrurol.2013.183</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrurol.2013.183</ArticleId><ArticleId IdType="pubmed">23999583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhanot R, Pietropaolo A, Tokas T, Kallidonis P, Skolarikos A, Keller EX, Coninck VD, Traxer O, Gozen A, Sarica K, Whitehurst L, Somani BK (2021) Predictors and strategies to avoid mortality following ureteroscopy for stone disease: a systematic review from european association of urologists sections of urolithiasis (EULIS) and Uro-technology (ESUT). Eur Urol Focus. https://doi.org/10.1016/j.euf.2021.02.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euf.2021.02.014</ArticleId><ArticleId IdType="pubmed">33674255</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhu W, Zeng G (2021) Percutaneous nephrolithotomy with suction: is this the future? Curr Opin Urol 31:95&#x2013;101. https://doi.org/10.1097/MOU.0000000000000854</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOU.0000000000000854</ArticleId><ArticleId IdType="pubmed">33470685</ArticleId></ArticleIdList></Reference><Reference><Citation>Chugh S, Pietropaolo A, Montanari E, Sarica K, Somani BK (2020) Predictors of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review from eau section of urolithiasis (EULIS). Curr Urol Rep 21:16. https://doi.org/10.1007/s11934-020-0969-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11934-020-0969-2</ArticleId><ArticleId IdType="pubmed">32211969</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhou C, Gao W, Huang H, Jiang X, Zhang D (2020) Does preoperative urine culture still play a role in predicting post-PCNL SIRS? a retrospective cohort study. Urolithiasis 48:251&#x2013;256. https://doi.org/10.1007/s00240-019-01148-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-019-01148-8</ArticleId><ArticleId IdType="pubmed">31324955</ArticleId></ArticleIdList></Reference><Reference><Citation>EAU Guidelines. Edn. Presented at the EAU Annual Congress Milan 2023. ISBN 978&#x2013;94&#x2013;92671&#x2013;19&#x2013;6.</Citation></Reference><Reference><Citation>Liu M, Chen J, Gao M, Zeng H, Cui Y, Zhu Z, Chen H (2021) Preoperative midstream urine cultures vs renal pelvic urine culture or stone culture in predicting systemic inflammatory response syndrome and urosepsis after percutaneous nephrolithotomy: a systematic review and meta-analysis. J Endourol 35:1467&#x2013;1478. https://doi.org/10.1089/end.2020.1140</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/end.2020.1140</ArticleId><ArticleId IdType="pubmed">34128382</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton-Diaz A, Vinay JI, Barahona J, Daels P, Gonz&#xe1;lez M, Hidalgo JP, Palma C, D&#xed;az P, Domenech A, Valenzuela R, Marchant F (2017) Concordance of renal stone culture: PMUC, RPUC, RSC and post-PCNL sepsis&#x2014;a non-randomized prospective observation cohort study. Int Urol Nephrol 49:31&#x2013;35. https://doi.org/10.1007/s11255-016-1457-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-016-1457-y</ArticleId><ArticleId IdType="pubmed">27848063</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr&#xf3;bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Linares-Espin&#xf3;s E, Hern&#xe1;ndez V, Dom&#xed;nguez-Escrig JL, Fern&#xe1;ndez-Pello S, Hevia V, Mayor J, Padilla-Fern&#xe1;ndez B, Ribal MJ (2018) Methodology of a systematic review. Actas Urol Esp 42:499&#x2013;506. https://doi.org/10.1016/j.acuro.2018.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acuro.2018.01.010</ArticleId><ArticleId IdType="pubmed">29731270</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddaway NR, Page MJ, Pritchard CC, McGuinness LA (2022) PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev. https://doi.org/10.1002/cl2.1230</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cl2.1230</ArticleId><ArticleId IdType="pubmed">36911350</ArticleId><ArticleId IdType="pmc">9682961</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan A-W, Churchill R, Deeks JJ, Hr&#xf3;bjartsson A, Kirkham J, J&#xfc;ni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch&#xfc;nemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https://doi.org/10.1136/bmj.i4919</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId><ArticleId IdType="pmc">5062054</ArticleId></ArticleIdList></Reference><Reference><Citation>Degirmenci T, Bozkurt IH, Celik S, Yarimoglu S, Basmaci I, Sefik E (2019) Does leaving residual fragments after percutaneous nephrolithotomy in patients with positive stone culture and/or renal pelvic urine culture increase the risk of infectious complications? Urolithiasis 47:371&#x2013;375. https://doi.org/10.1007/s00240-018-1063-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-018-1063-9</ArticleId><ArticleId IdType="pubmed">29869167</ArticleId></ArticleIdList></Reference><Reference><Citation>Roushani A, Falahatkar S, Sharifi SHH, Mahfoozi L, Saadat SMS, Allahkhah A, Herfeh NR, Moghaddam KG (2014) Intra-operative stone culture as an independent predictor of systemic inflammatory response syndrome after percutaneous nephrolithotomy. Urolithiasis 42:455&#x2013;459. https://doi.org/10.1007/s00240-014-0688-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-014-0688-6</ArticleId><ArticleId IdType="pubmed">25077454</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsiyakali N, Yucetas U, Karatas A, Karabay E, Okucu E, Erkan E (2020) Renal pelvis urine Gram stain as a traditional, but new marker in predicting postoperative fever and stone culture positivity in percutaneous nephrolithotomy: an observational, prospective, non-randomized cohort study. World J Urol. https://doi.org/10.1007/s00345-020-03381-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-020-03381-y</ArticleId><ArticleId IdType="pubmed">32725306</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman Y, Elshal AM, Elawdy MM, Omar H, Gaber A, Elsawy E, El-Nahas AR (2016) Stone culture retrieved during percutaneous nephrolithotomy: is it clinically relevant? Urolithiasis 44:327&#x2013;332. https://doi.org/10.1007/s00240-016-0858-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-016-0858-9</ArticleId><ArticleId IdType="pubmed">26781741</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvani C, Zanetti SP, Boeri L, Turetti M, Matinato C, Teri A, Bebi C, Malfatto M, Albo G, Piccoli M, Longo F, Montanari E, De Lorenzis E (2023) The clinical role of bacteremia and bacterial spread into the irrigation fluid during percutaneous nephrolithotomy: a prospective study. World J Urol 41:135&#x2013;142. https://doi.org/10.1007/s00345-022-04217-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-022-04217-7</ArticleId><ArticleId IdType="pubmed">36469113</ArticleId></ArticleIdList></Reference><Reference><Citation>Margel D, Ehrlich Y, Brown N, Lask D, Livne PM, Lifshitz DA (2006) Clinical implication of routine stone culture in percutaneous nephrolithotomy - a prospective study. Urology 67:26&#x2013;29. https://doi.org/10.1016/j.urology.2005.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2005.08.008</ArticleId><ArticleId IdType="pubmed">16413326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogan HS, Guliyev F, Cetinkaya YS, Sofikerim M, Ozden E, Sahin A (2007) Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol 39:737&#x2013;742. https://doi.org/10.1007/s11255-006-9147-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-006-9147-9</ArticleId><ArticleId IdType="pubmed">17294290</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh KP, Jain RJ, Parikh AK (2020) Does stone analysis have better predictive value than urine culture and stone culture for predicting systemic inflammatory response syndrome post retrograde intra renal surgery? a single center pilot study. Urol Sci 31:226&#x2013;232. https://doi.org/10.4103/UROS.UROS_46_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/UROS.UROS_46_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida S, Takazawa R, Uchida Y, Kohno Y, Waseda Y, Tsujii T (2019) The significance of intraoperative renal pelvic urine and stone cultures for patients at a high risk of post-ureteroscopy systemic inflammatory response syndrome. Urolithiasis 47:533&#x2013;540. https://doi.org/10.1007/s00240-019-01112-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-019-01112-6</ArticleId><ArticleId IdType="pubmed">30758524</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Liao W, Yang S, Song C, Xiong Y, Meng L (2016) Retrospectively analysis of risk factors for systemic inflammatory response syndrome following retrograde intrarenal stone surgery. Int J Clin Exp Med 9(5):8327</Citation></Reference><Reference><Citation>De Lorenzis E, Boeri L, Gallioli A, Fontana M, Zanetti SP, Longo F, Colombo R, Arghittu M, Piconi S, Albo G, Trinchieri A, Montanari E (2020) Feasibility and relevance of urine culture during stone fragmentation in patients undergoing percutaneous nephrolithotomy and retrograde intrarenal surgery: a prospective study. World J Urol. https://doi.org/10.1007/s00345-020-03387-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-020-03387-6</ArticleId><ArticleId IdType="pubmed">32734462</ArticleId><ArticleId IdType="pmc">8217000</ArticleId></ArticleIdList></Reference><Reference><Citation>Eswara JR, Shariftabrizi A, Sacco D (2013) Positive stone culture is associated with a higher rate of sepsis after endourological procedures. Urolithiasis 41:411&#x2013;414. https://doi.org/10.1007/s00240-013-0581-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-013-0581-8</ArticleId><ArticleId IdType="pubmed">23760449</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevo A, Golomb D, Lifshitz D, Yahav D (2019) Predicting the risk of sepsis and causative organisms following urinary stones removal using urinary versus stone and stent cultures. Eur J Clin Microbiol Infect Dis 38:1313&#x2013;1318. https://doi.org/10.1007/s10096-019-03555-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-019-03555-6</ArticleId><ArticleId IdType="pubmed">30972587</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi M, Takazawa R, Waseda Y, Tsujii T (2021) How does pre-operative antimicrobial treatment influence the intra-operative culture results and infectious complications in patients with positive baseline bladder urine culture undergoing ureteroscopic lithotripsy? Urolithiasis 49:335&#x2013;344. https://doi.org/10.1007/s00240-020-01240-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-020-01240-4</ArticleId><ArticleId IdType="pubmed">33426598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenke P, K&#xf6;ves B, Nagy K, Hultgren SJ, Mendling W, Wullt B, Grabe M, Wagenlehner FME, Cek M, Pickard R, Botto H, Naber KG, Bjerklund Johansen TE (2012) Update on biofilm infections in the urinary tract. World J Urol 30:51&#x2013;57. https://doi.org/10.1007/s00345-011-0689-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-011-0689-9</ArticleId><ArticleId IdType="pubmed">21590469</ArticleId></ArticleIdList></Reference><Reference><Citation>Batura D, Gopal Rao G (2020) A systematic review of the clinical significance of nephrostomy urine cultures. World J Urol 38:45&#x2013;55. https://doi.org/10.1007/s00345-019-02663-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-019-02663-4</ArticleId><ArticleId IdType="pubmed">30734071</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610&#x2013;1614. https://doi.org/10.1097/01.ju.0000154350.78826.96</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ju.0000154350.78826.96</ArticleId><ArticleId IdType="pubmed">15821509</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S, Dube S, Ahmed Khan F, Resident S, Professor A, Professor A, Ahmed Khan F (2023) A comparison of pre-operative bladder urine culture with intra-operative Renal stone culture. Int J Life Sci Biotechnol Pharma Res 12:69</Citation></Reference><Reference><Citation>Korets R, Graversen JA, Kates M, Mues AC, Gupta M (2011) Post-percutaneous nephrolithotomy systemic inflammatory response: a prospective analysis of preoperative urine, renal pelvic urine and stone cultures. J Urol 186:1899&#x2013;1903. https://doi.org/10.1016/j.juro.2011.06.064</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2011.06.064</ArticleId><ArticleId IdType="pubmed">21944106</ArticleId></ArticleIdList></Reference><Reference><Citation>Szlachta-McGinn A, Douglass KM, Chung UYR, Jackson NJ, Nickel JC, Ackerman AL (2022) Molecular diagnostic methods versus conventional urine culture for diagnosis and treatment of urinary tract infection: a systematic review and meta-analysis. Eur Urol Open Sci 44:113&#x2013;124. https://doi.org/10.1016/j.euros.2022.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euros.2022.08.009</ArticleId><ArticleId IdType="pubmed">36093322</ArticleId><ArticleId IdType="pmc">9459428</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent J-L, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801. https://doi.org/10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId><ArticleId IdType="pmc">4968574</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones P, Pietropaolo A, Chew B, Somani B (2021) Atlas of scoring systems, grading tools, and nomograms in endourology: a comprehensive overview from the tower endourological society research group. J Endourol. https://doi.org/10.1089/end.2021.0124</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/end.2021.0124</ArticleId><ArticleId IdType="pubmed">34015234</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietropaolo A, Geraghty RM, Veeratterapillay R, Rogers A, Kallidonis P, Villa L, Boeri L, Montanari E, Atis G, Emiliani E, Sener TE, Jaafari FA, Fitzpatrick J, Shaw M, Harding C, Somani BK (2021) A machine learning predictive model for post-ureteroscopy urosepsis needing intensive care unit admission: a case-control YAU endourology study from nine european centres. J Clin Med. https://doi.org/10.3390/jcm10173888</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173888</ArticleId><ArticleId IdType="pubmed">34501335</ArticleId><ArticleId IdType="pmc">8432042</ArticleId></ArticleIdList></Reference><Reference><Citation>Oduncu AF, K&#x131;yan GS, Yal&#xe7;&#x131;nl&#x131; S (2021) Comparison of qSOFA, SIRS, and NEWS scoring systems for diagnosis, mortality, and morbidity of sepsis in emergency department. Am J Emerg Med 48:54&#x2013;59. https://doi.org/10.1016/j.ajem.2021.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.04.006</ArticleId><ArticleId IdType="pubmed">33839632</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsyouf M, Hur D, Stokes P, Groegler J, Amasyali A, Li A, Thomas S, Hajiha M, Shah M, Baldwin DD (2020) The impact of patient, procedural, and staffing factors upon ureteroscopy cost. J Endourol 34:746&#x2013;751</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/end.2019.0709</ArticleId><ArticleId IdType="pubmed">31964178</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Peng L, Zheng Z, Zhong W (2022) Stone fragmentation urine culture as alternative role of stone culture in endourological urolithiasis management. World J Urol 40:1085&#x2013;1086</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-021-03701-w</ArticleId><ArticleId IdType="pubmed">33899134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzou DT, Stern KL, Duty BD et al (2023) Heterogeneity in stone culture protocols and endourologist practice patterns: a multi-institutional survey. Urolithiasis. https://doi.org/10.1007/s00240-022-01373-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-022-01373-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes T, Ho HC, Pietropaolo A et al (2020) Guidelines of guidelines for kidney and bladder stones. Turkish J Urol 46(1):S104</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/tud.2020.20315</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19417124</PMID><DateCompleted><Year>2009</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0091-2700</ISSN><JournalIssue CitedMedium="Print"><Volume>49</Volume><Issue>7</Issue><PubDate><Year>2009</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of clinical pharmacology</Title><ISOAbbreviation>J Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>758</StartPage><EndPage>767</EndPage><MedlinePgn>758-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0091270009334375</ELocationID><Abstract><AbstractText>This study seeks to measure the treatment effect of glucose-insulin-potassium (GIK) infusion on mortality in critically ill patients. A systematic review of randomized controlled trials is conducted, comparing GIK treatment with standard care or placebo in critically ill adult patients. The primary outcome variable is mortality. Two authors independently extract data and assess study quality. The primary analysis is based on the random effects model to produce pooled odds ratios (ORs) with 95% confidence intervals (CIs). The search yields 1720 potential publications; 23 studies are included in the final analysis, providing a sample of 22,525 patients. The combined results demonstrate no heterogeneity (P=.57, I2=0%) and no effect on mortality (OR=1.02; 95% CI, 0.93-1.11) with GIK treatment. No experimental studies of shock or sepsis populations are identified. This meta-analysis finds that there is no mortality benefit to GIK infusion in critically ill patients; however, study populations are limited to acute myocardial infarction and cardiovascular surgery patients. No studies are identified using GIK in patients with septic shock or other forms of circulatory shock, providing an absence of evidence regarding the effect of GIK as a therapy in patients with shock.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puskarich</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Carolinas Medical Center, PO Box 32861, Charlotte, NC 28232-2861, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Runyon</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Trzeciak</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kline</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Alan E</ForeName><Initials>AE</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 GM076652</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Clin Pharmacol</MedlineTA><NlmUniqueID>0366372</NlmUniqueID><ISSNLinking>0091-2700</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C030396">glucose-insulin-potassium cardioplegic solution</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>RWP5GA015D</RegistryNumber><NameOfSubstance UI="D011188">Potassium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011188" MajorTopicYN="N">Potassium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2010</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19417124</ArticleId><ArticleId IdType="mid">NIHMS221236</ArticleId><ArticleId IdType="pmc">PMC2918881</ArticleId><ArticleId IdType="doi">10.1177/0091270009334375</ArticleId><ArticleId IdType="pii">0091270009334375</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fishleder BL, Frieldand C, De MA, et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction: a preliminary clinical report. Am J Cardiol. 1962;9:166&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">13914751</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">15671428</ArticleId></ArticleIdList></Reference><Reference><Citation>Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152&#x2013;1156.</Citation><ArticleIdList><ArticleId IdType="pubmed">9286943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bothe W, Olschewski M, Beyersdorf F, et al. Glucose-insulin-potassium in cardiac surgery: a meta-analysis. Ann Thorac Surg. 2004;78:1650&#x2013;1657.</Citation><ArticleIdList><ArticleId IdType="pubmed">15511450</ArticleId></ArticleIdList></Reference><Reference><Citation>Law WR, McLane MP, Raymond RM. Effect of insulin on myocardial contractility during canine endotoxin shock. Cardiovasc Res. 1988;22:777&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pubmed">3076843</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond RM, McLane MP, Law WR, et al. Myocardial insulin resistance during acute endotoxin shock in dogs. Diabetes. 1988;37:1684&#x2013;1688.</Citation><ArticleIdList><ArticleId IdType="pubmed">3056762</ArticleId></ArticleIdList></Reference><Reference><Citation>Vary TC, Hazen S, Vary TC, et al. Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol Cell Biochem. 1999;198:113&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">10497885</ArticleId></ArticleIdList></Reference><Reference><Citation>Vary TC. Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate [abstract] Shock. 1996;6:89&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">8856841</ArticleId></ArticleIdList></Reference><Reference><Citation>Vary TC, Siegel JH, Nakatani T, et al. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol. 1986;250:E634&#x2013;E640.</Citation><ArticleIdList><ArticleId IdType="pubmed">3521310</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Neely JR. Effects of increased cardiac work on pyruvate dehydrogenase activity in hearts from diabetic animals. J Mol Cell Cardiol. 1983;15:347&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">6876184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutson NJ, Kerbey AL, Randle PJ, et al. Regulation of pyruvate dehydrogenase by insulin action. Prog Clin Biol Res. 1979;31:707&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pubmed">231784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Thota V, Dee L, et al. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996;183:949&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192364</ArticleId><ArticleId IdType="pubmed">8642298</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 4.2.6. Chichester, UK: Wiley; 2006.</Citation></Reference><Reference><Citation>Schipke JD, Friebe R, Gams E. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials. Eur J Cardiothorac Surg. 2006;29:479&#x2013;485.</Citation><ArticleIdList><ArticleId IdType="pubmed">16481185</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004;164:2005&#x2013;2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">15477435</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter JE, Schmidt FL. Fixed effects vs random effects meta-analysis models: implications for cumulative research knowledge. International Journal of Selection and Assessment. 2000;8:275&#x2013;292.</Citation></Reference><Reference><Citation>Terrin N, Schmid CH, Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol. 2005;58:894&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">16085192</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JL, Liu JL. Misleading funnel plot for detection of bias in meta-analysis. J Clin Epidemiol. 2000;53:477&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">10812319</ArticleId></ArticleIdList></Reference><Reference><Citation>Pentecost BL, Mayne NM, Lamb P. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet. 1968;1:946&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pubmed">4171584</ArticleId></ArticleIdList></Reference><Reference><Citation>Rackley CE, Rogers WJ, McDaniel HG, et al. Randomized study of glucose insulin potassium in patients with acute myocardial infarction [abstract] Clin Res. 1976;24:421A.</Citation></Reference><Reference><Citation>Stanley AWH, Jr, Prather JW. Glucose-insulin-potassium, patient mortality and the acute myocardial infarction: results from a prospective randomized study [abstract] Circulation. 1978;58(Supp 4 II):II&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Thys JP. The value of the polarizing treatment in myocardial infarction. Acta Cardiol. 1974;29:19&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">4544476</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle JA, Rogers WJ, Smith LR, et al. Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: results from a randomized clinical trial. Am Heart J. 1981;102:313&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">7023215</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J, McDaniel HG, Mantle JA, et al. Glucose-insulin-potassium infusion in acute myocardial infarction-results of a prospective randomized study [abstract] Clin Res. 1982;30:216A.</Citation></Reference><Reference><Citation>Oldfield GS, Commerford PJ, Opie LH. Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement. J Thoracic Cardiovas Surg. 1986;91:874&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pubmed">3520160</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman GM, Gradinac S, Taegtmeyer H, et al. Efficacy of metabolic support with glucose-insulin-potassium for left ventricular pump failure after aortocoronary bypass surgery. Circulation. 1989;80:I91&#x2013;I96.</Citation><ArticleIdList><ArticleId IdType="pubmed">2670331</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar HL, Philippides G, Fitzgerald C, et al. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thoracic Cardiovas Surg. 1997;113:354&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">9040630</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar HL, Chipkin S, Philippides G, et al. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">10921699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497&#x2013;1502.</Citation><ArticleIdList><ArticleId IdType="pubmed">15006999</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkoz A, Toprak HI, Sari S, et al. Glucose-insulin-potassium solution before cardiopulmonary bypass in coronary artery surgery. Turk Anest Rean Cem Mecnuiasi. 2000;28:361&#x2013;365.</Citation></Reference><Reference><Citation>Lindholm L, Bengtsson A, Hansdottir V, et al. Insulin (GIK) improves central mixed and hepatic venous oxygenation in clinical cardiac surgery. Scand Cardiovasc. 2001;35:347&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">11771827</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A, Grattan A, Harper M, et al. Coronary revascularization: a procedure in transition from on-pump to off-pump? The role of glucose-insulin-potassium revisited in a randomized, placebo-controlled study. J Cardiothorac Vasc Anesth. 2002;16:413&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">12154417</ArticleId></ArticleIdList></Reference><Reference><Citation>Lell WA, Nielsen VG, McGiffin DC, et al. Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg. 2002;73:1246&#x2013;1251.</Citation><ArticleIdList><ArticleId IdType="pubmed">11998815</ArticleId></ArticleIdList></Reference><Reference><Citation>Pache J, Kastrati A, Mehilli J, et al. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J. 2004;148:e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">15215812</ArticleId></ArticleIdList></Reference><Reference><Citation>Krljanac G, Vasiljevic Z, Radovanovic M, et al. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy. Am J Cardiol. 2005;96:1053&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pubmed">16214437</ArticleId></ArticleIdList></Reference><Reference><Citation>Koskenkari JK, Kaukoranta PK, Kiviluoma KT, et al. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery. Ann Thorac Surg. 2005;80:511&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">16039195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranasinghe AM, Quinn DW, Pagano D, et al. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation. 2006;114:I245&#x2013;I250.</Citation><ArticleIdList><ArticleId IdType="pubmed">16820580</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn DW, Pagano D, Bonser RS, et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg. 2006;131:34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">16399292</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanhui L, Zhang L, Zhang H, et al. The effects of high concentration glucose-insulin-potassium (GIK) on the hemodynamics of patients with acute myocardial infarction. Chin J Emerg Med. 2006;15:152&#x2013;155.</Citation></Reference><Reference><Citation>Zuurbier CJ, Hoek FJ, van DJ, et al. Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery. Br J Anaesth. 2008;100:442&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">18305079</ArticleId></ArticleIdList></Reference><Reference><Citation>Clowes GH., Jr Energy metabolism in sepsis: treatment based on different patterns in shock and high output stage. Ann Surg. 1974;179:684&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1356054</ArticleId><ArticleId IdType="pubmed">4823845</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisul JP, O&#x2019;Donnell TF, Jr, Stone MA, et al. Myocardial performance in clinical septic shock: effects of isoproterenol and glucose potassium insulin. J Surg Res. 1975;18:357&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">1095826</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J-L, Dufaye P, Berre J, et al. Infusion of glucose and insulin in circulatory shock. Crit Care Med. 1981;9:209.</Citation></Reference><Reference><Citation>Bronsveld W, van den Bos G. Use of glucose-insulin-potassium (GIK) in human septic shock. Crit Care Med. 1985;13:566&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">3891230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauritz W, Schindler I, Zadrobilek E, et al. Glucose-potassium-insulin in hypodynamic septic shock. Anaesthesist. 1986;35:623&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">3538938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdulay SS, Al-Khafaji A, Montgomery H. Glucose-insulin and potassium infusions in septic shock. Chest. 2006;129:800&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">16537885</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer LT, Beller BK, Drake JK, et al. Reversal of myocardial dysfunction in endotoxin shock with insulin. Can J Physiol Pharmacol. 1978;56:132&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">346182</ArticleId></ArticleIdList></Reference><Reference><Citation>Manny J, Rabinovici N, Manny N, et al. Effect of glucose-insulin-potassium on survival in experimental endotoxic shock. Surg Gynecol Obstet. 1978;147:405&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">684594</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronsveld W, van Lambalgen AA, van den Bos GC, et al. Ventricular function, hemodynamics, and oxygen consumption during infusions of blood and glucose-insulin-potassium (GIK) in canine endotoxin shock. Circ Shock. 1982;9:145&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">7044599</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuynman HA, Thijs LG, Straub JP, et al. Effects of glucose-insulin-potassium (GIK) on the position of the oxyhemoglobin dissociation curve, 2.3-diphosphoglycerate, and oxygen consumption in canine endotoxin shock. J Surg Res. 1983;34:246&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">6339816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronsveld W, van Lambalgen AA, van den Bos GC, et al. Effects of glucose-insulin-potassium (GIK) on myocardial blood flow and metabolism in canine endotoxin shock. Circ Shock. 1984;13:325&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">6383652</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1810543</ArticleId><ArticleId IdType="pubmed">17302989</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28607338</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1596</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Minerva anestesiologica</Title><ISOAbbreviation>Minerva Anestesiol</ISOAbbreviation></Journal><ArticleTitle>Blood purification with continuous veno-venous hemofiltration in patients with sepsis or ARDS: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>867</StartPage><EndPage>877</EndPage><MedlinePgn>867-877</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0375-9393.17.11946-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Severe inflammatory conditions, as severe sepsis/septic shock and acute respiratory distress syndrome (ARDS), are related to high morbidity and mortality. We performed a meta-analysis of randomized trials to assess if blood purification with continuous veno-venous hemofiltration (CVVH) reduces mortality in these settings.</AbstractText><AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">Online databases were searched for pertinent studies up to March 2017. We included randomized-controlled trials on the use of CVVH as blood purification technique in comparison to conventional therapy in adult patients with severe sepsis/septic shock or ARDS but no acute kidney injury needing renal replacement therapy.</AbstractText><AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">Eleven studies and 679 patients were included in the analysis. Patients who received CVVH had significantly lower mortality compared to conventional therapy (96 of 351 [27.35%] patients in the CVVH group vs. 129 of 328 [39.33%] in the conventional therapy group, OR=0.58 [95% CI: 0.42, 0.81], P=0.002, I2=10%, number needed to treat: 8) at longest follow-up available.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Overall, low-quality evidence indicates that blood purification with CVVH might be associated with a significant reduction in mortality when performed in patients with sepsis or ARDS. The evidence is still insufficient to support a definitive conclusion of benefit. Further high-quality randomized controlled trials, adequately powered for mortality, are needed to clarify the impact of CVVH on these conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino Foundation, Lugano, Switzerland - alessandroputzu@ymail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Ming-Xing</ForeName><Initials>MX</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Third Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boscolo Berto</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino Foundation, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrini</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassina</LastName><ForeName>Tiziano</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino Foundation, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Anestesiol</MedlineTA><NlmUniqueID>0375272</NlmUniqueID><ISSNLinking>0375-9393</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006440" MajorTopicYN="N">Hemofiltration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014680" MajorTopicYN="N">Veins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28607338</ArticleId><ArticleId IdType="doi">10.23736/S0375-9393.17.11946-2</ArticleId><ArticleId IdType="pii">S0375-9393.17.11946-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34303572</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1409</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Burns : journal of the International Society for Burn Injuries</Title><ISOAbbreviation>Burns</ISOAbbreviation></Journal><ArticleTitle>Systematic review of excision and grafting in burns: Comparing outcomes of early and late surgery in low and high-income countries.</ArticleTitle><Pagination><StartPage>1705</StartPage><EndPage>1713</EndPage><MedlinePgn>1705-1713</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.burns.2021.07.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0305-4179(21)00170-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION">While the benefits of early excision in burn surgery are clear, the advantages may be lost in low income countries with limited resources. It is important to identify the right timing of excision in different groups of patients, particularly those in low-income countries (LIC), as the burden of disease contributes to the highest global mortality and has the least resources. This systematic review and meta-analysis aims to determine the timing of excision in LICs and the outcomes associated with surgery: (1) mortality, (2) sepsis and (3) length of stay (LOS) compared to high income countries (HICs).</AbstractText><AbstractText Label="METHODOLOGY">The PRISMA guidelines and MOOSE checklist were followed for this review. Publications in English from year 1990 to 2017 that included data on the timing and type of burn surgery and outcomes were included. Searches were done using Web of Science, Cochrane collaboration and Pubmed using keywords "Burn and surgery", "Burn and excision", "Burn and excision and grafting" and "burn and skin grafting". Trial quality was evaluated using the Newcastle-Ottawa scale. Outcomes compared for early and late excisions were length of stay (LOS), sepsis and mortality between LICs and HICs.</AbstractText><AbstractText Label="RESULTS">From 278 citations, we selected 41 for full text evaluation, and identified 16 eligible trials. LOS is shorter in early excision compared to late excision in both LICs and HICs. Mortality is lower in late excision compared to early excision in both LICs and HICs. Further subgroup analysis of elderly patients in HICs confirmed that mortality is lower in late excision and unchanged if the elderly are excluded. Early excision reduces sepsis in both LIC and HIC.</AbstractText><AbstractText Label="DISCUSSION">The variable definitions of age, timing of excision, variable nature of % TBSA comparison, mixed inclusion of inhalation injury, co-morbidities and unquantified access to resources make the data difficult to interpret and it is not possible to draw accurate conclusions on the role of early excision for burns in low-middle income countries. A prospective study is needed in order to answer this question.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd and ISBI. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Lingwei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Trauma Sciences, Queen Mary University of London, Mile End Rd, Bethnal Green, London E1 4NS, United Kingdom. Electronic address: lingwei.borissov@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajandram</LastName><ForeName>Retnagowri</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia. Electronic address: retnagowri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allorto</LastName><ForeName>Nikki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Surgery, Pietermaritzburg Metropolitan Complex, University of Kwa-zulu Natal, South Africa. Electronic address: nikkiallorto@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Burns</MedlineTA><NlmUniqueID>8913178</NlmUniqueID><ISSNLinking>0305-4179</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="Y">Burns</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019049" MajorTopicYN="N">Developed Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058028" MajorTopicYN="N">Research Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016038" MajorTopicYN="N">Skin Transplantation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Burns</Keyword><Keyword MajorTopicYN="N">Early excision</Keyword><Keyword MajorTopicYN="N">High-income countries</Keyword><Keyword MajorTopicYN="N">Late excision</Keyword><Keyword MajorTopicYN="N">Low-income countries</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>25</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34303572</ArticleId><ArticleId IdType="doi">10.1016/j.burns.2021.07.001</ArticleId><ArticleId IdType="pii">S0305-4179(21)00170-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30324278</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1970-9366</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Internal and emergency medicine</Title><ISOAbbreviation>Intern Emerg Med</ISOAbbreviation></Journal><ArticleTitle>SIRS or qSOFA? Is that the question? Clinical and methodological observations from a meta-analysis and critical review on the prognostication of patients with suspected sepsis outside the ICU.</ArticleTitle><Pagination><StartPage>593</StartPage><EndPage>602</EndPage><MedlinePgn>593-602</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11739-018-1965-0</ELocationID><Abstract><AbstractText>The purpose of the study was to assess the prognostic performances, in terms of in-hospital mortality, of the quick sequential organ failure assessment (qSOFA) score and the systemic inflammatory response syndrome (SIRS) criteria applied to patients with suspected infection outside the ICU, and to critically reappraise the results and the clinical impact of the SEPSIS-3 study and of the subsequent trials. We performed bivariate meta-analysis, evaluation of the Bayesian post-test probabilities of death, and computation of the unidentified deaths for every 1000 screened cases (UDS<sub>1000</sub>). The use of qSOFA for screening instead of the SIRS implies a relevant increase in the UDS<sub>1000</sub>. However, this difference appears far smaller in the SEPSIS-3 study, largely due to an underestimation of SIRS sensitivity. The increment in the pre-test probability of death implied by a positive qSOFA is higher than that implied by a positivity of the SIRS. However, the included studies use highly variable definitions of "suspected sepsis" and carry very high levels of heterogeneity. SIRS overperforms qSOFA as a rule-out tool for mortality, while qSOFA shows a higher rule-in power. However, the evident lack of consistency across the published studies undermines the significance of both the meta-analytic approach and the reproducibility of the outcomes, and demands for a standardized definition of the target population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Franchini</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Department, Ospedale San Raffaele Scientific Institute, Pronto Soccorso, Via Olgettina 60, 20132, Milan, Italy. franchini.stefano@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarallo</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlucci</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Department, Ospedale San Raffaele Scientific Institute, Pronto Soccorso, Via Olgettina 60, 20132, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General and Emergency Surgery, Ospedale San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrini</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Ospedale San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tresoldi</LastName><ForeName>Moreno</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of General Medicine and Advanced Care, Ospedale San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Intern Emerg Med</MedlineTA><NlmUniqueID>101263418</NlmUniqueID><ISSNLinking>1828-0447</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Intern Emerg Med. 2019 Jun;14(4):591-592. doi: 10.1007/s11739-019-02091-7.</RefSource><PMID Version="1">31073828</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="Y">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SIRS</Keyword><Keyword MajorTopicYN="N">Sepsis prognosis</Keyword><Keyword MajorTopicYN="N">Sepsis screening</Keyword><Keyword MajorTopicYN="N">qSOFA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30324278</ArticleId><ArticleId IdType="doi">10.1007/s11739-018-1965-0</ArticleId><ArticleId IdType="pii">10.1007/s11739-018-1965-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2361-2369</Citation><ArticleIdList><ArticleId IdType="pubmed">28755060</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2017 Jan 17;317(3):290-300</Citation><ArticleIdList><ArticleId IdType="pubmed">28114553</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2006 Apr 1;163(7):670-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16410346</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2017 Apr 1;195(7):906-911</Citation><ArticleIdList><ArticleId IdType="pubmed">27649072</ArticleId></ArticleIdList></Reference><Reference><Citation>Intern Emerg Med. 2006;1(3):219-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17120470</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2003 Apr;29(4):530-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerebrovasc Dis. 2013;36(4):267-72</Citation><ArticleIdList><ArticleId IdType="pubmed">24135733</ArticleId></ArticleIdList></Reference><Reference><Citation>EJIFCC. 2009 Jan 20;19(4):203-11</Citation><ArticleIdList><ArticleId IdType="pubmed">27683318</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2017 Nov;45(11):1813-1819</Citation><ArticleIdList><ArticleId IdType="pubmed">28759474</ArticleId></ArticleIdList></Reference><Reference><Citation>Intern Emerg Med. 2018 Apr;13(3):405-412</Citation><ArticleIdList><ArticleId IdType="pubmed">28188577</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2014 Jul 2;312(1):90-2</Citation><ArticleIdList><ArticleId IdType="pubmed">24838355</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2016 May;149(5):1117-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26927525</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Radiol. 2015 Apr;25(4):932-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25599932</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2006 Jul 12;6:31</Citation><ArticleIdList><ArticleId IdType="pubmed">16836745</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2016 Dec;42(12):2024-2026</Citation><ArticleIdList><ArticleId IdType="pubmed">27815588</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crit Care. 2017 Apr;38:259-262</Citation><ArticleIdList><ArticleId IdType="pubmed">28011419</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2017 Mar 26;21(1):73</Citation><ArticleIdList><ArticleId IdType="pubmed">28342442</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2017 Jan 17;317(3):301-308</Citation><ArticleIdList><ArticleId IdType="pubmed">28114554</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Dis. 2016 Aug;8(8):E816-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27618927</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Dis. 2017 Apr;9(4):943-945</Citation><ArticleIdList><ArticleId IdType="pubmed">28523143</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Feb 23;315(8):775-87</Citation><ArticleIdList><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 2018 Feb;73(2):195-204</Citation><ArticleIdList><ArticleId IdType="pubmed">29150856</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2017 Nov 15;196(10):1287-1297</Citation><ArticleIdList><ArticleId IdType="pubmed">28613918</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2018 Feb 6;22(1):28</Citation><ArticleIdList><ArticleId IdType="pubmed">29409518</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2009 Oct;62(10):e1-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2000 Apr 19;283(15):2008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2006 Jun;34(6):1589-96</Citation><ArticleIdList><ArticleId IdType="pubmed">16625125</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Trauma Resusc Emerg Med. 2017 Jun 9;25(1):56</Citation><ArticleIdList><ArticleId IdType="pubmed">28599661</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2018 Mar;153(3):646-655</Citation><ArticleIdList><ArticleId IdType="pubmed">29289687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2018 Feb 20;168(4):266-275</Citation><ArticleIdList><ArticleId IdType="pubmed">29404582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 2017 Oct;70(4):544-552.e5</Citation><ArticleIdList><ArticleId IdType="pubmed">28262318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2017 Mar;151(3):586-596</Citation><ArticleIdList><ArticleId IdType="pubmed">27876592</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Feb 23;315(8):762-74</Citation><ArticleIdList><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2017 Nov;45(11):1805-1812</Citation><ArticleIdList><ArticleId IdType="pubmed">28737573</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72</Citation><ArticleIdList><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Acad Emerg Med. 2013 Jun;20(6):597-604</Citation><ArticleIdList><ArticleId IdType="pubmed">23758307</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2016 Jul 17;20(1):210</Citation><ArticleIdList><ArticleId IdType="pubmed">27423462</ArticleId></ArticleIdList></Reference><Reference><Citation>J Emerg Med. 2017 May;52(5):622-631</Citation><ArticleIdList><ArticleId IdType="pubmed">27823893</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34772325</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2374-4243</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Infectious diseases (London, England)</Title><ISOAbbreviation>Infect Dis (Lond)</ISOAbbreviation></Journal><ArticleTitle>Short- versus prolonged-course antibiotic therapy for sepsis or infectious diseases in critically ill adults: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>213</StartPage><EndPage>223</EndPage><MedlinePgn>213-223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/23744235.2021.2001046</ELocationID><Abstract><AbstractText Label="BACKGROUND">The 2016 International Guidelines for the Management of Sepsis and Septic Shock recommend antibiotic therapy for 7-10&#xa0;days for most patients with sepsis. However, evidence on critically ill patients is limited. Thus, we conducted the first systematic review and meta-analysis comparing the effectiveness and adverse events of shorter- (&#x2264;1&#xa0;week) with longer-course antibiotics in adults with critical infections including sepsis.</AbstractText><AbstractText Label="METHODS">We searched the MEDLINE, Cochrane Central Register of Controlled Trials, and Igaku Chuo Zasshi databases for randomised controlled trials (RCTs) and observational studies (OSs) from inception to 31 March 2021.</AbstractText><AbstractText Label="RESULTS">We included 6 of 3,766 identified articles, incorporating data from 4 RCTs and 2 OSs (1,721 patients) in meta-analyses. Three RCTs and one OS focussed on ventilator-associated pneumonia, and one RCT and one OS investigated intra-abdominal infections. The severity score levels were similar to that of sepsis, but no study comprehensively focussing on sepsis was found. There were no significant differences in mortality at a maximum follow-up of 30&#xa0;days (RR 1.08, 95%CI 0.80-1.46); 28-day mortality, clinical cure, the occurrence of new events, and the emergence of resistant organisms between the groups in the RCTs. The OSs findings were consistent. The quality of evidence was assessed as very low to moderate using the GRADE approach, with no uniform description of severity scores, sepsis, or adverse events.</AbstractText><AbstractText Label="CONCLUSIONS">Shorter, fixed-duration antibiotic therapy for clinically heterogeneous sepsis or severe infections was not associated with poorer outcomes, but the overall quality of evidence was poor.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3765-736X</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine and Department of Infectious Diseases, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Juntendo University Urayasu Hospital, Urayasu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshimura</LastName><ForeName>Jumpei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kikutani</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shime</LastName><ForeName>Nobuaki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Infect Dis (Lond)</MedlineTA><NlmUniqueID>101650235</NlmUniqueID><ISSNLinking>2374-4243</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="Y">Communicable Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053717" MajorTopicYN="Y">Pneumonia, Ventilator-Associated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">fixed duration antibiotic therapy</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">severity</Keyword><Keyword MajorTopicYN="N">short-course</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>13</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34772325</ArticleId><ArticleId IdType="doi">10.1080/23744235.2021.2001046</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27688630</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0972-5229</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine</Title><ISOAbbreviation>Indian J Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Systematic review of statins in sepsis: There is no evidence of dose response.</ArticleTitle><Pagination><StartPage>534</StartPage><EndPage>541</EndPage><MedlinePgn>534-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/0972-5229.190366</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Sepsis is a common cause of morbidity and mortality and is associated with significant costs to the healthcare organizations. We performed a systematic review and meta-analysis to assess whether high or low-dose statin therapy improved mortality in patients with sepsis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The trials analyzed in this study were multicenter or single center randomized control studies using statins for sepsis in a hospital setting. The patients included were adults with suspected or confirmed infection.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">This study found eight randomized controlled trials where participants were given either a statin or placebo daily for 14-28 days, the duration of their illness, or until their death or discharge, which ever occurred first.</AbstractText><AbstractText Label="PRIMARY AND SECONDARY OUTCOMES MEASURED" NlmCategory="UNASSIGNED">This meta-analysis measured the effect of statin therapy on in hospital and 28 days mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In unselected patients, there was no demonstrable difference in the 28 days mortality (relative risk [RR] 0.88 95% confidence interval [CI], 0.70-1.12 and P = 0.16). There was also no significant difference between statin versus placebo for in-hospital mortality (RR 0.98 95% CI, 0.85-1.14 P = 0.36). When the studies where divided into low-dose and high-dose groups, there were no statistically significant differences for in-hospital mortality between low-dose statin versus placebo for (RR 0.81 CI 0.44-1.49 P = 0.27) or high-dose statin versus placebo (RR 0.99 95% CI 0.85-1.16, P = 0.28). There was no significant difference in adverse effects between the high- and low-dose groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this meta-analysis, we found that the use of statins did not significantly improve either in-hospital mortality or 28-day mortality in patients with sepsis. In the low-dose group, there were fewer quality multicenter studies; hence, conclusions based on the results of this subgroup are limited.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moody</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tunnicliffe</LastName><ForeName>Bill</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Zahid</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manji</LastName><ForeName>Mav</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudibande</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitehouse</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snelson</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veenith</LastName><ForeName>Tonny</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK; Division of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK; School of Immunity and Infection, University of Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Crit Care Med</MedlineTA><NlmUniqueID>101208863</NlmUniqueID><ISSNLinking>0972-5229</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">High dose</Keyword><Keyword MajorTopicYN="N">low dose</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">statin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27688630</ArticleId><ArticleId IdType="pmc">PMC5027747</ArticleId><ArticleId IdType="doi">10.4103/0972-5229.190366</ArticleId><ArticleId IdType="pii">IJCCM-20-534</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006;34:344&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">16424713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A. Inpatient care for septicemia or sepsis: A challenge for patients and hospitals. NCHS Data Brief. 2011;62:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22142805</ArticleId></ArticleIdList></Reference><Reference><Citation>Torio CM, Andrews RM. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. 2006.  [Last cited on 2016 Jul 24].  Available from: http://www.ncbi.nlm.nih.gov/pubmed/24199255 .</Citation><ArticleIdList><ArticleId IdType="pubmed">24199255</ArticleId></ArticleIdList></Reference><Reference><Citation>Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins: Panacea for sepsis? Lancet Infect Dis. 2006;6:242&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16554249</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2694580</ArticleId><ArticleId IdType="pubmed">15822172</ArticleId></ArticleIdList></Reference><Reference><Citation>Merx MW, Liehn EA, Graf J, van de Sandt A, Schaltenbrand M, Schrader J, et al. Statin treatment after onset of sepsis in a murine model improves survival. Circulation. 2005;112:117&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">15998696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med. 2006;32:75&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16283159</ArticleId></ArticleIdList></Reference><Reference><Citation>Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: Multiple modifications at multiple levels. Lancet Infect Dis. 2007;7:358&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">17448939</ArticleId></ArticleIdList></Reference><Reference><Citation>Drage SM, Barber VS, Young JD. Statins and sepsis: Panacea or pandora's box? Lancet Infect Dis. 2007;7:80.</Citation><ArticleIdList><ArticleId IdType="pubmed">17251076</ArticleId></ArticleIdList></Reference><Reference><Citation>De Loecker I, Preiser JC. Statins in the critically ill. Ann Intensive Care. 2012;2:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3488539</ArticleId><ArticleId IdType="pubmed">22709377</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwood J, Mason JC. Statins and the vascular endothelial inflammatory response. Trends Immunol. 2007;28:88&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839264</ArticleId><ArticleId IdType="pubmed">17197237</ArticleId></ArticleIdList></Reference><Reference><Citation>Papazian L, Roch A, Charles PE, Penot-Ragon C, Perrin G, Roulier P, et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: A randomized clinical trial. JAMA. 2013;310:1692&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108510</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart TN. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370:2191&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4241052</ArticleId><ArticleId IdType="pubmed">24835849</ArticleId></ArticleIdList></Reference><Reference><Citation>Review Manager (RevMan) [Computer Program] Copenhagen: The Nordic Cochrane Centre; 2014. The Cochrane Collaboration.</Citation></Reference><Reference><Citation>Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] The Cochrane Collaboration. 2011.  [Last accessed on 2016 Sep 07].  Available from http://handbook.cochrane.org .</Citation></Reference><Reference><Citation>Hsu I, Spinler SA, Johnson NE. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Ann Pharmacother. 1995;29:743&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">8520093</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial) Am J Cardiol. 2003;92:152&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">12860216</ArticleId></ArticleIdList></Reference><Reference><Citation>Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, et al. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: A randomized double-blind placebo controlled clinical trial. Intensive Care Med. 2009;35:1255&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">19205663</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JM, Snaith C, Thickett DR, Linhartova L, Melody T, Hawkey P, et al. Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial) Crit Care. 2012;16:R231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672620</ArticleId><ArticleId IdType="pubmed">23232151</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford RH, Shear CL, Chremos AN, Dujovne C, Downton M, Franklin FA, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch Intern Med. 1991;151:43&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1985608</ArticleId></ArticleIdList></Reference><Reference><Citation>Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">11961152</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer JA. Learning from the cerivastatin experience. Lancet. 2001;358:1383&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11705478</ArticleId></ArticleIdList></Reference><Reference><Citation>McAuley DF, Laffey JG, O'Kane CM, Perkins GD, Mullan B, Trinder TJ, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med. 2014;371:1695&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">25268516</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande A, Pasupuleti V, Rothberg MB. Statin therapy and mortality from sepsis: A meta-analysis of randomized trials. Am J Med. 2015;128:410&#x2013;7.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">25526798</ArticleId></ArticleIdList></Reference><Reference><Citation>Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004;110:880&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15289367</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhas BB, Ashmi H, Bhat BV. Sepsis genomics: Stepping forward toward sepsis prevention.? Int J Adv Med Health Res. 2014;1:8&#x2013;15.</Citation></Reference><Reference><Citation>Kruger PS, Harward ML, Jones MA, Joyce CJ, Kostner KM, Roberts MS, et al. Continuation of statin therapy in patients with presumed infection: A randomized controlled trial. Am J Respir Crit Care Med. 2011;183:774&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">20959555</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger P, Bailey M, Bellomo R, Cooper DJ, Harward M, Higgins A, et al. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis. Am J Respir Crit Care Med. 2013;187:743&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23348980</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O'Kane CM, Elborn JS, et al. A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study) Am J Respir Crit Care Med. 2011;183:620&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20870757</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32237269</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1618</StartPage><EndPage>1625</EndPage><MedlinePgn>1618-1625</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.14812</ELocationID><Abstract><AbstractText Label="BACKGROUND">The efficacy and safety of recombinant human soluble thrombomodulin (rhsTM) have not been definitively proven. The effects may depend on the presence of sepsis-associated coagulopathy (SAC).</AbstractText><AbstractText Label="OBJECTIVES">The aim of this systematic review and meta-analysis was to evaluate the efficacy and safety of rhsTM in patients with SAC defined by high international normalized ratio and low platelet count.</AbstractText><AbstractText Label="PATIENTS/METHODS">EMBASE, MEDLINE, CENTRAL, and clinicaltrial.gov were searched for randomized controlled trials (RCTs) comparing rhsTM with placebo or no treatment in patients with sepsis. The efficacy outcome was 28-day mortality, and the safety outcome was major bleeding.</AbstractText><AbstractText Label="RESULTS">We included 3 RCTs with a total of 1633 patients. Twenty-eight-day mortality was higher in patients with SAC compared with those without SAC (risk ratio [RR] 1.32; 95% confidence intervals [CI], 1.06-1.64). rhsTM was associated with significantly lower 28-day mortality compared with placebo or no treatment in patients with SAC (RR 0.80; 95% CI, 0.65-0.98), but not in those without SAC (RR 1.17; 95% CI, 0.82-1.67) nor in the whole study population (RR 0.88; 95% CI, 0.74-1.04). There was no significant difference in major bleeding between rhsTM and controls in the whole population (RR 1.25; 95% CI, 0.80-1.96), patients with SAC (RR 0.94; 95% CI, 0.45-1.95), and those without SAC (RR 2.26; 95% CI, 0.95-5.35).</AbstractText><AbstractText Label="CONCLUSIONS">In patients with sepsis, SAC is associated with higher 28-day mortality. The administration of rhsTM reduced 28-day mortality in patients with SAC, but not in those without SAC.</AbstractText><CopyrightInformation>&#xa9; 2020 International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valeriani</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9729-3214</Identifier><AffiliationInfo><Affiliation>Department of Medical, Oral and Biotechnological Sciences, "G. D'Annunzio" University, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squizzato</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Research Centre on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese and Como, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Research Centre on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese and Como, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porreca</LastName><ForeName>Ettore</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical, Oral and Biotechnological Sciences, "G. D'Annunzio" University, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jean-Louis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erasme Hospital, Universit&#xe9; Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iba</LastName><ForeName>Toshiaki</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-0255-4088</Identifier><AffiliationInfo><Affiliation>Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiwara</LastName><ForeName>Akiyoshi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine and Critical Care, National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Nisio</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5930-7304</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Ageing Sciences, "G. D'Annunzio" University, Chieti-Pescara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018180">Thrombomodulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001778" MajorTopicYN="Y">Blood Coagulation Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019934" MajorTopicYN="N">International Normalized Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018180" MajorTopicYN="N">Thrombomodulin</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ART123</Keyword><Keyword MajorTopicYN="N">blood coagulation disorders</Keyword><Keyword MajorTopicYN="N">critically ill</Keyword><Keyword MajorTopicYN="N">disseminated intravascular coagulation</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32237269</ArticleId><ArticleId IdType="doi">10.1111/jth.14812</ArticleId><ArticleId IdType="pii">S1538-7836(22)01328-9</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801-810.</Citation></Reference><Reference><Citation>Fleischmann C, Scherag A, Adhikari NK, et al. International forum of acute care trialists. assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259-272.</Citation></Reference><Reference><Citation>Seymour CW, Kennedy JN, Wang S, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019;321(20):2003.</Citation></Reference><Reference><Citation>Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38-44.</Citation></Reference><Reference><Citation>Lyons PG, Micek ST, Hampton N, Kollef MH. Sepsis-associated coagulopathy severity predicts hospital mortality. Crit Care Med. 2018;46:736-742.</Citation></Reference><Reference><Citation>Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7:e017046.</Citation></Reference><Reference><Citation>Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2016;14:518-530.</Citation></Reference><Reference><Citation>Mohri M, Sugimoto E, Sata M, Asano T. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation-a comparison with other anticoagulants. Thromb Haemost. 1999;82:1687-1693.</Citation></Reference><Reference><Citation>Morser J. Thrombomodulin links coagulation to inflammation and immunity. Curr Drug Targets. 2012;13:421-431.</Citation></Reference><Reference><Citation>Aikawa N, Shimazaki S, Yamamoto Y, et al. Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial. Shock. 2011;35:349-354.</Citation></Reference><Reference><Citation>Ushizawa H, Isotani E, Takahashi H, Sera T, Otomo Y. Randomized controlled trial of novel recombinant human soluble thrombomodulin (RTM) for sepsis with disseminated intravascular coagulation patients in Japan. Intensive Care Med. 2012;S293-S294.</Citation></Reference><Reference><Citation>Vincent JL, Ramesh MK, Ernest D, et al. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med. 2013;41:2069-2079.</Citation></Reference><Reference><Citation>Hagiwara A, Tanaka N, Uemura T, Matsuda W, Kimura A. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial. BMJ Open. 2016;6:e012850.</Citation></Reference><Reference><Citation>Vincent JL, Francois B, Zabolotskikh I, et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the scarlet randomized clinical trial. JAMA. 2019;321:1993-2002.</Citation></Reference><Reference><Citation>Mori S, Ai T, Sera T, Ochiai K, Human OY. Soluble Recombinant Thrombomodulin, ART-123, Resolved Early Phase Coagulopathies, but Did Not Significantly Alter the 28 Day Outcome in the Treatment of DIC Associated with Infectious Systemic Inflammatory Response Syndromes. J Clin Med. 2019;8(10):1553.</Citation></Reference><Reference><Citation>Yamakawa K, Murao S, Aihara M. Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis. Thromb Haemost. 2019;119:56-65.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.</Citation></Reference><Reference><Citation>Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions version 520, 2017.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.</Citation></Reference><Reference><Citation>Sweeney TE, Azad TD, Donato M, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018;46:915-925.</Citation></Reference><Reference><Citation>Zhang Z, Zhang G, Goyal H, Mo L, Hong Y. Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysis. Crit Care. 2018;22:347.</Citation></Reference><Reference><Citation>L&#xe1;szl&#xf3; I, Tr&#xe1;sy D, Moln&#xe1;r Z, Fazakas J. Sepsis: from pathophysiology to individualized patient care. J Immunol Res. 2015;2015:510436.</Citation></Reference><Reference><Citation>Wiedermann CJ. Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited. J Thromb Haemost. 2018;16:455-457.</Citation></Reference><Reference><Citation>Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost. 2015;13:31-40.</Citation></Reference><Reference><Citation>Ogura T, Eguchi T, Amano M, et al. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis. Thromb Res. 2019;176:74-78.</Citation></Reference><Reference><Citation>Okuda A, Ogura T, Imanishi M, Miyano A, Nishioka N, Higuchi K. Clinical impact of recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholangitis. Gut Liv. 2018;12:471-477.</Citation></Reference><Reference><Citation>Suetani K, Okuse C, Nakahara K, et al. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation. World J Gastroenterol. 2015;21:533-540.</Citation></Reference><Reference><Citation>Eguchi Y, Gando S, Ishikura H, et al. Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation. J Intensive Care. 2014;2:30.</Citation></Reference><Reference><Citation>Dhainaut JF, Yan SB, Joyce DE, et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost. 2004;2:1924-1933.</Citation></Reference><Reference><Citation>Kienast J, Juers M, Wiedermann CJ, et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost. 2006;4:90-97.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28653134</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2614</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of clinical monitoring and computing</Title><ISOAbbreviation>J Clin Monit Comput</ISOAbbreviation></Journal><ArticleTitle>Goal-directed therapy: hit early and personalize!</ArticleTitle><Pagination><StartPage>375</StartPage><EndPage>377</EndPage><MedlinePgn>375-377</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10877-017-0043-x</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saugel</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. bernd.saugel@gmx.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michard</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>MiCo, Chemin de Chapallaz 4, 1135, Denens, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheeren</LastName><ForeName>Thomas W L</ForeName><Initials>TWL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Clin Monit Comput</MedlineTA><NlmUniqueID>9806357</NlmUniqueID><ISSNLinking>1387-1307</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006040" MajorTopicYN="Y">Goals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28653134</ArticleId><ArticleId IdType="doi">10.1007/s10877-017-0043-x</ArticleId><ArticleId IdType="pii">10.1007/s10877-017-0043-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curr Opin Crit Care. 2017 Aug;23 (4):334-341</Citation><ArticleIdList><ArticleId IdType="pubmed">28562384</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2016;2016:8268569</Citation><ArticleIdList><ArticleId IdType="pubmed">27703980</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2012 Aug;40(8):2536; author reply 2536-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22809947</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2014 Dec;40(12):1795-815</Citation><ArticleIdList><ArticleId IdType="pubmed">25392034</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2012 Oct;40(10):2923-4; author reply 2924-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22986670</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2016 Nov;117(5):569-575</Citation><ArticleIdList><ArticleId IdType="pubmed">27799171</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2015 May 08;19:224</Citation><ArticleIdList><ArticleId IdType="pubmed">25953531</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Monit Comput. 2018 Jun;32(3):403-414</Citation><ArticleIdList><ArticleId IdType="pubmed">28593456</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2015 Aug;121(2):264-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26197366</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 1974 Sep-Oct;2(5):279</Citation><ArticleIdList><ArticleId IdType="pubmed">4455456</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2009 Oct;35(10):1801-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19593546</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2017 Jul 1;119(1):18-21</Citation><ArticleIdList><ArticleId IdType="pubmed">28974083</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2016 Jun;116(6):750-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27199309</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2002 Aug;30(8):1686-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12163777</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Anaesthesiol. 2017 Apr;30(2):171-177</Citation><ArticleIdList><ArticleId IdType="pubmed">28092270</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Crit Care. 2017 Aug;23 (4):302-309</Citation><ArticleIdList><ArticleId IdType="pubmed">28538248</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Monit Comput. 2016 Apr;30(2):149-55</Citation><ArticleIdList><ArticleId IdType="pubmed">26026648</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2015 Jan;120(1):66-75</Citation><ArticleIdList><ArticleId IdType="pubmed">25625255</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2017 Jul 1;119(1):22-30</Citation><ArticleIdList><ArticleId IdType="pubmed">28605442</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2016 Sep;42(9):1350-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27155605</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40720942</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9735</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Blood purification</Title><ISOAbbreviation>Blood Purif</ISOAbbreviation></Journal><ArticleTitle>Interleukin-6 Removal and Clinical Effects of Oxiris: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000547587</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Sepsis is a life-threatening condition associated with high mortality due to an unregulated host immune response. Extracorporeal blood purification (EBP) therapies have been proposed as adjunctive treatments to immunomodulate patients; however, none have been consistently shown to be effective in reducing mortality. In several observational studies, Oxiris has been associated with cytokine reduction and a potential benefit in influencing inflammatory diseases. This meta-analysis explores the association between cytokine removal and clinical efficacy of the Oxiris membrane using interleukin-6 (IL-6) as a biomarker.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This review includes articles on EBP with Oxiris membranes in adult patients with sepsis/septic shock or COVID-19. No time or language restrictions were applied to the systematic literature search. Data extraction and statistical analysis were limited to the cytokines and clinical data reported in the included articles. The most representative cytokine was IL-6 and the selected outcomes included Vasoactive-Inotropic Score (VIS), SOFA score, procalcitonin (PCT) and C-reactive protein (CRP). The review used meta-analysis and unpaired t test to estimate differences between groups of patients treated with or without Oxiris.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study found no significant differences in demographics between the intervention and control groups at baseline. Intervention group showed a significant reduction in vasoactive inotropic score, norepinephrine dose, SOFA score, PCT, and CRP.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We reviewed 8 studies in which IL-6 was significantly reduced in the Oxiris group compared to the control. This meta-analysis found that the use of the Oxiris membrane resulted in significant clinical improvement during treatment.</AbstractText><CopyrightInformation>&#xa9; 2025 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ulsamer</LastName><ForeName>Arnau</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pomar&#xe8; Montin</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocciero</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parra Morales</LastName><ForeName>Tania Julieth</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Departamento de ortopedia y traumatolog&#xed;a, Universidad El Bosque, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tofani</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Statistics, Informatics, Applications, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>di Girolamo</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Anesthesia and Intensive Care, IRCCS Polyclinic San Donato, San Donato M.se, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romagnoli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Section of Oncological Anesthesia and Intensive Care, AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villa</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Section of Oncological Anesthesia and Intensive Care, AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Blood Purif</MedlineTA><NlmUniqueID>8402040</NlmUniqueID><ISSNLinking>0253-5068</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AN69</Keyword><Keyword MajorTopicYN="N">Extracorporeal blood purification</Keyword><Keyword MajorTopicYN="N">Interleukin-6</Keyword><Keyword MajorTopicYN="N">Oxiris</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>0</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>0</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40720942</ArticleId><ArticleId IdType="doi">10.1159/000547587</ArticleId><ArticleId IdType="pii">000547587</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28829405</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Probiotics Prevent Late-Onset Sepsis in Human Milk-Fed, Very Low Birth Weight Preterm Infants: Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">904</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu9080904</ELocationID><Abstract><AbstractText>Growing evidence supports the role of probiotics in reducing the risk of necrotizing enterocolitis, time to achieve full enteral feeding, and late-onset sepsis (LOS) in preterm infants. As reported for several neonatal clinical outcomes, recent data have suggested that nutrition might affect probiotics' efficacy. Nevertheless, the currently available literature does not explore the relationship between LOS prevention and type of feeding in preterm infants receiving probiotics. Thus, the aim of this systematic review and meta-analysis was to evaluate the effect of probiotics for LOS prevention in preterm infants according to type of feeding (exclusive human milk (HM) vs. exclusive formula or mixed feeding). Randomized-controlled trials involving preterm infants receiving probiotics and reporting on LOS were included in the systematic review. Only trials reporting on outcome according to feeding type were included in the meta-analysis. Fixed-effects models were used and random-effects models were used when significant heterogeneity was found. The results were expressed as risk ratio (RR) with 95% confidence interval (CI). Twenty-five studies were included in the meta-analysis. Overall, probiotic supplementation resulted in a significantly lower incidence of LOS (RR 0.79 (95% CI 0.71-0.88), <i>p</i> &lt; 0.0001). According to feeding type, the beneficial effect of probiotics was confirmed only in exclusively HM-fed preterm infants (RR 0.75 (95% CI 0.65-0.86), <i>p</i> &lt; 0.0001). Among HM-fed infants, only probiotic mixtures, and not single-strain products, were effective in reducing LOS incidence (RR 0.68 (95% CI 0.57-0.80) <i>p</i> &lt; 0.00001). The results of the present meta-analysis show that probiotics reduce LOS incidence in exclusively HM-fed preterm infants. Further efforts are required to clarify the relationship between probiotics supplementation, HM, and feeding practices in preterm infants.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aceti</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neonatology and Neonatal Intensive Care Unit, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, S.Orsola-Malpighi Hospital, 40138 Bologna, Italy. arianna.aceti2@unibo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maggio</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neonatal Unit, Catholic University, 00168 Rome, Italy. luca.maggio@fastwebnet.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beghetti</LastName><ForeName>Isadora</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Neonatology and Neonatal Intensive Care Unit, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, S.Orsola-Malpighi Hospital, 40138 Bologna, Italy. i.beghetti@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gori</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy. dedegori27@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barone</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neonatal Unit, Catholic University, 00168 Rome, Italy. gbarone85@yahoo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callegari</LastName><ForeName>Maria Luisa</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Institute of Microbiology, Catholic University, 29122 Piacenza, Italy. marialuisa.callegari@unicatt.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fantini</LastName><ForeName>Maria Pia</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy. mariapia.fantini@unibo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Indrio</LastName><ForeName>Flavia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Aldo Moro University, 70124 Bari, Italy. f.indrio@alice.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meneghin</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Neonatology, V. Buzzi Children Hospital, 20154 Milan, Italy. fabio.meneghin@icp.mi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Microbiology, Catholic University, 29122 Piacenza, Italy. lorenzo.morelli@unicatt.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccotti</LastName><ForeName>Gianvincenzo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, V. Buzzi Children Hospital, University of Milan, 20154 Milan, Italy. gianvincenzo.zuccotti@unimi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corvaglia</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neonatology and Neonatal Intensive Care Unit, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, S.Orsola-Malpighi Hospital, 40138 Bologna, Italy. luigi.corvaglia@unibo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Italian Society of Neonatology.</CollectiveName><AffiliationInfo><Affiliation>Department of Pediatrics, V. Buzzi Children Hospital, University of Milan, 20154 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001724" MajorTopicYN="N">Birth Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001942" MajorTopicYN="Y">Breast Feeding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041943" MajorTopicYN="N">Infant Formula</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="Y">Infant, Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019102" MajorTopicYN="Y">Infant, Very Low Birth Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008895" MajorTopicYN="Y">Milk, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="N">Probiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">human milk</Keyword><Keyword MajorTopicYN="N">late-onset sepsis</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">preterm infants</Keyword><Keyword MajorTopicYN="N">probiotic</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28829405</ArticleId><ArticleId IdType="pmc">PMC5579697</ArticleId><ArticleId IdType="doi">10.3390/nu9080904</ArticleId><ArticleId IdType="pii">nu9080904</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu L., Johnson H.L., Cousens S., Perin J., Scott S., Lawn J.E., Rudan I., Campbell H., Cibulskis R., Li M., et al. Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151&#x2013;2161. doi: 10.1016/S0140-6736(12)60560-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)60560-1</ArticleId><ArticleId IdType="pubmed">22579125</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y., Speer C.P. Late-onset neonatal sepsis: Recent developments. Arch. Dis. Child. Fetal Neonatal Ed. 2015;100:F257&#x2013;F263. doi: 10.1136/archdischild-2014-306213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2014-306213</ArticleId><ArticleId IdType="pmc">PMC4413803</ArticleId><ArticleId IdType="pubmed">25425653</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., Lemons J.A., Donovan E.F., Stark A.R., Tyson J.E., et al. Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285&#x2013;291. doi: 10.1542/peds.110.2.285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.110.2.285</ArticleId><ArticleId IdType="pubmed">12165580</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoll B.J., Hansen N.I., Adams-Chapman I., Fanaroff A.A., Hintz S.R., Vohr B.R., Higgins R.D., National Institute of Child Health and Human Development Neonatal Research Network Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357&#x2013;2365. doi: 10.1001/jama.292.19.2357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.292.19.2357</ArticleId><ArticleId IdType="pubmed">15547163</ArticleId></ArticleIdList></Reference><Reference><Citation>Collado M.C., Cernada M., Neu J., P&#xe9;rez-Mart&#xed;nez G., Gormaz M., Vento M. Factors influencing gastrointestinal tract and microbiota immune interaction in preterm infants. Pediatr. Res. 2015;77:726&#x2013;731. doi: 10.1038/pr.2015.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2015.54</ArticleId><ArticleId IdType="pubmed">25760550</ArticleId></ArticleIdList></Reference><Reference><Citation>Berrington J.E., Stewart C.J., Embleton N.D., Cummings S.P. Gut microbiota in preterm infants: Assessment and relevance to health and disease. Arch. Dis. Child. Fetal Neonatal Ed. 2013;98:F286&#x2013;F290. doi: 10.1136/archdischild-2012-302134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2012-302134</ArticleId><ArticleId IdType="pubmed">23009761</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart C.J., Marrs E.C.L., Magorrian S., Nelson A., Lanyon C., Perry J.D., Embleton N.D., Cummings S.P., Berrington J.E. The preterm gut microbiota: Changes associated with necrotizing enterocolitis and infection. Acta Paediatr. 2012;101:1121&#x2013;1127. doi: 10.1111/j.1651-2227.2012.02801.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2012.02801.x</ArticleId><ArticleId IdType="pubmed">22845166</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai V., Torrazza R.M., Ukhanova M., Wang X., Sun Y., Li N., Shuster J., Sharma R., Hudak M.L., Neu J. Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants. PLoS ONE. 2013;8:e52876. doi: 10.1371/journal.pone.0052876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052876</ArticleId><ArticleId IdType="pmc">PMC3544792</ArticleId><ArticleId IdType="pubmed">23341915</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders M.E., Guarner F., Guerrant R., Holt P.R., Quigley E.M., Sartor R.B., Sherman P.M., Mayer E.A. An update on the use and investigation of probiotics in health and disease. Gut. 2013;62:787&#x2013;796. doi: 10.1136/gutjnl-2012-302504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2012-302504</ArticleId><ArticleId IdType="pmc">PMC4351195</ArticleId><ArticleId IdType="pubmed">23474420</ArticleId></ArticleIdList></Reference><Reference><Citation>Slattery J., Macfabe D.F., Frye R.E. The significance of the enteric microbiome on the development of childhood disease: A review of prebiotic and probiotic therapies in disorders of childhood. Clin. Med. Insights Pediatr. 2016:91&#x2013;107. doi: 10.4137/CMPed.S38338.TYPE.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/CMPed.S38338.TYPE</ArticleId><ArticleId IdType="pmc">PMC5063840</ArticleId><ArticleId IdType="pubmed">27774001</ArticleId></ArticleIdList></Reference><Reference><Citation>AlFaleh K., Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 2014;9:584&#x2013;671. doi: 10.1002/ebch.1976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ebch.1976</ArticleId><ArticleId IdType="pubmed">25236307</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceti A., Gori D., Barone G., Callegari M.L., Di Mauro A., Fantini M.P., Indrio F., Maggio L., Meneghin F., Morelli L., et al. Probiotics for prevention of necrotizing enterocolitis in preterm infants: Systematic review and meta-analysis. Ital. J. Pediatr. 2015;41:89. doi: 10.1186/s13052-015-0199-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-015-0199-2</ArticleId><ArticleId IdType="pmc">PMC4644279</ArticleId><ArticleId IdType="pubmed">26567539</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceti A., Gori D., Barone G., Callegari M.L., Fantini M.P., Indrio F., Maggio L., Meneghin F., Morelli L., Zuccotti G., et al. Probiotics and time to achieve full enteral feeding in human milk-fed and formula-fed preterm infants: Systematic review and meta-analysis. Nutrients. 2016;8 doi: 10.3390/nu8080471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8080471</ArticleId><ArticleId IdType="pmc">PMC4997384</ArticleId><ArticleId IdType="pubmed">27483319</ArticleId></ArticleIdList></Reference><Reference><Citation>Athalie-Jape G., Deshpande G., Rao S., Patole S. Benefits of probiotics on enteral nutrition in preterm neonates-a systematic review. J. Paediatr. Child Health. 2014;50:15. doi: 10.3945/ajcn.114.092551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.114.092551</ArticleId><ArticleId IdType="pubmed">25411286</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S.C., Athalye-Jape G.K., Deshpande G.C., Simmer K.N., Patole S.K. Probiotic Supplementation and Late-Onset Sepsis in Preterm Infants: A Meta-analysis. Pediatrics. 2016;137:e20153684. doi: 10.1542/peds.2015-3684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2015-3684</ArticleId><ArticleId IdType="pubmed">26908700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G.-Q., Hu H.-J., Liu C.-Y., Shakya S., Li Z.-Y. Probiotics for Preventing Late-Onset Sepsis in Preterm Neonates: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine. 2016;95:e2581. doi: 10.1097/MD.0000000000002581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000002581</ArticleId><ArticleId IdType="pmc">PMC4778994</ArticleId><ArticleId IdType="pubmed">26937897</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlisle E.M., Morowitz M.J. The intestinal microbiome and necrotizing enterocolitis. Curr. Opin. Pediatr. 2013;25:382&#x2013;387. doi: 10.1097/MOP.0b013e3283600e91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0b013e3283600e91</ArticleId><ArticleId IdType="pubmed">23657248</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco A.R., Barile D., Underwood M.A., Mills D.A. The impact of the milk glycobiome on the neonate gut microbiota. Annu. Rev. Anim. Biosci. 2015;3:419&#x2013;445. doi: 10.1146/annurev-animal-022114-111112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-animal-022114-111112</ArticleId><ArticleId IdType="pmc">PMC4349412</ArticleId><ArticleId IdType="pubmed">25387230</ArticleId></ArticleIdList></Reference><Reference><Citation>Repa A., Thanhaeuser M., Endress D., Weber M., Kreissl A., Binder C., Berger A., Haiden N. Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formula. Pediatr. Res. 2015;77:381&#x2013;388. doi: 10.1038/pr.2014.192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2014.192</ArticleId><ArticleId IdType="pubmed">25423074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward R.E., Ninonuevo M., Mills D.A., Lebrilla C.B., German J.B. In vitro fermentation of breast milk oligosaccharides by bifidobacterium infantis and Lactobacillus gasseri. Appl. Environ. Microbiol. 2006;72:4497&#x2013;4499. doi: 10.1128/AEM.02515-05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02515-05</ArticleId><ArticleId IdType="pmc">PMC1489581</ArticleId><ArticleId IdType="pubmed">16751577</ArticleId></ArticleIdList></Reference><Reference><Citation>Underwood M.A., German J.B., Lebrilla C.B., Mills D.A. Bifidobacterium longum subspecies infantis: Champion colonizer of the infant gut. Pediatr. Res. 2014;77:229&#x2013;235. doi: 10.1038/pr.2014.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2014.156</ArticleId><ArticleId IdType="pmc">PMC4350908</ArticleId><ArticleId IdType="pubmed">25303277</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Green S. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley &amp; Sons; Hoboken, NJ, USA: 2011.</Citation></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., Sch&#xfc;nemann H.J. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Awad H., Mokhtar G., Imam S.S., Gad G.I., Hafez H., Aboushady N. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pakistan J. Biol. Sci. 2010;13:253&#x2013;262. doi: 10.3923/pjbs.2010.253.262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3923/pjbs.2010.253.262</ArticleId><ArticleId IdType="pubmed">20506712</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoni P., Rinaldi M., Cattani S., Pugni L., Romeo M.G., Messner H. Bovine Lactoferin Supplementation for Prevention of Late-Onset Sepsis in Very Low-Birth-Weight Neonates. J. Am. Med. Assoc. 2009;302:1421&#x2013;1428. doi: 10.1001/jama.2009.1403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1403</ArticleId><ArticleId IdType="pubmed">19809023</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren B. Preventive effect of Bifidobacterium tetravaccine tablets in premature infants with necrotizing enterocolitis. J. Pediatr. Pharm. 2010;16:24&#x2013;25.</Citation></Reference><Reference><Citation>Al-Hosni M., Duenas M., Hawk M., Stewart L.A., Borghese R.A., Cahoon M., Atwood L., Howard D., Ferrelli K., Soll R. Probiotics-supplemented feeding in extremely low-birth-weight infants. J. Perinatol. 2012;32:253&#x2013;259. doi: 10.1038/jp.2011.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jp.2011.51</ArticleId><ArticleId IdType="pubmed">21546942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin-Nun A., Bromiker R., Wilschanski M., Kaplan M., Rudensky B., Caplan M., Hammerman C. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J. Pediatr. 2005;147:192&#x2013;196. doi: 10.1016/j.jpeds.2005.03.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2005.03.054</ArticleId><ArticleId IdType="pubmed">16126048</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga T.D., da Silva G.A., de Lira P.I., de Carvalho Lima M. Efficacy of bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: A double-blind, randomized, controlled trial. Am. J. Clin. Nutr. 2011;93:81&#x2013;86. doi: 10.3945/ajcn.2010.29799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.2010.29799</ArticleId><ArticleId IdType="pubmed">20980486</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrzanowska-Liszewska D., Seliga-Siwecka J., Kornacka M.K. The effect of Lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants-double blinded randomized control trial. Early Hum. Dev. 2012;88:57&#x2013;60. doi: 10.1016/j.earlhumdev.2011.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.earlhumdev.2011.07.002</ArticleId><ArticleId IdType="pubmed">22055271</ArticleId></ArticleIdList></Reference><Reference><Citation>Costalos C., Skouteri V., Gounaris A., Sevastiadou S., Triandafilidou A., Ekonomidou C., Kontaxaki F., Petrochilou V. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum. Dev. 2003;74:89&#x2013;96. doi: 10.1016/S0378-3782(03)00090-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-3782(03)00090-2</ArticleId><ArticleId IdType="pubmed">14580749</ArticleId></ArticleIdList></Reference><Reference><Citation>Costeloe K., Hardy P., Juszczak E., Wilks M., Millar M.R. Bifidobacterium breve BBG-001 in very preterm infants: A randomised controlled phase 3 trial. Lancet. 2016;387:649&#x2013;660. doi: 10.1016/S0140-6736(15)01027-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)01027-2</ArticleId><ArticleId IdType="pubmed">26628328</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani C., Biadaioli R., Bertini G., Martelli E., Rubaltelli F.F. Probiotics feeding in prevention of urinary tract and necrotizing enterocolitis in preterm infants. Biol. Neonate. 2002;82:103&#x2013;108. doi: 10.1159/000063096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000063096</ArticleId><ArticleId IdType="pubmed">12169832</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirel G., Erdeve O., Celik I.H., Dilmen U. Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: A randomized, controlled study. Acta Paediatr. 2013;102:560&#x2013;565. doi: 10.1111/apa.12416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.12416</ArticleId><ArticleId IdType="pubmed">24028629</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilli D., Aydin B., Fettah N.D., &#xd6;zyaz&#x131;c&#x131; E., Beken S., Zenciro&#x11f;lu A., Okumu&#x15f; N., &#xd6;zyurt B.M., &#x130;pek M.&#x15e;., Akda&#x11f; A., et al. The propre-save study: Effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J. Pediatr. 2015;166:545&#x2013;551. doi: 10.1016/j.jpeds.2014.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2014.12.004</ArticleId><ArticleId IdType="pubmed">25596096</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta S., Ray P., Narang A. Comparison of stool colonization in premature infants by three dose regimes of a probiotic combination: A randomized controlled trial. Am. J. Perinatol. 2015;32:733&#x2013;740. doi: 10.1055/s-0034-1395473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1395473</ArticleId><ArticleId IdType="pubmed">25519197</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Carrocera L.A., Solis-Herrera A., Cabanillas-Ay&#xf3;n M., Gallardo-Sarmiento R.B., Garc&#xed;a-P&#xe9;rez C.S., Monta&#xf1;o-Rodr&#xed;guez R., Ech&#xe1;niz-Aviles M.O.L., Fernandez-Carrocera L.A., Cabanillas-Ayon M., Gallardo-Sarmiento R.B., et al. double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch. Dis. Child. Fetal Neonatal Ed. 2013;98:F5. doi: 10.1136/archdischild-2011-300435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2011-300435</ArticleId><ArticleId IdType="pubmed">22556209</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays S., Jacquot A., Gauthier H., Kempf C., Beissel A., Pidoux O., Jumas-Bilak E., Decullier E., Lachambre E., Beck L., et al. Probiotics and growth in preterm infants: A randomized controlled trial, PREMAPRO study. Clin. Nutr. 2016;35:802&#x2013;811. doi: 10.1016/j.clnu.2015.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2015.06.006</ArticleId><ArticleId IdType="pubmed">26220763</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikaru U., Koichi S., Yayoi S., Hiromichi S., Hiroaki S., Yoshikazu O., Seigo S., Nagata S., Toshiaki S., Yamashiro Y. Bifidobacteria prevents preterm infants from developing infection and sepsis. Int. J. Probiotics Prebiotics. 2010;5:33&#x2013;36.</Citation></Reference><Reference><Citation>Jacobs A.S.E., Tobin J.M. Probiotic effects on late-onset sepsis in very preterm infants: A randomized controlled trial. Pediatrics. 2013;132:1055&#x2013;1062. doi: 10.1542/peds.2013-1339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2013-1339</ArticleId><ArticleId IdType="pubmed">24249817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanic Z., Micetic Turk D., Burja S., Kanic V., Dinevski D. Influence of a combination of probiotics on bacterial infections in very low birthweight newborns. Wien. Klin. Wochenschr. 2015;127:210&#x2013;215. doi: 10.1007/s00508-015-0845-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-015-0845-0</ArticleId><ArticleId IdType="pubmed">26373743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitajima H., Sumida Y., Tanaka R., Yuki N., Takayama H., Fujimura M. Early administration of Bifidobacterium breve to preterm infants: Randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 1997;76:F101&#x2013;F107. doi: 10.1136/fn.76.2.F101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/fn.76.2.F101</ArticleId><ArticleId IdType="pmc">PMC1720633</ArticleId><ArticleId IdType="pubmed">9135288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H.-C., Su B.-H., Chen A.-C., Lin T.-W., Tsai C.-H., Yeh T.-F., Oh W. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115:1&#x2013;4. doi: 10.1542/peds.2004-1463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2004-1463</ArticleId><ArticleId IdType="pubmed">15629973</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H.-C., Hsu C.-H., Chen H.-L., Chung M.-Y., Hsu J.-F., Lien R.-I., Tsao L.-Y., Chen C.-H., Su B.-H. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: A multicenter, randomized, controlled trial. Pediatrics. 2008;122:693&#x2013;700. doi: 10.1542/peds.2007-3007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3007</ArticleId><ArticleId IdType="pubmed">18829790</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoni P., Mostert M., Leonessa M.L., Priolo C., Farina D., Monetti C., Latino M.A., Gomirato G. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: A randomized study. Clin. Infect. Dis. 2006;42:1735&#x2013;1742. doi: 10.1086/504324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/504324</ArticleId><ArticleId IdType="pubmed">16705580</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihatsch W.A., Vossbeck S., Eikmanns B., Hoegel J., Pohlandt F. Effect of bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: A randomized controlled trial. Neonatology. 2010;98:156&#x2013;163. doi: 10.1159/000280291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000280291</ArticleId><ArticleId IdType="pubmed">20234140</ArticleId></ArticleIdList></Reference><Reference><Citation>Millar M.R.R., Bacon C., Smith S.L.L., Walker V., Hall M.A.A. Enteral feeding of premature infants with Lactobacillus GG. Arch. Dis. Child. 1993;69:483&#x2013;487. doi: 10.1136/adc.69.5_Spec_No.483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.69.5_Spec_No.483</ArticleId><ArticleId IdType="pmc">PMC1029589</ArticleId><ArticleId IdType="pubmed">8285750</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncel M.Y., Sari F.N., Arayici S., Guzoglu N., Erdeve O., Uras N., Oguz S.S., Dilmen U. Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: A randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 2014;99:F110&#x2013;F115. doi: 10.1136/archdischild-2013-304745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2013-304745</ArticleId><ArticleId IdType="pubmed">24309022</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe4;rtty A., Luoto R., Kalliom&#xe4;ki M., Salminen S., Isolauri E. Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: A randomized, double-blind, placebo-controlled trial. J. Pediatr. 2013;163 doi: 10.1016/j.jpeds.2013.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2013.05.035</ArticleId><ArticleId IdType="pubmed">23915796</ArticleId></ArticleIdList></Reference><Reference><Citation>Patole S., Keil A.D., Chang A., Nathan E., Doherty D., Simmer K., Esvaran M., Conway P. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates-a randomised double blind placebo controlled trial. PLoS ONE. 2014;9:1&#x2013;8. doi: 10.1371/journal.pone.0089511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089511</ArticleId><ArticleId IdType="pmc">PMC3940439</ArticleId><ArticleId IdType="pubmed">24594833</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M.A., Lozano J.M., Rojas M.X., Rodriguez V.A., Rondon M.A., Bastidas J.A., Perez L.A., Rojas C., Ovalle O., Garcia-Harker J.E., et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics. 2012;130:e1113&#x2013;e1120. doi: 10.1542/peds.2011-3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2011-3584</ArticleId><ArticleId IdType="pubmed">23071204</ArticleId></ArticleIdList></Reference><Reference><Citation>Romeo M.G., Romeo D.M., Trovato L., Oliveri S., Palermo F., Cota F., Betta P. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: Incidence of late-onset sepsis and neurological outcome. J. Perinatol. 2011;31:63&#x2013;69. doi: 10.1038/jp.2010.57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jp.2010.57</ArticleId><ArticleId IdType="pmc">PMC3016918</ArticleId><ArticleId IdType="pubmed">20410904</ArticleId></ArticleIdList></Reference><Reference><Citation>Roug&#xe9; C., Piloquet H., Butel M.-J., Berger B., Rochat F., Ferraris L., Des Robert C., Legrand A., de la Cochetiere M.-F., N&#x2019;Guyen J.-M., et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: A randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 2009;89:1828&#x2013;1835. doi: 10.3945/ajcn.2008.26919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.2008.26919</ArticleId><ArticleId IdType="pubmed">19369375</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy A., Chaudhuri J., Sarkar D., Ghosh P., Swapna C. Role of enteric supplementation of probiotic on late-onset sepsisi by candida species in preterm low-boirth weight neonates: A randomized double blind, placebo-controlled trial. N. Am. J. Med. Sci. 2014;6:50&#x2013;57. doi: 10.4103/1947-2714.125870.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1947-2714.125870</ArticleId><ArticleId IdType="pmc">PMC3938875</ArticleId><ArticleId IdType="pubmed">24678479</ArticleId></ArticleIdList></Reference><Reference><Citation>Saengtawesin V., Tangpolkaiwalsak R., Kanjanapattankul W. Effect of oral probiotics supplementation in the prevention of necrotizing enterocolitis among very low birth weight preterm infants. J. Med. Assoc. Thail. 2014;97:S20&#x2013;S25.</Citation><ArticleIdList><ArticleId IdType="pubmed">25391168</ArticleId></ArticleIdList></Reference><Reference><Citation>Samanta M., Sarkar M., Ghosh P., Ghosh J., Sinha M., Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J. Trop. Pediatr. 2008;55:128&#x2013;131. doi: 10.1093/tropej/fmn091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmn091</ArticleId><ArticleId IdType="pubmed">18842610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sari F.N., Dizdar E.A., Oguz S., Erdeve O., Uras N., Dilmen U. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: A randomized, controlled trial. Eur. J. Clin. Nutr. 2011;65:434&#x2013;439. doi: 10.1038/ejcn.2010.278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2010.278</ArticleId><ArticleId IdType="pubmed">21245887</ArticleId></ArticleIdList></Reference><Reference><Citation>Serce O., Benzer D., Gursoy T., Karatekin G., Ovali F. Efficacy of saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: A randomised controlled trial. Early Hum. Dev. 2013;89:1033&#x2013;1036. doi: 10.1016/j.earlhumdev.2013.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.earlhumdev.2013.08.013</ArticleId><ArticleId IdType="pubmed">24041815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha A., Gupta S.S., Chellani H., Maliye C., Kumari V., Arya S., Garg B.S., Gaur S.D., Gaind R., Deotale V., et al. Role of probiotics VSL#3 in prevention of suspected sepsis in low birthweight infants in India: A randomised controlled trial. BMJ Open. 2015;5:e006564. doi: 10.1136/bmjopen-2014-006564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-006564</ArticleId><ArticleId IdType="pmc">PMC4499724</ArticleId><ArticleId IdType="pubmed">26163028</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratiki Z., Costalos C., Sevastiadou S., Kastanidou O., Skouroliakou M., Giakoumatou A., Petrohilou V. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum. Dev. 2007;83:575&#x2013;579. doi: 10.1016/j.earlhumdev.2006.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.earlhumdev.2006.12.002</ArticleId><ArticleId IdType="pubmed">17229535</ArticleId></ArticleIdList></Reference><Reference><Citation>Tewari V.V., Dubey S.K., Gupta G. Bacillus clausii for prevention of late-onset sepsis in preterm infants: A randomized controlled trial. J. Trop. Pediatr. 2015;61:377&#x2013;385. doi: 10.1093/tropej/fmv050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmv050</ArticleId><ArticleId IdType="pubmed">26246087</ArticleId></ArticleIdList></Reference><Reference><Citation>Totsu S., Yamasaki C., Terahara M., Uchiyama A., Kusuda S. Bifidobacterium and enteral feeding in preterm infants: Cluster-randomized trial. Pediatr. Int. 2014;56:714&#x2013;719. doi: 10.1111/ped.12330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.12330</ArticleId><ArticleId IdType="pmc">PMC4285294</ArticleId><ArticleId IdType="pubmed">24617812</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Wang Y., Wang Y., Fu J., Sun M., Mao Z., Vandenplas Y. A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants. J. Pediatr. (Rio. J.) 2016;92:296&#x2013;301. doi: 10.1016/j.jped.2015.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2015.08.013</ArticleId><ArticleId IdType="pubmed">26946967</ArticleId></ArticleIdList></Reference><Reference><Citation>Drago L., de Vecchi E. Should Lactobacillus sporogenes and Bacillus coagulans have a future? J. Chemother. 2009;21:371&#x2013;377. doi: 10.1179/joc.2009.21.4.371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/joc.2009.21.4.371</ArticleId><ArticleId IdType="pubmed">19622453</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffei D., Schanler R.J. Human milk is the feeding strategy to prevent necrotizing enterocolitis! Semin. Perinatol. 2017;41:36&#x2013;40. doi: 10.1053/j.semperi.2016.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semperi.2016.09.016</ArticleId><ArticleId IdType="pubmed">27836421</ArticleId></ArticleIdList></Reference><Reference><Citation>Schanler R.J., Shulman R.J., Lau C. Feeding strategies for premature infants: Beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics. 1999;103:1150&#x2013;1157. doi: 10.1542/peds.103.6.1150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.103.6.1150</ArticleId><ArticleId IdType="pubmed">10353922</ArticleId></ArticleIdList></Reference><Reference><Citation>Corvaglia L., Fantini M.P., Aceti A., Gibertoni D., Rucci P., Baronciani D., Faldella G. Predictors of full enteral feeding achievement in very low birth weight infants. PLoS ONE. 2014;9:e92235. doi: 10.1371/journal.pone.0092235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092235</ArticleId><ArticleId IdType="pmc">PMC3960219</ArticleId><ArticleId IdType="pubmed">24647523</ArticleId></ArticleIdList></Reference><Reference><Citation>Embleton N.D., Zalewski S., Berrington J.E. Probiotics for prevention of necrotizing enterocolitis and sepsis in preterm infants. Curr. Opin. Infect Dis. 2016;29:256&#x2013;261. doi: 10.1097/QCO.0000000000000269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000269</ArticleId><ArticleId IdType="pubmed">27023404</ArticleId></ArticleIdList></Reference><Reference><Citation>Eidelman A.I. Breastfeeding and the use of human milk: An analysis of the American Academy of Pediatrics 2012 Breastfeeding Policy Statement. Breastfeed. Med. 2012;129:e827&#x2013;e841. doi: 10.1089/bfm.2012.0067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bfm.2012.0067</ArticleId><ArticleId IdType="pubmed">22946888</ArticleId></ArticleIdList></Reference><Reference><Citation>Underwood M.A. Human milk for premature infant. Pediatr. Clin. N. Am. 2013;60:189&#x2013;207. doi: 10.1016/j.pcl.2012.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcl.2012.09.008</ArticleId><ArticleId IdType="pmc">PMC3508468</ArticleId><ArticleId IdType="pubmed">23178065</ArticleId></ArticleIdList></Reference><Reference><Citation>Peila C., Moro G., Bertino E., Cavallarin L., Giribaldi M., Giuliani F., Cresi F., Coscia A. The effect of holder pasteurization on nutrients and biologically-active components in donor human milk: A review. Nutrients. 2016;8:477. doi: 10.3390/nu8080477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8080477</ArticleId><ArticleId IdType="pmc">PMC4997390</ArticleId><ArticleId IdType="pubmed">27490567</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang D., Zhou W., Lun Z.J., Mu X., Wang D.X., Wu H. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. J. Int. Med. Res. 2013;41:1426&#x2013;1436. doi: 10.1177/0300060513493692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060513493692</ArticleId><ArticleId IdType="pubmed">23908398</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertelli C., Pillonel T., Torregrossa A., Prod&#x2019;hom G., Fischer C.J., Greub G., Giannoni E. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin. Infect. Dis. 2015;60:924&#x2013;927. doi: 10.1093/cid/ciu946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu946</ArticleId><ArticleId IdType="pubmed">25472946</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28350238</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9034</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of laparoendoscopic &amp; advanced surgical techniques. Part A</Title><ISOAbbreviation>J Laparoendosc Adv Surg Tech A</ISOAbbreviation></Journal><ArticleTitle>Safety and Effectiveness of Robot-Assisted Versus Open Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1109</StartPage><EndPage>1120</EndPage><MedlinePgn>1109-1120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/lap.2016.0437</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the safety and effectiveness of robot-assisted radical cystectomy (RARC) compared with open radical cystectomy (ORC) in bladder cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search for the systematic review was conducted using international databases as well as domestic databases up to April 2015. Outcomes of interest included baseline characteristics, complication rates, perioperative, and oncologic outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four articles were finally selected for inclusion in the meta-analysis. Complication rates of RARC were similar to those of ORC, except for 90-day overall complication rate, wound dehiscence, abscess, pneumonia, respiratory failure, and sepsis, which was lower after RARC. RARC was also associated with a smaller amount of estimated blood loss, lower transfusion rate, shorter length of hospital stay, shorter time to flatus, and more lymph node yield, whereas ORC was associated with a shorter operation time and lower rate of stricture. Considering oncologic outcomes, there were no differences between RARC and ORC.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">RARC seems to be associated with equivalent complication rates, a smaller amount of estimated blood loss, lower transfusion rate, shorter length of hospital stay, shorter time to flatus, and more lymph node yield. Randomized controlled trials with a large sample size and comparative studies with long-term follow-up data are warranted to assess our findings and the oncologic effectiveness of RARC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Soo Kyung</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>1 Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Department of Health Policy and Hospital Management, Graduate School of Public Health, Korea University , Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Na Rae</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>1 Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Department of Health Policy and Hospital Management, Graduate School of Public Health, Korea University , Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Seok Ho</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>3 Department of Urology, College of Medicine, Korea University , Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seon Heui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>4 Department of Nursing Science, College of Nursing, Gachon University , Incheon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Laparoendosc Adv Surg Tech A</MedlineTA><NlmUniqueID>9706293</NlmUniqueID><ISSNLinking>1092-6429</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015653" MajorTopicYN="N">Cystectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="N">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bladder cancer</Keyword><Keyword MajorTopicYN="N">cystectomy</Keyword><Keyword MajorTopicYN="N">robotics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28350238</ArticleId><ArticleId IdType="doi">10.1089/lap.2016.0437</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28045915</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Alkalosis in Critically Ill Patients with Severe Sepsis and Septic Shock.</ArticleTitle><Pagination><StartPage>e0168563</StartPage><MedlinePgn>e0168563</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0168563</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0168563</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Although metabolic alkalosis is a common occurrence in intensive care units (ICUs), no study has evaluated its prevalence or outcomes in patients with severe sepsis or septic shock.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective cohort study of critically ill patients suffering from severe sepsis and septic shock admitted to the ICUs of Halmstad and Varberg County hospitals. From 910 patient records, 627 patients met the inclusion criteria. We investigated the relationship between metabolic alkalosis and mortality. Further, we studied the relationship between metabolic alkalosis and ICU length of stay (LOS).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Metabolic alkalosis was associated with decreased 30-day and 12-month mortalities. This effect was however lost when a multivariate analysis was conducted, correcting for age, gender, pH on admission, base excess (BE) on admission, Simplified Acute Physiology Score III (SAPS III) and acute kidney injury (AKI). We then analyzed for any dose-response effect between the severity of metabolic alkalosis and mortality and found no relationship. Bivariate analysis showed that metabolic alkalosis had a significant effect on the length of ICU stay. When adjusting for age, sex, pH at admission, BE at admission, SAPS III and AKI in a multivariate analysis, metabolic alkalosis significantly contributed to prolonged ICU length of stay. In two separate sensitivity analyses pure metabolic alkalosis and late metabolic alkalosis (time of onset &gt;48 hours) were the only significant predictor of increased ICU length of stay.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Metabolic alkalosis did not have any effect on 30-day and 12-month mortalities after adjusting for age, sex, SAPS III-score, pH and BE on admission and AKI in a multivariate analysis. The presence of metabolic alkalosis was independently associated with an increased ICU length of stay.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kre&#xfc;</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6888-6173</Identifier><AffiliationInfo><Affiliation>Institute for Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, &#xd6;rebro University Hospital, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jazrawi</LastName><ForeName>Allan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Surgery, V&#xe4;stmanland County Hospital, V&#xe4;ster&#xe5;s, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baigi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medicine, General Medicine and Public Health, Gothenburg University, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Link&#xf6;ping University Hospital, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS One. 2017 Apr 5;12(4):e0175530. doi: 10.1371/journal.pone.0175530.</RefSource><PMID Version="1">28380074</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000471" MajorTopicYN="N">Alkalosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>1</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28045915</ArticleId><ArticleId IdType="pmc">PMC5207677</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0168563</ArticleId><ArticleId IdType="pii">PONE-D-16-24355</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Webster NR, Kulkarni V. Metabolic Alkalosis in the Critically Ill. Rev Clin Lab Sci. 1999;36(5):497&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">10560889</ArticleId></ArticleIdList></Reference><Reference><Citation>Lib&#xf3;rio AB, Noritomi DT, Leite TT, de Melo Bezerra CT, de Faria ER, Kellum JA. Increased serum bicarbonate in critically ill patients: a retrospective analysis. Intensive Care Med 2015;41(3):572 10.1007/s00134-015-3682-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3682-8</ArticleId><ArticleId IdType="pubmed">25672278</ArticleId></ArticleIdList></Reference><Reference><Citation>Raphael KL, Murphy RA, Shlipak MG, Satterfield S, Huston HK, Sebastian A, et al. Bicarbonate concentration, acid-base status, and mortality in the health, aging and body composition study. CJASN. 2016;11(2):308&#x2013;31 10.2215/CJN.06200615</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.06200615</ArticleId><ArticleId IdType="pmc">PMC4741040</ArticleId><ArticleId IdType="pubmed">26769766</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards SH. Pathophysiology of acid base balance: The theory practice relationship. Intensive Crit Care Nurs. 2008;24(1):28&#x2013;38 10.1016/j.iccn.2007.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iccn.2007.05.003</ArticleId><ArticleId IdType="pubmed">17689248</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer BF, Alpern RJ. Metabolic Alkalosis. J Am Soc Nephrol. 1997;8(9):1462&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">9294840</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgkin JE, Soeprono FF, Chan DM. Incidence of metabolic alkalemia in hospitalized patients. Crit Care Med 1980: 8:725&#x2013;728</Citation><ArticleIdList><ArticleId IdType="pubmed">6778655</ArticleId></ArticleIdList></Reference><Reference><Citation>Maehle K, Haug B, Flaaten H, Nielsen EW. Metabolic alkalosis is the most common acid-base disorder in ICU patients. Crit Care 2014;18:420 10.1186/cc13802</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13802</ArticleId><ArticleId IdType="pmc">PMC4056091</ArticleId><ArticleId IdType="pubmed">25001067</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubin A, Menises MM, Masevicius FD, Moseinco MC, Kutscherauer DO, Ventrice E,et al. Comparison of three different methods of evaluation of metabolic acid-base disorders. Crit Care Med. 2007; 35:1264&#x2013;1269. 10.1097/01.CCM.0000259536.11943.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000259536.11943.90</ArticleId><ArticleId IdType="pubmed">17334252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27870924</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2016</Year><Month>Nov</Month><Day>17</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e17850</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.17850</ELocationID><Abstract><AbstractText>Evaluation of preclinical evidence prior to initiating early-phase clinical studies has typically been performed by selecting individual studies in a non-systematic process that may introduce bias. Thus, in preparation for a first-in-human trial of mesenchymal stromal cells (MSCs) for septic shock, we applied systematic review methodology to evaluate all published preclinical evidence. We identified 20 controlled comparison experiments (980 animals from 18 publications) of <i>in vivo</i> sepsis models. Meta-analysis demonstrated that MSC treatment of preclinical sepsis significantly reduced mortality over a range of experimental conditions (odds ratio 0.27, 95% confidence interval 0.18-0.40, latest timepoint reported for each study). Risk of bias was unclear as few studies described elements such as randomization and no studies included an appropriately calculated sample size. Moreover, the presence of publication bias resulted in a ~30% overestimate of effect and threats to validity limit the strength of our conclusions. This novel prospective application of systematic review methodology serves as a template to evaluate preclinical evidence prior to initiating first-in-human clinical studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-0322-382X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Katrina J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Shirley Hj</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Regenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moher</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straus</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fergusson</LastName><ForeName>Dean A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Duncan J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-9113-8691</Identifier><AffiliationInfo><Affiliation>Regenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Molecular Medicine, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jazi</LastName><ForeName>Mazen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLeod</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winston</LastName><ForeName>Brent</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departments of Surgery and Critical Care Medicine, Keenan Research Centre of the Li KaShing Knowledge Institute, St. Michaels Hospital, The University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hutton</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walley</LastName><ForeName>Keith R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Lauralyn</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7421-1407</Identifier><AffiliationInfo><Affiliation>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NC/L000970/1</GrantID><Acronym>NC3RS_</Acronym><Agency>National Centre for the Replacement, Refinement and Reduction of Animals in Research</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045164" MajorTopicYN="Y">Mesenchymal Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="Y">Mesenchymal Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">global health</Keyword><Keyword MajorTopicYN="N">human biology</Keyword><Keyword MajorTopicYN="N">medicine</Keyword><Keyword MajorTopicYN="N">mouse</Keyword><Keyword MajorTopicYN="N">preclinical</Keyword><Keyword MajorTopicYN="N">rat</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">stem cells</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">translation</Keyword></KeywordList><CoiStatement>The authors declare that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>11</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27870924</ArticleId><ArticleId IdType="pmc">PMC5153252</ArticleId><ArticleId IdType="doi">10.7554/eLife.17850</ArticleId><ArticleId IdType="pii">e17850</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Begley CG, Ellis LM. Drug development: Raise standards for preclinical cancer research. Nature. 2012;483:531&#x2013;533. doi: 10.1038/483531a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/483531a</ArticleId><ArticleId IdType="pubmed">22460880</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi L-K, Tang B, Zhu B, Xie C-L, Li S, Lin T-X, Hunag J, Zhang W, Zhu J-Y. Systemic delivery of IL-10 by bone marrow derived stromal cells has therapeutic benefits in sepsis therapy*. Progress&#xa0;in Biochemistry&#xa0;and Biophysics. 2010;37:678&#x2013;685. doi: 10.3724/SP.J.1206.2010.00107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3724/SP.J.1206.2010.00107</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Institutes of Health&#xa0;Research  RCT Evaluation Criteria and Headings. 2016 http://www.cihr-irsc.gc.ca/e/39187.html</Citation></Reference><Reference><Citation>Chang CL, Leu S, Sung HC, Zhen YY, Cho CL, Chen A, Tsai TH, Chung SY, Chai HT, Sun CK, Yen CH, Yip HK. Impact of apoptotic adipose-derived mesenchymal stem cells on attenuating organ damage and reducing mortality in rat sepsis syndrome induced by cecal puncture and ligation. Journal of Translational Medicine. 2012;10:244. doi: 10.1186/1479-5876-10-244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-10-244</ArticleId><ArticleId IdType="pmc">PMC3543276</ArticleId><ArticleId IdType="pubmed">23217183</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao YH, Wu HP, Wu KH, Tsai YG, Peng CT, Lin KC, Chao WR, Lee MS, Fu YC, Fu Y-C. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis. PLoS One. 2014;9:e110338. doi: 10.1371/journal.pone.0110338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0110338</ArticleId><ArticleId IdType="pmc">PMC4206342</ArticleId><ArticleId IdType="pubmed">25337817</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohn LD, Becker BJ. How meta-analysis increases statistical power. Psychological Methods. 2003;8:243&#x2013;253. doi: 10.1037/1082-989X.8.3.243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1082-989X.8.3.243</ArticleId><ArticleId IdType="pubmed">14596489</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins FS, Tabak LA. Policy: Nih plans to enhance reproducibility. Nature. 2014;505:612&#x2013;613. doi: 10.1038/505612a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/505612a</ArticleId><ArticleId IdType="pmc">PMC4058759</ArticleId><ArticleId IdType="pubmed">24482835</ArticleId></ArticleIdList></Reference><Reference><Citation>Contopoulos-Ioannidis DG, Ntzani E, Ioannidis JP. Translation of highly promising basic science research into clinical applications. The American Journal of Medicine. 2003;114:477&#x2013;484. doi: 10.1016/S0002-9343(03)00013-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(03)00013-5</ArticleId><ArticleId IdType="pubmed">12731504</ArticleId></ArticleIdList></Reference><Reference><Citation>Crossley NA, Sena E, Goehler J, Horn J, van der Worp B, Bath PM, Macleod M, Dirnagl U. Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke. 2008;39:929&#x2013;934. doi: 10.1161/STROKEAHA.107.498725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.107.498725</ArticleId><ArticleId IdType="pubmed">18239164</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. Journal of Cell Science. 2006;119:2204&#x2013;2213. doi: 10.1242/jcs.02932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.02932</ArticleId><ArticleId IdType="pubmed">16684817</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries RB, Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. Updated version of the Embase search filter for animal studies. Laboratory Animals. 2014;48:88. doi: 10.1177/0023677213494374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0023677213494374</ArticleId><ArticleId IdType="pubmed">23836850</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315&#x2013;317. doi: 10.1080/14653240600855905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14653240600855905</ArticleId><ArticleId IdType="pubmed">16923606</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos CC, Murthy S, Hu P, Shan Y, Haitsma JJ, Mei SH, Stewart DJ, Liles WC. Network analysis of transcriptional responses induced by mesenchymal stem cell treatment of experimental sepsis. The American Journal of Pathology. 2012;181:1681&#x2013;1692. doi: 10.1016/j.ajpath.2012.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2012.08.009</ArticleId><ArticleId IdType="pubmed">23083833</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyson A, Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Critical Care Medicine. 2009;37:S30&#x2013;37. doi: 10.1097/CCM.0b013e3181922bd3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181922bd3</ArticleId><ArticleId IdType="pubmed">19104223</ArticleId></ArticleIdList></Reference><Reference><Citation>Food and Drug Administration  Department of Health and Human Services, Drugs for huamn use: Investigational New Drug Application. 2015 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=312.23</Citation></Reference><Reference><Citation>Gonzalez-Rey E, Anderson P, Gonzalez MA, Rico L, Buscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut. 2009;58:929&#x2013;939. doi: 10.1136/gut.2008.168534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2008.168534</ArticleId><ArticleId IdType="pubmed">19136511</ArticleId></ArticleIdList></Reference><Reference><Citation>Grankvist H, Kimmelman J. How do researchers decide early clinical trials? Medicine, Health Care and Philosophy. 2016;19:191&#x2013;198. doi: 10.1007/s11019-016-9685-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11019-016-9685-6</ArticleId><ArticleId IdType="pubmed">26833467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall SR, Tsoyi K, Ith B, Padera RF, Lederer JA, Wang Z, Liu X, Perrella MA. Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils. Stem Cells. 2013;31:397&#x2013;407. doi: 10.1002/stem.1270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1270</ArticleId><ArticleId IdType="pmc">PMC3572335</ArticleId><ArticleId IdType="pubmed">23132816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannoush EJ, Sifri ZC, Elhassan IO, Mohr AM, Alzate WD, Offin M, Livingston DH. Impact of enhanced mobilization of bone marrow derived cells to site of injury. The Journal of Trauma. 2011;71:283&#x2013;291. doi: 10.1097/TA.0b013e318222f380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e318222f380</ArticleId><ArticleId IdType="pubmed">21825928</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson VC, Kimmelman J, Fergusson D, Grimshaw JM, Hackam DG. Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Medicine. 2013;10:e1001489. doi: 10.1371/journal.pmed.1001489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001489</ArticleId><ArticleId IdType="pmc">PMC3720257</ArticleId><ArticleId IdType="pubmed">23935460</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT. Green S. Cochrane Handbook for Systematic Reviews of Interventions. ed. 5.0.2 2009.</Citation></Reference><Reference><Citation>Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, Heneghan C. The need for randomization in animal trials: an overview of systematic reviews. PLoS One. 2014;9:e98856. doi: 10.1371/journal.pone.0098856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0098856</ArticleId><ArticleId IdType="pmc">PMC4048216</ArticleId><ArticleId IdType="pubmed">24906117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE's risk of bias tool for animal studies. BMC Medical Research Methodology. 2014;14:43. doi: 10.1186/1471-2288-14-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-43</ArticleId><ArticleId IdType="pmc">PMC4230647</ArticleId><ArticleId IdType="pubmed">24667063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed. Laboratory Animals. 2010;44:170&#x2013;175. doi: 10.1258/la.2010.009117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/la.2010.009117</ArticleId><ArticleId IdType="pmc">PMC3104815</ArticleId><ArticleId IdType="pubmed">20551243</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn J, de Haan RJ, Vermeulen M, Luiten PG, Limburg M. Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke. 2001;32:2433&#x2013;2438. doi: 10.1161/hs1001.096009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hs1001.096009</ArticleId><ArticleId IdType="pubmed">11588338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JP. Why most published research findings are false. PLoS Medicine. 2005;2:e124. doi: 10.1371/journal.pmed.0020124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020124</ArticleId><ArticleId IdType="pmc">PMC1182327</ArticleId><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra PR, Moon JC, Coats AJ. Do results of the ENABLE (endothelin antagonist bosentan for lowering cardiac events in heart failure) study spell the end for non-selective endothelin antagonism in heart failure? International Journal of Cardiology. 2002;85:195. doi: 10.1016/S0167-5273(02)00182-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-5273(02)00182-1</ArticleId><ArticleId IdType="pubmed">12208583</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biology. 2010;8:e1000412. doi: 10.1371/journal.pbio.1000412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000412</ArticleId><ArticleId IdType="pmc">PMC2893951</ArticleId><ArticleId IdType="pubmed">20613859</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Darwish I, Monroy MF, Prockop DJ, Liles WC, Kain KC. Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome. BMC Immunology. 2014;15:1. doi: 10.1186/1471-2172-15-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2172-15-1</ArticleId><ArticleId IdType="pmc">PMC3898056</ArticleId><ArticleId IdType="pubmed">24423010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmelman J, Henderson V. Assessing risk/benefit for trials using preclinical evidence: a proposal. Journal of Medical Ethics. 2016;42:50&#x2013;53. doi: 10.1136/medethics-2015-102882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/medethics-2015-102882</ArticleId><ArticleId IdType="pmc">PMC4854630</ArticleId><ArticleId IdType="pubmed">26463620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleikers PW, Hooijmans C, G&#xf6;b E, Langhauser F, Rewell SS, Radermacher K, Ritskes-Hoitinga M, Howells DW, Kleinschnitz C, Schmidt HH. A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation. Scientific Reports. 2015;5:13428. doi: 10.1038/srep13428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13428</ArticleId><ArticleId IdType="pmc">PMC4550831</ArticleId><ArticleId IdType="pubmed">26310318</ArticleId></ArticleIdList></Reference><Reference><Citation>Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery. 2004;3:711&#x2013;716. doi: 10.1038/nrd1470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1470</ArticleId><ArticleId IdType="pubmed">15286737</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee J-W, Gupta N, Petrini M, Matthay MA. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. AJP: Lung Cellular and Molecular Physiology. 2012;302:L1003&#x2013;L1013. doi: 10.1152/ajplung.00180.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00180.2011</ArticleId><ArticleId IdType="pmc">PMC3362255</ArticleId><ArticleId IdType="pubmed">22427530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Briel M, Duffett M, Fox-Robichaud A, Cook DJ, Guyatt G, Lesur O, Meade MO. Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis. Critical Care Medicine. 2010;38:2401&#x2013;2408. doi: 10.1097/CCM.0b013e3181fa0468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181fa0468</ArticleId><ArticleId IdType="pubmed">20890192</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012;490:187&#x2013;191. doi: 10.1038/nature11556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11556</ArticleId><ArticleId IdType="pmc">PMC3511845</ArticleId><ArticleId IdType="pubmed">23060188</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DS, Nguyen QT, Lapointe N, Austin PC, Ohlsson A, Tu JV, Stewart DJ, Rouleau JL. Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure. Journal of Cardiac Failure. 2003;9 doi: 10.1054/S1071-9164(03)00125-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/S1071-9164(03)00125-8</ArticleId><ArticleId IdType="pubmed">14583897</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Li D, Liu X, Tang S, Wei F. Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. Journal of Inflammation. 2012;9:33. doi: 10.1186/1476-9255-9-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-9255-9-33</ArticleId><ArticleId IdType="pmc">PMC3502090</ArticleId><ArticleId IdType="pubmed">22974286</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang ZX, Sun JP, Wang P, Tian Q, Yang Z, Chen LA. Bone marrow-derived mesenchymal stem cells protect rats from endotoxin-induced acute lung injury. Chinese Medical Journal. 2011;124:2715&#x2013;2722.</Citation><ArticleIdList><ArticleId IdType="pubmed">22040430</ArticleId></ArticleIdList></Reference><Reference><Citation>Llovera G, Hofmann K, Roth S, Salas-P&#xe9;rdomo A, Ferrer-Ferrer M, Perego C, Zanier ER, Mamrak U, Rex A, Party H, Agin V, Fauchon C, Orset C, Haelewyn B, De Simoni MG, Dirnagl U, Grittner U, Planas AM, Plesnila N, Vivien D, Liesz A. Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia. Science Translational Medicine. 2015;7:299ra121. doi: 10.1126/scitranslmed.aaa9853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa9853</ArticleId><ArticleId IdType="pubmed">26246166</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo CJ, Zhang FJ, Zhang L, Geng YQ, Li QG, Hong Q, Fu B, Zhu F, Cui SY, Feng Z, Sun XF, Chen XM. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Shock. 2014;41:123&#x2013;129. doi: 10.1097/SHK.0000000000000080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000080</ArticleId><ArticleId IdType="pubmed">24169208</ArticleId></ArticleIdList></Reference><Reference><Citation>Macleod MR, Lawson McLean A, Kyriakopoulou A, Serghiou S, de Wilde A, Sherratt N, Hirst T, Hemblade R, Bahor Z, Nunes-Fonseca C, Potluru A, Thomson A, Baginskaite J, Egan K, Vesterinen H, Currie GL, Churilov L, Howells DW, Sena ES. Risk of bias in reports of in vivo research: a focus for improvement. PLoS Biology. 2015;13:e1002273. doi: 10.1371/journal.pbio.1002273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002273</ArticleId><ArticleId IdType="pmc">PMC4603955</ArticleId><ArticleId IdType="pubmed">26460723</ArticleId></ArticleIdList></Reference><Reference><Citation>Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA. Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke. 2008;39:2824&#x2013;2829. doi: 10.1161/STROKEAHA.108.515957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.515957</ArticleId><ArticleId IdType="pubmed">18635842</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann SK, Irvine C, Mead GE, Sena ES, Currie GL, Egan KE, Macleod MR, Howells DW. Efficacy of antidepressants in animal models of ischemic stroke: a systematic review and meta-analysis. Stroke. 2014;45:3055&#x2013;3063. doi: 10.1161/STROKEAHA.114.006304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.114.006304</ArticleId><ArticleId IdType="pubmed">25184357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, Liles WC, Stewart DJ, Stewart DJ. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. American Journal of Respiratory and Critical Care Medicine. 2010;182:1047. doi: 10.1164/rccm.201001-0010OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201001-0010OC</ArticleId><ArticleId IdType="pubmed">20558630</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonesinghe R, Khoury MJ, Janssens AC. Most published research findings are false-but a little replication goes a long way. PLoS Medicine. 2007;4:e28. doi: 10.1371/journal.pmed.0040028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040028</ArticleId><ArticleId IdType="pmc">PMC1808082</ArticleId><ArticleId IdType="pubmed">17326704</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, Rowan KM, ProMISe Trial Investigators Trial of early, goal-directed resuscitation for septic shock. New England Journal of Medicine. 2015;372:1301&#x2013;1311. doi: 10.1056/NEJMoa1500896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1500896</ArticleId><ArticleId IdType="pubmed">25776532</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health  Principles and Guidelines for Reporting Preclinical Research. 2015 http://www.nih.gov/research-training/rigor-reproducibility/principles-guidelines-reporting-preclinical-research</Citation></Reference><Reference><Citation>N&#xe9;meth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine. 2009;15:42&#x2013;49. doi: 10.1038/nm.1905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1905</ArticleId><ArticleId IdType="pmc">PMC2706487</ArticleId><ArticleId IdType="pubmed">19098906</ArticleId></ArticleIdList></Reference><Reference><Citation>Osuchowski MF, Remick DG, Lederer JA, Lang CH, Aasen AO, Aibiki M, Azevedo LC, Bahrami S, Boros M, Cooney R, Cuzzocrea S, Jiang Y, Junger WG, Hirasawa H, Hotchkiss RS, Li XA, Radermacher P, Redl H, Salomao R, Soebandrio A, Thiemermann C, Vincent JL, Ward P, Yao YM, Yu HP, Zingarelli B, Chaudry IH. Abandon the mouse research ship? Not just yet! Shock. 2014;41:463&#x2013;475. doi: 10.1097/SHK.0000000000000153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000153</ArticleId><ArticleId IdType="pmc">PMC4139038</ArticleId><ArticleId IdType="pubmed">24569509</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Z, Trikalinos TA, Kavvoura FK, Lau J, Ioannidis JP. Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PLoS Medicine. 2005;2:e124. doi: 10.1371/journal.pmed.0020334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020334</ArticleId><ArticleId IdType="pmc">PMC1285066</ArticleId><ArticleId IdType="pubmed">16285839</ArticleId></ArticleIdList></Reference><Reference><Citation>Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P, ARISE Investigators. ANZICS Clinical Trials Group Goal-directed resuscitation for patients with early septic shock. The New England Journal of Medicine. 2014;371:1496&#x2013;1506. doi: 10.1056/NEJMoa1404380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1404380</ArticleId><ArticleId IdType="pubmed">25272316</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrazza L, Lunardelli A, Luft C, Cruz CU, de Mesquita FC, Bitencourt S, Nunes FB, de Oliveira JR. Mesenchymal stem cells decrease splenocytes apoptosis in a sepsis experimental model. Inflammation Research. 2014;63:719&#x2013;728. doi: 10.1007/s00011-014-0745-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-014-0745-1</ArticleId><ArticleId IdType="pubmed">24888322</ArticleId></ArticleIdList></Reference><Reference><Citation>Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. The FASEB Journal. 2008;22:659&#x2013;661. doi: 10.1096/fj.07-9574LSF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.07-9574LSF</ArticleId><ArticleId IdType="pubmed">17942826</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochefort GY, Delorme B, Lopez A, H&#xe9;rault O, Bonnet P, Charbord P, Eder V, Domenech J. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells. 2006;24:2202&#x2013;2208. doi: 10.1634/stemcells.2006-0164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/stemcells.2006-0164</ArticleId><ArticleId IdType="pubmed">16778152</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooke EDM, Vesterinen HM, Sena ES, Egan KJ, Macleod MR. Dopamine agonists in animal models of Parkinson&#x2019;s disease: a systematic review and meta-analysis. Parkinsonism &amp; Related Disorders. 2011;17:313&#x2013;320. doi: 10.1016/j.parkreldis.2011.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2011.02.010</ArticleId><ArticleId IdType="pubmed">21376651</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, Bostrom A, Theodoss J, Al-Nakhala BM, Vieira FG, Ramasubbu J, Heywood JA. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis. 2008;9:4&#x2013;15. doi: 10.1080/17482960701856300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701856300</ArticleId><ArticleId IdType="pubmed">18273714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena ES, Currie GL, McCann SK, Macleod MR, Howells DW. Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. Journal of Cerebral Blood Flow &amp; Metabolism. 2014;34:737&#x2013;742. doi: 10.1038/jcbfm.2014.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2014.28</ArticleId><ArticleId IdType="pmc">PMC4013765</ArticleId><ArticleId IdType="pubmed">24549183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biology. 2010;8:e1000344. doi: 10.1371/journal.pbio.1000344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000344</ArticleId><ArticleId IdType="pmc">PMC2846857</ArticleId><ArticleId IdType="pubmed">20361022</ArticleId></ArticleIdList></Reference><Reference><Citation>Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, L&#xf3;pez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG, Inflammation and Host Response to Injury, Large Scale Collaborative Research Program Genomic responses in mouse models poorly mimic human inflammatory diseases. PNAS. 2013;110:3507&#x2013;3512. doi: 10.1073/pnas.1222878110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222878110</ArticleId><ArticleId IdType="pmc">PMC3587220</ArticleId><ArticleId IdType="pubmed">23401516</ArticleId></ArticleIdList></Reference><Reference><Citation>Sep&#xfa;lveda JC, Tom&#xe9; M, Fern&#xe1;ndez ME, Delgado M, Campisi J, Bernad A, Gonz&#xe1;lez MA. Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model. Stem Cells. 2014;32:1865&#xa0;. doi: 10.1002/stem.1654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1654</ArticleId><ArticleId IdType="pmc">PMC4209016</ArticleId><ArticleId IdType="pubmed">24496748</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U, SAINT II Trial Investigators NXY-059 for the treatment of acute ischemic stroke. New England Journal of Medicine. 2007;357:562&#x2013;571. doi: 10.1056/NEJMoa070240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa070240</ArticleId><ArticleId IdType="pubmed">17687131</ArticleId></ArticleIdList></Reference><Reference><Citation>Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Research &amp; Therapy. 2016;7:125. doi: 10.1186/s13287-016-0363-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-016-0363-7</ArticleId><ArticleId IdType="pmc">PMC5007684</ArticleId><ArticleId IdType="pubmed">27581859</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, R&#xfc;cker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. doi: 10.1136/bmj.d4002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d4002</ArticleId><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Critical Care Medicine. 2014;42:625&#x2013;631. doi: 10.1097/CCM.0000000000000026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000026</ArticleId><ArticleId IdType="pmc">PMC4313930</ArticleId><ArticleId IdType="pubmed">24201173</ArticleId></ArticleIdList></Reference><Reference><Citation>Steward O, Popovich PG, Dietrich WD, Kleitman N. Replication and reproducibility in spinal cord injury research. Experimental Neurology. 2012;233:597&#x2013;605. doi: 10.1016/j.expneurol.2011.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.06.017</ArticleId><ArticleId IdType="pubmed">22078756</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Health and Human Services, Food and Drug Administration  . Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products. 2013. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/UCM376521.pdf</Citation></Reference><Reference><Citation>van der Worp HB, Sena ES, Donnan GA, Howells DW, Macleod MR. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain. 2007;130:3063&#x2013;3074. doi: 10.1093/brain/awm083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm083</ArticleId><ArticleId IdType="pubmed">17478443</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter J, Ware LB, Matthay MA. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. The Lancet Respiratory Medicine. 2014;2:1016&#x2013;1026. doi: 10.1016/S2213-2600(14)70217-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70217-6</ArticleId><ArticleId IdType="pubmed">25465643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JF, Cao HC, Pan QL, Yu J, Li J, Li LJ. Mesenchymal stem cells from the human umbilical cord ameliorate fulminant hepatic failure and increase survival in mice. Hepatobiliary &amp; Pancreatic Diseases International. 2015;14:186&#x2013;193. doi: 10.1016/S1499-3872(15)60354-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1499-3872(15)60354-X</ArticleId><ArticleId IdType="pubmed">25865692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Liu D, Gong W, Zhao G, Liu L, Yang L, Hou Y. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143. Stem Cells. 2014;32:521&#x2013;533. doi: 10.1002/stem.1543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1543</ArticleId><ArticleId IdType="pubmed">24105952</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Yang C, Wang H, Li H, Du J, Gu W, Jiang J. Therapeutic effects of bone marrow-derived mesenchymal stem cells on pulmonary impact injury complicated with endotoxemia in rats. International Immunopharmacology. 2013;15:246&#x2013;253. doi: 10.1016/j.intimp.2012.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2012.12.008</ArticleId><ArticleId IdType="pubmed">23273653</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, Li Z, He C, Li R, Xia H, Li C, Xiao J, Chen ZY. Human umbilical cord mesenchymal stem cells and derived hepatocyte-like cells exhibit similar therapeutic effects on an acute liver failure mouse model. PLoS One. 2014;9:e104392. doi: 10.1371/journal.pone.0104392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104392</ArticleId><ArticleId IdType="pmc">PMC4125182</ArticleId><ArticleId IdType="pubmed">25101638</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37674453</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1972-6007</ISSN><JournalIssue CitedMedium="Internet"><Volume>174</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>La Clinica terapeutica</Title><ISOAbbreviation>Clin Ter</ISOAbbreviation></Journal><ArticleTitle>Evaluation of procalcitonin in hemorrhagic shock: a pilot study.</ArticleTitle><Pagination><StartPage>432</StartPage><EndPage>435</EndPage><MedlinePgn>432-435</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7417/CT.2023.2461</ELocationID><Abstract><AbstractText>An increased secretion of procalcitonin (PCT) is primarily due to systemic inflammation of bacterial origin, as PCT is used to diagnose and manage sepsis. However, other conditions can induce high plasma levels of PCT, and hemorrhagic shock may be one of these as we found in clinical practice. The aim of this pilot, observational and prospective study was to investigate the role of PCT in hemorrhagic shock and if it could help in distinguishing between different types of shock. We enrolled 15 patients who entered the shock room of our Emergency Department (ED) with a diagnosis of hemodynamic shock, defined as hypotension (systolic blood pressure &lt; 90 mmHg, or medial arterial pressure &lt; 65 mmHg), and/or elevated lactate level (&gt; 2 mmol/L), with one or more signs of cerebral or systemic hypoperfusion. For all the patients we dosed PCT at the time of admission, and we collected them into three different groups - septic, hemorrhagic and mixed shock - based on clinical presentation and laboratory and instrumental examination. First results did not show a significant increase of PCT in patients with hemorrhagic shock alone (average 0.12 &#xb1; 0.07 ng/mL), while PCT levels were similarly high in those with septic and mixed shock (17.63 &#xb1; 32.16 and 24.62 &#xb1; 33.02 respectively). PCT is not a marker of bleeding shock and does not help in distinguishing if bleeding or sepsis have the major impact on hemodynamics in those with mixed shock. However, patients with sepsis usually access the ED a few days after the initial infectious and inflammatory process has begun, while those with a major bleeding ask for intervention at the very first beginning. Thus, it may be helpful to see is PCT levels rise after some time from the bleeding start, or to investigate a different biomarker that rises earlier in course of systemic disfunction, such as presepsin. Finally, we also aimed at investigating if PCT levels would show any correlation with age of patients, regardless of the type of shock: results provided an higher PCT in individuals &#x2265; 80 years old, than in those &lt; 80 years old.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Piccioni</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valletta</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franza</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manca</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanza</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Foundation "Ospedale Alba-Bra Onlus", Department of Emergency Medicine, Anesthesia and Critical Care Medicine, Michele and Pietro Ferrero Hospital, Verduno Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savioli</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine and Surgery, IRCCS Fondanzione Policlinico San Matteo, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasbarrini</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covino</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franceschi</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Clin Ter</MedlineTA><NlmUniqueID>0372604</NlmUniqueID><ISSNLinking>0009-9074</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000594167">presepsin protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018950">Lipopolysaccharide Receptors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="N">Procalcitonin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012771" MajorTopicYN="Y">Shock, Hemorrhagic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018950" MajorTopicYN="N">Lipopolysaccharide Receptors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hemorrhagic shock</Keyword><Keyword MajorTopicYN="N">procalcitonin</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>3</Hour><Minute>51</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37674453</ArticleId><ArticleId IdType="doi">10.7417/CT.2023.2461</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32824268</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Effects of both Pro- and Synbiotics in Liver Surgery and Transplantation with Special Focus on the Gut-Liver Axis-A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2461</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu12082461</ELocationID><Abstract><AbstractText>The gut-liver axis is of upmost importance for the development of infections after surgery. Further bacterial translocation due to surgery-related dysbiosis is associated with limited detoxification function of the liver compromising outcome of surgical therapy. After liver surgery, about 30% of patients develop a bacterial infection, with the risk of bacteremia or even sepsis-associated liver failure and mortality in &gt;40%. The potential benefit of pro-/synbiotics given before surgery is still under debate. Thus, a systematic literature search on trials comparing patients with or without supplementation and outcome after liver resection or transplantation was performed. Our search strategy revealed 12 relevant studies on perioperative administration of pro-/synbiotics in liver surgery. The pro-/synbiotic combinations and concentrations as well as administration timeframes differed between studies. Five studies were performed in liver transplantation and 7 in liver resection. All studies but one reported lower infection rates (pooled RR: 0.46, 95% CI: 0.31-0.67) with pro-/synbiotics. Liver function was assessed after LT/LR in 3 and 5 studies, respectively. Pro-/synbiotics improved function in 1/3 and 2/5 studies, respectively. Concluding, perioperative pro-/synbiotics clearly reduce infection after liver surgery. However, standard protocols with both well-defined probiotic strain preparations and administration timeframes are pending.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General, Visceral, and Transplant Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pregartner</LastName><ForeName>Gudrun</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schemmer</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>General, Visceral, and Transplant Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056692">Prebiotics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="N">Liver Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056692" MajorTopicYN="N">Prebiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="N">Probiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058616" MajorTopicYN="N">Synbiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">gut&#x2013;liver axis</Keyword><Keyword MajorTopicYN="N">liver surgery</Keyword><Keyword MajorTopicYN="N">liver transplantation</Keyword><Keyword MajorTopicYN="N">pro-/synbiotic</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32824268</ArticleId><ArticleId IdType="pmc">PMC7468972</ArticleId><ArticleId IdType="doi">10.3390/nu12082461</ArticleId><ArticleId IdType="pii">nu12082461</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rayes N., Schutz T., Lochs H. Probiotika, Prabiotika und Synbiotika in der Chirurgie und bei kritisch Kranken auf der Intensivstation. Leberresektion, Transplantation. In: Bischoff S.C., editor. Probiotika, Pr&#xe4;biotika and Synbiotika. 1st ed. Georg Thieme Verlag KG; Stuttgart, Germany: 2009. p. 296.</Citation></Reference><Reference><Citation>Rahbari N.N., Wente M., Schemmer P., Diener M.K., Hoffmann K., Motschall E., Schmidt J., Weitz J., B&#xfc;chler M.W. Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br. J. Surg. 2008;95:424&#x2013;432. doi: 10.1002/bjs.6141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.6141</ArticleId><ArticleId IdType="pubmed">18314921</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahbari N.N., Elbers H., Koch M., Vogler P., Striebel F., Bruckner T., Mehrabi A., Schemmer P., B&#xfc;chler M.W., Weitz J. Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection. Br. J. Surg. 2014;101:200&#x2013;207. doi: 10.1002/bjs.9387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9387</ArticleId><ArticleId IdType="pubmed">24402888</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann K., M&#xfc;ller-B&#xfc;tow V., Franz C., Hinz U., Longerich T., B&#xfc;chler M.W., Schemmer P. Factors predictive of survival after stapler hepatectomy of hepatocellular carcinoma: A multivariate, single-center analysis. Anticancer Res. 2014;34:767&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">24511011</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruns H., Lozanovski V.J., Schultze D., Hillebrand N., Hinz U., B&#xfc;chler M.W., Schemmer P. Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: A multivariate analysis. PLoS ONE. 2014;9:e98782. doi: 10.1371/journal.pone.0098782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0098782</ArticleId><ArticleId IdType="pmc">PMC4048202</ArticleId><ArticleId IdType="pubmed">24905210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann K., Unsinn M., Hinz U., Weiss K.H., Waldburger N., Longerich T., Radeleff B., Schirmacher P., B&#xfc;chler M.W., Schemmer P. Outcome after a liver resection of benign lesions. HPB (Oxford) 2015;17:994&#x2013;1000. doi: 10.1111/hpb.12496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hpb.12496</ArticleId><ArticleId IdType="pmc">PMC4605338</ArticleId><ArticleId IdType="pubmed">26456947</ArticleId></ArticleIdList></Reference><Reference><Citation>Schemmer P., Friess H., B&#xfc;chler M.W. Recent advances in surgical therapy for primary and metastatic liver cancer. Ann. Surg. Hepatol. 2002;7:124&#x2013;133.</Citation></Reference><Reference><Citation>Nickkholgh A., Weitz J., Encke J., Sauer P., Mehrabi A., B&#xfc;chler M.W., Schmidt J., Schemmer P. Utilization of extended donor criteria in liver transplantation: A comprehensive review of the literature. Nephrol. Dial. Transplant. 2007;22:viii29&#x2013;viii36. doi: 10.1093/ndt/gfm654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfm654</ArticleId><ArticleId IdType="pubmed">17890260</ArticleId></ArticleIdList></Reference><Reference><Citation>Schemmer P., Friess H., Dervenis C., Schmidt J., Weitz J., Uhl W., B&#xfc;chler M.W. The use of endo GIA vascular staplers in liver surgery and their potential benefit: A review. Dig. Surg. 2007;24:300&#x2013;305. doi: 10.1159/000103662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000103662</ArticleId><ArticleId IdType="pubmed">17657156</ArticleId></ArticleIdList></Reference><Reference><Citation>Schemmer P., Bruns H., Weitz J., Schmidt J., B&#xfc;chler M.W. Liver transection using vascular stapler: A review. HPB (Oxford) 2008;10:249&#x2013;252. doi: 10.1080/13651820802166930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13651820802166930</ArticleId><ArticleId IdType="pmc">PMC2518299</ArticleId><ArticleId IdType="pubmed">18773103</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S., Hoffmann K., Schemmer P. Treatment of hepatocellular carcinoma: A systematic review. Liver Cancer. 2012;1:144&#x2013;158. doi: 10.1159/000343828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000343828</ArticleId><ArticleId IdType="pmc">PMC3760458</ArticleId><ArticleId IdType="pubmed">24159579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotthardt D.N., Weiss K.H., Rupp C., Bode K., Eckerle I., Rudolph G., Bergemann J., Kloeters-Plachky P., Chahoud F., B&#xfc;chler M.W., et al. Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation. Endoscopy. 2013;45:890&#x2013;896. doi: 10.1055/s-0033-1344713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1344713</ArticleId><ArticleId IdType="pubmed">24165814</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishman J.A. Infection in solid-organ transplant recipients. N. Engl. J. Med. 2007;357:2601&#x2013;2614. doi: 10.1056/NEJMra064928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra064928</ArticleId><ArticleId IdType="pubmed">18094380</ArticleId></ArticleIdList></Reference><Reference><Citation>Xourafas D., Pawlik T.M., Cloyd J.M. Early Morbidity and Mortality after Minimally Invasive Liver Resection for Hepatocellular Carcinoma: A Propensity-Score Matched Comparison with Open Resection. J. Gastrointest. Surg. 2019;23:1435&#x2013;1442. doi: 10.1007/s11605-018-4016-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-018-4016-2</ArticleId><ArticleId IdType="pubmed">30377911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan Y., Su S., Li B., Fang C. Efficacy of probiotics and prebiotics in prevention of infectious complications following hepatic resections: Systematic review and meta-analysis. J. Gastrointest. Liver Dis. 2019;28:205&#x2013;211. doi: 10.15403/jgld-182.</Citation><ArticleIdList><ArticleId IdType="doi">10.15403/jgld-182</ArticleId><ArticleId IdType="pubmed">31204407</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001;29:1303&#x2013;1310. doi: 10.1097/00003246-200107000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaido T., Mori A., Oike F., Mizumoto M., Ogura Y., Hata K., Yoshizawa A., Iida T., Uemoto S. Impact of pretransplant nutritional sta- tus in patients undergoing liver transplantation. Hepatogastroenterology. 2010;57:1489&#x2013;1492.</Citation><ArticleIdList><ArticleId IdType="pubmed">21443108</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N., Paterson D.L., Gayowski T., Wagener M.M., Marino I.R. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transplant. 2000;6:54&#x2013;61. doi: 10.1002/lt.500060112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.500060112</ArticleId><ArticleId IdType="pubmed">10648578</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from through 2000. N. Engl. J. Med. 2003;348:1546&#x2013;1554. doi: 10.1056/NEJMoa022139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022139</ArticleId><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman B.T., Schmidt U., Berman M.F., Bittner E.A. Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery: A large, nationwide sample. Anesthesiology. 2010;112:917&#x2013;925. doi: 10.1097/ALN.0b013e3181cea3d0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181cea3d0</ArticleId><ArticleId IdType="pubmed">20357565</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore L.J., Moore F.A., Todd S.R., Jones S.L., Turner K.L., Bass B.L. Sepsis in general surgery: The 2005&#x2014;National surgical quality improvement program perspective. Arch. Surg. 2010;145:695&#x2013;700. doi: 10.1001/archsurg.2010.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2010.107</ArticleId><ArticleId IdType="pubmed">20644134</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel T.R., Dombrovskiy V.Y., Carson J.L., Graham A.M., Lowry S.F. Postoperative sepsis in the United States. Ann. Surg. 2010;252:1065&#x2013;1071. doi: 10.1097/SLA.0b013e3181dcf36e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181dcf36e</ArticleId><ArticleId IdType="pmc">PMC2951484</ArticleId><ArticleId IdType="pubmed">20571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.J., Martinez E.G., Gregorio G.V., Dans L.F. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst. Rev. 2010;2010:CD003048. doi: 10.1002/14651858.CD003048.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003048.pub3</ArticleId><ArticleId IdType="pmc">PMC6532699</ArticleId><ArticleId IdType="pubmed">21069673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J.S., Bousvaros A., Lee J.W., Diaz A., Davidson E.J. Efficacy of probiotic use in acute diarrhea in children: A meta-analysis. Dig. Dis. Sci. 2002;47:2625&#x2013;2634. doi: 10.1023/A:1020501202369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1020501202369</ArticleId><ArticleId IdType="pubmed">12452406</ArticleId></ArticleIdList></Reference><Reference><Citation>Szajewska H., Mrukowicz J.Z. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: A systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr. 2001;33(Suppl. S2):17&#x2013;25. doi: 10.1097/00005176-200110002-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005176-200110002-00004</ArticleId><ArticleId IdType="pubmed">11698781</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Niel C.W., Feudtner C., Garrison M.M., Christakis D.A. Lactobacillus therapy for acute infectious diarrhea in children: A meta-analysis. Pediatrics. 2002;109:678&#x2013;684. doi: 10.1542/peds.109.4.678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.4.678</ArticleId><ArticleId IdType="pubmed">11927715</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland L.V. Meta-analysis of probiotics for the prevention of traveler&#x2019;s diarrhea. Travel Med. Infect. Dis. 2007;5:97&#x2013;105. doi: 10.1016/j.tmaid.2005.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2005.10.003</ArticleId><ArticleId IdType="pubmed">17298915</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston B.C., Supina A.L., Ospina M., Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev. 2007;2007:CD004827.</Citation><ArticleIdList><ArticleId IdType="pubmed">17443557</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston B.C., Supina A.L., Ospina M., Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: A meta-analysis of randomized placebo-controlled trials. CMAJ. 2006;175:377&#x2013;383. doi: 10.1503/cmaj.051603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.051603</ArticleId><ArticleId IdType="pmc">PMC1534112</ArticleId><ArticleId IdType="pubmed">16908901</ArticleId></ArticleIdList></Reference><Reference><Citation>Szajewska H., Ruszczy&#x144;ski M., Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials. J. Pediatr. 2006;149:367&#x2013;372. doi: 10.1016/j.jpeds.2006.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2006.04.053</ArticleId><ArticleId IdType="pubmed">16939749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremonini F., Di Caro S., Nista E.C., Bartolozzi F., Capelli G., Gasbarrini G., Gasbarrini A. Meta-analysis: The effect of probiotic administration on antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 2002;16:1461&#x2013;1467. doi: 10.1046/j.1365-2036.2002.01318.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2036.2002.01318.x</ArticleId><ArticleId IdType="pubmed">12182746</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza A.L., Rajkumar C., Cooke J., Bulpitt C.J. Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. BMJ. 2002;324:1361. doi: 10.1136/bmj.324.7350.1361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.324.7350.1361</ArticleId><ArticleId IdType="pmc">PMC115209</ArticleId><ArticleId IdType="pubmed">12052801</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrelak J.A., Whitten D.L., Myers S.P. Is Lactobacillus rhamnosus GG effec- tive in preventing the onset of antibiotic-associated diarrhoea: A systematic review. Digestion. 2005;72:51&#x2013;56. doi: 10.1159/000087637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000087637</ArticleId><ArticleId IdType="pubmed">16113542</ArticleId></ArticleIdList></Reference><Reference><Citation>Szajewska H., Mrukowicz J. Meta-analysis: Non-pathogenic yeast Saccharo- myces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 2005;22:365&#x2013;372. doi: 10.1111/j.1365-2036.2005.02624.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2005.02624.x</ArticleId><ArticleId IdType="pubmed">16128673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S.C., Hart A.L., Kamm M.A., Stagg A.J., Knight S.C. Mechanisms of action of probiotics: Recent advances. Inflamm. Bowel Dis. 2009;15:300&#x2013;310. doi: 10.1002/ibd.20602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.20602</ArticleId><ArticleId IdType="pubmed">18626975</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen T.D., Pyrsopoulos N., Rustgi V.K. Microbiota and the liver. Liver Transplant. 2018;24:539&#x2013;550. doi: 10.1002/lt.25008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.25008</ArticleId><ArticleId IdType="pubmed">29316191</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Altman D.G., G&#xf8;tzsche P.C., J&#xfc;ni P., Moher D., Oxman A.D., Savovic J., Schulz K.F., Weeks L., Sterne J.A. Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in dandomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G.A., Shea B., O&#x2019;Connell D. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-Randomised Studies in Meta-Analyses.  [(accessed on 27 October 2017)]; Available online:  http://www.ahri.a/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Gr&#x105;t M., Wronka K.M., Lewandowski Z., Gr&#x105;t K., Krasnod&#x119;bski M., Stypu&#x142;kowski J., Ho&#x142;&#xf3;wko W., Masior &#x141;., Kosi&#x144;ska I., Wasilewicz M., et al. Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo- controlled trial. Clin. Nutr. 2017;36:1530&#x2013;1539. doi: 10.1016/j.clnu.2017.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2017.04.021</ArticleId><ArticleId IdType="pubmed">28506447</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayes N., Seehofer D., Hansen S., Boucsein K., M&#xfc;ller A.R., Serke S., Bengmark S., Neuhaus P. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation. 2002;74:123&#x2013;127. doi: 10.1097/00007890-200207150-00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007890-200207150-00021</ArticleId><ArticleId IdType="pubmed">12134110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayes N., Seehofer D., Theruvath T., Schiller R.A., Langrehr J.M., Jonas S., Bengmark S., Neuhaus P. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation&#x2014;A randomized, double-blind trial. Am. J. Transplant. 2005;5:125&#x2013;130. doi: 10.1111/j.1600-6143.2004.00649.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2004.00649.x</ArticleId><ArticleId IdType="pubmed">15636620</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi S., Takatsuki M., Hidaka M., Soyama A., Ichikawa T., Kanematsu T. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: A prospective randomized study. Am. J. Surg. 2011;201:498&#x2013;502. doi: 10.1016/j.amjsurg.2010.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2010.02.013</ArticleId><ArticleId IdType="pubmed">20619394</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen J., Wu J., Chalson H., Merigan L., Mitchell A. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg. Nutr. 2013;2:142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3924667</ArticleId><ArticleId IdType="pubmed">24570932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanazawa H., Nagino M., Kamiya S., Komatsu S., Mayumi T., Takagi K., Asahara T., Nomoto K., Tanaka R., Nimura Y. Synbiotics reduce postoperative infectious complications: A randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch. Surg. 2005;390:104&#x2013;113. doi: 10.1007/s00423-004-0536-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-004-0536-1</ArticleId><ArticleId IdType="pubmed">15711820</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Li C., Huang M., Tong C., Zhang X., Wang L., Peng H., Lan P., Zhang P., Huang N., et al. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: A double-center and double-blind randomized clinical trial. BMC Gastroenterol. 2015;15:34. doi: 10.1186/s12876-015-0260-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-015-0260-z</ArticleId><ArticleId IdType="pmc">PMC4374379</ArticleId><ArticleId IdType="pubmed">25881090</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifatbegovic Z., Mesic D., Ljuca F., Zildzic M., Avdagic M., Grbic K., Agic M., Hadziefendic B. Effect of probiotics on liver function after surgery resection for malignancy in the liver cirrhotic. Med. Arch. 2010;64:208&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">21246916</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayes N., Pilarski T., Stockmann M., Bengmark S., Neuhaus P., Seehofer D. Effect of pre- and probiotics on liver regeneration after resection: A randomised, double-blind pilot study. Benef. Microbes. 2012;3:237&#x2013;244. doi: 10.3920/BM2012.0006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2012.0006</ArticleId><ArticleId IdType="pubmed">22968413</ArticleId></ArticleIdList></Reference><Reference><Citation>Usami M., Miyoshi M., Kanbara Y., Aoyama M., Sakaki H., Shuno K., Hirata K., Takahashi M., Ueno K., Tabata S., et al. Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. JPEN J. Parenter. Enter. Nutr. 2011;35:317&#x2013;328. doi: 10.1177/0148607110379813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607110379813</ArticleId><ArticleId IdType="pubmed">21527594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugawara G., Nagino M., Nishio H., Ebata T., Takagi K., Asahara T., Nomoto K., Nimura Y. Perioperative Synbiotic Treatment to Prevent Postoperative Infectious Complications in Biliary Cancer Surgery: A Randomized Controlled Trial. Ann. Surg. 2006;244:706&#x2013;714. doi: 10.1097/01.sla.0000219039.20924.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000219039.20924.88</ArticleId><ArticleId IdType="pmc">PMC1856608</ArticleId><ArticleId IdType="pubmed">17060763</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida H., Sasaki M., Maehira H., Mori H., Yasukawa D., Takebayashi K., Kurihara M., Bamba S., Tani M. The effect of preoperative synbiotic treatment to prevent surgical-site infection in hepatic resection. J. Clin. Biochem. Nutr. 2020;66:67&#x2013;73. doi: 10.3164/jcbn.19-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.19-46</ArticleId><ArticleId IdType="pmc">PMC6983438</ArticleId><ArticleId IdType="pubmed">32001959</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawas T., Al Halabi S., Hernaez R., Carey W.D., Cho W.K. Patients Receiving Prebiotics and Probiotics Before Liver Transplantation Develop Fewer Infections Than Controls: A Systematic Review and Meta-Analysis. Clin. Gastroenterol. Hepatol. 2015;13:1567&#x2013;1574. doi: 10.1016/j.cgh.2015.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2015.05.027</ArticleId><ArticleId IdType="pubmed">26044318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 1999;274:10689&#x2013;10692. doi: 10.1074/jbc.274.16.10689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.16.10689</ArticleId><ArticleId IdType="pubmed">10196138</ArticleId></ArticleIdList></Reference><Reference><Citation>Faure E., Equils O., Sieling P.A., Thomas L., Zhang F.X., Kirschning C.J., Polentarutti N., Muzio M., Arditi M. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-and TLR-in endothelial cells. J. Biol. Chem. 2000;275:11058&#x2013;11063. doi: 10.1074/jbc.275.15.11058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.15.11058</ArticleId><ArticleId IdType="pubmed">10753909</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseaux C., Thuru X., Gelot A., Barnich N., Neut C., Dubuqoy L., Dubuquoy C., Merour E., Geboes K., Chamaillard M., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 2007;13:35&#x2013;37. doi: 10.1038/nm1521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1521</ArticleId><ArticleId IdType="pubmed">17159985</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnerty C.C., Mabvuure N.T., Ali A., Kozar R.A., Herndon D.N. The surgically induced stress response. JPEN J. Parenter. Enter. Nutr. 2013;37(Suppl. S5):21S&#x2013;29S. doi: 10.1177/0148607113496117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607113496117</ArticleId><ArticleId IdType="pmc">PMC3920901</ArticleId><ArticleId IdType="pubmed">24009246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury A.H., Adiamah A., Kushairi A., Varadhan K.K., Krznaric Z., Kulkarni A.D., Neal K.R., Lobo D.N. Perioperative Probiotics or Synbiotics in Adults Undergoing Elective Abdominal Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Ann. Surg. 2020;271:1036&#x2013;1047. doi: 10.1097/SLA.0000000000003581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000003581</ArticleId><ArticleId IdType="pubmed">31469748</ArticleId></ArticleIdList></Reference><Reference><Citation>Skonieczna-&#x17b;ydecka K., Kaczmarczyk M., &#x141;oniewski I., Lara L.F., Koulaouzidis A., Misera A., Maciejewska D., Marlicz W. A Systematic Review, Meta-Analysis, and Meta-Regression Evaluating the Efficacy and Mechanisms of Action of Probiotics and Synbiotics in the Prevention of Surgical Site Infections and Surgery-Related Complications. J. Clin. Med. 2018;7:556. doi: 10.3390/jcm7120556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7120556</ArticleId><ArticleId IdType="pmc">PMC6307089</ArticleId><ArticleId IdType="pubmed">30558358</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran C.P., Musa S.A., Rahman T.M. The use of probiotics in the surgical patient. Eur. Surg. 2011;44:91&#x2013;98. doi: 10.1007/s10353-011-0613-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10353-011-0613-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T., Shirabe K., Yoshiya S., Matono R., Morita K., Hashimoto N., Ikegami T., Yoshizumi T., Baba H., Maehara Y. Nutrition Support and Infections Associated With Hepatic Resection and Liver Transplantation in Patients With Chronic Liver Disease. J. Parenter. Enter. Nutr. 2012;37:318&#x2013;326. doi: 10.1177/0148607112456041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607112456041</ArticleId><ArticleId IdType="pubmed">22898793</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnabl B., Brenner D.A. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146:1513&#x2013;1524. doi: 10.1053/j.gastro.2014.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2014.01.020</ArticleId><ArticleId IdType="pmc">PMC3996054</ArticleId><ArticleId IdType="pubmed">24440671</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Duan Z.P., Ha D.K., Bengmark S., Kurtovic J., Riordan S.M. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441&#x2013;1449. doi: 10.1002/hep.20194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.20194</ArticleId><ArticleId IdType="pubmed">15122774</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath A., Leber B., Schmerboeck B., Tawdrous M., Zettel G., Hartl A., Madl T., Stryeck S., Fuchs D., Lemesch S., et al. Randomised clinical trial: The effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment. Pharmacol. Ther. 2016;44:926&#x2013;935. doi: 10.1111/apt.13788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.13788</ArticleId><ArticleId IdType="pmc">PMC5053220</ArticleId><ArticleId IdType="pubmed">27593544</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh D.C., Wu C.C., Ho W.M., Cheng S.B., Lu I.Y., Liu T.J., P&#x2019;eng F.K. Bacterial translocation after cirrhotic liver resection: A clinical investigation of patients. J. Surg. Res. 2003;111:209&#x2013;214. doi: 10.1016/S0022-4804(03)00112-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-4804(03)00112-4</ArticleId><ArticleId IdType="pubmed">12850464</ArticleId></ArticleIdList></Reference><Reference><Citation>Viehman J.A., Clancy C.J., Clarke L., Shields R.K., Silveira F.P., Kwak E.J., Vergidis P., Hughes C., Humar A., Nguyen M.H. Surgical site infections after liver transplantation: Emergence of multidrug-resistant bacteria and implications for prophylaxis and treatment strategies. Transplantation. 2016;100:2107&#x2013;2114. doi: 10.1097/TP.0000000000001356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000001356</ArticleId><ArticleId IdType="pubmed">27479167</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgenson M.R., Descourouez J.L., Siodlak M., Tjugum S., Rice J.P., Fernandez L.A. Efficacy and Safety of Probiotics and Synbiotics in Liver Transplantation. Pharmacotherapy. 2018;38:758&#x2013;768. doi: 10.1002/phar.2130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.2130</ArticleId><ArticleId IdType="pubmed">29804307</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29887194</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8171</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The American journal of emergency medicine</Title><ISOAbbreviation>Am J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Interleukin-6 as a diagnostic marker for infection in critically ill patients: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>260</StartPage><EndPage>265</EndPage><MedlinePgn>260-265</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajem.2018.05.040</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-6757(18)30418-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">The ability of blood levels of interleukin (IL)-6 to differentiate between infection and non-infection in critically ill patients with suspected infection is unclear. We assessed the diagnostic accuracy of serum IL-6 levels for the diagnosis of infection in critically ill patients.</AbstractText><AbstractText Label="METHODS">We systematically searched the PubMed, MEDLINE, Cochrane Resister of Controlled Trials, Cochrane Database of Systematic Reviews, CINAHL, and Igaku Chuo Zasshi databases for studies published from 1986 to August 2016 that evaluated the accuracy of IL-6 levels for the diagnosis of infection. We constructed 2&#x202f;&#xd7;&#x202f;2 tables and calculated summary estimates of sensitivity and specificity using a bivariate random-effects model.</AbstractText><AbstractText Label="RESULTS">The literature search identified 775 articles, six of which with a total of 527 patients were included according to the predefined criteria. The pooled sensitivity, specificity, and diagnostic odds ratio were 0.73 (95% confidence interval [CI], 0.61-0.82), 0.76 (95% CI, 0.61-0.87), and 2.31 (95% CI, 1.20-3.48), respectively. The area under the curve (AUC) of the summary receiver operator characteristic (SROC) curve was 0.81 (95% CI, 0.78-0.85). In the secondary analysis of two studies with a total of 263 adult critically ill patients with organ dysfunction, the pooled sensitivity, specificity, and diagnostic odds ratio were 0.81 (95% CI, 0.75-0.86), 0.77 (95% CI, 0.67-0.84), and 2.87 (95% CI 2.15-3.60), respectively.</AbstractText><AbstractText Label="CONCLUSIONS">Blood levels of IL-6 have a moderate diagnostic value and a potential clinical utility to differentiate infection in critically ill patients with suspected infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iwase</LastName><ForeName>Shinya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8677, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakada</LastName><ForeName>Taka-Aki</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8677, Japan. Electronic address: taka.nakada@chiba-u.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hattori</LastName><ForeName>Noriyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8677, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Waka</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8677, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Nozomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8677, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aizimu</LastName><ForeName>Tuerxun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Frontier Medical Engineering, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hemodialysis and Surgery, Chemotherapy Research Institute, Kaken Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morizane</LastName><ForeName>Toshio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Japan Council for Quality Health Care, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oda</LastName><ForeName>Shigeto</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8677, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Emerg Med</MedlineTA><NlmUniqueID>8309942</NlmUniqueID><ISSNLinking>0735-6757</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Critically ill patients</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Organ dysfunction</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29887194</ArticleId><ArticleId IdType="doi">10.1016/j.ajem.2018.05.040</ArticleId><ArticleId IdType="pii">S0735-6757(18)30418-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31858518</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-9064</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Seminars in thrombosis and hemostasis</Title><ISOAbbreviation>Semin Thromb Hemost</ISOAbbreviation></Journal><ArticleTitle>Immature Platelets As a Predictor of Disease Severity and Mortality in Sepsis and Septic Shock: A Systematic Review.</ArticleTitle><Pagination><StartPage>320</StartPage><EndPage>327</EndPage><MedlinePgn>320-327</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0039-3400256</ELocationID><Abstract><AbstractText>Sepsis is associated with high morbidity and mortality, and short-term mortality remains above 30% despite relevant supportive and antibiotic treatments. The aim of this systematic review was to summarize and discuss the current evidence of the association of an increased number of circulating immature platelets with disease severity and mortality in patients with sepsis or septic shock. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and was registered at the PROSPERO database (registration number: CRD42018104326). A systematic literature search was performed in PubMed, Web of Science, Scopus, and Embase on June 20, 2018, without time restrictions. The included studies were quality-assessed by the National Institutes of Health's Quality Assessment Tools. In total, 14 studies were included. The parameters used for the determination of platelet maturity were mean platelet volume, immature platelets fraction, reticulated platelet percentage, and absolute immature platelets count. Nine studies reported significantly increased immature platelet markers in nonsurvivors of septic shock compared with survivors, as well as in patients with severe sepsis or septic shock compared with patients without severe sepsis and septic shock. Six of these nine studies demonstrated that increased immature platelet markers were predictors of mortality and/or disease severity (area under the receiver operating curve: 0.599-0.886). This review suggests that an increased number of circulating immature platelets is associated with increased disease severity and mortality in patients with sepsis and septic shock. Larger studies are needed to confirm whether immature platelets should be routinely monitored to support the prediction of disease severity and mortality in septic patients.</AbstractText><CopyrightInformation>Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thorup</LastName><ForeName>Christian Velling</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency, Randers Regional Hospital, Randers, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hvas</LastName><ForeName>Anne-Mette</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Semin Thromb Hemost</MedlineTA><NlmUniqueID>0431155</NlmUniqueID><ISSNLinking>0094-6176</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001792" MajorTopicYN="N">Blood Platelets</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None of the authors has any conflicts of interest regarding this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31858518</ArticleId><ArticleId IdType="doi">10.1055/s-0039-3400256</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26535507</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-1815</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>11</Issue><PubDate><Year>2015</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Pediatric emergency care</Title><ISOAbbreviation>Pediatr Emerg Care</ISOAbbreviation></Journal><ArticleTitle>Colloids for the Initial Management of Severe Sepsis and Septic Shock in Pediatric Patients: A Systematic Review.</ArticleTitle><Pagination><StartPage>e11</StartPage><EndPage>e16</EndPage><MedlinePgn>e11-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PEC.0000000000000601</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The goal of this study was to perform a systematic review of the literature assessing the use of colloids for the initial treatment of severe sepsis and septic shock in pediatric patients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">The PICO [Patient, Intervention, Comparison, Outcome] method was used for the selection of studies, and the Cochrane Bias Tool was used to analyze the quality of the selected studies.</AbstractText><AbstractText Label="DATA SEARCH" NlmCategory="UNASSIGNED">Relevant studies were sought using the following databases: EMBASE (1980 to March 2014), PubMed (1970 to March 2014), Cochrane (1980 to March 2014), Web of Science, and Scopus. Searches used the following key words: isotonic solution, crystalloid, saline solution, colloid, resuscitation, fluid therapy, sepsis and septic shock, starch, and gelatin. The filters children and clinical trial were used when possible.</AbstractText><AbstractText Label="REVIEW METHOD" NlmCategory="METHODS">Study selection was performed by 1 examiner. The selected articles were analyzed by 2 examiners who validated the articles according to the Cochrane Bias Tool. Discrepancies were resolved by consensus or by a third examiner.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">A total of 110 articles were selected based on the key words. Of these, 99 were excluded because they assessed postoperative follow-up, burn cases, cardiac surgery, or nutritional therapy or were review articles, guidelines, or editorials. One study was included after an analysis of previous reviews. A total of 12 articles were selected for analysis because they were reports of clinical trials conducted with prospective cohorts and they analyzed the use of crystalloids and colloids or colloids only in the initial treatment of severe sepsis or septic shock in children and adolescents. The total number of patients was 4375, and they ranged in age from 2 months to 15 years, with most patients between 5 and 15 years. Five studies assessed patients diagnosed with malaria, 5 assessed patients with dengue shock syndrome, 1 studied febrile diseases, and 1 examined the progression of patients with septic shock caused by various causes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The studies analyzed did not find evidence to suggest that the use of colloids is superior to crystalloids. In some studies, the fluid volume needed to achieve initial stabilization was smaller in the group given colloids. Crystalloids are the preferred therapeutic option because of their effectiveness, low cost, and wide availability. Colloids may be the first choice in cases of malaria when the central nervous system is affected.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Medeiros</LastName><ForeName>Daniela Nasu Monteiro</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>From the *Pediatric Intensive Care Unit, Hospital Municipal Dr Mois&#xe9;s Deutsch-M Boi Mirim; &#x2020;Pediatric Intensive Care Unit, Hospital Israelita Albert Einstein; and &#x2021;Pediatric Intensive Care Department, Instituto da Crian&#xe7;a, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferranti</LastName><ForeName>Juliana Ferreira</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Delgado</LastName><ForeName>Artur Figueiredo</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>de Carvalho</LastName><ForeName>Werther Brunow</ForeName><Initials>WB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Emerg Care</MedlineTA><NlmUniqueID>8507560</NlmUniqueID><ISSNLinking>0749-5161</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003102">Colloids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Pediatr Emerg Care. 2016 Apr;32(4):e10. doi: 10.1097/PEC.0000000000000772.</RefSource><PMID Version="1">27028948</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003102" MajorTopicYN="N">Colloids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26535507</ArticleId><ArticleId IdType="doi">10.1097/PEC.0000000000000601</ArticleId><ArticleId IdType="pii">00006565-201511000-00018</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29049073</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>125</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Outcomes in Obstructive Sleep Apnea Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis of Comparative Studies.</ArticleTitle><Pagination><StartPage>2030</StartPage><EndPage>2037</EndPage><MedlinePgn>2030-2037</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000002558</ELocationID><Abstract><AbstractText Label="BACKGROUND">Obstructive sleep apnea (OSA) is a common comorbidity in patients undergoing cardiac surgery and may predispose patients to postoperative complications. The purpose of this meta-analysis is to determine the evidence of postoperative complications associated with OSA patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS">A literature search of Cochrane Database of Systematic Reviews, Medline, Medline In-process, Web of Science, Scopus, EMBASE, Cochrane Central Register of Controlled Trials, and CINAHL until October 2016 was performed. The search was constrained to studies in adult cardiac surgical patients with diagnosed or suspected OSA. All included studies must report at least 1 postoperative complication. The primary outcome is major adverse cardiac or cerebrovascular events (MACCEs) up to 30 days after surgery, which includes death from all-cause mortality, myocardial infarction, myocardial injury, nonfatal cardiac arrest, revascularization process, pulmonary embolism, deep venous thrombosis, newly documented postoperative atrial fibrillation (POAF), stroke, and congestive heart failure. Secondary outcome is newly documented POAF. The other exploratory outcomes include the following: (1) postoperative tracheal intubation and mechanical ventilation; (2) infection and/or sepsis; (3) unplanned intensive care unit (ICU) admission; and (4) duration of stay in hospital and ICU. Meta-analysis and meta- regression were conducted using Cochrane Review Manager 5.3 (Cochrane, London, UK) and OpenBUGS v3.0, respectively.</AbstractText><AbstractText Label="RESULTS">Eleven comparative studies were included (n = 1801 patients; OSA versus non-OSA: 688 vs 1113, respectively). MACCEs were 33.3% higher odds in OSA versus non-OSA patients (OSA versus non-OSA: 31% vs 10.6%; odds ratio [OR], 2.4; 95% confidence interval [CI], 1.38-4.2; P = .002). The odds of newly documented POAF (OSA versus non-OSA: 31% vs 21%; OR, 1.94; 95% CI, 1.13-3.33; P = .02) was higher in OSA compared to non-OSA. Even though the postoperative tracheal intubation and mechanical ventilation (OSA versus non-OSA: 13% vs 5.4%; OR, 2.67; 95% CI, 1.03-6.89; P = .04) were significantly higher in OSA patients, the length of ICU stay and hospital stay were not significantly prolonged in patients with OSA compared to non-OSA. The majority of OSA patients were not treated with continuous positive airway pressure therapy. Meta-regression and sensitivity analysis of the subgroups did not impact the OR of postoperative complications for OSA versus non-OSA groups.</AbstractText><AbstractText Label="CONCLUSIONS">Our meta-analysis demonstrates that after cardiac surgery, MACCEs and newly documented POAF were 33.3% and 18.1% higher odds in OSA versus non-OSA patients, respectively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nagappa</LastName><ForeName>Mahesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Perioperative Medicine, London Health Sciences Centre and St Joseph Health Care, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patra</LastName><ForeName>Jayadeep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Mandeep</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaw</LastName><ForeName>Roop</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departments of Hospital Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outcomes Research (Anesthesiology), Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Davy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Medical Evidence, Decision Integrity and Clinical Impact (MEDICI), Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Frances</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2018 Jul;127(1):315-317. doi: 10.1213/ANE.0000000000003383.</RefSource><PMID Version="1">29677056</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2018 Jul;127(1):314-315. doi: 10.1213/ANE.0000000000003382.</RefSource><PMID Version="1">29677064</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="N">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29049073</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000002558</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35344150</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1128-045X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Techniques in coloproctology</Title><ISOAbbreviation>Tech Coloproctol</ISOAbbreviation></Journal><ArticleTitle>Surgical outcomes of Turnbull-Cutait delayed coloanal anastomosis with pull-through versus immediate coloanal anastomosis with diverting stoma after total mesorectal excision for low rectal cancer: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>603</StartPage><EndPage>613</EndPage><MedlinePgn>603-613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10151-022-02601-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Theoretical advantages of Turnbull-Cutait pull-through delayed coloanal anastomosis (DCAA) are a reduced risk of anastomotic leak and therefore avoidance of stoma. Gradually abandoned in favor of immediate coloanal anastomosis (ICAA) with diverting stoma, DCAA has regained popularity in recent years in reconstructive surgery for low RC, especially when combined with minimally invasive surgery (MIS). The aim of this study was to perform the first meta-analysis, exploring the safety and outcomes of DCAA compared to ICAA with protective stoma.</AbstractText><AbstractText Label="METHODS">A systematic search of MEDLINE, EMBASE, and CENTRAL and Google Scholar databases was performed for studies published from January 2000 until December 2020. The systematic review and meta-analysis were performed according to the Cochrane Handbook for Systematic Review on Interventions recommendations and Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines.</AbstractText><AbstractText Label="RESULTS">Out of 2626 studies screened, 9 were included in the systematic review and 4 studies in the meta-analysis. Outcomes included were postoperative complications, pelvic sepsis and risk of definitive stoma. Considering postoperative complications classified as Clavien-Dindo III, no significant difference existed in the rate of postoperative morbidity between DCAA and ICAA (13% versus 21%; OR 1.17; 95% CI 0.38-3.62; p&#x2009;=&#x2009;0.78; I<sup>2</sup>&#x2009;=&#x2009;20%). Patients in the DCAA group experienced a lower rate of postoperative pelvic sepsis compared with patients undergoing ICAA with diverting stoma (7% versus 14%; OR 0.37; 95% CI 0.16-0.85; p&#x2009;=&#x2009;0.02; I<sup>2</sup>&#x2009;=&#x2009;0%). The risk of definitive stoma was comparable between the two groups (2% versus 2% OR 0.77; 95% CI 0.15-3.85; p&#x2009;=&#x2009;0.75; I<sup>2</sup>&#x2009;=&#x2009;0%).</AbstractText><AbstractText Label="CONCLUSIONS">According to the limited current evidence, DCAA is associated with a significant decrease in pelvic sepsis. Further prospective trials focusing on oncologic and functional outcomes are needed.</AbstractText><CopyrightInformation>&#xa9; 2022. Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>La Raja</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foppa</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maroli</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontovounisios</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Royal Marsden Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben David</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvello</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinelli</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1493-1768</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. antonino.spinelli@hunimed.eu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy. antonino.spinelli@hunimed.eu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Tech Coloproctol</MedlineTA><NlmUniqueID>9613614</NlmUniqueID><ISSNLinking>1123-6337</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001003" MajorTopicYN="N">Anal Canal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="N">Anastomotic Leak</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anastomotic leak</Keyword><Keyword MajorTopicYN="N">Delayed coloanal anastomosis</Keyword><Keyword MajorTopicYN="N">Diverting stoma</Keyword><Keyword MajorTopicYN="N">Pull-through</Keyword><Keyword MajorTopicYN="N">Rectal cancer</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>28</Day><Hour>12</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35344150</ArticleId><ArticleId IdType="doi">10.1007/s10151-022-02601-4</ArticleId><ArticleId IdType="pii">10.1007/s10151-022-02601-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rullier E, Denost Q, Vendrely V, Rullier A, Laurent C (2013) Low rectal cancer. Dis Colon Rectum. https://doi.org/10.1097/DCR.0b013e31827c4a8c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0b013e31827c4a8c</ArticleId><ArticleId IdType="pubmed">23575394</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksen MT, Wibe A, Norstein J, Haffner J, Wiig JN (2005) Anastomotic leakage following routine mesorectal excision for rectal cancer in a national cohort of patients. Colorectal Dis. https://doi.org/10.1111/j.1463-1318.2004.00700.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1463-1318.2004.00700.x</ArticleId><ArticleId IdType="pubmed">15606585</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell SW et al (2003) Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence. Br J Surg. https://doi.org/10.1002/bjs.4219</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.4219</ArticleId><ArticleId IdType="pubmed">14515297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna MH, Vinci A, Pigazzi A (2015) Diverting ileostomy in colorectal surgery: when is it necessary? Langenbeck&#x2019;s Arch Surg. https://doi.org/10.1007/s00423-015-1275-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-015-1275-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthiessen P, Hallb&#xf6;&#xf6;k O, Ruteg&#xe5;rd J, Simert G, Sj&#xf6;dahl R (2007) Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer. Ann Surg. https://doi.org/10.1097/SLA.0b013e3180603024</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3180603024</ArticleId><ArticleId IdType="pubmed">17667498</ArticleId><ArticleId IdType="pmc">1933561</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisarska M et al (2018) Defunctioning ileostomy reduces leakage rate in rectal cancer surgery&#x2014;systematic review and meta-analysis. Oncotarget. https://doi.org/10.18632/oncotarget.25015</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.25015</ArticleId><ArticleId IdType="pubmed">29755692</ArticleId><ArticleId IdType="pmc">5945534</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg PK, Goel A, Sharma S, Chishi N, Gaur MK (2019) Protective diversion stoma in low anterior resection for rectal cancer: a meta-analysis of randomized controlled trials. Visc Med. https://doi.org/10.1159/000497168</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000497168</ArticleId><ArticleId IdType="pubmed">31367612</ArticleId><ArticleId IdType="pmc">6616072</ArticleId></ArticleIdList></Reference><Reference><Citation>Gessler B, Haglind E, Angenete E (2012) Loop ileostomies in colorectal cancer patients&#x2013;morbidity and risk factors for nonreversal. J Surg Res. https://doi.org/10.1016/j.jss.2012.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2012.08.018</ArticleId><ArticleId IdType="pubmed">22940030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Deeb A-P, Rickles AS, Iannuzzi JC, Monson JRT, Fleming FJ (2013) Closure of defunctioning loop ileostomy is associated with considerable morbidity. Colorectal Dis. https://doi.org/10.1111/codi.12029</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.12029</ArticleId><ArticleId IdType="pubmed">23398663</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielsen AK et al (2017) Early closure of a temporary ileostomy in patients with rectal cancer. Ann Surg. https://doi.org/10.1097/SLA.0000000000001829</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001829</ArticleId><ArticleId IdType="pubmed">27322187</ArticleId></ArticleIdList></Reference><Reference><Citation>Man VCM, Choi HK, Law WL, Foo DCC (2016) Morbidities after closure of ileostomy: analysis of risk factors. Int J Colorectal Dis. https://doi.org/10.1007/s00384-015-2327-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-015-2327-2</ArticleId><ArticleId IdType="pubmed">26245947</ArticleId></ArticleIdList></Reference><Reference><Citation>Munakata S et al (2017) &#x201c;Defunctioning loop ileostomy with restorative proctocolectomy for rectal cancer: friend or foe?&#x201d; J Anus Rectum Colon. https://doi.org/10.23922/jarc.2017-023</Citation><ArticleIdList><ArticleId IdType="doi">10.23922/jarc.2017-023</ArticleId><ArticleId IdType="pubmed">31583314</ArticleId></ArticleIdList></Reference><Reference><Citation>Murken D, Bleier J (2019) Ostomy-related complications. Clin Colon Rectal Surg. https://doi.org/10.1055/s-0038-1676995</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1676995</ArticleId><ArticleId IdType="pubmed">31061647</ArticleId><ArticleId IdType="pmc">6494607</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD (1999) Quality of life in stoma patients. Dis Colon Rectum. https://doi.org/10.1007/BF02236209</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02236209</ArticleId><ArticleId IdType="pubmed">10613475</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaz-Alkaya S (2019) Overview of psychosocial problems in individuals with stoma: a review of literature. Int Wound J. https://doi.org/10.1111/iwj.13018</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iwj.13018</ArticleId><ArticleId IdType="pubmed">30392194</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull RB, Cuthbertson A (1961) Abdominorectal pull-through resection for cancer and for hirschsprung&#x2019;s disease: delayed posterior colorectal anastomosis. Clevel Clin J Med. https://doi.org/10.3949/ccjm.28.2.109</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.28.2.109</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutait DE, Figliolini FJ (1961) A new method of colorectal anastomosis in abdominoperineal resection. Dis Colon Rectum. https://doi.org/10.1007/BF02627230</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02627230</ArticleId><ArticleId IdType="pubmed">13892805</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight CD, Griffen FD (1980) An improved technique for low anterior resection of the rectum using the EEA stapler. Surgery 88(5):710&#x2013;714</Citation><ArticleIdList><ArticleId IdType="pubmed">7434211</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks AG (1972) Transanal technique in low rectal anasto. Proc R Soc Med 65(11):975&#x2013;976</Citation><ArticleIdList><ArticleId IdType="pubmed">4565861</ArticleId><ArticleId IdType="pmc">1644685</ArticleId></ArticleIdList></Reference><Reference><Citation>Remzi FH, el Gazzaz G, Kiran RP, Kirat HT, Fazio VW (2009) Outcomes following Turnbull-Cutait abdominoperineal pull-through compared with coloanal anastomosis. Br J Surg. https://doi.org/10.1002/bjs.6458</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.6458</ArticleId><ArticleId IdType="pubmed">19358179</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallet J et al (2014) Anastomotic salvage after rectal cancer resection using the Turnbull-Cutait delayed anastomosis. Can J Surg. https://doi.org/10.1503/cjs.001014</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cjs.001014</ArticleId><ArticleId IdType="pubmed">25421083</ArticleId><ArticleId IdType="pmc">4245271</ArticleId></ArticleIdList></Reference><Reference><Citation>Patsouras D, Yassin NA, Phillips RKS (2014) Clinical outcomes of colo-anal pull-through procedure for complex rectal conditions. Colorectal Dis. https://doi.org/10.1111/codi.12532</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.12532</ArticleId><ArticleId IdType="pubmed">25160680</ArticleId></ArticleIdList></Reference><Reference><Citation>Fixot K, Galifet M, Scherrer M-L, Germain A, Bresler L (2014) Abdominoperineal pull-through resection with delayed coloanal anastomosis as treatment option for complex recto-urinary fistulas. Int J Colorectal Dis. https://doi.org/10.1007/s00384-013-1787-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-013-1787-5</ArticleId><ArticleId IdType="pubmed">24162720</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianco F, Belli A, de Franciscis S, Falato A, Romano GM (2016) &#x2018;Scarless&#x2019; and no-stoma surgery for low rectal cancer: the laparoscopic pull-through delayed &#x2018;high&#x2019; colo-anal anastomosis. Updates Surg. https://doi.org/10.1007/s13304-016-0358-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13304-016-0358-z</ArticleId><ArticleId IdType="pubmed">27040273</ArticleId></ArticleIdList></Reference><Reference><Citation>Sage P-Y, Trilling B, Waroquet P-A, Voirin D, Girard E, Faucheron J-L (2018) Laparoscopic delayed coloanal anastomosis without diverting ileostomy for low rectal cancer surgery: 85 consecutive patients from a single institution. Tech Coloproctol. https://doi.org/10.1007/s10151-018-1813-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10151-018-1813-2</ArticleId><ArticleId IdType="pubmed">30413997</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarry J, Faucheron JL, Moreno W, Bellera CA, Evrard S (2011) Delayed colo-anal anastomosis is an alternative to prophylactic diverting stoma after total mesorectal excision for middle and low rectal carcinomas. Eur J Surg Oncol (EJSO). https://doi.org/10.1016/j.ejso.2010.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2010.12.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagne E et al (2000) Functional results of delayed coloanal anastomosis after preoperative radiotherapy for lower third rectal cancer11No competing interests declared. J Am Coll Surg. https://doi.org/10.1016/S1072-7515(00)00756-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1072-7515(00)00756-0</ArticleId><ArticleId IdType="pubmed">11129813</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallet J, Milot H, Drolet S, Desrosiers E, Gr&#xe9;goire RC, Bouchard A (2014) The clinical results of the Turnbull-Cutait delayed coloanal anastomosis: a systematic review. Tech Coloproctol. https://doi.org/10.1007/s10151-014-1132-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10151-014-1132-1</ArticleId><ArticleId IdType="pubmed">24615720</ArticleId></ArticleIdList></Reference><Reference><Citation>Portale G, Popesc GO, Parotto M, Cavallin F (2019) Delayed colo-anal anastomosis for rectal cancer: pelvic morbidity, functional results and oncological outcomes: a systematic review. World J Surg. https://doi.org/10.1007/s00268-019-04918-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-019-04918-y</ArticleId><ArticleId IdType="pubmed">30690655</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021)., vol. Cochrane. 2021. Accessed: May 19, 2021. [Online]. Available: from www.training.cochrane.org/handbook</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. https://doi.org/10.1371/journal.pmed.1000097</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pubmed">19753108</ArticleId><ArticleId IdType="pmc">2735783</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications. Ann Surg. https://doi.org/10.1097/01.sla.0000133083.54934.ae</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000133083.54934.ae</ArticleId><ArticleId IdType="pubmed">15570203</ArticleId><ArticleId IdType="pmc">1356513</ArticleId></ArticleIdList></Reference><Reference><Citation>Review Manager (RevMan) (2014) The Nordic Cochrane Centre. The Cochrane Collaboration, Copenhagen</Citation></Reference><Reference><Citation>Xiong Y, Huang P, Ren QG (2016) Transanal pull-through procedure with delayed versus immediate coloanal anastomosis for anus-preserving curative resection of lower rectal cancer: a case-control study. Am Surg 82(6):533&#x2013;539</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481608200615</ArticleId></ArticleIdList></Reference><Reference><Citation>Guner OS, Tumay LV (2021) &lt;scp&gt;Turnbull&#x2013;Cutait&lt;/scp&gt; technique without ileostomy after total mesorectal excision is associated with acceptably low early post-operative morbidity. ANZ J Surg. https://doi.org/10.1111/ans.16412</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.16412</ArticleId><ArticleId IdType="pubmed">33124139</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujahari AK, Anand S (2015) Trans-anal exteriorisation of colon and delayed colo-anal anastomosis for sphincter preservation in low carcinoma rectum. Int J Colorectal Dis. https://doi.org/10.1007/s00384-014-2059-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-014-2059-8</ArticleId><ArticleId IdType="pubmed">25370156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois M-O et al (2020) Delayed coloanal anastomosis: an alternative option for restorative rectal cancer surgery after high-dose pelvic radiotherapy for prostate cancer. Colorectal Dis. https://doi.org/10.1111/codi.15144</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.15144</ArticleId><ArticleId IdType="pubmed">32463973</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondo S et al (2020) Two-stage turnbull-cutait pull-through coloanal anastomosis for low rectal cancer. JAMA Surg. https://doi.org/10.1001/jamasurg.2020.1625</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2020.1625</ArticleId><ArticleId IdType="pubmed">32492131</ArticleId><ArticleId IdType="pmc">7270870</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow A, Tilney HS, Paraskeva P, Jeyarajah S, Zacharakis E, Purkayastha S (2009) The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6107 cases. Int J Colorectal Dis. https://doi.org/10.1007/s00384-009-0660-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-009-0660-z</ArticleId><ArticleId IdType="pubmed">19221766</ArticleId></ArticleIdList></Reference><Reference><Citation>Celerier B, Denost Q, van Geluwe B, Pontallier A, Rullier E (2016) The risk of definitive stoma formation at 10 years after low and ultralow anterior resection for rectal cancer. Colorectal Dis. https://doi.org/10.1111/codi.13124</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.13124</ArticleId><ArticleId IdType="pubmed">26391723</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino N et al (2018) Nomogram for predicting anastomotic leakage after low anterior resection for rectal cancer. Int J Colorectal Dis. https://doi.org/10.1007/s00384-018-2970-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-018-2970-5</ArticleId><ArticleId IdType="pubmed">29411120</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekkis P et al (2015) Hand-sewn coloanal anastomosis for low rectal cancer: technique and long-term outcome. Colorectal Dis. https://doi.org/10.1111/codi.13028</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.13028</ArticleId><ArticleId IdType="pubmed">26096142</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin ST, Heneghan HM, Winter DC (2012) Systematic review of outcomes after intersphincteric resection for low rectal cancer. Br J Surg. https://doi.org/10.1002/bjs.8677</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.8677</ArticleId><ArticleId IdType="pubmed">23148025</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H et al (2018) The severity of anastomotic leakage may negatively impact the long-term prognosis of colorectal cancer. Anticancer Res. https://doi.org/10.21873/anticanres.12255</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/anticanres.12255</ArticleId><ArticleId IdType="pubmed">30504409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange MM, van de Velde CJH (2008) Faecal and urinary incontinence after multimodality treatment of rectal cancer. PLoS Med. https://doi.org/10.1371/journal.pmed.0050202</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050202</ArticleId><ArticleId IdType="pubmed">18842066</ArticleId><ArticleId IdType="pmc">2561075</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26558621</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>11</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials.</ArticleTitle><Pagination><StartPage>e0142605</StartPage><MedlinePgn>e0142605</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0142605</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0142605</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Hypotensive state is frequently observed in several critical conditions. If an adequate mean arterial pressure is not promptly restored, insufficient tissue perfusion and organ dysfunction may develop. Fluids and catecholamines are the cornerstone of critical hypotensive states management. Catecholamines side effects such as increased myocardial oxygen consumption and development of arrhythmias are well known. Thus, in recent years, interest in catecholamine-sparing agents such as vasopressin, terlipressin and methylene blue has increased; however, few randomized trials, mostly with small sample sizes, have been performed. We therefore conducted a meta-analysis of randomized trials to investigate the effect of non-catecholaminergic vasopressors on mortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, BioMed Central and Embase were searched (update December 31st, 2014) by two independent investigators. Inclusion criteria were: random allocation to treatment, at least one group receiving a non-catecholaminergic vasopressor, patients with or at risk for vasodilatory shock. Exclusion criteria were: crossover studies, pediatric population, non-human studies, studies published as abstract only, lack of data on mortality. Studied drugs were vasopressin, terlipressin and methylene blue. Primary endpoint was mortality at the longest follow-up available.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1,608 patients from 20 studies were included in our analysis. The studied settings were sepsis (10/20 studies [50%]), cardiac surgery (7/20 [35%]), vasodilatory shock due to any cause (2/20 [19%]), and acute traumatic injury (1/20 [5%]). Overall, pooled estimates showed that treatment with non-catecholaminergic agents improves survival (278/810 [34.3%] versus 309/798 [38.7%], risk ratio = 0.88, 95% confidence interval = 0.79 to 0.98, p = 0.02). None of the drugs was associated with significant reduction in mortality when analyzed independently. Results were not confirmed when analyzing studies with a low risk of bias.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Catecholamine-sparing agents in patients with or at risk for vasodilatory shock may improve survival. Further researches on this topic are needed to confirm the finding.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musu</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences "M. Aresu", Cagliari University, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silvetti</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saleh</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajjar</LastName><ForeName>Ludhmila A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Surgical Intensive Care Unit, Department of Cardiopneumology, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Academician EN Meshalkin Novosibirsk State Budget Research Institute of Circulation Pathology, Novosibirsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finco</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences "M. Aresu", Cagliari University, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>11000-17-2</RegistryNumber><NameOfSubstance UI="D014667">Vasopressins</NameOfSubstance></Chemical><Chemical><RegistryNumber>50-57-7</RegistryNumber><NameOfSubstance UI="D008236">Lypressin</NameOfSubstance></Chemical><Chemical><RegistryNumber>7Z5X49W53P</RegistryNumber><NameOfSubstance UI="D000077585">Terlipressin</NameOfSubstance></Chemical><Chemical><RegistryNumber>T42P99266K</RegistryNumber><NameOfSubstance UI="D008751">Methylene Blue</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008236" MajorTopicYN="N">Lypressin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008751" MajorTopicYN="N">Methylene Blue</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012769" MajorTopicYN="N">Shock</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077585" MajorTopicYN="N">Terlipressin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014667" MajorTopicYN="N">Vasopressins</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26558621</ArticleId><ArticleId IdType="pmc">PMC4641698</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0142605</ArticleId><ArticleId IdType="pii">PONE-D-15-29442</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119: 507&#x2013;15. 10.1097/ALN.0b013e3182a10e26</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a10e26</ArticleId><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M, Asfar P, Radermacher P, Vincent JL, Martin C. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature. Crit Care. 2015;19: 101 10.1186/s13054-015-0794-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0794-z</ArticleId><ArticleId IdType="pmc">PMC4355573</ArticleId><ArticleId IdType="pubmed">25888071</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39: 165&#x2013;228. 10.1007/s00134-012-2769-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2769-8</ArticleId><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgoin A, Leone M, Delmas A, Garnier F, Alban&#xe8;se J, Martin C. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med. 2005;33: 780&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15818105</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362: 779&#x2013;89. 10.1056/NEJMoa0907118</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0907118</ArticleId><ArticleId IdType="pubmed">20200382</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;nser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24: 293&#x2013;316. 10.1177/0885066609340519</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066609340519</ArticleId><ArticleId IdType="pubmed">19703817</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittinger CA, Torgersen C, Luckner G, Schr&#xf6;der DC, Lorenz I, D&#xfc;nser MW. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med. 2012;38: 950&#x2013;8. 10.1007/s00134-012-2531-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2531-2</ArticleId><ArticleId IdType="pubmed">22527060</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy B, Collin S, Sennoun N, Ducrocq N, Kimmoun A, Asfar P, et al. Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside. Intensive Care Med. 2010;36: 2019&#x2013;29. 10.1007/s00134-010-2045-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-010-2045-8</ArticleId><ArticleId IdType="pubmed">20862451</ArticleId></ArticleIdList></Reference><Reference><Citation>Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345: 588&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">11529214</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, H&#xe9;bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358: 877&#x2013;87. 10.1056/NEJMoa067373</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa067373</ArticleId><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi E, Park M, Azevedo LC. Therapeutic strategies for high-dose vasopressor-dependent shock. Crit Care Res Pract. 2013;2013: 654708 10.1155/2013/654708</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/654708</ArticleId><ArticleId IdType="pmc">PMC3787628</ArticleId><ArticleId IdType="pubmed">24151551</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasin L, Umbrello M, Greco T, Zambon M, Pappalardo F, Crivellari M, et al. Methylene blue as a vasopressor: a meta-analysis of randomised trials. Crit Care Resusc. 2013;15: 42&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23432501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavigne D. Vasopressin and methylene blue: alternate therapies in vasodilatory shock. Semin Cardiothorac Vasc Anesth. 2010;14: 186&#x2013;9. 10.1177/1089253210379271</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1089253210379271</ArticleId><ArticleId IdType="pubmed">20705641</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Bellomo R, Langenberg C, Haase M, Haase A, Doolan L, et al. Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review. Ann Thorac Surg. 2007;83: 715&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">17258030</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondi-Zoccai GG, Agostoni P, Abbate A, Testa L, Burzotta F. A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials. Int J Epidemiol. 2005;34: 224&#x2013;5; author reply 225.</Citation><ArticleIdList><ArticleId IdType="pubmed">15659479</ArticleId></ArticleIdList></Reference><Reference><Citation>
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.  Available: www.cochrane-handbook.org.</Citation></Reference><Reference><Citation>Biondi-Zoccai G, Landoni G, Modena MG. A journey into clinical evidence: from case reports to mixed treatment comparisons. HSR Proc Intensive Care Cardiovasc Anesth. 2011;3: 93&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484626</ArticleId><ArticleId IdType="pubmed">23441269</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondi-Zoccai G, Lotrionte M, Landoni G, Modena MG. The rough guide to systematic reviews and meta-analyses. HSR Proc Intensive Care Cardiovasc Anesth. 2011;3: 161&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484632</ArticleId><ArticleId IdType="pubmed">23439862</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6: e1000100 10.1371/journal.pmed.1000100</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000100</ArticleId><ArticleId IdType="pmc">PMC2707010</ArticleId><ArticleId IdType="pubmed">19621070</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco T, Zangrillo A, Biondi-Zoccai G, Landoni G. Meta-analysis: pitfalls and hints. Heart Lung Vessel. 2013;5: 219&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3868184</ArticleId><ArticleId IdType="pubmed">24364016</ArticleId></ArticleIdList></Reference><Reference><Citation>Alban&#xe8;se J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med. 2005;33: 1897&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">16148457</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohn SM, McCarthy J, Stewart RM, Jonas RB, Dent DL, Michalek JE. Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg. 2011;35: 430&#x2013;9. 10.1007/s00268-010-0875-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-010-0875-8</ArticleId><ArticleId IdType="pubmed">21161222</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;nser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107: 2313&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12732600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasija S, Makhija N, Choudhury M, Hote M, Chauhan S, Kiran U. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2010;24: 230&#x2013;8. 10.1053/j.jvca.2009.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2009.08.001</ArticleId><ArticleId IdType="pubmed">19875309</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua F, Wang X, Zhu L. Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock. J Emerg Med. 2013;44: 434&#x2013;9. 10.1016/j.jemermed.2012.02.073</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2012.02.073</ArticleId><ArticleId IdType="pmc">PMC9904411</ArticleId><ArticleId IdType="pubmed">22921855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbj&#xf8;rnsson B, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001;29: 1860&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11588440</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauzier F, L&#xe9;vy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med. 2006;32: 1782&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17019548</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004;77: 496&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14759425</ArticleId></ArticleIdList></Reference><Reference><Citation>Luckner G, D&#xfc;nser MW, Stadlbauer KH, Mayr VD, Jochberger S, Wenzel V, et al. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care. 2006;10: R40</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1550871</ArticleId><ArticleId IdType="pubmed">16542484</ArticleId></ArticleIdList></Reference><Reference><Citation>Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47: 699&#x2013;703; discussion 703&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10528604</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslow AD, Stearns G, Butala P, Schwartz CS, Gough J, Singh AK. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg. 2006;103: 2&#x2013;8, table of contents.</Citation><ArticleIdList><ArticleId IdType="pubmed">16790616</ArticleId></ArticleIdList></Reference><Reference><Citation>Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care. 2002;30: 755&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">12500513</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DL, Garrido MJ, Madigan JD, Helman DN, Faber J, Williams MR, et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003;75: 926&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">12645718</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Lange M, D&#xfc;nser M, Rehberg S, Van Aken H, et al. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth. 2008;100: 494&#x2013;503. 10.1093/bja/aen017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen017</ArticleId><ArticleId IdType="pubmed">18308741</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13: R130 10.1186/cc7990</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7990</ArticleId><ArticleId IdType="pmc">PMC2750187</ArticleId><ArticleId IdType="pubmed">19664253</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto Y, Nohmi T, Higa Y, Seki K, Yamashita A. Vasopressin Does Not Raise Cardiac Enzymes Following Cardiac Surgery: A Randomized Double-Blind Clinical Trial. J Cardiothorac Vasc Anesth. 2014. 10.1053/j.jvca.2014.07.007 In press</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2014.07.007</ArticleId><ArticleId IdType="pubmed">25440643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozal E, Kuralay E, Yildirim V, Kilic S, Bolcal C, K&#xfc;c&#xfc;karslan N, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005;79: 1615&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15854942</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos G, Sintou E, Siminelakis S, Koletsis E, Baikoussis NG, Apostolakis E. Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study. J Cardiothorac Surg. 2010; 5:17 10.1186/1749-8090-5-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-5-17</ArticleId><ArticleId IdType="pmc">PMC2855562</ArticleId><ArticleId IdType="pubmed">20346182</ArticleId></ArticleIdList></Reference><Reference><Citation>Svoboda P, Scheer P, Kantorov&#xe1; I, Doubek J, Dudra J, Radvan M, et al. Terlipressin in the treatment of late phase catecholamine-resistant septic shock. Hepatogastroenterology. 2012;59: 1043&#x2013;7. 10.5754/hge10550</Citation><ArticleIdList><ArticleId IdType="doi">10.5754/hge10550</ArticleId><ArticleId IdType="pubmed">22580654</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29: 1303&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2010;376: 1339&#x2013;46. 10.1016/S0140-6736(10)60446-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60446-1</ArticleId><ArticleId IdType="pmc">PMC7136988</ArticleId><ArticleId IdType="pubmed">20934212</ArticleId></ArticleIdList></Reference><Reference><Citation>Waechter J, Kumar A, Lapinsky SE, Marshall J, Dodek P, Arabi Y, et al. Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med. 2014;42: 2158&#x2013;68. 10.1097/CCM.0000000000000520</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000520</ArticleId><ArticleId IdType="pubmed">25072761</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr VD, D&#xfc;nser MW, Greil V, Jochberger S, Luckner G, Ulmer H, et al. Causes of death and determinants of outcome in critically ill patients. Crit Care. 2006;10: R154</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1794454</ArticleId><ArticleId IdType="pubmed">17083735</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Takanashi M, Gallagher E, Fuse A, Suzaki S, Inagaki O, et al. Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med. 1995;21: 204&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">7790605</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA. Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care. 2011;15: 226 10.1186/cc8224</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8224</ArticleId><ArticleId IdType="pmc">PMC3387647</ArticleId><ArticleId IdType="pubmed">21892977</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35: 33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">17133186</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Gordon AC, Cooper DJ, H&#xe9;bert PC, Singer J, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med. 2009;37: 811&#x2013;8. 10.1097/CCM.0b013e3181961ace</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181961ace</ArticleId><ArticleId IdType="pubmed">19237882</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;nser MW, Mayr AJ, Stallinger A, Ulmer H, Ritsch N, Knotzer H, et al. Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med. 2002;28: 746&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">12107681</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, et al. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 2010;36: 83&#x2013;91. 10.1007/s00134-009-1687-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1687-x</ArticleId><ArticleId IdType="pubmed">19841897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014;42: 1325&#x2013;33. 10.1097/CCM.0000000000000212</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000212</ArticleId><ArticleId IdType="pubmed">24557425</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Ashby D, Brett SJ. Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH). BMJ Open. 2014;4: e005866 10.1136/bmjopen-2014-005866</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005866</ArticleId><ArticleId IdType="pmc">PMC4091463</ArticleId><ArticleId IdType="pubmed">24993769</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Pietropaoli P, Westphal M. Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock. Expert Opin Pharmacother. 2009;10: 2569&#x2013;75. 10.1517/14656560903257808</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14656560903257808</ArticleId><ArticleId IdType="pubmed">19735216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange M, Ertmer C, Westphal M. Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med. 2008;34: 821&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">18066524</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Nassar AP, Cardoso SO, Manetta JA, Pereira VG, Esp&#xf3;sito DC, et al. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care. 2012;16: R154 10.1186/cc11469</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11469</ArticleId><ArticleId IdType="pmc">PMC3580743</ArticleId><ArticleId IdType="pubmed">22889256</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer B, Brunner F, Schmidt K. Novel actions of methylene blue. Eur Heart J. 1993;14 Suppl I: 22&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7507438</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang DH, Nelson LS, Hoffman RS. Methylene blue for distributive shock: a potential new use of an old antidote. J Med Toxicol. 2013;9: 242&#x2013;9. 10.1007/s13181-013-0298-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13181-013-0298-7</ArticleId><ArticleId IdType="pmc">PMC3770994</ArticleId><ArticleId IdType="pubmed">23580172</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner MM, Lin HM, Danforth D, Rao S, Hosseinian L, Fischer GW. Methylene blue is associated with poor outcomes in vasoplegic shock. J Cardiothorac Vasc Anesth. 2013;27: 1233&#x2013;8. 10.1053/j.jvca.2013.02.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.02.026</ArticleId><ArticleId IdType="pubmed">23972738</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Pasin L, Di Prima AL, Dossi R, Taddeo D, Zangrillo A. Methylene blue: between scylla (meta-analysis) and charybdis (propensity). J Cardiothorac Vasc Anesth. 2014;28: e12&#x2013;3. 10.1053/j.jvca.2013.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.12.012</ArticleId><ArticleId IdType="pubmed">24630472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A, Putzu A, Monaco F, Oriani A, Frau G, De Luca M, et al. Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials. J Crit Care. 2015. 10.1016/j.jcrc.2015.05.017 In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.05.017</ArticleId><ArticleId IdType="pubmed">26093802</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehberg S, Ertmer C, Vincent JL, Spiegel HU, K&#xf6;hler G, Erren M, et al. Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med. 2010;38: 2016&#x2013;23. 10.1097/CCM.0b013e3181ef4694</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181ef4694</ArticleId><ArticleId IdType="pubmed">20657271</ArticleId></ArticleIdList></Reference><Reference><Citation>Polito A, Parisini E, Ricci Z, Picardo S, Annane D. Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med. 2012;38: 9&#x2013;19. 10.1007/s00134-011-2407-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2407-x</ArticleId><ArticleId IdType="pubmed">22127480</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar S, Zedan A, Nugent K. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci. 2015;349: 80&#x2013;8. 10.1097/MAJ.0000000000000341</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAJ.0000000000000341</ArticleId><ArticleId IdType="pubmed">25247756</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino EA, Winterton D, Nardelli P, Pasin L, Calabr&#xf2; MG, Bove T, et al. The Blue Coma: the role of methylene blue in unexplained coma after cardiac surgery. A case series. J Cardiothorac Vasc Anesth. 2015. doi: 10.1053/j.jvca.2015.09.011 In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.09.011</ArticleId><ArticleId IdType="pubmed">26703972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28527564</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-4119</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>7</Issue><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery</Title><ISOAbbreviation>J Craniomaxillofac Surg</ISOAbbreviation></Journal><ArticleTitle>Prospective comparison of perioperative antibiotic management protocols in oncological head and neck surgery.</ArticleTitle><Pagination><StartPage>1078</StartPage><EndPage>1082</EndPage><MedlinePgn>1078-1082</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcms.2017.04.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1010-5182(17)30133-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The adequate perioperative antibiotic prophylaxis in head and neck cancer surgery is an important and easy applicable tool to decrease nosocomial morbidity and mortality by reducing the rate of infections. In the study a strictly perioperative antibiosis is compared with an extended postoperative prophylactic antibiosis. We aim to clarify the value of postoperative prophylactic antibiosis for the recovery and clinical course of patients.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">In this prospective study 75 consecutive patients, who underwent major oncological head and neck surgery were included and divided in three groups, each containing 25 patients. The first group received peri- and postoperative antibiotic prophylaxis (POAP) from the day of operation until the fifth day postoperatively. The second group was treated with perioperative antibiotic prophylaxis (PEAP) only. The third group received perioperative antibiotic prophylaxis and increased local antiseptic care (PAPAC). General anamnestic data was collected, as well as duration of hospitalisation, stay on intensive care unit, rate and type of infections, surgical closure of the tracheostomy, and postoperative blood parameters.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no statistically significant differences in general diseases or extent of surgery between the groups. There were statistically significant fewer patients suffering from surgical site infections in subjects with POAP (n&#xa0;=&#xa0;1) in comparison to PEAP (n&#xa0;=&#xa0;9; p&#xa0;=&#xa0;0.011) and PAPAC (n&#xa0;=&#xa0;9; p&#xa0;=&#xa0;0.011). In contrast, other nosocomial infections (pneumonia, urinary tract infection, sepsis) did not decrease under a prolonged antibiotic prophylaxis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Based on findings of the study, we recommend an extended postoperative antibiotic prophylaxis for patients undergoing major oncological head and neck surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bartella</LastName><ForeName>Alexander K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, RWTH Aachen University, Pauwelsstra&#xdf;e 30, 52074 Aachen, Germany. Electronic address: abartella@ukaachen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamal</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, RWTH Aachen University, Pauwelsstra&#xdf;e 30, 52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teichmann</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, RWTH Aachen University, Pauwelsstra&#xdf;e 30, 52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kloss-Brandst&#xe4;tter</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, RWTH Aachen University, Pauwelsstra&#xdf;e 30, 52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steiner</LastName><ForeName>Timm</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, RWTH Aachen University, Pauwelsstra&#xdf;e 30, 52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf6;lzle</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, RWTH Aachen University, Pauwelsstra&#xdf;e 30, 52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lethaus</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, RWTH Aachen University, Pauwelsstra&#xdf;e 30, 52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Craniomaxillofac Surg</MedlineTA><NlmUniqueID>8704309</NlmUniqueID><ISSNLinking>1010-5182</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006258" MajorTopicYN="N">Head and Neck Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotic prophylaxis</Keyword><Keyword MajorTopicYN="N">Head and neck cancer surgery</Keyword><Keyword MajorTopicYN="N">OSCC</Keyword><Keyword MajorTopicYN="N">Surgical side infections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28527564</ArticleId><ArticleId IdType="doi">10.1016/j.jcms.2017.04.001</ArticleId><ArticleId IdType="pii">S1010-5182(17)30133-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23876943</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-6749</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Season>Jun-Jul</Season></PubDate></JournalIssue><Title>Medicina intensiva</Title><ISOAbbreviation>Med Intensiva</ISOAbbreviation></Journal><ArticleTitle>Protein C zymogen in adults with severe sepsis or septic shock.</ArticleTitle><Pagination><StartPage>278</StartPage><EndPage>282</EndPage><MedlinePgn>278-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medin.2013.04.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0210-5691(13)00106-X</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Activated protein C is associated with a risk of bleeding and its effects on survival in septic shock patients are questionable. Protein C zymogen has no risk of bleeding and improves the outcome of patients with septic shock. We hereby describe the largest published case series of adult patients receiving protein C zymogen.</AbstractText><AbstractText Label="DESIGN, SETTING AND PARTICIPANTS" NlmCategory="METHODS">A prospective study on 23 adult patients with severe sepsis or septic shock, two or more organ failures and at high risk for bleeding, treated with protein C zymogen (50IU/kg bolus followed by continuous infusion of 3IU/kg/h for 72h).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Z-test evidenced a significant reduction between the expected mortality (53%) and the observed mortality 30% (Z value=1.99, p=0.046) in our sample population. Protein C levels increased from 34&#xb1;18% to 66&#xb1;22% at 6h after PC bolus (p&lt;0.001), and kept on increasing during 72h of administration (p&lt;0.001 to baseline). Sequential Organ Failure Assessment (SOFA), score of organ dysfunction, decreased from baseline to 7 days after administration of protein C from 14&#xb1;2 to 7&#xb1;4 (p&lt;0.001). No adverse event drug related was noted.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Protein C zymogen administration is safe and its use in septic patients should be investigated through a randomized controlled trial.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Espa&#xf1;a, S.L. and SEMICYUC. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crivellari</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silvetti</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerli</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappalardo</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Intensiva</MedlineTA><NlmUniqueID>9207689</NlmUniqueID><ISSNLinking>0210-5691</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004792">Enzyme Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011486">Protein C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004792" MajorTopicYN="N">Enzyme Precursors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011486" MajorTopicYN="N">Protein C</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bleeding</Keyword><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Cuidados cr&#xed;ticos</Keyword><Keyword MajorTopicYN="N">Cuidados intensivos</Keyword><Keyword MajorTopicYN="N">Hemorragia</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Protein C zymogen</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Zim&#xf3;geno de prote&#xed;na C</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23876943</ArticleId><ArticleId IdType="doi">10.1016/j.medin.2013.04.005</ArticleId><ArticleId IdType="pii">S0210-5691(13)00106-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35967816</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-861X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in nutrition</Title><ISOAbbreviation>Front Nutr</ISOAbbreviation></Journal><ArticleTitle>The effect of intravenous vitamin C on clinical outcomes in patients with sepsis or septic shock: A meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>964484</StartPage><MedlinePgn>964484</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">964484</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnut.2022.964484</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Vitamin C deficiency is common among patients with sepsis and has been associated with poor clinical outcomes. Nevertheless, the effect of intravenous (IV) vitamin C for the treatment of sepsis remains controversial. The purpose of this meta-analysis was to evaluate the effect of IV vitamin C in patients with sepsis or septic shock.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Electronic databases (PubMed, Embase, Scopus, and Cochrane Library) were searched from inception through May 25, 2022 for randomized controlled trials evaluating the effect of IV vitamin C treatment in patients with sepsis. The primary outcome was short-term mortality, and secondary outcomes including the duration of vasopressor, length of intensive care unit (ICU) stay, and Sequential Organ Failure Assessment (SOFA) score after vitamin C treatment. Subgroup analyses were performed based on the type of disease, dose and duration of IV vitamin C.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 10 studies were included, with a total sample of 755 septic patients. The IV vitamin C was associated with a significant reduction in the short-term mortality (OR 0.51, 95% CI 0.37-0.69, <i>I</i> <sup>2</sup> = 0%) and duration of vasopressor (MD -27.88, 95% CI -49.84 to -5.92, <i>I</i> <sup>2</sup> = 95%). The length of ICU stay (MD -0.68, 95% CI -2.13 to 0.78, <i>I</i> <sup>2</sup> = 74%) and SOFA score (MD -0.05, 95% CI -1.69 to 1.58, <i>I</i> <sup>2</sup> = 86%) were not significantly different between two groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In patients with sepsis or septic shock, the IV vitamin C reduced the short-term mortality rate and duration of vasopressor, with no effect on the length of ICU stay and SOFA score. Further trials are required to explore the optimal dosage and duration of IV vitamin C.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">https://inplasy.com/inplasy-2022-6-0013/, identifier INPLASY202260013.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Zhu, Xu, Zhang and Ye.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Huiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Lishui People's Hospital, Lishui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiaoya</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Lishui People's Hospital, Lishui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Qiaoping</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Lishui People's Hospital, Lishui, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nutr</MedlineTA><NlmUniqueID>101642264</NlmUniqueID><ISSNLinking>2296-861X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ascorbic acid</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword><Keyword MajorTopicYN="N">vitamin C</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>15</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35967816</ArticleId><ArticleId IdType="pmc">PMC9366349</ArticleId><ArticleId IdType="doi">10.3389/fnut.2022.964484</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. (2016) 315:801&#x2013;10. 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. (2021) 49:e1063&#x2013;143. 10.1097/ccm.0000000000005337</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0000000000005337</ArticleId><ArticleId IdType="pubmed">34605781</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med. (2016) 193:259&#x2013;72. 10.1164/rccm.201504-0781OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201504-0781OC</ArticleId><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority - a who resolution. N Engl J Med. (2017) 377:414&#x2013;7. 10.1056/NEJMp1707170</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1707170</ArticleId><ArticleId IdType="pubmed">28658587</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the global burden of disease study. Lancet. (2020) 395:200&#x2013;11. 10.1016/s0140-6736(19)32989-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(19)32989-7</ArticleId><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. JAMA. (2018) 319:62&#x2013;75. 10.1001/jama.2017.17687</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.17687</ArticleId><ArticleId IdType="pmc">PMC5839473</ArticleId><ArticleId IdType="pubmed">29297082</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald EL, Badke CM, Hintz LK, Spewak M, Sanchez-Pinto LN. Vitamin therapy in sepsis. Pediatr Res. (2022) 91:328&#x2013;36. 10.1038/s41390-021-01673-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-021-01673-6</ArticleId><ArticleId IdType="pmc">PMC8325544</ArticleId><ArticleId IdType="pubmed">34333556</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AC, Maggini S. Vitamin c and immune function. Nutrients. (2017) 9:1211. 10.3390/nu9111211</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111211</ArticleId><ArticleId IdType="pmc">PMC5707683</ArticleId><ArticleId IdType="pubmed">29099763</ArticleId></ArticleIdList></Reference><Reference><Citation>Spoelstra-de Man AME, Elbers PWG, Oudemans-van Straaten HM. Making sense of early high-dose intravenous vitamin C in ischemia/reperfusion injury. Crit Care. (2018) 22:70. 10.1186/s13054-018-1996-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-1996-y</ArticleId><ArticleId IdType="pmc">PMC5861638</ArticleId><ArticleId IdType="pubmed">29558975</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AC, Shaw GM, Fowler AA, Natarajan R. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care. (2015) 19:418. 10.1186/s13054-015-1131-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1131-2</ArticleId><ArticleId IdType="pmc">PMC4661979</ArticleId><ArticleId IdType="pubmed">26612352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JX. Evaluation of vitamin C for adjuvant sepsis therapy. Antioxid Redox Signal. (2013) 19:2129&#x2013;40. 10.1089/ars.2013.5401</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5401</ArticleId><ArticleId IdType="pmc">PMC3869437</ArticleId><ArticleId IdType="pubmed">23682970</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher BJ, Kraskauskas D, Martin EJ, Farkas D, Wegelin JA, Brophy D, et al. Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid. Am J Physiol Lung Cell Mol Physiol. (2012) 303:L20&#x2013;32. 10.1152/ajplung.00300.2011</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00300.2011</ArticleId><ArticleId IdType="pubmed">22523283</ArticleId></ArticleIdList></Reference><Reference><Citation>Galley HF, Walker BE, Howdle PD, Webster NR. Regulation of nitric oxide synthase activity in cultured human endothelial cells: effect of antioxidants. Free Radic Biol Med. (1996) 21:97&#x2013;101. 10.1016/0891-5849(95)02216-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0891-5849(95)02216-3</ArticleId><ArticleId IdType="pubmed">8791097</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Salanti G, Belletti A, Bellomo R, Carr A, Furukawa TA, et al. Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis. Intensive Care Med. (2022) 48:16&#x2013;24. 10.1007/s00134-021-06558-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06558-0</ArticleId><ArticleId IdType="pmc">PMC8724116</ArticleId><ArticleId IdType="pubmed">34750650</ArticleId></ArticleIdList></Reference><Reference><Citation>Assouline B, Faivre A, Verissimo T, Sangla F, Berchtold L, Giraud R, et al. Thiamine, ascorbic acid, and hydrocortisone as a metabolic resuscitation cocktail in sepsis: a meta-analysis of randomized controlled trials with trial sequential analysis. Crit Care Med. (2021) 49:2112&#x2013;20. 10.1097/ccm.0000000000005262</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0000000000005262</ArticleId><ArticleId IdType="pubmed">34582409</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao R, Zhu Y, Yu Y, Li Z, Wang L, Zheng L, et al. Combination therapy of thiamine, vitamin C and hydrocortisone in treating patients with sepsis and septic shock: a meta-analysis and trial sequential analysis. Burns Trauma. (2021) 9:tkab040. 10.1093/burnst/tkab040</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/burnst/tkab040</ArticleId><ArticleId IdType="pmc">PMC8660008</ArticleId><ArticleId IdType="pubmed">34901285</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayed Y, Alzghoul BN, Banifadel M, Venigandla H, Hyde R, Sutchu S, et al. Vitamin C, thiamine, and hydrocortisone in the treatment of sepsis: a meta-analysis and trial sequential analysis of randomized controlled trials. J Intensive Care Med. (2022) 37:327&#x2013;36. 10.1177/0885066620987809</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066620987809</ArticleId><ArticleId IdType="pubmed">33511898</ArticleId></ArticleIdList></Reference><Reference><Citation>Na W, Shen H, Li Y, Qu D. Hydrocortisone, ascorbic acid, and thiamine (HAT) for sepsis and septic shock: a meta-analysis with sequential trial analysis. J Intensive Care. (2021) 9:75. 10.1186/s40560-021-00589-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-021-00589-x</ArticleId><ArticleId IdType="pmc">PMC8684090</ArticleId><ArticleId IdType="pubmed">34922637</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai B, Lv X, Lin M, Feng C, Chen C. Clinical efficacy and safety of vitamin C in the treatment of septic shock patients: systematic review and meta-analysis. Ann Palliat Med. (2022) 11:1369&#x2013;80. 10.21037/apm-22-225</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-22-225</ArticleId><ArticleId IdType="pubmed">35523745</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Zeng J, Li DH, Yang GY, Wang K, Deng HF, et al. Efficacy of intravenous vitamin C intervention for septic patients: a systematic review and meta-analysis based on randomized controlled trials. Am J Emerg Med. (2021) 50:242&#x2013;50. 10.1016/j.ajem.2021.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.08.012</ArticleId><ArticleId IdType="pubmed">34416515</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. The cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. (2011) 343:d5928. 10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ.(2003) 327:557&#x2013;60. 10.1136/bmj.327.7414.557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. (1997) 315:629&#x2013;34. 10.1136/bmj.315.7109.629</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JJ, Ortiz-Reyes A, Dhaliwal R, Clarke J, Hill A, Stoppe C, et al. IV Vitamin C in critically ill patients: a systematic review and meta-analysis. Crit Care Med. (2022) 50:e304&#x2013;12. 10.1097/ccm.0000000000005320</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0000000000005320</ArticleId><ArticleId IdType="pubmed">34637420</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung SY, Lee MT, Baek MS, Kim WY. Vitamin C for &#x2265; 5 days is associated with decreased hospital mortality in sepsis subgroups: a nationwide cohort study. Crit Care. (2022) 26:3. 10.1186/s13054-021-03872-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03872-3</ArticleId><ArticleId IdType="pmc">PMC8728994</ArticleId><ArticleId IdType="pubmed">34983595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferr&#xf3;n-Celma I, Mansilla A, Hassan L, Garcia-Navarro A, Comino AM, Bueno P, et al. Effect of vitamin C administration on neutrophil apoptosis in septic patients after abdominal surgery. J Surg Res. (2009) 153:224&#x2013;30. 10.1016/j.jss.2008.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2008.04.024</ArticleId><ArticleId IdType="pubmed">18952228</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AA, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. (2014) 12:32. 10.1186/1479-5876-12-32</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-12-32</ArticleId><ArticleId IdType="pmc">PMC3937164</ArticleId><ArticleId IdType="pubmed">24484547</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AA, III, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, et al. effect of vitamin c infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the citris-ali randomized clinical trial. JAMA. (2019) 322:1261&#x2013;70. 10.1001/jama.2019.11825</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.11825</ArticleId><ArticleId IdType="pmc">PMC6777268</ArticleId><ArticleId IdType="pubmed">31573637</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv SJ, Zhang GH, Xia JM, Yu H, Zhao F. Early use of high-dose vitamin C is beneficial in treatment of sepsis. Ir J Med Sci. (2021) 190:1183&#x2013;8. 10.1007/s11845-020-02394-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-020-02394-1</ArticleId><ArticleId IdType="pubmed">33094466</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoodpoor A, Shadvar K, Sanaie S, Hadipoor MR, Pourmoghaddam MA, Saghaleini SH. Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study. BMC Infect Dis. (2021) 21:616. 10.1186/s12879-021-06288-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06288-0</ArticleId><ArticleId IdType="pmc">PMC8240083</ArticleId><ArticleId IdType="pubmed">34187382</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosengrave P, Spencer E, Williman J, Mehrtens J, Morgan S, Doyle T, et al. Intravenous vitamin C administration to patients with septic shock: a pilot randomised controlled trial. Crit Care. (2022) 26:26. 10.1186/s13054-022-03900-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-03900-w</ArticleId><ArticleId IdType="pmc">PMC8786621</ArticleId><ArticleId IdType="pubmed">35073968</ArticleId></ArticleIdList></Reference><Reference><Citation>Wacker DA, Burton SL, Berger JP, Hegg AJ, Heisdorffer J, Wang Q, et al. Evaluating Vitamin C in Septic Shock: a randomized controlled trial of Vitamin c monotherapy. Crit Care Med. (2022) 50:e458&#x2013;67. 10.1097/CCM.0000000000005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005427</ArticleId><ArticleId IdType="pmc">PMC9005102</ArticleId><ArticleId IdType="pubmed">34982738</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabet MH, Mohammadi M, Ramezani M, Khalili H. Effect of high-dose ascorbic acid on vasopressor&#x2019;s requirement in septic shock. J Res Pharm Pract. (2016) 5:94&#x2013;100. 10.4103/2279-042X.179569</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2279-042X.179569</ArticleId><ArticleId IdType="pmc">PMC4843590</ArticleId><ArticleId IdType="pubmed">27162802</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, et al. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care. (2021) 11:5. 10.1186/s13613-020-00792-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00792-3</ArticleId><ArticleId IdType="pmc">PMC7794643</ArticleId><ArticleId IdType="pubmed">33420963</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib NT, Ahmed I. Early Adjuvant Intravenous Vitamin C Treatment in Septic Shock may Resolve the Vasopressor Dependence. Int J Microbiol Adv Immunol. (2017) 5:77&#x2013;81. 10.19070/2329-9967-1700015</Citation><ArticleIdList><ArticleId IdType="doi">10.19070/2329-9967-1700015</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. (2014) 14:135. 10.1186/1471-2288-14-135</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. (2017) 21:300. 10.1186/s13054-017-1891-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1891-y</ArticleId><ArticleId IdType="pmc">PMC5725835</ArticleId><ArticleId IdType="pubmed">29228951</ArticleId></ArticleIdList></Reference><Reference><Citation>Borrelli E, Roux-Lombard P, Grau GE, Girardin E, Ricou B, Dayer J, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit. Care Med. (1996) 24:392&#x2013;7. 10.1097/00003246-199603000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199603000-00006</ArticleId><ArticleId IdType="pubmed">8625625</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JX. Mechanism of action of vitamin C in sepsis: ascorbate modulates redox signaling in endothelium. Biofactors. (2009) 35:5&#x2013;13. 10.1002/biof.7</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.7</ArticleId><ArticleId IdType="pmc">PMC2767105</ArticleId><ArticleId IdType="pubmed">19319840</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning J, Mitchell B, Appadurai DA, Shakya A, Pierce LJ, Wang H, et al. Vitamin C promotes maturation of T-cells. Antioxid Redox Signal. (2013) 19:2054&#x2013;67. 10.1089/ars.2012.4988</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2012.4988</ArticleId><ArticleId IdType="pmc">PMC3869442</ArticleId><ArticleId IdType="pubmed">23249337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashiouris MG, L&#x2019;Heureux M, Cable CA, Fisher BJ, Leichtle SW, Fowler AA. The emerging role of vitamin c as a treatment for sepsis. Nutrients. (2020) 12:292. 10.3390/nu12020292</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12020292</ArticleId><ArticleId IdType="pmc">PMC7070236</ArticleId><ArticleId IdType="pubmed">31978969</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikirova N, Riordan N, Casciari J. Modulation of cytokines in cancer patients by intravenous ascorbate therapy. Med Sci Monit. (2016) 22:14&#x2013;25. 10.12659/msm.895368</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/msm.895368</ArticleId><ArticleId IdType="pmc">PMC4756791</ArticleId><ArticleId IdType="pubmed">26724916</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudemans-van Straaten HM, Spoelstra-de Man AM, de Waard MC. Vitamin C revisited. Crit Care. (2014) 18:460. 10.1186/s13054-014-0460-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0460-x</ArticleId><ArticleId IdType="pmc">PMC4423646</ArticleId><ArticleId IdType="pubmed">25185110</ArticleId></ArticleIdList></Reference><Reference><Citation>de Grooth H-J, Manubulu-Choo W-P, Zandvliet AS, Spoelstra - de Man AME, Girbes AR, Swart EL, et al. Vitamin C pharmacokinetics in critically ill patients: a randomized trial of four iv regimens. Chest. (2018) 153:1368&#x2013;77. 10.1016/j.chest.2018.02.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.02.025</ArticleId><ArticleId IdType="pubmed">29522710</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Deane AM, Nair P. Metabolic support in sepsis: corticosteroids and vitamins: the why, the when, the how. Curr Opin Crit Care. (2020) 26:363&#x2013;8. 10.1097/mcc.0000000000000736</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mcc.0000000000000736</ArticleId><ArticleId IdType="pubmed">32487845</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care. (2013) 17:R2. 10.1186/cc11919</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11919</ArticleId><ArticleId IdType="pmc">PMC4056100</ArticleId><ArticleId IdType="pubmed">23302257</ArticleId></ArticleIdList></Reference><Reference><Citation>Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. (2010) 5:e11414. 10.1371/journal.pone.0011414</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011414</ArticleId><ArticleId IdType="pmc">PMC2898816</ArticleId><ArticleId IdType="pubmed">20628650</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37120426</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1435-2451</ISSN><JournalIssue CitedMedium="Internet"><Volume>408</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>29</Day></PubDate></JournalIssue><Title>Langenbeck's archives of surgery</Title><ISOAbbreviation>Langenbecks Arch Surg</ISOAbbreviation></Journal><ArticleTitle>Effect of thoracic epidural anesthesia on postoperative outcome in major liver surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>168</StartPage><MedlinePgn>168</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">168</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00423-023-02900-w</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Postoperative complications after major liver surgery are common. Thoracic epidural anesthesia may provide beneficial effects on postoperative outcome. We strove to compare postoperative outcomes in major liver surgery patients with and without thoracic epidural anesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective cohort study in a single university medical center. Patients undergoing elective major liver surgery between April 2012 and December 2016 were eligible for inclusion. We divided patients into two groups according to whether or not they had thoracic epidural anesthesia for major liver surgery. The primary outcome was postoperative hospital length of stay, i.e., from day of surgery until hospital discharge. Secondary outcomes included 30-day postoperative mortality and major postoperative complications. Additionally, we investigated the effect of thoracic epidural anesthesia on perioperative analgesia doses and the safety of thoracic epidural anesthesia.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 328 patients included in this study, 177 (54.3%) received thoracic epidural anesthesia. There were no clinically important differences in postoperative hospital length of stay (11.0 [7.00-17.0] vs. 9.00 [7.00-14.0] days, p = 0.316, primary outcome), death (0.0 vs. 2.7%, p = 0.995), or the incidence of postoperative renal failure (0.6 vs. 0.0%, p = 0.99), sepsis (0.0 vs. 1.3%, p = 0.21), or pulmonary embolism (0.6 vs. 1.4%, p = 0.59) between patients with or without thoracic epidural anesthesia. Perioperative analgesia doses - including the intraoperative sufentanil dose (0.228 [0.170-0.332] vs. 0.405 [0.315-0.565] &#x3bc;g&#xb7;kg<sup>-1</sup>&#xb7;h<sup>-1</sup>, p &lt; 0.0001) - were lower in patients with thoracic epidural anesthesia. No major thoracic epidural anesthesia-associated infections or bleedings occurred.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This retrospective analysis suggests that thoracic epidural anesthesia does not reduce postoperative hospital length of stay in patients undergoing major liver surgery - but it may reduce perioperative analgesia doses. Thoracic epidural anesthesia was safe in this cohort of patients undergoing major liver surgery. These findings need to be confirmed in robust clinical trials.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Behem</LastName><ForeName>Christoph R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany. c.behem@uke.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegner</LastName><ForeName>Juliane C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinnschmidt</LastName><ForeName>Hans O</ForeName><Initials>HO</Initials><AffiliationInfo><Affiliation>Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greiwe</LastName><ForeName>Gillis</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graessler</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funcke</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitzschke</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trepte</LastName><ForeName>Constantin J C</ForeName><Initials>CJC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haas</LastName><ForeName>Sebastian A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Rostock University Medical Center, Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Langenbecks Arch Surg</MedlineTA><NlmUniqueID>9808285</NlmUniqueID><ISSNLinking>1435-2443</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="Y">Anesthesia, Epidural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015360" MajorTopicYN="Y">Analgesia, Epidural</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidural anesthesia</Keyword><Keyword MajorTopicYN="N">Hepatectomy</Keyword><Keyword MajorTopicYN="N">Liver neoplasms</Keyword><Keyword MajorTopicYN="N">Pain management</Keyword><Keyword MajorTopicYN="N">Perioperative care</Keyword></KeywordList><CoiStatement>Constantin J. C. Trepte has received honorary for lectures by Maquet. All other authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>29</Day><Hour>23</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37120426</ArticleId><ArticleId IdType="pmc">PMC10148777</ArticleId><ArticleId IdType="doi">10.1007/s00423-023-02900-w</ArticleId><ArticleId IdType="pii">10.1007/s00423-023-02900-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hughes MJ, Ventham NT, Harrison EM, Wigmore SJ. Central venous pressure and liver resection: a systematic review and meta-analysis. HPB (Oxford) 2015;17(10):863&#x2013;871. doi: 10.1111/hpb.12462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hpb.12462</ArticleId><ArticleId IdType="pmc">PMC4571753</ArticleId><ArticleId IdType="pubmed">26292655</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosero EB, Cheng GS, Khatri KP, Joshi GP. Evaluation of epidural analgesia for open major liver resection surgery from a US inpatient sample. Proc (Bayl Univ Med Cent) 2014;27(4):305&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4255849</ArticleId><ArticleId IdType="pubmed">25484494</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones C, Kelliher L, Dickinson M, Riga A, Worthington T, Scott MJ, et al. Randomized clinical trial on enhanced recovery versus standard care following open liver resection. Br J Surg. 2013;100(8):1015&#x2013;1024. doi: 10.1002/bjs.9165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9165</ArticleId><ArticleId IdType="pubmed">23696477</ArticleId></ArticleIdList></Reference><Reference><Citation>Melloul E, Hubner M, Scott M, Snowden C, Prentis J, Dejong CH, et al. Guidelines for perioperative care for liver surgery: enhanced recovery after surgery (ERAS) society recommendations. World J Surg. 2016;40(10):2425&#x2013;2440. doi: 10.1007/s00268-016-3700-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-016-3700-1</ArticleId><ArticleId IdType="pubmed">27549599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganapathi S, Roberts G, Mogford S, Bahlmann B, Ateleanu B, Kumar N. Epidural analgesia provides effective pain relief in patients undergoing open liver surgery. Br J Pain. 2015;9(2):78&#x2013;85. doi: 10.1177/2049463714525140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2049463714525140</ArticleId><ArticleId IdType="pmc">PMC4616967</ArticleId><ArticleId IdType="pubmed">26516562</ArticleId></ArticleIdList></Reference><Reference><Citation>Freise H, Van Aken HK. Risks and benefits of thoracic epidural anaesthesia. Br J Anaesth. 2011;107(6):859&#x2013;868. doi: 10.1093/bja/aer339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aer339</ArticleId><ArticleId IdType="pubmed">22058144</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahnenkamp K, Theilmeier G, Van Aken HK, Hoenemann CW. The effects of local anesthetics on perioperative coagulation, inflammation, and microcirculation. Anesth Analg. 2002;94(6):1441&#x2013;1447. doi: 10.1213/00000539-200206000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-200206000-00011</ArticleId><ArticleId IdType="pubmed">12032003</ArticleId></ArticleIdList></Reference><Reference><Citation>Takita K, Uchida Y, Hase T, Kamiyama T, Morimoto Y. Co-existing liver disease increases the risk of postoperative thrombocytopenia in patients undergoing hepatic resection: implications for the risk of epidural hematoma associated with the removal of an epidural catheter. J Anesth. 2014;28(4):554&#x2013;558. doi: 10.1007/s00540-013-1776-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-013-1776-4</ArticleId><ArticleId IdType="pubmed">24375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamenkovic DM, Jankovic ZB, Toogood GJ, Lodge JP, Bellamy MC. Epidural analgesia and liver resection: postoperative coagulation disorders and epidural catheter removal. Minerva Anestesiol. 2011;77(7):671&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pubmed">19037193</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas P, Prout J, Papadopoulos G, Mallett SV. Epidural anaesthesia and analgesia for liver resection. Anaesthesia. 2013;68(6):628&#x2013;635. doi: 10.1111/anae.12191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12191</ArticleId><ArticleId IdType="pubmed">23662750</ArticleId></ArticleIdList></Reference><Reference><Citation>Siniscalchi A, Gamberini L, Bardi T, Laici C, Gamberini E, Francorsi L, et al. Role of epidural anesthesia in a fast track liver resection protocol for cirrhotic patients &#x2014; results after three years of practice. World J Hepatol. 2016;8(26):1097&#x2013;1104. doi: 10.4254/wjh.v8.i26.1097.</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v8.i26.1097</ArticleId><ArticleId IdType="pmc">PMC5026992</ArticleId><ArticleId IdType="pubmed">27660677</ArticleId></ArticleIdList></Reference><Reference><Citation>Merath K, Hyer JM, Mehta R, Bagante F, Paredes A, Wu L, et al. Use of perioperative epidural analgesia among Medicare patients undergoing hepatic and pancreatic surgery. HPB (Oxford) 2019;21(8):1064&#x2013;1071. doi: 10.1016/j.hpb.2018.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2018.12.008</ArticleId><ArticleId IdType="pubmed">30718186</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes M, McNally S, McKeown DW, Wigmore S. Effect of analgesic modality on outcome following open liver surgery: a systematic review of postoperative analgesia. Minerva Anestesiol. 2015;81(5):541&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">24918191</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaak C, Spies C, Schneider A, Jara M, Vorderwulbecke G, Kuhlmann AD, et al. Epidural anesthesia in liver surgery&#x2014;a propensity score-matched analysis. Pain Med. 2020;21(11):2650&#x2013;2660. doi: 10.1093/pm/pnaa130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pm/pnaa130</ArticleId><ArticleId IdType="pubmed">32651587</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Pu Y, Zhao Z, Yang X. Influence of combined epidural anesthesia on cognitive function, inflammation and stress response in elderly liver cancer patients undergoing surgery. Oncol Lett. 2020;19(4):2733&#x2013;2738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7068239</ArticleId><ArticleId IdType="pubmed">32218825</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RD. Miller&#x2019;s anesthesia. 8. Philadelphia: Elsevier; 2015.</Citation></Reference><Reference><Citation>Clarke H, Chandy T, Srinivas C, Ladak S, Okubo N, Mitsakakis N, et al. Epidural analgesia provides better pain management after live liver donation: a retrospective study. Liver Transpl. 2011;17(3):315&#x2013;323. doi: 10.1002/lt.22221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.22221</ArticleId><ArticleId IdType="pubmed">21384514</ArticleId></ArticleIdList></Reference><Reference><Citation>Revie EJ, Massie LJ, McNally SJ, McKeown DW, Garden OJ, Wigmore SJ. Effectiveness of epidural analgesia following open liver resection. HPB (Oxford) 2011;13(3):206&#x2013;211. doi: 10.1111/j.1477-2574.2010.00274.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1477-2574.2010.00274.x</ArticleId><ArticleId IdType="pmc">PMC3048973</ArticleId><ArticleId IdType="pubmed">21309939</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S, DeRoche A, Adams L, Slocum KV, Clark CJ, Fino NF, et al. Effect of epidural compared to patient-controlled intravenous analgesia on outcomes for patients undergoing liver resection for neoplastic disease. J Surg Oncol. 2017;115(4):402&#x2013;406. doi: 10.1002/jso.24534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.24534</ArticleId><ArticleId IdType="pmc">PMC5400729</ArticleId><ArticleId IdType="pubmed">28185289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambakamba P, Slankamenac K, Tschuor C, Kron P, Wirsching A, Maurer K, et al. Epidural analgesia and perioperative kidney function after major liver resection. Br J Surg. 2015;102(7):805&#x2013;812. doi: 10.1002/bjs.9810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9810</ArticleId><ArticleId IdType="pubmed">25877255</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber KL, Chelly JE, Lang RS, Abuelkasem E, Geller DA, Marsh JW, et al. Epidural versus paravertebral nerve block for postoperative analgesia in patients undergoing open liver resection: a randomized clinical trial. Reg Anesth Pain Med. 2016;41(4):460&#x2013;468. doi: 10.1097/AAP.0000000000000422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AAP.0000000000000422</ArticleId><ArticleId IdType="pubmed">27281726</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausken J, Fretland AA, Edwin B, Andersen MH, Dagenborg VJ, Bjornelv GMW, et al. Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery: a prospective, randomized, controlled, noninferiority trial. Ann Surg. 2019;270(2):193&#x2013;199. doi: 10.1097/SLA.0000000000003209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000003209</ArticleId><ArticleId IdType="pubmed">30676382</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell R, Ward D, Jeffery J, Toogood GJ, Lodge JA, Rao K, et al. A randomized controlled trial comparing epidural analgesia versus continuous local anesthetic infiltration via abdominal wound catheter in open liver resection. Ann Surg. 2019;269(3):413&#x2013;419. doi: 10.1097/SLA.0000000000002988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002988</ArticleId><ArticleId IdType="pubmed">30080727</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Nishimori M, Kopp SL. Epidural local anesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, vomiting, and pain after abdominal surgery: a Cochrane review. Anesth Analg. 2016;123(6):1591&#x2013;1602. doi: 10.1213/ANE.0000000000001628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001628</ArticleId><ArticleId IdType="pubmed">27870743</ArticleId></ArticleIdList></Reference><Reference><Citation>Elterman KG, Xiong Z. Coagulation profile changes and safety of epidural analgesia after hepatectomy: a retrospective study. J Anesth. 2015;29(3):367&#x2013;372. doi: 10.1007/s00540-014-1933-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-014-1933-4</ArticleId><ArticleId IdType="pubmed">25391365</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SJ, Gwak MS, Ko JS, Kim GS, Ahn HJ, Yang M, et al. The changes in coagulation profile and epidural catheter safety for living liver donors: a report on 6 years of our experience. Liver Transpl. 2007;13(1):62&#x2013;70. doi: 10.1002/lt.20933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.20933</ArticleId><ArticleId IdType="pubmed">17192873</ArticleId></ArticleIdList></Reference><Reference><Citation>Karna ST, Pandey CK, Sharma S, Singh A, Tandon M, Pandey VK. Postoperative coagulopathy after live related donor hepatectomy: incidence, predictors and implications for safety of thoracic epidural catheter. J Postgrad Med. 2015;61(3):176&#x2013;180. doi: 10.4103/0022-3859.159419.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0022-3859.159419</ArticleId><ArticleId IdType="pmc">PMC4943418</ArticleId><ArticleId IdType="pubmed">26119437</ArticleId></ArticleIdList></Reference><Reference><Citation>Koul A, Pant D, Rudravaram S, Sood J. Thoracic epidural analgesia in donor hepatectomy: an analysis. Liver Transpl. 2018;24(2):214&#x2013;221. doi: 10.1002/lt.24989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.24989</ArticleId><ArticleId IdType="pubmed">29205784</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk T, Wolf A, Van Aken H, Burkle H, Wiebalck A, Steinfeldt T. Incidence of spinal haematoma after epidural puncture: analysis from the German network for safety in regional anaesthesia. Eur J Anaesthesiol. 2012;29(4):170&#x2013;176. doi: 10.1097/EJA.0b013e3283504fec.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e3283504fec</ArticleId><ArticleId IdType="pubmed">22374389</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook TM, Counsell D, Wildsmith JA, Royal College of Anaesthetists Third National Audit Project Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth. 2009;102(2):179&#x2013;190. doi: 10.1093/bja/aen360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen360</ArticleId><ArticleId IdType="pubmed">19139027</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell R, Pandanaboyana S, Prasad KR. Epidural versus local anaesthetic infiltration via wound catheters in open liver resection: a meta-analysis. ANZ J Surg. 2015;85(1-2):16&#x2013;21. doi: 10.1111/ans.12683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.12683</ArticleId><ArticleId IdType="pubmed">24888251</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilidis P, Roberts KJ, Sutcliffe RP. Local anaesthetic infiltration via wound catheter versus epidural analgesia in open hepatectomy: a systematic review and meta-analysis of randomised controlled trials. HPB (Oxford) 2019;21(8):945&#x2013;952. doi: 10.1016/j.hpb.2019.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2019.02.007</ArticleId><ArticleId IdType="pubmed">30879991</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings KC, III, Zimmerman NM, Maheshwari K, Cooper GS, Cummings LC. Epidural compared with non-epidural analgesia and cardiopulmonary complications after colectomy: a retrospective cohort study of 20,880 patients using a national quality database. J Clin Anesth. 2018;47:12&#x2013;18. doi: 10.1016/j.jclinane.2018.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2018.03.005</ArticleId><ArticleId IdType="pmc">PMC5936664</ArticleId><ArticleId IdType="pubmed">29544203</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampe S, Weinreich G, Darr C, Eicker K, Stamatis G, Hachenberg T. The impact of epidural analgesia compared to systemic opioid-based analgesia with regard to length of hospital stay and recovery of bowel function: retrospective evaluation of 1555 patients undergoing thoracotomy. J Cardiothorac Surg. 2014;9:175. doi: 10.1186/s13019-014-0175-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-014-0175-8</ArticleId><ArticleId IdType="pmc">PMC4246432</ArticleId><ArticleId IdType="pubmed">25417134</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30465190</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4626</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract</Title><ISOAbbreviation>J Gastrointest Surg</ISOAbbreviation></Journal><ArticleTitle>Laparoscopic Repair for Perforated Peptic Ulcer Disease Has Better Outcomes Than Open Repair.</ArticleTitle><Pagination><StartPage>618</StartPage><EndPage>625</EndPage><MedlinePgn>618-625</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11605-018-4047-8</ELocationID><Abstract><AbstractText Label="PURPOSE">Over the last 3 decades, laparoscopic procedures have emerged as the standard treatment for many elective and emergency surgical conditions. Despite the increased use of laparoscopic surgery, the role of laparoscopic repair for perforated peptic ulcer remains controversial among general surgeons. The aim of this study was to compare the outcomes of laparoscopic versus open repair for perforated peptic ulcer.</AbstractText><AbstractText Label="METHODS">A systemic literature review was conducted using Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. A search was conducted using MEDLINE, EMBASE, PubMed and Cochrane Database of all randomised controlled trials (RCT) that compared laparoscopic (LR) with open repair (OR) for perforated peptic ulcer (PPU). Data was extracted using a standardised form and subsequently analysed.</AbstractText><AbstractText Label="RESULTS">The meta-analysis using data from 7 RCT showed that LR for PPU has decreased overall post-operative morbidity (LR&#x2009;=&#x2009;8.9% vs. OR&#x2009;=&#x2009;17.0%) (OR&#x2009;=&#x2009;0.54, 95% CI 0.37 to 0.79, p&#x2009;&lt;&#x2009;0.01), wound infections, (LR&#x2009;=&#x2009;2.2% vs. OR&#x2009;=&#x2009;6.3%) (OR&#x2009;=&#x2009;0.3, 95% CI 0.16 to 0.5, p&#x2009;&lt;&#x2009;0.01) and shorter duration of hospital stay (6.6&#xa0;days vs. 8.2&#xa0;days, p&#x2009;=&#x2009;0.01). There were no significant differences in length of operation, leakage rate, incidence of intra-abdominal abscess, post-operative sepsis, respiratory complications, re-operation rate or mortality. There was no publication bias and the quality of the studies ranged from poor to good.</AbstractText><AbstractText Label="CONCLUSION">These results demonstrate that laparoscopic repair for perforated peptic ulcer has a reduced morbidity and total hospital stay compared with open approach. There are no significant differences in mortality, post-operative sepsis, abscess and re-operation rates. LR should be the preferred treatment option for patients with perforated peptic ulcer disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quah</LastName><ForeName>Gaik S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>The Whiteley-Martin Research Centre, Discipline of Surgery, Nepean Hospital, The University of Sydney, Level 5, South Block, P.O. Box 63, Penrith, NSW, 2751, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eslick</LastName><ForeName>Guy D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>The Whiteley-Martin Research Centre, Discipline of Surgery, Nepean Hospital, The University of Sydney, Level 5, South Block, P.O. Box 63, Penrith, NSW, 2751, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0002-1743-7052</Identifier><AffiliationInfo><Affiliation>The Whiteley-Martin Research Centre, Discipline of Surgery, Nepean Hospital, The University of Sydney, Level 5, South Block, P.O. Box 63, Penrith, NSW, 2751, Australia. m.cox@sydney.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Gastrointest Surg</MedlineTA><NlmUniqueID>9706084</NlmUniqueID><ISSNLinking>1091-255X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004381" MajorTopicYN="N">Duodenal Ulcer</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="Y">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010439" MajorTopicYN="N">Peptic Ulcer Perforation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013276" MajorTopicYN="N">Stomach Ulcer</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Laparoscopic repair</Keyword><Keyword MajorTopicYN="N">Open repair</Keyword><Keyword MajorTopicYN="N">Perforated ulcer</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30465190</ArticleId><ArticleId IdType="doi">10.1007/s11605-018-4047-8</ArticleId><ArticleId IdType="pii">S1091-255X(23)01929-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World J Surg. 2000 Mar;24(3):277-83</Citation><ArticleIdList><ArticleId IdType="pubmed">10658061</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2001 Apr;136(4):438-41</Citation><ArticleIdList><ArticleId IdType="pubmed">11296116</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Laparosc Endosc Percutan Tech. 2001 Oct;11(5):313-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11668228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2002 Mar;235(3):313-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11882751</ArticleId></ArticleIdList></Reference><Reference><Citation>Langenbecks Arch Surg. 2002 Nov;387(7-8):298-302</Citation><ArticleIdList><ArticleId IdType="pubmed">12447556</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Surg. 1992 Oct;62(10):795-801</Citation><ArticleIdList><ArticleId IdType="pubmed">1359868</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2004 Jul;18(7):1013-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15136924</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2005 Oct;92(10):1195-207</Citation><ArticleIdList><ArticleId IdType="pubmed">16175515</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2009 Jan;33(1):80-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18958520</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2009 Jul;33(7):1368-73</Citation><ArticleIdList><ArticleId IdType="pubmed">19430829</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009 Jul 21;339:b2535</Citation><ArticleIdList><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2010 Jun;24(6):1231-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20033725</ArticleId></ArticleIdList></Reference><Reference><Citation>Dig Surg. 2010 Aug;27(3):161-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20571260</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1990 Sep;77(9):1006</Citation><ArticleIdList><ArticleId IdType="pubmed">2145052</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinics (Sao Paulo). 2011;66(3):417-20</Citation><ArticleIdList><ArticleId IdType="pubmed">21552665</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2011 Aug;15(8):1329-35</Citation><ArticleIdList><ArticleId IdType="pubmed">21567292</ArticleId></ArticleIdList></Reference><Reference><Citation>JSLS. 2010 Oct-Dec;14(4):476-483</Citation><ArticleIdList><ArticleId IdType="pubmed">21605512</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2012 Oct;16(10):1929-39</Citation><ArticleIdList><ArticleId IdType="pubmed">22890606</ArticleId></ArticleIdList></Reference><Reference><Citation>J Epidemiol. 2012;22(6):508-16</Citation><ArticleIdList><ArticleId IdType="pubmed">22955110</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2013 Mar;100(4):543-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23288621</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004778</Citation><ArticleIdList><ArticleId IdType="pubmed">23450555</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Surg. 2013 Oct;26(5):294-304</Citation><ArticleIdList><ArticleId IdType="pubmed">23514054</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 1990 Apr;9(4):363-7; discussion 369-83</Citation><ArticleIdList><ArticleId IdType="pubmed">2362976</ArticleId></ArticleIdList></Reference><Reference><Citation>JSLS. 2013 Jan-Mar;17(1):15-22</Citation><ArticleIdList><ArticleId IdType="pubmed">23743368</ArticleId></ArticleIdList></Reference><Reference><Citation>Best Pract Res Clin Gastroenterol. 2014 Feb;28(1):3-17</Citation><ArticleIdList><ArticleId IdType="pubmed">24485251</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2014 Jul;18(7):1261-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24610235</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Surg. 2015 Jun;18:196-204</Citation><ArticleIdList><ArticleId IdType="pubmed">25958296</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1989 Nov;76(11):1121-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2597964</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2015 Dec;30(12):1603-15</Citation><ArticleIdList><ArticleId IdType="pubmed">26189028</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg Oncol. 2015 Aug 15;13:250</Citation><ArticleIdList><ArticleId IdType="pubmed">26271770</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2016 Feb;159(2):451-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26297055</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Sep 09;5:13976</Citation><ArticleIdList><ArticleId IdType="pubmed">26350958</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Surg. 2015 Dec;77(Suppl 2):403-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26730034</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2016 Jan 14;22(2):668-80</Citation><ArticleIdList><ArticleId IdType="pubmed">26811616</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2016 Mar 7;22(9):2701-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26973409</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Gastroenterol. 2016 Mar 15;16:37</Citation><ArticleIdList><ArticleId IdType="pubmed">26979491</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2016 Apr 04;4:CD011391</Citation><ArticleIdList><ArticleId IdType="pubmed">27043078</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Surg. 2016 Sep;33 Pt A:124-32</Citation><ArticleIdList><ArticleId IdType="pubmed">27504848</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2017 Sep;214(3):538-546</Citation><ArticleIdList><ArticleId IdType="pubmed">28412996</ArticleId></ArticleIdList></Reference><Reference><Citation>United European Gastroenterol J. 2017 Jun;5(4):542-553</Citation><ArticleIdList><ArticleId IdType="pubmed">28588886</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 1993 Oct;114(4):815-9; discussion 819-21</Citation><ArticleIdList><ArticleId IdType="pubmed">8211699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1993 Nov;218(5):630-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8239777</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1996 Feb;17(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1996 Aug;224(2):131-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8757375</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1997 Sep 13;315(7109):629-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1998 Jan;85(1):32-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9462379</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1998 Apr;175(4):325-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9568663</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 1997 Mar-Apr;1(2):188-92; discussion 192-3</Citation><ArticleIdList><ArticleId IdType="pubmed">9834347</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36289602</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Immunomodulation by Hemoadsorption-Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock: A Prospective Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2340</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines10102340</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sepsis is often associated with liver dysfunction, which is an indicator of poor outcomes. Specific diagnostic tools that detect hepatic dysfunction in its early stages are scarce. So far, the immune modulatory effects of hemoadsorption with CytoSorb<sup>&#xae;</sup> on liver function are unclear.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We assessed the hepatic function by using the dynamic LiMAx<sup>&#xae;</sup> test and biochemical parameters in 21 patients with sepsis or septic shock receiving CytoSorb<sup>&#xae;</sup> in a prospective, observational study. Points of measurement: T<sub>1</sub>: diagnosis of sepsis or septic shock; T<sub>2</sub> and T<sub>3</sub>: 24 h and 48 h after the start of CytoSorb<sup>&#xae;</sup>; T<sub>4</sub>: 24 h after termination of CytoSorb<sup>&#xae;</sup>.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The hepatic biotransformation capacity measured by LiMAx<sup>&#xae;</sup> was severely impaired in up to 95 % of patients. Despite a rapid shock reversal under CytoSorb<sup>&#xae;</sup>, a significant improvement in LiMAx<sup>&#xae;</sup> values appeared from T<sub>3</sub> to T<sub>4</sub>. This decline and recovery of liver function were not reflected by common parameters of hepatic metabolism that remained mostly within the normal range.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hepatic dysfunction can effectively and safely be diagnosed with LiMAx<sup>&#xae;</sup> in ventilated ICU patients under CytoSorb<sup>&#xae;</sup>. Various static liver parameters are of limited use since they do not adequately reflect hepatic dysfunction and impaired hepatic metabolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Praxenthaler</LastName><ForeName>Janina</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8266-1800</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr-University Bochum, Klinikum Herford, 32049 Herford, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, KSOB-Clinics, Klinikum Traunstein, 83278 Traunstein, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwier</LastName><ForeName>Elke</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9279-2986</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr-University Bochum, Klinikum Herford, 32049 Herford, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altmann</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr-University Bochum, Klinikum Herford, 32049 Herford, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Knappschaftskrankenhaus Bochum, 44892 Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirchner</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of General and Visceral Surgery, Thoracic Surgery and Proctology, Ruhr University Bochum, Klinikum Herford, 32049 Herford, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bialas</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Data Science and Intelligent Analytics, University of Applied Science, FH Kufstein Tirol, 6330 Kufstein, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henzler</LastName><ForeName>Dietrich</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr-University Bochum, Klinikum Herford, 32049 Herford, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;hler</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0399-8382</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr-University Bochum, Klinikum Herford, 32049 Herford, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, AMEOS-Klinikum Halberstadt, 38820 Halberstadt, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CytoSorb&#xae;</Keyword><Keyword MajorTopicYN="N">Interleukin-6</Keyword><Keyword MajorTopicYN="N">LiMAx&#xae;</Keyword><Keyword MajorTopicYN="N">dynamic liver function test</Keyword><Keyword MajorTopicYN="N">hemoadsorption</Keyword><Keyword MajorTopicYN="N">hepatic dysfunction</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">sepsis-associated liver dysfunction</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword><Keyword MajorTopicYN="N">static liver parameters</Keyword></KeywordList><CoiStatement>TK had received lecture fees from Cytosorbent Europe. The Department of Anesthesiology at Klinikum Herford received an unrestricted research grant from Cytosorbent Europe in 2018. The authors declare that they have no other competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36289602</ArticleId><ArticleId IdType="pmc">PMC9598581</ArticleId><ArticleId IdType="doi">10.3390/biomedicines10102340</ArticleId><ArticleId IdType="pii">biomedicines10102340</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rudd K.E., Johnson S.C., Agesa K.M., Shackelford K.A., Tsoi D., Kievlan D.R., Colombara D.V., Ikuta K.S., Kissoon N., Finfer S., et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: Analysis for the Global Burden of Disease Study. Lancet. 2020;395:200&#x2013;211. doi: 10.1016/S0140-6736(19)32989-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32989-7</ArticleId><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C., Schwarzkopf D., Reinhart K. Inzidenz der Sepsis in Deutschland und weltweit. Med. Klin.-Intensivmed. Und Notf. 2021;117:264&#x2013;268. doi: 10.1007/s00063-021-00777-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00063-021-00777-5</ArticleId><ArticleId IdType="pmc">PMC7841759</ArticleId><ArticleId IdType="pubmed">33507316</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M., Gerlach H., Vogelmann T., Preissing F., Stiefel J., Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit. Care. 2020;24:239. doi: 10.1186/s13054-020-02950-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02950-2</ArticleId><ArticleId IdType="pmc">PMC7236499</ArticleId><ArticleId IdType="pubmed">32430052</ArticleId></ArticleIdList></Reference><Reference><Citation>Brienza N., Dalfino L., Cinnella G., Diele C., Bruno F., Fiore T. Jaundice in critical illness: Promoting factors of a concealed reality. Intensive Care Med. 2006;32:267&#x2013;274. doi: 10.1007/s00134-005-0023-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-0023-3</ArticleId><ArticleId IdType="pubmed">16450099</ArticleId></ArticleIdList></Reference><Reference><Citation>Soultati A.S., Dourakis S.P., Alexopoulou A., Deutsch M., Vasilieva L., Archimandritis A.J. Predicting utility of a model for end stage liver disease in alcoholic liver disease. World J. Gastroenterol. 2006;12:4020&#x2013;4025. doi: 10.3748/wjg.v12.i25.4020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v12.i25.4020</ArticleId><ArticleId IdType="pmc">PMC4087713</ArticleId><ArticleId IdType="pubmed">16810751</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer L., Jordan B., Druml W., Bauer P., Metnitz P.G. Austrian Epidemiologic Study on Intensive Care, A.S.D.I.S.G. Incidence and prognosis of early hepatic dysfunction in critically ill patients&#x2014;A prospective multicenter study. Crit. Care Med. 2007;35:1099&#x2013;1104. doi: 10.1097/01.CCM.0000259462.97164.A0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000259462.97164.A0</ArticleId><ArticleId IdType="pubmed">17334250</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel J.J., Taneja A., Niccum D., Kumar G., Jacobs E., Nanchal R. The association of serum bilirubin levels on the outcomes of severe sepsis. J. Intensive Care Med. 2015;30:23&#x2013;29. doi: 10.1177/0885066613488739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066613488739</ArticleId><ArticleId IdType="pubmed">23753252</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai R., Sheu C.C., Su L., Gong M.N., Tejera P., Chen F., Wang Z., Convery M.P., Thompson B.T., Christiani D.C. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Thorax. 2009;64:784&#x2013;790. doi: 10.1136/thx.2009.113464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2009.113464</ArticleId><ArticleId IdType="pmc">PMC2735615</ArticleId><ArticleId IdType="pubmed">19482841</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierrakos C., Velissaris D., Felleiter P., Antonelli M., Vanhems P., Sakr Y., Vincent J.L. Increased mortality in critically ill patients with mild or moderate hyperbilirubinemia. J. Crit. Care. 2017;40:31&#x2013;35. doi: 10.1016/j.jcrc.2017.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.01.017</ArticleId><ArticleId IdType="pubmed">28314169</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesseler N., Launey Y., Aninat C., Morel F., Mall&#xe9;dant Y., Seguin P. Clinical review: The liver in sepsis. Crit. Care. 2012;16:235. doi: 10.1186/cc11381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11381</ArticleId><ArticleId IdType="pmc">PMC3682239</ArticleId><ArticleId IdType="pubmed">23134597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wlodzimirow K.A., Eslami S., Abu-Hanna A., Nieuwoudt M., Chamuleau R.A. Systematic review: Acute liver failure-one disease, more than 40 definitions. Aliment. Pharmacol. Ther. 2012;35:1245&#x2013;1256. doi: 10.1111/j.1365-2036.2012.05097.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2012.05097.x</ArticleId><ArticleId IdType="pubmed">22506515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wo&#x17a;nica E.A., Inglot M., Wo&#x17a;nica R.K., &#x141;ysenko L. Liver dysfunction in sepsis. Adv. Clin. Exp. Med. 2018;27:547&#x2013;551. doi: 10.17219/acem/68363.</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/acem/68363</ArticleId><ArticleId IdType="pubmed">29558045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine Storm. N. Engl. J. Med. 2020;383:2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalan R., Gines P., Olson J.C., Mookerjee R.P., Moreau R., Garcia-Tsao G., Arroyo V., Kamath P.S. Acute-on chronic liver failure. J. Hepatol. 2012;57:1336&#x2013;1348. doi: 10.1016/j.jhep.2012.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2012.06.026</ArticleId><ArticleId IdType="pubmed">22750750</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesseler N., Launey Y., Aninat C., White J., Corlu A., Pieper K., Malledant Y., Seguin P. Liver Dysfunction Is Associated with Long-Term Mortality in Septic Shock. Am. J. Respir. Crit. Care Med. 2016;193:335&#x2013;337. doi: 10.1164/rccm.201508-1660LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201508-1660LE</ArticleId><ArticleId IdType="pubmed">26829424</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J., Li S. The role of the liver in sepsis. Int. Rev. Immunol. 2014;33:498&#x2013;510. doi: 10.3109/08830185.2014.889129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2014.889129</ArticleId><ArticleId IdType="pmc">PMC4160418</ArticleId><ArticleId IdType="pubmed">24611785</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ger B., Drolz A., Michl B., Schellongowski P., Bojic A., Nikfardjam M., Zauner C., Heinz G., Trauner M., Fuhrmann V. Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology. 2012;56:2297&#x2013;2304. doi: 10.1002/hep.25896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.25896</ArticleId><ArticleId IdType="pubmed">22706920</ArticleId></ArticleIdList></Reference><Reference><Citation>Koskinas J., Gomatos I.P., Tiniakos D.G., Memos N., Boutsikou M., Garatzioti A., Archimandritis A., Betrosian A. Liver histology in ICU patients dying from sepsis: A clinico-pathological study. World J. Gastroenterol. 2008;14:1389&#x2013;1393. doi: 10.3748/wjg.14.1389.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.14.1389</ArticleId><ArticleId IdType="pmc">PMC2693687</ArticleId><ArticleId IdType="pubmed">18322953</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M., Deng F., Qi D., Hu Z., Zhang L. The Hyperbilirubinemia and Potential Predictors Influence on Long-Term Outcomes in Sepsis: A Population-Based Propensity Score-Matched Study. Front. Med. 2021;8:713917. doi: 10.3389/fmed.2021.713917.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.713917</ArticleId><ArticleId IdType="pmc">PMC8484885</ArticleId><ArticleId IdType="pubmed">34604255</ArticleId></ArticleIdList></Reference><Reference><Citation>Spapen H. Liver perfusion in sepsis, septic shock, and multiorgan failure. Anat. Rec. 2008;291:714&#x2013;720. doi: 10.1002/ar.20646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.20646</ArticleId><ArticleId IdType="pubmed">18484618</ArticleId></ArticleIdList></Reference><Reference><Citation>te Boekhorst T., Urlus M., Doesburg W., Yap S.H., Goris R.J. Etiologic factors of jaundice in severely ill patients. A retrospective study in patients admitted to an intensive care unit with severe trauma or with septic intra-abdominal complications following surgery and without evidence of bile duct obstruction. J. Hepatol. 1988;7:111&#x2013;117. doi: 10.1016/S0168-8278(88)80514-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-8278(88)80514-2</ArticleId><ArticleId IdType="pubmed">3183348</ArticleId></ArticleIdList></Reference><Reference><Citation>Trauner M., Meier P.J., Boyer J.L. Molecular pathogenesis of cholestasis. N. Engl. J. Med. 1998;339:1217&#x2013;1227. doi: 10.1056/NEJM199810223391707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199810223391707</ArticleId><ArticleId IdType="pubmed">9780343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakka S.G. Assessing liver function. Curr. Opin. Crit. Care. 2007;13:207&#x2013;214. doi: 10.1097/MCC.0b013e328012b268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0b013e328012b268</ArticleId><ArticleId IdType="pubmed">17327744</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaffarnik M.F., Lock J.F., Vetter H., Ahmadi N., Lojewski C., Malinowski M., Neuhaus P., Stockmann M. Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: A prospective study with the LiMAx test. Crit. Care. 2013;17:R259. doi: 10.1186/cc13089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13089</ArticleId><ArticleId IdType="pmc">PMC4057158</ArticleId><ArticleId IdType="pubmed">24172237</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockmann M., Lock J.F., Riecke B., Heyne K., Martus P., Fricke M., Lehmann S., Niehues S.M., Schwabe M., Lemke A.J., et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann. Surg. 2009;250:119&#x2013;125. doi: 10.1097/SLA.0b013e3181ad85b5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181ad85b5</ArticleId><ArticleId IdType="pubmed">19561474</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaffarnik M.F., Ahmadi N., Lock J.F., Wuensch T., Pratschke J., Stockmann M., Malinowski M. Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study. PLoS ONE. 2017;12:e0178237. doi: 10.1371/journal.pone.0178237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0178237</ArticleId><ArticleId IdType="pmc">PMC5441649</ArticleId><ArticleId IdType="pubmed">28542386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicha S.G., Frey O.R., Roehr A.C., Pratschke J., Stockmann M., Alraish R., Wuensch T., Kaffarnik M. Linezolid in liver failure: Exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot study. Int. J. Antimicrob. Agents. 2017;50:557&#x2013;563. doi: 10.1016/j.ijantimicag.2017.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2017.06.023</ArticleId><ArticleId IdType="pubmed">28711678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchner C., Sibai J., Schwier E., Henzler D., Eickmeyer C., Winde G., K&#xf6;hler T. Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx&#xae;. Case Rep. Crit. Care. 2019;2019:5362514. doi: 10.1155/2019/5362514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/5362514</ArticleId><ArticleId IdType="pmc">PMC6948309</ArticleId><ArticleId IdType="pubmed">31949955</ArticleId></ArticleIdList></Reference><Reference><Citation>Alraish R., Wicha S.G., Frey O.R., Roehr A.C., Pratschke J., Stockmann M., Wuensch T., Kaffarnik M. Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx) Ann. Intensive Care. 2020;10:106. doi: 10.1186/s13613-020-00707-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00707-2</ArticleId><ArticleId IdType="pmc">PMC7403243</ArticleId><ArticleId IdType="pubmed">32754775</ArticleId></ArticleIdList></Reference><Reference><Citation>Buechter M., Gerken G., Hoyer D.P., Bertram S., Theysohn J.M., Thodou V., Kahraman A. Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: A case report. BMC Anesthesiol. 2018;18:71. doi: 10.1186/s12871-018-0538-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-018-0538-0</ArticleId><ArticleId IdType="pmc">PMC6011251</ArticleId><ArticleId IdType="pubmed">29925334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaffarnik M., Stoeger G., Liebich J., Grieser C., Pratschke J., Stockmann M. Liver Function, Quantified by LiMAx Test, After Major Abdominal Surgery. Comparison Between Open and Laparoscopic Approach. World J. Surg. 2018;42:557&#x2013;566. doi: 10.1007/s00268-017-4170-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-017-4170-9</ArticleId><ArticleId IdType="pubmed">28840295</ArticleId></ArticleIdList></Reference><Reference><Citation>Guengerich F.P., Krauser J.A., Johnson W.W. Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2. Biochemistry. 2004;43:10775&#x2013;10788. doi: 10.1021/bi0491393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0491393</ArticleId><ArticleId IdType="pubmed">15311939</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockmann M. Wertigkeit Eines Neu Entwickelten Verfahrens Zur Bestimmung der Leberfunktion in der Leberchirurgie (LiMAx-Test) Charit&#xe9;-Universit&#xe4;tsmedizin Berlin; Berlin, Germany: 2009.</Citation></Reference><Reference><Citation>Stockmann M., Lock J.F., Malinowski M., Niehues S.M., Seehofer D., Neuhaus P. The LiMAx test: A new liver function test for predicting postoperative outcome in liver surgery. HPB. 2010;12:139&#x2013;146. doi: 10.1111/j.1477-2574.2009.00151.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1477-2574.2009.00151.x</ArticleId><ArticleId IdType="pmc">PMC2826673</ArticleId><ArticleId IdType="pubmed">20495659</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara M., Bednarsch J., Valle E., Lock J.F., Malinowski M., Schulz A., Seehofer D., Jung T., Stockmann M. Reliable assessment of liver function using LiMAx. J. Surg. Res. 2015;193:184&#x2013;189. doi: 10.1016/j.jss.2014.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2014.07.041</ArticleId><ArticleId IdType="pubmed">25150081</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockmann M., Lock J.F., Malinowski M., Seehofer D., Puhl G., Pratschke J., Neuhaus P. How to define initial poor graft function after liver transplantation?&#x2014;A new functional definition by the LiMAx test. Transpl. Int. 2010;23:1023&#x2013;1032. doi: 10.1111/j.1432-2277.2010.01089.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-2277.2010.01089.x</ArticleId><ArticleId IdType="pubmed">20444241</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler T., Pletz M.W., Altmann S., Kirchner C., Schwier E., Henzler D., Winde G., Eickmeyer C. Pericarditis Caused by Enterococcus faecium with acute liver failure treated by a multifaceted approach including antimicrobials and hemoadsorption. Case Rep. Crit. Care. 2021;2021:8824050. doi: 10.1155/2021/8824050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8824050</ArticleId><ArticleId IdType="pmc">PMC7987411</ArticleId><ArticleId IdType="pubmed">33815848</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli C., Cuoghi A., Magnani S., Atti M., Ricci D., Siniscalchi A., Mancini E., Faenza S. Removal of Bilirubin with a New Adsorbent System: In Vitro Kinetics. Blood Purif. 2019;47:10&#x2013;15. doi: 10.1159/000492378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000492378</ArticleId><ArticleId IdType="pubmed">30219813</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruda M.C., Ruggeberg K.G., O&#x2019;Sullivan P., Guliashvili T., Scheirer A.R., Golobish T.D., Capponi V.J., Chan P.P. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb&#xae; sorbent porous polymer beads. PLoS ONE. 2018;13:e0191676. doi: 10.1371/journal.pone.0191676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0191676</ArticleId><ArticleId IdType="pmc">PMC5784931</ArticleId><ArticleId IdType="pubmed">29370247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum J.A., Song M., Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit. Care Med. 2004;32:801&#x2013;805. doi: 10.1097/01.CCM.0000114997.39857.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000114997.39857.69</ArticleId><ArticleId IdType="pubmed">15090965</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler T., Schwier E., Praxenthaler J., Kirchner C., Henzler D., Eickmeyer C. Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb&#xae;-Basics, Indications and Perspectives-A Scoping Review. Int. J. Mol. Sci. 2021;22:12786. doi: 10.3390/ijms222312786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222312786</ArticleId><ArticleId IdType="pmc">PMC8657779</ArticleId><ArticleId IdType="pubmed">34884590</ArticleId></ArticleIdList></Reference><Reference><Citation>Malard B., Lambert C., Kellum J.A. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med. Exp. 2018;6:12. doi: 10.1186/s40635-018-0177-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-018-0177-2</ArticleId><ArticleId IdType="pmc">PMC5935601</ArticleId><ArticleId IdType="pubmed">29728790</ArticleId></ArticleIdList></Reference><Reference><Citation>Poli E.C., Rimmel&#xe9; T., Schneider A.G. Hemoadsorption with CytoSorb&#xae;. Intensive Care Med. 2019;45:236&#x2013;239. doi: 10.1007/s00134-018-5464-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5464-6</ArticleId><ArticleId IdType="pubmed">30446798</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter K., Bordoni V., Dall&#x2019;Olio G., Ricatti M.G., Soli M., Ruperti S., Soffiati G., Galloni E., D&#x2019;Intini V., Bellomo R., et al. In vitro removal of therapeutic drugs with a novel adsorbent system. Blood Purif. 2002;20:380&#x2013;388. doi: 10.1159/000063108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000063108</ArticleId><ArticleId IdType="pubmed">12169849</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieckmann J.C., Geiger R., Hornburg D., Wolf T., Kveler K., Jarrossay D., Sallusto F., Shen-Orr S.S., Lanzavecchia A., Mann M., et al. Social network architecture of human immune cells unveiled by quantitative proteomics. Nat. Immunol. 2017;18:583&#x2013;593. doi: 10.1038/ni.3693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3693</ArticleId><ArticleId IdType="pubmed">28263321</ArticleId></ArticleIdList></Reference><Reference><Citation>Honore P.M., Hoste E., Moln&#xe1;r Z., Jacobs R., Joannes-Boyau O., Malbrain M.L.N.G., Forni L.G. Cytokine removal in human septic shock: Where are we and where are we going? Ann. Intensive Care. 2019;9:56. doi: 10.1186/s13613-019-0530-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-019-0530-y</ArticleId><ArticleId IdType="pmc">PMC6517449</ArticleId><ArticleId IdType="pubmed">31089920</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehler T., Schwier E., Henzler D., Eickmeyer C. Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement. J. Crit. Care. 2021;66:187&#x2013;188. doi: 10.1016/j.jcrc.2021.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.07.011</ArticleId><ArticleId IdType="pmc">PMC8314144</ArticleId><ArticleId IdType="pubmed">34330558</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig C., R&#xf6;hr A.C., Frey O.R., Brinkmann A., Roberts J.A., Wichmann D., Braune S., Kluge S., Nierhaus A. In vitro removal of anti-infective agents by a novel cytokine adsorbent system. Int. J. Artif. Organs. 2019;42:57&#x2013;64. doi: 10.1177/0391398818812601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0391398818812601</ArticleId><ArticleId IdType="pubmed">30545255</ArticleId></ArticleIdList></Reference><Reference><Citation>Kogelmann K., Jarczak D., Scheller M., Dr&#xfc;ner M. Hemoadsorption by CytoSorb in septic patients: A case series. Crit. Care. 2017;21:74. doi: 10.1186/s13054-017-1662-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1662-9</ArticleId><ArticleId IdType="pmc">PMC5366999</ArticleId><ArticleId IdType="pubmed">28343448</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer W.P., Duran S., Kuijper M., Ince C. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: A propensity-score-weighted retrospective study. Crit. Care. 2019;23:317. doi: 10.1186/s13054-019-2588-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2588-1</ArticleId><ArticleId IdType="pmc">PMC6749645</ArticleId><ArticleId IdType="pubmed">31533846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rugg C., Klose R., Hornung R., Innerhofer N., Bachler M., Schmid S., Fries D., Str&#xf6;hle M. Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective &#x2018;Genetic&#x2019; Matched Analysis. Biomedicines. 2020;8:539. doi: 10.3390/biomedicines8120539.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8120539</ArticleId><ArticleId IdType="pmc">PMC7760738</ArticleId><ArticleId IdType="pubmed">33255912</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz P., Schwier E., Eickmeyer C., Henzler D., K&#xf6;hler T. High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock: A retrospective cohort study. J. Crit. Care. 2021;64:184&#x2013;192. doi: 10.1016/j.jcrc.2021.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.04.011</ArticleId><ArticleId IdType="pubmed">33962219</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhokia V.D., Madhavan D., Austin A., Morris C.G. Novel use of Cytosorb&#x2122; haemadsorption to provide biochemical control in liver impairment. J. Intensive Care Soc. 2019;20:174&#x2013;181. doi: 10.1177/1751143718772789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1751143718772789</ArticleId><ArticleId IdType="pmc">PMC6475986</ArticleId><ArticleId IdType="pubmed">31037112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocskay K., Tomescu D., Faltlhauser A., Jacob D., Friesecke S., Malbrain M., Kogelmann K., Bogdanski R., Bach F., Fritz H., et al. Hemoadsorption in &#x2018;Liver Indication&#x2019;-Analysis of 109 Patients&#x2019; Data from the CytoSorb International Registry. J. Clin. Med. 2021;10:5182. doi: 10.3390/jcm10215182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10215182</ArticleId><ArticleId IdType="pmc">PMC8584981</ArticleId><ArticleId IdType="pubmed">34768702</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf C., Liebchen U., Paal M., Becker-Pennrich A., Irlbeck M., Zoller M., Schroeder I. Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: A pilot study. Sci. Rep. 2021;11:10190. doi: 10.1038/s41598-021-89712-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89712-4</ArticleId><ArticleId IdType="pmc">PMC8119427</ArticleId><ArticleId IdType="pubmed">33986443</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Nakajima M., Chiba K., Yamamoto T., Tani M., Ishizaki T., Kuroiwa Y. Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2. Br. J. Clin. Pharmacol. 1998;45:361&#x2013;368. doi: 10.1046/j.1365-2125.1998.t01-1-00692.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2125.1998.t01-1-00692.x</ArticleId><ArticleId IdType="pmc">PMC1873964</ArticleId><ArticleId IdType="pubmed">9578183</ArticleId></ArticleIdList></Reference><Reference><Citation>Batty K.T., Davis T.M., Ilett K.F., Dusci L.J., Langton S.R. The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects. Br. J. Clin. Pharmacol. 1995;39:305&#x2013;311. doi: 10.1111/j.1365-2125.1995.tb04453.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.1995.tb04453.x</ArticleId><ArticleId IdType="pmc">PMC1365008</ArticleId><ArticleId IdType="pubmed">7619673</ArticleId></ArticleIdList></Reference><Reference><Citation>Granfors M.T., Backman J.T., Neuvonen M., Neuvonen P.J. Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism. Clin. Pharmacol. Ther. 2004;76:598&#x2013;606. doi: 10.1016/j.clpt.2004.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clpt.2004.08.018</ArticleId><ArticleId IdType="pubmed">15592331</ArticleId></ArticleIdList></Reference><Reference><Citation>Danie W.A., Syrek M., Ry&#x142;ko Z., W&#xf3;jcikowski J. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes. Pol. J. Pharmacol. 2001;53:351&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">11990081</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwier E., Kirchner C., Eickmeyer C., Winde G., Henzler D., Kohler T. Profound decrease of liver maximum function capacity test of isoflurane sedated patients: A report of three cases. Clin. Case Rep. 2021;9:e04862. doi: 10.1002/ccr3.4862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.4862</ArticleId><ArticleId IdType="pmc">PMC8462060</ArticleId><ArticleId IdType="pubmed">34594555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A., Evans L.E., Alhazzani W., Levy M.M., Antonelli M., Ferrer R., Kumar A., Sevransky J.E., Sprung C.L., Nunnally M.E., et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43:304&#x2013;377. doi: 10.1007/s00134-017-4683-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4683-6</ArticleId><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: A severity of disease classification system. Crit. Care Med. 1985;13:818&#x2013;829. doi: 10.1097/00003246-198510000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-198510000-00009</ArticleId><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., Moreno R., Takala J., Willatts S., De Mendon&#xe7;a A., Bruining H., Reinhart C.K., Suter P.M., Thijs L.G. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Riecke B., Neuhaus P., Stockmann M. Major influence of oxygen supply on 13CO2:12CO2 ratio measurement by nondispersive isotope-selective infrared spectroscopy. Helicobacter. 2005;10:620&#x2013;622. doi: 10.1111/j.1523-5378.2005.00357.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-5378.2005.00357.x</ArticleId><ArticleId IdType="pubmed">16302989</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 2012;120:c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky P.M. Renal replacement therapy in acute kidney injury. Adv. Chronic Kidney Dis. 2013;20:76&#x2013;84. doi: 10.1053/j.ackd.2012.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ackd.2012.09.004</ArticleId><ArticleId IdType="pmc">PMC3531877</ArticleId><ArticleId IdType="pubmed">23265599</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimski T., Brandenburger T., Slowinski T., Kindgen-Milles D. Feasibility and safety of combined cytokine adsorption and continuous veno-venous hemodialysis with regional citrate anticoagulation in patients with septic shock. Int. J. Artif. Organs. 2020;43:10&#x2013;16. doi: 10.1177/0391398819866459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0391398819866459</ArticleId><ArticleId IdType="pubmed">31379256</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlton M., Sims M., Coats T., Thompson J.P. The microcirculation and its measurement in sepsis. J. Intensive Care Soc. 2017;18:221&#x2013;227. doi: 10.1177/1751143716678638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1751143716678638</ArticleId><ArticleId IdType="pmc">PMC5665123</ArticleId><ArticleId IdType="pubmed">29118834</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince C. The microcirculation is the motor of sepsis. Crit. Care. 2005;9((Suppl. 4)):S13&#x2013;S19. doi: 10.1186/cc3753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3753</ArticleId><ArticleId IdType="pmc">PMC3226164</ArticleId><ArticleId IdType="pubmed">16168069</ArticleId></ArticleIdList></Reference><Reference><Citation>Remick D.G. Pathophysiology of sepsis. Am. J. Pathol. 2007;170:1435&#x2013;1444. doi: 10.2353/ajpath.2007.060872.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.060872</ArticleId><ArticleId IdType="pmc">PMC1854939</ArticleId><ArticleId IdType="pubmed">17456750</ArticleId></ArticleIdList></Reference><Reference><Citation>Henzler D., Scheffler M., Westheider A., K&#xf6;hler T. Microcirculation measurements: Barriers for use in clinical routine. Clin. Hemorheol. Microcirc. 2017;67:505&#x2013;509. doi: 10.3233/CH-179229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-179229</ArticleId><ArticleId IdType="pubmed">28885216</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C.M., French C., Machado F.R., McIntyre L., Ostermann M., Prescott H.C., et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181&#x2013;1247. doi: 10.1007/s00134-021-06506-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Friesecke S., Stecher S.S., Gross S., Felix S.B., Nierhaus A. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: A prospective single-center study. J. Artif. Organs. 2017;20:252&#x2013;259. doi: 10.1007/s10047-017-0967-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10047-017-0967-4</ArticleId><ArticleId IdType="pubmed">28589286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawchar F., Rao C., Akil A., Mehta Y., Rugg C., Scheier J., Adamson H., Deliargyris E., Molnar Z. The Potential Role of Extracorporeal Cytokine Removal in Hemodynamic Stabilization in Hyperinflammatory Shock. Biomedicines. 2021;9:768. doi: 10.3390/biomedicines9070768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9070768</ArticleId><ArticleId IdType="pmc">PMC8301410</ArticleId><ArticleId IdType="pubmed">34356830</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xe4;ger K., Fritzler D., Fischer G., Schr&#xf6;der J., Skrabal C., Liebold A., Reinelt H. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: A case series. Int. J. Artif. Organs. 2016;39:141&#x2013;146. doi: 10.5301/ijao.5000492.</Citation><ArticleIdList><ArticleId IdType="doi">10.5301/ijao.5000492</ArticleId><ArticleId IdType="pubmed">27140295</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xe4;ger K., Sch&#xfc;tz C., Fischer G., Schr&#xf6;der J., Skrabal C., Liebold A., Reinelt H. Cytokine Reduction in the Setting of an ARDS-Associated Inflammatory Response with Multiple Organ Failure. Case Rep. Crit. Care. 2016;2016:9852073. doi: 10.1155/2016/9852073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9852073</ArticleId><ArticleId IdType="pmc">PMC4739007</ArticleId><ArticleId IdType="pubmed">26885411</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xe4;ger K., Skrabal C., Fischer G., Datzmann T., Schroeder J., Fritzler D., Hartmann J., Liebold A., Reinelt H. Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass-a case series. Int. J. Artif. Organs. 2017;40:240&#x2013;249. doi: 10.5301/ijao.5000583.</Citation><ArticleIdList><ArticleId IdType="doi">10.5301/ijao.5000583</ArticleId><ArticleId IdType="pmc">PMC6159853</ArticleId><ArticleId IdType="pubmed">28525670</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xe4;ger K., Skrabal C., Fischer G., Schroeder J., Marenski L., Liebold A., Reinelt H., Datzmann T. Hemoadsorption treatment with CytoSorb in patients with extracorporeal life support therapy: A case series. Int. J. Artif. Organs. 2019;43:422&#x2013;429. doi: 10.1177/0391398819895287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0391398819895287</ArticleId><ArticleId IdType="pubmed">31868089</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrion J., Schapira M., Luwaert R., Colin L., Delannoy A., Heller F.R. Hypoxic hepatitis: Clinical and hemodynamic study in 142 consecutive cases. Medicine. 2003;82:392&#x2013;406. doi: 10.1097/01.md.0000101573.54295.bd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000101573.54295.bd</ArticleId><ArticleId IdType="pubmed">14663289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lescot T., Karvellas C., Beaussier M., Magder S. Acquired liver injury in the intensive care unit. Anesthesiology. 2012;117:898&#x2013;904. doi: 10.1097/ALN.0b013e318266c6df.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318266c6df</ArticleId><ArticleId IdType="pubmed">22854981</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapper E.B., Sengupta N., Bonder A. The Incidence and Outcomes of Ischemic Hepatitis: A Systematic Review with Meta-analysis. Am. J. Med. 2015;128:1314&#x2013;1321. doi: 10.1016/j.amjmed.2015.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2015.07.033</ArticleId><ArticleId IdType="pubmed">26299319</ArticleId></ArticleIdList></Reference><Reference><Citation>Elferink M.G., Olinga P., Draaisma A.L., Merema M.T., Faber K.N., Slooff M.J., Meijer D.K., Groothuis G.M. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol. 2004;287:G1008&#x2013;G1016. doi: 10.1152/ajpgi.00071.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00071.2004</ArticleId><ArticleId IdType="pubmed">15205115</ArticleId></ArticleIdList></Reference><Reference><Citation>Geier A., Fickert P., Trauner M. Mechanisms of disease: Mechanisms and clinical implications of cholestasis in sepsis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006;3:574&#x2013;585. doi: 10.1038/ncpgasthep0602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpgasthep0602</ArticleId><ArticleId IdType="pubmed">17008927</ArticleId></ArticleIdList></Reference><Reference><Citation>Moseley R.H. Sepsis and cholestasis. Clin. Liver Dis. 2004;8:83&#x2013;94. doi: 10.1016/S1089-3261(03)00134-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1089-3261(03)00134-X</ArticleId><ArticleId IdType="pubmed">15062195</ArticleId></ArticleIdList></Reference><Reference><Citation>Trauner M., Fickert P., Stauber R.E. Inflammation-induced cholestasis. J. Gastroenterol. Hepatol. 1999;14:946&#x2013;959. doi: 10.1046/j.1440-1746.1999.01982.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1746.1999.01982.x</ArticleId><ArticleId IdType="pubmed">10530489</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn P. Leberwertver&#xe4;nderungen und Leberdysfunktion bei Sepsis. Intensiv-Und Notf. 2020;45:159. doi: 10.5414/VDX01066.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/VDX01066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper P., Tacke F., Steffen H.-M., Michels G. Leberfunktionsst&#xf6;rungen bei Sepsis. Med. Klin.-Intensivmed. Und Notf. 2020;115:609&#x2013;619. doi: 10.1007/s00063-020-00707-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00063-020-00707-x</ArticleId><ArticleId IdType="pubmed">32725325</ArticleId></ArticleIdList></Reference><Reference><Citation>Sponholz C., Gonnert F.A., Kortgen A., Bauer M. Monitoring of liver function in the critically ill. Anaesthesist. 2014;63:603&#x2013;612. doi: 10.1007/s00101-014-2326-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00101-014-2326-7</ArticleId><ArticleId IdType="pubmed">24997165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lock J.F., Kotobi A.N., Malinowski M., Schulz A., Jara M., Neuhaus P., Stockmann M. Predicting the prognosis in acute liver failure: Results from a retrospective pilot study using the LiMAx test. Ann. Hepatol. 2013;12:556&#x2013;562. doi: 10.1016/S1665-2681(19)31339-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1665-2681(19)31339-0</ArticleId><ArticleId IdType="pubmed">23813133</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockmann M., Vondran F.W.R., Fahrner R., Tautenhahn H.M., Mittler J., Bektas H., Malinowski M., Jara M., Klein I., Lock J.F., et al. Randomized clinical trial comparing liver resection with and without perioperative assessment of liver function. BJS Open. 2018;2:301&#x2013;309. doi: 10.1002/bjs5.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs5.81</ArticleId><ArticleId IdType="pmc">PMC6156169</ArticleId><ArticleId IdType="pubmed">30263981</ArticleId></ArticleIdList></Reference><Reference><Citation>Alraish R., Wicha S.G., Frey O.R., Roehr A.C., Pratschke J., Stockmann M., Wuensch T., Kaffarnik M. Liver function, quantified by the LiMAx test, as a predictor for the clinical outcome of critically ill patients treated with linezolid. Technol. Health Care. 2022;30:309&#x2013;321. doi: 10.3233/THC-191847.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/THC-191847</ArticleId><ArticleId IdType="pubmed">34180433</ArticleId></ArticleIdList></Reference><Reference><Citation>David S., Thamm K., Schmidt B.M.W., Falk C.S., Kielstein J.T. Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient. J. Intensive Care. 2017;5:12. doi: 10.1186/s40560-017-0208-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-017-0208-1</ArticleId><ArticleId IdType="pmc">PMC5251288</ArticleId><ArticleId IdType="pubmed">28127437</ArticleId></ArticleIdList></Reference><Reference><Citation>Napp L.C., Ziegeler S., Kindgen-Milles D. Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support. Blood Purif. 2019;48:203&#x2013;214. doi: 10.1159/000500015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000500015</ArticleId><ArticleId IdType="pmc">PMC6878728</ArticleId><ArticleId IdType="pubmed">31096211</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimmel&#xe9; T., Kellum J.A. Clinical review: Blood purification for sepsis. Crit. Care. 2011;15:205. doi: 10.1186/cc9411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9411</ArticleId><ArticleId IdType="pmc">PMC3222040</ArticleId><ArticleId IdType="pubmed">21371356</ArticleId></ArticleIdList></Reference><Reference><Citation>Friesecke S., Tr&#xe4;ger K., Schittek G.A., Molnar Z., Bach F., Kogelmann K., Bogdanski R., Weyland A., Nierhaus A., Nestler F., et al. International registry on the use of the CytoSorb&#xae; adsorber in ICU patients: Study protocol and preliminary results. Med. Klin. Intensivmed. Notfmed. 2019;114:699&#x2013;707. doi: 10.1007/s00063-017-0342-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00063-017-0342-5</ArticleId><ArticleId IdType="pubmed">28871441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth E., Kovacs E., Racz K., Soltesz A., Szigeti S., Kiss N., Csikos G., Koritsanszky K.B., Berzsenyi V., Trembickij G., et al. Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation-an observational study. Clin. Transplant. 2018;32:e13211. doi: 10.1111/ctr.13211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.13211</ArticleId><ArticleId IdType="pubmed">29377282</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf C., Schroeder I., Paal M., Winkels M., Irlbeck M., Zoller M., Liebchen U. Can the cytokine adsorber CytoSorb((R)) help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis. Ann. Intensive Care. 2021;11:115. doi: 10.1186/s13613-021-00905-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00905-6</ArticleId><ArticleId IdType="pmc">PMC8295971</ArticleId><ArticleId IdType="pubmed">34292421</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga H., Hirasawa H., Nishida O., Oda S., Nakamura M., Mashiko K., Matsuda K., Kitamura N., Kikuchi Y., Fuke N. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: A preliminary report. Blood Purif. 2014;38:211&#x2013;218. doi: 10.1159/000369377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369377</ArticleId><ArticleId IdType="pubmed">25531978</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M., Press A.T., Trauner M. The liver in sepsis: Patterns of response and injury. Curr. Opin. Crit. Care. 2013;19:123&#x2013;127. doi: 10.1097/MCC.0b013e32835eba6d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0b013e32835eba6d</ArticleId><ArticleId IdType="pubmed">23448974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolder U., Ton-Nu H.T., Schteingart C.D., Frick E., Hofmann A.F. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: Impaired uptake and secretion. Gastroenterology. 1997;112:214&#x2013;225. doi: 10.1016/S0016-5085(97)70238-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0016-5085(97)70238-5</ArticleId><ArticleId IdType="pubmed">8978362</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford J.M., Boyer J.L. Clinicopathology conferences: Inflammation-induced cholestasis. Hepatology. 1998;28:253&#x2013;260. doi: 10.1002/hep.510280133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.510280133</ArticleId><ArticleId IdType="pubmed">9657120</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvatits T., Drolz A., Trauner M., Fuhrmann V. Liver Injury and Failure in Critical Illness. Hepatology. 2019;70:2204&#x2013;2215. doi: 10.1002/hep.30824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.30824</ArticleId><ArticleId IdType="pubmed">31215660</ArticleId></ArticleIdList></Reference><Reference><Citation>Strnad P., Tacke F., Koch A., Trautwein C. Liver-guardian, modifier and target of sepsis. Nat. Rev. Gastroenterol. Hepatol. 2017;14:55&#x2013;66. doi: 10.1038/nrgastro.2016.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2016.168</ArticleId><ArticleId IdType="pubmed">27924081</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J.Y., Li L., Zhao X., Ding F., Hou X., Peng Z. Hemoperfusion with CytoSorb(R) in Critically Ill COVID-19 Patients. Blood Purif. 2021;51:410&#x2013;416. doi: 10.1159/000517721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000517721</ArticleId><ArticleId IdType="pmc">PMC8450818</ArticleId><ArticleId IdType="pubmed">34407530</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockmann H., Thelen P., Stroben F., Pigorsch M., Keller T., Krannich A., Spies C., Treskatsch S., Ocken M., Kunz J.V., et al. CytoSorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open-Label, Randomized Controlled Pilot Study. Crit. Care Med. 2022;50:964&#x2013;976. doi: 10.1097/CCM.0000000000005493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005493</ArticleId><ArticleId IdType="pmc">PMC9112514</ArticleId><ArticleId IdType="pubmed">35135967</ArticleId></ArticleIdList></Reference><Reference><Citation>Supady A., Zahn T., Kuhl M., Maier S., Benk C., Kaier K., B&#xf6;ttiger B.W., Bode C., Lother A., Staudacher D.L., et al. Cytokine adsorption in patients with post-cardiac arrest syndrome after extracorporeal cardiopulmonary resuscitation (CYTER)-A single-centre, open-label, randomised, controlled trial. Resuscitation. 2022;173:169&#x2013;178. doi: 10.1016/j.resuscitation.2022.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2022.02.001</ArticleId><ArticleId IdType="pubmed">35143902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kogelmann K., H&#xfc;bner T., Schwameis F., Dr&#xfc;ner M., Scheller M., Jarczak D. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. J. Clin. Med. 2021;10:2939. doi: 10.3390/jcm10132939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132939</ArticleId><ArticleId IdType="pmc">PMC8268021</ArticleId><ArticleId IdType="pubmed">34209001</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin T.M., Heyne K., Luchterhand A., Jan B., Vondran F.W.R., Polychronidis G., Malinowski M., Nikolic A., Tautenhahn H.M., Jara M., et al. Kinetic validation of the LiMAx test during 10 000 intravenous (13)C-methacetin breath tests. J. Breath Res. 2017;12:016005. doi: 10.1088/1752-7163/aa820b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1752-7163/aa820b</ArticleId><ArticleId IdType="pubmed">28742055</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuhrmann V., Kneidinger N., Herkner H., Heinz G., Nikfardjam M., Bojic A., Schellongowski P., Angermayr B., Sch&#xf6;niger-Hekele M., Madl C., et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011;37:1302&#x2013;1310. doi: 10.1007/s00134-011-2248-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2248-7</ArticleId><ArticleId IdType="pubmed">21647720</ArticleId></ArticleIdList></Reference><Reference><Citation>Recknagel P., Gonnert F.A., Westermann M., Lambeck S., Lupp A., Rudiger A., Dyson A., Carr&#xe9; J.E., Kortgen A., Krafft C., et al. Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: Experimental studies in rodent models of peritonitis. PLoS Med. 2012;9:e1001338. doi: 10.1371/journal.pmed.1001338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001338</ArticleId><ArticleId IdType="pmc">PMC3496669</ArticleId><ArticleId IdType="pubmed">23152722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcillo J.A., Doughty L., Kofos D., Frye R.F., Kaplan S.S., Sasser H., Burckart G.J. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Med. 2003;29:980&#x2013;984. doi: 10.1007/s00134-003-1758-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1758-3</ArticleId><ArticleId IdType="pubmed">12698250</ArticleId></ArticleIdList></Reference><Reference><Citation>Frye R.F., Schneider V.M., Frye C.S., Feldman A.M. Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure. J. Card. Fail. 2002;8:315&#x2013;319. doi: 10.1054/jcaf.2002.127773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/jcaf.2002.127773</ArticleId><ArticleId IdType="pubmed">12411982</ArticleId></ArticleIdList></Reference><Reference><Citation>Buechter M., Thimm J., Baba H.A., Bertram S., Willuweit K., Gerken G., Kahraman A. Liver Maximum Capacity: A Novel Test to Accurately Diagnose Different Stages of Liver Fibrosis. Digestion. 2019;100:45&#x2013;54. doi: 10.1159/000493573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493573</ArticleId><ArticleId IdType="pubmed">30278435</ArticleId></ArticleIdList></Reference><Reference><Citation>Buechter M., Kersting S., Gerken G., Kahraman A. Enzymatic liver function measured by LiMAx-a reliable diagnostic and prognostic tool in chronic liver disease. Sci. Rep. 2019;9:13577. doi: 10.1038/s41598-019-49746-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49746-1</ArticleId><ArticleId IdType="pmc">PMC6753134</ArticleId><ArticleId IdType="pubmed">31537822</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., van der Poll T. Coagulation and sepsis. Thromb. Res. 2017;149:38&#x2013;44. doi: 10.1016/j.thromres.2016.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.11.007</ArticleId><ArticleId IdType="pubmed">27886531</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler A.P., Bernard G.R. Treating patients with severe sepsis. N. Engl. J. Med. 1999;340:207&#x2013;214. doi: 10.1056/NEJM199901213400307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199901213400307</ArticleId><ArticleId IdType="pubmed">9895401</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., de Jonge E., van der Poll T. Sepsis and disseminated intravascular coagulation. J. Thromb. Thrombolysis. 2003;16:43&#x2013;47. doi: 10.1023/B:THRO.0000014592.27892.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:THRO.0000014592.27892.11</ArticleId><ArticleId IdType="pubmed">14760211</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan R., Koppe S. Modern management of acute liver failure. Gastroenterol. Clin. 2018;47:313&#x2013;326. doi: 10.1016/j.gtc.2018.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gtc.2018.01.005</ArticleId><ArticleId IdType="pubmed">29735026</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiodt F.V., Atillasoy E., Shakil A.O., Schiff E.R., Caldwell C., Kowdley K.V., Stribling R., Crippin J.S., Flamm S., Somberg K.A., et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transplant. Surg. 1999;5:29&#x2013;34. doi: 10.1002/lt.500050102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.500050102</ArticleId><ArticleId IdType="pubmed">9873089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostapowicz G., Fontana R.J., Schi&#xf8;dt F.V., Larson A., Davern T.J., Han S.H., McCashland T.M., Shakil A.O., Hay J.E., Hynan L., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med. 2002;137:947&#x2013;954. doi: 10.7326/0003-4819-137-12-200212170-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-137-12-200212170-00007</ArticleId><ArticleId IdType="pubmed">12484709</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufour D.R., Lott J.A., Nolte F.S., Gretch D.R., Koff R.S., Seeff L.B. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin. Chem. 2000;46:2027&#x2013;2049. doi: 10.1093/clinchem/46.12.2027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/46.12.2027</ArticleId><ArticleId IdType="pubmed">11106349</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenniskens M., Langouche L., Vanwijngaerden Y.M., Mesotten D., Van den Berghe G. Cholestatic liver (dys)function during sepsis and other critical illnesses. Intensive Care Med. 2016;42:16&#x2013;27. doi: 10.1007/s00134-015-4054-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4054-0</ArticleId><ArticleId IdType="pubmed">26392257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32236745</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1128-045X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Techniques in coloproctology</Title><ISOAbbreviation>Tech Coloproctol</ISOAbbreviation></Journal><ArticleTitle>Rectal stump management in inflammatory bowel disease: a cohort study, systematic review and proportional analysis of perioperative complications.</ArticleTitle><Pagination><StartPage>671</StartPage><EndPage>684</EndPage><MedlinePgn>671-684</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10151-020-02188-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">The aim of this study was to analyse local single-institution data and perform a systematic review of the literature to calculate precise risk estimates of rectal stump-related morbidity and mortality following subtotal colectomy in patients with inflammatory bowel disease (IBD), including Crohn's colitis, ulcerative colitis and indeterminate colitis.</AbstractText><AbstractText Label="METHODS">Institutional information systems were interrogated to obtain local patient data. A systematic review of MEDLINE and EMBASE was performed to identify relevant articles. Fixed-effects or random-effects meta-analysis of proportions was performed to calculate pooled incidence estimates, including local data.</AbstractText><AbstractText Label="RESULTS">Sixty-one patients were included locally and all had their rectal stump closed intra-abdominally. Four patients (8.3%) had a rectal stump perforation and 30-day mortality was 0. Fourteen papers were included in our review alongside local data, with a total of 1330 patients included. Pooled mortality was 1.7% (95% confidence interval, CI 1.0-2.8), pooled incidence of pelvic abscess/sepsis, stump leak and wound infection was 5.7% (95% CI 4.4-7.3), 4.9% (95% CI 3.7-6.6) and 11.3% (95% CI 7.8-16), respectively. Subcutaneous placement of the stump was associated with the highest incidence of stump leak (12.6%, 95% CI 8.3-18.6), and closure of the stump with both staples and suture was associated with the highest incidence of pelvic abscess (11.1%, 95% CI 5.8-20.3). Mortality and the incidence of wound infection were similar across stump closure techniques. There was evidence suggesting considerable heterogeneity and publication bias among studies.</AbstractText><AbstractText Label="CONCLUSIONS">This study provides estimates of morbidity associated with the rectal stump after subtotal colectomy for IBD. A closed intra-abdominal stump seems to be associated with the highest rate of pelvic abscess/sepsis. Further work in form of an international collaborative project would allow individual patient data analysis and identification of risk factors for complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lawday</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. slawday@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leaning</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flannery</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Summers</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>G A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodhand</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bethune</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>S A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, European University Cyprus, Nicosia, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Mediterranean Hospital of Cyprus, Limassol, Cyprus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Tech Coloproctol</MedlineTA><NlmUniqueID>9613614</NlmUniqueID><ISSNLinking>1123-6337</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="N">Colectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003092" MajorTopicYN="Y">Colitis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="Y">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012007" MajorTopicYN="N">Rectum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Inflammatory bowel disease</Keyword><Keyword MajorTopicYN="N">Morbidity</Keyword><Keyword MajorTopicYN="N">Rectal stump</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32236745</ArticleId><ArticleId IdType="doi">10.1007/s10151-020-02188-8</ArticleId><ArticleId IdType="pii">10.1007/s10151-020-02188-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bryan S, Andronis L, Hyde C, Connock M, Fry-Smith A, Wang D (2010) Infliximab for the treatment of acute exacerbations of ulcerative colitis. Health Technol Assess 14(Suppl 1):9&#x2013;15</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta14suppl1/02</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer RG, Easley KA, Rankin GB (1993) Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 38(6):1137&#x2013;1146</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01295733</ArticleId></ArticleIdList></Reference><Reference><Citation>Frid NL, Bulut O, Pachler J (2013) Acceptable short-term outcome of laparoscopic subtotal colectomy for inflammatory bowel disease. Dan Med J 60(6):A4645</Citation><ArticleIdList><ArticleId IdType="pubmed">23743115</ArticleId></ArticleIdList></Reference><Reference><Citation>Messenger DE, Mihailovic D, MacRae HM, O'Connor BI, Victor JC, McLeod RS (2014) Subtotal colectomy in severe ulcerative and Crohn&#x2019;s colitis: what benefit does the laparoscopic approach confer? Dis Colon Rectum 57(12):1349&#x2013;1357</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000000238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross H, Steele SR, Varma M, Dykes S, Cima R, Buie WD et al (2014) Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum 57(1):5&#x2013;22</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000000030</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong S, Steele SR, Boutrous M, Bordineau L, Chun J, Stewart DB et al (2015) Clinical practice guideline for the surgical management of Crohn&#x2019;s disease. Dis Colon Rectum 58(11):1021&#x2013;1036</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000000450</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SR, Fearnhead NS, Faiz OD, Abercrombie JF, Acheson AG, Arnott RG et al (2018) The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Dis 20(S8):3&#x2013;117</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.14448</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady RR, Collie MH, Ho GT, Bartolo DC, Wilson RG, Dunlop MG (2008) Outcomes of the rectal remnant following colectomy for ulcerative colitis. Colorectal Dis 10(2):144&#x2013;150</Citation><ArticleIdList><ArticleId IdType="pubmed">17302914</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter FM, McLeod RS, Cohen Z (1991) Subtotal colectomy for ulcerative colitis: complications related to the rectal remnant. Dis Colon Rectum 34(11):1005&#x2013;1009</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02049965</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch LA, Bauer JJ, Gorfine SR, Gelernt IM (1995) Subtotal colectomy with Hartmann&#x2019;s pouch for inflammatory bowel disease. Dis Colon Rectum 38(6):635&#x2013;639</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02054125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyle SM, Steyn RS, Keenan RA (1992) Management of the rectum following colectomy for acute colitis. Aust N Z J Surg 62(3):196&#x2013;199</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-2197.1992.tb05462.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https://doi.org/10.1136/bmj.b2700</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pubmed">2714672</ArticleId><ArticleId IdType="pmc">2714672</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https://doi.org/10.1136/bmj.i491</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i491</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId><ArticleId IdType="pmc">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629&#x2013;634</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrechtsen D, Bergan A, Nygaard K, Gjone E, Flatmark A (1981) Urgent surgery for ulcerative colitis: early colectomy in 132 patients. World J Surg 5(4):607&#x2013;615</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01655016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohm G, O'Dwyer ST (2007) The fate of the rectal stump after subtotal colectomy for ulcerative colitis. Int J Colorectal Dis 22(3):277&#x2013;282</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-006-0127-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleshner PR, Michelassi F, Rubin M, Hanauer SB, Plevy SE, Targan SR (1995) Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin. Dis Colon Rectum 38(12):1241&#x2013;1245</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02049146</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Stocchi L, Remzi F, Kiran RP (2013) Factors associated with postoperative morbidity, reoperation and readmission rates after laparoscopic total abdominal colectomy for ulcerative colitis. Colorectal Dis 15(9):1123&#x2013;1129</Citation><ArticleIdList><ArticleId IdType="pubmed">23627886</ArticleId></ArticleIdList></Reference><Reference><Citation>Koudahl G, Aagaard P (1971) The management of the rectal stump after subtotal colectomy for ulcerative colitis. Scand J Gastroenterol 9:127&#x2013;129</Citation></Reference><Reference><Citation>Ng RL, Davies AH, Grace RH, Mortensen NJ (1992) Subcutaneous rectal stump closure after emergency subtotal colectomy. Br J Surg 79(7):701&#x2013;703</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.1800790737</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellino G, Sciaudone G, Candilio G, Canonico S, Selvaggi F (2012) Rectosigmoid stump washout as an alternative to permanent mucous fistula in patients undergoing subtotal colectomy for ulcerative colitis in emergency settings. BMC Surg 12(Suppl 1):S31</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2482-12-S1-S31</ArticleId></ArticleIdList></Reference><Reference><Citation>Trickett JP, Tilney HS, Gudgeon AM, Mellor SG, Edwards DP (2005) Management of the rectal stump after emergency sub-total colectomy: which surgical option is associated with the lowest morbidity? Colorectal Dis 7(5):519&#x2013;522</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1463-1318.2005.00875.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojdemann M, Wettergren A, Hartvigsen A, Myrhoj T, Svendsen LB, Bulow S (1995) Closure of rectal stump after colectomy for acute colitis. Int J Colorectal Dis 10(4):197&#x2013;199</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00346218</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T, Keighley MR (1999) Long-term outcome of total colectomy and ileostomy for Crohn disease. Scand J Gastroenterol 34(3):280&#x2013;286</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365529950173690</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedrikovetski S, Dudi-Venkata N, Kroon HM, Liu J, Andrews JM, Lewis M, Lawrence M, Sammour T (2019) Systematic review of rectal stump management during and after emergency total colectomy for acute severe ulcerative colitis. ANZ J Surg. https://doi.org/10.1111/ans.15075</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.15075</ArticleId><ArticleId IdType="pubmed">31272135</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24388280</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Peri-operative changes in serum immune markers after trauma: a systematic review.</ArticleTitle><Pagination><StartPage>934</StartPage><EndPage>941</EndPage><MedlinePgn>934-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2013.12.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(13)00570-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Surgery is a posttraumatic immune stimulus which contributes to the systemic inflammatory response syndrome and multiple organ failure (MOF). Serum markers may facilitate post-injury immune monitoring, predict complications and guide the timing of surgery.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate whether immune markers increase after surgery in trauma patients, if this is affected by the timing of surgery, and whether immune markers correlate with clinical outcomes.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Systematic review of MEDLINE, Cochrane and EMBASE using a combination of keywords including trauma, biological markers, immune monitoring, and surgical procedures. The last search was performed on 26/11/13. The search considered English language studies enrolling adult trauma patients. Outcomes were perioperative immune markers plus clinical outcomes including mortality, MOF, sepsis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">1612 Articles were identified using the search strategy. 1548 Articles were excluded by title and 40 excluded by abstract, leaving 24 articles for full text review. Of these articles, fifteen studies were eligible for study inclusion. The disparity in interventions and outcome measures precluded combined statistical analysis. The surgical intervention studied was mostly intramedullary nailing of long bone fractures. All articles described a postoperative increase in at least one marker. Interleukin (IL)-6 and IL-10 were consistently elevated and tested in the greatest number of patients. Many studies did not correlate markers with clinical outcomes and few significant associations were demonstrated. Two studies considered the timing of surgery and showed greater increase in IL-6 after "early" surgery, though definitions of timing were dissimilar.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">An increase in posttraumatic serum cytokines has been demonstrated after surgery, but without consistent clinical associations. The timing of surgery may modulate this increase. Future research directions include confirmation of findings in larger populations, clarifying clinical associations, and evaluation of other surgical interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Easton</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Trauma Service, Division of Surgery, John Hunter Hospital, Newcastle, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balogh</LastName><ForeName>Zsolt J</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Trauma Service, Division of Surgery, John Hunter Hospital, Newcastle, NSW, Australia. Electronic address: Zsolt.balogh@hnehealth.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050723" MajorTopicYN="N">Fractures, Bone</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009104" MajorTopicYN="N">Multiple Trauma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biological markers</Keyword><Keyword MajorTopicYN="N">Immune monitoring</Keyword><Keyword MajorTopicYN="N">Multiple organ failure</Keyword><Keyword MajorTopicYN="N">Second hit</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24388280</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2013.12.002</ArticleId><ArticleId IdType="pii">S0020-1383(13)00570-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39915868</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Postoperative sepsis and its sequential impact on dementia.</ArticleTitle><Pagination><StartPage>66</StartPage><MedlinePgn>66</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">66</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-025-05276-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative sepsis is a severe complication associated with increased mortality and potential long-term cognitive decline, including dementia. However, the relationship between postoperative sepsis and dementia remains poorly understood.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study used data from the National Database in Taiwan, covering the period from January 1, 2005, to December 31, 2022. The index period for surgeries was set between January 1, 2008, and December 31, 2013, allowing the identification of patients without prior dementia. A landmark period of 12&#xa0;months following surgery was defined to capture the number of postoperative sepsis events, which were then analyzed for their impact on dementia risk. After 1:4 propensity score matching (PSM), dementia and mortality were evaluated using Cox proportional hazards and Fine-Gray competing risk models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Following PSM, 778 patients were in the postoperative sepsis group and 3,112 in the non-postoperative sepsis group. Dementia incidence was higher in the postoperative sepsis group (26%) compared to the non- postoperative sepsis group (13.6%), with a hazard ratio (HR) of 1.25 (95% CI, 1.03-1.52). A dose-response relationship was observed, with dementia rates of 24.5% for one postoperative sepsis event and 34.9% for two or more events, the latter showing an HR of 1.77 (95% CI, 1.17-2.66). Mortality was also elevated in the postoperative sepsis group (40.5% vs. 31.6%; HR 1.45, 95% CI, 1.28-1.65).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Postoperative sepsis is significantly associated with increased dementia risk in a dose-dependent manner. These findings highlight the importance of enhancing perioperative infection control to reduce both immediate and long-term cognitive complications.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Mingyang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fangfang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yangyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Mengrong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Zhongyuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Medical Sciences of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wan-Ming</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Szu-Yuan</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, No. 83, Nanchang St., Luodong Township, Yilan County, 265, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centers for Regional Anesthesia and Pain Medicine, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiaqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China. zhangjiq@zzu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dementia risk</Keyword><Keyword MajorTopicYN="N">Perioperative infection control</Keyword><Keyword MajorTopicYN="N">Postoperative sepsis</Keyword><Keyword MajorTopicYN="N">Propensity score matching</Keyword><Keyword MajorTopicYN="N">Real-world database analysis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study was conducted using de-identified data from the National Health Insurance Research Database (NHIRD), a publicly available database in Taiwan. Since the data are fully anonymized and do not contain identifiable personal information, the study does not involve human participants directly. As such, ethical approval and informed consent were not required. This complies with the relevant guidelines and regulations for the use of anonymized secondary data in research. Conflict of interest: The authors declare no competing interests related to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>7</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>7</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>6</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39915868</ArticleId><ArticleId IdType="pmc">PMC11800527</ArticleId><ArticleId IdType="doi">10.1186/s13054-025-05276-z</ArticleId><ArticleId IdType="pii">10.1186/s13054-025-05276-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, Abdoli A, Abualhasan A, Abu-Gharbieh E, Akram TT, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):E105&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810394</ArticleId><ArticleId IdType="pubmed">34998485</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimo A, Seeher K, Cataldi R, Cyhlarova E, Dielemann JL, Frisell O, Guerchet M, Jonsson L, Malaha AK, Nichols E, et al. The worldwide costs of dementia in 2019. Alzheimers Dement. 2023;19(7):2865&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10842637</ArticleId><ArticleId IdType="pubmed">36617519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhou Y, Fang X, Qu G. Care burden on family caregivers of patients with dementia and affecting factors in China: a systematic review. Front Psychiatr. 2022;13:1004552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9760850</ArticleId><ArticleId IdType="pubmed">36545040</ArticleId></ArticleIdList></Reference><Reference><Citation>Berrios-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, Reinke CE, Morgan S, Solomkin JS, Mazuski JE, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">28467526</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen NS, Bock JM, May AK. Sepsis and postoperative surgical site infections. Surgery. 2023;174(2):403&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36775759</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaeke P, De Man JG, Coenen S, Jorens PG, De Winter BY, Hubens G. Clinical- and surgery-specific risk factors for post-operative sepsis: a systematic review and meta-analysis of over 30 million patients. Surg Today. 2020;50(5):427&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">31172283</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Cao M, Tao H, Fei Z, Huang X, Liang P, Liu B, Liu J, Lu X, Ma P, et al. Evidence-based guideline for the prevention and management of perioperative infection. J Evid Based Med. 2023;16(1):50&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">36852502</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhole S, Mahakalkar C, Kshirsagar S, Bhargava A. Antibiotic prophylaxis in surgery: current insights and future directions for surgical site infection prevention. Cureus. 2023;15(10): e47858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10680052</ArticleId><ArticleId IdType="pubmed">38021553</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzambi R, Bhaskaran K, Smeeth L, Brayne C, Chaturvedi N, Warren-Gash C. Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study. Lancet Healthy Longev. 2021;2(7):e426&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245326</ArticleId><ArticleId IdType="pubmed">34240064</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ton AMP, Meijer-van Leijsen EM, Bergkamp MI, Bronkhorst EM, Pickkers P, De Leeuw FE, Tuladhar AM, Abdo WF. Dementia risk and structural brain changes following nonneurological infections during 9-year follow-up. Crit Care Med. 2022;50(4):554&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">34432713</ArticleId></ArticleIdList></Reference><Reference><Citation>Janbek J, Laursen TM, Frimodt-M&#xf8;ller N, Magyari M, Haas JG, Lathe R, Waldemar G. Hospital-diagnosed infections, autoimmune diseases, and subsequent dementia incidence. JAMA Netw Open. 2023;6(9): e2332635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10485730</ArticleId><ArticleId IdType="pubmed">37676660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei S, Li X, Zhao H, Feng Z, Chun L, Xie Y, Li J. Dementia risk or cognitive impairment in sepsis survivals: a systematic review and meta-analysis. Front Aging Neurosci. 2022;14: 839472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8959917</ArticleId><ArticleId IdType="pubmed">35356300</ArticleId></ArticleIdList></Reference><Reference><Citation>Raz L, Knoefel J, Bhaskar K. The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab. 2016;36(1):172&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758551</ArticleId><ArticleId IdType="pubmed">26174330</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Van Hoecke L, Vandenbroucke RE. The impact of systemic inflammation on alzheimer&#x2019;s disease pathology. Front Immunol. 2021;12: 796867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8770958</ArticleId><ArticleId IdType="pubmed">35069578</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MA, Kareem O, Khushtar M, Akbar M, Haque MR, Iqubal A, Haider MF, Pottoo FH, Abdulla FS, Al-Haidar MB, et al. Neuroinflammation: a potential risk for dementia. Int J Mol Sci. 2022;23(2):616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8775769</ArticleId><ArticleId IdType="pubmed">35054805</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345288</ArticleId><ArticleId IdType="pubmed">20978258</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzambi R, Bhaskaran K, Brayne C, Davidson JA, Smeeth L, Warren-Gash C. Common bacterial infections and dementia risk or cognitive decline: a systematic review. J Alzheimers Dis. 2020;76(4):1609&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7504996</ArticleId><ArticleId IdType="pubmed">32651320</ArticleId></ArticleIdList></Reference><Reference><Citation>Asby D, Boche D, Allan S, Love S, Miners JS. Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer&#x2019;s disease. Brain. 2021;144(6):1869&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320299</ArticleId><ArticleId IdType="pubmed">33723589</ArticleId></ArticleIdList></Reference><Reference><Citation>Basak JM, Ferreiro A, Cohen LS, Sheehan PW, Nadarajah CJ, Kanan MF, Sukhum KV, Dantas G, Musiek ES. Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer&#x2019;s disease. Neurobiol Dis. 2021;152: 105292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057119</ArticleId><ArticleId IdType="pubmed">33556539</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. Lancet Neurol. 2014;13(6):630&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24849863</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmler A, Widmann CN, Okulla T, Urbach H, Kaiser M, Widman G, Mormann F, Weide J, Fliessbach K, Hoeft A, et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatr. 2013;84(1):62&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23134661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritze T, Doblhammer G, Widmann CN, Heneka MT. Time course of dementia following sepsis in German health claims data. Neurol Neuroimmunol Neuroinflamm. 2021. 10.1212/NXI.0000000000000911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803331</ArticleId><ArticleId IdType="pubmed">33293458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao LT, Sheu JJ, Lin HC, Tsai MC, Chung SD. Association between sepsis and dementia. J Clin Neurosci. 2015;22(9):1430&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">26165470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernainy P, Cohen AA, Murray E, Losina E, Lamontagne F, Sourial N. Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: a panel discussion. BMC Proc. 2024;18(Suppl 2):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10795211</ArticleId><ArticleId IdType="pubmed">38233894</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Dementia risk after major elective surgery based on the route of anaesthesia: a propensity score-matched population-based cohort study. EClinicalMedicine. 2023;55: 101727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9641180</ArticleId><ArticleId IdType="pubmed">36386032</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Dementia risk amongst older adults with hip fracture receiving general anaesthesia or regional anaesthesia: a propensity-score-matched population-based cohort study. Br J Anaesth. 2023;130(3):305&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">36593163</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Long-term opioid use and dementia risk in patients with chronic pain. J Am Med Dir Assoc. 2023;24(9):1420-1426.e1422.</Citation><ArticleIdList><ArticleId IdType="pubmed">37545051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction. Brain. 2023;147:1474&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">37878862</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa R, Sposato K, Abbo LM. Preventing surgical site infections: implementing strategies throughout the perioperative continuum. AORN J. 2023;117(5):300&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">37102746</ArticleId></ArticleIdList></Reference><Reference><Citation>Osagwu M, Okobi E, Ekor E. Postoperative infections: risk factors, prevention, and management strategies. Int J Med Sci Dent Res. 2024;7:52&#x2013;76.</Citation></Reference><Reference><Citation>Li Y, Ji M, Yang J. Current understanding of long-term cognitive impairment after sepsis. Front Immunol. 2022;13: 855006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9120941</ArticleId><ArticleId IdType="pubmed">35603184</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon EH, Ward DD, Xiong H, Berkovsky S, Hubbard RE. Delirium and incident dementia in hospital patients in New South Wales, Australia: retrospective cohort study. BMJ. 2024;384: e077634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10966895</ArticleId><ArticleId IdType="pubmed">38537951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling L, Mui OOY, Laupland KB, Lefrant JY, Roberts JA, Gopalan PD, Lipman J, Joynt GM. CaBo OMi: scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patients. J Intensive Care. 2022;10(1):44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9465866</ArticleId><ArticleId IdType="pubmed">36089642</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki RF, Golde TE, Heneka MT, Readhead B. Do infections have a role in the pathogenesis of Alzheimer disease? Nat Rev Neurol. 2020;16(4):193&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32152461</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler L, Walker KA. The role of chronic infection in Alzheimer&#x2019;s disease: instigators, co-conspirators, or bystanders? Curr Clin Microbiol Rep. 2021;8(4):199&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8849576</ArticleId><ArticleId IdType="pubmed">35186664</ArticleId></ArticleIdList></Reference><Reference><Citation>Richmond-Rakerd LS, Iyer MT, D&#x2019;Souza S, Khalifeh L, Caspi A, Moffitt TE, Milne BJ. Associations of hospital-treated infections with subsequent dementia: nationwide 30-year analysis. Nat Aging. 2024;4(6):783&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">38714911</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipil&#xe4; PN, Heikkil&#xe4; N, Lindbohm JV, Hakulinen C, Vahtera J, Elovainio M, Suominen S, V&#xe4;&#xe4;n&#xe4;nen A, Koskinen A, Nyberg ST, et al. Hospital-treated infectious diseases and the dementia risk: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis. 2021;21(11):1557&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592915</ArticleId><ArticleId IdType="pubmed">34166620</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue Y, Shue F, Bu G, Kanekiyo T. Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer&#x2019;s disease. Molecular Neurodegener. 2023. 10.1186/s13024-023-00640-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10334598</ArticleId><ArticleId IdType="pubmed">37434208</ArticleId></ArticleIdList></Reference><Reference><Citation>Manabe T, Heneka MT. Cerebral dysfunctions caused by sepsis during ageing. Nat Rev Immunol. 2022;22(7):444&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8582341</ArticleId><ArticleId IdType="pubmed">34764472</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendeln A-C, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, Wagner J, Haesler LM, Wild K, Skodras A, et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018;556(7701):332&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6038912</ArticleId><ArticleId IdType="pubmed">29643512</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sousa VL, Ara&#xfa;jo SB, Antonio LM, Silva-Queiroz M, Colodeti LC, Soares C, Barros-Arag&#xe3;o F, Mota-Araujo HP, Alves VS, Coutinho-Silva R, et al. Innate immune memory mediates increased susceptibility to Alzheimer&#x2019;s disease-like pathology in sepsis surviving mice. Brain Behav Immun. 2021;95:287&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33838250</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippensteel JA, Anderson BJ, Orfila JE, McMurtry SA, Dietz RM, Su G, Ford JA, Oshima K, Yang Y, Zhang F, et al. Circulating heparan sulfate fragments mediate septic cognitive dysfunction. J Clin Invest. 2019;129(4):1779&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6436867</ArticleId><ArticleId IdType="pubmed">30720464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozben T, Ozben S. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer&#x2019;s disease. Clin Biochem. 2019;72:87&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30954437</ArticleId></ArticleIdList></Reference><Reference><Citation>Andjelkovic AV, Situ M, Citalan-Madrid AF, Stamatovic SM, Xiang J, Keep RF. Blood-brain barrier dysfunction in normal aging and neurodegeneration: mechanisms, impact, and treatments. Stroke. 2023;54(3):661&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9993074</ArticleId><ArticleId IdType="pubmed">36848419</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda S, Sato N, Morishita R. Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. Front Aging Neurosci. 2014;6:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4114193</ArticleId><ArticleId IdType="pubmed">25120476</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5829048</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehlenbach WJ, Sonnen JA, Montine TJ, Larson EB. Association between sepsis and microvascular brain injury. Crit Care Med. 2019;47(11):1531&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31389836</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38609748</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1036-7314</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Australian critical care : official journal of the Confederation of Australian Critical Care Nurses</Title><ISOAbbreviation>Aust Crit Care</ISOAbbreviation></Journal><ArticleTitle>Hemodynamic goals in sepsis and septic shock resuscitation: An umbrella review of systematic reviews and meta-analyses with trial sequential analysis.</ArticleTitle><Pagination><StartPage>818</StartPage><EndPage>826</EndPage><MedlinePgn>818-826</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aucc.2024.03.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1036-7314(24)00059-6</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this study was to verify whether any parameter among those used as the target for haemodynamic optimisation (e.g., mean arterial pressure, central venous oxygen saturation, systolic or diastolic dysfunction, CO<sub>2</sub> gap, lactates, right ventricular dysfunction, and PvaCO<sub>2</sub>/CavO<sub>2</sub> ratio) is correlated with mortality in an undifferentiated population with sepsis or septic shock.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An umbrella review, searching MEDLINE, the Cochrane Database of Systematic Reviews, Health Technology Assessment Database, and the JBI Database of Systematic Reviews and Implementation Reports, was performed. We included systematic reviews and meta-analyses enrolling a population of unselected patients with sepsis or septic shock. The main outcome was mortality. Two authors conducted data extraction and risk-of-bias assessments independently. We used a random-effects model to pool binary and continuous data and summarised estimates of effect using equivalent odds ratios (eORs). We used the ROBIS tool to assess risk of bias and the assessment of multiple systematic reviews 2 score to assess global quality.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">17 systematic reviews and meta-analyses (15 828 patients) were included in the quantitative analysis. Diastolic dysfunction (eOR: 1.42; 95% confidence interval [CI]: 1.14-1.76), PvaCO<sub>2</sub>/CavO<sub>2</sub> ratio (eOR: 2.15; 95% CI: 1.37-3.37), and CO<sub>2</sub> gap (eOR: 1.86; 95% CI: 1.07-3.25) showed a significant correlation with mortality. Lactates were the parameter with highest inconsistency (I<sup>2</sup>&#xa0;=&#xa0;92%). Central venous oxygen saturation and right ventricle dysfunction showed significant statistical excess test of significance (p-value&#xa0;=&#xa0;0.009 and 0.005, respectively). None of the considered parameters showed statistically significant publication bias.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">According to this umbrella review, diastolic dysfunction is the haemodynamic variable that is most closely linked to the prognosis of septic patients. The PvaCO<sub>2</sub>/CavO<sub>2</sub> ratio and the CO<sub>2</sub>gap are significantly related to the mortality of septic patients, but the poor quality of evidence or the low number of cases, studied so far, limit their clinical applicability.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">PROSPERO: International prospective register of systematic reviews, 2023, CRD42023432813 (Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023432813).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Orso</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, ASUFC University Hospital of Udine, Udine, Italy. Electronic address: sd7782.do@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Federici</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, ASUFC University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lio</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, ASUFC University Hospital of Udine, Udine, Italy; Department of Medical Sciences (DAME), University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mearelli</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, ASUGI University Hospital of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, ASUFC University Hospital of Udine, Udine, Italy; Department of Medical Sciences (DAME), University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Aust Crit Care</MedlineTA><NlmUniqueID>9207852</NlmUniqueID><ISSNLinking>1036-7314</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="Y">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CO(2)gap</Keyword><Keyword MajorTopicYN="N">Hemodynamic</Keyword><Keyword MajorTopicYN="N">Mean arterial pressure (MAP)</Keyword><Keyword MajorTopicYN="N">ScVO(2)</Keyword><Keyword MajorTopicYN="N">Septic shock monitoring</Keyword><Keyword MajorTopicYN="N">Umbrella review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>12</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38609748</ArticleId><ArticleId IdType="doi">10.1016/j.aucc.2024.03.005</ArticleId><ArticleId IdType="pii">S1036-7314(24)00059-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40383152</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Mortality, diagnosis, and etiology of disseminated intravascular coagulation-a systematic review and meta-analysis: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation.</ArticleTitle><Pagination><StartPage>2663</StartPage><EndPage>2679</EndPage><MedlinePgn>2663-2679</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtha.2025.04.033</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1538-7836(25)00323-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Establishing global standards for diagnosis and treatment of disseminated intravascular coagulation (DIC) requires a comprehensive evaluation of its global epidemiology. However, obtaining epidemiologic evidence on DIC from a single cohort study is challenging.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We aimed to evaluate global epidemiology and mortality of DIC by conducting a systematic literature review.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted proportional meta-analyses of observational studies on DIC patients. We searched MEDLINE, Scopus, and the Cochrane Central Register of Controlled Trials and selected studies reporting mortality of patients with DIC. The diseases underlying DIC included sepsis, trauma, solid cancer, hematologic neoplasia, burn, heat stroke, snakebite, and others. We measured all-cause mortality as the primary outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 119 studies, the most common diseases underlying DIC were sepsis in 52 studies and trauma in 31 studies. The International Society on Thrombosis and Haemostasis overt DIC and the Japanese Association for Acute Medicine DIC criteria were most frequently used to diagnose DIC. Pooled odds ratio (ie, increased risk) of mortality associated with development of DIC varied depending on the underlying disease: 3.15 in sepsis and 4.80 in trauma. Pooled raw mortality of DIC patients also varied widely by underlying disease: 42% in sepsis, 36% in trauma, 8% in snakebite, 28% in leukemia, and 32% in heat stroke. Pooled mortality and odds ratio for mortality also varied by the diagnostic criteria. We observed no clear yearly trend of improvement in mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Mortality of DIC is very high but heterogeneous depending on underlying disease and diagnostic criteria, which should be taken into consideration in standardization of diagnosis and treatment of DIC.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Umemura</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan; Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: plum00022@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarlatescu</LastName><ForeName>Ecaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Medicine and Pharmacy "Carol Davila," Bucharest and Department of Anaesthesia and Intensive Care, Fundeni Clinical Institute, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwagha</LastName><ForeName>Theresa U</ForeName><Initials>TU</Initials><AffiliationInfo><Affiliation>Department of Haematology and Immunology, College of Medicine, University of Nigeria Ituku Ozalla Campus, Enugu, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Jerrold H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Othman</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada; School of Baccalaureate Nursing, St. Lawrence College, Kingston, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Hunter</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Reilly</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helms</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>French National Institute of Health and Medical Research, United Medical Resources 1260, Regenerative Nanomedicine, F&#xe9;d&#xe9;ration de Medicine Translationnelle de Strasbourg, Strasbourg University Hospital, Medical Intensive Care Unit-National Health Commission, Strasbourg University, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iba</LastName><ForeName>Toshiaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004211" MajorTopicYN="Y">Disseminated Intravascular Coagulation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood coagulation disorders</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">disseminated intravascular coagulation</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList><CoiStatement>Declaration of competing interests There are no competing interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>31</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>19</Day><Hour>0</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>18</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40383152</ArticleId><ArticleId IdType="doi">10.1016/j.jtha.2025.04.033</ArticleId><ArticleId IdType="pii">S1538-7836(25)00323-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40274050</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-4577</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical nutrition ESPEN</Title><ISOAbbreviation>Clin Nutr ESPEN</ISOAbbreviation></Journal><ArticleTitle>Adipokines in critically ill patients: A systematic review and meta-analysis of observational studies.</ArticleTitle><Pagination><StartPage>216</StartPage><EndPage>227</EndPage><MedlinePgn>216-227</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clnesp.2025.03.176</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-4577(25)00267-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Critical illness is a hypermetabolic state with high mortality rates. Adipokines, including leptin, adiponectin, and resistin, regulate energy balance, inflammation, and metabolism and may influence outcomes in critically ill patients. This study evaluated changes in adipokine levels in ICU patients compared to healthy controls and explored their associations with clinical outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis of 34 case-control studies involving 3365 participants were conducted. Pooled weighted mean difference (WMD) of adipokine levels between critically ill patients and controls were calculated using random-effects models. Subgroup analyses were performed based on ICU type (Medical, Surgical, Mixed), septic status (septic or non-septic), and injury phase (ebb or flow). Publication bias and sensitivity analyses were also conducted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Leptin (WMD: 3.22 ng/mL; 95 % CI: 0.91 to 5.53) and resistin (WMD: 19.86 ng/mL; 95 % CI: 14.78 to 24.95) levels were significantly elevated in critically ill patients, while adiponectin levels showed no significant difference (WMD: 0.37 &#x3bc;g/dL; 95 % CI: -1.81 to 2.55). Subgroup analyses revealed higher leptin and resistin levels in mixed-ICU and septic patients. Leptin also increased during the ebb phase, but heterogeneity remained high (I<sup>2</sup> &gt; 97 %).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Leptin and resistin levels are elevated in critical illness, potentially serving as biomarkers for disease severity. However, high heterogeneity limits generalizability. Future research should standardize protocols and investigate adipokines' prognostic and therapeutic roles in critical care.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kolahi</LastName><ForeName>Ahmadreza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gholizadeh</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shab-Bidar</LastName><ForeName>Sakineh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: s.shabbidar@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Nutr ESPEN</MedlineTA><NlmUniqueID>101654592</NlmUniqueID><ISSNLinking>2405-4577</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054392">Adipokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052243">Resistin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020738">Leptin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052242">Adiponectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054392" MajorTopicYN="Y">Adipokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052243" MajorTopicYN="N">Resistin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020738" MajorTopicYN="N">Leptin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052242" MajorTopicYN="N">Adiponectin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adipokines</Keyword><Keyword MajorTopicYN="N">Adiponectin</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Critical illness</Keyword><Keyword MajorTopicYN="N">Leptin</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Resistin</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflicts of interest related to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>24</Day><Hour>19</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40274050</ArticleId><ArticleId IdType="doi">10.1016/j.clnesp.2025.03.176</ArticleId><ArticleId IdType="pii">S2405-4577(25)00267-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16356226</PMID><DateCompleted><Year>2006</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2005</Year></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of hemodynamic optimization: relationship to methodological quality.</ArticleTitle><Pagination><StartPage>R771</StartPage><EndPage>R779</EndPage><MedlinePgn>R771-9</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">To review systematically the effect of interventions aimed at hemodynamic optimization and to relate this to the quality of individual published trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic, computerized bibliographic search of published studies and citation reviews of relevant studies was performed. All randomized clinical trials in which adult patients were included in a trial deliberately aiming at an optimized or maximized hemodynamic condition of the patients (with oxygen delivery, cardiac index, oxygen consumption, mixed venous oxygen saturation and/or stroke volume as end-points) were selected. A total of 30 studies were selected for independent review. Two reviewers extracted data on population, intervention, outcome and methodological quality. Agreement between reviewers was high: differences were eventually resolved by third-party decision. The methodological quality of the studies was moderate (mean 9.0, SD 1.7), and the outcomes of the randomized clinical trials were not related to their quality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Efforts to achieve an optimized hemodynamic condition resulted in a decreased mortality rate (relative risk ratio (RR) 0.75 (95% confidence interval (CI) 0.62 to 0.90) in all studies combined. This was due to a significantly decreased mortality in peri-operative intervention studies (RR 0.66 (95% CI 0.54 to 0.81). Overall, patients with sepsis and overt organ failure do not benefit from this method (RR 0.92 (95% CI 0.75 to 1.11)).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This systematic review showed that interventions aimed at hemodynamic optimization reduced mortality. In particular, trials including peri-operative interventions aimed at the hemodynamic optimization of high-risk surgical patients reduce mortality. Overall, this effect was not related to the trial quality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Poeze</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Hospital Maastricht, P Debyelaan 25, 6202 AZ Maastricht, The Netherlands. m.poeze@ah.unimaas.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greve</LastName><ForeName>Jan Willem M</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Ramsay</LastName><ForeName>Graham</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2005</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2005</Year><Month>11</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16356226</ArticleId><ArticleId IdType="pmc">PMC1414050</ArticleId><ArticleId IdType="doi">10.1186/cc3902</ArticleId><ArticleId IdType="pii">cc3902</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wo CC, Shoemaker WC, Appel PL, Bishop MH, Kram HB, Hardin E. Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness. Crit Care Med. 1993;21:218&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">8428472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop MH, Shoemaker WC, Appel PL, Wo CJ, Zwick C, Kram HB, Meade P, Kennedy F, Fleming AW. Relationship between supranormal circulatory values, time delays, and outcome in severely traumatized patients. Crit Care Med. 1993;21:56&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">8420731</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest. 1988;94:1176&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pubmed">3191758</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyland DK, Cook DJ, King D, Kernerman P, Brun-Buisson C. Maximizing oxygen delivery in critically ill patients: a methodological appraisal of the evidence. Crit Care Med. 1996;24:517&#x2013;524. doi: 10.1097/00003246-199603000-00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199603000-00025</ArticleId><ArticleId IdType="pubmed">8625644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med. 2002;30:1686&#x2013;1692. doi: 10.1097/00003246-200208000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200208000-00002</ArticleId><ArticleId IdType="pubmed">12163777</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd O, Hayes M. The oxygen trail: the goal. Br Med Bull. 1999;55:125&#x2013;139. doi: 10.1258/0007142991902330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/0007142991902330</ArticleId><ArticleId IdType="pubmed">10695083</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bie RA. Methodology of systematic reviews: an introduction. Phys Ther Rev. 1996;1:47&#x2013;51.</Citation></Reference><Reference><Citation>Boissel JP. Standards for reporting clinical trials. Clin Trials Metaanal. 1992;28:5&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10150101</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers TC, Smith H, Jnr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981;2:31&#x2013;49. doi: 10.1016/0197-2456(81)90056-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(81)90056-8</ArticleId><ArticleId IdType="pubmed">7261638</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibbald WJ, Fox G, Martin C. Abnormalities of vascular reactivity in the sepsis syndrome. Chest. 1991;100:155S&#x2013;159S.</Citation><ArticleIdList><ArticleId IdType="pubmed">1884640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno S, Tanabe G, Yamada H, Kusano C, Yoshidome S, Nuruki K, Yamamoto S, Aikou T. Response of patients with cirrhosis who have undergone partial hepatectomy to treatment aimed at achieving supranormal oxygen delivery and consumption. Surgery. 1998;123:278&#x2013;286. doi: 10.1067/msy.1998.85942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/msy.1998.85942</ArticleId><ArticleId IdType="pubmed">9526519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, McManus E. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ. 1999;318:1099&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27840</ArticleId><ArticleId IdType="pubmed">10213716</ArticleId></ArticleIdList></Reference><Reference><Citation>Velmahos GC, Demetriades D, Shoemaker WC, Chan LS, Tatevossian R, Wo CC, Vassiliu P, Cornwell EE, 3rd, Roth B, Belzberg H, et al. Endpoints of resuscitation of critically injured patients: normal or supranormal? A prospective randomized trial. Ann Surg. 2000;232:409&#x2013;418. doi: 10.1097/00000658-200009000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-200009000-00013</ArticleId><ArticleId IdType="pmc">PMC1421154</ArticleId><ArticleId IdType="pubmed">10973391</ArticleId></ArticleIdList></Reference><Reference><Citation>Takala J, Meier Hellmann A, Eddleston J, Hulstaert P, Sramek V, for the European Multicenter Study Group on Dopexamine in Major Abdominal Surgery Effect of dopexamine on outcome after major abdominal surgery: a prospective, randomized, controlled multicenter study. Crit Care Med. 2000;28:3417&#x2013;3423. doi: 10.1097/00003246-200010000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200010000-00007</ArticleId><ArticleId IdType="pubmed">11057795</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuchschmidt J, Fried J, Astiz M, Rackow E. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest. 1992;102:216&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">1623756</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Levy MM, Smith P, Takiguchi SA, Miyasaki A, Myers SA. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med. 1993;21:830&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pubmed">8504649</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Takanishi D, Myers SA, Takiguchi SA, Severino R, Hasaniya N, Levy MM, McNamara JJ. Frequency of mortality and myocardial infarction during maximizing oxygen delivery: a prospective, randomized trial. Crit Care Med. 1995;23:1025&#x2013;1032. doi: 10.1097/00003246-199506000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199506000-00006</ArticleId><ArticleId IdType="pubmed">7774212</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Burchell S, Hasaniya NW, Takanishi DM, Myers SA, Takiguchi SA. Relationship of mortality to increasing oxygen delivery in patients &gt; or = 50 years of age: a prospective, randomized trial. Crit Care Med. 1998;26:1011&#x2013;1019. doi: 10.1097/00003246-199806000-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199806000-00018</ArticleId><ArticleId IdType="pubmed">9635648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994;330:1717&#x2013;1722. doi: 10.1056/NEJM199406163302404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199406163302404</ArticleId><ArticleId IdType="pubmed">7993413</ArticleId></ArticleIdList></Reference><Reference><Citation>Alia I, Esteban A, Gordo F, Lorente JA, Diaz C, Rodriguez JA, Frutos F. A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest. 1999;115:453&#x2013;461. doi: 10.1378/chest.115.2.453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.115.2.453</ArticleId><ArticleId IdType="pubmed">10027447</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R, for the SvO2 Collaborative Group A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med. 1995;333:1025&#x2013;1032. doi: 10.1056/NEJM199510193331601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199510193331601</ArticleId><ArticleId IdType="pubmed">7675044</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo SM, Salgado PF, Castillo VG, Borim AA, Polachini CA, Palchetti JC, Brienzi SL, de Oliveira GG. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med. 2000;28:3396&#x2013;3404. doi: 10.1097/00003246-200010000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200010000-00003</ArticleId><ArticleId IdType="pubmed">11057792</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming A, Bishop M, Shoemaker W, Appel P, Sufficool W, Kuvhenguwha A, Kennedy F, Wo CJ. Prospective trial of supranormal values as goals of resuscitation in severe trauma. Arch Surg. 1992;127:1175&#x2013;1181.</Citation><ArticleIdList><ArticleId IdType="pubmed">1417482</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA. 1993;270:2699&#x2013;2707. doi: 10.1001/jama.270.22.2699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.270.22.2699</ArticleId><ArticleId IdType="pubmed">7907668</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop MH, Shoemaker WC, Appel PL, Meade P, Ordog GJ, Wasserberger J, Wo CJ, Rimle DA, Kram HB, Umali R, et al. Prospective, randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. J Trauma. 1995;38:780&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pubmed">7760409</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham RM, Neunaber K, Mazuski JE, Shapiro MJ, Baue AE. The use of oxygen consumption and delivery as endpoints for resuscitation in critically ill patients. J Trauma. 1996;41:32&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">8676421</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonazzi M, Gentile F, Biasi GM, Migliavacca S, Esposti D, Cipolla M, Marsicano M, Prampolini F, Ornaghi M, Sternjakob S, Tshomba Y. Impact of perioperative haemodynamic monitoring on cardiac morbidity after major vascular surgery in low risk patients. A randomised pilot trial. Eur J Vasc Endovasc Surg. 2002;23:445&#x2013;451. doi: 10.1053/ejvs.2002.1617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ejvs.2002.1617</ArticleId><ArticleId IdType="pubmed">12027474</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler DW, Wright JG, Choban PS, Flancbaum L. A prospective randomized trial of preoperative 'optimization' of cardiac function in patients undergoing elective peripheral vascular surgery. Surgery. 1997;122:584&#x2013;592. doi: 10.1016/S0039-6060(97)90132-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0039-6060(97)90132-X</ArticleId><ArticleId IdType="pubmed">9308617</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;1377. doi: 10.1056/NEJMoa010307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010307</ArticleId><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Polonen P, Ruokonen E, Hippelainen M, Poyhonen M, Takala J. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90:1052&#x2013;1059.</Citation><ArticleIdList><ArticleId IdType="pubmed">10781452</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz RJ, Whitfield GF, LaMura JJ, Raciti A, Krishnamurthy S. The role of physiologic monitoring in patients with fractures of the hip. J Trauma. 1985;25:309&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">3989888</ArticleId></ArticleIdList></Reference><Reference><Citation>Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg. 1995;130:423&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">7535996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair S, James S, Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. BMJ. 1997;315:909&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127619</ArticleId><ArticleId IdType="pubmed">9361539</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlauk JF, Abrams JH, Gilmour IJ, O'Connor SR, Knighton DR, Cerra FB. Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trial. Ann Surg. 1991;214:289&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1358649</ArticleId><ArticleId IdType="pubmed">1929610</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender JS, Smith-Meek MA, Jones CE. Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery: results of a prospective, randomized trial. Ann Surg. 1997;226:229&#x2013;236. doi: 10.1097/00000658-199709000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199709000-00002</ArticleId><ArticleId IdType="pmc">PMC1191013</ArticleId><ArticleId IdType="pubmed">9339929</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine RJ, Duke ML, Inman MH, Grayburn PA, Hagino RT, Kakish HB, Clagett GP. Effectiveness of pulmonary artery catheters in aortic surgery: a randomized trial. J Vasc Surg. 1998;27:203&#x2013;211. doi: 10.1016/S0741-5214(98)70351-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-5214(98)70351-9</ArticleId><ArticleId IdType="pubmed">9510275</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, Papsdorf M, Piper S, Padberg W, Hempelmann G. Influence of dopexamine hydrochloride on hemodynamics and regulators of circulation in patients undergoing major abdominal surgery. Acta Anaesthesiol Scand. 1998;42:941&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pubmed">9773139</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway DH, Mayall R, Abdul-Latif MS, Gilligan S, Tackaberry C. Randomised controlled trial investigating the influence of intravenous fluid titration using oesophageal Doppler monitoring during bowel surgery. Anaesthesia. 2002;57:845&#x2013;849. doi: 10.1046/j.1365-2044.2002.02708.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2044.2002.02708.x</ArticleId><ArticleId IdType="pubmed">12190747</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, Canadian Critical Care Clinical Trials Group et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348:5&#x2013;14. doi: 10.1056/NEJMoa021108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa021108</ArticleId><ArticleId IdType="pubmed">12510037</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrison RN, Wilson MA, Matheson PJ, Spain DA. Preoperative saline loading improves outcome after elective, noncardiac surgical procedures. Am Surg. 1996;62:223&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">8607583</ArticleId></ArticleIdList></Reference><Reference><Citation>Blow O, Magliore L, Claridge JA, Butler K, Young JS. The golden hour and the silver day: detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma. J Trauma. 1999;47:964&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pubmed">10568731</ArticleId></ArticleIdList></Reference><Reference><Citation>Poeze M, Greve JW, Ramsay G. Goal-oriented hemodynamic therapy: a plea for a closer look at using peri-operative oxygen transport optimisation. Intensive Care Med. 2000;26:635&#x2013;637. doi: 10.1007/s001340051216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340051216</ArticleId><ArticleId IdType="pubmed">10923742</ArticleId></ArticleIdList></Reference><Reference><Citation>Poeze M, Greve JW, Ramsay G. Oxygen delivery in septic shock. Chest. 1999;116:1145. doi: 10.1378/chest.116.4.1145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.116.4.1145</ArticleId><ArticleId IdType="pubmed">10531197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollenberg SM, Cunnion RE. Endothelial and vascular smooth muscle function in sepsis. J Crit Care. 1994;9:262&#x2013;280. doi: 10.1016/0883-9441(94)90006-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0883-9441(94)90006-X</ArticleId><ArticleId IdType="pubmed">7889136</ArticleId></ArticleIdList></Reference><Reference><Citation>Abid O, Akca S, Haji-Michael P, Vincent JL. Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med. 2000;28:947&#x2013;949. doi: 10.1097/00003246-200004000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200004000-00006</ArticleId><ArticleId IdType="pubmed">10809264</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31679383</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1735-3947</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Archives of Iranian medicine</Title><ISOAbbreviation>Arch Iran Med</ISOAbbreviation></Journal><ArticleTitle>Impact on Efficacy and Safety of Hydrocortisone in Sepsis and Septic Shock - A Systematic Literature Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>394</StartPage><EndPage>402</EndPage><MedlinePgn>394-402</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND">Sepsis and septic shock are major causes of morbidity and mortality worldwide, associated with a high economic and social burden on healthcare systems and communities, yet with few definite treatment modalities. The efficacy of steroids in the management of sepsis or septic shock remains a controversy and subject of investigation due to their theoretical beneficial effects.</AbstractText><AbstractText Label="METHODS">This was a systematic literature review and meta-analysis on randomized controlled trials of hydrocortisone usage in sepsis or septic shock as of 2000, following the GRADE methodology, considering a primary outcome of 28 day all-cause mortality.</AbstractText><AbstractText Label="RESULTS">Ten randomized control trials were included in the review, 9 of which reported 28 day mortality either as a primary or secondary outcome. Relative risk of dying at 28 days was 0.93 in favor of hydrocortisone (95% CI: 0.86-1.01; P = 0.056). Other secondary outcomes of the review were similarly statistically insignificant. The quality of evidence was graded as very low to low.</AbstractText><AbstractText Label="CONCLUSION">Hydrocortisone, when used in sepsis or septic shock, in critically ill adult patients showed a statistically insignificant trend towards decreasing 28 day all-cause mortality. This warrants consideration of clinical significance for each patient individually.</AbstractText><CopyrightInformation>&#xa9; 2019 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aletreby</LastName><ForeName>Waleed Tharwat</ForeName><Initials>WT</Initials><Identifier Source="ORCID">0000-0001-8387-1829</Identifier><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharthy</LastName><ForeName>Abdulrahman Mishaal</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madi</LastName><ForeName>Ahmed Fouad</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soliman</LastName><ForeName>Ibrahim Refaat</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamido</LastName><ForeName>Hend Mohammed</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramadan</LastName><ForeName>Omar Elsayed</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzayer</LastName><ForeName>Wasim</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huwait</LastName><ForeName>Basim Mohammed</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alodat</LastName><ForeName>Mohammed Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mumtaz</LastName><ForeName>Shahzad Ahmed</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmood</LastName><ForeName>Nasir Nasim</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Kurdi</LastName><ForeName>Mahmoud Hussien</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrag</LastName><ForeName>Hazem Abdulgaffar</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karakitsos</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, Keck Medical School, USC, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><MedlineTA>Arch Iran Med</MedlineTA><NlmUniqueID>100889644</NlmUniqueID><ISSNLinking>1029-2977</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Efficacy</Keyword><Keyword MajorTopicYN="N">Hydrocortisone</Keyword><Keyword MajorTopicYN="N">Safety</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31679383</ArticleId><ArticleId IdType="pii">S1029-2977-22(07)394-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31982391</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>157</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Lower vs&#xa0;Higher Fluid Volumes During Initial Management of Sepsis: A Systematic Review With Meta-Analysis and Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>1478</StartPage><EndPage>1496</EndPage><MedlinePgn>1478-1496</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2019.11.050</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(20)30123-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE">IV fluids are recommended during the initial management of sepsis, but the quality of evidence is low, and clinical equipoise exists. We aimed to assess patient-important benefits and harms of lower vs&#xa0;higher fluid volumes in adult patients with sepsis.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review with meta-analysis and trial sequential analysis (TSA) of randomized clinical trials of IV fluid volume separation in adult patients with sepsis. We adhered to our published protocol; the Cochrane handbook; the Preferred Reporting Items for Systematic Reviews and Meta-Analyses; and the Grading of Recommendations Assessment, Development and Evaluation statements. The primary outcomes were all-cause mortality, serious adverse events (SAEs), and quality of life.</AbstractText><AbstractText Label="RESULTS">We included nine trials (n&#xa0;= 637); all were published after 2015 and had an overall high risk of bias. We found no statistically significant difference between lower vs&#xa0;higher fluid volumes in all-cause mortality (relative risk [RR], 0.87; 95%&#xa0;CI, 0.69-1.10; I<sup>2</sup>&#xa0;= 0%; TSA-adjusted CI, 0.34-2.22) or SAEs (RR, 0.91; 95%&#xa0;CI, 0.78-1.05; I<sup>2</sup>&#xa0;= 0%; TSA-adjusted CI, 0.68-1.21). No trials reported on quality of life. We did not find differences in the secondary or exploratory outcomes. The quality of evidence was very low across all outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">In this systematic review, we found very low quantity and quality of evidence supporting the decision on the volumes of IV fluid therapy in adults with sepsis.</AbstractText><AbstractText Label="TRIAL REGISTRY">ClinicalTrials.gov; No.: NCT03668236; URL: www.clinicaltrials.gov.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Tine Sylvest</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark. Electronic address: tine.sylvest.meyhoff@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Morten Hylander</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjortrup</LastName><ForeName>Peter Buhl</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Department of Clinical Science and Education, S&#xf6;dersjukhuset, Section of Anaesthesia and Intensive Care, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetterslev</LastName><ForeName>J&#xf8;rn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03668236</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2020 Jun;157(6):1403-1404. doi: 10.1016/j.chest.2020.01.015.</RefSource><PMID Version="1">32505300</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2020 Jul;158(1):427-428. doi: 10.1016/j.chest.2020.02.030.</RefSource><PMID Version="1">32654720</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2020 Jul;158(1):428. doi: 10.1016/j.chest.2020.02.031.</RefSource><PMID Version="1">32654721</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fluid therapy</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">resuscitation</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31982391</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2019.11.050</ArticleId><ArticleId IdType="pii">S0012-3692(20)30123-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25003759</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1549-1676</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>PLoS medicine</Title><ISOAbbreviation>PLoS Med</ISOAbbreviation></Journal><ArticleTitle>Severe maternal sepsis in the UK, 2011-2012: a national case-control study.</ArticleTitle><Pagination><StartPage>e1001672</StartPage><MedlinePgn>e1001672</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1001672</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pmed.1001672</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In light of increasing rates and severity of sepsis worldwide, this study aimed to estimate the incidence of, and describe the causative organisms, sources of infection, and risk factors for, severe maternal sepsis in the UK.</AbstractText><AbstractText Label="METHODS AND FINDINGS" NlmCategory="RESULTS">A prospective case-control study included 365 confirmed cases of severe maternal sepsis and 757 controls from all UK obstetrician-led maternity units from June 1, 2011, to May 31, 2012. Incidence of severe sepsis was 4.7 (95% CI 4.2-5.2) per 10,000 maternities; 71 (19.5%) women developed septic shock; and five (1.4%) women died. Genital tract infection (31.0%) and the organism Escherichia coli (21.1%) were most common. Women had significantly increased adjusted odds ratios (aORs) of severe sepsis if they were black or other ethnic minority (aOR&#x200a;=&#x200a;1.82; 95% CI 1.82-2.51), were primiparous (aOR&#x200a;=&#x200a;1.60; 95% CI 1.17-2.20), had a pre-existing medical problem (aOR&#x200a;=&#x200a;1.40; 95% CI 1.01-1.94), had febrile illness or were taking antibiotics in the 2 wk prior to presentation (aOR&#x200a;=&#x200a;12.07; 95% CI 8.11-17.97), or had an operative vaginal delivery (aOR&#x200a;=&#x200a;2.49; 95% CI 1.32-4.70), pre-labour cesarean (aOR&#x200a;=&#x200a;3.83; 95% CI 2.24-6.56), or cesarean after labour onset (aOR&#x200a;=&#x200a;8.06; 95% CI 4.65-13.97). Median time between delivery and sepsis was 3 d (interquartile range&#x200a;=&#x200a;1-7 d). Multiple pregnancy (aOR&#x200a;=&#x200a;5.75; 95% CI 1.54-21.45) and infection with group A streptococcus (aOR&#x200a;=&#x200a;4.84; 2.17-10.78) were associated with progression to septic shock; for 16 (50%) women with a group A streptococcal infection there was &lt;2 h-and for 24 (75%) women, &lt;9 h-between the first sign of systemic inflammatory response syndrome and a diagnosis of severe sepsis. A limitation of this study was the proportion of women with sepsis without an identified organism or infection source (16.4%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For each maternal sepsis death, approximately 50 women have life-threatening morbidity from sepsis. Follow-up to ensure infection is eradicated is important. The rapid progression to severe sepsis highlights the importance of following the international Surviving Sepsis Campaign guideline of early administration of high-dose intravenous antibiotics within 1 h of admission to hospital for anyone with suspected sepsis. Signs of severe sepsis in peripartum women, particularly with confirmed or suspected group A streptococcal infection, should be regarded as an obstetric emergency. Please see later in the article for the Editors' Summary.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Acosta</LastName><ForeName>Colleen D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>National Perinatal Epidemiology Unit, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurinczuk</LastName><ForeName>Jennifer J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>National Perinatal Epidemiology Unit, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>D Nuala</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Northwick Park Hospital, Harrow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuffnell</LastName><ForeName>Derek J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Bradford Royal Infirmary, Bradford Hospitals NHS Trust, Bradford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sellers</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St. Michael's Hospital, University Hospitals Bristol NHS Trust, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Perinatal Epidemiology Unit, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>United Kingdom Obstetric Surveillance System</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NIHR-RP-011-032</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RP-PG-0608-10038</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Med</MedlineTA><NlmUniqueID>101231360</NlmUniqueID><ISSNLinking>1549-1277</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>SS is Chair of the Claims Advisory Committee at the Medical Protection Society for which she receives an honorarium. All other authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25003759</ArticleId><ArticleId IdType="pmc">PMC4086731</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1001672</ArticleId><ArticleId IdType="pii">PMEDICINE-D-14-00626</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Waterstone M, Bewley S, Wolfe C (2001) Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 322: 1089&#x2013;1093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC31259</ArticleId><ArticleId IdType="pubmed">11337436</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, et al. (2011) Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006&#x2013;2008. The eighth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 118 (Suppl 1) 1&#x2013;203 10.1111/j.1471-0528.2010.02847.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2010.02847.x</ArticleId><ArticleId IdType="pubmed">21356004</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutte JM, Steegers EAP, Schuitemaker NWE, Santema JG, de Boer K, et al. (2010) Rise in maternal mortality in the Netherlands. BJOG 117: 399&#x2013;406 10.1111/j.1471-0528.2009.02382.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2009.02382.x</ArticleId><ArticleId IdType="pubmed">19943828</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta CD, Knight M, Lee HC, Kurinczuk JJ, Gould JB, et al. (2013) The continuum of maternal sepsis severity: incidence and risk factors in a population-based cohort study. PLoS ONE 8: e67175 10.1371/journal.pone.0067175</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067175</ArticleId><ArticleId IdType="pmc">PMC3699572</ArticleId><ArticleId IdType="pubmed">23843991</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan KS, Wojdyla D, Say L, G&#xfc;lmezoglu AM, Van Look PFA (2006) WHO analysis of causes of maternal death: a systematic review. Lancet 367: 1066&#x2013;1074 10.1016/S0140-6736(06)68397-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)68397-9</ArticleId><ArticleId IdType="pubmed">16581405</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta CD, Knight M (2013) Sepsis and maternal mortality. Curr Opin Obstet Gynecol 25: 109&#x2013;116 10.1097/GCO.0b013e32835e0e82</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GCO.0b013e32835e0e82</ArticleId><ArticleId IdType="pubmed">23385771</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuitemaker N, van Roosmalen J, Dekker G, van Dongen P, van Geijn H, et al. (1998) Increased maternal mortality in The Netherlands from group A streptococcal infections. Eur J Obstet Gynecol Reprod Biol 76: 61&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">9481549</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight M, Kurinczuk JJ, Tuffnell D, Brocklehurst P (2005) The UK Obstetric Surveillance System for rare disorders of pregnancy. BJOG 112: 263&#x2013;265 10.1111/j.1471-0528.2005.00609.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2005.00609.x</ArticleId><ArticleId IdType="pubmed">15713136</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644&#x2013;1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health (2000) Comprehensive critical care. London: Department of Health.</Citation></Reference><Reference><Citation>Office for National Statistics (2013) Live births in England and Wales by characteristics of mother 1, 2011. Available: http://www.ons.gov.uk/ons/rel/vsob1/characteristics-of-Mother-1&#x2014;england-and-wales/2011/sb-characteristics-of-mother-1.html. Accessed 10 June 2014.</Citation></Reference><Reference><Citation>Northern Ireland Statistics and Research Agency (2012) Live births 1887 to 2012. Available: http://www.nisra.gov.uk/demography/default.asp8.htm. Accessed 16 August 2012.</Citation></Reference><Reference><Citation>General Register Office for Scotland (2013) Vital events reference tables 2011. Available: http://www.gro-scotland.gov.uk/statistics/theme/vital-events/general/ref-tables/2011/section-3-births.html. Accessed 19 February 2013.</Citation></Reference><Reference><Citation>Paruk F (2008) Infection in obstetric critical care. Best Pract Res Clin Obstet Gynaecol 22: 865&#x2013;883 10.1016/j.bpobgyn.2008.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpobgyn.2008.06.011</ArticleId><ArticleId IdType="pubmed">18693141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, et al. (2004) Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care 8: R82&#x2013;R90 10.1186/cc2459</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2459</ArticleId><ArticleId IdType="pmc">PMC420030</ArticleId><ArticleId IdType="pubmed">15025782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindquist A, Knight M, Kurinczuk JJ (2013) Variation in severe maternal morbidity according to socioeconomic position: a UK national case-control study. BMJ Open 3: e002742 10.1136/bmjopen-2013-002742</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2013-002742</ArticleId><ArticleId IdType="pmc">PMC3686175</ArticleId><ArticleId IdType="pubmed">23794588</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland JM, Altman DG (1994) Matching. BMJ 309: 1128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2541945</ArticleId><ArticleId IdType="pubmed">7987107</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharaj D (2007) Puerperal pyrexia: a review. Part I. Obstet Gynecol Surv 62: 393&#x2013;399 10.1097/01.ogx.0000265998.40912.5e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ogx.0000265998.40912.5e</ArticleId><ArticleId IdType="pubmed">17511893</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta CD, Bhattacharya S, Tuffnell D, Kurinczuk JJ, Knight M (2012) Maternal sepsis: a Scottish population-based case-control study. BJOG 119: 474&#x2013;483 10.1111/j.1471-0528.2011.03239.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2011.03239.x</ArticleId><ArticleId IdType="pmc">PMC3328752</ArticleId><ArticleId IdType="pubmed">22251396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer HMC, Schutte JM, Zwart JJ, Schuitemaker NWE, Steegers EAP, et al. (2009) Maternal mortality and severe morbidity from sepsis in the Netherlands. Acta Obstet Gynecol Scand 88: 647&#x2013;653 10.1080/00016340902926734</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016340902926734</ArticleId><ArticleId IdType="pubmed">19412806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer ME, Bateman BT, Bauer ST, Shanks AM, Mhyre JM (2013) Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg 117: 944&#x2013;950 10.1213/ANE.0b013e3182a009c3</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182a009c3</ArticleId><ArticleId IdType="pubmed">24023020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriskandan S (2011) Severe peripartum sepsis. J R Coll Physicians Edinb 41: 339&#x2013;346 10.4997/JRCPE.2011.411</Citation><ArticleIdList><ArticleId IdType="doi">10.4997/JRCPE.2011.411</ArticleId><ArticleId IdType="pubmed">22184573</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelboam R, Tilley R, Blackburn J (2010) Time to antibiotics in sepsis. Crit Care 14: 1&#x2013;1 10.1186/cc8282</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8282</ArticleId></ArticleIdList></Reference><Reference><Citation>Senior K (2012) In the dark about sepsis. Lancet Infect Dis 12: 751&#x2013;752 10.1016/S1473-3099(12)70233-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(12)70233-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, et al. (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39: 165&#x2013;228 10.1007/s00134-012-2769-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2769-8</ArticleId><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39355351</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Outcomes after noncardiac surgery in patients with left ventricular assist devices: a systematic review.</ArticleTitle><Pagination><StartPage>1414444</StartPage><MedlinePgn>1414444</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1414444</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2024.1414444</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The number of patients living with left ventricular assist devices (LVADs) has gradually increased in the past decade. Non-cardiac surgery (NCS) in patients with LVAD poses a unique situation with its inherent challenges.</AbstractText><AbstractText Label="AIM" NlmCategory="UNASSIGNED">We conducted a comprehensive review to investigate the perioperative complications and mortality associated with emergent or elective NCS in patients with LVAD.</AbstractText><AbstractText Label="METHOD" NlmCategory="UNASSIGNED">A comprehensive literature search for any papers referring to continuous LVAD patients with NCS. All publications with at least five durable LVAD patients who had NCS were eligible for inclusion.</AbstractText><AbstractText Label="RESULT" NlmCategory="UNASSIGNED">Twenty articles matching our criteria were found and included in our study. This systematic review included 6,476 LVAD patients who underwent 6,824 NCS. There were 5-3,216 LVAD patients with NCS in each study. The median age was between 39 and 65 years, and most of the patients (78.8%) were male. Thirty-day postoperative mortality ranged from 0% to 60%. Eight studies reported no death within the 30 days of the operation. Common complications include gastrointestinal (GI) bleeding, intracranial bleeding, infection, acute kidney injury (AKI), urinary tract infection (UTI), stroke, sepsis, pneumonia, and VAD exchange. Emergent abdominal surgery had the highest (up to 60%) mortality rate, and vascular and neurological operations had the highest complication rates. Due to the diverse range of patients in each publication and the combination of outcomes presented in various publications, a meta-analysis was not conducted.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In LVAD patients, noncardiac surgery may be performed effectively and safely. LVAD patients who undergo non-cardiac surgery may require more transfusions due to their complex coagulopathies. However, perioperative management of LVAD patients undergoing emergent NCS should be optimized to reduce mortality.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">https://osf.io/fetsb/.</AbstractText><CopyrightInformation>&#xa9; 2024 Alamouti-Fard, Garg, Yazji, Brigham, Jacob, Wadiwala and Pham.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alamouti-Fard</LastName><ForeName>Emad</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Pankaj</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yazji</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brigham</LastName><ForeName>Tara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mayo Clinic Libraries, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Heart and Lung Transplant National Recovery Program, United Network for Organ Sharing (UNOS), Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadiwala</LastName><ForeName>Ishaq J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Oregon Health and Sciences University, Portland, OR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Si M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">left ventricular assist device</Keyword><Keyword MajorTopicYN="N">mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">outcome</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39355351</ArticleId><ArticleId IdType="pmc">PMC11442201</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2024.1414444</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lippi G, Sanchis-Gomar F. Global epidemiology and future trends of heart failure. AME Med J. (2020) 5. 10.21037/amj.2020.03.03</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/amj.2020.03.03</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant. (2017) 36(10):1080&#x2013;6. 10.1016/j.healun.2017.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2017.07.005</ArticleId><ArticleId IdType="pubmed">28942782</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. (2017) 135(10):e146&#x2013;603. 10.1161/CIR.0000000000000485</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000485</ArticleId><ArticleId IdType="pmc">PMC5408160</ArticleId><ArticleId IdType="pubmed">28122885</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics&#x2014;2020 update: a report from the American Heart Association. Circulation. (2020) 141(9):e139&#x2013;596. 10.1161/CIR.0000000000000757</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000757</ArticleId><ArticleId IdType="pubmed">31992061</ArticleId></ArticleIdList></Reference><Reference><Citation>Berardi C, Bravo CA, Li S, Khorsandi M, Keenan JE, Auld J, et al. The history of durable left ventricular assist devices and comparison of outcomes: heartware, heartmate II, heartmate 3, and the future of mechanical circulatory support. J Clin Med. (2022) 11(7):2022. 10.3390/jcm11072022</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11072022</ArticleId><ArticleId IdType="pmc">PMC9000165</ArticleId><ArticleId IdType="pubmed">35407630</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhu K, Lam PH, Mehra MR. Evolving trends in mechanical circulatory support: clinical development of a fully magnetically levitated durable ventricular assist device. Trends Cardiovasc Med. (2020) 30(4):223&#x2013;9. 10.1016/j.tcm.2019.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2019.05.013</ArticleId><ArticleId IdType="pubmed">31201005</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Goldstein DJ, Cleveland JC, Cowger JA, Hall S, Salerno CT, et al. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA. (2022) 328(12):1233&#x2013;42. 10.1001/jama.2022.16197</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.16197</ArticleId><ArticleId IdType="pmc">PMC9459909</ArticleId><ArticleId IdType="pubmed">36074476</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J. (2021) 372. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauman ZM, Cunningham R, Hodson A, Shostrom V, Evans CH, Schlitzkus LL. Emergent general surgery operations in patients with left ventricular assist devices. Am Surg. (2021) 87(1):8&#x2013;14. 10.1177/0003134820950683</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003134820950683</ArticleId><ArticleId IdType="pubmed">32972206</ArticleId></ArticleIdList></Reference><Reference><Citation>Beetz O, Bajunaid A, Mei&#xdf;ler L, Vondran FW, Kleine M, Cammann S, et al. Abdominal surgery in patients with ventricular assist devices: a single-center report. Asaio J. (2020) 66(8):890&#x2013;8. 10.1097/MAT.0000000000001085</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000001085</ArticleId><ArticleId IdType="pubmed">32740349</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger R, Nemeth A, Salewski C, Sandoval Boburg R, Acharya M, Weymann A, et al. Is it safe for patients with left ventricular assist devices to undergo non-cardiac surgery? Medicina (Kaunas). (2020) 56(9):424. 10.3390/medicina56090424</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina56090424</ArticleId><ArticleId IdType="pmc">PMC7559908</ArticleId><ArticleId IdType="pubmed">32842512</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat G, Kumar S, Aggarwal A, Pauwaa S, Rossell G, Kurien S, et al. Experience with noncardiac surgery in destination therapy left ventricular assist devices patients. Asaio J. (2012) 58(4):396&#x2013;401. 10.1097/MAT.0b013e31825b8d36</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0b013e31825b8d36</ArticleId><ArticleId IdType="pubmed">22713727</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CW, Dumon KR, Shaked O, Acker MA, Atluri P, Dempsey DT. Non-cardiac surgery in patients with continuous-flow left ventricular assist devices: a single institutional experience. J Investig Med. (2017) 65(5):912&#x2013;8. 10.1136/jim-2016-000297</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2016-000297</ArticleId><ArticleId IdType="pubmed">28341625</ArticleId></ArticleIdList></Reference><Reference><Citation>daSilva-deAbreu A, Garikapati K, Alhafez BA, Desai S, Eiswirth C, Krim S, et al. Laparoscopic sleeve gastrectomy in patients with obesity and ventricular assist devices: a comprehensive outcome analysis. Obes Surg. (2021) 31(2):884&#x2013;90. 10.1007/s11695-020-04948-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-020-04948-9</ArticleId><ArticleId IdType="pubmed">32840719</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nde&#x15f; E, Uzun O, &#xc7;iyiltepe H, Aday U, &#xc7;etin DA, G&#xfc;lmez S, et al. Emergency abdominal surgery in patients with left ventricular assist device: short- and long-term results. Postepy Kardiol Interwencyjnej. (2017) 13(4):313&#x2013;9. 10.5114/aic.2017.71613</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aic.2017.71613</ArticleId><ArticleId IdType="pmc">PMC5770862</ArticleId><ArticleId IdType="pubmed">29362574</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins RB, Go K, Raymond SL, Ayzengart A, Friedman J. Laparoscopic sleeve gastrectomy in patients with heart failure and left ventricular assist devices as a bridge to transplant. Surg Obes Relat Dis. (2018) 14(9):1269&#x2013;73. 10.1016/j.soard.2018.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2018.04.005</ArticleId><ArticleId IdType="pubmed">29929856</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeng EI, Miller AH, Friedman J, Tapia-Ruano SA, Reilly K, Parker A, et al. Ventricular assist device implantation and bariatric surgery: a route to transplantation in morbidly obese patients with End-stage heart failure. Asaio J. (2021) 67(2):163&#x2013;8. 10.1097/MAT.0000000000001212</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000001212</ArticleId><ArticleId IdType="pubmed">32701629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettyle SM, Chervu NL, Rao AS, Sadi S, Majure D, Sava JA, et al. Outcomes following noncardiac surgery in patients with ventricular assist devices: a single-center experience. Am Surg. (2017) 83(8):842&#x2013;6. 10.1177/000313481708300833</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481708300833</ArticleId><ArticleId IdType="pubmed">28822388</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan JA, Paone G, Nemeh HW, Henry SE, Gerlach B, Williams CT, et al. Non-cardiac surgery in patients on long-term left ventricular assist device support. J Heart Lung Transplant. (2012) 31(7):757&#x2013;63. 10.1016/j.healun.2012.02.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2012.02.023</ArticleId><ArticleId IdType="pubmed">22425233</ArticleId></ArticleIdList></Reference><Reference><Citation>Punchai S, Nor Hanipah Z, Sharma G, Aminian A, Steckner K, Cywinski J, et al. Laparoscopic sleeve gastrectomy in heart failure patients with left ventricular assist device. Obes Surg. (2019) 29(4):1122&#x2013;9. 10.1007/s11695-018-3570-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-018-3570-8</ArticleId><ArticleId IdType="pubmed">30723879</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg JH, Garvin KL, Hartman CW, Konigsberg BS. Total joint arthroplasty in patients with an implanted left ventricular assist device. Arthroplasty Today. (2023) 19:101005. 10.1016/j.artd.2022.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artd.2022.07.021</ArticleId><ArticleId IdType="pmc">PMC9722486</ArticleId><ArticleId IdType="pubmed">36483330</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustum N, Schmitto J, Aper JD, Hanke T, Haverich JS, et al. A. Vascular procedures in patients with left ventricular assist devices: single-center experience. Indian J Thorac Cardiovasc Surg. (2021) 37(5):514&#x2013;20. 10.1007/s12055-021-01192-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12055-021-01192-3</ArticleId><ArticleId IdType="pmc">PMC8387529</ArticleId><ArticleId IdType="pubmed">34511757</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigneswaran Y, Wang V, Krezalek M, Prachand V, Wyers S, Juricek C, et al. Laparoscopic procedures in patients with cardiac ventricular assist devices. Surg Endosc. (2019) 33(7):2181&#x2013;6. 10.1007/s00464-018-6497-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-018-6497-1</ArticleId><ArticleId IdType="pubmed">30367296</ArticleId></ArticleIdList></Reference><Reference><Citation>Zenilman A, Pechman D, Moran-Atkin E, Choi J, Camacho D. Bariatric surgery in patients with left ventricular assist devices: a safe and effective method of weight loss as a gateway to heart transplantation. Surg Obes Relat Dis. (2019) 15(10):1780&#x2013;4. 10.1016/j.soard.2019.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2019.08.003</ArticleId><ArticleId IdType="pubmed">31540743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilbermints V, Israeli O, Ben-Gal T, Rubchevsky V, Aravot D, Kashtan H, et al. Abdominal surgery in patients with a ventricular assist device: a single center experience in Israel. Isr Med Assoc J. (2020) 22(6):369&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">32558443</ArticleId></ArticleIdList></Reference><Reference><Citation>Briasoulis A, Chehab O, Alvarez P. In-hospital outcomes of left ventricular assist devices (LVAD) patients undergoing noncardiac surgery. Asaio J. (2021) 67(2):144&#x2013;8. 10.1097/MAT.0000000000001205</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000001205</ArticleId><ArticleId IdType="pubmed">32501823</ArticleId></ArticleIdList></Reference><Reference><Citation>McElderry B, Alvarez P, Hanna M, Chaudhury P, Bhat P, Starling RC. Outcomes of bariatric surgery in patients with left ventricular assist device. J Heart Lung Transplant. (2022) 41(7):914&#x2013;8. 10.1016/j.healun.2022.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2022.04.003</ArticleId><ArticleId IdType="pubmed">35537903</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentias A, Briasoulis A, Sarrazin MSV, Alvarez PA. Trends, perioperative adverse events, and survival of patients with left ventricular assist devices undergoing noncardiac surgery. JAMA Netw Open. (2020) 3(11):e2025118. 10.1001/jamanetworkopen.2020.25118</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.25118</ArticleId><ArticleId IdType="pmc">PMC7662145</ArticleId><ArticleId IdType="pubmed">33180131</ArticleId></ArticleIdList></Reference><Reference><Citation>Place A, McCrum M, Bell T, Nirula R. EGS Plus: predicting futility in LVAD patients with emergency surgical disease. Am J Surg. (2022) 224(6):1421&#x2013;5. 10.1016/j.amjsurg.2022.10.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2022.10.031</ArticleId><ArticleId IdType="pubmed">36319484</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanaiha Y, Xing H, Morales RR, Morchi R, Ragalie W, Benharash P. Abdominal operations after left ventricular assist device implantation and heart transplantation. J Surg Res. (2019) 243:481&#x2013;7. 10.1016/j.jss.2019.06.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2019.06.045</ArticleId><ArticleId IdType="pubmed">31377487</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghavi S, Jayarajan SN, Ambur V, Mangi AA, Chan E, Dauer E, et al. Noncardiac surgical procedures after left ventricular assist device implantation. Asaio J. (2016) 62(4):370&#x2013;4. 10.1097/MAT.0000000000000366</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000000366</ArticleId><ArticleId IdType="pubmed">26978709</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. (2016) 35(1):1&#x2013;23. 10.1016/j.healun.2015.10.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2015.10.023</ArticleId><ArticleId IdType="pubmed">26776864</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda WR, Batsis JA, Sarr MG, Collazo-Clavell ML, Clark MM, Somers VK, et al. Impact of bariatric surgery on quality of life, functional capacity, and symptoms in patients with heart failure. Obes Surg. (2013) 23:1011&#x2013;5. 10.1007/s11695-013-0953-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-013-0953-8</ArticleId><ArticleId IdType="pubmed">23604694</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani GV, McCloskey C, Ramanathan RC, Mathier MA. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol. (2008) 31(11):516&#x2013;20. 10.1002/clc.20315</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.20315</ArticleId><ArticleId IdType="pmc">PMC6652810</ArticleId><ArticleId IdType="pubmed">19006115</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene J, Tran T, Shope T. Sleeve gastrectomy and left ventricular assist device for heart transplant. JSLS. (2017) 21(3):e2017.00049. 10.4293/JSLS.2017.00049</Citation><ArticleIdList><ArticleId IdType="doi">10.4293/JSLS.2017.00049</ArticleId><ArticleId IdType="pmc">PMC5610117</ArticleId><ArticleId IdType="pubmed">28951657</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekhaimar M, Correa A, Hamo C, Doshi A, Young A, Roldan J, et al. Glp-1 receptor agonists are associated with weight loss among lvad patients with diabetes and obesity. J Card Fail. (2023) 29(4):617. 10.1016/j.cardfail.2022.10.175</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2022.10.175</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. Journal of the Medical Library Association: JMLA. (2016) 104(3):240. 10.3163/1536-5050.104.3.014</Citation><ArticleIdList><ArticleId IdType="doi">10.3163/1536-5050.104.3.014</ArticleId><ArticleId IdType="pmc">PMC4915647</ArticleId><ArticleId IdType="pubmed">27366130</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29121301</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Tissue Doppler assessment of diastolic function and relationship with mortality in critically ill septic patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>583</StartPage><EndPage>594</EndPage><MedlinePgn>583-594</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aex254</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Myocardial dysfunction may contribute to circulatory failure in sepsis. There is growing evidence of an association between left ventricular diastolic dysfunction (LVDD) and mortality in septic patients. Utilizing echocardiography, we know that tissue Doppler imaging (TDI) variables e' and E/e' are reliable predictors of LVDD and are useful measurements to estimate left ventricular (LV) filling pressures.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic review and meta-analysis to investigate the association of e' and E/e' with mortality of patients with severe sepsis or septic shock. In the primary analysis, we included studies providing transthoracic TDI data for e' and E/e' and their association with mortality. Subgroup analyses were conducted according to myocardial regional focus of TDI assessment (septal, lateral or averaged). Three secondary analyses were performed: one included data from a transoesophageal study, another excluded studies reporting data at a very early (&lt;6&#x2009;h) or late (&gt;48&#x2009;h) stage following diagnosis, and the third pooled data only from studies excluding patients with heart valve disease.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The primary analysis included 16 studies with 1507 patients with severe sepsis and/or septic shock. A significant association was found between mortality and both lower e' [standard mean difference (SMD) 0.33; 95% confidence interval (CI): 0.05, 0.62; P=0.02] and higher E/e' (SMD -0.33; 95% CI: -0.57, -0.10; P=0.006). In the subgroup analyses, only the lateral TDI values showed significant association with mortality (lower e' SMD 0.45; 95% CI: 0.11, 0.78; P=0.009; higher E/e' SMD -0.49; 95% CI: -0.76, -0.22; P=0.0003). The findings of the primary analysis were confirmed by all secondary analyses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is a strong association between both lower e' and higher E/e' and mortality in septic patients.</AbstractText><CopyrightInformation>&#xa9; The Author 2017. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Via Tricomi 5, 90127 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corredor</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anaesthesiology and Critical Care, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcadipane</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Via Tricomi 5, 90127 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landesberg</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieillard-Baron</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, University Hospital Ambroise Par&#xe9;, Intensive Care Unit, Section Thorax-Vascular Disease-Abdomen-Metabolism, 92100 Boulogne-Billancourt, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), Universit&#xe9; Versailles Saint Quentin en Yvelines, 94807 Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, St George's Hospital and Medical School, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, St Georges University Hospitals NHS Trust, Blackshaw Road, SW17?0QT London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003971" MajorTopicYN="N">Diastole</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015150" MajorTopicYN="N">Echocardiography, Doppler</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054144" MajorTopicYN="N">Heart Failure, Diastolic</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diastolic dysfunction</Keyword><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword><Keyword MajorTopicYN="N">severe sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29121301</ArticleId><ArticleId IdType="doi">10.1093/bja/aex254</ArticleId><ArticleId IdType="pii">S0007-0912(17)53796-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31599180</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>7-8</Issue><PubDate><Year>2019</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Thoracic endovascular aortic repair versus open chest surgical repair for patients with type B aortic dissection: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>360</StartPage><EndPage>370</EndPage><MedlinePgn>360-370</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2019.1679874</ELocationID><Abstract><AbstractText><b>Aim:</b> This meta-analysis study aimed to compare the efficacy and safety of TEVAR versus OCSR for TBAD patients.<b>Methods:</b> We systematically searched PubMed, EmBase, and the Cochrane library to identify studies compared the effectiveness of TEVAR and OCSR in TBAD patients from the inception up to July 2019. The summary results were calculated using a random-effects model.<b>Results:</b> The electronic search identified 1,894 studies, and 18 studies with 9,664 TBAD patients were included. We noted patients received TEVAR were associated with a reduced risk of in-hospital mortality, acute renal failure, respiratory failure, and bleeding as compared with OCSR, whereas no significant differences between groups for the risk of stroke, myocardial infarction, paraplegia, mesenteric ischaemia/infarction, reinterventions, sepsis, and spinal cord ischaemia.<b>Conclusions:</b> The findings of this meta-analysis study suggested that TEVAR resulted in more short-term survival benefits. Moreover, the reduced risk of acute renal failure, respiratory failure and bleeding was detected in TEVAR group. The treatment effects of TEVAR versus OCSR on specific complications should be further verified by a study with high-level of evidence.Key messageComprehensive collected studies investigated the treatment effectiveness between TEVAR and OCSR for TBAD patientsTEVAR resulted in more survival benefits, in addition to lower risk of acute renal failure, respiratory failure and bleedingThe results of stratified analyses according to patients' characteristics were conducted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jianping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Suining Central Hospital, Suining, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, Suining Central Hospital, Suining, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Gaowu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Radiology, Suining Central Hospital, Suining, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yongheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Suining Central Hospital, Suining, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Suining Central Hospital, Suining, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Suining Central Hospital, Suining, Sichuan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="N">Aortic Dissection</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="N">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic dissection</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">thoracic endovascular aortic repair</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31599180</ArticleId><ArticleId IdType="pmc">PMC7877884</ArticleId><ArticleId IdType="doi">10.1080/07853890.2019.1679874</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coady MA, Ikonomidis JS, Cheung AT, et al. . Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation. 2010;121(25):2780&#x2013;2804.</Citation><ArticleIdList><ArticleId IdType="pubmed">20530003</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T, Mehta RH, Ince H, et al. . Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the International Registry of Aortic Dissection (IRAD). Circulation. 2003;108(90101): II 312&#x2013;II317.</Citation><ArticleIdList><ArticleId IdType="pubmed">12970252</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrera AL, Miller CC, 3rd, Safi HJ, et al. . Outcomes of medical management of acute type B aortic dissection. Circulation. 2006;114(1_suppl):I384&#x2013;I389.</Citation><ArticleIdList><ArticleId IdType="pubmed">16820605</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai TT, Evangelista A, Nienaber CA, et al. . Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med. 2007;357(4):349&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">17652650</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarchi S, Nienaber CA, Rampoldi V, et al. . Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2006;114(1_suppl):I-357&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">16820600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes GC, Andersen ND, McCann RL. Management of acute type B aortic dissection. J Thorac Cardiovasc Surg. 2013;145(3 Suppl):S202&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">23267526</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachs T, Pomposelli F, Hagberg R, et al. . Open and endovascular repair of type B aortic dissection in the nationwide inpatient sample. J Vasc Surg. 2010;52(4):860&#x2013;866. Discussion 866.</Citation><ArticleIdList><ArticleId IdType="pubmed">20619592</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna JM, Andersen ND, Ganapathi AM, et al. . Five-year results for endovascular repair of acute complicated type B aortic dissection. J Vasc Surg. 2014;59(1):96&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">24094903</ArticleId></ArticleIdList></Reference><Reference><Citation>Nienaber CA, Rousseau H, Eggebrecht H, et al. . Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) trial. Circulation. 2009;120(25):2519&#x2013;2528.</Citation><ArticleIdList><ArticleId IdType="pubmed">19996018</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan P, Wong A, Davies I, et al. . Thoracic endovascular repair versus open surgical repair - which is the more cost-effective intervention for descending thoracic aortic pathologies? Eur J Cardiothorac Surg. 2011;40(4):869&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pubmed">21353586</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi A, Walker KL, Martin TD, et al. . Midterm cost and effectiveness of thoracic endovascular aortic repair versus open repair. Ann Thorac Surg. 2012;93(2):473&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">22197617</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang ZW, Zhou Z, et al. . Endovascular stent-graft placement or open surgery for the treatment of acute type B aortic dissection: a meta-analysis. Ann Vasc Surg. 2012;26:454&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">22285374</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute; 2009.</Citation></Reference><Reference><Citation>Higgins JP, Green S Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. 2011; Oxford (UK): The Cochrane Collaboration; 2011.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Making. 2005;25(6):646&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">16282215</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobias A Assessing the influence of a single study in meta-analysis. Stata Tech Bull. 1999;47:17.</Citation></Reference><Reference><Citation>Deeks JJ, Higgins JPT, Altman DG. Analyzing data and undertaking meta-analyses In: Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions 501, Vol. 2008. Oxford (UK): The Cochrane Collaboration; 2008.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. . Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326(7382):219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1125071</ArticleId><ArticleId IdType="pubmed">12543843</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, et al. . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai TT, Fattori R, Trimarchi S, et al. . Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation. 2006;114(21):2226&#x2013;2231.</Citation><ArticleIdList><ArticleId IdType="pubmed">17101856</ArticleId></ArticleIdList></Reference><Reference><Citation>Fattori R, Tsai TT, Myrmel T, et al. . Complicated acute type B dissection: is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv. 2008;1(4):395&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">19463336</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel HJ, Williams DM, Upchurch GR, Jr, et al. . A comparative analysis of open and endovascular repair for the ruptured descending thoracic aorta. J Vasc Surg. 2009;50(6):1265&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pubmed">19782517</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbade J, Jenniches M, Borger MA, et al. . Outcome of patients suffering from acute type B aortic dissection: a retrospective single-centre analysis of 135 consecutive patients. Eur J Cardiothorac Surg. 2010;38(3):285&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">20381372</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastroroberto P, Onorati F, Zofrea S, et al. . Outcome of open and endovascular repair in acute type B aortic dissection: a retrospective and observational study. J Cardiothorac Surg. 2010;5(1):23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856556</ArticleId><ArticleId IdType="pubmed">20380711</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeeshan A, Woo EY, Bavaria JE, et al. . Thoracic endovascular aortic repair for acute complicated type B aortic dissection: superiority relative to conventional open surgical and medical therapy. J Thorac Cardiovasc Surg. 2010;140(6):S109&#x2013;S115. Discussion S142-S146.</Citation><ArticleIdList><ArticleId IdType="pubmed">21092775</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad MF, Ergul EA, Patel VI, et al. . Management of diseases of the descending thoracic aorta in the endovascular era: a Medicare population study. Ann Surg. 2010;252(4):603&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">20881766</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunt ME, Egorova NN, Moskowitz AJ. Propensity score-matched analysis of open surgical and endovascular repair for type B aortic dissection. Int J Vasc Med. 2011;2011:364046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3180776</ArticleId><ArticleId IdType="pubmed">21961067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson DA, Patel HJ, Williams DM, et al. . Early open and endovascular thoracic aortic repair for complicated type B aortic dissection. Ann Thorac Surg. 2013;96(1):23&#x2013;30. Discussion 230.</Citation><ArticleIdList><ArticleId IdType="pubmed">23477564</ArticleId></ArticleIdList></Reference><Reference><Citation>Nozdrzykowski M, Etz CD, Luehr M, et al. . Optimal treatment for patients with chronic Stanford type B aortic dissection: endovascularly, surgically or both?. Eur J Cardiothorac Surg. 2013;44(3):e165&#x2013;174. Discussion e174.</Citation><ArticleIdList><ArticleId IdType="pubmed">23761415</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen ND, Keenan JE, Ganapathi AM, et al. . Current management and outcome of chronic type B aortic dissection: results with open and endovascular repair since the advent of thoracic endografting. Ann Cardiothorac Surg. 2014;3(3):264&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052409</ArticleId><ArticleId IdType="pubmed">24967165</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bogerijen GH, Patel HJ, Williams DM, et al. . Propensity adjusted analysis of open and endovascular thoracic aortic repair for chronic type B dissection: a twenty-year evaluation. Ann Thorac Surg. 2015;99(4):1260&#x2013;1266.</Citation><ArticleIdList><ArticleId IdType="pubmed">25686670</ArticleId></ArticleIdList></Reference><Reference><Citation>Afifi RO, Sandhu HK, Leake SS, et al. . Outcomes of patients with acute type B (DeBakey III) aortic dissection: a 13-year, single-center experience. Circulation. 2015;132(8):748&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4548541</ArticleId><ArticleId IdType="pubmed">26304666</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou HP, Chang HT, Chen CK, et al. . Outcome comparison between thoracic endovascular and open repair for type B aortic dissection: A population-based longitudinal study. J Chin Med Assoc. 2015;78(4):241&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">25669134</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Wang B, Meng Q, et al. . Long-term efficacy of endovascular vs open surgical repair for complicated type-B aortic dissection: a single-center retrospective study and meta-analysis. Braz J Med Biol Res. 2016;49(6):e5194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4932819</ArticleId><ArticleId IdType="pubmed">27254661</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou X, Chen EP, Duwayri YM, et al. . The Impact of Thoracic Endovascular Aortic Repair on Long-Term Survival in Type B Aortic Dissection. Ann Thorac Surg. 2018;105(1):31&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">28811003</ArticleId></ArticleIdList></Reference><Reference><Citation>Li FR, Wu X, Yuan J, et al. . Comparison of thoracic endovascular aortic repair, open surgery and best medical treatment for type B aortic dissection: A meta-analysis. Int J Cardiol. 2018;250:240&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">29066151</ArticleId></ArticleIdList></Reference><Reference><Citation>Harky A, Chan JSK, Wong CHM, et al. . Systematic review and meta-analysis of acute type B thoracic aortic dissection, open, or endovascular repair. J Vasc Surg. 2019;69(5):1599&#x2013;1609. e1592.</Citation><ArticleIdList><ArticleId IdType="pubmed">30598351</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26884914</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1940-5901</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>11</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>International journal of clinical and experimental medicine</Title><ISOAbbreviation>Int J Clin Exp Med</ISOAbbreviation></Journal><ArticleTitle>Efficacy of traditional Chinese medicine on sepsis: a systematic review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>20024</StartPage><EndPage>20034</EndPage><MedlinePgn>20024-34</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Traditional Chinese medicine (TCM) has been used for treatment of sepsis in China, but results still remain equivocal. To evaluate the safety and efficacy of TCM for sepsis, we conducted this Meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Databases searched included randomized controlled trials (RCTs) published in PubMed, Embase and Cochrane Central Register of Controlled Trials (CENTRAL) (up to December 2014). The studies included used routine therapy treating sepsis in the control group and TCM was added on that basis in the experimental group. Methodological quality was assessed by Cochrane criteria for risk of bias.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten RCTs with 691 participants were identified and analyzed. In the meta-analysis, TCM plus routine therapy reduced the 28-day mortality compared to routine therapy alone, [RR = 0.67; 95% CI: 0.51~0.87; P = 0.002]; The decrease in length of ICU-stay [MD = -1.82; 95% CI: -2.60~-1.04; P&lt;0.00001]; Acute physiology and chronic health evaluation system (APACHE II) score [MD = -2.95; 95% CI: -3.99~-1.91; P&lt;0.00001]; Serum inflammatory factors concentration after treatment [SMD = -0.50; 95% CI:-0.68~-0.33; P&lt;0.00001], including TNF-&#x3b1; [SMD = -0.61; 95% CI: -0.85~-0.38; P&lt;0.00001] and IL-6 [SMD = -0.40; 95% CI: -0.75~-0.04; P = 0.03] in subgroup analysis all had statistical significance.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Addition of TCM has better effects in participants with sepsis, while more high-quality studies are needed to draw firm conclusion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated People's Hospital of Jiangsu University Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Miao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical College, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical College China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Xin-Yu</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Hebei North University School of Medicine Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Cheng-Bao</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Hebei North University School of Medicine Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Shang-Ping</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Changzheng Hospital, Second Military Medical University China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Traditional Chinese Medicine, Changhai Hospital Second Military Medical University Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Dong-Hua</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated People's Hospital of Jiangsu University Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Huai'an First People's Hospital, Nanjing Medical University China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Clin Exp Med</MedlineTA><NlmUniqueID>101471010</NlmUniqueID><ISSNLinking>1940-5901</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Traditional Chinese medicine</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>11</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26884914</ArticleId><ArticleId IdType="pmc">PMC4723759</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2249616</ArticleId><ArticleId IdType="pubmed">18058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med. 2013;39:165&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">16424713</ArticleId></ArticleIdList></Reference><Reference><Citation>Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, Jauregui L, Krell K, Pachl J, Takahashi T, Peckelsen C, Cordasco E, Chang CS, Oeyen S, Aikawa N, Maruyama T, Schein R, Kalil AC, Van Nuffelen M, Lynn M, Rossignol DP, Gogate J, Roberts MB, Wheeler JL, Vincent JL ACCESS Study Group. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309:1154&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">23512062</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackwell TS, Christman JW. Sepsis and cytokines: current status. Br J Anaesth. 1996;77:110&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">8703620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Su Q, Wang C. Study on predictors of mortality and risk factors in patients with septic shock. Journal of Traumatic Surgery. 2007;9:8.</Citation></Reference><Reference><Citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pubmed">23984731</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Xu T, Lew in MR. Future possibilities for the treatment of septic shock with herbal components. Am J Emerg Med. 2009;27:107&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19041541</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R, Zhang Z, Xu M, Chang X, Qiao Q, Wang L, Meng X. [Effect of Sini decoction on function of hypothalamic-pituitary-adrenal axis in patients with sepsis] . Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26:184&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">24598293</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao M, Liu B, Wang JQ, Tao XG, Zhou SS, Jin K, Zhang CP. Effect of Xuebijing injection on T helper 17 and CD+ CD+ regulatory T cells in patients with sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011;23:430&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">21787474</ArticleId></ArticleIdList></Reference><Reference><Citation>Su YL, Wang H, Zhang SW. Effect of Qishen Huoxue Granule in treating severe sepsis. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28:209&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">18476417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Wang YQ, Cao SH, Liang Y. Platelet parameters and platelet Toll-like receptor 4 (TLR4) expression in patients with sepsis and the effect of a joint treatment-plan integrating traditional Chinese and western medicine: a clinical study. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011;23:616&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pubmed">22005564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang CH, Zhou G, Gong X, Zhang R, Qu XG, Zeng C, Liu JL. Effect of Henyan medicinal recipe on the regulation of immunity in patients with severe sepsis: a prospective clinical trial. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011;23:77&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">21315002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CX, Gao PY, Xie Q. Effect of modified Qianyang Pellet on extravascular lung water and its corrected factors at the early fluid resuscitation stage of septic shock. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011;31:200&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">21425574</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang RL, Lei S, Wang LC, Wu JN, Zhi YH, Wu YC, Zhu MF, Huang LQ, Ye XH. Effect of Shenfu injection on tissue oxygen metabolism in patients with severe sepsis. Chin J Tradit Chin Med Pharm. 2009;24:965&#x2013;967.</Citation></Reference><Reference><Citation>Qiu ZL, Ye YP, Zhang N. [Clinical efficacy of Shenfu injection in treating severe sepsis and its effects on serum levels of interleukin-6 and interleukin-10] . Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32:348&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">22686081</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SL, Chen HL, Yin S. Peripheral blood monocyte activation in acute abdominal diseases with sepsis and its treatment with Fufang Qingxia decoction. Journal of Dalian Medical University. 2010;32:294&#x2013;298.</Citation></Reference><Reference><Citation>Gao ZL, Yu XQ, Yang M. Clinical trial of treating stress-induced hyperglycemia patients with sepsis by supplementing Qi, Nourishing Yin and promoting blood flow. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32:1336&#x2013;1339.</Citation><ArticleIdList><ArticleId IdType="pubmed">23163141</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Chichester, England; Hoboken, NJ: Wiley-Blackwell; 2008.</Citation></Reference><Reference><Citation>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pubmed">1597042</ArticleId></ArticleIdList></Reference><Reference><Citation>Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8:776&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2786961</ArticleId><ArticleId IdType="pubmed">18802444</ArticleId></ArticleIdList></Reference><Reference><Citation>Surbatovic M, Veljovic M, Jevdjic J, Popovic N, Djordjevic D, Radakovic S. Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma. Mediators Inflamm. 2013;2013:362793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3859159</ArticleId><ArticleId IdType="pubmed">24371374</ArticleId></ArticleIdList></Reference><Reference><Citation>Terregino CA, Lopez BL, Karras DJ, Killian AJ, Arnold GK. Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death? Ann Emerg Med. 2000;35:26&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">10613937</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Cui N, Miao B, Zhao E. Immune dysregulation in patients with severe acute pancreatitis. Inflammation. 2011;34:36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">20405190</ArticleId></ArticleIdList></Reference><Reference><Citation>Latifi SQ, Riordan MA, Levine AD, Stallion A. Persistent elevation of serum interleukin-6 in intraabdominal sepsis identifies those with prolonged length of stay. J Pediatr Surg. 2004;39:1548&#x2013;1552.</Citation><ArticleIdList><ArticleId IdType="pubmed">15486902</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich&#xe9; F, Panis Y, Laisn&#xe9; MJ, Briard C, Cholley B, Bernard-Poenaru O, Graulet AM, Gu&#xe9;ris J, Valleur P. High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Surgery. 1996;120:801&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">8909514</ArticleId></ArticleIdList></Reference><Reference><Citation>Surbatovi&#x107; M, Radakovi&#x107; S, Jovanovi&#x107; K, Romi&#x107; P. New strategies in multiple organ dysfunction syndrome therapy for sepsis. Srp Arh Celok Lek. 2005;133:379&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">16623265</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BK, Vanitha J. Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: a review. Curr Med Chem. 2004;11:1423&#x2013;1430.</Citation><ArticleIdList><ArticleId IdType="pubmed">15180575</ArticleId></ArticleIdList></Reference><Reference><Citation>Varon J. Herbal medicine in acute care medicine: past, present, and future. Am J Emerg Med. 2009;27:113&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">19041542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Xu T, Lewin MR. Future possibilities for the treatment of septic shock with herbal components. Am J Emerg Med. 2009;27:107&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">19041541</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng SM, Wang SZ, Zhao JP. Effect of rhubarb on inflammatory cytokines and complements in patients with systemic inflammation reaction syndrome and its significance. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002;22:264&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">12584786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko SK, Lee SM, Whang WK. Anti-platelet aggregation activity of stilbene derivatives from Rheum undulatum. Arch Pharm Res. 1999;22:401&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">10489881</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda H, Morikawa T, Toguchida I, Park JY, Harima S, Yoshikawa M. Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides. Bioorg Med Chem. 2001;9:41&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">11197344</ArticleId></ArticleIdList></Reference><Reference><Citation>Du DJ. Chinese herbal medicine and tumor necrosis factor. Sichuan Journal of Physiological Sciences. 1992;2:92&#x2013;94.</Citation></Reference><Reference><Citation>Wu CD, Li MZ, Zhang YP. Effects of Reduqing Injection on Plasma TNF-&#x3b1; and IL-6 Levels in Rabbits with Endotoxin-induced DIC. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1995;15:356&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">7549388</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DC, Yang JD, Jing BW, Yang XY, Chen XY, Li HH. The impact of rhubarb on gastrointestinal dynamics: basic and clinical research. Chin Criti Care Med. 1997;9:411&#x2013;413.</Citation></Reference><Reference><Citation>Chen DC, Jing BW, Yang XY, Song ZF, Yan M, Zhao L, Wei HW, Yv KL, Zhang XY, Ma J. The protective effect of rhubarb on gut in critical illness. Chin Criti Care Med. 2000;12:87&#x2013;90.</Citation></Reference><Reference><Citation>Lam SK, Ng TB. Isolation of a novel thermolabile heterodimeric ribonuclease with antifungal and antiproliferative activities from roots of the sanchi ginseng Panax notoginseng. Biochem Biophys Res Commun. 2001;285:419&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">11444859</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24330744</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>R291</StartPage><MedlinePgn>R291</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/cc13157</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Procalcitonin (PCT) algorithms for antibiotic treatment decisions have been studied in adult patients from primary care, emergency department, and intensive care unit (ICU) settings, suggesting that procalcitonin-guided therapy may reduce antibiotic exposure without increasing the mortality rate. However, information on the efficacy and safety of this approach in the most vulnerable population of critically ill patients with severe sepsis and septic shock is missing.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Two reviewers independently performed a systematic search in PubMed, Embase, ISI Web of Knowledge, BioMed Central, ScienceDirect, Cochrane Central Register of Controlled Trials, http://www.ClinicalTrials.gov and http://www.ISRCTN.org. Eligible studies had to be randomized controlled clinical trials or cohort studies which compare procalcitonin-guided therapy with standard care in severe sepsis patients and report at least one of the following outcomes: hospital mortality, 28-day mortality, duration of antimicrobial therapy, length of stay in the intensive care unit or length of hospital stay. Disagreements about inclusion of studies and judgment of bias were solved by consensus.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Finally seven studies comprising a total of 1,075 patients with severe sepsis or septic shock were included in the meta-analysis. Both hospital mortality (RR [relative risk]: 0.91, 95%CI [confidence interval]: 0.61; 1.36) and 28-day mortality (RR: 1.02, 95%CI: 0.85; 1.23) were not different between procalcitonin-guided therapy and standard treatment groups. Duration of antimicrobial therapy was significantly reduced in favor of procalcitonin-guided therapy (HR [hazard ratio]: 1.27, 95%CI: 1.01; 1.53). Combined estimates of the length of stay in the ICU and in hospital did not differ between groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Procalcitonin-guided therapy is a helpful approach to guide antibiotic therapy and surgical interventions without a beneficial effect on mortality. The major benefit of PCT-guided therapy consists of a shorter duration of antibiotic treatment compared to standard care. Trials are needed to investigate the effect of PCT-guided therapy on mortality, length of ICU and in-hospital stay in severe sepsis patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prkno</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Wacker</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Brunkhorst</LastName><ForeName>Frank M</ForeName><Initials>FM</Initials></Author><Author ValidYN="Y"><LastName>Schlattmann</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606589">CALCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-12-9</RegistryNumber><NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>JHB2QIZ69Z</RegistryNumber><NameOfSubstance UI="D015740">Calcitonin Gene-Related Peptide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2014 May 13;18(3):142. doi: 10.1186/cc13870.</RefSource><PMID Version="1">25032999</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2014 May 03;18(3):427. doi: 10.1186/cc13856.</RefSource><PMID Version="1">25033407</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2014 May 03;18(3):427.</RefSource><PMID Version="1">25473656</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002116" MajorTopicYN="N">Calcitonin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015740" MajorTopicYN="N">Calcitonin Gene-Related Peptide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="N">Protein Precursors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>12</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24330744</ArticleId><ArticleId IdType="pmc">PMC4056085</ArticleId><ArticleId IdType="doi">10.1186/cc13157</ArticleId><ArticleId IdType="pii">cc13157</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007;17:606&#x2013;618. doi: 10.1007/s00134-006-0517-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-006-0517-7</ArticleId><ArticleId IdType="pubmed">17323051</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunbuisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B. Incidence, risk-factors, and outcome of severe sepsis and septic shock in adults - a multicenter prospective-study in intensive-care units. JAMA. 1995;17:968&#x2013;974. doi: 10.1001/jama.1995.03530120060042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1995.03530120060042</ArticleId><ArticleId IdType="pubmed">7674528</ArticleId></ArticleIdList></Reference><Reference><Citation>Heublein S, Hartmann M, Hagel S, Hutagalung R, Brunkhorst FM. Epidemiology of sepsis in German hospitals derived from administrative databases. Infection. 2013;17:S71.</Citation></Reference><Reference><Citation>Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents. 2002;17:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12127705</ArticleId></ArticleIdList></Reference><Reference><Citation>Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;17:515&#x2013;518. doi: 10.1016/0140-6736(93)90277-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)90277-N</ArticleId><ArticleId IdType="pmc">PMC7141580</ArticleId><ArticleId IdType="pubmed">8094770</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;17:1322&#x2013;1331. doi: 10.1001/archinternmed.2011.318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2011.318</ArticleId><ArticleId IdType="pubmed">21824946</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H, Huang T, Jing J, Shen H, Cui W. Effect of Procalcitonin-Guided Treatment in Patients with Infections: a Systematic Review and Meta-Analysis. Infection. 2009;17:497&#x2013;507. doi: 10.1007/s15010-009-9034-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-009-9034-2</ArticleId><ArticleId IdType="pubmed">19826761</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012;17:651&#x2013;662. doi: 10.1093/cid/cis464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis464</ArticleId><ArticleId IdType="pmc">PMC3412690</ArticleId><ArticleId IdType="pubmed">22573847</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Huang J, Xu T, Lin Y. Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials [article in Chinese] Zhonghua Jie He He Hu Xi Za Zhi. 2012;17:275&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">22781200</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyland DK, Johnson AP, Reynolds SC, Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: A systematic review and an economic evaluation. Crit Care Med. 2011;17:1792&#x2013;1799. doi: 10.1097/CCM.0b013e31821201a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31821201a5</ArticleId><ArticleId IdType="pubmed">21358400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010;17:2229&#x2013;2241. doi: 10.1097/CCM.0b013e3181f17bf9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181f17bf9</ArticleId><ArticleId IdType="pubmed">20729729</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med. 2012;17:940&#x2013;949. doi: 10.1007/s00134-012-2563-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2563-7</ArticleId><ArticleId IdType="pubmed">22538461</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal R, Schwartz DN. Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. Clin Infect Dis. 2011;17:379&#x2013;387. doi: 10.1093/cid/cir408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cir408</ArticleId><ArticleId IdType="pubmed">21810753</ArticleId></ArticleIdList></Reference><Reference><Citation>Noorani HZ, Adams E, Pitrak D, Belinson S, Aronson N. Future Research Needs on Procalcitonin-Guided Antibiotic Therapy. Future Research Needs Paper No. 29.   http://www.effectivehealthcare.ahrq.gov/ehc/products/497/1377/FRN29_Procalcitonin_FinalReport_20130109.pdf.</Citation><ArticleIdList><ArticleId IdType="pubmed">24783273</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;17:W65&#x2013;W94.</Citation><ArticleIdList><ArticleId IdType="pubmed">19622512</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;17:264&#x2013;269. doi: 10.7326/0003-4819-151-4-200908180-00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-4-200908180-00135</ArticleId><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;17:864&#x2013;874. doi: 10.1097/00003246-199206000-00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199206000-00025</ArticleId><ArticleId IdType="pubmed">1597042</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H, Gastmeier P, Gerlach H, Grundling M, John S, Kern W, Kreymann G, Kruger W, Kujath P, Marggraf G, Martin J, Mayer K, Meier-Hellmann A, Oppert M, Putensen C, Quintel M, Ragaller M, Rossaint R, Seifert H, Spies C, Stuber F, Weiler N, Weimann A, Werdan K, Welte T. Prevention, diagnosis, treatment, and follow-up care of sepsis - First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI) Anaesthesist. 2010;17:347&#x2013;370. doi: 10.1007/s00101-010-1719-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00101-010-1719-5</ArticleId><ArticleId IdType="pubmed">20414762</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, Sterne JAC.  In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Higgins JPT, Green S, editor. Chapter 8: Assessing risk of bias in included studies. (updated March 2011)  http://www.cochrane-handbook.org.</Citation></Reference><Reference><Citation>R Development Core Team. R: A Language and Environment for Statistical Computing.   http://www.R-project.org/</Citation></Reference><Reference><Citation>Schwarzer G. Meta: Meta-Analysis with R, R Package Version: 1.6-1.   http://CRAN.R-project.org/package=meta.</Citation></Reference><Reference><Citation>Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;17:882&#x2013;893. doi: 10.1016/j.jclinepi.2005.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2005.01.016</ArticleId><ArticleId IdType="pubmed">16085191</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet D. Modelling Survival Data in Medical Research. 2. Boca Raton (FL): CRC Press; 2003.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;17:557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;17:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Maxime V, Faller JP, Mezher C, Clec&#x2019;h C, Martel P, Gonzales H, Feissel M, Cohen Y, Capellier G, Gharbi M, Nardi O. Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial. BMJ Open. 2013;17:e002186. doi:10.1136/bmjopen-2012-00218doi:10.1136/bmjopen-2012-00218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3586059</ArticleId><ArticleId IdType="pubmed">23418298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Regnier B, Brun-Buisson C, Chastre J, Wolff M. Use of procalcitonin to reduce patients&#x2019; exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;17:463&#x2013;474. doi: 10.1016/S0140-6736(09)61879-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61879-1</ArticleId><ArticleId IdType="pubmed">20097417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochreiter M, Koehler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;17:R83. doi: 10.1186/cc7903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7903</ArticleId><ArticleId IdType="pmc">PMC2717450</ArticleId><ArticleId IdType="pubmed">19493352</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, Thornberg KJ, Loken J, Steensen M, Fox Z, Tousi H, Soe-Jensen P, Lauritsen AO, Strange D, Petersen PL, Reiter N, Hestad S, Thormar K, Fjeldborg P, Larsen KM, Drenck NE, Ostergaard C, Kjaer J, Grarup J, Lundgren JD. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial. Crit Care Med. 2011;17:2048&#x2013;2058. doi: 10.1097/CCM.0b013e31821e8791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31821e8791</ArticleId><ArticleId IdType="pubmed">21572328</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobre V, Harbarth S, Graf L-D, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients - A randomized trial. Am J Respir Crit Care Med. 2008;17:498&#x2013;505. doi: 10.1164/rccm.200708-1238OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200708-1238OC</ArticleId><ArticleId IdType="pubmed">18096708</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, von Spiegel T. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg. 2009;17:221&#x2013;226. doi: 10.1007/s00423-008-0432-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-008-0432-1</ArticleId><ArticleId IdType="pubmed">19034493</ArticleId></ArticleIdList></Reference><Reference><Citation>Svoboda P, Kantorova I, Scheer P, Radvanova J, Radvan M. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? Hepatogastroenterology. 2007;17:359&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">17523274</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, Marsch S, Azzola A, Rakic J, Mueller B, Tamm M. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009;17:1364&#x2013;1375. doi: 10.1183/09031936.00053209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00053209</ArticleId><ArticleId IdType="pubmed">19797133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagnenko SF, Shliapnikov SA, Korol&#x2019;kov AI. Cholangitis and biliary sepsis: problem and ways of solution. Vestn Khir Im I I Grek. 2009;17:17&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">19663273</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;17:580&#x2013;637. doi: 10.1097/CCM.0b013e31827e83af.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827e83af</ArticleId><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals - A challenge to hospital leadership. JAMA. 1996;17:234&#x2013;240. doi: 10.1001/jama.1996.03530270074035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1996.03530270074035</ArticleId><ArticleId IdType="pubmed">8604178</ArticleId></ArticleIdList></Reference><Reference><Citation>Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect. 2009;17:12&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">19366364</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;17:S82&#x2013;S89. doi: 10.1086/499406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/499406</ArticleId><ArticleId IdType="pubmed">16355321</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts RR, Hota B, Ahmad I, Scott RD II, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship. Clin Infect Dis. 2009;17:1175&#x2013;1184. doi: 10.1086/605630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605630</ArticleId><ArticleId IdType="pubmed">19739972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30903246</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>1829</StartPage><EndPage>1840</EndPage><MedlinePgn>1829-1840</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-019-04984-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">To assess the impact of primary tumor resection (PTR) on survival and morbidity in incurable colorectal cancer.</AbstractText><AbstractText Label="METHODS">Systematic literature review and meta-analysis to compare PTR versus primary tumor intact (PTI).</AbstractText><AbstractText Label="RESULTS">Seventy-seven studies were included, reporting on 159,991 participants (94,745 PTR; 65,246 PTI). PTR improved overall survival (hazard ratio [HR] 0.59, P&#x2009;&lt;&#x2009;0.0001; mean difference [MD] 7.27&#xa0;months, P&#x2009;&lt;&#x2009;0.0001), cancer-specific survival (HR 0.47, MD 10.80), and progression-free survival (HR 0.76, MD 1.67). Overall survival remained significantly improved during subgroup analysis of asymptomatic patients (HR 0.69, MD 3.86), elderly patients (HR 0.46, MD 7.71), patients diagnosed after 2000 (HR 0.62, MD 7.29), patients with colon (HR 0.58, MD 6.31) or rectal (HR 0.54, MD 6.88) primary tumor, patients undergoing resection of primary tumor versus non-resectional surgery (NRS) to treat primary tumor complications (HR 0.56, MD 8.72), and of studies with propensity score analysis (HR 0.65, MD 5.68). Overall survival per treatment strategy was: [PTI/chemotherapy] 14.30&#xa0;months, [PTI/bevacizumab] 17.27&#xa0;months, [PTR/chemotherapy] 21.52&#xa0;months, [PTR/bevacizumab] 27.52&#xa0;months. PTR resulted in 4.5% perioperative mortality and 22.4% morbidity (major adverse events 10.2%, minor 18.5%, reoperation 2.5%, intraabdominal collection/sepsis 2.2%). PTI had 21.7% morbidity (obstruction 14.4%, anemia 11.0%, hemorrhage 1.5%, perforation 0.6%, adverse events requiring surgery 15.8%). NRS resulted in 10.6% perioperative mortality and 21.7% morbidity (major 7.9%, minor 21.7%, reoperation 0.1%).</AbstractText><AbstractText Label="CONCLUSIONS">PTR in patients with incurable colorectal cancer results in a limited improvement of survival without a significant increase in morbidity. PTR should be considered by the multidisciplinary team on an individual patient basis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simillis</LastName><ForeName>Constantinos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, West Middlesex University Hospital, Twickenham Road, Isleworth, London, TW7 6AF, UK. csimillis@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, UK. csimillis@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalakouti</LastName><ForeName>Eliana</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, West Middlesex University Hospital, Twickenham Road, Isleworth, London, TW7 6AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afxentiou</LastName><ForeName>Thalia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Oncology, Royal Marsden Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontovounisios</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, West Middlesex University Hospital, Twickenham Road, Isleworth, London, TW7 6AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Jason J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, West Middlesex University Hospital, Twickenham Road, Isleworth, London, TW7 6AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunningham</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Oncology, Royal Marsden Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamina</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cantonal Hospital Winterthur, Winterthur, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tekkis</LastName><ForeName>Paris P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, West Middlesex University Hospital, Twickenham Road, Isleworth, London, TW7 6AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Royal Marsden Hospital, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074322">Antineoplastic Agents, Immunological</NameOfSubstance></Chemical><Chemical><RegistryNumber>2S9ZZM9Q9V</RegistryNumber><NameOfSubstance UI="D000068258">Bevacizumab</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000074322" MajorTopicYN="N">Antineoplastic Agents, Immunological</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068258" MajorTopicYN="N">Bevacizumab</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="N">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30903246</ArticleId><ArticleId IdType="doi">10.1007/s00268-019-04984-2</ArticleId><ArticleId IdType="pii">10.1007/s00268-019-04984-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cancer. 1949 Sep;2(5):767-76</Citation><ArticleIdList><ArticleId IdType="pubmed">18136914</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2004 Jan 15;22(2):229-37</Citation><ArticleIdList><ArticleId IdType="pubmed">14657227</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg Oncol. 2009 Mar 10;7:28</Citation><ArticleIdList><ArticleId IdType="pubmed">19284542</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1988 Nov;31(11):842-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2460299</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2006 Nov 1;66(21):10365-76</Citation><ArticleIdList><ArticleId IdType="pubmed">17062557</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatogastroenterology. 2015 Jun;62(140):876-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26902020</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2014 Nov;21(12):3917-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24859937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1997 Nov 1;127(9):820-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9382404</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2002 Jun 15;21(11):1539-58</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2016 Jan 19;17:34</Citation><ArticleIdList><ArticleId IdType="pubmed">26782254</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Oncol. 2014 Dec;19(6):1037-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24526390</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg Oncol. 2015 Apr 24;13:162</Citation><ArticleIdList><ArticleId IdType="pubmed">25908502</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 2016 Nov 1;139(9):2082-94</Citation><ArticleIdList><ArticleId IdType="pubmed">27342618</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2012 Aug;14(8):920-30</Citation><ArticleIdList><ArticleId IdType="pubmed">21899714</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2006 Nov 7;12(41):6634-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17075976</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2016 Apr;59(4):299-305</Citation><ArticleIdList><ArticleId IdType="pubmed">26953988</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2004 Jan 1;22(1):23-30</Citation><ArticleIdList><ArticleId IdType="pubmed">14665611</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2004 Jun 3;350(23):2335-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15175435</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2005 Sep;92(9):1155-60</Citation><ArticleIdList><ArticleId IdType="pubmed">16035135</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2015 Feb 12;15:47</Citation><ArticleIdList><ArticleId IdType="pubmed">25849254</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2015 Feb;157(2):362-80</Citation><ArticleIdList><ArticleId IdType="pubmed">25616950</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Nov 13;5:16516</Citation><ArticleIdList><ArticleId IdType="pubmed">26563729</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2008 Jul 20;26(21):3523-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18640933</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Colorectal Cancer. 2015 Dec;14(4):e41-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26140732</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2014 Sep;57(9):1049-58</Citation><ArticleIdList><ArticleId IdType="pubmed">25101600</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin J Cancer. 2016 Jun 29;35(1):58</Citation><ArticleIdList><ArticleId IdType="pubmed">27357402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2015 Jul;262(1):112-20</Citation><ArticleIdList><ArticleId IdType="pubmed">25373464</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Oncol. 2014 Mar;109(3):239-44</Citation><ArticleIdList><ArticleId IdType="pubmed">24165972</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):107-16</Citation><ArticleIdList><ArticleId IdType="pubmed">11163503</ArticleId></ArticleIdList></Reference><Reference><Citation>Wideochir Inne Tech Maloinwazyjne. 2016;11(4):274-282</Citation><ArticleIdList><ArticleId IdType="pubmed">28194248</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Today. 2014 Dec;44(12):2287-92</Citation><ArticleIdList><ArticleId IdType="pubmed">24623012</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Surg. 2010;8(4):305-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20380899</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2010 Jul;12(7 Online):e61-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19486103</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2018 Mar;91:99-106</Citation><ArticleIdList><ArticleId IdType="pubmed">29353165</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2015 Jan;51(2):166-76</Citation><ArticleIdList><ArticleId IdType="pubmed">25465185</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2004 May;19(3):197-202</Citation><ArticleIdList><ArticleId IdType="pubmed">14618348</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2013 Jan;49(1):90-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22926014</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg Oncol. 2017 Jul 27;15(1):138</Citation><ArticleIdList><ArticleId IdType="pubmed">28750680</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterol Clin Biol. 2004 May;28(5):434-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15243315</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Surg. 2004 May;70(5):433-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15156952</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2011 Feb;54(2):214-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21228671</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2011 Aug;54(8):930-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21730780</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2007 Oct;8(10):898-911</Citation><ArticleIdList><ArticleId IdType="pubmed">17888735</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2012 Apr 05;12:142</Citation><ArticleIdList><ArticleId IdType="pubmed">22480173</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2017 Sep 21;358:j4008</Citation><ArticleIdList><ArticleId IdType="pubmed">28935701</ArticleId></ArticleIdList></Reference><Reference><Citation>ANZ J Surg. 2004 Apr;74(4):229-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15043733</ArticleId></ArticleIdList></Reference><Reference><Citation>Onco Targets Ther. 2013;6:267-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23569390</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2008 Jun;10(5):498-502</Citation><ArticleIdList><ArticleId IdType="pubmed">17949445</ArticleId></ArticleIdList></Reference><Reference><Citation>J Korean Soc Coloproctol. 2012 Feb;28(1):35-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22413080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2014 Sep;21(9):2949-55</Citation><ArticleIdList><ArticleId IdType="pubmed">24763981</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Oncol. 2010 Feb;33(1):52-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19704367</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1997 Jan;40(1):11-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9102251</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2009 Sep;24(9):1097-109</Citation><ArticleIdList><ArticleId IdType="pubmed">19495779</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2014 Jun;57(6):679-86</Citation><ArticleIdList><ArticleId IdType="pubmed">24807591</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1964 May-Jun;7:211-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14159372</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg Oncol. 2013 Jul;39(7):734-41</Citation><ArticleIdList><ArticleId IdType="pubmed">23523316</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Oncol Rep. 2003 Nov;5(6):473-81</Citation><ArticleIdList><ArticleId IdType="pubmed">14521806</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2011 Sep;47 Suppl 3:S61-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21944031</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2014 Oct 02;14:741</Citation><ArticleIdList><ArticleId IdType="pubmed">25277170</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2017 Jul;32(7):1085-1090</Citation><ArticleIdList><ArticleId IdType="pubmed">28497402</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 1987 Jun;122(6):640-3</Citation><ArticleIdList><ArticleId IdType="pubmed">2437881</ArticleId></ArticleIdList></Reference><Reference><Citation>Jpn J Surg. 1988 Jan;18(1):7-17</Citation><ArticleIdList><ArticleId IdType="pubmed">3386073</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1997 Sep 13;315(7109):629-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg Oncol. 2010 Dec;36(12):1187-94</Citation><ArticleIdList><ArticleId IdType="pubmed">20864304</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2001 Oct;88(10):1352-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11578291</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Colorectal Cancer. 2016 Sep;15(3):e125-32</Citation><ArticleIdList><ArticleId IdType="pubmed">26803709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 1995 Feb;1(2):149-53</Citation><ArticleIdList><ArticleId IdType="pubmed">7585012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1954 Sep;7(5):1016-9</Citation><ArticleIdList><ArticleId IdType="pubmed">13199780</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2007 Jun;9(5):430-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17504340</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2014 Nov;21(12):3900-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24849523</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2001 Sep 22;358(9286):966-70</Citation><ArticleIdList><ArticleId IdType="pubmed">11583750</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2012 Jan;255(1):86-94</Citation><ArticleIdList><ArticleId IdType="pubmed">22156924</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2004 Aug;240(2):205-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2015 Jun;30(6):807-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25922146</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2011 May 20;29(15):2011-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21502544</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Oncol. 2005 Mar 15;89(4):211-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15726622</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Apr 2;360(14):1408-17</Citation><ArticleIdList><ArticleId IdType="pubmed">19339720</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1996 Aug;83(8):1116-20</Citation><ArticleIdList><ArticleId IdType="pubmed">8869321</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg Oncol. 2009 Feb;35(2):164-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18644695</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Oncol. 2015 Jan;32(1):441</Citation><ArticleIdList><ArticleId IdType="pubmed">25502088</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2014 Mar;18(3):592-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24297651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2014 May;21(5):1632-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24419756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 1999 Oct-Nov;6(7):651-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10560850</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Oncol. 2010 Jul 1;102(1):94-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20578086</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Metastasis Rev. 2010 Dec;29(4):737-50</Citation><ArticleIdList><ArticleId IdType="pubmed">20878451</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan To Kagaku Ryoho. 2013 Nov;40(12):1981-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24393986</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Today. 2017 Feb;47(2):159-165</Citation><ArticleIdList><ArticleId IdType="pubmed">27549772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Coloproctol. 2014 Aug;30(4):175-81</Citation><ArticleIdList><ArticleId IdType="pubmed">25210686</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2007 Nov;22(11):1301-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17486358</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2008 May;10(4):336-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17868410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2007 Sep;14(9):2567-76</Citation><ArticleIdList><ArticleId IdType="pubmed">17541693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2010 Feb;17(2):432-40</Citation><ArticleIdList><ArticleId IdType="pubmed">19936838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2005 Aug;12(8):637-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15965730</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatogastroenterology. 2013 Nov-Dec;60(128):1945-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24719932</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2011 May;54(5):535-44</Citation><ArticleIdList><ArticleId IdType="pubmed">21471753</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1990 Oct;33(10):846-50</Citation><ArticleIdList><ArticleId IdType="pubmed">1698594</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2001 Dec 6;345(23):1655-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11759643</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleve Clin J Med. 2008 Jun;75(6):431-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18595551</ArticleId></ArticleIdList></Reference><Reference><Citation>Jpn J Clin Oncol. 2013 Jan;43(1):28-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23107836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2009 Aug;250(2):187-96</Citation><ArticleIdList><ArticleId IdType="pubmed">19638912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2009 Nov;20(11):1842-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19406901</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Physiol Biochem. 2016;39(3):1239-46</Citation><ArticleIdList><ArticleId IdType="pubmed">27595400</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2014 Mar 1;120(5):683-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24222180</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2007 May 30;7:91</Citation><ArticleIdList><ArticleId IdType="pubmed">17537235</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg Oncol. 2014 Jun;40(6):685-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24630774</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2017 Apr 1;123(7):1124-1133</Citation><ArticleIdList><ArticleId IdType="pubmed">27479827</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Surg. 2014;12(7):737-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24802519</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2003 May;196(5):722-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12742204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2011 Jun;253(6):1069-79</Citation><ArticleIdList><ArticleId IdType="pubmed">21451388</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2008 Apr;143(4):352-8; discussion 358</Citation><ArticleIdList><ArticleId IdType="pubmed">18427022</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 1998 Dec 30;17(24):2815-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9921604</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2010 Jul 28;16(28):3561-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20653065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2011 Nov;18(12):3252-60</Citation><ArticleIdList><ArticleId IdType="pubmed">21822557</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2003 Apr;52(4):568-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12631671</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1981 Nov-Dec;24(8):606-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6172244</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2018 Mar;22(3):460-466</Citation><ArticleIdList><ArticleId IdType="pubmed">29124549</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2012 Mar;14(3):314-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21689309</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2004 Sep 1;22(17):3475-84</Citation><ArticleIdList><ArticleId IdType="pubmed">15337795</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Oncol. 2016 Jul;114(1):75-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27111137</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Surg. 2010;8(5):336-41</Citation><ArticleIdList><ArticleId IdType="pubmed">20171303</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37386663</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2731-3786</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of anesthesia, analgesia and critical care</Title><ISOAbbreviation>J Anesth Analg Crit Care</ISOAbbreviation></Journal><ArticleTitle>Empiric treatment of patients with sepsis and septic shock and place in therapy of cefiderocol: a systematic review and expert opinion statement.</ArticleTitle><Pagination><StartPage>34</StartPage><MedlinePgn>34</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">34</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s44158-022-00062-7</ELocationID><Abstract><AbstractText>Carbapenem-resistant Gram-negative bacteria are frequent causes of sepsis and septic shock in intensive care unit (ICU) and thus considered a public health threat. Until now, the best available therapies consist of combinations of preexisting or new antibiotics with &#x3b2;-lactamase inhibitors (either new or preexisting). Several mechanisms of resistance, especially those mediated by metallo-&#x3b2;-lactamases (MBL), are responsible for the inefficacy of these treatments, leaving an unmet medical need. Intravenous cefiderocol has been recently approved by the American Food and Drug Administration (FDA) and European Medicines Agency (EMA) for the treatment of complicated urinary tract infections and nosocomial pneumonia due to Gram-negative, when limited therapeutical options are available. In addition, its ability to hijack bacterial iron uptake mechanisms makes cefiderocol stable against the whole Ambler &#x3b2;-lactamase inhibitors and increases the in vitro efficacy against Gram-negative pathogens (e.g., Enterobacterales spp., Pseudomonas aeruginosa, and Acinetobacter baumannii). Trials have already demonstrated their non-inferiority to comparators. In 2021, ESCMID guidelines released a conditional recommendation supporting the use of cefiderocol against metallo-&#x3b2;-lactamase-producing Enterobacterales and against Acinetobacter baumannii. This review provides the opinion of experts about the general management of empiric treatment of patients with sepsis and septic shock in the intensive care unit and detects the proper place in therapy of cefiderocol considering recent evidence sought through a systematic search.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1416-9993</Identifier><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Palermo, Italy. andrea.cortegiani@unipa.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo, University of Palermo, Via del Vespro129, 90127, Palermo, Italy. andrea.cortegiani@unipa.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingoglia</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo, University of Palermo, Via del Vespro129, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ippolito</LastName><ForeName>Mariachiara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo, University of Palermo, Via del Vespro129, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girardis</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falcone</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, Infectious Diseases Unit, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pea</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SSD Clinical Pharmacology Unit, University Hospital, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugliese</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology Critical Care Medicine and Pain Therapy, Policlinico Umberto I, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefani</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Catania, Department of Biomedical and Biotechnological Sciences, Biological Tower, Third floor -Est Tower, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viale</LastName><ForeName>Pierluigi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant'Orsola Hospital, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giarratano</LastName><ForeName>Antonino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo, University of Palermo, Via del Vespro129, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Anesth Analg Crit Care</MedlineTA><NlmUniqueID>9918591885906676</NlmUniqueID><ISSNLinking>2731-3786</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carbapenem resistance</Keyword><Keyword MajorTopicYN="N">Cefiderocol</Keyword><Keyword MajorTopicYN="N">Gram-negative bacteria</Keyword><Keyword MajorTopicYN="N">Multidrug resistance</Keyword><Keyword MajorTopicYN="N">Nosocomial pneumonia</Keyword><Keyword MajorTopicYN="N">Urinary tract infection</Keyword></KeywordList><CoiStatement>Dr. Cortegiani received fee for lectures or board memberships from Gilead, MSD, and Pfizer. Dr. Falcone has received research grants and/or speaker honoraria from Angelini, Menarini, Merck Sharp &amp; Dohme, Nordic Pharma, Pfizer, and Shionogi, outside the submitted work. Dr. Girardis reported that he participated in numerous advisory board sponsored by the pharmaceutical company, also of antibiotics, as well as Shionogi outside the submitted work. Dr. Pea participated in advisory boards and/or received speaker honoraria from Angelini, Basilea Pharmaceutica, Bei Gene, Gilead Sciences, Hikma, Merck Sharp &amp; Dohme, Novartis, and Sanofi Aventis, outside the submitted work. Dr. Stefani has received research grants from Shionogi. Dr. Viale has received honoraria and/or support from Biomerieux, Gilead Sciences, Merck Sharp &amp; Dohme, Novartis, and Pfizer outside the submitted work. All other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>23</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37386663</ArticleId><ArticleId IdType="pmc">PMC9361889</ArticleId><ArticleId IdType="doi">10.1186/s44158-022-00062-7</ArticleId><ArticleId IdType="pii">10.1186/s44158-022-00062-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, Thaden JT, Stryjewski ME, van Duin D. Gram-Negative Committee of the Antibacterial Resistance Leadership Group (ARLG)a. Gram-negative bacterial infections: research priorities, accomplishments, and future directions of the Antibacterial Resistance Leadership Group. Clin Infect Dis. 2017;64(suppl_1):S30&#x2013;S35. doi: 10.1093/cid/ciw829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw829</ArticleId><ArticleId IdType="pmc">PMC5848311</ArticleId><ArticleId IdType="pubmed">28350901</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A, Graziano E, Tagliaferri E, Leonildi A, Barnini S, Farcomeni A, Menichetti F. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care. 2020;24(1):29. doi: 10.1186/s13054-020-2742-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-2742-9</ArticleId><ArticleId IdType="pmc">PMC6993311</ArticleId><ArticleId IdType="pubmed">32000834</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone M, Tiseo G, Antonelli A, Giordano C, Di Pilato V, Bertolucci P, Parisio EM, Leonildi A, Aiezza N, Baccani I, Tagliaferri E, Righi L, Forni S, Sani S, Mechi MT, Pieralli F, Barnini S, Rossolini GM, Menichetti F. Clinical features and outcomes of bloodstream infections caused by New Delhi metallo-&#x3b2;-lactamase-producing Enterobacterales during a regional outbreak. Open Forum. Infect Dis. 2020;7(2):ofaa011. doi: 10.1093/ofid/ofaa011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa011</ArticleId><ArticleId IdType="pmc">PMC7003035</ArticleId><ArticleId IdType="pubmed">32042848</ArticleId></ArticleIdList></Reference><Reference><Citation>Retamar P, Portillo MM, L&#xf3;pez-Prieto MD, Rodr&#xed;guez-L&#xf3;pez F, de Cueto M, Garc&#xed;a MV, G&#xf3;mez MJ, Del Arco A, Mu&#xf1;oz A, S&#xe1;nchez-Porto A, Torres-Tortosa M, Mart&#xed;n-Aspas A, Arroyo A, Garc&#xed;a-Figueras C, Acosta F, Corzo JE, Le&#xf3;n-Ruiz L, Escobar-Lara T, Rodr&#xed;guez-Ba&#xf1;o J, SAEI/SAMPAC Bacteremia Group Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother. 2012;56(1):472&#x2013;478. doi: 10.1128/AAC.00462-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00462-11</ArticleId><ArticleId IdType="pmc">PMC3256027</ArticleId><ArticleId IdType="pubmed">22005999</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortegiani A, Russotto V, Graziano G, Geraci D, Saporito L, Cocorullo G, Raineri SM, Mammina C, Giarratano A. Use of Cepheid Xpert Carba-R&#xae; for rapid detection of carbapenemase-producing bacteria in abdominal septic patients admitted to intensive care unit. PLoS One. 2016;11(8):e0160643. doi: 10.1371/journal.pone.0160643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0160643</ArticleId><ArticleId IdType="pmc">PMC4973873</ArticleId><ArticleId IdType="pubmed">27490684</ArticleId></ArticleIdList></Reference><Reference><Citation>La terapia antibiotica empirica ragionata: un approccio mirato e precoce nel paziente settico. https://www.itjem.org/2017/11/27/la-terapia-antibiotica-empirica-ragionata-un-approccio-mirato-e-precoce-nel-paziente-settico/. Accessed 09 Feb 2022.</Citation></Reference><Reference><Citation>Syed YY. Cefiderocol: a review in serious gram-negative bacterial infections. Drugs. 2021;81(13):1559&#x2013;1571. doi: 10.1007/s40265-021-01580-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-021-01580-4</ArticleId><ArticleId IdType="pmc">PMC8383240</ArticleId><ArticleId IdType="pubmed">34427896</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong&#x2019;uti S, Czech M, Robilotti E, Holubar M (2021) Cefiderocol: a new cephalosporin stratagem against multidrug resistant gram-negative bacteria. Clin Infect Dis:ciab757. 10.1093/cid/ciab757</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9989360</ArticleId><ArticleId IdType="pubmed">34492098</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Yamawaki K. Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin. Clin Infect Dis. 2019;69(Suppl 7):S538&#x2013;S543. doi: 10.1093/cid/ciz826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz826</ArticleId><ArticleId IdType="pmc">PMC6853759</ArticleId><ArticleId IdType="pubmed">31724047</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto S, Singley CM, Hoover J, Nakamura R, Echols R, Rittenhouse S, Tsuji M, Yamano Y. Efficacy of cefiderocol against carbapenem-resistant gram-negative bacilli in immunocompetent-rat respiratory tract infection models recreating human plasma pharmacokinetics. Antimicrob Agents Chemother. 2017;61(9):e00700&#x2013;e00717. doi: 10.1128/AAC.00700-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00700-17</ArticleId><ArticleId IdType="pmc">PMC5571323</ArticleId><ArticleId IdType="pubmed">28630178</ArticleId></ArticleIdList></Reference><Reference><Citation>Stainton SM, Monogue ML, Tsuji M, Yamano Y, Echols R, Nicolau DP. Efficacy of humanized cefiderocol exposures over 72 hours against a diverse group of gram-negative isolates in the neutropenic murine thigh infection model. Antimicrob Agents Chemother. 2019;63(2):e01040&#x2013;e01018. doi: 10.1128/AAC.01040-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01040-18</ArticleId><ArticleId IdType="pmc">PMC6355589</ArticleId><ArticleId IdType="pubmed">30420477</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki S, Katsube T, Shen H, Tomek C, Narukawa Y. Metabolism, excretion, and pharmacokinetics of [14 C]-cefiderocol (S-649266), a siderophore cephalosporin, in healthy subjects following intravenous administration. J Clin Pharmacol. 2019;59(7):958&#x2013;967. doi: 10.1002/jcph.1386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.1386</ArticleId><ArticleId IdType="pmc">PMC6593826</ArticleId><ArticleId IdType="pubmed">30730562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazmierczak KM, Tsuji M, Wise MG, Hackel M, Yamano Y, Echols R, Sahm DF. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-&#x3b2;-lactamase-producing isolates (SIDERO-WT-2014 Study) Int J Antimicrob Agents. 2019;53(2):177&#x2013;184. doi: 10.1016/j.ijantimicag.2018.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2018.10.007</ArticleId><ArticleId IdType="pubmed">30395986</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlowsky JA, Hackel MA, Tsuji M, Yamano Y, Echols R, Sahm DF. In vitro activity of cefiderocol, a siderophore cephalosporin, against gram-negative bacilli isolated by clinical laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015. Int J Antimicrob Agents. 2019;53(4):456&#x2013;466. doi: 10.1016/j.ijantimicag.2018.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2018.11.007</ArticleId><ArticleId IdType="pubmed">30471402</ArticleId></ArticleIdList></Reference><Reference><Citation>Stracquadanio S, Torti E, Longshaw C, Henriksen AS, Stefani S. In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014-2018 studies in Italy. J Glob Antimicrob Resist. 2021;25:390&#x2013;398. doi: 10.1016/j.jgar.2021.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgar.2021.04.019</ArticleId><ArticleId IdType="pubmed">34020073</ArticleId></ArticleIdList></Reference><Reference><Citation>Timsit JF, Paul M, Shields RK, Echols R, Baba T, Yamano Y, Portsmouth S (2022) Cefiderocol for the treatment of infections due to metallo-beta-lactamase-producing pathogens in the CREDIBLE-CR and APEKS-NP phase 3 randomized studies. Clin Infect Dis:ciac078. 10.1093/cid/ciac078</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9522395</ArticleId><ArticleId IdType="pubmed">35148378</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pilato V, Henrici De Angelis L, Aiezza N, Baccani I, Niccolai C, Parisio EM, Giordano C, Camarlinghi G, Barnini S, Forni S, Righi L, Mechi MT, Giani T, Antonelli A, Rossolini GM, the Tuscan Clinical Microbiology Laboratory Network Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation. Lancet Microbe. 2022;3:e224&#x2013;e234. doi: 10.1016/S2666-5247(21)00268-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00268-8</ArticleId><ArticleId IdType="pubmed">35544076</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs MR, Abdelhamed AM, Good CE, Rhoads DD, Hujer KM, Hujer AM, Domitrovic TN, Rudin SD, Richter SS, van Duin D, Kreiswirth BN, Greco C, Fouts DE, Bonomo RA. ARGONAUT-I: activity of cefiderocol (S-649266), a siderophore cephalosporin, against gram-negative bacteria, including carbapenem-resistant nonfermenters and Enterobacteriaceae with defined extended-spectrum &#x3b2;-lactamases and carbapenemases. Antimicrob Agents Chemother. 2018;63(1):e01801&#x2013;e01818. doi: 10.1128/AAC.01801-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01801-18</ArticleId><ArticleId IdType="pmc">PMC6325197</ArticleId><ArticleId IdType="pubmed">30323050</ArticleId></ArticleIdList></Reference><Reference><Citation>Portsmouth S, van Veenhuyzen D, Echols R, Machida M, Ferreira JCA, Ariyasu M, Tenke P, Nagata TD. Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2018;18(12):1319&#x2013;1328. doi: 10.1016/S1473-3099(18)30554-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30554-1</ArticleId><ArticleId IdType="pubmed">30509675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wunderink RG, Matsunaga Y, Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Menon A, Pogue JM, Shorr AF, Timsit JF, Zeitlinger M, Nagata TD. Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis. 2021;21(2):213&#x2013;225. doi: 10.1016/S1473-3099(20)30731-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30731-3</ArticleId><ArticleId IdType="pubmed">33058798</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre- Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis. 2021;21(2):226&#x2013;240. doi: 10.1016/S1473-3099(20)30796-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30796-9</ArticleId><ArticleId IdType="pubmed">33058795</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson DL, Kinoshita M, Baba T, Echols R, Portsmouth S. Outcomes with cefiderocol treatment in patients with bacteraemia enrolled into prospective phase 2 and phase 3 randomised clinical studies. Infect Dis Ther. 2022;11(2):853&#x2013;870. doi: 10.1007/s40121-022-00598-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-022-00598-9</ArticleId><ArticleId IdType="pmc">PMC8960491</ArticleId><ArticleId IdType="pubmed">35184255</ArticleId></ArticleIdList></Reference><Reference><Citation>Portsmouth S, Echols R, Toyoizumi K, Tillotson G, Nagata TD. Structured patient interview to assess clinical outcomes in complicated urinary tract infections in the APEKS-cUTI study: pilot investigation. Ther Adv Infect Dis. 2021;8:20499361211058257. doi: 10.1177/20499361211058257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211058257</ArticleId><ArticleId IdType="pmc">PMC8637798</ArticleId><ArticleId IdType="pubmed">34868583</ArticleId></ArticleIdList></Reference><Reference><Citation>Portsmouth S, Bass A, Echols R, Tillotson G. Heterogeneity of recent phase 3 complicated urinary tract infection clinical trials. Open Forum. Infect Dis. 2021;8(3):ofab045. doi: 10.1093/ofid/ofab045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab045</ArticleId><ArticleId IdType="pmc">PMC7953653</ArticleId><ArticleId IdType="pubmed">33738315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsueh SC, Chao CM, Wang CY, Lai CC, Chen CH. Clinical efficacy and safety of cefiderocol in the treatment of acute bacterial infections: a systematic review and meta-analysis of randomised controlled trials. J Glob Antimicrob Resist. 2021;24:376&#x2013;382. doi: 10.1016/j.jgar.2021.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgar.2021.02.004</ArticleId><ArticleId IdType="pubmed">33596476</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascale R, Pasquini Z, Bartoletti M, Caiazzo L, Fornaro G, Bussini L, Volpato F, Marchionni E, Rinaldi M, Trapani F, Temperoni C, Gaibani P, Ambretti S, Barchiesi F, Viale P, Giannella M. Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study. JAC Antimicrob Resist. 2021;3(4):dlab174. doi: 10.1093/jacamr/dlab174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jacamr/dlab174</ArticleId><ArticleId IdType="pmc">PMC8599913</ArticleId><ArticleId IdType="pubmed">34806011</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone M, Tiseo G, Leonildi A, Della Sala L, Vecchione A, Barnini S, Farcomeni A, Menichetti F (2022) Cefiderocol-compared to colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother:e0214221. 10.1128/aac.02142-21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9112922</ArticleId><ArticleId IdType="pubmed">35311522</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone M, Tiseo G (2022) Cefiderocol for the treatment of metallo-beta-lactamases producing Gram negative bacilli: lights and shadows from the literature. Clin Infect Dis:ciac082. 10.1093/cid/ciac082</Citation><ArticleIdList><ArticleId IdType="pubmed">35136982</ArticleId></ArticleIdList></Reference><Reference><Citation>Saisho Y, Katsube T, White S, Fukase H, Shimada J. Pharmacokinetics, safety, and tolerability of cefiderocol, a novel siderophore cephalosporin for Gram-negative bacteria, in healthy subjects. Antimicrob Agents Chemother. 2018;62(3):e02163&#x2013;e02117. doi: 10.1128/AAC.02163-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02163-17</ArticleId><ArticleId IdType="pmc">PMC5826143</ArticleId><ArticleId IdType="pubmed">29311072</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaar EP, Echols R, Matsunaga Y, Menon A, Portsmouth S. Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study. Eur J Clin Microbiol Infect Dis. 2022;41(3):467&#x2013;476. doi: 10.1007/s10096-021-04399-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-021-04399-9</ArticleId><ArticleId IdType="pmc">PMC8831352</ArticleId><ArticleId IdType="pubmed">35025025</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsunaga Y, Sonoyama T, Casanova L, et al. (Epub2020) Safety profile of the novel siderophore cephalosporin cefiderocol in randomized phase 2 and phase 3 clinical studies of serious Gram-negative infections [abstract no. 1292] Open Forum Infect Dis. 2020;7(Suppl 1):S661&#x2013;S662. doi: 10.1093/ofid/ofaa439.1475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa439.1475</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleibtreu A, Dortet L, Bonnin RA, Wyplosz B, Sacleux SC, Mihaila L, Dupont H, Junot H, Bunel V, Grall N, Razazi K, Duran C, Tattevin P, Dinh A, The Cefiderocol French Study Group OBO Susceptibility testing is key for the success of cefiderocol treatment: a retrospective cohort study. Microorganisms. 2021;9(2):282. doi: 10.3390/microorganisms9020282.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9020282</ArticleId><ArticleId IdType="pmc">PMC7911443</ArticleId><ArticleId IdType="pubmed">33573148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanabria C, Migoya E, Mason JW, Stanworth SH, Katsube T, Machida M, Narukawa Y, Den Nagata T. Effect of cefiderocol, a siderophore cephalosporin, on QT/QTc interval in healthy adult subjects. Clin Ther. 2019;41(9):1724&#x2013;1736.e4. doi: 10.1016/j.clinthera.2019.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.07.006</ArticleId><ArticleId IdType="pubmed">31378318</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsube T, Echols R, Arjona Ferreira JC, Krenz HK, Berg JK, Galloway C. Cefiderocol, a siderophore cephalosporin for gram-negative bacterial infections: pharmacokinetics and safety in subjects with renal impairment. J Clin Pharmacol. 2017;57(5):584&#x2013;591. doi: 10.1002/jcph.841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.841</ArticleId><ArticleId IdType="pmc">PMC5412848</ArticleId><ArticleId IdType="pubmed">27874971</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul M, Carrara E, Retamar P, T&#xe4;ngd&#xe9;n T, Bitterman R, Bonomo RA, de Waele J, Daikos GL, Akova M, Harbarth S, Pulcini C, Garnacho-Montero J, Seme K, Tumbarello M, Lindemann PC, Gandra S, Yu Y, Bassetti M, Mouton JW, Tacconelli E, Rodr&#xed;guez- BJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) Clin Microbiol Infect. 2021;16:S1198-743X(21)00679-0. doi: 10.1016/j.cmi.2021.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.025</ArticleId><ArticleId IdType="pubmed">34923128</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone M, Tiseo G, Nicastro M, Leonildi A, Vecchione A, Casella C, Forfori F, Malacarne P, Guarracino F, Barnini S, Menichetti F. Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant gram-negative infections in intensive care unit patients. Clin Infect Dis. 2021;72(11):2021&#x2013;2024. doi: 10.1093/cid/ciaa1410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1410</ArticleId><ArticleId IdType="pubmed">32941593</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamma PD, Aitken SL, Bonomo RA, et al. Infectious Diseases Society of America guidance on the treatment of antimicrobial resistant gram-negative infections. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">37463564</ArticleId></ArticleIdList></Reference><Reference><Citation>Naseer S, Weinstein EA, Rubin DB, Suvarna K, Wei X, Higgins K, Goodwin A, Jang SH, Iarikov D, Farley J, Nambiar S. US Food and Drug Administration (FDA): benefit-risk considerations for cefiderocol (Fetroja&#xae;) Clin Infect Dis. 2021;72(12):e1103&#x2013;e1111. doi: 10.1093/cid/ciaa1799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1799</ArticleId><ArticleId IdType="pubmed">33393598</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavaro DF, Belati A, Diella L, Stufano M, Romanelli F, Scalone L, Stolfa S, Ronga L, Maurmo L, Dell&#x2019;Aera M, Mosca A, Dalfino L, Grasso S, Saracino A. Cefiderocol-based combination therapy for &#x201c;Difficult-to-Treat&#x201d; gram-negative severe infections: real-life case series and future perspectives. Antibiotics (Basel) 2021;10(6):652. doi: 10.3390/antibiotics10060652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10060652</ArticleId><ArticleId IdType="pmc">PMC8227820</ArticleId><ArticleId IdType="pubmed">34072342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38290288</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: systematic review, meta-analysis, and perspective of observational studies.</ArticleTitle><Pagination><StartPage>104981</StartPage><MedlinePgn>104981</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104981</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2024.104981</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(24)00016-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mechanistic studies have established a biological role of sterol metabolism in infection and immunity with clinical data linking deranged cholesterol metabolism during sepsis with poorer outcomes. In this systematic review we assess the relationship between biomarkers of cholesterol homeostasis and mortality in critical illness.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We identified articles by searching a total of seven electronic databases from inception to October 2023. Prospective observational cohort studies included those subjects who had systemic cholesterol (Total Cholesterol (TC), HDL-C or LDL-C) levels assessed on the first day of ICU admission and short-term mortality recorded. Meta-analysis and meta-regression were used to evaluate overall mean differences in serum cholesterol levels between survivors and non-survivors. Study quality was assessed using the Newcastle-Ottawa Scale.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">From 6469 studies identified by searches, 24 studies with 2542 participants were included in meta-analysis. Non-survivors had distinctly lower HDL-C at ICU admission&#xa0;-7.06&#xa0;mg/dL (95% CI&#xa0;-9.21 to&#xa0;-4.91, p&#xa0;&lt;&#xa0;0.0001) in comparison with survivors. Corresponding differences were also seen less robustly for TC&#xa0;-21.86&#xa0;mg/dL (95% CI&#xa0;-31.23 to&#xa0;-12.49, p&#xa0;&lt;&#xa0;0.0001) and LDL-C&#xa0;-8.79&#xa0;mg/dL (95% CI,&#xa0;-13.74 to&#xa0;-3.83, p&#xa0;=&#xa0;0.0005).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Systemic cholesterol levels (TC, HDL-C and LDL-C) on admission to critical care are inversely related to mortality. This finding is consistent with the notion that inflammatory and metabolic setpoints are coupled, such that the maladaptive-setpoint changes of cholesterol in critical illness are related to underlying inflammatory processes. We highlight the potential of HDL-biomarkers as early predictors of severity of illness and emphasise that future research should consider the metabolic and functional heterogeneity of HDLs.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">EU-ERDF-Welsh Government Ser Cymru programme, BBSRC, and EU-FP7 ClouDx-i project (PG).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Rory</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Deanery of Biomedical Sciences, University of Edinburgh Medical School, Edinburgh, UK. Electronic address: raz2vic@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chengyuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care and Pain Medicine, NHS Lothian, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Deslit</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Cardiff, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotecha</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Child Health, School of Medicine, University of Cardiff, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelghaffar</LastName><ForeName>Mariam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Royal College of Surgeons in Ireland, Bahrain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forster</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>LifeArc, Edinburgh Bioquarter, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos Rodrigues</LastName><ForeName>Patricia Dos</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Cardiff, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reisinger</LastName><ForeName>Alexander C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Intensive Care Unit, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Project Sepsis, Systems Immunity Research Institute, School of Medicine, University of Cardiff, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Fergus</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watkins</LastName><ForeName>W John</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Dept of Immunity and Infection, School of Medicine, Cardiff University, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffith</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Anaesthesia, Critical Care and Pain, Molecular, Genetics, and Population Health Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghazal</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Project Sepsis, Systems Immunity Research Institute, School of Medicine, University of Cardiff, Cardiff, UK. Electronic address: GhazalP@cardiff.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008076" MajorTopicYN="N">Cholesterol, HDL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008078" MajorTopicYN="N">Cholesterol, LDL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cholesterol</Keyword><Keyword MajorTopicYN="N">Critical illness</Keyword><Keyword MajorTopicYN="N">Immunometabolism</Keyword><Keyword MajorTopicYN="N">Lipids</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declaration of interests Peter Ghazal is a member of the development board for Sepsis Trust UK with no cash incentive, Received funding from the EDRF Ser Cymru (Welsh Government) programme, EU-FP7 projects: ClouDx-I and NeoVanc. Thorsten F&#xf6;rster is an inventor of patent US20170022568&#x2014;&#x201c;Molecular Predictors Of Sepsis&#x201d; and is declared as an existing interest in intellectual property around transcriptomic markers of sepsis, but is not related to the current work beyond the broad theme of sepsis.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>18</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38290288</ArticleId><ArticleId IdType="pmc">PMC10844818</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2024.104981</ArticleId><ArticleId IdType="pii">S2352-3964(24)00016-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Montecucco F., Favari E., Norata G.D., Ronda N., Nofer J.R., Vuilleumier N. Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions. Handb Exp Pharmacol. 2015;224:455&#x2013;482. https://pubmed.ncbi.nlm.nih.gov/25522998/ [cited 2023 Nov 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">25522998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.Y., Yu M., Morin E.E., Kang J., Kaplan M.J., Schwendeman A. High-density lipoprotein in lupus: disease biomarkers and potential therapeutic strategy. Arthritis Rheumatol. 2020;72(1):20&#x2013;30. https://pubmed.ncbi.nlm.nih.gov/31350818/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6935404</ArticleId><ArticleId IdType="pubmed">31350818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.Y., Lee E.Y., Park J.K., Song Y.W., Kim J.R., Cho K.H. Patients with rheumatoid arthritis show altered lipoprotein profiles with dysfunctional high-density lipoproteins that can exacerbate inflammatory and atherogenic process. PLoS One. 2016;11(10) https://pubmed.ncbi.nlm.nih.gov/27736980/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5063466</ArticleId><ArticleId IdType="pubmed">27736980</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson K.A., Ghazal P. Interferon control of the sterol metabolic network: bidirectional molecular circuitry-mediating host protection. Front Immunol. 2016;7:634. https://pubmed.ncbi.nlm.nih.gov/28066443/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5179542</ArticleId><ArticleId IdType="pubmed">28066443</ArticleId></ArticleIdList></Reference><Reference><Citation>Fessler M.B. The intracellular cholesterol landscape: dynamic integrator of the immune response. Trends Immunol. 2016;37(12):819. [cited 2023 Mar 14];Available from:/pmc/articles/PMC5135597/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5135597</ArticleId><ArticleId IdType="pubmed">27692616</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z., Mates J.M., Cheplowitz A.M., et al.  Blood-borne lipopolysaccharide is rapidly eliminated by liver sinusoidal endothelial cells via high-density lipoprotein. J&#xa0;Immunol. 2016;197(6):2390&#x2013;2399. https://pubmed.ncbi.nlm.nih.gov/27534554/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5010928</ArticleId><ArticleId IdType="pubmed">27534554</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin E.E., Guo L., Schwendeman A., Li X.A. HDL in sepsis - risk factor and therapeutic approach. Front Pharmacol. 2015;6:244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4616240</ArticleId><ArticleId IdType="pubmed">26557091</ArticleId></ArticleIdList></Reference><Reference><Citation>Levels J.H.M., Abraham P.R., Van Barreveld E.P., Meijers J.C.M., Van Deventer S.J.H. Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect Immun. 2003;71(6):3280&#x2013;3284. https://pubmed.ncbi.nlm.nih.gov/12761109/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC155762</ArticleId><ArticleId IdType="pubmed">12761109</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou M., Mouratis M.A., Lepper P.M., et al.  Serum proteins modulate lipopolysaccharide and lipoteichoic acid-induced activation and contribute to the clinical outcome of sepsis. Virulence. 2012;3(2):136&#x2013;145. https://pubmed.ncbi.nlm.nih.gov/22460642/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">22460642</ArticleId></ArticleIdList></Reference><Reference><Citation>De Nardo D., Labzin L.I., Kono H., et al.  High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol. 2014;15(2):152&#x2013;160. https://pubmed.ncbi.nlm.nih.gov/24317040/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4009731</ArticleId><ArticleId IdType="pubmed">24317040</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajkrt D., Doran J.E., Koster F., et al.  Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J&#xa0;Exp Med. 1996;184(5):1601&#x2013;1608. https://pubmed.ncbi.nlm.nih.gov/8920850/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192853</ArticleId><ArticleId IdType="pubmed">8920850</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas A.T., Hubsch A.P., Rogers B.C. Reconstituted high-density lipoprotein reduces LPS-stimulated TNF alpha. J&#xa0;Surg Res. 1995;59(5):544&#x2013;552. https://pubmed.ncbi.nlm.nih.gov/7475000/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">7475000</ArticleId></ArticleIdList></Reference><Reference><Citation>Surbatovic M., Popovic N., Vojvodic D., et al.  Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis. Sci Rep. 2015;5 https://pubmed.ncbi.nlm.nih.gov/26079127/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468818</ArticleId><ArticleId IdType="pubmed">26079127</ArticleId></ArticleIdList></Reference><Reference><Citation>Damas P., Ledoux D., Nys M., et al.  Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992;215(4):356&#x2013;362. https://pubmed.ncbi.nlm.nih.gov/1558416/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1242452</ArticleId><ArticleId IdType="pubmed">1558416</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman G., Jankowski S., Marchant A., Goldman M., Kahn R.J., Vincent J.L. Blood interleukin 10 levels parallel the severity of septic shock. J&#xa0;Crit Care. 1997;12(4):183&#x2013;187. https://pubmed.ncbi.nlm.nih.gov/9459114/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">9459114</ArticleId></ArticleIdList></Reference><Reference><Citation>Damas P., Reuter A., Gysen P., Demonty J., Lamy M., Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 1989;17(10):975&#x2013;978. https://pubmed.ncbi.nlm.nih.gov/2791581/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">2791581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lekkou A., Mouzaki A., Siagris D., Ravani I., Gogos C.A. Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. J&#xa0;Crit Care. 2014;29(5):723&#x2013;727. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=medl&amp;NEWS=N&amp;AN=24891152 Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">24891152</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraunberger P., Pilz G., Cremer P., Werdan K., Walli A.K. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock. 1998;10(5):359&#x2013;363. https://pubmed.ncbi.nlm.nih.gov/9840652/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">9840652</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon B.R., Parker T.S., Levine D.M., et al.  Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med. 2001;29(8):1563&#x2013;1568. https://pubmed.ncbi.nlm.nih.gov/11505128/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">11505128</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlage S., Gnewuch C., Liebisch G., et al.  Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Med. 2009;35(11):1877&#x2013;1885. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=med5&amp;NEWS=N&amp;AN=19669126 Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">19669126</ArticleId></ArticleIdList></Reference><Reference><Citation>Memi&#x15f; D., Gursoy O., Tasdogan M., et al.  High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis. J&#xa0;Clin Anesth. 2007;19(3):186&#x2013;191. https://pubmed.ncbi.nlm.nih.gov/17531726/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">17531726</ArticleId></ArticleIdList></Reference><Reference><Citation>Desmoulin F., Galinier M., Trouillet C., et al.  Metabonomics analysis of plasma reveals the lactate to cholesterol ratio as an independent prognostic factor of short-term mortality in acute heart failure. PLoS One. 2013;8(4) http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=medl&amp;NEWS=N&amp;AN=23573279 Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3616116</ArticleId><ArticleId IdType="pubmed">23573279</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.H., Liang H.Y., Li H.Y., Ding X.F., Sun T.W., Wang J. Effect of low high-density lipoprotein levels on mortality of septic patients: a systematic review and meta-analysis of cohort studies. World J Emerg Med. 2020;11(2):109&#x2013;116. https://pubmed.ncbi.nlm.nih.gov/32076477/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7010535</ArticleId><ArticleId IdType="pubmed">32076477</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmaenner D.A., Arina P., Kleyman A., et al.  Association between hypocholesterolemia and mortality in critically ill patients with sepsis: a systematic review and meta-analysis. Crit Care Explor. 2023;5(2) https://pubmed.ncbi.nlm.nih.gov/36751516/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894355</ArticleId><ArticleId IdType="pubmed">36751516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S., Couret D., Tran-Dinh A., et al.  High-density lipoproteins during sepsis: from bench to bedside. Crit Care. 2020;24(1):134. https://pubmed.ncbi.nlm.nih.gov/32264946/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7140566</ArticleId><ArticleId IdType="pubmed">32264946</ArticleId></ArticleIdList></Reference><Reference><Citation>Guirgis F.W., Black L.P., Rosenthal M.D., et al.  LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock. BMJ Open. 2019;9(9) https://pubmed.ncbi.nlm.nih.gov/31537565/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6756323</ArticleId><ArticleId IdType="pubmed">31537565</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup D.F., Berlin J.A., Morton S.C., et al.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2013;2012. https://pubmed.ncbi.nlm.nih.gov/10789670/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G., Shea B., Ottawa Hospital Research Institute  Newcastle-Ottawa quality assessment scale cohort studies. 2000. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [cited 2017 Nov 7] Available from:</Citation></Reference><Reference><Citation>Wan X., Wang W., Liu J., Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):1&#x2013;13. https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/1471-2288-14-135 [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraunberger P., Nagel D., Walli A.K., Seidel D., Werdan K. Serum cholesterol and mortality in patients with multiple organ failure. Crit Care Med. 2000;28(10):3574&#x2013;3575. https://pubmed.ncbi.nlm.nih.gov/11057826/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">11057826</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger A.C., Schuller M., Holzer M., et al.  Arylesterase activity of HDL associated paraoxonase as a potential prognostic marker in patients with sepsis and septic shock-a prospective pilot study. Front Med. 2020;7 https://pubmed.ncbi.nlm.nih.gov/33195328/ [cited 2023 Jul 3];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7642222</ArticleId><ArticleId IdType="pubmed">33195328</ArticleId></ArticleIdList></Reference><Reference><Citation>Etogo-Asse F.E., Vincent R.P., Hughes S.A., et al.  High density lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness. Liver Int. 2012;32(1):128&#x2013;136. https://pubmed.ncbi.nlm.nih.gov/22098564/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">22098564</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraati M., Nazari M.R., Taher M.T., Farhadi N. Comparison of lipid profile in septic and non-septic patients. Iran J Clin Infect Dis. 2011;6(4):144&#x2013;147.</Citation></Reference><Reference><Citation>Berb&#xe9;e J.F.P., Van Der Hoogt C.C., De Haas C.J.C., et al.  Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis. Intensive Care Med. 2008;34(5):907&#x2013;911. https://pubmed.ncbi.nlm.nih.gov/18231776/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">18231776</ArticleId></ArticleIdList></Reference><Reference><Citation>Biller K., Fae P., Germann R., Drexel H., Walli A.K., Fraunberger P. Cholesterol rather than procalcitonin or C-reactive protein predicts mortality in patients with infection. Shock. 2014;42(2):129&#x2013;132. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=medl&amp;NEWS=N&amp;AN=24727873 Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">24727873</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonville D.A., Parker T.S., Levine D.M., et al.  The relationships of hypocholesterolemia to cytokine concentrations and mortality in critically ill patients with systemic inflammatory response syndrome. Surg Infect. 2004;5(1):39&#x2013;49. https://pubmed.ncbi.nlm.nih.gov/15142422/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">15142422</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien Y.F., Chen C.Y., Hsu C.L., Chen K.Y., Yu C.J. Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission. J&#xa0;Crit Care. 2015;30(3):506&#x2013;510. https://pubmed.ncbi.nlm.nih.gov/25702844/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">25702844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien J.Y., Jerng J.S., Yu C.J., Yang P.C. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med. 2005;33(8):1688&#x2013;1693. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=med5&amp;NEWS=N&amp;AN=16096442 Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">16096442</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es S.M., Lima E.Q., Cipullo J.P., Lobo S.M., Burdmann E.A. Low insulin-like growth factor-1 and hypocholesterolemia as mortality predictors in acute kidney injury in the intensive care unit. Crit Care Med. 2008;36(12):3165&#x2013;3170. https://pubmed.ncbi.nlm.nih.gov/19020431/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">19020431</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x130;nal V., Yamanel L., Ta&#x15f;kin G., Tapan S., C&#xf6;mert B. Paraoxonase 1 activity and survival in sepsis patients. Balkan Med J. 2015;32(2):183&#x2013;188. http://search.ebscohost.com/login.aspx?direct=true&amp;db=jlh&amp;AN=109812146&amp;site=ehost-live Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4432699</ArticleId><ArticleId IdType="pubmed">26167343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.H., Park M.S., Park B.H., et al.  Prognostic implications of serum lipid metabolism over time during sepsis. BioMed Res Int. 2015;2015 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=medl&amp;NEWS=N&amp;AN=26351639 Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4553311</ArticleId><ArticleId IdType="pubmed">26351639</ArticleId></ArticleIdList></Reference><Reference><Citation>Luthold S., Berneis K., Bady P., Muller B. Effects of infectious disease on plasma lipids and their diagnostic significance in critical illness. Eur J Clin Invest. 2007;37(7):573&#x2013;579. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=med5&amp;NEWS=N&amp;AN=17576209 Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">17576209</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y.S., Chen Y.C., Tian Y.C., et al.  Serum levels of apolipoprotein A-I and high-density lipoprotein can predict organ failure in acute pancreatitis. Crit Care. 2015;19(1):88. https://pubmed.ncbi.nlm.nih.gov/25851781/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4363356</ArticleId><ArticleId IdType="pubmed">25851781</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachyla S.A., Marochkov A.V., Lipnitski A.L., Nikiforova Y.G. The prognostic value of procalcitonin, C-reactive protein and cholesterol in patients with an infection and multiple organ dysfunction. Korean J Anesthesiol. 2017;70(3):305. [cited 2023 Jun 19];Available from:/pmc/articles/PMC5453892/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5453892</ArticleId><ArticleId IdType="pubmed">28580081</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S., De Tymowski C., Assadi M., et al.  Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: results from the ApoCOVID study. PLoS One. 2020;15(9) https://pubmed.ncbi.nlm.nih.gov/32970772/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7514065</ArticleId><ArticleId IdType="pubmed">32970772</ArticleId></ArticleIdList></Reference><Reference><Citation>Delirrad M., Gharebaghi N., Mobarhan S., Nejadrahim R. Relationship between lipid profile and sepsis outcome in intensive care unit. Arch Clin Infect Dis. 2020;15(2) https://brieflands.com/articles/archcid-93533.html [cited 2023 Jun 19];Available from:</Citation></Reference><Reference><Citation>Tanaka S., Labreuche J., Drumez E., et al. Low HDL levels in sepsis versus trauma patients in intensive care unit. Ann Intensive Care. 2017;7(1):60. [cited 2023 Mar 14];Available from:/pmc/articles/PMC5461227/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5461227</ArticleId><ArticleId IdType="pubmed">28589535</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaliq W., Gro&#xdf;mann P., Neugebauer S., et al.  Lipid metabolic signatures deviate in sepsis survivors compared to non-survivors. Comput Struct Biotechnol J. 2020;18:3678&#x2013;3691. https://pubmed.ncbi.nlm.nih.gov/33304464/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7711192</ArticleId><ArticleId IdType="pubmed">33304464</ArticleId></ArticleIdList></Reference><Reference><Citation>Levels J.H.M., Pajkrt D., Schultz M., et al.  Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis. Biochim Biophys Acta. 2007;1771(12):1429&#x2013;1438. https://pubmed.ncbi.nlm.nih.gov/17980169/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">17980169</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S., De Tymowski C., Stern J., et al.  Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis. PLoS One. 2022;17(8) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0272352 [cited 2023 Jul 18];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9394828</ArticleId><ArticleId IdType="pubmed">35994439</ArticleId></ArticleIdList></Reference><Reference><Citation>Guirgis F.W., Dodani S., Leeuwenburgh C., et al. HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock. PLoS One. 2018;13(9) [cited 2023 Jul 19];Available from:/pmc/articles/PMC6138388/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138388</ArticleId><ArticleId IdType="pubmed">30216360</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzundere O., Memis D., Inal M.T., Gultekin A., Turan F.N. Factors affecting acute renal failure in intensive care unit and effect of these factors on mortality. Turkiye Klinikleri J Med Sci. 2015;35(4):248&#x2013;255. http://www.turkiyeklinikleri.com/pdf/?pdf=8ff2c4494d48b2e7f47a6cf1fb95272a Available from:</Citation></Reference><Reference><Citation>Oliva M.H., Assef A.P., Cardenas V.T. Risk factors related to death in patients admitted to the intensive care unit with sepsis. Rev Habanera Ciencias M&#xe9;d. 2022;21(4) https://revhabanera.sld.cu/index.php/rhab/article/view/4432 Available from:</Citation></Reference><Reference><Citation>Lee S.H., Lee J.Y., Hong T.H., Kim B.O., Lee Y.J., Lee J.G. Severe persistent hypocholesterolemia after emergency gastrointestinal surgery predicts in-hospital mortality in critically ill patients with diffuse peritonitis. PLoS One. 2018;13(7) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0200187 [cited 2023 Jul 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6034864</ArticleId><ArticleId IdType="pubmed">29979773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785. [cited 2023 Nov 19];Available from:/pmc/articles/PMC5953768/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953768</ArticleId><ArticleId IdType="pubmed">29141096</ArticleId></ArticleIdList></Reference><Reference><Citation>Guetta V., Cannon R.O. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation. 1996;93(10):1928&#x2013;1937. https://www.ahajournals.org/doi/abs/10.1161/01.cir.93.10.1928 [cited 2023 Nov 19];Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.93.10.1928</ArticleId><ArticleId IdType="pubmed">8635273</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiger K.J., Martin S.S., Blaha M.J., et al.  Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B) J&#xa0;Am Heart Assoc. 2014;3(2) https://pubmed.ncbi.nlm.nih.gov/24755154/ [cited 2023 Nov 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4187479</ArticleId><ArticleId IdType="pubmed">24755154</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Sun R., Chen Q., et al. Association between HDL-C levels and menopause: a meta-analysis. Hormones. 2021;20(1):49. [cited 2023 Nov 19];Available from:/pmc/articles/PMC7889539/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889539</ArticleId><ArticleId IdType="pubmed">32557344</ArticleId></ArticleIdList></Reference><Reference><Citation>Antequera A., Lopez-Alcalde J., Stallings E., et al.  Sex as a prognostic factor for mortality in critically ill adults with sepsis: a systematic review and meta-analysis. BMJ Open. 2021;11(9) https://bmjopen.bmj.com/content/11/9/e048982 [cited 2023 Nov 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461281</ArticleId><ArticleId IdType="pubmed">34551945</ArticleId></ArticleIdList></Reference><Reference><Citation>Modra L., Higgins A., Vithanage R., Abeygunawardana V., Bailey M., Bellomo R. Sex differences in illness severity and mortality among adult intensive care patients: a systematic review and meta-analysis. J&#xa0;Crit Care. 2021;65:116&#x2013;123. https://pubmed.ncbi.nlm.nih.gov/34118502/ [cited 2023 Nov 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">34118502</ArticleId></ArticleIdList></Reference><Reference><Citation>May A.K., Dossett L.A., Norris P.R., et al. Estradiol is associated with mortality in critically ill trauma and surgical patients. Crit Care Med. 2008;36(1):62. [cited 2023 Nov 19];Available from:/pmc/articles/PMC2654262/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2654262</ArticleId><ArticleId IdType="pubmed">18090358</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J.Y., Liu K.T., Abraham E., et al.  Serum estradiol levels predict survival and acute kidney injury in patients with septic shock- A prospective study. PLoS One. 2014;9(6) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0097967 [cited 2023 Nov 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4048195</ArticleId><ArticleId IdType="pubmed">24904990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang G., Insel M.B., Weis J.M., et al. Bioavailable estradiol concentrations are elevated and predict mortality in septic patients: a prospective cohort study. Crit Care. 2016;20(1):335. [cited 2023 Nov 19];Available from:/pmc/articles/PMC5073735/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5073735</ArticleId><ArticleId IdType="pubmed">27765072</ArticleId></ArticleIdList></Reference><Reference><Citation>Felici N., Liu D., Maret J., et al. Long-term abnormalities of lipid profile after a single episode of sepsis. Front Cardiovasc Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8634493</ArticleId><ArticleId IdType="pubmed">34869619</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmaenner D.A., Kleyman A., Press A., Bauer M., Singer M. The many roles of cholesterol in sepsis A review. Am J Respir Crit Care Med. 2022;205(4):388&#x2013;396. [cited 2023 Nov 30];Available from:/pmc/articles/PMC8886946/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8886946</ArticleId><ArticleId IdType="pubmed">34715007</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinder M., Walley K.R., Boyd J.H., Brunham L.R. Causal inference for genetically determined levels of high-density lipoprotein cholesterol and risk of infectious disease. Arterioscler Thromb Vasc Biol. 2020;40(1):267&#x2013;278. https://pubmed.ncbi.nlm.nih.gov/31694394/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6946100</ArticleId><ArticleId IdType="pubmed">31694394</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen C.M., Varbo A., Tybj&#xe6;rg-Hansen A., Frikke-Schmidt R., Nordestgaard B.G. U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies. Eur Heart J. 2018;39(14):1181&#x2013;1190. https://pubmed.ncbi.nlm.nih.gov/29228167/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">29228167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton F., Pedersen K.M., Ghazal P., Nordestgaard B.G., Smith G.D. Low levels of small HDL particles predict but do not influence risk of sepsis. Crit Care. 2023;27(1):1&#x2013;19. https://ccforum.biomedcentral.com/articles/10.1186/s13054-023-04589-1 [cited 2023 Nov 17];Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04589-1</ArticleId><ArticleId IdType="pmc">PMC10563213</ArticleId><ArticleId IdType="pubmed">37814277</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q.P., Wei W.Q., Chaugai S., et al. Association between low-density lipoprotein cholesterol levels and risk for sepsis among patients admitted to the hospital with infection. JAMA Netw Open. 2019;2(1) [cited 2023 Nov 17];Available from:/pmc/articles/PMC6447031/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447031</ArticleId><ArticleId IdType="pubmed">30657536</ArticleId></ArticleIdList></Reference><Reference><Citation>Walley K.R., Boyd J.H., Kong H.J.J., Russell J.A. Low low-density lipoprotein levels are associated with, but do not causally contribute to, increased mortality in sepsis. Crit Care Med. 2019;47(3):463&#x2013;466. https://pubmed.ncbi.nlm.nih.gov/30394916/ [cited 2023 Nov 17];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">30394916</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano S., Shimizu K., Ogura H., et al.  Low total cholesterol and high total bilirubin are associated with prognosis in patients with prolonged sepsis. J&#xa0;Crit Care. 2016;31(1):36&#x2013;40. https://pubmed.ncbi.nlm.nih.gov/26596698/ [cited 2023 Jul 28];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">26596698</ArticleId></ArticleIdList></Reference><Reference><Citation>Guirgis F.W., Black L.P., DeVos E., et al.  Lipid intensive drug therapy for sepsis pilot: a Bayesian phase I clinical trial. J&#xa0;Am Coll Emerg Physicians Open. 2020;1(6):1332&#x2013;1340. https://onlinelibrary.wiley.com/doi/full/10.1002/emp2.12237 [cited 2023 Jul 28];Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emp2.12237</ArticleId><ArticleId IdType="pmc">PMC7771745</ArticleId><ArticleId IdType="pubmed">33392541</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N.K., Tashima A.K., Brunialti M.K.C., et al. Proteomic study revealed cellular assembly and lipid metabolism dysregulation in sepsis secondary to community-acquired pneumonia. Sci Rep. 2017;7(1) [cited 2023 Jul 28];Available from:/pmc/articles/PMC5688086/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5688086</ArticleId><ArticleId IdType="pubmed">29142235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N.K., Ferreira B.L., Tashima A.K., et al. Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis. Clin Proteomics. 2019;16(1):29. [cited 2023 Jul 28];Available from:/pmc/articles/PMC6631513/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6631513</ArticleId><ArticleId IdType="pubmed">31341447</ArticleId></ArticleIdList></Reference><Reference><Citation>Guirgis F.W., Black L.P., Henson M., et al. A&#xa0;hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes. Crit Care. 2021;25(1):341. [cited 2023 Jul 28];Available from:/pmc/articles/PMC8447561/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447561</ArticleId><ArticleId IdType="pubmed">34535154</ArticleId></ArticleIdList></Reference><Reference><Citation>Golucci A.P.B.S., Marson F.A.L., Ribeiro A.F., Nogueira R.J.N. Lipid profile associated with the systemic inflammatory response syndrome and sepsis in critically ill patients. Nutrition. 2018;55&#x2013;56:7&#x2013;14. https://pubmed.ncbi.nlm.nih.gov/29960160/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">29960160</ArticleId></ArticleIdList></Reference><Reference><Citation>Tall A.R., Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 2015;15(2):104. [cited 2023 Nov 30];Available from:/pmc/articles/PMC4669071/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4669071</ArticleId><ArticleId IdType="pubmed">25614320</ArticleId></ArticleIdList></Reference><Reference><Citation>Khovidhunkit W., Kim M.S., Memon R.A., et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J&#xa0;Lipid Res. 2004;45(7):1169&#x2013;1196. https://pubmed.ncbi.nlm.nih.gov/15102878/ [cited 2023 Nov 17];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">15102878</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzobo K.E., Kraaijenhof J.M., Stroes E.S.G., Nurmohamed N.S., Kroon J. Lipoprotein(a): an underestimated inflammatory mastermind. Atherosclerosis. 2022;349:101&#x2013;109. http://www.atherosclerosis-journal.com/article/S0021915022001812/fulltext [cited 2023 Nov 30];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">35606070</ArticleId></ArticleIdList></Reference><Reference><Citation>Feingold K.R., Grunfeld C. In: Endotext [Internet] Feingold K.R., Anawalt B., Blackman M.R., et al., editors. MDText.com, Inc.; South Dartmouth (MA): 2000. The effect of inflammation and infection on lipids and lipoproteins.</Citation></Reference><Reference><Citation>Du X.M., Kim M.J., Hou L., et al.  HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Circ Res. 2015;116(7):1133&#x2013;1142. https://pubmed.ncbi.nlm.nih.gov/25589556/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">25589556</ArticleId></ArticleIdList></Reference><Reference><Citation>Harsl&#xf8;f M., Pedersen K.M., Afzal S., Davey Smith G., Nordestgaard B.G. Lower levels of small HDL particles associated with increased infectious disease morbidity and mortality: a population-based cohort study of 30 195 individuals. Cardiovasc Res. 2023;119(4):957&#x2013;968. doi: 10.1093/cvr/cvac194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac194</ArticleId><ArticleId IdType="pubmed">36537045</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohatgi A., Westerterp M., von Eckardstein A., Remaley A., Rye K.A. HDL in the 21st century: a multifunctional roadmap for future HDL research. Circulation. 2021;143(23) [cited 2023 Nov 30];Available from:/pmc/articles/PMC8189312/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189312</ArticleId><ArticleId IdType="pubmed">34097448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontush A., Lhomme M., Chapman M.J. Unraveling the complexities of the HDL lipidome. J&#xa0;Lipid Res. 2013;54(11):2950&#x2013;2963. https://pubmed.ncbi.nlm.nih.gov/23543772/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3793600</ArticleId><ArticleId IdType="pubmed">23543772</ArticleId></ArticleIdList></Reference><Reference><Citation>Matera R., Horvath K.V., Nair H., Schaefer E.J., Asztalos B.F. HDL particle measurement: comparison of 5 methods. Clin Chem. 2018;64(3):492&#x2013;500. https://pubmed.ncbi.nlm.nih.gov/29203475/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">29203475</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinder M., Wang Y., Madsen C.M., et al.  Inhibition of cholesteryl ester transfer protein preserves high-density lipoprotein cholesterol and improves survival in sepsis. Circulation. 2021;143(9):921&#x2013;934. https://pubmed.ncbi.nlm.nih.gov/33228395/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">33228395</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine D.M., Parker T.S., Donnelly T.M., Walsh A., Rubin A.L. In&#xa0;vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA. 1993;90(24) [cited 2023 Mar 14];Available from:/pmc/articles/PMC48121/?report=abstract.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC48121</ArticleId><ArticleId IdType="pubmed">8265667</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause B.R., Remaley A.T. Reconstituted HDL for the acute treatment of acute coronary syndrome. Curr Opin Lipidol. 2013;24(6):480&#x2013;486. https://pubmed.ncbi.nlm.nih.gov/24184938/ [cited 2023 Mar 14];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">24184938</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasid O., Cavaillon J.M., Herwanto V., Suwarto S., Rumende C.M. Subgroup analysis of the lipid infusion and patient outcomes in sepsis trial (LIPOS) reveals benefit in a subgroup not treated with stress replacement doses of corticosteroids. Crit Care. 2014;18(2):1&#x2013;53. https://ccforum.biomedcentral.com/articles/10.1186/cc14065 [cited 2023 Aug 30];Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc14065</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger P.R., Tomayko J.F., Angus D.C., et al.  Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial. Crit Care Med. 2009;37(11):2929&#x2013;2938. https://journals.lww.com/ccmjournal/fulltext/2009/11000/efficacy_and_safety_of_a_phospholipid_emulsion.10.aspx [cited 2023 Aug 30];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">19770753</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasi A., Fiorentino M., Franzin R., et al.  Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project. BMC Med. 2023;21(1):1&#x2013;18. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-03057-5 [cited 2023 Nov 17];Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03057-5</ArticleId><ArticleId IdType="pmc">PMC10621167</ArticleId><ArticleId IdType="pubmed">37915050</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Morin E.E., Yu M., et al.  Replenishing HDL with synthetic HDL has multiple protective effects against sepsis in mice. Sci Signal. 2022;15(725) https://www.science.org/doi/10.1126/scisignal.abl9322 [cited 2023 Nov 29];Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abl9322</ArticleId><ArticleId IdType="pmc">PMC9825056</ArticleId><ArticleId IdType="pubmed">35290084</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz B., Ucar B., Ak&#x15f;it A., Aydogdu S.D., Colak O., Colak E. Diagnostic values of lipid and lipoprotein levels in late onset neonatal sepsis. Scand J Infect Dis. 2009;41(4):263&#x2013;267. https://pubmed.ncbi.nlm.nih.gov/19221931/ [cited 2023 Jun 19];Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">19221931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38128732</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Mortality in patients with septic cardiomyopathy identified by longitudinal strain by speckle tracking echocardiography: An updated systematic review and meta-analysis with trial sequential analysis.</ArticleTitle><Pagination><StartPage>101339</StartPage><MedlinePgn>101339</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2023.101339</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(23)00147-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Septic cardiomyopathy is associated with poor outcomes but its definition remains unclear. In a previous meta-analysis, left ventricular (LV) longitudinal strain (LS) showed significant prognostic value in septic patients, but findings were not robust due to a limited number of studies, differences in effect size and no adjustment for confounders.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted an updated systematic review (PubMed and Scopus up to 14.02.2023) and meta-analysis to investigate the association between LS and survival in septic patients. We included studies reporting global (from three apical views) or regional LS (one or two apical windows). A secondary analysis evaluated the association between LV ejection fraction (EF) and survival using data from the selected studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included fourteen studies (1678 patients, survival 69.6%) and demonstrated an association between better performance (more negative LS) and survival with a mean difference (MD) of -1.45%[-2.10, -0.80] (p&#x2009;&lt;&#x2009;0.0001;I<sup>2</sup>&#x2009;=&#x2009;42%). No subgroup differences were found stratifying studies according to number of views used to calculate LS (p&#x2009;=&#x2009;0.31;I<sup>2</sup>&#x2009;=&#x2009;16%), severity of sepsis (p&#x2009;=&#x2009;0.42;I<sup>2</sup>&#x2009;=&#x2009;0%), and sepsis criteria (p&#x2009;=&#x2009;0.59;I<sup>2</sup>&#x2009;=&#x2009;0%). Trial sequential analysis and sensitivity analyses confirmed the primary findings. Grade of evidence was low. In the included studies, thirteen reported LVEF and we found an association between higher LVEF and survival (MD&#x2009;=&#x2009;2.44% [0.44,4.45]; p&#x2009;=&#x2009;0.02;I<sup>2</sup>&#x2009;=&#x2009;42%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We confirmed that more negative LS values are associated with higher survival in septic patients. The clinical relevance of this difference and whether the use of LS may improve understanding of septic cardiomyopathy and prognostication deserve further investigation. The association found between LVEF and survival is of unlikely clinical meaning.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="BACKGROUND">PROSPERO number CRD42023432354.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pruszczyk</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>2nd Department of Anesthesiology and Intensive Care, Medical University of Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zawadka</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>2nd Department of Anesthesiology and Intensive Care, Medical University of Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andruszkiewicz</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>2nd Department of Anesthesiology and Intensive Care, Medical University of Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaVia</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, "Policlinico-San Marco" University Hospital, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herpain</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, St.-Pierre University Hospital, Universit&#xe9; Libre de Bruxelles, 1050 Brussels, Belgium; Experimental Laboratory of Intensive Care, Universit&#xe9; Libre de Bruxelles, 1050 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Ryota</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dugar</LastName><ForeName>Siddharth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Biomedical and Clinical Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, "Policlinico-San Marco" University Hospital, Catania, Italy; Department of General Surgery and Medico-Surgical Specialties, School of Anaesthesia and Intensive Care, University of Catania, Catania, Italy. Electronic address: filipposanfi@yahoo.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="Y">Echocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Left ventricle</Keyword><Keyword MajorTopicYN="N">Septic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Speckle tracking</Keyword><Keyword MajorTopicYN="N">Systolic function</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>21</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38128732</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2023.101339</ArticleId><ArticleId IdType="pii">S2352-5568(23)00147-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37036186</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9098</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of surgical oncology</Title><ISOAbbreviation>J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>A prospective study evaluating perioperative quality metrics of cancer surgery: Experience from a tertiary care cancer centre in India.</ArticleTitle><Pagination><StartPage>385</StartPage><EndPage>392</EndPage><MedlinePgn>385-392</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jso.27278</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Well-defined quality metrics were studied at this high-volume tertiary care academic oncology centre to evaluate surgical quality and outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective cohort of 691 patients undergoing major surgeries for all cancers was observed between 1 September 2018 and 30 August 2019 and predefined quality indicators in three categories: namely, optimal hospital resource utilisation, quality of surgery and perioperative outcomes were recorded during their admission period. Surgical procedures were divided into group I versus group II involving simple/moderate complexity versus high complexity procedures for analysis done using appropriate tests in STATA v14.0.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">There were 373 versus 318 patients in group I versus group II with a mean of 48 years of age and 459 (66.43%) being females. Mean BMI was 24.58&#x2009;kg/m<sup>2</sup> , haemoglobin 12.12&#x2009;g/dL and mean serum albumin of 4.25&#x2009;g (SD&#x2009;&#xb1;&#x2009;0.6). A total of 667(96.53%) patients had an Eastern Co-Operative Oncology Group performance score of 1 with 271 (39.22%) having comorbidities and 195 (28.22%) having tobacco/alcohol addictions. A total of 393 (56.87%) patients underwent prehabilitation. 83% of patients belonged to lower-middle socioeconomic status and 32% of patients had some prior surgical intervention. Neoadjuvant therapy was administered in 44.5% versus 37.42%, mean preoperative hospital stay was 3.65 versus 6.16 days whereas postoperative was 2.6 versus 6.09 days with total stay being 6.27 versus 12.21 days, mean surgical duration was 132 versus 268&#x2009;min with mean blood loss of 100 versus 245&#x2009;mL (group I vs. group II, respectively). Intraoperative events, namely, unexpected bleeding and hypotension occurred in 144 (20.84%) patients while packed red blood cells and/or fresh frozen plasma transfusion was required in 56 (8.1%) patients. 40% of patients needed intensive care unit care postoperatively with 45 (6.51%) patients having some event (hypotension, sepsis, acute kidney injury, etc.). A total of 29 (&lt;4%) patients had &#x2265;grade 3 surgical complications while &#x2265;grade 2 medical complications occurred in 6.43% versus 12.58% of patients (group I vs. group II). A total of 90 (13.02%) patients were readmitted, 15 (2.17%) re-explored and 5 (0.72%) patients died.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Optimal surgical outcomes in this study compared to international standards underpin the need for well-defined multidisciplinary perioperative pathways to be followed for each organ system and this framework can be adopted by other cancer centres in LMIC to achieve good surgical outcomes.</AbstractText><CopyrightInformation>&#xa9; 2023 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Prashant</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Army Hospital (Research and Referral), New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deo</LastName><ForeName>Suryanarayana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1955-8234</Identifier><AffiliationInfo><Affiliation>BRAIRCH, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ray</LastName><ForeName>Mukur Dipi</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>BRAIRCH, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sunil</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9942-3403</Identifier><AffiliationInfo><Affiliation>BRAIRCH, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Mahroof Ahmed</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>BRAIRCH, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatnagar</LastName><ForeName>Sushma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BRAIRCH, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Seema</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BRAIRCH, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Oncol</MedlineTA><NlmUniqueID>0222643</NlmUniqueID><ISSNLinking>0022-4790</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016913" MajorTopicYN="Y">Blood Component Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019985" MajorTopicYN="N">Benchmarking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063128" MajorTopicYN="N">Tertiary Healthcare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cancer surgery</Keyword><Keyword MajorTopicYN="N">low- and middle-income countries</Keyword><Keyword MajorTopicYN="N">perioperative outcomes</Keyword><Keyword MajorTopicYN="N">quality indicators</Keyword><Keyword MajorTopicYN="N">quality metrics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>10</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37036186</ArticleId><ArticleId IdType="doi">10.1002/jso.27278</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Peeters KCMJ, van de Velde CJH. Surgical quality assurance in breast, gastric and rectal cancer. J Surg Oncol. 2003;84(3):107-112.</Citation></Reference><Reference><Citation>Gagliardi AR, Fung Kee Fung M, Langer B, Stern H, Brown AD. Development of ovarian cancer surgery quality indicators using a modified Delphi approach. Gynecol Oncol. 2005;97:446-456.</Citation></Reference><Reference><Citation>Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44(3 suppl):166-203.</Citation></Reference><Reference><Citation>Auerbach AD, Maselli J, Carter J, Pekow PS, Lindenauer PK. The relationship between case-volume, care quality, and outcomes of complex cancer surgery. J Am Coll Surg. 2010;211(5):601-608.</Citation></Reference><Reference><Citation>Shellenberger TD. Quality indicators in head and neck operations: a comparison with published benchmarks. Arch Otolaryngol Head Neck Surg. 2011;137(11):1086-1093.</Citation></Reference><Reference><Citation>Leroy R, De Gendt C, Stordeur S, et al. Quality indicators for the management of head and neck squamous cell carcinoma (KCE short report 305Cs). KCE; 2019.</Citation></Reference><Reference><Citation>Liu RQ, Wiseman SM. Quality indicators for thyroid cancer surgery: current perspective. Expert Rev Anticancer Ther. 2016;16:919-928. doi:10.1080/14737140.2016.1222274</Citation></Reference><Reference><Citation>Bonte A-S, Luyckx A, Wyckmans L, Trinh XB, van Dam PA. Quality indicators for the management of endometrial, cervical and ovarian cancer. Eur J Surg Oncol. 2018;45:528-537. doi:10.1016/j.ejso.2018.10.051</Citation></Reference><Reference><Citation>Walters DM, McMurry TL, Isbell JM, Stukenborg GJ, Kozower BD. Understanding mortality as a quality indicator after esophagectomy. Ann Thorac Surg. 2014;98:506-511.</Citation></Reference><Reference><Citation>van der Kaaij RT, de Rooij MV, van Coevorden F, et al. Using Textbook Outcome as a Measure of Quality of Care in Oesophagogastric Cancer Surgery. Wiley Online Library. http://www.bjs.co.uk</Citation></Reference><Reference><Citation>Claassen YHM, van Sandick JW, Hartgrink HH, et al. Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial. Br J Surg. 2018;105:728-735.</Citation></Reference><Reference><Citation>Sunil BJ, Seshadri RA, Mahajan V, Ellusami HR. Postoperative morbidity and mortality following D2 gastrectomy-an audit of 456 cases. Indian J Surg Oncol. 2016;7(1):4-10.</Citation></Reference><Reference><Citation>McColl RJ, McGahan CE, Cai E, et al. Impact of hospital volume on quality indicators for rectal cancer surgery in British Columbia, Canada. Am J Surg, 213(2):388-394. doi:10.1016/j.amjsurg.2016.07.007</Citation></Reference><Reference><Citation>Vrijens F, Verleye L, De Gendt C, et al. Quality indicators for the management of lung cancer (KCE report 266Cs). KCE; 2016.</Citation></Reference><Reference><Citation>Kim ML, Matheson L, Garrard B, et al. Use of clinical quality indicators to improve lung cancer care in a regional/rural network of health services. Aust J Rural Health. 2019;27:183-187.</Citation></Reference><Reference><Citation>Numan RC, Berge MT, Burgers JA, et al. Pre- and postoperative care for stage I-III NSCLC: which quality of care indicators are evidence-based? Lung Cancer. 2016;101:120-128.</Citation></Reference><Reference><Citation>Howard JD Jr., Ising MS, Delisle ME, Martin II RCG. Hospital readmission after pancreaticoduodenectomy: a systematic review and meta-analysis. Am J Surg. 2019;217:156-162.</Citation></Reference><Reference><Citation>Mirkin KA, Hollenbeak CS, Wong J. Time to surgery: a misguided quality metric in early stage pancreatic cancer. J Gastrointest Surg. 2018;22:1365-1375. doi:10.1007/s11605-018-3730-0</Citation></Reference><Reference><Citation>Lucas DJ, Ejaz A, Bischof DA, Schneider EB, Pawlik TM. Variation in readmission by hospital after colorectal cancer surgery. JAMA Surg. 2014;149(12):1272-1277.</Citation></Reference><Reference><Citation>Dai W, Yang XJ, Zhuang X, et al. Reoperation for hemostasis within 24 hours can get a better short-term outcome when indicated after lung cancer surgery. J Thorac Dis. 2017;9(10):3677-3683.</Citation></Reference><Reference><Citation>Dixon E, Datta I, Sutherland FR, Vauthey JN. Blood loss in surgical oncology: neglected quality indicator? J Surg Oncol. 2009;99:508-512.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33461118</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Systolic dysfunction as evaluated by tissue Doppler imaging echocardiography and mortality in septic patients: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>256</StartPage><EndPage>264</EndPage><MedlinePgn>256-264</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2020.12.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(20)30820-0</ELocationID><Abstract><AbstractText Label="PURPOSE">Septic induced cardiomyopathy has a wide spectrum of presentation, being associated with systolic and/or diastolic dysfunction. There is currently no evidence of association between left ventricular (LV) systolic dysfunction and mortality in septic patients.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review and meta-analysis to investigate the association between systolic wave (s') obtained with Tissue Doppler Imaging (TDI) and mortality in septic patients. Secondary outcome was the association of LV ejection fraction with mortality.</AbstractText><AbstractText Label="RESULTS">In the primary analysis we included a total of 13 studies (1197 patients, mortality 39.9%); overall s' wave was not significantly different between survivors and non-survivors (Standardized Mean Difference 0.20, 95%Confidence-Interval&#xa0;-&#xa0;0.18, 0.59). This result was confirmed also in sub-groups analyses according to regional criteria of TDI sampling. A post-hoc analysis including only septic shock patients confirmed that s' wave was not associated with mortality. Several sensitivity analyses confirmed these results. We found no evidence of publication bias. The secondary analysis (11 studies, 1081 patients, mortality 36.7%) showed that LV ejection fraction was not associated with mortality (Mean Difference 0.98, 95% Confidence-Interval&#xa0;-&#xa0;1.79,3.75).</AbstractText><AbstractText Label="CONCLUSIONS">There is no association between mortality and LV systolic function as evaluated by TDI s' wave in septic patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Policlinico - San Marco University Hospital, Catania, Italy. Electronic address: filipposanfi@yahoo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Nepean Clinical School, University of Sydney, Kingswood, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franchi</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Neuroscience, Anesthesia and Intensive Care Unit, University of Siena, Via Bracci 1, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Policlinico - San Marco University Hospital, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieillard-Baron</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Intensive Care Medicine Unit, Assistance Publique-H&#xf4;pitaux de Paris, University Hospital Ambroise, Boulogne-Billancourt, INSERM UMR-1018, CESP, Team Kidney and Heart, University of Versailles Saint-Quentin en Yvelines, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astuto</LastName><ForeName>Marinella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Policlinico - San Marco University Hospital, Catania, Italy; Department of General Surgery and Medical-Surgical Specialties, Section of Anesthesia and Intensive Care, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015150" MajorTopicYN="N">Echocardiography, Doppler</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="Y">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Severe sepsis</Keyword><Keyword MajorTopicYN="N">Systolic dysfunction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>18</Day><Hour>20</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33461118</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2020.12.026</ArticleId><ArticleId IdType="pii">S0883-9441(20)30820-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33075298</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.</ArticleTitle><Pagination><StartPage>1233</StartPage><EndPage>1244</EndPage><MedlinePgn>1233-1244</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(20)30404-5</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(20)30404-5</ELocationID><Abstract><AbstractText>The description of a so-called cytokine storm in patients with COVID-19 has prompted consideration of anti-cytokine therapies, particularly interleukin-6 antagonists. However, direct systematic comparisons of COVID-19 with other critical illnesses associated with elevated cytokine concentrations have not been reported. In this Rapid Review, we report the results of a systematic review and meta-analysis of COVID-19 studies published or posted as preprints between Nov 1, 2019, and April 14, 2020, in which interleukin-6 concentrations in patients with severe or critical disease were recorded. 25 COVID-19 studies (n=1245 patients) were ultimately included. Comparator groups included four trials each in sepsis (n=5320), cytokine release syndrome (n=72), and acute respiratory distress syndrome unrelated to COVID-19 (n=2767). In patients with severe or critical COVID-19, the pooled mean serum interleukin-6 concentration was 36&#xb7;7 pg/mL (95% CI 21&#xb7;6-62&#xb7;3 pg/mL; I<sup>2</sup>=57&#xb7;7%). Mean interleukin-6 concentrations were nearly 100 times higher in patients with cytokine release syndrome (3110&#xb7;5 pg/mL, 632&#xb7;3-15&#x2008;302&#xb7;9 pg/mL; p&lt;0&#xb7;0001), 27 times higher in patients with sepsis (983&#xb7;6 pg/mL, 550&#xb7;1-1758&#xb7;4 pg/mL; p&lt;0&#xb7;0001), and 12 times higher in patients with acute respiratory distress syndrome unrelated to COVID-19 (460 pg/mL, 216&#xb7;3-978&#xb7;7 pg/mL; p&lt;0&#xb7;0001). Our findings question the role of a cytokine storm in COVID-19-induced organ dysfunction. Many questions remain about the immune features of COVID-19 and the potential role of anti-cytokine and immune-modulating treatments in patients with the disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leisman</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Feinstein Institute for Medical Research, Manhasset, NY, USA. Electronic address: dleisman@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronner</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinotti</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Levy Library, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Feinstein Institute for Medical Research, Manhasset, NY, USA; Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA; Zucker School of Medicine at Hofstra-Northwell, Hempstead, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Pratik</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco School of Medicine, San Francisco, CA, USA; Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calfee</LastName><ForeName>Carolyn S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco School of Medicine, San Francisco, CA, USA; Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, USA; Cardiovascular Research Institute, University of California, San Francisco School of Medicine, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirayama</LastName><ForeName>Alexandre V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Clinical Research Division and Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastroiani</LastName><ForeName>Fiore</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Northwell Health, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turtle</LastName><ForeName>Cameron J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Clinical Research Division and Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harhay</LastName><ForeName>Michael O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics and Palliative and Advanced Illness Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco School of Medicine, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deutschman</LastName><ForeName>Clifford S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Feinstein Institute for Medical Research, Manhasset, NY, USA; Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA; Zucker School of Medicine at Hofstra-Northwell, Hempstead, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 HL141678</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM121102</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008440</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 GM132794</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL140026</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2021 Feb;9(2):e14-e15. doi: 10.1016/S2213-2600(20)30603-2.</RefSource><PMID Version="1">33460572</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>19</Day><Hour>20</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33075298</ArticleId><ArticleId IdType="pmc">PMC7567529</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(20)30404-5</ArticleId><ArticleId IdType="pii">S2213-2600(20)30404-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cummings MJ, Baldwin MR, Abrams D. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763&#x2013;1770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237188</ArticleId><ArticleId IdType="pubmed">32442528</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Liu L, Zhang D. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395:1517&#x2013;1520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164875</ArticleId><ArticleId IdType="pubmed">32311318</ArticleId></ArticleIdList></Reference><Reference><Citation>England JT, Abdulla A, Biggs CM. Weathering the COVID-19 storm: lessons from hematologic cytokine syndromes. Blood Rev. 2020 doi: 10.1016/j.blre.2020.100707. published online May 15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100707</ArticleId><ArticleId IdType="pmc">PMC7227559</ArticleId><ArticleId IdType="pubmed">32425294</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368:473&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance. https://apps.who.int/iris/handle/10665/331446</Citation></Reference><Reference><Citation>National Health Commission of China  Diagnosis and treatment protocol for novel coronavirus pneumonia. https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diagnosis.and.Treatment.of.COVID-19.V7.pdf</Citation></Reference><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526&#x2013;2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Delucchi KL, Thompson BT, McAuley DF, Matthay MA, Calfee CS. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 2018;44:1859&#x2013;1869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6317524</ArticleId><ArticleId IdType="pubmed">30291376</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Delucchi KL, McAuley DF, O'Kane CM, Matthay MA, Calfee CS. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. Lancet Respir Med. 2020;8:247&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543720</ArticleId><ArticleId IdType="pubmed">31948926</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Kennedy JN, Wang S. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321:2003&#x2013;2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537818</ArticleId><ArticleId IdType="pubmed">31104070</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelapu SS, Locke FL, Bartlett NL. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell lymphoma. N Engl J Med. 2017;377:2531&#x2013;2544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5882485</ArticleId><ArticleId IdType="pubmed">29226797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay KA, Hanafi LA, Li D. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood. 2017;130:2295&#x2013;2306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5701525</ArticleId><ArticleId IdType="pubmed">28924019</ArticleId></ArticleIdList></Reference><Reference><Citation>Maude SL, Frey N, Shaw PA. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371:1507&#x2013;1517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4267531</ArticleId><ArticleId IdType="pubmed">25317870</ArticleId></ArticleIdList></Reference><Reference><Citation>Maude SL, Laetsch TW, Buechner J. Tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia. N Engl J Med. 2018;378:439&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5996391</ArticleId><ArticleId IdType="pubmed">29385370</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Antony J, Zarin W. A scoping review of rapid review methods. BMC Med. 2015;13:224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4574114</ArticleId><ArticleId IdType="pubmed">26377409</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman DE, Harhay MO, Lederer DJ. Development and reporting of prediction models: guidance for authors from editors of respiratory, sleep, and critical care journals. Crit Care Med. 2020;48:623&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161722</ArticleId><ArticleId IdType="pubmed">32141923</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederer DJ, Bell SC, Branson RD. Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc. 2019;16:22&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">30230362</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JT, Chandler JJ, Cumpston M, Li T, Page M, Welch V. 2nd edn. John Wiley &amp; Sons; Chichester: 2019. Cochrane handbook for systematic reviews of interventions.</Citation></Reference><Reference><Citation>Harrell FE. 1st edn. Springer-Verlag; New York, NY: 2001. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis.</Citation></Reference><Reference><Citation>Qin C, Zhou L, Hu Z. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71:762&#x2013;786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620&#x2013;2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Zhou X, Zhu C. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Front Mol Biosci. 2020;7:157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7350507</ArticleId><ArticleId IdType="pubmed">32719810</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q, Huang D, Ou P. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020;75:1742&#x2013;1752.</Citation><ArticleIdList><ArticleId IdType="pubmed">32239761</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Tan Y. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) Front Immunol. 2020;11:827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Li T, Han M. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92:791&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228247</ArticleId><ArticleId IdType="pubmed">32181911</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical Features of 69 Cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71:769&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184452</ArticleId><ArticleId IdType="pubmed">32176772</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Shen C, Li J. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 2020;146:119. 27.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7189843</ArticleId><ArticleId IdType="pubmed">32360286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Fan H, Zhang L. Retrospective Analysis of clinical features in 101 death cases with COVID-19. medRxiv. 2020 doi: 10.1101/2020.03.09.20033068. published online March 17. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.09.20033068</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Zhao B, Qu Y. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa449. published online April 17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa449</ArticleId><ArticleId IdType="pmc">PMC7184354</ArticleId><ArticleId IdType="pubmed">32301997</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu S, Fu X, Song Y. Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China. medRxiv. 2020 doi: 10.1101/2020.04.03.20051763. published online April 6. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.03.20051763</ArticleId></ArticleIdList></Reference><Reference><Citation>Gritti G, Raimondi F, Ripamonti D. Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support. medRxiv. 2020 doi: 10.1101/2020.04.01.20048561. published online April 3. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.01.20048561</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold T, Jurinovic V, Arnreich C. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146:128. 36.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233239</ArticleId><ArticleId IdType="pubmed">32425269</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Yang R, Xu Y, Gong P. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv. 2020 doi: 10.1101/2020.02.27.20029009. published online March 5. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.27.20029009</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li S, Liu J. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7165294</ArticleId><ArticleId IdType="pubmed">32361250</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zhang J, Yang Y. The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. EMBO Mol Med. 2020;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280589</ArticleId><ArticleId IdType="pubmed">32428990</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Tan M, Chen X. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology. 2020;160:261&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283723</ArticleId><ArticleId IdType="pubmed">32460357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S, Yi Q, Fan S. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) medRxiv. 2020 doi: 10.1101/2020.02.10.20021832. published online Feb 12. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.10.20021832</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Li Y-r, Zeng Q. Clinical characteristics of SARS-CoV-2 pneumonia compared to controls in Chinese Han population. medRxiv. 2020 doi: 10.1101/2020.03.08.20031658. published online March 10. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.08.20031658</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Zhou X, Qiu Y. Clinical characteristics of 82 death cases with COVID-19. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347130</ArticleId><ArticleId IdType="pubmed">32645044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang X, Fuz Z. Potential factors for prediction of disease severity of COVID-19 patients. medRxiv. 2020 doi: 10.1101/2020.03.20.20039818. published online March 23. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.20.20039818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Matthay MA, Calfee CS. Is a &#x201c;cytokine storm&#x201d; relevant to COVID-19? JAMA Intern Med. 2020 https://doi.10.1001/jamainternmed.2020.3313 published online June 30.</Citation><ArticleIdList><ArticleId IdType="pubmed">32602883</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383:590&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, Wang Q, Zhang D. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100419</ArticleId><ArticleId IdType="pubmed">32296069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Xu W, Hu G. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020;17:894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7348563</ArticleId><ArticleId IdType="pubmed">32651469</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020;46:1105&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186535</ArticleId><ArticleId IdType="pubmed">32347323</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR. Dexamethasone in hospitalized patients with Covid-19&#x2014;preliminary report. N Engl J Med. 2020 https://doi.org.10.1056/NEJMoa2021436 published online July 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay MA, Zemans RL, Zimmerman GA. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6709677</ArticleId><ArticleId IdType="pubmed">30872586</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee CS, Janz DR, Bernard GR. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest. 2015;147:1539&#x2013;1548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4451708</ArticleId><ArticleId IdType="pubmed">26033126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaller T, Hirschb&#xfc;hl K, Burkhardt K. Postmortem examination of patients with COVID-19. JAMA. 2020;323</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243161</ArticleId><ArticleId IdType="pubmed">32437497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Calfee CS, Cherian S. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study. Lancet Respir Med. 2020 doi: 10.1016/S2213-2600(20)30366-0. published online Aug 27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30366-0</ArticleId><ArticleId IdType="pmc">PMC7718296</ArticleId><ArticleId IdType="pubmed">32861275</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4077177</ArticleId><ArticleId IdType="pubmed">24232462</ArticleId></ArticleIdList></Reference><Reference><Citation>Remy KE, Mazer M, Striker DA. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7526441</ArticleId><ArticleId IdType="pubmed">32687484</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay KA, Hanafi LA, Li D. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood. 2017;130:2295&#x2013;2306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5701525</ArticleId><ArticleId IdType="pubmed">28924019</ArticleId></ArticleIdList></Reference><Reference><Citation>Brudno JN, Kochenderfer JN. Toxicities of chimeric antigen receptor T cells: recognition and management. Blood. 2016;127:3321&#x2013;3330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4929924</ArticleId><ArticleId IdType="pubmed">27207799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DW, Gardner R, Porter DL. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4093680</ArticleId><ArticleId IdType="pubmed">24876563</ArticleId></ArticleIdList></Reference><Reference><Citation>Teachey DT, Lacey SF, Shaw PA. Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor t-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 2016;6:664&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5448406</ArticleId><ArticleId IdType="pubmed">27076371</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Rivi&#xe8;re I, Gonen M. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med. 2018;378:449&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6637939</ArticleId><ArticleId IdType="pubmed">29385376</ArticleId></ArticleIdList></Reference><Reference><Citation>Giavridis T, van der Stegen SJC, Eyquem J, Hamieh M, Piersigilli A, Sadelain M. CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat Med. 2018;24:731&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6410714</ArticleId><ArticleId IdType="pubmed">29808005</ArticleId></ArticleIdList></Reference><Reference><Citation>Norelli M, Camisa B, Barbiera G. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat Med. 2018;24:739&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">29808007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Casals M, Brito-Zer&#xf3;n P, L&#xf3;pez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383:1503&#x2013;1516.</Citation><ArticleIdList><ArticleId IdType="pubmed">24290661</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, Nilsson-Payant BE, Liu WC. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036. 45.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2:e437&#x2013;e445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252093</ArticleId><ArticleId IdType="pubmed">32835247</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhimraj A, Morgan RL, Shumaker AH. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa478. published online April 27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa478</ArticleId><ArticleId IdType="pmc">PMC7197612</ArticleId><ArticleId IdType="pubmed">32338708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008;112:3959&#x2013;3964.</Citation><ArticleIdList><ArticleId IdType="pubmed">18784373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Teachey DT, Pequignot E. Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy. J Immunol Methods. 2016;434:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490247</ArticleId><ArticleId IdType="pubmed">27049586</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39095375</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>02</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Risk factors for acute kidney injury in preterm neonates after noncardiac surgery: a single-center retrospective cohort study.</ArticleTitle><Pagination><StartPage>17965</StartPage><MedlinePgn>17965</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17965</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-67782-4</ELocationID><Abstract><AbstractText>Postoperative acute kidney injury (AKI) is a common complication that is associated with chronic kidney disease, early postsurgical mortality, and prolonged hospital stays. Preterm neonates who undergo surgery are at risk factors for AKI due to underdeveloped kidneys. To date, little is known about the incidence and perioperative risk factors for AKI in preterm neonates undergoing noncardiac surgery. Preterm neonates who underwent noncardiac surgery between January May 1, 2020, and February 28, 2023, were enrolled in the trial according to the inclusion criteria. Both multivariable and logistic regression analyses were used to analyze the associations between characteristic data and AKI. In total, 106 preterm neonates met the inclusion criteria, and 25 preterm neonates (23.6%) developed postoperative AKI. Multivariate analysis revealed that the factors associated with AKI were gestational age&#x2009;&lt;&#x2009;32&#xa0;weeks [OR: 4.88; 95% CI (1.23-19.42)], preoperative sepsis [OR: 3.98; 95% CI (1.29-12.28)], and intraoperative hypotension [OR: 3.75; 95% CI (1.26-11.15)]. Preterm neonates who developed AKI were more likely to have longer hospital length of stays (38 [18,69] days vs. 21[12,46]) and higher medical costs (93,181.6 [620450.0,173,219.0] &#xffe5; vs. 58,134.6 [31015.1,97,224,1) &#xffe5; than neonates who did not develop AKI. Preterm neonates who underwent noncardiac surgery had a high incidence of AKI. Independent risk factors for AKI in preterm neonates who underwent noncardiac surgery were low gestational age, preoperative sepsis, and intraoperative hypotension. Preterm neonates who developed AKI were more likely to have longer hospital stays and higher medical costs.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Su-Jing</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fang</LastName><ForeName>Tuan-Fang</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Min-Yi</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Nan-Nan</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gu</LastName><ForeName>Hong-Bin</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dan</LastName><ForeName>Ying-Zhi</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lu</LastName><ForeName>Guo-Lin</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China. guolinlu2020@fjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021Y9172</GrantID><Agency>Joint Funds for the Innovation of science and Technology, Fujian province</Agency><Country/></Grant><Grant><GrantID>2022J011067</GrantID><Agency>the Natural Science Foundation of Fujian Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="Y">Infant, Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Noncardiac surgery</Keyword><Keyword MajorTopicYN="N">Preterm neonate</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>3</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>3</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39095375</ArticleId><ArticleId IdType="pmc">PMC11297254</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-67782-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-67782-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Srinivasan, N., Schwartz, A., John, E., Price, R. &amp; Amin, S. Acute kidney injury impairs postnatal renal adaptation and increases morbidity and mortality in very low-birth-weight infants. Am. J. Perinatol.35(1), 39&#x2013;47 (2018). 10.1055/s-0037-1604470</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1604470</ArticleId><ArticleId IdType="pubmed">28768337</ArticleId></ArticleIdList></Reference><Reference><Citation>Akcan-Arikan, A. et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int.71(10), 1028&#x2013;1035 (2007). 10.1038/sj.ki.5002231</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002231</ArticleId><ArticleId IdType="pubmed">17396113</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalaby, M. A. et al. Incidence, risk factors, and outcome of neonatal acute kidney injury: a prospective cohort study. Pediatr. Nephrol.33(9), 1617&#x2013;1624 (2018). 10.1007/s00467-018-3966-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-018-3966-7</ArticleId><ArticleId IdType="pubmed">29869723</ArticleId></ArticleIdList></Reference><Reference><Citation>Jetton, J. G. et al. Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc. Health1(3), 184&#x2013;194 (2017). 10.1016/S2352-4642(17)30069-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(17)30069-X</ArticleId><ArticleId IdType="pmc">PMC5933049</ArticleId><ArticleId IdType="pubmed">29732396</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y., Hua, X., Yang, G., Xiang, B. &amp; Jiang, X. Incidence, risk factors, and outcomes of acute kidney injury in neonates after surgical procedures. Pediatr. Nephrol.35(7), 1341&#x2013;1346 (2020). 10.1007/s00467-020-04532-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-020-04532-4</ArticleId><ArticleId IdType="pubmed">32232634</ArticleId></ArticleIdList></Reference><Reference><Citation>Englberger, L. et al. Clinical accuracy of RIFLE and acute kidney injury network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit. Care15(1), R16 (2011). 10.1186/cc9960</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9960</ArticleId><ArticleId IdType="pmc">PMC3222049</ArticleId><ArticleId IdType="pubmed">21232094</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman, C., Tambay Perez, A., Selewski, D. T. &amp; Steflik, H. J. Neonatal acute kidney injury. Front. Pediatr.10, 842544 (2022). 10.3389/fped.2022.842544</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.842544</ArticleId><ArticleId IdType="pmc">PMC9021424</ArticleId><ArticleId IdType="pubmed">35463895</ArticleId></ArticleIdList></Reference><Reference><Citation>Grocott, M. P. et al. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: A cochrane systematic review. Br. J. Anaesth.111(4), 535&#x2013;548 (2013). 10.1093/bja/aet155</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet155</ArticleId><ArticleId IdType="pubmed">23661403</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg, P. M. et al. Severe acute kidney injury in neonates with necrotizing enterocolitis: Risk factors and outcomes. Pediatr. Res.90(3), 642&#x2013;649 (2021). 10.1038/s41390-020-01320-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-020-01320-6</ArticleId><ArticleId IdType="pmc">PMC8277891</ArticleId><ArticleId IdType="pubmed">33446918</ArticleId></ArticleIdList></Reference><Reference><Citation>Blinder, J. J. et al. Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J. Thorac. Cardiovasc. Surg.143(2), 368&#x2013;374 (2012). 10.1016/j.jtcvs.2011.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2011.06.021</ArticleId><ArticleId IdType="pubmed">21798562</ArticleId></ArticleIdList></Reference><Reference><Citation>Jetton, J. G. &amp; Askenazi, D. J. Update on acute kidney injury in the neonate. Curr. Opin. Pediatr.24(2), 191&#x2013;196 (2012). 10.1097/MOP.0b013e32834f62d5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0b013e32834f62d5</ArticleId><ArticleId IdType="pmc">PMC5545784</ArticleId><ArticleId IdType="pubmed">22227783</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub, A. S., Connors, J., Carey, A., Blanco, V. &amp; Green, R. S. The spectrum of onset of acute kidney injury in premature infants less than 30 weeks gestation. J. Perinatol.36(6), 474&#x2013;480 (2016). 10.1038/jp.2015.217</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jp.2015.217</ArticleId><ArticleId IdType="pubmed">26796125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingert, T. et al. Acute kidney injury and outcomes in children undergoing noncardiac surgery: A propensity-matched analysis. Anesth. Analg.132(2), 332&#x2013;340 (2021). 10.1213/ANE.0000000000005069</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005069</ArticleId><ArticleId IdType="pmc">PMC7855789</ArticleId><ArticleId IdType="pubmed">32739953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojanovi&#x107;, V., Bari&#x161;i&#x107;, N., Milanovi&#x107;, B. &amp; Doronjski, A. Acute kidney injury in preterm infants admitted to a neonatal intensive care unit. Pediatr. Nephrol.29(11), 2213&#x2013;2220 (2014). 10.1007/s00467-014-2837-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-014-2837-0</ArticleId><ArticleId IdType="pubmed">24839217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanaugh, K. J., Jetton, J. G. &amp; Kent, A. L. Neonatal acute kidney injury: Understanding of the impact on the smallest patients. Crit. Care Clin.37(2), 349&#x2013;363 (2021). 10.1016/j.ccc.2020.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2020.11.007</ArticleId><ArticleId IdType="pubmed">33752860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, C. C. et al. Incidence and outcomes of acute kidney injury in extremely-low-birth-weight infants. PLoS One12(11), e0187764 (2017). 10.1371/journal.pone.0187764</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0187764</ArticleId><ArticleId IdType="pmc">PMC5673227</ArticleId><ArticleId IdType="pubmed">29108006</ArticleId></ArticleIdList></Reference><Reference><Citation>Blatt, N. B., Srinivasan, S., Mottes, T., Shanley, M. M. &amp; Shanley, T. P. Biology of sepsis: its relevance to pediatric nephrology. Pediatr. Nephrol.29(12), 2273&#x2013;2287 (2014). 10.1007/s00467-013-2677-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-013-2677-3</ArticleId><ArticleId IdType="pmc">PMC4092055</ArticleId><ArticleId IdType="pubmed">24408224</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent, K., Murphy, H. J., Ross, J. R. &amp; Twombley, K. E. Acute kidney injury guidelines are associated with improved recognition and follow-up for neonatal patients. Adv. Neonatal. Care20(4), 269&#x2013;275 (2020). 10.1097/ANC.0000000000000664</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANC.0000000000000664</ArticleId><ArticleId IdType="pubmed">31567184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojo, B. &amp; Campbell, C. H. Perioperative acute kidney injury: Impact and recent update. Curr. Opin. Anaesthesiol.35(2), 215&#x2013;223 (2022). 10.1097/ACO.0000000000001104</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000001104</ArticleId><ArticleId IdType="pubmed">35102042</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi, Y. &amp; Yamaoka, K. Analysis of intraoperative modifiable factors to prevent acute kidney injury after elective noncardiac surgery: Intraoperative hypotension and crystalloid administration related to acute kidney injury. JA Clin. Rep.7(1), 27 (2021). 10.1186/s40981-021-00429-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40981-021-00429-9</ArticleId><ArticleId IdType="pmc">PMC7991025</ArticleId><ArticleId IdType="pubmed">33761037</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi, V. et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: A retrospective cohort analysis. Anesthesiology126(1), 47&#x2013;65 (2017). 10.1097/ALN.0000000000001432</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001432</ArticleId><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmody, J. B., Swanson, J. R., Rhone, E. T. &amp; Charlton, J. R. Recognition and reporting of AKI in very low birth weight infants. Clin. J. Am. Soc. Nephrol.9(12), 2036&#x2013;2043 (2014). 10.2215/CJN.05190514</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05190514</ArticleId><ArticleId IdType="pmc">PMC4255405</ArticleId><ArticleId IdType="pubmed">25280497</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19219439</PMID><DateCompleted><Year>2009</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1262</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>5</Issue><PubDate><Year>2009</Year><Month>May</Month></PubDate></JournalIssue><Title>International journal of colorectal disease</Title><ISOAbbreviation>Int J Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>Loop ileostomy versus loop colostomy for fecal diversion after colorectal or coloanal anastomosis: a meta-analysis.</ArticleTitle><Pagination><StartPage>479</StartPage><EndPage>488</EndPage><MedlinePgn>479-88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00384-009-0662-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sphincter-saving surgery for the treatment of middle and low rectal cancer has spread considerably when total mesorectal excision became standard treatment. In order to reduce leakage-related complications, surgeons often perform a derivative stoma, a loop ileostomy (LI), or a loop colostomy (LC), but to date, there is no evidence on which is the better technique to adopt.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic review and meta-analysis of all randomized controlled trials until 2007 and observational studies comparing temporary LI and LC for temporary decompression of colorectal and/or coloanal anastomoses. Clinically relevant events were grouped into four study outcomes: general outcome measures: dehydratation and wound infection GOM construction of the stoma outcome measures: parastomal hernia, stenosis, sepsis, prolapse, retraction, necrosis, and hemorrhage closure of the stoma outcome measures: anastomotic leak or fistula, wound infection COM, occlusion and hernia functioning of the stoma outcome measures: occlusion and skin irritation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twelve comparative studies were included in this analysis, five randomized controlled trials and seven observational studies. Overall, the included studies reported on 1,529 patients, 894 (58.5%) undergoing defunctioning LI. LI reduced the risk of construction of the stoma outcome measure (odds ratio, OR = 0.47). Specifically, patients undergoing LI had a lower risk of prolapse (OR = 0.21) and sepsis (OR = 0.54). LI was associated with an excess risk of occlusion after stoma closure (OR = 2.13) and dehydratation (OR = 4.61). No other significant difference was found for outcomes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our overview shows that LI is associated with a lower risk of construction of the stoma outcome measures.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rondelli</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General and Oncologic Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reboldi</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Rulli</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Barberini</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Guerrisi</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Izzo</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Bolognese</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Covarelli</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Boselli</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Becattini</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Noya</LastName><ForeName>G</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int J Colorectal Dis</MedlineTA><NlmUniqueID>8607899</NlmUniqueID><ISSNLinking>0179-1958</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001003" MajorTopicYN="N">Anal Canal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="Y">Anastomosis, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003125" MajorTopicYN="Y">Colostomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="Y">Feces</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007081" MajorTopicYN="Y">Ileostomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012007" MajorTopicYN="N">Rectum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>35</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>2</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>2</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>5</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19219439</ArticleId><ArticleId IdType="doi">10.1007/s00384-009-0662-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stat Med. 2002 Jun 15;21(11):1539-58</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann R Coll Surg Engl. 1987 Jan;69(1):5-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3566123</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2002 Jun;89(6):704-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12027979</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1997 Sep 13;315(7109):629-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>G Chir. 2002 Jan-Feb;23(1-2):48-52</Citation><ArticleIdList><ArticleId IdType="pubmed">12043472</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1995 Sep 16;311(7007):753-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7549720</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1998 Jan;85(1):76-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9462389</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1986 Jul;73(7):566-70</Citation><ArticleIdList><ArticleId IdType="pubmed">3524742</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Chir Scand. 1987 Mar;153(3):229-32</Citation><ArticleIdList><ArticleId IdType="pubmed">3604525</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Chir Belg. 2006 Jan-Feb;106(1):40-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16612911</ArticleId></ArticleIdList></Reference><Reference><Citation>J Enterostomal Ther. 1983 May-Jun;10(3):92-4</Citation><ArticleIdList><ArticleId IdType="pubmed">6554284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2005 Jun 21;142(12 Pt 2):1112-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15968036</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2005 Sep;92(9):1150-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16035134</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2003 Oct;90(10):1261-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14515297</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2007 May;31(5):1142-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17354030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1986 Jun 28;1(8496):1479-82</Citation><ArticleIdList><ArticleId IdType="pubmed">2425199</ArticleId></ArticleIdList></Reference><Reference><Citation>Asian J Surg. 2004 Jul;27(3):202-10; discussion 211-2</Citation><ArticleIdList><ArticleId IdType="pubmed">15564161</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2002 Sep;45(9):1164-71</Citation><ArticleIdList><ArticleId IdType="pubmed">12352230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2004 Feb;77(2):745-53</Citation><ArticleIdList><ArticleId IdType="pubmed">14759484</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2001 Mar;25(3):274-7; discussion 277-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11343175</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Chir. 2001 Feb;126(1):18-25</Citation><ArticleIdList><ArticleId IdType="pubmed">11255967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2007 Aug;246(2):207-14</Citation><ArticleIdList><ArticleId IdType="pubmed">17667498</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1998 Aug;85(8):1114-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9718009</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2005 Sep;92(9):1137-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15997447</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2001 Mar;136(3):338-42</Citation><ArticleIdList><ArticleId IdType="pubmed">11231858</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2000 Apr 19;283(15):2008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2004 Aug;240(2):255-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15273549</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirurg. 1988 Dec;59(12):842-4</Citation><ArticleIdList><ArticleId IdType="pubmed">3234094</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Chir Scand. 1980;146(3):203-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7468042</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2005 Feb;48(2):243-50</Citation><ArticleIdList><ArticleId IdType="pubmed">15714246</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Chir Iugosl. 2001;48(3):39-42</Citation><ArticleIdList><ArticleId IdType="pubmed">11889985</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2005 Feb;92(2):211-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15584062</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2001 Mar;88(3):360-3</Citation><ArticleIdList><ArticleId IdType="pubmed">11260099</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004647</Citation><ArticleIdList><ArticleId IdType="pubmed">17253517</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25466837</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Mild induced hypothermia: effects on sepsis-related coagulopathy--results from a randomized controlled trial.</ArticleTitle><Pagination><StartPage>175</StartPage><EndPage>182</EndPage><MedlinePgn>175-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2014.10.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(14)00585-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Coagulopathy associates with poor outcome in sepsis. Mild induced hypothermia has been proposed as treatment in sepsis but it is not known whether this intervention worsens functional coagulopathy.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Interim analysis data from an ongoing randomized controlled trial; The Cooling And Surviving Septic shock (CASS) study. Patients suffering severe sepsis/septic shock are allocated to either mild induced hypothermia (cooling to 32-34&#xb0;C for 24hours) or control (uncontrolled temperature).</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">NCT01455116. Thrombelastography (TEG) is performed three times during the first day after study enrollment in all patients. Reaction time (R), maximum amplitude (MA) and patients' characteristics are here reported.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred patients (control n=50 and intervention n=50; male n=59; median age 68years) with complete TEG during follow-up were included. At enrollment, 3%, 38%, and 59% had a hypocoagulable, normocoagulable, and hypercoagulable TEG clot strength (MA), respectively. In the hypothermia group, functional coagulopathy improved during the hypothermia phase, measured by R and MA, in patients with hypercoagulation as well as in patients with hypocoagulation (correlation between &#x394;R and initial R: rho=-0.60, p&lt;0.0001 and correlation between &#x394;MA and initial MA: rho=-0.50, p=0.0002). Similar results were not observed in the control group neither for R (rho=-0.03, p=0.8247) nor MA (rho=-0.15, p=0.3115).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Mild induced hypothermia did seem to improve functional coagulopathy in septic patients. This improvement of functional coagulopathy parameters during the hypothermia intervention persisted after rewarming. Randomized trials are warranted to determine whether the positive effect on sepsis-related coagulopathy can be transformed to improved survival.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johansen</LastName><ForeName>Maria E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark. Electronic address: Maria.Egede.Johansen@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Jens-Ulrik</ForeName><Initials>JU</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bestle</LastName><ForeName>Morten H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Nordsjaellands hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrowski</LastName><ForeName>Sisse R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thormar</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Bispebjerg Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Henrik Planck</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital Roskilde, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poulsen</LastName><ForeName>Lone</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital Gentofte, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kj&#xe6;r</LastName><ForeName>Jesper</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzi-Lepri</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark; Department of Virology, Royal Free and University College Medical School London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neurointensive Care Unit 2093, Department of Neuroanaesthesiology, University Hospital Rigshospitalet, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xf8;nnesen</LastName><ForeName>Else</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Aarhus University Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lundgren</LastName><ForeName>Jens D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>P&#xe4;r I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, Denmark; Department of Surgery, University of Texas Medical School at Houston, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01455116</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001778" MajorTopicYN="N">Blood Coagulation Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004548" MajorTopicYN="N">Elasticity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="Y">Hypothermia, Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013916" MajorTopicYN="N">Thrombelastography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="N">Thrombophilia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014783" MajorTopicYN="N">Viscosity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coagulopathy</Keyword><Keyword MajorTopicYN="N">Mild induced hypothermia</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Thrombelastography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25466837</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2014.10.028</ArticleId><ArticleId IdType="pii">S0049-3848(14)00585-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33935160</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Extracorporeal Cytokine Adsorption Therapy As a Preventive Measure in Cardiac Surgery and As a Therapeutic Add-On Treatment in Sepsis: An Updated Systematic Review of Comparative Efficacy and Safety.</ArticleTitle><Pagination><StartPage>1347</StartPage><EndPage>1357</EndPage><MedlinePgn>1347-1357</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000005023</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Evaluating whether there is a clinical benefit of using extracorporeal cytokine adsorption therapy in two indications.</AbstractText><AbstractText Label="DESIGN">Systematic review.</AbstractText><AbstractText Label="SETTING">Search on four databases, Medline, Embase, The Cochrane Library, and the European Network for Health Technology Assessment planned and ongoing projects database.</AbstractText><AbstractText Label="PATIENTS">Patients with sepsis/septic shock; patients undergoing cardiac surgery.</AbstractText><AbstractText Label="INTERVENTIONS">Cytokine adsorption.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Randomized controlled trials and prospective studies with concurrent control were eligible for the evidence synthesis. The quality of the individual studies and the strength of the available evidence were assessed using the Cochrane risk of bias tool and the Grading of Recommendations, Assessment, Development, and Evaluation approach, respectively. For the preventive treatment of extracorporeal cytokine adsorption therapy in patients undergoing cardiac surgery, we found very low-quality inconclusive evidence for mortality (five randomized controlled trials, n = 163), length of stay in the ICU (five randomized controlled trials, n = 163), and length of hospitalization (three randomized controlled trials, n = 101). Very low-quality inconclusive evidence was found for (serious) adverse events (four randomized controlled trials, n = 148). For the therapeutic treatment of extracorporeal cytokine adsorption therapy in patients with sepsis/septic shock, we found very low-quality inconclusive evidence for mortality up to 60-day follow-up (two randomized controlled trials, n = 117), organ function (two randomized controlled trials, n = 117) and length of stay in the ICU (one randomized controlled trial, n = 20). Very low-quality inconclusive evidence was found for (serious) adverse events (two randomized controlled trials, n = 117).</AbstractText><AbstractText Label="CONCLUSIONS">Given the available evidence, the efficacy and safety of extracorporeal cytokine adsorption therapy in combination with standard care in the investigated indications was not established. We strongly recommend considering well-powered studies with patient-relevant endpoints instead of investing further research funds on studies that may not shed light on the clinical benefit of extracorporeal cytokine adsorption therapy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goetz</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>HTA Austria-Austrian Institute for Health Technology Assessment GmbH (Former: Ludwig Boltzmann Institute for HTA), Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawlik</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Klinik Favoriten, Wiener Gesundheitsverbund, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>HTA Austria-Austrian Institute for Health Technology Assessment GmbH (Former: Ludwig Boltzmann Institute for HTA), Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2021 Aug 1;49(8):1372-1374. doi: 10.1097/CCM.0000000000005046.</RefSource><PMID Version="1">34261932</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33935160</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000005023</ArticleId><ArticleId IdType="pii">00003246-202108000-00012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Panagiotou A, Gaiao S, Cruz DN. Extracorporeal therapies in sepsis. J Intensive Care Med. 2013; 28:281&#x2013;295</Citation></Reference><Reference><Citation>Rimmel&#xe9; T, Kellum JA. Clinical review: Blood purification for sepsis. Crit Care. 2011; 15:205</Citation></Reference><Reference><Citation>Jaffer U, Wade RG, Gourlay T. Cytokines in the systemic inflammatory response syndrome: A review. HSR Proc Intensive Care Cardiovasc Anesth. 2010; 2:161&#x2013;175</Citation></Reference><Reference><Citation>Halter J, Steinberg J, Fink G, et al. Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass. J Extra Corpor Technol. 2005; 37:272&#x2013;277</Citation></Reference><Reference><Citation>Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993; 103:565&#x2013;575</Citation></Reference><Reference><Citation>CytoSorbents. CytoSorb&#xae; Therapy, Indications and Set-up. 2016. Available at: http://cytosorb-therapy.com/wp-content/uploads/2016/09/Kitteltaschen_Booklet_EN_07062016_final_low.pdf . Accessed March 6, 2017</Citation></Reference><Reference><Citation>Gr&#xf6;ssmann N, Wolf S, Rosian K, et al. Pre-reimbursement: Early assessment for coverage decisions. Wien Med Wochenschr. 2019; 169:254&#x2013;262</Citation></Reference><Reference><Citation>Mad P, Geiger-Gritsch S, Hinterreiter G, et al. Pre-coverage assessments of new hospital interventions on Austria: Methodology and 3 years of experience. Int J Technol Assess Health Care. 2012; 28:171&#x2013;179</Citation></Reference><Reference><Citation>Goetz G, Hawlik K. &gt;Extracorporeal Cytokine Haemadsorption Therapy in Patients with Sepsis or SIRS, Decision Support Document No. 106/Update 2020; 2020. Vienna: Ludwig Boltzmann Institute for Health Technology Assessment. Available at: https://eprints.aihta.at/1253/1/DSD_106_Update2020.pdf . Accessed April 6, 2021</Citation></Reference><Reference><Citation>Hawlik K, Wild C. Extracorporeal Cytokine Haemadsorption Therapy in Patients With Sepsis or SIRS, Decision Support Document No.106. Vienna, Austria: Ludwig Boltzmann Institute for Health Technology Assessment, 2017</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol. 2009; 62:e1&#x2013;e34</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg. 2010; 8:336&#x2013;341</Citation></Reference><Reference><Citation>EUnetHTA Methodology Guidelines 2015. Available at: https://www.eunethta.eu/methodology-guidelines/ . Accessed February 1, 2019</Citation></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011; 64:383&#x2013;394</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928</Citation></Reference><Reference><Citation>Bernardi MH, Rinoesl H, Dragosits K, et al. Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care. 2016; 20:96</Citation></Reference><Reference><Citation>Garau I, M&#xe4;rz A, Sehner S, et al. Hemadsorption during cardiopulmonary bypass reduces interleukin 8 and tumor necrosis factor &#x3b1; serum levels in cardiac surgery: A randomized controlled trial. Minerva Anestesiol. 2019; 85:715&#x2013;723</Citation></Reference><Reference><Citation>Gleason TG, Argenziano M, Bavaria JE, et al. Hemoadsorption to reduce plasma-free hemoglobin during cardiac surgery: Results of REFRESH I pilot study. Semin Thorac Cardiovasc Surg. 2019; 31:783&#x2013;793</Citation></Reference><Reference><Citation>Poli EC, Alberio L, Bauer-Doerries A, et al. Cytokine clearance with CytoSorb&#xae; during cardiac surgery: A pilot randomized controlled trial. Crit Care. 2019; 23:108</Citation></Reference><Reference><Citation>Wagner R, Soucek P, Ondrasek J, et al. Plasma levels of myocardial MicroRNA-133a increase by intraoperative cytokine hemoadsorption in the complex cardiovascular operation. J Clin Med Res. 2019; 11:789&#x2013;797</Citation></Reference><Reference><Citation>Sch&#xe4;dler D, Pausch C, Heise D, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS One. 2017; 12:e0187015</Citation></Reference><Reference><Citation>Hawchar F, L&#xe1;szl&#xf3; I, &#xd6;veges N, et al. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. J Crit Care. 2019; 49:172&#x2013;178</Citation></Reference><Reference><Citation>Ankawi G, Xie Y, Yang B, et al. What have we learned about the use of cytosorb adsorption columns? Blood Purif. 2019; 48:196&#x2013;202</Citation></Reference><Reference><Citation>Poli EC, Rimmel&#xe9; T, Schneider AG. Hemoadsorption with CytoSorb&#xae;. Intensive Care Med. 2019; 45:236&#x2013;239</Citation></Reference><Reference><Citation>Morris C, Gray L, Giovannelli M. Early report: The use of Cytosorb&#x2122; haemabsorption column as an adjunct in managing severe sepsis: Initial experiences, review and recommendations. J Intensive Care Soc. 2015; 16:257&#x2013;264</Citation></Reference><Reference><Citation>Brunkhorst FM, Weigand M, Pletz M, Gastmeier P, et al.: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF).S3-Leitlinie Sepsis &#x2013; Pr&#xe4;vention, Diagnose, Therapie und Nachsorge, 2018.</Citation></Reference><Reference><Citation>CytoSorbents: COVID-19 &amp; CytoSorb Therapy. 2020. Available at: https://cytosorb-therapy.com/en/covid-19/ . Accessed June 15, 2020</Citation></Reference><Reference><Citation>CytoSorbents: U.S. FDA Grants CytoSorb&#xae; Emergency Use Authorization for Use in Patients With COVID-19 Infection. 2020. Available at: https://cytosorbents.com/us-fda-authorize-cytosorb-for-use-covid-19/ . Accessed June 15, 2020</Citation></Reference><Reference><Citation>The dangers of the fast track. Nat Med. 2011; 17:389</Citation></Reference><Reference><Citation>Zhai MZ, Lye CT, Kesselheim AS. Need for transparency and reliable evidence in emergency use authorizations for coronavirus disease 2019 (COVID-19) therapies. JAMA Intern Med. 2020; 180:1145&#x2013;1146</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22172797</PMID><DateCompleted><Year>2012</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2012</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2012</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Incidence and risk factors for sepsis in surgical patients: a cohort study.</ArticleTitle><Pagination><StartPage>159</StartPage><EndPage>166</EndPage><MedlinePgn>159-66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2011.08.001</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of the study was to evaluate risk factors for infection and sepsis in surgical patients admitted to the intensive care unit (ICU).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Data were prospectively collected from a cohort of surgical patients from January 2005 to December 2007. We analyzed the incidence of infection and sepsis and certain other variables from the pre-, intra-, and postoperative periods as risk factors for infection and sepsis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We studied 625 surgical patients. The mortality rate was 18.2%, and the mean age of the subjects was 53.1 &#xb1; 18.8 years. The incidences of severe sepsis and septic shock were 5% and 11.5%, respectively. A multivariate analysis showed that the following variables were associated with sepsis in the postoperative period: urgent surgery (odds ratio, 2.63; 95% confidence interval [CI], 1.50-4.63), fluid resuscitation (odds ratio, 1.90; 95% CI, 1.18-3.05), vasoactive drugs (odds ratio, 2.58; 95% CI, 1.61-4.14), and mechanical ventilation (odds ratio, 5.51; 95% CI, 3.07-9.89). A Sequential Organ Failure Assessment was associated with infection or sepsis upon ICU admission (area under the curve, 0.737 &#xb1; 0.019; 95% CI, 0.748-0.825).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study showed that sepsis has high incidence and mortality in surgical patients admitted to the ICU. Urgent surgeries, mechanical ventilation, fluid resuscitation, and vasoactive drugs in the postoperative period and Sequential Organ Failure Assessment at ICU admission were risk factors for sepsis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elias</LastName><ForeName>Adriana Cristina Galbiati Parminondi</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>University Hospital of Londrina, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuo</LastName><ForeName>Tiemi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Grion</LastName><ForeName>Cintia Magalh&#xe3;es Carvalho</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Lucienne Tibery Queiroz</ForeName><Initials>LT</Initials></Author><Author ValidYN="Y"><LastName>Verri</LastName><ForeName>Paulo Henrique</ForeName><Initials>PH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22172797</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2011.08.001</ArticleId><ArticleId IdType="pii">S0883-9441(11)00377-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34582409</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Thiamine, Ascorbic Acid, and Hydrocortisone As a Metabolic Resuscitation Cocktail in Sepsis: A Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>2112</StartPage><EndPage>2120</EndPage><MedlinePgn>2112-2120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000005262</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Sepsis is a common condition in the ICU. Despite much research, its prognosis remains poor. In 2017, a retrospective before/after study reported promising results using a combination of thiamine, ascorbic acid, and hydrocortisone called "metabolic resuscitation cocktail" and several randomized controlled trials assessing its effectiveness were performed.</AbstractText><AbstractText Label="DESIGN">We conducted a systematic review and meta-analysis of randomized controlled trials in septic ICU patients to assess the effects of this combination therapy.</AbstractText><AbstractText Label="SETTING">PubMed, Embase, and the Cochrane library databases were searched from inception to March of 2021. Data were extracted independently by two authors. The main outcome was the change in Sequential Organ Failure Assessment score within 72 hours. Secondary outcomes included renal composite endpoints (acute kidney injury) Kidney Disease - Improving Global Outcome organization stage 3 or need for renal replacement therapy, vasopressor duration, and 28-day mortality.</AbstractText><AbstractText Label="SUBJECTS">We included randomized controlled trials with patients admitted to the ICU with sepsis or septic shock.</AbstractText><AbstractText Label="INTERVENTION">The trials compared a combination of thiamine, ascorbic acid, and hydrocortisone to standard care or placebo in patients admitted to ICU with sepsis or septic shock.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">We included eight randomized controlled trials (n = 1,335 patients). Within 72 hours, the median of mean improvement was -1.8 and -3.2 in the control and intervention groups, respectively (eight randomized controlled trials, n = 1,253 patients); weighted mean difference -0.82 (95% CI, -1.15 to -0.48). Data were homogeneous and the funnel plot did not suggest any publication bias. Duration of vasopressor requirement was significantly reduced in the intervention group (six randomized controlled trials). There was no evidence of a difference regarding the ICU mortality and the renal composite outcome (acute kidney injury KDIGO 3 or need for renal replacement therapy, seven randomized controlled trials).</AbstractText><AbstractText Label="CONCLUSIONS">Metabolic resuscitation cocktail administrated in ICU septic patients improves change in Sequential Organ Failure Assessment score within 72 hours. However, this improvement is modest and its clinical relevance is questionable. The impact on renal failure and mortality remains unclear.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Assouline</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, Department of Acute Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faivre</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology, Department of Medicine and Cell Physiology, University Hospital and University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service of Nephrology, Department of Internal Medicine Specialties, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verissimo</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology, Department of Medicine and Cell Physiology, University Hospital and University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sangla</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, Department of Acute Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berchtold</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Service of Nephrology, Department of Internal Medicine Specialties, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giraud</LastName><ForeName>Rapha&#xeb;l</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, Department of Acute Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendjelid</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, Department of Acute Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sgardello</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elia</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical Faculty, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anesthesiology, Department of Acute Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugin</LastName><ForeName>J&#xe9;r&#xf4;me</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, Department of Acute Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Seigneux</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, Department of Acute Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Nephrology, Department of Medicine and Cell Physiology, University Hospital and University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service of Nephrology, Department of Internal Medicine Specialties, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anesthesiology, Department of Acute Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legouis</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, Department of Acute Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Nephrology, Department of Medicine and Cell Physiology, University Hospital and University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical><Chemical><RegistryNumber>X66NSO3N35</RegistryNumber><NameOfSubstance UI="D013831">Thiamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2021 Dec 1;49(12):2154-2157. doi: 10.1097/CCM.0000000000005319.</RefSource><PMID Version="1">34793385</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008660" MajorTopicYN="N">Metabolism</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013831" MajorTopicYN="N">Thiamine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Dr. Legouis was supported by a young researcher grant from University Hospital of Geneva (PRD 20-2017-I). Drs. de Seigneux and Legouis were supported by a STARTER grant (RS03-25) from the HUG private foundation (the foundation of the Geneva University Hospitals and the University of Geneva&#x2019;s Faculty of Medicine). Dr. de Seigneux was supported by a SNF grant SNSF PP00P3-187186/1. Dr. Faivre is the recipient of a grant from the Swiss National Science Foundation (323530_191224). Dr. Elia disclosed that she is employed by the University Hospital of Geneva, Switzerland and that she is on the editorial board of the European Journal of Anesthesiology. The remaining authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>17</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34582409</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000005262</ArticleId><ArticleId IdType="pii">00003246-202112000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315:801&#x2013;810</Citation></Reference><Reference><Citation>Sakr Y, Jaschinski U, Wittebole X, et al.; ICON Investigators: Sepsis in intensive care unit patients: Worldwide data from the intensive care over nations audit. Open Forum Infect Dis. 2018; 5:ofy313</Citation></Reference><Reference><Citation>Vincent JL, Sakr Y, Sprung CL, et al.; Sepsis Occurrence in Acutely Ill Patients Investigators: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006; 34:344&#x2013;353</Citation></Reference><Reference><Citation>Fleischmann C, Scherag A, Adhikari NK, et al.; International Forum of Acute Care Trialists: Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016; 193:259&#x2013;272</Citation></Reference><Reference><Citation>Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015; 372:1629&#x2013;1638</Citation></Reference><Reference><Citation>Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med. 2007; 35:1244&#x2013;1250</Citation></Reference><Reference><Citation>Reinhart K, Daniels R, Kissoon N, et al. Recognizing sepsis as a global health priority - a WHO resolution. N Engl J Med. 2017; 377:414&#x2013;417</Citation></Reference><Reference><Citation>Hotchkiss RS, Moldawer LL, Opal SM, et al. Sepsis and septic shock. Nat Rev Dis Primers. 2016; 2:16045</Citation></Reference><Reference><Citation>Stevenson EK, Rubenstein AR, Radin GT, et al. Two decades of mortality trends among patients with severe sepsis: A comparative meta-analysis*. Crit Care Med. 2014; 42:625&#x2013;631</Citation></Reference><Reference><Citation>Luhr R, Cao Y, S&#xf6;derquist B, et al. Trends in sepsis mortality over time in randomised sepsis trials: A systematic literature review and meta-analysis of mortality in the control arm, 2002-2016. Crit Care. 2019; 23:241</Citation></Reference><Reference><Citation>Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study. Chest. 2017; 151:1229&#x2013;1238</Citation></Reference><Reference><Citation>Mohamed ZU, Prasannan P, Moni M, et al. Vitamin C Therapy for Routine Care in Septic Shock (ViCTOR) trial: Effect of intravenous vitamin C, thiamine, and hydrocortisone administration on inpatient mortality among patients with septic shock. Indian J Crit Care Med. 2020; 24:653&#x2013;661</Citation></Reference><Reference><Citation>Moskowitz A, Huang DT, Hou PC, et al.; ACTS Clinical Trial Investigators: Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: The ACTS randomized clinical trial. JAMA. 2020; 324:642&#x2013;650</Citation></Reference><Reference><Citation>Fujii T, Luethi N, Young PJ, et al.; VITAMINS Trial Investigators: Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: The VITAMINS randomized clinical trial. JAMA. 2020; 323:423&#x2013;431</Citation></Reference><Reference><Citation>Wani SJ, Mufti SA, Jan RA, et al. Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: Results from an open label randomised controlled clinical trial and a review of the literature. Infect Dis (Lond). 2020; 52:271&#x2013;278</Citation></Reference><Reference><Citation>Iglesias J, Vassallo AV, Patel VV, et al. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: The ORANGES trial. Chest. 2020; 158:164&#x2013;173</Citation></Reference><Reference><Citation>Chang P, Liao Y, Guan J, et al. Combined treatment with hydrocortisone, vitamin c, and thiamine for sepsis and septic shock: A randomized controlled trial. Chest. 2020; 158:174&#x2013;182</Citation></Reference><Reference><Citation>Sevransky JE, Rothman RE, Hager DN, et al.; VICTAS Investigators: Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: The VICTAS randomized clinical trial. JAMA. 2021; 325:742&#x2013;750</Citation></Reference><Reference><Citation>Reddy PR, Samavedam S, Aluru N, et al. Metabolic resuscitation using hydrocortisone, ascorbic acid, and thiamine: Do individual components influence reversal of shock independently? Indian J Crit Care Med. 2020; 24:649&#x2013;652</Citation></Reference><Reference><Citation>Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017; 43:1751&#x2013;1763</Citation></Reference><Reference><Citation>McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021; 12:55&#x2013;61</Citation></Reference><Reference><Citation>Biggerstaff BJ, Jackson D. The exact distribution of Cochran&#x2019;s heterogeneity statistic in one-way random effects meta-analysis. Stat Med. 2008; 27:6093&#x2013;6110</Citation></Reference><Reference><Citation>Jackson D. The implications of publication bias for meta-analysis&#x2019; other parameter. Stat Med. 2006; 25:2911&#x2013;2921</Citation></Reference><Reference><Citation>Jackson D. The power of the standard test for the presence of heterogeneity in meta-analysis. Stat Med. 2006; 25:2688&#x2013;2699</Citation></Reference><Reference><Citation>Depeint F, Bruce WR, Shangari N, et al. Mitochondrial function and toxicity: Role of B vitamins on the one-carbon transfer pathways. Chem Biol Interact. 2006; 163:113&#x2013;132</Citation></Reference><Reference><Citation>Donnino MW, Carney E, Cocchi MN, et al. Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010; 25:576&#x2013;581</Citation></Reference><Reference><Citation>Cruickshank AM, Telfer AB, Shenkin A. Thiamine deficiency in the critically ill. Intensive Care Med. 1988; 14:384&#x2013;387</Citation></Reference><Reference><Citation>Harrison FE, May JM. Vitamin C function in the brain: Vital role of the ascorbate transporter SVCT2. Free Radic Biol Med. 2009; 46:719&#x2013;730</Citation></Reference><Reference><Citation>Stone KJ, Townsley BH. The effect of L-ascorbate on catecholamine biosynthesis. Biochem J. 1973; 131:611&#x2013;613</Citation></Reference><Reference><Citation>Levin EY, Levenberg B, Kaufman S. The enzymatic conversion of 3,4-dihydroxyphenylethylamine to norepinephrine. J Biol Chem. 1960; 235:2080&#x2013;2086</Citation></Reference><Reference><Citation>Prigge ST, Mains RE, Eipper BA, et al. New insights into copper monooxygenases and peptide amidation: Structure, mechanism and function. Cell Mol Life Sci. 2000; 57:1236&#x2013;1259</Citation></Reference><Reference><Citation>Dillon PF, Root-Bernstein R, Robinson NE, et al. Receptor-mediated enhancement of beta adrenergic drug activity by ascorbate in vitro and in vivo. PLoS One. 2010; 5:e15130</Citation></Reference><Reference><Citation>Carr AC, Rosengrave PC, Bayer S, et al. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. 2017; 21:300</Citation></Reference><Reference><Citation>de Grooth H-J, Spoelstra-de Man AME, Oudemans-van Straaten HM. Early plasma vitamin C concentration, organ dysfunction and ICU mortality. Intensive Care Med. 2014; 40:1&#x2013;308</Citation></Reference><Reference><Citation>Rochwerg B, Oczkowski SJ, Siemieniuk RAC, et al. Corticosteroids in sepsis: An updated systematic review and meta-analysis. Crit Care Med. 2018; 46:1411&#x2013;1420</Citation></Reference><Reference><Citation>Ryg&#xe5;rd SL, Butler E, Granholm A, et al. Low-dose corticosteroids for adult patients with septic shock: A systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2018; 44:1003&#x2013;1016</Citation></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017; 45:486&#x2013;552</Citation></Reference><Reference><Citation>Okamoto K, Tanaka H, Makino Y, et al. Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism. Biochem Pharmacol. 1998; 56:79&#x2013;86</Citation></Reference><Reference><Citation>Okamoto K, Tanaka H, Ogawa H, et al. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem. 1999; 274:10363&#x2013;10371</Citation></Reference><Reference><Citation>Fujita I, Hirano J, Itoh N, et al. Dexamethasone induces sodium-dependant vitamin C transporter in a mouse osteoblastic cell line MC3T3-E1. Br J Nutr. 2001; 86:145&#x2013;149</Citation></Reference><Reference><Citation>Barabutis N, Khangoora V, Marik PE, et al. Hydrocortisone and ascorbic acid synergistically prevent and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Chest. 2017; 152:954&#x2013;962</Citation></Reference><Reference><Citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013; 369:840&#x2013;851</Citation></Reference><Reference><Citation>Guideline on clinical investigation of medicinal products for the treatment of sepsis. Ed Eur Med Agency. 2006; 9</Citation></Reference><Reference><Citation>Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001; 286:1754&#x2013;1758</Citation></Reference><Reference><Citation>Garc&#xed;a-Gigorro R, S&#xe1;ez-de la Fuente I, Mar&#xed;n Mateos H, et al. Utility of SOFA and &#x394;-SOFA scores for predicting outcome in critically ill patients from the emergency department. Eur J Emerg Med. 2018; 25:387&#x2013;393</Citation></Reference><Reference><Citation>de Grooth HJ, Geenen IL, Girbes AR, et al. SOFA and mortality endpoints in randomized controlled trials: A systematic review and meta-regression analysis. Crit Care. 2017; 21:38</Citation></Reference><Reference><Citation>Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for treating sepsis in children and adults. Cochrane Database Syst Rev. 2019; 12:CD002243</Citation></Reference><Reference><Citation>Sprung CL, Cohen SL, Sjokvist P, et al.; Ethicus Study Group: End-of-life practices in European intensive care units: The Ethicus Study. JAMA. 2003; 290:790&#x2013;797</Citation></Reference><Reference><Citation>Thorlund K, Devereaux PJ, Wetterslev J, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009; 38:276&#x2013;286</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30075792</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>183</StartPage><MedlinePgn>183</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">183</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-018-2113-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Sepsis-induced myocardial dysfunction is associated with poor outcomes, but traditional measurements of systolic function such as left ventricular ejection fraction (LVEF) do not directly correlate with prognosis. Global longitudinal strain (GLS) utilizing speckle-tracking echocardiography (STE) could be a better marker of intrinsic left ventricular (LV) function, reflecting myocardial deformation rather than displacement and volume changes. We sought to investigate the prognostic value of GLS in patients with sepsis and/or septic shock.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review (PubMed and Embase up to 26 October 2017) and meta-analysis to investigate the association between GLS and mortality at longest follow up in patients with severe sepsis and/or septic shock. In the primary analysis, we included studies reporting transthoracic echocardiography data on GLS according to mortality. A secondary analysis evaluated the association between LVEF and mortality including data from studies reporting GLS.</AbstractText><AbstractText Label="RESULTS">We included eight studies in the primary analysis with a total of 794 patients (survival 68%, n&#x2009;=&#x2009;540). We found a significant association between worse LV function and GLS values and mortality: standard mean difference (SMD) -&#x2009;0.26; 95% confidence interval (CI) -&#x2009;0.47, -&#x2009;0.04; p&#x2009;=&#x2009;0.02 (low heterogeneity, I<sup>2</sup>&#xa0;=&#x2009;43%). No significant association was found between LVEF and mortality in the same population of patients (eight studies; SMD, 0.02; 95% CI -&#x2009;0.14, 0.17; p&#x2009;=&#x2009;0.83; no heterogeneity, I<sup>2</sup>&#xa0;=&#x2009;3%).</AbstractText><AbstractText Label="CONCLUSIONS">Worse GLS (less negative)&#xa0;values are associated with higher mortality in patients with severe sepsis or septic shock, while such association is not valid for LVEF. More critical care research is warranted to confirm the better ability of STE in demonstrating underlying intrinsic myocardial disease compared to LVEF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>F</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5144-0776</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Via Tricomi 5, 90127, Palermo, Italy. filipposanfi@yahoo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corredor</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine, Bart's Heart Centre St. Bartholomew's Hospital, W. Smithfield, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, St Georges University Hospitals NHS Trust, Blackshaw Road, London, SW170QT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tritapepe</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Respiratory, Nephrological, Anaesthetic and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorini</LastName><ForeName>F L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcadipane</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Via Tricomi 5, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieillard-Baron</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Assistance Publique-Hopitaux de Paris, University Hospital Ambroise Par&#xe9;, Intensive Care Unit, Section Thorax-Vascular Disease-Abdomen-Metabolism, 92100, Boulogne-Billancourt, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), Universite' Versailles Saint Quentin en Yvelines, 94807, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Humanitas Clinical and Research Center, Via A. Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele - Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2019 Feb 8;23(1):38. doi: 10.1186/s13054-019-2312-1.</RefSource><PMID Version="1">30736846</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D025401" MajorTopicYN="N">Echocardiography, Stress</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Global longitudinal strain</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Left ventricular ejection fraction</Keyword><Keyword MajorTopicYN="N">Speckle tracking</Keyword><Keyword MajorTopicYN="N">Systolic dysfunction</Keyword></KeywordList><CoiStatement>Not applicable. Not applicable. The authors declare that they have no competing interests. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30075792</ArticleId><ArticleId IdType="pmc">PMC6091069</ArticleId><ArticleId IdType="doi">10.1186/s13054-018-2113-y</ArticleId><ArticleId IdType="pii">10.1186/s13054-018-2113-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, et al. Year in review in intensive care medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation. Intensive Care Med. 2012;38(3):345&#x2013;358. doi: 10.1007/s00134-012-2467-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2467-6</ArticleId><ArticleId IdType="pmc">PMC3291826</ArticleId><ArticleId IdType="pubmed">22270471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gullo A, Foti A, Murabito P, Li Volti G, Astuto M, Stissi C, Rubulotta F, Sanfilippo F, Santonocito C, Sganga G, et al. Spectrum of sepsis, mediators, source control and management of bundles. Front Biosci (Elite Ed) 2010;2:906&#x2013;911. doi: 10.2741/e150.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/e150</ArticleId><ArticleId IdType="pubmed">20515762</ArticleId></ArticleIdList></Reference><Reference><Citation>Beesley SJ, Weber G, Sarge T, Nikravan S, Grissom CK, Lanspa MJ, Shahul S, Brown SM. Septic cardiomyopathy. Crit Care Med. 2018;46(4):625&#x2013;634. doi: 10.1097/CCM.0000000000002851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002851</ArticleId><ArticleId IdType="pubmed">29227368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter JD, Doddi M. Sepsis and the heart. Br J Anaesth. 2010;104(1):3&#x2013;11. doi: 10.1093/bja/aep339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep339</ArticleId><ArticleId IdType="pubmed">19939836</ArticleId></ArticleIdList></Reference><Reference><Citation>Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, Dunser MW. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg. 2009;108(6):1841&#x2013;1847. doi: 10.1213/ane.0b013e318195e11d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318195e11d</ArticleId><ArticleId IdType="pubmed">19448210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammann P, Fehr T, Minder EI, Gunter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27(6):965&#x2013;969. doi: 10.1007/s001340100920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340100920</ArticleId><ArticleId IdType="pubmed">11497154</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F, Corredor C, Fletcher N, Landesberg G, Benedetto U, Foex P, Cecconi M. Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis. Intensive Care Med. 2015;41(6):1004&#x2013;13. 10.1007/s00134-015-3748-7. Epub 2015 Mar 24.</Citation><ArticleIdList><ArticleId IdType="pubmed">25800584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F, Corredor C, Arcadipane A, Landesberg G, Vieillard-Baron A, Cecconi M, Fletcher N. Tissue Doppler assessment of diastolic function and relationship with mortality in critically ill septic patients: a systematic review and meta-analysis. Br J Anaesth. 2017;119(4):583&#x2013;594. doi: 10.1093/bja/aex254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex254</ArticleId><ArticleId IdType="pubmed">29121301</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100(4):483&#x2013;490. doi: 10.7326/0003-4819-100-4-483.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-100-4-483</ArticleId><ArticleId IdType="pubmed">6703540</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med. 2008;36(6):1701&#x2013;1706. doi: 10.1097/CCM.0b013e318174db05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318174db05</ArticleId><ArticleId IdType="pubmed">18496368</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SJ, Nalos M, McLean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care. 2013;17(3):R96. doi: 10.1186/cc12741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12741</ArticleId><ArticleId IdType="pmc">PMC4056117</ArticleId><ArticleId IdType="pubmed">23706109</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795&#x2013;1815. doi: 10.1007/s00134-014-3525-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3525-z</ArticleId><ArticleId IdType="pmc">PMC4239778</ArticleId><ArticleId IdType="pubmed">25392034</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard-Baron A. Septic cardiomyopathy. Ann Intensive Care. 2011;1(1):6. doi: 10.1186/2110-5820-1-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-1-6</ArticleId><ArticleId IdType="pmc">PMC3159902</ArticleId><ArticleId IdType="pubmed">21906334</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignon P, Huang SJ. Global longitudinal strain in septic cardiomyopathy: the hidden part of the iceberg? Intensive Care Med. 2015;41(10):1851&#x2013;1853. doi: 10.1007/s00134-015-3962-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3962-3</ArticleId><ArticleId IdType="pubmed">26183488</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, Kaluski E, Krakover R, Vered Z. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr. 2004;17(10):1021&#x2013;1029. doi: 10.1016/j.echo.2004.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2004.06.019</ArticleId><ArticleId IdType="pubmed">15452466</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr. 2011;12(3):167&#x2013;205. doi: 10.1093/ejechocard/jer021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejechocard/jer021</ArticleId><ArticleId IdType="pubmed">21385887</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1&#x2013;34. doi: 10.1016/j.jclinepi.2009.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.006</ArticleId><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165&#x2013;228. doi: 10.1007/s00134-012-2769-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2769-8</ArticleId><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed 10 Jan 2018.</Citation></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. doi: 10.1186/1471-2288-5-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri V, Innocenti F, Guzzo A, Guerrini E, Vignaroli D, Pini R. Left ventricular systolic longitudinal function as predictor of outcome in patients with sepsis. Circ Cardiovasc Imaging. 2015;8(11):e003865.</Citation><ArticleIdList><ArticleId IdType="pubmed">26546483</ArticleId></ArticleIdList></Reference><Reference><Citation>Innocenti F, Palmieri V, Guzzo A, Stefanone VT, Donnini C, Pini R. SOFA score and left ventricular systolic function as predictors of short-term outcome in patients with sepsis. Intern Emerg Med. 2018;13(1):51&#x2013;58. 10.1007/s11739-016-1579-3. Epub 2016 Dec 1.</Citation><ArticleIdList><ArticleId IdType="pubmed">27909859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang WT, Lee WH, Lee WT, Chen PS, Su YR, Liu PY, Liu YW, Tsai WC. Left ventricular global longitudinal strain is independently associated with mortality in septic shock patients. Intensive Care Med. 2015;41(10):1791&#x2013;1799. doi: 10.1007/s00134-015-3970-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3970-3</ArticleId><ArticleId IdType="pubmed">26183489</ArticleId></ArticleIdList></Reference><Reference><Citation>Landesberg G, Jaffe AS, Gilon D, Levin PD, Goodman S, Abu-Baih A, Beeri R, Weissman C, Sprung CL, Landesberg A. Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*. Crit Care Med. 2014;42(4):790&#x2013;800. doi: 10.1097/CCM.0000000000000107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000107</ArticleId><ArticleId IdType="pubmed">24365861</ArticleId></ArticleIdList></Reference><Reference><Citation>De Geer L, Engvall J, Oscarsson A. Strain echocardiography in septic shock - a comparison with systolic and diastolic function parameters, cardiac biomarkers and outcome. Crit Care. 2015;19:122. doi: 10.1186/s13054-015-0857-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0857-1</ArticleId><ArticleId IdType="pmc">PMC4374340</ArticleId><ArticleId IdType="pubmed">25882600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanspa MJ, Shahul S, Hersh A, Wilson EL, Olsen TD, Hirshberg EL, Grissom CK, Brown SM. Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients. Ann Intensive Care. 2017;7(1):17. doi: 10.1186/s13613-017-0240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-017-0240-2</ArticleId><ArticleId IdType="pmc">PMC5315651</ArticleId><ArticleId IdType="pubmed">28213737</ArticleId></ArticleIdList></Reference><Reference><Citation>Orde SR, Pulido JN, Masaki M, Gillespie S, Spoon JN, Kane GC, Oh JK. Outcome prediction in sepsis: speckle tracking echocardiography based assessment of myocardial function. Crit Care. 2014;18(4):R149. doi: 10.1186/cc13987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13987</ArticleId><ArticleId IdType="pmc">PMC4227017</ArticleId><ArticleId IdType="pubmed">25015102</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahul S, Gulati G, Hacker MR, Mahmood F, Canelli R, Nizamuddin J, Mahmood B, Mueller A, Simon BA, Novack V, et al. Detection of myocardial dysfunction in septic shock: a speckle-tracking echocardiography study. Anesth Analg. 2015;121(6):1547&#x2013;1554. doi: 10.1213/ANE.0000000000000943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000943</ArticleId><ArticleId IdType="pubmed">26397444</ArticleId></ArticleIdList></Reference><Reference><Citation>Boissier F, Razazi K, Seemann A, Bedet A, Thille AW, de Prost N, Lim P, Brun-Buisson C, Mekontso Dessap A. Left ventricular systolic dysfunction during septic shock: the role of loading conditions. Intensive Care Med. 2017;43(5):633&#x2013;642. doi: 10.1007/s00134-017-4698-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4698-z</ArticleId><ArticleId IdType="pubmed">28204860</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaky A, Gill EA, Lin CP, Bendjelid K, Treggiari MM. Characteristics of sepsis-induced cardiac dysfunction using speckle-tracking echocardiography: a feasibility study. Anaesth Intensive Care. 2016;44(1):65&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5050013</ArticleId><ArticleId IdType="pubmed">26673591</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla K, Hallman C, Bech-Hanssen O, Haney M, Ricksten SE. Strain echocardiography identifies impaired longitudinal systolic function in patients with septic shock and preserved ejection fraction. Cardiovasc Ultrasound. 2015;13:30. doi: 10.1186/s12947-015-0025-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12947-015-0025-4</ArticleId><ArticleId IdType="pmc">PMC4487964</ArticleId><ArticleId IdType="pubmed">26134971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng PY, Sin WC, Ng AK, Chan WM. Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS) Crit Care. 2016;20(1):145. doi: 10.1186/s13054-016-1327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1327-0</ArticleId><ArticleId IdType="pmc">PMC4867983</ArticleId><ArticleId IdType="pubmed">27177587</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Liu JJ, Du WH, Wang X, Chen ZQ, Zhang LC. 2D speckle tracking imaging to assess sepsis induced early systolic myocardial dysfunction and its underlying mechanisms. Eur Rev Med Pharmacol Sci. 2014;18(20):3105&#x2013;3114.</Citation><ArticleIdList><ArticleId IdType="pubmed">25392112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hestenes SM, Halvorsen PS, Skulstad H, Remme EW, Espinoza A, Hyler S, Bugge JF, Fosse E, Nielsen EW, Edvardsen T. Advantages of strain echocardiography in assessment of myocardial function in severe sepsis: an experimental study. Crit Care Med. 2014;42(6):e432&#x2013;e440. doi: 10.1097/CCM.0000000000000310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000310</ArticleId><ArticleId IdType="pubmed">24633187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C, Monzy S, Roudaut R, Habib G, Lafitte S. Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. J Am Soc Echocardiogr. 2010;23(10):1019&#x2013;1024. doi: 10.1016/j.echo.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2010.07.019</ArticleId><ArticleId IdType="pubmed">20810243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ, Murphy RT. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart. 2010;96(9):701&#x2013;707. doi: 10.1136/hrt.2009.173997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2009.173997</ArticleId><ArticleId IdType="pubmed">20424152</ArticleId></ArticleIdList></Reference><Reference><Citation>Yajima R, Kataoka A, Takahashi A, Uehara M, Saito M, Yamaguchi C, Lee K, Komuro I, Funabashi N. Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: comparison with multislice CT. Int J Cardiol. 2012;158(3):423&#x2013;432. doi: 10.1016/j.ijcard.2011.01.096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.01.096</ArticleId><ArticleId IdType="pubmed">21354635</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahul S, Rhee J, Hacker MR, Gulati G, Mitchell JD, Hess P, Mahmood F, Arany Z, Rana S, Talmor D. Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ Cardiovasc Imaging. 2012;5(6):734&#x2013;739. doi: 10.1161/CIRCIMAGING.112.973818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.112.973818</ArticleId><ArticleId IdType="pmc">PMC3871635</ArticleId><ArticleId IdType="pubmed">22891044</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellavia D, Abraham TP, Pellikka PA, Al-Zahrani GB, Dispenzieri A, Oh JK, Bailey KR, Wood CM, Novo S, Miyazaki C, et al. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr. 2007;20(10):1194&#x2013;1202. doi: 10.1016/j.echo.2007.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2007.02.025</ArticleId><ArticleId IdType="pubmed">17596912</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YW, Su CT, Sung JM, Wang SP, Su YR, Yang CS, Tsai LM, Chen JH, Tsai WC. Association of left ventricular longitudinal strain with mortality among stable hemodialysis patients with preserved left ventricular ejection fraction. Clin J Am Soc Nephrol. 2013;8(9):1564&#x2013;1574. doi: 10.2215/CJN.10671012.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.10671012</ArticleId><ArticleId IdType="pmc">PMC3805079</ArticleId><ArticleId IdType="pubmed">23704303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014;100(21):1673&#x2013;1680. doi: 10.1136/heartjnl-2014-305538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2014-305538</ArticleId><ArticleId IdType="pubmed">24860005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1&#x2013;39.e14. doi: 10.1016/j.echo.2014.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Farsalinos KE, Daraban AM, Unlu S, Thomas JD, Badano LP, Voigt JU. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE inter-vendor comparison study. J Am Soc Echocardiogr. 2015;28(10):1171&#x2013;1181. doi: 10.1016/j.echo.2015.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2015.06.011</ArticleId><ArticleId IdType="pubmed">26209911</ArticleId></ArticleIdList></Reference><Reference><Citation>Barraud D, Faivre V, Damy T, Welschbillig S, Gayat E, Heymes C, Payen D, Shah AM, Mebazaa A. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med. 2007;35(5):1376&#x2013;1382. doi: 10.1097/01.CCM.0000261889.18102.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000261889.18102.84</ArticleId><ArticleId IdType="pubmed">17414729</ArticleId></ArticleIdList></Reference><Reference><Citation>Jianhui L, Rosenblatt-Velin N, Loukili N, Pacher P, Feihl F, Waeber B, Liaudet L. Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism. Am J Phys Heart Circ Phys. 2010;299(2):H492&#x2013;H501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2930391</ArticleId><ArticleId IdType="pubmed">20525873</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinsky MR, Rico P. Cardiac contractility is not depressed in early canine endotoxic shock. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1087&#x2013;1093. doi: 10.1164/ajrccm.161.4.9904033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.4.9904033</ArticleId><ArticleId IdType="pubmed">10764295</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F, Santonocito C, Panarello G, Arcadipane A. The role of speckle tracking echocardiography for prognostication in patients with severe sepsis or septic shock. Crit Care. 2016;20:284. doi: 10.1186/s13054-016-1451-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1451-x</ArticleId><ArticleId IdType="pmc">PMC5018936</ArticleId><ArticleId IdType="pubmed">27616201</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymanski C, Levy F, Tribouilloy C. Should LVEF be replaced by global longitudinal strain? Heart. 2014;100(21):1655&#x2013;1656. doi: 10.1136/heartjnl-2014-306186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2014-306186</ArticleId><ArticleId IdType="pubmed">25049321</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard Baron A, Schmitt JM, Beauchet A, Augarde R, Prin S, Page B, Jardin F. Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology. 2001;94(3):400&#x2013;406. doi: 10.1097/00000542-200103000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200103000-00007</ArticleId><ArticleId IdType="pubmed">11374597</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardin F, Fourme T, Page B, Loubieres Y, Vieillard-Baron A, Beauchet A, Bourdarias JP. Persistent preload defect in severe sepsis despite fluid loading: a longitudinal echocardiographic study in patients with septic shock. Chest. 1999;116(5):1354&#x2013;1359. doi: 10.1378/chest.116.5.1354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.116.5.1354</ArticleId><ArticleId IdType="pubmed">10559099</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu S, Frank LH, Fenton KE, Sable CA, Levy RJ, Berger JT. Two-dimensional speckle tracking imaging detects impaired myocardial performance in children with septic shock, not recognized by conventional echocardiography. Pediatr Crit Care Med. 2012;13(3):259&#x2013;264. doi: 10.1097/PCC.0b013e3182288445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3182288445</ArticleId><ArticleId IdType="pubmed">21760563</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YW, Tsai WC, Su CT, Lin CC, Chen JH. Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. J Card Fail. 2009;15(9):782&#x2013;789. doi: 10.1016/j.cardfail.2009.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2009.05.006</ArticleId><ArticleId IdType="pubmed">19879465</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner A, Bijnens B, Hansen M, How OJ, Aarsaether E, Muller S, Sutherland GR, Myrmel T. Left ventricular size determines tissue Doppler-derived longitudinal strain and strain rate. Eur J Echocardiogr. 2009;10(2):271&#x2013;277. doi: 10.1093/ejechocard/jen230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejechocard/jen230</ArticleId><ArticleId IdType="pubmed">18827033</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns AT, La Gerche A, D'Hooge J, MacIsaac AI, Prior DL. Left ventricular strain and strain rate: characterization of the effect of load in human subjects. Eur J Echocardiogr. 2010;11(3):283&#x2013;289. doi: 10.1093/ejechocard/jep214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejechocard/jep214</ArticleId><ArticleId IdType="pubmed">20026455</ArticleId></ArticleIdList></Reference><Reference><Citation>Aissaoui N, Guerot E, Combes A, Delouche A, Chastre J, Leprince P, Leger P, Diehl JL, Fagon JY, Diebold B. Two-dimensional strain rate and Doppler tissue myocardial velocities: analysis by echocardiography of hemodynamic and functional changes of the failed left ventricle during different degrees of extracorporeal life support. J Am Soc Echocardiogr. 2012;25(6):632&#x2013;640. doi: 10.1016/j.echo.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2012.02.009</ArticleId><ArticleId IdType="pubmed">22421027</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JO, Shin DH, Cho SW, Song YB, Kim JH, Kim YG, Lee SC, Park SW. Effect of preload on left ventricular longitudinal strain by 2D speckle tracking. Echocardiography (Mount Kisco, NY) 2008;25(8):873&#x2013;879. doi: 10.1111/j.1540-8175.2008.00707.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8175.2008.00707.x</ArticleId><ArticleId IdType="pubmed">18986415</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HE, Chang SA, Kim HK, Shin DH, Kim JH, Seo MK, Kim YJ, Cho GY, Sohn DW, Oh BH, et al. Impact of loading condition on the 2D speckle tracking-derived left ventricular dyssynchrony index in nonischemic dilated cardiomyopathy. Circ Cardiovasc Imaging. 2010;3(3):272&#x2013;281. doi: 10.1161/CIRCIMAGING.109.890848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.109.890848</ArticleId><ArticleId IdType="pubmed">20190282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafati C, Gardette M, Leone M, Reydellet L, Blasco V, Lannelongue A, Sayagh F, Wiramus S, Antonini F, Albanese J, et al. Use of speckle-tracking strain in preload-dependent patients, need for cautious interpretation! Ann Intensive Care. 2018;8(1):29. doi: 10.1186/s13613-018-0376-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0376-8</ArticleId><ArticleId IdType="pmc">PMC5821613</ArticleId><ArticleId IdType="pubmed">29468335</ArticleId></ArticleIdList></Reference><Reference><Citation>Carasso S, Cohen O, Mutlak D, Adler Z, Lessick J, Reisner SA, Rakowski H, Bolotin G, Agmon Y. Differential effects of afterload on left ventricular long- and short-axis function: insights from a clinical model of patients with aortic valve stenosis undergoing aortic valve replacement. Am Heart J. 2009;158(4):540&#x2013;545. doi: 10.1016/j.ahj.2009.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2009.07.008</ArticleId><ArticleId IdType="pubmed">19781412</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki S, Daimon M, Miyazaki T, Onishi Y, Koiso Y, Nishizaki Y, Ichikawa R, Chiang SJ, Makinae H, Suzuki H, et al. Global longitudinal strain in relation to the severity of aortic stenosis: a two-dimensional speckle-tracking study. Echocardiography (Mount Kisco, NY) 2011;28(7):703&#x2013;708. doi: 10.1111/j.1540-8175.2011.01419.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8175.2011.01419.x</ArticleId><ArticleId IdType="pubmed">21564277</ArticleId></ArticleIdList></Reference><Reference><Citation>Paonessa JR, Brennan T, Pimentel M, Steinhaus D, Feng M, Celi LA. Hyperdynamic left ventricular ejection fraction in the intensive care unit. Crit Care. 2015;19:288. doi: 10.1186/s13054-015-1012-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1012-8</ArticleId><ArticleId IdType="pmc">PMC4528812</ArticleId><ArticleId IdType="pubmed">26250903</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi K, Negishi T, Haluska BA, Hare JL, Plana JC, Marwick TH. Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging. 2014;15(3):324&#x2013;331. doi: 10.1093/ehjci/jet159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jet159</ArticleId><ArticleId IdType="pubmed">24057661</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesbitt GC, Mankad S, Oh JK. Strain imaging in echocardiography: methods and clinical applications. Int J Cardiovasc Imaging. 2009;25(Suppl 1):9&#x2013;22. doi: 10.1007/s10554-008-9414-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-008-9414-1</ArticleId><ArticleId IdType="pubmed">19145475</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokke TM, Hasselberg NE, Smedsrud MK, Sarvari SI, Haugaa KH, Smiseth OA, Edvardsen T, Remme EW. Geometry as a confounder when assessing ventricular systolic function: comparison between ejection fraction and strain. J Am Coll Cardiol. 2017;70(8):942&#x2013;954. doi: 10.1016/j.jacc.2017.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.06.046</ArticleId><ArticleId IdType="pubmed">28818204</ArticleId></ArticleIdList></Reference><Reference><Citation>van Melle JP, van der Vleuten PA, Hummel YM, Nijveldt R, Tio RA, Voors AA, Zijlstra F. Predictive value of tissue Doppler imaging for left ventricular ejection fraction, remodelling, and infarct size after percutaneous coronary intervention for acute myocardial infarction. Eur J Echocardiogr. 2010;11(7):596&#x2013;601. doi: 10.1093/ejechocard/jeq023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejechocard/jeq023</ArticleId><ArticleId IdType="pubmed">20211849</ArticleId></ArticleIdList></Reference><Reference><Citation>Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23(4):351&#x2013;369. doi: 10.1016/j.echo.2010.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2010.02.015</ArticleId><ArticleId IdType="pubmed">20362924</ArticleId></ArticleIdList></Reference><Reference><Citation>Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, Stoylen A, Ihlen H, Lima JA, Smiseth OA, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006;47(4):789&#x2013;793. doi: 10.1016/j.jacc.2005.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.10.040</ArticleId><ArticleId IdType="pubmed">16487846</ArticleId></ArticleIdList></Reference><Reference><Citation>Buss SJ, Mereles D, Emami M, Korosoglou G, Riffel JH, Bertel D, Schonland SO, Hegenbart U, Katus HA, Hardt SE. Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus. Clin Res Cardiol. 2012;101(4):273&#x2013;280. doi: 10.1007/s00392-011-0389-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-011-0389-x</ArticleId><ArticleId IdType="pubmed">22139127</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SJ, Ting I, Huang AM, Slama M, McLean AS. Longitudinal wall fractional shortening: an M-mode index based on mitral annular plane systolic excursion (MAPSE) that correlates and predicts left ventricular longitudinal strain (LVLS) in intensive care patients. Crit Care. 2017;21(1):292. doi: 10.1186/s13054-017-1876-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1876-x</ArticleId><ArticleId IdType="pmc">PMC5702151</ArticleId><ArticleId IdType="pubmed">29178915</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander O, Welters ID, Foex P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med. 2005;33(1):81&#x2013;88. doi: 10.1097/01.CCM.0000150028.64264.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000150028.64264.14</ArticleId><ArticleId IdType="pubmed">15644652</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310(16):1683&#x2013;1691. doi: 10.1001/jama.2013.278477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.278477</ArticleId><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F, Santonocito C, Morelli A, Foex P. Beta-blocker use in severe sepsis and septic shock: a systematic review. Curr Med Res Opin. 2015;31(10):1817&#x2013;1825. doi: 10.1185/03007995.2015.1062357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007995.2015.1062357</ArticleId><ArticleId IdType="pubmed">26121122</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushmer RF, Crystal DK. Changes in configuration of the ventricular chambers during the cardiac cycle. Circulation. 1951;4(2):211&#x2013;218. doi: 10.1161/01.CIR.4.2.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.4.2.211</ArticleId><ArticleId IdType="pubmed">14859397</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdev A, Villarraga HR, Frantz RP, McGoon MD, Hsiao JF, Maalouf JF, Ammash NM, McCully RB, Miller FA, Pellikka PA, et al. Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest. 2011;139(6):1299&#x2013;1309. doi: 10.1378/chest.10-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-2015</ArticleId><ArticleId IdType="pubmed">21148241</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckberg G, Hoffman JI, Mahajan A, Saleh S, Coghlan C. Cardiac mechanics revisited: the relationship of cardiac architecture to ventricular function. Circulation. 2008;118(24):2571&#x2013;2587. doi: 10.1161/CIRCULATIONAHA.107.754424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.754424</ArticleId><ArticleId IdType="pubmed">19064692</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xdc;nl&#xfc; S, Mirea O, Duchenne J, Pagourelias ED, B&#xe9;zy S, Thomas JD, Badano LP, Voigt J-U. Comparison of feasibility, accuracy, and reproducibility of layer-specific global longitudinal strain measurements among five different vendors: a report from the EACVI-ASE strain standardization task force. J Am Soc Echocardiogr. 2018;31(3):374&#x2013;380. doi: 10.1016/j.echo.2017.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2017.11.008</ArticleId><ArticleId IdType="pubmed">29246512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yingchoncharoen T, Agarwal S, Popovic ZB, Marwick TH. Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr. 2013;26(2):185&#x2013;191. doi: 10.1016/j.echo.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2012.10.008</ArticleId><ArticleId IdType="pubmed">23218891</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittinger CA, Dunser MW, Torgersen C, Luckner G, Lorenz I, Schmid S, Joannidis M, Moser P, Hasibeder WR, Halabi M, et al. Histologic pathologies of the myocardium in septic shock: a prospective observational study. Shock. 2013;39(4):329&#x2013;335. doi: 10.1097/SHK.0b013e318289376b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318289376b</ArticleId><ArticleId IdType="pubmed">23376953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang HY, Bassel-Duby R, Maass DL, Johnston WE, Horton JW, Tao W. Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. Am J Phys Heart Circ Phys. 2007;292(5):H2408&#x2013;H2416.</Citation><ArticleIdList><ArticleId IdType="pubmed">17220181</ArticleId></ArticleIdList></Reference><Reference><Citation>Celes MR, Torres-Duenas D, Prado CM, Campos EC, Moreira JE, Cunha FQ, Rossi MA. Increased sarcolemmal permeability as an early event in experimental septic cardiomyopathy: a potential role for oxidative damage to lipids and proteins. Shock. 2010;33(3):322&#x2013;331. doi: 10.1097/SHK.0b013e3181b38ef6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3181b38ef6</ArticleId><ArticleId IdType="pubmed">20160610</ArticleId></ArticleIdList></Reference><Reference><Citation>Supinski GS, Callahan LA. Hemin prevents cardiac and diaphragm mitochondrial dysfunction in sepsis. Free Radic Biol Med. 2006;40(1):127&#x2013;137. doi: 10.1016/j.freeradbiomed.2005.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.09.025</ArticleId><ArticleId IdType="pubmed">16337886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang QS, Martinez B, Yao X, Maass DL, Ma L, Wolf SE, Minei JP. Sepsis-induced cardiac mitochondrial dysfunction involves altered mitochondrial-localization of tyrosine kinase Src and tyrosine phosphatase SHP2. PLoS One. 2012;7(8):e43424. doi: 10.1371/journal.pone.0043424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043424</ArticleId><ArticleId IdType="pmc">PMC3428365</ArticleId><ArticleId IdType="pubmed">22952679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ersboll M, Valeur N, Mogensen UM, Andersen MJ, Moller JE, Velazquez EJ, Hassager C, Sogaard P, Kober L. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2013;61(23):2365&#x2013;2373. doi: 10.1016/j.jacc.2013.02.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.02.061</ArticleId><ArticleId IdType="pubmed">23563128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine NM, Chen L, Bastiansen PM, Frantz RP, Pellikka PA, Oh JK, Kane GC. Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension. Circ Cardiovasc Imaging. 2013;6(5):711&#x2013;721. doi: 10.1161/CIRCIMAGING.113.000640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.113.000640</ArticleId><ArticleId IdType="pubmed">23811750</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34036628</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-6777</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Neurourology and urodynamics</Title><ISOAbbreviation>Neurourol Urodyn</ISOAbbreviation></Journal><ArticleTitle>Differences in surgical and functional outcomes in benign prostate hyperplasia patients with only lower urinary tract symptoms versus those in retention: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1389</StartPage><EndPage>1401</EndPage><MedlinePgn>1389-1401</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/nau.24708</ELocationID><Abstract><AbstractText Label="AIMS">To evaluate outcomes after benign prostate hyperplasia (BPH) surgery among men with lower urinary tract symptoms (LUTS) only versus those with urinary retention (UR).</AbstractText><AbstractText Label="METHODS">The protocol was registered in PROSPERO with ID#232253. Eligible studies identified from four electronic databases. Search, data extraction and quality assessment were performed independently by two reviewers. Studies with perioperative, functional, early and late complication outcomes included.</AbstractText><AbstractText Label="RESULTS">Twenty-five studies, 14&#x2009;593 patients including 1 randomized controlled trial, 11 prospective and 13 retrospective studies included for meta-analysis. This showed higher risk of immediate transient recatherization (risk ratio [RR]: 5.29, p&#x2009;&lt;&#x2009;0.00001), longer days to trial-off-catheter (mean difference [MD]: 0.25, p&#x2009;&lt;&#x2009;0.00001), longer hospitalization stay in the UR group (MD: 0.35, p&#x2009;&lt;&#x2009;0.00001), and higher risk of intraoperative blood transfusions (RR: 1.90, p&#x2009;=&#x2009;0.002), postoperative urinary tract infections (RR: 1.49, p&#x2009;&lt;&#x2009;0.00001) and sepsis (RR: 8.15, p&#x2009;=&#x2009;0.009) too. Failure of surgery like permanent recatheterization (RR: 5.27, p&#x2009;&lt;&#x2009;0.00001) was more in preoperative UR group. Negligible differences seen in long term functional outcomes between the two groups (International Prostate Symptom Score at 12 months, MD: -0.06, p&#x2009;=&#x2009;0.68; Quality of Life at 12 months, MD: 0.20, p&#x2009;&lt;&#x2009;0.00001; maximum urinary flow rate at 12 months, MD: -0.33, p&#x2009;=&#x2009;0.10; and postvoid residual volume at 12 months, MD: 4.32, p&#x2009;&lt;&#x2009;0.00001).</AbstractText><AbstractText Label="CONCLUSIONS">Preoperative UR patients undergoing surgery for BPH have higher risk of postoperative complications versus LUTS only group including the need for permanent catheterization. Both groups had similar long-term functional outcomes. We could infer that patients with UR on whom surgery is successful, with time may recover bladder function akin to patients with LUTS alone.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Law</LastName><ForeName>Yu Xi Terence</ForeName><Initials>YXT</Initials><Identifier Source="ORCID">0000-0002-5277-7511</Identifier><AffiliationInfo><Affiliation>Department of Urology, National University Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellani</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7354-9190</Identifier><AffiliationInfo><Affiliation>Division of Urology, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Universit&#xe0; Politecnica delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dell'atti</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Urology, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Universit&#xe0; Politecnica delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aho</LastName><ForeName>Tevita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teoh</LastName><ForeName>Jeremy Yuen-Chun</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0002-9361-2342</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine, S.H. Ho Urology Center, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauhar</LastName><ForeName>Vineet</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Urology, Ng Teng Fong General Hospital, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurourol Urodyn</MedlineTA><NlmUniqueID>8303326</NlmUniqueID><ISSNLinking>0733-2467</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059411" MajorTopicYN="Y">Lower Urinary Tract Symptoms</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011470" MajorTopicYN="Y">Prostatic Hyperplasia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">lower urinary tract symptoms</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">outcome studies</Keyword><Keyword MajorTopicYN="N">prostate hyperplasia</Keyword><Keyword MajorTopicYN="N">urinary retention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>26</Day><Hour>7</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34036628</ArticleId><ArticleId IdType="doi">10.1002/nau.24708</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Chapple CR . Lower urinary tract symptoms suggestive of benign prostatic obstruction-Triumph: design and implementation. Eur Urol. 2001;39(Suppl 3):31-36. https://doi.org/10.1159/000052565</Citation></Reference><Reference><Citation>Stoevelaar HJ , Van de Beek C , Casparie AF , McDonnell J , Nijs HG . Treatment choice for benign prostatic hyperplasia: a matter of urologist preference? J Urol. 1999;161(1):133-138.</Citation></Reference><Reference><Citation>Parsons JK , Dahm P , K&#xf6;hler TS , Lerner LB , Wilt TJ . Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. J Urol. 2020;204(4):799-804. https://doi.org/10.1097/JU.0000000000001298</Citation></Reference><Reference><Citation>Gravas S , Cornu JN , Gacci M , et al. EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) 2020. European Association of Urology Guidelines. 2020 Edition . European Association of Urology Guidelines Office; 2020.</Citation></Reference><Reference><Citation>Huang S-W , Tsai C-Y , Tseng C-S , et al. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. BMJ. 2019;367:l5919. https://doi.org/10.1136/bmj.l5919</Citation></Reference><Reference><Citation>Gilling PJ , Williams AK . Holmium laser enucleation of the prostate is the single best treatment for benign prostatic hyperplasia refractory to medication. J Endourol. Sep 2008;22(9):2113-2115. https://doi.org/10.1089/end.2008.9732</Citation></Reference><Reference><Citation>Michalak J , Tzou D , Funk J . HoLEP: the gold standard for the surgical management of BPH in the 21(st) Century. Am J Clin Exp Urol. 2015;3(1):36-42.</Citation></Reference><Reference><Citation>Gondran-Tellier B , McManus R , Sichez PC , et al. Efficacy and safety of surgery for benign prostatic obstruction in patients with preoperative urinary catheter. J Endourol. 2021;35(1):102-108. https://doi.org/10.1089/end.2020.0704</Citation></Reference><Reference><Citation>Higgins JP , Altman DG , G&#xf8;tzsche PC , et al. The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928</Citation></Reference><Reference><Citation>Sterne JAC , Savovi&#x107; J , Page MJ , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898</Citation></Reference><Reference><Citation>Sterne JA , Hern&#xe1;n MA , Reeves BC , et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https://doi.org/10.1136/bmj.i4919</Citation></Reference><Reference><Citation>Ali Y , Kehinde EO , Mahmoud AH , Al-Sahsah M , El-Barky E . Failure to pass urine following transurethral resection of the prostate (TURP): does the patient's mode of presentation determine the outcome of TURP? Kuwait Med J. 2010;42(4):277-281.</Citation></Reference><Reference><Citation>Alivizatos G , Ferakis N , Mitropoulos D , Skolarikos A , Livadas K , Kastriotis I . Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications. J Endourol. 2005;19(1):72-78.</Citation></Reference><Reference><Citation>Anderson CB , Helfand BT , McVary KT . Holmium laser prostatic resection for patients presenting with acute urinary retention. BJU Int. 2008;102(11):1623-1628. https://doi.org/10.1111/j.1464-410X.2008.07915.x</Citation></Reference><Reference><Citation>Balslev Jorgensen J , Seidelin C , Petersen F , Frimodt-Moller C . Does old age contraindicate TURP. Eur Urol. 1997;31(3):281-285. https://doi.org/10.1159/000474468</Citation></Reference><Reference><Citation>Chen JS , Chang CH , Yang WH , Kao YH . Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study. BJU Int. 2012;110(11 C):E896-E901. https://doi.org/10.1111/j.1464-410X.2012.11471.x</Citation></Reference><Reference><Citation>Cho SY , Ro YK , Kim H , Son H . Preoperative urinary retention increased the risk of urinary retention after photoselective vaporization of the prostate. The world journal of men's health. 2015;33(3):182-187. https://doi.org/10.5534/wjmh.2015.33.3.182</Citation></Reference><Reference><Citation>Choi YS , Bae WJ , Kim SJ , et al. Efficacy and safety of 120-W GreenLight High-Performance System laser photo vaporization of the prostate: 3-year results with specific considerations. Prostate Int. 2013;1(4):169-176. https://doi.org/10.12954/PI.13030</Citation></Reference><Reference><Citation>Goueli R , Meskawi M , Thomas D , et al. Efficacy, safety, and durability of 532&#x2009;nm laser photovaporization of the prostate with GreenLight 180 W XPS in men with acute urinary retention. J Endourol. 2017;31(11):1189-1194. https://doi.org/10.1089/end.2017.0488</Citation></Reference><Reference><Citation>Hashim H , Worthington J , Abrams P , et al. Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial. The Lancet. 2020;396(10243):50-61. https://doi.org/10.1016/S0140-6736%2820%2930537-7</Citation></Reference><Reference><Citation>He LY , Zhang YC , He JL , et al. The effect of immediate surgical bipolar plasmakinetic transurethral resection of the prostate on prostatic hyperplasia with acute urinary retention. Asian J Androl. 2016;18(1):134-139. https://doi.org/10.4103/1008-682X.157395</Citation></Reference><Reference><Citation>Johnsen NV , Kammann TJ , Marien T , Pickens RB , Miller NL . Comparison of holmium laser prostate enucleation outcomes in patients with or without preoperative urinary retention. J Urol. 2016;195(4):1021-1026. https://doi.org/10.1016/j.juro.2015.10.116</Citation></Reference><Reference><Citation>Khan M , Khan AL , Khan S , Nawaz H . Benign prostatic hyperplasia: mode of presentation and postoperative outcome. J Pak Med Assoc. 2005;55(1):20-23.</Citation></Reference><Reference><Citation>Li YH , Li GQ , Guo SM , Che YN , Wang X , Cheng FT . Clinical analysis of urinary tract infection in patients undergoing transurethral resection of the prostate. Eur Rev Med Pharmacol Sci. 2017;21(20):4487-4492.</Citation></Reference><Reference><Citation>Liu CC , Huang SP , Chou YH , Wang CJ , Huang CH . Current indications for transurethral resection of the prostate and associated complications. Kaohsiung J Med Sci. 2003;19(2):49-53. https://doi.org/10.1016/s1607-551x%2809%2970448-6</Citation></Reference><Reference><Citation>Liu X , Wang Y , Gao J , Shan Y . Comparison of 120 W 2-mum laser resection of the prostate outcomes in patients with or without preoperative urinary retention. Wideochirurgia I Inne Techniki Maloinwazyjne. 2016;11(4):223-228. https://doi.org/10.5114/wiitm.2016.63352</Citation></Reference><Reference><Citation>Loh SY , Chin CM . A demographic profile of patients undergoing transurethral resection of the prostate for benign prostate hyperplasia and presenting in acute urinary retention. BJU Int. 2002;89(6):531-533. https://doi.org/10.1046/j.1464-410X.2002.02662.x</Citation></Reference><Reference><Citation>Mebust WK , Holtgrewe HL , Cockett ATK , Peters PC . Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989;141(2):243-247. https://doi.org/10.1016/S0022-5347(17)40731-2</Citation></Reference><Reference><Citation>Ruszat R , Wyler S , Seifert HH , et al. Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol. 2006;50(5):1040-1049. https://doi.org/10.1016/j.eururo.2006.01.019</Citation></Reference><Reference><Citation>Sagen E , Hedelin H , Nelzen O , Peeker R . Defining and discriminating responders from non-responders following transurethral resection of the prostate. Scandinavian J Urol. 2018;52(5-6):437-444. https://doi.org/10.1080/21681805.2018.1536677</Citation></Reference><Reference><Citation>Shum CF , Mukherjee A , Teo CPC . Catheter-free discharge on first postoperative day after bipolar transurethral resection of prostate: Clinical outcomes of 100 cases. Int J Urol. 2014;21(3):313-318. https://doi.org/10.1111/iju.12246</Citation></Reference><Reference><Citation>Talic RF . Transurethral electrovaporization-resection of the prostate using the 'wing' cutting electrode: preliminary results of safety and efficacy in the treatment of men with prostatic outflow obstruction. Urology. 1999;53(1):106-110. https://doi.org/10.1016/S0090-4295%2898%2900437-3</Citation></Reference><Reference><Citation>Tracey JM , Warner JN . Transurethral bipolar enucleation of the prostate is an effective treatment option for men with urinary retention. Urology. 2016;87:166-171. https://doi.org/10.1016/j.urology.2015.10.011</Citation></Reference><Reference><Citation>Trotsenko P , Wetterauer C , Grimsehl P , et al. Efficacy, safety, and perioperative outcomes of holmium laser enucleation of the prostate-a comparison of patients with lower urinary tract symptoms and urinary retention. Lasers Med Sci. 2020. https://link.springer.com/article/10.1007%2Fs10103-020-03170-4</Citation></Reference><Reference><Citation>Woo H , Reich O , Bachmann A , et al. Outcome of GreenLight HPS 120-W Laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (&#x2265; 80&#x2009;ml). European Urology Supplements. 2008;7(4):378-383. https://doi.org/10.1016/j.eursup.2008.01.016</Citation></Reference><Reference><Citation>Woo HH . Photoselective vaporization of the prostate using the 120-W lithium triborate laser in enlarged prostates (&gt;120 cc). BJU Int. 2011;108(6):860-863. https://doi.org/10.1111/j.1464-410X.2010.09855.x</Citation></Reference><Reference><Citation>Shimizu S , Saito M , Kinoshita Y , et al. Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger. BJU Int. 2009;104(5):713-717. https://doi.org/10.1111/j.1464-410X.2009.08471.x</Citation></Reference><Reference><Citation>Madersbacher H , Cardozo L , Chapple C , et al. What are the causes and consequences of bladder overdistension? ICI-RS 2011. Neurourol Urodyn. 2012;31(3):317-321. https://doi.org/10.1002/nau.22224</Citation></Reference><Reference><Citation>Rubilotta E , Balzarro M , Gubbiotti M , Antonelli A . Outcomes of transurethral resection of the prostate in unobstructed patients with concomitant detrusor underactivity. Neurourol Urodyn.&#xa0; 2020;39(8):2179-2185. https://doi.org/10.1002/nau.24470</Citation></Reference><Reference><Citation>Spiro LH , Labay G , Orkin LA . Prostatic infarction. Role in acute urinary retention. Urology. 1974;3(3):345-347. https://doi.org/10.1016/s0090-4295(74)80119-6</Citation></Reference><Reference><Citation>Strachan JR , Corbishley CM , Shearer RJ . Postoperative retention associated with acute prostatic infarction. Br J Urol. 1993;72(3):311-313. https://doi.org/10.1111/j.1464-410x.1993.tb00724.x</Citation></Reference><Reference><Citation>Westhofen T , Schott M , Keller P , Tamalunas A , Stief CG , Magistro G . Superiority of holmium laser enucleation of the prostate over transurethral resection of the prostate in a matched-pair analysis of bleeding complications under various antithrombotic regimens. J Endourol. 2021;35:328-334. https://doi.org/10.1089/end.2020.0321</Citation></Reference><Reference><Citation>Colau A , Lucet JC , Rufat P , Botto H , Benoit G , Jardin A . Incidence and risk factors of bacteriuria after transurethral resection of the prostate. Eur Urol. 2001;39(3):272-276. https://doi.org/10.1159/000052452</Citation></Reference><Reference><Citation>Chughtai B , Simma-Chiang V , Kaplan SA . Evaluation and management of post-transurethral resection of the prostate lower urinary tract symptoms. Curr Urol Rep. 2014;15(9):434. https://doi.org/10.1007/s11934-014-0434-1</Citation></Reference><Reference><Citation>Kim SJ , Al Hussein Alawamlh O , Chughtai B , Lee RK . Lower urinary tract symptoms following transurethral resection of prostate. Curr Urol Rep. 2018;19(10):85. https://doi.org/10.1007/s11934-018-0838-4</Citation></Reference><Reference><Citation>Gomes CM , Nunes RV , Ara&#xfa;jo RM , et al. Urodynamic evaluation of patients with lower urinary tract symptoms and small prostate volume. Urol Int. 2008;81(2):129-134. https://doi.org/10.1159/000144049</Citation></Reference><Reference><Citation>Tubaro A , Carter S , Trucchi A , Punzo G , Petta S , Miano L . Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage. Drugs Aging. 2003;20(3):185-195. https://doi.org/10.2165/00002512-200320030-00003</Citation></Reference><Reference><Citation>Lazzeri M , Sansalone S , Guazzoni G , Barbagli G . Incidence, causes, and complications of urethral stricture disease. European Urology Supplements. 2016;15(1):2-6. https://doi.org/10.1016/j.eursup.2015.10.002</Citation></Reference><Reference><Citation>Teoh JY , Chan CK , Wang MH , et al. Transurethral resection of prostate for acute urinary retention is linked to shorter survival in younger men. Asian J Androl. 2019;21(5):468-472. https://doi.org/10.4103/aja.aja_101_18</Citation></Reference><Reference><Citation>Dindo D , Demartines N , Clavien P-A . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213. https://doi.org/10.1097/01.sla.0000133083.54934.ae</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27401660</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1976-2437</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Yonsei medical journal</Title><ISOAbbreviation>Yonsei Med J</ISOAbbreviation></Journal><ArticleTitle>Protocol-Based Resuscitation for Septic Shock: A Meta-Analysis of Randomized Trials and Observational Studies.</ArticleTitle><Pagination><StartPage>1260</StartPage><EndPage>1270</EndPage><MedlinePgn>1260-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3349/ymj.2016.57.5.1260</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Owing to the recommendations of the Surviving Sepsis Campaign guidelines, protocol-based resuscitation or goal-directed therapy (GDT) is broadly advocated for the treatment of septic shock. However, the most recently published trials showed no survival benefit from protocol-based resuscitation in septic shock patients. Hence, we aimed to assess the effect of GDT on clinical outcomes in such patients.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We performed a systematic review that included a meta-analysis. We used electronic search engines including PubMed, Embase, and the Cochrane database to find studies comparing protocol-based GDT to common or standard care in patients with septic shock and severe sepsis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 13269 septic shock patients in 24 studies were included [12 randomized controlled trials (RCTs) and 12 observational studies]. The overall mortality odds ratio (OR) [95% confidence interval (CI)] for GDT versus conventional care was 0.746 (0.631-0.883). In RCTs only, the mortality OR (95% CI) for GDT versus conventional care in the meta-analysis was 0.93 (0.75-1.16). The beneficial effect of GDT decreased as more recent studies were added in an alternative, cumulative meta-analysis. No significant publication bias was found.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The result of this meta-analysis suggests that GDT reduces mortality in patients with severe sepsis or septic shock. However, our cumulative meta-analysis revealed that the reduction of mortality risk was diminished as more recent studies were added.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Woo Kyung</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ha Yeon</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jinae</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Shin Ok</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Chung-Ang University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jeong Min</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na</LastName><ForeName>Sungwon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea. nswksj@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Yonsei Med J</MedlineTA><NlmUniqueID>0414003</NlmUniqueID><ISSNLinking>0513-5796</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="Y">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword><Keyword MajorTopicYN="N">shock</Keyword></KeywordList><CoiStatement>The authors have no financial conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27401660</ArticleId><ArticleId IdType="pmc">PMC4960395</ArticleId><ArticleId IdType="doi">10.3349/ymj.2016.57.5.1260</ArticleId><ArticleId IdType="pii">57.1260</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambon M, Ceola M, Almeida-de-Castro R, Gullo A, Vincent JL. Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care. 2008;23:455&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">19056006</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Ortega A, Suberviola B, Garc&#xed;a-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med. 2010;38:1036&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pubmed">20154597</ArticleId></ArticleIdList></Reference><Reference><Citation>ARISE Investigators; ANZICS Clinical Trials Group. Peake SL, Delaney A, Bailey M, Bellomo R, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496&#x2013;1506.</Citation><ArticleIdList><ArticleId IdType="pubmed">25272316</ArticleId></ArticleIdList></Reference><Reference><Citation>ProCESS Investigators. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683&#x2013;1693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu WJ, Wang F, Bakker J, Tang L, Liu JC. The effect of goal-directed therapy on mortality in patients with sepsis - earlier is better: a meta-analysis of randomized controlled trials. Crit Care. 2014;18:570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4232636</ArticleId><ArticleId IdType="pubmed">25327977</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhu G, Han L, Fu P. Early goal-directed therapy in the management of severe sepsis or septic shock in adults: a meta-analysis of randomized controlled trials. BMC Med. 2015;13:71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4393610</ArticleId><ArticleId IdType="pubmed">25885654</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1&#x2013;e34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101&#x2013;129.</Citation></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Focht A, Horton JM, Kline JA. Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock. Chest. 2007;132:425&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703721</ArticleId><ArticleId IdType="pubmed">17573521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994;330:1717&#x2013;1722.</Citation><ArticleIdList><ArticleId IdType="pubmed">7993413</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuchschmidt J, Fried J, Astiz M, Rackow E. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest. 1992;102:216&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">1623756</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Levy MM, Smith P, Takiguchi SA, Miyasaki A, Myers SA. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med. 1993;21:830&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pubmed">8504649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333:1025&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">7675044</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#xed;a I, Esteban A, Gordo F, Lorente JA, Diaz C, Rodriguez JA, et al. A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest. 1999;115:453&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">10027447</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2918907</ArticleId><ArticleId IdType="pubmed">20179283</ArticleId></ArticleIdList></Reference><Reference><Citation>Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med. 2006;34:2707&#x2013;2713.</Citation><ArticleIdList><ArticleId IdType="pubmed">16943733</ArticleId></ArticleIdList></Reference><Reference><Citation>Coba V, Whitmill M, Mooney R, Horst HM, Brandt MM, Digiovine B, et al. Resuscitation bundle compliance in severe sepsis and septic shock: improves survival, is better late than never. J Intensive Care Med. 2011;26:304&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">21220270</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews B, Muchemwa L, Kelly P, Lakhi S, Heimburger DC, Bernard GR. Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia. Crit Care Med. 2014;42:2315&#x2013;2324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4199893</ArticleId><ArticleId IdType="pubmed">25072757</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301&#x2013;1311.</Citation><ArticleIdList><ArticleId IdType="pubmed">25776532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Artigas A, Levy MM, Blanco J, Gonz&#xe1;lez-D&#xed;az G, Garnacho- Montero J, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA. 2008;299:2294&#x2013;2303.</Citation><ArticleIdList><ArticleId IdType="pubmed">18492971</ArticleId></ArticleIdList></Reference><Reference><Citation>MacRedmond R, Hollohan K, Stenstrom R, Nebre R, Jaswal D, Dodek P. Introduction of a comprehensive management protocol for severe sepsis is associated with sustained improvements in timeliness of care and survival. Qual Saf Health Care. 2010;19:e46.</Citation><ArticleIdList><ArticleId IdType="pubmed">20671074</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F, Melody T, Daniels DF, Giles S, Fox S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care. 2005;9:R764&#x2013;R770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1414020</ArticleId><ArticleId IdType="pubmed">16356225</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med. 2007;35:1105&#x2013;1112.</Citation><ArticleIdList><ArticleId IdType="pubmed">17334251</ArticleId></ArticleIdList></Reference><Reference><Citation>Puskarich MA, Marchick MR, Kline JA, Steuerwald MT, Jones AE. One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study. Crit Care. 2009;13:R167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784398</ArticleId><ArticleId IdType="pubmed">19845956</ArticleId></ArticleIdList></Reference><Reference><Citation>De Miguel-Yanes JM, Mu&#xf1;oz-Gonz&#xe1;lez J, Andueza-Lillo JA, Moyano-Villaseca B, Gonz&#xe1;lez-Ramallo VJ, Bustamante-Fermosel A. Implementation of a bundle of actions to improve adherence to the Surviving Sepsis Campaign guidelines at the ED. Am J Emerg Med. 2009;27:668&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">19751623</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock. 2006;26:551&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">17117128</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe CA, Mistry CD, Rzechula K, Kulstad CE. Evaluation of a modified early goal-directed therapy protocol. Am J Emerg Med. 2010;28:689&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">20637384</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24615720</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1128-045X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Techniques in coloproctology</Title><ISOAbbreviation>Tech Coloproctol</ISOAbbreviation></Journal><ArticleTitle>The clinical results of the Turnbull-Cutait delayed coloanal anastomosis: a systematic review.</ArticleTitle><Pagination><StartPage>579</StartPage><EndPage>590</EndPage><MedlinePgn>579-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10151-014-1132-1</ELocationID><Abstract><AbstractText>Turnbull and Cutait described abdominoperineal pull-through followed by delayed coloanal anastomosis (DCA) in 1961. DCA could reduce anastomotic leaks, pelvic morbidity and use of stomas. Strong evidence about its clinical benefits is still lacking. This systematic review examined the clinical outcomes of DCA for the treatment of malignant or benign colorectal conditions. A systematic search of electronic medical databases was conducted. Two independent reviewers selected studies, extracted data and assessed risk of bias. The primary outcome was pelvic morbidity (anastomotic leak, pelvic abscess or sepsis, use of stoma). Fecal continence and survival data were also analyzed. From 1,251 citations, we included seven observational studies including 1,124 patients. All included studies were considered at high risk of bias. Two studies comparing DCA with immediate anastomosis reported a significant decrease in anastomotic leak, and pelvic abscess or sepsis. Low rates of pelvic morbidity were reported in the other five studies: anastomotic leak 0-7&#xa0;%, pelvic abscess 0-11.8&#xa0;% and pelvic sepsis 6.8-10&#xa0;%. Rates of permanent stoma after DCA were low in six studies (1-6&#xa0;%), with one study reporting an incidence of 25&#xa0;%. Fecal continence was reported as satisfying in all studies. No differences were observed in a comparative setting. Survival data were reported in four studies. Clinical heterogeneity and methodological issues precluded meta-analysis. Based on retrospective evidence, DCA offers a low rate of anastomotic leak, pelvic morbidity and use of stoma, with reasonable fecal continence. Results are encouraging, but prospective studies are needed for comparison with standard of care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hallet</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Universit&#xe9; Laval, Quebec, QC, Canada, juliehallet@me.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milot</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Drolet</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Desrosiers</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Gr&#xe9;goire</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Bouchard</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Tech Coloproctol</MedlineTA><NlmUniqueID>9613614</NlmUniqueID><ISSNLinking>1123-6337</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001003" MajorTopicYN="N">Anal Canal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003108" MajorTopicYN="N">Colonic Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012002" MajorTopicYN="N">Rectal Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24615720</ArticleId><ArticleId IdType="doi">10.1007/s10151-014-1132-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dis Colon Rectum. 2002 Oct;45(10):1304-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12394426</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1985 May;28(5):294-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3996144</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleve Clin Q. 1961 Apr;28:109-15</Citation><ArticleIdList><ArticleId IdType="pubmed">13778709</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2005 Jan;7(1):51-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15606585</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2006 Sep;49(9):1379-83</Citation><ArticleIdList><ArticleId IdType="pubmed">16819570</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2000 Dec;191(6):643-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11129813</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2001 Jul;25(7):876-81</Citation><ArticleIdList><ArticleId IdType="pubmed">11572027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1998 Jul;228(1):64-70</Citation><ArticleIdList><ArticleId IdType="pubmed">9671068</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc R Soc Med. 1970;63 Suppl:121-8</Citation><ArticleIdList><ArticleId IdType="pubmed">5525478</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2011 Oct;54(10):1313-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21904148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2008 Jul;248(1):52-60</Citation><ArticleIdList><ArticleId IdType="pubmed">18580207</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2006 Jan;93(1):19-32</Citation><ArticleIdList><ArticleId IdType="pubmed">16273532</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2005 May;48(5):1021-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15789125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chir (Paris). 2009 Oct;146(5):458-63</Citation><ArticleIdList><ArticleId IdType="pubmed">19833335</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirurgie. 1999 Jun;124(3):240-50; discussion 251</Citation><ArticleIdList><ArticleId IdType="pubmed">10429297</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 1998;13(4):160-3</Citation><ArticleIdList><ArticleId IdType="pubmed">9810519</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1961 Sep-Oct;4:335-42</Citation><ArticleIdList><ArticleId IdType="pubmed">13882795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2010 May;251(5):807-18</Citation><ArticleIdList><ArticleId IdType="pubmed">20395841</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2005 Sep;92(9):1150-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16035134</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1998 Jun;41(6):740-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9645742</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2003 Oct;90(10):1261-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14515297</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Gynecol Obstet. 1982 Apr;154(4):566-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7038951</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1948 Apr 10;1(6502):551-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18909673</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2010 Jul;14(7):1190-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20094811</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1999 Sep 15;282(11):1054-60</Citation><ArticleIdList><ArticleId IdType="pubmed">10493204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Oct 20;370(9596):1453-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2009 Apr;96(4):424-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19283735</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1993 Jan;36(1):77-97</Citation><ArticleIdList><ArticleId IdType="pubmed">8416784</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2011 Sep;202(3):291-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21871983</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg Oncol. 2011 Feb;37(2):127-33</Citation><ArticleIdList><ArticleId IdType="pubmed">21186091</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2007 Jan;11(1):8-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17390180</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1978 Oct;65(10):695-8</Citation><ArticleIdList><ArticleId IdType="pubmed">709078</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2009 Jun;24(6):711-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19221766</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2010 Jul;25(7):873-80</Citation><ArticleIdList><ArticleId IdType="pubmed">20195620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2004 Aug;240(2):255-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15273549</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2000 Apr 19;283(15):2008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Acad Natl Med. 2004;188(9):1509-24; discussion 1524-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15997621</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37087374</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Comparing minimally invasive surgical and open approaches to pelvic exenteration for locally advanced or recurrent pelvic malignancies - Systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1362</StartPage><EndPage>1373</EndPage><MedlinePgn>1362-1373</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2023.04.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(23)00440-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Pelvic exenteration (PE) is a complex multivisceral surgical procedure indicated for locally advanced or recurrent pelvic malignancies. It poses significant technical challenges which account for the high risk of morbidity and mortality associated with the procedure. Developments in minimally invasive surgical (MIS) approaches and enhanced peri-operative care have facilitated improved long term outcomes. However, the optimum approach to PE remains controversial.</AbstractText><AbstractText Label="METHODS">A systematic literature search was conducted in accordance with PRISMA guidelines to identify studies comparing MIS (robotic or laparoscopic) approaches for PE versus the open approach for patients with locally advanced or recurrent pelvic malignancies. The methodological quality of the included studies was assessed systematically and a meta-analysis was conducted.</AbstractText><AbstractText Label="RESULTS">11 studies were identified, including 2009 patients, of whom 264 (13.1%) underwent MIS PE approaches. The MIS group displayed comparable R0 resections (Risk Ratio [RR] 1.02, 95% Confidence Interval [95% CI] 0.98, 1.07, p&#xa0;=&#xa0;0.35)) and Lymph node yield (Weighted Mean Difference [WMD] 1.42, 95% CI -0.58, 3.43, p&#xa0;=&#xa0;0.16), and although MIS had a trend towards improved towards improved survival and recurrence outcomes, this did not reach statistical significance. MIS was associated with prolonged operating times (WMD 67.93, 95% CI 4.43, 131.42, p&#xa0;&lt;&#xa0;0.00001) however, this correlated with less intra-operative blood loss, and a shorter length of post-operative stay (WMD -3.89, 955 CI -6.53,&#xa0;-1.25, p&#xa0;&lt;&#xa0;0.00001). Readmission rates were higher with MIS (RR 2.11, 95% CI 1.11, 4.02, p&#xa0;=&#xa0;0.02), however, rates of pelvic abscess/sepsis were decreased (RR 0.45, 95% CI 0.21, 0.95, p&#xa0;=&#xa0;0.04), and there was no difference in overall, major, or specific morbidity and mortality.</AbstractText><AbstractText Label="CONCLUSION">MIS approaches are a safe and feasible option for PE, with no differences in survival or recurrence outcomes compared to the open approach. MIS also reduced the length of post-operative stay and decreased blood loss, offset by increased operating time.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Odhr&#xe1;n K</ForeName><Initials>OK</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doogan</LastName><ForeName>Katie L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>&#xc9;anna J</ForeName><Initials>&#xc9;J</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland. Electronic address: eannaryan@rcsi.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donnelly</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Ian S</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Royal College of Surgeons in Ireland, 123. St. Stephen's Green, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Creavin</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davey</LastName><ForeName>Matthew G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Surgery, Royal College of Surgeons in Ireland, 123. St. Stephen's Green, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennelly</LastName><ForeName>Rory</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland; Centre for Colorectal Disease, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanly</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland; Centre for Colorectal Disease, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Se&#xe1;n T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland; Centre for Colorectal Disease, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Des C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin, Ireland; Centre for Colorectal Disease, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland; School of Medicine, University College, Dublin, Dublin 4, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010386" MajorTopicYN="Y">Pelvic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010385" MajorTopicYN="Y">Pelvic Exenteration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010388" MajorTopicYN="N">Pelvis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal malignancy</Keyword><Keyword MajorTopicYN="N">Gynaecological malignancy</Keyword><Keyword MajorTopicYN="N">Laparoscopic surgery</Keyword><Keyword MajorTopicYN="N">Minimally invasive surgery</Keyword><Keyword MajorTopicYN="N">Pelvic exenteration</Keyword><Keyword MajorTopicYN="N">Robotic surgery</Keyword><Keyword MajorTopicYN="N">Surgical outcomes</Keyword><Keyword MajorTopicYN="N">Urological malignancy</Keyword></KeywordList><CoiStatement>Declaration of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>23</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>22</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37087374</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2023.04.003</ArticleId><ArticleId IdType="pii">S0748-7983(23)00440-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28979458</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1751-1437</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of the Intensive Care Society</Title><ISOAbbreviation>J Intensive Care Soc</ISOAbbreviation></Journal><ArticleTitle>Tissue Doppler indices of diastolic function in critically ill patients and association with mortality - a systematic review.</ArticleTitle><Pagination><StartPage>51</StartPage><EndPage>62</EndPage><MedlinePgn>51-62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1751143715595641</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Systolic impairment is well reported in critically ill patients but diastolic function has been relatively understudied. The objective of this review was to assess tissue Doppler indices of diastolic function in critically ill patients along with any association with mortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of articles in English using Medline, EMBASE, CINAHL and the Cochrane database of systematic reviews. Search terms included diastolic function, diastolic dysfunction, diastolic abnormal*, diastolic heart failure, diastolic filling, ventricular relaxation, pulmonary artery occlusion pressure, left ventricular filling pressure, cardiac dysfunction, intensive care, critical care, critically ill, critical illness, sepsis and septic shock. Only studies of critically ill adult patients (excluding post-cardiac surgical patients) whose diastolic function was assessed using tissue Doppler imaging were included. Study quality was assessed using a modified version of the Newcastle-Ottawa Scale (NOS).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nineteen studies were included, with a total of 1365 patients. All trials were observational. There was a large heterogeneity in patient populations and the methodology of tissue Doppler assessment of diastology resulting in a descriptive analysis. Patient groups included severe sepsis or septic shock (5 studies), septic shock (5 studies), systemic inflammatory response syndrome and shock (1 study), septic shock and acute lung injury (1 study), cancer and septic shock (2 studies), general ICU patients (1 study), combined medical and surgical ICU (2 studies) and sub-arachnoid haemorrhage patients (2 studies). Seventeen studies scored 5/6 on the NOS with the remaining two scoring 4/6. Fourteen studies reported on numbers of patients diagnosed with diastolic dysfunction (500/999, mean 50%, range 20-92%). Three studies found that diastolic dysfunction was an independent predictor of mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Current data shows a large range in the incidence of diastolic dysfunction in this patient population and a variable link with mortality. Future research should focus on the definition of normal values for diastolic function in critically ill patients along with the effects of ICU therapies and consensus criteria for its assessment in this patient population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garry</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthetics, Oxford University Hospitals NHS Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newton</LastName><ForeName>Jim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, OUH NHS Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colebourn</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, OUH NHS Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Intensive Care Soc</MedlineTA><NlmUniqueID>101538668</NlmUniqueID><ISSNLinking>1751-1437</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diastolic dysfunction</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28979458</ArticleId><ArticleId IdType="pmc">PMC5606373</ArticleId><ArticleId IdType="doi">10.1177/1751143715595641</ArticleId><ArticleId IdType="pii">10.1177_1751143715595641</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>MacLean LD, Mulligan WG, McLean AP, et al. Patterns of septic shock in man&#x2013;a detailed study of 56 patients. Ann Surg 1967; 166: 543&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1477449</ArticleId><ArticleId IdType="pubmed">6061542</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Int Med 1984; 100: 483&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">6703540</ArticleId></ArticleIdList></Reference><Reference><Citation>Orde SR, Pulido JN, Masaki M, et al. Outcome prediction in sepsis: Speckle tracking echocardiography based assessment of myocardial function. Crit Care 2014; 18: R149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227017</ArticleId><ArticleId IdType="pubmed">25015102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10: 165&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">19270053</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignon P, Allot V, Lesage J, et al. Diagnosis of left ventricular diastolic dysfunction in the setting of acute changes in loading conditions. Crit Care 2007; 11: R43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206469</ArticleId><ArticleId IdType="pubmed">17428322</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacques DC, Pinsky MR, Severyn D, et al. Influence of alterations in loading on mitral annular velocity by tissue Doppler echocardiography and its associated ability to predict filling pressures. Chest 2004; 126: 1910&#x2013;1918.</Citation><ArticleIdList><ArticleId IdType="pubmed">15596692</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539&#x2013;2550.</Citation><ArticleIdList><ArticleId IdType="pubmed">17428822</ArticleId></ArticleIdList></Reference><Reference><Citation>Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med 2004; 351: 1097&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">15356307</ArticleId></ArticleIdList></Reference><Reference><Citation>Aurigemma GP. Diastolic heart failure&#x2013;a common and lethal condition by any name. N Engl J Med 2006; 355: 308&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">16855273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O'Connell D, et&#xa0;al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [19/01/2015]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Mourad M, Chow-Chine L, Faucher M, et al. Early diastolic dysfunction is associated with intensive care unit mortality in cancer patients presenting with septic shock. Br J Anaesth 2014; 112: 102&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">24046293</ArticleId></ArticleIdList></Reference><Reference><Citation>Landesberg G, Jaffe AS, Gilon D, et al. Troponin elevation in severe sepsis and septic shock: The role of left ventricular diastolic dysfunction and right ventricular dilatation. Crit Care Med 2014; 42: 790&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">24365861</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturgess DJ, Parmar D, Dulhunty JM, et al. A preliminary evaluation of plasma b-type natriuretic peptide as a screening test for left ventricular diastolic dysfunction in non-cardiac intensive care. Anaesth Intensive Care 2013; 41: 591&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">23977909</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergenzaun L, Ohlin H, Gudmundsson P, et al. High-sensitive cardiac Troponin T is superior to echocardiography in predicting 1-year mortality in patients with SIRS and shock in intensive care. BMC Anesthesiol 2012; 12: 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3524030</ArticleId><ArticleId IdType="pubmed">23006477</ArticleId></ArticleIdList></Reference><Reference><Citation>Furian T, Aguiar C, Prado K, et al. Ventricular dysfunction and dilation in severe sepsis and septic shock: Relation to endothelial function and mortality. J Crit Care 2012; 27: 319.e9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">21855287</ArticleId></ArticleIdList></Reference><Reference><Citation>Landesberg G, Gilon D, Meroz Y, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J 2012; 33: 895&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345552</ArticleId><ArticleId IdType="pubmed">21911341</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahjoub Y, Benoit-Fallet H, Airapetian N, et al. Improvement of left ventricular relaxation as assessed by tissue Doppler imaging in fluid-responsive critically ill septic patients. Intensive Care Med 2012; 38: 1461&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pubmed">22717694</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturgess DJ, Marwick TH, Joyce C, et al. Prediction of hospital outcome in septic shock: A prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care 2010; 14: R44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887156</ArticleId><ArticleId IdType="pubmed">20331902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidis I, Nikolaou M, Dimopoulou I, et al. Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: A complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome. Shock 2010; 33: 141&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">19487972</ArticleId></ArticleIdList></Reference><Reference><Citation>Meaudre E, Jego C, Kenane N, et al. B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: a prospective study in non-cardiac patients. Crit Care 2009; 13: R76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717439</ArticleId><ArticleId IdType="pubmed">19454040</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanabe M, Crago EA, Suffoletto MS, et al. Relation of elevation in cardiac troponin I to clinical severity, cardiac dysfunction, and pulmonary congestion in patients with subarachnoid hemorrhage. Am J Cardiol 2008; 102: 1545&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3666562</ArticleId><ArticleId IdType="pubmed">19026312</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhemad B, Nicolas-Robin A, Arbelot C, et al. Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med 2008; 36: 766&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pubmed">18431265</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchecopar-Chevreuil C, Francois B, Clavel M, et al. Cardiac morphological and functional changes during early septic shock: A transesophageal echocardiographic study. Intensive Care Med 2008; 34: 250&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">18004543</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokart D, Sannini A, Brun JP, et al. N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shock. Crit Care 2007; 11: R37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206454</ArticleId><ArticleId IdType="pubmed">17359530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturgess DJ, Marwick TH, Joyce CJ, et al. Tissue Doppler in critical illness: A retrospective cohort study. Crit Care 2007; 11: R97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2556740</ArticleId><ArticleId IdType="pubmed">17803827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhemad B, Nicolas-Robin A, Benois A, et al. Echocardiographic Doppler assessment of pulmonary capillary wedge pressure in surgical patients with postoperative circulatory shock and acute lung injury. Anesthesiology 2003; 98: 1091&#x2013;1100.</Citation><ArticleIdList><ArticleId IdType="pubmed">12717130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi N, Czarnecki A, Ahmadie R, et al. The utility of tissue Doppler imaging for the noninvasive determination of left ventricular filling pressures in patients with septic shock. J Intensive Care Med 2010; 25: 163&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">20444737</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SM, Pittman JE, Hirshberg EL, et al. Diastolic dysfunction and mortality in early severe sepsis and septic shock: a prospective, observational echocardiography study. Crit Ultrasound J 2012; 4: 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3512479</ArticleId><ArticleId IdType="pubmed">22870900</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulido JN, Afessa B, Masaki M, et al. Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. Mayo Clinic Proc 2012; 87: 620&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538477</ArticleId><ArticleId IdType="pubmed">22683055</ArticleId></ArticleIdList></Reference><Reference><Citation>Landesberg G, Levin PD, Gilon D, et&#xa0;al. Myocardial dysfunction in severe sepsis and septic shock&#x2009;-&#x2009;no correlation with inflammatory cytokines in real-life clinical setting. Chest 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25591166</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: A systematic review and annotated bibliography. Int J Epidemiol 2007; 36: 666&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">17470488</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignon P, AitHssain A, Francois B, et al. Echocardiographic assessment of pulmonary artery occlusion pressure in ventilated patients: A transoesophageal study. Crit Care 2008; 12: R18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2374607</ArticleId><ArticleId IdType="pubmed">18284668</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25946168</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies.</ArticleTitle><Pagination><StartPage>e0125827</StartPage><MedlinePgn>e0125827</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0125827</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0125827</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several reports suggest that implementation of the Surviving Sepsis Campaign (SSC) guidelines is associated with mortality reduction in sepsis. However, adherence to the guideline-based resuscitation and management sepsis bundles is still poor.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To perform a systematic review of studies evaluating the impact of performance improvement programs on compliance with Surviving Sepsis Campaign (SSC) guideline-based bundles and/or mortality.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Medline (PubMed), Scopus and Intercollegiate Studies Institute Web of Knowledge databases from 2004 (first publication of the SSC guidelines) to October 2014.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Studies on adult patients with sepsis, severe sepsis or septic shock that evaluated changes in compliance to individual/combined bundle targets and/or mortality following the implementation of performance improvement programs. Interventions may consist of educational programs, process changes or both.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Data from the included studies were extracted independently by two authors. Unadjusted binary data were collected in order to calculate odds ratios (OR) for compliance to individual/combined bundle targets. Adjusted (if available) or unadjusted data of mortality were collected. Random-effects models were used for the data synthesis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty observational studies were selected. Despite high inconsistency across studies, performance improvement programs were associated with increased compliance with the complete 6-hour bundle (OR = 4.12 [95% confidence interval 2.95-5.76], I(2) = 87.72%, k = 25, N = 50,081) and the complete 24-hour bundle (OR = 2.57 [1.74-3.77], I(2) = 85.22%, k = 11, N = 45,846) and with a reduction in mortality (OR = 0.66 [0.61-0.72], I(2) = 87.93%, k = 48, N = 434,447). Funnel plots showed asymmetry.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Performance improvement programs are associated with increased adherence to resuscitation and management sepsis bundles and with reduced mortality in patients with sepsis, severe sepsis or septic shock.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Damiani</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Department of Biomedical Sciences and Public Health, Universit&#xe0; Politecnica delle Marche, Via Tronto 10, 60126 Torrette di Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donati</LastName><ForeName>Abele</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Department of Biomedical Sciences and Public Health, Universit&#xe0; Politecnica delle Marche, Via Tronto 10, 60126 Torrette di Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serafini</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Modena University Hospital, L.go del Pozzo 71, 41100 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Modena University Hospital, L.go del Pozzo 71, 41100 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adrario</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Department of Biomedical Sciences and Public Health, Universit&#xe0; Politecnica delle Marche, Via Tronto 10, 60126 Torrette di Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelaia</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Department of Biomedical Sciences and Public Health, Universit&#xe0; Politecnica delle Marche, Via Tronto 10, 60126 Torrette di Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busani</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Modena University Hospital, L.go del Pozzo 71, 41100 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girardis</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Modena University Hospital, L.go del Pozzo 71, 41100 Modena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="Y">Guideline Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010043" MajorTopicYN="Y">Outcome and Process Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>5</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25946168</ArticleId><ArticleId IdType="pmc">PMC4422717</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0125827</ArticleId><ArticleId IdType="pii">PONE-D-14-50776</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014; 5: 4&#x2013;11. 10.4161/viru.27372</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.27372</ArticleId><ArticleId IdType="pmc">PMC3916382</ArticleId><ArticleId IdType="pubmed">24335434</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend SR, Schorr C, Levy MM, Dellinger RP.Reducing mortality in severe sepsis: The Surviving Sepsis Campaign. Clin Chest Med. 2008; 29: 721&#x2013;733. 10.1016/j.ccm.2008.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2008.06.011</ArticleId><ArticleId IdType="pubmed">18954706</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: International Guidelines for the Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med. 2013; 41: 580&#x2013;637. 10.1097/CCM.0b013e31827e83af</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827e83af</ArticleId><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Pronovost PJ, Dellinger RP, Townsend S, Resar RK, Clemmer TP, et al. Sepsis change bundles: Converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med. 2004; 32: S595&#x2013;S597.</Citation><ArticleIdList><ArticleId IdType="pubmed">15542969</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F, Melody T, Daniels DF, Giles S, Fox S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital-mortality in patients with severe sepsis: a prospective observational study. Crit Care. 2005; 9: R764&#x2013;R770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1414020</ArticleId><ArticleId IdType="pubmed">16356225</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Zanten ARH, Brinkman S, Arbous MS, Abu-Hanna A, Levy MM, de Keizer NF; Netherlands Patient Safety Agency Sepsis Expert Group. Guideline bundles adherence and mortality in severe sepsis and septic shock. Crit Care Med. 2014; 42: 1890&#x2013;1898. 10.1097/CCM.0000000000000297</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000297</ArticleId><ArticleId IdType="pubmed">24670937</ArticleId></ArticleIdList></Reference><Reference><Citation>Djurkovic S, Baracaldo JC, Guerra JA, Sartorius J, Haupt MT. A survey of clinicians addressing the approach to the management of severe sepsis and septic shock in the United States. J Crit Care. 2010; 25: 658.e1&#x2013;658.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20646900</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010; 36: 222&#x2013;231. 10.1007/s00134-009-1738-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1738-3</ArticleId><ArticleId IdType="pmc">PMC2826633</ArticleId><ArticleId IdType="pubmed">20069275</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliano KK, Lecardo M, Staul LA. Impact of Protocol Watch on compliance with the Surviving Sepsis Campaign. Am J Crit Care. 2011; 20: 330&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">21724635</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg GM, Vasquez DG, Hale LDS, Nyberg SM, Moran DA. Evaluation of process variations in noncompliance in implementation of evidence-based sepsis care. J Healthc Qual. 2013; 35: 60&#x2013;69. 10.1111/j.1945-1474.2011.00168.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1945-1474.2011.00168.x</ArticleId><ArticleId IdType="pubmed">22093135</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS sepsis definitions conference. Crit Care Med. 2003; 31: 1250&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pubmed">12682500</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004; 30: 536&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">14997291</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998; 52:377&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1756728</ArticleId><ArticleId IdType="pubmed">9764259</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Chichester, UK: John Wiley and Sons, Ltd; 2009.</Citation></Reference><Reference><Citation>Lipsey MW, Wilson DB, eds. Practical Meta-Analysis. Vol 49 Thousand Oaks, CA: Sage; 2001.</Citation></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ. 2003; 327: 557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001; 54: 1046&#x2013;1055.</Citation><ArticleIdList><ArticleId IdType="pubmed">11576817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond CM, Djogovic D, Villa-Roel C, Bullard MJ, Meurer DP, Rowe BH. Pilot study comparing sepsis management with and without electronic clinical practice guidelines in an academic emergency department. J Emerg Med. 2013; 44: 698&#x2013;708. 10.1016/j.jemermed.2012.08.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2012.08.025</ArticleId><ArticleId IdType="pubmed">23137959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon CM, Holthaus CV, Zubrow MT, Posa P, Gunaga S, Kella V, et al. The GENESIS Project (GENeralized Early Sepsis Intervention Strategies): a multicenter quality improvement collaborative. J Intensive Care Med. 2012; 10.1177/0885066612453025</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066612453025</ArticleId><ArticleId IdType="pubmed">22902347</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuzzo M, Rambaldi M, Pinelli G, Campesato M, Pigna A, Zanello M, et al. Hospital staff education on severe sepsis/septic shock and hospital mortality: an original hypothesis. BMC Anesthesiology. 2012; 12: 28 10.1186/1471-2253-12-28</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-12-28</ArticleId><ArticleId IdType="pmc">PMC3524041</ArticleId><ArticleId IdType="pubmed">23167611</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study. Crit Care Med. 2010; 38: 1036&#x2013;1043. 10.1097/CCM.0b013e3181d455b6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181d455b6</ArticleId><ArticleId IdType="pubmed">20154597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Chang SC, Pu C, Tang GJ. The impact of nationwide education program on clinical practice in sepsis care and mortality of severe sepsis: a population-based study in Taiwan. PLoS ONE. 2013; 8: e77414 10.1371/journal.pone.0077414</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077414</ArticleId><ArticleId IdType="pmc">PMC3790748</ArticleId><ArticleId IdType="pubmed">24124616</ArticleId></ArticleIdList></Reference><Reference><Citation>De Miguel-Yanes JM, Munoz-Gonzalez J, Andueza-Lillo JA, Moyano-Villaseca B, Gonzalez-Ramallo VJ, Bustamante-Fermosel A. Implementation of a bundle of actions to improve adherence to the Surviving Sepsis Campaign guidelines at the ED. Am J Emerg Med. 2009; 27: 668&#x2013;674. 10.1016/j.ajem.2008.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2008.05.010</ArticleId><ArticleId IdType="pubmed">19751623</ArticleId></ArticleIdList></Reference><Reference><Citation>El Solh AA, Akinnusi ME, Alsawalha LN, Pineda LA. Outcome in septic shock in older adults after implementation of the sepsis &#x201c;bundle&#x201d;. JAGS. 2008; 56: 272&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">18047494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Dias G, Garnacho-Montero J, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA. 2008; 299: 2294&#x2013;2303. 10.1001/jama.299.19.2294</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.299.19.2294</ArticleId><ArticleId IdType="pubmed">18492971</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis M, Rich T, Williamson T, Peterson D. Effect of an emergency department sepsis protocol on time to antibiotics in severe sepsis. CJEM. 2010; 12: 303&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">20650022</ArticleId></ArticleIdList></Reference><Reference><Citation>Girardis M, Rinaldi L, Donno L, Marietta M, Codeluppi M, Marchegiano P, et al. Effects on management and outcome of severe sepsis and septic shock patients admitted to the intensive care unit after implementation of a sepsis program: a pilot study. Crit Care. 2009; 13: R143 10.1186/cc8029</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8029</ArticleId><ArticleId IdType="pmc">PMC2784353</ArticleId><ArticleId IdType="pubmed">19728879</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurnani PK, Patel GP, Crank CW, Vais D, Lateef O, Akimov S, et al. Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: a single-center, before-and-after study. Clinical Therapeutics. 2010; 32: 1285&#x2013;1293. 10.1016/j.clinthera.2010.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2010.07.003</ArticleId><ArticleId IdType="pubmed">20678676</ArticleId></ArticleIdList></Reference><Reference><Citation>Heppner HJ, Singler K, Kwetkat A, Popp S, Esslinger AS, Bahrmann P, et al. Do clinical guidelines improve management of sepsis in critically ill elderly patients? A before-and-after study of the implementation of a sepsis protocol. Wien Klin Wochenschr. 2012; 124: 692&#x2013;698. 10.1007/s00508-012-0229-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-012-0229-7</ArticleId><ArticleId IdType="pubmed">22948390</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoo WES, Muehlberg K, Ferraro RG, Jumaoas MC. Successes and lessons learned implementing the sepsis bundle. J Healthc Qual. 2009; 31: 9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">19753803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob ST, Banura P, Baeten JM, Moore CC, Meya D, Nakiyingi L, et al. The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: a prospective intervention study. Crit Care Med. 2012; 40: 2050&#x2013;2058. 10.1097/CCM.0b013e31824e65d7</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31824e65d7</ArticleId><ArticleId IdType="pmc">PMC3378757</ArticleId><ArticleId IdType="pubmed">22564958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon K, Shin TG, Sim MS, Suh GY, Lim SY, Song HG, et al. Improvements in compliance with resuscitation bundles and achievement of end points after an educational program on the management of severe sepsis and septic shock. SHOCK. 2012; 37: 463&#x2013;467. 10.1097/SHK.0b013e31824c31d1</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e31824c31d1</ArticleId><ArticleId IdType="pubmed">22301605</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Troyer JL, Kline JA. Cost-effectiveness of an emergency department based early sepsis resuscitation protocol. Crit Care Med. 2011; 39: 1306&#x2013;1312. 10.1097/CCM.0b013e31821201be</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31821201be</ArticleId><ArticleId IdType="pmc">PMC3102146</ArticleId><ArticleId IdType="pubmed">21336115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan WS, Mahadevan M, Tan JH, Guo J, Ibrahim I. Feasibility of introduction and implementation of the Surviving Sepsis Campaign bundle in a Singapore Emergency Department. Eur J Emerg Med. 2013; 20: 344&#x2013;349. 10.1097/MEJ.0b013e32835c2ba3</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEJ.0b013e32835c2ba3</ArticleId><ArticleId IdType="pubmed">23211272</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguna-P&#xe9;rez A, Chilet-Rosell E, Delgado Lacosta M, Alvarez-Dardet C, Uris Selles J, Munoz-Mendoza CL. Clinical pathway intervention compliance and effectiveness when used in the treatment of patients with severe sepsis and septic shock at an Intensive Care Unit in Spain. Rev Lat Am Enfermagem. 2012; 20: 635&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">22990147</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRosa JA, Ahmad N, Feinberg M, Shah M, DiBrienza R, Studer S. The use of an early alert system to improve compliance with sepsis bundles and to assess impact on mortality. Crit Care Res Pract. 2012; 2012: 980369 10.1155/2012/980369</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/980369</ArticleId><ArticleId IdType="pmc">PMC3296210</ArticleId><ArticleId IdType="pubmed">22461981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefrant JY, Muller L, Raillard A, Jung B, Beaudroit L, Favier L, et al. Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study. Ann Fr Anesth Reanim. 2010; 29: 621&#x2013;628. 10.1016/j.annfar.2010.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annfar.2010.04.007</ArticleId><ArticleId IdType="pubmed">20634026</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Rhodes A, Phillips GS, Townsend SR, Schorr CA, Beale R, et al. Surviving Sepsis Campaign: Association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2014; 43: 3&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">25275252</ArticleId></ArticleIdList></Reference><Reference><Citation>MacRedmond R, Hollohan K, Stenstrom R, Nebre R, Jaswal D, Dodek P. Introduction of a comprehensive management protocol for severe sepsis is associated with sustained improvements in timeliness of care and survival. Qual Saf Health Care. 2010; 19: e46 10.1136/qshc.2009.033407</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/qshc.2009.033407</ArticleId><ArticleId IdType="pubmed">20671074</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinley BA, Moore LJ, Sucher JF, Todd SR, Turner KL, Valdivia A, et al. Computer protocol facilitates evidence-based Care of sepsis in the surgical intensive care unit. J Trauma. 2011; 70: 1153&#x2013;1167. 10.1097/TA.0b013e31821598e9</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31821598e9</ArticleId><ArticleId IdType="pubmed">21610430</ArticleId></ArticleIdList></Reference><Reference><Citation>Memon JI, Rehmani RS, Alaithan AM, El Gammal A, Lone TM, Ghorab K, et al. Impact of 6-hour sepsis resuscitation bundle compliance on hospital mortality in a Saudi hospital. Crit Care Res Pract. 2012; 2012: 273268 10.1155/2012/273268</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/273268</ArticleId><ArticleId IdType="pmc">PMC3469084</ArticleId><ArticleId IdType="pubmed">23082248</ArticleId></ArticleIdList></Reference><Reference><Citation>Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, et al. Before&#x2014;after study of a standardized hospital order set for the management of septic shock. Crit Care Med. 2006; 34: 2707&#x2013;2713.</Citation><ArticleIdList><ArticleId IdType="pubmed">16943733</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RR 3rd, Dong L, Nelson NC, Brown SM, Kuttler KG, Probst DR, et al. Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med. 2013; 188: 77&#x2013;82. 10.1164/rccm.201212-2199OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201212-2199OC</ArticleId><ArticleId IdType="pmc">PMC3735248</ArticleId><ArticleId IdType="pubmed">23631750</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore LJ, Jones SL, Kreiner LA, McKinley B, Sucher JF, Todd SR, et al. Validation of a screening tool for the early identification of sepsis. J Trauma. 2009; 66: 1539&#x2013;1547. 10.1097/TA.0b013e3181a3ac4b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181a3ac4b</ArticleId><ArticleId IdType="pubmed">19509612</ArticleId></ArticleIdList></Reference><Reference><Citation>Na S, Kuan WS, Mahadevan M, Li CH, Shrikhande P, Ray S, et al. Implementation of early goal-directed therapy and the surviving sepsis campaign resuscitation bundle in Asia. Int J Qual Health Care. 2012; 24: 452&#x2013;462. 10.1093/intqhc/mzs045</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzs045</ArticleId><ArticleId IdType="pubmed">22899698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med. 2007; 35: 1105&#x2013;1112.</Citation><ArticleIdList><ArticleId IdType="pubmed">17334251</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HM, Schiavoni A, Scott KD, Tanios MA. Implementation of sepsis management guideline in a community-based teaching hospital&#x2014;can education be potentially beneficial for septic patients? Int J Clin Pract. 2012; 66: 705&#x2013;710. 10.1111/j.1742-1241.2012.02939.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-1241.2012.02939.x</ArticleId><ArticleId IdType="pubmed">22698423</ArticleId></ArticleIdList></Reference><Reference><Citation>Noritomi DT, Ranzani OT, Monteiro MB, Ferreira EM, Santos SR, Leibel F, et al. Implementation of a multifaceted sepsis education program in an emerging country setting: clinical outcomes and cost-effectiveness in a long-term follow-up study. Intensive Care Med. 2014; 40: 182&#x2013;191. 10.1007/s00134-013-3131-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-3131-5</ArticleId><ArticleId IdType="pubmed">24146003</ArticleId></ArticleIdList></Reference><Reference><Citation>Palleschi MT, Sirianni S, O&#x2019;Connor N, Dunn D, Hasenau SM. An interprofessional process to improve early identification and treatment for sepsis. J Healthc Qualt. 2014; 36: 23&#x2013;31. 10.1111/jhq.12006</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhq.12006</ArticleId><ArticleId IdType="pubmed">23534854</ArticleId></ArticleIdList></Reference><Reference><Citation>Patocka C, Turner J, Xue X, Segal E. Evaluation of an emergency department triage screening tool for suspected severe sepsis and septic shock. J Healthc Qual. 2014; 36: 52&#x2013;61. 10.1111/jhq.12055</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhq.12055</ArticleId><ArticleId IdType="pubmed">24372995</ArticleId></ArticleIdList></Reference><Reference><Citation>Plambech MZ, Lurie AI, Ipsen HL. Initial, successful implementation of sepsis guidelines in an emergency department. Dan Med J. 2012; 59: A4545</Citation><ArticleIdList><ArticleId IdType="pubmed">23290285</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawyer AM, Deal EN, Labelle AJ, Witt C, Thiel SW, Heard K, et al. Implementation of a real-time computerized sepsis alert in nonintensive care unit patients. Crit Care Med. 2011; 39: 469&#x2013;473. 10.1097/CCM.0b013e318205df85</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318205df85</ArticleId><ArticleId IdType="pubmed">21169824</ArticleId></ArticleIdList></Reference><Reference><Citation>Schramm GE, Kashyap R, Mullon JJ, Gajic O, Afessa B. Septic shock: a multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality. Crit Care Med. 2011; 39: 252&#x2013;258. 10.1097/CCM.0b013e3181ffde08</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181ffde08</ArticleId><ArticleId IdType="pubmed">21057312</ArticleId></ArticleIdList></Reference><Reference><Citation>Seoane L, Winterbottom F, Nash T, Behrhorst J, Chacko E, Shum L, et al. Using quality improvement principles to improve the care of patients with severe sepsis and septic shock. Ochsner J. 2013; 13: 359&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3776511</ArticleId><ArticleId IdType="pubmed">24052765</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J, et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapy (MUST) protocol. Crit Care Med. 2006; 34: 1025&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484890</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiramizo SC, Marra AR, Durao MS, Paes AT, Edmond MB, Pavao dos Santos OF. Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting. PLoS ONE. 2011; 6: e26790 10.1371/journal.pone.0026790</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026790</ArticleId><ArticleId IdType="pmc">PMC3207817</ArticleId><ArticleId IdType="pubmed">22073193</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman LZ, Hoesel M, Desai A, Posa P, Purtill MA, Brandt MM. It takes an intensivist. Am J Surg. 2011; 201: 320&#x2013;323. 10.1016/j.amjsurg.2010.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2010.09.013</ArticleId><ArticleId IdType="pubmed">21367371</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweet DD, Jaswal D, Fu W, Bouchard M, Sivapalan P, Rachel J, et al. Effect of an emergency department sepsis protocol on the care of septic patients admitted to the intensive care unit. CJEM. 2010; 12: 414&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">20880435</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel SW, Asghar MF, Micek ST, Reichlay RM, Doherty JA, Kollef MH. Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis. Crit Care Med. 2009; 37: 819&#x2013;824. 10.1097/CCM.0b013e318196206b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318196206b</ArticleId><ArticleId IdType="pubmed">19237883</ArticleId></ArticleIdList></Reference><Reference><Citation>Tromp M, Hulscher M, Bleeker-Rovers CP, Peters L, van den Berg DTNA, Borm GF, et al. The role of nurses in the recognition and treatment of patients with sepsis in the emergency department: a prospective before-and-after intervention study. Int J Nurs Stud. 2010; 47: 1464&#x2013;1473. 10.1016/j.ijnurstu.2010.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2010.04.007</ArticleId><ArticleId IdType="pubmed">20494356</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;e F, Fourcade O, Marty P, Sanchez P, Samii K, Genestal M. The hemodynamic &#x201c;target&#x201d;: a visual tool of goal-directed therapy for septic patients. Clinics. 2007; 62: 447&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">17823708</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Xiong Y, Schorr C, Dellinger RP. Impact of sepsis bundle strategy on outcomes of patients suffering from severe sepsis and septic shock in China. J Emerg Med. 2013; 44: 735&#x2013;741. 10.1016/j.jemermed.2012.07.084</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2012.07.084</ArticleId><ArticleId IdType="pubmed">23332802</ArticleId></ArticleIdList></Reference><Reference><Citation>Westphal GA, Koening A, Caldeira Filho M, Feij&#xf2; J, de Oliveira LT, Nunes F, et al. Reduced mortality after the implementation of a protocol for the early detection of severe sepsis. J Crit Care. 2011; 26: 76&#x2013;81. 10.1016/j.jcrc.2010.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2010.08.001</ArticleId><ArticleId IdType="pubmed">21036531</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012; 12: 919&#x2013;924. 10.1016/S1473-3099(12)70239-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(12)70239-6</ArticleId><ArticleId IdType="pubmed">23103175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang MJ, Shin TG, Jo IJ, Jeon K, Suh GY, Sim MS, et al. Factors influencing compliance with early resuscitation bundle in the management of severe sepsis and septic shock. Shock. 2012; 38: 474&#x2013;9. 10.1097/SHK.0b013e31826eea2b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e31826eea2b</ArticleId><ArticleId IdType="pubmed">23042195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012; 366: 2055&#x2013;2064. 10.1056/NEJMoa1202290</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1202290</ArticleId><ArticleId IdType="pubmed">22616830</ArticleId></ArticleIdList></Reference><Reference><Citation>ProCESS Investigators, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014; 370: 1683&#x2013;1693. 10.1056/NEJMoa1401602</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401602</ArticleId><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>The ARISE Investigators and the ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014; 371: 1496&#x2013;506. 10.1056/NEJMoa1404380</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1404380</ArticleId><ArticleId IdType="pubmed">25272316</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med. 2014; 42: 2&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313930</ArticleId><ArticleId IdType="pubmed">24201173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x2013;2012. JAMA. 2014; 311: 1308&#x2013;1316. 10.1001/jama.2014.2637</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.2637</ArticleId><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29204670</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.</ArticleTitle><Pagination><StartPage>167</StartPage><EndPage>178</EndPage><MedlinePgn>167-178</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-017-5004-9</ELocationID><Abstract><AbstractText Label="PURPOSE">Polymyxin B-immobilized hemoperfusion (PMX-HP) is an adjuvant therapy for sepsis or septic shock that clears circulating endotoxin. Prior trials have shown that PMX-HP improves surrogate endpoints. We aimed to conduct an evidence synthesis to evaluate the efficacy and safety of PMX-HP in critically ill adult patients with sepsis or septic shock.</AbstractText><AbstractText Label="METHODS">We searched for randomized controlled trials (RCTs) in MEDLINE, EMBASE, the Cochrane Library, the Health Technology Assessment Database, CINAHL, "Igaku Chuo Zasshi", the National Institute of Health Clinical Trials Register, the World Health Organization International Clinical Trials Registry Platform, the University Hospital Medical Information Network Clinical Trials Registry, the reference lists of retrieved articles, and publications by manufacturers of PMX-HP. The primary outcomes were 28-day all-cause mortality, the number of patients with at least one serious adverse event, and organ dysfunction scores. The GRADE methodology for the certainty of evidence was used.</AbstractText><AbstractText Label="RESULTS">Six trials (857 participants; weighted mean age 62.5&#xa0;years) proved eligible. Patient-oriented primary outcomes were assessed. The pooled risk ratio (RR) for 28-day mortality associated with PMX-HP was 1.03 [95% confidence interval (CI) 0.78-1.36; I <sup>2</sup>&#xa0;=&#xa0;25%; n&#xa0;=&#xa0;797]. The pooled RR for adverse events was 2.17 (95% CI 0.68-6.94; I <sup>2</sup>&#xa0;=&#xa0;0%; n&#xa0;=&#xa0;717). Organ dysfunction scores over 24-72&#xa0;h after PMX-HP treatment did not change significantly (standardized mean difference - 0.26; 95% CI - 0.64 to 0.12; I <sup>2</sup>&#xa0;=&#xa0;78%; n&#xa0;=&#xa0;797). The certainty of the body of evidence was judged as low for both benefit and harm using the GRADE methodology.</AbstractText><AbstractText Label="CONCLUSIONS">There is currently insufficient evidence to support the routine use of PMX-HP to treat patients with sepsis or septic shock.</AbstractText><AbstractText Label="REGISTRATION">PROSPERO International Prospective Register of Systematic Reviews (CRD42016038356).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3854-4081</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Preventive Medicine, Kyoto University Graduate School of Medicine, Yoshida Hon-machi, Sakyo-ku, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Japan Society for the Promotion of Science, 5-3-1 Kojimachi, Chiyoda-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganeko</LastName><ForeName>Riki</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Kyoto University Hospital, 54 Kawaharacho, Syogoin, Sakyo-ku, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kataoka</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Higashi-Naniwa-Cho 2-17-77, Amagasaki, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furukawa</LastName><ForeName>Toshi A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine, Yoshida Konoe-cho, Sakyo-Ku, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Featherstone</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Alberta Research Center for Health Evidence (ARCHE), University of Alberta, 11405-87 Avenue Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doi</LastName><ForeName>Kent</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jean-Louis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erasme University Hospital, Unversit&#xe9; Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasero</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, San Giovanni Battista Hospital, University of Turin, Via Giuseppe Verdi, 8, 10124, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robert</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Service de R&#xe9;animation M&#xe9;dicale, CHU-Poitiers, University of Poitiers, 86000, Poitiers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronco</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nephrology Dialysis and Transplantation, International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Viale Rodolfi 37, 36100, Vicenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagshaw</LastName><ForeName>Sean M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, 2-124 Clinical Sciences Building, 8440-112 ST NW, Edmonton, Canada, T6G 2B7. bagshaw@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP16J10320</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>J2VZ07J96K</RegistryNumber><NameOfSubstance UI="D011112">Polymyxin B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Intensive Care Med. 2018 Feb;44(2):279-280. doi: 10.1007/s00134-018-5055-6.</RefSource><PMID Version="1">29340720</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006464" MajorTopicYN="Y">Hemoperfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011112" MajorTopicYN="Y">Polymyxin B</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Polymyxin B-immobilized hemoperfusion</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29204670</ArticleId><ArticleId IdType="doi">10.1007/s00134-017-5004-9</ArticleId><ArticleId IdType="pii">10.1007/s00134-017-5004-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nephron. 2000 Oct;86(2):210</Citation><ArticleIdList><ArticleId IdType="pubmed">11015003</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2008 Sep;34(9):1638-45</Citation><ArticleIdList><ArticleId IdType="pubmed">18463848</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2010 May;38(5):1360-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20308884</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Jun 17;301(23):2445-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19531784</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock. 2005 May;23(5):400-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15834304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Apher Dial. 2003 Feb;7(1):108-14</Citation><ArticleIdList><ArticleId IdType="pubmed">12921125</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2011 Jul 13;306(2):194-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21750297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock. 2017 Jan;47(1):93-99</Citation><ArticleIdList><ArticleId IdType="pubmed">27984535</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2013 Apr 25;17(2):R65</Citation><ArticleIdList><ArticleId IdType="pubmed">23561510</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hosp Infect. 2003 Jan;53(1):58-63</Citation><ArticleIdList><ArticleId IdType="pubmed">12495686</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Jul 3;359(1):7-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18492867</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Nov 21;6(11):e012908</Citation><ArticleIdList><ArticleId IdType="pubmed">27872122</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 1998 Nov;26(11):1793-800</Citation><ArticleIdList><ArticleId IdType="pubmed">9824069</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2013 Aug;66(8):847-55</Citation><ArticleIdList><ArticleId IdType="pubmed">23747228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Apher. 1998 Feb;2(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10227782</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephron Clin Pract. 2003;94(2):c33-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12845235</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2003 Apr;29(4):530-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2001 Nov;29(11):2046-50</Citation><ArticleIdList><ArticleId IdType="pubmed">11700393</ArticleId></ArticleIdList></Reference><Reference><Citation>ASAIO J. 2002 May-Jun;48(3):244-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12058997</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2014 May 15;189(10):1204-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24635548</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 1991 Jan;99(1):169-75</Citation><ArticleIdList><ArticleId IdType="pubmed">1984950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1993 Oct 15;119(8):771-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8379598</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2015 Jun;41(6):975-84</Citation><ArticleIdList><ArticleId IdType="pubmed">25862039</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2014 Jun 11;15:218</Citation><ArticleIdList><ArticleId IdType="pubmed">24916483</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2004 Mar;32(3):858-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15090974</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2000 May;161(5):1429-36</Citation><ArticleIdList><ArticleId IdType="pubmed">10806135</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2004 Aug 1;190(3):527-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15243928</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2004 Sep;30(9):1838-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15197430</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood Purif. 2001;19(4):361-8; discussion 368-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11574732</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 1996 Jul;22(7):707-10</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2000 Nov;28(11):3581-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11098957</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2009 Mar;37(3):803-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19237881</ArticleId></ArticleIdList></Reference><Reference><Citation>ASAIO J. 2002 Jan-Feb;48(1):41-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11814097</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2017 Aug;45(8):e858-e864</Citation><ArticleIdList><ArticleId IdType="pubmed">28445237</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Oct 22;361(17):1627-38</Citation><ArticleIdList><ArticleId IdType="pubmed">19846848</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2011 Apr;64(4):383-94</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2014 Apr 2;311(13):1308-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Feb 23;315(8):801-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2007;11(2):R47</Citation><ArticleIdList><ArticleId IdType="pubmed">17448226</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2013 Sep;41(9):2209-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23860248</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2009 Sep;62(9):944-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19230612</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2013 Feb;41(2):580-637</Citation><ArticleIdList><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood Purif. 2011;32(4):331-40</Citation><ArticleIdList><ArticleId IdType="pubmed">22086346</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2006 May;32(5):713-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16550372</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2009 Jul 21;6(7):e1000097</Citation><ArticleIdList><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26266907</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2197-425X</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Intensive care medicine experimental</Title><ISOAbbreviation>Intensive Care Med Exp</ISOAbbreviation></Journal><ArticleTitle>Uncontrolled sepsis: a systematic review of translational immunology studies in intensive care medicine.</ArticleTitle><Pagination><StartPage>6</StartPage><MedlinePgn>6</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/2197-425X-2-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The design of clinical immunology studies in sepsis presents several fundamental challenges to improving the translational understanding of pathologic mechanisms. We undertook a systematic review of bed-to-benchside studies to test the hypothesis that variable clinical design methodologies used to investigate immunologic function in sepsis contribute to apparently conflicting laboratory data, and identify potential alternatives that overcome various obstacles to improve experimental design.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic review of the design methodology employed to study neutrophil function (respiratory burst), monocyte endotoxin tolerance and lymphocyte apoptosis in the intensive care setting, over the past 15&#xa0;years. We specifically focussed on how control samples were defined, taking into account age, gender, ethnicity, concomitant therapies, timing of sample collection and the criteria used to diagnose sepsis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 57 eligible studies, the majority of which (74%) used case-control methodology. Healthy volunteers represented the control population selected in 83% of studies. Comprehensive demographic data on age, gender and ethnicity were provided in &#x2264;48% of case control studies. Documentation of diseases associated with immunosuppression, malignancy and immunomodulatory therapies was rare. Less than half (44%) of studies undertook independent adjudication for the diagnosis of sepsis while 68% provided microbiological data. The timing of sample collection was defined by highly variable clinical criteria. By contrast, surgical studies avoided many such confounders, although only one study in surgical patients monitored the study group for development of sepsis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found several important and common limitations in the clinical design of translational immunologic studies in human sepsis. Major elective surgery overcame many of these methodological limitations. The failure of adequate clinical design in mechanistic studies may contribute to the lack of translational therapeutic progress in intensive care medicine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cain</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Clinical Physiology, Wolfson Institute for Biomedical Research, Department of Medicine, University College London, London, WC1E 6BT, UK, davicain@googlemail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Arroyo</LastName><ForeName>Ana Gutierrez</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><LastName>Ackland</LastName><ForeName>Gareth L</ForeName><Initials>GL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Intensive Care Med Exp</MedlineTA><NlmUniqueID>101645149</NlmUniqueID><ISSNLinking>2197-425X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>2</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26266907</ArticleId><ArticleId IdType="pmc">PMC4513024</ArticleId><ArticleId IdType="doi">10.1186/2197-425X-2-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care. 2006;10:R42. doi: 10.1186/cc4854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc4854</ArticleId><ArticleId IdType="pmc">PMC1550902</ArticleId><ArticleId IdType="pubmed">16542492</ArticleId></ArticleIdList></Reference><Reference><Citation>Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35:1244&#x2013;1250. doi: 10.1097/01.CCM.0000261890.41311.E9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000261890.41311.E9</ArticleId><ArticleId IdType="pubmed">17414736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Thompson BT, Barie PS, Dhainaut J-F, Douglas IS, Finfer S, G&#xe5;rdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD. Drotrecogin Alfa (activated) in adults with septic shock. N Engl J Med. 2012;366:2055&#x2013;2064. doi: 10.1056/NEJMoa1202290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1202290</ArticleId><ArticleId IdType="pubmed">22616830</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre P-F, Reinhart K, Cuthbertson BH, Payen D, Briegel J. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111&#x2013;124. doi: 10.1056/NEJMoa071366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa071366</ArticleId><ArticleId IdType="pubmed">18184957</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Chittock DR, Su SY-S, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, H&#xe9;bert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283&#x2013;1297. doi: 10.1056/NEJMoa0810625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810625</ArticleId><ArticleId IdType="pubmed">19318384</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172:2731&#x2013;2738.</Citation><ArticleIdList><ArticleId IdType="pubmed">14978070</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, L&#xf3;pez MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, Calvano SE, McDonald-Smith GP, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208:2581&#x2013;2590. doi: 10.1084/jem.20111354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111354</ArticleId><ArticleId IdType="pmc">PMC3244029</ArticleId><ArticleId IdType="pubmed">22110166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010;23:590&#x2013;615. doi: 10.1128/CMR.00078-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00078-09</ArticleId><ArticleId IdType="pmc">PMC2901655</ArticleId><ArticleId IdType="pubmed">20610825</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 1993;362:849&#x2013;852. doi: 10.1038/362849a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362849a0</ArticleId><ArticleId IdType="pubmed">8479523</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikawa K, Akamatsu H, Maekawa N, Nishina K, Niwa Y. Propofol inhibits human neutrophil functions. Anesth Analg. 1998;87:695&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">9728856</ArticleId></ArticleIdList></Reference><Reference><Citation>White M, Mahon V, Grealy R, Doherty DG, Stordeur P, Kelleher DP, McManus R, Ryan T. Post-operative infection and sepsis in humans is associated with deficient gene expression of &#x3b3;c cytokines and their apoptosis mediators. Crit Care. 2011;15:R158. doi: 10.1186/cc10293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10293</ArticleId><ArticleId IdType="pmc">PMC3219032</ArticleId><ArticleId IdType="pubmed">21711552</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos SS, Brunialti MKC, Rigato O, Machado FR, Silva E, Salomao R. Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes. Shock. 2012;38:18&#x2013;23. doi: 10.1097/SHK.0b013e318257114e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318257114e</ArticleId><ArticleId IdType="pubmed">22575991</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruns T, Peter J, Hagel S, Herrmann A, Stallmach A. The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection. Clin Exp Immunol. 2011;164:346&#x2013;356. doi: 10.1111/j.1365-2249.2011.04373.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2011.04373.x</ArticleId><ArticleId IdType="pmc">PMC3087930</ArticleId><ArticleId IdType="pubmed">21413941</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, Salom&#xe3;o R. Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock. 2003;20:208&#x2013;212. doi: 10.1097/01.shk.0000079425.52617.db.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.shk.0000079425.52617.db</ArticleId><ArticleId IdType="pubmed">12923490</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth E, Fischer G, Schneider EM, Moldawer LL, Georgieff M, Weiss M. Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock. Cytokine. 2002;17:275&#x2013;284. doi: 10.1006/cyto.2002.1010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cyto.2002.1010</ArticleId><ArticleId IdType="pubmed">12027409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariano F, Tetta C, Guida G, Triolo G, Camussi G. Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Kidney Int. 2001;60:1598&#x2013;1605. doi: 10.1046/j.1523-1755.2001.00974.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2001.00974.x</ArticleId><ArticleId IdType="pubmed">11576379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed NA, McGill S, Yee J, Hu F, Michel RP, Christou NV. Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis) Crit Care Med. 1999;27:2459&#x2013;2468. doi: 10.1097/00003246-199911000-00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199911000-00023</ArticleId><ArticleId IdType="pubmed">10579265</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual C, Bredle D, Karzai W, Meier-Hellmann A, Oberhoffer M, Reinhart K. Effect of plasma and LPS on respiratory burst of neutrophils in septic patients. Intensive Care Med. 1998;24:1181&#x2013;1186. doi: 10.1007/s001340050742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050742</ArticleId><ArticleId IdType="pubmed">9876981</ArticleId></ArticleIdList></Reference><Reference><Citation>Paunel-G&#xf6;rg&#xfc;l&#xfc; A, L&#xf6;gters T, Floh&#xe9; S, Cinatl J, Altrichter J, Windolf J, Scholz M. Stimulation of Fas signaling down-regulates activity of neutrophils from major trauma patients with SIRS. Immunobiology. 2011;216:334&#x2013;342. doi: 10.1016/j.imbio.2010.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2010.07.005</ArticleId><ArticleId IdType="pubmed">20832139</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih H-C, Huang M-S, Lee C-H. Polymorphonuclear cell priming associated with NF-kB activation in patients with severe injury is partially dependent on macrophage migration inhibitory factor. J Am Coll Surg. 2010;211:791&#x2013;797. doi: 10.1016/j.jamcollsurg.2010.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2010.07.028</ArticleId><ArticleId IdType="pubmed">20980171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasten KR, Goetzman HS, Reid MR, Rasper AM, Adediran SG, Robinson CT, Cave CM, Solomkin JS, Lentsch AB, Johannigman JA, Caldwell CC. Divergent adaptive and innate immunological responses are observed in humans following blunt trauma. BMC Immunol. 2010;11:4. doi: 10.1186/1471-2172-11-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2172-11-4</ArticleId><ArticleId IdType="pmc">PMC2823662</ArticleId><ArticleId IdType="pubmed">20100328</ArticleId></ArticleIdList></Reference><Reference><Citation>Valente SA, Fallon WF, Alexander TS, Tomas ER, Evancho-Chapman MM, Schmidt SP, Gorski R, Pizov O, DeFine L, Clark AJ. Immunologic function in the elderly after injury&#x2013;the neutrophil and innate immunity. J Trauma. 2009;67:968&#x2013;974. doi: 10.1097/TA.0b013e3181b84279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181b84279</ArticleId><ArticleId IdType="pubmed">19901656</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaid G, Cave C, Williams MA, Hennigan RF, Bokoch G, Solomkin JS. Mechanisms of human neutrophil oxidant production after severe injury. Surgery. 2001;130:669&#x2013;675. doi: 10.1067/msy.2001.116923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/msy.2001.116923</ArticleId><ArticleId IdType="pubmed">11602898</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertel W, Keel M, Buergi U, Hartung T, Imhof HG, Trentz O. Granulocyte colony-stimulating factor inhibits neutrophil apoptosis at the local site after severe head and thoracic injury. J Trauma. 1999;46:784&#x2013;792. doi: 10.1097/00005373-199905000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199905000-00005</ArticleId><ArticleId IdType="pubmed">10338394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogura H, Tanaka H, Koh T, Hashiguchi N, Kuwagata Y, Hosotsubo H, Shimazu T, Sugimoto H. Priming, second-hit priming, and apoptosis in leukocytes from trauma patients. J Trauma. 1999;46:774&#x2013;781. doi: 10.1097/00005373-199905000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199905000-00004</ArticleId><ArticleId IdType="pubmed">10338393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T, Ogata M, Kawasaki C, Okamoto K, Sata T. Effects of epidural anaesthesia on surgical stress-induced immunosuppression during upper abdominal surgery. Br J Anaesth. 2007;98:196&#x2013;203. doi: 10.1093/bja/ael334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/ael334</ArticleId><ArticleId IdType="pubmed">17218378</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf6;hlich D, Trabold B, Rothe G, Hoerauf K, Wittmann S. Inhibition of the neutrophil oxidative response by propofol: preserved in vivo function despite in vitro inhibition. Eur J Anaesthesiol. 2006;23:948&#x2013;953. doi: 10.1017/S0265021506000822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0265021506000822</ArticleId><ArticleId IdType="pubmed">16780613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiezer MJ, Meijer C, Sietses C, Prins HA, Cuesta MA, Beelen RH, Meijer S, van Leeuwen PA. Bactericidal/permeability-increasing protein preserves leukocyte functions after major liver resection. Ann Surg. 2000;232:208&#x2013;215. doi: 10.1097/00000658-200008000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-200008000-00010</ArticleId><ArticleId IdType="pmc">PMC1421132</ArticleId><ArticleId IdType="pubmed">10903599</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih HC, Su CH, Lee CH. Superoxide production of neutrophils after severe injury: impact of subsequent surgery and sepsis. Am J Emerg Med. 1999;17:15&#x2013;18. doi: 10.1016/S0735-6757(99)90005-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-6757(99)90005-0</ArticleId><ArticleId IdType="pubmed">9928689</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu TF, Yoza BK, El Gazzar M, Vachharajani VT, McCall CE. NAD&#x2009;+&#x2009;-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J Biol Chem. 2011;286:9856&#x2013;9864. doi: 10.1074/jbc.M110.196790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.196790</ArticleId><ArticleId IdType="pmc">PMC3058977</ArticleId><ArticleId IdType="pubmed">21245135</ArticleId></ArticleIdList></Reference><Reference><Citation>Pachot A, Cazalis M-A, Venet F, Turrel F, Faudot C, Voirin N, Diasparra J, Bourgoin N, Poitevin F, Mougin B, Lepape A, Monneret G. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol. 2008;180:6421&#x2013;6429.</Citation><ArticleIdList><ArticleId IdType="pubmed">18424766</ArticleId></ArticleIdList></Reference><Reference><Citation>West MA, Koons A, Crandall M, Skinner R, Worley M, Shapiro MB. Whole blood leukocyte mitogen activated protein kinases activation differentiates intensive care unit patients with systemic inflammatory response syndrome and sepsis. J Trauma. 2007;62:805&#x2013;811. doi: 10.1097/01.ta.0000259267.74789.9b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ta.0000259267.74789.9b</ArticleId><ArticleId IdType="pubmed">17426533</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;rter L, Mica L, Stocker R, Trentz O, Keel M. Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock. 2004;22:403&#x2013;409. doi: 10.1097/01.shk.0000142256.23382.5d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.shk.0000142256.23382.5d</ArticleId><ArticleId IdType="pubmed">15489631</ArticleId></ArticleIdList></Reference><Reference><Citation>Escoll P, del Fresno C, Garc&#xed;a L, Vall&#xe9;s G, Lend&#xed;nez MJ, Arnalich F, L&#xf3;pez-Collazo E. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun. 2003;311:465&#x2013;472. doi: 10.1016/j.bbrc.2003.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2003.10.019</ArticleId><ArticleId IdType="pubmed">14592437</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvano JE, Agnese DM, Um JY, Goshima M, Singhal R, Coyle SM, Reddell MT, Kumar A, Calvano SE, Lowry SF. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Shock. 2003;20:415&#x2013;419. doi: 10.1097/01.shk.0000092269.01859.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.shk.0000092269.01859.44</ArticleId><ArticleId IdType="pubmed">14560104</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfeir T, Saha DC, Astiz M, Rackow EC. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med. 2001;29:129&#x2013;133. doi: 10.1097/00003246-200101000-00026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200101000-00026</ArticleId><ArticleId IdType="pubmed">11176172</ArticleId></ArticleIdList></Reference><Reference><Citation>Heagy W, Hansen C, Nieman K, Cohen M, Richardson C, Rodriguez JL, West MA. Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify &#x201c;septic&#x201d; intensive care unit patients. Shock. 2000;14:271&#x2013;276. doi: 10.1097/00024382-200014030-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-200014030-00005</ArticleId><ArticleId IdType="pubmed">11028542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann M, Gornikiewicz A, Sautner T, Waldmann E, Weber T, Mittlb&#xf6;ck M, Roth E, F&#xfc;gger R. Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock. 1999;12:421&#x2013;427. doi: 10.1097/00024382-199912000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-199912000-00002</ArticleId><ArticleId IdType="pubmed">10588509</ArticleId></ArticleIdList></Reference><Reference><Citation>Heagy W, Nieman K, Hansen C, Cohen M, Danielson D, West MA. Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. Surg Infect (Larchmt) 2003;4:171&#x2013;180. doi: 10.1089/109629603766956960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/109629603766956960</ArticleId><ArticleId IdType="pubmed">12906717</ArticleId></ArticleIdList></Reference><Reference><Citation>Floh&#xe9; S, Lendemans S, Schade F-U, Kreuzfelder E, Waydhas C. Influence of surgical intervention in the immune response of severely injured patients. Intensive Care Med. 2004;30:96&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">14605804</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttenschoen K, Schneider ME, Utz K, Kornmann M, Beger HG, Carli Buttenschoen D. Effect of major abdominal surgery on endotoxin release and expression of Toll-like receptors 2/4. Langenbecks Arch Surg. 2009;394:293&#x2013;302. doi: 10.1007/s00423-008-0357-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-008-0357-8</ArticleId><ArticleId IdType="pubmed">18546014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T, Ogata M, Kawasaki C, Tomihisa T, Okamoto K, Shigematsu A. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth Analg. 2001;92:1322&#x2013;1326. doi: 10.1097/00000539-200105000-00046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200105000-00046</ArticleId><ArticleId IdType="pubmed">11323370</ArticleId></ArticleIdList></Reference><Reference><Citation>Roger P-M, Hyvernat H, Ticchioni M, Kumar G, Dellamonica J, Bernardin G. The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells. J Crit Care. 2012;27:384&#x2013;393. doi: 10.1016/j.jcrc.2012.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2012.04.010</ArticleId><ArticleId IdType="pubmed">22824083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Li J, Lou J, Zhou Y, Bo L, Zhu J, Zhu K, Wan X, Cai Z, Deng X. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit Care. 2011;15:R70. doi: 10.1186/cc10059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10059</ArticleId><ArticleId IdType="pmc">PMC3222003</ArticleId><ArticleId IdType="pubmed">21349174</ArticleId></ArticleIdList></Reference><Reference><Citation>Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Ch&#xe9;ron A, Allaouchiche B, Gueyffier F, Ayala A, Monneret G, Venet F. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care. 2011;15:R99. doi: 10.1186/cc10112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10112</ArticleId><ArticleId IdType="pmc">PMC3219369</ArticleId><ArticleId IdType="pubmed">21418617</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaki I, Kranidioti H, Karagianni V, Spyridaki A, Kotsaki A, Routsi C, Giamarellos-Bourboulis EJ. An early circulating factor in severe sepsis modulates apoptosis of monocytes and lymphocytes. J Leukoc Biol. 2011;89:343&#x2013;349. doi: 10.1189/jlb.0410232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0410232</ArticleId><ArticleId IdType="pubmed">21030664</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanassia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, et al. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care. 2010;14:R96. doi: 10.1186/cc9031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9031</ArticleId><ArticleId IdType="pmc">PMC2911733</ArticleId><ArticleId IdType="pubmed">20504311</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogerwerf JJ, van Zoelen MA, Wiersinga WJ, van&#x2019;t Veer C, de Vos AF, de Boer A, Schultz MJ, Hooibrink B, de Jonge E, van derPoll T. Gene expression profiling of apoptosis regulators in patients with sepsis. J Innate Immun. 2010;2:461&#x2013;468. doi: 10.1159/000317035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000317035</ArticleId><ArticleId IdType="pubmed">20571256</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef AA, Suliman GA, Mabrouk MM. The value of correlation of serum 20S proteasome concentration and percentage of lymphocytic apoptosis in critically ill patients: a prospective observational study. Crit Care. 2010;14:R215. doi: 10.1186/cc9340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9340</ArticleId><ArticleId IdType="pmc">PMC3220007</ArticleId><ArticleId IdType="pubmed">21108816</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrel-Davin F, Guignant C, Lepape A, Mougin B, Monneret G, Venet F. Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients. Crit Care. 2010;14:R133. doi: 10.1186/cc9181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9181</ArticleId><ArticleId IdType="pmc">PMC2945101</ArticleId><ArticleId IdType="pubmed">20626850</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelekanou A, Tsangaris I, Kotsaki A, Karagianni V, Giamarellou H, Armaganidis A, Giamarellos-Bourboulis EJ. Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study. Crit Care. 2009;13:R172. doi: 10.1186/cc8148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8148</ArticleId><ArticleId IdType="pmc">PMC2811921</ArticleId><ArticleId IdType="pubmed">19883512</ArticleId></ArticleIdList></Reference><Reference><Citation>Delogu G, Famularo G, Tellan G, Marandola M, Antonucci A, Signore M, Marcellini S, Moretti S. Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock. Infection. 2008;36:485&#x2013;487. doi: 10.1007/s15010-008-7070-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-008-7070-y</ArticleId><ArticleId IdType="pubmed">18791840</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber SU, Schewe J, Lehmann LE, M&#xfc;ller S, Book M, Klaschik S, Hoeft A, St&#xfc;ber F. Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. 12:1&#x2013;10. Crit Care. 2008;12(5):R128. doi: 10.1186/cc7088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7088</ArticleId><ArticleId IdType="pmc">PMC2592767</ArticleId><ArticleId IdType="pubmed">18925930</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth G, Moser B, Krenn C, Brunner M, Haisjackl M, Almer G, Gerlitz S, Wolner E, Boltz-Nitulescu G, Ankersmit HJ. Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun. 2003;308:840&#x2013;846. doi: 10.1016/S0006-291X(03)01482-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-291X(03)01482-7</ArticleId><ArticleId IdType="pubmed">12927795</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, Tattevin P, Thomas R, Fauchet R, Dr&#xe9;nou B. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock. 2002;18:487&#x2013;494. doi: 10.1097/00024382-200212000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-200212000-00001</ArticleId><ArticleId IdType="pubmed">12462554</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE, Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG, Karl IE. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol. 2001;166:6952&#x2013;6963.</Citation><ArticleIdList><ArticleId IdType="pubmed">11359857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27:1230&#x2013;1251. doi: 10.1097/00003246-199907000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199907000-00002</ArticleId><ArticleId IdType="pubmed">10446814</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay G, Bankey PE, Miller-Graziano CL. Trauma patients&#x2019; elevated tumor necrosis related apoptosis inducing ligand (TRAIL) contributes to increased T cell apoptosis. Clin Immunol. 2012;145:44&#x2013;54. doi: 10.1016/j.clim.2012.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2012.07.010</ArticleId><ArticleId IdType="pmc">PMC3448438</ArticleId><ArticleId IdType="pubmed">22926077</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini JD, De AK, Kodys K, Puyana JC, Furse RK, Miller-Graziano C. Relationships between T lymphocyte apoptosis and anergy following trauma. J Surg Res. 2000;88:200&#x2013;206. doi: 10.1006/jsre.1999.5797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsre.1999.5797</ArticleId><ArticleId IdType="pubmed">10644489</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, Schmieg RE, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Karl IE, Buchman TG. Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med. 2000;28:3207&#x2013;3217. doi: 10.1097/00003246-200009000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200009000-00016</ArticleId><ArticleId IdType="pubmed">11008984</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadima A, Boutsikou M, Lagoudianakis EE, Kataki A, Konstadoulakis M, Georgiou L, Katergiannakis V, Manouras A. Lymphocyte apoptosis after major abdominal surgery is not influenced by anesthetic technique: a comparative study of general anesthesia versus combined general and epidural analgesia. J Clin Anesth. 2009;21:414&#x2013;421. doi: 10.1016/j.jclinane.2008.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2008.10.015</ArticleId><ArticleId IdType="pubmed">19833274</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#x142;otwi&#x144;ski R, Olszewski W, S&#x142;odkowski M, Lech G, Zaleska M, K&#x119;dziora S, W&#x142;uka A, Domaszewska A, S&#x142;otwi&#x144;ska S, Krasnod&#x119;bski W, W&#xf3;jcik Z. Apoptosis in lymphocytes of pancreatic cancer patients: influence of preoperative enteral immunonutrition and extensive surgery. Arch Immunol Ther Exp (Warsz) 2011;59:385&#x2013;397. doi: 10.1007/s00005-011-0140-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-011-0140-3</ArticleId><ArticleId IdType="pubmed">21818634</ArticleId></ArticleIdList></Reference><Reference><Citation>Delogu G, Famularo G, Moretti S, De Luca A, Tellan G, Antonucci A, Marandola M, Signore L. Interleukin-10 and apoptotic death of circulating lymphocytes in surgical/anesthesia trauma. J Trauma. 2001;51:92&#x2013;97. doi: 10.1097/00005373-200107000-00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-200107000-00015</ArticleId><ArticleId IdType="pubmed">11468474</ArticleId></ArticleIdList></Reference><Reference><Citation>Delogu G, Moretti S, Antonucci A, Marcellini S, Masciangelo R, Famularo G, Signore L, De Simone C. Apoptosis and surgical trauma: dysregulated expression of death and survival factors on peripheral lymphocytes. Arch Surg. 2000;135:1141&#x2013;1147. doi: 10.1001/archsurg.135.10.1141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.135.10.1141</ArticleId><ArticleId IdType="pubmed">11030869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasajima K, Inokuchi K, Onda M, Miyashita M, Okawa KI, Matsutani T, Takubo K. Detection of T cell apoptosis after major operations. Eur J Surg. 1999;165:1020&#x2013;1023. doi: 10.1080/110241599750007829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/110241599750007829</ArticleId><ArticleId IdType="pubmed">10595603</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto M, Shimaoka M, Hosotsubo K, Tanigami H, Taenaka N, Kiyono H, Yoshiya I. Up-regulation of Fas ligand (FasL) mRNA expression in peripheral blood mononuclear cells (PBMC) after major surgery. Clin Exp Immunol. 1998;112:120&#x2013;125. doi: 10.1046/j.1365-2249.1998.00535.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.1998.00535.x</ArticleId><ArticleId IdType="pmc">PMC1904941</ArticleId><ArticleId IdType="pubmed">9566799</ArticleId></ArticleIdList></Reference><Reference><Citation>Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest. 2013;123:958&#x2013;965. doi: 10.1172/JCI64096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI64096</ArticleId><ArticleId IdType="pmc">PMC3582124</ArticleId><ArticleId IdType="pubmed">23454758</ArticleId></ArticleIdList></Reference><Reference><Citation>Frink M, Pape H-C, van Griensven M, Krettek C, Chaudry IH, Hildebrand F. Influence of sex and age on mods and cytokines after multiple injuries. Shock. 2007;27:151&#x2013;156. doi: 10.1097/01.shk.0000239767.64786.de.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.shk.0000239767.64786.de</ArticleId><ArticleId IdType="pubmed">17224789</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Elia C, Mascia L, Barberis B, Cardellino S, Livigni S, Fiore G, Filippini C, Ranieri V. The influence of gender on the epidemiology of and outcome from severe sepsis. Crit Care. 2013;17:R50. doi: 10.1186/cc12570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12570</ArticleId><ArticleId IdType="pmc">PMC3733421</ArticleId><ArticleId IdType="pubmed">23506971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, Weissfeld LA, Angus DC. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA. 2010;303:2495&#x2013;2503. doi: 10.1001/jama.2010.851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.851</ArticleId><ArticleId IdType="pmc">PMC3910506</ArticleId><ArticleId IdType="pubmed">20571016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fildes JE, Shaw SM, Yonan N, Williams SG. The immune system and chronic heart failure: is the heart in control? J Am Coll Cardiol. 2009;53:1013&#x2013;1020. doi: 10.1016/j.jacc.2008.11.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.11.046</ArticleId><ArticleId IdType="pubmed">19298913</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity&#x2019;s roles in cancer suppression and promotion. Science. 2011;331:1565&#x2013;1570. doi: 10.1126/science.1203486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1203486</ArticleId><ArticleId IdType="pubmed">21436444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644&#x2013;1655. doi: 10.1378/chest.101.6.1644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.101.6.1644</ArticleId><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250&#x2013;1256. doi: 10.1097/01.CCM.0000050454.01978.3B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000050454.01978.3B</ArticleId><ArticleId IdType="pubmed">12682500</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut J-F, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent J-L. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17&#x2013;60. doi: 10.1007/s00134-007-0934-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0934-2</ArticleId><ArticleId IdType="pmc">PMC2249616</ArticleId><ArticleId IdType="pubmed">18058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104&#x2013;107. doi: 10.1038/nature08780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08780</ArticleId><ArticleId IdType="pmc">PMC2843437</ArticleId><ArticleId IdType="pubmed">20203610</ArticleId></ArticleIdList></Reference><Reference><Citation>Menu P, Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol. 2011;166:1&#x2013;15. doi: 10.1111/j.1365-2249.2011.04440.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2011.04440.x</ArticleId><ArticleId IdType="pmc">PMC3193914</ArticleId><ArticleId IdType="pubmed">21762124</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenesch F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol. 2012;2:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3417661</ArticleId><ArticleId IdType="pubmed">22919604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010;23:590&#x2013;615. doi: 10.1128/CMR.00078-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00078-09</ArticleId><ArticleId IdType="pmc">PMC2901655</ArticleId><ArticleId IdType="pubmed">20610825</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikawa K, Akamatsu H, Maekawa N, Nishina K, Niwa Y. Propofol inhibits human neutrophil. Anesth Analg. 1998;87:695&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">9728856</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther. 2004;11:354&#x2013;365. doi: 10.1097/01.mjt.0000132250.95650.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mjt.0000132250.95650.85</ArticleId><ArticleId IdType="pubmed">15356431</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson EH, Louie R, Zingmond DS, Brook RH, Hall BL, Han L, Rapp M, Ko CY. A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg. 2012;256:973&#x2013;981. doi: 10.1097/SLA.0b013e31826b4c4f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31826b4c4f</ArticleId><ArticleId IdType="pubmed">23095667</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818&#x2013;829. doi: 10.1097/00003246-198510000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-198510000-00009</ArticleId><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619&#x2013;1636. doi: 10.1378/chest.100.6.1619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.100.6.1619</ArticleId><ArticleId IdType="pubmed">1959406</ArticleId></ArticleIdList></Reference><Reference><Citation>ASA Physical Status Classification System. http://www.asahq.org/For-Members/Clinical-Information/ASA-Physical-Status-Classification-System.aspx. Accessed 27 Jun 2013</Citation></Reference><Reference><Citation>Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am Rev Respir Dis. 1989;139:1058&#x2013;1059. doi: 10.1164/ajrccm/139.4.946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm/139.4.946</ArticleId><ArticleId IdType="pubmed">2539031</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker SP, O&#x2019;Neill B, Haddon W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187&#x2013;196. doi: 10.1097/00005373-197403000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-197403000-00001</ArticleId><ArticleId IdType="pubmed">4814394</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25099709</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>349</Volume><PubDate><Year>2014</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality.</ArticleTitle><Pagination><StartPage>g4561</StartPage><MedlinePgn>g4561</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">g4561</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.g4561</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the efficacy and safety of pooled human albumin solutions as part of fluid volume expansion and resuscitation (with or without improvement of baseline hypoalbuminaemia) in critically unwell adults with sepsis of any severity.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of randomised clinical trials, with trial sequential analysis, subgroup, and meta-regression analyses.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">PubMed, PubMed Central, Web of Science (includes Medline, Conference Proceedings Citation Index, Data Citation Index, Chinese Science Citation Database, CAB abstracts, Derwent Innovations Index), OvidSP (includes Embase, Ovid Medline, HMIC, PsycINFO, Maternity and Infant Care, Transport Database), Cochrane Library, clinicaltrials.gov, controlled-trials.com, online material, relevant conference proceedings, hand searching of reference lists, and contact with authors as necessary.</AbstractText><AbstractText Label="ELIGIBILITY CRITERIA" NlmCategory="METHODS">Prospective randomised clinical trials of adults with sepsis of any severity (with or without baseline hypoalbuminaemia) in critical or intensive care who received pooled human albumin solutions as part of fluid volume expansion and resuscitation (with or without improvement of hypoalbuminaemia) compared with those who received control fluids (crystalloid or colloid), were included if all-cause mortality outcome data were available. No restriction of language, date, publication status, or primary study endpoint was applied.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Two reviewers independently assessed articles for inclusion, extracted data to assess risk of bias, trial methods, patients, interventions, comparisons, and outcome. The relative risk of all-cause mortality was calculated using a random effects model accounting for clinical heterogeneity.</AbstractText><AbstractText Label="PRIMARY OUTCOME MEASURE" NlmCategory="METHODS">All-cause mortality at final follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighteen articles reporting on 16 primary clinical trials that included 4190 adults in critical or intensive care with sepsis, severe sepsis, or septic shock. A median of 70.0 g daily of pooled human albumin was received over a median of 3 days by adults with a median age of 60.8 years as part of fluid volume expansion and resuscitation, with or without correction of hypoalbuminaemia. The relative risk of death was similar between albumin groups (that received a median of 175 g in total) and control fluid groups (relative risk 0.94; 95% confidence interval 0.87 to 1.01; P=0.11; I(2)=0%). Trial sequential analysis corrected the 95% confidence interval for random error (0.85 to 1.02; D(2)=0%). Eighty eight per cent of the required information size (meta-analysis sample size) of 4894 patients was achieved, and the cumulative effect size measure (z score) entered the futility area, supporting the notion of no relative benefit of albumin (GRADE quality of evidence was moderate). Evidence of no difference was also found when albumin was compared with crystalloid fluid (relative risk 0.93; 0.86 to 1.01; P=0.07; I(2)=0%) in 3878 patents (GRADE quality of evidence was high; 79.9% of required information size) or colloid fluids in 299 patients (relative risk 1.04; 0.79 to 1.38; P=0.76; I(2)=0%) (GRADE quality of evidence was very low; 5.8% of required information size). When studies at high risk of bias were excluded in a predefined subgroup analysis, the finding of no mortality benefit remained, and the cumulative z score was just outside the boundary of futility. Overall, the meta-analysis was robust to sensitivity, subgroup, meta-regression, and trial sequential analyses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this analysis, human albumin solutions as part of fluid volume expansion and resuscitation for critically unwell adults with sepsis of any severity (with or without baseline hypoalbuminaemia) were not robustly effective at reducing all-cause mortality. Albumin seems to be safe in this setting, as a signal towards harm was not detected, but this analysis does not support a recommendation for use.</AbstractText><CopyrightInformation>&#xa9; Patel et al 2014.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Amit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, UK MRC Clinical Sciences Centre, Hammersmith Hospital, Imperial College London, London, UK Centre for Haematology, Hammersmith Hospital, Imperial College London, London, UK amit.patel@imperial.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laffan</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Centre for Haematology, Hammersmith Hospital, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waheed</LastName><ForeName>Umeer</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brett</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007552">Isotonic Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012709">Serum Albumin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>BMJ. 2014;349:g4850</RefSource></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2014 Jul 22;349:g4611. doi: 10.1136/bmj.g4611.</RefSource><PMID Version="1">25099711</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="N">Crystalloid Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034141" MajorTopicYN="N">Hypoalbuminemia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007552" MajorTopicYN="N">Isotonic Solutions</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012709" MajorTopicYN="N">Serum Albumin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>7</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25099709</ArticleId><ArticleId IdType="pmc">PMC4106199</ArticleId><ArticleId IdType="doi">10.1136/bmj.g4561</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bunn F, Trivedi D. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2012;7:CD001319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7028006</ArticleId><ArticleId IdType="pubmed">22786474</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob M, Chappell D, Conzen P, Wilkes MM, Becker BF, Rehm M. Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials. Crit Care 2008;12:R34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2447554</ArticleId><ArticleId IdType="pubmed">18318896</ArticleId></ArticleIdList></Reference><Reference><Citation>Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013;2:CD000567.</Citation><ArticleIdList><ArticleId IdType="pubmed">23450531</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2011;(11):CD001208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7055200</ArticleId><ArticleId IdType="pubmed">22071799</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al; SAFE TRIPS Investigators. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 2010;14:R185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219291</ArticleId><ArticleId IdType="pubmed">20950434</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim JM, Vermeulen LC, Erstad BL, Matuszewski KA, Burnett DA, Vlasses PH. Albumin and nonprotein colloid solution use in US academic health centers. Arch Intern Med 1995;155:2450-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">7503604</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56.</Citation><ArticleIdList><ArticleId IdType="pubmed">15163774</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R; SAFE Study Investigators. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011;37:86-96.</Citation><ArticleIdList><ArticleId IdType="pubmed">20924555</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006;34:344-53.</Citation><ArticleIdList><ArticleId IdType="pubmed">16424713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, et al; PROWESS-SHOCK Study Group. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012;366:2055-64.</Citation><ArticleIdList><ArticleId IdType="pubmed">22616830</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, H&#xe9;bert PC, Cooper DJ, et al; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87.</Citation><ArticleIdList><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Intravenous fluid therapy in adults in hospital. NICE clinical guideline 174 2013 (December): www.nice.org.uk/nicemedia/live/14330/66015/15.pdf.</Citation></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al; Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228. 10.1007/s00134-012-2769-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.</Citation><ArticleIdList><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopher KB, Reed GW, Nurok M, Moromizato T, Gibbons FK, Topulos GP. Change of serum albumin and risk of all-cause mortality in critical illness: a cohort study. Intensive Care Med 2012;38(suppl 1):1.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Artero A, Zaragoza R, Camarena JJ, Sancho S, Gonz&#xe1;lez R, Nogueira JM. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care 2010;25:276-81.</Citation><ArticleIdList><ArticleId IdType="pubmed">20149587</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidet B, Mosqueda GJ, Priol G, Aegerter P. The COASST study: cost-effectiveness of albumin in severe sepsis and septic shock. J Crit Care 2007;22:197-203.</Citation><ArticleIdList><ArticleId IdType="pubmed">17869969</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med 2006;34:2536-40.</Citation><ArticleIdList><ArticleId IdType="pubmed">16915107</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, et al; SAFE Study Investigators. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 2006;333:1044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1647335</ArticleId><ArticleId IdType="pubmed">17040925</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997;50:693-703.</Citation><ArticleIdList><ArticleId IdType="pubmed">9250267</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 2011;39:386-91.</Citation><ArticleIdList><ArticleId IdType="pubmed">21248514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Davey Smith G. Sifting the evidence-what&#x2019;s wrong with significance tests? BMJ 2001;322:226-31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1119478</ArticleId><ArticleId IdType="pubmed">11159626</ArticleId></ArticleIdList></Reference><Reference><Citation>Administration UFaD. FDA Safety Communication: Boxed Warning on increased mortality and severe renal injury, and additional warning on risk of bleeding, for use of hydroxyethyl starch solutions in some settings. 2013. www.fda.gov/biologicsbloodvaccines/safetyavailability/ucm358271.htm.</Citation></Reference><Reference><Citation>Agency EM. Hydroxyethyl-starch solutions (HES) no longer to be used in patients with sepsis or burn injuries or in critically ill patients. EMA/809470/2013 2013. www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Solutions_for_infusion_containing_hydroxyethyl_starch/European_Commission_final_decision/WC500162361.pdf.</Citation></Reference><Reference><Citation>Patel A, Waheed U, Brett SJ. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 2013;39:811-22.</Citation><ArticleIdList><ArticleId IdType="pubmed">23430019</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, &#xc5;neman A, et al; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer&#x2019;s acetate in severe sepsis. N Engl J Med 2012;367:124-34.</Citation><ArticleIdList><ArticleId IdType="pubmed">22738085</ArticleId></ArticleIdList></Reference><Reference><Citation>Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11289347</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S; CHEST Management Committee. Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013;39:558-68.</Citation><ArticleIdList><ArticleId IdType="pubmed">23407978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Joannidis M. Increased mortality after infusion of &#x201c;modern&#x201d; hydroxyethyl starch. Swiss Med Wkly 2013;143:w13747.</Citation><ArticleIdList><ArticleId IdType="pubmed">23348833</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013;309:678-88.</Citation><ArticleIdList><ArticleId IdType="pubmed">23423413</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Boldt: the great pretender. BMJ 2013;346:f1738.</Citation><ArticleIdList><ArticleId IdType="pubmed">23512099</ArticleId></ArticleIdList></Reference><Reference><Citation>Editors in chief statement regarding published clinical trials conducted without IRB approval by Joachim Boldt. 2011. www.aaeditor.org/EIC.Joint.Statement.on.Retractions.pdf.</Citation><ArticleIdList><ArticleId IdType="pubmed">21540815</ArticleId></ArticleIdList></Reference><Reference><Citation>Hospital L. Hospital Presents Results of Final Report: Committee Completes Investigation in the Case of Dr Boldt. 2012. www.klilu.de/content/veranstaltungen___presse/pressearchiv/2012/hospital_presents_results_of_final_report_committee_completes_investigation_in_the_case_of_dr_boldt/index_ger.html.</Citation></Reference><Reference><Citation>Leitch A, Craig G, Sadler P. Human albumin solution resuscitation in severe sepsis and septic shock. J Intensive Care Soc 2013;14:45-52.</Citation></Reference><Reference><Citation>Farrugia A, Bansal M, Balboni S, Kimber MC, Martin GS, Cassar J. Choice of fluids in severe septic patients - a cost-effectiveness analysis informed by recent clinical trials. Rev Recent Clin Trials 2013;9:21-30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4112378</ArticleId><ArticleId IdType="pubmed">24330133</ArticleId></ArticleIdList></Reference><Reference><Citation>Charpentier J, Mira JP, Group ES. Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study. Intensive Care Med 2011;37(suppl 1):S115.</Citation></Reference><Reference><Citation>Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al; ALBIOS Study Investigators. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014;370:1412-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">24635772</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, et al; UK Medical Research Council International Working Party. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 2001;29:880-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11373487</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.</Citation><ArticleIdList><ArticleId IdType="pubmed">1597042</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Cochrane Collaboration, 2011.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A, et al. Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 1993;269:2749-53.</Citation><ArticleIdList><ArticleId IdType="pubmed">8492400</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagiotou OA, Contopoulos-Ioannidis DG, Ioannidis JP, Rehnborg CF. Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment. BMJ 2013;346:f707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3570069</ArticleId><ArticleId IdType="pubmed">23403829</ArticleId></ArticleIdList></Reference><Reference><Citation>Onwuegbuzie AJ, Leech NL. Post hoc power: A concept whose time has come. Underst Stat 2004;3:201-30.</Citation></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.</Citation><ArticleIdList><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63.</Citation><ArticleIdList><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-33.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-29.</Citation><ArticleIdList><ArticleId IdType="pubmed">11106885</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Sch&#xfc;nemann HJ; GRADE Working Group. What is &#x201c;quality of evidence&#x201d; and why is it important to clinicians?. BMJ 2008;336:995-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2364804</ArticleId><ArticleId IdType="pubmed">18456631</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21:1559-73.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111920</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ 2013;346:f2304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3634626</ArticleId><ArticleId IdType="pubmed">23616031</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care 2013;17:R2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056100</ArticleId><ArticleId IdType="pubmed">23302257</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al; The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al; ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009;136(suppl):e28.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013;346:f839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3573769</ArticleId><ArticleId IdType="pubmed">23418281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care 2010;14:R191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219298</ArticleId><ArticleId IdType="pubmed">21029460</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Siami S, Jaber S, Martin C, Elatrous S, Decl&#xe8;re AD, et al; CRISTAL Investigators. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 2013;310:1809-17.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108515</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas-Rueddel DO, Vlasakov V, Reinhart K, Jaeschke R, Rueddel H, Hutagalung R, et al. Safety of gelatin for volume resuscitation--a systematic review and meta-analysis. Intensive Care Med 2012;38:1134-42.</Citation><ArticleIdList><ArticleId IdType="pubmed">22527076</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Brett SJ. Gelatin solutions for critically unwell septic adults. Br J Hosp Med (Lond) 2013;74:657.</Citation><ArticleIdList><ArticleId IdType="pubmed">24220537</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen IL. Guidelines for the use of innovative therapies in sepsis. Crit Care Med 1993;21:476-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8440122</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003;237:319-34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1514323</ArticleId><ArticleId IdType="pubmed">12616115</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Navickis RJ, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004;32:2029-38.</Citation><ArticleIdList><ArticleId IdType="pubmed">15483411</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?. Int J Epidemiol 2009;38:276-86.</Citation><ArticleIdList><ArticleId IdType="pubmed">18824467</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Engstr&#xf8;m J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA). Copenhagen Trial Unit. Centre for Clinical Intervention Research, 2011.</Citation></Reference><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 2008;61:64-75.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol 2009;9:86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2809074</ArticleId><ArticleId IdType="pubmed">20042080</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, Heesen M, M&#xfc;ller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996;83:254-61.</Citation><ArticleIdList><ArticleId IdType="pubmed">8694302</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, Heesen M, Welters I, Padberg W, Martin K, Hempelmann G. Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Br J Anaesth 1995;75:740-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8672323</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, M&#xfc;ller M, Heesen M, Heyn O, Hempelmann G. Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med 1996;22:1075-81.</Citation><ArticleIdList><ArticleId IdType="pubmed">8923073</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, Muller M, Heesen M, Neumann K, Hempelmann GG. Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 1996;24:385-91.</Citation><ArticleIdList><ArticleId IdType="pubmed">8625624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolecek M, Svoboda P, Kantorov&#xe1; I, Scheer P, Sas I, B&#xed;brov&#xe1; J, et al. Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. Hepatogastroenterology 2009;56:1622-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20214205</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman G, Jankowski S, Shahla M, Gomez J, Vincent JL. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients. J Clin Anesth 2008;20:528-33.</Citation><ArticleIdList><ArticleId IdType="pubmed">19019650</ArticleId></ArticleIdList></Reference><Reference><Citation>Haupt MT, Rackow EC. Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med 1982;10:159-62.</Citation><ArticleIdList><ArticleId IdType="pubmed">6174274</ArticleId></ArticleIdList></Reference><Reference><Citation>Metildi LA, Shackford SR, Virgilio RW, Peters RM. Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet 1984;158:207-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">6701732</ArticleId></ArticleIdList></Reference><Reference><Citation>Palumbo D, Servillo G, D&#x2019;Amato L, Volpe ML, Capogrosso G, De Robertis E, et al. The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol 2006;72:655-64.</Citation><ArticleIdList><ArticleId IdType="pubmed">16865084</ArticleId></ArticleIdList></Reference><Reference><Citation>Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, Haupt MT, et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983;11:839-50.</Citation><ArticleIdList><ArticleId IdType="pubmed">6194934</ArticleId></ArticleIdList></Reference><Reference><Citation>Rackow EC, Mecher C, Astiz ME, Griffel M, Falk JL, Weil MH. Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med 1989;17:394-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2468447</ArticleId></ArticleIdList></Reference><Reference><Citation>Trof RJ, Sukul SP, Twisk JW, Girbes AR, Groeneveld AB. Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia. Intensive Care Med 2010;36:697-701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2837190</ArticleId><ArticleId IdType="pubmed">20165941</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 2009;37:1275-81.</Citation><ArticleIdList><ArticleId IdType="pubmed">19242338</ArticleId></ArticleIdList></Reference><Reference><Citation>Veneman TF, Oude Nijhuis J, Woittiez AJ. Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial. Wien Klin Wochenschr 2004;116:305-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15237655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulanov AIu, Gorodetski&#x12d; VM, Shulutko EM, Vasil&#x2019;ev SA, Orel EB, Malofeev VN, et al. [Effect of different colloid volume-replacing solutions on a changed hemostasis system]. Anesteziol Reanimatol 2004;(2):25-30.</Citation><ArticleIdList><ArticleId IdType="pubmed">15206272</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernest D, Belzberg AS, Dodek PM. Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999;27:46-50.</Citation><ArticleIdList><ArticleId IdType="pubmed">9934892</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk JL, Rackow EC, Astiz ME, Weil MH. Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol 1988;28:412-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">2455740</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley EF, Borlase BC, Dzik WH, Bistrian BR, Benotti PN. Albumin supplementation in the critically ill. A prospective, randomized trial. Arch Surg 1990;125:739-42.</Citation><ArticleIdList><ArticleId IdType="pubmed">2111981</ArticleId></ArticleIdList></Reference><Reference><Citation>Golub R, Sorrento JJ Jr, Cantu R Jr, Nierman DM, Moideen A, Stein HD. Efficacy of albumin supplementation in the surgical intensive care unit: a prospective, randomized study. Crit Care Med 1994;22:613-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8143470</ArticleId></ArticleIdList></Reference><Reference><Citation>Gondos T, Marjanek Z, Ulakcsai Z, Szab&#xf3; Z, Bog&#xe1;r L, K&#xe1;rolyi M, et al. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesthesiol 2010;27:794-800.</Citation><ArticleIdList><ArticleId IdType="pubmed">20520555</ArticleId></ArticleIdList></Reference><Reference><Citation>Hondebrink Y, Jeekel L, Oude Nijhuis J, Woittiez AJJ. Restoration of colloid osmotic pressure in hypoalbuminaemic patients. Intensive Care Med 1997;23(supplement 1):S184.</Citation></Reference><Reference><Citation>Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002;30:2175-82.</Citation><ArticleIdList><ArticleId IdType="pubmed">12394941</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005;33:1681-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16096441</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre LA, Fergusson DA, Cook DJ, Rowe BH, Bagshaw SM, Easton D, et al; Canadian Critical Care Trials Group. Fluid Resuscitation with 5% albumin versus Normal Saline in Early Septic Shock: a pilot randomized, controlled trial. J Crit Care 2012;27:e1-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22176806</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JM, Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004;32:755-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15090958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin H, Carlson S, DeMeo M, Ganger D, Craig RM. Randomized, double-blind study of intravenous human albumin in hypoalbuminemic patients receiving total parenteral nutrition. Crit Care Med 1997;25:249-52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9034259</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell MA, Scott A, Day A, Riley B, Soni N. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia 1992;47:7-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1536412</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell MA, Soni N, Riley B. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline. 1. Outcome and duration of stay in the intensive care unit. Anaesthesia 1992;47:3-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1536399</ArticleId></ArticleIdList></Reference><Reference><Citation>Verheij J, van Lingen A, Beishuizen A, Christiaans HM, de Jong JR, Girbes AR, et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 2006;32:1030-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16791665</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojtysiak SL, Brown RO, Roberson D, Powers DA, Kudsk KA. Effect of hypoalbuminemia and parenteral nutrition on free water excretion and electrolyte-free water resorption. Crit Care Med 1992;20:164-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1737453</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Norton R, Bellomo R, Boyce N, French J, Myburgh J. The SAFE study: saline vs. albumin for fluid resuscitation in the critically ill. Vox Sang 2004;87(Suppl 2):123-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">15209896</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr W, Prowse C. Retraction: Finfer S, Norton R, Bellomo R, Boyce N, French J, Myburch J, on behalf of the SAFE Study Investigators. The SAFE study: saline vs. albumin for fluid resuscitation in the critically ill. Vox Sang 2004; 87 (Suppl. 2): S123-31. 2004;87:142.</Citation><ArticleIdList><ArticleId IdType="pubmed">15355508</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmer B, Hondebrink J, Oude Nijhuis J, Woittiez AJ. Restoration of colloid osmotic pressure in hypoalbuminaemic patients. Neth J Med 1998;52:A42.</Citation></Reference><Reference><Citation>Almeida A, Martin G, Hajjar L. Lactated Ringer Versus Albumin in Early Sepsis Therapy (RASP). 2013. http://clinicaltrials.gov/ct2/show/NCT01337934.</Citation></Reference><Reference><Citation>Wang Y, An YZ, Ma PL; China Critical Care Clinical Trial Group. Albumin for fluid resuscitation in patients with sepsis: what do we expect for? Chin Med J (Engl) 2013;126:3379-82.</Citation><ArticleIdList><ArticleId IdType="pubmed">24033969</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal M, Farrugia A, Balboni S, Martin G. Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies. Curr Drug Saf 2013;8:236-45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3856428</ArticleId><ArticleId IdType="pubmed">23909705</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15090974</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536-55.</Citation><ArticleIdList><ArticleId IdType="pubmed">14997291</ArticleId></ArticleIdList></Reference><Reference><Citation>Salerno F, Navickis RJ, Wilkes MM. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol 2013;11:123-30.</Citation><ArticleIdList><ArticleId IdType="pubmed">23178229</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui JY, Xu HL, Wang AT, Zhu X, Yao GQ, Liu F. [Influence of albumin as a resuscitation fluid on the prognosis of patients with sepsis: a Meta-analysis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2012;24:18-23.</Citation><ArticleIdList><ArticleId IdType="pubmed">22248746</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SG. Systematic review - why sources of heterogeneity in metaanalysis should be investigated. BMJ 1994;309:1351-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2541868</ArticleId><ArticleId IdType="pubmed">7866085</ArticleId></ArticleIdList></Reference><Reference><Citation>Schortgen F, Girou E, Deye N, Brochard L; CRYCO Study Group. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008;34:2157-68.</Citation><ArticleIdList><ArticleId IdType="pubmed">18685828</ArticleId></ArticleIdList></Reference><Reference><Citation>LeLorier J, Gr&#xe9;goire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-42.</Citation><ArticleIdList><ArticleId IdType="pubmed">9262498</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin--serious adverse events reported worldwide in 1998-2000. Br J Anaesth 2003;91:625-30.</Citation><ArticleIdList><ArticleId IdType="pubmed">14570782</ArticleId></ArticleIdList></Reference><Reference><Citation>von Hoegen I, Waller C. Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med 2001;29:994-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11378610</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor E. The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1. Transfusion 1999;39:1160-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10604241</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, Muller M, Mentges D, Papsdorf M, Hempelmann G. Retraction note: Volume therapy in the critically ill: is there a difference? Intensive Care Med 2014;40:145.</Citation><ArticleIdList><ArticleId IdType="pubmed">9503219</ArticleId></ArticleIdList></Reference><Reference><Citation>Notice of formal retraction of an article by Dr Joachim Boldt. Br J Anaesth 2014;112:397.</Citation><ArticleIdList><ArticleId IdType="pubmed">24431372</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartog CS, Brunkhorst FM, Bloos F, Bogatsch H, Engel C, Sengebusch K, et al. Practice of volume therapy in patients with severe sepsis: results from a nationwide sepsis prevalence study. Intensive Care Med 2010;36:553-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">19953220</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JM. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998;95:459-65.</Citation><ArticleIdList><ArticleId IdType="pubmed">9748422</ArticleId></ArticleIdList></Reference><Reference><Citation>British National Formulary (BNF). 65 ed. BMJ Group, Pharmaceutical Press, 2013.</Citation></Reference><Reference><Citation>Bar-Or D, Bar-Or R, Rael LT, Gardner DK, Slone DS, Craun ML. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005;33:1638-41.</Citation><ArticleIdList><ArticleId IdType="pubmed">16003075</ArticleId></ArticleIdList></Reference><Reference><Citation>Matejtschuk P, Dash CH, Gascoigne EW. Production of human albumin solution: a continually developing colloid. Br J Anaesth 2000;85:887-95.</Citation><ArticleIdList><ArticleId IdType="pubmed">11732525</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre L, Fergusson DA, Rowe B, Cook DJ, Arabi Y, Bagshaw SM, et al; Canadian Critical Care Trials Group. The PRECISE RCT: evolution of an early septic shock fluid resuscitation trial. Transfus Med Rev 2012;26:333-41.</Citation><ArticleIdList><ArticleId IdType="pubmed">22222146</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36645804</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>138</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Postoperative Pulmonary Complications in the ENIGMA II Trial: A Post Hoc Analysis.</ArticleTitle><Pagination><StartPage>354</StartPage><EndPage>363</EndPage><MedlinePgn>354-363</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000004497</ELocationID><Abstract><AbstractText Label="BACKGROUND">Nitrous oxide promotes absorption atelectasis in poorly ventilated lung segments at high inspired concentrations. The Evaluation of Nitrous oxide In the Gas Mixture for Anesthesia (ENIGMA) trial found a higher incidence of postoperative pulmonary complications and wound sepsis with nitrous oxide anesthesia in major surgery compared to a fraction of inspired oxygen of 0.8 without nitrous oxide. The larger ENIGMA II trial randomized patients to nitrous oxide or air at a fraction of inspired oxygen of 0.3 but found no effect on wound infection or sepsis. However, postoperative pulmonary complications were not measured. In the current study, post hoc data were collected to determine whether atelectasis and pneumonia incidences were higher with nitrous oxide in patients who were recruited to the Australian cohort of ENIGMA II.</AbstractText><AbstractText Label="METHODS">Digital health records of patients who participated in the trial at 10 Australian hospitals were examined blinded to trial treatment allocation. The primary endpoint was the incidence of atelectasis, defined as lung atelectasis or collapse reported on chest radiology. Pneumonia, as a secondary endpoint, required a diagnostic chest radiology report with fever, leukocytosis, or positive sputum culture. Comparison of the nitrous oxide and nitrous oxide-free groups was done according to intention to treat using chi-square tests.</AbstractText><AbstractText Label="RESULTS">Data from 2,328 randomized patients were included in the final data set. The two treatment groups were similar in surgical type and duration, risk factors, and perioperative management recorded for ENIGMA II. There was a 19.3% lower incidence of atelectasis with nitrous oxide (171 of 1,169 [14.6%] vs. 210 of 1,159 [18.1%]; odds ratio, 0.77; 95% CI, 0.62 to 0.97; P = 0.023). There was no difference in pneumonia incidence (60 of 1,169 [5.1%] vs. 52 of 1159 [4.5%]; odds ratio, 1.15; 95% CI, 0.77 to 1.72; P = 0.467) or combined pulmonary complications (odds ratio, 0.84; 95% CI, 0.69 to 1.03; P = 0.093).</AbstractText><AbstractText Label="CONCLUSIONS">In contrast to the earlier ENIGMA trial, nitrous oxide anesthesia in the ENIGMA II trial was associated with a lower incidence of lung atelectasis, but not pneumonia, after major surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, the American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0003-1185-2869</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia; and the Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liskaser</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsh</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etherington</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Barwon Health, Geelong, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torlot</LastName><ForeName>Frederick</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Perth Hospital, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Manisha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Fremantle Hospital, Fremantle, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrett</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Westmead Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chee</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia; the Royal Melbourne Hospital, Parkville, Victoria, Australia; and Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Perioperative Medicine, The Alfred, Melbourne, Victoria, Australia; and Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>K50XQU1029</RegistryNumber><NameOfSubstance UI="D009609">Nitrous Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009609" MajorTopicYN="N">Nitrous Oxide</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001261" MajorTopicYN="Y">Pulmonary Atelectasis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>16</Day><Hour>13</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36645804</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000004497</ArticleId><ArticleId IdType="pii">137556</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36474639</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2516-5410</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>World journal of pediatric surgery</Title><ISOAbbreviation>World J Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>Perioperative mortality in children in a tertiary teaching hospital in Nigeria: a prospective study.</ArticleTitle><Pagination><StartPage>e000237</StartPage><MedlinePgn>e000237</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e000237</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/wjps-2020-000237</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Perioperative mortality is one of the tools that can help to assess the adequacy of healthcare delivery in a nation. This audit was conducted to determine the 24-hour, 7-day and 30-day perioperative mortality rates and the predictors of mortality in a pediatric surgical cohort.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a prospective study of children whose ages ranged from a few hours to 15 years and who were operated on between May 2019 and April 2020. The primary outcome was to determine the incidence of in-hospital perioperative mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 530 procedures were done in 502 children. Their ages ranged from a few hours to 15 years with a median of 36 months. The 24-hour, 7-day and 30-day mortality rates were 113.2 per 10&#x2009;000 procedures [95% confidence interval (CI) =40 to 210], 207.6 per 10&#x2009;000 procedures (95% CI=110 to 320) and 320.8 per 10&#x2009;000 procedures (95% CI=190 to 470), respectively. Congenital anomalies complicated by postoperative sepsis contributed to death in the majority of cases. The predictors of mortality were neonatal age group [adjusted odds ratio (AOR)=19.92, 95% CI=2.32 to 170.37, p=0.006], higher American Society of Anesthesiologists Physical Status III and above (AOR=21.6, 95% CI=3.05 to 152.91, p=0.002), emergency surgery (AOR=17.1, 95% CI=5.21 to 60.27, p=0.001), congenital anomalies (AOR=12.7, 95% CI=3.37 to 47.52, p=0.001), and multiple surgical procedures (AOR=9.7, 95% CI=2.79 to 33.54, p=0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Perioperative mortality remains high in our institution.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Talabi</LastName><ForeName>Ademola Olusegun</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojo</LastName><ForeName>Olugbenga Olalekan</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aaron</LastName><ForeName>Olurotimi Idowu</ForeName><Initials>OI</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Obafemi Awolowo University/Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sowande</LastName><ForeName>Oludayo Adedapo</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faponle</LastName><ForeName>Folayemi Aramide</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Obafemi Awolowo University/Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adejuyigbe</LastName><ForeName>Olusanya</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>World J Pediatr Surg</MedlineTA><NlmUniqueID>101761337</NlmUniqueID><ISSNLinking>2516-5410</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthetics</Keyword><Keyword MajorTopicYN="N">sudden infant death</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>7</Day><Hour>2</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36474639</ArticleId><ArticleId IdType="pmc">PMC9716982</ArticleId><ArticleId IdType="doi">10.1136/wjps-2020-000237</ArticleId><ArticleId IdType="pii">wjps-2020-000237</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiser TG, Regenbogen SE, Thompson KD, et al. . An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008;372:139&#x2013;44. 10.1016/S0140-6736(08)60878-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60878-8</ArticleId><ArticleId IdType="pubmed">18582931</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Groen RS, Kyamanywa P, et al. . Surgical care needs of low-resource populations: an estimate of the prevalence of surgically treatable conditions and avoidable deaths in 48 countries. Lancet 2015;385:S1. 10.1016/S0140-6736(15)60796-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60796-6</ArticleId><ArticleId IdType="pubmed">26313055</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies JF, Lenglet A, van Wijhe M, et al. . Perioperative mortality: analysis of 3 years of operative data across 7 general surgical projects of M&#xe9;decins sans Fronti&#xe8;res in Democratic Republic of Congo, central African Republic, and South Sudan. Surgery 2016;159:1269&#x2013;78. 10.1016/j.surg.2015.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2015.12.022</ArticleId><ArticleId IdType="pubmed">26883163</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton MW, Hurt SE, McEvoy MD, et al. . Pediatric perioperative mortality in Kenya: a prospective cohort study from 24 hospitals. Anesthesiology 2020;132:452&#x2013;60. 10.1097/ALN.0000000000003070</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003070</ArticleId><ArticleId IdType="pubmed">31809324</ArticleId></ArticleIdList></Reference><Reference><Citation>Torborg A, Cronje L, Thomas J, et al. . South African Paediatric Surgical Outcomes Study: a&#xa0;14-day prospective, observational cohort study of paediatric surgical patients. Br J Anaesth 2019;122:224&#x2013;32. 10.1016/j.bja.2018.11.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.11.015</ArticleId><ArticleId IdType="pubmed">30686308</ArticleId></ArticleIdList></Reference><Reference><Citation>Faponle AF, Sowande OA, Adejuyigbe O. Anaesthesia for neonatal surgical emergencies in a semi-urban Hospital, Nigeria. East Afr Med J 2004;81:568&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15868965</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirdan LB, Ngiloi PJ, Elhalaby EA. Neonatal surgery in Africa. Semin Pediatr Surg 2012;21:151&#x2013;9. 10.1053/j.sempedsurg.2012.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.sempedsurg.2012.01.007</ArticleId><ArticleId IdType="pubmed">22475121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekenze SO, Modekwe VO, Ajuzieogu OV, et al. . Neonatal surgery in a developing country: outcome of co-ordinated interdisciplinary collaboration. J Paediatr Child Health 2017;53:976&#x2013;80. 10.1111/jpc.13610</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.13610</ArticleId><ArticleId IdType="pubmed">28600851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekeke ON, Okonta KE, Igwe PO. Surgical inpatient mortality in a Nigerian tertiary hospital. Niger J Clin Pract 2016;19:308&#x2013;12. 10.4103/1119-3077.179286</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1119-3077.179286</ArticleId><ArticleId IdType="pubmed">27022789</ArticleId></ArticleIdList></Reference><Reference><Citation>GlobalSurg Collaborative . Determinants of morbidity and mortality following emergency abdominal surgery in children in low-income and middle-income countries. BMJ Glob Health 2016;1:000091. 10.1136/bmjgh-2016-000091</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2016-000091</ArticleId><ArticleId IdType="pmc">PMC5321375</ArticleId><ArticleId IdType="pubmed">28588977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng-Kamstra JS, Greenberg SLM, Kotagal M, et al. . Use and definitions of perioperative mortality rates in low-income and middle-income countries: a systematic review. Lancet 2015;385:S29. 10.1016/S0140-6736(15)60824-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60824-8</ArticleId><ArticleId IdType="pubmed">26313076</ArticleId></ArticleIdList></Reference><Reference><Citation>Watters DA, Hollands MJ, Gruen RL, et al. . Perioperative mortality rate (POMR): a global indicator of access to safe surgery and anaesthesia. World J Surg 2015;39:856&#x2013;64. 10.1007/s00268-014-2638-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-014-2638-4</ArticleId><ArticleId IdType="pubmed">24841805</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbilgic O, Langham MR, Walter AI, et al. . A novel risk classification system for 30-day mortality in children undergoing surgery. PLoS One 2018;13:e0191176. 10.1371/journal.pone.0191176</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0191176</ArticleId><ArticleId IdType="pmc">PMC5774754</ArticleId><ArticleId IdType="pubmed">29351327</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonasso PC, Dassinger MS, Ryan ML, et al. . 24-Hour and 30-day perioperative mortality in pediatric surgery. J Pediatr Surg 2019;54:628&#x2013;30. 10.1016/j.jpedsurg.2018.06.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2018.06.026</ArticleId><ArticleId IdType="pubmed">30017066</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston MH, DCruz J, Pemberton J, et al. . Mortality of pediatric surgical conditions in low and middle income countries in Africa. J Pediatr Surg 2015;50:760&#x2013;4. 10.1016/j.jpedsurg.2015.02.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2015.02.031</ArticleId><ArticleId IdType="pubmed">25783373</ArticleId></ArticleIdList></Reference><Reference><Citation>Talabi AO, Sowande OA, Adenekan AT, et al. . A 10-year retrospective review of perioperative mortality in pediatric general surgery at Ile-Ife Hospital, Nigeria. J Pediatr Surg 2018;53:2072&#x2013;6. 10.1016/j.jpedsurg.2018.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2018.03.005</ArticleId><ArticleId IdType="pubmed">29606409</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudziak J, Snock C, Phiri TZ, et al. . Pre-Existing malnutrition increases operative mortality in a sub-Saharan Africa burn unit. J Am Coll Surg 2017;225:S107. 10.1016/j.jamcollsurg.2017.07.237</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2017.07.237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sowande OA, Ogundoyin OO, Adejuyigbe O. Pattern and factors affecting management outcome of neonatal emergency surgery in Ile-Ife, Nigeria. Surgical Practice 2007;11:71&#x2013;5. 10.1111/j.1744-1633.2007.00341.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1744-1633.2007.00341.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Osifo OD, Okolo JC. Neonatal intestinal obstruction in Benin, Nigeria. Afr J Paediatr Surg 2009;6:98&#x2013;101. 10.4103/0189-6725.54772</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0189-6725.54772</ArticleId><ArticleId IdType="pubmed">19661639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ademuyiwa AO, Sowande OA, Ijaduola TK, et al. . Determinants of mortality in neonatal intestinal obstruction in Ile Ife, Nigeria. Afr J Paediatr Surg 2009;6:11&#x2013;13. 10.4103/0189-6725.48568</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0189-6725.48568</ArticleId><ArticleId IdType="pubmed">19661658</ArticleId></ArticleIdList></Reference><Reference><Citation>Putzu A, Calderine E, Camarda V. Unreported deaths in pediatric surgery and anesthesia: a national, twenty year report. Signa Vitae 2016;12:101&#x2013;5. 10.22514/SV121.102016.17</Citation><ArticleIdList><ArticleId IdType="doi">10.22514/SV121.102016.17</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bruin L, Pasma W, van der Werff DBM, et al. . Perioperative hospital mortality at a tertiary paediatric institution. Br J Anaesth 2015;115:608&#x2013;15. 10.1093/bja/aev286</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aev286</ArticleId><ArticleId IdType="pubmed">26385669</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Griend BF, Lister NA, McKenzie IM, et al. . Postoperative mortality in children after 101,885 anesthetics at a tertiary pediatric hospital. Anesth Analg 2011;112:1440&#x2013;7. 10.1213/ANE.0b013e318213be52</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e318213be52</ArticleId><ArticleId IdType="pubmed">21543787</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasr VG, DiNardo JA, Faraoni D. Development of a pediatric risk assessment score to predict perioperative mortality in children undergoing noncardiac surgery. Anesth Analg 2017;124:1514&#x2013;9. 10.1213/ANE.0000000000001541</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001541</ArticleId><ArticleId IdType="pubmed">27575562</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez LP, Pignaton W, Kusano PS, et al. . Anesthesia-related mortality in pediatric patients: a systematic review. Clinics 2012;67:381&#x2013;7. 10.6061/clinics/2012(04)12</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2012(04)12</ArticleId><ArticleId IdType="pmc">PMC3317253</ArticleId><ArticleId IdType="pubmed">22522764</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg AC, Huang L, Jiang H, et al. . Perioperative risk factors for major complications in pediatric surgery: a study in surgical risk assessment for children. J Am Coll Surg 2011;212:768&#x2013;78. 10.1016/j.jamcollsurg.2011.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2011.02.006</ArticleId><ArticleId IdType="pubmed">21435918</ArticleId></ArticleIdList></Reference><Reference><Citation>Pignaton W, Braz JRC, Kusano PS. Perioperative and anaesthesia-related death: an 8-year observational survey from a tertiary teaching hospital. Medicine 2016;85:e2208. 10.1097/MD.0000000000002208</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000002208</ArticleId><ArticleId IdType="pmc">PMC4718226</ArticleId><ArticleId IdType="pubmed">26765400</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyedepo OO, Nasir AA, Ige OA. Anaesthetic outcomes in neonatal surgical care in a tertiary health facility in Nigeria. Sierra Leone J Biomed Res 2019;11:23&#x2013;8.</Citation></Reference><Reference><Citation>Cronj&#xe9; L. A review of paediatric anaesthetic-related mortality, serious adverse events and critical incidents. South Africa J Anaesth Analg 2015;21:147&#x2013;53. 10.1080/22201181.2015.1119503</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22201181.2015.1119503</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis SJ, Newland MC, Simonson JA, et al. . Anesthesia-related cardiac arrest. Anesthesiology 2014;120:829&#x2013;38. 10.1097/ALN.0000000000000153</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000153</ArticleId><ArticleId IdType="pubmed">24496124</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22116442</PMID><DateCompleted><Year>2012</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0065-1419</ISSN><JournalIssue CitedMedium="Print"><Volume>113</Volume><PubDate><Year>2012</Year></PubDate></JournalIssue><Title>Acta neurochirurgica. Supplement</Title><ISOAbbreviation>Acta Neurochir Suppl</ISOAbbreviation></Journal><ArticleTitle>Complications of endoscopic third ventriculostomy: a systematic review.</ArticleTitle><Pagination><StartPage>149</StartPage><EndPage>153</EndPage><MedlinePgn>149-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-3-7091-0923-6_30</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Endoscopic third ventriculostomy (ETV) is an established treatment for hydrocephalus. Most studies focus on success rates, and complications are insufficiently charted. The aim of this study was to perform a systematic review of ETV complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A Medline search discovered 24 series of ETV (seven in children, five in adults, and 12 in a mixed-age group) with detailed complications reports.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The analysis included 2,672 ETVs performed on 2,617 patients. The cause of hydrocephalus was aqueductal stenosis in 25.9%, tumor 37.0%, meningomyelocele-Chiari II 6.1%, posthemorrhagic 5.8%, postinfectious 1.4%, cysts 3.3%, Chiari I 0.4%, Dandy-Walker malformation 0.3%, cerebellar infarct 0.9%, normal pressure hydrocephalus 1.3%, and not recorded 16.8%. Overall complication rate was 8.8%. Permanent morbidity was 2.1%, neurologic in 1.2% (hemiparesis, gaze palsy, memory disorders, and/or altered consciousness), hypothalamic in 0.9% (diabetes insipidus, weight gain, or precocious puberty). Intraoperative hemorrhage was present in 3.9%, severe in 0.6% (including four cases [0.14%] of basilar rupture). Other surgical complications were 1.13% (three thalamic infarcts, six subdural, six intracerebral, and two epidural hematomas). Cerebrospinal fluid (CSF) infections occurred in 1.8%, CSF leak in 1.7%, anesthetic complications (bradycardia and hypotension) in 0.19% of cases. Postoperative mortality was 0.22% (six patients; sepsis two, hemorrhage three, and thalamic injury one). Another two children suffered delayed "sudden death" (after 25 and 60 months), caused by acute hydrocephalus due to stoma occlusion. There were no differences between pediatric and adult patients or short and long series (cutoff 100 patients). All deaths were reported in long series. Complication rates were insignificantly higher in short series.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Permanent morbidity after ETV is 2.1%, mortality is 0.22%. The incidence of delayed "sudden death" is 0.07%.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bouras</LastName><ForeName>Triantafyllos</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sgouros</LastName><ForeName>Spyros</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Acta Neurochir Suppl</MedlineTA><NlmUniqueID>100962752</NlmUniqueID><ISSNLinking>0065-1419</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006849" MajorTopicYN="N">Hydrocephalus</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020542" MajorTopicYN="N">Third Ventricle</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014696" MajorTopicYN="N">Ventriculostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22116442</ArticleId><ArticleId IdType="doi">10.1007/978-3-7091-0923-6_30</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40326905</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1119-3077</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Nigerian journal of clinical practice</Title><ISOAbbreviation>Niger J Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Pediatric Perioperative Mortality in Southeastern (SE) Nigeria-A Multicenter, Prospective Study.</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>231</EndPage><MedlinePgn>225-231</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/njcp.njcp_695_24</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The perioperative mortality rate is a key indicator of the quality of surgical services in low and middle-income countries (LMIC). Objective: To determine the perioperative mortality rate of pediatric surgical conditions and the predictive factors in Southeastern Nigeria. Methodology: A prospective, multicenter study of peri-operative mortalities occurring in children under 18 years in five tertiary hospitals in Southeastern Nigeria over nine months was conducted. All-cause and case-specific in-hospital peri-operative mortality rates, as well as predictive factors, were identified. The mortality rate was expressed as percentages with a 95% confidence interval. The data were analyzed using SPSS 26.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 775 patients underwent anesthesia or surgery, with 28 deaths. The 30-day perioperative mortality rate was 3.61% (95% CI = 2.41- 5.18); 1.94% (95% CI = 1.09-3.17 within 24 hours, and 1.17% (95% CI = 0.91-2.91) from 24 hours to 30 days after the procedure. The mortality rate was 100% for gastroschisis and ruptured omphalocele, with overwhelming sepsis being the major cause of death (53.6%). Significant determinants of mortality were a higher ASA status (AOR)=13.944, 95% CI=1.509-128.851, p=0.020, sedation without ventilatory support (AOR)=15.295, 95% CI=3.304-70.800, p=0.001, and associated comorbidities (AOR)=65.448, 95% CI=11.244-380.962, p=0.001.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The pediatric peri-operative mortality rate in Southeastern Nigeria is high for gastroschisis. Associated comorbidities, higher ASA status, and sedation without ventilatory support were significant predictors ofmortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Nigerian Journal of Clinical Practice.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nwankwo</LastName><ForeName>E P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, College of Medicine, University of Nigeria Nsukka, Enugu State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onyejesi</LastName><ForeName>D C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, College of Medicine, University of Nigeria Nsukka, Enugu State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chukwu</LastName><ForeName>I S</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Federal Medical Center, Umuahia, Abia State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modekwe</LastName><ForeName>V I</ForeName><Initials>VI</Initials><AffiliationInfo><Affiliation>Department of Surgery, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwangwu</LastName><ForeName>E I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, College of Medicine, University of Nigeria Nsukka, Enugu State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Federal Medical Center, Owerri, Imo State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezomike</LastName><ForeName>U O</ForeName><Initials>UO</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, College of Medicine, University of Nigeria Nsukka, Enugu State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omebe</LastName><ForeName>S E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekenze</LastName><ForeName>S O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, College of Medicine, University of Nigeria Nsukka, Enugu State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aliozor</LastName><ForeName>S C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Surgery, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aniwada</LastName><ForeName>E C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, College of Medicine, University of Nigeria Nsukka, Enugu State, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Niger J Clin Pract</MedlineTA><NlmUniqueID>101150032</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="Y">Perioperative Period</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>6</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>6</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>6</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40326905</ArticleId><ArticleId IdType="doi">10.4103/njcp.njcp_695_24</ArticleId><ArticleId IdType="pii">01253091-202502000-00014</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Rose J, Weiser TG, Hider P, Wilson L, Gruen RL, Bickler SW. Estimated need for surgery worldwide based on prevalence of diseases: A modelling strategy for the WHO Global Health Estimate. Lancet Glob Health 2015;3:S13&#x2013;20.</Citation></Reference><Reference><Citation>Linden AF, Sekidde FS, Galukande M, Knowlton LM, Chackungal S, McQueen KK. Challenges of surgery in developing countries: A survey of surgical and anesthesia capacity in Uganda&#x2019;s public hospitals. World J Surg 2012;36:1056&#x2013;65.</Citation></Reference><Reference><Citation>Bickler SW, Rode H. Surgical services for children in developing countries. Bull the World Health Org 2002;80:829&#x2013;35.</Citation></Reference><Reference><Citation>Ng-Kamstra JS, Arya S, Greenberg SL, Kotagal M, Arsenault C, Ljungman D, et al. Perioperative mortality rates in low-income and middle-income countries: A systematic review and meta-analysis. BMJ Glob Health 2018;3:e000810.</Citation></Reference><Reference><Citation>Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, et al. Global Surgery 2030: Evidence and solutions for achieving health, welfare, and economic development. Lancet 2015;386:569&#x2013;624.</Citation></Reference><Reference><Citation>de Bruin L, Pasma W, Van Der Werff DB, Schouten TA, Haas F, Van Der Zee DC, et al. Perioperative hospital mortality at a tertiary paediatric institution. Br J Anaesth 2015;115:608&#x2013;15.</Citation></Reference><Reference><Citation>Watters DA, Hollands MJ, Gruen RL, Maoate K, Perndt H, McDougall RJ, et al. Perioperative mortality rate (POMR): A global indicator of access to safe surgery and anaesthesia. World J Surg 2015;39:856&#x2013;64.</Citation></Reference><Reference><Citation>Putzu A, Calderini E, Camarda V, Landoni G. Unreported deaths in pediatric surgery and anesthesia: A national, twenty-year report. Signa Vitae 2016;12:101&#x2013;5.</Citation></Reference><Reference><Citation>Bonasso PC, Dassinger MS, Ryan ML, Gowen MS, Burford JM, Smith SD. 24-hour and 30-day perioperative mortality in pediatric surgery. J Pediatr Surg 2019;54:628&#x2013;30.</Citation></Reference><Reference><Citation>Talabi AO, Ojo OO, Aaron OI, Sowande OA, Faponle FA, Adejuyigbe O. Perioperative mortality in children in a tertiary teaching hospital in Nigeria: A prospective study. World J of Pediatr Surg 2021;4:e000237.</Citation></Reference><Reference><Citation>Newton MW, Hurt SE, McEvoy MD, Shi Y, Shotwell MS, Kamau J, et al. Pediatric perioperative mortality in Kenya: A prospective cohort study from 24 hospitals. Anesthesiology 2020;132:452&#x2013;60.</Citation></Reference><Reference><Citation>Wright NJ, Leather AJ, Ade-Ajayi N, Sevdalis N, Davies J, Poenaru D, et al. Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: A multicentre, international, prospective cohort study. Lancet 2021;398:325&#x2013;39.</Citation></Reference><Reference><Citation>Anyanwu LC, Ade-Ajayi N, Rolle U. Major abdominal wall defects in the low- and middle-income setting: Current status and priorities. Pediatr Surg Int 2020;36:579&#x2013;90.</Citation></Reference><Reference><Citation>Georgeades C, Mowrer A, Ortega G, Abdullah F, Salazar JH. Improved mortality of patients with gastroschisis: A historical literature review of advances in surgery and critical care from 1960&#x2013;2020. Children 2022;9:1504.</Citation></Reference><Reference><Citation>Puri A, Lal B, Nangia S. A pilot study on neonatal surgical mortality: A multivariable analysis of predictors of mortality in a resource-limited setting. J Indian Assoc Pediatr Surg 2019;24:36.</Citation></Reference><Reference><Citation>Tangel VE, Krul SD, Stolker RJ, Bramaer WM, de Graaf JC, Hoeks SE. Perioperative mortality in pediatric patients: A systematic review of risk assessment tools for use in the preoperative setting. Anesthesiology 2022;1;137:555&#x2013;67.</Citation></Reference><Reference><Citation>Hasan MS, Islam N, Mitul AR. Neonatal surgical morbidity and mortality at a single tertiary center in a low-and middle-income country: A retrospective study of clinical outcomes. Front Surg 2022;9:15.</Citation></Reference><Reference><Citation>Ammar S, Sellami S, Sellami I, Hamad AB, Hbaieb M, Jarraya A, et al. Risk factors of early mortality after neonatal surgery in Tunisia. J Pediatr Surg 2020;55:2233&#x2013;7.</Citation></Reference><Reference><Citation>Badawi N, Adelson P, Roberts C, Spence K, Laing S, Cass D. Neonatal surgery in New South Wales&#x2014;What is performed where?. J Pediatr Surg 2003;38:1025&#x2013;31.</Citation></Reference><Reference><Citation>Yagi M, Kohno M, Asagiri K, Ikeda T, Okada T, Kanada S, et al. Twenty-year trends in neonatal surgery based on a nationwide Japanese surveillance program. Pediatr Surg Int 2015;31:955&#x2013;62.</Citation></Reference><Reference><Citation>Bucher BT, Duggan EM, Grubb PH, France DJ, Lally KP, Blakely ML. Does the american college of surgeons national surgical quality improvement program pediatric provide actionable quality improvement data for surgical neonates?. J Pediatr Surg 2016;51:1440&#x2013;4.</Citation></Reference><Reference><Citation>Crombleholme TM, D&#x2019;Alton M, Cendron M, Alman B, Goldberg MD, Klauber GT, et al. Prenatal diagnosis and the pediatric surgeon: The impact of prenatal consultation on perinatal management. J Pediatr Surg 1996;31:156&#x2013;63.</Citation></Reference><Reference><Citation>Arunda M, Emmelin A, Asamoah BO. Effectiveness of antenatal care services in reducing neonatal mortality in Kenya: Analysis of national survey data. Glob Health Action 2017;10:1328796.</Citation></Reference><Reference><Citation>Livingston MH, DCruz J, Pemberton J, Ozgediz D, Poenaru D. Mortality of pediatric surgical conditions in low- and middle-income countries in Africa. J Pediatr Surg 2015;50:760&#x2013;4.</Citation></Reference><Reference><Citation>Flores-P&#xe9;rez C, Moreno-Rocha LA, Ch&#xe1;vez-Pacheco JL, Noguez-M&#xe9;ndez NA, Flores-P&#xe9;rez J, Alc&#xe1;ntara-Morales MF, et al. Sedation level with midazolam: A pediatric surgery approach. Saudi Pharm J 2022;30:906&#x2013;17.</Citation></Reference><Reference><Citation>Nasr VG, Staffa SJ, Zurakowski D, DiNardo JA, Faraoni D. Pediatric risk stratification is improved by integrating both patient comorbidities and intrinsic surgical risk. Anesthesiology 2019;130:971&#x2013;80.</Citation></Reference><Reference><Citation>Evans FM, Wake PB, Gathuya ZN, McDougall RJ. Access to safe pediatric anesthesia in LMICs&#x2014;the problem is clear; it is time to solve it!. Anesth Analg 2022;134:724&#x2013;7.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>